Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'ipilimumab'
(id=4345283 ; fe=ipilimumab ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=122406 creation date=2017-02-12 touchdate=2025-07-30 12:43:04.000)
≈ 6033 relations sortantes

  1. ipilimumab -- r_associated #0: 458 / 1 -> médecine
    n1=ipilimumab | n2=médecine | rel=r_associated | relid=0 | w=458
  2. ipilimumab -- r_associated #0: 109 / 0.238 -> en:absorbable adhesion barrier gel
    n1=ipilimumab | n2=en:absorbable adhesion barrier gel | rel=r_associated | relid=0 | w=109
  3. ipilimumab -- r_associated #0: 109 / 0.238 -> en:acetohexamide
    n1=ipilimumab | n2=en:acetohexamide | rel=r_associated | relid=0 | w=109
  4. ipilimumab -- r_associated #0: 109 / 0.238 -> en:alk inhibitor x-396
    n1=ipilimumab | n2=en:alk inhibitor x-396 | rel=r_associated | relid=0 | w=109
  5. ipilimumab -- r_associated #0: 109 / 0.238 -> en:aminoglutethimide
    n1=ipilimumab | n2=en:aminoglutethimide | rel=r_associated | relid=0 | w=109
  6. ipilimumab -- r_associated #0: 109 / 0.238 -> en:anti-cd33 monoclonal antibody-dm4 conjugate ave9633
    n1=ipilimumab | n2=en:anti-cd33 monoclonal antibody-dm4 conjugate ave9633 | rel=r_associated | relid=0 | w=109
  7. ipilimumab -- r_associated #0: 109 / 0.238 -> en:anti-dll4 monoclonal antibody regn421
    n1=ipilimumab | n2=en:anti-dll4 monoclonal antibody regn421 | rel=r_associated | relid=0 | w=109
  8. ipilimumab -- r_associated #0: 109 / 0.238 -> en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ t-lymphocytes jcar017
    n1=ipilimumab | n2=en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ t-lymphocytes jcar017 | rel=r_associated | relid=0 | w=109
  9. ipilimumab -- r_associated #0: 109 / 0.238 -> en:autologous ebv-ctl cd19car zeta
    n1=ipilimumab | n2=en:autologous ebv-ctl cd19car zeta | rel=r_associated | relid=0 | w=109
  10. ipilimumab -- r_associated #0: 109 / 0.238 -> en:azimexon
    n1=ipilimumab | n2=en:azimexon | rel=r_associated | relid=0 | w=109
  11. ipilimumab -- r_associated #0: 109 / 0.238 -> en:budesonide
    n1=ipilimumab | n2=en:budesonide | rel=r_associated | relid=0 | w=109
  12. ipilimumab -- r_associated #0: 109 / 0.238 -> en:capmatinib
    n1=ipilimumab | n2=en:capmatinib | rel=r_associated | relid=0 | w=109
  13. ipilimumab -- r_associated #0: 109 / 0.238 -> en:carbon c 13 phytofluene
    n1=ipilimumab | n2=en:carbon c 13 phytofluene | rel=r_associated | relid=0 | w=109
  14. ipilimumab -- r_associated #0: 109 / 0.238 -> en:cdc7 kinase inhibitor nms-1116354
    n1=ipilimumab | n2=en:cdc7 kinase inhibitor nms-1116354 | rel=r_associated | relid=0 | w=109
  15. ipilimumab -- r_associated #0: 109 / 0.238 -> en:cdk4/6 inhibitor shr6390
    n1=ipilimumab | n2=en:cdk4/6 inhibitor shr6390 | rel=r_associated | relid=0 | w=109
  16. ipilimumab -- r_associated #0: 109 / 0.238 -> en:clioquinol
    n1=ipilimumab | n2=en:clioquinol | rel=r_associated | relid=0 | w=109
  17. ipilimumab -- r_associated #0: 109 / 0.238 -> en:enadenotucirev
    n1=ipilimumab | n2=en:enadenotucirev | rel=r_associated | relid=0 | w=109
  18. ipilimumab -- r_associated #0: 109 / 0.238 -> en:ethambutol
    n1=ipilimumab | n2=en:ethambutol | rel=r_associated | relid=0 | w=109
  19. ipilimumab -- r_associated #0: 109 / 0.238 -> en:fludarabine phosphate
    n1=ipilimumab | n2=en:fludarabine phosphate | rel=r_associated | relid=0 | w=109
  20. ipilimumab -- r_associated #0: 109 / 0.238 -> en:furosemide
    n1=ipilimumab | n2=en:furosemide | rel=r_associated | relid=0 | w=109
  21. ipilimumab -- r_associated #0: 109 / 0.238 -> en:human lactoferrin peptide hlf1-11
    n1=ipilimumab | n2=en:human lactoferrin peptide hlf1-11 | rel=r_associated | relid=0 | w=109
  22. ipilimumab -- r_associated #0: 109 / 0.238 -> en:insulin aspart
    n1=ipilimumab | n2=en:insulin aspart | rel=r_associated | relid=0 | w=109
  23. ipilimumab -- r_associated #0: 109 / 0.238 -> en:iodine i-131
    n1=ipilimumab | n2=en:iodine i-131 | rel=r_associated | relid=0 | w=109
  24. ipilimumab -- r_associated #0: 109 / 0.238 -> en:ipriflavone
    n1=ipilimumab | n2=en:ipriflavone | rel=r_associated | relid=0 | w=109
  25. ipilimumab -- r_associated #0: 109 / 0.238 -> en:lasw1510
    n1=ipilimumab | n2=en:lasw1510 | rel=r_associated | relid=0 | w=109
  26. ipilimumab -- r_associated #0: 109 / 0.238 -> en:loxoribine
    n1=ipilimumab | n2=en:loxoribine | rel=r_associated | relid=0 | w=109
  27. ipilimumab -- r_associated #0: 109 / 0.238 -> en:monoclonal antibody 14g2a
    n1=ipilimumab | n2=en:monoclonal antibody 14g2a | rel=r_associated | relid=0 | w=109
  28. ipilimumab -- r_associated #0: 109 / 0.238 -> en:moxifloxacin hydrochloride
    n1=ipilimumab | n2=en:moxifloxacin hydrochloride | rel=r_associated | relid=0 | w=109
  29. ipilimumab -- r_associated #0: 109 / 0.238 -> en:mureletecan
    n1=ipilimumab | n2=en:mureletecan | rel=r_associated | relid=0 | w=109
  30. ipilimumab -- r_associated #0: 109 / 0.238 -> en:octreotide acetate
    n1=ipilimumab | n2=en:octreotide acetate | rel=r_associated | relid=0 | w=109
  31. ipilimumab -- r_associated #0: 109 / 0.238 -> en:p70s6k/akt inhibitor msc2363318a
    n1=ipilimumab | n2=en:p70s6k/akt inhibitor msc2363318a | rel=r_associated | relid=0 | w=109
  32. ipilimumab -- r_associated #0: 109 / 0.238 -> en:pelitinib
    n1=ipilimumab | n2=en:pelitinib | rel=r_associated | relid=0 | w=109
  33. ipilimumab -- r_associated #0: 109 / 0.238 -> en:perampanel
    n1=ipilimumab | n2=en:perampanel | rel=r_associated | relid=0 | w=109
  34. ipilimumab -- r_associated #0: 109 / 0.238 -> en:pi3k inhibitor wx-037
    n1=ipilimumab | n2=en:pi3k inhibitor wx-037 | rel=r_associated | relid=0 | w=109
  35. ipilimumab -- r_associated #0: 109 / 0.238 -> en:pirs2 phosphopeptide-tetanus peptide vaccine
    n1=ipilimumab | n2=en:pirs2 phosphopeptide-tetanus peptide vaccine | rel=r_associated | relid=0 | w=109
  36. ipilimumab -- r_associated #0: 109 / 0.238 -> en:quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine
    n1=ipilimumab | n2=en:quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine | rel=r_associated | relid=0 | w=109
  37. ipilimumab -- r_associated #0: 109 / 0.238 -> en:radotinib hydrochloride
    n1=ipilimumab | n2=en:radotinib hydrochloride | rel=r_associated | relid=0 | w=109
  38. ipilimumab -- r_associated #0: 109 / 0.238 -> en:recombinant fowlpox-prostate specific antigen vaccine
    n1=ipilimumab | n2=en:recombinant fowlpox-prostate specific antigen vaccine | rel=r_associated | relid=0 | w=109
  39. ipilimumab -- r_associated #0: 109 / 0.238 -> en:recombinant interferon alfa
    n1=ipilimumab | n2=en:recombinant interferon alfa | rel=r_associated | relid=0 | w=109
  40. ipilimumab -- r_associated #0: 109 / 0.238 -> en:resiquimod topical gel
    n1=ipilimumab | n2=en:resiquimod topical gel | rel=r_associated | relid=0 | w=109
  41. ipilimumab -- r_associated #0: 109 / 0.238 -> en:rnr inhibitor coh29
    n1=ipilimumab | n2=en:rnr inhibitor coh29 | rel=r_associated | relid=0 | w=109
  42. ipilimumab -- r_associated #0: 109 / 0.238 -> en:roquinimex
    n1=ipilimumab | n2=en:roquinimex | rel=r_associated | relid=0 | w=109
  43. ipilimumab -- r_associated #0: 109 / 0.238 -> en:sunless tanning lotion
    n1=ipilimumab | n2=en:sunless tanning lotion | rel=r_associated | relid=0 | w=109
  44. ipilimumab -- r_associated #0: 109 / 0.238 -> en:tamoxifen citrate
    n1=ipilimumab | n2=en:tamoxifen citrate | rel=r_associated | relid=0 | w=109
  45. ipilimumab -- r_associated #0: 109 / 0.238 -> en:therapeutic epinephrine
    n1=ipilimumab | n2=en:therapeutic epinephrine | rel=r_associated | relid=0 | w=109
  46. ipilimumab -- r_associated #0: 109 / 0.238 -> en:threonine tyrosine kinase inhibitor cfi-402257
    n1=ipilimumab | n2=en:threonine tyrosine kinase inhibitor cfi-402257 | rel=r_associated | relid=0 | w=109
  47. ipilimumab -- r_associated #0: 109 / 0.238 -> en:tlr7 agonist 852a
    n1=ipilimumab | n2=en:tlr7 agonist 852a | rel=r_associated | relid=0 | w=109
  48. ipilimumab -- r_associated #0: 109 / 0.238 -> en:ulocuplumab
    n1=ipilimumab | n2=en:ulocuplumab | rel=r_associated | relid=0 | w=109
  49. ipilimumab -- r_associated #0: 109 / 0.238 -> en:umbilical cord blood-derived hematopoietic cd34-positive progenitor cells
    n1=ipilimumab | n2=en:umbilical cord blood-derived hematopoietic cd34-positive progenitor cells | rel=r_associated | relid=0 | w=109
  50. ipilimumab -- r_associated #0: 109 / 0.238 -> en:vorinostat
    n1=ipilimumab | n2=en:vorinostat | rel=r_associated | relid=0 | w=109
  51. ipilimumab -- r_associated #0: 109 / 0.238 -> en:vx-803
    n1=ipilimumab | n2=en:vx-803 | rel=r_associated | relid=0 | w=109
  52. ipilimumab -- r_associated #0: 109 / 0.238 -> en:zirconium zr 89 bevacizumab
    n1=ipilimumab | n2=en:zirconium zr 89 bevacizumab | rel=r_associated | relid=0 | w=109
  53. ipilimumab -- r_associated #0: 108 / 0.236 -> en:6,8-bis(benzylthio)octanoic acid
    n1=ipilimumab | n2=en:6,8-bis(benzylthio)octanoic acid | rel=r_associated | relid=0 | w=108
  54. ipilimumab -- r_associated #0: 108 / 0.236 -> en:714-x
    n1=ipilimumab | n2=en:714-x | rel=r_associated | relid=0 | w=108
  55. ipilimumab -- r_associated #0: 108 / 0.236 -> en:abatacept
    n1=ipilimumab | n2=en:abatacept | rel=r_associated | relid=0 | w=108
  56. ipilimumab -- r_associated #0: 108 / 0.236 -> en:acivicin
    n1=ipilimumab | n2=en:acivicin | rel=r_associated | relid=0 | w=108
  57. ipilimumab -- r_associated #0: 108 / 0.236 -> en:adenovirus rsv-tk
    n1=ipilimumab | n2=en:adenovirus rsv-tk | rel=r_associated | relid=0 | w=108
  58. ipilimumab -- r_associated #0: 108 / 0.236 -> en:adenovirus-psa prostate cancer vaccine
    n1=ipilimumab | n2=en:adenovirus-psa prostate cancer vaccine | rel=r_associated | relid=0 | w=108
  59. ipilimumab -- r_associated #0: 108 / 0.236 -> en:aim2(-1)/ht001(-1)/taf1b(-1) frameshift peptide vaccine
    n1=ipilimumab | n2=en:aim2(-1)/ht001(-1)/taf1b(-1) frameshift peptide vaccine | rel=r_associated | relid=0 | w=108
  60. ipilimumab -- r_associated #0: 108 / 0.236 -> en:alvac-cea b7.1 vaccine
    n1=ipilimumab | n2=en:alvac-cea b7.1 vaccine | rel=r_associated | relid=0 | w=108
  61. ipilimumab -- r_associated #0: 108 / 0.236 -> en:aminosyn
    n1=ipilimumab | n2=en:aminosyn | rel=r_associated | relid=0 | w=108
  62. ipilimumab -- r_associated #0: 108 / 0.236 -> en:anhydrovinblastine
    n1=ipilimumab | n2=en:anhydrovinblastine | rel=r_associated | relid=0 | w=108
  63. ipilimumab -- r_associated #0: 108 / 0.236 -> en:anti-c-fms monoclonal antibody amg 820
    n1=ipilimumab | n2=en:anti-c-fms monoclonal antibody amg 820 | rel=r_associated | relid=0 | w=108
  64. ipilimumab -- r_associated #0: 108 / 0.236 -> en:anti-cd200 monoclonal antibody alxn6000
    n1=ipilimumab | n2=en:anti-cd200 monoclonal antibody alxn6000 | rel=r_associated | relid=0 | w=108
  65. ipilimumab -- r_associated #0: 108 / 0.236 -> en:anti-cd37 antibody-drug conjugate imgn529
    n1=ipilimumab | n2=en:anti-cd37 antibody-drug conjugate imgn529 | rel=r_associated | relid=0 | w=108
  66. ipilimumab -- r_associated #0: 108 / 0.236 -> en:anti-cd44 monoclonal antibody ro5429083
    n1=ipilimumab | n2=en:anti-cd44 monoclonal antibody ro5429083 | rel=r_associated | relid=0 | w=108
  67. ipilimumab -- r_associated #0: 108 / 0.236 -> en:anti-hcv e2 monoclonal antibody mbl-hcv1
    n1=ipilimumab | n2=en:anti-hcv e2 monoclonal antibody mbl-hcv1 | rel=r_associated | relid=0 | w=108
  68. ipilimumab -- r_associated #0: 108 / 0.236 -> en:anti-icam-1 monoclonal antibody bi-505
    n1=ipilimumab | n2=en:anti-icam-1 monoclonal antibody bi-505 | rel=r_associated | relid=0 | w=108
  69. ipilimumab -- r_associated #0: 108 / 0.236 -> en:anti-il-1 alpha monoclonal antibody ca-18c3
    n1=ipilimumab | n2=en:anti-il-1 alpha monoclonal antibody ca-18c3 | rel=r_associated | relid=0 | w=108
  70. ipilimumab -- r_associated #0: 108 / 0.236 -> en:anti-il-8 monoclonal antibody humax-il8
    n1=ipilimumab | n2=en:anti-il-8 monoclonal antibody humax-il8 | rel=r_associated | relid=0 | w=108
  71. ipilimumab -- r_associated #0: 108 / 0.236 -> en:anti-lag-3 monoclonal antibody lag525
    n1=ipilimumab | n2=en:anti-lag-3 monoclonal antibody lag525 | rel=r_associated | relid=0 | w=108
  72. ipilimumab -- r_associated #0: 108 / 0.236 -> en:anti-thymocyte globulin
    n1=ipilimumab | n2=en:anti-thymocyte globulin | rel=r_associated | relid=0 | w=108
  73. ipilimumab -- r_associated #0: 108 / 0.236 -> en:azaribine
    n1=ipilimumab | n2=en:azaribine | rel=r_associated | relid=0 | w=108
  74. ipilimumab -- r_associated #0: 108 / 0.236 -> en:bisoprolol fumarate
    n1=ipilimumab | n2=en:bisoprolol fumarate | rel=r_associated | relid=0 | w=108
  75. ipilimumab -- r_associated #0: 108 / 0.236 -> en:calcium regulating agent
    n1=ipilimumab | n2=en:calcium regulating agent | rel=r_associated | relid=0 | w=108
  76. ipilimumab -- r_associated #0: 108 / 0.236 -> en:carrot/jilin ginseng/licorice root/tangerine peel/soy beverage
    n1=ipilimumab | n2=en:carrot/jilin ginseng/licorice root/tangerine peel/soy beverage | rel=r_associated | relid=0 | w=108
  77. ipilimumab -- r_associated #0: 108 / 0.236 -> en:casein/whey protein/soy protein/pea protein/fat mix/epa/dha-based nutritional supplement
    n1=ipilimumab | n2=en:casein/whey protein/soy protein/pea protein/fat mix/epa/dha-based nutritional supplement | rel=r_associated | relid=0 | w=108
  78. ipilimumab -- r_associated #0: 108 / 0.236 -> en:ccl21-expressing h1944 cell vaccine
    n1=ipilimumab | n2=en:ccl21-expressing h1944 cell vaccine | rel=r_associated | relid=0 | w=108
  79. ipilimumab -- r_associated #0: 108 / 0.236 -> en:chp-ny-eso-1 peptide vaccine imf-001
    n1=ipilimumab | n2=en:chp-ny-eso-1 peptide vaccine imf-001 | rel=r_associated | relid=0 | w=108
  80. ipilimumab -- r_associated #0: 108 / 0.236 -> en:citric acid + magnesium oxide + sodium picosulfate
    n1=ipilimumab | n2=en:citric acid + magnesium oxide + sodium picosulfate | rel=r_associated | relid=0 | w=108
  81. ipilimumab -- r_associated #0: 108 / 0.236 -> en:daflon 500
    n1=ipilimumab | n2=en:daflon 500 | rel=r_associated | relid=0 | w=108
  82. ipilimumab -- r_associated #0: 108 / 0.236 -> en:diarylsulfonylurea compound
    n1=ipilimumab | n2=en:diarylsulfonylurea compound | rel=r_associated | relid=0 | w=108
  83. ipilimumab -- r_associated #0: 108 / 0.236 -> en:dimethyl sulfoxide
    n1=ipilimumab | n2=en:dimethyl sulfoxide | rel=r_associated | relid=0 | w=108
  84. ipilimumab -- r_associated #0: 108 / 0.236 -> en:drugs used in metabolic disorders
    n1=ipilimumab | n2=en:drugs used in metabolic disorders | rel=r_associated | relid=0 | w=108
  85. ipilimumab -- r_associated #0: 108 / 0.236 -> en:dtgm fusion protein
    n1=ipilimumab | n2=en:dtgm fusion protein | rel=r_associated | relid=0 | w=108
  86. ipilimumab -- r_associated #0: 108 / 0.236 -> en:enzalutamide
    n1=ipilimumab | n2=en:enzalutamide | rel=r_associated | relid=0 | w=108
  87. ipilimumab -- r_associated #0: 108 / 0.236 -> en:enzymatically-hydrolyzed whey protein-based nutritional supplement
    n1=ipilimumab | n2=en:enzymatically-hydrolyzed whey protein-based nutritional supplement | rel=r_associated | relid=0 | w=108
  88. ipilimumab -- r_associated #0: 108 / 0.236 -> en:enzyme inhibitor
    n1=ipilimumab | n2=en:enzyme inhibitor | rel=r_associated | relid=0 | w=108
  89. ipilimumab -- r_associated #0: 108 / 0.236 -> en:epirubicin hydrochloride
    n1=ipilimumab | n2=en:epirubicin hydrochloride | rel=r_associated | relid=0 | w=108
  90. ipilimumab -- r_associated #0: 108 / 0.236 -> en:estradiol vaginal ring
    n1=ipilimumab | n2=en:estradiol vaginal ring | rel=r_associated | relid=0 | w=108
  91. ipilimumab -- r_associated #0: 108 / 0.236 -> en:fluorescent antibody sgm-101
    n1=ipilimumab | n2=en:fluorescent antibody sgm-101 | rel=r_associated | relid=0 | w=108
  92. ipilimumab -- r_associated #0: 108 / 0.236 -> en:forodesine hydrochloride
    n1=ipilimumab | n2=en:forodesine hydrochloride | rel=r_associated | relid=0 | w=108
  93. ipilimumab -- r_associated #0: 108 / 0.236 -> en:fosfestrol
    n1=ipilimumab | n2=en:fosfestrol | rel=r_associated | relid=0 | w=108
  94. ipilimumab -- r_associated #0: 108 / 0.236 -> en:gadolinium-chelate
    n1=ipilimumab | n2=en:gadolinium-chelate | rel=r_associated | relid=0 | w=108
  95. ipilimumab -- r_associated #0: 108 / 0.236 -> en:gimeracil
    n1=ipilimumab | n2=en:gimeracil | rel=r_associated | relid=0 | w=108
  96. ipilimumab -- r_associated #0: 108 / 0.236 -> en:hafnium oxide-containing nanoparticles nbtxr3
    n1=ipilimumab | n2=en:hafnium oxide-containing nanoparticles nbtxr3 | rel=r_associated | relid=0 | w=108
  97. ipilimumab -- r_associated #0: 108 / 0.236 -> en:highly purified staphylococcal protein a prtx-100
    n1=ipilimumab | n2=en:highly purified staphylococcal protein a prtx-100 | rel=r_associated | relid=0 | w=108
  98. ipilimumab -- r_associated #0: 108 / 0.236 -> en:hla-a*2402-restricted koc1-ttk-co16-depdc1-mphosph1 multipeptide vaccine
    n1=ipilimumab | n2=en:hla-a*2402-restricted koc1-ttk-co16-depdc1-mphosph1 multipeptide vaccine | rel=r_associated | relid=0 | w=108
  99. ipilimumab -- r_associated #0: 108 / 0.236 -> en:hla-a*2404-restricted rnf43-tomm34-vegfr1-vegfr2 multipeptide vaccine
    n1=ipilimumab | n2=en:hla-a*2404-restricted rnf43-tomm34-vegfr1-vegfr2 multipeptide vaccine | rel=r_associated | relid=0 | w=108
  100. ipilimumab -- r_associated #0: 108 / 0.236 -> en:hla-a1, a2, b35-restricted survivin peptides/montanide isa-51 vaccine
    n1=ipilimumab | n2=en:hla-a1, a2, b35-restricted survivin peptides/montanide isa-51 vaccine | rel=r_associated | relid=0 | w=108
  101. ipilimumab -- r_associated #0: 108 / 0.236 -> en:holmium ho 166 poly(l-lactic acid) microspheres
    n1=ipilimumab | n2=en:holmium ho 166 poly(l-lactic acid) microspheres | rel=r_associated | relid=0 | w=108
  102. ipilimumab -- r_associated #0: 108 / 0.236 -> en:iodine i 124 monoclonal antibody 3f8
    n1=ipilimumab | n2=en:iodine i 124 monoclonal antibody 3f8 | rel=r_associated | relid=0 | w=108
  103. ipilimumab -- r_associated #0: 108 / 0.236 -> en:iophendylate
    n1=ipilimumab | n2=en:iophendylate | rel=r_associated | relid=0 | w=108
  104. ipilimumab -- r_associated #0: 108 / 0.236 -> en:ipatasertib
    n1=ipilimumab | n2=en:ipatasertib | rel=r_associated | relid=0 | w=108
  105. ipilimumab -- r_associated #0: 108 / 0.236 -> en:iridium ir 192
    n1=ipilimumab | n2=en:iridium ir 192 | rel=r_associated | relid=0 | w=108
  106. ipilimumab -- r_associated #0: 108 / 0.236 -> en:ketamine hydrochloride
    n1=ipilimumab | n2=en:ketamine hydrochloride | rel=r_associated | relid=0 | w=108
  107. ipilimumab -- r_associated #0: 108 / 0.236 -> en:levetiracetam
    n1=ipilimumab | n2=en:levetiracetam | rel=r_associated | relid=0 | w=108
  108. ipilimumab -- r_associated #0: 108 / 0.236 -> en:liposomal cytarabine-daunorubicin cpx-351
    n1=ipilimumab | n2=en:liposomal cytarabine-daunorubicin cpx-351 | rel=r_associated | relid=0 | w=108
  109. ipilimumab -- r_associated #0: 108 / 0.236 -> en:liposome-incorporated grb2 antisense oligodeoxynucleotide
    n1=ipilimumab | n2=en:liposome-incorporated grb2 antisense oligodeoxynucleotide | rel=r_associated | relid=0 | w=108
  110. ipilimumab -- r_associated #0: 108 / 0.236 -> en:lorazepam
    n1=ipilimumab | n2=en:lorazepam | rel=r_associated | relid=0 | w=108
  111. ipilimumab -- r_associated #0: 108 / 0.236 -> en:membrane-disrupting peptide ep-100
    n1=ipilimumab | n2=en:membrane-disrupting peptide ep-100 | rel=r_associated | relid=0 | w=108
  112. ipilimumab -- r_associated #0: 108 / 0.236 -> en:mercaptopurine oral suspension
    n1=ipilimumab | n2=en:mercaptopurine oral suspension | rel=r_associated | relid=0 | w=108
  113. ipilimumab -- r_associated #0: 108 / 0.236 -> en:metformin hydrochloride
    n1=ipilimumab | n2=en:metformin hydrochloride | rel=r_associated | relid=0 | w=108
  114. ipilimumab -- r_associated #0: 108 / 0.236 -> en:monoclonal antibody 11d10 anti-idiotype vaccine
    n1=ipilimumab | n2=en:monoclonal antibody 11d10 anti-idiotype vaccine | rel=r_associated | relid=0 | w=108
  115. ipilimumab -- r_associated #0: 108 / 0.236 -> en:multidrug resistance modulator
    n1=ipilimumab | n2=en:multidrug resistance modulator | rel=r_associated | relid=0 | w=108
  116. ipilimumab -- r_associated #0: 108 / 0.236 -> en:multikinase inhibitor at9283
    n1=ipilimumab | n2=en:multikinase inhibitor at9283 | rel=r_associated | relid=0 | w=108
  117. ipilimumab -- r_associated #0: 108 / 0.236 -> en:mvf-her-2(628-647)-crl 1005 vaccine
    n1=ipilimumab | n2=en:mvf-her-2(628-647)-crl 1005 vaccine | rel=r_associated | relid=0 | w=108
  118. ipilimumab -- r_associated #0: 108 / 0.236 -> en:nandrolone decanoate
    n1=ipilimumab | n2=en:nandrolone decanoate | rel=r_associated | relid=0 | w=108
  119. ipilimumab -- r_associated #0: 108 / 0.236 -> en:netazepide
    n1=ipilimumab | n2=en:netazepide | rel=r_associated | relid=0 | w=108
  120. ipilimumab -- r_associated #0: 108 / 0.236 -> en:ny-eso-1 peptide vaccine
    n1=ipilimumab | n2=en:ny-eso-1 peptide vaccine | rel=r_associated | relid=0 | w=108
  121. ipilimumab -- r_associated #0: 108 / 0.236 -> en:ny-eso-1/mart-1 peptide-pulsed dendritic cell vaccine
    n1=ipilimumab | n2=en:ny-eso-1/mart-1 peptide-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=108
  122. ipilimumab -- r_associated #0: 108 / 0.236 -> en:oprozomib
    n1=ipilimumab | n2=en:oprozomib | rel=r_associated | relid=0 | w=108
  123. ipilimumab -- r_associated #0: 108 / 0.236 -> en:oxaliplatin-encapsulated transferrin-conjugated n-glutaryl phosphatidylethanolamine liposome
    n1=ipilimumab | n2=en:oxaliplatin-encapsulated transferrin-conjugated n-glutaryl phosphatidylethanolamine liposome | rel=r_associated | relid=0 | w=108
  124. ipilimumab -- r_associated #0: 108 / 0.236 -> en:p16_37-63 peptide vaccine
    n1=ipilimumab | n2=en:p16_37-63 peptide vaccine | rel=r_associated | relid=0 | w=108
  125. ipilimumab -- r_associated #0: 108 / 0.236 -> en:pak4 inhibitor pf-03758309
    n1=ipilimumab | n2=en:pak4 inhibitor pf-03758309 | rel=r_associated | relid=0 | w=108
  126. ipilimumab -- r_associated #0: 108 / 0.236 -> en:patent blue v dye
    n1=ipilimumab | n2=en:patent blue v dye | rel=r_associated | relid=0 | w=108
  127. ipilimumab -- r_associated #0: 108 / 0.236 -> en:pc-spes
    n1=ipilimumab | n2=en:pc-spes | rel=r_associated | relid=0 | w=108
  128. ipilimumab -- r_associated #0: 108 / 0.236 -> en:phosphomannopentaose sulfate
    n1=ipilimumab | n2=en:phosphomannopentaose sulfate | rel=r_associated | relid=0 | w=108
  129. ipilimumab -- r_associated #0: 108 / 0.236 -> en:pi3k inhibitor gsk2126458
    n1=ipilimumab | n2=en:pi3k inhibitor gsk2126458 | rel=r_associated | relid=0 | w=108
  130. ipilimumab -- r_associated #0: 108 / 0.236 -> en:pi3k-delta inhibitor amg 319
    n1=ipilimumab | n2=en:pi3k-delta inhibitor amg 319 | rel=r_associated | relid=0 | w=108
  131. ipilimumab -- r_associated #0: 108 / 0.236 -> en:pi3k-gamma inhibitor ipi-549
    n1=ipilimumab | n2=en:pi3k-gamma inhibitor ipi-549 | rel=r_associated | relid=0 | w=108
  132. ipilimumab -- r_associated #0: 108 / 0.236 -> en:pimonidazole
    n1=ipilimumab | n2=en:pimonidazole | rel=r_associated | relid=0 | w=108
  133. ipilimumab -- r_associated #0: 108 / 0.236 -> en:piperine extract (standardized)
    n1=ipilimumab | n2=en:piperine extract (standardized) | rel=r_associated | relid=0 | w=108
  134. ipilimumab -- r_associated #0: 108 / 0.236 -> en:polihexanide solution
    n1=ipilimumab | n2=en:polihexanide solution | rel=r_associated | relid=0 | w=108
  135. ipilimumab -- r_associated #0: 108 / 0.236 -> en:prexasertib
    n1=ipilimumab | n2=en:prexasertib | rel=r_associated | relid=0 | w=108
  136. ipilimumab -- r_associated #0: 108 / 0.236 -> en:propranolol hydrochloride
    n1=ipilimumab | n2=en:propranolol hydrochloride | rel=r_associated | relid=0 | w=108
  137. ipilimumab -- r_associated #0: 108 / 0.236 -> en:pyrogen
    n1=ipilimumab | n2=en:pyrogen | rel=r_associated | relid=0 | w=108
  138. ipilimumab -- r_associated #0: 108 / 0.236 -> en:recombinant vaccinia psa vaccine
    n1=ipilimumab | n2=en:recombinant vaccinia psa vaccine | rel=r_associated | relid=0 | w=108
  139. ipilimumab -- r_associated #0: 108 / 0.236 -> en:rizatriptan benzoate
    n1=ipilimumab | n2=en:rizatriptan benzoate | rel=r_associated | relid=0 | w=108
  140. ipilimumab -- r_associated #0: 108 / 0.236 -> en:rosabulin
    n1=ipilimumab | n2=en:rosabulin | rel=r_associated | relid=0 | w=108
  141. ipilimumab -- r_associated #0: 108 / 0.236 -> en:sodium citrate
    n1=ipilimumab | n2=en:sodium citrate | rel=r_associated | relid=0 | w=108
  142. ipilimumab -- r_associated #0: 108 / 0.236 -> en:sodium dibunate
    n1=ipilimumab | n2=en:sodium dibunate | rel=r_associated | relid=0 | w=108
  143. ipilimumab -- r_associated #0: 108 / 0.236 -> en:substance p/neurokinin 1 receptor antagonist
    n1=ipilimumab | n2=en:substance p/neurokinin 1 receptor antagonist | rel=r_associated | relid=0 | w=108
  144. ipilimumab -- r_associated #0: 108 / 0.236 -> en:sulfasalazine
    n1=ipilimumab | n2=en:sulfasalazine | rel=r_associated | relid=0 | w=108
  145. ipilimumab -- r_associated #0: 108 / 0.236 -> en:survivin/p53/her2 antigen-loaded autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:survivin/p53/her2 antigen-loaded autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=108
  146. ipilimumab -- r_associated #0: 108 / 0.236 -> en:taltirelin hydrate
    n1=ipilimumab | n2=en:taltirelin hydrate | rel=r_associated | relid=0 | w=108
  147. ipilimumab -- r_associated #0: 108 / 0.236 -> en:taxane analogue mst-997
    n1=ipilimumab | n2=en:taxane analogue mst-997 | rel=r_associated | relid=0 | w=108
  148. ipilimumab -- r_associated #0: 108 / 0.236 -> en:technetium tc 99m galactosyl human serum albumin
    n1=ipilimumab | n2=en:technetium tc 99m galactosyl human serum albumin | rel=r_associated | relid=0 | w=108
  149. ipilimumab -- r_associated #0: 108 / 0.236 -> en:teicoplanin
    n1=ipilimumab | n2=en:teicoplanin | rel=r_associated | relid=0 | w=108
  150. ipilimumab -- r_associated #0: 108 / 0.236 -> en:theophylline
    n1=ipilimumab | n2=en:theophylline | rel=r_associated | relid=0 | w=108
  151. ipilimumab -- r_associated #0: 108 / 0.236 -> en:timonacic
    n1=ipilimumab | n2=en:timonacic | rel=r_associated | relid=0 | w=108
  152. ipilimumab -- r_associated #0: 108 / 0.236 -> en:topical piperidine nitroxide mts-01
    n1=ipilimumab | n2=en:topical piperidine nitroxide mts-01 | rel=r_associated | relid=0 | w=108
  153. ipilimumab -- r_associated #0: 108 / 0.236 -> en:transdermal estrogen
    n1=ipilimumab | n2=en:transdermal estrogen | rel=r_associated | relid=0 | w=108
  154. ipilimumab -- r_associated #0: 108 / 0.236 -> en:triamcinolone
    n1=ipilimumab | n2=en:triamcinolone | rel=r_associated | relid=0 | w=108
  155. ipilimumab -- r_associated #0: 108 / 0.236 -> en:vardenafil hydrochloride trihydrate
    n1=ipilimumab | n2=en:vardenafil hydrochloride trihydrate | rel=r_associated | relid=0 | w=108
  156. ipilimumab -- r_associated #0: 108 / 0.236 -> en:vinorelbine tartrate oral
    n1=ipilimumab | n2=en:vinorelbine tartrate oral | rel=r_associated | relid=0 | w=108
  157. ipilimumab -- r_associated #0: 108 / 0.236 -> en:zhongyao fufang
    n1=ipilimumab | n2=en:zhongyao fufang | rel=r_associated | relid=0 | w=108
  158. ipilimumab -- r_associated #0: 107 / 0.234 -> en:6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases isoform 3 inhibitor act-pfk-158
    n1=ipilimumab | n2=en:6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases isoform 3 inhibitor act-pfk-158 | rel=r_associated | relid=0 | w=107
  159. ipilimumab -- r_associated #0: 107 / 0.234 -> en:absorbable gelatin sponge
    n1=ipilimumab | n2=en:absorbable gelatin sponge | rel=r_associated | relid=0 | w=107
  160. ipilimumab -- r_associated #0: 107 / 0.234 -> en:absorbable modified polymer hemostatic powder
    n1=ipilimumab | n2=en:absorbable modified polymer hemostatic powder | rel=r_associated | relid=0 | w=107
  161. ipilimumab -- r_associated #0: 107 / 0.234 -> en:ac regimen
    n1=ipilimumab | n2=en:ac regimen | rel=r_associated | relid=0 | w=107
  162. ipilimumab -- r_associated #0: 107 / 0.234 -> en:ad-hcmv-flt3l
    n1=ipilimumab | n2=en:ad-hcmv-flt3l | rel=r_associated | relid=0 | w=107
  163. ipilimumab -- r_associated #0: 107 / 0.234 -> en:alk/trk inhibitor tsr-011
    n1=ipilimumab | n2=en:alk/trk inhibitor tsr-011 | rel=r_associated | relid=0 | w=107
  164. ipilimumab -- r_associated #0: 107 / 0.234 -> en:allogeneic epstein-barr virus-specific cytotoxic t-lymphocytes
    n1=ipilimumab | n2=en:allogeneic epstein-barr virus-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=107
  165. ipilimumab -- r_associated #0: 107 / 0.234 -> en:allogeneic large multivalent immunogen breast cancer vaccine
    n1=ipilimumab | n2=en:allogeneic large multivalent immunogen breast cancer vaccine | rel=r_associated | relid=0 | w=107
  166. ipilimumab -- r_associated #0: 107 / 0.234 -> en:almurtide
    n1=ipilimumab | n2=en:almurtide | rel=r_associated | relid=0 | w=107
  167. ipilimumab -- r_associated #0: 107 / 0.234 -> en:alpha fetoprotein plasmid dna vaccine
    n1=ipilimumab | n2=en:alpha fetoprotein plasmid dna vaccine | rel=r_associated | relid=0 | w=107
  168. ipilimumab -- r_associated #0: 107 / 0.234 -> en:alvac-eso-1 vaccine
    n1=ipilimumab | n2=en:alvac-eso-1 vaccine | rel=r_associated | relid=0 | w=107
  169. ipilimumab -- r_associated #0: 107 / 0.234 -> en:amantadine hydrochloride
    n1=ipilimumab | n2=en:amantadine hydrochloride | rel=r_associated | relid=0 | w=107
  170. ipilimumab -- r_associated #0: 107 / 0.234 -> en:amonafide dihydrochloride
    n1=ipilimumab | n2=en:amonafide dihydrochloride | rel=r_associated | relid=0 | w=107
  171. ipilimumab -- r_associated #0: 107 / 0.234 -> en:amrubicin hydrochloride
    n1=ipilimumab | n2=en:amrubicin hydrochloride | rel=r_associated | relid=0 | w=107
  172. ipilimumab -- r_associated #0: 107 / 0.234 -> en:anti-cd133-car vector-transduced allogeneic t lymphocytes
    n1=ipilimumab | n2=en:anti-cd133-car vector-transduced allogeneic t lymphocytes | rel=r_associated | relid=0 | w=107
  173. ipilimumab -- r_associated #0: 107 / 0.234 -> en:anti-cd22 scfv tcrz:41bb-car lentiviral vector-transduced autologous t-lymphocytes
    n1=ipilimumab | n2=en:anti-cd22 scfv tcrz:41bb-car lentiviral vector-transduced autologous t-lymphocytes | rel=r_associated | relid=0 | w=107
  174. ipilimumab -- r_associated #0: 107 / 0.234 -> en:anti-cd3 x anti-cd20 bispecific antibody-armed activated t cells
    n1=ipilimumab | n2=en:anti-cd3 x anti-cd20 bispecific antibody-armed activated t cells | rel=r_associated | relid=0 | w=107
  175. ipilimumab -- r_associated #0: 107 / 0.234 -> en:anti-il-13 humanized monoclonal antibody tnx-650
    n1=ipilimumab | n2=en:anti-il-13 humanized monoclonal antibody tnx-650 | rel=r_associated | relid=0 | w=107
  176. ipilimumab -- r_associated #0: 107 / 0.234 -> en:anti-ox40 monoclonal antibody moxr0916
    n1=ipilimumab | n2=en:anti-ox40 monoclonal antibody moxr0916 | rel=r_associated | relid=0 | w=107
  177. ipilimumab -- r_associated #0: 107 / 0.234 -> en:anti-vegfr2-car retroviral vector-transduced autologous t-lymphocytes
    n1=ipilimumab | n2=en:anti-vegfr2-car retroviral vector-transduced autologous t-lymphocytes | rel=r_associated | relid=0 | w=107
  178. ipilimumab -- r_associated #0: 107 / 0.234 -> en:anti-vegfr3 monoclonal antibody imc-3c5
    n1=ipilimumab | n2=en:anti-vegfr3 monoclonal antibody imc-3c5 | rel=r_associated | relid=0 | w=107
  179. ipilimumab -- r_associated #0: 107 / 0.234 -> en:antineoplastic agent
    n1=ipilimumab | n2=en:antineoplastic agent | rel=r_associated | relid=0 | w=107
  180. ipilimumab -- r_associated #0: 107 / 0.234 -> en:ar antagonist odm-201
    n1=ipilimumab | n2=en:ar antagonist odm-201 | rel=r_associated | relid=0 | w=107
  181. ipilimumab -- r_associated #0: 107 / 0.234 -> en:asparaginase erwinia chrysanthemi
    n1=ipilimumab | n2=en:asparaginase erwinia chrysanthemi | rel=r_associated | relid=0 | w=107
  182. ipilimumab -- r_associated #0: 107 / 0.234 -> en:atenolol
    n1=ipilimumab | n2=en:atenolol | rel=r_associated | relid=0 | w=107
  183. ipilimumab -- r_associated #0: 107 / 0.234 -> en:atorvastatin calcium
    n1=ipilimumab | n2=en:atorvastatin calcium | rel=r_associated | relid=0 | w=107
  184. ipilimumab -- r_associated #0: 107 / 0.234 -> en:aurora kinase inhibitor bi 811283
    n1=ipilimumab | n2=en:aurora kinase inhibitor bi 811283 | rel=r_associated | relid=0 | w=107
  185. ipilimumab -- r_associated #0: 107 / 0.234 -> en:autologous anti-cd19 car-expressing t lymphocytes
    n1=ipilimumab | n2=en:autologous anti-cd19 car-expressing t lymphocytes | rel=r_associated | relid=0 | w=107
  186. ipilimumab -- r_associated #0: 107 / 0.234 -> en:autologous anti-mart-1 f5 t-cell receptor gene-engineered peripheral blood lymphocytes
    n1=ipilimumab | n2=en:autologous anti-mart-1 f5 t-cell receptor gene-engineered peripheral blood lymphocytes | rel=r_associated | relid=0 | w=107
  187. ipilimumab -- r_associated #0: 107 / 0.234 -> en:autologous cultured acute myeloid leukemia-specific cytotoxic t lymphocytes
    n1=ipilimumab | n2=en:autologous cultured acute myeloid leukemia-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=107
  188. ipilimumab -- r_associated #0: 107 / 0.234 -> en:autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine
    n1=ipilimumab | n2=en:autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine | rel=r_associated | relid=0 | w=107
  189. ipilimumab -- r_associated #0: 107 / 0.234 -> en:av2-dm antiviral spray
    n1=ipilimumab | n2=en:av2-dm antiviral spray | rel=r_associated | relid=0 | w=107
  190. ipilimumab -- r_associated #0: 107 / 0.234 -> en:benzoylphenylurea
    n1=ipilimumab | n2=en:benzoylphenylurea | rel=r_associated | relid=0 | w=107
  191. ipilimumab -- r_associated #0: 107 / 0.234 -> en:beta-glucan mm-10-001
    n1=ipilimumab | n2=en:beta-glucan mm-10-001 | rel=r_associated | relid=0 | w=107
  192. ipilimumab -- r_associated #0: 107 / 0.234 -> en:bms-214662
    n1=ipilimumab | n2=en:bms-214662 | rel=r_associated | relid=0 | w=107
  193. ipilimumab -- r_associated #0: 107 / 0.234 -> en:bms-817378
    n1=ipilimumab | n2=en:bms-817378 | rel=r_associated | relid=0 | w=107
  194. ipilimumab -- r_associated #0: 107 / 0.234 -> en:braf(v600e) inhibitor cep-32496
    n1=ipilimumab | n2=en:braf(v600e) inhibitor cep-32496 | rel=r_associated | relid=0 | w=107
  195. ipilimumab -- r_associated #0: 107 / 0.234 -> en:bromelains
    n1=ipilimumab | n2=en:bromelains | rel=r_associated | relid=0 | w=107
  196. ipilimumab -- r_associated #0: 107 / 0.234 -> en:bromodomain inhibitor abbv-075
    n1=ipilimumab | n2=en:bromodomain inhibitor abbv-075 | rel=r_associated | relid=0 | w=107
  197. ipilimumab -- r_associated #0: 107 / 0.234 -> en:bropirimine
    n1=ipilimumab | n2=en:bropirimine | rel=r_associated | relid=0 | w=107
  198. ipilimumab -- r_associated #0: 107 / 0.234 -> en:buformin hydrochloride
    n1=ipilimumab | n2=en:buformin hydrochloride | rel=r_associated | relid=0 | w=107
  199. ipilimumab -- r_associated #0: 107 / 0.234 -> en:caf regimen
    n1=ipilimumab | n2=en:caf regimen | rel=r_associated | relid=0 | w=107
  200. ipilimumab -- r_associated #0: 107 / 0.234 -> en:calamine
    n1=ipilimumab | n2=en:calamine | rel=r_associated | relid=0 | w=107
  201. ipilimumab -- r_associated #0: 107 / 0.234 -> en:calcipotriene
    n1=ipilimumab | n2=en:calcipotriene | rel=r_associated | relid=0 | w=107
  202. ipilimumab -- r_associated #0: 107 / 0.234 -> en:candesartan cilexetil
    n1=ipilimumab | n2=en:candesartan cilexetil | rel=r_associated | relid=0 | w=107
  203. ipilimumab -- r_associated #0: 107 / 0.234 -> en:cannabidiol
    n1=ipilimumab | n2=en:cannabidiol | rel=r_associated | relid=0 | w=107
  204. ipilimumab -- r_associated #0: 107 / 0.234 -> en:capox regimen
    n1=ipilimumab | n2=en:capox regimen | rel=r_associated | relid=0 | w=107
  205. ipilimumab -- r_associated #0: 107 / 0.234 -> en:carbohydrate supplement drink
    n1=ipilimumab | n2=en:carbohydrate supplement drink | rel=r_associated | relid=0 | w=107
  206. ipilimumab -- r_associated #0: 107 / 0.234 -> en:carbon c 13 acetate
    n1=ipilimumab | n2=en:carbon c 13 acetate | rel=r_associated | relid=0 | w=107
  207. ipilimumab -- r_associated #0: 107 / 0.234 -> en:carbon c 14 selumetinib
    n1=ipilimumab | n2=en:carbon c 14 selumetinib | rel=r_associated | relid=0 | w=107
  208. ipilimumab -- r_associated #0: 107 / 0.234 -> en:carcinoembryonic antigen peptide vaccine
    n1=ipilimumab | n2=en:carcinoembryonic antigen peptide vaccine | rel=r_associated | relid=0 | w=107
  209. ipilimumab -- r_associated #0: 107 / 0.234 -> en:caricotamide/tretazicar
    n1=ipilimumab | n2=en:caricotamide/tretazicar | rel=r_associated | relid=0 | w=107
  210. ipilimumab -- r_associated #0: 107 / 0.234 -> en:cd-expressing bifidobacterium aps001f
    n1=ipilimumab | n2=en:cd-expressing bifidobacterium aps001f | rel=r_associated | relid=0 | w=107
  211. ipilimumab -- r_associated #0: 107 / 0.234 -> en:ceftriaxone sodium
    n1=ipilimumab | n2=en:ceftriaxone sodium | rel=r_associated | relid=0 | w=107
  212. ipilimumab -- r_associated #0: 107 / 0.234 -> en:cephalothin sodium
    n1=ipilimumab | n2=en:cephalothin sodium | rel=r_associated | relid=0 | w=107
  213. ipilimumab -- r_associated #0: 107 / 0.234 -> en:cetuximab
    n1=ipilimumab | n2=en:cetuximab | rel=r_associated | relid=0 | w=107
  214. ipilimumab -- r_associated #0: 107 / 0.234 -> en:chromomycin a3
    n1=ipilimumab | n2=en:chromomycin a3 | rel=r_associated | relid=0 | w=107
  215. ipilimumab -- r_associated #0: 107 / 0.234 -> en:collagen/aloe vera/vitamin e/lidocaine topical hydrogel
    n1=ipilimumab | n2=en:collagen/aloe vera/vitamin e/lidocaine topical hydrogel | rel=r_associated | relid=0 | w=107
  216. ipilimumab -- r_associated #0: 107 / 0.234 -> en:colorectal tumor-associated peptides vaccine ima910
    n1=ipilimumab | n2=en:colorectal tumor-associated peptides vaccine ima910 | rel=r_associated | relid=0 | w=107
  217. ipilimumab -- r_associated #0: 107 / 0.234 -> en:copper cu 64-dota b-fab
    n1=ipilimumab | n2=en:copper cu 64-dota b-fab | rel=r_associated | relid=0 | w=107
  218. ipilimumab -- r_associated #0: 107 / 0.234 -> en:copper cu 64-dota-rituximab
    n1=ipilimumab | n2=en:copper cu 64-dota-rituximab | rel=r_associated | relid=0 | w=107
  219. ipilimumab -- r_associated #0: 107 / 0.234 -> en:cyanocobalamin/dexamethasone/gentamicin/procaine formulation
    n1=ipilimumab | n2=en:cyanocobalamin/dexamethasone/gentamicin/procaine formulation | rel=r_associated | relid=0 | w=107
  220. ipilimumab -- r_associated #0: 107 / 0.234 -> en:cytotoxic agent
    n1=ipilimumab | n2=en:cytotoxic agent | rel=r_associated | relid=0 | w=107
  221. ipilimumab -- r_associated #0: 107 / 0.234 -> en:desipramine hydrochloride
    n1=ipilimumab | n2=en:desipramine hydrochloride | rel=r_associated | relid=0 | w=107
  222. ipilimumab -- r_associated #0: 107 / 0.234 -> en:diltiazem hydrochloride
    n1=ipilimumab | n2=en:diltiazem hydrochloride | rel=r_associated | relid=0 | w=107
  223. ipilimumab -- r_associated #0: 107 / 0.234 -> en:dwj1319
    n1=ipilimumab | n2=en:dwj1319 | rel=r_associated | relid=0 | w=107
  224. ipilimumab -- r_associated #0: 107 / 0.234 -> en:efs-ada lentiviral vector-transduced cd34-positive autologous lymphocytes
    n1=ipilimumab | n2=en:efs-ada lentiviral vector-transduced cd34-positive autologous lymphocytes | rel=r_associated | relid=0 | w=107
  225. ipilimumab -- r_associated #0: 107 / 0.234 -> en:eicosapentaenoic acid
    n1=ipilimumab | n2=en:eicosapentaenoic acid | rel=r_associated | relid=0 | w=107
  226. ipilimumab -- r_associated #0: 107 / 0.234 -> en:elesclomol
    n1=ipilimumab | n2=en:elesclomol | rel=r_associated | relid=0 | w=107
  227. ipilimumab -- r_associated #0: 107 / 0.234 -> en:enobosarm
    n1=ipilimumab | n2=en:enobosarm | rel=r_associated | relid=0 | w=107
  228. ipilimumab -- r_associated #0: 107 / 0.234 -> en:enteric-coated trpm8 agonist d-3263 hydrochloride
    n1=ipilimumab | n2=en:enteric-coated trpm8 agonist d-3263 hydrochloride | rel=r_associated | relid=0 | w=107
  229. ipilimumab -- r_associated #0: 107 / 0.234 -> en:epoetin zeta
    n1=ipilimumab | n2=en:epoetin zeta | rel=r_associated | relid=0 | w=107
  230. ipilimumab -- r_associated #0: 107 / 0.234 -> en:erythromycin topical cream
    n1=ipilimumab | n2=en:erythromycin topical cream | rel=r_associated | relid=0 | w=107
  231. ipilimumab -- r_associated #0: 107 / 0.234 -> en:essiac
    n1=ipilimumab | n2=en:essiac | rel=r_associated | relid=0 | w=107
  232. ipilimumab -- r_associated #0: 107 / 0.234 -> en:ethylchlorformate vaccine
    n1=ipilimumab | n2=en:ethylchlorformate vaccine | rel=r_associated | relid=0 | w=107
  233. ipilimumab -- r_associated #0: 107 / 0.234 -> en:etidronic acid
    n1=ipilimumab | n2=en:etidronic acid | rel=r_associated | relid=0 | w=107
  234. ipilimumab -- r_associated #0: 107 / 0.234 -> en:fat emulsion
    n1=ipilimumab | n2=en:fat emulsion | rel=r_associated | relid=0 | w=107
  235. ipilimumab -- r_associated #0: 107 / 0.234 -> en:filgrastim
    n1=ipilimumab | n2=en:filgrastim | rel=r_associated | relid=0 | w=107
  236. ipilimumab -- r_associated #0: 107 / 0.234 -> en:fingolimod
    n1=ipilimumab | n2=en:fingolimod | rel=r_associated | relid=0 | w=107
  237. ipilimumab -- r_associated #0: 107 / 0.234 -> en:flt3/kit kinase inhibitor akn-028
    n1=ipilimumab | n2=en:flt3/kit kinase inhibitor akn-028 | rel=r_associated | relid=0 | w=107
  238. ipilimumab -- r_associated #0: 107 / 0.234 -> en:fluorescence imaging agent emi-137
    n1=ipilimumab | n2=en:fluorescence imaging agent emi-137 | rel=r_associated | relid=0 | w=107
  239. ipilimumab -- r_associated #0: 107 / 0.234 -> en:fluoxetine
    n1=ipilimumab | n2=en:fluoxetine | rel=r_associated | relid=0 | w=107
  240. ipilimumab -- r_associated #0: 107 / 0.234 -> en:fosaprepitant dimeglumine
    n1=ipilimumab | n2=en:fosaprepitant dimeglumine | rel=r_associated | relid=0 | w=107
  241. ipilimumab -- r_associated #0: 107 / 0.234 -> en:fosbretabulin disodium
    n1=ipilimumab | n2=en:fosbretabulin disodium | rel=r_associated | relid=0 | w=107
  242. ipilimumab -- r_associated #0: 107 / 0.234 -> en:gadoterate meglumine
    n1=ipilimumab | n2=en:gadoterate meglumine | rel=r_associated | relid=0 | w=107
  243. ipilimumab -- r_associated #0: 107 / 0.234 -> en:galantamine hydrobromide
    n1=ipilimumab | n2=en:galantamine hydrobromide | rel=r_associated | relid=0 | w=107
  244. ipilimumab -- r_associated #0: 107 / 0.234 -> en:galiximab
    n1=ipilimumab | n2=en:galiximab | rel=r_associated | relid=0 | w=107
  245. ipilimumab -- r_associated #0: 107 / 0.234 -> en:gallium ga 68-labeled-nodaga-mj9
    n1=ipilimumab | n2=en:gallium ga 68-labeled-nodaga-mj9 | rel=r_associated | relid=0 | w=107
  246. ipilimumab -- r_associated #0: 107 / 0.234 -> en:ganitumab
    n1=ipilimumab | n2=en:ganitumab | rel=r_associated | relid=0 | w=107
  247. ipilimumab -- r_associated #0: 107 / 0.234 -> en:gemcitabine hydrochloride emulsion
    n1=ipilimumab | n2=en:gemcitabine hydrochloride emulsion | rel=r_associated | relid=0 | w=107
  248. ipilimumab -- r_associated #0: 107 / 0.234 -> en:glimepiride
    n1=ipilimumab | n2=en:glimepiride | rel=r_associated | relid=0 | w=107
  249. ipilimumab -- r_associated #0: 107 / 0.234 -> en:glutaminase-asparaginase
    n1=ipilimumab | n2=en:glutaminase-asparaginase | rel=r_associated | relid=0 | w=107
  250. ipilimumab -- r_associated #0: 107 / 0.234 -> en:glycosylated recombinant human g-csf avi-014
    n1=ipilimumab | n2=en:glycosylated recombinant human g-csf avi-014 | rel=r_associated | relid=0 | w=107
  251. ipilimumab -- r_associated #0: 107 / 0.234 -> en:gusperimus trihydrochloride
    n1=ipilimumab | n2=en:gusperimus trihydrochloride | rel=r_associated | relid=0 | w=107
  252. ipilimumab -- r_associated #0: 107 / 0.234 -> en:h1299 tumor cell lysate vaccine
    n1=ipilimumab | n2=en:h1299 tumor cell lysate vaccine | rel=r_associated | relid=0 | w=107
  253. ipilimumab -- r_associated #0: 107 / 0.234 -> en:her-2/neu peptide vaccine
    n1=ipilimumab | n2=en:her-2/neu peptide vaccine | rel=r_associated | relid=0 | w=107
  254. ipilimumab -- r_associated #0: 107 / 0.234 -> en:hetastarch
    n1=ipilimumab | n2=en:hetastarch | rel=r_associated | relid=0 | w=107
  255. ipilimumab -- r_associated #0: 107 / 0.234 -> en:hla-a*2402-restricted vegfr1 peptide vaccine
    n1=ipilimumab | n2=en:hla-a*2402-restricted vegfr1 peptide vaccine | rel=r_associated | relid=0 | w=107
  256. ipilimumab -- r_associated #0: 107 / 0.234 -> en:hyb2055
    n1=ipilimumab | n2=en:hyb2055 | rel=r_associated | relid=0 | w=107
  257. ipilimumab -- r_associated #0: 107 / 0.234 -> en:ibandronate
    n1=ipilimumab | n2=en:ibandronate | rel=r_associated | relid=0 | w=107
  258. ipilimumab -- r_associated #0: 107 / 0.234 -> en:ibogaine
    n1=ipilimumab | n2=en:ibogaine | rel=r_associated | relid=0 | w=107
  259. ipilimumab -- r_associated #0: 107 / 0.234 -> en:idronoxil
    n1=ipilimumab | n2=en:idronoxil | rel=r_associated | relid=0 | w=107
  260. ipilimumab -- r_associated #0: 107 / 0.234 -> en:in 111 satumomab pendetide
    n1=ipilimumab | n2=en:in 111 satumomab pendetide | rel=r_associated | relid=0 | w=107
  261. ipilimumab -- r_associated #0: 107 / 0.234 -> en:indinavir sulfate
    n1=ipilimumab | n2=en:indinavir sulfate | rel=r_associated | relid=0 | w=107
  262. ipilimumab -- r_associated #0: 107 / 0.234 -> en:indium in 111-cmd-193
    n1=ipilimumab | n2=en:indium in 111-cmd-193 | rel=r_associated | relid=0 | w=107
  263. ipilimumab -- r_associated #0: 107 / 0.234 -> en:insect extract
    n1=ipilimumab | n2=en:insect extract | rel=r_associated | relid=0 | w=107
  264. ipilimumab -- r_associated #0: 107 / 0.234 -> en:iodinated contrast agent
    n1=ipilimumab | n2=en:iodinated contrast agent | rel=r_associated | relid=0 | w=107
  265. ipilimumab -- r_associated #0: 107 / 0.234 -> en:iodine / potassium iodide / zinc phenolsulfonate
    n1=ipilimumab | n2=en:iodine / potassium iodide / zinc phenolsulfonate | rel=r_associated | relid=0 | w=107
  266. ipilimumab -- r_associated #0: 107 / 0.234 -> en:iodine i 123 iodobenzamide
    n1=ipilimumab | n2=en:iodine i 123 iodobenzamide | rel=r_associated | relid=0 | w=107
  267. ipilimumab -- r_associated #0: 107 / 0.234 -> en:irinotecan/p-glycoprotein inhibitor hm30181ak combination tablet
    n1=ipilimumab | n2=en:irinotecan/p-glycoprotein inhibitor hm30181ak combination tablet | rel=r_associated | relid=0 | w=107
  268. ipilimumab -- r_associated #0: 107 / 0.234 -> en:iron
    n1=ipilimumab | n2=en:iron | rel=r_associated | relid=0 | w=107
  269. ipilimumab -- r_associated #0: 107 / 0.234 -> en:ivacaftor
    n1=ipilimumab | n2=en:ivacaftor | rel=r_associated | relid=0 | w=107
  270. ipilimumab -- r_associated #0: 107 / 0.234 -> en:jak inhibitor incb047986
    n1=ipilimumab | n2=en:jak inhibitor incb047986 | rel=r_associated | relid=0 | w=107
  271. ipilimumab -- r_associated #0: 107 / 0.234 -> en:kit/pdgfr inhibitor dcc-2618
    n1=ipilimumab | n2=en:kit/pdgfr inhibitor dcc-2618 | rel=r_associated | relid=0 | w=107
  272. ipilimumab -- r_associated #0: 107 / 0.234 -> en:lactobacillus rhamnosus/l. jensenii/l. crispatus/l. gasseri oral supplement
    n1=ipilimumab | n2=en:lactobacillus rhamnosus/l. jensenii/l. crispatus/l. gasseri oral supplement | rel=r_associated | relid=0 | w=107
  273. ipilimumab -- r_associated #0: 107 / 0.234 -> en:lactoperoxidase/lysozyme/lactoferrin-based prebiotic vaginal lubricant
    n1=ipilimumab | n2=en:lactoperoxidase/lysozyme/lactoferrin-based prebiotic vaginal lubricant | rel=r_associated | relid=0 | w=107
  274. ipilimumab -- r_associated #0: 107 / 0.234 -> en:lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells
    n1=ipilimumab | n2=en:lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells | rel=r_associated | relid=0 | w=107
  275. ipilimumab -- r_associated #0: 107 / 0.234 -> en:letrozole
    n1=ipilimumab | n2=en:letrozole | rel=r_associated | relid=0 | w=107
  276. ipilimumab -- r_associated #0: 107 / 0.234 -> en:lidocaine
    n1=ipilimumab | n2=en:lidocaine | rel=r_associated | relid=0 | w=107
  277. ipilimumab -- r_associated #0: 107 / 0.234 -> en:linsitinib
    n1=ipilimumab | n2=en:linsitinib | rel=r_associated | relid=0 | w=107
  278. ipilimumab -- r_associated #0: 107 / 0.234 -> en:liposomal mitoxantrone hydrochloride
    n1=ipilimumab | n2=en:liposomal mitoxantrone hydrochloride | rel=r_associated | relid=0 | w=107
  279. ipilimumab -- r_associated #0: 107 / 0.234 -> en:loratadine
    n1=ipilimumab | n2=en:loratadine | rel=r_associated | relid=0 | w=107
  280. ipilimumab -- r_associated #0: 107 / 0.234 -> en:lyophilized black raspberry saliva substitute
    n1=ipilimumab | n2=en:lyophilized black raspberry saliva substitute | rel=r_associated | relid=0 | w=107
  281. ipilimumab -- r_associated #0: 107 / 0.234 -> en:mapatumumab
    n1=ipilimumab | n2=en:mapatumumab | rel=r_associated | relid=0 | w=107
  282. ipilimumab -- r_associated #0: 107 / 0.234 -> en:masitinib mesylate
    n1=ipilimumab | n2=en:masitinib mesylate | rel=r_associated | relid=0 | w=107
  283. ipilimumab -- r_associated #0: 107 / 0.234 -> en:mct/lct/fish oil omega-3 fatty acid lipid emulsion
    n1=ipilimumab | n2=en:mct/lct/fish oil omega-3 fatty acid lipid emulsion | rel=r_associated | relid=0 | w=107
  284. ipilimumab -- r_associated #0: 107 / 0.234 -> en:mdm2 antagonist ro5045337
    n1=ipilimumab | n2=en:mdm2 antagonist ro5045337 | rel=r_associated | relid=0 | w=107
  285. ipilimumab -- r_associated #0: 107 / 0.234 -> en:meta-fluorine f 18 fluorobenzylguanidine
    n1=ipilimumab | n2=en:meta-fluorine f 18 fluorobenzylguanidine | rel=r_associated | relid=0 | w=107
  286. ipilimumab -- r_associated #0: 107 / 0.234 -> en:methoxyamine hydrochloride
    n1=ipilimumab | n2=en:methoxyamine hydrochloride | rel=r_associated | relid=0 | w=107
  287. ipilimumab -- r_associated #0: 107 / 0.234 -> en:micellar nanoparticle-encapsulated cisplatin nc-6004
    n1=ipilimumab | n2=en:micellar nanoparticle-encapsulated cisplatin nc-6004 | rel=r_associated | relid=0 | w=107
  288. ipilimumab -- r_associated #0: 107 / 0.234 -> en:mitolactol
    n1=ipilimumab | n2=en:mitolactol | rel=r_associated | relid=0 | w=107
  289. ipilimumab -- r_associated #0: 107 / 0.234 -> en:mrna-derived prostate cancer vaccine cv9103
    n1=ipilimumab | n2=en:mrna-derived prostate cancer vaccine cv9103 | rel=r_associated | relid=0 | w=107
  290. ipilimumab -- r_associated #0: 107 / 0.234 -> en:multitargeted tyrosine kinase inhibitor jnj-26483327
    n1=ipilimumab | n2=en:multitargeted tyrosine kinase inhibitor jnj-26483327 | rel=r_associated | relid=0 | w=107
  291. ipilimumab -- r_associated #0: 107 / 0.234 -> en:mycobacterium tuberculosis arabinomannan z-100
    n1=ipilimumab | n2=en:mycobacterium tuberculosis arabinomannan z-100 | rel=r_associated | relid=0 | w=107
  292. ipilimumab -- r_associated #0: 107 / 0.234 -> en:nanoparticle albumin-bound docetaxel
    n1=ipilimumab | n2=en:nanoparticle albumin-bound docetaxel | rel=r_associated | relid=0 | w=107
  293. ipilimumab -- r_associated #0: 107 / 0.234 -> en:nutritional supplement drink
    n1=ipilimumab | n2=en:nutritional supplement drink | rel=r_associated | relid=0 | w=107
  294. ipilimumab -- r_associated #0: 107 / 0.234 -> en:ny-eso-1/gla-se vaccine id-g305
    n1=ipilimumab | n2=en:ny-eso-1/gla-se vaccine id-g305 | rel=r_associated | relid=0 | w=107
  295. ipilimumab -- r_associated #0: 107 / 0.234 -> en:o-chloroacetylcarbamoylfumagillol
    n1=ipilimumab | n2=en:o-chloroacetylcarbamoylfumagillol | rel=r_associated | relid=0 | w=107
  296. ipilimumab -- r_associated #0: 107 / 0.234 -> en:p53/hdm2 interaction inhibitor cgm097
    n1=ipilimumab | n2=en:p53/hdm2 interaction inhibitor cgm097 | rel=r_associated | relid=0 | w=107
  297. ipilimumab -- r_associated #0: 107 / 0.234 -> en:paclitaxel-loaded polymeric micelle
    n1=ipilimumab | n2=en:paclitaxel-loaded polymeric micelle | rel=r_associated | relid=0 | w=107
  298. ipilimumab -- r_associated #0: 107 / 0.234 -> en:pan-pim inhibitor incb053914
    n1=ipilimumab | n2=en:pan-pim inhibitor incb053914 | rel=r_associated | relid=0 | w=107
  299. ipilimumab -- r_associated #0: 107 / 0.234 -> en:pan-vegfr/tie2 tyrosine kinase inhibitor cep-11981
    n1=ipilimumab | n2=en:pan-vegfr/tie2 tyrosine kinase inhibitor cep-11981 | rel=r_associated | relid=0 | w=107
  300. ipilimumab -- r_associated #0: 107 / 0.234 -> en:peg-linked l-rna oligonucleotide hepcidin-targeting agent nox-h94
    n1=ipilimumab | n2=en:peg-linked l-rna oligonucleotide hepcidin-targeting agent nox-h94 | rel=r_associated | relid=0 | w=107
  301. ipilimumab -- r_associated #0: 107 / 0.234 -> en:pentamethylmelamine
    n1=ipilimumab | n2=en:pentamethylmelamine | rel=r_associated | relid=0 | w=107
  302. ipilimumab -- r_associated #0: 107 / 0.234 -> en:peptides hydrolases
    n1=ipilimumab | n2=en:peptides hydrolases | rel=r_associated | relid=0 | w=107
  303. ipilimumab -- r_associated #0: 107 / 0.234 -> en:pim kinase inhibitor sgi-1776
    n1=ipilimumab | n2=en:pim kinase inhibitor sgi-1776 | rel=r_associated | relid=0 | w=107
  304. ipilimumab -- r_associated #0: 107 / 0.234 -> en:plitidepsin
    n1=ipilimumab | n2=en:plitidepsin | rel=r_associated | relid=0 | w=107
  305. ipilimumab -- r_associated #0: 107 / 0.234 -> en:polyethylene glycol
    n1=ipilimumab | n2=en:polyethylene glycol | rel=r_associated | relid=0 | w=107
  306. ipilimumab -- r_associated #0: 107 / 0.234 -> en:polyglutamate camptothecin
    n1=ipilimumab | n2=en:polyglutamate camptothecin | rel=r_associated | relid=0 | w=107
  307. ipilimumab -- r_associated #0: 107 / 0.234 -> en:protein kinase c inhibitor lxs196
    n1=ipilimumab | n2=en:protein kinase c inhibitor lxs196 | rel=r_associated | relid=0 | w=107
  308. ipilimumab -- r_associated #0: 107 / 0.234 -> en:psa:154-163(155l) peptide vaccine
    n1=ipilimumab | n2=en:psa:154-163(155l) peptide vaccine | rel=r_associated | relid=0 | w=107
  309. ipilimumab -- r_associated #0: 107 / 0.234 -> en:qs21
    n1=ipilimumab | n2=en:qs21 | rel=r_associated | relid=0 | w=107
  310. ipilimumab -- r_associated #0: 107 / 0.234 -> en:rebimastat
    n1=ipilimumab | n2=en:rebimastat | rel=r_associated | relid=0 | w=107
  311. ipilimumab -- r_associated #0: 107 / 0.234 -> en:recombinant human papillomavirus nonavalent vaccine
    n1=ipilimumab | n2=en:recombinant human papillomavirus nonavalent vaccine | rel=r_associated | relid=0 | w=107
  312. ipilimumab -- r_associated #0: 107 / 0.234 -> en:rogletimide
    n1=ipilimumab | n2=en:rogletimide | rel=r_associated | relid=0 | w=107
  313. ipilimumab -- r_associated #0: 107 / 0.234 -> en:roxithromycin
    n1=ipilimumab | n2=en:roxithromycin | rel=r_associated | relid=0 | w=107
  314. ipilimumab -- r_associated #0: 107 / 0.234 -> en:s-equol
    n1=ipilimumab | n2=en:s-equol | rel=r_associated | relid=0 | w=107
  315. ipilimumab -- r_associated #0: 107 / 0.234 -> en:salvia officinalis extract tablet
    n1=ipilimumab | n2=en:salvia officinalis extract tablet | rel=r_associated | relid=0 | w=107
  316. ipilimumab -- r_associated #0: 107 / 0.234 -> en:senna extract
    n1=ipilimumab | n2=en:senna extract | rel=r_associated | relid=0 | w=107
  317. ipilimumab -- r_associated #0: 107 / 0.234 -> en:silicon phthalocyanine 4
    n1=ipilimumab | n2=en:silicon phthalocyanine 4 | rel=r_associated | relid=0 | w=107
  318. ipilimumab -- r_associated #0: 107 / 0.234 -> en:sirolimus
    n1=ipilimumab | n2=en:sirolimus | rel=r_associated | relid=0 | w=107
  319. ipilimumab -- r_associated #0: 107 / 0.234 -> en:sodium phosphate
    n1=ipilimumab | n2=en:sodium phosphate | rel=r_associated | relid=0 | w=107
  320. ipilimumab -- r_associated #0: 107 / 0.234 -> en:sodium picosulfate/magnesium oxide/citric acid laxative
    n1=ipilimumab | n2=en:sodium picosulfate/magnesium oxide/citric acid laxative | rel=r_associated | relid=0 | w=107
  321. ipilimumab -- r_associated #0: 107 / 0.234 -> en:sting-activating cyclic dinucleotide agonist miw815
    n1=ipilimumab | n2=en:sting-activating cyclic dinucleotide agonist miw815 | rel=r_associated | relid=0 | w=107
  322. ipilimumab -- r_associated #0: 107 / 0.234 -> en:sulforaphane-cyclodextrin complex
    n1=ipilimumab | n2=en:sulforaphane-cyclodextrin complex | rel=r_associated | relid=0 | w=107
  323. ipilimumab -- r_associated #0: 107 / 0.234 -> en:sunscreen
    n1=ipilimumab | n2=en:sunscreen | rel=r_associated | relid=0 | w=107
  324. ipilimumab -- r_associated #0: 107 / 0.234 -> en:tasidotin
    n1=ipilimumab | n2=en:tasidotin | rel=r_associated | relid=0 | w=107
  325. ipilimumab -- r_associated #0: 107 / 0.234 -> en:technetium tc-99m dextran
    n1=ipilimumab | n2=en:technetium tc-99m dextran | rel=r_associated | relid=0 | w=107
  326. ipilimumab -- r_associated #0: 107 / 0.234 -> en:timcodar dimesylate
    n1=ipilimumab | n2=en:timcodar dimesylate | rel=r_associated | relid=0 | w=107
  327. ipilimumab -- r_associated #0: 107 / 0.234 -> en:tlr9 agonist duk-cpg-001
    n1=ipilimumab | n2=en:tlr9 agonist duk-cpg-001 | rel=r_associated | relid=0 | w=107
  328. ipilimumab -- r_associated #0: 107 / 0.234 -> en:tolfenamic acid
    n1=ipilimumab | n2=en:tolfenamic acid | rel=r_associated | relid=0 | w=107
  329. ipilimumab -- r_associated #0: 107 / 0.234 -> en:topical myristyl nicotinate cream
    n1=ipilimumab | n2=en:topical myristyl nicotinate cream | rel=r_associated | relid=0 | w=107
  330. ipilimumab -- r_associated #0: 107 / 0.234 -> en:topical sirolimus
    n1=ipilimumab | n2=en:topical sirolimus | rel=r_associated | relid=0 | w=107
  331. ipilimumab -- r_associated #0: 107 / 0.234 -> en:tretinoin
    n1=ipilimumab | n2=en:tretinoin | rel=r_associated | relid=0 | w=107
  332. ipilimumab -- r_associated #0: 107 / 0.234 -> en:trimethoprim-sulfamethoxazole
    n1=ipilimumab | n2=en:trimethoprim-sulfamethoxazole | rel=r_associated | relid=0 | w=107
  333. ipilimumab -- r_associated #0: 107 / 0.234 -> en:trivalent influenza vaccine
    n1=ipilimumab | n2=en:trivalent influenza vaccine | rel=r_associated | relid=0 | w=107
  334. ipilimumab -- r_associated #0: 107 / 0.234 -> en:trivalent live-attenuated influenza vaccine
    n1=ipilimumab | n2=en:trivalent live-attenuated influenza vaccine | rel=r_associated | relid=0 | w=107
  335. ipilimumab -- r_associated #0: 107 / 0.234 -> en:von hippel-lindau peptide vaccine
    n1=ipilimumab | n2=en:von hippel-lindau peptide vaccine | rel=r_associated | relid=0 | w=107
  336. ipilimumab -- r_associated #0: 107 / 0.234 -> en:weight control agent
    n1=ipilimumab | n2=en:weight control agent | rel=r_associated | relid=0 | w=107
  337. ipilimumab -- r_associated #0: 107 / 0.234 -> en:wnt signaling inhibitor sm04755
    n1=ipilimumab | n2=en:wnt signaling inhibitor sm04755 | rel=r_associated | relid=0 | w=107
  338. ipilimumab -- r_associated #0: 107 / 0.234 -> en:wt1 peptide vaccine ocv-501
    n1=ipilimumab | n2=en:wt1 peptide vaccine ocv-501 | rel=r_associated | relid=0 | w=107
  339. ipilimumab -- r_associated #0: 107 / 0.234 -> en:xenon
    n1=ipilimumab | n2=en:xenon | rel=r_associated | relid=0 | w=107
  340. ipilimumab -- r_associated #0: 107 / 0.234 -> en:yttrium y 90 glass microspheres
    n1=ipilimumab | n2=en:yttrium y 90 glass microspheres | rel=r_associated | relid=0 | w=107
  341. ipilimumab -- r_associated #0: 106 / 0.231 -> cancer
    n1=ipilimumab | n2=cancer | rel=r_associated | relid=0 | w=106
  342. ipilimumab -- r_associated #0: 106 / 0.231 -> carcinologie
    n1=ipilimumab | n2=carcinologie | rel=r_associated | relid=0 | w=106
  343. ipilimumab -- r_associated #0: 106 / 0.231 -> en:10 ml ipilimumab 5 mg/ml injection
    n1=ipilimumab | n2=en:10 ml ipilimumab 5 mg/ml injection | rel=r_associated | relid=0 | w=106
  344. ipilimumab -- r_associated #0: 106 / 0.231 -> en:ad5cmv-p53 gene
    n1=ipilimumab | n2=en:ad5cmv-p53 gene | rel=r_associated | relid=0 | w=106
  345. ipilimumab -- r_associated #0: 106 / 0.231 -> en:adenosine-a2a receptor antagonist cpi-444
    n1=ipilimumab | n2=en:adenosine-a2a receptor antagonist cpi-444 | rel=r_associated | relid=0 | w=106
  346. ipilimumab -- r_associated #0: 106 / 0.231 -> en:allogeneic gm-csf-secreting breast cancer vaccine
    n1=ipilimumab | n2=en:allogeneic gm-csf-secreting breast cancer vaccine | rel=r_associated | relid=0 | w=106
  347. ipilimumab -- r_associated #0: 106 / 0.231 -> en:alpha-folate receptor-targeting thymidylate synthase inhibitor onx-0801
    n1=ipilimumab | n2=en:alpha-folate receptor-targeting thymidylate synthase inhibitor onx-0801 | rel=r_associated | relid=0 | w=106
  348. ipilimumab -- r_associated #0: 106 / 0.231 -> en:amino acid injection
    n1=ipilimumab | n2=en:amino acid injection | rel=r_associated | relid=0 | w=106
  349. ipilimumab -- r_associated #0: 106 / 0.231 -> en:aminobenzoate potassium
    n1=ipilimumab | n2=en:aminobenzoate potassium | rel=r_associated | relid=0 | w=106
  350. ipilimumab -- r_associated #0: 106 / 0.231 -> en:amuvatinib
    n1=ipilimumab | n2=en:amuvatinib | rel=r_associated | relid=0 | w=106
  351. ipilimumab -- r_associated #0: 106 / 0.231 -> en:anti-cd20 monoclonal antibody pro131921
    n1=ipilimumab | n2=en:anti-cd20 monoclonal antibody pro131921 | rel=r_associated | relid=0 | w=106
  352. ipilimumab -- r_associated #0: 106 / 0.231 -> en:anti-cd20 monoclonal antibody tl011
    n1=ipilimumab | n2=en:anti-cd20 monoclonal antibody tl011 | rel=r_associated | relid=0 | w=106
  353. ipilimumab -- r_associated #0: 106 / 0.231 -> en:anti-cd3/anti-cd20 trifunctional bispecific monoclonal antibody fbta05
    n1=ipilimumab | n2=en:anti-cd3/anti-cd20 trifunctional bispecific monoclonal antibody fbta05 | rel=r_associated | relid=0 | w=106
  354. ipilimumab -- r_associated #0: 106 / 0.231 -> en:anti-cd40 monoclonal antibody sea-cd40
    n1=ipilimumab | n2=en:anti-cd40 monoclonal antibody sea-cd40 | rel=r_associated | relid=0 | w=106
  355. ipilimumab -- r_associated #0: 106 / 0.231 -> en:anti-cd40l fc-fusion protein bms-986004
    n1=ipilimumab | n2=en:anti-cd40l fc-fusion protein bms-986004 | rel=r_associated | relid=0 | w=106
  356. ipilimumab -- r_associated #0: 106 / 0.231 -> en:anti-egfr monoclonal antibody mixture mm-151
    n1=ipilimumab | n2=en:anti-egfr monoclonal antibody mixture mm-151 | rel=r_associated | relid=0 | w=106
  357. ipilimumab -- r_associated #0: 106 / 0.231 -> en:anti-egfr tap antibody-drug conjugate imgn289
    n1=ipilimumab | n2=en:anti-egfr tap antibody-drug conjugate imgn289 | rel=r_associated | relid=0 | w=106
  358. ipilimumab -- r_associated #0: 106 / 0.231 -> en:anti-gpa33/cd3 monoclonal antibody mgd007
    n1=ipilimumab | n2=en:anti-gpa33/cd3 monoclonal antibody mgd007 | rel=r_associated | relid=0 | w=106
  359. ipilimumab -- r_associated #0: 106 / 0.231 -> en:anti-interferon gamma monoclonal antibody ni-0501
    n1=ipilimumab | n2=en:anti-interferon gamma monoclonal antibody ni-0501 | rel=r_associated | relid=0 | w=106
  360. ipilimumab -- r_associated #0: 106 / 0.231 -> en:anti-lamp1 antibody-drug conjugate sar428926
    n1=ipilimumab | n2=en:anti-lamp1 antibody-drug conjugate sar428926 | rel=r_associated | relid=0 | w=106
  361. ipilimumab -- r_associated #0: 106 / 0.231 -> en:anti-ox40 monoclonal antibody
    n1=ipilimumab | n2=en:anti-ox40 monoclonal antibody | rel=r_associated | relid=0 | w=106
  362. ipilimumab -- r_associated #0: 106 / 0.231 -> en:anti-slitrk6 monoclonal antibody-mmae conjugate ags15e
    n1=ipilimumab | n2=en:anti-slitrk6 monoclonal antibody-mmae conjugate ags15e | rel=r_associated | relid=0 | w=106
  363. ipilimumab -- r_associated #0: 106 / 0.231 -> en:anti-tf monoclonal antibody-mmae conjugate
    n1=ipilimumab | n2=en:anti-tf monoclonal antibody-mmae conjugate | rel=r_associated | relid=0 | w=106
  364. ipilimumab -- r_associated #0: 106 / 0.231 -> en:antibody-drug conjugate pf-06647020
    n1=ipilimumab | n2=en:antibody-drug conjugate pf-06647020 | rel=r_associated | relid=0 | w=106
  365. ipilimumab -- r_associated #0: 106 / 0.231 -> en:antilipemic agent
    n1=ipilimumab | n2=en:antilipemic agent | rel=r_associated | relid=0 | w=106
  366. ipilimumab -- r_associated #0: 106 / 0.231 -> en:apatinib
    n1=ipilimumab | n2=en:apatinib | rel=r_associated | relid=0 | w=106
  367. ipilimumab -- r_associated #0: 106 / 0.231 -> en:artemether sublingual spray
    n1=ipilimumab | n2=en:artemether sublingual spray | rel=r_associated | relid=0 | w=106
  368. ipilimumab -- r_associated #0: 106 / 0.231 -> en:asaley
    n1=ipilimumab | n2=en:asaley | rel=r_associated | relid=0 | w=106
  369. ipilimumab -- r_associated #0: 106 / 0.231 -> en:atr kinase inhibitor azd6738
    n1=ipilimumab | n2=en:atr kinase inhibitor azd6738 | rel=r_associated | relid=0 | w=106
  370. ipilimumab -- r_associated #0: 106 / 0.231 -> en:autologous cd123car-cd28-cd3zeta-egfrt-expressing t lymphocytes
    n1=ipilimumab | n2=en:autologous cd123car-cd28-cd3zeta-egfrt-expressing t lymphocytes | rel=r_associated | relid=0 | w=106
  371. ipilimumab -- r_associated #0: 106 / 0.231 -> en:autologous dendritic cell vaccine act2001
    n1=ipilimumab | n2=en:autologous dendritic cell vaccine act2001 | rel=r_associated | relid=0 | w=106
  372. ipilimumab -- r_associated #0: 106 / 0.231 -> en:autologous il-21-modulated cd8+ mart1-specific t cells
    n1=ipilimumab | n2=en:autologous il-21-modulated cd8+ mart1-specific t cells | rel=r_associated | relid=0 | w=106
  373. ipilimumab -- r_associated #0: 106 / 0.231 -> en:azlocillin
    n1=ipilimumab | n2=en:azlocillin | rel=r_associated | relid=0 | w=106
  374. ipilimumab -- r_associated #0: 106 / 0.231 -> en:bafetinib
    n1=ipilimumab | n2=en:bafetinib | rel=r_associated | relid=0 | w=106
  375. ipilimumab -- r_associated #0: 106 / 0.231 -> en:bi-shrna-furin/gm-csf-expressing autologous tumor cell vaccine
    n1=ipilimumab | n2=en:bi-shrna-furin/gm-csf-expressing autologous tumor cell vaccine | rel=r_associated | relid=0 | w=106
  376. ipilimumab -- r_associated #0: 106 / 0.231 -> en:bisantrene hydrochloride
    n1=ipilimumab | n2=en:bisantrene hydrochloride | rel=r_associated | relid=0 | w=106
  377. ipilimumab -- r_associated #0: 106 / 0.231 -> en:bosutinib
    n1=ipilimumab | n2=en:bosutinib | rel=r_associated | relid=0 | w=106
  378. ipilimumab -- r_associated #0: 106 / 0.231 -> en:br96-doxorubicin immunoconjugate
    n1=ipilimumab | n2=en:br96-doxorubicin immunoconjugate | rel=r_associated | relid=0 | w=106
  379. ipilimumab -- r_associated #0: 106 / 0.231 -> en:braf/egfr inhibitor bgb-283
    n1=ipilimumab | n2=en:braf/egfr inhibitor bgb-283 | rel=r_associated | relid=0 | w=106
  380. ipilimumab -- r_associated #0: 106 / 0.231 -> en:bruceantin
    n1=ipilimumab | n2=en:bruceantin | rel=r_associated | relid=0 | w=106
  381. ipilimumab -- r_associated #0: 106 / 0.231 -> en:carbidopa
    n1=ipilimumab | n2=en:carbidopa | rel=r_associated | relid=0 | w=106
  382. ipilimumab -- r_associated #0: 106 / 0.231 -> en:carbon c 11 pbr-28
    n1=ipilimumab | n2=en:carbon c 11 pbr-28 | rel=r_associated | relid=0 | w=106
  383. ipilimumab -- r_associated #0: 106 / 0.231 -> en:carbon c 14 oxaliplatin
    n1=ipilimumab | n2=en:carbon c 14 oxaliplatin | rel=r_associated | relid=0 | w=106
  384. ipilimumab -- r_associated #0: 106 / 0.231 -> en:carboplatin-taxol regimen
    n1=ipilimumab | n2=en:carboplatin-taxol regimen | rel=r_associated | relid=0 | w=106
  385. ipilimumab -- r_associated #0: 106 / 0.231 -> en:carvedilol
    n1=ipilimumab | n2=en:carvedilol | rel=r_associated | relid=0 | w=106
  386. ipilimumab -- r_associated #0: 106 / 0.231 -> en:cationic liposome-encapsulated paclitaxel
    n1=ipilimumab | n2=en:cationic liposome-encapsulated paclitaxel | rel=r_associated | relid=0 | w=106
  387. ipilimumab -- r_associated #0: 106 / 0.231 -> en:cc-1088
    n1=ipilimumab | n2=en:cc-1088 | rel=r_associated | relid=0 | w=106
  388. ipilimumab -- r_associated #0: 106 / 0.231 -> en:cenersen
    n1=ipilimumab | n2=en:cenersen | rel=r_associated | relid=0 | w=106
  389. ipilimumab -- r_associated #0: 106 / 0.231 -> en:cetuximab-ir700 conjugate rm-1929
    n1=ipilimumab | n2=en:cetuximab-ir700 conjugate rm-1929 | rel=r_associated | relid=0 | w=106
  390. ipilimumab -- r_associated #0: 106 / 0.231 -> en:chlorotoxin [131i]
    n1=ipilimumab | n2=en:chlorotoxin [131i] | rel=r_associated | relid=0 | w=106
  391. ipilimumab -- r_associated #0: 106 / 0.231 -> en:chlorpropamide
    n1=ipilimumab | n2=en:chlorpropamide | rel=r_associated | relid=0 | w=106
  392. ipilimumab -- r_associated #0: 106 / 0.231 -> en:clevudine
    n1=ipilimumab | n2=en:clevudine | rel=r_associated | relid=0 | w=106
  393. ipilimumab -- r_associated #0: 106 / 0.231 -> en:clotrimazole
    n1=ipilimumab | n2=en:clotrimazole | rel=r_associated | relid=0 | w=106
  394. ipilimumab -- r_associated #0: 106 / 0.231 -> en:copovithane
    n1=ipilimumab | n2=en:copovithane | rel=r_associated | relid=0 | w=106
  395. ipilimumab -- r_associated #0: 106 / 0.231 -> en:cp-547632
    n1=ipilimumab | n2=en:cp-547632 | rel=r_associated | relid=0 | w=106
  396. ipilimumab -- r_associated #0: 106 / 0.231 -> en:cytarabine monophosphate prodrug mb07133
    n1=ipilimumab | n2=en:cytarabine monophosphate prodrug mb07133 | rel=r_associated | relid=0 | w=106
  397. ipilimumab -- r_associated #0: 106 / 0.231 -> en:dasabuvir
    n1=ipilimumab | n2=en:dasabuvir | rel=r_associated | relid=0 | w=106
  398. ipilimumab -- r_associated #0: 106 / 0.231 -> en:deferiprone
    n1=ipilimumab | n2=en:deferiprone | rel=r_associated | relid=0 | w=106
  399. ipilimumab -- r_associated #0: 106 / 0.231 -> en:dendritic cell-mart-1 peptide vaccine
    n1=ipilimumab | n2=en:dendritic cell-mart-1 peptide vaccine | rel=r_associated | relid=0 | w=106
  400. ipilimumab -- r_associated #0: 106 / 0.231 -> en:diphtheria toxoid/tetanus toxoid/acellular pertussis adsorbed, recombinant hepatitis b/inactivated poliovirus vaccine combined
    n1=ipilimumab | n2=en:diphtheria toxoid/tetanus toxoid/acellular pertussis adsorbed, recombinant hepatitis b/inactivated poliovirus vaccine combined | rel=r_associated | relid=0 | w=106
  401. ipilimumab -- r_associated #0: 106 / 0.231 -> en:dm4-conjugated anti-cripto monoclonal antibody biib015
    n1=ipilimumab | n2=en:dm4-conjugated anti-cripto monoclonal antibody biib015 | rel=r_associated | relid=0 | w=106
  402. ipilimumab -- r_associated #0: 106 / 0.231 -> en:dna-rna transcription regulator
    n1=ipilimumab | n2=en:dna-rna transcription regulator | rel=r_associated | relid=0 | w=106
  403. ipilimumab -- r_associated #0: 106 / 0.231 -> en:doxorubicin-hpma conjugate
    n1=ipilimumab | n2=en:doxorubicin-hpma conjugate | rel=r_associated | relid=0 | w=106
  404. ipilimumab -- r_associated #0: 106 / 0.231 -> en:e. coli cd-expressing genetically modified neural stem cells
    n1=ipilimumab | n2=en:e. coli cd-expressing genetically modified neural stem cells | rel=r_associated | relid=0 | w=106
  405. ipilimumab -- r_associated #0: 106 / 0.231 -> en:eculizumab
    n1=ipilimumab | n2=en:eculizumab | rel=r_associated | relid=0 | w=106
  406. ipilimumab -- r_associated #0: 106 / 0.231 -> en:eflornithine hydrochloride ointment
    n1=ipilimumab | n2=en:eflornithine hydrochloride ointment | rel=r_associated | relid=0 | w=106
  407. ipilimumab -- r_associated #0: 106 / 0.231 -> en:eicosapentaenoic acid-enriched nutritional supplement
    n1=ipilimumab | n2=en:eicosapentaenoic acid-enriched nutritional supplement | rel=r_associated | relid=0 | w=106
  408. ipilimumab -- r_associated #0: 106 / 0.231 -> en:ethiodized oil
    n1=ipilimumab | n2=en:ethiodized oil | rel=r_associated | relid=0 | w=106
  409. ipilimumab -- r_associated #0: 106 / 0.231 -> en:f16-il2 fusion protein
    n1=ipilimumab | n2=en:f16-il2 fusion protein | rel=r_associated | relid=0 | w=106
  410. ipilimumab -- r_associated #0: 106 / 0.231 -> en:fentanyl citrate pectin-based nasal spray
    n1=ipilimumab | n2=en:fentanyl citrate pectin-based nasal spray | rel=r_associated | relid=0 | w=106
  411. ipilimumab -- r_associated #0: 106 / 0.231 -> en:fermented wheat germ extract
    n1=ipilimumab | n2=en:fermented wheat germ extract | rel=r_associated | relid=0 | w=106
  412. ipilimumab -- r_associated #0: 106 / 0.231 -> en:fluorescent imaging ligand otl38
    n1=ipilimumab | n2=en:fluorescent imaging ligand otl38 | rel=r_associated | relid=0 | w=106
  413. ipilimumab -- r_associated #0: 106 / 0.231 -> en:fluorine f 18 dabrafenib
    n1=ipilimumab | n2=en:fluorine f 18 dabrafenib | rel=r_associated | relid=0 | w=106
  414. ipilimumab -- r_associated #0: 106 / 0.231 -> en:fluorine f 18 iso-1
    n1=ipilimumab | n2=en:fluorine f 18 iso-1 | rel=r_associated | relid=0 | w=106
  415. ipilimumab -- r_associated #0: 106 / 0.231 -> en:gallium ga 68-labeled mln6907
    n1=ipilimumab | n2=en:gallium ga 68-labeled mln6907 | rel=r_associated | relid=0 | w=106
  416. ipilimumab -- r_associated #0: 106 / 0.231 -> en:gallium ga 68-rgd
    n1=ipilimumab | n2=en:gallium ga 68-rgd | rel=r_associated | relid=0 | w=106
  417. ipilimumab -- r_associated #0: 106 / 0.231 -> en:ganciclovir
    n1=ipilimumab | n2=en:ganciclovir | rel=r_associated | relid=0 | w=106
  418. ipilimumab -- r_associated #0: 106 / 0.231 -> en:gemcitabine-cisplatin regimen
    n1=ipilimumab | n2=en:gemcitabine-cisplatin regimen | rel=r_associated | relid=0 | w=106
  419. ipilimumab -- r_associated #0: 106 / 0.231 -> en:geranylgeranyltransferase i inhibitor
    n1=ipilimumab | n2=en:geranylgeranyltransferase i inhibitor | rel=r_associated | relid=0 | w=106
  420. ipilimumab -- r_associated #0: 106 / 0.231 -> en:ghrelin peptide analogue
    n1=ipilimumab | n2=en:ghrelin peptide analogue | rel=r_associated | relid=0 | w=106
  421. ipilimumab -- r_associated #0: 106 / 0.231 -> en:globo h-dt vaccine obi-833
    n1=ipilimumab | n2=en:globo h-dt vaccine obi-833 | rel=r_associated | relid=0 | w=106
  422. ipilimumab -- r_associated #0: 106 / 0.231 -> en:glucocorticoid receptor antagonist cort125134
    n1=ipilimumab | n2=en:glucocorticoid receptor antagonist cort125134 | rel=r_associated | relid=0 | w=106
  423. ipilimumab -- r_associated #0: 106 / 0.231 -> en:glycopeptide antibiotic
    n1=ipilimumab | n2=en:glycopeptide antibiotic | rel=r_associated | relid=0 | w=106
  424. ipilimumab -- r_associated #0: 106 / 0.231 -> en:glycosylated recombinant human interleukin-7
    n1=ipilimumab | n2=en:glycosylated recombinant human interleukin-7 | rel=r_associated | relid=0 | w=106
  425. ipilimumab -- r_associated #0: 106 / 0.231 -> en:gonadotropin-releasing hormone analog
    n1=ipilimumab | n2=en:gonadotropin-releasing hormone analog | rel=r_associated | relid=0 | w=106
  426. ipilimumab -- r_associated #0: 106 / 0.231 -> en:guanabenz acetate
    n1=ipilimumab | n2=en:guanabenz acetate | rel=r_associated | relid=0 | w=106
  427. ipilimumab -- r_associated #0: 106 / 0.231 -> en:haloperidol
    n1=ipilimumab | n2=en:haloperidol | rel=r_associated | relid=0 | w=106
  428. ipilimumab -- r_associated #0: 106 / 0.231 -> en:harringtonines
    n1=ipilimumab | n2=en:harringtonines | rel=r_associated | relid=0 | w=106
  429. ipilimumab -- r_associated #0: 106 / 0.231 -> en:hdac inhibitor 4sc-202
    n1=ipilimumab | n2=en:hdac inhibitor 4sc-202 | rel=r_associated | relid=0 | w=106
  430. ipilimumab -- r_associated #0: 106 / 0.231 -> en:hdac inhibitor cxd101
    n1=ipilimumab | n2=en:hdac inhibitor cxd101 | rel=r_associated | relid=0 | w=106
  431. ipilimumab -- r_associated #0: 106 / 0.231 -> en:herba scutellaria barbata
    n1=ipilimumab | n2=en:herba scutellaria barbata | rel=r_associated | relid=0 | w=106
  432. ipilimumab -- r_associated #0: 106 / 0.231 -> en:hexamethylene bisacetamide
    n1=ipilimumab | n2=en:hexamethylene bisacetamide | rel=r_associated | relid=0 | w=106
  433. ipilimumab -- r_associated #0: 106 / 0.231 -> en:hexaminolevulinate
    n1=ipilimumab | n2=en:hexaminolevulinate | rel=r_associated | relid=0 | w=106
  434. ipilimumab -- r_associated #0: 106 / 0.231 -> en:hla-matched donor mononuclear cell-enriched leukocytes apocell
    n1=ipilimumab | n2=en:hla-matched donor mononuclear cell-enriched leukocytes apocell | rel=r_associated | relid=0 | w=106
  435. ipilimumab -- r_associated #0: 106 / 0.231 -> en:htert/survivin/melanoma tumor cell-derived mrna-transfected dendritic cell vaccine
    n1=ipilimumab | n2=en:htert/survivin/melanoma tumor cell-derived mrna-transfected dendritic cell vaccine | rel=r_associated | relid=0 | w=106
  436. ipilimumab -- r_associated #0: 106 / 0.231 -> en:hubc1-huil12 fusion protein as1409
    n1=ipilimumab | n2=en:hubc1-huil12 fusion protein as1409 | rel=r_associated | relid=0 | w=106
  437. ipilimumab -- r_associated #0: 106 / 0.231 -> en:humanized monoclonal antibody 3f8
    n1=ipilimumab | n2=en:humanized monoclonal antibody 3f8 | rel=r_associated | relid=0 | w=106
  438. ipilimumab -- r_associated #0: 106 / 0.231 -> en:hycanthone
    n1=ipilimumab | n2=en:hycanthone | rel=r_associated | relid=0 | w=106
  439. ipilimumab -- r_associated #0: 106 / 0.231 -> en:hydrated sodium calcium aluminosilicate
    n1=ipilimumab | n2=en:hydrated sodium calcium aluminosilicate | rel=r_associated | relid=0 | w=106
  440. ipilimumab -- r_associated #0: 106 / 0.231 -> en:hydroxytyrosol
    n1=ipilimumab | n2=en:hydroxytyrosol | rel=r_associated | relid=0 | w=106
  441. ipilimumab -- r_associated #0: 106 / 0.231 -> en:ibrutinib
    n1=ipilimumab | n2=en:ibrutinib | rel=r_associated | relid=0 | w=106
  442. ipilimumab -- r_associated #0: 106 / 0.231 -> en:ibutilide
    n1=ipilimumab | n2=en:ibutilide | rel=r_associated | relid=0 | w=106
  443. ipilimumab -- r_associated #0: 106 / 0.231 -> en:ic9-gd2-cd28-ox40-expressing t lymphocytes
    n1=ipilimumab | n2=en:ic9-gd2-cd28-ox40-expressing t lymphocytes | rel=r_associated | relid=0 | w=106
  444. ipilimumab -- r_associated #0: 106 / 0.231 -> en:ichthammol/lanolin/petrolatum
    n1=ipilimumab | n2=en:ichthammol/lanolin/petrolatum | rel=r_associated | relid=0 | w=106
  445. ipilimumab -- r_associated #0: 106 / 0.231 -> en:imatinib mesylate
    n1=ipilimumab | n2=en:imatinib mesylate | rel=r_associated | relid=0 | w=106
  446. ipilimumab -- r_associated #0: 106 / 0.231 -> en:imipramine
    n1=ipilimumab | n2=en:imipramine | rel=r_associated | relid=0 | w=106
  447. ipilimumab -- r_associated #0: 106 / 0.231 -> en:immediate-release onapristone
    n1=ipilimumab | n2=en:immediate-release onapristone | rel=r_associated | relid=0 | w=106
  448. ipilimumab -- r_associated #0: 106 / 0.231 -> en:immunopotentiation
    n1=ipilimumab | n2=en:immunopotentiation | rel=r_associated | relid=0 | w=106
  449. ipilimumab -- r_associated #0: 106 / 0.231 -> en:in 111 monoclonal antibody b3
    n1=ipilimumab | n2=en:in 111 monoclonal antibody b3 | rel=r_associated | relid=0 | w=106
  450. ipilimumab -- r_associated #0: 106 / 0.231 -> en:incomplete freund's adjuvant
    n1=ipilimumab | n2=en:incomplete freund's adjuvant | rel=r_associated | relid=0 | w=106
  451. ipilimumab -- r_associated #0: 106 / 0.231 -> en:indocyanine green solution
    n1=ipilimumab | n2=en:indocyanine green solution | rel=r_associated | relid=0 | w=106
  452. ipilimumab -- r_associated #0: 106 / 0.231 -> en:indocyanine green/albumin solution
    n1=ipilimumab | n2=en:indocyanine green/albumin solution | rel=r_associated | relid=0 | w=106
  453. ipilimumab -- r_associated #0: 106 / 0.231 -> en:injectable astragalus membranaceus polysaccharide
    n1=ipilimumab | n2=en:injectable astragalus membranaceus polysaccharide | rel=r_associated | relid=0 | w=106
  454. ipilimumab -- r_associated #0: 106 / 0.231 -> en:inosine 5'-monophosphate dehydrogenase inhibitor ff-10501-01
    n1=ipilimumab | n2=en:inosine 5'-monophosphate dehydrogenase inhibitor ff-10501-01 | rel=r_associated | relid=0 | w=106
  455. ipilimumab -- r_associated #0: 106 / 0.231 -> en:inosine pranobex
    n1=ipilimumab | n2=en:inosine pranobex | rel=r_associated | relid=0 | w=106
  456. ipilimumab -- r_associated #0: 106 / 0.231 -> en:interleukin-12 gene
    n1=ipilimumab | n2=en:interleukin-12 gene | rel=r_associated | relid=0 | w=106
  457. ipilimumab -- r_associated #0: 106 / 0.231 -> en:iobenguane i-131
    n1=ipilimumab | n2=en:iobenguane i-131 | rel=r_associated | relid=0 | w=106
  458. ipilimumab -- r_associated #0: 106 / 0.231 -> en:iodine i 124 monoclonal antibody a33
    n1=ipilimumab | n2=en:iodine i 124 monoclonal antibody a33 | rel=r_associated | relid=0 | w=106
  459. ipilimumab -- r_associated #0: 106 / 0.231 -> en:iodine i 131 monoclonal antibody 3f8
    n1=ipilimumab | n2=en:iodine i 131 monoclonal antibody 3f8 | rel=r_associated | relid=0 | w=106
  460. ipilimumab -- r_associated #0: 106 / 0.231 -> en:iodine i 131 monoclonal antibody g-250
    n1=ipilimumab | n2=en:iodine i 131 monoclonal antibody g-250 | rel=r_associated | relid=0 | w=106
  461. ipilimumab -- r_associated #0: 106 / 0.231 -> en:iodine i 131 phospholipid ether analogue clr1404
    n1=ipilimumab | n2=en:iodine i 131 phospholipid ether analogue clr1404 | rel=r_associated | relid=0 | w=106
  462. ipilimumab -- r_associated #0: 106 / 0.231 -> en:iodohippurate
    n1=ipilimumab | n2=en:iodohippurate | rel=r_associated | relid=0 | w=106
  463. ipilimumab -- r_associated #0: 106 / 0.231 -> en:ipilimumab 5 mg/ml injection [yervoy]
    n1=ipilimumab | n2=en:ipilimumab 5 mg/ml injection [yervoy] | rel=r_associated | relid=0 | w=106
  464. ipilimumab -- r_associated #0: 106 / 0.231 -> en:iso-fludelone
    n1=ipilimumab | n2=en:iso-fludelone | rel=r_associated | relid=0 | w=106
  465. ipilimumab -- r_associated #0: 106 / 0.231 -> en:isodecyl oleate
    n1=ipilimumab | n2=en:isodecyl oleate | rel=r_associated | relid=0 | w=106
  466. ipilimumab -- r_associated #0: 106 / 0.231 -> en:isoetharine
    n1=ipilimumab | n2=en:isoetharine | rel=r_associated | relid=0 | w=106
  467. ipilimumab -- r_associated #0: 106 / 0.231 -> en:isosource hn
    n1=ipilimumab | n2=en:isosource hn | rel=r_associated | relid=0 | w=106
  468. ipilimumab -- r_associated #0: 106 / 0.231 -> en:isotein hn
    n1=ipilimumab | n2=en:isotein hn | rel=r_associated | relid=0 | w=106
  469. ipilimumab -- r_associated #0: 106 / 0.231 -> en:juven
    n1=ipilimumab | n2=en:juven | rel=r_associated | relid=0 | w=106
  470. ipilimumab -- r_associated #0: 106 / 0.231 -> en:ksp inhibitor azd4877
    n1=ipilimumab | n2=en:ksp inhibitor azd4877 | rel=r_associated | relid=0 | w=106
  471. ipilimumab -- r_associated #0: 106 / 0.231 -> en:lactobacillus fermented extract
    n1=ipilimumab | n2=en:lactobacillus fermented extract | rel=r_associated | relid=0 | w=106
  472. ipilimumab -- r_associated #0: 106 / 0.231 -> en:linifanib
    n1=ipilimumab | n2=en:linifanib | rel=r_associated | relid=0 | w=106
  473. ipilimumab -- r_associated #0: 106 / 0.231 -> en:lipid encapsulated anti-plk1 sirna tkm-plk1
    n1=ipilimumab | n2=en:lipid encapsulated anti-plk1 sirna tkm-plk1 | rel=r_associated | relid=0 | w=106
  474. ipilimumab -- r_associated #0: 106 / 0.231 -> en:lisinopril
    n1=ipilimumab | n2=en:lisinopril | rel=r_associated | relid=0 | w=106
  475. ipilimumab -- r_associated #0: 106 / 0.231 -> en:live-attenuated double-deleted listeria monocytogenes bacteria jnj-64041809
    n1=ipilimumab | n2=en:live-attenuated double-deleted listeria monocytogenes bacteria jnj-64041809 | rel=r_associated | relid=0 | w=106
  476. ipilimumab -- r_associated #0: 106 / 0.231 -> en:lonidamine
    n1=ipilimumab | n2=en:lonidamine | rel=r_associated | relid=0 | w=106
  477. ipilimumab -- r_associated #0: 106 / 0.231 -> en:lurasidone
    n1=ipilimumab | n2=en:lurasidone | rel=r_associated | relid=0 | w=106
  478. ipilimumab -- r_associated #0: 106 / 0.231 -> en:lurbinectedin
    n1=ipilimumab | n2=en:lurbinectedin | rel=r_associated | relid=0 | w=106
  479. ipilimumab -- r_associated #0: 106 / 0.231 -> en:lutetium lu 177-dota-octreotate
    n1=ipilimumab | n2=en:lutetium lu 177-dota-octreotate | rel=r_associated | relid=0 | w=106
  480. ipilimumab -- r_associated #0: 106 / 0.231 -> en:macimorelin
    n1=ipilimumab | n2=en:macimorelin | rel=r_associated | relid=0 | w=106
  481. ipilimumab -- r_associated #0: 106 / 0.231 -> en:malignant glioma tumor lysate-pulsed autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:malignant glioma tumor lysate-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=106
  482. ipilimumab -- r_associated #0: 106 / 0.231 -> en:mammaglobin-a dna vaccine
    n1=ipilimumab | n2=en:mammaglobin-a dna vaccine | rel=r_associated | relid=0 | w=106
  483. ipilimumab -- r_associated #0: 106 / 0.231 -> en:maribavir
    n1=ipilimumab | n2=en:maribavir | rel=r_associated | relid=0 | w=106
  484. ipilimumab -- r_associated #0: 106 / 0.231 -> en:met tyrosine kinase inhibitor pf-04217903
    n1=ipilimumab | n2=en:met tyrosine kinase inhibitor pf-04217903 | rel=r_associated | relid=0 | w=106
  485. ipilimumab -- r_associated #0: 106 / 0.231 -> en:met tyrosine kinase inhibitor sgx523
    n1=ipilimumab | n2=en:met tyrosine kinase inhibitor sgx523 | rel=r_associated | relid=0 | w=106
  486. ipilimumab -- r_associated #0: 106 / 0.231 -> en:mezlocillin
    n1=ipilimumab | n2=en:mezlocillin | rel=r_associated | relid=0 | w=106
  487. ipilimumab -- r_associated #0: 106 / 0.231 -> en:minocycline-edta
    n1=ipilimumab | n2=en:minocycline-edta | rel=r_associated | relid=0 | w=106
  488. ipilimumab -- r_associated #0: 106 / 0.231 -> en:mitotane
    n1=ipilimumab | n2=en:mitotane | rel=r_associated | relid=0 | w=106
  489. ipilimumab -- r_associated #0: 106 / 0.231 -> en:monoclonal antibodies, antineoplastic
    n1=ipilimumab | n2=en:monoclonal antibodies, antineoplastic | rel=r_associated | relid=0 | w=106
  490. ipilimumab -- r_associated #0: 106 / 0.231 -> en:monoclonal antibody 105ad7 anti-idiotype vaccine
    n1=ipilimumab | n2=en:monoclonal antibody 105ad7 anti-idiotype vaccine | rel=r_associated | relid=0 | w=106
  491. ipilimumab -- r_associated #0: 106 / 0.231 -> en:monoclonal antibody e2.3
    n1=ipilimumab | n2=en:monoclonal antibody e2.3 | rel=r_associated | relid=0 | w=106
  492. ipilimumab -- r_associated #0: 106 / 0.231 -> en:mutant p53 activator coti-2
    n1=ipilimumab | n2=en:mutant p53 activator coti-2 | rel=r_associated | relid=0 | w=106
  493. ipilimumab -- r_associated #0: 106 / 0.231 -> en:nabilone
    n1=ipilimumab | n2=en:nabilone | rel=r_associated | relid=0 | w=106
  494. ipilimumab -- r_associated #0: 106 / 0.231 -> en:nabiximols
    n1=ipilimumab | n2=en:nabiximols | rel=r_associated | relid=0 | w=106
  495. ipilimumab -- r_associated #0: 106 / 0.231 -> en:nafazatrom
    n1=ipilimumab | n2=en:nafazatrom | rel=r_associated | relid=0 | w=106
  496. ipilimumab -- r_associated #0: 106 / 0.231 -> en:nasal saline irrigation solution
    n1=ipilimumab | n2=en:nasal saline irrigation solution | rel=r_associated | relid=0 | w=106
  497. ipilimumab -- r_associated #0: 106 / 0.231 -> en:natural ifn-alpha opc-18
    n1=ipilimumab | n2=en:natural ifn-alpha opc-18 | rel=r_associated | relid=0 | w=106
  498. ipilimumab -- r_associated #0: 106 / 0.231 -> en:nicotine gum
    n1=ipilimumab | n2=en:nicotine gum | rel=r_associated | relid=0 | w=106
  499. ipilimumab -- r_associated #0: 106 / 0.231 -> en:olodaterol
    n1=ipilimumab | n2=en:olodaterol | rel=r_associated | relid=0 | w=106
  500. ipilimumab -- r_associated #0: 106 / 0.231 -> en:oncolytic hsv-1 rrp450
    n1=ipilimumab | n2=en:oncolytic hsv-1 rrp450 | rel=r_associated | relid=0 | w=106
  501. ipilimumab -- r_associated #0: 106 / 0.231 -> en:opioid agonist gic-1002
    n1=ipilimumab | n2=en:opioid agonist gic-1002 | rel=r_associated | relid=0 | w=106
  502. ipilimumab -- r_associated #0: 106 / 0.231 -> en:oral azacitidine
    n1=ipilimumab | n2=en:oral azacitidine | rel=r_associated | relid=0 | w=106
  503. ipilimumab -- r_associated #0: 106 / 0.231 -> en:oseltamivir phosphate
    n1=ipilimumab | n2=en:oseltamivir phosphate | rel=r_associated | relid=0 | w=106
  504. ipilimumab -- r_associated #0: 106 / 0.231 -> en:otlertuzumab
    n1=ipilimumab | n2=en:otlertuzumab | rel=r_associated | relid=0 | w=106
  505. ipilimumab -- r_associated #0: 106 / 0.231 -> en:ovine submaxillary mucin
    n1=ipilimumab | n2=en:ovine submaxillary mucin | rel=r_associated | relid=0 | w=106
  506. ipilimumab -- r_associated #0: 106 / 0.231 -> en:p501-as15 vaccine
    n1=ipilimumab | n2=en:p501-as15 vaccine | rel=r_associated | relid=0 | w=106
  507. ipilimumab -- r_associated #0: 106 / 0.231 -> en:paricalcitol
    n1=ipilimumab | n2=en:paricalcitol | rel=r_associated | relid=0 | w=106
  508. ipilimumab -- r_associated #0: 106 / 0.231 -> en:parp inhibitor azd2461
    n1=ipilimumab | n2=en:parp inhibitor azd2461 | rel=r_associated | relid=0 | w=106
  509. ipilimumab -- r_associated #0: 106 / 0.231 -> en:pg13-cd19-h3 (anti-cd19 car) retroviral vector-transduced peripheral blood lymphocytes
    n1=ipilimumab | n2=en:pg13-cd19-h3 (anti-cd19 car) retroviral vector-transduced peripheral blood lymphocytes | rel=r_associated | relid=0 | w=106
  510. ipilimumab -- r_associated #0: 106 / 0.231 -> en:pi3kalpha inhibitor azd8835
    n1=ipilimumab | n2=en:pi3kalpha inhibitor azd8835 | rel=r_associated | relid=0 | w=106
  511. ipilimumab -- r_associated #0: 106 / 0.231 -> en:pirotinib
    n1=ipilimumab | n2=en:pirotinib | rel=r_associated | relid=0 | w=106
  512. ipilimumab -- r_associated #0: 106 / 0.231 -> en:plicamycin
    n1=ipilimumab | n2=en:plicamycin | rel=r_associated | relid=0 | w=106
  513. ipilimumab -- r_associated #0: 106 / 0.231 -> en:plx73086
    n1=ipilimumab | n2=en:plx73086 | rel=r_associated | relid=0 | w=106
  514. ipilimumab -- r_associated #0: 106 / 0.231 -> en:polymyxin b
    n1=ipilimumab | n2=en:polymyxin b | rel=r_associated | relid=0 | w=106
  515. ipilimumab -- r_associated #0: 106 / 0.231 -> en:pramipexole dihydrochloride
    n1=ipilimumab | n2=en:pramipexole dihydrochloride | rel=r_associated | relid=0 | w=106
  516. ipilimumab -- r_associated #0: 106 / 0.231 -> en:prednisolone
    n1=ipilimumab | n2=en:prednisolone | rel=r_associated | relid=0 | w=106
  517. ipilimumab -- r_associated #0: 106 / 0.231 -> en:proliferant agent
    n1=ipilimumab | n2=en:proliferant agent | rel=r_associated | relid=0 | w=106
  518. ipilimumab -- r_associated #0: 106 / 0.231 -> en:psa rna-pulsed dendritic cell vaccine
    n1=ipilimumab | n2=en:psa rna-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=106
  519. ipilimumab -- r_associated #0: 106 / 0.231 -> en:psicrip-mfg-s-tk1-67
    n1=ipilimumab | n2=en:psicrip-mfg-s-tk1-67 | rel=r_associated | relid=0 | w=106
  520. ipilimumab -- r_associated #0: 106 / 0.231 -> en:quinine
    n1=ipilimumab | n2=en:quinine | rel=r_associated | relid=0 | w=106
  521. ipilimumab -- r_associated #0: 106 / 0.231 -> en:r1 cooling gel plus r2 moisturizing/sun protecting lotion
    n1=ipilimumab | n2=en:r1 cooling gel plus r2 moisturizing/sun protecting lotion | rel=r_associated | relid=0 | w=106
  522. ipilimumab -- r_associated #0: 106 / 0.231 -> en:rabusertib
    n1=ipilimumab | n2=en:rabusertib | rel=r_associated | relid=0 | w=106
  523. ipilimumab -- r_associated #0: 106 / 0.231 -> en:radiopharmaceutical compound
    n1=ipilimumab | n2=en:radiopharmaceutical compound | rel=r_associated | relid=0 | w=106
  524. ipilimumab -- r_associated #0: 106 / 0.231 -> en:recombinant human adenovirus type 5 h101
    n1=ipilimumab | n2=en:recombinant human adenovirus type 5 h101 | rel=r_associated | relid=0 | w=106
  525. ipilimumab -- r_associated #0: 106 / 0.231 -> en:recombinant interleukin-1-beta
    n1=ipilimumab | n2=en:recombinant interleukin-1-beta | rel=r_associated | relid=0 | w=106
  526. ipilimumab -- r_associated #0: 106 / 0.231 -> en:recombinant leukocyte interleukin
    n1=ipilimumab | n2=en:recombinant leukocyte interleukin | rel=r_associated | relid=0 | w=106
  527. ipilimumab -- r_associated #0: 106 / 0.231 -> en:reproductive system drug
    n1=ipilimumab | n2=en:reproductive system drug | rel=r_associated | relid=0 | w=106
  528. ipilimumab -- r_associated #0: 106 / 0.231 -> en:rg 12915
    n1=ipilimumab | n2=en:rg 12915 | rel=r_associated | relid=0 | w=106
  529. ipilimumab -- r_associated #0: 106 / 0.231 -> en:rilotumumab
    n1=ipilimumab | n2=en:rilotumumab | rel=r_associated | relid=0 | w=106
  530. ipilimumab -- r_associated #0: 106 / 0.231 -> en:rivaroxaban
    n1=ipilimumab | n2=en:rivaroxaban | rel=r_associated | relid=0 | w=106
  531. ipilimumab -- r_associated #0: 106 / 0.231 -> en:rk-0202
    n1=ipilimumab | n2=en:rk-0202 | rel=r_associated | relid=0 | w=106
  532. ipilimumab -- r_associated #0: 106 / 0.231 -> en:saccharomyces boulardii preparation
    n1=ipilimumab | n2=en:saccharomyces boulardii preparation | rel=r_associated | relid=0 | w=106
  533. ipilimumab -- r_associated #0: 106 / 0.231 -> en:sapacitabine
    n1=ipilimumab | n2=en:sapacitabine | rel=r_associated | relid=0 | w=106
  534. ipilimumab -- r_associated #0: 106 / 0.231 -> en:sardomozide
    n1=ipilimumab | n2=en:sardomozide | rel=r_associated | relid=0 | w=106
  535. ipilimumab -- r_associated #0: 106 / 0.231 -> en:sb injection
    n1=ipilimumab | n2=en:sb injection | rel=r_associated | relid=0 | w=106
  536. ipilimumab -- r_associated #0: 106 / 0.231 -> en:sb-743921
    n1=ipilimumab | n2=en:sb-743921 | rel=r_associated | relid=0 | w=106
  537. ipilimumab -- r_associated #0: 106 / 0.231 -> en:sb-as02b adjuvant
    n1=ipilimumab | n2=en:sb-as02b adjuvant | rel=r_associated | relid=0 | w=106
  538. ipilimumab -- r_associated #0: 106 / 0.231 -> en:selumetinib
    n1=ipilimumab | n2=en:selumetinib | rel=r_associated | relid=0 | w=106
  539. ipilimumab -- r_associated #0: 106 / 0.231 -> en:serine/threonine kinase inhibitor xl418
    n1=ipilimumab | n2=en:serine/threonine kinase inhibitor xl418 | rel=r_associated | relid=0 | w=106
  540. ipilimumab -- r_associated #0: 106 / 0.231 -> en:shu yu wan formula
    n1=ipilimumab | n2=en:shu yu wan formula | rel=r_associated | relid=0 | w=106
  541. ipilimumab -- r_associated #0: 106 / 0.231 -> en:sodium hyaluronate topical hydrogel
    n1=ipilimumab | n2=en:sodium hyaluronate topical hydrogel | rel=r_associated | relid=0 | w=106
  542. ipilimumab -- r_associated #0: 106 / 0.231 -> en:solitomab
    n1=ipilimumab | n2=en:solitomab | rel=r_associated | relid=0 | w=106
  543. ipilimumab -- r_associated #0: 106 / 0.231 -> en:stavudine
    n1=ipilimumab | n2=en:stavudine | rel=r_associated | relid=0 | w=106
  544. ipilimumab -- r_associated #0: 106 / 0.231 -> en:street drugs
    n1=ipilimumab | n2=en:street drugs | rel=r_associated | relid=0 | w=106
  545. ipilimumab -- r_associated #0: 106 / 0.231 -> en:sulfate-based laxative bli850
    n1=ipilimumab | n2=en:sulfate-based laxative bli850 | rel=r_associated | relid=0 | w=106
  546. ipilimumab -- r_associated #0: 106 / 0.231 -> en:sulindac
    n1=ipilimumab | n2=en:sulindac | rel=r_associated | relid=0 | w=106
  547. ipilimumab -- r_associated #0: 106 / 0.231 -> en:survivin mrna antagonist ezn-3042
    n1=ipilimumab | n2=en:survivin mrna antagonist ezn-3042 | rel=r_associated | relid=0 | w=106
  548. ipilimumab -- r_associated #0: 106 / 0.231 -> en:synthetic glioblastoma mutated tumor-specific peptides vaccine therapy apvac2
    n1=ipilimumab | n2=en:synthetic glioblastoma mutated tumor-specific peptides vaccine therapy apvac2 | rel=r_associated | relid=0 | w=106
  549. ipilimumab -- r_associated #0: 106 / 0.231 -> en:syp-0704a
    n1=ipilimumab | n2=en:syp-0704a | rel=r_associated | relid=0 | w=106
  550. ipilimumab -- r_associated #0: 106 / 0.231 -> en:tafamidis meglumine
    n1=ipilimumab | n2=en:tafamidis meglumine | rel=r_associated | relid=0 | w=106
  551. ipilimumab -- r_associated #0: 106 / 0.231 -> en:tallimustine
    n1=ipilimumab | n2=en:tallimustine | rel=r_associated | relid=0 | w=106
  552. ipilimumab -- r_associated #0: 106 / 0.231 -> en:tegafur-gimeracil-oteracil potassium
    n1=ipilimumab | n2=en:tegafur-gimeracil-oteracil potassium | rel=r_associated | relid=0 | w=106
  553. ipilimumab -- r_associated #0: 106 / 0.231 -> en:tesevatinib
    n1=ipilimumab | n2=en:tesevatinib | rel=r_associated | relid=0 | w=106
  554. ipilimumab -- r_associated #0: 106 / 0.231 -> en:therapeutic dendritic cells/cytokine-induced killer cells
    n1=ipilimumab | n2=en:therapeutic dendritic cells/cytokine-induced killer cells | rel=r_associated | relid=0 | w=106
  555. ipilimumab -- r_associated #0: 106 / 0.231 -> en:therapeutic insulin
    n1=ipilimumab | n2=en:therapeutic insulin | rel=r_associated | relid=0 | w=106
  556. ipilimumab -- r_associated #0: 106 / 0.231 -> en:therapeutic progesterone
    n1=ipilimumab | n2=en:therapeutic progesterone | rel=r_associated | relid=0 | w=106
  557. ipilimumab -- r_associated #0: 106 / 0.231 -> en:thioureidobutyronitrile
    n1=ipilimumab | n2=en:thioureidobutyronitrile | rel=r_associated | relid=0 | w=106
  558. ipilimumab -- r_associated #0: 106 / 0.231 -> en:tigapotide
    n1=ipilimumab | n2=en:tigapotide | rel=r_associated | relid=0 | w=106
  559. ipilimumab -- r_associated #0: 106 / 0.231 -> en:tlr4 agonist gla-se
    n1=ipilimumab | n2=en:tlr4 agonist gla-se | rel=r_associated | relid=0 | w=106
  560. ipilimumab -- r_associated #0: 106 / 0.231 -> en:tris-acryl gelatin microspheres
    n1=ipilimumab | n2=en:tris-acryl gelatin microspheres | rel=r_associated | relid=0 | w=106
  561. ipilimumab -- r_associated #0: 106 / 0.231 -> en:tti-237
    n1=ipilimumab | n2=en:tti-237 | rel=r_associated | relid=0 | w=106
  562. ipilimumab -- r_associated #0: 106 / 0.231 -> en:tumor peptide-loaded myeloid dendritic cells
    n1=ipilimumab | n2=en:tumor peptide-loaded myeloid dendritic cells | rel=r_associated | relid=0 | w=106
  563. ipilimumab -- r_associated #0: 106 / 0.231 -> en:tw1025 supplement
    n1=ipilimumab | n2=en:tw1025 supplement | rel=r_associated | relid=0 | w=106
  564. ipilimumab -- r_associated #0: 106 / 0.231 -> en:uncaria tomentosa extract
    n1=ipilimumab | n2=en:uncaria tomentosa extract | rel=r_associated | relid=0 | w=106
  565. ipilimumab -- r_associated #0: 106 / 0.231 -> en:vegfr2-169 peptide vaccine
    n1=ipilimumab | n2=en:vegfr2-169 peptide vaccine | rel=r_associated | relid=0 | w=106
  566. ipilimumab -- r_associated #0: 106 / 0.231 -> en:vinblastine sulfate
    n1=ipilimumab | n2=en:vinblastine sulfate | rel=r_associated | relid=0 | w=106
  567. ipilimumab -- r_associated #0: 106 / 0.231 -> en:vitamin a compound
    n1=ipilimumab | n2=en:vitamin a compound | rel=r_associated | relid=0 | w=106
  568. ipilimumab -- r_associated #0: 106 / 0.231 -> en:voglibose
    n1=ipilimumab | n2=en:voglibose | rel=r_associated | relid=0 | w=106
  569. ipilimumab -- r_associated #0: 106 / 0.231 -> en:yangzheng xiaoji supplement
    n1=ipilimumab | n2=en:yangzheng xiaoji supplement | rel=r_associated | relid=0 | w=106
  570. ipilimumab -- r_associated #0: 106 / 0.231 -> en:yttrium y 90 monoclonal antibody mn-14
    n1=ipilimumab | n2=en:yttrium y 90 monoclonal antibody mn-14 | rel=r_associated | relid=0 | w=106
  571. ipilimumab -- r_associated #0: 106 / 0.231 -> en:zinc oxide
    n1=ipilimumab | n2=en:zinc oxide | rel=r_associated | relid=0 | w=106
  572. ipilimumab -- r_associated #0: 106 / 0.231 -> immunothérapie
    n1=ipilimumab | n2=immunothérapie | rel=r_associated | relid=0 | w=106
  573. ipilimumab -- r_associated #0: 106 / 0.231 -> maladies
    n1=ipilimumab | n2=maladies | rel=r_associated | relid=0 | w=106
  574. ipilimumab -- r_associated #0: 106 / 0.231 -> médecine spécialisée
    n1=ipilimumab | n2=médecine spécialisée | rel=r_associated | relid=0 | w=106
  575. ipilimumab -- r_associated #0: 106 / 0.231 -> oncologie
    n1=ipilimumab | n2=oncologie | rel=r_associated | relid=0 | w=106
  576. ipilimumab -- r_associated #0: 106 / 0.231 -> pharmacie
    (médicaments)
    n1=ipilimumab | n2=pharmacie
    (médicaments)
    | rel=r_associated | relid=0 | w=106
  577. ipilimumab -- r_associated #0: 105 / 0.229 -> en:[18f]l-fmac
    n1=ipilimumab | n2=en:[18f]l-fmac | rel=r_associated | relid=0 | w=105
  578. ipilimumab -- r_associated #0: 105 / 0.229 -> en:13-deoxydoxorubicin
    n1=ipilimumab | n2=en:13-deoxydoxorubicin | rel=r_associated | relid=0 | w=105
  579. ipilimumab -- r_associated #0: 105 / 0.229 -> en:14c bms-275183
    n1=ipilimumab | n2=en:14c bms-275183 | rel=r_associated | relid=0 | w=105
  580. ipilimumab -- r_associated #0: 105 / 0.229 -> en:16,16-dimethyl prostaglandin e2
    n1=ipilimumab | n2=en:16,16-dimethyl prostaglandin e2 | rel=r_associated | relid=0 | w=105
  581. ipilimumab -- r_associated #0: 105 / 0.229 -> en:18f-fhbg
    n1=ipilimumab | n2=en:18f-fhbg | rel=r_associated | relid=0 | w=105
  582. ipilimumab -- r_associated #0: 105 / 0.229 -> en:2-0, 3-0 desulfated heparin
    n1=ipilimumab | n2=en:2-0, 3-0 desulfated heparin | rel=r_associated | relid=0 | w=105
  583. ipilimumab -- r_associated #0: 105 / 0.229 -> en:2g-1 tcr retroviral vector-transduced lymphocytes
    n1=ipilimumab | n2=en:2g-1 tcr retroviral vector-transduced lymphocytes | rel=r_associated | relid=0 | w=105
  584. ipilimumab -- r_associated #0: 105 / 0.229 -> en:4-(n-(s-glutathionylacetyl)amino)phenylarsenoxide
    n1=ipilimumab | n2=en:4-(n-(s-glutathionylacetyl)amino)phenylarsenoxide | rel=r_associated | relid=0 | w=105
  585. ipilimumab -- r_associated #0: 105 / 0.229 -> en:40 ml ipilimumab 5 mg/ml injection [yervoy]
    n1=ipilimumab | n2=en:40 ml ipilimumab 5 mg/ml injection [yervoy] | rel=r_associated | relid=0 | w=105
  586. ipilimumab -- r_associated #0: 105 / 0.229 -> en:7-cyanoquinocarcinol
    n1=ipilimumab | n2=en:7-cyanoquinocarcinol | rel=r_associated | relid=0 | w=105
  587. ipilimumab -- r_associated #0: 105 / 0.229 -> en:7-hydroxystaurosporine
    n1=ipilimumab | n2=en:7-hydroxystaurosporine | rel=r_associated | relid=0 | w=105
  588. ipilimumab -- r_associated #0: 105 / 0.229 -> en:abemaciclib
    n1=ipilimumab | n2=en:abemaciclib | rel=r_associated | relid=0 | w=105
  589. ipilimumab -- r_associated #0: 105 / 0.229 -> en:abiraterone acetate
    n1=ipilimumab | n2=en:abiraterone acetate | rel=r_associated | relid=0 | w=105
  590. ipilimumab -- r_associated #0: 105 / 0.229 -> en:acarbose
    n1=ipilimumab | n2=en:acarbose | rel=r_associated | relid=0 | w=105
  591. ipilimumab -- r_associated #0: 105 / 0.229 -> en:acaricides
    n1=ipilimumab | n2=en:acaricides | rel=r_associated | relid=0 | w=105
  592. ipilimumab -- r_associated #0: 105 / 0.229 -> en:acetic acid
    n1=ipilimumab | n2=en:acetic acid | rel=r_associated | relid=0 | w=105
  593. ipilimumab -- r_associated #0: 105 / 0.229 -> en:acoustic coupling fluid
    n1=ipilimumab | n2=en:acoustic coupling fluid | rel=r_associated | relid=0 | w=105
  594. ipilimumab -- r_associated #0: 105 / 0.229 -> en:acyclovir sodium
    n1=ipilimumab | n2=en:acyclovir sodium | rel=r_associated | relid=0 | w=105
  595. ipilimumab -- r_associated #0: 105 / 0.229 -> en:adh-1
    n1=ipilimumab | n2=en:adh-1 | rel=r_associated | relid=0 | w=105
  596. ipilimumab -- r_associated #0: 105 / 0.229 -> en:adrtvp-1-transduced prostate cancer cell-based vaccine
    n1=ipilimumab | n2=en:adrtvp-1-transduced prostate cancer cell-based vaccine | rel=r_associated | relid=0 | w=105
  597. ipilimumab -- r_associated #0: 105 / 0.229 -> en:afamelanotide
    n1=ipilimumab | n2=en:afamelanotide | rel=r_associated | relid=0 | w=105
  598. ipilimumab -- r_associated #0: 105 / 0.229 -> en:afp464
    n1=ipilimumab | n2=en:afp464 | rel=r_associated | relid=0 | w=105
  599. ipilimumab -- r_associated #0: 105 / 0.229 -> en:afuresertib
    n1=ipilimumab | n2=en:afuresertib | rel=r_associated | relid=0 | w=105
  600. ipilimumab -- r_associated #0: 105 / 0.229 -> en:agaricus blazei murill extract
    n1=ipilimumab | n2=en:agaricus blazei murill extract | rel=r_associated | relid=0 | w=105
  601. ipilimumab -- r_associated #0: 105 / 0.229 -> en:akt inhibitor sr13668
    n1=ipilimumab | n2=en:akt inhibitor sr13668 | rel=r_associated | relid=0 | w=105
  602. ipilimumab -- r_associated #0: 105 / 0.229 -> en:aldesleukin
    n1=ipilimumab | n2=en:aldesleukin | rel=r_associated | relid=0 | w=105
  603. ipilimumab -- r_associated #0: 105 / 0.229 -> en:alk-fak inhibitor cep-37440
    n1=ipilimumab | n2=en:alk-fak inhibitor cep-37440 | rel=r_associated | relid=0 | w=105
  604. ipilimumab -- r_associated #0: 105 / 0.229 -> en:alkylating agent
    n1=ipilimumab | n2=en:alkylating agent | rel=r_associated | relid=0 | w=105
  605. ipilimumab -- r_associated #0: 105 / 0.229 -> en:allogeneic cd19-specific car-modified cd8 plus central memory-derived virus-specific t cells
    n1=ipilimumab | n2=en:allogeneic cd19-specific car-modified cd8 plus central memory-derived virus-specific t cells | rel=r_associated | relid=0 | w=105
  606. ipilimumab -- r_associated #0: 105 / 0.229 -> en:allogeneic glioblastoma stem-like cell line lysate-pulsed autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:allogeneic glioblastoma stem-like cell line lysate-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=105
  607. ipilimumab -- r_associated #0: 105 / 0.229 -> en:allogeneic melanoma vaccine agi-101h
    n1=ipilimumab | n2=en:allogeneic melanoma vaccine agi-101h | rel=r_associated | relid=0 | w=105
  608. ipilimumab -- r_associated #0: 105 / 0.229 -> en:allogeneic mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:allogeneic mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=105
  609. ipilimumab -- r_associated #0: 105 / 0.229 -> en:alloxan
    n1=ipilimumab | n2=en:alloxan | rel=r_associated | relid=0 | w=105
  610. ipilimumab -- r_associated #0: 105 / 0.229 -> en:alogliptin
    n1=ipilimumab | n2=en:alogliptin | rel=r_associated | relid=0 | w=105
  611. ipilimumab -- r_associated #0: 105 / 0.229 -> en:alpelisib
    n1=ipilimumab | n2=en:alpelisib | rel=r_associated | relid=0 | w=105
  612. ipilimumab -- r_associated #0: 105 / 0.229 -> en:alpha-lipoic acid
    n1=ipilimumab | n2=en:alpha-lipoic acid | rel=r_associated | relid=0 | w=105
  613. ipilimumab -- r_associated #0: 105 / 0.229 -> en:alpha-tocopheryloxyacetic acid
    n1=ipilimumab | n2=en:alpha-tocopheryloxyacetic acid | rel=r_associated | relid=0 | w=105
  614. ipilimumab -- r_associated #0: 105 / 0.229 -> en:altiratinib
    n1=ipilimumab | n2=en:altiratinib | rel=r_associated | relid=0 | w=105
  615. ipilimumab -- r_associated #0: 105 / 0.229 -> en:amilomer
    n1=ipilimumab | n2=en:amilomer | rel=r_associated | relid=0 | w=105
  616. ipilimumab -- r_associated #0: 105 / 0.229 -> en:aminolevulinic acid hydrochloride
    n1=ipilimumab | n2=en:aminolevulinic acid hydrochloride | rel=r_associated | relid=0 | w=105
  617. ipilimumab -- r_associated #0: 105 / 0.229 -> en:aminopterin
    n1=ipilimumab | n2=en:aminopterin | rel=r_associated | relid=0 | w=105
  618. ipilimumab -- r_associated #0: 105 / 0.229 -> en:amoxicillin
    n1=ipilimumab | n2=en:amoxicillin | rel=r_associated | relid=0 | w=105
  619. ipilimumab -- r_associated #0: 105 / 0.229 -> en:androgen receptor antagonist shr3680
    n1=ipilimumab | n2=en:androgen receptor antagonist shr3680 | rel=r_associated | relid=0 | w=105
  620. ipilimumab -- r_associated #0: 105 / 0.229 -> en:androgen receptor ligand-binding domain-encoding plasmid dna vaccine mvi-118
    n1=ipilimumab | n2=en:androgen receptor ligand-binding domain-encoding plasmid dna vaccine mvi-118 | rel=r_associated | relid=0 | w=105
  621. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ang2/vegf-binding peptides-antibody fusion protein cvx-241
    n1=ipilimumab | n2=en:ang2/vegf-binding peptides-antibody fusion protein cvx-241 | rel=r_associated | relid=0 | w=105
  622. ipilimumab -- r_associated #0: 105 / 0.229 -> en:angiogenesis/heparanase inhibitor pg545
    n1=ipilimumab | n2=en:angiogenesis/heparanase inhibitor pg545 | rel=r_associated | relid=0 | w=105
  623. ipilimumab -- r_associated #0: 105 / 0.229 -> en:angiostatin
    n1=ipilimumab | n2=en:angiostatin | rel=r_associated | relid=0 | w=105
  624. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anlotinib hydrochloride
    n1=ipilimumab | n2=en:anlotinib hydrochloride | rel=r_associated | relid=0 | w=105
  625. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-ags-16 monoclonal antibody ags-16m18
    n1=ipilimumab | n2=en:anti-ags-16 monoclonal antibody ags-16m18 | rel=r_associated | relid=0 | w=105
  626. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-ags-5 antibody-drug conjugate asg-5me
    n1=ipilimumab | n2=en:anti-ags-5 antibody-drug conjugate asg-5me | rel=r_associated | relid=0 | w=105
  627. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-ang2 monoclonal antibody medi-3617
    n1=ipilimumab | n2=en:anti-ang2 monoclonal antibody medi-3617 | rel=r_associated | relid=0 | w=105
  628. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-b7-h3 antibody ds-5573a
    n1=ipilimumab | n2=en:anti-b7-h3 antibody ds-5573a | rel=r_associated | relid=0 | w=105
  629. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-c-met monoclonal antibody abt-700
    n1=ipilimumab | n2=en:anti-c-met monoclonal antibody abt-700 | rel=r_associated | relid=0 | w=105
  630. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-c-met monoclonal antibody argx-111
    n1=ipilimumab | n2=en:anti-c-met monoclonal antibody argx-111 | rel=r_associated | relid=0 | w=105
  631. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-c-met monoclonal antibody sait301
    n1=ipilimumab | n2=en:anti-c-met monoclonal antibody sait301 | rel=r_associated | relid=0 | w=105
  632. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-cd19 monoclonal antibody mdx-1342
    n1=ipilimumab | n2=en:anti-cd19 monoclonal antibody mdx-1342 | rel=r_associated | relid=0 | w=105
  633. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-cd22-car m971-bbz lentiviral vector-transduced autologous t lymphocytes
    n1=ipilimumab | n2=en:anti-cd22-car m971-bbz lentiviral vector-transduced autologous t lymphocytes | rel=r_associated | relid=0 | w=105
  634. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-cd25-pbd antibody-drug conjugate adct-301
    n1=ipilimumab | n2=en:anti-cd25-pbd antibody-drug conjugate adct-301 | rel=r_associated | relid=0 | w=105
  635. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-cd3/anti-egfr-bispecific monoclonal antibody-armed activated autologous t-lymphocytes
    n1=ipilimumab | n2=en:anti-cd3/anti-egfr-bispecific monoclonal antibody-armed activated autologous t-lymphocytes | rel=r_associated | relid=0 | w=105
  636. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-cd30/cd16a monoclonal antibody afm13
    n1=ipilimumab | n2=en:anti-cd30/cd16a monoclonal antibody afm13 | rel=r_associated | relid=0 | w=105
  637. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-cd45 monoclonal antibody
    n1=ipilimumab | n2=en:anti-cd45 monoclonal antibody | rel=r_associated | relid=0 | w=105
  638. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-cd45 monoclonal antibody bc8
    n1=ipilimumab | n2=en:anti-cd45 monoclonal antibody bc8 | rel=r_associated | relid=0 | w=105
  639. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-cd47 monoclonal antibody cc-90002
    n1=ipilimumab | n2=en:anti-cd47 monoclonal antibody cc-90002 | rel=r_associated | relid=0 | w=105
  640. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-ceacam5 antibody-drug conjugate sar408701
    n1=ipilimumab | n2=en:anti-ceacam5 antibody-drug conjugate sar408701 | rel=r_associated | relid=0 | w=105
  641. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-ctla-4 monoclonal antibody agen1884
    n1=ipilimumab | n2=en:anti-ctla-4 monoclonal antibody agen1884 | rel=r_associated | relid=0 | w=105
  642. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-ctla4 moab rna/gitrl rna-transfected autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:anti-ctla4 moab rna/gitrl rna-transfected autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=105
  643. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/docetaxel
    n1=ipilimumab | n2=en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/docetaxel | rel=r_associated | relid=0 | w=105
  644. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/fowlpox-psa-tricom vaccine/sargramostim/vaccinia-psa-tricom vaccine
    n1=ipilimumab | n2=en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/fowlpox-psa-tricom vaccine/sargramostim/vaccinia-psa-tricom vaccine | rel=r_associated | relid=0 | w=105
  645. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-dkk-1 monoclonal antibody ly2812176
    n1=ipilimumab | n2=en:anti-dkk-1 monoclonal antibody ly2812176 | rel=r_associated | relid=0 | w=105
  646. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-dkk1 monoclonal antibody bhq880
    n1=ipilimumab | n2=en:anti-dkk1 monoclonal antibody bhq880 | rel=r_associated | relid=0 | w=105
  647. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-dll4/vegf bispecific monoclonal antibody omp-305b83
    n1=ipilimumab | n2=en:anti-dll4/vegf bispecific monoclonal antibody omp-305b83 | rel=r_associated | relid=0 | w=105
  648. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-endoglin chimeric monoclonal antibody trc105
    n1=ipilimumab | n2=en:anti-endoglin chimeric monoclonal antibody trc105 | rel=r_associated | relid=0 | w=105
  649. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-enpp3/mmaf antibody-drug conjugate ags-16m8f
    n1=ipilimumab | n2=en:anti-enpp3/mmaf antibody-drug conjugate ags-16m8f | rel=r_associated | relid=0 | w=105
  650. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-epha2 monoclonal antibody ds-8895a
    n1=ipilimumab | n2=en:anti-epha2 monoclonal antibody ds-8895a | rel=r_associated | relid=0 | w=105
  651. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-epha3 monoclonal antibody kb004
    n1=ipilimumab | n2=en:anti-epha3 monoclonal antibody kb004 | rel=r_associated | relid=0 | w=105
  652. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-fgfr2 antibody-drug conjugate bay1187982
    n1=ipilimumab | n2=en:anti-fgfr2 antibody-drug conjugate bay1187982 | rel=r_associated | relid=0 | w=105
  653. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-fgfr3 monoclonal antibody b-701
    n1=ipilimumab | n2=en:anti-fgfr3 monoclonal antibody b-701 | rel=r_associated | relid=0 | w=105
  654. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-fgfr3 monoclonal antibody mfgr1877s
    n1=ipilimumab | n2=en:anti-fgfr3 monoclonal antibody mfgr1877s | rel=r_associated | relid=0 | w=105
  655. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-gd2 monoclonal antibody morab-028
    n1=ipilimumab | n2=en:anti-gd2 monoclonal antibody morab-028 | rel=r_associated | relid=0 | w=105
  656. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-her2 monoclonal antibody ct-p6
    n1=ipilimumab | n2=en:anti-her2 monoclonal antibody ct-p6 | rel=r_associated | relid=0 | w=105
  657. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-hgf monoclonal antibody tak-701
    n1=ipilimumab | n2=en:anti-hgf monoclonal antibody tak-701 | rel=r_associated | relid=0 | w=105
  658. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-icos agonist antibody gsk3359609
    n1=ipilimumab | n2=en:anti-icos agonist antibody gsk3359609 | rel=r_associated | relid=0 | w=105
  659. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-icos monoclonal antibody medi-570
    n1=ipilimumab | n2=en:anti-icos monoclonal antibody medi-570 | rel=r_associated | relid=0 | w=105
  660. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-idiotypic monoclonal antibody bec2
    n1=ipilimumab | n2=en:anti-idiotypic monoclonal antibody bec2 | rel=r_associated | relid=0 | w=105
  661. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-igf-1r monoclonal antibody ave1642
    n1=ipilimumab | n2=en:anti-igf-1r monoclonal antibody ave1642 | rel=r_associated | relid=0 | w=105
  662. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-infective agent
    n1=ipilimumab | n2=en:anti-infective agent | rel=r_associated | relid=0 | w=105
  663. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-kir3dl2 monoclonal antibody iph4102
    n1=ipilimumab | n2=en:anti-kir3dl2 monoclonal antibody iph4102 | rel=r_associated | relid=0 | w=105
  664. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-melanin monoclonal antibody pti-6d2
    n1=ipilimumab | n2=en:anti-melanin monoclonal antibody pti-6d2 | rel=r_associated | relid=0 | w=105
  665. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-mesothelin car vector-transduced autologous t-lymphocytes
    n1=ipilimumab | n2=en:anti-mesothelin car vector-transduced autologous t-lymphocytes | rel=r_associated | relid=0 | w=105
  666. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-myostatin monoclonal antibody ly2495655
    n1=ipilimumab | n2=en:anti-myostatin monoclonal antibody ly2495655 | rel=r_associated | relid=0 | w=105
  667. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-ox40 antibody bms 986178
    n1=ipilimumab | n2=en:anti-ox40 antibody bms 986178 | rel=r_associated | relid=0 | w=105
  668. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-pdgfr alpha monoclonal antibody medi-575
    n1=ipilimumab | n2=en:anti-pdgfr alpha monoclonal antibody medi-575 | rel=r_associated | relid=0 | w=105
  669. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-plgf monoclonal antibody tb-403
    n1=ipilimumab | n2=en:anti-plgf monoclonal antibody tb-403 | rel=r_associated | relid=0 | w=105
  670. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-prame immunotherapeutic gsk2302032a
    n1=ipilimumab | n2=en:anti-prame immunotherapeutic gsk2302032a | rel=r_associated | relid=0 | w=105
  671. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-psma monoclonal antibody-mmae conjugate
    n1=ipilimumab | n2=en:anti-psma monoclonal antibody-mmae conjugate | rel=r_associated | relid=0 | w=105
  672. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-tweak monoclonal antibody ro5458640
    n1=ipilimumab | n2=en:anti-tweak monoclonal antibody ro5458640 | rel=r_associated | relid=0 | w=105
  673. ipilimumab -- r_associated #0: 105 / 0.229 -> en:anti-vegfc monoclonal antibody vgx-100
    n1=ipilimumab | n2=en:anti-vegfc monoclonal antibody vgx-100 | rel=r_associated | relid=0 | w=105
  674. ipilimumab -- r_associated #0: 105 / 0.229 -> en:antineoplaston as2-1
    n1=ipilimumab | n2=en:antineoplaston as2-1 | rel=r_associated | relid=0 | w=105
  675. ipilimumab -- r_associated #0: 105 / 0.229 -> en:apc8015f
    n1=ipilimumab | n2=en:apc8015f | rel=r_associated | relid=0 | w=105
  676. ipilimumab -- r_associated #0: 105 / 0.229 -> en:api 31510 topical cream
    n1=ipilimumab | n2=en:api 31510 topical cream | rel=r_associated | relid=0 | w=105
  677. ipilimumab -- r_associated #0: 105 / 0.229 -> en:apilimod dimesylate capsule
    n1=ipilimumab | n2=en:apilimod dimesylate capsule | rel=r_associated | relid=0 | w=105
  678. ipilimumab -- r_associated #0: 105 / 0.229 -> en:apoptosis inducer gcs-100
    n1=ipilimumab | n2=en:apoptosis inducer gcs-100 | rel=r_associated | relid=0 | w=105
  679. ipilimumab -- r_associated #0: 105 / 0.229 -> en:aromatase inhibitor
    n1=ipilimumab | n2=en:aromatase inhibitor | rel=r_associated | relid=0 | w=105
  680. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ashwagandha root powder extract
    n1=ipilimumab | n2=en:ashwagandha root powder extract | rel=r_associated | relid=0 | w=105
  681. ipilimumab -- r_associated #0: 105 / 0.229 -> en:asp4132
    n1=ipilimumab | n2=en:asp4132 | rel=r_associated | relid=0 | w=105
  682. ipilimumab -- r_associated #0: 105 / 0.229 -> en:asp9521
    n1=ipilimumab | n2=en:asp9521 | rel=r_associated | relid=0 | w=105
  683. ipilimumab -- r_associated #0: 105 / 0.229 -> en:atezolizumab
    n1=ipilimumab | n2=en:atezolizumab | rel=r_associated | relid=0 | w=105
  684. ipilimumab -- r_associated #0: 105 / 0.229 -> en:attenuated corynebacterium parvum
    n1=ipilimumab | n2=en:attenuated corynebacterium parvum | rel=r_associated | relid=0 | w=105
  685. ipilimumab -- r_associated #0: 105 / 0.229 -> en:aurora a kinase inhibitor tas-119
    n1=ipilimumab | n2=en:aurora a kinase inhibitor tas-119 | rel=r_associated | relid=0 | w=105
  686. ipilimumab -- r_associated #0: 105 / 0.229 -> en:autologous cd133-positive btsc mrna-pulsed autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:autologous cd133-positive btsc mrna-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=105
  687. ipilimumab -- r_associated #0: 105 / 0.229 -> en:autologous colon cancer cell vaccine
    n1=ipilimumab | n2=en:autologous colon cancer cell vaccine | rel=r_associated | relid=0 | w=105
  688. ipilimumab -- r_associated #0: 105 / 0.229 -> en:autologous dendritic cell-adenovirus ccl21 vaccine
    n1=ipilimumab | n2=en:autologous dendritic cell-adenovirus ccl21 vaccine | rel=r_associated | relid=0 | w=105
  689. ipilimumab -- r_associated #0: 105 / 0.229 -> en:autologous gm-csf-secreting lethally irradiated colorectal cancer cell vaccine
    n1=ipilimumab | n2=en:autologous gm-csf-secreting lethally irradiated colorectal cancer cell vaccine | rel=r_associated | relid=0 | w=105
  690. ipilimumab -- r_associated #0: 105 / 0.229 -> en:autologous heat-shock protein 70 peptide vaccine ag-858
    n1=ipilimumab | n2=en:autologous heat-shock protein 70 peptide vaccine ag-858 | rel=r_associated | relid=0 | w=105
  691. ipilimumab -- r_associated #0: 105 / 0.229 -> en:autologous immunoglobulin idiotype-klh conjugate vaccine
    n1=ipilimumab | n2=en:autologous immunoglobulin idiotype-klh conjugate vaccine | rel=r_associated | relid=0 | w=105
  692. ipilimumab -- r_associated #0: 105 / 0.229 -> en:autologous muc1-mannan fusion protein pulsed dendritic cell vaccine
    n1=ipilimumab | n2=en:autologous muc1-mannan fusion protein pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=105
  693. ipilimumab -- r_associated #0: 105 / 0.229 -> en:autologous pluripotent aldhbr stem cells ald-451
    n1=ipilimumab | n2=en:autologous pluripotent aldhbr stem cells ald-451 | rel=r_associated | relid=0 | w=105
  694. ipilimumab -- r_associated #0: 105 / 0.229 -> en:avelumab
    n1=ipilimumab | n2=en:avelumab | rel=r_associated | relid=0 | w=105
  695. ipilimumab -- r_associated #0: 105 / 0.229 -> en:azathioprine sodium
    n1=ipilimumab | n2=en:azathioprine sodium | rel=r_associated | relid=0 | w=105
  696. ipilimumab -- r_associated #0: 105 / 0.229 -> en:azithromycin
    n1=ipilimumab | n2=en:azithromycin | rel=r_associated | relid=0 | w=105
  697. ipilimumab -- r_associated #0: 105 / 0.229 -> en:b-raf/vegfr-2 inhibitor raf265
    n1=ipilimumab | n2=en:b-raf/vegfr-2 inhibitor raf265 | rel=r_associated | relid=0 | w=105
  698. ipilimumab -- r_associated #0: 105 / 0.229 -> en:baclofen
    n1=ipilimumab | n2=en:baclofen | rel=r_associated | relid=0 | w=105
  699. ipilimumab -- r_associated #0: 105 / 0.229 -> en:baclofen/amitriptyline/ketamine gel
    n1=ipilimumab | n2=en:baclofen/amitriptyline/ketamine gel | rel=r_associated | relid=0 | w=105
  700. ipilimumab -- r_associated #0: 105 / 0.229 -> en:balanced crystalloid solution
    n1=ipilimumab | n2=en:balanced crystalloid solution | rel=r_associated | relid=0 | w=105
  701. ipilimumab -- r_associated #0: 105 / 0.229 -> en:bc-819 plasmid/polyethylenimine complex
    n1=ipilimumab | n2=en:bc-819 plasmid/polyethylenimine complex | rel=r_associated | relid=0 | w=105
  702. ipilimumab -- r_associated #0: 105 / 0.229 -> en:bcma-specific car-expressing t lymphocytes
    n1=ipilimumab | n2=en:bcma-specific car-expressing t lymphocytes | rel=r_associated | relid=0 | w=105
  703. ipilimumab -- r_associated #0: 105 / 0.229 -> en:bcr-abl p210-b3a2 breakpoint-derived pentapeptide vaccine
    n1=ipilimumab | n2=en:bcr-abl p210-b3a2 breakpoint-derived pentapeptide vaccine | rel=r_associated | relid=0 | w=105
  704. ipilimumab -- r_associated #0: 105 / 0.229 -> en:beacopp regimen
    n1=ipilimumab | n2=en:beacopp regimen | rel=r_associated | relid=0 | w=105
  705. ipilimumab -- r_associated #0: 105 / 0.229 -> en:beetroot juice
    n1=ipilimumab | n2=en:beetroot juice | rel=r_associated | relid=0 | w=105
  706. ipilimumab -- r_associated #0: 105 / 0.229 -> en:belagenpumatucel-l
    n1=ipilimumab | n2=en:belagenpumatucel-l | rel=r_associated | relid=0 | w=105
  707. ipilimumab -- r_associated #0: 105 / 0.229 -> en:belinostat
    n1=ipilimumab | n2=en:belinostat | rel=r_associated | relid=0 | w=105
  708. ipilimumab -- r_associated #0: 105 / 0.229 -> en:benazepril hydrochloride
    n1=ipilimumab | n2=en:benazepril hydrochloride | rel=r_associated | relid=0 | w=105
  709. ipilimumab -- r_associated #0: 105 / 0.229 -> en:bendamustine-containing nanoparticle-based formulation rxdx-107
    n1=ipilimumab | n2=en:bendamustine-containing nanoparticle-based formulation rxdx-107 | rel=r_associated | relid=0 | w=105
  710. ipilimumab -- r_associated #0: 105 / 0.229 -> en:bet inhibitor cpi-0610
    n1=ipilimumab | n2=en:bet inhibitor cpi-0610 | rel=r_associated | relid=0 | w=105
  711. ipilimumab -- r_associated #0: 105 / 0.229 -> en:beta alethine
    n1=ipilimumab | n2=en:beta alethine | rel=r_associated | relid=0 | w=105
  712. ipilimumab -- r_associated #0: 105 / 0.229 -> en:beta-elemene
    n1=ipilimumab | n2=en:beta-elemene | rel=r_associated | relid=0 | w=105
  713. ipilimumab -- r_associated #0: 105 / 0.229 -> en:betamethasone
    n1=ipilimumab | n2=en:betamethasone | rel=r_associated | relid=0 | w=105
  714. ipilimumab -- r_associated #0: 105 / 0.229 -> en:bi 831266
    n1=ipilimumab | n2=en:bi 831266 | rel=r_associated | relid=0 | w=105
  715. ipilimumab -- r_associated #0: 105 / 0.229 -> en:biomed 101
    n1=ipilimumab | n2=en:biomed 101 | rel=r_associated | relid=0 | w=105
  716. ipilimumab -- r_associated #0: 105 / 0.229 -> en:bispecific antibody mdx447
    n1=ipilimumab | n2=en:bispecific antibody mdx447 | rel=r_associated | relid=0 | w=105
  717. ipilimumab -- r_associated #0: 105 / 0.229 -> en:bivalent hpv16/18 therapeutic cervical cancer vaccine
    n1=ipilimumab | n2=en:bivalent hpv16/18 therapeutic cervical cancer vaccine | rel=r_associated | relid=0 | w=105
  718. ipilimumab -- r_associated #0: 105 / 0.229 -> en:bl22 immunotoxin
    n1=ipilimumab | n2=en:bl22 immunotoxin | rel=r_associated | relid=0 | w=105
  719. ipilimumab -- r_associated #0: 105 / 0.229 -> en:black cohosh
    n1=ipilimumab | n2=en:black cohosh | rel=r_associated | relid=0 | w=105
  720. ipilimumab -- r_associated #0: 105 / 0.229 -> en:bmi1 inhibitor ptc596
    n1=ipilimumab | n2=en:bmi1 inhibitor ptc596 | rel=r_associated | relid=0 | w=105
  721. ipilimumab -- r_associated #0: 105 / 0.229 -> en:bms-986156
    n1=ipilimumab | n2=en:bms-986156 | rel=r_associated | relid=0 | w=105
  722. ipilimumab -- r_associated #0: 105 / 0.229 -> en:bone cements
    n1=ipilimumab | n2=en:bone cements | rel=r_associated | relid=0 | w=105
  723. ipilimumab -- r_associated #0: 105 / 0.229 -> en:bowman-birk inhibitor concentrate
    n1=ipilimumab | n2=en:bowman-birk inhibitor concentrate | rel=r_associated | relid=0 | w=105
  724. ipilimumab -- r_associated #0: 105 / 0.229 -> en:briciclib sodium
    n1=ipilimumab | n2=en:briciclib sodium | rel=r_associated | relid=0 | w=105
  725. ipilimumab -- r_associated #0: 105 / 0.229 -> en:brivanib
    n1=ipilimumab | n2=en:brivanib | rel=r_associated | relid=0 | w=105
  726. ipilimumab -- r_associated #0: 105 / 0.229 -> en:bromacrylide
    n1=ipilimumab | n2=en:bromacrylide | rel=r_associated | relid=0 | w=105
  727. ipilimumab -- r_associated #0: 105 / 0.229 -> en:btk inhibitor gdc-0853
    n1=ipilimumab | n2=en:btk inhibitor gdc-0853 | rel=r_associated | relid=0 | w=105
  728. ipilimumab -- r_associated #0: 105 / 0.229 -> en:cabozantinib s-malate
    n1=ipilimumab | n2=en:cabozantinib s-malate | rel=r_associated | relid=0 | w=105
  729. ipilimumab -- r_associated #0: 105 / 0.229 -> en:calaspargase pegol
    n1=ipilimumab | n2=en:calaspargase pegol | rel=r_associated | relid=0 | w=105
  730. ipilimumab -- r_associated #0: 105 / 0.229 -> en:calcium chloride
    n1=ipilimumab | n2=en:calcium chloride | rel=r_associated | relid=0 | w=105
  731. ipilimumab -- r_associated #0: 105 / 0.229 -> en:calcium-46 chloride aqueous solution
    n1=ipilimumab | n2=en:calcium-46 chloride aqueous solution | rel=r_associated | relid=0 | w=105
  732. ipilimumab -- r_associated #0: 105 / 0.229 -> en:calendula officinalis/plantago major/cochlearia armoracia/hamamelis virginiana herbal toothpaste
    n1=ipilimumab | n2=en:calendula officinalis/plantago major/cochlearia armoracia/hamamelis virginiana herbal toothpaste | rel=r_associated | relid=0 | w=105
  733. ipilimumab -- r_associated #0: 105 / 0.229 -> en:calfactant
    n1=ipilimumab | n2=en:calfactant | rel=r_associated | relid=0 | w=105
  734. ipilimumab -- r_associated #0: 105 / 0.229 -> en:calusterone
    n1=ipilimumab | n2=en:calusterone | rel=r_associated | relid=0 | w=105
  735. ipilimumab -- r_associated #0: 105 / 0.229 -> en:campy cva agar
    n1=ipilimumab | n2=en:campy cva agar | rel=r_associated | relid=0 | w=105
  736. ipilimumab -- r_associated #0: 105 / 0.229 -> en:canertinib dihydrochloride
    n1=ipilimumab | n2=en:canertinib dihydrochloride | rel=r_associated | relid=0 | w=105
  737. ipilimumab -- r_associated #0: 105 / 0.229 -> en:car.cd30-expressing autologous epstein-barr virus-specific cytotoxic t-lymphocytes
    n1=ipilimumab | n2=en:car.cd30-expressing autologous epstein-barr virus-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=105
  738. ipilimumab -- r_associated #0: 105 / 0.229 -> en:carbamazepine
    n1=ipilimumab | n2=en:carbamazepine | rel=r_associated | relid=0 | w=105
  739. ipilimumab -- r_associated #0: 105 / 0.229 -> en:carbetimer
    n1=ipilimumab | n2=en:carbetimer | rel=r_associated | relid=0 | w=105
  740. ipilimumab -- r_associated #0: 105 / 0.229 -> en:carbon c 11 erlotinib hydrochloride
    n1=ipilimumab | n2=en:carbon c 11 erlotinib hydrochloride | rel=r_associated | relid=0 | w=105
  741. ipilimumab -- r_associated #0: 105 / 0.229 -> en:carbon c 14 roniciclib
    n1=ipilimumab | n2=en:carbon c 14 roniciclib | rel=r_associated | relid=0 | w=105
  742. ipilimumab -- r_associated #0: 105 / 0.229 -> en:carbon c 14 telotristat etiprate
    n1=ipilimumab | n2=en:carbon c 14 telotristat etiprate | rel=r_associated | relid=0 | w=105
  743. ipilimumab -- r_associated #0: 105 / 0.229 -> en:carboplatin-taxol-bevacizumab regimen
    n1=ipilimumab | n2=en:carboplatin-taxol-bevacizumab regimen | rel=r_associated | relid=0 | w=105
  744. ipilimumab -- r_associated #0: 105 / 0.229 -> en:carcinoembryonic antigen peptide 1-6d virus-like replicon particles vaccine
    n1=ipilimumab | n2=en:carcinoembryonic antigen peptide 1-6d virus-like replicon particles vaccine | rel=r_associated | relid=0 | w=105
  745. ipilimumab -- r_associated #0: 105 / 0.229 -> en:carcinoembryonic antigen rna-pulsed dc cancer vaccine
    n1=ipilimumab | n2=en:carcinoembryonic antigen rna-pulsed dc cancer vaccine | rel=r_associated | relid=0 | w=105
  746. ipilimumab -- r_associated #0: 105 / 0.229 -> en:carubicin
    n1=ipilimumab | n2=en:carubicin | rel=r_associated | relid=0 | w=105
  747. ipilimumab -- r_associated #0: 105 / 0.229 -> en:caseinate protein isolate
    n1=ipilimumab | n2=en:caseinate protein isolate | rel=r_associated | relid=0 | w=105
  748. ipilimumab -- r_associated #0: 105 / 0.229 -> en:casopitant mesylate
    n1=ipilimumab | n2=en:casopitant mesylate | rel=r_associated | relid=0 | w=105
  749. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ccr2 antagonist ccx872-b
    n1=ipilimumab | n2=en:ccr2 antagonist ccx872-b | rel=r_associated | relid=0 | w=105
  750. ipilimumab -- r_associated #0: 105 / 0.229 -> en:cd28car/cd137car-expressing t-lymphocytes
    n1=ipilimumab | n2=en:cd28car/cd137car-expressing t-lymphocytes | rel=r_associated | relid=0 | w=105
  751. ipilimumab -- r_associated #0: 105 / 0.229 -> en:cd40 agonist monoclonal antibody cp-870,893
    n1=ipilimumab | n2=en:cd40 agonist monoclonal antibody cp-870,893 | rel=r_associated | relid=0 | w=105
  752. ipilimumab -- r_associated #0: 105 / 0.229 -> en:cd40 agonist monoclonal antibody ro7009789
    n1=ipilimumab | n2=en:cd40 agonist monoclonal antibody ro7009789 | rel=r_associated | relid=0 | w=105
  753. ipilimumab -- r_associated #0: 105 / 0.229 -> en:cea/tetanus toxoid t helper epitope fusion protein-expressing dna plasmid vaccine
    n1=ipilimumab | n2=en:cea/tetanus toxoid t helper epitope fusion protein-expressing dna plasmid vaccine | rel=r_associated | relid=0 | w=105
  754. ipilimumab -- r_associated #0: 105 / 0.229 -> en:cebpa-targeting sarna mtl-cebpa liposome
    n1=ipilimumab | n2=en:cebpa-targeting sarna mtl-cebpa liposome | rel=r_associated | relid=0 | w=105
  755. ipilimumab -- r_associated #0: 105 / 0.229 -> en:cefixime
    n1=ipilimumab | n2=en:cefixime | rel=r_associated | relid=0 | w=105
  756. ipilimumab -- r_associated #0: 105 / 0.229 -> en:celecoxib
    n1=ipilimumab | n2=en:celecoxib | rel=r_associated | relid=0 | w=105
  757. ipilimumab -- r_associated #0: 105 / 0.229 -> en:cevimeline hydrochloride
    n1=ipilimumab | n2=en:cevimeline hydrochloride | rel=r_associated | relid=0 | w=105
  758. ipilimumab -- r_associated #0: 105 / 0.229 -> en:chewing gum dosage form
    n1=ipilimumab | n2=en:chewing gum dosage form | rel=r_associated | relid=0 | w=105
  759. ipilimumab -- r_associated #0: 105 / 0.229 -> en:chinese herbs
    n1=ipilimumab | n2=en:chinese herbs | rel=r_associated | relid=0 | w=105
  760. ipilimumab -- r_associated #0: 105 / 0.229 -> en:chlorambucil
    n1=ipilimumab | n2=en:chlorambucil | rel=r_associated | relid=0 | w=105
  761. ipilimumab -- r_associated #0: 105 / 0.229 -> en:chlorhexidine
    n1=ipilimumab | n2=en:chlorhexidine | rel=r_associated | relid=0 | w=105
  762. ipilimumab -- r_associated #0: 105 / 0.229 -> en:chlorhexidine/ethyl alcohol mouthwash
    n1=ipilimumab | n2=en:chlorhexidine/ethyl alcohol mouthwash | rel=r_associated | relid=0 | w=105
  763. ipilimumab -- r_associated #0: 105 / 0.229 -> en:chlorotoxin-indocyanine green imaging agent blz-100
    n1=ipilimumab | n2=en:chlorotoxin-indocyanine green imaging agent blz-100 | rel=r_associated | relid=0 | w=105
  764. ipilimumab -- r_associated #0: 105 / 0.229 -> en:choleretic agent
    n1=ipilimumab | n2=en:choleretic agent | rel=r_associated | relid=0 | w=105
  765. ipilimumab -- r_associated #0: 105 / 0.229 -> en:cidofovir
    n1=ipilimumab | n2=en:cidofovir | rel=r_associated | relid=0 | w=105
  766. ipilimumab -- r_associated #0: 105 / 0.229 -> en:cinacalcet hydrochloride
    n1=ipilimumab | n2=en:cinacalcet hydrochloride | rel=r_associated | relid=0 | w=105
  767. ipilimumab -- r_associated #0: 105 / 0.229 -> en:cipatinib
    n1=ipilimumab | n2=en:cipatinib | rel=r_associated | relid=0 | w=105
  768. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ciprofloxacin
    n1=ipilimumab | n2=en:ciprofloxacin | rel=r_associated | relid=0 | w=105
  769. ipilimumab -- r_associated #0: 105 / 0.229 -> en:cirmtuzumab
    n1=ipilimumab | n2=en:cirmtuzumab | rel=r_associated | relid=0 | w=105
  770. ipilimumab -- r_associated #0: 105 / 0.229 -> en:claudiximab
    n1=ipilimumab | n2=en:claudiximab | rel=r_associated | relid=0 | w=105
  771. ipilimumab -- r_associated #0: 105 / 0.229 -> en:clofibrate
    n1=ipilimumab | n2=en:clofibrate | rel=r_associated | relid=0 | w=105
  772. ipilimumab -- r_associated #0: 105 / 0.229 -> en:clonidine-containing mucoadhesive buccal tablet
    n1=ipilimumab | n2=en:clonidine-containing mucoadhesive buccal tablet | rel=r_associated | relid=0 | w=105
  773. ipilimumab -- r_associated #0: 105 / 0.229 -> en:clostridium novyi-nt spores
    n1=ipilimumab | n2=en:clostridium novyi-nt spores | rel=r_associated | relid=0 | w=105
  774. ipilimumab -- r_associated #0: 105 / 0.229 -> en:cmf regimen
    n1=ipilimumab | n2=en:cmf regimen | rel=r_associated | relid=0 | w=105
  775. ipilimumab -- r_associated #0: 105 / 0.229 -> en:cocoa extract
    n1=ipilimumab | n2=en:cocoa extract | rel=r_associated | relid=0 | w=105
  776. ipilimumab -- r_associated #0: 105 / 0.229 -> en:compound kushen injection
    n1=ipilimumab | n2=en:compound kushen injection | rel=r_associated | relid=0 | w=105
  777. ipilimumab -- r_associated #0: 105 / 0.229 -> en:compound sodium lactate solution
    n1=ipilimumab | n2=en:compound sodium lactate solution | rel=r_associated | relid=0 | w=105
  778. ipilimumab -- r_associated #0: 105 / 0.229 -> en:copper cu 64-dota-anti-her3 monoclonal antibody u3-1287
    n1=ipilimumab | n2=en:copper cu 64-dota-anti-her3 monoclonal antibody u3-1287 | rel=r_associated | relid=0 | w=105
  779. ipilimumab -- r_associated #0: 105 / 0.229 -> en:copper gluconate
    n1=ipilimumab | n2=en:copper gluconate | rel=r_associated | relid=0 | w=105
  780. ipilimumab -- r_associated #0: 105 / 0.229 -> en:cosmeceuticals
    n1=ipilimumab | n2=en:cosmeceuticals | rel=r_associated | relid=0 | w=105
  781. ipilimumab -- r_associated #0: 105 / 0.229 -> en:coxsackievirus a21
    n1=ipilimumab | n2=en:coxsackievirus a21 | rel=r_associated | relid=0 | w=105
  782. ipilimumab -- r_associated #0: 105 / 0.229 -> en:crizotinib
    n1=ipilimumab | n2=en:crizotinib | rel=r_associated | relid=0 | w=105
  783. ipilimumab -- r_associated #0: 105 / 0.229 -> en:crolibulin
    n1=ipilimumab | n2=en:crolibulin | rel=r_associated | relid=0 | w=105
  784. ipilimumab -- r_associated #0: 105 / 0.229 -> en:crystalline genistein formulation axp107-11
    n1=ipilimumab | n2=en:crystalline genistein formulation axp107-11 | rel=r_associated | relid=0 | w=105
  785. ipilimumab -- r_associated #0: 105 / 0.229 -> en:cycloserine
    n1=ipilimumab | n2=en:cycloserine | rel=r_associated | relid=0 | w=105
  786. ipilimumab -- r_associated #0: 105 / 0.229 -> en:cyp17 lyase inhibitor asn001
    n1=ipilimumab | n2=en:cyp17 lyase inhibitor asn001 | rel=r_associated | relid=0 | w=105
  787. ipilimumab -- r_associated #0: 105 / 0.229 -> en:d vitamin
    n1=ipilimumab | n2=en:d vitamin | rel=r_associated | relid=0 | w=105
  788. ipilimumab -- r_associated #0: 105 / 0.229 -> en:dab389 epidermal growth factor
    n1=ipilimumab | n2=en:dab389 epidermal growth factor | rel=r_associated | relid=0 | w=105
  789. ipilimumab -- r_associated #0: 105 / 0.229 -> en:dabrafenib
    n1=ipilimumab | n2=en:dabrafenib | rel=r_associated | relid=0 | w=105
  790. ipilimumab -- r_associated #0: 105 / 0.229 -> en:dacomitinib
    n1=ipilimumab | n2=en:dacomitinib | rel=r_associated | relid=0 | w=105
  791. ipilimumab -- r_associated #0: 105 / 0.229 -> en:dakins solution
    n1=ipilimumab | n2=en:dakins solution | rel=r_associated | relid=0 | w=105
  792. ipilimumab -- r_associated #0: 105 / 0.229 -> en:dalbavancin
    n1=ipilimumab | n2=en:dalbavancin | rel=r_associated | relid=0 | w=105
  793. ipilimumab -- r_associated #0: 105 / 0.229 -> en:darbepoetin alfa
    n1=ipilimumab | n2=en:darbepoetin alfa | rel=r_associated | relid=0 | w=105
  794. ipilimumab -- r_associated #0: 105 / 0.229 -> en:deferoxamine mesylate
    n1=ipilimumab | n2=en:deferoxamine mesylate | rel=r_associated | relid=0 | w=105
  795. ipilimumab -- r_associated #0: 105 / 0.229 -> en:dehydroemetine
    n1=ipilimumab | n2=en:dehydroemetine | rel=r_associated | relid=0 | w=105
  796. ipilimumab -- r_associated #0: 105 / 0.229 -> en:dendritic cell-autologous lung tumor vaccine
    n1=ipilimumab | n2=en:dendritic cell-autologous lung tumor vaccine | rel=r_associated | relid=0 | w=105
  797. ipilimumab -- r_associated #0: 105 / 0.229 -> en:dendritic cell-cea peptide vaccine
    n1=ipilimumab | n2=en:dendritic cell-cea peptide vaccine | rel=r_associated | relid=0 | w=105
  798. ipilimumab -- r_associated #0: 105 / 0.229 -> en:dendritic cell-gp100-mart-1 antigen vaccine
    n1=ipilimumab | n2=en:dendritic cell-gp100-mart-1 antigen vaccine | rel=r_associated | relid=0 | w=105
  799. ipilimumab -- r_associated #0: 105 / 0.229 -> en:denintuzumab mafodotin
    n1=ipilimumab | n2=en:denintuzumab mafodotin | rel=r_associated | relid=0 | w=105
  800. ipilimumab -- r_associated #0: 105 / 0.229 -> en:dental disclosing preparation
    n1=ipilimumab | n2=en:dental disclosing preparation | rel=r_associated | relid=0 | w=105
  801. ipilimumab -- r_associated #0: 105 / 0.229 -> en:designer drugs
    n1=ipilimumab | n2=en:designer drugs | rel=r_associated | relid=0 | w=105
  802. ipilimumab -- r_associated #0: 105 / 0.229 -> en:desvenlafaxine succinate
    n1=ipilimumab | n2=en:desvenlafaxine succinate | rel=r_associated | relid=0 | w=105
  803. ipilimumab -- r_associated #0: 105 / 0.229 -> en:dexpanthenol
    n1=ipilimumab | n2=en:dexpanthenol | rel=r_associated | relid=0 | w=105
  804. ipilimumab -- r_associated #0: 105 / 0.229 -> en:dextroamphetamine-amphetamine
    n1=ipilimumab | n2=en:dextroamphetamine-amphetamine | rel=r_associated | relid=0 | w=105
  805. ipilimumab -- r_associated #0: 105 / 0.229 -> en:diammonium glycyrrhizinate
    n1=ipilimumab | n2=en:diammonium glycyrrhizinate | rel=r_associated | relid=0 | w=105
  806. ipilimumab -- r_associated #0: 105 / 0.229 -> en:diclofenac sodium gel
    n1=ipilimumab | n2=en:diclofenac sodium gel | rel=r_associated | relid=0 | w=105
  807. ipilimumab -- r_associated #0: 105 / 0.229 -> en:dimethicone/polymer barrier cream
    n1=ipilimumab | n2=en:dimethicone/polymer barrier cream | rel=r_associated | relid=0 | w=105
  808. ipilimumab -- r_associated #0: 105 / 0.229 -> en:diphenhydramine hydrochloride
    n1=ipilimumab | n2=en:diphenhydramine hydrochloride | rel=r_associated | relid=0 | w=105
  809. ipilimumab -- r_associated #0: 105 / 0.229 -> en:diphenhydramine hydrochloride/dexamethasone/nystatin magic mouthwash
    n1=ipilimumab | n2=en:diphenhydramine hydrochloride/dexamethasone/nystatin magic mouthwash | rel=r_associated | relid=0 | w=105
  810. ipilimumab -- r_associated #0: 105 / 0.229 -> en:diphtheria toxoid/tetanus toxoid vaccine adsorbed
    n1=ipilimumab | n2=en:diphtheria toxoid/tetanus toxoid vaccine adsorbed | rel=r_associated | relid=0 | w=105
  811. ipilimumab -- r_associated #0: 105 / 0.229 -> en:diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine adsorbed
    n1=ipilimumab | n2=en:diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine adsorbed | rel=r_associated | relid=0 | w=105
  812. ipilimumab -- r_associated #0: 105 / 0.229 -> en:dipyridamole
    n1=ipilimumab | n2=en:dipyridamole | rel=r_associated | relid=0 | w=105
  813. ipilimumab -- r_associated #0: 105 / 0.229 -> en:divalproex sodium
    n1=ipilimumab | n2=en:divalproex sodium | rel=r_associated | relid=0 | w=105
  814. ipilimumab -- r_associated #0: 105 / 0.229 -> en:dna binding agent
    n1=ipilimumab | n2=en:dna binding agent | rel=r_associated | relid=0 | w=105
  815. ipilimumab -- r_associated #0: 105 / 0.229 -> en:dna interference oligonucleotide pnt2258
    n1=ipilimumab | n2=en:dna interference oligonucleotide pnt2258 | rel=r_associated | relid=0 | w=105
  816. ipilimumab -- r_associated #0: 105 / 0.229 -> en:docusate
    n1=ipilimumab | n2=en:docusate | rel=r_associated | relid=0 | w=105
  817. ipilimumab -- r_associated #0: 105 / 0.229 -> en:dofequidar fumarate
    n1=ipilimumab | n2=en:dofequidar fumarate | rel=r_associated | relid=0 | w=105
  818. ipilimumab -- r_associated #0: 105 / 0.229 -> en:doxorubicin-eluting beads
    n1=ipilimumab | n2=en:doxorubicin-eluting beads | rel=r_associated | relid=0 | w=105
  819. ipilimumab -- r_associated #0: 105 / 0.229 -> en:drug groups primarily affecting the musculoskeletal system
    n1=ipilimumab | n2=en:drug groups primarily affecting the musculoskeletal system | rel=r_associated | relid=0 | w=105
  820. ipilimumab -- r_associated #0: 105 / 0.229 -> en:drug-device combination product
    n1=ipilimumab | n2=en:drug-device combination product | rel=r_associated | relid=0 | w=105
  821. ipilimumab -- r_associated #0: 105 / 0.229 -> en:drugs used to treat addiction
    n1=ipilimumab | n2=en:drugs used to treat addiction | rel=r_associated | relid=0 | w=105
  822. ipilimumab -- r_associated #0: 105 / 0.229 -> en:drugs, chinese herbal
    n1=ipilimumab | n2=en:drugs, chinese herbal | rel=r_associated | relid=0 | w=105
  823. ipilimumab -- r_associated #0: 105 / 0.229 -> en:dt(388)il3 fusion protein sl-401
    n1=ipilimumab | n2=en:dt(388)il3 fusion protein sl-401 | rel=r_associated | relid=0 | w=105
  824. ipilimumab -- r_associated #0: 105 / 0.229 -> en:duborimycin
    n1=ipilimumab | n2=en:duborimycin | rel=r_associated | relid=0 | w=105
  825. ipilimumab -- r_associated #0: 105 / 0.229 -> en:e2f1 pathway activator arq 171
    n1=ipilimumab | n2=en:e2f1 pathway activator arq 171 | rel=r_associated | relid=0 | w=105
  826. ipilimumab -- r_associated #0: 105 / 0.229 -> en:east indian sandalwood oil mouth rinse
    n1=ipilimumab | n2=en:east indian sandalwood oil mouth rinse | rel=r_associated | relid=0 | w=105
  827. ipilimumab -- r_associated #0: 105 / 0.229 -> en:eg5 kinesin-related motor protein inhibitor arq 621
    n1=ipilimumab | n2=en:eg5 kinesin-related motor protein inhibitor arq 621 | rel=r_associated | relid=0 | w=105
  828. ipilimumab -- r_associated #0: 105 / 0.229 -> en:egfr/her2 kinase inhibitor tak-285
    n1=ipilimumab | n2=en:egfr/her2 kinase inhibitor tak-285 | rel=r_associated | relid=0 | w=105
  829. ipilimumab -- r_associated #0: 105 / 0.229 -> en:egfrbi-armed autologous t cells
    n1=ipilimumab | n2=en:egfrbi-armed autologous t cells | rel=r_associated | relid=0 | w=105
  830. ipilimumab -- r_associated #0: 105 / 0.229 -> en:eif4e antisense oligonucleotide isis 183750
    n1=ipilimumab | n2=en:eif4e antisense oligonucleotide isis 183750 | rel=r_associated | relid=0 | w=105
  831. ipilimumab -- r_associated #0: 105 / 0.229 -> en:embolic agent
    n1=ipilimumab | n2=en:embolic agent | rel=r_associated | relid=0 | w=105
  832. ipilimumab -- r_associated #0: 105 / 0.229 -> en:erastin analogue prlx 93936
    n1=ipilimumab | n2=en:erastin analogue prlx 93936 | rel=r_associated | relid=0 | w=105
  833. ipilimumab -- r_associated #0: 105 / 0.229 -> en:erk inhibitor cc-90003
    n1=ipilimumab | n2=en:erk inhibitor cc-90003 | rel=r_associated | relid=0 | w=105
  834. ipilimumab -- r_associated #0: 105 / 0.229 -> en:erk inhibitor ltt462
    n1=ipilimumab | n2=en:erk inhibitor ltt462 | rel=r_associated | relid=0 | w=105
  835. ipilimumab -- r_associated #0: 105 / 0.229 -> en:esmolol
    n1=ipilimumab | n2=en:esmolol | rel=r_associated | relid=0 | w=105
  836. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ethylchlorformate
    n1=ipilimumab | n2=en:ethylchlorformate | rel=r_associated | relid=0 | w=105
  837. ipilimumab -- r_associated #0: 105 / 0.229 -> en:etodolac
    n1=ipilimumab | n2=en:etodolac | rel=r_associated | relid=0 | w=105
  838. ipilimumab -- r_associated #0: 105 / 0.229 -> en:etoposide prodrug cap7.1
    n1=ipilimumab | n2=en:etoposide prodrug cap7.1 | rel=r_associated | relid=0 | w=105
  839. ipilimumab -- r_associated #0: 105 / 0.229 -> en:exisulind
    n1=ipilimumab | n2=en:exisulind | rel=r_associated | relid=0 | w=105
  840. ipilimumab -- r_associated #0: 105 / 0.229 -> en:fas receptor agonist apo010
    n1=ipilimumab | n2=en:fas receptor agonist apo010 | rel=r_associated | relid=0 | w=105
  841. ipilimumab -- r_associated #0: 105 / 0.229 -> en:fda established names and unique ingredient identifier codes terminology
    n1=ipilimumab | n2=en:fda established names and unique ingredient identifier codes terminology | rel=r_associated | relid=0 | w=105
  842. ipilimumab -- r_associated #0: 105 / 0.229 -> en:fentanyl citrate-containing nasal spray
    n1=ipilimumab | n2=en:fentanyl citrate-containing nasal spray | rel=r_associated | relid=0 | w=105
  843. ipilimumab -- r_associated #0: 105 / 0.229 -> en:fgfr inhibitor azd4547
    n1=ipilimumab | n2=en:fgfr inhibitor azd4547 | rel=r_associated | relid=0 | w=105
  844. ipilimumab -- r_associated #0: 105 / 0.229 -> en:fgfr inhibitor debio 1347
    n1=ipilimumab | n2=en:fgfr inhibitor debio 1347 | rel=r_associated | relid=0 | w=105
  845. ipilimumab -- r_associated #0: 105 / 0.229 -> en:fgfr/vegfr/pdgfr/flt3/src inhibitor xl999
    n1=ipilimumab | n2=en:fgfr/vegfr/pdgfr/flt3/src inhibitor xl999 | rel=r_associated | relid=0 | w=105
  846. ipilimumab -- r_associated #0: 105 / 0.229 -> en:fingolimod hydrochloride
    n1=ipilimumab | n2=en:fingolimod hydrochloride | rel=r_associated | relid=0 | w=105
  847. ipilimumab -- r_associated #0: 105 / 0.229 -> en:firtecan pegol
    n1=ipilimumab | n2=en:firtecan pegol | rel=r_associated | relid=0 | w=105
  848. ipilimumab -- r_associated #0: 105 / 0.229 -> en:flanvotumab
    n1=ipilimumab | n2=en:flanvotumab | rel=r_associated | relid=0 | w=105
  849. ipilimumab -- r_associated #0: 105 / 0.229 -> en:floxuridine
    n1=ipilimumab | n2=en:floxuridine | rel=r_associated | relid=0 | w=105
  850. ipilimumab -- r_associated #0: 105 / 0.229 -> en:fluorides
    n1=ipilimumab | n2=en:fluorides | rel=r_associated | relid=0 | w=105
  851. ipilimumab -- r_associated #0: 105 / 0.229 -> en:fluorine f 18 alfatide ii
    n1=ipilimumab | n2=en:fluorine f 18 alfatide ii | rel=r_associated | relid=0 | w=105
  852. ipilimumab -- r_associated #0: 105 / 0.229 -> en:fluorine f 18 fluoro-peg6-ipqa
    n1=ipilimumab | n2=en:fluorine f 18 fluoro-peg6-ipqa | rel=r_associated | relid=0 | w=105
  853. ipilimumab -- r_associated #0: 105 / 0.229 -> en:fluorine f 18 fluorodopa
    n1=ipilimumab | n2=en:fluorine f 18 fluorodopa | rel=r_associated | relid=0 | w=105
  854. ipilimumab -- r_associated #0: 105 / 0.229 -> en:fluorine f 18 fluoromethylcholine
    n1=ipilimumab | n2=en:fluorine f 18 fluoromethylcholine | rel=r_associated | relid=0 | w=105
  855. ipilimumab -- r_associated #0: 105 / 0.229 -> en:fluorine f 18 fluorthanatrace
    n1=ipilimumab | n2=en:fluorine f 18 fluorthanatrace | rel=r_associated | relid=0 | w=105
  856. ipilimumab -- r_associated #0: 105 / 0.229 -> en:fluorine f 18 fmdht
    n1=ipilimumab | n2=en:fluorine f 18 fmdht | rel=r_associated | relid=0 | w=105
  857. ipilimumab -- r_associated #0: 105 / 0.229 -> en:fluorine f 18-av-133
    n1=ipilimumab | n2=en:fluorine f 18-av-133 | rel=r_associated | relid=0 | w=105
  858. ipilimumab -- r_associated #0: 105 / 0.229 -> en:fms/trk tyrosine kinase inhibitor plx7486
    n1=ipilimumab | n2=en:fms/trk tyrosine kinase inhibitor plx7486 | rel=r_associated | relid=0 | w=105
  859. ipilimumab -- r_associated #0: 105 / 0.229 -> en:folate receptor alpha-loaded dendritic cell vaccine
    n1=ipilimumab | n2=en:folate receptor alpha-loaded dendritic cell vaccine | rel=r_associated | relid=0 | w=105
  860. ipilimumab -- r_associated #0: 105 / 0.229 -> en:folate receptor-targeted tubulysin conjugate ec1456
    n1=ipilimumab | n2=en:folate receptor-targeted tubulysin conjugate ec1456 | rel=r_associated | relid=0 | w=105
  861. ipilimumab -- r_associated #0: 105 / 0.229 -> en:folate receptor-targeted vinca alkaloid ec0489
    n1=ipilimumab | n2=en:folate receptor-targeted vinca alkaloid ec0489 | rel=r_associated | relid=0 | w=105
  862. ipilimumab -- r_associated #0: 105 / 0.229 -> en:folate receptor-targeted vinca alkaloid/mitomycin c ec0225
    n1=ipilimumab | n2=en:folate receptor-targeted vinca alkaloid/mitomycin c ec0225 | rel=r_associated | relid=0 | w=105
  863. ipilimumab -- r_associated #0: 105 / 0.229 -> en:folic acid
    n1=ipilimumab | n2=en:folic acid | rel=r_associated | relid=0 | w=105
  864. ipilimumab -- r_associated #0: 105 / 0.229 -> en:formoterol fumarate oral
    n1=ipilimumab | n2=en:formoterol fumarate oral | rel=r_associated | relid=0 | w=105
  865. ipilimumab -- r_associated #0: 105 / 0.229 -> en:fowlpox virus vaccine vector
    n1=ipilimumab | n2=en:fowlpox virus vaccine vector | rel=r_associated | relid=0 | w=105
  866. ipilimumab -- r_associated #0: 105 / 0.229 -> en:freeze-dried black raspberry bioadhesive gel
    n1=ipilimumab | n2=en:freeze-dried black raspberry bioadhesive gel | rel=r_associated | relid=0 | w=105
  867. ipilimumab -- r_associated #0: 105 / 0.229 -> en:fruit and vegetable extract
    n1=ipilimumab | n2=en:fruit and vegetable extract | rel=r_associated | relid=0 | w=105
  868. ipilimumab -- r_associated #0: 105 / 0.229 -> en:fu-lv regimen
    n1=ipilimumab | n2=en:fu-lv regimen | rel=r_associated | relid=0 | w=105
  869. ipilimumab -- r_associated #0: 105 / 0.229 -> en:gadodiamide
    n1=ipilimumab | n2=en:gadodiamide | rel=r_associated | relid=0 | w=105
  870. ipilimumab -- r_associated #0: 105 / 0.229 -> en:galectin inhibitor gr-md-02
    n1=ipilimumab | n2=en:galectin inhibitor gr-md-02 | rel=r_associated | relid=0 | w=105
  871. ipilimumab -- r_associated #0: 105 / 0.229 -> en:galeterone
    n1=ipilimumab | n2=en:galeterone | rel=r_associated | relid=0 | w=105
  872. ipilimumab -- r_associated #0: 105 / 0.229 -> en:gastroenteral dosage form product
    n1=ipilimumab | n2=en:gastroenteral dosage form product | rel=r_associated | relid=0 | w=105
  873. ipilimumab -- r_associated #0: 105 / 0.229 -> en:gemcitabine elaidate
    n1=ipilimumab | n2=en:gemcitabine elaidate | rel=r_associated | relid=0 | w=105
  874. ipilimumab -- r_associated #0: 105 / 0.229 -> en:gemcitabine-phosphoramidate hydrochloride nuc-1031
    n1=ipilimumab | n2=en:gemcitabine-phosphoramidate hydrochloride nuc-1031 | rel=r_associated | relid=0 | w=105
  875. ipilimumab -- r_associated #0: 105 / 0.229 -> en:giracodazole
    n1=ipilimumab | n2=en:giracodazole | rel=r_associated | relid=0 | w=105
  876. ipilimumab -- r_associated #0: 105 / 0.229 -> en:gliclazide
    n1=ipilimumab | n2=en:gliclazide | rel=r_associated | relid=0 | w=105
  877. ipilimumab -- r_associated #0: 105 / 0.229 -> en:glioblastoma cancer vaccine erc1671
    n1=ipilimumab | n2=en:glioblastoma cancer vaccine erc1671 | rel=r_associated | relid=0 | w=105
  878. ipilimumab -- r_associated #0: 105 / 0.229 -> en:glioblastoma multiforme multipeptide vaccine ima950
    n1=ipilimumab | n2=en:glioblastoma multiforme multipeptide vaccine ima950 | rel=r_associated | relid=0 | w=105
  879. ipilimumab -- r_associated #0: 105 / 0.229 -> en:glucuronic acid
    n1=ipilimumab | n2=en:glucuronic acid | rel=r_associated | relid=0 | w=105
  880. ipilimumab -- r_associated #0: 105 / 0.229 -> en:glufosfamide
    n1=ipilimumab | n2=en:glufosfamide | rel=r_associated | relid=0 | w=105
  881. ipilimumab -- r_associated #0: 105 / 0.229 -> en:gluten-free/fiber-enriched compact nutritional supplement drink
    n1=ipilimumab | n2=en:gluten-free/fiber-enriched compact nutritional supplement drink | rel=r_associated | relid=0 | w=105
  882. ipilimumab -- r_associated #0: 105 / 0.229 -> en:glycerin enema
    n1=ipilimumab | n2=en:glycerin enema | rel=r_associated | relid=0 | w=105
  883. ipilimumab -- r_associated #0: 105 / 0.229 -> en:glycine
    n1=ipilimumab | n2=en:glycine | rel=r_associated | relid=0 | w=105
  884. ipilimumab -- r_associated #0: 105 / 0.229 -> en:gm-k562 cell vaccine
    n1=ipilimumab | n2=en:gm-k562 cell vaccine | rel=r_associated | relid=0 | w=105
  885. ipilimumab -- r_associated #0: 105 / 0.229 -> en:gold sodium thiomalate
    n1=ipilimumab | n2=en:gold sodium thiomalate | rel=r_associated | relid=0 | w=105
  886. ipilimumab -- r_associated #0: 105 / 0.229 -> en:gp209-2m antigen
    n1=ipilimumab | n2=en:gp209-2m antigen | rel=r_associated | relid=0 | w=105
  887. ipilimumab -- r_associated #0: 105 / 0.229 -> en:granisetron hydrochloride
    n1=ipilimumab | n2=en:granisetron hydrochloride | rel=r_associated | relid=0 | w=105
  888. ipilimumab -- r_associated #0: 105 / 0.229 -> en:granisetron hydrochloride nasal spray
    n1=ipilimumab | n2=en:granisetron hydrochloride nasal spray | rel=r_associated | relid=0 | w=105
  889. ipilimumab -- r_associated #0: 105 / 0.229 -> en:heme iron polypeptide
    n1=ipilimumab | n2=en:heme iron polypeptide | rel=r_associated | relid=0 | w=105
  890. ipilimumab -- r_associated #0: 105 / 0.229 -> en:hemiasterlin analog e7974
    n1=ipilimumab | n2=en:hemiasterlin analog e7974 | rel=r_associated | relid=0 | w=105
  891. ipilimumab -- r_associated #0: 105 / 0.229 -> en:heterodimeric interleukin-15
    n1=ipilimumab | n2=en:heterodimeric interleukin-15 | rel=r_associated | relid=0 | w=105
  892. ipilimumab -- r_associated #0: 105 / 0.229 -> en:hif-1alpha inhibitor px-478
    n1=ipilimumab | n2=en:hif-1alpha inhibitor px-478 | rel=r_associated | relid=0 | w=105
  893. ipilimumab -- r_associated #0: 105 / 0.229 -> en:histamine dihydrochloride
    n1=ipilimumab | n2=en:histamine dihydrochloride | rel=r_associated | relid=0 | w=105
  894. ipilimumab -- r_associated #0: 105 / 0.229 -> en:histone-lysine n-methyltransferase ezh2 inhibitor gsk2816126
    n1=ipilimumab | n2=en:histone-lysine n-methyltransferase ezh2 inhibitor gsk2816126 | rel=r_associated | relid=0 | w=105
  895. ipilimumab -- r_associated #0: 105 / 0.229 -> en:hla-a*0201 restricted tert(572y)/tert(572) peptides vaccine vx-001
    n1=ipilimumab | n2=en:hla-a*0201 restricted tert(572y)/tert(572) peptides vaccine vx-001 | rel=r_associated | relid=0 | w=105
  896. ipilimumab -- r_associated #0: 105 / 0.229 -> en:hla-a*0201-restricted trp2-gp100-epha2-her2 multipeptide vaccine
    n1=ipilimumab | n2=en:hla-a*0201-restricted trp2-gp100-epha2-her2 multipeptide vaccine | rel=r_associated | relid=0 | w=105
  897. ipilimumab -- r_associated #0: 105 / 0.229 -> en:hla-a2-restricted synthetic glioma antigen peptides vaccine
    n1=ipilimumab | n2=en:hla-a2-restricted synthetic glioma antigen peptides vaccine | rel=r_associated | relid=0 | w=105
  898. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ho 166 dotmp
    n1=ipilimumab | n2=en:ho 166 dotmp | rel=r_associated | relid=0 | w=105
  899. ipilimumab -- r_associated #0: 105 / 0.229 -> en:homeopathic remedies
    n1=ipilimumab | n2=en:homeopathic remedies | rel=r_associated | relid=0 | w=105
  900. ipilimumab -- r_associated #0: 105 / 0.229 -> en:hormone, hormone metabolite, hormone precursor, synthetic hormone substitute, and/or hormone antagonist
    n1=ipilimumab | n2=en:hormone, hormone metabolite, hormone precursor, synthetic hormone substitute, and/or hormone antagonist | rel=r_associated | relid=0 | w=105
  901. ipilimumab -- r_associated #0: 105 / 0.229 -> en:hsp90 antagonist kw-2478
    n1=ipilimumab | n2=en:hsp90 antagonist kw-2478 | rel=r_associated | relid=0 | w=105
  902. ipilimumab -- r_associated #0: 105 / 0.229 -> en:hsp90 inhibitor ab-010
    n1=ipilimumab | n2=en:hsp90 inhibitor ab-010 | rel=r_associated | relid=0 | w=105
  903. ipilimumab -- r_associated #0: 105 / 0.229 -> en:hsp90 inhibitor biib028
    n1=ipilimumab | n2=en:hsp90 inhibitor biib028 | rel=r_associated | relid=0 | w=105
  904. ipilimumab -- r_associated #0: 105 / 0.229 -> en:hsv-tk-transduced donor lymphocytes
    n1=ipilimumab | n2=en:hsv-tk-transduced donor lymphocytes | rel=r_associated | relid=0 | w=105
  905. ipilimumab -- r_associated #0: 105 / 0.229 -> en:htert multipeptide/montanide isa-51 vg/imiquimod gx 301
    n1=ipilimumab | n2=en:htert multipeptide/montanide isa-51 vg/imiquimod gx 301 | rel=r_associated | relid=0 | w=105
  906. ipilimumab -- r_associated #0: 105 / 0.229 -> en:huang lian
    n1=ipilimumab | n2=en:huang lian | rel=r_associated | relid=0 | w=105
  907. ipilimumab -- r_associated #0: 105 / 0.229 -> en:human monoclonal antibody 216
    n1=ipilimumab | n2=en:human monoclonal antibody 216 | rel=r_associated | relid=0 | w=105
  908. ipilimumab -- r_associated #0: 105 / 0.229 -> en:hydrocodone/acetaminophen
    n1=ipilimumab | n2=en:hydrocodone/acetaminophen | rel=r_associated | relid=0 | w=105
  909. ipilimumab -- r_associated #0: 105 / 0.229 -> en:hypoglycemic agents
    n1=ipilimumab | n2=en:hypoglycemic agents | rel=r_associated | relid=0 | w=105
  910. ipilimumab -- r_associated #0: 105 / 0.229 -> en:i.s.p. lotion
    n1=ipilimumab | n2=en:i.s.p. lotion | rel=r_associated | relid=0 | w=105
  911. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ifosfamide / mesna
    n1=ipilimumab | n2=en:ifosfamide / mesna | rel=r_associated | relid=0 | w=105
  912. ipilimumab -- r_associated #0: 105 / 0.229 -> en:igf-1r/ir inhibitor kw-2450
    n1=ipilimumab | n2=en:igf-1r/ir inhibitor kw-2450 | rel=r_associated | relid=0 | w=105
  913. ipilimumab -- r_associated #0: 105 / 0.229 -> en:il-12-expressing hsv-1
    n1=ipilimumab | n2=en:il-12-expressing hsv-1 | rel=r_associated | relid=0 | w=105
  914. ipilimumab -- r_associated #0: 105 / 0.229 -> en:il-2 recombinant fusion protein alt-801
    n1=ipilimumab | n2=en:il-2 recombinant fusion protein alt-801 | rel=r_associated | relid=0 | w=105
  915. ipilimumab -- r_associated #0: 105 / 0.229 -> en:imiquimod
    n1=ipilimumab | n2=en:imiquimod | rel=r_associated | relid=0 | w=105
  916. ipilimumab -- r_associated #0: 105 / 0.229 -> en:immunomodulating agent
    n1=ipilimumab | n2=en:immunomodulating agent | rel=r_associated | relid=0 | w=105
  917. ipilimumab -- r_associated #0: 105 / 0.229 -> en:in 111 folic acid
    n1=ipilimumab | n2=en:in 111 folic acid | rel=r_associated | relid=0 | w=105
  918. ipilimumab -- r_associated #0: 105 / 0.229 -> en:indium in 111 anti-egfr monoclonal antibody abt-806
    n1=ipilimumab | n2=en:indium in 111 anti-egfr monoclonal antibody abt-806 | rel=r_associated | relid=0 | w=105
  919. ipilimumab -- r_associated #0: 105 / 0.229 -> en:indium in 111 her2-specific high-affinity protein aby-025
    n1=ipilimumab | n2=en:indium in 111 her2-specific high-affinity protein aby-025 | rel=r_associated | relid=0 | w=105
  920. ipilimumab -- r_associated #0: 105 / 0.229 -> en:indium in 111-labeled macroaggregated albumin
    n1=ipilimumab | n2=en:indium in 111-labeled macroaggregated albumin | rel=r_associated | relid=0 | w=105
  921. ipilimumab -- r_associated #0: 105 / 0.229 -> en:information
    n1=ipilimumab | n2=en:information | rel=r_associated | relid=0 | w=105
  922. ipilimumab -- r_associated #0: 105 / 0.229 -> en:iniparib
    n1=ipilimumab | n2=en:iniparib | rel=r_associated | relid=0 | w=105
  923. ipilimumab -- r_associated #0: 105 / 0.229 -> en:innate immunostimulator rbbx-01
    n1=ipilimumab | n2=en:innate immunostimulator rbbx-01 | rel=r_associated | relid=0 | w=105
  924. ipilimumab -- r_associated #0: 105 / 0.229 -> en:inosine dialdehyde
    n1=ipilimumab | n2=en:inosine dialdehyde | rel=r_associated | relid=0 | w=105
  925. ipilimumab -- r_associated #0: 105 / 0.229 -> en:inpact
    n1=ipilimumab | n2=en:inpact | rel=r_associated | relid=0 | w=105
  926. ipilimumab -- r_associated #0: 105 / 0.229 -> en:insulin lispro
    n1=ipilimumab | n2=en:insulin lispro | rel=r_associated | relid=0 | w=105
  927. ipilimumab -- r_associated #0: 105 / 0.229 -> en:interferon alfacon-1
    n1=ipilimumab | n2=en:interferon alfacon-1 | rel=r_associated | relid=0 | w=105
  928. ipilimumab -- r_associated #0: 105 / 0.229 -> en:interleukin-10
    n1=ipilimumab | n2=en:interleukin-10 | rel=r_associated | relid=0 | w=105
  929. ipilimumab -- r_associated #0: 105 / 0.229 -> en:intetumumab
    n1=ipilimumab | n2=en:intetumumab | rel=r_associated | relid=0 | w=105
  930. ipilimumab -- r_associated #0: 105 / 0.229 -> en:intoplicine
    n1=ipilimumab | n2=en:intoplicine | rel=r_associated | relid=0 | w=105
  931. ipilimumab -- r_associated #0: 105 / 0.229 -> en:intrinsic factor/iron/liver/multivitamins
    n1=ipilimumab | n2=en:intrinsic factor/iron/liver/multivitamins | rel=r_associated | relid=0 | w=105
  932. ipilimumab -- r_associated #0: 105 / 0.229 -> en:iodine
    n1=ipilimumab | n2=en:iodine | rel=r_associated | relid=0 | w=105
  933. ipilimumab -- r_associated #0: 105 / 0.229 -> en:iodine i 123 anti-cea recombinant diabody t84.66
    n1=ipilimumab | n2=en:iodine i 123 anti-cea recombinant diabody t84.66 | rel=r_associated | relid=0 | w=105
  934. ipilimumab -- r_associated #0: 105 / 0.229 -> en:iodine i 131 anti-fibronectin antibody fragment l19-sip
    n1=ipilimumab | n2=en:iodine i 131 anti-fibronectin antibody fragment l19-sip | rel=r_associated | relid=0 | w=105
  935. ipilimumab -- r_associated #0: 105 / 0.229 -> en:iodine i 131 monoclonal antibody 81c6
    n1=ipilimumab | n2=en:iodine i 131 monoclonal antibody 81c6 | rel=r_associated | relid=0 | w=105
  936. ipilimumab -- r_associated #0: 105 / 0.229 -> en:iodine i-123 mip-1095
    n1=ipilimumab | n2=en:iodine i-123 mip-1095 | rel=r_associated | relid=0 | w=105
  937. ipilimumab -- r_associated #0: 105 / 0.229 -> en:iopromide
    n1=ipilimumab | n2=en:iopromide | rel=r_associated | relid=0 | w=105
  938. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ipratropium
    n1=ipilimumab | n2=en:ipratropium | rel=r_associated | relid=0 | w=105
  939. ipilimumab -- r_associated #0: 105 / 0.229 -> en:isocarboxazid
    n1=ipilimumab | n2=en:isocarboxazid | rel=r_associated | relid=0 | w=105
  940. ipilimumab -- r_associated #0: 105 / 0.229 -> en:isoleucine + leucine + valine
    n1=ipilimumab | n2=en:isoleucine + leucine + valine | rel=r_associated | relid=0 | w=105
  941. ipilimumab -- r_associated #0: 105 / 0.229 -> en:isosorbide
    n1=ipilimumab | n2=en:isosorbide | rel=r_associated | relid=0 | w=105
  942. ipilimumab -- r_associated #0: 105 / 0.229 -> en:isosource
    n1=ipilimumab | n2=en:isosource | rel=r_associated | relid=0 | w=105
  943. ipilimumab -- r_associated #0: 105 / 0.229 -> en:isosulfan blue/potassium phosphate/sodium phosphate
    n1=ipilimumab | n2=en:isosulfan blue/potassium phosphate/sodium phosphate | rel=r_associated | relid=0 | w=105
  944. ipilimumab -- r_associated #0: 105 / 0.229 -> en:itraconazole
    n1=ipilimumab | n2=en:itraconazole | rel=r_associated | relid=0 | w=105
  945. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ivac mutanome vaccine
    n1=ipilimumab | n2=en:ivac mutanome vaccine | rel=r_associated | relid=0 | w=105
  946. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ixabepilone
    n1=ipilimumab | n2=en:ixabepilone | rel=r_associated | relid=0 | w=105
  947. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ixazomib citrate
    n1=ipilimumab | n2=en:ixazomib citrate | rel=r_associated | relid=0 | w=105
  948. ipilimumab -- r_associated #0: 105 / 0.229 -> en:jak2 inhibitor bms-911543
    n1=ipilimumab | n2=en:jak2 inhibitor bms-911543 | rel=r_associated | relid=0 | w=105
  949. ipilimumab -- r_associated #0: 105 / 0.229 -> en:jak2 inhibitor tg101348
    n1=ipilimumab | n2=en:jak2 inhibitor tg101348 | rel=r_associated | relid=0 | w=105
  950. ipilimumab -- r_associated #0: 105 / 0.229 -> en:kava-based supplement
    n1=ipilimumab | n2=en:kava-based supplement | rel=r_associated | relid=0 | w=105
  951. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ketamine/amitriptyline np-h cream
    n1=ipilimumab | n2=en:ketamine/amitriptyline np-h cream | rel=r_associated | relid=0 | w=105
  952. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ketoprofen
    n1=ipilimumab | n2=en:ketoprofen | rel=r_associated | relid=0 | w=105
  953. ipilimumab -- r_associated #0: 105 / 0.229 -> en:l-4-chlorokynurenine
    n1=ipilimumab | n2=en:l-4-chlorokynurenine | rel=r_associated | relid=0 | w=105
  954. ipilimumab -- r_associated #0: 105 / 0.229 -> en:leflunomide
    n1=ipilimumab | n2=en:leflunomide | rel=r_associated | relid=0 | w=105
  955. ipilimumab -- r_associated #0: 105 / 0.229 -> en:leukemic apoptotic corpse-pulsed autologous dendritic cells
    n1=ipilimumab | n2=en:leukemic apoptotic corpse-pulsed autologous dendritic cells | rel=r_associated | relid=0 | w=105
  956. ipilimumab -- r_associated #0: 105 / 0.229 -> en:leuprolide
    n1=ipilimumab | n2=en:leuprolide | rel=r_associated | relid=0 | w=105
  957. ipilimumab -- r_associated #0: 105 / 0.229 -> en:levonantradol
    n1=ipilimumab | n2=en:levonantradol | rel=r_associated | relid=0 | w=105
  958. ipilimumab -- r_associated #0: 105 / 0.229 -> en:levothyroxine sodium
    n1=ipilimumab | n2=en:levothyroxine sodium | rel=r_associated | relid=0 | w=105
  959. ipilimumab -- r_associated #0: 105 / 0.229 -> en:light-emitting oncolytic vaccinia virus gl-onc1
    n1=ipilimumab | n2=en:light-emitting oncolytic vaccinia virus gl-onc1 | rel=r_associated | relid=0 | w=105
  960. ipilimumab -- r_associated #0: 105 / 0.229 -> en:limonene
    n1=ipilimumab | n2=en:limonene | rel=r_associated | relid=0 | w=105
  961. ipilimumab -- r_associated #0: 105 / 0.229 -> en:liothyronine i-131
    n1=ipilimumab | n2=en:liothyronine i-131 | rel=r_associated | relid=0 | w=105
  962. ipilimumab -- r_associated #0: 105 / 0.229 -> en:liothyronine sodium
    n1=ipilimumab | n2=en:liothyronine sodium | rel=r_associated | relid=0 | w=105
  963. ipilimumab -- r_associated #0: 105 / 0.229 -> en:liposomal curcumin
    n1=ipilimumab | n2=en:liposomal curcumin | rel=r_associated | relid=0 | w=105
  964. ipilimumab -- r_associated #0: 105 / 0.229 -> en:liposomal muc1/pet-lipid a vaccine
    n1=ipilimumab | n2=en:liposomal muc1/pet-lipid a vaccine | rel=r_associated | relid=0 | w=105
  965. ipilimumab -- r_associated #0: 105 / 0.229 -> en:liposomal nddp
    n1=ipilimumab | n2=en:liposomal nddp | rel=r_associated | relid=0 | w=105
  966. ipilimumab -- r_associated #0: 105 / 0.229 -> en:liposomal oxaliplatin
    n1=ipilimumab | n2=en:liposomal oxaliplatin | rel=r_associated | relid=0 | w=105
  967. ipilimumab -- r_associated #0: 105 / 0.229 -> en:liposomal rhenium re 186
    n1=ipilimumab | n2=en:liposomal rhenium re 186 | rel=r_associated | relid=0 | w=105
  968. ipilimumab -- r_associated #0: 105 / 0.229 -> en:liposome-encapsulated recombinant human cu/zn superoxide-dismutase
    n1=ipilimumab | n2=en:liposome-encapsulated recombinant human cu/zn superoxide-dismutase | rel=r_associated | relid=0 | w=105
  969. ipilimumab -- r_associated #0: 105 / 0.229 -> en:lisofylline
    n1=ipilimumab | n2=en:lisofylline | rel=r_associated | relid=0 | w=105
  970. ipilimumab -- r_associated #0: 105 / 0.229 -> en:live attenuated measles virus vaccine
    n1=ipilimumab | n2=en:live attenuated measles virus vaccine | rel=r_associated | relid=0 | w=105
  971. ipilimumab -- r_associated #0: 105 / 0.229 -> en:liver extract
    n1=ipilimumab | n2=en:liver extract | rel=r_associated | relid=0 | w=105
  972. ipilimumab -- r_associated #0: 105 / 0.229 -> en:lmp-2:340-349 peptide vaccine
    n1=ipilimumab | n2=en:lmp-2:340-349 peptide vaccine | rel=r_associated | relid=0 | w=105
  973. ipilimumab -- r_associated #0: 105 / 0.229 -> en:lmp-2:419-427 peptide vaccine
    n1=ipilimumab | n2=en:lmp-2:419-427 peptide vaccine | rel=r_associated | relid=0 | w=105
  974. ipilimumab -- r_associated #0: 105 / 0.229 -> en:lonaprisan
    n1=ipilimumab | n2=en:lonaprisan | rel=r_associated | relid=0 | w=105
  975. ipilimumab -- r_associated #0: 105 / 0.229 -> en:loperamide hydrochloride
    n1=ipilimumab | n2=en:loperamide hydrochloride | rel=r_associated | relid=0 | w=105
  976. ipilimumab -- r_associated #0: 105 / 0.229 -> en:losartan potassium
    n1=ipilimumab | n2=en:losartan potassium | rel=r_associated | relid=0 | w=105
  977. ipilimumab -- r_associated #0: 105 / 0.229 -> en:lubiprostone
    n1=ipilimumab | n2=en:lubiprostone | rel=r_associated | relid=0 | w=105
  978. ipilimumab -- r_associated #0: 105 / 0.229 -> en:lugol's solution
    n1=ipilimumab | n2=en:lugol's solution | rel=r_associated | relid=0 | w=105
  979. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ly2880070
    n1=ipilimumab | n2=en:ly2880070 | rel=r_associated | relid=0 | w=105
  980. ipilimumab -- r_associated #0: 105 / 0.229 -> en:mage-a3-expressing adenovirus type 5 vaccine
    n1=ipilimumab | n2=en:mage-a3-expressing adenovirus type 5 vaccine | rel=r_associated | relid=0 | w=105
  981. ipilimumab -- r_associated #0: 105 / 0.229 -> en:mage-a3/12-specific tcr gene-transduced autologous pbls
    n1=ipilimumab | n2=en:mage-a3/12-specific tcr gene-transduced autologous pbls | rel=r_associated | relid=0 | w=105
  982. ipilimumab -- r_associated #0: 105 / 0.229 -> en:maitake mushroom extract
    n1=ipilimumab | n2=en:maitake mushroom extract | rel=r_associated | relid=0 | w=105
  983. ipilimumab -- r_associated #0: 105 / 0.229 -> en:mart-1:26-35(27l) peptide vaccine
    n1=ipilimumab | n2=en:mart-1:26-35(27l) peptide vaccine | rel=r_associated | relid=0 | w=105
  984. ipilimumab -- r_associated #0: 105 / 0.229 -> en:matuzumab
    n1=ipilimumab | n2=en:matuzumab | rel=r_associated | relid=0 | w=105
  985. ipilimumab -- r_associated #0: 105 / 0.229 -> en:mcpyv tag-specific polyclonal autologous cd8-positive t cells
    n1=ipilimumab | n2=en:mcpyv tag-specific polyclonal autologous cd8-positive t cells | rel=r_associated | relid=0 | w=105
  986. ipilimumab -- r_associated #0: 105 / 0.229 -> en:mdr modulator cbt-1
    n1=ipilimumab | n2=en:mdr modulator cbt-1 | rel=r_associated | relid=0 | w=105
  987. ipilimumab -- r_associated #0: 105 / 0.229 -> en:measles/mumps/rubella vaccine
    n1=ipilimumab | n2=en:measles/mumps/rubella vaccine | rel=r_associated | relid=0 | w=105
  988. ipilimumab -- r_associated #0: 105 / 0.229 -> en:meclocycline sulfosalicylate
    n1=ipilimumab | n2=en:meclocycline sulfosalicylate | rel=r_associated | relid=0 | w=105
  989. ipilimumab -- r_associated #0: 105 / 0.229 -> en:meglumine ioxithalamate
    n1=ipilimumab | n2=en:meglumine ioxithalamate | rel=r_associated | relid=0 | w=105
  990. ipilimumab -- r_associated #0: 105 / 0.229 -> en:mek-1/mekk-1 inhibitor e6201
    n1=ipilimumab | n2=en:mek-1/mekk-1 inhibitor e6201 | rel=r_associated | relid=0 | w=105
  991. ipilimumab -- r_associated #0: 105 / 0.229 -> en:melanoma antigen recognized by t-cells 1
    n1=ipilimumab | n2=en:melanoma antigen recognized by t-cells 1 | rel=r_associated | relid=0 | w=105
  992. ipilimumab -- r_associated #0: 105 / 0.229 -> en:melanoma helper peptide vaccine
    n1=ipilimumab | n2=en:melanoma helper peptide vaccine | rel=r_associated | relid=0 | w=105
  993. ipilimumab -- r_associated #0: 105 / 0.229 -> en:melk inhibitor ots167
    n1=ipilimumab | n2=en:melk inhibitor ots167 | rel=r_associated | relid=0 | w=105
  994. ipilimumab -- r_associated #0: 105 / 0.229 -> en:mercaptopurine anhydrous
    n1=ipilimumab | n2=en:mercaptopurine anhydrous | rel=r_associated | relid=0 | w=105
  995. ipilimumab -- r_associated #0: 105 / 0.229 -> en:mesalamine
    n1=ipilimumab | n2=en:mesalamine | rel=r_associated | relid=0 | w=105
  996. ipilimumab -- r_associated #0: 105 / 0.229 -> en:methadone hydrochloride
    n1=ipilimumab | n2=en:methadone hydrochloride | rel=r_associated | relid=0 | w=105
  997. ipilimumab -- r_associated #0: 105 / 0.229 -> en:methimazole
    n1=ipilimumab | n2=en:methimazole | rel=r_associated | relid=0 | w=105
  998. ipilimumab -- r_associated #0: 105 / 0.229 -> en:methotrexate-encapsulating autologous tumor-derived microparticles
    n1=ipilimumab | n2=en:methotrexate-encapsulating autologous tumor-derived microparticles | rel=r_associated | relid=0 | w=105
  999. ipilimumab -- r_associated #0: 105 / 0.229 -> en:methoxsalen
    n1=ipilimumab | n2=en:methoxsalen | rel=r_associated | relid=0 | w=105
  1000. ipilimumab -- r_associated #0: 105 / 0.229 -> en:methoxyflurane
    n1=ipilimumab | n2=en:methoxyflurane | rel=r_associated | relid=0 | w=105
  1001. ipilimumab -- r_associated #0: 105 / 0.229 -> en:methylene blue
    n1=ipilimumab | n2=en:methylene blue | rel=r_associated | relid=0 | w=105
  1002. ipilimumab -- r_associated #0: 105 / 0.229 -> en:methylnaltrexone
    n1=ipilimumab | n2=en:methylnaltrexone | rel=r_associated | relid=0 | w=105
  1003. ipilimumab -- r_associated #0: 105 / 0.229 -> en:methylprednisolone
    n1=ipilimumab | n2=en:methylprednisolone | rel=r_associated | relid=0 | w=105
  1004. ipilimumab -- r_associated #0: 105 / 0.229 -> en:metyrosine
    n1=ipilimumab | n2=en:metyrosine | rel=r_associated | relid=0 | w=105
  1005. ipilimumab -- r_associated #0: 105 / 0.229 -> en:miglustat
    n1=ipilimumab | n2=en:miglustat | rel=r_associated | relid=0 | w=105
  1006. ipilimumab -- r_associated #0: 105 / 0.229 -> en:milk protein-based energy drink
    n1=ipilimumab | n2=en:milk protein-based energy drink | rel=r_associated | relid=0 | w=105
  1007. ipilimumab -- r_associated #0: 105 / 0.229 -> en:mitogen
    n1=ipilimumab | n2=en:mitogen | rel=r_associated | relid=0 | w=105
  1008. ipilimumab -- r_associated #0: 105 / 0.229 -> en:mln2704
    n1=ipilimumab | n2=en:mln2704 | rel=r_associated | relid=0 | w=105
  1009. ipilimumab -- r_associated #0: 105 / 0.229 -> en:mogamulizumab
    n1=ipilimumab | n2=en:mogamulizumab | rel=r_associated | relid=0 | w=105
  1010. ipilimumab -- r_associated #0: 105 / 0.229 -> en:monoclonal antibody cc49
    n1=ipilimumab | n2=en:monoclonal antibody cc49 | rel=r_associated | relid=0 | w=105
  1011. ipilimumab -- r_associated #0: 105 / 0.229 -> en:monoclonal antibody cep-37250/khk2804
    n1=ipilimumab | n2=en:monoclonal antibody cep-37250/khk2804 | rel=r_associated | relid=0 | w=105
  1012. ipilimumab -- r_associated #0: 105 / 0.229 -> en:monoclonal antibody hu3s193
    n1=ipilimumab | n2=en:monoclonal antibody hu3s193 | rel=r_associated | relid=0 | w=105
  1013. ipilimumab -- r_associated #0: 105 / 0.229 -> en:monoclonal antibody mx35 f(ab')2
    n1=ipilimumab | n2=en:monoclonal antibody mx35 f(ab')2 | rel=r_associated | relid=0 | w=105
  1014. ipilimumab -- r_associated #0: 105 / 0.229 -> en:mouse monoclonal antibody
    n1=ipilimumab | n2=en:mouse monoclonal antibody | rel=r_associated | relid=0 | w=105
  1015. ipilimumab -- r_associated #0: 105 / 0.229 -> en:moxalactam
    n1=ipilimumab | n2=en:moxalactam | rel=r_associated | relid=0 | w=105
  1016. ipilimumab -- r_associated #0: 105 / 0.229 -> en:mps1 kinase inhibitor bay1161909
    n1=ipilimumab | n2=en:mps1 kinase inhibitor bay1161909 | rel=r_associated | relid=0 | w=105
  1017. ipilimumab -- r_associated #0: 105 / 0.229 -> en:muc-2-klh vaccine
    n1=ipilimumab | n2=en:muc-2-klh vaccine | rel=r_associated | relid=0 | w=105
  1018. ipilimumab -- r_associated #0: 105 / 0.229 -> en:muc1 peptide-poly-iclc adjuvant vaccine
    n1=ipilimumab | n2=en:muc1 peptide-poly-iclc adjuvant vaccine | rel=r_associated | relid=0 | w=105
  1019. ipilimumab -- r_associated #0: 105 / 0.229 -> en:muc1-klh vaccine/qs21
    n1=ipilimumab | n2=en:muc1-klh vaccine/qs21 | rel=r_associated | relid=0 | w=105
  1020. ipilimumab -- r_associated #0: 105 / 0.229 -> en:mucoadhesive oral wound rinse
    n1=ipilimumab | n2=en:mucoadhesive oral wound rinse | rel=r_associated | relid=0 | w=105
  1021. ipilimumab -- r_associated #0: 105 / 0.229 -> en:mucoprotective agent xer2020
    n1=ipilimumab | n2=en:mucoprotective agent xer2020 | rel=r_associated | relid=0 | w=105
  1022. ipilimumab -- r_associated #0: 105 / 0.229 -> en:multikinase inhibitor 4sc-203
    n1=ipilimumab | n2=en:multikinase inhibitor 4sc-203 | rel=r_associated | relid=0 | w=105
  1023. ipilimumab -- r_associated #0: 105 / 0.229 -> en:multipeptide vaccine s-588210
    n1=ipilimumab | n2=en:multipeptide vaccine s-588210 | rel=r_associated | relid=0 | w=105
  1024. ipilimumab -- r_associated #0: 105 / 0.229 -> en:mva-ebna1/lmp2 vaccine
    n1=ipilimumab | n2=en:mva-ebna1/lmp2 vaccine | rel=r_associated | relid=0 | w=105
  1025. ipilimumab -- r_associated #0: 105 / 0.229 -> en:mvf-her-2(597-626)/mvf-her-2 (266-296) peptide vaccine
    n1=ipilimumab | n2=en:mvf-her-2(597-626)/mvf-her-2 (266-296) peptide vaccine | rel=r_associated | relid=0 | w=105
  1026. ipilimumab -- r_associated #0: 105 / 0.229 -> en:naloxone hydrochloride
    n1=ipilimumab | n2=en:naloxone hydrochloride | rel=r_associated | relid=0 | w=105
  1027. ipilimumab -- r_associated #0: 105 / 0.229 -> en:nanoparticle albumin-bound rapamycin
    n1=ipilimumab | n2=en:nanoparticle albumin-bound rapamycin | rel=r_associated | relid=0 | w=105
  1028. ipilimumab -- r_associated #0: 105 / 0.229 -> en:naphthalimide analogue unbs5162
    n1=ipilimumab | n2=en:naphthalimide analogue unbs5162 | rel=r_associated | relid=0 | w=105
  1029. ipilimumab -- r_associated #0: 105 / 0.229 -> en:natalizumab
    n1=ipilimumab | n2=en:natalizumab | rel=r_associated | relid=0 | w=105
  1030. ipilimumab -- r_associated #0: 105 / 0.229 -> en:nd-420
    n1=ipilimumab | n2=en:nd-420 | rel=r_associated | relid=0 | w=105
  1031. ipilimumab -- r_associated #0: 105 / 0.229 -> en:neoantigen-based glioblastoma vaccine
    n1=ipilimumab | n2=en:neoantigen-based glioblastoma vaccine | rel=r_associated | relid=0 | w=105
  1032. ipilimumab -- r_associated #0: 105 / 0.229 -> en:neoantigen-based melanoma-poly-iclc vaccine
    n1=ipilimumab | n2=en:neoantigen-based melanoma-poly-iclc vaccine | rel=r_associated | relid=0 | w=105
  1033. ipilimumab -- r_associated #0: 105 / 0.229 -> en:nesiritide
    n1=ipilimumab | n2=en:nesiritide | rel=r_associated | relid=0 | w=105
  1034. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ng-nitro-l-arginine
    n1=ipilimumab | n2=en:ng-nitro-l-arginine | rel=r_associated | relid=0 | w=105
  1035. ipilimumab -- r_associated #0: 105 / 0.229 -> en:niacin
    n1=ipilimumab | n2=en:niacin | rel=r_associated | relid=0 | w=105
  1036. ipilimumab -- r_associated #0: 105 / 0.229 -> en:non-adjuvanted a(h1n1) influenza vaccine
    n1=ipilimumab | n2=en:non-adjuvanted a(h1n1) influenza vaccine | rel=r_associated | relid=0 | w=105
  1037. ipilimumab -- r_associated #0: 105 / 0.229 -> en:nonenzyme proteolytic agent
    n1=ipilimumab | n2=en:nonenzyme proteolytic agent | rel=r_associated | relid=0 | w=105
  1038. ipilimumab -- r_associated #0: 105 / 0.229 -> en:notch signaling pathway inhibitor mk0752
    n1=ipilimumab | n2=en:notch signaling pathway inhibitor mk0752 | rel=r_associated | relid=0 | w=105
  1039. ipilimumab -- r_associated #0: 105 / 0.229 -> en:novobiocin
    n1=ipilimumab | n2=en:novobiocin | rel=r_associated | relid=0 | w=105
  1040. ipilimumab -- r_associated #0: 105 / 0.229 -> en:nsclc antigen-loaded dendritic cell-derived exosomesnon-small cell lung cancer tumor antigen-loaded dendritic cell-derived exosomes
    n1=ipilimumab | n2=en:nsclc antigen-loaded dendritic cell-derived exosomesnon-small cell lung cancer tumor antigen-loaded dendritic cell-derived exosomes | rel=r_associated | relid=0 | w=105
  1041. ipilimumab -- r_associated #0: 105 / 0.229 -> en:nucleotide analogue gs 9219
    n1=ipilimumab | n2=en:nucleotide analogue gs 9219 | rel=r_associated | relid=0 | w=105
  1042. ipilimumab -- r_associated #0: 105 / 0.229 -> en:nutlin-3a
    n1=ipilimumab | n2=en:nutlin-3a | rel=r_associated | relid=0 | w=105
  1043. ipilimumab -- r_associated #0: 105 / 0.229 -> en:nv1020
    n1=ipilimumab | n2=en:nv1020 | rel=r_associated | relid=0 | w=105
  1044. ipilimumab -- r_associated #0: 105 / 0.229 -> en:octreotide pamoate
    n1=ipilimumab | n2=en:octreotide pamoate | rel=r_associated | relid=0 | w=105
  1045. ipilimumab -- r_associated #0: 105 / 0.229 -> en:olaparib
    n1=ipilimumab | n2=en:olaparib | rel=r_associated | relid=0 | w=105
  1046. ipilimumab -- r_associated #0: 105 / 0.229 -> en:oncolytic adenovirus icovir5-infected autologous mesenchymal stem cells
    n1=ipilimumab | n2=en:oncolytic adenovirus icovir5-infected autologous mesenchymal stem cells | rel=r_associated | relid=0 | w=105
  1047. ipilimumab -- r_associated #0: 105 / 0.229 -> en:opcs/green tea/spirullina/curcumin/antrodia camphorate/fermented soymilk extract capsule
    n1=ipilimumab | n2=en:opcs/green tea/spirullina/curcumin/antrodia camphorate/fermented soymilk extract capsule | rel=r_associated | relid=0 | w=105
  1048. ipilimumab -- r_associated #0: 105 / 0.229 -> en:oral fludarabine phosphate
    n1=ipilimumab | n2=en:oral fludarabine phosphate | rel=r_associated | relid=0 | w=105
  1049. ipilimumab -- r_associated #0: 105 / 0.229 -> en:oral rehydration solution os-1
    n1=ipilimumab | n2=en:oral rehydration solution os-1 | rel=r_associated | relid=0 | w=105
  1050. ipilimumab -- r_associated #0: 105 / 0.229 -> en:orteronel
    n1=ipilimumab | n2=en:orteronel | rel=r_associated | relid=0 | w=105
  1051. ipilimumab -- r_associated #0: 105 / 0.229 -> en:over the counter product
    n1=ipilimumab | n2=en:over the counter product | rel=r_associated | relid=0 | w=105
  1052. ipilimumab -- r_associated #0: 105 / 0.229 -> en:oxaliplatin
    n1=ipilimumab | n2=en:oxaliplatin | rel=r_associated | relid=0 | w=105
  1053. ipilimumab -- r_associated #0: 105 / 0.229 -> en:oxymetholone
    n1=ipilimumab | n2=en:oxymetholone | rel=r_associated | relid=0 | w=105
  1054. ipilimumab -- r_associated #0: 105 / 0.229 -> en:oxymorphone hydrochloride
    n1=ipilimumab | n2=en:oxymorphone hydrochloride | rel=r_associated | relid=0 | w=105
  1055. ipilimumab -- r_associated #0: 105 / 0.229 -> en:p-cadherin inhibitor pca062
    n1=ipilimumab | n2=en:p-cadherin inhibitor pca062 | rel=r_associated | relid=0 | w=105
  1056. ipilimumab -- r_associated #0: 105 / 0.229 -> en:p-tefb inhibitor bay1143572
    n1=ipilimumab | n2=en:p-tefb inhibitor bay1143572 | rel=r_associated | relid=0 | w=105
  1057. ipilimumab -- r_associated #0: 105 / 0.229 -> en:p53-hdm2 interaction inhibitor mi-773
    n1=ipilimumab | n2=en:p53-hdm2 interaction inhibitor mi-773 | rel=r_associated | relid=0 | w=105
  1058. ipilimumab -- r_associated #0: 105 / 0.229 -> en:padre 965.10
    n1=ipilimumab | n2=en:padre 965.10 | rel=r_associated | relid=0 | w=105
  1059. ipilimumab -- r_associated #0: 105 / 0.229 -> en:pan-fgfr tyrosine kinase inhibitor jnj-42756493
    n1=ipilimumab | n2=en:pan-fgfr tyrosine kinase inhibitor jnj-42756493 | rel=r_associated | relid=0 | w=105
  1060. ipilimumab -- r_associated #0: 105 / 0.229 -> en:pan-raf kinase inhibitor cct3833
    n1=ipilimumab | n2=en:pan-raf kinase inhibitor cct3833 | rel=r_associated | relid=0 | w=105
  1061. ipilimumab -- r_associated #0: 105 / 0.229 -> en:pan-selectin antagonist gmi-1070
    n1=ipilimumab | n2=en:pan-selectin antagonist gmi-1070 | rel=r_associated | relid=0 | w=105
  1062. ipilimumab -- r_associated #0: 105 / 0.229 -> en:papaverine
    n1=ipilimumab | n2=en:papaverine | rel=r_associated | relid=0 | w=105
  1063. ipilimumab -- r_associated #0: 105 / 0.229 -> en:parsatuzumab
    n1=ipilimumab | n2=en:parsatuzumab | rel=r_associated | relid=0 | w=105
  1064. ipilimumab -- r_associated #0: 105 / 0.229 -> en:pbtl cd19car-28 zeta
    n1=ipilimumab | n2=en:pbtl cd19car-28 zeta | rel=r_associated | relid=0 | w=105
  1065. ipilimumab -- r_associated #0: 105 / 0.229 -> en:pe/hpv16 e7/kdel fusion protein tvgv-1
    n1=ipilimumab | n2=en:pe/hpv16 e7/kdel fusion protein tvgv-1 | rel=r_associated | relid=0 | w=105
  1066. ipilimumab -- r_associated #0: 105 / 0.229 -> en:peg-interleukin-2
    n1=ipilimumab | n2=en:peg-interleukin-2 | rel=r_associated | relid=0 | w=105
  1067. ipilimumab -- r_associated #0: 105 / 0.229 -> en:pegfilgrastim
    n1=ipilimumab | n2=en:pegfilgrastim | rel=r_associated | relid=0 | w=105
  1068. ipilimumab -- r_associated #0: 105 / 0.229 -> en:pegfilgrastim anti-neutropenic factor
    n1=ipilimumab | n2=en:pegfilgrastim anti-neutropenic factor | rel=r_associated | relid=0 | w=105
  1069. ipilimumab -- r_associated #0: 105 / 0.229 -> en:peldesine
    n1=ipilimumab | n2=en:peldesine | rel=r_associated | relid=0 | w=105
  1070. ipilimumab -- r_associated #0: 105 / 0.229 -> en:penicillin v potassium
    n1=ipilimumab | n2=en:penicillin v potassium | rel=r_associated | relid=0 | w=105
  1071. ipilimumab -- r_associated #0: 105 / 0.229 -> en:pentamidine isethionate
    n1=ipilimumab | n2=en:pentamidine isethionate | rel=r_associated | relid=0 | w=105
  1072. ipilimumab -- r_associated #0: 105 / 0.229 -> en:pentetic acid
    n1=ipilimumab | n2=en:pentetic acid | rel=r_associated | relid=0 | w=105
  1073. ipilimumab -- r_associated #0: 105 / 0.229 -> en:perflutren lipid microspheres
    n1=ipilimumab | n2=en:perflutren lipid microspheres | rel=r_associated | relid=0 | w=105
  1074. ipilimumab -- r_associated #0: 105 / 0.229 -> en:personalized synthetic long peptide breast cancer vaccine
    n1=ipilimumab | n2=en:personalized synthetic long peptide breast cancer vaccine | rel=r_associated | relid=0 | w=105
  1075. ipilimumab -- r_associated #0: 105 / 0.229 -> en:pgg beta-glucan
    n1=ipilimumab | n2=en:pgg beta-glucan | rel=r_associated | relid=0 | w=105
  1076. ipilimumab -- r_associated #0: 105 / 0.229 -> en:pharmaceutical preparations, dental
    n1=ipilimumab | n2=en:pharmaceutical preparations, dental | rel=r_associated | relid=0 | w=105
  1077. ipilimumab -- r_associated #0: 105 / 0.229 -> en:phenprocoumon
    n1=ipilimumab | n2=en:phenprocoumon | rel=r_associated | relid=0 | w=105
  1078. ipilimumab -- r_associated #0: 105 / 0.229 -> en:phosphaplatin pt-112
    n1=ipilimumab | n2=en:phosphaplatin pt-112 | rel=r_associated | relid=0 | w=105
  1079. ipilimumab -- r_associated #0: 105 / 0.229 -> en:pi3k alpha/mtor inhibitor pwt33597 mesylate
    n1=ipilimumab | n2=en:pi3k alpha/mtor inhibitor pwt33597 mesylate | rel=r_associated | relid=0 | w=105
  1080. ipilimumab -- r_associated #0: 105 / 0.229 -> en:pi3k inhibitor gdc-0084
    n1=ipilimumab | n2=en:pi3k inhibitor gdc-0084 | rel=r_associated | relid=0 | w=105
  1081. ipilimumab -- r_associated #0: 105 / 0.229 -> en:pi3k inhibitor gdc-0941 bismesylate
    n1=ipilimumab | n2=en:pi3k inhibitor gdc-0941 bismesylate | rel=r_associated | relid=0 | w=105
  1082. ipilimumab -- r_associated #0: 105 / 0.229 -> en:pimonidazole hydrochloride
    n1=ipilimumab | n2=en:pimonidazole hydrochloride | rel=r_associated | relid=0 | w=105
  1083. ipilimumab -- r_associated #0: 105 / 0.229 -> en:piperazinedione
    n1=ipilimumab | n2=en:piperazinedione | rel=r_associated | relid=0 | w=105
  1084. ipilimumab -- r_associated #0: 105 / 0.229 -> en:piroxicam
    n1=ipilimumab | n2=en:piroxicam | rel=r_associated | relid=0 | w=105
  1085. ipilimumab -- r_associated #0: 105 / 0.229 -> en:pixantrone dimaleate
    n1=ipilimumab | n2=en:pixantrone dimaleate | rel=r_associated | relid=0 | w=105
  1086. ipilimumab -- r_associated #0: 105 / 0.229 -> en:plasmacytoid dendritic cell vaccine
    n1=ipilimumab | n2=en:plasmacytoid dendritic cell vaccine | rel=r_associated | relid=0 | w=105
  1087. ipilimumab -- r_associated #0: 105 / 0.229 -> en:plerixafor
    n1=ipilimumab | n2=en:plerixafor | rel=r_associated | relid=0 | w=105
  1088. ipilimumab -- r_associated #0: 105 / 0.229 -> en:pngvl4a-sig/e7(detox)/hsp70 dna vaccine
    n1=ipilimumab | n2=en:pngvl4a-sig/e7(detox)/hsp70 dna vaccine | rel=r_associated | relid=0 | w=105
  1089. ipilimumab -- r_associated #0: 105 / 0.229 -> en:poly-alendronate dextran-guanidine conjugate
    n1=ipilimumab | n2=en:poly-alendronate dextran-guanidine conjugate | rel=r_associated | relid=0 | w=105
  1090. ipilimumab -- r_associated #0: 105 / 0.229 -> en:poly-gamma glutamic acid
    n1=ipilimumab | n2=en:poly-gamma glutamic acid | rel=r_associated | relid=0 | w=105
  1091. ipilimumab -- r_associated #0: 105 / 0.229 -> en:polyacrylamide hydrogel
    n1=ipilimumab | n2=en:polyacrylamide hydrogel | rel=r_associated | relid=0 | w=105
  1092. ipilimumab -- r_associated #0: 105 / 0.229 -> en:polyamine analogue
    n1=ipilimumab | n2=en:polyamine analogue | rel=r_associated | relid=0 | w=105
  1093. ipilimumab -- r_associated #0: 105 / 0.229 -> en:polyethyleneglycol-7-ethyl-10-hydroxycamptothecin dfp-13318
    n1=ipilimumab | n2=en:polyethyleneglycol-7-ethyl-10-hydroxycamptothecin dfp-13318 | rel=r_associated | relid=0 | w=105
  1094. ipilimumab -- r_associated #0: 105 / 0.229 -> en:polyvalent melanoma vaccine
    n1=ipilimumab | n2=en:polyvalent melanoma vaccine | rel=r_associated | relid=0 | w=105
  1095. ipilimumab -- r_associated #0: 105 / 0.229 -> en:polyvinylpyrrolidone-sodium hyaluronate gel
    n1=ipilimumab | n2=en:polyvinylpyrrolidone-sodium hyaluronate gel | rel=r_associated | relid=0 | w=105
  1096. ipilimumab -- r_associated #0: 105 / 0.229 -> en:pomalidomide
    n1=ipilimumab | n2=en:pomalidomide | rel=r_associated | relid=0 | w=105
  1097. ipilimumab -- r_associated #0: 105 / 0.229 -> en:pomegranate liquid extract
    n1=ipilimumab | n2=en:pomegranate liquid extract | rel=r_associated | relid=0 | w=105
  1098. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ponatinib hydrochloride
    n1=ipilimumab | n2=en:ponatinib hydrochloride | rel=r_associated | relid=0 | w=105
  1099. ipilimumab -- r_associated #0: 105 / 0.229 -> en:pracinostat
    n1=ipilimumab | n2=en:pracinostat | rel=r_associated | relid=0 | w=105
  1100. ipilimumab -- r_associated #0: 105 / 0.229 -> en:pralatrexate
    n1=ipilimumab | n2=en:pralatrexate | rel=r_associated | relid=0 | w=105
  1101. ipilimumab -- r_associated #0: 105 / 0.229 -> en:prasterone
    n1=ipilimumab | n2=en:prasterone | rel=r_associated | relid=0 | w=105
  1102. ipilimumab -- r_associated #0: 105 / 0.229 -> en:pregabalin
    n1=ipilimumab | n2=en:pregabalin | rel=r_associated | relid=0 | w=105
  1103. ipilimumab -- r_associated #0: 105 / 0.229 -> en:primary prostate cancer tissue/htert/survivin mrna-loaded autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:primary prostate cancer tissue/htert/survivin mrna-loaded autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=105
  1104. ipilimumab -- r_associated #0: 105 / 0.229 -> en:product bases and inactive substances
    n1=ipilimumab | n2=en:product bases and inactive substances | rel=r_associated | relid=0 | w=105
  1105. ipilimumab -- r_associated #0: 105 / 0.229 -> en:proflavine
    n1=ipilimumab | n2=en:proflavine | rel=r_associated | relid=0 | w=105
  1106. ipilimumab -- r_associated #0: 105 / 0.229 -> en:propofol
    n1=ipilimumab | n2=en:propofol | rel=r_associated | relid=0 | w=105
  1107. ipilimumab -- r_associated #0: 105 / 0.229 -> en:psoralen
    n1=ipilimumab | n2=en:psoralen | rel=r_associated | relid=0 | w=105
  1108. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ptvg-hp plasmid dna vaccine
    n1=ipilimumab | n2=en:ptvg-hp plasmid dna vaccine | rel=r_associated | relid=0 | w=105
  1109. ipilimumab -- r_associated #0: 105 / 0.229 -> en:quinacrine hydrochloride
    n1=ipilimumab | n2=en:quinacrine hydrochloride | rel=r_associated | relid=0 | w=105
  1110. ipilimumab -- r_associated #0: 105 / 0.229 -> en:r 7160
    n1=ipilimumab | n2=en:r 7160 | rel=r_associated | relid=0 | w=105
  1111. ipilimumab -- r_associated #0: 105 / 0.229 -> en:r-(-)-gossypol acetic acid
    n1=ipilimumab | n2=en:r-(-)-gossypol acetic acid | rel=r_associated | relid=0 | w=105
  1112. ipilimumab -- r_associated #0: 105 / 0.229 -> en:rabeprazole sodium
    n1=ipilimumab | n2=en:rabeprazole sodium | rel=r_associated | relid=0 | w=105
  1113. ipilimumab -- r_associated #0: 105 / 0.229 -> en:radiopharmaceutical bay1862864
    n1=ipilimumab | n2=en:radiopharmaceutical bay1862864 | rel=r_associated | relid=0 | w=105
  1114. ipilimumab -- r_associated #0: 105 / 0.229 -> en:raf kinase inhibitor xl281
    n1=ipilimumab | n2=en:raf kinase inhibitor xl281 | rel=r_associated | relid=0 | w=105
  1115. ipilimumab -- r_associated #0: 105 / 0.229 -> en:raf/mek serine/threonine kinase inhibitor ro5126766
    n1=ipilimumab | n2=en:raf/mek serine/threonine kinase inhibitor ro5126766 | rel=r_associated | relid=0 | w=105
  1116. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ramipril
    n1=ipilimumab | n2=en:ramipril | rel=r_associated | relid=0 | w=105
  1117. ipilimumab -- r_associated #0: 105 / 0.229 -> en:recombinant b. pertussis adenylate cyclase toxin-tyrosinase a2 epitope vaccine
    n1=ipilimumab | n2=en:recombinant b. pertussis adenylate cyclase toxin-tyrosinase a2 epitope vaccine | rel=r_associated | relid=0 | w=105
  1118. ipilimumab -- r_associated #0: 105 / 0.229 -> en:recombinant bispecific single-chain antibody rm28
    n1=ipilimumab | n2=en:recombinant bispecific single-chain antibody rm28 | rel=r_associated | relid=0 | w=105
  1119. ipilimumab -- r_associated #0: 105 / 0.229 -> en:recombinant cell-surface anchored sialidase das181
    n1=ipilimumab | n2=en:recombinant cell-surface anchored sialidase das181 | rel=r_associated | relid=0 | w=105
  1120. ipilimumab -- r_associated #0: 105 / 0.229 -> en:recombinant ephb4-hsa fusion protein
    n1=ipilimumab | n2=en:recombinant ephb4-hsa fusion protein | rel=r_associated | relid=0 | w=105
  1121. ipilimumab -- r_associated #0: 105 / 0.229 -> en:recombinant fowlpox gm-csf vaccine adjuvant
    n1=ipilimumab | n2=en:recombinant fowlpox gm-csf vaccine adjuvant | rel=r_associated | relid=0 | w=105
  1122. ipilimumab -- r_associated #0: 105 / 0.229 -> en:recombinant gonadorelin
    n1=ipilimumab | n2=en:recombinant gonadorelin | rel=r_associated | relid=0 | w=105
  1123. ipilimumab -- r_associated #0: 105 / 0.229 -> en:recombinant human albumin-human granulocyte colony-stimulating factor
    n1=ipilimumab | n2=en:recombinant human albumin-human granulocyte colony-stimulating factor | rel=r_associated | relid=0 | w=105
  1124. ipilimumab -- r_associated #0: 105 / 0.229 -> en:recombinant human egf-rp64k/montanide isa 51 vaccine
    n1=ipilimumab | n2=en:recombinant human egf-rp64k/montanide isa 51 vaccine | rel=r_associated | relid=0 | w=105
  1125. ipilimumab -- r_associated #0: 105 / 0.229 -> en:recombinant human hyaluronidase
    n1=ipilimumab | n2=en:recombinant human hyaluronidase | rel=r_associated | relid=0 | w=105
  1126. ipilimumab -- r_associated #0: 105 / 0.229 -> en:recombinant human interleukin-15
    n1=ipilimumab | n2=en:recombinant human interleukin-15 | rel=r_associated | relid=0 | w=105
  1127. ipilimumab -- r_associated #0: 105 / 0.229 -> en:recombinant interferon alfa-2a
    n1=ipilimumab | n2=en:recombinant interferon alfa-2a | rel=r_associated | relid=0 | w=105
  1128. ipilimumab -- r_associated #0: 105 / 0.229 -> en:recombinant interferon gamma
    n1=ipilimumab | n2=en:recombinant interferon gamma | rel=r_associated | relid=0 | w=105
  1129. ipilimumab -- r_associated #0: 105 / 0.229 -> en:recombinant mage-3.1 antigen
    n1=ipilimumab | n2=en:recombinant mage-3.1 antigen | rel=r_associated | relid=0 | w=105
  1130. ipilimumab -- r_associated #0: 105 / 0.229 -> en:recombinant platelet factor 4
    n1=ipilimumab | n2=en:recombinant platelet factor 4 | rel=r_associated | relid=0 | w=105
  1131. ipilimumab -- r_associated #0: 105 / 0.229 -> en:recombinant saccharomyces cerevisia-cea(610d)-expressing vaccine gi-6207
    n1=ipilimumab | n2=en:recombinant saccharomyces cerevisia-cea(610d)-expressing vaccine gi-6207 | rel=r_associated | relid=0 | w=105
  1132. ipilimumab -- r_associated #0: 105 / 0.229 -> en:recombinant vaccinia-muc-1 vaccine
    n1=ipilimumab | n2=en:recombinant vaccinia-muc-1 vaccine | rel=r_associated | relid=0 | w=105
  1133. ipilimumab -- r_associated #0: 105 / 0.229 -> en:recombinant vaccinia-ny-eso-1 vaccine
    n1=ipilimumab | n2=en:recombinant vaccinia-ny-eso-1 vaccine | rel=r_associated | relid=0 | w=105
  1134. ipilimumab -- r_associated #0: 105 / 0.229 -> en:recombinant vaccinia-tricom vaccine
    n1=ipilimumab | n2=en:recombinant vaccinia-tricom vaccine | rel=r_associated | relid=0 | w=105
  1135. ipilimumab -- r_associated #0: 105 / 0.229 -> en:rectal dosage form product
    n1=ipilimumab | n2=en:rectal dosage form product | rel=r_associated | relid=0 | w=105
  1136. ipilimumab -- r_associated #0: 105 / 0.229 -> en:refametinib
    n1=ipilimumab | n2=en:refametinib | rel=r_associated | relid=0 | w=105
  1137. ipilimumab -- r_associated #0: 105 / 0.229 -> en:regorafenib
    n1=ipilimumab | n2=en:regorafenib | rel=r_associated | relid=0 | w=105
  1138. ipilimumab -- r_associated #0: 105 / 0.229 -> en:retinoic acid agent
    n1=ipilimumab | n2=en:retinoic acid agent | rel=r_associated | relid=0 | w=105
  1139. ipilimumab -- r_associated #0: 105 / 0.229 -> en:retinoid analogue nrx 195183
    n1=ipilimumab | n2=en:retinoid analogue nrx 195183 | rel=r_associated | relid=0 | w=105
  1140. ipilimumab -- r_associated #0: 105 / 0.229 -> en:retrovector encoding mutant anti-cyclin g1
    n1=ipilimumab | n2=en:retrovector encoding mutant anti-cyclin g1 | rel=r_associated | relid=0 | w=105
  1141. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ribavirin+interferon alpha-2b
    n1=ipilimumab | n2=en:ribavirin+interferon alpha-2b | rel=r_associated | relid=0 | w=105
  1142. ipilimumab -- r_associated #0: 105 / 0.229 -> en:rifampin
    n1=ipilimumab | n2=en:rifampin | rel=r_associated | relid=0 | w=105
  1143. ipilimumab -- r_associated #0: 105 / 0.229 -> en:risedronate sodium
    n1=ipilimumab | n2=en:risedronate sodium | rel=r_associated | relid=0 | w=105
  1144. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ritonavir
    n1=ipilimumab | n2=en:ritonavir | rel=r_associated | relid=0 | w=105
  1145. ipilimumab -- r_associated #0: 105 / 0.229 -> en:rituximab
    n1=ipilimumab | n2=en:rituximab | rel=r_associated | relid=0 | w=105
  1146. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ro6874813
    n1=ipilimumab | n2=en:ro6874813 | rel=r_associated | relid=0 | w=105
  1147. ipilimumab -- r_associated #0: 105 / 0.229 -> en:rubidium rb-82
    n1=ipilimumab | n2=en:rubidium rb-82 | rel=r_associated | relid=0 | w=105
  1148. ipilimumab -- r_associated #0: 105 / 0.229 -> en:rubitecan
    n1=ipilimumab | n2=en:rubitecan | rel=r_associated | relid=0 | w=105
  1149. ipilimumab -- r_associated #0: 105 / 0.229 -> en:s-adenosylmethionine
    n1=ipilimumab | n2=en:s-adenosylmethionine | rel=r_associated | relid=0 | w=105
  1150. ipilimumab -- r_associated #0: 105 / 0.229 -> en:s1p receptor agonist krp203
    n1=ipilimumab | n2=en:s1p receptor agonist krp203 | rel=r_associated | relid=0 | w=105
  1151. ipilimumab -- r_associated #0: 105 / 0.229 -> en:samarium sm-153 lexidronam pentasodium
    n1=ipilimumab | n2=en:samarium sm-153 lexidronam pentasodium | rel=r_associated | relid=0 | w=105
  1152. ipilimumab -- r_associated #0: 105 / 0.229 -> en:saw palmetto berry extract
    n1=ipilimumab | n2=en:saw palmetto berry extract | rel=r_associated | relid=0 | w=105
  1153. ipilimumab -- r_associated #0: 105 / 0.229 -> en:sedoxantrone trihydrochloride
    n1=ipilimumab | n2=en:sedoxantrone trihydrochloride | rel=r_associated | relid=0 | w=105
  1154. ipilimumab -- r_associated #0: 105 / 0.229 -> en:selenium
    n1=ipilimumab | n2=en:selenium | rel=r_associated | relid=0 | w=105
  1155. ipilimumab -- r_associated #0: 105 / 0.229 -> en:seliciclib
    n1=ipilimumab | n2=en:seliciclib | rel=r_associated | relid=0 | w=105
  1156. ipilimumab -- r_associated #0: 105 / 0.229 -> en:semuloparin
    n1=ipilimumab | n2=en:semuloparin | rel=r_associated | relid=0 | w=105
  1157. ipilimumab -- r_associated #0: 105 / 0.229 -> en:senna fruit
    n1=ipilimumab | n2=en:senna fruit | rel=r_associated | relid=0 | w=105
  1158. ipilimumab -- r_associated #0: 105 / 0.229 -> en:sepantronium bromide
    n1=ipilimumab | n2=en:sepantronium bromide | rel=r_associated | relid=0 | w=105
  1159. ipilimumab -- r_associated #0: 105 / 0.229 -> en:serum-derived bovine immunoglobulin protein isolate
    n1=ipilimumab | n2=en:serum-derived bovine immunoglobulin protein isolate | rel=r_associated | relid=0 | w=105
  1160. ipilimumab -- r_associated #0: 105 / 0.229 -> en:sh u04722
    n1=ipilimumab | n2=en:sh u04722 | rel=r_associated | relid=0 | w=105
  1161. ipilimumab -- r_associated #0: 105 / 0.229 -> en:sheddase inhibitor incb007839
    n1=ipilimumab | n2=en:sheddase inhibitor incb007839 | rel=r_associated | relid=0 | w=105
  1162. ipilimumab -- r_associated #0: 105 / 0.229 -> en:signal transduction inhibitor
    n1=ipilimumab | n2=en:signal transduction inhibitor | rel=r_associated | relid=0 | w=105
  1163. ipilimumab -- r_associated #0: 105 / 0.229 -> en:simtrazene
    n1=ipilimumab | n2=en:simtrazene | rel=r_associated | relid=0 | w=105
  1164. ipilimumab -- r_associated #0: 105 / 0.229 -> en:simtuzumab
    n1=ipilimumab | n2=en:simtuzumab | rel=r_associated | relid=0 | w=105
  1165. ipilimumab -- r_associated #0: 105 / 0.229 -> en:smac mimetic gdc-0152
    n1=ipilimumab | n2=en:smac mimetic gdc-0152 | rel=r_associated | relid=0 | w=105
  1166. ipilimumab -- r_associated #0: 105 / 0.229 -> en:smac mimetic gdc-0917
    n1=ipilimumab | n2=en:smac mimetic gdc-0917 | rel=r_associated | relid=0 | w=105
  1167. ipilimumab -- r_associated #0: 105 / 0.229 -> en:smoothened antagonist lde225 topical
    n1=ipilimumab | n2=en:smoothened antagonist lde225 topical | rel=r_associated | relid=0 | w=105
  1168. ipilimumab -- r_associated #0: 105 / 0.229 -> en:sodium fluoride
    n1=ipilimumab | n2=en:sodium fluoride | rel=r_associated | relid=0 | w=105
  1169. ipilimumab -- r_associated #0: 105 / 0.229 -> en:spebrutinib
    n1=ipilimumab | n2=en:spebrutinib | rel=r_associated | relid=0 | w=105
  1170. ipilimumab -- r_associated #0: 105 / 0.229 -> en:staphylococcal enterotoxin a
    n1=ipilimumab | n2=en:staphylococcal enterotoxin a | rel=r_associated | relid=0 | w=105
  1171. ipilimumab -- r_associated #0: 105 / 0.229 -> en:stat3 inhibitor opb-31121
    n1=ipilimumab | n2=en:stat3 inhibitor opb-31121 | rel=r_associated | relid=0 | w=105
  1172. ipilimumab -- r_associated #0: 105 / 0.229 -> en:stimulant/agonist
    n1=ipilimumab | n2=en:stimulant/agonist | rel=r_associated | relid=0 | w=105
  1173. ipilimumab -- r_associated #0: 105 / 0.229 -> en:strawberry-blackberry-black raspberry-blueberry mixture
    n1=ipilimumab | n2=en:strawberry-blackberry-black raspberry-blueberry mixture | rel=r_associated | relid=0 | w=105
  1174. ipilimumab -- r_associated #0: 105 / 0.229 -> en:streptozocin
    n1=ipilimumab | n2=en:streptozocin | rel=r_associated | relid=0 | w=105
  1175. ipilimumab -- r_associated #0: 105 / 0.229 -> en:sunitinib malate
    n1=ipilimumab | n2=en:sunitinib malate | rel=r_associated | relid=0 | w=105
  1176. ipilimumab -- r_associated #0: 105 / 0.229 -> en:superagonist interleukin-15:interleukin-15 receptor alphasu/fc fusion complex alt-803
    n1=ipilimumab | n2=en:superagonist interleukin-15:interleukin-15 receptor alphasu/fc fusion complex alt-803 | rel=r_associated | relid=0 | w=105
  1177. ipilimumab -- r_associated #0: 105 / 0.229 -> en:sustained-release lipid inhaled cisplatin
    n1=ipilimumab | n2=en:sustained-release lipid inhaled cisplatin | rel=r_associated | relid=0 | w=105
  1178. ipilimumab -- r_associated #0: 105 / 0.229 -> en:sustained-release mitomycin c hydrogel formulation
    n1=ipilimumab | n2=en:sustained-release mitomycin c hydrogel formulation | rel=r_associated | relid=0 | w=105
  1179. ipilimumab -- r_associated #0: 105 / 0.229 -> en:synthetic antiestrogen
    n1=ipilimumab | n2=en:synthetic antiestrogen | rel=r_associated | relid=0 | w=105
  1180. ipilimumab -- r_associated #0: 105 / 0.229 -> en:synthetic brain tumor peptides-pulsed autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:synthetic brain tumor peptides-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=105
  1181. ipilimumab -- r_associated #0: 105 / 0.229 -> en:synthetic htert dna vaccine ino-1400
    n1=ipilimumab | n2=en:synthetic htert dna vaccine ino-1400 | rel=r_associated | relid=0 | w=105
  1182. ipilimumab -- r_associated #0: 105 / 0.229 -> en:synthetic hypericin
    n1=ipilimumab | n2=en:synthetic hypericin | rel=r_associated | relid=0 | w=105
  1183. ipilimumab -- r_associated #0: 105 / 0.229 -> en:synthetic melanoma-associated antigens vaccine
    n1=ipilimumab | n2=en:synthetic melanoma-associated antigens vaccine | rel=r_associated | relid=0 | w=105
  1184. ipilimumab -- r_associated #0: 105 / 0.229 -> en:synthetic peptides e-pra and e-psm vaccine
    n1=ipilimumab | n2=en:synthetic peptides e-pra and e-psm vaccine | rel=r_associated | relid=0 | w=105
  1185. ipilimumab -- r_associated #0: 105 / 0.229 -> en:taliglucerase alfa
    n1=ipilimumab | n2=en:taliglucerase alfa | rel=r_associated | relid=0 | w=105
  1186. ipilimumab -- r_associated #0: 105 / 0.229 -> en:tapentadol hydrochloride
    n1=ipilimumab | n2=en:tapentadol hydrochloride | rel=r_associated | relid=0 | w=105
  1187. ipilimumab -- r_associated #0: 105 / 0.229 -> en:tarp 27-35 peptide vaccine
    n1=ipilimumab | n2=en:tarp 27-35 peptide vaccine | rel=r_associated | relid=0 | w=105
  1188. ipilimumab -- r_associated #0: 105 / 0.229 -> en:tasquinimod
    n1=ipilimumab | n2=en:tasquinimod | rel=r_associated | relid=0 | w=105
  1189. ipilimumab -- r_associated #0: 105 / 0.229 -> en:taurolidine
    n1=ipilimumab | n2=en:taurolidine | rel=r_associated | relid=0 | w=105
  1190. ipilimumab -- r_associated #0: 105 / 0.229 -> en:tazarotene
    n1=ipilimumab | n2=en:tazarotene | rel=r_associated | relid=0 | w=105
  1191. ipilimumab -- r_associated #0: 105 / 0.229 -> en:technetium tc-99m mebrofenin
    n1=ipilimumab | n2=en:technetium tc-99m mebrofenin | rel=r_associated | relid=0 | w=105
  1192. ipilimumab -- r_associated #0: 105 / 0.229 -> en:technetium tc-99m sulfur colloid
    n1=ipilimumab | n2=en:technetium tc-99m sulfur colloid | rel=r_associated | relid=0 | w=105
  1193. ipilimumab -- r_associated #0: 105 / 0.229 -> en:teglarinad chloride
    n1=ipilimumab | n2=en:teglarinad chloride | rel=r_associated | relid=0 | w=105
  1194. ipilimumab -- r_associated #0: 105 / 0.229 -> en:telavancin hydrochloride
    n1=ipilimumab | n2=en:telavancin hydrochloride | rel=r_associated | relid=0 | w=105
  1195. ipilimumab -- r_associated #0: 105 / 0.229 -> en:telomerase-specific type 5 adenovirus obp-301
    n1=ipilimumab | n2=en:telomerase-specific type 5 adenovirus obp-301 | rel=r_associated | relid=0 | w=105
  1196. ipilimumab -- r_associated #0: 105 / 0.229 -> en:teloxantrone hydrochloride
    n1=ipilimumab | n2=en:teloxantrone hydrochloride | rel=r_associated | relid=0 | w=105
  1197. ipilimumab -- r_associated #0: 105 / 0.229 -> en:tesmilifene
    n1=ipilimumab | n2=en:tesmilifene | rel=r_associated | relid=0 | w=105
  1198. ipilimumab -- r_associated #0: 105 / 0.229 -> en:testosterone vaginal cream
    n1=ipilimumab | n2=en:testosterone vaginal cream | rel=r_associated | relid=0 | w=105
  1199. ipilimumab -- r_associated #0: 105 / 0.229 -> en:tetanus-cmv fusion peptide vaccine
    n1=ipilimumab | n2=en:tetanus-cmv fusion peptide vaccine | rel=r_associated | relid=0 | w=105
  1200. ipilimumab -- r_associated #0: 105 / 0.229 -> en:tetrodotoxin
    n1=ipilimumab | n2=en:tetrodotoxin | rel=r_associated | relid=0 | w=105
  1201. ipilimumab -- r_associated #0: 105 / 0.229 -> en:therapeutic allogeneic cytotoxic t-lymphocytes
    n1=ipilimumab | n2=en:therapeutic allogeneic cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=105
  1202. ipilimumab -- r_associated #0: 105 / 0.229 -> en:therapeutic angiotensin-(1-7)
    n1=ipilimumab | n2=en:therapeutic angiotensin-(1-7) | rel=r_associated | relid=0 | w=105
  1203. ipilimumab -- r_associated #0: 105 / 0.229 -> en:therapeutic estetrol
    n1=ipilimumab | n2=en:therapeutic estetrol | rel=r_associated | relid=0 | w=105
  1204. ipilimumab -- r_associated #0: 105 / 0.229 -> en:thiamine
    n1=ipilimumab | n2=en:thiamine | rel=r_associated | relid=0 | w=105
  1205. ipilimumab -- r_associated #0: 105 / 0.229 -> en:thioguanine
    n1=ipilimumab | n2=en:thioguanine | rel=r_associated | relid=0 | w=105
  1206. ipilimumab -- r_associated #0: 105 / 0.229 -> en:thioredoxin-1 inhibitor px-12
    n1=ipilimumab | n2=en:thioredoxin-1 inhibitor px-12 | rel=r_associated | relid=0 | w=105
  1207. ipilimumab -- r_associated #0: 105 / 0.229 -> en:thymopentin
    n1=ipilimumab | n2=en:thymopentin | rel=r_associated | relid=0 | w=105
  1208. ipilimumab -- r_associated #0: 105 / 0.229 -> en:til 1383i t cell receptor-transduced autologous t cells
    n1=ipilimumab | n2=en:til 1383i t cell receptor-transduced autologous t cells | rel=r_associated | relid=0 | w=105
  1209. ipilimumab -- r_associated #0: 105 / 0.229 -> en:tiotropium bromide monohydrate
    n1=ipilimumab | n2=en:tiotropium bromide monohydrate | rel=r_associated | relid=0 | w=105
  1210. ipilimumab -- r_associated #0: 105 / 0.229 -> en:tobramycin sulfate
    n1=ipilimumab | n2=en:tobramycin sulfate | rel=r_associated | relid=0 | w=105
  1211. ipilimumab -- r_associated #0: 105 / 0.229 -> en:topical calcitriol
    n1=ipilimumab | n2=en:topical calcitriol | rel=r_associated | relid=0 | w=105
  1212. ipilimumab -- r_associated #0: 105 / 0.229 -> en:topical gemcitabine hydrochloride
    n1=ipilimumab | n2=en:topical gemcitabine hydrochloride | rel=r_associated | relid=0 | w=105
  1213. ipilimumab -- r_associated #0: 105 / 0.229 -> en:total tumor rna-loaded dendritic cell vaccine
    n1=ipilimumab | n2=en:total tumor rna-loaded dendritic cell vaccine | rel=r_associated | relid=0 | w=105
  1214. ipilimumab -- r_associated #0: 105 / 0.229 -> en:trabedersen
    n1=ipilimumab | n2=en:trabedersen | rel=r_associated | relid=0 | w=105
  1215. ipilimumab -- r_associated #0: 105 / 0.229 -> en:trifluridine/tipiracil hydrochloride combination agent tas-102
    n1=ipilimumab | n2=en:trifluridine/tipiracil hydrochloride combination agent tas-102 | rel=r_associated | relid=0 | w=105
  1216. ipilimumab -- r_associated #0: 105 / 0.229 -> en:trimetrexate
    n1=ipilimumab | n2=en:trimetrexate | rel=r_associated | relid=0 | w=105
  1217. ipilimumab -- r_associated #0: 105 / 0.229 -> en:triptolide analog
    n1=ipilimumab | n2=en:triptolide analog | rel=r_associated | relid=0 | w=105
  1218. ipilimumab -- r_associated #0: 105 / 0.229 -> en:triptorelin
    n1=ipilimumab | n2=en:triptorelin | rel=r_associated | relid=0 | w=105
  1219. ipilimumab -- r_associated #0: 105 / 0.229 -> en:triptorelin pamoate
    n1=ipilimumab | n2=en:triptorelin pamoate | rel=r_associated | relid=0 | w=105
  1220. ipilimumab -- r_associated #0: 105 / 0.229 -> en:tubercidin
    n1=ipilimumab | n2=en:tubercidin | rel=r_associated | relid=0 | w=105
  1221. ipilimumab -- r_associated #0: 105 / 0.229 -> en:tumor-associated antigen peptide vaccine grn-1201
    n1=ipilimumab | n2=en:tumor-associated antigen peptide vaccine grn-1201 | rel=r_associated | relid=0 | w=105
  1222. ipilimumab -- r_associated #0: 105 / 0.229 -> en:tyroserleutide
    n1=ipilimumab | n2=en:tyroserleutide | rel=r_associated | relid=0 | w=105
  1223. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ulimorelin hyrdrochloride
    n1=ipilimumab | n2=en:ulimorelin hyrdrochloride | rel=r_associated | relid=0 | w=105
  1224. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ulipristal acetate
    n1=ipilimumab | n2=en:ulipristal acetate | rel=r_associated | relid=0 | w=105
  1225. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ulixertinib
    n1=ipilimumab | n2=en:ulixertinib | rel=r_associated | relid=0 | w=105
  1226. ipilimumab -- r_associated #0: 105 / 0.229 -> en:urethane
    n1=ipilimumab | n2=en:urethane | rel=r_associated | relid=0 | w=105
  1227. ipilimumab -- r_associated #0: 105 / 0.229 -> en:vaginal dosage form product
    n1=ipilimumab | n2=en:vaginal dosage form product | rel=r_associated | relid=0 | w=105
  1228. ipilimumab -- r_associated #0: 105 / 0.229 -> en:valganciclovir
    n1=ipilimumab | n2=en:valganciclovir | rel=r_associated | relid=0 | w=105
  1229. ipilimumab -- r_associated #0: 105 / 0.229 -> en:valproic acid
    n1=ipilimumab | n2=en:valproic acid | rel=r_associated | relid=0 | w=105
  1230. ipilimumab -- r_associated #0: 105 / 0.229 -> en:varicella-zoster virus strain oka/merck live antigen
    n1=ipilimumab | n2=en:varicella-zoster virus strain oka/merck live antigen | rel=r_associated | relid=0 | w=105
  1231. ipilimumab -- r_associated #0: 105 / 0.229 -> en:vemurafenib
    n1=ipilimumab | n2=en:vemurafenib | rel=r_associated | relid=0 | w=105
  1232. ipilimumab -- r_associated #0: 105 / 0.229 -> en:verteporfin
    n1=ipilimumab | n2=en:verteporfin | rel=r_associated | relid=0 | w=105
  1233. ipilimumab -- r_associated #0: 105 / 0.229 -> en:vinorelbine tartrate
    n1=ipilimumab | n2=en:vinorelbine tartrate | rel=r_associated | relid=0 | w=105
  1234. ipilimumab -- r_associated #0: 105 / 0.229 -> en:visilizumab
    n1=ipilimumab | n2=en:visilizumab | rel=r_associated | relid=0 | w=105
  1235. ipilimumab -- r_associated #0: 105 / 0.229 -> en:vitamin k1-containing urea skin cream
    n1=ipilimumab | n2=en:vitamin k1-containing urea skin cream | rel=r_associated | relid=0 | w=105
  1236. ipilimumab -- r_associated #0: 105 / 0.229 -> en:vortioxetine hydrobromide
    n1=ipilimumab | n2=en:vortioxetine hydrobromide | rel=r_associated | relid=0 | w=105
  1237. ipilimumab -- r_associated #0: 105 / 0.229 -> en:wheatgrass juice
    n1=ipilimumab | n2=en:wheatgrass juice | rel=r_associated | relid=0 | w=105
  1238. ipilimumab -- r_associated #0: 105 / 0.229 -> en:whey protein isolate
    n1=ipilimumab | n2=en:whey protein isolate | rel=r_associated | relid=0 | w=105
  1239. ipilimumab -- r_associated #0: 105 / 0.229 -> en:wt1 235-243 peptide vaccine
    n1=ipilimumab | n2=en:wt1 235-243 peptide vaccine | rel=r_associated | relid=0 | w=105
  1240. ipilimumab -- r_associated #0: 105 / 0.229 -> en:wu-ling-san
    n1=ipilimumab | n2=en:wu-ling-san | rel=r_associated | relid=0 | w=105
  1241. ipilimumab -- r_associated #0: 105 / 0.229 -> en:wx-uk1
    n1=ipilimumab | n2=en:wx-uk1 | rel=r_associated | relid=0 | w=105
  1242. ipilimumab -- r_associated #0: 105 / 0.229 -> en:xanthohumol
    n1=ipilimumab | n2=en:xanthohumol | rel=r_associated | relid=0 | w=105
  1243. ipilimumab -- r_associated #0: 105 / 0.229 -> en:ym598
    n1=ipilimumab | n2=en:ym598 | rel=r_associated | relid=0 | w=105
  1244. ipilimumab -- r_associated #0: 105 / 0.229 -> en:yoshi-864
    n1=ipilimumab | n2=en:yoshi-864 | rel=r_associated | relid=0 | w=105
  1245. ipilimumab -- r_associated #0: 105 / 0.229 -> en:yttrium y 90 monoclonal antibody bre-3
    n1=ipilimumab | n2=en:yttrium y 90 monoclonal antibody bre-3 | rel=r_associated | relid=0 | w=105
  1246. ipilimumab -- r_associated #0: 105 / 0.229 -> en:yttrium y 90-edotreotide
    n1=ipilimumab | n2=en:yttrium y 90-edotreotide | rel=r_associated | relid=0 | w=105
  1247. ipilimumab -- r_associated #0: 105 / 0.229 -> en:zen003365
    n1=ipilimumab | n2=en:zen003365 | rel=r_associated | relid=0 | w=105
  1248. ipilimumab -- r_associated #0: 105 / 0.229 -> en:zeniplatin
    n1=ipilimumab | n2=en:zeniplatin | rel=r_associated | relid=0 | w=105
  1249. ipilimumab -- r_associated #0: 105 / 0.229 -> en:zinostatin
    n1=ipilimumab | n2=en:zinostatin | rel=r_associated | relid=0 | w=105
  1250. ipilimumab -- r_associated #0: 105 / 0.229 -> en:zirconium zr 89-labeled anti-pd-l1 monoclonal antibody mpdl3280a
    n1=ipilimumab | n2=en:zirconium zr 89-labeled anti-pd-l1 monoclonal antibody mpdl3280a | rel=r_associated | relid=0 | w=105
  1251. ipilimumab -- r_associated #0: 105 / 0.229 -> en:zoptarelin doxorubicin
    n1=ipilimumab | n2=en:zoptarelin doxorubicin | rel=r_associated | relid=0 | w=105
  1252. ipilimumab -- r_associated #0: 105 / 0.229 -> IgG
    n1=ipilimumab | n2=IgG | rel=r_associated | relid=0 | w=105
  1253. ipilimumab -- r_associated #0: 105 / 0.229 -> IgG1
    n1=ipilimumab | n2=IgG1 | rel=r_associated | relid=0 | w=105
  1254. ipilimumab -- r_associated #0: 105 / 0.229 -> traitement
    (médecine)
    n1=ipilimumab | n2=traitement
    (médecine)
    | rel=r_associated | relid=0 | w=105
  1255. ipilimumab -- r_associated #0: 105 / 0.229 -> Yervoy
    n1=ipilimumab | n2=Yervoy | rel=r_associated | relid=0 | w=105
  1256. ipilimumab -- r_associated #0: 104 / 0.227 -> CTLA-4
    n1=ipilimumab | n2=CTLA-4 | rel=r_associated | relid=0 | w=104
  1257. ipilimumab -- r_associated #0: 104 / 0.227 -> en:5-ht3 receptor antagonist
    n1=ipilimumab | n2=en:5-ht3 receptor antagonist | rel=r_associated | relid=0 | w=104
  1258. ipilimumab -- r_associated #0: 104 / 0.227 -> en:851b gel
    n1=ipilimumab | n2=en:851b gel | rel=r_associated | relid=0 | w=104
  1259. ipilimumab -- r_associated #0: 104 / 0.227 -> en:abciximab
    n1=ipilimumab | n2=en:abciximab | rel=r_associated | relid=0 | w=104
  1260. ipilimumab -- r_associated #0: 104 / 0.227 -> en:acalabrutinib
    n1=ipilimumab | n2=en:acalabrutinib | rel=r_associated | relid=0 | w=104
  1261. ipilimumab -- r_associated #0: 104 / 0.227 -> en:acetaminophen
    n1=ipilimumab | n2=en:acetaminophen | rel=r_associated | relid=0 | w=104
  1262. ipilimumab -- r_associated #0: 104 / 0.227 -> en:acetazolamide sodium
    n1=ipilimumab | n2=en:acetazolamide sodium | rel=r_associated | relid=0 | w=104
  1263. ipilimumab -- r_associated #0: 104 / 0.227 -> en:acridine carboxamide
    n1=ipilimumab | n2=en:acridine carboxamide | rel=r_associated | relid=0 | w=104
  1264. ipilimumab -- r_associated #0: 104 / 0.227 -> en:actinium ac 225 lintuzumab
    n1=ipilimumab | n2=en:actinium ac 225 lintuzumab | rel=r_associated | relid=0 | w=104
  1265. ipilimumab -- r_associated #0: 104 / 0.227 -> en:activin type 2b receptor fc fusion protein stm 434
    n1=ipilimumab | n2=en:activin type 2b receptor fc fusion protein stm 434 | rel=r_associated | relid=0 | w=104
  1266. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ad-hcmv-tk
    n1=ipilimumab | n2=en:ad-hcmv-tk | rel=r_associated | relid=0 | w=104
  1267. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ad5-cmv-nis
    n1=ipilimumab | n2=en:ad5-cmv-nis | rel=r_associated | relid=0 | w=104
  1268. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ad5f35-lmp1/lmp2-transduced autologous dendritic cells
    n1=ipilimumab | n2=en:ad5f35-lmp1/lmp2-transduced autologous dendritic cells | rel=r_associated | relid=0 | w=104
  1269. ipilimumab -- r_associated #0: 104 / 0.227 -> en:adenovector encoding mda7
    n1=ipilimumab | n2=en:adenovector encoding mda7 | rel=r_associated | relid=0 | w=104
  1270. ipilimumab -- r_associated #0: 104 / 0.227 -> en:adenovirus encoding human aquaporin-1
    n1=ipilimumab | n2=en:adenovirus encoding human aquaporin-1 | rel=r_associated | relid=0 | w=104
  1271. ipilimumab -- r_associated #0: 104 / 0.227 -> en:adenovirus-mediated human interleukin-12 inxn-2001 plus activator ligand inxn-1001
    n1=ipilimumab | n2=en:adenovirus-mediated human interleukin-12 inxn-2001 plus activator ligand inxn-1001 | rel=r_associated | relid=0 | w=104
  1272. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ae37 peptide/gm-csf vaccine
    n1=ipilimumab | n2=en:ae37 peptide/gm-csf vaccine | rel=r_associated | relid=0 | w=104
  1273. ipilimumab -- r_associated #0: 104 / 0.227 -> en:aerosol sargramostim
    n1=ipilimumab | n2=en:aerosol sargramostim | rel=r_associated | relid=0 | w=104
  1274. ipilimumab -- r_associated #0: 104 / 0.227 -> en:afimoxifene
    n1=ipilimumab | n2=en:afimoxifene | rel=r_associated | relid=0 | w=104
  1275. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ag-024322
    n1=ipilimumab | n2=en:ag-024322 | rel=r_associated | relid=0 | w=104
  1276. ipilimumab -- r_associated #0: 104 / 0.227 -> en:aglatimagene besadenovec
    n1=ipilimumab | n2=en:aglatimagene besadenovec | rel=r_associated | relid=0 | w=104
  1277. ipilimumab -- r_associated #0: 104 / 0.227 -> en:akt/erk inhibitor onc201
    n1=ipilimumab | n2=en:akt/erk inhibitor onc201 | rel=r_associated | relid=0 | w=104
  1278. ipilimumab -- r_associated #0: 104 / 0.227 -> en:algenpantucel-l
    n1=ipilimumab | n2=en:algenpantucel-l | rel=r_associated | relid=0 | w=104
  1279. ipilimumab -- r_associated #0: 104 / 0.227 -> en:allogeneic hla-a2/4-1bb ligand-expressing melanoma vaccine
    n1=ipilimumab | n2=en:allogeneic hla-a2/4-1bb ligand-expressing melanoma vaccine | rel=r_associated | relid=0 | w=104
  1280. ipilimumab -- r_associated #0: 104 / 0.227 -> en:allogeneic natural killer cell line mg4101
    n1=ipilimumab | n2=en:allogeneic natural killer cell line mg4101 | rel=r_associated | relid=0 | w=104
  1281. ipilimumab -- r_associated #0: 104 / 0.227 -> en:allogeneic natural killer cell line nk-92
    n1=ipilimumab | n2=en:allogeneic natural killer cell line nk-92 | rel=r_associated | relid=0 | w=104
  1282. ipilimumab -- r_associated #0: 104 / 0.227 -> en:allovectin-7
    n1=ipilimumab | n2=en:allovectin-7 | rel=r_associated | relid=0 | w=104
  1283. ipilimumab -- r_associated #0: 104 / 0.227 -> en:alpha-1,3-galactosyltransferase-expressing allogeneic renal cell carcinoma vaccine
    n1=ipilimumab | n2=en:alpha-1,3-galactosyltransferase-expressing allogeneic renal cell carcinoma vaccine | rel=r_associated | relid=0 | w=104
  1284. ipilimumab -- r_associated #0: 104 / 0.227 -> en:alprostadil
    n1=ipilimumab | n2=en:alprostadil | rel=r_associated | relid=0 | w=104
  1285. ipilimumab -- r_associated #0: 104 / 0.227 -> en:alvac-cea vaccine
    n1=ipilimumab | n2=en:alvac-cea vaccine | rel=r_associated | relid=0 | w=104
  1286. ipilimumab -- r_associated #0: 104 / 0.227 -> en:alvimopan
    n1=ipilimumab | n2=en:alvimopan | rel=r_associated | relid=0 | w=104
  1287. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ammonium glycyrrhizate
    n1=ipilimumab | n2=en:ammonium glycyrrhizate | rel=r_associated | relid=0 | w=104
  1288. ipilimumab -- r_associated #0: 104 / 0.227 -> en:amphotericin b deoxycholate
    n1=ipilimumab | n2=en:amphotericin b deoxycholate | rel=r_associated | relid=0 | w=104
  1289. ipilimumab -- r_associated #0: 104 / 0.227 -> en:amsilarotene
    n1=ipilimumab | n2=en:amsilarotene | rel=r_associated | relid=0 | w=104
  1290. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anastrozole
    n1=ipilimumab | n2=en:anastrozole | rel=r_associated | relid=0 | w=104
  1291. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anaxirone
    n1=ipilimumab | n2=en:anaxirone | rel=r_associated | relid=0 | w=104
  1292. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ancestim
    n1=ipilimumab | n2=en:ancestim | rel=r_associated | relid=0 | w=104
  1293. ipilimumab -- r_associated #0: 104 / 0.227 -> en:angiogenesis inhibitor
    n1=ipilimumab | n2=en:angiogenesis inhibitor | rel=r_associated | relid=0 | w=104
  1294. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti c-kit antibody-drug conjugate lop628
    n1=ipilimumab | n2=en:anti c-kit antibody-drug conjugate lop628 | rel=r_associated | relid=0 | w=104
  1295. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-a5b1 integrin monoclonal antibody pf-04605412
    n1=ipilimumab | n2=en:anti-a5b1 integrin monoclonal antibody pf-04605412 | rel=r_associated | relid=0 | w=104
  1296. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-alk-1 monoclonal antibody pf-03446962
    n1=ipilimumab | n2=en:anti-alk-1 monoclonal antibody pf-03446962 | rel=r_associated | relid=0 | w=104
  1297. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-alpha5beta1 integrin antibody mint1526a
    n1=ipilimumab | n2=en:anti-alpha5beta1 integrin antibody mint1526a | rel=r_associated | relid=0 | w=104
  1298. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-androgen
    n1=ipilimumab | n2=en:anti-androgen | rel=r_associated | relid=0 | w=104
  1299. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-b4 blocked ricin immunotoxin
    n1=ipilimumab | n2=en:anti-b4 blocked ricin immunotoxin | rel=r_associated | relid=0 | w=104
  1300. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-c4.4a antibody-drug conjugate bay1129980
    n1=ipilimumab | n2=en:anti-c4.4a antibody-drug conjugate bay1129980 | rel=r_associated | relid=0 | w=104
  1301. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-cd123 monoclonal antibody khk2823
    n1=ipilimumab | n2=en:anti-cd123 monoclonal antibody khk2823 | rel=r_associated | relid=0 | w=104
  1302. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-cd123/cd3 bispecific antibody jnj-63709178
    n1=ipilimumab | n2=en:anti-cd123/cd3 bispecific antibody jnj-63709178 | rel=r_associated | relid=0 | w=104
  1303. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-cd19 monoclonal antibody medi-551
    n1=ipilimumab | n2=en:anti-cd19 monoclonal antibody medi-551 | rel=r_associated | relid=0 | w=104
  1304. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-cd20/cd3 monoclonal antibody regn1979
    n1=ipilimumab | n2=en:anti-cd20/cd3 monoclonal antibody regn1979 | rel=r_associated | relid=0 | w=104
  1305. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-cd3 immunotoxin a-dmdt390-bisfv(ucht1)
    n1=ipilimumab | n2=en:anti-cd3 immunotoxin a-dmdt390-bisfv(ucht1) | rel=r_associated | relid=0 | w=104
  1306. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-cd38 monoclonal antibody mor03087
    n1=ipilimumab | n2=en:anti-cd38 monoclonal antibody mor03087 | rel=r_associated | relid=0 | w=104
  1307. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-cd38 monoclonal antibody sar650984
    n1=ipilimumab | n2=en:anti-cd38 monoclonal antibody sar650984 | rel=r_associated | relid=0 | w=104
  1308. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-cd45 bc8 monoclonal antibody-streptavidin conjugate
    n1=ipilimumab | n2=en:anti-cd45 bc8 monoclonal antibody-streptavidin conjugate | rel=r_associated | relid=0 | w=104
  1309. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-cd7 immunotoxin
    n1=ipilimumab | n2=en:anti-cd7 immunotoxin | rel=r_associated | relid=0 | w=104
  1310. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-cd73 monoclonal antibody medi9447
    n1=ipilimumab | n2=en:anti-cd73 monoclonal antibody medi9447 | rel=r_associated | relid=0 | w=104
  1311. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-cd98 monoclonal antibody khk2898
    n1=ipilimumab | n2=en:anti-cd98 monoclonal antibody khk2898 | rel=r_associated | relid=0 | w=104
  1312. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-cea bite monoclonal antibody amg211
    n1=ipilimumab | n2=en:anti-cea bite monoclonal antibody amg211 | rel=r_associated | relid=0 | w=104
  1313. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-cea tcr retroviral vector-transduced autologous peripheral blood lymphocytes
    n1=ipilimumab | n2=en:anti-cea tcr retroviral vector-transduced autologous peripheral blood lymphocytes | rel=r_associated | relid=0 | w=104
  1314. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-cea-car autologous t lymphocytes
    n1=ipilimumab | n2=en:anti-cea-car autologous t lymphocytes | rel=r_associated | relid=0 | w=104
  1315. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-ctla-4 mab rna-transfected autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:anti-ctla-4 mab rna-transfected autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=104
  1316. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-egfr monoclonal antibody gt-mab 5.2-gex
    n1=ipilimumab | n2=en:anti-egfr monoclonal antibody gt-mab 5.2-gex | rel=r_associated | relid=0 | w=104
  1317. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-egfr monoclonal antibody ro5083945
    n1=ipilimumab | n2=en:anti-egfr monoclonal antibody ro5083945 | rel=r_associated | relid=0 | w=104
  1318. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-erbb2/anti-erbb3 bispecific monoclonal antibody mm-111
    n1=ipilimumab | n2=en:anti-erbb2/anti-erbb3 bispecific monoclonal antibody mm-111 | rel=r_associated | relid=0 | w=104
  1319. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-fgfr2 antibody bay1179470
    n1=ipilimumab | n2=en:anti-fgfr2 antibody bay1179470 | rel=r_associated | relid=0 | w=104
  1320. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-flt3 monoclonal antibody imc-eb10
    n1=ipilimumab | n2=en:anti-flt3 monoclonal antibody imc-eb10 | rel=r_associated | relid=0 | w=104
  1321. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-gitr monoclonal antibody mk-4166
    n1=ipilimumab | n2=en:anti-gitr monoclonal antibody mk-4166 | rel=r_associated | relid=0 | w=104
  1322. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-her-2-car retroviral vector-transduced autologous peripheral blood lymphocytes
    n1=ipilimumab | n2=en:anti-her-2-car retroviral vector-transduced autologous peripheral blood lymphocytes | rel=r_associated | relid=0 | w=104
  1323. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-her2 antibody-drug conjugate medi4276
    n1=ipilimumab | n2=en:anti-her2 antibody-drug conjugate medi4276 | rel=r_associated | relid=0 | w=104
  1324. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-igf1/2 monoclonal antibody medi-573
    n1=ipilimumab | n2=en:anti-igf1/2 monoclonal antibody medi-573 | rel=r_associated | relid=0 | w=104
  1325. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-il-15 monoclonal antibody amg 714
    n1=ipilimumab | n2=en:anti-il-15 monoclonal antibody amg 714 | rel=r_associated | relid=0 | w=104
  1326. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-il-4/il-13 combination agent qbx258
    n1=ipilimumab | n2=en:anti-il-4/il-13 combination agent qbx258 | rel=r_associated | relid=0 | w=104
  1327. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-inflammatory agents
    n1=ipilimumab | n2=en:anti-inflammatory agents | rel=r_associated | relid=0 | w=104
  1328. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-kir monoclonal antibody iph 2101
    n1=ipilimumab | n2=en:anti-kir monoclonal antibody iph 2101 | rel=r_associated | relid=0 | w=104
  1329. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-lgr5 monoclonal antibody bnc101
    n1=ipilimumab | n2=en:anti-lgr5 monoclonal antibody bnc101 | rel=r_associated | relid=0 | w=104
  1330. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-liv-1 monoclonal antibody-mmae conjugate sgn-liv1a
    n1=ipilimumab | n2=en:anti-liv-1 monoclonal antibody-mmae conjugate sgn-liv1a | rel=r_associated | relid=0 | w=104
  1331. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-m-csf monoclonal antibody mcs110
    n1=ipilimumab | n2=en:anti-m-csf monoclonal antibody mcs110 | rel=r_associated | relid=0 | w=104
  1332. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-mesothelin cir mrna-electroporated autologous t cells
    n1=ipilimumab | n2=en:anti-mesothelin cir mrna-electroporated autologous t cells | rel=r_associated | relid=0 | w=104
  1333. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-muc1 car-transduced autologous t-lymphocytes
    n1=ipilimumab | n2=en:anti-muc1 car-transduced autologous t-lymphocytes | rel=r_associated | relid=0 | w=104
  1334. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-muc1 monoclonal antibody bth1704
    n1=ipilimumab | n2=en:anti-muc1 monoclonal antibody bth1704 | rel=r_associated | relid=0 | w=104
  1335. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-ox40 monoclonal antibody medi0562
    n1=ipilimumab | n2=en:anti-ox40 monoclonal antibody medi0562 | rel=r_associated | relid=0 | w=104
  1336. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-p53 t-cell receptor-transduced peripheral blood lymphocytes
    n1=ipilimumab | n2=en:anti-p53 t-cell receptor-transduced peripheral blood lymphocytes | rel=r_associated | relid=0 | w=104
  1337. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-pd-1 monoclonal antibody bgb-a317
    n1=ipilimumab | n2=en:anti-pd-1 monoclonal antibody bgb-a317 | rel=r_associated | relid=0 | w=104
  1338. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-psma/cd3 monoclonal antibody mor209/es414
    n1=ipilimumab | n2=en:anti-psma/cd3 monoclonal antibody mor209/es414 | rel=r_associated | relid=0 | w=104
  1339. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-sclu monoclonal antibody ab-16b5
    n1=ipilimumab | n2=en:anti-sclu monoclonal antibody ab-16b5 | rel=r_associated | relid=0 | w=104
  1340. ipilimumab -- r_associated #0: 104 / 0.227 -> en:anti-tgf-beta rii monoclonal antibody imc-tr1
    n1=ipilimumab | n2=en:anti-tgf-beta rii monoclonal antibody imc-tr1 | rel=r_associated | relid=0 | w=104
  1341. ipilimumab -- r_associated #0: 104 / 0.227 -> en:antibody-drug conjugate pf-06664178
    n1=ipilimumab | n2=en:antibody-drug conjugate pf-06664178 | rel=r_associated | relid=0 | w=104
  1342. ipilimumab -- r_associated #0: 104 / 0.227 -> en:antileukemic agent
    n1=ipilimumab | n2=en:antileukemic agent | rel=r_associated | relid=0 | w=104
  1343. ipilimumab -- r_associated #0: 104 / 0.227 -> en:antimetabolite
    n1=ipilimumab | n2=en:antimetabolite | rel=r_associated | relid=0 | w=104
  1344. ipilimumab -- r_associated #0: 104 / 0.227 -> en:antimetabolite ff-10502
    n1=ipilimumab | n2=en:antimetabolite ff-10502 | rel=r_associated | relid=0 | w=104
  1345. ipilimumab -- r_associated #0: 104 / 0.227 -> en:antimitotic agent
    n1=ipilimumab | n2=en:antimitotic agent | rel=r_associated | relid=0 | w=104
  1346. ipilimumab -- r_associated #0: 104 / 0.227 -> en:antineoplastic agents, hormonal
    n1=ipilimumab | n2=en:antineoplastic agents, hormonal | rel=r_associated | relid=0 | w=104
  1347. ipilimumab -- r_associated #0: 104 / 0.227 -> en:antineoplastics, other
    n1=ipilimumab | n2=en:antineoplastics, other | rel=r_associated | relid=0 | w=104
  1348. ipilimumab -- r_associated #0: 104 / 0.227 -> en:archexin
    n1=ipilimumab | n2=en:archexin | rel=r_associated | relid=0 | w=104
  1349. ipilimumab -- r_associated #0: 104 / 0.227 -> en:arnebia indigo jade pearl topical cream
    n1=ipilimumab | n2=en:arnebia indigo jade pearl topical cream | rel=r_associated | relid=0 | w=104
  1350. ipilimumab -- r_associated #0: 104 / 0.227 -> en:arsenic trioxide
    n1=ipilimumab | n2=en:arsenic trioxide | rel=r_associated | relid=0 | w=104
  1351. ipilimumab -- r_associated #0: 104 / 0.227 -> en:artemisia vulgaris
    n1=ipilimumab | n2=en:artemisia vulgaris | rel=r_associated | relid=0 | w=104
  1352. ipilimumab -- r_associated #0: 104 / 0.227 -> en:artichoke whole phytocomplex concentrate
    n1=ipilimumab | n2=en:artichoke whole phytocomplex concentrate | rel=r_associated | relid=0 | w=104
  1353. ipilimumab -- r_associated #0: 104 / 0.227 -> en:asparaginase
    n1=ipilimumab | n2=en:asparaginase | rel=r_associated | relid=0 | w=104
  1354. ipilimumab -- r_associated #0: 104 / 0.227 -> en:asulacrine isethionate
    n1=ipilimumab | n2=en:asulacrine isethionate | rel=r_associated | relid=0 | w=104
  1355. ipilimumab -- r_associated #0: 104 / 0.227 -> en:atm kinase inhibitor azd0156
    n1=ipilimumab | n2=en:atm kinase inhibitor azd0156 | rel=r_associated | relid=0 | w=104
  1356. ipilimumab -- r_associated #0: 104 / 0.227 -> en:atr-101
    n1=ipilimumab | n2=en:atr-101 | rel=r_associated | relid=0 | w=104
  1357. ipilimumab -- r_associated #0: 104 / 0.227 -> en:atropine sulfate
    n1=ipilimumab | n2=en:atropine sulfate | rel=r_associated | relid=0 | w=104
  1358. ipilimumab -- r_associated #0: 104 / 0.227 -> en:aurora b serine/threonine kinase inhibitor tak-901
    n1=ipilimumab | n2=en:aurora b serine/threonine kinase inhibitor tak-901 | rel=r_associated | relid=0 | w=104
  1359. ipilimumab -- r_associated #0: 104 / 0.227 -> en:autologous bone marrow-derived cd34/cxcr4-positive stem cells amr-001
    n1=ipilimumab | n2=en:autologous bone marrow-derived cd34/cxcr4-positive stem cells amr-001 | rel=r_associated | relid=0 | w=104
  1360. ipilimumab -- r_associated #0: 104 / 0.227 -> en:autologous dendritic cell-adenovirus p53 vaccine
    n1=ipilimumab | n2=en:autologous dendritic cell-adenovirus p53 vaccine | rel=r_associated | relid=0 | w=104
  1361. ipilimumab -- r_associated #0: 104 / 0.227 -> en:autologous epstein-barr virus-transformed b-lymphoblastoid cell vaccine
    n1=ipilimumab | n2=en:autologous epstein-barr virus-transformed b-lymphoblastoid cell vaccine | rel=r_associated | relid=0 | w=104
  1362. ipilimumab -- r_associated #0: 104 / 0.227 -> en:autologous melanoma lysate/ny-eso-1-pulsed autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:autologous melanoma lysate/ny-eso-1-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=104
  1363. ipilimumab -- r_associated #0: 104 / 0.227 -> en:autologous nsclc peptide-specific dendritic cell vaccine
    n1=ipilimumab | n2=en:autologous nsclc peptide-specific dendritic cell vaccine | rel=r_associated | relid=0 | w=104
  1364. ipilimumab -- r_associated #0: 104 / 0.227 -> en:autologous peripheral blood lymphocytes cotransduced with retroviral vectors encoding inducible il-12 and anti-ny-eso-1 tcr
    n1=ipilimumab | n2=en:autologous peripheral blood lymphocytes cotransduced with retroviral vectors encoding inducible il-12 and anti-ny-eso-1 tcr | rel=r_associated | relid=0 | w=104
  1365. ipilimumab -- r_associated #0: 104 / 0.227 -> en:autologous sarcoma lysate-pulsed dendritic cell vaccine
    n1=ipilimumab | n2=en:autologous sarcoma lysate-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=104
  1366. ipilimumab -- r_associated #0: 104 / 0.227 -> en:avanafil
    n1=ipilimumab | n2=en:avanafil | rel=r_associated | relid=0 | w=104
  1367. ipilimumab -- r_associated #0: 104 / 0.227 -> en:axitinib
    n1=ipilimumab | n2=en:axitinib | rel=r_associated | relid=0 | w=104
  1368. ipilimumab -- r_associated #0: 104 / 0.227 -> en:axl inhibitor bgb324
    n1=ipilimumab | n2=en:axl inhibitor bgb324 | rel=r_associated | relid=0 | w=104
  1369. ipilimumab -- r_associated #0: 104 / 0.227 -> en:azacitidine
    n1=ipilimumab | n2=en:azacitidine | rel=r_associated | relid=0 | w=104
  1370. ipilimumab -- r_associated #0: 104 / 0.227 -> en:azurin:50-77 cell penetrating peptide p28
    n1=ipilimumab | n2=en:azurin:50-77 cell penetrating peptide p28 | rel=r_associated | relid=0 | w=104
  1371. ipilimumab -- r_associated #0: 104 / 0.227 -> en:b7-dc crosslinking antibody rhigm12b7
    n1=ipilimumab | n2=en:b7-dc crosslinking antibody rhigm12b7 | rel=r_associated | relid=0 | w=104
  1372. ipilimumab -- r_associated #0: 104 / 0.227 -> en:bardoxolone methyl
    n1=ipilimumab | n2=en:bardoxolone methyl | rel=r_associated | relid=0 | w=104
  1373. ipilimumab -- r_associated #0: 104 / 0.227 -> en:baricitinib
    n1=ipilimumab | n2=en:baricitinib | rel=r_associated | relid=0 | w=104
  1374. ipilimumab -- r_associated #0: 104 / 0.227 -> en:basiliximab
    n1=ipilimumab | n2=en:basiliximab | rel=r_associated | relid=0 | w=104
  1375. ipilimumab -- r_associated #0: 104 / 0.227 -> en:beclomethasone dipropionate
    n1=ipilimumab | n2=en:beclomethasone dipropionate | rel=r_associated | relid=0 | w=104
  1376. ipilimumab -- r_associated #0: 104 / 0.227 -> en:benaxibine
    n1=ipilimumab | n2=en:benaxibine | rel=r_associated | relid=0 | w=104
  1377. ipilimumab -- r_associated #0: 104 / 0.227 -> en:bendamustine-vorinostat fusion molecule edo-s101
    n1=ipilimumab | n2=en:bendamustine-vorinostat fusion molecule edo-s101 | rel=r_associated | relid=0 | w=104
  1378. ipilimumab -- r_associated #0: 104 / 0.227 -> en:bep regimen
    n1=ipilimumab | n2=en:bep regimen | rel=r_associated | relid=0 | w=104
  1379. ipilimumab -- r_associated #0: 104 / 0.227 -> en:berubicin hydrochloride
    n1=ipilimumab | n2=en:berubicin hydrochloride | rel=r_associated | relid=0 | w=104
  1380. ipilimumab -- r_associated #0: 104 / 0.227 -> en:bet bromodomain inhibitor zen-3694
    n1=ipilimumab | n2=en:bet bromodomain inhibitor zen-3694 | rel=r_associated | relid=0 | w=104
  1381. ipilimumab -- r_associated #0: 104 / 0.227 -> en:bet inhibitor bms-986158
    n1=ipilimumab | n2=en:bet inhibitor bms-986158 | rel=r_associated | relid=0 | w=104
  1382. ipilimumab -- r_associated #0: 104 / 0.227 -> en:bet inhibitor ten-010
    n1=ipilimumab | n2=en:bet inhibitor ten-010 | rel=r_associated | relid=0 | w=104
  1383. ipilimumab -- r_associated #0: 104 / 0.227 -> en:beta endophorin
    n1=ipilimumab | n2=en:beta endophorin | rel=r_associated | relid=0 | w=104
  1384. ipilimumab -- r_associated #0: 104 / 0.227 -> en:bevacizumab
    n1=ipilimumab | n2=en:bevacizumab | rel=r_associated | relid=0 | w=104
  1385. ipilimumab -- r_associated #0: 104 / 0.227 -> en:bifidobacterium lactis/lactobacillus acidophilus/l. plantarum/l. salivarius probiotic supplement
    n1=ipilimumab | n2=en:bifidobacterium lactis/lactobacillus acidophilus/l. plantarum/l. salivarius probiotic supplement | rel=r_associated | relid=0 | w=104
  1386. ipilimumab -- r_associated #0: 104 / 0.227 -> en:bis(choline)tetrathiomolybdate
    n1=ipilimumab | n2=en:bis(choline)tetrathiomolybdate | rel=r_associated | relid=0 | w=104
  1387. ipilimumab -- r_associated #0: 104 / 0.227 -> en:bisacodyl
    n1=ipilimumab | n2=en:bisacodyl | rel=r_associated | relid=0 | w=104
  1388. ipilimumab -- r_associated #0: 104 / 0.227 -> en:bismuth bi213 monoclonal antibody m195
    n1=ipilimumab | n2=en:bismuth bi213 monoclonal antibody m195 | rel=r_associated | relid=0 | w=104
  1389. ipilimumab -- r_associated #0: 104 / 0.227 -> en:bismuth compound
    n1=ipilimumab | n2=en:bismuth compound | rel=r_associated | relid=0 | w=104
  1390. ipilimumab -- r_associated #0: 104 / 0.227 -> en:bismuth subcitrate
    n1=ipilimumab | n2=en:bismuth subcitrate | rel=r_associated | relid=0 | w=104
  1391. ipilimumab -- r_associated #0: 104 / 0.227 -> en:boswellia serrata extract
    n1=ipilimumab | n2=en:boswellia serrata extract | rel=r_associated | relid=0 | w=104
  1392. ipilimumab -- r_associated #0: 104 / 0.227 -> en:botanical extracts rinse izn-6n4
    n1=ipilimumab | n2=en:botanical extracts rinse izn-6n4 | rel=r_associated | relid=0 | w=104
  1393. ipilimumab -- r_associated #0: 104 / 0.227 -> en:botanical lotion cg428
    n1=ipilimumab | n2=en:botanical lotion cg428 | rel=r_associated | relid=0 | w=104
  1394. ipilimumab -- r_associated #0: 104 / 0.227 -> en:botulinum toxin type a
    n1=ipilimumab | n2=en:botulinum toxin type a | rel=r_associated | relid=0 | w=104
  1395. ipilimumab -- r_associated #0: 104 / 0.227 -> en:bovine lactoferrin supplement
    n1=ipilimumab | n2=en:bovine lactoferrin supplement | rel=r_associated | relid=0 | w=104
  1396. ipilimumab -- r_associated #0: 104 / 0.227 -> en:brd4 inhibitor plx51107
    n1=ipilimumab | n2=en:brd4 inhibitor plx51107 | rel=r_associated | relid=0 | w=104
  1397. ipilimumab -- r_associated #0: 104 / 0.227 -> en:brigatinib
    n1=ipilimumab | n2=en:brigatinib | rel=r_associated | relid=0 | w=104
  1398. ipilimumab -- r_associated #0: 104 / 0.227 -> en:brincidofovir
    n1=ipilimumab | n2=en:brincidofovir | rel=r_associated | relid=0 | w=104
  1399. ipilimumab -- r_associated #0: 104 / 0.227 -> en:broad-spectrum human papillomavirus vaccine v505
    n1=ipilimumab | n2=en:broad-spectrum human papillomavirus vaccine v505 | rel=r_associated | relid=0 | w=104
  1400. ipilimumab -- r_associated #0: 104 / 0.227 -> en:bryostatin 1
    n1=ipilimumab | n2=en:bryostatin 1 | rel=r_associated | relid=0 | w=104
  1401. ipilimumab -- r_associated #0: 104 / 0.227 -> en:buspirone hydrochloride
    n1=ipilimumab | n2=en:buspirone hydrochloride | rel=r_associated | relid=0 | w=104
  1402. ipilimumab -- r_associated #0: 104 / 0.227 -> en:busulfan/melphalan regimen
    n1=ipilimumab | n2=en:busulfan/melphalan regimen | rel=r_associated | relid=0 | w=104
  1403. ipilimumab -- r_associated #0: 104 / 0.227 -> en:bw a773u
    n1=ipilimumab | n2=en:bw a773u | rel=r_associated | relid=0 | w=104
  1404. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cadazolid
    n1=ipilimumab | n2=en:cadazolid | rel=r_associated | relid=0 | w=104
  1405. ipilimumab -- r_associated #0: 104 / 0.227 -> en:caffeine
    n1=ipilimumab | n2=en:caffeine | rel=r_associated | relid=0 | w=104
  1406. ipilimumab -- r_associated #0: 104 / 0.227 -> en:canarypox-hil-12 melanoma vaccine
    n1=ipilimumab | n2=en:canarypox-hil-12 melanoma vaccine | rel=r_associated | relid=0 | w=104
  1407. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cancer peptide vaccine s-588410
    n1=ipilimumab | n2=en:cancer peptide vaccine s-588410 | rel=r_associated | relid=0 | w=104
  1408. ipilimumab -- r_associated #0: 104 / 0.227 -> en:caracemide
    n1=ipilimumab | n2=en:caracemide | rel=r_associated | relid=0 | w=104
  1409. ipilimumab -- r_associated #0: 104 / 0.227 -> en:carbamide peroxide
    n1=ipilimumab | n2=en:carbamide peroxide | rel=r_associated | relid=0 | w=104
  1410. ipilimumab -- r_associated #0: 104 / 0.227 -> en:carbon c 13/nitrogen n 15-labeled valine
    n1=ipilimumab | n2=en:carbon c 13/nitrogen n 15-labeled valine | rel=r_associated | relid=0 | w=104
  1411. ipilimumab -- r_associated #0: 104 / 0.227 -> en:carbon c 14 lenvatinib mesylate
    n1=ipilimumab | n2=en:carbon c 14 lenvatinib mesylate | rel=r_associated | relid=0 | w=104
  1412. ipilimumab -- r_associated #0: 104 / 0.227 -> en:carboplatin/etoposide/melphalan regimen
    n1=ipilimumab | n2=en:carboplatin/etoposide/melphalan regimen | rel=r_associated | relid=0 | w=104
  1413. ipilimumab -- r_associated #0: 104 / 0.227 -> en:carboxylesterase-expressing allogeneic neural stem cells
    n1=ipilimumab | n2=en:carboxylesterase-expressing allogeneic neural stem cells | rel=r_associated | relid=0 | w=104
  1414. ipilimumab -- r_associated #0: 104 / 0.227 -> en:carfilzomib
    n1=ipilimumab | n2=en:carfilzomib | rel=r_associated | relid=0 | w=104
  1415. ipilimumab -- r_associated #0: 104 / 0.227 -> en:carmustine
    n1=ipilimumab | n2=en:carmustine | rel=r_associated | relid=0 | w=104
  1416. ipilimumab -- r_associated #0: 104 / 0.227 -> en:carrot juice
    n1=ipilimumab | n2=en:carrot juice | rel=r_associated | relid=0 | w=104
  1417. ipilimumab -- r_associated #0: 104 / 0.227 -> en:caspofungin acetate
    n1=ipilimumab | n2=en:caspofungin acetate | rel=r_associated | relid=0 | w=104
  1418. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cathelicidin ll-37
    n1=ipilimumab | n2=en:cathelicidin ll-37 | rel=r_associated | relid=0 | w=104
  1419. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ccr2 antagonist pf-04136309
    n1=ipilimumab | n2=en:ccr2 antagonist pf-04136309 | rel=r_associated | relid=0 | w=104
  1420. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cd19car-cd3zeta-4-1bb-expressing allogeneic t-lymphocyte cells
    n1=ipilimumab | n2=en:cd19car-cd3zeta-4-1bb-expressing allogeneic t-lymphocyte cells | rel=r_associated | relid=0 | w=104
  1421. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cd20-targeted polypeptide tru-015
    n1=ipilimumab | n2=en:cd20-targeted polypeptide tru-015 | rel=r_associated | relid=0 | w=104
  1422. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cd33car-cd3zeta-4-1bb-expressing autologous t-lymphocytes
    n1=ipilimumab | n2=en:cd33car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=104
  1423. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cdc7 inhibitor tak-931
    n1=ipilimumab | n2=en:cdc7 inhibitor tak-931 | rel=r_associated | relid=0 | w=104
  1424. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cdk/jak2/flt3 inhibitor tg02 citrate
    n1=ipilimumab | n2=en:cdk/jak2/flt3 inhibitor tg02 citrate | rel=r_associated | relid=0 | w=104
  1425. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cdk4 inhibitor p1446a-05
    n1=ipilimumab | n2=en:cdk4 inhibitor p1446a-05 | rel=r_associated | relid=0 | w=104
  1426. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cdk4/6 inhibitor g1t28
    n1=ipilimumab | n2=en:cdk4/6 inhibitor g1t28 | rel=r_associated | relid=0 | w=104
  1427. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cdki at7519
    n1=ipilimumab | n2=en:cdki at7519 | rel=r_associated | relid=0 | w=104
  1428. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cef regimen
    n1=ipilimumab | n2=en:cef regimen | rel=r_associated | relid=0 | w=104
  1429. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cefepime hydrochloride
    n1=ipilimumab | n2=en:cefepime hydrochloride | rel=r_associated | relid=0 | w=104
  1430. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cefotaxime
    n1=ipilimumab | n2=en:cefotaxime | rel=r_associated | relid=0 | w=104
  1431. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ceftobiprole medocaril
    n1=ipilimumab | n2=en:ceftobiprole medocaril | rel=r_associated | relid=0 | w=104
  1432. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cenisertib
    n1=ipilimumab | n2=en:cenisertib | rel=r_associated | relid=0 | w=104
  1433. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ceramide
    n1=ipilimumab | n2=en:ceramide | rel=r_associated | relid=0 | w=104
  1434. ipilimumab -- r_associated #0: 104 / 0.227 -> en:certolizumab
    n1=ipilimumab | n2=en:certolizumab | rel=r_associated | relid=0 | w=104
  1435. ipilimumab -- r_associated #0: 104 / 0.227 -> en:chelating agents and antidotes
    n1=ipilimumab | n2=en:chelating agents and antidotes | rel=r_associated | relid=0 | w=104
  1436. ipilimumab -- r_associated #0: 104 / 0.227 -> en:chk1 inhibitor gdc-0425
    n1=ipilimumab | n2=en:chk1 inhibitor gdc-0425 | rel=r_associated | relid=0 | w=104
  1437. ipilimumab -- r_associated #0: 104 / 0.227 -> en:chk1 inhibitor mk-8776
    n1=ipilimumab | n2=en:chk1 inhibitor mk-8776 | rel=r_associated | relid=0 | w=104
  1438. ipilimumab -- r_associated #0: 104 / 0.227 -> en:chlorambucil-prednisone regimen
    n1=ipilimumab | n2=en:chlorambucil-prednisone regimen | rel=r_associated | relid=0 | w=104
  1439. ipilimumab -- r_associated #0: 104 / 0.227 -> en:chlorhexidine gluconate
    n1=ipilimumab | n2=en:chlorhexidine gluconate | rel=r_associated | relid=0 | w=104
  1440. ipilimumab -- r_associated #0: 104 / 0.227 -> en:chop regimen
    n1=ipilimumab | n2=en:chop regimen | rel=r_associated | relid=0 | w=104
  1441. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cinobufagin
    n1=ipilimumab | n2=en:cinobufagin | rel=r_associated | relid=0 | w=104
  1442. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cisatracurium besylate
    n1=ipilimumab | n2=en:cisatracurium besylate | rel=r_associated | relid=0 | w=104
  1443. ipilimumab -- r_associated #0: 104 / 0.227 -> en:clindamycin/hydrocortisone lotion
    n1=ipilimumab | n2=en:clindamycin/hydrocortisone lotion | rel=r_associated | relid=0 | w=104
  1444. ipilimumab -- r_associated #0: 104 / 0.227 -> en:clodronate disodium
    n1=ipilimumab | n2=en:clodronate disodium | rel=r_associated | relid=0 | w=104
  1445. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cmv pp65 peptide-pulsed autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:cmv pp65 peptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=104
  1446. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cndo-109-activated allogeneic natural killer cells
    n1=ipilimumab | n2=en:cndo-109-activated allogeneic natural killer cells | rel=r_associated | relid=0 | w=104
  1447. ipilimumab -- r_associated #0: 104 / 0.227 -> en:coffee dietary supplement
    n1=ipilimumab | n2=en:coffee dietary supplement | rel=r_associated | relid=0 | w=104
  1448. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cold contaminant-free iobenguane i-131
    n1=ipilimumab | n2=en:cold contaminant-free iobenguane i-131 | rel=r_associated | relid=0 | w=104
  1449. ipilimumab -- r_associated #0: 104 / 0.227 -> en:colistin sulfate
    n1=ipilimumab | n2=en:colistin sulfate | rel=r_associated | relid=0 | w=104
  1450. ipilimumab -- r_associated #0: 104 / 0.227 -> en:complement c5 inhibitor alxn1210
    n1=ipilimumab | n2=en:complement c5 inhibitor alxn1210 | rel=r_associated | relid=0 | w=104
  1451. ipilimumab -- r_associated #0: 104 / 0.227 -> en:conditionally replicative adenovirus 5/3-delta24
    n1=ipilimumab | n2=en:conditionally replicative adenovirus 5/3-delta24 | rel=r_associated | relid=0 | w=104
  1452. ipilimumab -- r_associated #0: 104 / 0.227 -> en:corifollitropin alfa
    n1=ipilimumab | n2=en:corifollitropin alfa | rel=r_associated | relid=0 | w=104
  1453. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cromolyn sodium inhalant pa101
    n1=ipilimumab | n2=en:cromolyn sodium inhalant pa101 | rel=r_associated | relid=0 | w=104
  1454. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ctla 4-directed antibody interactions
    n1=ipilimumab | n2=en:ctla 4-directed antibody interactions | rel=r_associated | relid=0 | w=104
  1455. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cxcr4 antagonist bl-8040
    n1=ipilimumab | n2=en:cxcr4 antagonist bl-8040 | rel=r_associated | relid=0 | w=104
  1456. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cxcr4 inhibitor msx-122
    n1=ipilimumab | n2=en:cxcr4 inhibitor msx-122 | rel=r_associated | relid=0 | w=104
  1457. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cxcr4 peptide antagonist ly2510924
    n1=ipilimumab | n2=en:cxcr4 peptide antagonist ly2510924 | rel=r_associated | relid=0 | w=104
  1458. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cyclosporine
    n1=ipilimumab | n2=en:cyclosporine | rel=r_associated | relid=0 | w=104
  1459. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cyp17 inhibitor cfg920
    n1=ipilimumab | n2=en:cyp17 inhibitor cfg920 | rel=r_associated | relid=0 | w=104
  1460. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cyp17 inhibitor vt-464
    n1=ipilimumab | n2=en:cyp17 inhibitor vt-464 | rel=r_associated | relid=0 | w=104
  1461. ipilimumab -- r_associated #0: 104 / 0.227 -> en:cystemustine
    n1=ipilimumab | n2=en:cystemustine | rel=r_associated | relid=0 | w=104
  1462. ipilimumab -- r_associated #0: 104 / 0.227 -> en:d-methionine formulation mrx-1024
    n1=ipilimumab | n2=en:d-methionine formulation mrx-1024 | rel=r_associated | relid=0 | w=104
  1463. ipilimumab -- r_associated #0: 104 / 0.227 -> en:d1/3-mage-3-his fusion protein
    n1=ipilimumab | n2=en:d1/3-mage-3-his fusion protein | rel=r_associated | relid=0 | w=104
  1464. ipilimumab -- r_associated #0: 104 / 0.227 -> en:dalteparin
    n1=ipilimumab | n2=en:dalteparin | rel=r_associated | relid=0 | w=104
  1465. ipilimumab -- r_associated #0: 104 / 0.227 -> en:dapsone
    n1=ipilimumab | n2=en:dapsone | rel=r_associated | relid=0 | w=104
  1466. ipilimumab -- r_associated #0: 104 / 0.227 -> en:dc-cholesterol liposome
    n1=ipilimumab | n2=en:dc-cholesterol liposome | rel=r_associated | relid=0 | w=104
  1467. ipilimumab -- r_associated #0: 104 / 0.227 -> en:decitabine
    n1=ipilimumab | n2=en:decitabine | rel=r_associated | relid=0 | w=104
  1468. ipilimumab -- r_associated #0: 104 / 0.227 -> en:dehydrated human amnion/chorion membrane
    n1=ipilimumab | n2=en:dehydrated human amnion/chorion membrane | rel=r_associated | relid=0 | w=104
  1469. ipilimumab -- r_associated #0: 104 / 0.227 -> en:demineralized bone matrix
    n1=ipilimumab | n2=en:demineralized bone matrix | rel=r_associated | relid=0 | w=104
  1470. ipilimumab -- r_associated #0: 104 / 0.227 -> en:denosumab
    n1=ipilimumab | n2=en:denosumab | rel=r_associated | relid=0 | w=104
  1471. ipilimumab -- r_associated #0: 104 / 0.227 -> en:dental agent
    n1=ipilimumab | n2=en:dental agent | rel=r_associated | relid=0 | w=104
  1472. ipilimumab -- r_associated #0: 104 / 0.227 -> en:deoxycytidine
    n1=ipilimumab | n2=en:deoxycytidine | rel=r_associated | relid=0 | w=104
  1473. ipilimumab -- r_associated #0: 104 / 0.227 -> en:detoxpc
    n1=ipilimumab | n2=en:detoxpc | rel=r_associated | relid=0 | w=104
  1474. ipilimumab -- r_associated #0: 104 / 0.227 -> en:deuterated 3-methylhistidine
    n1=ipilimumab | n2=en:deuterated 3-methylhistidine | rel=r_associated | relid=0 | w=104
  1475. ipilimumab -- r_associated #0: 104 / 0.227 -> en:deuterated phenanthrene
    n1=ipilimumab | n2=en:deuterated phenanthrene | rel=r_associated | relid=0 | w=104
  1476. ipilimumab -- r_associated #0: 104 / 0.227 -> en:deuterium oxide
    n1=ipilimumab | n2=en:deuterium oxide | rel=r_associated | relid=0 | w=104
  1477. ipilimumab -- r_associated #0: 104 / 0.227 -> en:dexamethasone
    n1=ipilimumab | n2=en:dexamethasone | rel=r_associated | relid=0 | w=104
  1478. ipilimumab -- r_associated #0: 104 / 0.227 -> en:dexmedetomidine hydrochloride
    n1=ipilimumab | n2=en:dexmedetomidine hydrochloride | rel=r_associated | relid=0 | w=104
  1479. ipilimumab -- r_associated #0: 104 / 0.227 -> en:dextran sulfate sodium
    n1=ipilimumab | n2=en:dextran sulfate sodium | rel=r_associated | relid=0 | w=104
  1480. ipilimumab -- r_associated #0: 104 / 0.227 -> en:dezaguanine
    n1=ipilimumab | n2=en:dezaguanine | rel=r_associated | relid=0 | w=104
  1481. ipilimumab -- r_associated #0: 104 / 0.227 -> en:dhea mustard
    n1=ipilimumab | n2=en:dhea mustard | rel=r_associated | relid=0 | w=104
  1482. ipilimumab -- r_associated #0: 104 / 0.227 -> en:dianicline
    n1=ipilimumab | n2=en:dianicline | rel=r_associated | relid=0 | w=104
  1483. ipilimumab -- r_associated #0: 104 / 0.227 -> en:didemnin b
    n1=ipilimumab | n2=en:didemnin b | rel=r_associated | relid=0 | w=104
  1484. ipilimumab -- r_associated #0: 104 / 0.227 -> en:dienogest
    n1=ipilimumab | n2=en:dienogest | rel=r_associated | relid=0 | w=104
  1485. ipilimumab -- r_associated #0: 104 / 0.227 -> en:diethylhomospermine
    n1=ipilimumab | n2=en:diethylhomospermine | rel=r_associated | relid=0 | w=104
  1486. ipilimumab -- r_associated #0: 104 / 0.227 -> en:dinitrochlorobenzene
    n1=ipilimumab | n2=en:dinitrochlorobenzene | rel=r_associated | relid=0 | w=104
  1487. ipilimumab -- r_associated #0: 104 / 0.227 -> en:dinitrofluorobenzene
    n1=ipilimumab | n2=en:dinitrofluorobenzene | rel=r_associated | relid=0 | w=104
  1488. ipilimumab -- r_associated #0: 104 / 0.227 -> en:disaccharide tripeptide glycerol dipalmitoyl
    n1=ipilimumab | n2=en:disaccharide tripeptide glycerol dipalmitoyl | rel=r_associated | relid=0 | w=104
  1489. ipilimumab -- r_associated #0: 104 / 0.227 -> en:distilled water
    n1=ipilimumab | n2=en:distilled water | rel=r_associated | relid=0 | w=104
  1490. ipilimumab -- r_associated #0: 104 / 0.227 -> en:dna-pk/tor kinase inhibitor cc-115
    n1=ipilimumab | n2=en:dna-pk/tor kinase inhibitor cc-115 | rel=r_associated | relid=0 | w=104
  1491. ipilimumab -- r_associated #0: 104 / 0.227 -> en:docetaxel
    n1=ipilimumab | n2=en:docetaxel | rel=r_associated | relid=0 | w=104
  1492. ipilimumab -- r_associated #0: 104 / 0.227 -> en:docetaxel formulation ckd-810
    n1=ipilimumab | n2=en:docetaxel formulation ckd-810 | rel=r_associated | relid=0 | w=104
  1493. ipilimumab -- r_associated #0: 104 / 0.227 -> en:donor-derived wt1/prame/ny-eso-1/survivin-specific t-lymphocytes
    n1=ipilimumab | n2=en:donor-derived wt1/prame/ny-eso-1/survivin-specific t-lymphocytes | rel=r_associated | relid=0 | w=104
  1494. ipilimumab -- r_associated #0: 104 / 0.227 -> en:doxorubicin hcl inhalation solution
    n1=ipilimumab | n2=en:doxorubicin hcl inhalation solution | rel=r_associated | relid=0 | w=104
  1495. ipilimumab -- r_associated #0: 104 / 0.227 -> en:drotrecogin alfa (activated)
    n1=ipilimumab | n2=en:drotrecogin alfa (activated) | rel=r_associated | relid=0 | w=104
  1496. ipilimumab -- r_associated #0: 104 / 0.227 -> en:drug products by va class
    n1=ipilimumab | n2=en:drug products by va class | rel=r_associated | relid=0 | w=104
  1497. ipilimumab -- r_associated #0: 104 / 0.227 -> en:dual variable domain immunoglobulin abt-165
    n1=ipilimumab | n2=en:dual variable domain immunoglobulin abt-165 | rel=r_associated | relid=0 | w=104
  1498. ipilimumab -- r_associated #0: 104 / 0.227 -> en:dulanermin
    n1=ipilimumab | n2=en:dulanermin | rel=r_associated | relid=0 | w=104
  1499. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ebv-specific cytotoxic t-lymphocyte
    n1=ipilimumab | n2=en:ebv-specific cytotoxic t-lymphocyte | rel=r_associated | relid=0 | w=104
  1500. ipilimumab -- r_associated #0: 104 / 0.227 -> en:echinomycin
    n1=ipilimumab | n2=en:echinomycin | rel=r_associated | relid=0 | w=104
  1501. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ef5
    n1=ipilimumab | n2=en:ef5 | rel=r_associated | relid=0 | w=104
  1502. ipilimumab -- r_associated #0: 104 / 0.227 -> en:elisidepsin
    n1=ipilimumab | n2=en:elisidepsin | rel=r_associated | relid=0 | w=104
  1503. ipilimumab -- r_associated #0: 104 / 0.227 -> en:eltrombopag olamine
    n1=ipilimumab | n2=en:eltrombopag olamine | rel=r_associated | relid=0 | w=104
  1504. ipilimumab -- r_associated #0: 104 / 0.227 -> en:enavatuzumab
    n1=ipilimumab | n2=en:enavatuzumab | rel=r_associated | relid=0 | w=104
  1505. ipilimumab -- r_associated #0: 104 / 0.227 -> en:epcam-specific car-expressing autologous t-lymphocytes
    n1=ipilimumab | n2=en:epcam-specific car-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=104
  1506. ipilimumab -- r_associated #0: 104 / 0.227 -> en:epipropidine
    n1=ipilimumab | n2=en:epipropidine | rel=r_associated | relid=0 | w=104
  1507. ipilimumab -- r_associated #0: 104 / 0.227 -> en:epoetin alfa
    n1=ipilimumab | n2=en:epoetin alfa | rel=r_associated | relid=0 | w=104
  1508. ipilimumab -- r_associated #0: 104 / 0.227 -> en:epothilone compound
    n1=ipilimumab | n2=en:epothilone compound | rel=r_associated | relid=0 | w=104
  1509. ipilimumab -- r_associated #0: 104 / 0.227 -> en:erbb-2 inhibitor arry-380
    n1=ipilimumab | n2=en:erbb-2 inhibitor arry-380 | rel=r_associated | relid=0 | w=104
  1510. ipilimumab -- r_associated #0: 104 / 0.227 -> en:erk inhibitor gdc-0994
    n1=ipilimumab | n2=en:erk inhibitor gdc-0994 | rel=r_associated | relid=0 | w=104
  1511. ipilimumab -- r_associated #0: 104 / 0.227 -> en:erythromycin
    n1=ipilimumab | n2=en:erythromycin | rel=r_associated | relid=0 | w=104
  1512. ipilimumab -- r_associated #0: 104 / 0.227 -> en:esorubicin
    n1=ipilimumab | n2=en:esorubicin | rel=r_associated | relid=0 | w=104
  1513. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ethacrynic acid
    n1=ipilimumab | n2=en:ethacrynic acid | rel=r_associated | relid=0 | w=104
  1514. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ethinyl estradiol/norethindrone
    n1=ipilimumab | n2=en:ethinyl estradiol/norethindrone | rel=r_associated | relid=0 | w=104
  1515. ipilimumab -- r_associated #0: 104 / 0.227 -> en:etidronate-cytarabine conjugate mbc-11
    n1=ipilimumab | n2=en:etidronate-cytarabine conjugate mbc-11 | rel=r_associated | relid=0 | w=104
  1516. ipilimumab -- r_associated #0: 104 / 0.227 -> en:etoglucid
    n1=ipilimumab | n2=en:etoglucid | rel=r_associated | relid=0 | w=104
  1517. ipilimumab -- r_associated #0: 104 / 0.227 -> en:etoposide
    n1=ipilimumab | n2=en:etoposide | rel=r_associated | relid=0 | w=104
  1518. ipilimumab -- r_associated #0: 104 / 0.227 -> en:exemestane
    n1=ipilimumab | n2=en:exemestane | rel=r_associated | relid=0 | w=104
  1519. ipilimumab -- r_associated #0: 104 / 0.227 -> en:extended release bupivacaine hydrochloride resorbable matrix formulation
    n1=ipilimumab | n2=en:extended release bupivacaine hydrochloride resorbable matrix formulation | rel=r_associated | relid=0 | w=104
  1520. ipilimumab -- r_associated #0: 104 / 0.227 -> en:extended release flucytosine
    n1=ipilimumab | n2=en:extended release flucytosine | rel=r_associated | relid=0 | w=104
  1521. ipilimumab -- r_associated #0: 104 / 0.227 -> en:factor viia inhibitor pci-27483
    n1=ipilimumab | n2=en:factor viia inhibitor pci-27483 | rel=r_associated | relid=0 | w=104
  1522. ipilimumab -- r_associated #0: 104 / 0.227 -> en:fenofibrate
    n1=ipilimumab | n2=en:fenofibrate | rel=r_associated | relid=0 | w=104
  1523. ipilimumab -- r_associated #0: 104 / 0.227 -> en:fermented soybean protein beverage
    n1=ipilimumab | n2=en:fermented soybean protein beverage | rel=r_associated | relid=0 | w=104
  1524. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ferrous sulfate
    n1=ipilimumab | n2=en:ferrous sulfate | rel=r_associated | relid=0 | w=104
  1525. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ferumoxides injectable solution
    n1=ipilimumab | n2=en:ferumoxides injectable solution | rel=r_associated | relid=0 | w=104
  1526. ipilimumab -- r_associated #0: 104 / 0.227 -> en:fgfr inhibitor ly2874455
    n1=ipilimumab | n2=en:fgfr inhibitor ly2874455 | rel=r_associated | relid=0 | w=104
  1527. ipilimumab -- r_associated #0: 104 / 0.227 -> en:fibrin sealant
    n1=ipilimumab | n2=en:fibrin sealant | rel=r_associated | relid=0 | w=104
  1528. ipilimumab -- r_associated #0: 104 / 0.227 -> en:figitumumab
    n1=ipilimumab | n2=en:figitumumab | rel=r_associated | relid=0 | w=104
  1529. ipilimumab -- r_associated #0: 104 / 0.227 -> en:flu matrix peptide p58-66
    n1=ipilimumab | n2=en:flu matrix peptide p58-66 | rel=r_associated | relid=0 | w=104
  1530. ipilimumab -- r_associated #0: 104 / 0.227 -> en:fluorescent protease-activated peptide avb-620
    n1=ipilimumab | n2=en:fluorescent protease-activated peptide avb-620 | rel=r_associated | relid=0 | w=104
  1531. ipilimumab -- r_associated #0: 104 / 0.227 -> en:fluorine 18 f fludarabine
    n1=ipilimumab | n2=en:fluorine 18 f fludarabine | rel=r_associated | relid=0 | w=104
  1532. ipilimumab -- r_associated #0: 104 / 0.227 -> en:fluorine f 18 4-l-fluoroglutamine (2s,4r)
    n1=ipilimumab | n2=en:fluorine f 18 4-l-fluoroglutamine (2s,4r) | rel=r_associated | relid=0 | w=104
  1533. ipilimumab -- r_associated #0: 104 / 0.227 -> en:fluorine f 18 rgd-k5
    n1=ipilimumab | n2=en:fluorine f 18 rgd-k5 | rel=r_associated | relid=0 | w=104
  1534. ipilimumab -- r_associated #0: 104 / 0.227 -> en:fluorine f-18 fluoropaclitaxel
    n1=ipilimumab | n2=en:fluorine f-18 fluoropaclitaxel | rel=r_associated | relid=0 | w=104
  1535. ipilimumab -- r_associated #0: 104 / 0.227 -> en:fluorodeoxygalactose f-18
    n1=ipilimumab | n2=en:fluorodeoxygalactose f-18 | rel=r_associated | relid=0 | w=104
  1536. ipilimumab -- r_associated #0: 104 / 0.227 -> en:fluorouracil-e therapeutic implant
    n1=ipilimumab | n2=en:fluorouracil-e therapeutic implant | rel=r_associated | relid=0 | w=104
  1537. ipilimumab -- r_associated #0: 104 / 0.227 -> en:fluoxymesterone
    n1=ipilimumab | n2=en:fluoxymesterone | rel=r_associated | relid=0 | w=104
  1538. ipilimumab -- r_associated #0: 104 / 0.227 -> en:flurbiprofen
    n1=ipilimumab | n2=en:flurbiprofen | rel=r_associated | relid=0 | w=104
  1539. ipilimumab -- r_associated #0: 104 / 0.227 -> en:flurocitabine
    n1=ipilimumab | n2=en:flurocitabine | rel=r_associated | relid=0 | w=104
  1540. ipilimumab -- r_associated #0: 104 / 0.227 -> en:folfox regimen
    n1=ipilimumab | n2=en:folfox regimen | rel=r_associated | relid=0 | w=104
  1541. ipilimumab -- r_associated #0: 104 / 0.227 -> en:forodesine
    n1=ipilimumab | n2=en:forodesine | rel=r_associated | relid=0 | w=104
  1542. ipilimumab -- r_associated #0: 104 / 0.227 -> en:fosbretabulin tromethamine
    n1=ipilimumab | n2=en:fosbretabulin tromethamine | rel=r_associated | relid=0 | w=104
  1543. ipilimumab -- r_associated #0: 104 / 0.227 -> en:fosquidone
    n1=ipilimumab | n2=en:fosquidone | rel=r_associated | relid=0 | w=104
  1544. ipilimumab -- r_associated #0: 104 / 0.227 -> en:freund's adjuvant
    n1=ipilimumab | n2=en:freund's adjuvant | rel=r_associated | relid=0 | w=104
  1545. ipilimumab -- r_associated #0: 104 / 0.227 -> en:fructooligosaccharide/lactobacillus paracasei/lactobacillus rhamnosus/lactobacillus acidophilus/bifidobacterium lactis probiotic supplement
    n1=ipilimumab | n2=en:fructooligosaccharide/lactobacillus paracasei/lactobacillus rhamnosus/lactobacillus acidophilus/bifidobacterium lactis probiotic supplement | rel=r_associated | relid=0 | w=104
  1546. ipilimumab -- r_associated #0: 104 / 0.227 -> en:g250 peptide vaccine
    n1=ipilimumab | n2=en:g250 peptide vaccine | rel=r_associated | relid=0 | w=104
  1547. ipilimumab -- r_associated #0: 104 / 0.227 -> en:gag:267-274 peptide vaccine
    n1=ipilimumab | n2=en:gag:267-274 peptide vaccine | rel=r_associated | relid=0 | w=104
  1548. ipilimumab -- r_associated #0: 104 / 0.227 -> en:gallium ga 68-edotreotide
    n1=ipilimumab | n2=en:gallium ga 68-edotreotide | rel=r_associated | relid=0 | w=104
  1549. ipilimumab -- r_associated #0: 104 / 0.227 -> en:gallium ga 68-labeled dota di-hsg peptide imp-288
    n1=ipilimumab | n2=en:gallium ga 68-labeled dota di-hsg peptide imp-288 | rel=r_associated | relid=0 | w=104
  1550. ipilimumab -- r_associated #0: 104 / 0.227 -> en:gallium ga 68-nota-bbn(7-14)-rgd
    n1=ipilimumab | n2=en:gallium ga 68-nota-bbn(7-14)-rgd | rel=r_associated | relid=0 | w=104
  1551. ipilimumab -- r_associated #0: 104 / 0.227 -> en:galnac-anti-c5 sirna aln-cc5
    n1=ipilimumab | n2=en:galnac-anti-c5 sirna aln-cc5 | rel=r_associated | relid=0 | w=104
  1552. ipilimumab -- r_associated #0: 104 / 0.227 -> en:gamma-secretase inhibitor ly3039478
    n1=ipilimumab | n2=en:gamma-secretase inhibitor ly3039478 | rel=r_associated | relid=0 | w=104
  1553. ipilimumab -- r_associated #0: 104 / 0.227 -> en:gataparsen sodium
    n1=ipilimumab | n2=en:gataparsen sodium | rel=r_associated | relid=0 | w=104
  1554. ipilimumab -- r_associated #0: 104 / 0.227 -> en:gavilimomab
    n1=ipilimumab | n2=en:gavilimomab | rel=r_associated | relid=0 | w=104
  1555. ipilimumab -- r_associated #0: 104 / 0.227 -> en:gelatin
    n1=ipilimumab | n2=en:gelatin | rel=r_associated | relid=0 | w=104
  1556. ipilimumab -- r_associated #0: 104 / 0.227 -> en:genetically engineered ny-eso-1-specific t lymphocytes
    n1=ipilimumab | n2=en:genetically engineered ny-eso-1-specific t lymphocytes | rel=r_associated | relid=0 | w=104
  1557. ipilimumab -- r_associated #0: 104 / 0.227 -> en:genetically-modified mage-a3-expressing mg1 maraba virus vaccine
    n1=ipilimumab | n2=en:genetically-modified mage-a3-expressing mg1 maraba virus vaccine | rel=r_associated | relid=0 | w=104
  1558. ipilimumab -- r_associated #0: 104 / 0.227 -> en:gentamicin
    n1=ipilimumab | n2=en:gentamicin | rel=r_associated | relid=0 | w=104
  1559. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ginseng compound
    n1=ipilimumab | n2=en:ginseng compound | rel=r_associated | relid=0 | w=104
  1560. ipilimumab -- r_associated #0: 104 / 0.227 -> en:gk567
    n1=ipilimumab | n2=en:gk567 | rel=r_associated | relid=0 | w=104
  1561. ipilimumab -- r_associated #0: 104 / 0.227 -> en:glembatumumab vedotin
    n1=ipilimumab | n2=en:glembatumumab vedotin | rel=r_associated | relid=0 | w=104
  1562. ipilimumab -- r_associated #0: 104 / 0.227 -> en:globulin component macrophage-activating factor
    n1=ipilimumab | n2=en:globulin component macrophage-activating factor | rel=r_associated | relid=0 | w=104
  1563. ipilimumab -- r_associated #0: 104 / 0.227 -> en:glutaminase inhibitor cb-839
    n1=ipilimumab | n2=en:glutaminase inhibitor cb-839 | rel=r_associated | relid=0 | w=104
  1564. ipilimumab -- r_associated #0: 104 / 0.227 -> en:glycooptimized trastuzumab-gex
    n1=ipilimumab | n2=en:glycooptimized trastuzumab-gex | rel=r_associated | relid=0 | w=104
  1565. ipilimumab -- r_associated #0: 104 / 0.227 -> en:gm-csf-encoding oncolytic adenovirus cgtg-102
    n1=ipilimumab | n2=en:gm-csf-encoding oncolytic adenovirus cgtg-102 | rel=r_associated | relid=0 | w=104
  1566. ipilimumab -- r_associated #0: 104 / 0.227 -> en:gm2-klh vaccine
    n1=ipilimumab | n2=en:gm2-klh vaccine | rel=r_associated | relid=0 | w=104
  1567. ipilimumab -- r_associated #0: 104 / 0.227 -> en:golimumab
    n1=ipilimumab | n2=en:golimumab | rel=r_associated | relid=0 | w=104
  1568. ipilimumab -- r_associated #0: 104 / 0.227 -> en:green tea extract
    n1=ipilimumab | n2=en:green tea extract | rel=r_associated | relid=0 | w=104
  1569. ipilimumab -- r_associated #0: 104 / 0.227 -> en:gvax lung cancer vaccine
    n1=ipilimumab | n2=en:gvax lung cancer vaccine | rel=r_associated | relid=0 | w=104
  1570. ipilimumab -- r_associated #0: 104 / 0.227 -> en:hdac inhibitor ar-42
    n1=ipilimumab | n2=en:hdac inhibitor ar-42 | rel=r_associated | relid=0 | w=104
  1571. ipilimumab -- r_associated #0: 104 / 0.227 -> en:heat-killed mycobacterial product imm-101
    n1=ipilimumab | n2=en:heat-killed mycobacterial product imm-101 | rel=r_associated | relid=0 | w=104
  1572. ipilimumab -- r_associated #0: 104 / 0.227 -> en:heat-treated varicella-zoster virus vaccine v212
    n1=ipilimumab | n2=en:heat-treated varicella-zoster virus vaccine v212 | rel=r_associated | relid=0 | w=104
  1573. ipilimumab -- r_associated #0: 104 / 0.227 -> en:hedgehog inhibitor pf-04449913
    n1=ipilimumab | n2=en:hedgehog inhibitor pf-04449913 | rel=r_associated | relid=0 | w=104
  1574. ipilimumab -- r_associated #0: 104 / 0.227 -> en:high-selenium baker's yeast
    n1=ipilimumab | n2=en:high-selenium baker's yeast | rel=r_associated | relid=0 | w=104
  1575. ipilimumab -- r_associated #0: 104 / 0.227 -> en:hla-a*0201-restricted vegfr1 peptide vaccine
    n1=ipilimumab | n2=en:hla-a*0201-restricted vegfr1 peptide vaccine | rel=r_associated | relid=0 | w=104
  1576. ipilimumab -- r_associated #0: 104 / 0.227 -> en:hpph
    n1=ipilimumab | n2=en:hpph | rel=r_associated | relid=0 | w=104
  1577. ipilimumab -- r_associated #0: 104 / 0.227 -> en:hpv e1/e2 interaction inhibitor gel ap611074
    n1=ipilimumab | n2=en:hpv e1/e2 interaction inhibitor gel ap611074 | rel=r_associated | relid=0 | w=104
  1578. ipilimumab -- r_associated #0: 104 / 0.227 -> en:hpv-16 e6 peptides vaccine/candida albicans extract
    n1=ipilimumab | n2=en:hpv-16 e6 peptides vaccine/candida albicans extract | rel=r_associated | relid=0 | w=104
  1579. ipilimumab -- r_associated #0: 104 / 0.227 -> en:htert mrna/survivin peptide-double-loaded autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:htert mrna/survivin peptide-double-loaded autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=104
  1580. ipilimumab -- r_associated #0: 104 / 0.227 -> en:htert-lamp mrna-loaded autologous dendritic cell vaccine grnvac1
    n1=ipilimumab | n2=en:htert-lamp mrna-loaded autologous dendritic cell vaccine grnvac1 | rel=r_associated | relid=0 | w=104
  1581. ipilimumab -- r_associated #0: 104 / 0.227 -> en:huachansu
    n1=ipilimumab | n2=en:huachansu | rel=r_associated | relid=0 | w=104
  1582. ipilimumab -- r_associated #0: 104 / 0.227 -> en:hydroxyurea
    n1=ipilimumab | n2=en:hydroxyurea | rel=r_associated | relid=0 | w=104
  1583. ipilimumab -- r_associated #0: 104 / 0.227 -> en:hypertonic saline
    n1=ipilimumab | n2=en:hypertonic saline | rel=r_associated | relid=0 | w=104
  1584. ipilimumab -- r_associated #0: 104 / 0.227 -> en:i 131 monoclonal antibody a33
    n1=ipilimumab | n2=en:i 131 monoclonal antibody a33 | rel=r_associated | relid=0 | w=104
  1585. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ibritumomab
    n1=ipilimumab | n2=en:ibritumomab | rel=r_associated | relid=0 | w=104
  1586. ipilimumab -- r_associated #0: 104 / 0.227 -> en:icatibant
    n1=ipilimumab | n2=en:icatibant | rel=r_associated | relid=0 | w=104
  1587. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ichthammol
    n1=ipilimumab | n2=en:ichthammol | rel=r_associated | relid=0 | w=104
  1588. ipilimumab -- r_associated #0: 104 / 0.227 -> en:icotinib hydrochloride
    n1=ipilimumab | n2=en:icotinib hydrochloride | rel=r_associated | relid=0 | w=104
  1589. ipilimumab -- r_associated #0: 104 / 0.227 -> en:idarucizumab
    n1=ipilimumab | n2=en:idarucizumab | rel=r_associated | relid=0 | w=104
  1590. ipilimumab -- r_associated #0: 104 / 0.227 -> en:idh1r132h mutation-targeting idh1 peptide vaccine
    n1=ipilimumab | n2=en:idh1r132h mutation-targeting idh1 peptide vaccine | rel=r_associated | relid=0 | w=104
  1591. ipilimumab -- r_associated #0: 104 / 0.227 -> en:idoxuridine
    n1=ipilimumab | n2=en:idoxuridine | rel=r_associated | relid=0 | w=104
  1592. ipilimumab -- r_associated #0: 104 / 0.227 -> en:igf-1r inhibitor pl225b
    n1=ipilimumab | n2=en:igf-1r inhibitor pl225b | rel=r_associated | relid=0 | w=104
  1593. ipilimumab -- r_associated #0: 104 / 0.227 -> en:iloprost
    n1=ipilimumab | n2=en:iloprost | rel=r_associated | relid=0 | w=104
  1594. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ilx23-7553
    n1=ipilimumab | n2=en:ilx23-7553 | rel=r_associated | relid=0 | w=104
  1595. ipilimumab -- r_associated #0: 104 / 0.227 -> en:imatinib
    n1=ipilimumab | n2=en:imatinib | rel=r_associated | relid=0 | w=104
  1596. ipilimumab -- r_associated #0: 104 / 0.227 -> en:imetelstat sodium
    n1=ipilimumab | n2=en:imetelstat sodium | rel=r_associated | relid=0 | w=104
  1597. ipilimumab -- r_associated #0: 104 / 0.227 -> en:immunocytokine nhs-il2-lt
    n1=ipilimumab | n2=en:immunocytokine nhs-il2-lt | rel=r_associated | relid=0 | w=104
  1598. ipilimumab -- r_associated #0: 104 / 0.227 -> en:immunotoxin d2c7-(scdsfv)-pe38kdel
    n1=ipilimumab | n2=en:immunotoxin d2c7-(scdsfv)-pe38kdel | rel=r_associated | relid=0 | w=104
  1599. ipilimumab -- r_associated #0: 104 / 0.227 -> en:imp321
    n1=ipilimumab | n2=en:imp321 | rel=r_associated | relid=0 | w=104
  1600. ipilimumab -- r_associated #0: 104 / 0.227 -> en:in 111 monoclonal antibody m170
    n1=ipilimumab | n2=en:in 111 monoclonal antibody m170 | rel=r_associated | relid=0 | w=104
  1601. ipilimumab -- r_associated #0: 104 / 0.227 -> en:indium in 111 monoclonal antibody bre-3
    n1=ipilimumab | n2=en:indium in 111 monoclonal antibody bre-3 | rel=r_associated | relid=0 | w=104
  1602. ipilimumab -- r_associated #0: 104 / 0.227 -> en:indium in 111 monoclonal antibody hupam4
    n1=ipilimumab | n2=en:indium in 111 monoclonal antibody hupam4 | rel=r_associated | relid=0 | w=104
  1603. ipilimumab -- r_associated #0: 104 / 0.227 -> en:indium in-111 pentetreotide
    n1=ipilimumab | n2=en:indium in-111 pentetreotide | rel=r_associated | relid=0 | w=104
  1604. ipilimumab -- r_associated #0: 104 / 0.227 -> en:indole-3-carbinol/calcium/schizandra/vitamin d3/milk thistle/stinging nettle/lignan-based nutritional capsule
    n1=ipilimumab | n2=en:indole-3-carbinol/calcium/schizandra/vitamin d3/milk thistle/stinging nettle/lignan-based nutritional capsule | rel=r_associated | relid=0 | w=104
  1605. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ingenol mebutate gel
    n1=ipilimumab | n2=en:ingenol mebutate gel | rel=r_associated | relid=0 | w=104
  1606. ipilimumab -- r_associated #0: 104 / 0.227 -> en:invert sugar
    n1=ipilimumab | n2=en:invert sugar | rel=r_associated | relid=0 | w=104
  1607. ipilimumab -- r_associated #0: 104 / 0.227 -> en:iodine i 124 monoclonal antibody 8h9
    n1=ipilimumab | n2=en:iodine i 124 monoclonal antibody 8h9 | rel=r_associated | relid=0 | w=104
  1608. ipilimumab -- r_associated #0: 104 / 0.227 -> en:iodine i 124-iodo-azomycin galactopyranoside
    n1=ipilimumab | n2=en:iodine i 124-iodo-azomycin galactopyranoside | rel=r_associated | relid=0 | w=104
  1609. ipilimumab -- r_associated #0: 104 / 0.227 -> en:iodine i 124-labeled anti-psca a11 minibody
    n1=ipilimumab | n2=en:iodine i 124-labeled anti-psca a11 minibody | rel=r_associated | relid=0 | w=104
  1610. ipilimumab -- r_associated #0: 104 / 0.227 -> en:iodine i 131 monoclonal antibody f16sip
    n1=ipilimumab | n2=en:iodine i 131 monoclonal antibody f16sip | rel=r_associated | relid=0 | w=104
  1611. ipilimumab -- r_associated #0: 104 / 0.227 -> en:iodine i 131 rituximab
    n1=ipilimumab | n2=en:iodine i 131 rituximab | rel=r_associated | relid=0 | w=104
  1612. ipilimumab -- r_associated #0: 104 / 0.227 -> en:iodine i 131 tenatumomab
    n1=ipilimumab | n2=en:iodine i 131 tenatumomab | rel=r_associated | relid=0 | w=104
  1613. ipilimumab -- r_associated #0: 104 / 0.227 -> en:iodine i-124 fiau
    n1=ipilimumab | n2=en:iodine i-124 fiau | rel=r_associated | relid=0 | w=104
  1614. ipilimumab -- r_associated #0: 104 / 0.227 -> en:iodine/phenol/potassium iodide/trichloroacetic acid
    n1=ipilimumab | n2=en:iodine/phenol/potassium iodide/trichloroacetic acid | rel=r_associated | relid=0 | w=104
  1615. ipilimumab -- r_associated #0: 104 / 0.227 -> en:iodohippurate sodium i-131
    n1=ipilimumab | n2=en:iodohippurate sodium i-131 | rel=r_associated | relid=0 | w=104
  1616. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ipecac
    n1=ipilimumab | n2=en:ipecac | rel=r_associated | relid=0 | w=104
  1617. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ipodic acid
    n1=ipilimumab | n2=en:ipodic acid | rel=r_associated | relid=0 | w=104
  1618. ipilimumab -- r_associated #0: 104 / 0.227 -> en:irinotecan hydrochloride
    n1=ipilimumab | n2=en:irinotecan hydrochloride | rel=r_associated | relid=0 | w=104
  1619. ipilimumab -- r_associated #0: 104 / 0.227 -> en:irofulven
    n1=ipilimumab | n2=en:irofulven | rel=r_associated | relid=0 | w=104
  1620. ipilimumab -- r_associated #0: 104 / 0.227 -> en:isavuconazole
    n1=ipilimumab | n2=en:isavuconazole | rel=r_associated | relid=0 | w=104
  1621. ipilimumab -- r_associated #0: 104 / 0.227 -> en:isolate compound
    n1=ipilimumab | n2=en:isolate compound | rel=r_associated | relid=0 | w=104
  1622. ipilimumab -- r_associated #0: 104 / 0.227 -> en:isoparaffin
    n1=ipilimumab | n2=en:isoparaffin | rel=r_associated | relid=0 | w=104
  1623. ipilimumab -- r_associated #0: 104 / 0.227 -> en:isoproterenol / phenylephrine
    n1=ipilimumab | n2=en:isoproterenol / phenylephrine | rel=r_associated | relid=0 | w=104
  1624. ipilimumab -- r_associated #0: 104 / 0.227 -> en:krn5500
    n1=ipilimumab | n2=en:krn5500 | rel=r_associated | relid=0 | w=104
  1625. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ksp inhibitor arry-520
    n1=ipilimumab | n2=en:ksp inhibitor arry-520 | rel=r_associated | relid=0 | w=104
  1626. ipilimumab -- r_associated #0: 104 / 0.227 -> en:l-377,202
    n1=ipilimumab | n2=en:l-377,202 | rel=r_associated | relid=0 | w=104
  1627. ipilimumab -- r_associated #0: 104 / 0.227 -> en:l-arginine/korean ginseng/ginkgo biloba/damiana-based supplement
    n1=ipilimumab | n2=en:l-arginine/korean ginseng/ginkgo biloba/damiana-based supplement | rel=r_associated | relid=0 | w=104
  1628. ipilimumab -- r_associated #0: 104 / 0.227 -> en:l-leucyl-l-leucine methyl ester
    n1=ipilimumab | n2=en:l-leucyl-l-leucine methyl ester | rel=r_associated | relid=0 | w=104
  1629. ipilimumab -- r_associated #0: 104 / 0.227 -> en:labradimil
    n1=ipilimumab | n2=en:labradimil | rel=r_associated | relid=0 | w=104
  1630. ipilimumab -- r_associated #0: 104 / 0.227 -> en:lamotrigine
    n1=ipilimumab | n2=en:lamotrigine | rel=r_associated | relid=0 | w=104
  1631. ipilimumab -- r_associated #0: 104 / 0.227 -> en:las41007
    n1=ipilimumab | n2=en:las41007 | rel=r_associated | relid=0 | w=104
  1632. ipilimumab -- r_associated #0: 104 / 0.227 -> en:lenapenem
    n1=ipilimumab | n2=en:lenapenem | rel=r_associated | relid=0 | w=104
  1633. ipilimumab -- r_associated #0: 104 / 0.227 -> en:lenograstim
    n1=ipilimumab | n2=en:lenograstim | rel=r_associated | relid=0 | w=104
  1634. ipilimumab -- r_associated #0: 104 / 0.227 -> en:lenzilumab
    n1=ipilimumab | n2=en:lenzilumab | rel=r_associated | relid=0 | w=104
  1635. ipilimumab -- r_associated #0: 104 / 0.227 -> en:lestaurtinib
    n1=ipilimumab | n2=en:lestaurtinib | rel=r_associated | relid=0 | w=104
  1636. ipilimumab -- r_associated #0: 104 / 0.227 -> en:letermovir
    n1=ipilimumab | n2=en:letermovir | rel=r_associated | relid=0 | w=104
  1637. ipilimumab -- r_associated #0: 104 / 0.227 -> en:leuprolide acetate
    n1=ipilimumab | n2=en:leuprolide acetate | rel=r_associated | relid=0 | w=104
  1638. ipilimumab -- r_associated #0: 104 / 0.227 -> en:levodopa
    n1=ipilimumab | n2=en:levodopa | rel=r_associated | relid=0 | w=104
  1639. ipilimumab -- r_associated #0: 104 / 0.227 -> en:levonorgestrel-releasing intrauterine system
    n1=ipilimumab | n2=en:levonorgestrel-releasing intrauterine system | rel=r_associated | relid=0 | w=104
  1640. ipilimumab -- r_associated #0: 104 / 0.227 -> en:linezolid
    n1=ipilimumab | n2=en:linezolid | rel=r_associated | relid=0 | w=104
  1641. ipilimumab -- r_associated #0: 104 / 0.227 -> en:lintuzumab
    n1=ipilimumab | n2=en:lintuzumab | rel=r_associated | relid=0 | w=104
  1642. ipilimumab -- r_associated #0: 104 / 0.227 -> en:lipid
    n1=ipilimumab | n2=en:lipid | rel=r_associated | relid=0 | w=104
  1643. ipilimumab -- r_associated #0: 104 / 0.227 -> en:lisdexamfetamine dimesylate
    n1=ipilimumab | n2=en:lisdexamfetamine dimesylate | rel=r_associated | relid=0 | w=104
  1644. ipilimumab -- r_associated #0: 104 / 0.227 -> en:listeria monocytogenes-llo-psa vaccine adxs31-142
    n1=ipilimumab | n2=en:listeria monocytogenes-llo-psa vaccine adxs31-142 | rel=r_associated | relid=0 | w=104
  1645. ipilimumab -- r_associated #0: 104 / 0.227 -> en:live-attenuated listeria monocytogenes encoding egfrviii-mesothelin vaccine jnj-64041757
    n1=ipilimumab | n2=en:live-attenuated listeria monocytogenes encoding egfrviii-mesothelin vaccine jnj-64041757 | rel=r_associated | relid=0 | w=104
  1646. ipilimumab -- r_associated #0: 104 / 0.227 -> en:lna-based antimir-155 mrg-106
    n1=ipilimumab | n2=en:lna-based antimir-155 mrg-106 | rel=r_associated | relid=0 | w=104
  1647. ipilimumab -- r_associated #0: 104 / 0.227 -> en:lomustine
    n1=ipilimumab | n2=en:lomustine | rel=r_associated | relid=0 | w=104
  1648. ipilimumab -- r_associated #0: 104 / 0.227 -> en:lorvotuzumab mertansine
    n1=ipilimumab | n2=en:lorvotuzumab mertansine | rel=r_associated | relid=0 | w=104
  1649. ipilimumab -- r_associated #0: 104 / 0.227 -> en:lutetium lu 177 dota-tetulomab
    n1=ipilimumab | n2=en:lutetium lu 177 dota-tetulomab | rel=r_associated | relid=0 | w=104
  1650. ipilimumab -- r_associated #0: 104 / 0.227 -> en:lutetium lu 177 monoclonal antibody cc49
    n1=ipilimumab | n2=en:lutetium lu 177 monoclonal antibody cc49 | rel=r_associated | relid=0 | w=104
  1651. ipilimumab -- r_associated #0: 104 / 0.227 -> en:lutetium lu 177-dota-tate
    n1=ipilimumab | n2=en:lutetium lu 177-dota-tate | rel=r_associated | relid=0 | w=104
  1652. ipilimumab -- r_associated #0: 104 / 0.227 -> en:lutetium lu 177-edotreotide
    n1=ipilimumab | n2=en:lutetium lu 177-edotreotide | rel=r_associated | relid=0 | w=104
  1653. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mage-10.a2
    n1=ipilimumab | n2=en:mage-10.a2 | rel=r_associated | relid=0 | w=104
  1654. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mage-a1, her-2/neu, fbp peptides cancer vaccine
    n1=ipilimumab | n2=en:mage-a1, her-2/neu, fbp peptides cancer vaccine | rel=r_associated | relid=0 | w=104
  1655. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mage-a3 peptide vaccine
    n1=ipilimumab | n2=en:mage-a3 peptide vaccine | rel=r_associated | relid=0 | w=104
  1656. ipilimumab -- r_associated #0: 104 / 0.227 -> en:magnesium hydroxide
    n1=ipilimumab | n2=en:magnesium hydroxide | rel=r_associated | relid=0 | w=104
  1657. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mart-1/gp100/tyrosinase/mage-a3 peptides-loaded irradiated allogeneic plasmacytoid dendritic cells
    n1=ipilimumab | n2=en:mart-1/gp100/tyrosinase/mage-a3 peptides-loaded irradiated allogeneic plasmacytoid dendritic cells | rel=r_associated | relid=0 | w=104
  1658. ipilimumab -- r_associated #0: 104 / 0.227 -> en:matricaria recutita gel
    n1=ipilimumab | n2=en:matricaria recutita gel | rel=r_associated | relid=0 | w=104
  1659. ipilimumab -- r_associated #0: 104 / 0.227 -> en:maytansine
    n1=ipilimumab | n2=en:maytansine | rel=r_associated | relid=0 | w=104
  1660. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mdm2 inhibitor ds-3032b
    n1=ipilimumab | n2=en:mdm2 inhibitor ds-3032b | rel=r_associated | relid=0 | w=104
  1661. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mechlorethamine hydrochloride gel
    n1=ipilimumab | n2=en:mechlorethamine hydrochloride gel | rel=r_associated | relid=0 | w=104
  1662. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mefloquine
    n1=ipilimumab | n2=en:mefloquine | rel=r_associated | relid=0 | w=104
  1663. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mek 1/2 inhibitor as703988/msc2015103b
    n1=ipilimumab | n2=en:mek 1/2 inhibitor as703988/msc2015103b | rel=r_associated | relid=0 | w=104
  1664. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mek inhibitor ci-1040
    n1=ipilimumab | n2=en:mek inhibitor ci-1040 | rel=r_associated | relid=0 | w=104
  1665. ipilimumab -- r_associated #0: 104 / 0.227 -> en:melphalan-flufenamide prodrug
    n1=ipilimumab | n2=en:melphalan-flufenamide prodrug | rel=r_associated | relid=0 | w=104
  1666. ipilimumab -- r_associated #0: 104 / 0.227 -> en:menatetrenone
    n1=ipilimumab | n2=en:menatetrenone | rel=r_associated | relid=0 | w=104
  1667. ipilimumab -- r_associated #0: 104 / 0.227 -> en:merestinib
    n1=ipilimumab | n2=en:merestinib | rel=r_associated | relid=0 | w=104
  1668. ipilimumab -- r_associated #0: 104 / 0.227 -> en:met tyrosine kinase inhibitor bms-777607
    n1=ipilimumab | n2=en:met tyrosine kinase inhibitor bms-777607 | rel=r_associated | relid=0 | w=104
  1669. ipilimumab -- r_associated #0: 104 / 0.227 -> en:met tyrosine kinase inhibitor sar125844
    n1=ipilimumab | n2=en:met tyrosine kinase inhibitor sar125844 | rel=r_associated | relid=0 | w=104
  1670. ipilimumab -- r_associated #0: 104 / 0.227 -> en:metatinib tromethamine
    n1=ipilimumab | n2=en:metatinib tromethamine | rel=r_associated | relid=0 | w=104
  1671. ipilimumab -- r_associated #0: 104 / 0.227 -> en:methionine c 11
    n1=ipilimumab | n2=en:methionine c 11 | rel=r_associated | relid=0 | w=104
  1672. ipilimumab -- r_associated #0: 104 / 0.227 -> en:methylene dimethane sulfonate
    n1=ipilimumab | n2=en:methylene dimethane sulfonate | rel=r_associated | relid=0 | w=104
  1673. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mirabegron
    n1=ipilimumab | n2=en:mirabegron | rel=r_associated | relid=0 | w=104
  1674. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mitoflaxone
    n1=ipilimumab | n2=en:mitoflaxone | rel=r_associated | relid=0 | w=104
  1675. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mitomycin
    n1=ipilimumab | n2=en:mitomycin | rel=r_associated | relid=0 | w=104
  1676. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mitoxantrone
    n1=ipilimumab | n2=en:mitoxantrone | rel=r_associated | relid=0 | w=104
  1677. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mitozolomide
    n1=ipilimumab | n2=en:mitozolomide | rel=r_associated | relid=0 | w=104
  1678. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mknk1 inhibitor bay 1143269
    n1=ipilimumab | n2=en:mknk1 inhibitor bay 1143269 | rel=r_associated | relid=0 | w=104
  1679. ipilimumab -- r_associated #0: 104 / 0.227 -> en:modified-release calcifediol capsule
    n1=ipilimumab | n2=en:modified-release calcifediol capsule | rel=r_associated | relid=0 | w=104
  1680. ipilimumab -- r_associated #0: 104 / 0.227 -> en:molecular target inhibitors
    n1=ipilimumab | n2=en:molecular target inhibitors | rel=r_associated | relid=0 | w=104
  1681. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mometasone furoate
    n1=ipilimumab | n2=en:mometasone furoate | rel=r_associated | relid=0 | w=104
  1682. ipilimumab -- r_associated #0: 104 / 0.227 -> en:monoclonal antibody
    n1=ipilimumab | n2=en:monoclonal antibody | rel=r_associated | relid=0 | w=104
  1683. ipilimumab -- r_associated #0: 104 / 0.227 -> en:monoclonal antibody amg 228
    n1=ipilimumab | n2=en:monoclonal antibody amg 228 | rel=r_associated | relid=0 | w=104
  1684. ipilimumab -- r_associated #0: 104 / 0.227 -> en:monoclonal antibody cal
    n1=ipilimumab | n2=en:monoclonal antibody cal | rel=r_associated | relid=0 | w=104
  1685. ipilimumab -- r_associated #0: 104 / 0.227 -> en:monoclonal antibody cd19
    n1=ipilimumab | n2=en:monoclonal antibody cd19 | rel=r_associated | relid=0 | w=104
  1686. ipilimumab -- r_associated #0: 104 / 0.227 -> en:monosialotetrahexosylganglioside
    n1=ipilimumab | n2=en:monosialotetrahexosylganglioside | rel=r_associated | relid=0 | w=104
  1687. ipilimumab -- r_associated #0: 104 / 0.227 -> en:morphine
    n1=ipilimumab | n2=en:morphine | rel=r_associated | relid=0 | w=104
  1688. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mps1 inhibitor bay 1217389
    n1=ipilimumab | n2=en:mps1 inhibitor bay 1217389 | rel=r_associated | relid=0 | w=104
  1689. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mtig7192a
    n1=ipilimumab | n2=en:mtig7192a | rel=r_associated | relid=0 | w=104
  1690. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mtorc1/2 kinase inhibitor bi 860585
    n1=ipilimumab | n2=en:mtorc1/2 kinase inhibitor bi 860585 | rel=r_associated | relid=0 | w=104
  1691. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mtorc1/mtorc2/dhfr inhibitor abtl0812
    n1=ipilimumab | n2=en:mtorc1/mtorc2/dhfr inhibitor abtl0812 | rel=r_associated | relid=0 | w=104
  1692. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mucoadhesive paclitaxel formulation
    n1=ipilimumab | n2=en:mucoadhesive paclitaxel formulation | rel=r_associated | relid=0 | w=104
  1693. ipilimumab -- r_associated #0: 104 / 0.227 -> en:multi-glioblastoma-peptide-targeting autologous dendritic cell vaccine ict-107
    n1=ipilimumab | n2=en:multi-glioblastoma-peptide-targeting autologous dendritic cell vaccine ict-107 | rel=r_associated | relid=0 | w=104
  1694. ipilimumab -- r_associated #0: 104 / 0.227 -> en:multi-peptide cmv-modified vaccinia ankara vaccine
    n1=ipilimumab | n2=en:multi-peptide cmv-modified vaccinia ankara vaccine | rel=r_associated | relid=0 | w=104
  1695. ipilimumab -- r_associated #0: 104 / 0.227 -> en:multikinase inhibitor arry614
    n1=ipilimumab | n2=en:multikinase inhibitor arry614 | rel=r_associated | relid=0 | w=104
  1696. ipilimumab -- r_associated #0: 104 / 0.227 -> en:murine tyrp2 plasmid dna vaccine
    n1=ipilimumab | n2=en:murine tyrp2 plasmid dna vaccine | rel=r_associated | relid=0 | w=104
  1697. ipilimumab -- r_associated #0: 104 / 0.227 -> en:muscle relaxant
    n1=ipilimumab | n2=en:muscle relaxant | rel=r_associated | relid=0 | w=104
  1698. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mutant-selective egfr inhibitor pf-06459988
    n1=ipilimumab | n2=en:mutant-selective egfr inhibitor pf-06459988 | rel=r_associated | relid=0 | w=104
  1699. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mva-fcu1 tg4023
    n1=ipilimumab | n2=en:mva-fcu1 tg4023 | rel=r_associated | relid=0 | w=104
  1700. ipilimumab -- r_associated #0: 104 / 0.227 -> en:myc-targeting sirna dcr-myc
    n1=ipilimumab | n2=en:myc-targeting sirna dcr-myc | rel=r_associated | relid=0 | w=104
  1701. ipilimumab -- r_associated #0: 104 / 0.227 -> en:mycophenolic acid
    n1=ipilimumab | n2=en:mycophenolic acid | rel=r_associated | relid=0 | w=104
  1702. ipilimumab -- r_associated #0: 104 / 0.227 -> en:nafoxidine hydrochloride
    n1=ipilimumab | n2=en:nafoxidine hydrochloride | rel=r_associated | relid=0 | w=104
  1703. ipilimumab -- r_associated #0: 104 / 0.227 -> en:naloxegol
    n1=ipilimumab | n2=en:naloxegol | rel=r_associated | relid=0 | w=104
  1704. ipilimumab -- r_associated #0: 104 / 0.227 -> en:nanoparticle-encapsulated docetaxel
    n1=ipilimumab | n2=en:nanoparticle-encapsulated docetaxel | rel=r_associated | relid=0 | w=104
  1705. ipilimumab -- r_associated #0: 104 / 0.227 -> en:napabucasin
    n1=ipilimumab | n2=en:napabucasin | rel=r_associated | relid=0 | w=104
  1706. ipilimumab -- r_associated #0: 104 / 0.227 -> en:navy bean powder
    n1=ipilimumab | n2=en:navy bean powder | rel=r_associated | relid=0 | w=104
  1707. ipilimumab -- r_associated #0: 104 / 0.227 -> en:nelfinavir mesylate
    n1=ipilimumab | n2=en:nelfinavir mesylate | rel=r_associated | relid=0 | w=104
  1708. ipilimumab -- r_associated #0: 104 / 0.227 -> en:nelipepimut-s plus gm-csf vaccine
    n1=ipilimumab | n2=en:nelipepimut-s plus gm-csf vaccine | rel=r_associated | relid=0 | w=104
  1709. ipilimumab -- r_associated #0: 104 / 0.227 -> en:neuromuscular blocking agents
    n1=ipilimumab | n2=en:neuromuscular blocking agents | rel=r_associated | relid=0 | w=104
  1710. ipilimumab -- r_associated #0: 104 / 0.227 -> en:neuropharmacologic agent
    n1=ipilimumab | n2=en:neuropharmacologic agent | rel=r_associated | relid=0 | w=104
  1711. ipilimumab -- r_associated #0: 104 / 0.227 -> en:nifurtimox
    n1=ipilimumab | n2=en:nifurtimox | rel=r_associated | relid=0 | w=104
  1712. ipilimumab -- r_associated #0: 104 / 0.227 -> en:nilotinib
    n1=ipilimumab | n2=en:nilotinib | rel=r_associated | relid=0 | w=104
  1713. ipilimumab -- r_associated #0: 104 / 0.227 -> en:nimotuzumab
    n1=ipilimumab | n2=en:nimotuzumab | rel=r_associated | relid=0 | w=104
  1714. ipilimumab -- r_associated #0: 104 / 0.227 -> en:nivolumab
    n1=ipilimumab | n2=en:nivolumab | rel=r_associated | relid=0 | w=104
  1715. ipilimumab -- r_associated #0: 104 / 0.227 -> en:norethindrone acetate
    n1=ipilimumab | n2=en:norethindrone acetate | rel=r_associated | relid=0 | w=104
  1716. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ns5b polymerase inhibitor bms-791325
    n1=ipilimumab | n2=en:ns5b polymerase inhibitor bms-791325 | rel=r_associated | relid=0 | w=104
  1717. ipilimumab -- r_associated #0: 104 / 0.227 -> en:nucleoside analog dfp-10917
    n1=ipilimumab | n2=en:nucleoside analog dfp-10917 | rel=r_associated | relid=0 | w=104
  1718. ipilimumab -- r_associated #0: 104 / 0.227 -> en:nutraceutical tbl-12
    n1=ipilimumab | n2=en:nutraceutical tbl-12 | rel=r_associated | relid=0 | w=104
  1719. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ny-eso-1 protein vaccine plus montanide isa-51 vg
    n1=ipilimumab | n2=en:ny-eso-1 protein vaccine plus montanide isa-51 vg | rel=r_associated | relid=0 | w=104
  1720. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ny-eso-1-specific tcr gene-transduced t lymphocytes tbi-1301
    n1=ipilimumab | n2=en:ny-eso-1-specific tcr gene-transduced t lymphocytes tbi-1301 | rel=r_associated | relid=0 | w=104
  1721. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ny-eso-1/lage-1 peptide vaccine
    n1=ipilimumab | n2=en:ny-eso-1/lage-1 peptide vaccine | rel=r_associated | relid=0 | w=104
  1722. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ny-eso-1/prame/mage-a3/wt-1 peptide vaccine
    n1=ipilimumab | n2=en:ny-eso-1/prame/mage-a3/wt-1 peptide vaccine | rel=r_associated | relid=0 | w=104
  1723. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ny-eso-1b peptide vaccine
    n1=ipilimumab | n2=en:ny-eso-1b peptide vaccine | rel=r_associated | relid=0 | w=104
  1724. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ny-eso-b
    n1=ipilimumab | n2=en:ny-eso-b | rel=r_associated | relid=0 | w=104
  1725. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ofloxacin
    n1=ipilimumab | n2=en:ofloxacin | rel=r_associated | relid=0 | w=104
  1726. ipilimumab -- r_associated #0: 104 / 0.227 -> en:oprelvekin
    n1=ipilimumab | n2=en:oprelvekin | rel=r_associated | relid=0 | w=104
  1727. ipilimumab -- r_associated #0: 104 / 0.227 -> en:oral milataxel
    n1=ipilimumab | n2=en:oral milataxel | rel=r_associated | relid=0 | w=104
  1728. ipilimumab -- r_associated #0: 104 / 0.227 -> en:oral picoplatin
    n1=ipilimumab | n2=en:oral picoplatin | rel=r_associated | relid=0 | w=104
  1729. ipilimumab -- r_associated #0: 104 / 0.227 -> en:orantinib
    n1=ipilimumab | n2=en:orantinib | rel=r_associated | relid=0 | w=104
  1730. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ormaplatin
    n1=ipilimumab | n2=en:ormaplatin | rel=r_associated | relid=0 | w=104
  1731. ipilimumab -- r_associated #0: 104 / 0.227 -> en:osimertinib
    n1=ipilimumab | n2=en:osimertinib | rel=r_associated | relid=0 | w=104
  1732. ipilimumab -- r_associated #0: 104 / 0.227 -> en:oxandrolone
    n1=ipilimumab | n2=en:oxandrolone | rel=r_associated | relid=0 | w=104
  1733. ipilimumab -- r_associated #0: 104 / 0.227 -> en:oxytocics
    n1=ipilimumab | n2=en:oxytocics | rel=r_associated | relid=0 | w=104
  1734. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ozone-based agent
    n1=ipilimumab | n2=en:ozone-based agent | rel=r_associated | relid=0 | w=104
  1735. ipilimumab -- r_associated #0: 104 / 0.227 -> en:p-cadherin-targeting agent pf-06671008
    n1=ipilimumab | n2=en:p-cadherin-targeting agent pf-06671008 | rel=r_associated | relid=0 | w=104
  1736. ipilimumab -- r_associated #0: 104 / 0.227 -> en:paclitaxel
    n1=ipilimumab | n2=en:paclitaxel | rel=r_associated | relid=0 | w=104
  1737. ipilimumab -- r_associated #0: 104 / 0.227 -> en:paclitaxel trevatide
    n1=ipilimumab | n2=en:paclitaxel trevatide | rel=r_associated | relid=0 | w=104
  1738. ipilimumab -- r_associated #0: 104 / 0.227 -> en:padeliporfin
    n1=ipilimumab | n2=en:padeliporfin | rel=r_associated | relid=0 | w=104
  1739. ipilimumab -- r_associated #0: 104 / 0.227 -> en:palm extract phytonutrient supplement
    n1=ipilimumab | n2=en:palm extract phytonutrient supplement | rel=r_associated | relid=0 | w=104
  1740. ipilimumab -- r_associated #0: 104 / 0.227 -> en:pan-pim kinase inhibitor azd1208
    n1=ipilimumab | n2=en:pan-pim kinase inhibitor azd1208 | rel=r_associated | relid=0 | w=104
  1741. ipilimumab -- r_associated #0: 104 / 0.227 -> en:panitumumab-irdye800
    n1=ipilimumab | n2=en:panitumumab-irdye800 | rel=r_associated | relid=0 | w=104
  1742. ipilimumab -- r_associated #0: 104 / 0.227 -> en:pantoprazole sodium
    n1=ipilimumab | n2=en:pantoprazole sodium | rel=r_associated | relid=0 | w=104
  1743. ipilimumab -- r_associated #0: 104 / 0.227 -> en:parathyroid hormone-related protein (1-36)
    n1=ipilimumab | n2=en:parathyroid hormone-related protein (1-36) | rel=r_associated | relid=0 | w=104
  1744. ipilimumab -- r_associated #0: 104 / 0.227 -> en:parp inhibitor bgb-290
    n1=ipilimumab | n2=en:parp inhibitor bgb-290 | rel=r_associated | relid=0 | w=104
  1745. ipilimumab -- r_associated #0: 104 / 0.227 -> en:pasireotide
    n1=ipilimumab | n2=en:pasireotide | rel=r_associated | relid=0 | w=104
  1746. ipilimumab -- r_associated #0: 104 / 0.227 -> en:pd l 506
    n1=ipilimumab | n2=en:pd l 506 | rel=r_associated | relid=0 | w=104
  1747. ipilimumab -- r_associated #0: 104 / 0.227 -> en:pd0325901
    n1=ipilimumab | n2=en:pd0325901 | rel=r_associated | relid=0 | w=104
  1748. ipilimumab -- r_associated #0: 104 / 0.227 -> en:pediatric nutritional supplement drink
    n1=ipilimumab | n2=en:pediatric nutritional supplement drink | rel=r_associated | relid=0 | w=104
  1749. ipilimumab -- r_associated #0: 104 / 0.227 -> en:peg-3350/sodium sulfate/sodium chloride/potassium chloride/sodium ascorbate/ascorbic acid-based laxative
    n1=ipilimumab | n2=en:peg-3350/sodium sulfate/sodium chloride/potassium chloride/sodium ascorbate/ascorbic acid-based laxative | rel=r_associated | relid=0 | w=104
  1750. ipilimumab -- r_associated #0: 104 / 0.227 -> en:peg-pei-cholesterol lipopolymer-encased il-12 dna plasmid vector gen-1
    n1=ipilimumab | n2=en:peg-pei-cholesterol lipopolymer-encased il-12 dna plasmid vector gen-1 | rel=r_associated | relid=0 | w=104
  1751. ipilimumab -- r_associated #0: 104 / 0.227 -> en:pegylated liposomal belotecan
    n1=ipilimumab | n2=en:pegylated liposomal belotecan | rel=r_associated | relid=0 | w=104
  1752. ipilimumab -- r_associated #0: 104 / 0.227 -> en:pegylated recombinant human interleukin-10 am0010
    n1=ipilimumab | n2=en:pegylated recombinant human interleukin-10 am0010 | rel=r_associated | relid=0 | w=104
  1753. ipilimumab -- r_associated #0: 104 / 0.227 -> en:pentoxifylline
    n1=ipilimumab | n2=en:pentoxifylline | rel=r_associated | relid=0 | w=104
  1754. ipilimumab -- r_associated #0: 104 / 0.227 -> en:pep-cmv vaccine
    n1=ipilimumab | n2=en:pep-cmv vaccine | rel=r_associated | relid=0 | w=104
  1755. ipilimumab -- r_associated #0: 104 / 0.227 -> en:perflubron
    n1=ipilimumab | n2=en:perflubron | rel=r_associated | relid=0 | w=104
  1756. ipilimumab -- r_associated #0: 104 / 0.227 -> en:perflutren
    n1=ipilimumab | n2=en:perflutren | rel=r_associated | relid=0 | w=104
  1757. ipilimumab -- r_associated #0: 104 / 0.227 -> en:personalized polyepitope plasmid dna breast cancer vaccine
    n1=ipilimumab | n2=en:personalized polyepitope plasmid dna breast cancer vaccine | rel=r_associated | relid=0 | w=104
  1758. ipilimumab -- r_associated #0: 104 / 0.227 -> en:phenethyl isothiocyanate
    n1=ipilimumab | n2=en:phenethyl isothiocyanate | rel=r_associated | relid=0 | w=104
  1759. ipilimumab -- r_associated #0: 104 / 0.227 -> en:phosphorodiamidate morpholino oligomer avi-4126
    n1=ipilimumab | n2=en:phosphorodiamidate morpholino oligomer avi-4126 | rel=r_associated | relid=0 | w=104
  1760. ipilimumab -- r_associated #0: 104 / 0.227 -> en:photosensitizer luz 11
    n1=ipilimumab | n2=en:photosensitizer luz 11 | rel=r_associated | relid=0 | w=104
  1761. ipilimumab -- r_associated #0: 104 / 0.227 -> en:phytochemical
    n1=ipilimumab | n2=en:phytochemical | rel=r_associated | relid=0 | w=104
  1762. ipilimumab -- r_associated #0: 104 / 0.227 -> en:pi3k family kinase inhibitor xl147
    n1=ipilimumab | n2=en:pi3k family kinase inhibitor xl147 | rel=r_associated | relid=0 | w=104
  1763. ipilimumab -- r_associated #0: 104 / 0.227 -> en:pi3k inhibitor px-866
    n1=ipilimumab | n2=en:pi3k inhibitor px-866 | rel=r_associated | relid=0 | w=104
  1764. ipilimumab -- r_associated #0: 104 / 0.227 -> en:pi3k/mtor kinase inhibitor pf-04691502
    n1=ipilimumab | n2=en:pi3k/mtor kinase inhibitor pf-04691502 | rel=r_associated | relid=0 | w=104
  1765. ipilimumab -- r_associated #0: 104 / 0.227 -> en:pioglitazone hydrochloride
    n1=ipilimumab | n2=en:pioglitazone hydrochloride | rel=r_associated | relid=0 | w=104
  1766. ipilimumab -- r_associated #0: 104 / 0.227 -> en:pirarubicin
    n1=ipilimumab | n2=en:pirarubicin | rel=r_associated | relid=0 | w=104
  1767. ipilimumab -- r_associated #0: 104 / 0.227 -> en:pladienolide derivative e7107
    n1=ipilimumab | n2=en:pladienolide derivative e7107 | rel=r_associated | relid=0 | w=104
  1768. ipilimumab -- r_associated #0: 104 / 0.227 -> en:plant extracts
    n1=ipilimumab | n2=en:plant extracts | rel=r_associated | relid=0 | w=104
  1769. ipilimumab -- r_associated #0: 104 / 0.227 -> en:plant-derived hematopoiesis enhancer pg2
    n1=ipilimumab | n2=en:plant-derived hematopoiesis enhancer pg2 | rel=r_associated | relid=0 | w=104
  1770. ipilimumab -- r_associated #0: 104 / 0.227 -> en:plk1 inhibitor tak-960
    n1=ipilimumab | n2=en:plk1 inhibitor tak-960 | rel=r_associated | relid=0 | w=104
  1771. ipilimumab -- r_associated #0: 104 / 0.227 -> en:pngvl4a-crt/e7(detox) dna vaccine
    n1=ipilimumab | n2=en:pngvl4a-crt/e7(detox) dna vaccine | rel=r_associated | relid=0 | w=104
  1772. ipilimumab -- r_associated #0: 104 / 0.227 -> en:polaprezinc
    n1=ipilimumab | n2=en:polaprezinc | rel=r_associated | relid=0 | w=104
  1773. ipilimumab -- r_associated #0: 104 / 0.227 -> en:polifeprosan 20 with carmustine implant
    n1=ipilimumab | n2=en:polifeprosan 20 with carmustine implant | rel=r_associated | relid=0 | w=104
  1774. ipilimumab -- r_associated #0: 104 / 0.227 -> en:poly ic
    n1=ipilimumab | n2=en:poly ic | rel=r_associated | relid=0 | w=104
  1775. ipilimumab -- r_associated #0: 104 / 0.227 -> en:polymeric camptothecin prodrug xmt-1001
    n1=ipilimumab | n2=en:polymeric camptothecin prodrug xmt-1001 | rel=r_associated | relid=0 | w=104
  1776. ipilimumab -- r_associated #0: 104 / 0.227 -> en:polyvalent antigen-klh conjugate vaccine
    n1=ipilimumab | n2=en:polyvalent antigen-klh conjugate vaccine | rel=r_associated | relid=0 | w=104
  1777. ipilimumab -- r_associated #0: 104 / 0.227 -> en:porcupine inhibitor etc-1922159
    n1=ipilimumab | n2=en:porcupine inhibitor etc-1922159 | rel=r_associated | relid=0 | w=104
  1778. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ppe-expressing replication-defective hsv-1 vector np2
    n1=ipilimumab | n2=en:ppe-expressing replication-defective hsv-1 vector np2 | rel=r_associated | relid=0 | w=104
  1779. ipilimumab -- r_associated #0: 104 / 0.227 -> en:prochlorperazine
    n1=ipilimumab | n2=en:prochlorperazine | rel=r_associated | relid=0 | w=104
  1780. ipilimumab -- r_associated #0: 104 / 0.227 -> en:proflavine hemisulfate
    n1=ipilimumab | n2=en:proflavine hemisulfate | rel=r_associated | relid=0 | w=104
  1781. ipilimumab -- r_associated #0: 104 / 0.227 -> en:propacetamol
    n1=ipilimumab | n2=en:propacetamol | rel=r_associated | relid=0 | w=104
  1782. ipilimumab -- r_associated #0: 104 / 0.227 -> en:proteasome inhibitor
    n1=ipilimumab | n2=en:proteasome inhibitor | rel=r_associated | relid=0 | w=104
  1783. ipilimumab -- r_associated #0: 104 / 0.227 -> en:protein phosphatase 2a inhibitor lb-100
    n1=ipilimumab | n2=en:protein phosphatase 2a inhibitor lb-100 | rel=r_associated | relid=0 | w=104
  1784. ipilimumab -- r_associated #0: 104 / 0.227 -> en:pseudomonas aeruginosa preparation
    n1=ipilimumab | n2=en:pseudomonas aeruginosa preparation | rel=r_associated | relid=0 | w=104
  1785. ipilimumab -- r_associated #0: 104 / 0.227 -> en:psma/tarp peptide vaccine
    n1=ipilimumab | n2=en:psma/tarp peptide vaccine | rel=r_associated | relid=0 | w=104
  1786. ipilimumab -- r_associated #0: 104 / 0.227 -> en:pva microporous hydrospheres
    n1=ipilimumab | n2=en:pva microporous hydrospheres | rel=r_associated | relid=0 | w=104
  1787. ipilimumab -- r_associated #0: 104 / 0.227 -> en:pyrazole derivative
    n1=ipilimumab | n2=en:pyrazole derivative | rel=r_associated | relid=0 | w=104
  1788. ipilimumab -- r_associated #0: 104 / 0.227 -> en:quarfloxin
    n1=ipilimumab | n2=en:quarfloxin | rel=r_associated | relid=0 | w=104
  1789. ipilimumab -- r_associated #0: 104 / 0.227 -> en:quisinostat
    n1=ipilimumab | n2=en:quisinostat | rel=r_associated | relid=0 | w=104
  1790. ipilimumab -- r_associated #0: 104 / 0.227 -> en:r-chop regimen
    n1=ipilimumab | n2=en:r-chop regimen | rel=r_associated | relid=0 | w=104
  1791. ipilimumab -- r_associated #0: 104 / 0.227 -> en:raf kinase inhibitor lgx818
    n1=ipilimumab | n2=en:raf kinase inhibitor lgx818 | rel=r_associated | relid=0 | w=104
  1792. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ranibizumab
    n1=ipilimumab | n2=en:ranibizumab | rel=r_associated | relid=0 | w=104
  1793. ipilimumab -- r_associated #0: 104 / 0.227 -> en:rasburicase
    n1=ipilimumab | n2=en:rasburicase | rel=r_associated | relid=0 | w=104
  1794. ipilimumab -- r_associated #0: 104 / 0.227 -> en:receptor tyrosine kinase inhibitor r1530
    n1=ipilimumab | n2=en:receptor tyrosine kinase inhibitor r1530 | rel=r_associated | relid=0 | w=104
  1795. ipilimumab -- r_associated #0: 104 / 0.227 -> en:recombinant human 6ckine
    n1=ipilimumab | n2=en:recombinant human 6ckine | rel=r_associated | relid=0 | w=104
  1796. ipilimumab -- r_associated #0: 104 / 0.227 -> en:recombinant human fusion protein l19tnfalpha
    n1=ipilimumab | n2=en:recombinant human fusion protein l19tnfalpha | rel=r_associated | relid=0 | w=104
  1797. ipilimumab -- r_associated #0: 104 / 0.227 -> en:recombinant interferon
    n1=ipilimumab | n2=en:recombinant interferon | rel=r_associated | relid=0 | w=104
  1798. ipilimumab -- r_associated #0: 104 / 0.227 -> en:recombinant interferon alfa-2b
    n1=ipilimumab | n2=en:recombinant interferon alfa-2b | rel=r_associated | relid=0 | w=104
  1799. ipilimumab -- r_associated #0: 104 / 0.227 -> en:recombinant interferon alpha 2b-like protein
    n1=ipilimumab | n2=en:recombinant interferon alpha 2b-like protein | rel=r_associated | relid=0 | w=104
  1800. ipilimumab -- r_associated #0: 104 / 0.227 -> en:recombinant soluble human cd4 protein
    n1=ipilimumab | n2=en:recombinant soluble human cd4 protein | rel=r_associated | relid=0 | w=104
  1801. ipilimumab -- r_associated #0: 104 / 0.227 -> en:recombinant transforming growth factor-beta-2
    n1=ipilimumab | n2=en:recombinant transforming growth factor-beta-2 | rel=r_associated | relid=0 | w=104
  1802. ipilimumab -- r_associated #0: 104 / 0.227 -> en:recombinant urokinase
    n1=ipilimumab | n2=en:recombinant urokinase | rel=r_associated | relid=0 | w=104
  1803. ipilimumab -- r_associated #0: 104 / 0.227 -> en:reduced glutathione-l-cysteine-anthocyanins gel
    n1=ipilimumab | n2=en:reduced glutathione-l-cysteine-anthocyanins gel | rel=r_associated | relid=0 | w=104
  1804. ipilimumab -- r_associated #0: 104 / 0.227 -> en:renal agents
    n1=ipilimumab | n2=en:renal agents | rel=r_associated | relid=0 | w=104
  1805. ipilimumab -- r_associated #0: 104 / 0.227 -> en:repaglinide
    n1=ipilimumab | n2=en:repaglinide | rel=r_associated | relid=0 | w=104
  1806. ipilimumab -- r_associated #0: 104 / 0.227 -> en:resiniferatoxin
    n1=ipilimumab | n2=en:resiniferatoxin | rel=r_associated | relid=0 | w=104
  1807. ipilimumab -- r_associated #0: 104 / 0.227 -> en:retaspimycin hydrochloride
    n1=ipilimumab | n2=en:retaspimycin hydrochloride | rel=r_associated | relid=0 | w=104
  1808. ipilimumab -- r_associated #0: 104 / 0.227 -> en:retrovirus vector ln
    n1=ipilimumab | n2=en:retrovirus vector ln | rel=r_associated | relid=0 | w=104
  1809. ipilimumab -- r_associated #0: 104 / 0.227 -> en:revm10 gene/polas gene
    n1=ipilimumab | n2=en:revm10 gene/polas gene | rel=r_associated | relid=0 | w=104
  1810. ipilimumab -- r_associated #0: 104 / 0.227 -> en:rft5-dga immunotoxin
    n1=ipilimumab | n2=en:rft5-dga immunotoxin | rel=r_associated | relid=0 | w=104
  1811. ipilimumab -- r_associated #0: 104 / 0.227 -> en:rhenium re-188 ethiodized oil
    n1=ipilimumab | n2=en:rhenium re-188 ethiodized oil | rel=r_associated | relid=0 | w=104
  1812. ipilimumab -- r_associated #0: 104 / 0.227 -> en:rhizoxin
    n1=ipilimumab | n2=en:rhizoxin | rel=r_associated | relid=0 | w=104
  1813. ipilimumab -- r_associated #0: 104 / 0.227 -> en:riboflavin
    n1=ipilimumab | n2=en:riboflavin | rel=r_associated | relid=0 | w=104
  1814. ipilimumab -- r_associated #0: 104 / 0.227 -> en:rice bran
    n1=ipilimumab | n2=en:rice bran | rel=r_associated | relid=0 | w=104
  1815. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ropinirole hydrochloride
    n1=ipilimumab | n2=en:ropinirole hydrochloride | rel=r_associated | relid=0 | w=104
  1816. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ror1 car-specific autologous t-lymphocytes
    n1=ipilimumab | n2=en:ror1 car-specific autologous t-lymphocytes | rel=r_associated | relid=0 | w=104
  1817. ipilimumab -- r_associated #0: 104 / 0.227 -> en:rotavirus vaccine
    n1=ipilimumab | n2=en:rotavirus vaccine | rel=r_associated | relid=0 | w=104
  1818. ipilimumab -- r_associated #0: 104 / 0.227 -> en:scb01a
    n1=ipilimumab | n2=en:scb01a | rel=r_associated | relid=0 | w=104
  1819. ipilimumab -- r_associated #0: 104 / 0.227 -> en:selective estrogen receptor degrader/modulator rad1901
    n1=ipilimumab | n2=en:selective estrogen receptor degrader/modulator rad1901 | rel=r_associated | relid=0 | w=104
  1820. ipilimumab -- r_associated #0: 104 / 0.227 -> en:sheng-mai san
    n1=ipilimumab | n2=en:sheng-mai san | rel=r_associated | relid=0 | w=104
  1821. ipilimumab -- r_associated #0: 104 / 0.227 -> en:short chain fatty acid hqk-1004
    n1=ipilimumab | n2=en:short chain fatty acid hqk-1004 | rel=r_associated | relid=0 | w=104
  1822. ipilimumab -- r_associated #0: 104 / 0.227 -> en:sig12d loder
    n1=ipilimumab | n2=en:sig12d loder | rel=r_associated | relid=0 | w=104
  1823. ipilimumab -- r_associated #0: 104 / 0.227 -> en:silmitasertib
    n1=ipilimumab | n2=en:silmitasertib | rel=r_associated | relid=0 | w=104
  1824. ipilimumab -- r_associated #0: 104 / 0.227 -> en:simethicone
    n1=ipilimumab | n2=en:simethicone | rel=r_associated | relid=0 | w=104
  1825. ipilimumab -- r_associated #0: 104 / 0.227 -> en:sirna-expressing sv40 vector
    n1=ipilimumab | n2=en:sirna-expressing sv40 vector | rel=r_associated | relid=0 | w=104
  1826. ipilimumab -- r_associated #0: 104 / 0.227 -> en:sizofiran
    n1=ipilimumab | n2=en:sizofiran | rel=r_associated | relid=0 | w=104
  1827. ipilimumab -- r_associated #0: 104 / 0.227 -> en:smokeless tobacco
    n1=ipilimumab | n2=en:smokeless tobacco | rel=r_associated | relid=0 | w=104
  1828. ipilimumab -- r_associated #0: 104 / 0.227 -> en:sodium alginate microspheres
    n1=ipilimumab | n2=en:sodium alginate microspheres | rel=r_associated | relid=0 | w=104
  1829. ipilimumab -- r_associated #0: 104 / 0.227 -> en:sodium bicarbonate solution
    n1=ipilimumab | n2=en:sodium bicarbonate solution | rel=r_associated | relid=0 | w=104
  1830. ipilimumab -- r_associated #0: 104 / 0.227 -> en:sodium butyrate
    n1=ipilimumab | n2=en:sodium butyrate | rel=r_associated | relid=0 | w=104
  1831. ipilimumab -- r_associated #0: 104 / 0.227 -> en:sodium glycididazole
    n1=ipilimumab | n2=en:sodium glycididazole | rel=r_associated | relid=0 | w=104
  1832. ipilimumab -- r_associated #0: 104 / 0.227 -> en:sodium sulfate/potassium sulfate/magnesium sulfate-based laxative
    n1=ipilimumab | n2=en:sodium sulfate/potassium sulfate/magnesium sulfate-based laxative | rel=r_associated | relid=0 | w=104
  1833. ipilimumab -- r_associated #0: 104 / 0.227 -> en:spironolactone
    n1=ipilimumab | n2=en:spironolactone | rel=r_associated | relid=0 | w=104
  1834. ipilimumab -- r_associated #0: 104 / 0.227 -> en:src kinase inhibitor kx2-391
    n1=ipilimumab | n2=en:src kinase inhibitor kx2-391 | rel=r_associated | relid=0 | w=104
  1835. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ss1(dsfv)-pe38 immunotoxin
    n1=ipilimumab | n2=en:ss1(dsfv)-pe38 immunotoxin | rel=r_associated | relid=0 | w=104
  1836. ipilimumab -- r_associated #0: 104 / 0.227 -> en:sulfatinib
    n1=ipilimumab | n2=en:sulfatinib | rel=r_associated | relid=0 | w=104
  1837. ipilimumab -- r_associated #0: 104 / 0.227 -> en:sumatriptan succinate
    n1=ipilimumab | n2=en:sumatriptan succinate | rel=r_associated | relid=0 | w=104
  1838. ipilimumab -- r_associated #0: 104 / 0.227 -> en:sun protection agent md-3511356
    n1=ipilimumab | n2=en:sun protection agent md-3511356 | rel=r_associated | relid=0 | w=104
  1839. ipilimumab -- r_associated #0: 104 / 0.227 -> en:survivin antigen vaccine dpx-survivac
    n1=ipilimumab | n2=en:survivin antigen vaccine dpx-survivac | rel=r_associated | relid=0 | w=104
  1840. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tac regimen
    n1=ipilimumab | n2=en:tac regimen | rel=r_associated | relid=0 | w=104
  1841. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tacedinaline
    n1=ipilimumab | n2=en:tacedinaline | rel=r_associated | relid=0 | w=104
  1842. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tacrolimus
    n1=ipilimumab | n2=en:tacrolimus | rel=r_associated | relid=0 | w=104
  1843. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tak-448
    n1=ipilimumab | n2=en:tak-448 | rel=r_associated | relid=0 | w=104
  1844. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tanibirumab
    n1=ipilimumab | n2=en:tanibirumab | rel=r_associated | relid=0 | w=104
  1845. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tarenflurbil
    n1=ipilimumab | n2=en:tarenflurbil | rel=r_associated | relid=0 | w=104
  1846. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tauromustine
    n1=ipilimumab | n2=en:tauromustine | rel=r_associated | relid=0 | w=104
  1847. ipilimumab -- r_associated #0: 104 / 0.227 -> en:technetium tc 99 hydrazinonicotinamide-tricine-linked interleukin-2
    n1=ipilimumab | n2=en:technetium tc 99 hydrazinonicotinamide-tricine-linked interleukin-2 | rel=r_associated | relid=0 | w=104
  1848. ipilimumab -- r_associated #0: 104 / 0.227 -> en:technetium tc 99m-labeled albumin microspheres
    n1=ipilimumab | n2=en:technetium tc 99m-labeled albumin microspheres | rel=r_associated | relid=0 | w=104
  1849. ipilimumab -- r_associated #0: 104 / 0.227 -> en:technetium tc-99m
    n1=ipilimumab | n2=en:technetium tc-99m | rel=r_associated | relid=0 | w=104
  1850. ipilimumab -- r_associated #0: 104 / 0.227 -> en:technetium tc-99m sestamibi
    n1=ipilimumab | n2=en:technetium tc-99m sestamibi | rel=r_associated | relid=0 | w=104
  1851. ipilimumab -- r_associated #0: 104 / 0.227 -> en:technetium tc-99m-nc100692
    n1=ipilimumab | n2=en:technetium tc-99m-nc100692 | rel=r_associated | relid=0 | w=104
  1852. ipilimumab -- r_associated #0: 104 / 0.227 -> en:teduglutide
    n1=ipilimumab | n2=en:teduglutide | rel=r_associated | relid=0 | w=104
  1853. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tegafur-gimeracil-oteracil potassium-leucovorin calcium oral formulation
    n1=ipilimumab | n2=en:tegafur-gimeracil-oteracil potassium-leucovorin calcium oral formulation | rel=r_associated | relid=0 | w=104
  1854. ipilimumab -- r_associated #0: 104 / 0.227 -> en:telomerase peptide vaccine gv1001
    n1=ipilimumab | n2=en:telomerase peptide vaccine gv1001 | rel=r_associated | relid=0 | w=104
  1855. ipilimumab -- r_associated #0: 104 / 0.227 -> en:telomerase: 540-548 peptide vaccine
    n1=ipilimumab | n2=en:telomerase: 540-548 peptide vaccine | rel=r_associated | relid=0 | w=104
  1856. ipilimumab -- r_associated #0: 104 / 0.227 -> en:teratogen
    n1=ipilimumab | n2=en:teratogen | rel=r_associated | relid=0 | w=104
  1857. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tesetaxel
    n1=ipilimumab | n2=en:tesetaxel | rel=r_associated | relid=0 | w=104
  1858. ipilimumab -- r_associated #0: 104 / 0.227 -> en:testosterone enanthate
    n1=ipilimumab | n2=en:testosterone enanthate | rel=r_associated | relid=0 | w=104
  1859. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tetanus toxoid vaccine
    n1=ipilimumab | n2=en:tetanus toxoid vaccine | rel=r_associated | relid=0 | w=104
  1860. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tetraphenyl chlorin disulfonate
    n1=ipilimumab | n2=en:tetraphenyl chlorin disulfonate | rel=r_associated | relid=0 | w=104
  1861. ipilimumab -- r_associated #0: 104 / 0.227 -> en:thalicarpine
    n1=ipilimumab | n2=en:thalicarpine | rel=r_associated | relid=0 | w=104
  1862. ipilimumab -- r_associated #0: 104 / 0.227 -> en:therapeutic cortisone
    n1=ipilimumab | n2=en:therapeutic cortisone | rel=r_associated | relid=0 | w=104
  1863. ipilimumab -- r_associated #0: 104 / 0.227 -> en:therapeutic gamma delta t-lymphocytes
    n1=ipilimumab | n2=en:therapeutic gamma delta t-lymphocytes | rel=r_associated | relid=0 | w=104
  1864. ipilimumab -- r_associated #0: 104 / 0.227 -> en:therapeutic hepatitis c immune globulin
    n1=ipilimumab | n2=en:therapeutic hepatitis c immune globulin | rel=r_associated | relid=0 | w=104
  1865. ipilimumab -- r_associated #0: 104 / 0.227 -> en:thl-p
    n1=ipilimumab | n2=en:thl-p | rel=r_associated | relid=0 | w=104
  1866. ipilimumab -- r_associated #0: 104 / 0.227 -> en:thrombopoietin receptor agonist lgd-4665
    n1=ipilimumab | n2=en:thrombopoietin receptor agonist lgd-4665 | rel=r_associated | relid=0 | w=104
  1867. ipilimumab -- r_associated #0: 104 / 0.227 -> en:thymidylate synthase inhibitor dfp-11207
    n1=ipilimumab | n2=en:thymidylate synthase inhibitor dfp-11207 | rel=r_associated | relid=0 | w=104
  1868. ipilimumab -- r_associated #0: 104 / 0.227 -> en:thyroxine
    n1=ipilimumab | n2=en:thyroxine | rel=r_associated | relid=0 | w=104
  1869. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tibolone
    n1=ipilimumab | n2=en:tibolone | rel=r_associated | relid=0 | w=104
  1870. ipilimumab -- r_associated #0: 104 / 0.227 -> en:timolol maleate gel forming solution
    n1=ipilimumab | n2=en:timolol maleate gel forming solution | rel=r_associated | relid=0 | w=104
  1871. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tlr7 agonist ana773 tosylate
    n1=ipilimumab | n2=en:tlr7 agonist ana773 tosylate | rel=r_associated | relid=0 | w=104
  1872. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tlr9 agonist mgn1703
    n1=ipilimumab | n2=en:tlr9 agonist mgn1703 | rel=r_associated | relid=0 | w=104
  1873. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tn(c)-klh conjugate vaccine
    n1=ipilimumab | n2=en:tn(c)-klh conjugate vaccine | rel=r_associated | relid=0 | w=104
  1874. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tocilizumab
    n1=ipilimumab | n2=en:tocilizumab | rel=r_associated | relid=0 | w=104
  1875. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tocolytic agents
    n1=ipilimumab | n2=en:tocolytic agents | rel=r_associated | relid=0 | w=104
  1876. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tomato-soy juice
    n1=ipilimumab | n2=en:tomato-soy juice | rel=r_associated | relid=0 | w=104
  1877. ipilimumab -- r_associated #0: 104 / 0.227 -> en:topical keratin
    n1=ipilimumab | n2=en:topical keratin | rel=r_associated | relid=0 | w=104
  1878. ipilimumab -- r_associated #0: 104 / 0.227 -> en:topical menthol cream
    n1=ipilimumab | n2=en:topical menthol cream | rel=r_associated | relid=0 | w=104
  1879. ipilimumab -- r_associated #0: 104 / 0.227 -> en:topical trichloroacetic acid
    n1=ipilimumab | n2=en:topical trichloroacetic acid | rel=r_associated | relid=0 | w=104
  1880. ipilimumab -- r_associated #0: 104 / 0.227 -> en:topoisomerase i inhibitor genz-644282
    n1=ipilimumab | n2=en:topoisomerase i inhibitor genz-644282 | rel=r_associated | relid=0 | w=104
  1881. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tosedostat
    n1=ipilimumab | n2=en:tosedostat | rel=r_associated | relid=0 | w=104
  1882. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tositumomab
    n1=ipilimumab | n2=en:tositumomab | rel=r_associated | relid=0 | w=104
  1883. ipilimumab -- r_associated #0: 104 / 0.227 -> en:trametinib
    n1=ipilimumab | n2=en:trametinib | rel=r_associated | relid=0 | w=104
  1884. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tranexamic acid
    n1=ipilimumab | n2=en:tranexamic acid | rel=r_associated | relid=0 | w=104
  1885. ipilimumab -- r_associated #0: 104 / 0.227 -> en:transferrin receptor-targeted liposomal p53 cdna
    n1=ipilimumab | n2=en:transferrin receptor-targeted liposomal p53 cdna | rel=r_associated | relid=0 | w=104
  1886. ipilimumab -- r_associated #0: 104 / 0.227 -> en:triamcinolone acetonide
    n1=ipilimumab | n2=en:triamcinolone acetonide | rel=r_associated | relid=0 | w=104
  1887. ipilimumab -- r_associated #0: 104 / 0.227 -> en:trientine hydrochloride
    n1=ipilimumab | n2=en:trientine hydrochloride | rel=r_associated | relid=0 | w=104
  1888. ipilimumab -- r_associated #0: 104 / 0.227 -> en:trifluoperazine hydrochloride
    n1=ipilimumab | n2=en:trifluoperazine hydrochloride | rel=r_associated | relid=0 | w=104
  1889. ipilimumab -- r_associated #0: 104 / 0.227 -> en:trifluridine
    n1=ipilimumab | n2=en:trifluridine | rel=r_associated | relid=0 | w=104
  1890. ipilimumab -- r_associated #0: 104 / 0.227 -> en:trilostane
    n1=ipilimumab | n2=en:trilostane | rel=r_associated | relid=0 | w=104
  1891. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tropomyosin receptor kinase inhibitor azd7451
    n1=ipilimumab | n2=en:tropomyosin receptor kinase inhibitor azd7451 | rel=r_associated | relid=0 | w=104
  1892. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tubulin-binding agent ssr97225
    n1=ipilimumab | n2=en:tubulin-binding agent ssr97225 | rel=r_associated | relid=0 | w=104
  1893. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tucotuzumab celmoleukin
    n1=ipilimumab | n2=en:tucotuzumab celmoleukin | rel=r_associated | relid=0 | w=104
  1894. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tumor cell-derived dribbles vaccine
    n1=ipilimumab | n2=en:tumor cell-derived dribbles vaccine | rel=r_associated | relid=0 | w=104
  1895. ipilimumab -- r_associated #0: 104 / 0.227 -> en:tyrosinase-klh
    n1=ipilimumab | n2=en:tyrosinase-klh | rel=r_associated | relid=0 | w=104
  1896. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ubidecarenone injectable nanosuspension
    n1=ipilimumab | n2=en:ubidecarenone injectable nanosuspension | rel=r_associated | relid=0 | w=104
  1897. ipilimumab -- r_associated #0: 104 / 0.227 -> en:umbilical cord blood-derived natural killer cells
    n1=ipilimumab | n2=en:umbilical cord blood-derived natural killer cells | rel=r_associated | relid=0 | w=104
  1898. ipilimumab -- r_associated #0: 104 / 0.227 -> en:umeclidinium
    n1=ipilimumab | n2=en:umeclidinium | rel=r_associated | relid=0 | w=104
  1899. ipilimumab -- r_associated #0: 104 / 0.227 -> en:uracil
    n1=ipilimumab | n2=en:uracil | rel=r_associated | relid=0 | w=104
  1900. ipilimumab -- r_associated #0: 104 / 0.227 -> en:urea
    n1=ipilimumab | n2=en:urea | rel=r_associated | relid=0 | w=104
  1901. ipilimumab -- r_associated #0: 104 / 0.227 -> en:vaccinia virus dd-cdsr
    n1=ipilimumab | n2=en:vaccinia virus dd-cdsr | rel=r_associated | relid=0 | w=104
  1902. ipilimumab -- r_associated #0: 104 / 0.227 -> en:vaccinia-tyrosinase vaccine
    n1=ipilimumab | n2=en:vaccinia-tyrosinase vaccine | rel=r_associated | relid=0 | w=104
  1903. ipilimumab -- r_associated #0: 104 / 0.227 -> en:vaccinium myrtillus/macleaya cordata/echinacea angustifolia extract granules
    n1=ipilimumab | n2=en:vaccinium myrtillus/macleaya cordata/echinacea angustifolia extract granules | rel=r_associated | relid=0 | w=104
  1904. ipilimumab -- r_associated #0: 104 / 0.227 -> en:vegfr inhibitor krn951
    n1=ipilimumab | n2=en:vegfr inhibitor krn951 | rel=r_associated | relid=0 | w=104
  1905. ipilimumab -- r_associated #0: 104 / 0.227 -> en:vegfr-2 dna vaccine vxm01
    n1=ipilimumab | n2=en:vegfr-2 dna vaccine vxm01 | rel=r_associated | relid=0 | w=104
  1906. ipilimumab -- r_associated #0: 104 / 0.227 -> en:verubulin hydrochloride
    n1=ipilimumab | n2=en:verubulin hydrochloride | rel=r_associated | relid=0 | w=104
  1907. ipilimumab -- r_associated #0: 104 / 0.227 -> en:vigabatrin
    n1=ipilimumab | n2=en:vigabatrin | rel=r_associated | relid=0 | w=104
  1908. ipilimumab -- r_associated #0: 104 / 0.227 -> en:vincristine sulfate
    n1=ipilimumab | n2=en:vincristine sulfate | rel=r_associated | relid=0 | w=104
  1909. ipilimumab -- r_associated #0: 104 / 0.227 -> en:vinzolidine
    n1=ipilimumab | n2=en:vinzolidine | rel=r_associated | relid=0 | w=104
  1910. ipilimumab -- r_associated #0: 104 / 0.227 -> en:volasertib
    n1=ipilimumab | n2=en:volasertib | rel=r_associated | relid=0 | w=104
  1911. ipilimumab -- r_associated #0: 104 / 0.227 -> en:volociximab
    n1=ipilimumab | n2=en:volociximab | rel=r_associated | relid=0 | w=104
  1912. ipilimumab -- r_associated #0: 104 / 0.227 -> en:vosaroxin
    n1=ipilimumab | n2=en:vosaroxin | rel=r_associated | relid=0 | w=104
  1913. ipilimumab -- r_associated #0: 104 / 0.227 -> en:water o-15
    n1=ipilimumab | n2=en:water o-15 | rel=r_associated | relid=0 | w=104
  1914. ipilimumab -- r_associated #0: 104 / 0.227 -> en:wt1 124-138 peptide vaccine
    n1=ipilimumab | n2=en:wt1 124-138 peptide vaccine | rel=r_associated | relid=0 | w=104
  1915. ipilimumab -- r_associated #0: 104 / 0.227 -> en:xpo1 inhibitor kpt-8602
    n1=ipilimumab | n2=en:xpo1 inhibitor kpt-8602 | rel=r_associated | relid=0 | w=104
  1916. ipilimumab -- r_associated #0: 104 / 0.227 -> en:y 90 monoclonal antibody hmfg1
    n1=ipilimumab | n2=en:y 90 monoclonal antibody hmfg1 | rel=r_associated | relid=0 | w=104
  1917. ipilimumab -- r_associated #0: 104 / 0.227 -> en:y 90 monoclonal antibody m195
    n1=ipilimumab | n2=en:y 90 monoclonal antibody m195 | rel=r_associated | relid=0 | w=104
  1918. ipilimumab -- r_associated #0: 104 / 0.227 -> en:y-shape branched pegylated filgrastim
    n1=ipilimumab | n2=en:y-shape branched pegylated filgrastim | rel=r_associated | relid=0 | w=104
  1919. ipilimumab -- r_associated #0: 104 / 0.227 -> en:yangzheng xiaoji extract
    n1=ipilimumab | n2=en:yangzheng xiaoji extract | rel=r_associated | relid=0 | w=104
  1920. ipilimumab -- r_associated #0: 104 / 0.227 -> en:yttrium y 90 anti-cd45 monoclonal antibody ahn-12
    n1=ipilimumab | n2=en:yttrium y 90 anti-cd45 monoclonal antibody ahn-12 | rel=r_associated | relid=0 | w=104
  1921. ipilimumab -- r_associated #0: 104 / 0.227 -> en:yttrium y 90 monoclonal antibody idec-159
    n1=ipilimumab | n2=en:yttrium y 90 monoclonal antibody idec-159 | rel=r_associated | relid=0 | w=104
  1922. ipilimumab -- r_associated #0: 104 / 0.227 -> en:yttrium y 90-dota-biotin
    n1=ipilimumab | n2=en:yttrium y 90-dota-biotin | rel=r_associated | relid=0 | w=104
  1923. ipilimumab -- r_associated #0: 104 / 0.227 -> en:yttrium y 90-dota-di-hsg peptide imp-288
    n1=ipilimumab | n2=en:yttrium y 90-dota-di-hsg peptide imp-288 | rel=r_associated | relid=0 | w=104
  1924. ipilimumab -- r_associated #0: 104 / 0.227 -> en:yttrium-90 polycarbonate brachytherapy plaque
    n1=ipilimumab | n2=en:yttrium-90 polycarbonate brachytherapy plaque | rel=r_associated | relid=0 | w=104
  1925. ipilimumab -- r_associated #0: 104 / 0.227 -> en:zalutumumab
    n1=ipilimumab | n2=en:zalutumumab | rel=r_associated | relid=0 | w=104
  1926. ipilimumab -- r_associated #0: 104 / 0.227 -> en:zinc finger nuclease zfn-603
    n1=ipilimumab | n2=en:zinc finger nuclease zfn-603 | rel=r_associated | relid=0 | w=104
  1927. ipilimumab -- r_associated #0: 104 / 0.227 -> en:zinc oxide/aluminum starch octenylsuccinate/glycyrrhetinic phytosome/vitamin e/botanical extracts-based skin protectant paste
    n1=ipilimumab | n2=en:zinc oxide/aluminum starch octenylsuccinate/glycyrrhetinic phytosome/vitamin e/botanical extracts-based skin protectant paste | rel=r_associated | relid=0 | w=104
  1928. ipilimumab -- r_associated #0: 104 / 0.227 -> en:ziv-aflibercept
    n1=ipilimumab | n2=en:ziv-aflibercept | rel=r_associated | relid=0 | w=104
  1929. ipilimumab -- r_associated #0: 103 / 0.225 -> en:[18f]-labeled substance p antagonist receptor quantifier
    n1=ipilimumab | n2=en:[18f]-labeled substance p antagonist receptor quantifier | rel=r_associated | relid=0 | w=103
  1930. ipilimumab -- r_associated #0: 103 / 0.225 -> en:11c topotecan
    n1=ipilimumab | n2=en:11c topotecan | rel=r_associated | relid=0 | w=103
  1931. ipilimumab -- r_associated #0: 103 / 0.225 -> en:3-deazauridine
    n1=ipilimumab | n2=en:3-deazauridine | rel=r_associated | relid=0 | w=103
  1932. ipilimumab -- r_associated #0: 103 / 0.225 -> en:3'-c-ethynylcytidine
    n1=ipilimumab | n2=en:3'-c-ethynylcytidine | rel=r_associated | relid=0 | w=103
  1933. ipilimumab -- r_associated #0: 103 / 0.225 -> en:5-fitc-labeled colon-heptapeptide
    n1=ipilimumab | n2=en:5-fitc-labeled colon-heptapeptide | rel=r_associated | relid=0 | w=103
  1934. ipilimumab -- r_associated #0: 103 / 0.225 -> en:50% oxygen/50% nitrous oxide premix
    n1=ipilimumab | n2=en:50% oxygen/50% nitrous oxide premix | rel=r_associated | relid=0 | w=103
  1935. ipilimumab -- r_associated #0: 103 / 0.225 -> en:6-azauridine
    n1=ipilimumab | n2=en:6-azauridine | rel=r_associated | relid=0 | w=103
  1936. ipilimumab -- r_associated #0: 103 / 0.225 -> en:abt-510
    n1=ipilimumab | n2=en:abt-510 | rel=r_associated | relid=0 | w=103
  1937. ipilimumab -- r_associated #0: 103 / 0.225 -> en:abvd regimen
    n1=ipilimumab | n2=en:abvd regimen | rel=r_associated | relid=0 | w=103
  1938. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ad-sig-hmuc-1/ecdcd40l vaccine
    n1=ipilimumab | n2=en:ad-sig-hmuc-1/ecdcd40l vaccine | rel=r_associated | relid=0 | w=103
  1939. ipilimumab -- r_associated #0: 103 / 0.225 -> en:adenovector-transduced ap1903-inducible myd88/cd40-expressing autologous psma-specific prostate cancer vaccine bpx-201
    n1=ipilimumab | n2=en:adenovector-transduced ap1903-inducible myd88/cd40-expressing autologous psma-specific prostate cancer vaccine bpx-201 | rel=r_associated | relid=0 | w=103
  1940. ipilimumab -- r_associated #0: 103 / 0.225 -> en:adenovirus encoding rat her-2/neu
    n1=ipilimumab | n2=en:adenovirus encoding rat her-2/neu | rel=r_associated | relid=0 | w=103
  1941. ipilimumab -- r_associated #0: 103 / 0.225 -> en:adenovirus her2-transduced autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:adenovirus her2-transduced autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=103
  1942. ipilimumab -- r_associated #0: 103 / 0.225 -> en:aeg35156
    n1=ipilimumab | n2=en:aeg35156 | rel=r_associated | relid=0 | w=103
  1943. ipilimumab -- r_associated #0: 103 / 0.225 -> en:agatolimod sodium
    n1=ipilimumab | n2=en:agatolimod sodium | rel=r_associated | relid=0 | w=103
  1944. ipilimumab -- r_associated #0: 103 / 0.225 -> en:akt inhibitor gsk2141795
    n1=ipilimumab | n2=en:akt inhibitor gsk2141795 | rel=r_associated | relid=0 | w=103
  1945. ipilimumab -- r_associated #0: 103 / 0.225 -> en:alcohol
    n1=ipilimumab | n2=en:alcohol | rel=r_associated | relid=0 | w=103
  1946. ipilimumab -- r_associated #0: 103 / 0.225 -> en:allergenic extract
    n1=ipilimumab | n2=en:allergenic extract | rel=r_associated | relid=0 | w=103
  1947. ipilimumab -- r_associated #0: 103 / 0.225 -> en:allogeneic cmv/adv-specific cytotoxic t lymphocytes
    n1=ipilimumab | n2=en:allogeneic cmv/adv-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=103
  1948. ipilimumab -- r_associated #0: 103 / 0.225 -> en:allogeneic tumor cell vaccine
    n1=ipilimumab | n2=en:allogeneic tumor cell vaccine | rel=r_associated | relid=0 | w=103
  1949. ipilimumab -- r_associated #0: 103 / 0.225 -> en:alpha-fetoprotein peptide-pulsed autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:alpha-fetoprotein peptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=103
  1950. ipilimumab -- r_associated #0: 103 / 0.225 -> en:alvac-mart-1 vaccine
    n1=ipilimumab | n2=en:alvac-mart-1 vaccine | rel=r_associated | relid=0 | w=103
  1951. ipilimumab -- r_associated #0: 103 / 0.225 -> en:alvocidib hydrochloride
    n1=ipilimumab | n2=en:alvocidib hydrochloride | rel=r_associated | relid=0 | w=103
  1952. ipilimumab -- r_associated #0: 103 / 0.225 -> en:american ginseng
    n1=ipilimumab | n2=en:american ginseng | rel=r_associated | relid=0 | w=103
  1953. ipilimumab -- r_associated #0: 103 / 0.225 -> en:amidino tic
    n1=ipilimumab | n2=en:amidino tic | rel=r_associated | relid=0 | w=103
  1954. ipilimumab -- r_associated #0: 103 / 0.225 -> en:aminolevulinic acid
    n1=ipilimumab | n2=en:aminolevulinic acid | rel=r_associated | relid=0 | w=103
  1955. ipilimumab -- r_associated #0: 103 / 0.225 -> en:amt2003
    n1=ipilimumab | n2=en:amt2003 | rel=r_associated | relid=0 | w=103
  1956. ipilimumab -- r_associated #0: 103 / 0.225 -> en:amylin analog
    n1=ipilimumab | n2=en:amylin analog | rel=r_associated | relid=0 | w=103
  1957. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anamorelin hydrochloride
    n1=ipilimumab | n2=en:anamorelin hydrochloride | rel=r_associated | relid=0 | w=103
  1958. ipilimumab -- r_associated #0: 103 / 0.225 -> en:androgen receptor antisense oligonucleotide azd5312
    n1=ipilimumab | n2=en:androgen receptor antisense oligonucleotide azd5312 | rel=r_associated | relid=0 | w=103
  1959. ipilimumab -- r_associated #0: 103 / 0.225 -> en:andrographolide
    n1=ipilimumab | n2=en:andrographolide | rel=r_associated | relid=0 | w=103
  1960. ipilimumab -- r_associated #0: 103 / 0.225 -> en:androstane steroid he3235
    n1=ipilimumab | n2=en:androstane steroid he3235 | rel=r_associated | relid=0 | w=103
  1961. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anesthetic agent
    n1=ipilimumab | n2=en:anesthetic agent | rel=r_associated | relid=0 | w=103
  1962. ipilimumab -- r_associated #0: 103 / 0.225 -> en:angiogenesis inhibitor gt-111
    n1=ipilimumab | n2=en:angiogenesis inhibitor gt-111 | rel=r_associated | relid=0 | w=103
  1963. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anthocyanin-rich corn extract
    n1=ipilimumab | n2=en:anthocyanin-rich corn extract | rel=r_associated | relid=0 | w=103
  1964. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-allergic agents
    n1=ipilimumab | n2=en:anti-allergic agents | rel=r_associated | relid=0 | w=103
  1965. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-amyloid monoclonal antibody neod001
    n1=ipilimumab | n2=en:anti-amyloid monoclonal antibody neod001 | rel=r_associated | relid=0 | w=103
  1966. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-angiopoietin monoclonal antibody amg 780
    n1=ipilimumab | n2=en:anti-angiopoietin monoclonal antibody amg 780 | rel=r_associated | relid=0 | w=103
  1967. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-ca6-dm4 immunoconjugate sar566658
    n1=ipilimumab | n2=en:anti-ca6-dm4 immunoconjugate sar566658 | rel=r_associated | relid=0 | w=103
  1968. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-cd123 x anti-cd3 bispecific antibody xmab1404
    n1=ipilimumab | n2=en:anti-cd123 x anti-cd3 bispecific antibody xmab1404 | rel=r_associated | relid=0 | w=103
  1969. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-cd19/anti-cd22 bispecific immunotoxin dt2219arl
    n1=ipilimumab | n2=en:anti-cd19/anti-cd22 bispecific immunotoxin dt2219arl | rel=r_associated | relid=0 | w=103
  1970. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-cd3 okt3/humanized anti-gd2 3f8 bispecific antibody-activated t lymphocytes
    n1=ipilimumab | n2=en:anti-cd3 okt3/humanized anti-gd2 3f8 bispecific antibody-activated t lymphocytes | rel=r_associated | relid=0 | w=103
  1971. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-cd30 monoclonal antibody mdx-1401
    n1=ipilimumab | n2=en:anti-cd30 monoclonal antibody mdx-1401 | rel=r_associated | relid=0 | w=103
  1972. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-cd70 antibody-drug conjugate sgn-cd70a
    n1=ipilimumab | n2=en:anti-cd70 antibody-drug conjugate sgn-cd70a | rel=r_associated | relid=0 | w=103
  1973. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-cea igcd28tcr-transduced autologous t cells
    n1=ipilimumab | n2=en:anti-cea igcd28tcr-transduced autologous t cells | rel=r_associated | relid=0 | w=103
  1974. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-csf1r monoclonal antibody fpa008
    n1=ipilimumab | n2=en:anti-csf1r monoclonal antibody fpa008 | rel=r_associated | relid=0 | w=103
  1975. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-egfr monoclonal antibody gc1118
    n1=ipilimumab | n2=en:anti-egfr monoclonal antibody gc1118 | rel=r_associated | relid=0 | w=103
  1976. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-egfr monoclonal antibody mixture sym004
    n1=ipilimumab | n2=en:anti-egfr monoclonal antibody mixture sym004 | rel=r_associated | relid=0 | w=103
  1977. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-egfr monoclonal antibody syn004
    n1=ipilimumab | n2=en:anti-egfr monoclonal antibody syn004 | rel=r_associated | relid=0 | w=103
  1978. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-egfrviii immunotoxin mr1-1
    n1=ipilimumab | n2=en:anti-egfrviii immunotoxin mr1-1 | rel=r_associated | relid=0 | w=103
  1979. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-erbb3 monoclonal antibody ktn3379
    n1=ipilimumab | n2=en:anti-erbb3 monoclonal antibody ktn3379 | rel=r_associated | relid=0 | w=103
  1980. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-fgf23 igg1 monoclonal antibody krn23
    n1=ipilimumab | n2=en:anti-fgf23 igg1 monoclonal antibody krn23 | rel=r_associated | relid=0 | w=103
  1981. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-gitr agonistic monoclonal antibody incagn01876
    n1=ipilimumab | n2=en:anti-gitr agonistic monoclonal antibody incagn01876 | rel=r_associated | relid=0 | w=103
  1982. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-hepcidin monoclonal antibody ly2787106
    n1=ipilimumab | n2=en:anti-hepcidin monoclonal antibody ly2787106 | rel=r_associated | relid=0 | w=103
  1983. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-her2-car autologous cmv-specific cytotoxic t-lymphocytes
    n1=ipilimumab | n2=en:anti-her2-car autologous cmv-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=103
  1984. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-hif-1alpha lna antisense oligonucleotide ezn-2968
    n1=ipilimumab | n2=en:anti-hif-1alpha lna antisense oligonucleotide ezn-2968 | rel=r_associated | relid=0 | w=103
  1985. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-human chorionic gonadotropin vaccine
    n1=ipilimumab | n2=en:anti-human chorionic gonadotropin vaccine | rel=r_associated | relid=0 | w=103
  1986. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-human gitr monoclonal antibody trx518
    n1=ipilimumab | n2=en:anti-human gitr monoclonal antibody trx518 | rel=r_associated | relid=0 | w=103
  1987. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-mesothelin antibody-drug conjugate bms-986148
    n1=ipilimumab | n2=en:anti-mesothelin antibody-drug conjugate bms-986148 | rel=r_associated | relid=0 | w=103
  1988. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-myeloma monoclonal antibody-dm4 immunoconjugate bt-062
    n1=ipilimumab | n2=en:anti-myeloma monoclonal antibody-dm4 immunoconjugate bt-062 | rel=r_associated | relid=0 | w=103
  1989. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-napi2b/mmae antibody-drug conjugate dnib0600a
    n1=ipilimumab | n2=en:anti-napi2b/mmae antibody-drug conjugate dnib0600a | rel=r_associated | relid=0 | w=103
  1990. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-nucleolin aptamer as1411
    n1=ipilimumab | n2=en:anti-nucleolin aptamer as1411 | rel=r_associated | relid=0 | w=103
  1991. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-ny-eso1 tcr-transduced autologous cd62l+-derived t-lymphocytes
    n1=ipilimumab | n2=en:anti-ny-eso1 tcr-transduced autologous cd62l+-derived t-lymphocytes | rel=r_associated | relid=0 | w=103
  1992. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-ofa immunotherapeutic bb-mpi-03
    n1=ipilimumab | n2=en:anti-ofa immunotherapeutic bb-mpi-03 | rel=r_associated | relid=0 | w=103
  1993. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-pd-1 monoclonal antibody medi0680
    n1=ipilimumab | n2=en:anti-pd-1 monoclonal antibody medi0680 | rel=r_associated | relid=0 | w=103
  1994. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-pd-l1 monoclonal antibody mdx-1105
    n1=ipilimumab | n2=en:anti-pd-l1 monoclonal antibody mdx-1105 | rel=r_associated | relid=0 | w=103
  1995. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-psma monoclonal antibody mdx1201-a488
    n1=ipilimumab | n2=en:anti-psma monoclonal antibody mdx1201-a488 | rel=r_associated | relid=0 | w=103
  1996. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-ta-muc1 monoclonal antibody pankomab
    n1=ipilimumab | n2=en:anti-ta-muc1 monoclonal antibody pankomab | rel=r_associated | relid=0 | w=103
  1997. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anti-tissue factor monoclonal antibody morab-066
    n1=ipilimumab | n2=en:anti-tissue factor monoclonal antibody morab-066 | rel=r_associated | relid=0 | w=103
  1998. ipilimumab -- r_associated #0: 103 / 0.225 -> en:antibody-drug conjugate bay79-4620
    n1=ipilimumab | n2=en:antibody-drug conjugate bay79-4620 | rel=r_associated | relid=0 | w=103
  1999. ipilimumab -- r_associated #0: 103 / 0.225 -> en:antibody-drug conjugate dfrf4539a
    n1=ipilimumab | n2=en:antibody-drug conjugate dfrf4539a | rel=r_associated | relid=0 | w=103
  2000. ipilimumab -- r_associated #0: 103 / 0.225 -> en:anticarcinogenic agents
    n1=ipilimumab | n2=en:anticarcinogenic agents | rel=r_associated | relid=0 | w=103
  2001. ipilimumab -- r_associated #0: 103 / 0.225 -> en:antidiuretic
    n1=ipilimumab | n2=en:antidiuretic | rel=r_associated | relid=0 | w=103
  2002. ipilimumab -- r_associated #0: 103 / 0.225 -> en:antineoplastic adjuvants
    n1=ipilimumab | n2=en:antineoplastic adjuvants | rel=r_associated | relid=0 | w=103
  2003. ipilimumab -- r_associated #0: 103 / 0.225 -> en:antineoplastic agent trx-818
    n1=ipilimumab | n2=en:antineoplastic agent trx-818 | rel=r_associated | relid=0 | w=103
  2004. ipilimumab -- r_associated #0: 103 / 0.225 -> en:antineoplastic alkylating agent
    n1=ipilimumab | n2=en:antineoplastic alkylating agent | rel=r_associated | relid=0 | w=103
  2005. ipilimumab -- r_associated #0: 103 / 0.225 -> en:antineoplastic hormones
    n1=ipilimumab | n2=en:antineoplastic hormones | rel=r_associated | relid=0 | w=103
  2006. ipilimumab -- r_associated #0: 103 / 0.225 -> en:antineoplastic vinca alkaloid
    n1=ipilimumab | n2=en:antineoplastic vinca alkaloid | rel=r_associated | relid=0 | w=103
  2007. ipilimumab -- r_associated #0: 103 / 0.225 -> en:antispasmodic agent
    n1=ipilimumab | n2=en:antispasmodic agent | rel=r_associated | relid=0 | w=103
  2008. ipilimumab -- r_associated #0: 103 / 0.225 -> en:apaziquone
    n1=ipilimumab | n2=en:apaziquone | rel=r_associated | relid=0 | w=103
  2009. ipilimumab -- r_associated #0: 103 / 0.225 -> en:apoptosis inducer bzl101
    n1=ipilimumab | n2=en:apoptosis inducer bzl101 | rel=r_associated | relid=0 | w=103
  2010. ipilimumab -- r_associated #0: 103 / 0.225 -> en:aprepitant
    n1=ipilimumab | n2=en:aprepitant | rel=r_associated | relid=0 | w=103
  2011. ipilimumab -- r_associated #0: 103 / 0.225 -> en:arginine butyrate
    n1=ipilimumab | n2=en:arginine butyrate | rel=r_associated | relid=0 | w=103
  2012. ipilimumab -- r_associated #0: 103 / 0.225 -> en:aspirin
    n1=ipilimumab | n2=en:aspirin | rel=r_associated | relid=0 | w=103
  2013. ipilimumab -- r_associated #0: 103 / 0.225 -> en:atamestane
    n1=ipilimumab | n2=en:atamestane | rel=r_associated | relid=0 | w=103
  2014. ipilimumab -- r_associated #0: 103 / 0.225 -> en:atn-161
    n1=ipilimumab | n2=en:atn-161 | rel=r_associated | relid=0 | w=103
  2015. ipilimumab -- r_associated #0: 103 / 0.225 -> en:aurora a kinase/tyrosine kinase inhibitor enmd-2076
    n1=ipilimumab | n2=en:aurora a kinase/tyrosine kinase inhibitor enmd-2076 | rel=r_associated | relid=0 | w=103
  2016. ipilimumab -- r_associated #0: 103 / 0.225 -> en:autologous cd19car-cd28-cd3zeta-egfrt-expressing tcm-enriched t cells
    n1=ipilimumab | n2=en:autologous cd19car-cd28-cd3zeta-egfrt-expressing tcm-enriched t cells | rel=r_associated | relid=0 | w=103
  2017. ipilimumab -- r_associated #0: 103 / 0.225 -> en:autologous dendritic cell-based immunotherapeutic av0113
    n1=ipilimumab | n2=en:autologous dendritic cell-based immunotherapeutic av0113 | rel=r_associated | relid=0 | w=103
  2018. ipilimumab -- r_associated #0: 103 / 0.225 -> en:autologous dinitrophenyl-modified ovarian cancer vaccine
    n1=ipilimumab | n2=en:autologous dinitrophenyl-modified ovarian cancer vaccine | rel=r_associated | relid=0 | w=103
  2019. ipilimumab -- r_associated #0: 103 / 0.225 -> en:autologous expanded mesenchymal stem cells oti-010
    n1=ipilimumab | n2=en:autologous expanded mesenchymal stem cells oti-010 | rel=r_associated | relid=0 | w=103
  2020. ipilimumab -- r_associated #0: 103 / 0.225 -> en:autologous hnscc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine
    n1=ipilimumab | n2=en:autologous hnscc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine | rel=r_associated | relid=0 | w=103
  2021. ipilimumab -- r_associated #0: 103 / 0.225 -> en:autologous ny-eso-1-melanoma-specific cd8+ t-lymphocytes
    n1=ipilimumab | n2=en:autologous ny-eso-1-melanoma-specific cd8+ t-lymphocytes | rel=r_associated | relid=0 | w=103
  2022. ipilimumab -- r_associated #0: 103 / 0.225 -> en:autologous t-lymphocytes-expressing ny-eso-1-c259-specific enhanced t-cell receptors
    n1=ipilimumab | n2=en:autologous t-lymphocytes-expressing ny-eso-1-c259-specific enhanced t-cell receptors | rel=r_associated | relid=0 | w=103
  2023. ipilimumab -- r_associated #0: 103 / 0.225 -> en:autologous trimix-dc melanoma vaccine
    n1=ipilimumab | n2=en:autologous trimix-dc melanoma vaccine | rel=r_associated | relid=0 | w=103
  2024. ipilimumab -- r_associated #0: 103 / 0.225 -> en:azapicyl
    n1=ipilimumab | n2=en:azapicyl | rel=r_associated | relid=0 | w=103
  2025. ipilimumab -- r_associated #0: 103 / 0.225 -> en:azaserine
    n1=ipilimumab | n2=en:azaserine | rel=r_associated | relid=0 | w=103
  2026. ipilimumab -- r_associated #0: 103 / 0.225 -> en:aziridinylbenzoquinone rh1
    n1=ipilimumab | n2=en:aziridinylbenzoquinone rh1 | rel=r_associated | relid=0 | w=103
  2027. ipilimumab -- r_associated #0: 103 / 0.225 -> en:batanopride
    n1=ipilimumab | n2=en:batanopride | rel=r_associated | relid=0 | w=103
  2028. ipilimumab -- r_associated #0: 103 / 0.225 -> en:bay 56-3722
    n1=ipilimumab | n2=en:bay 56-3722 | rel=r_associated | relid=0 | w=103
  2029. ipilimumab -- r_associated #0: 103 / 0.225 -> en:bbr 3464
    n1=ipilimumab | n2=en:bbr 3464 | rel=r_associated | relid=0 | w=103
  2030. ipilimumab -- r_associated #0: 103 / 0.225 -> en:bcg solution
    n1=ipilimumab | n2=en:bcg solution | rel=r_associated | relid=0 | w=103
  2031. ipilimumab -- r_associated #0: 103 / 0.225 -> en:bcg vaccine
    n1=ipilimumab | n2=en:bcg vaccine | rel=r_associated | relid=0 | w=103
  2032. ipilimumab -- r_associated #0: 103 / 0.225 -> en:becatecarin
    n1=ipilimumab | n2=en:becatecarin | rel=r_associated | relid=0 | w=103
  2033. ipilimumab -- r_associated #0: 103 / 0.225 -> en:belimumab
    n1=ipilimumab | n2=en:belimumab | rel=r_associated | relid=0 | w=103
  2034. ipilimumab -- r_associated #0: 103 / 0.225 -> en:beloranib
    n1=ipilimumab | n2=en:beloranib | rel=r_associated | relid=0 | w=103
  2035. ipilimumab -- r_associated #0: 103 / 0.225 -> en:belotecan hydrochloride
    n1=ipilimumab | n2=en:belotecan hydrochloride | rel=r_associated | relid=0 | w=103
  2036. ipilimumab -- r_associated #0: 103 / 0.225 -> en:benegrastim
    n1=ipilimumab | n2=en:benegrastim | rel=r_associated | relid=0 | w=103
  2037. ipilimumab -- r_associated #0: 103 / 0.225 -> en:bet inhibitor gsk2820151
    n1=ipilimumab | n2=en:bet inhibitor gsk2820151 | rel=r_associated | relid=0 | w=103
  2038. ipilimumab -- r_associated #0: 103 / 0.225 -> en:bet inhibitor incb054329
    n1=ipilimumab | n2=en:bet inhibitor incb054329 | rel=r_associated | relid=0 | w=103
  2039. ipilimumab -- r_associated #0: 103 / 0.225 -> en:beta-carotene
    n1=ipilimumab | n2=en:beta-carotene | rel=r_associated | relid=0 | w=103
  2040. ipilimumab -- r_associated #0: 103 / 0.225 -> en:bexarotene
    n1=ipilimumab | n2=en:bexarotene | rel=r_associated | relid=0 | w=103
  2041. ipilimumab -- r_associated #0: 103 / 0.225 -> en:bi-functional alkylating agent val-083
    n1=ipilimumab | n2=en:bi-functional alkylating agent val-083 | rel=r_associated | relid=0 | w=103
  2042. ipilimumab -- r_associated #0: 103 / 0.225 -> en:bicalutamide
    n1=ipilimumab | n2=en:bicalutamide | rel=r_associated | relid=0 | w=103
  2043. ipilimumab -- r_associated #0: 103 / 0.225 -> en:bifunctional expression vector plasmid dna-bi-shrna ews/fli1 type 1 lipoplex
    n1=ipilimumab | n2=en:bifunctional expression vector plasmid dna-bi-shrna ews/fli1 type 1 lipoplex | rel=r_associated | relid=0 | w=103
  2044. ipilimumab -- r_associated #0: 103 / 0.225 -> en:biricodar dicitrate
    n1=ipilimumab | n2=en:biricodar dicitrate | rel=r_associated | relid=0 | w=103
  2045. ipilimumab -- r_associated #0: 103 / 0.225 -> en:birinapant
    n1=ipilimumab | n2=en:birinapant | rel=r_associated | relid=0 | w=103
  2046. ipilimumab -- r_associated #0: 103 / 0.225 -> en:black raspberry nectar
    n1=ipilimumab | n2=en:black raspberry nectar | rel=r_associated | relid=0 | w=103
  2047. ipilimumab -- r_associated #0: 103 / 0.225 -> en:blue citrus-based herbal capsule
    n1=ipilimumab | n2=en:blue citrus-based herbal capsule | rel=r_associated | relid=0 | w=103
  2048. ipilimumab -- r_associated #0: 103 / 0.225 -> en:bovine cartilage
    n1=ipilimumab | n2=en:bovine cartilage | rel=r_associated | relid=0 | w=103
  2049. ipilimumab -- r_associated #0: 103 / 0.225 -> en:brassica vegetable
    n1=ipilimumab | n2=en:brassica vegetable | rel=r_associated | relid=0 | w=103
  2050. ipilimumab -- r_associated #0: 103 / 0.225 -> en:breflate
    n1=ipilimumab | n2=en:breflate | rel=r_associated | relid=0 | w=103
  2051. ipilimumab -- r_associated #0: 103 / 0.225 -> en:brn01
    n1=ipilimumab | n2=en:brn01 | rel=r_associated | relid=0 | w=103
  2052. ipilimumab -- r_associated #0: 103 / 0.225 -> en:bromocriptine mesylate
    n1=ipilimumab | n2=en:bromocriptine mesylate | rel=r_associated | relid=0 | w=103
  2053. ipilimumab -- r_associated #0: 103 / 0.225 -> en:brostallicin
    n1=ipilimumab | n2=en:brostallicin | rel=r_associated | relid=0 | w=103
  2054. ipilimumab -- r_associated #0: 103 / 0.225 -> en:btk inhibitor bgb-3111
    n1=ipilimumab | n2=en:btk inhibitor bgb-3111 | rel=r_associated | relid=0 | w=103
  2055. ipilimumab -- r_associated #0: 103 / 0.225 -> en:bupivacaine hydrochloride
    n1=ipilimumab | n2=en:bupivacaine hydrochloride | rel=r_associated | relid=0 | w=103
  2056. ipilimumab -- r_associated #0: 103 / 0.225 -> en:buprenorphine transdermal matrix patch
    n1=ipilimumab | n2=en:buprenorphine transdermal matrix patch | rel=r_associated | relid=0 | w=103
  2057. ipilimumab -- r_associated #0: 103 / 0.225 -> en:burixafor
    n1=ipilimumab | n2=en:burixafor | rel=r_associated | relid=0 | w=103
  2058. ipilimumab -- r_associated #0: 103 / 0.225 -> en:butocin
    n1=ipilimumab | n2=en:butocin | rel=r_associated | relid=0 | w=103
  2059. ipilimumab -- r_associated #0: 103 / 0.225 -> en:c-met inhibitor mk2461
    n1=ipilimumab | n2=en:c-met inhibitor mk2461 | rel=r_associated | relid=0 | w=103
  2060. ipilimumab -- r_associated #0: 103 / 0.225 -> en:c-met inhibitor mk8033
    n1=ipilimumab | n2=en:c-met inhibitor mk8033 | rel=r_associated | relid=0 | w=103
  2061. ipilimumab -- r_associated #0: 103 / 0.225 -> en:cafusertib hydrochloride
    n1=ipilimumab | n2=en:cafusertib hydrochloride | rel=r_associated | relid=0 | w=103
  2062. ipilimumab -- r_associated #0: 103 / 0.225 -> en:calcium channel blocker
    n1=ipilimumab | n2=en:calcium channel blocker | rel=r_associated | relid=0 | w=103
  2063. ipilimumab -- r_associated #0: 103 / 0.225 -> en:calcium gluconate
    n1=ipilimumab | n2=en:calcium gluconate | rel=r_associated | relid=0 | w=103
  2064. ipilimumab -- r_associated #0: 103 / 0.225 -> en:calcium saccharate
    n1=ipilimumab | n2=en:calcium saccharate | rel=r_associated | relid=0 | w=103
  2065. ipilimumab -- r_associated #0: 103 / 0.225 -> en:canakinumab
    n1=ipilimumab | n2=en:canakinumab | rel=r_associated | relid=0 | w=103
  2066. ipilimumab -- r_associated #0: 103 / 0.225 -> en:carbogen
    n1=ipilimumab | n2=en:carbogen | rel=r_associated | relid=0 | w=103
  2067. ipilimumab -- r_associated #0: 103 / 0.225 -> en:carbon c 11 methylaminoisobutyrate
    n1=ipilimumab | n2=en:carbon c 11 methylaminoisobutyrate | rel=r_associated | relid=0 | w=103
  2068. ipilimumab -- r_associated #0: 103 / 0.225 -> en:carbon c-13 dextromethorphan
    n1=ipilimumab | n2=en:carbon c-13 dextromethorphan | rel=r_associated | relid=0 | w=103
  2069. ipilimumab -- r_associated #0: 103 / 0.225 -> en:carbon nanoparticle-based formulation
    n1=ipilimumab | n2=en:carbon nanoparticle-based formulation | rel=r_associated | relid=0 | w=103
  2070. ipilimumab -- r_associated #0: 103 / 0.225 -> en:carbutamide
    n1=ipilimumab | n2=en:carbutamide | rel=r_associated | relid=0 | w=103
  2071. ipilimumab -- r_associated #0: 103 / 0.225 -> en:carmustine in ethanol
    n1=ipilimumab | n2=en:carmustine in ethanol | rel=r_associated | relid=0 | w=103
  2072. ipilimumab -- r_associated #0: 103 / 0.225 -> en:carmustine sustained-release implant wafer
    n1=ipilimumab | n2=en:carmustine sustained-release implant wafer | rel=r_associated | relid=0 | w=103
  2073. ipilimumab -- r_associated #0: 103 / 0.225 -> en:carvedilol phosphate extended-release capsule
    n1=ipilimumab | n2=en:carvedilol phosphate extended-release capsule | rel=r_associated | relid=0 | w=103
  2074. ipilimumab -- r_associated #0: 103 / 0.225 -> en:cd133 antigen peptide-pulsed autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:cd133 antigen peptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=103
  2075. ipilimumab -- r_associated #0: 103 / 0.225 -> en:cd19car-cd28zeta-4-1bb-expressing allogeneic t lymphocytes
    n1=ipilimumab | n2=en:cd19car-cd28zeta-4-1bb-expressing allogeneic t lymphocytes | rel=r_associated | relid=0 | w=103
  2076. ipilimumab -- r_associated #0: 103 / 0.225 -> en:cd40 agonistic monoclonal antibody apx005m
    n1=ipilimumab | n2=en:cd40 agonistic monoclonal antibody apx005m | rel=r_associated | relid=0 | w=103
  2077. ipilimumab -- r_associated #0: 103 / 0.225 -> en:cd95 ecd/igg-fc fusion protein apg101
    n1=ipilimumab | n2=en:cd95 ecd/igg-fc fusion protein apg101 | rel=r_associated | relid=0 | w=103
  2078. ipilimumab -- r_associated #0: 103 / 0.225 -> en:cdk2/trka inhibitor pha-848125 ac
    n1=ipilimumab | n2=en:cdk2/trka inhibitor pha-848125 ac | rel=r_associated | relid=0 | w=103
  2079. ipilimumab -- r_associated #0: 103 / 0.225 -> en:cedefingol
    n1=ipilimumab | n2=en:cedefingol | rel=r_associated | relid=0 | w=103
  2080. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ceftazidime sodium
    n1=ipilimumab | n2=en:ceftazidime sodium | rel=r_associated | relid=0 | w=103
  2081. ipilimumab -- r_associated #0: 103 / 0.225 -> en:cenp-e inhibitor gsk-923295
    n1=ipilimumab | n2=en:cenp-e inhibitor gsk-923295 | rel=r_associated | relid=0 | w=103
  2082. ipilimumab -- r_associated #0: 103 / 0.225 -> en:cfms tyrosine kinase inhibitor arry-382
    n1=ipilimumab | n2=en:cfms tyrosine kinase inhibitor arry-382 | rel=r_associated | relid=0 | w=103
  2083. ipilimumab -- r_associated #0: 103 / 0.225 -> en:checkpoint kinase inhibitor azd7762
    n1=ipilimumab | n2=en:checkpoint kinase inhibitor azd7762 | rel=r_associated | relid=0 | w=103
  2084. ipilimumab -- r_associated #0: 103 / 0.225 -> en:checkpoint kinase inhibitor xl844
    n1=ipilimumab | n2=en:checkpoint kinase inhibitor xl844 | rel=r_associated | relid=0 | w=103
  2085. ipilimumab -- r_associated #0: 103 / 0.225 -> en:chining decoction
    n1=ipilimumab | n2=en:chining decoction | rel=r_associated | relid=0 | w=103
  2086. ipilimumab -- r_associated #0: 103 / 0.225 -> en:chk1 inhibitor pf-477736
    n1=ipilimumab | n2=en:chk1 inhibitor pf-477736 | rel=r_associated | relid=0 | w=103
  2087. ipilimumab -- r_associated #0: 103 / 0.225 -> en:chlorpromazine
    n1=ipilimumab | n2=en:chlorpromazine | rel=r_associated | relid=0 | w=103
  2088. ipilimumab -- r_associated #0: 103 / 0.225 -> en:cholecalciferol
    n1=ipilimumab | n2=en:cholecalciferol | rel=r_associated | relid=0 | w=103
  2089. ipilimumab -- r_associated #0: 103 / 0.225 -> en:citicoline
    n1=ipilimumab | n2=en:citicoline | rel=r_associated | relid=0 | w=103
  2090. ipilimumab -- r_associated #0: 103 / 0.225 -> en:cixutumumab
    n1=ipilimumab | n2=en:cixutumumab | rel=r_associated | relid=0 | w=103
  2091. ipilimumab -- r_associated #0: 103 / 0.225 -> en:clarithromycin
    n1=ipilimumab | n2=en:clarithromycin | rel=r_associated | relid=0 | w=103
  2092. ipilimumab -- r_associated #0: 103 / 0.225 -> en:clevidipine
    n1=ipilimumab | n2=en:clevidipine | rel=r_associated | relid=0 | w=103
  2093. ipilimumab -- r_associated #0: 103 / 0.225 -> en:codeine phosphate
    n1=ipilimumab | n2=en:codeine phosphate | rel=r_associated | relid=0 | w=103
  2094. ipilimumab -- r_associated #0: 103 / 0.225 -> en:colloidal gold-bound tumor necrosis factor
    n1=ipilimumab | n2=en:colloidal gold-bound tumor necrosis factor | rel=r_associated | relid=0 | w=103
  2095. ipilimumab -- r_associated #0: 103 / 0.225 -> en:copanlisib
    n1=ipilimumab | n2=en:copanlisib | rel=r_associated | relid=0 | w=103
  2096. ipilimumab -- r_associated #0: 103 / 0.225 -> en:cord blood-derived expanded natural killer cell infusion pnk-007
    n1=ipilimumab | n2=en:cord blood-derived expanded natural killer cell infusion pnk-007 | rel=r_associated | relid=0 | w=103
  2097. ipilimumab -- r_associated #0: 103 / 0.225 -> en:cp-609,754
    n1=ipilimumab | n2=en:cp-609,754 | rel=r_associated | relid=0 | w=103
  2098. ipilimumab -- r_associated #0: 103 / 0.225 -> en:cp-724,714
    n1=ipilimumab | n2=en:cp-724,714 | rel=r_associated | relid=0 | w=103
  2099. ipilimumab -- r_associated #0: 103 / 0.225 -> en:cpg-28 oligodeoxynucleotide
    n1=ipilimumab | n2=en:cpg-28 oligodeoxynucleotide | rel=r_associated | relid=0 | w=103
  2100. ipilimumab -- r_associated #0: 103 / 0.225 -> en:creatine monohydrate
    n1=ipilimumab | n2=en:creatine monohydrate | rel=r_associated | relid=0 | w=103
  2101. ipilimumab -- r_associated #0: 103 / 0.225 -> en:crenolanib besylate
    n1=ipilimumab | n2=en:crenolanib besylate | rel=r_associated | relid=0 | w=103
  2102. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ct2584 hms
    n1=ipilimumab | n2=en:ct2584 hms | rel=r_associated | relid=0 | w=103
  2103. ipilimumab -- r_associated #0: 103 / 0.225 -> en:cyl-02 plasmid dna
    n1=ipilimumab | n2=en:cyl-02 plasmid dna | rel=r_associated | relid=0 | w=103
  2104. ipilimumab -- r_associated #0: 103 / 0.225 -> en:cytochlor
    n1=ipilimumab | n2=en:cytochlor | rel=r_associated | relid=0 | w=103
  2105. ipilimumab -- r_associated #0: 103 / 0.225 -> en:cytokine agent
    n1=ipilimumab | n2=en:cytokine agent | rel=r_associated | relid=0 | w=103
  2106. ipilimumab -- r_associated #0: 103 / 0.225 -> en:dactinomycin
    n1=ipilimumab | n2=en:dactinomycin | rel=r_associated | relid=0 | w=103
  2107. ipilimumab -- r_associated #0: 103 / 0.225 -> en:dalantercept
    n1=ipilimumab | n2=en:dalantercept | rel=r_associated | relid=0 | w=103
  2108. ipilimumab -- r_associated #0: 103 / 0.225 -> en:danazol
    n1=ipilimumab | n2=en:danazol | rel=r_associated | relid=0 | w=103
  2109. ipilimumab -- r_associated #0: 103 / 0.225 -> en:daporinad
    n1=ipilimumab | n2=en:daporinad | rel=r_associated | relid=0 | w=103
  2110. ipilimumab -- r_associated #0: 103 / 0.225 -> en:daptomycin
    n1=ipilimumab | n2=en:daptomycin | rel=r_associated | relid=0 | w=103
  2111. ipilimumab -- r_associated #0: 103 / 0.225 -> en:dbve-pc regimen
    n1=ipilimumab | n2=en:dbve-pc regimen | rel=r_associated | relid=0 | w=103
  2112. ipilimumab -- r_associated #0: 103 / 0.225 -> en:dcds0780a
    n1=ipilimumab | n2=en:dcds0780a | rel=r_associated | relid=0 | w=103
  2113. ipilimumab -- r_associated #0: 103 / 0.225 -> en:dcr ligand-bearing liposome-encapsulated melanoma antigens vaccine
    n1=ipilimumab | n2=en:dcr ligand-bearing liposome-encapsulated melanoma antigens vaccine | rel=r_associated | relid=0 | w=103
  2114. ipilimumab -- r_associated #0: 103 / 0.225 -> en:delanzomib
    n1=ipilimumab | n2=en:delanzomib | rel=r_associated | relid=0 | w=103
  2115. ipilimumab -- r_associated #0: 103 / 0.225 -> en:demcizumab
    n1=ipilimumab | n2=en:demcizumab | rel=r_associated | relid=0 | w=103
  2116. ipilimumab -- r_associated #0: 103 / 0.225 -> en:dextran
    n1=ipilimumab | n2=en:dextran | rel=r_associated | relid=0 | w=103
  2117. ipilimumab -- r_associated #0: 103 / 0.225 -> en:dher2 vaccine+as15 adjuvant
    n1=ipilimumab | n2=en:dher2 vaccine+as15 adjuvant | rel=r_associated | relid=0 | w=103
  2118. ipilimumab -- r_associated #0: 103 / 0.225 -> en:dianhydrogalactitol
    n1=ipilimumab | n2=en:dianhydrogalactitol | rel=r_associated | relid=0 | w=103
  2119. ipilimumab -- r_associated #0: 103 / 0.225 -> en:diaziquone
    n1=ipilimumab | n2=en:diaziquone | rel=r_associated | relid=0 | w=103
  2120. ipilimumab -- r_associated #0: 103 / 0.225 -> en:diclofenac epolamine patch
    n1=ipilimumab | n2=en:diclofenac epolamine patch | rel=r_associated | relid=0 | w=103
  2121. ipilimumab -- r_associated #0: 103 / 0.225 -> en:dihydro-5-azacytidine
    n1=ipilimumab | n2=en:dihydro-5-azacytidine | rel=r_associated | relid=0 | w=103
  2122. ipilimumab -- r_associated #0: 103 / 0.225 -> en:dimethyl fumarate
    n1=ipilimumab | n2=en:dimethyl fumarate | rel=r_associated | relid=0 | w=103
  2123. ipilimumab -- r_associated #0: 103 / 0.225 -> en:dinutuximab
    n1=ipilimumab | n2=en:dinutuximab | rel=r_associated | relid=0 | w=103
  2124. ipilimumab -- r_associated #0: 103 / 0.225 -> en:disulfiram
    n1=ipilimumab | n2=en:disulfiram | rel=r_associated | relid=0 | w=103
  2125. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ditiocarb
    n1=ipilimumab | n2=en:ditiocarb | rel=r_associated | relid=0 | w=103
  2126. ipilimumab -- r_associated #0: 103 / 0.225 -> en:dna minor groove binding agent sg2000
    n1=ipilimumab | n2=en:dna minor groove binding agent sg2000 | rel=r_associated | relid=0 | w=103
  2127. ipilimumab -- r_associated #0: 103 / 0.225 -> en:dna vaccine vb10.16
    n1=ipilimumab | n2=en:dna vaccine vb10.16 | rel=r_associated | relid=0 | w=103
  2128. ipilimumab -- r_associated #0: 103 / 0.225 -> en:dna vector ppra-psm vaccine
    n1=ipilimumab | n2=en:dna vector ppra-psm vaccine | rel=r_associated | relid=0 | w=103
  2129. ipilimumab -- r_associated #0: 103 / 0.225 -> en:docetaxel emulsion anx-514
    n1=ipilimumab | n2=en:docetaxel emulsion anx-514 | rel=r_associated | relid=0 | w=103
  2130. ipilimumab -- r_associated #0: 103 / 0.225 -> en:dolasetron mesylate
    n1=ipilimumab | n2=en:dolasetron mesylate | rel=r_associated | relid=0 | w=103
  2131. ipilimumab -- r_associated #0: 103 / 0.225 -> en:dornase alfa inhalation solution
    n1=ipilimumab | n2=en:dornase alfa inhalation solution | rel=r_associated | relid=0 | w=103
  2132. ipilimumab -- r_associated #0: 103 / 0.225 -> en:dovitinib lactate
    n1=ipilimumab | n2=en:dovitinib lactate | rel=r_associated | relid=0 | w=103
  2133. ipilimumab -- r_associated #0: 103 / 0.225 -> en:doxorubicin hydrochloride
    n1=ipilimumab | n2=en:doxorubicin hydrochloride | rel=r_associated | relid=0 | w=103
  2134. ipilimumab -- r_associated #0: 103 / 0.225 -> en:drug products by generic ingredient combinations
    n1=ipilimumab | n2=en:drug products by generic ingredient combinations | rel=r_associated | relid=0 | w=103
  2135. ipilimumab -- r_associated #0: 103 / 0.225 -> en:drug values
    n1=ipilimumab | n2=en:drug values | rel=r_associated | relid=0 | w=103
  2136. ipilimumab -- r_associated #0: 103 / 0.225 -> en:dta-h19 plasmid
    n1=ipilimumab | n2=en:dta-h19 plasmid | rel=r_associated | relid=0 | w=103
  2137. ipilimumab -- r_associated #0: 103 / 0.225 -> en:duloxetine hydrochloride
    n1=ipilimumab | n2=en:duloxetine hydrochloride | rel=r_associated | relid=0 | w=103
  2138. ipilimumab -- r_associated #0: 103 / 0.225 -> en:dutasteride
    n1=ipilimumab | n2=en:dutasteride | rel=r_associated | relid=0 | w=103
  2139. ipilimumab -- r_associated #0: 103 / 0.225 -> en:e1a lipid complex
    n1=ipilimumab | n2=en:e1a lipid complex | rel=r_associated | relid=0 | w=103
  2140. ipilimumab -- r_associated #0: 103 / 0.225 -> en:e7046
    n1=ipilimumab | n2=en:e7046 | rel=r_associated | relid=0 | w=103
  2141. ipilimumab -- r_associated #0: 103 / 0.225 -> en:e7820
    n1=ipilimumab | n2=en:e7820 | rel=r_associated | relid=0 | w=103
  2142. ipilimumab -- r_associated #0: 103 / 0.225 -> en:egfr inhibitor azd3759
    n1=ipilimumab | n2=en:egfr inhibitor azd3759 | rel=r_associated | relid=0 | w=103
  2143. ipilimumab -- r_associated #0: 103 / 0.225 -> en:egfr inhibitor hm61713
    n1=ipilimumab | n2=en:egfr inhibitor hm61713 | rel=r_associated | relid=0 | w=103
  2144. ipilimumab -- r_associated #0: 103 / 0.225 -> en:electrokinetically modified water
    n1=ipilimumab | n2=en:electrokinetically modified water | rel=r_associated | relid=0 | w=103
  2145. ipilimumab -- r_associated #0: 103 / 0.225 -> en:elliptinium acetate
    n1=ipilimumab | n2=en:elliptinium acetate | rel=r_associated | relid=0 | w=103
  2146. ipilimumab -- r_associated #0: 103 / 0.225 -> en:emactuzumab
    n1=ipilimumab | n2=en:emactuzumab | rel=r_associated | relid=0 | w=103
  2147. ipilimumab -- r_associated #0: 103 / 0.225 -> en:enalapril maleate
    n1=ipilimumab | n2=en:enalapril maleate | rel=r_associated | relid=0 | w=103
  2148. ipilimumab -- r_associated #0: 103 / 0.225 -> en:entospletinib
    n1=ipilimumab | n2=en:entospletinib | rel=r_associated | relid=0 | w=103
  2149. ipilimumab -- r_associated #0: 103 / 0.225 -> en:enzastaurin hydrochloride
    n1=ipilimumab | n2=en:enzastaurin hydrochloride | rel=r_associated | relid=0 | w=103
  2150. ipilimumab -- r_associated #0: 103 / 0.225 -> en:enzyme agent
    n1=ipilimumab | n2=en:enzyme agent | rel=r_associated | relid=0 | w=103
  2151. ipilimumab -- r_associated #0: 103 / 0.225 -> en:epigallocatechin gallate
    n1=ipilimumab | n2=en:epigallocatechin gallate | rel=r_associated | relid=0 | w=103
  2152. ipilimumab -- r_associated #0: 103 / 0.225 -> en:epoch regimen
    n1=ipilimumab | n2=en:epoch regimen | rel=r_associated | relid=0 | w=103
  2153. ipilimumab -- r_associated #0: 103 / 0.225 -> en:epothilone analog utd1
    n1=ipilimumab | n2=en:epothilone analog utd1 | rel=r_associated | relid=0 | w=103
  2154. ipilimumab -- r_associated #0: 103 / 0.225 -> en:eritoran tetrasodium
    n1=ipilimumab | n2=en:eritoran tetrasodium | rel=r_associated | relid=0 | w=103
  2155. ipilimumab -- r_associated #0: 103 / 0.225 -> en:erk inhibitor mk-8353
    n1=ipilimumab | n2=en:erk inhibitor mk-8353 | rel=r_associated | relid=0 | w=103
  2156. ipilimumab -- r_associated #0: 103 / 0.225 -> en:escherichia coli monoclonal antibody
    n1=ipilimumab | n2=en:escherichia coli monoclonal antibody | rel=r_associated | relid=0 | w=103
  2157. ipilimumab -- r_associated #0: 103 / 0.225 -> en:eslicarbazepine
    n1=ipilimumab | n2=en:eslicarbazepine | rel=r_associated | relid=0 | w=103
  2158. ipilimumab -- r_associated #0: 103 / 0.225 -> en:esomeprazole magnesium
    n1=ipilimumab | n2=en:esomeprazole magnesium | rel=r_associated | relid=0 | w=103
  2159. ipilimumab -- r_associated #0: 103 / 0.225 -> en:estrogens, conjugated
    n1=ipilimumab | n2=en:estrogens, conjugated | rel=r_associated | relid=0 | w=103
  2160. ipilimumab -- r_associated #0: 103 / 0.225 -> en:etanercept
    n1=ipilimumab | n2=en:etanercept | rel=r_associated | relid=0 | w=103
  2161. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ethinyl estradiol/levonorgestrel
    n1=ipilimumab | n2=en:ethinyl estradiol/levonorgestrel | rel=r_associated | relid=0 | w=103
  2162. ipilimumab -- r_associated #0: 103 / 0.225 -> en:etoricoxib
    n1=ipilimumab | n2=en:etoricoxib | rel=r_associated | relid=0 | w=103
  2163. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ezatiostat hydrochloride
    n1=ipilimumab | n2=en:ezatiostat hydrochloride | rel=r_associated | relid=0 | w=103
  2164. ipilimumab -- r_associated #0: 103 / 0.225 -> en:f-18 fluoroethyltyrosine
    n1=ipilimumab | n2=en:f-18 fluoroethyltyrosine | rel=r_associated | relid=0 | w=103
  2165. ipilimumab -- r_associated #0: 103 / 0.225 -> en:fak inhibitor gsk2256098
    n1=ipilimumab | n2=en:fak inhibitor gsk2256098 | rel=r_associated | relid=0 | w=103
  2166. ipilimumab -- r_associated #0: 103 / 0.225 -> en:fak inhibitor pf-00562271
    n1=ipilimumab | n2=en:fak inhibitor pf-00562271 | rel=r_associated | relid=0 | w=103
  2167. ipilimumab -- r_associated #0: 103 / 0.225 -> en:fentanyl matrix transdermal patch
    n1=ipilimumab | n2=en:fentanyl matrix transdermal patch | rel=r_associated | relid=0 | w=103
  2168. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ferric carboxymaltose solution
    n1=ipilimumab | n2=en:ferric carboxymaltose solution | rel=r_associated | relid=0 | w=103
  2169. ipilimumab -- r_associated #0: 103 / 0.225 -> en:fgf/fgfr pathway inhibitor e7090
    n1=ipilimumab | n2=en:fgf/fgfr pathway inhibitor e7090 | rel=r_associated | relid=0 | w=103
  2170. ipilimumab -- r_associated #0: 103 / 0.225 -> en:fluciclatide f-18
    n1=ipilimumab | n2=en:fluciclatide f-18 | rel=r_associated | relid=0 | w=103
  2171. ipilimumab -- r_associated #0: 103 / 0.225 -> en:fluorine f 18 bay 85-8050
    n1=ipilimumab | n2=en:fluorine f 18 bay 85-8050 | rel=r_associated | relid=0 | w=103
  2172. ipilimumab -- r_associated #0: 103 / 0.225 -> en:fluorine f 18 choline
    n1=ipilimumab | n2=en:fluorine f 18 choline | rel=r_associated | relid=0 | w=103
  2173. ipilimumab -- r_associated #0: 103 / 0.225 -> en:fluorine f 18 ef5
    n1=ipilimumab | n2=en:fluorine f 18 ef5 | rel=r_associated | relid=0 | w=103
  2174. ipilimumab -- r_associated #0: 103 / 0.225 -> en:fluorine f 18 fdht
    n1=ipilimumab | n2=en:fluorine f 18 fdht | rel=r_associated | relid=0 | w=103
  2175. ipilimumab -- r_associated #0: 103 / 0.225 -> en:fluorine f 18 feqa
    n1=ipilimumab | n2=en:fluorine f 18 feqa | rel=r_associated | relid=0 | w=103
  2176. ipilimumab -- r_associated #0: 103 / 0.225 -> en:fluorine f 18 fp-r01-mg-f2
    n1=ipilimumab | n2=en:fluorine f 18 fp-r01-mg-f2 | rel=r_associated | relid=0 | w=103
  2177. ipilimumab -- r_associated #0: 103 / 0.225 -> en:fluorouracil
    n1=ipilimumab | n2=en:fluorouracil | rel=r_associated | relid=0 | w=103
  2178. ipilimumab -- r_associated #0: 103 / 0.225 -> en:fluzoparib
    n1=ipilimumab | n2=en:fluzoparib | rel=r_associated | relid=0 | w=103
  2179. ipilimumab -- r_associated #0: 103 / 0.225 -> en:fms inhibitor jnj-40346527
    n1=ipilimumab | n2=en:fms inhibitor jnj-40346527 | rel=r_associated | relid=0 | w=103
  2180. ipilimumab -- r_associated #0: 103 / 0.225 -> en:folate receptor-targeted technetium tc-99m ec20
    n1=ipilimumab | n2=en:folate receptor-targeted technetium tc-99m ec20 | rel=r_associated | relid=0 | w=103
  2181. ipilimumab -- r_associated #0: 103 / 0.225 -> en:folate-fitc
    n1=ipilimumab | n2=en:folate-fitc | rel=r_associated | relid=0 | w=103
  2182. ipilimumab -- r_associated #0: 103 / 0.225 -> en:folfirinox regimen
    n1=ipilimumab | n2=en:folfirinox regimen | rel=r_associated | relid=0 | w=103
  2183. ipilimumab -- r_associated #0: 103 / 0.225 -> en:foretinib
    n1=ipilimumab | n2=en:foretinib | rel=r_associated | relid=0 | w=103
  2184. ipilimumab -- r_associated #0: 103 / 0.225 -> en:foscarnet sodium
    n1=ipilimumab | n2=en:foscarnet sodium | rel=r_associated | relid=0 | w=103
  2185. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ft-2102
    n1=ipilimumab | n2=en:ft-2102 | rel=r_associated | relid=0 | w=103
  2186. ipilimumab -- r_associated #0: 103 / 0.225 -> en:fulranumab
    n1=ipilimumab | n2=en:fulranumab | rel=r_associated | relid=0 | w=103
  2187. ipilimumab -- r_associated #0: 103 / 0.225 -> en:fulvestrant
    n1=ipilimumab | n2=en:fulvestrant | rel=r_associated | relid=0 | w=103
  2188. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ga-68-labeled f(ab') 2- trastuzumab
    n1=ipilimumab | n2=en:ga-68-labeled f(ab') 2- trastuzumab | rel=r_associated | relid=0 | w=103
  2189. ipilimumab -- r_associated #0: 103 / 0.225 -> en:galactose
    n1=ipilimumab | n2=en:galactose | rel=r_associated | relid=0 | w=103
  2190. ipilimumab -- r_associated #0: 103 / 0.225 -> en:galectin-1 inhibitor otx008
    n1=ipilimumab | n2=en:galectin-1 inhibitor otx008 | rel=r_associated | relid=0 | w=103
  2191. ipilimumab -- r_associated #0: 103 / 0.225 -> en:gallium citrate ga-67
    n1=ipilimumab | n2=en:gallium citrate ga-67 | rel=r_associated | relid=0 | w=103
  2192. ipilimumab -- r_associated #0: 103 / 0.225 -> en:gallium ga 68 dota-jr11
    n1=ipilimumab | n2=en:gallium ga 68 dota-jr11 | rel=r_associated | relid=0 | w=103
  2193. ipilimumab -- r_associated #0: 103 / 0.225 -> en:gallium ga 68-labeled bnota-prgd2
    n1=ipilimumab | n2=en:gallium ga 68-labeled bnota-prgd2 | rel=r_associated | relid=0 | w=103
  2194. ipilimumab -- r_associated #0: 103 / 0.225 -> en:gallium ga 68-neb
    n1=ipilimumab | n2=en:gallium ga 68-neb | rel=r_associated | relid=0 | w=103
  2195. ipilimumab -- r_associated #0: 103 / 0.225 -> en:gallium ga 68-nota-aca-bbn(7-14)
    n1=ipilimumab | n2=en:gallium ga 68-nota-aca-bbn(7-14) | rel=r_associated | relid=0 | w=103
  2196. ipilimumab -- r_associated #0: 103 / 0.225 -> en:gallium ga 68-nota-nfb
    n1=ipilimumab | n2=en:gallium ga 68-nota-nfb | rel=r_associated | relid=0 | w=103
  2197. ipilimumab -- r_associated #0: 103 / 0.225 -> en:gallium maltolate
    n1=ipilimumab | n2=en:gallium maltolate | rel=r_associated | relid=0 | w=103
  2198. ipilimumab -- r_associated #0: 103 / 0.225 -> en:gamboge resin extract tsb-9-w1
    n1=ipilimumab | n2=en:gamboge resin extract tsb-9-w1 | rel=r_associated | relid=0 | w=103
  2199. ipilimumab -- r_associated #0: 103 / 0.225 -> en:gamma secretase inhibitor pf-03084014
    n1=ipilimumab | n2=en:gamma secretase inhibitor pf-03084014 | rel=r_associated | relid=0 | w=103
  2200. ipilimumab -- r_associated #0: 103 / 0.225 -> en:gamma-secretase inhibitor ro4929097
    n1=ipilimumab | n2=en:gamma-secretase inhibitor ro4929097 | rel=r_associated | relid=0 | w=103
  2201. ipilimumab -- r_associated #0: 103 / 0.225 -> en:gemcitabine
    n1=ipilimumab | n2=en:gemcitabine | rel=r_associated | relid=0 | w=103
  2202. ipilimumab -- r_associated #0: 103 / 0.225 -> en:gemcitabine hydrochloride
    n1=ipilimumab | n2=en:gemcitabine hydrochloride | rel=r_associated | relid=0 | w=103
  2203. ipilimumab -- r_associated #0: 103 / 0.225 -> en:gemtuzumab ozogamicin
    n1=ipilimumab | n2=en:gemtuzumab ozogamicin | rel=r_associated | relid=0 | w=103
  2204. ipilimumab -- r_associated #0: 103 / 0.225 -> en:gitr agonist medi1873
    n1=ipilimumab | n2=en:gitr agonist medi1873 | rel=r_associated | relid=0 | w=103
  2205. ipilimumab -- r_associated #0: 103 / 0.225 -> en:glibornuride
    n1=ipilimumab | n2=en:glibornuride | rel=r_associated | relid=0 | w=103
  2206. ipilimumab -- r_associated #0: 103 / 0.225 -> en:glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=103
  2207. ipilimumab -- r_associated #0: 103 / 0.225 -> en:gliquidone
    n1=ipilimumab | n2=en:gliquidone | rel=r_associated | relid=0 | w=103
  2208. ipilimumab -- r_associated #0: 103 / 0.225 -> en:globo h-klh immunostimulant opt-822
    n1=ipilimumab | n2=en:globo h-klh immunostimulant opt-822 | rel=r_associated | relid=0 | w=103
  2209. ipilimumab -- r_associated #0: 103 / 0.225 -> en:glucarpidase
    n1=ipilimumab | n2=en:glucarpidase | rel=r_associated | relid=0 | w=103
  2210. ipilimumab -- r_associated #0: 103 / 0.225 -> en:glutathione
    n1=ipilimumab | n2=en:glutathione | rel=r_associated | relid=0 | w=103
  2211. ipilimumab -- r_associated #0: 103 / 0.225 -> en:gluten-free dha/epa/gla/antioxidant-rich nutritional liquid
    n1=ipilimumab | n2=en:gluten-free dha/epa/gla/antioxidant-rich nutritional liquid | rel=r_associated | relid=0 | w=103
  2212. ipilimumab -- r_associated #0: 103 / 0.225 -> en:gnrh antagonist tak-385
    n1=ipilimumab | n2=en:gnrh antagonist tak-385 | rel=r_associated | relid=0 | w=103
  2213. ipilimumab -- r_associated #0: 103 / 0.225 -> en:gossypol
    n1=ipilimumab | n2=en:gossypol | rel=r_associated | relid=0 | w=103
  2214. ipilimumab -- r_associated #0: 103 / 0.225 -> en:gp100:209-217(210m) peptide vaccine
    n1=ipilimumab | n2=en:gp100:209-217(210m) peptide vaccine | rel=r_associated | relid=0 | w=103
  2215. ipilimumab -- r_associated #0: 103 / 0.225 -> en:gp2013
    n1=ipilimumab | n2=en:gp2013 | rel=r_associated | relid=0 | w=103
  2216. ipilimumab -- r_associated #0: 103 / 0.225 -> en:gp96-secreting allogeneic bladder cancer cell vaccine hs-410
    n1=ipilimumab | n2=en:gp96-secreting allogeneic bladder cancer cell vaccine hs-410 | rel=r_associated | relid=0 | w=103
  2217. ipilimumab -- r_associated #0: 103 / 0.225 -> en:green tea lozenge
    n1=ipilimumab | n2=en:green tea lozenge | rel=r_associated | relid=0 | w=103
  2218. ipilimumab -- r_associated #0: 103 / 0.225 -> en:gs/pan-notch inhibitor bms-906024
    n1=ipilimumab | n2=en:gs/pan-notch inhibitor bms-906024 | rel=r_associated | relid=0 | w=103
  2219. ipilimumab -- r_associated #0: 103 / 0.225 -> en:hdm2 inhibitor hdm201
    n1=ipilimumab | n2=en:hdm2 inhibitor hdm201 | rel=r_associated | relid=0 | w=103
  2220. ipilimumab -- r_associated #0: 103 / 0.225 -> en:hdm2 inhibitor mk-8242
    n1=ipilimumab | n2=en:hdm2 inhibitor mk-8242 | rel=r_associated | relid=0 | w=103
  2221. ipilimumab -- r_associated #0: 103 / 0.225 -> en:hemorrhoid preparation
    n1=ipilimumab | n2=en:hemorrhoid preparation | rel=r_associated | relid=0 | w=103
  2222. ipilimumab -- r_associated #0: 103 / 0.225 -> en:her-2-positive b-cell peptide antigen p467-dt-crm197/montanide vaccine imu-131
    n1=ipilimumab | n2=en:her-2-positive b-cell peptide antigen p467-dt-crm197/montanide vaccine imu-131 | rel=r_associated | relid=0 | w=103
  2223. ipilimumab -- r_associated #0: 103 / 0.225 -> en:hexaminolevulinate hydrochloride
    n1=ipilimumab | n2=en:hexaminolevulinate hydrochloride | rel=r_associated | relid=0 | w=103
  2224. ipilimumab -- r_associated #0: 103 / 0.225 -> en:hla-a*0201-restricted urlc10-vegfr1-vegfr2 multipeptide vaccine
    n1=ipilimumab | n2=en:hla-a*0201-restricted urlc10-vegfr1-vegfr2 multipeptide vaccine | rel=r_associated | relid=0 | w=103
  2225. ipilimumab -- r_associated #0: 103 / 0.225 -> en:hla-a*2402-restricted cdca1-a24-56 peptide vaccine
    n1=ipilimumab | n2=en:hla-a*2402-restricted cdca1-a24-56 peptide vaccine | rel=r_associated | relid=0 | w=103
  2226. ipilimumab -- r_associated #0: 103 / 0.225 -> en:hla-a*2402-restricted urlc10 peptides vaccine
    n1=ipilimumab | n2=en:hla-a*2402-restricted urlc10 peptides vaccine | rel=r_associated | relid=0 | w=103
  2227. ipilimumab -- r_associated #0: 103 / 0.225 -> en:hla-a*2402-restricted urlc10-koc1-vegfr1-vegfr2 multipeptide vaccine
    n1=ipilimumab | n2=en:hla-a*2402-restricted urlc10-koc1-vegfr1-vegfr2 multipeptide vaccine | rel=r_associated | relid=0 | w=103
  2228. ipilimumab -- r_associated #0: 103 / 0.225 -> en:hla-a*2402-restricted urlc10-ttk-koc1 multipeptide vaccine
    n1=ipilimumab | n2=en:hla-a*2402-restricted urlc10-ttk-koc1 multipeptide vaccine | rel=r_associated | relid=0 | w=103
  2229. ipilimumab -- r_associated #0: 103 / 0.225 -> en:honey
    n1=ipilimumab | n2=en:honey | rel=r_associated | relid=0 | w=103
  2230. ipilimumab -- r_associated #0: 103 / 0.225 -> en:hpv e6/e7 dna vaccine gx-188e
    n1=ipilimumab | n2=en:hpv e6/e7 dna vaccine gx-188e | rel=r_associated | relid=0 | w=103
  2231. ipilimumab -- r_associated #0: 103 / 0.225 -> en:hsp70-peptide tkd/il-2-activated autologous natural killer cells
    n1=ipilimumab | n2=en:hsp70-peptide tkd/il-2-activated autologous natural killer cells | rel=r_associated | relid=0 | w=103
  2232. ipilimumab -- r_associated #0: 103 / 0.225 -> en:hsp90 inhibitor debio 0932
    n1=ipilimumab | n2=en:hsp90 inhibitor debio 0932 | rel=r_associated | relid=0 | w=103
  2233. ipilimumab -- r_associated #0: 103 / 0.225 -> en:human prostate-specific membrane antigen plasmid dna vaccine
    n1=ipilimumab | n2=en:human prostate-specific membrane antigen plasmid dna vaccine | rel=r_associated | relid=0 | w=103
  2234. ipilimumab -- r_associated #0: 103 / 0.225 -> en:human varicella zoster immune globulin
    n1=ipilimumab | n2=en:human varicella zoster immune globulin | rel=r_associated | relid=0 | w=103
  2235. ipilimumab -- r_associated #0: 103 / 0.225 -> en:hyaluronic acid-based hydrating vaginal gel
    n1=ipilimumab | n2=en:hyaluronic acid-based hydrating vaginal gel | rel=r_associated | relid=0 | w=103
  2236. ipilimumab -- r_associated #0: 103 / 0.225 -> en:hyperimmune bovine colostrum
    n1=ipilimumab | n2=en:hyperimmune bovine colostrum | rel=r_associated | relid=0 | w=103
  2237. ipilimumab -- r_associated #0: 103 / 0.225 -> en:hypoxia-activated prodrug th-302
    n1=ipilimumab | n2=en:hypoxia-activated prodrug th-302 | rel=r_associated | relid=0 | w=103
  2238. ipilimumab -- r_associated #0: 103 / 0.225 -> en:i 123 monoclonal antibody 81c6
    n1=ipilimumab | n2=en:i 123 monoclonal antibody 81c6 | rel=r_associated | relid=0 | w=103
  2239. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ibuprofen
    n1=ipilimumab | n2=en:ibuprofen | rel=r_associated | relid=0 | w=103
  2240. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ibuprofen injection
    n1=ipilimumab | n2=en:ibuprofen injection | rel=r_associated | relid=0 | w=103
  2241. ipilimumab -- r_associated #0: 103 / 0.225 -> en:icrucumab
    n1=ipilimumab | n2=en:icrucumab | rel=r_associated | relid=0 | w=103
  2242. ipilimumab -- r_associated #0: 103 / 0.225 -> en:il-10 immunomodulator mk-1966
    n1=ipilimumab | n2=en:il-10 immunomodulator mk-1966 | rel=r_associated | relid=0 | w=103
  2243. ipilimumab -- r_associated #0: 103 / 0.225 -> en:il4-pseudomonas exotoxin fusion protein prx321
    n1=ipilimumab | n2=en:il4-pseudomonas exotoxin fusion protein prx321 | rel=r_associated | relid=0 | w=103
  2244. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ilaprazole
    n1=ipilimumab | n2=en:ilaprazole | rel=r_associated | relid=0 | w=103
  2245. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ilx-295501
    n1=ipilimumab | n2=en:ilx-295501 | rel=r_associated | relid=0 | w=103
  2246. ipilimumab -- r_associated #0: 103 / 0.225 -> en:immunomodulators
    n1=ipilimumab | n2=en:immunomodulators | rel=r_associated | relid=0 | w=103
  2247. ipilimumab -- r_associated #0: 103 / 0.225 -> en:immunomodulatory agent cc-11006
    n1=ipilimumab | n2=en:immunomodulatory agent cc-11006 | rel=r_associated | relid=0 | w=103
  2248. ipilimumab -- r_associated #0: 103 / 0.225 -> en:immunotherapeutic agent
    n1=ipilimumab | n2=en:immunotherapeutic agent | rel=r_associated | relid=0 | w=103
  2249. ipilimumab -- r_associated #0: 103 / 0.225 -> en:in 111 monoclonal antibody mn-14
    n1=ipilimumab | n2=en:in 111 monoclonal antibody mn-14 | rel=r_associated | relid=0 | w=103
  2250. ipilimumab -- r_associated #0: 103 / 0.225 -> en:indibulin
    n1=ipilimumab | n2=en:indibulin | rel=r_associated | relid=0 | w=103
  2251. ipilimumab -- r_associated #0: 103 / 0.225 -> en:indinavir
    n1=ipilimumab | n2=en:indinavir | rel=r_associated | relid=0 | w=103
  2252. ipilimumab -- r_associated #0: 103 / 0.225 -> en:indium in 111 bevacizumab
    n1=ipilimumab | n2=en:indium in 111 bevacizumab | rel=r_associated | relid=0 | w=103
  2253. ipilimumab -- r_associated #0: 103 / 0.225 -> en:indium in 111 girentuximab
    n1=ipilimumab | n2=en:indium in 111 girentuximab | rel=r_associated | relid=0 | w=103
  2254. ipilimumab -- r_associated #0: 103 / 0.225 -> en:indium in 111-dota-biotin
    n1=ipilimumab | n2=en:indium in 111-dota-biotin | rel=r_associated | relid=0 | w=103
  2255. ipilimumab -- r_associated #0: 103 / 0.225 -> en:indium in-111 ibritumomab tiuxetan
    n1=ipilimumab | n2=en:indium in-111 ibritumomab tiuxetan | rel=r_associated | relid=0 | w=103
  2256. ipilimumab -- r_associated #0: 103 / 0.225 -> en:indoleamine 2,3-dioxygenase peptide vaccine
    n1=ipilimumab | n2=en:indoleamine 2,3-dioxygenase peptide vaccine | rel=r_associated | relid=0 | w=103
  2257. ipilimumab -- r_associated #0: 103 / 0.225 -> en:inecalcitol
    n1=ipilimumab | n2=en:inecalcitol | rel=r_associated | relid=0 | w=103
  2258. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ingenol
    n1=ipilimumab | n2=en:ingenol | rel=r_associated | relid=0 | w=103
  2259. ipilimumab -- r_associated #0: 103 / 0.225 -> en:inproquone
    n1=ipilimumab | n2=en:inproquone | rel=r_associated | relid=0 | w=103
  2260. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ins316
    n1=ipilimumab | n2=en:ins316 | rel=r_associated | relid=0 | w=103
  2261. ipilimumab -- r_associated #0: 103 / 0.225 -> en:insulin glargine
    n1=ipilimumab | n2=en:insulin glargine | rel=r_associated | relid=0 | w=103
  2262. ipilimumab -- r_associated #0: 103 / 0.225 -> en:interleukin-2 liposome
    n1=ipilimumab | n2=en:interleukin-2 liposome | rel=r_associated | relid=0 | w=103
  2263. ipilimumab -- r_associated #0: 103 / 0.225 -> en:interleukin-6
    n1=ipilimumab | n2=en:interleukin-6 | rel=r_associated | relid=0 | w=103
  2264. ipilimumab -- r_associated #0: 103 / 0.225 -> en:intranasal ketamine
    n1=ipilimumab | n2=en:intranasal ketamine | rel=r_associated | relid=0 | w=103
  2265. ipilimumab -- r_associated #0: 103 / 0.225 -> en:invert sugar/potassium chloride/sodium chloride
    n1=ipilimumab | n2=en:invert sugar/potassium chloride/sodium chloride | rel=r_associated | relid=0 | w=103
  2266. ipilimumab -- r_associated #0: 103 / 0.225 -> en:iodine i 124 nm404
    n1=ipilimumab | n2=en:iodine i 124 nm404 | rel=r_associated | relid=0 | w=103
  2267. ipilimumab -- r_associated #0: 103 / 0.225 -> en:iodine i 131 monoclonal antibody tnt-1/b
    n1=ipilimumab | n2=en:iodine i 131 monoclonal antibody tnt-1/b | rel=r_associated | relid=0 | w=103
  2268. ipilimumab -- r_associated #0: 103 / 0.225 -> en:iodine i 131-labeled anti-cea/anti-hsg bispecific monoclonal antibody tf2
    n1=ipilimumab | n2=en:iodine i 131-labeled anti-cea/anti-hsg bispecific monoclonal antibody tf2 | rel=r_associated | relid=0 | w=103
  2269. ipilimumab -- r_associated #0: 103 / 0.225 -> en:iodoquinol
    n1=ipilimumab | n2=en:iodoquinol | rel=r_associated | relid=0 | w=103
  2270. ipilimumab -- r_associated #0: 103 / 0.225 -> en:iofolastat i123
    n1=ipilimumab | n2=en:iofolastat i123 | rel=r_associated | relid=0 | w=103
  2271. ipilimumab -- r_associated #0: 103 / 0.225 -> en:irish moss/mineral oil
    n1=ipilimumab | n2=en:irish moss/mineral oil | rel=r_associated | relid=0 | w=103
  2272. ipilimumab -- r_associated #0: 103 / 0.225 -> en:iron/multivitamins/procaine
    n1=ipilimumab | n2=en:iron/multivitamins/procaine | rel=r_associated | relid=0 | w=103
  2273. ipilimumab -- r_associated #0: 103 / 0.225 -> en:iron/multivitamins/sorbitol
    n1=ipilimumab | n2=en:iron/multivitamins/sorbitol | rel=r_associated | relid=0 | w=103
  2274. ipilimumab -- r_associated #0: 103 / 0.225 -> en:isis 3521
    n1=ipilimumab | n2=en:isis 3521 | rel=r_associated | relid=0 | w=103
  2275. ipilimumab -- r_associated #0: 103 / 0.225 -> en:isoflurane
    n1=ipilimumab | n2=en:isoflurane | rel=r_associated | relid=0 | w=103
  2276. ipilimumab -- r_associated #0: 103 / 0.225 -> en:isopropamide
    n1=ipilimumab | n2=en:isopropamide | rel=r_associated | relid=0 | w=103
  2277. ipilimumab -- r_associated #0: 103 / 0.225 -> en:isopropamide / prochlorperazine
    n1=ipilimumab | n2=en:isopropamide / prochlorperazine | rel=r_associated | relid=0 | w=103
  2278. ipilimumab -- r_associated #0: 103 / 0.225 -> en:isosource vhn
    n1=ipilimumab | n2=en:isosource vhn | rel=r_associated | relid=0 | w=103
  2279. ipilimumab -- r_associated #0: 103 / 0.225 -> en:isosulfan blue
    n1=ipilimumab | n2=en:isosulfan blue | rel=r_associated | relid=0 | w=103
  2280. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ispaghula extract
    n1=ipilimumab | n2=en:ispaghula extract | rel=r_associated | relid=0 | w=103
  2281. ipilimumab -- r_associated #0: 103 / 0.225 -> en:j5 antiserum
    n1=ipilimumab | n2=en:j5 antiserum | rel=r_associated | relid=0 | w=103
  2282. ipilimumab -- r_associated #0: 103 / 0.225 -> en:kanglaite
    n1=ipilimumab | n2=en:kanglaite | rel=r_associated | relid=0 | w=103
  2283. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ketorolac tromethamine
    n1=ipilimumab | n2=en:ketorolac tromethamine | rel=r_associated | relid=0 | w=103
  2284. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ksa-klh conjugate vaccine
    n1=ipilimumab | n2=en:ksa-klh conjugate vaccine | rel=r_associated | relid=0 | w=103
  2285. ipilimumab -- r_associated #0: 103 / 0.225 -> en:l-gossypol
    n1=ipilimumab | n2=en:l-gossypol | rel=r_associated | relid=0 | w=103
  2286. ipilimumab -- r_associated #0: 103 / 0.225 -> en:laetrile
    n1=ipilimumab | n2=en:laetrile | rel=r_associated | relid=0 | w=103
  2287. ipilimumab -- r_associated #0: 103 / 0.225 -> en:lamellar body mimetic mouth spray lms-611
    n1=ipilimumab | n2=en:lamellar body mimetic mouth spray lms-611 | rel=r_associated | relid=0 | w=103
  2288. ipilimumab -- r_associated #0: 103 / 0.225 -> en:lanreotide acetate copolymer microparticles
    n1=ipilimumab | n2=en:lanreotide acetate copolymer microparticles | rel=r_associated | relid=0 | w=103
  2289. ipilimumab -- r_associated #0: 103 / 0.225 -> en:lapachone
    n1=ipilimumab | n2=en:lapachone | rel=r_associated | relid=0 | w=103
  2290. ipilimumab -- r_associated #0: 103 / 0.225 -> en:lapuleucel-t
    n1=ipilimumab | n2=en:lapuleucel-t | rel=r_associated | relid=0 | w=103
  2291. ipilimumab -- r_associated #0: 103 / 0.225 -> en:laronidase
    n1=ipilimumab | n2=en:laronidase | rel=r_associated | relid=0 | w=103
  2292. ipilimumab -- r_associated #0: 103 / 0.225 -> en:lentivirus vector ccr5 shrna/trim5alpha/tar decoy-transduced autologous cd34-positive hematopoietic progenitor cells
    n1=ipilimumab | n2=en:lentivirus vector ccr5 shrna/trim5alpha/tar decoy-transduced autologous cd34-positive hematopoietic progenitor cells | rel=r_associated | relid=0 | w=103
  2293. ipilimumab -- r_associated #0: 103 / 0.225 -> en:leuprolide mesylate injectable suspension
    n1=ipilimumab | n2=en:leuprolide mesylate injectable suspension | rel=r_associated | relid=0 | w=103
  2294. ipilimumab -- r_associated #0: 103 / 0.225 -> en:liposomal bupivacaine
    n1=ipilimumab | n2=en:liposomal bupivacaine | rel=r_associated | relid=0 | w=103
  2295. ipilimumab -- r_associated #0: 103 / 0.225 -> en:liposomal cytarabine
    n1=ipilimumab | n2=en:liposomal cytarabine | rel=r_associated | relid=0 | w=103
  2296. ipilimumab -- r_associated #0: 103 / 0.225 -> en:liraglutide
    n1=ipilimumab | n2=en:liraglutide | rel=r_associated | relid=0 | w=103
  2297. ipilimumab -- r_associated #0: 103 / 0.225 -> en:live-attenuated listeria encoding human mesothelin vaccine crs-207
    n1=ipilimumab | n2=en:live-attenuated listeria encoding human mesothelin vaccine crs-207 | rel=r_associated | relid=0 | w=103
  2298. ipilimumab -- r_associated #0: 103 / 0.225 -> en:lmb-2 immunotoxin
    n1=ipilimumab | n2=en:lmb-2 immunotoxin | rel=r_associated | relid=0 | w=103
  2299. ipilimumab -- r_associated #0: 103 / 0.225 -> en:long-acting release pasireotide
    n1=ipilimumab | n2=en:long-acting release pasireotide | rel=r_associated | relid=0 | w=103
  2300. ipilimumab -- r_associated #0: 103 / 0.225 -> en:lucatumumab
    n1=ipilimumab | n2=en:lucatumumab | rel=r_associated | relid=0 | w=103
  2301. ipilimumab -- r_associated #0: 103 / 0.225 -> en:lumacaftor, ivacaftor drug combination
    n1=ipilimumab | n2=en:lumacaftor, ivacaftor drug combination | rel=r_associated | relid=0 | w=103
  2302. ipilimumab -- r_associated #0: 103 / 0.225 -> en:lurtotecan liposome
    n1=ipilimumab | n2=en:lurtotecan liposome | rel=r_associated | relid=0 | w=103
  2303. ipilimumab -- r_associated #0: 103 / 0.225 -> en:mac321
    n1=ipilimumab | n2=en:mac321 | rel=r_associated | relid=0 | w=103
  2304. ipilimumab -- r_associated #0: 103 / 0.225 -> en:magnesium citrate
    n1=ipilimumab | n2=en:magnesium citrate | rel=r_associated | relid=0 | w=103
  2305. ipilimumab -- r_associated #0: 103 / 0.225 -> en:mannose-binding lectin
    n1=ipilimumab | n2=en:mannose-binding lectin | rel=r_associated | relid=0 | w=103
  2306. ipilimumab -- r_associated #0: 103 / 0.225 -> en:mart-1 reactive cd8+ lymphocytes
    n1=ipilimumab | n2=en:mart-1 reactive cd8+ lymphocytes | rel=r_associated | relid=0 | w=103
  2307. ipilimumab -- r_associated #0: 103 / 0.225 -> en:mart-1:27-35 peptide vaccine
    n1=ipilimumab | n2=en:mart-1:27-35 peptide vaccine | rel=r_associated | relid=0 | w=103
  2308. ipilimumab -- r_associated #0: 103 / 0.225 -> en:mast cell stabilizer tf002
    n1=ipilimumab | n2=en:mast cell stabilizer tf002 | rel=r_associated | relid=0 | w=103
  2309. ipilimumab -- r_associated #0: 103 / 0.225 -> en:mct/lct lipid emulsion
    n1=ipilimumab | n2=en:mct/lct lipid emulsion | rel=r_associated | relid=0 | w=103
  2310. ipilimumab -- r_associated #0: 103 / 0.225 -> en:mdm2 inhibitor amg-232
    n1=ipilimumab | n2=en:mdm2 inhibitor amg-232 | rel=r_associated | relid=0 | w=103
  2311. ipilimumab -- r_associated #0: 103 / 0.225 -> en:mebendazole
    n1=ipilimumab | n2=en:mebendazole | rel=r_associated | relid=0 | w=103
  2312. ipilimumab -- r_associated #0: 103 / 0.225 -> en:mechlorethamine
    n1=ipilimumab | n2=en:mechlorethamine | rel=r_associated | relid=0 | w=103
  2313. ipilimumab -- r_associated #0: 103 / 0.225 -> en:mechlorethamine hydrochloride
    n1=ipilimumab | n2=en:mechlorethamine hydrochloride | rel=r_associated | relid=0 | w=103
  2314. ipilimumab -- r_associated #0: 103 / 0.225 -> en:megestrol
    n1=ipilimumab | n2=en:megestrol | rel=r_associated | relid=0 | w=103
  2315. ipilimumab -- r_associated #0: 103 / 0.225 -> en:mek/aurora kinase inhibitor bi 847325
    n1=ipilimumab | n2=en:mek/aurora kinase inhibitor bi 847325 | rel=r_associated | relid=0 | w=103
  2316. ipilimumab -- r_associated #0: 103 / 0.225 -> en:melan-a/mage-3.dp4 peptide vaccine
    n1=ipilimumab | n2=en:melan-a/mage-3.dp4 peptide vaccine | rel=r_associated | relid=0 | w=103
  2317. ipilimumab -- r_associated #0: 103 / 0.225 -> en:melitac 12.1 peptide vaccine
    n1=ipilimumab | n2=en:melitac 12.1 peptide vaccine | rel=r_associated | relid=0 | w=103
  2318. ipilimumab -- r_associated #0: 103 / 0.225 -> en:mesna
    n1=ipilimumab | n2=en:mesna | rel=r_associated | relid=0 | w=103
  2319. ipilimumab -- r_associated #0: 103 / 0.225 -> en:metahexamide
    n1=ipilimumab | n2=en:metahexamide | rel=r_associated | relid=0 | w=103
  2320. ipilimumab -- r_associated #0: 103 / 0.225 -> en:methazolamide
    n1=ipilimumab | n2=en:methazolamide | rel=r_associated | relid=0 | w=103
  2321. ipilimumab -- r_associated #0: 103 / 0.225 -> en:methotrexate
    n1=ipilimumab | n2=en:methotrexate | rel=r_associated | relid=0 | w=103
  2322. ipilimumab -- r_associated #0: 103 / 0.225 -> en:metoprolol
    n1=ipilimumab | n2=en:metoprolol | rel=r_associated | relid=0 | w=103
  2323. ipilimumab -- r_associated #0: 103 / 0.225 -> en:mgmtp140k-encoding retroviral vector
    n1=ipilimumab | n2=en:mgmtp140k-encoding retroviral vector | rel=r_associated | relid=0 | w=103
  2324. ipilimumab -- r_associated #0: 103 / 0.225 -> en:midazolam hydrochloride
    n1=ipilimumab | n2=en:midazolam hydrochloride | rel=r_associated | relid=0 | w=103
  2325. ipilimumab -- r_associated #0: 103 / 0.225 -> en:mifamurtide
    n1=ipilimumab | n2=en:mifamurtide | rel=r_associated | relid=0 | w=103
  2326. ipilimumab -- r_associated #0: 103 / 0.225 -> en:milk thistle
    n1=ipilimumab | n2=en:milk thistle | rel=r_associated | relid=0 | w=103
  2327. ipilimumab -- r_associated #0: 103 / 0.225 -> en:mistletoe extract
    n1=ipilimumab | n2=en:mistletoe extract | rel=r_associated | relid=0 | w=103
  2328. ipilimumab -- r_associated #0: 103 / 0.225 -> en:mitoxantrone hydrochloride
    n1=ipilimumab | n2=en:mitoxantrone hydrochloride | rel=r_associated | relid=0 | w=103
  2329. ipilimumab -- r_associated #0: 103 / 0.225 -> en:mivobulin isethionate
    n1=ipilimumab | n2=en:mivobulin isethionate | rel=r_associated | relid=0 | w=103
  2330. ipilimumab -- r_associated #0: 103 / 0.225 -> en:mk-4280
    n1=ipilimumab | n2=en:mk-4280 | rel=r_associated | relid=0 | w=103
  2331. ipilimumab -- r_associated #0: 103 / 0.225 -> en:mocetinostat
    n1=ipilimumab | n2=en:mocetinostat | rel=r_associated | relid=0 | w=103
  2332. ipilimumab -- r_associated #0: 103 / 0.225 -> en:monalizumab
    n1=ipilimumab | n2=en:monalizumab | rel=r_associated | relid=0 | w=103
  2333. ipilimumab -- r_associated #0: 103 / 0.225 -> en:monoacetyldiglyceride ec-18
    n1=ipilimumab | n2=en:monoacetyldiglyceride ec-18 | rel=r_associated | relid=0 | w=103
  2334. ipilimumab -- r_associated #0: 103 / 0.225 -> en:monoclonal antibody 4b5 anti-idiotype vaccine
    n1=ipilimumab | n2=en:monoclonal antibody 4b5 anti-idiotype vaccine | rel=r_associated | relid=0 | w=103
  2335. ipilimumab -- r_associated #0: 103 / 0.225 -> en:monoclonal antibody a27.15
    n1=ipilimumab | n2=en:monoclonal antibody a27.15 | rel=r_associated | relid=0 | w=103
  2336. ipilimumab -- r_associated #0: 103 / 0.225 -> en:monoclonal antibody a33
    n1=ipilimumab | n2=en:monoclonal antibody a33 | rel=r_associated | relid=0 | w=103
  2337. ipilimumab -- r_associated #0: 103 / 0.225 -> en:monoclonal antibody huafp31
    n1=ipilimumab | n2=en:monoclonal antibody huafp31 | rel=r_associated | relid=0 | w=103
  2338. ipilimumab -- r_associated #0: 103 / 0.225 -> en:monoclonal antibody l6
    n1=ipilimumab | n2=en:monoclonal antibody l6 | rel=r_associated | relid=0 | w=103
  2339. ipilimumab -- r_associated #0: 103 / 0.225 -> en:monoclonal antibody lym-1
    n1=ipilimumab | n2=en:monoclonal antibody lym-1 | rel=r_associated | relid=0 | w=103
  2340. ipilimumab -- r_associated #0: 103 / 0.225 -> en:monoclonal antibody me1-14 f(ab')2
    n1=ipilimumab | n2=en:monoclonal antibody me1-14 f(ab')2 | rel=r_associated | relid=0 | w=103
  2341. ipilimumab -- r_associated #0: 103 / 0.225 -> en:monoclonal antibody t101
    n1=ipilimumab | n2=en:monoclonal antibody t101 | rel=r_associated | relid=0 | w=103
  2342. ipilimumab -- r_associated #0: 103 / 0.225 -> en:mopp regimen
    n1=ipilimumab | n2=en:mopp regimen | rel=r_associated | relid=0 | w=103
  2343. ipilimumab -- r_associated #0: 103 / 0.225 -> en:morphine sulfate sustained-release tablet
    n1=ipilimumab | n2=en:morphine sulfate sustained-release tablet | rel=r_associated | relid=0 | w=103
  2344. ipilimumab -- r_associated #0: 103 / 0.225 -> en:mouse prostate-specific membrane antigen plasmid dna vaccine
    n1=ipilimumab | n2=en:mouse prostate-specific membrane antigen plasmid dna vaccine | rel=r_associated | relid=0 | w=103
  2345. ipilimumab -- r_associated #0: 103 / 0.225 -> en:moxetumomab pasudotox
    n1=ipilimumab | n2=en:moxetumomab pasudotox | rel=r_associated | relid=0 | w=103
  2346. ipilimumab -- r_associated #0: 103 / 0.225 -> en:mtf-1 inhibitor apto-253 hcl
    n1=ipilimumab | n2=en:mtf-1 inhibitor apto-253 hcl | rel=r_associated | relid=0 | w=103
  2347. ipilimumab -- r_associated #0: 103 / 0.225 -> en:mtor kinase inhibitor osi-027
    n1=ipilimumab | n2=en:mtor kinase inhibitor osi-027 | rel=r_associated | relid=0 | w=103
  2348. ipilimumab -- r_associated #0: 103 / 0.225 -> en:muc1 antigen/sb as-2
    n1=ipilimumab | n2=en:muc1 antigen/sb as-2 | rel=r_associated | relid=0 | w=103
  2349. ipilimumab -- r_associated #0: 103 / 0.225 -> en:muc1-targeted peptide go-203-2c
    n1=ipilimumab | n2=en:muc1-targeted peptide go-203-2c | rel=r_associated | relid=0 | w=103
  2350. ipilimumab -- r_associated #0: 103 / 0.225 -> en:multitargeted kinase inhibitor mgcd516
    n1=ipilimumab | n2=en:multitargeted kinase inhibitor mgcd516 | rel=r_associated | relid=0 | w=103
  2351. ipilimumab -- r_associated #0: 103 / 0.225 -> en:multitargeted tyrosine kinase inhibitor mgcd265
    n1=ipilimumab | n2=en:multitargeted tyrosine kinase inhibitor mgcd265 | rel=r_associated | relid=0 | w=103
  2352. ipilimumab -- r_associated #0: 103 / 0.225 -> en:muscarinic agonist apd515
    n1=ipilimumab | n2=en:muscarinic agonist apd515 | rel=r_associated | relid=0 | w=103
  2353. ipilimumab -- r_associated #0: 103 / 0.225 -> en:n-methylformamide
    n1=ipilimumab | n2=en:n-methylformamide | rel=r_associated | relid=0 | w=103
  2354. ipilimumab -- r_associated #0: 103 / 0.225 -> en:nafarelin
    n1=ipilimumab | n2=en:nafarelin | rel=r_associated | relid=0 | w=103
  2355. ipilimumab -- r_associated #0: 103 / 0.225 -> en:nanoparticle albumin-bound thiocolchicine dimer nab-5404
    n1=ipilimumab | n2=en:nanoparticle albumin-bound thiocolchicine dimer nab-5404 | rel=r_associated | relid=0 | w=103
  2356. ipilimumab -- r_associated #0: 103 / 0.225 -> en:nanosomal docetaxel lipid suspension
    n1=ipilimumab | n2=en:nanosomal docetaxel lipid suspension | rel=r_associated | relid=0 | w=103
  2357. ipilimumab -- r_associated #0: 103 / 0.225 -> en:natural killer cells zrx101
    n1=ipilimumab | n2=en:natural killer cells zrx101 | rel=r_associated | relid=0 | w=103
  2358. ipilimumab -- r_associated #0: 103 / 0.225 -> en:nelarabine
    n1=ipilimumab | n2=en:nelarabine | rel=r_associated | relid=0 | w=103
  2359. ipilimumab -- r_associated #0: 103 / 0.225 -> en:neomycin
    n1=ipilimumab | n2=en:neomycin | rel=r_associated | relid=0 | w=103
  2360. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ngfr-transduced autologous t lymphocytes
    n1=ipilimumab | n2=en:ngfr-transduced autologous t lymphocytes | rel=r_associated | relid=0 | w=103
  2361. ipilimumab -- r_associated #0: 103 / 0.225 -> en:nitroglycerin transdermal patch
    n1=ipilimumab | n2=en:nitroglycerin transdermal patch | rel=r_associated | relid=0 | w=103
  2362. ipilimumab -- r_associated #0: 103 / 0.225 -> en:nortriptyline hydrochloride
    n1=ipilimumab | n2=en:nortriptyline hydrochloride | rel=r_associated | relid=0 | w=103
  2363. ipilimumab -- r_associated #0: 103 / 0.225 -> en:noscapine hydrochloride
    n1=ipilimumab | n2=en:noscapine hydrochloride | rel=r_associated | relid=0 | w=103
  2364. ipilimumab -- r_associated #0: 103 / 0.225 -> en:nrf2 activator rta 408
    n1=ipilimumab | n2=en:nrf2 activator rta 408 | rel=r_associated | relid=0 | w=103
  2365. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ny-eso-1/mage-a4/prame/survivin/ssx-specific autologous cytotoxic t lymphoyctes
    n1=ipilimumab | n2=en:ny-eso-1/mage-a4/prame/survivin/ssx-specific autologous cytotoxic t lymphoyctes | rel=r_associated | relid=0 | w=103
  2366. ipilimumab -- r_associated #0: 103 / 0.225 -> en:o6-benzylguanine
    n1=ipilimumab | n2=en:o6-benzylguanine | rel=r_associated | relid=0 | w=103
  2367. ipilimumab -- r_associated #0: 103 / 0.225 -> en:obinutuzumab
    n1=ipilimumab | n2=en:obinutuzumab | rel=r_associated | relid=0 | w=103
  2368. ipilimumab -- r_associated #0: 103 / 0.225 -> en:odanacatib
    n1=ipilimumab | n2=en:odanacatib | rel=r_associated | relid=0 | w=103
  2369. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ofatumumab
    n1=ipilimumab | n2=en:ofatumumab | rel=r_associated | relid=0 | w=103
  2370. ipilimumab -- r_associated #0: 103 / 0.225 -> en:omacetaxine mepesuccinate
    n1=ipilimumab | n2=en:omacetaxine mepesuccinate | rel=r_associated | relid=0 | w=103
  2371. ipilimumab -- r_associated #0: 103 / 0.225 -> en:omeprazole
    n1=ipilimumab | n2=en:omeprazole | rel=r_associated | relid=0 | w=103
  2372. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ondansetron
    n1=ipilimumab | n2=en:ondansetron | rel=r_associated | relid=0 | w=103
  2373. ipilimumab -- r_associated #0: 103 / 0.225 -> en:oral sodium phenylbutyrate
    n1=ipilimumab | n2=en:oral sodium phenylbutyrate | rel=r_associated | relid=0 | w=103
  2374. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ortataxel
    n1=ipilimumab | n2=en:ortataxel | rel=r_associated | relid=0 | w=103
  2375. ipilimumab -- r_associated #0: 103 / 0.225 -> en:otic preparation
    n1=ipilimumab | n2=en:otic preparation | rel=r_associated | relid=0 | w=103
  2376. ipilimumab -- r_associated #0: 103 / 0.225 -> en:otsgc-a24 vaccine
    n1=ipilimumab | n2=en:otsgc-a24 vaccine | rel=r_associated | relid=0 | w=103
  2377. ipilimumab -- r_associated #0: 103 / 0.225 -> en:oxycodone hydrochloride/naloxone hydrochloride prolonged-release tablet
    n1=ipilimumab | n2=en:oxycodone hydrochloride/naloxone hydrochloride prolonged-release tablet | rel=r_associated | relid=0 | w=103
  2378. ipilimumab -- r_associated #0: 103 / 0.225 -> en:p-cadherin antagonist pf-03732010
    n1=ipilimumab | n2=en:p-cadherin antagonist pf-03732010 | rel=r_associated | relid=0 | w=103
  2379. ipilimumab -- r_associated #0: 103 / 0.225 -> en:p-p68 inhibitor rx-5902
    n1=ipilimumab | n2=en:p-p68 inhibitor rx-5902 | rel=r_associated | relid=0 | w=103
  2380. ipilimumab -- r_associated #0: 103 / 0.225 -> en:p.dom-wt1-37 dna vaccine
    n1=ipilimumab | n2=en:p.dom-wt1-37 dna vaccine | rel=r_associated | relid=0 | w=103
  2381. ipilimumab -- r_associated #0: 103 / 0.225 -> en:p38 mapk inhibitor ly3007113
    n1=ipilimumab | n2=en:p38 mapk inhibitor ly3007113 | rel=r_associated | relid=0 | w=103
  2382. ipilimumab -- r_associated #0: 103 / 0.225 -> en:paclitaxel albumin-stabilized nanoparticle formulation
    n1=ipilimumab | n2=en:paclitaxel albumin-stabilized nanoparticle formulation | rel=r_associated | relid=0 | w=103
  2383. ipilimumab -- r_associated #0: 103 / 0.225 -> en:paclitaxel injection concentrate for nanodispersion
    n1=ipilimumab | n2=en:paclitaxel injection concentrate for nanodispersion | rel=r_associated | relid=0 | w=103
  2384. ipilimumab -- r_associated #0: 103 / 0.225 -> en:paclitaxel vitamin e-based emulsion
    n1=ipilimumab | n2=en:paclitaxel vitamin e-based emulsion | rel=r_associated | relid=0 | w=103
  2385. ipilimumab -- r_associated #0: 103 / 0.225 -> en:palbociclib
    n1=ipilimumab | n2=en:palbociclib | rel=r_associated | relid=0 | w=103
  2386. ipilimumab -- r_associated #0: 103 / 0.225 -> en:pan-pi3k/mtor inhibitor pqr309
    n1=ipilimumab | n2=en:pan-pi3k/mtor inhibitor pqr309 | rel=r_associated | relid=0 | w=103
  2387. ipilimumab -- r_associated #0: 103 / 0.225 -> en:parecoxib sodium
    n1=ipilimumab | n2=en:parecoxib sodium | rel=r_associated | relid=0 | w=103
  2388. ipilimumab -- r_associated #0: 103 / 0.225 -> en:patient-specific follicular lymphoma-derived anti-idiotype vaccine
    n1=ipilimumab | n2=en:patient-specific follicular lymphoma-derived anti-idiotype vaccine | rel=r_associated | relid=0 | w=103
  2389. ipilimumab -- r_associated #0: 103 / 0.225 -> en:pbcar3 phosphopeptide-tetanus peptide vaccine
    n1=ipilimumab | n2=en:pbcar3 phosphopeptide-tetanus peptide vaccine | rel=r_associated | relid=0 | w=103
  2390. ipilimumab -- r_associated #0: 103 / 0.225 -> en:pbn derivative okn-007
    n1=ipilimumab | n2=en:pbn derivative okn-007 | rel=r_associated | relid=0 | w=103
  2391. ipilimumab -- r_associated #0: 103 / 0.225 -> en:pcv regimen
    n1=ipilimumab | n2=en:pcv regimen | rel=r_associated | relid=0 | w=103
  2392. ipilimumab -- r_associated #0: 103 / 0.225 -> en:peginterferon alfa-2a
    n1=ipilimumab | n2=en:peginterferon alfa-2a | rel=r_associated | relid=0 | w=103
  2393. ipilimumab -- r_associated #0: 103 / 0.225 -> en:pegylated anti-gfr antibody fragment
    n1=ipilimumab | n2=en:pegylated anti-gfr antibody fragment | rel=r_associated | relid=0 | w=103
  2394. ipilimumab -- r_associated #0: 103 / 0.225 -> en:pegylated liposomal doxorubicin hydrochloride
    n1=ipilimumab | n2=en:pegylated liposomal doxorubicin hydrochloride | rel=r_associated | relid=0 | w=103
  2395. ipilimumab -- r_associated #0: 103 / 0.225 -> en:pegylated paclitaxel
    n1=ipilimumab | n2=en:pegylated paclitaxel | rel=r_associated | relid=0 | w=103
  2396. ipilimumab -- r_associated #0: 103 / 0.225 -> en:pegylated recombinant human hyaluronidase ph20
    n1=ipilimumab | n2=en:pegylated recombinant human hyaluronidase ph20 | rel=r_associated | relid=0 | w=103
  2397. ipilimumab -- r_associated #0: 103 / 0.225 -> en:pentavalent klh conjugate vaccine
    n1=ipilimumab | n2=en:pentavalent klh conjugate vaccine | rel=r_associated | relid=0 | w=103
  2398. ipilimumab -- r_associated #0: 103 / 0.225 -> en:pentetic acid calcium
    n1=ipilimumab | n2=en:pentetic acid calcium | rel=r_associated | relid=0 | w=103
  2399. ipilimumab -- r_associated #0: 103 / 0.225 -> en:peptide 946 melanoma vaccine
    n1=ipilimumab | n2=en:peptide 946 melanoma vaccine | rel=r_associated | relid=0 | w=103
  2400. ipilimumab -- r_associated #0: 103 / 0.225 -> en:perflubutane
    n1=ipilimumab | n2=en:perflubutane | rel=r_associated | relid=0 | w=103
  2401. ipilimumab -- r_associated #0: 103 / 0.225 -> en:perfosfamide
    n1=ipilimumab | n2=en:perfosfamide | rel=r_associated | relid=0 | w=103
  2402. ipilimumab -- r_associated #0: 103 / 0.225 -> en:perifosine
    n1=ipilimumab | n2=en:perifosine | rel=r_associated | relid=0 | w=103
  2403. ipilimumab -- r_associated #0: 103 / 0.225 -> en:perillyl alcohol
    n1=ipilimumab | n2=en:perillyl alcohol | rel=r_associated | relid=0 | w=103
  2404. ipilimumab -- r_associated #0: 103 / 0.225 -> en:pharmaceutical base or inactive agent
    n1=ipilimumab | n2=en:pharmaceutical base or inactive agent | rel=r_associated | relid=0 | w=103
  2405. ipilimumab -- r_associated #0: 103 / 0.225 -> en:pi3k-delta inhibitor incb050465
    n1=ipilimumab | n2=en:pi3k-delta inhibitor incb050465 | rel=r_associated | relid=0 | w=103
  2406. ipilimumab -- r_associated #0: 103 / 0.225 -> en:pi3k-delta inhibitor pwt143
    n1=ipilimumab | n2=en:pi3k-delta inhibitor pwt143 | rel=r_associated | relid=0 | w=103
  2407. ipilimumab -- r_associated #0: 103 / 0.225 -> en:pi3k/mtorc1/mtorc2 inhibitor dcbci0901
    n1=ipilimumab | n2=en:pi3k/mtorc1/mtorc2 inhibitor dcbci0901 | rel=r_associated | relid=0 | w=103
  2408. ipilimumab -- r_associated #0: 103 / 0.225 -> en:picibanil
    n1=ipilimumab | n2=en:picibanil | rel=r_associated | relid=0 | w=103
  2409. ipilimumab -- r_associated #0: 103 / 0.225 -> en:pidilizumab
    n1=ipilimumab | n2=en:pidilizumab | rel=r_associated | relid=0 | w=103
  2410. ipilimumab -- r_associated #0: 103 / 0.225 -> en:pilocarpine hydrochloride
    n1=ipilimumab | n2=en:pilocarpine hydrochloride | rel=r_associated | relid=0 | w=103
  2411. ipilimumab -- r_associated #0: 103 / 0.225 -> en:pirfenidone
    n1=ipilimumab | n2=en:pirfenidone | rel=r_associated | relid=0 | w=103
  2412. ipilimumab -- r_associated #0: 103 / 0.225 -> en:pivaloyloxymethylbutyrate
    n1=ipilimumab | n2=en:pivaloyloxymethylbutyrate | rel=r_associated | relid=0 | w=103
  2413. ipilimumab -- r_associated #0: 103 / 0.225 -> en:placebo administration
    n1=ipilimumab | n2=en:placebo administration | rel=r_associated | relid=0 | w=103
  2414. ipilimumab -- r_associated #0: 103 / 0.225 -> en:plozalizumab
    n1=ipilimumab | n2=en:plozalizumab | rel=r_associated | relid=0 | w=103
  2415. ipilimumab -- r_associated #0: 103 / 0.225 -> en:polo-like kinase 1 inhibitor nms-1286937
    n1=ipilimumab | n2=en:polo-like kinase 1 inhibitor nms-1286937 | rel=r_associated | relid=0 | w=103
  2416. ipilimumab -- r_associated #0: 103 / 0.225 -> en:poly iclc
    n1=ipilimumab | n2=en:poly iclc | rel=r_associated | relid=0 | w=103
  2417. ipilimumab -- r_associated #0: 103 / 0.225 -> en:polysaccharide-k
    n1=ipilimumab | n2=en:polysaccharide-k | rel=r_associated | relid=0 | w=103
  2418. ipilimumab -- r_associated #0: 103 / 0.225 -> en:posaconazole
    n1=ipilimumab | n2=en:posaconazole | rel=r_associated | relid=0 | w=103
  2419. ipilimumab -- r_associated #0: 103 / 0.225 -> en:poziotinib
    n1=ipilimumab | n2=en:poziotinib | rel=r_associated | relid=0 | w=103
  2420. ipilimumab -- r_associated #0: 103 / 0.225 -> en:prodrugs
    n1=ipilimumab | n2=en:prodrugs | rel=r_associated | relid=0 | w=103
  2421. ipilimumab -- r_associated #0: 103 / 0.225 -> en:progesterone vaginal insert
    n1=ipilimumab | n2=en:progesterone vaginal insert | rel=r_associated | relid=0 | w=103
  2422. ipilimumab -- r_associated #0: 103 / 0.225 -> en:promegapoietin
    n1=ipilimumab | n2=en:promegapoietin | rel=r_associated | relid=0 | w=103
  2423. ipilimumab -- r_associated #0: 103 / 0.225 -> en:promestriene
    n1=ipilimumab | n2=en:promestriene | rel=r_associated | relid=0 | w=103
  2424. ipilimumab -- r_associated #0: 103 / 0.225 -> en:pronase oral solution
    n1=ipilimumab | n2=en:pronase oral solution | rel=r_associated | relid=0 | w=103
  2425. ipilimumab -- r_associated #0: 103 / 0.225 -> en:pv-10
    n1=ipilimumab | n2=en:pv-10 | rel=r_associated | relid=0 | w=103
  2426. ipilimumab -- r_associated #0: 103 / 0.225 -> en:pyrazine diazohydroxide
    n1=ipilimumab | n2=en:pyrazine diazohydroxide | rel=r_associated | relid=0 | w=103
  2427. ipilimumab -- r_associated #0: 103 / 0.225 -> en:quizartinib
    n1=ipilimumab | n2=en:quizartinib | rel=r_associated | relid=0 | w=103
  2428. ipilimumab -- r_associated #0: 103 / 0.225 -> en:r-cvp regimen
    n1=ipilimumab | n2=en:r-cvp regimen | rel=r_associated | relid=0 | w=103
  2429. ipilimumab -- r_associated #0: 103 / 0.225 -> en:radioprotective agent
    n1=ipilimumab | n2=en:radioprotective agent | rel=r_associated | relid=0 | w=103
  2430. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ranitidine hydrochloride/bismuth potassium citrate/sucralfate hydrate formulation
    n1=ipilimumab | n2=en:ranitidine hydrochloride/bismuth potassium citrate/sucralfate hydrate formulation | rel=r_associated | relid=0 | w=103
  2431. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ranpirnase
    n1=ipilimumab | n2=en:ranpirnase | rel=r_associated | relid=0 | w=103
  2432. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ras peptide cancer vaccine
    n1=ipilimumab | n2=en:ras peptide cancer vaccine | rel=r_associated | relid=0 | w=103
  2433. ipilimumab -- r_associated #0: 103 / 0.225 -> en:rbl001/rbl002 vaccine
    n1=ipilimumab | n2=en:rbl001/rbl002 vaccine | rel=r_associated | relid=0 | w=103
  2434. ipilimumab -- r_associated #0: 103 / 0.225 -> en:recombinant adenovirus encoding p53
    n1=ipilimumab | n2=en:recombinant adenovirus encoding p53 | rel=r_associated | relid=0 | w=103
  2435. ipilimumab -- r_associated #0: 103 / 0.225 -> en:recombinant granulocyte-macrophage colony-stimulating factor
    n1=ipilimumab | n2=en:recombinant granulocyte-macrophage colony-stimulating factor | rel=r_associated | relid=0 | w=103
  2436. ipilimumab -- r_associated #0: 103 / 0.225 -> en:recombinant human endostatin
    n1=ipilimumab | n2=en:recombinant human endostatin | rel=r_associated | relid=0 | w=103
  2437. ipilimumab -- r_associated #0: 103 / 0.225 -> en:recombinant interferon beta
    n1=ipilimumab | n2=en:recombinant interferon beta | rel=r_associated | relid=0 | w=103
  2438. ipilimumab -- r_associated #0: 103 / 0.225 -> en:recombinant interleukin-1-alpha
    n1=ipilimumab | n2=en:recombinant interleukin-1-alpha | rel=r_associated | relid=0 | w=103
  2439. ipilimumab -- r_associated #0: 103 / 0.225 -> en:recombinant prame protein plus as15 adjuvant gsk2302025a
    n1=ipilimumab | n2=en:recombinant prame protein plus as15 adjuvant gsk2302025a | rel=r_associated | relid=0 | w=103
  2440. ipilimumab -- r_associated #0: 103 / 0.225 -> en:recombinant thymosin
    n1=ipilimumab | n2=en:recombinant thymosin | rel=r_associated | relid=0 | w=103
  2441. ipilimumab -- r_associated #0: 103 / 0.225 -> en:recombinant vaccinia-b7.1 vaccine
    n1=ipilimumab | n2=en:recombinant vaccinia-b7.1 vaccine | rel=r_associated | relid=0 | w=103
  2442. ipilimumab -- r_associated #0: 103 / 0.225 -> en:regadenoson
    n1=ipilimumab | n2=en:regadenoson | rel=r_associated | relid=0 | w=103
  2443. ipilimumab -- r_associated #0: 103 / 0.225 -> en:remifentanil hydrochloride
    n1=ipilimumab | n2=en:remifentanil hydrochloride | rel=r_associated | relid=0 | w=103
  2444. ipilimumab -- r_associated #0: 103 / 0.225 -> en:renal cell carcinoma peptides vaccine ima901
    n1=ipilimumab | n2=en:renal cell carcinoma peptides vaccine ima901 | rel=r_associated | relid=0 | w=103
  2445. ipilimumab -- r_associated #0: 103 / 0.225 -> en:resiquimod
    n1=ipilimumab | n2=en:resiquimod | rel=r_associated | relid=0 | w=103
  2446. ipilimumab -- r_associated #0: 103 / 0.225 -> en:reslizumab
    n1=ipilimumab | n2=en:reslizumab | rel=r_associated | relid=0 | w=103
  2447. ipilimumab -- r_associated #0: 103 / 0.225 -> en:respiratory form tiotropium
    n1=ipilimumab | n2=en:respiratory form tiotropium | rel=r_associated | relid=0 | w=103
  2448. ipilimumab -- r_associated #0: 103 / 0.225 -> en:retinyl acetate
    n1=ipilimumab | n2=en:retinyl acetate | rel=r_associated | relid=0 | w=103
  2449. ipilimumab -- r_associated #0: 103 / 0.225 -> en:rhenium re 188 bmeda-labeled liposomes
    n1=ipilimumab | n2=en:rhenium re 188 bmeda-labeled liposomes | rel=r_associated | relid=0 | w=103
  2450. ipilimumab -- r_associated #0: 103 / 0.225 -> en:rhenium re-186 hydroxyethylidene diphosphonate
    n1=ipilimumab | n2=en:rhenium re-186 hydroxyethylidene diphosphonate | rel=r_associated | relid=0 | w=103
  2451. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ribociclib
    n1=ipilimumab | n2=en:ribociclib | rel=r_associated | relid=0 | w=103
  2452. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ribosome-inactivating protein cy503
    n1=ipilimumab | n2=en:ribosome-inactivating protein cy503 | rel=r_associated | relid=0 | w=103
  2453. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ricin immunoconjugate
    n1=ipilimumab | n2=en:ricin immunoconjugate | rel=r_associated | relid=0 | w=103
  2454. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ridaforolimus
    n1=ipilimumab | n2=en:ridaforolimus | rel=r_associated | relid=0 | w=103
  2455. ipilimumab -- r_associated #0: 103 / 0.225 -> en:rifampicin+isoniazid
    n1=ipilimumab | n2=en:rifampicin+isoniazid | rel=r_associated | relid=0 | w=103
  2456. ipilimumab -- r_associated #0: 103 / 0.225 -> en:rigosertib sodium
    n1=ipilimumab | n2=en:rigosertib sodium | rel=r_associated | relid=0 | w=103
  2457. ipilimumab -- r_associated #0: 103 / 0.225 -> en:riluzole
    n1=ipilimumab | n2=en:riluzole | rel=r_associated | relid=0 | w=103
  2458. ipilimumab -- r_associated #0: 103 / 0.225 -> en:rindopepimut
    n1=ipilimumab | n2=en:rindopepimut | rel=r_associated | relid=0 | w=103
  2459. ipilimumab -- r_associated #0: 103 / 0.225 -> en:rofecoxib
    n1=ipilimumab | n2=en:rofecoxib | rel=r_associated | relid=0 | w=103
  2460. ipilimumab -- r_associated #0: 103 / 0.225 -> en:rosuvastatin calcium
    n1=ipilimumab | n2=en:rosuvastatin calcium | rel=r_associated | relid=0 | w=103
  2461. ipilimumab -- r_associated #0: 103 / 0.225 -> en:rucaparib phosphate
    n1=ipilimumab | n2=en:rucaparib phosphate | rel=r_associated | relid=0 | w=103
  2462. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ruthenium ru-106
    n1=ipilimumab | n2=en:ruthenium ru-106 | rel=r_associated | relid=0 | w=103
  2463. ipilimumab -- r_associated #0: 103 / 0.225 -> en:rutin
    n1=ipilimumab | n2=en:rutin | rel=r_associated | relid=0 | w=103
  2464. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ruxolitinib phosphate
    n1=ipilimumab | n2=en:ruxolitinib phosphate | rel=r_associated | relid=0 | w=103
  2465. ipilimumab -- r_associated #0: 103 / 0.225 -> en:sacituzumab govitecan
    n1=ipilimumab | n2=en:sacituzumab govitecan | rel=r_associated | relid=0 | w=103
  2466. ipilimumab -- r_associated #0: 103 / 0.225 -> en:safingol
    n1=ipilimumab | n2=en:safingol | rel=r_associated | relid=0 | w=103
  2467. ipilimumab -- r_associated #0: 103 / 0.225 -> en:saponin-based immunoadjuvant obi-821
    n1=ipilimumab | n2=en:saponin-based immunoadjuvant obi-821 | rel=r_associated | relid=0 | w=103
  2468. ipilimumab -- r_associated #0: 103 / 0.225 -> en:sdf-1-targeted agent nox-a12
    n1=ipilimumab | n2=en:sdf-1-targeted agent nox-a12 | rel=r_associated | relid=0 | w=103
  2469. ipilimumab -- r_associated #0: 103 / 0.225 -> en:selective estrogen receptor modulator
    n1=ipilimumab | n2=en:selective estrogen receptor modulator | rel=r_associated | relid=0 | w=103
  2470. ipilimumab -- r_associated #0: 103 / 0.225 -> en:seocalcitol
    n1=ipilimumab | n2=en:seocalcitol | rel=r_associated | relid=0 | w=103
  2471. ipilimumab -- r_associated #0: 103 / 0.225 -> en:serine protease inhibitor wx-671
    n1=ipilimumab | n2=en:serine protease inhibitor wx-671 | rel=r_associated | relid=0 | w=103
  2472. ipilimumab -- r_associated #0: 103 / 0.225 -> en:shi pi yin herbal decoction
    n1=ipilimumab | n2=en:shi pi yin herbal decoction | rel=r_associated | relid=0 | w=103
  2473. ipilimumab -- r_associated #0: 103 / 0.225 -> en:sialyl lewis-keyhole limpet hemocyanin conjugate vaccine
    n1=ipilimumab | n2=en:sialyl lewis-keyhole limpet hemocyanin conjugate vaccine | rel=r_associated | relid=0 | w=103
  2474. ipilimumab -- r_associated #0: 103 / 0.225 -> en:sialyl tn antigen
    n1=ipilimumab | n2=en:sialyl tn antigen | rel=r_associated | relid=0 | w=103
  2475. ipilimumab -- r_associated #0: 103 / 0.225 -> en:sildenafil citrate
    n1=ipilimumab | n2=en:sildenafil citrate | rel=r_associated | relid=0 | w=103
  2476. ipilimumab -- r_associated #0: 103 / 0.225 -> en:siplizumab
    n1=ipilimumab | n2=en:siplizumab | rel=r_associated | relid=0 | w=103
  2477. ipilimumab -- r_associated #0: 103 / 0.225 -> en:sirna-transfected peripheral blood mononuclear cells apn401
    n1=ipilimumab | n2=en:sirna-transfected peripheral blood mononuclear cells apn401 | rel=r_associated | relid=0 | w=103
  2478. ipilimumab -- r_associated #0: 103 / 0.225 -> en:smoothened antagonist bms-833923
    n1=ipilimumab | n2=en:smoothened antagonist bms-833923 | rel=r_associated | relid=0 | w=103
  2479. ipilimumab -- r_associated #0: 103 / 0.225 -> en:sodium ferric gluconate complex in sucrose
    n1=ipilimumab | n2=en:sodium ferric gluconate complex in sucrose | rel=r_associated | relid=0 | w=103
  2480. ipilimumab -- r_associated #0: 103 / 0.225 -> en:sonepcizumab
    n1=ipilimumab | n2=en:sonepcizumab | rel=r_associated | relid=0 | w=103
  2481. ipilimumab -- r_associated #0: 103 / 0.225 -> en:sorivudine
    n1=ipilimumab | n2=en:sorivudine | rel=r_associated | relid=0 | w=103
  2482. ipilimumab -- r_associated #0: 103 / 0.225 -> en:spirogermanium
    n1=ipilimumab | n2=en:spirogermanium | rel=r_associated | relid=0 | w=103
  2483. ipilimumab -- r_associated #0: 103 / 0.225 -> en:sr-t100 gel
    n1=ipilimumab | n2=en:sr-t100 gel | rel=r_associated | relid=0 | w=103
  2484. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ssr411298
    n1=ipilimumab | n2=en:ssr411298 | rel=r_associated | relid=0 | w=103
  2485. ipilimumab -- r_associated #0: 103 / 0.225 -> en:stat3 decoy oligonucleotide
    n1=ipilimumab | n2=en:stat3 decoy oligonucleotide | rel=r_associated | relid=0 | w=103
  2486. ipilimumab -- r_associated #0: 103 / 0.225 -> en:stat3 inhibitor opb-51602
    n1=ipilimumab | n2=en:stat3 inhibitor opb-51602 | rel=r_associated | relid=0 | w=103
  2487. ipilimumab -- r_associated #0: 103 / 0.225 -> en:streptavidin
    n1=ipilimumab | n2=en:streptavidin | rel=r_associated | relid=0 | w=103
  2488. ipilimumab -- r_associated #0: 103 / 0.225 -> en:sucralfate
    n1=ipilimumab | n2=en:sucralfate | rel=r_associated | relid=0 | w=103
  2489. ipilimumab -- r_associated #0: 103 / 0.225 -> en:sugammadex sodium
    n1=ipilimumab | n2=en:sugammadex sodium | rel=r_associated | relid=0 | w=103
  2490. ipilimumab -- r_associated #0: 103 / 0.225 -> en:sulforaphane
    n1=ipilimumab | n2=en:sulforaphane | rel=r_associated | relid=0 | w=103
  2491. ipilimumab -- r_associated #0: 103 / 0.225 -> en:sumac/black cumin powder
    n1=ipilimumab | n2=en:sumac/black cumin powder | rel=r_associated | relid=0 | w=103
  2492. ipilimumab -- r_associated #0: 103 / 0.225 -> en:survivin antigen
    n1=ipilimumab | n2=en:survivin antigen | rel=r_associated | relid=0 | w=103
  2493. ipilimumab -- r_associated #0: 103 / 0.225 -> en:synbiotic supplement
    n1=ipilimumab | n2=en:synbiotic supplement | rel=r_associated | relid=0 | w=103
  2494. ipilimumab -- r_associated #0: 103 / 0.225 -> en:synchrovax sem plasmid dna vaccine
    n1=ipilimumab | n2=en:synchrovax sem plasmid dna vaccine | rel=r_associated | relid=0 | w=103
  2495. ipilimumab -- r_associated #0: 103 / 0.225 -> en:t-type calcium channel blocker abt-639
    n1=ipilimumab | n2=en:t-type calcium channel blocker abt-639 | rel=r_associated | relid=0 | w=103
  2496. ipilimumab -- r_associated #0: 103 / 0.225 -> en:tabalumab
    n1=ipilimumab | n2=en:tabalumab | rel=r_associated | relid=0 | w=103
  2497. ipilimumab -- r_associated #0: 103 / 0.225 -> en:tadalafil
    n1=ipilimumab | n2=en:tadalafil | rel=r_associated | relid=0 | w=103
  2498. ipilimumab -- r_associated #0: 103 / 0.225 -> en:talaporfin sodium
    n1=ipilimumab | n2=en:talaporfin sodium | rel=r_associated | relid=0 | w=103
  2499. ipilimumab -- r_associated #0: 103 / 0.225 -> en:talazoparib
    n1=ipilimumab | n2=en:talazoparib | rel=r_associated | relid=0 | w=103
  2500. ipilimumab -- r_associated #0: 103 / 0.225 -> en:talmapimod
    n1=ipilimumab | n2=en:talmapimod | rel=r_associated | relid=0 | w=103
  2501. ipilimumab -- r_associated #0: 103 / 0.225 -> en:tarp 29-37-9v peptide vaccine
    n1=ipilimumab | n2=en:tarp 29-37-9v peptide vaccine | rel=r_associated | relid=0 | w=103
  2502. ipilimumab -- r_associated #0: 103 / 0.225 -> en:tas-108
    n1=ipilimumab | n2=en:tas-108 | rel=r_associated | relid=0 | w=103
  2503. ipilimumab -- r_associated #0: 103 / 0.225 -> en:taselisib
    n1=ipilimumab | n2=en:taselisib | rel=r_associated | relid=0 | w=103
  2504. ipilimumab -- r_associated #0: 103 / 0.225 -> en:taxane analogue tpi 287
    n1=ipilimumab | n2=en:taxane analogue tpi 287 | rel=r_associated | relid=0 | w=103
  2505. ipilimumab -- r_associated #0: 103 / 0.225 -> en:technetium tc 94m sestamibi
    n1=ipilimumab | n2=en:technetium tc 94m sestamibi | rel=r_associated | relid=0 | w=103
  2506. ipilimumab -- r_associated #0: 103 / 0.225 -> en:technetium tc 99m epratuzumab
    n1=ipilimumab | n2=en:technetium tc 99m epratuzumab | rel=r_associated | relid=0 | w=103
  2507. ipilimumab -- r_associated #0: 103 / 0.225 -> en:technetium tc 99m-3prgd2
    n1=ipilimumab | n2=en:technetium tc 99m-3prgd2 | rel=r_associated | relid=0 | w=103
  2508. ipilimumab -- r_associated #0: 103 / 0.225 -> en:technetium tc-99m ethylenedicysteine-deoxyglucose
    n1=ipilimumab | n2=en:technetium tc-99m ethylenedicysteine-deoxyglucose | rel=r_associated | relid=0 | w=103
  2509. ipilimumab -- r_associated #0: 103 / 0.225 -> en:tecogalan sodium
    n1=ipilimumab | n2=en:tecogalan sodium | rel=r_associated | relid=0 | w=103
  2510. ipilimumab -- r_associated #0: 103 / 0.225 -> en:tegafur-uracil
    n1=ipilimumab | n2=en:tegafur-uracil | rel=r_associated | relid=0 | w=103
  2511. ipilimumab -- r_associated #0: 103 / 0.225 -> en:therapeutic immune globulin
    n1=ipilimumab | n2=en:therapeutic immune globulin | rel=r_associated | relid=0 | w=103
  2512. ipilimumab -- r_associated #0: 103 / 0.225 -> en:therapeutic testosterone
    n1=ipilimumab | n2=en:therapeutic testosterone | rel=r_associated | relid=0 | w=103
  2513. ipilimumab -- r_associated #0: 103 / 0.225 -> en:thiarabine
    n1=ipilimumab | n2=en:thiarabine | rel=r_associated | relid=0 | w=103
  2514. ipilimumab -- r_associated #0: 103 / 0.225 -> en:thioinosine
    n1=ipilimumab | n2=en:thioinosine | rel=r_associated | relid=0 | w=103
  2515. ipilimumab -- r_associated #0: 103 / 0.225 -> en:thiotepa
    n1=ipilimumab | n2=en:thiotepa | rel=r_associated | relid=0 | w=103
  2516. ipilimumab -- r_associated #0: 103 / 0.225 -> en:tilorone
    n1=ipilimumab | n2=en:tilorone | rel=r_associated | relid=0 | w=103
  2517. ipilimumab -- r_associated #0: 103 / 0.225 -> en:titanium dioxide/zinc oxide sunscreen
    n1=ipilimumab | n2=en:titanium dioxide/zinc oxide sunscreen | rel=r_associated | relid=0 | w=103
  2518. ipilimumab -- r_associated #0: 103 / 0.225 -> en:tizanidine hydrochloride
    n1=ipilimumab | n2=en:tizanidine hydrochloride | rel=r_associated | relid=0 | w=103
  2519. ipilimumab -- r_associated #0: 103 / 0.225 -> en:tlr 7/8 agonist medi9197
    n1=ipilimumab | n2=en:tlr 7/8 agonist medi9197 | rel=r_associated | relid=0 | w=103
  2520. ipilimumab -- r_associated #0: 103 / 0.225 -> en:tlr agonist cadi-05
    n1=ipilimumab | n2=en:tlr agonist cadi-05 | rel=r_associated | relid=0 | w=103
  2521. ipilimumab -- r_associated #0: 103 / 0.225 -> en:tlr4 agonist gsk1795091
    n1=ipilimumab | n2=en:tlr4 agonist gsk1795091 | rel=r_associated | relid=0 | w=103
  2522. ipilimumab -- r_associated #0: 103 / 0.225 -> en:tlr7/8/9 antagonist imo-8400
    n1=ipilimumab | n2=en:tlr7/8/9 antagonist imo-8400 | rel=r_associated | relid=0 | w=103
  2523. ipilimumab -- r_associated #0: 103 / 0.225 -> en:tlr9 agonist sd-101
    n1=ipilimumab | n2=en:tlr9 agonist sd-101 | rel=r_associated | relid=0 | w=103
  2524. ipilimumab -- r_associated #0: 103 / 0.225 -> en:tocladesine
    n1=ipilimumab | n2=en:tocladesine | rel=r_associated | relid=0 | w=103
  2525. ipilimumab -- r_associated #0: 103 / 0.225 -> en:tocotrienol-rich fraction
    n1=ipilimumab | n2=en:tocotrienol-rich fraction | rel=r_associated | relid=0 | w=103
  2526. ipilimumab -- r_associated #0: 103 / 0.225 -> en:tolbutamide
    n1=ipilimumab | n2=en:tolbutamide | rel=r_associated | relid=0 | w=103
  2527. ipilimumab -- r_associated #0: 103 / 0.225 -> en:topical betulinic acid
    n1=ipilimumab | n2=en:topical betulinic acid | rel=r_associated | relid=0 | w=103
  2528. ipilimumab -- r_associated #0: 103 / 0.225 -> en:topiramate
    n1=ipilimumab | n2=en:topiramate | rel=r_associated | relid=0 | w=103
  2529. ipilimumab -- r_associated #0: 103 / 0.225 -> en:topoisomerase-ii inhibitor
    n1=ipilimumab | n2=en:topoisomerase-ii inhibitor | rel=r_associated | relid=0 | w=103
  2530. ipilimumab -- r_associated #0: 103 / 0.225 -> en:tpo receptor agonist ono-7746
    n1=ipilimumab | n2=en:tpo receptor agonist ono-7746 | rel=r_associated | relid=0 | w=103
  2531. ipilimumab -- r_associated #0: 103 / 0.225 -> en:transgenic lymphocyte immunization vaccine
    n1=ipilimumab | n2=en:transgenic lymphocyte immunization vaccine | rel=r_associated | relid=0 | w=103
  2532. ipilimumab -- r_associated #0: 103 / 0.225 -> en:triciribine phosphate
    n1=ipilimumab | n2=en:triciribine phosphate | rel=r_associated | relid=0 | w=103
  2533. ipilimumab -- r_associated #0: 103 / 0.225 -> en:trimethylcolchicinic acid
    n1=ipilimumab | n2=en:trimethylcolchicinic acid | rel=r_associated | relid=0 | w=103
  2534. ipilimumab -- r_associated #0: 103 / 0.225 -> en:trk inhibitor loxo-101
    n1=ipilimumab | n2=en:trk inhibitor loxo-101 | rel=r_associated | relid=0 | w=103
  2535. ipilimumab -- r_associated #0: 103 / 0.225 -> en:tropisetron
    n1=ipilimumab | n2=en:tropisetron | rel=r_associated | relid=0 | w=103
  2536. ipilimumab -- r_associated #0: 103 / 0.225 -> en:tropisetron hydrochloride
    n1=ipilimumab | n2=en:tropisetron hydrochloride | rel=r_associated | relid=0 | w=103
  2537. ipilimumab -- r_associated #0: 103 / 0.225 -> en:tsp-1 mimetic fusion protein cvx-045
    n1=ipilimumab | n2=en:tsp-1 mimetic fusion protein cvx-045 | rel=r_associated | relid=0 | w=103
  2538. ipilimumab -- r_associated #0: 103 / 0.225 -> en:tumor-cells apoptosis factor hormone-peptide
    n1=ipilimumab | n2=en:tumor-cells apoptosis factor hormone-peptide | rel=r_associated | relid=0 | w=103
  2539. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ubenimex
    n1=ipilimumab | n2=en:ubenimex | rel=r_associated | relid=0 | w=103
  2540. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ublituximab
    n1=ipilimumab | n2=en:ublituximab | rel=r_associated | relid=0 | w=103
  2541. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ulinastatin
    n1=ipilimumab | n2=en:ulinastatin | rel=r_associated | relid=0 | w=103
  2542. ipilimumab -- r_associated #0: 103 / 0.225 -> en:ulvwf multimer-targeting agent arc1779
    n1=ipilimumab | n2=en:ulvwf multimer-targeting agent arc1779 | rel=r_associated | relid=0 | w=103
  2543. ipilimumab -- r_associated #0: 103 / 0.225 -> en:umbilical cord blood-derived mesenchymal stem cells
    n1=ipilimumab | n2=en:umbilical cord blood-derived mesenchymal stem cells | rel=r_associated | relid=0 | w=103
  2544. ipilimumab -- r_associated #0: 103 / 0.225 -> en:urlc10-cdca1-koc1 multipeptide vaccine
    n1=ipilimumab | n2=en:urlc10-cdca1-koc1 multipeptide vaccine | rel=r_associated | relid=0 | w=103
  2545. ipilimumab -- r_associated #0: 103 / 0.225 -> en:urokinase-derived peptide a6
    n1=ipilimumab | n2=en:urokinase-derived peptide a6 | rel=r_associated | relid=0 | w=103
  2546. ipilimumab -- r_associated #0: 103 / 0.225 -> en:vadastuximab talirine
    n1=ipilimumab | n2=en:vadastuximab talirine | rel=r_associated | relid=0 | w=103
  2547. ipilimumab -- r_associated #0: 103 / 0.225 -> en:vamp regimen
    n1=ipilimumab | n2=en:vamp regimen | rel=r_associated | relid=0 | w=103
  2548. ipilimumab -- r_associated #0: 103 / 0.225 -> en:varenicline
    n1=ipilimumab | n2=en:varenicline | rel=r_associated | relid=0 | w=103
  2549. ipilimumab -- r_associated #0: 103 / 0.225 -> en:varlilumab
    n1=ipilimumab | n2=en:varlilumab | rel=r_associated | relid=0 | w=103
  2550. ipilimumab -- r_associated #0: 103 / 0.225 -> en:vegf/hgf-targeting darpin mp0250
    n1=ipilimumab | n2=en:vegf/hgf-targeting darpin mp0250 | rel=r_associated | relid=0 | w=103
  2551. ipilimumab -- r_associated #0: 103 / 0.225 -> en:veip regimen
    n1=ipilimumab | n2=en:veip regimen | rel=r_associated | relid=0 | w=103
  2552. ipilimumab -- r_associated #0: 103 / 0.225 -> en:viagenpumatucel-l
    n1=ipilimumab | n2=en:viagenpumatucel-l | rel=r_associated | relid=0 | w=103
  2553. ipilimumab -- r_associated #0: 103 / 0.225 -> en:vildagliptin
    n1=ipilimumab | n2=en:vildagliptin | rel=r_associated | relid=0 | w=103
  2554. ipilimumab -- r_associated #0: 103 / 0.225 -> en:vitamin
    n1=ipilimumab | n2=en:vitamin | rel=r_associated | relid=0 | w=103
  2555. ipilimumab -- r_associated #0: 103 / 0.225 -> en:white carrot
    n1=ipilimumab | n2=en:white carrot | rel=r_associated | relid=0 | w=103
  2556. ipilimumab -- r_associated #0: 103 / 0.225 -> en:wnt-5a mimic hexapeptide foxy-5
    n1=ipilimumab | n2=en:wnt-5a mimic hexapeptide foxy-5 | rel=r_associated | relid=0 | w=103
  2557. ipilimumab -- r_associated #0: 103 / 0.225 -> en:wt1 126-134 peptide vaccine
    n1=ipilimumab | n2=en:wt1 126-134 peptide vaccine | rel=r_associated | relid=0 | w=103
  2558. ipilimumab -- r_associated #0: 103 / 0.225 -> en:xpo1 inhibitor sl-801
    n1=ipilimumab | n2=en:xpo1 inhibitor sl-801 | rel=r_associated | relid=0 | w=103
  2559. ipilimumab -- r_associated #0: 103 / 0.225 -> en:yttrium y 90 daclizumab
    n1=ipilimumab | n2=en:yttrium y 90 daclizumab | rel=r_associated | relid=0 | w=103
  2560. ipilimumab -- r_associated #0: 103 / 0.225 -> en:yttrium y 90 dota anti-cea monoclonal antibody m5a
    n1=ipilimumab | n2=en:yttrium y 90 dota anti-cea monoclonal antibody m5a | rel=r_associated | relid=0 | w=103
  2561. ipilimumab -- r_associated #0: 103 / 0.225 -> en:yttrium y 90 monoclonal antibody hu3s193
    n1=ipilimumab | n2=en:yttrium y 90 monoclonal antibody hu3s193 | rel=r_associated | relid=0 | w=103
  2562. ipilimumab -- r_associated #0: 103 / 0.225 -> en:yttrium y-90 clivatuzumab tetraxetan
    n1=ipilimumab | n2=en:yttrium y-90 clivatuzumab tetraxetan | rel=r_associated | relid=0 | w=103
  2563. ipilimumab -- r_associated #0: 103 / 0.225 -> en:zanolimumab
    n1=ipilimumab | n2=en:zanolimumab | rel=r_associated | relid=0 | w=103
  2564. ipilimumab -- r_associated #0: 103 / 0.225 -> en:zinc finger nuclease zfn-758
    n1=ipilimumab | n2=en:zinc finger nuclease zfn-758 | rel=r_associated | relid=0 | w=103
  2565. ipilimumab -- r_associated #0: 103 / 0.225 -> en:zinc gluconate
    n1=ipilimumab | n2=en:zinc gluconate | rel=r_associated | relid=0 | w=103
  2566. ipilimumab -- r_associated #0: 103 / 0.225 -> en:zirconium zr 89 girentuximab
    n1=ipilimumab | n2=en:zirconium zr 89 girentuximab | rel=r_associated | relid=0 | w=103
  2567. ipilimumab -- r_associated #0: 103 / 0.225 -> en:zolmitriptan
    n1=ipilimumab | n2=en:zolmitriptan | rel=r_associated | relid=0 | w=103
  2568. ipilimumab -- r_associated #0: 102 / 0.223 -> en:1,2-carbon c 13-labeled glucose
    n1=ipilimumab | n2=en:1,2-carbon c 13-labeled glucose | rel=r_associated | relid=0 | w=102
  2569. ipilimumab -- r_associated #0: 102 / 0.223 -> en:18-f-fluoroacetate
    n1=ipilimumab | n2=en:18-f-fluoroacetate | rel=r_associated | relid=0 | w=102
  2570. ipilimumab -- r_associated #0: 102 / 0.223 -> en:18f-fluoroazomycin arabinoside
    n1=ipilimumab | n2=en:18f-fluoroazomycin arabinoside | rel=r_associated | relid=0 | w=102
  2571. ipilimumab -- r_associated #0: 102 / 0.223 -> en:18f-fluoromisonidazole
    n1=ipilimumab | n2=en:18f-fluoromisonidazole | rel=r_associated | relid=0 | w=102
  2572. ipilimumab -- r_associated #0: 102 / 0.223 -> en:2-methoxyestradiol
    n1=ipilimumab | n2=en:2-methoxyestradiol | rel=r_associated | relid=0 | w=102
  2573. ipilimumab -- r_associated #0: 102 / 0.223 -> en:2'-f-ara-deoxyuridine
    n1=ipilimumab | n2=en:2'-f-ara-deoxyuridine | rel=r_associated | relid=0 | w=102
  2574. ipilimumab -- r_associated #0: 102 / 0.223 -> en:3-iodo-2-propynylbutylcarbamate
    n1=ipilimumab | n2=en:3-iodo-2-propynylbutylcarbamate | rel=r_associated | relid=0 | w=102
  2575. ipilimumab -- r_associated #0: 102 / 0.223 -> en:4-1bb agonist monoclonal antibody pf-05082566
    n1=ipilimumab | n2=en:4-1bb agonist monoclonal antibody pf-05082566 | rel=r_associated | relid=0 | w=102
  2576. ipilimumab -- r_associated #0: 102 / 0.223 -> en:4-peptide melanoma vaccine
    n1=ipilimumab | n2=en:4-peptide melanoma vaccine | rel=r_associated | relid=0 | w=102
  2577. ipilimumab -- r_associated #0: 102 / 0.223 -> en:4-thio-2-deoxycytidine
    n1=ipilimumab | n2=en:4-thio-2-deoxycytidine | rel=r_associated | relid=0 | w=102
  2578. ipilimumab -- r_associated #0: 102 / 0.223 -> en:4'-iodo-4'-deoxydoxorubicin
    n1=ipilimumab | n2=en:4'-iodo-4'-deoxydoxorubicin | rel=r_associated | relid=0 | w=102
  2579. ipilimumab -- r_associated #0: 102 / 0.223 -> en:8-hydroxyquinoline sulfate ointment
    n1=ipilimumab | n2=en:8-hydroxyquinoline sulfate ointment | rel=r_associated | relid=0 | w=102
  2580. ipilimumab -- r_associated #0: 102 / 0.223 -> en:abagovomab
    n1=ipilimumab | n2=en:abagovomab | rel=r_associated | relid=0 | w=102
  2581. ipilimumab -- r_associated #0: 102 / 0.223 -> en:abbv-221
    n1=ipilimumab | n2=en:abbv-221 | rel=r_associated | relid=0 | w=102
  2582. ipilimumab -- r_associated #0: 102 / 0.223 -> en:absorbable fibrin sealant patch
    n1=ipilimumab | n2=en:absorbable fibrin sealant patch | rel=r_associated | relid=0 | w=102
  2583. ipilimumab -- r_associated #0: 102 / 0.223 -> en:acadesine
    n1=ipilimumab | n2=en:acadesine | rel=r_associated | relid=0 | w=102
  2584. ipilimumab -- r_associated #0: 102 / 0.223 -> en:acellular cadaveric dermal matrix
    n1=ipilimumab | n2=en:acellular cadaveric dermal matrix | rel=r_associated | relid=0 | w=102
  2585. ipilimumab -- r_associated #0: 102 / 0.223 -> en:acitretin
    n1=ipilimumab | n2=en:acitretin | rel=r_associated | relid=0 | w=102
  2586. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ad5.sstr/tk.rgd
    n1=ipilimumab | n2=en:ad5.sstr/tk.rgd | rel=r_associated | relid=0 | w=102
  2587. ipilimumab -- r_associated #0: 102 / 0.223 -> en:adenosine a2a receptor antagonist pbf-509
    n1=ipilimumab | n2=en:adenosine a2a receptor antagonist pbf-509 | rel=r_associated | relid=0 | w=102
  2588. ipilimumab -- r_associated #0: 102 / 0.223 -> en:adenosine a3 receptor agonist cf102
    n1=ipilimumab | n2=en:adenosine a3 receptor agonist cf102 | rel=r_associated | relid=0 | w=102
  2589. ipilimumab -- r_associated #0: 102 / 0.223 -> en:adenoviral transduced hil-12-expressing autologous dendritic cells inxn-3001 plus activator ligand inxn-1001
    n1=ipilimumab | n2=en:adenoviral transduced hil-12-expressing autologous dendritic cells inxn-3001 plus activator ligand inxn-1001 | rel=r_associated | relid=0 | w=102
  2590. ipilimumab -- r_associated #0: 102 / 0.223 -> en:adenovirus b7-1
    n1=ipilimumab | n2=en:adenovirus b7-1 | rel=r_associated | relid=0 | w=102
  2591. ipilimumab -- r_associated #0: 102 / 0.223 -> en:adenovirus vector
    n1=ipilimumab | n2=en:adenovirus vector | rel=r_associated | relid=0 | w=102
  2592. ipilimumab -- r_associated #0: 102 / 0.223 -> en:adenovirus/cytomegalovirus/epstein-barr virus-specific allogeneic cytotoxic t lymphocytes
    n1=ipilimumab | n2=en:adenovirus/cytomegalovirus/epstein-barr virus-specific allogeneic cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=102
  2593. ipilimumab -- r_associated #0: 102 / 0.223 -> en:akt inhibitor azd5363
    n1=ipilimumab | n2=en:akt inhibitor azd5363 | rel=r_associated | relid=0 | w=102
  2594. ipilimumab -- r_associated #0: 102 / 0.223 -> en:alkalinizing agent (substance)
    n1=ipilimumab | n2=en:alkalinizing agent (substance) | rel=r_associated | relid=0 | w=102
  2595. ipilimumab -- r_associated #0: 102 / 0.223 -> en:allodepleted t cell immunotherapeutic atir101
    n1=ipilimumab | n2=en:allodepleted t cell immunotherapeutic atir101 | rel=r_associated | relid=0 | w=102
  2596. ipilimumab -- r_associated #0: 102 / 0.223 -> en:allogeneic renal cell carcinoma vaccine mgn1601
    n1=ipilimumab | n2=en:allogeneic renal cell carcinoma vaccine mgn1601 | rel=r_associated | relid=0 | w=102
  2597. ipilimumab -- r_associated #0: 102 / 0.223 -> en:allopurinol
    n1=ipilimumab | n2=en:allopurinol | rel=r_associated | relid=0 | w=102
  2598. ipilimumab -- r_associated #0: 102 / 0.223 -> en:aloe vera gel
    n1=ipilimumab | n2=en:aloe vera gel | rel=r_associated | relid=0 | w=102
  2599. ipilimumab -- r_associated #0: 102 / 0.223 -> en:alpha fetoprotein adenoviral vector vaccine
    n1=ipilimumab | n2=en:alpha fetoprotein adenoviral vector vaccine | rel=r_associated | relid=0 | w=102
  2600. ipilimumab -- r_associated #0: 102 / 0.223 -> en:alpha-1-proteinase inhibitor human
    n1=ipilimumab | n2=en:alpha-1-proteinase inhibitor human | rel=r_associated | relid=0 | w=102
  2601. ipilimumab -- r_associated #0: 102 / 0.223 -> en:alpha-lipoic acid-palladium/vitamin/mineral supplement
    n1=ipilimumab | n2=en:alpha-lipoic acid-palladium/vitamin/mineral supplement | rel=r_associated | relid=0 | w=102
  2602. ipilimumab -- r_associated #0: 102 / 0.223 -> en:alteplase
    n1=ipilimumab | n2=en:alteplase | rel=r_associated | relid=0 | w=102
  2603. ipilimumab -- r_associated #0: 102 / 0.223 -> en:altretamine
    n1=ipilimumab | n2=en:altretamine | rel=r_associated | relid=0 | w=102
  2604. ipilimumab -- r_associated #0: 102 / 0.223 -> en:aluminum hydroxide/magnesium hydroxide
    n1=ipilimumab | n2=en:aluminum hydroxide/magnesium hydroxide | rel=r_associated | relid=0 | w=102
  2605. ipilimumab -- r_associated #0: 102 / 0.223 -> en:amatuximab
    n1=ipilimumab | n2=en:amatuximab | rel=r_associated | relid=0 | w=102
  2606. ipilimumab -- r_associated #0: 102 / 0.223 -> en:amikacin sulfate
    n1=ipilimumab | n2=en:amikacin sulfate | rel=r_associated | relid=0 | w=102
  2607. ipilimumab -- r_associated #0: 102 / 0.223 -> en:aminocamptothecin colloidal dispersion
    n1=ipilimumab | n2=en:aminocamptothecin colloidal dispersion | rel=r_associated | relid=0 | w=102
  2608. ipilimumab -- r_associated #0: 102 / 0.223 -> en:amolimogene bepiplasmid
    n1=ipilimumab | n2=en:amolimogene bepiplasmid | rel=r_associated | relid=0 | w=102
  2609. ipilimumab -- r_associated #0: 102 / 0.223 -> en:analgesic agent
    n1=ipilimumab | n2=en:analgesic agent | rel=r_associated | relid=0 | w=102
  2610. ipilimumab -- r_associated #0: 102 / 0.223 -> en:androgen antagonist apc-100
    n1=ipilimumab | n2=en:androgen antagonist apc-100 | rel=r_associated | relid=0 | w=102
  2611. ipilimumab -- r_associated #0: 102 / 0.223 -> en:androgen receptor antagonist arn-509
    n1=ipilimumab | n2=en:androgen receptor antagonist arn-509 | rel=r_associated | relid=0 | w=102
  2612. ipilimumab -- r_associated #0: 102 / 0.223 -> en:androgen receptor inhibitor epi-506
    n1=ipilimumab | n2=en:androgen receptor inhibitor epi-506 | rel=r_associated | relid=0 | w=102
  2613. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anguidine
    n1=ipilimumab | n2=en:anguidine | rel=r_associated | relid=0 | w=102
  2614. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-5t4 antibody-drug conjugate pf-06263507
    n1=ipilimumab | n2=en:anti-5t4 antibody-drug conjugate pf-06263507 | rel=r_associated | relid=0 | w=102
  2615. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-cd123 monoclonal antibody csl362
    n1=ipilimumab | n2=en:anti-cd123 monoclonal antibody csl362 | rel=r_associated | relid=0 | w=102
  2616. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-cd123/cd3 monoclonal antibody mgd006
    n1=ipilimumab | n2=en:anti-cd123/cd3 monoclonal antibody mgd006 | rel=r_associated | relid=0 | w=102
  2617. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-cd22 monoclonal antibody-mmae conjugate dcdt2980s
    n1=ipilimumab | n2=en:anti-cd22 monoclonal antibody-mmae conjugate dcdt2980s | rel=r_associated | relid=0 | w=102
  2618. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-cd70 antibody-drug conjugate mdx-1203
    n1=ipilimumab | n2=en:anti-cd70 antibody-drug conjugate mdx-1203 | rel=r_associated | relid=0 | w=102
  2619. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-cea/anti-dtpa-in (f6-734) bispecific antibody
    n1=ipilimumab | n2=en:anti-cea/anti-dtpa-in (f6-734) bispecific antibody | rel=r_associated | relid=0 | w=102
  2620. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-cea/anti-hsg bispecific monoclonal antibody tf2
    n1=ipilimumab | n2=en:anti-cea/anti-hsg bispecific monoclonal antibody tf2 | rel=r_associated | relid=0 | w=102
  2621. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-ceacam1 monoclonal antibody cm-24
    n1=ipilimumab | n2=en:anti-ceacam1 monoclonal antibody cm-24 | rel=r_associated | relid=0 | w=102
  2622. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-ctgf monoclonal antibody fg-3019
    n1=ipilimumab | n2=en:anti-ctgf monoclonal antibody fg-3019 | rel=r_associated | relid=0 | w=102
  2623. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/mdx-1379 melanoma vaccine
    n1=ipilimumab | n2=en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/mdx-1379 melanoma vaccine | rel=r_associated | relid=0 | w=102
  2624. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-dll4 monoclonal antibody medi0639
    n1=ipilimumab | n2=en:anti-dll4 monoclonal antibody medi0639 | rel=r_associated | relid=0 | w=102
  2625. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-egfrviii antibody drug conjugate amg 595
    n1=ipilimumab | n2=en:anti-egfrviii antibody drug conjugate amg 595 | rel=r_associated | relid=0 | w=102
  2626. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-egp-2 immunotoxin moc31-pe
    n1=ipilimumab | n2=en:anti-egp-2 immunotoxin moc31-pe | rel=r_associated | relid=0 | w=102
  2627. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-endosialin monoclonal antibody morab-004
    n1=ipilimumab | n2=en:anti-endosialin monoclonal antibody morab-004 | rel=r_associated | relid=0 | w=102
  2628. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-enpp3 antibody-drug conjugate ags-16c3f
    n1=ipilimumab | n2=en:anti-enpp3 antibody-drug conjugate ags-16c3f | rel=r_associated | relid=0 | w=102
  2629. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-erbb3/anti-igf-1r bispecific monoclonal antibody mm-141
    n1=ipilimumab | n2=en:anti-erbb3/anti-igf-1r bispecific monoclonal antibody mm-141 | rel=r_associated | relid=0 | w=102
  2630. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-gpc3 monoclonal antibody gc33
    n1=ipilimumab | n2=en:anti-gpc3 monoclonal antibody gc33 | rel=r_associated | relid=0 | w=102
  2631. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-integrin monoclonal antibody-dm4 immunoconjugate imgn388
    n1=ipilimumab | n2=en:anti-integrin monoclonal antibody-dm4 immunoconjugate imgn388 | rel=r_associated | relid=0 | w=102
  2632. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-interleukin 6 monoclonal antibody ald518
    n1=ipilimumab | n2=en:anti-interleukin 6 monoclonal antibody ald518 | rel=r_associated | relid=0 | w=102
  2633. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-lag-3 monoclonal antibody bms-986016
    n1=ipilimumab | n2=en:anti-lag-3 monoclonal antibody bms-986016 | rel=r_associated | relid=0 | w=102
  2634. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-masp-2 monoclonal antibody oms721
    n1=ipilimumab | n2=en:anti-masp-2 monoclonal antibody oms721 | rel=r_associated | relid=0 | w=102
  2635. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-mesothelin icasp9m28z car-transduced autologous t lymphocytes
    n1=ipilimumab | n2=en:anti-mesothelin icasp9m28z car-transduced autologous t lymphocytes | rel=r_associated | relid=0 | w=102
  2636. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-mesothelin/mmae antibody-drug conjugate dmot4039a
    n1=ipilimumab | n2=en:anti-mesothelin/mmae antibody-drug conjugate dmot4039a | rel=r_associated | relid=0 | w=102
  2637. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-met/egfr monoclonal antibody ly3164530
    n1=ipilimumab | n2=en:anti-met/egfr monoclonal antibody ly3164530 | rel=r_associated | relid=0 | w=102
  2638. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-pd-1 fusion protein amp-224
    n1=ipilimumab | n2=en:anti-pd-1 fusion protein amp-224 | rel=r_associated | relid=0 | w=102
  2639. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-pd-1 monoclonal antibody pdr001
    n1=ipilimumab | n2=en:anti-pd-1 monoclonal antibody pdr001 | rel=r_associated | relid=0 | w=102
  2640. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-pd-1 monoclonal antibody regn2810
    n1=ipilimumab | n2=en:anti-pd-1 monoclonal antibody regn2810 | rel=r_associated | relid=0 | w=102
  2641. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-sema4d monoclonal antibody vx15/2503
    n1=ipilimumab | n2=en:anti-sema4d monoclonal antibody vx15/2503 | rel=r_associated | relid=0 | w=102
  2642. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-tf monoclonal antibody alt-836
    n1=ipilimumab | n2=en:anti-tf monoclonal antibody alt-836 | rel=r_associated | relid=0 | w=102
  2643. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-tlr2 monoclonal antibody opn-305
    n1=ipilimumab | n2=en:anti-tlr2 monoclonal antibody opn-305 | rel=r_associated | relid=0 | w=102
  2644. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anti-tumor necrosis factor alpha drug
    n1=ipilimumab | n2=en:anti-tumor necrosis factor alpha drug | rel=r_associated | relid=0 | w=102
  2645. ipilimumab -- r_associated #0: 102 / 0.223 -> en:antiarthritic agent
    n1=ipilimumab | n2=en:antiarthritic agent | rel=r_associated | relid=0 | w=102
  2646. ipilimumab -- r_associated #0: 102 / 0.223 -> en:antibody-drug conjugate adct-402
    n1=ipilimumab | n2=en:antibody-drug conjugate adct-402 | rel=r_associated | relid=0 | w=102
  2647. ipilimumab -- r_associated #0: 102 / 0.223 -> en:anticachexia agent mt-102
    n1=ipilimumab | n2=en:anticachexia agent mt-102 | rel=r_associated | relid=0 | w=102
  2648. ipilimumab -- r_associated #0: 102 / 0.223 -> en:antifungal agent f901318
    n1=ipilimumab | n2=en:antifungal agent f901318 | rel=r_associated | relid=0 | w=102
  2649. ipilimumab -- r_associated #0: 102 / 0.223 -> en:antimoniotungstate
    n1=ipilimumab | n2=en:antimoniotungstate | rel=r_associated | relid=0 | w=102
  2650. ipilimumab -- r_associated #0: 102 / 0.223 -> en:antimony
    n1=ipilimumab | n2=en:antimony | rel=r_associated | relid=0 | w=102
  2651. ipilimumab -- r_associated #0: 102 / 0.223 -> en:antineoplastic anthraquinone
    n1=ipilimumab | n2=en:antineoplastic anthraquinone | rel=r_associated | relid=0 | w=102
  2652. ipilimumab -- r_associated #0: 102 / 0.223 -> en:antineoplastic antibiotic
    n1=ipilimumab | n2=en:antineoplastic antibiotic | rel=r_associated | relid=0 | w=102
  2653. ipilimumab -- r_associated #0: 102 / 0.223 -> en:antineoplastic metal complex preparation
    n1=ipilimumab | n2=en:antineoplastic metal complex preparation | rel=r_associated | relid=0 | w=102
  2654. ipilimumab -- r_associated #0: 102 / 0.223 -> en:antiperspirant cream f511
    n1=ipilimumab | n2=en:antiperspirant cream f511 | rel=r_associated | relid=0 | w=102
  2655. ipilimumab -- r_associated #0: 102 / 0.223 -> en:antiplatelet agent
    n1=ipilimumab | n2=en:antiplatelet agent | rel=r_associated | relid=0 | w=102
  2656. ipilimumab -- r_associated #0: 102 / 0.223 -> en:antitumor b
    n1=ipilimumab | n2=en:antitumor b | rel=r_associated | relid=0 | w=102
  2657. ipilimumab -- r_associated #0: 102 / 0.223 -> en:antroquinonol capsule
    n1=ipilimumab | n2=en:antroquinonol capsule | rel=r_associated | relid=0 | w=102
  2658. ipilimumab -- r_associated #0: 102 / 0.223 -> en:apf530
    n1=ipilimumab | n2=en:apf530 | rel=r_associated | relid=0 | w=102
  2659. ipilimumab -- r_associated #0: 102 / 0.223 -> en:apoptosis inducer mpc-2130
    n1=ipilimumab | n2=en:apoptosis inducer mpc-2130 | rel=r_associated | relid=0 | w=102
  2660. ipilimumab -- r_associated #0: 102 / 0.223 -> en:arsanilic acid
    n1=ipilimumab | n2=en:arsanilic acid | rel=r_associated | relid=0 | w=102
  2661. ipilimumab -- r_associated #0: 102 / 0.223 -> en:artesunate
    n1=ipilimumab | n2=en:artesunate | rel=r_associated | relid=0 | w=102
  2662. ipilimumab -- r_associated #0: 102 / 0.223 -> en:asian ginseng
    n1=ipilimumab | n2=en:asian ginseng | rel=r_associated | relid=0 | w=102
  2663. ipilimumab -- r_associated #0: 102 / 0.223 -> en:asp9853
    n1=ipilimumab | n2=en:asp9853 | rel=r_associated | relid=0 | w=102
  2664. ipilimumab -- r_associated #0: 102 / 0.223 -> en:astragalus-based formulation qing shu yi qi tang
    n1=ipilimumab | n2=en:astragalus-based formulation qing shu yi qi tang | rel=r_associated | relid=0 | w=102
  2665. ipilimumab -- r_associated #0: 102 / 0.223 -> en:atiprimod
    n1=ipilimumab | n2=en:atiprimod | rel=r_associated | relid=0 | w=102
  2666. ipilimumab -- r_associated #0: 102 / 0.223 -> en:aurora kinase inhibitor mln8054
    n1=ipilimumab | n2=en:aurora kinase inhibitor mln8054 | rel=r_associated | relid=0 | w=102
  2667. ipilimumab -- r_associated #0: 102 / 0.223 -> en:autologous anti-gp100:154-162 t-cell receptor gene-engineered peripheral blood lymphocytes
    n1=ipilimumab | n2=en:autologous anti-gp100:154-162 t-cell receptor gene-engineered peripheral blood lymphocytes | rel=r_associated | relid=0 | w=102
  2668. ipilimumab -- r_associated #0: 102 / 0.223 -> en:autologous anti-psma gene-modified t-lymphocytes
    n1=ipilimumab | n2=en:autologous anti-psma gene-modified t-lymphocytes | rel=r_associated | relid=0 | w=102
  2669. ipilimumab -- r_associated #0: 102 / 0.223 -> en:autologous beta-a(t87q)-globin gene-transduced cd34-positive cells
    n1=ipilimumab | n2=en:autologous beta-a(t87q)-globin gene-transduced cd34-positive cells | rel=r_associated | relid=0 | w=102
  2670. ipilimumab -- r_associated #0: 102 / 0.223 -> en:autologous ct7/mage-a3/wt1 mrna-electroporated langerhans-type dendritic cells
    n1=ipilimumab | n2=en:autologous ct7/mage-a3/wt1 mrna-electroporated langerhans-type dendritic cells | rel=r_associated | relid=0 | w=102
  2671. ipilimumab -- r_associated #0: 102 / 0.223 -> en:autologous dendritic cells/cmv pp65 peptide
    n1=ipilimumab | n2=en:autologous dendritic cells/cmv pp65 peptide | rel=r_associated | relid=0 | w=102
  2672. ipilimumab -- r_associated #0: 102 / 0.223 -> en:autologous gm-csf-secreting breast cancer vaccine
    n1=ipilimumab | n2=en:autologous gm-csf-secreting breast cancer vaccine | rel=r_associated | relid=0 | w=102
  2673. ipilimumab -- r_associated #0: 102 / 0.223 -> en:autologous gm-csf-secreting melanoma vaccine
    n1=ipilimumab | n2=en:autologous gm-csf-secreting melanoma vaccine | rel=r_associated | relid=0 | w=102
  2674. ipilimumab -- r_associated #0: 102 / 0.223 -> en:autologous lymphoma cell lysate-pulsed autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:autologous lymphoma cell lysate-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=102
  2675. ipilimumab -- r_associated #0: 102 / 0.223 -> en:autologous lymphoma cell/autologous dendritic cell electrofusion hybrid vaccine
    n1=ipilimumab | n2=en:autologous lymphoma cell/autologous dendritic cell electrofusion hybrid vaccine | rel=r_associated | relid=0 | w=102
  2676. ipilimumab -- r_associated #0: 102 / 0.223 -> en:autologous lymphoma immunoglobulin-derived scfv-chemokine dna vaccine
    n1=ipilimumab | n2=en:autologous lymphoma immunoglobulin-derived scfv-chemokine dna vaccine | rel=r_associated | relid=0 | w=102
  2677. ipilimumab -- r_associated #0: 102 / 0.223 -> en:autologous melanoma lysate/klh-pulsed autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:autologous melanoma lysate/klh-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=102
  2678. ipilimumab -- r_associated #0: 102 / 0.223 -> en:autologous mesenchymal stem cells apceth_101
    n1=ipilimumab | n2=en:autologous mesenchymal stem cells apceth_101 | rel=r_associated | relid=0 | w=102
  2679. ipilimumab -- r_associated #0: 102 / 0.223 -> en:autologous sarcoma cell lysate
    n1=ipilimumab | n2=en:autologous sarcoma cell lysate | rel=r_associated | relid=0 | w=102
  2680. ipilimumab -- r_associated #0: 102 / 0.223 -> en:autologous tns9.3.55-transduced cd34-positive cells
    n1=ipilimumab | n2=en:autologous tns9.3.55-transduced cd34-positive cells | rel=r_associated | relid=0 | w=102
  2681. ipilimumab -- r_associated #0: 102 / 0.223 -> en:autologous tumor infiltrating lymphocytes ln-144
    n1=ipilimumab | n2=en:autologous tumor infiltrating lymphocytes ln-144 | rel=r_associated | relid=0 | w=102
  2682. ipilimumab -- r_associated #0: 102 / 0.223 -> en:autonomic agents
    n1=ipilimumab | n2=en:autonomic agents | rel=r_associated | relid=0 | w=102
  2683. ipilimumab -- r_associated #0: 102 / 0.223 -> en:avn944
    n1=ipilimumab | n2=en:avn944 | rel=r_associated | relid=0 | w=102
  2684. ipilimumab -- r_associated #0: 102 / 0.223 -> en:b16alphagal melanoma vaccine
    n1=ipilimumab | n2=en:b16alphagal melanoma vaccine | rel=r_associated | relid=0 | w=102
  2685. ipilimumab -- r_associated #0: 102 / 0.223 -> en:b43-pap immunotoxin
    n1=ipilimumab | n2=en:b43-pap immunotoxin | rel=r_associated | relid=0 | w=102
  2686. ipilimumab -- r_associated #0: 102 / 0.223 -> en:bacteriophage phi x 174
    n1=ipilimumab | n2=en:bacteriophage phi x 174 | rel=r_associated | relid=0 | w=102
  2687. ipilimumab -- r_associated #0: 102 / 0.223 -> en:bay 86-4367
    n1=ipilimumab | n2=en:bay 86-4367 | rel=r_associated | relid=0 | w=102
  2688. ipilimumab -- r_associated #0: 102 / 0.223 -> en:bazedoxifene
    n1=ipilimumab | n2=en:bazedoxifene | rel=r_associated | relid=0 | w=102
  2689. ipilimumab -- r_associated #0: 102 / 0.223 -> en:bcl-2 inhibitor bcl201
    n1=ipilimumab | n2=en:bcl-2 inhibitor bcl201 | rel=r_associated | relid=0 | w=102
  2690. ipilimumab -- r_associated #0: 102 / 0.223 -> en:bcr-abl (b2a2)-derived peptide vaccine
    n1=ipilimumab | n2=en:bcr-abl (b2a2)-derived peptide vaccine | rel=r_associated | relid=0 | w=102
  2691. ipilimumab -- r_associated #0: 102 / 0.223 -> en:berberine chloride
    n1=ipilimumab | n2=en:berberine chloride | rel=r_associated | relid=0 | w=102
  2692. ipilimumab -- r_associated #0: 102 / 0.223 -> en:bet inhibitor bay1238097
    n1=ipilimumab | n2=en:bet inhibitor bay1238097 | rel=r_associated | relid=0 | w=102
  2693. ipilimumab -- r_associated #0: 102 / 0.223 -> en:bet inhibitor ft-1101
    n1=ipilimumab | n2=en:bet inhibitor ft-1101 | rel=r_associated | relid=0 | w=102
  2694. ipilimumab -- r_associated #0: 102 / 0.223 -> en:bet inhibitor gsk525762
    n1=ipilimumab | n2=en:bet inhibitor gsk525762 | rel=r_associated | relid=0 | w=102
  2695. ipilimumab -- r_associated #0: 102 / 0.223 -> en:beta-hydroxy-beta-methylbutyrate supplement
    n1=ipilimumab | n2=en:beta-hydroxy-beta-methylbutyrate supplement | rel=r_associated | relid=0 | w=102
  2696. ipilimumab -- r_associated #0: 102 / 0.223 -> en:betulinic acid
    n1=ipilimumab | n2=en:betulinic acid | rel=r_associated | relid=0 | w=102
  2697. ipilimumab -- r_associated #0: 102 / 0.223 -> en:bimatoprost
    n1=ipilimumab | n2=en:bimatoprost | rel=r_associated | relid=0 | w=102
  2698. ipilimumab -- r_associated #0: 102 / 0.223 -> en:biological factors
    n1=ipilimumab | n2=en:biological factors | rel=r_associated | relid=0 | w=102
  2699. ipilimumab -- r_associated #0: 102 / 0.223 -> en:black seed oil
    n1=ipilimumab | n2=en:black seed oil | rel=r_associated | relid=0 | w=102
  2700. ipilimumab -- r_associated #0: 102 / 0.223 -> en:black tea
    n1=ipilimumab | n2=en:black tea | rel=r_associated | relid=0 | w=102
  2701. ipilimumab -- r_associated #0: 102 / 0.223 -> en:bleomycin sulfate
    n1=ipilimumab | n2=en:bleomycin sulfate | rel=r_associated | relid=0 | w=102
  2702. ipilimumab -- r_associated #0: 102 / 0.223 -> en:blex 404
    n1=ipilimumab | n2=en:blex 404 | rel=r_associated | relid=0 | w=102
  2703. ipilimumab -- r_associated #0: 102 / 0.223 -> en:bone metastasis targeting peptide-11
    n1=ipilimumab | n2=en:bone metastasis targeting peptide-11 | rel=r_associated | relid=0 | w=102
  2704. ipilimumab -- r_associated #0: 102 / 0.223 -> en:boron phenylalanine
    n1=ipilimumab | n2=en:boron phenylalanine | rel=r_associated | relid=0 | w=102
  2705. ipilimumab -- r_associated #0: 102 / 0.223 -> en:boronophenylalanine-fructose complex
    n1=ipilimumab | n2=en:boronophenylalanine-fructose complex | rel=r_associated | relid=0 | w=102
  2706. ipilimumab -- r_associated #0: 102 / 0.223 -> en:bortezomib
    n1=ipilimumab | n2=en:bortezomib | rel=r_associated | relid=0 | w=102
  2707. ipilimumab -- r_associated #0: 102 / 0.223 -> en:braf inhibitor
    n1=ipilimumab | n2=en:braf inhibitor | rel=r_associated | relid=0 | w=102
  2708. ipilimumab -- r_associated #0: 102 / 0.223 -> en:braf inhibitor plx8394
    n1=ipilimumab | n2=en:braf inhibitor plx8394 | rel=r_associated | relid=0 | w=102
  2709. ipilimumab -- r_associated #0: 102 / 0.223 -> en:branched-chain amino acid supplement
    n1=ipilimumab | n2=en:branched-chain amino acid supplement | rel=r_associated | relid=0 | w=102
  2710. ipilimumab -- r_associated #0: 102 / 0.223 -> en:brilacidin oral rinse
    n1=ipilimumab | n2=en:brilacidin oral rinse | rel=r_associated | relid=0 | w=102
  2711. ipilimumab -- r_associated #0: 102 / 0.223 -> en:budesonide/formoterol fumarate dihydrate inhalation aerosol
    n1=ipilimumab | n2=en:budesonide/formoterol fumarate dihydrate inhalation aerosol | rel=r_associated | relid=0 | w=102
  2712. ipilimumab -- r_associated #0: 102 / 0.223 -> en:bupropion + naltrexone
    n1=ipilimumab | n2=en:bupropion + naltrexone | rel=r_associated | relid=0 | w=102
  2713. ipilimumab -- r_associated #0: 102 / 0.223 -> en:c-met inhibitor msc2156119j
    n1=ipilimumab | n2=en:c-met inhibitor msc2156119j | rel=r_associated | relid=0 | w=102
  2714. ipilimumab -- r_associated #0: 102 / 0.223 -> en:c-visa bikdd:liposome
    n1=ipilimumab | n2=en:c-visa bikdd:liposome | rel=r_associated | relid=0 | w=102
  2715. ipilimumab -- r_associated #0: 102 / 0.223 -> en:c3-targeted complement inhibitor apl-2
    n1=ipilimumab | n2=en:c3-targeted complement inhibitor apl-2 | rel=r_associated | relid=0 | w=102
  2716. ipilimumab -- r_associated #0: 102 / 0.223 -> en:calcitriol
    n1=ipilimumab | n2=en:calcitriol | rel=r_associated | relid=0 | w=102
  2717. ipilimumab -- r_associated #0: 102 / 0.223 -> en:camptothecin
    n1=ipilimumab | n2=en:camptothecin | rel=r_associated | relid=0 | w=102
  2718. ipilimumab -- r_associated #0: 102 / 0.223 -> en:cancell
    n1=ipilimumab | n2=en:cancell | rel=r_associated | relid=0 | w=102
  2719. ipilimumab -- r_associated #0: 102 / 0.223 -> en:candida albicans skin test reagent
    n1=ipilimumab | n2=en:candida albicans skin test reagent | rel=r_associated | relid=0 | w=102
  2720. ipilimumab -- r_associated #0: 102 / 0.223 -> en:canfosfamide hydrochloride
    n1=ipilimumab | n2=en:canfosfamide hydrochloride | rel=r_associated | relid=0 | w=102
  2721. ipilimumab -- r_associated #0: 102 / 0.223 -> en:cannabinol
    n1=ipilimumab | n2=en:cannabinol | rel=r_associated | relid=0 | w=102
  2722. ipilimumab -- r_associated #0: 102 / 0.223 -> en:capsaicin
    n1=ipilimumab | n2=en:capsaicin | rel=r_associated | relid=0 | w=102
  2723. ipilimumab -- r_associated #0: 102 / 0.223 -> en:captopril
    n1=ipilimumab | n2=en:captopril | rel=r_associated | relid=0 | w=102
  2724. ipilimumab -- r_associated #0: 102 / 0.223 -> en:carbon c11 temozolomide
    n1=ipilimumab | n2=en:carbon c11 temozolomide | rel=r_associated | relid=0 | w=102
  2725. ipilimumab -- r_associated #0: 102 / 0.223 -> en:carbon-11 acetate
    n1=ipilimumab | n2=en:carbon-11 acetate | rel=r_associated | relid=0 | w=102
  2726. ipilimumab -- r_associated #0: 102 / 0.223 -> en:carcinoembryonic antigen peptide 1
    n1=ipilimumab | n2=en:carcinoembryonic antigen peptide 1 | rel=r_associated | relid=0 | w=102
  2727. ipilimumab -- r_associated #0: 102 / 0.223 -> en:cdk inhibitor sns-032
    n1=ipilimumab | n2=en:cdk inhibitor sns-032 | rel=r_associated | relid=0 | w=102
  2728. ipilimumab -- r_associated #0: 102 / 0.223 -> en:cebranopadol
    n1=ipilimumab | n2=en:cebranopadol | rel=r_associated | relid=0 | w=102
  2729. ipilimumab -- r_associated #0: 102 / 0.223 -> en:cell cycle checkpoint/dna repair antagonist ic83
    n1=ipilimumab | n2=en:cell cycle checkpoint/dna repair antagonist ic83 | rel=r_associated | relid=0 | w=102
  2730. ipilimumab -- r_associated #0: 102 / 0.223 -> en:cemadotin hydrochloride
    n1=ipilimumab | n2=en:cemadotin hydrochloride | rel=r_associated | relid=0 | w=102
  2731. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ceruminolytic agent
    n1=ipilimumab | n2=en:ceruminolytic agent | rel=r_associated | relid=0 | w=102
  2732. ipilimumab -- r_associated #0: 102 / 0.223 -> en:cetrorelix
    n1=ipilimumab | n2=en:cetrorelix | rel=r_associated | relid=0 | w=102
  2733. ipilimumab -- r_associated #0: 102 / 0.223 -> en:changchun marina
    n1=ipilimumab | n2=en:changchun marina | rel=r_associated | relid=0 | w=102
  2734. ipilimumab -- r_associated #0: 102 / 0.223 -> en:chlorozotocin
    n1=ipilimumab | n2=en:chlorozotocin | rel=r_associated | relid=0 | w=102
  2735. ipilimumab -- r_associated #0: 102 / 0.223 -> en:choline magnesium trisalicylate
    n1=ipilimumab | n2=en:choline magnesium trisalicylate | rel=r_associated | relid=0 | w=102
  2736. ipilimumab -- r_associated #0: 102 / 0.223 -> en:cisplatin-e therapeutic implant
    n1=ipilimumab | n2=en:cisplatin-e therapeutic implant | rel=r_associated | relid=0 | w=102
  2737. ipilimumab -- r_associated #0: 102 / 0.223 -> en:clanfenur
    n1=ipilimumab | n2=en:clanfenur | rel=r_associated | relid=0 | w=102
  2738. ipilimumab -- r_associated #0: 102 / 0.223 -> en:clindamycin
    n1=ipilimumab | n2=en:clindamycin | rel=r_associated | relid=0 | w=102
  2739. ipilimumab -- r_associated #0: 102 / 0.223 -> en:clostridium butyricum-containing probiotic
    n1=ipilimumab | n2=en:clostridium butyricum-containing probiotic | rel=r_associated | relid=0 | w=102
  2740. ipilimumab -- r_associated #0: 102 / 0.223 -> en:cmvpp65-a*0201 peptide vaccine
    n1=ipilimumab | n2=en:cmvpp65-a*0201 peptide vaccine | rel=r_associated | relid=0 | w=102
  2741. ipilimumab -- r_associated #0: 102 / 0.223 -> en:cobalamin
    n1=ipilimumab | n2=en:cobalamin | rel=r_associated | relid=0 | w=102
  2742. ipilimumab -- r_associated #0: 102 / 0.223 -> en:cocculus/nux vomica/tabacum/petroleum extract
    n1=ipilimumab | n2=en:cocculus/nux vomica/tabacum/petroleum extract | rel=r_associated | relid=0 | w=102
  2743. ipilimumab -- r_associated #0: 102 / 0.223 -> en:colchicine
    n1=ipilimumab | n2=en:colchicine | rel=r_associated | relid=0 | w=102
  2744. ipilimumab -- r_associated #0: 102 / 0.223 -> en:colesevelam hydrochloride
    n1=ipilimumab | n2=en:colesevelam hydrochloride | rel=r_associated | relid=0 | w=102
  2745. ipilimumab -- r_associated #0: 102 / 0.223 -> en:colloidal oatmeal cream
    n1=ipilimumab | n2=en:colloidal oatmeal cream | rel=r_associated | relid=0 | w=102
  2746. ipilimumab -- r_associated #0: 102 / 0.223 -> en:conatumumab
    n1=ipilimumab | n2=en:conatumumab | rel=r_associated | relid=0 | w=102
  2747. ipilimumab -- r_associated #0: 102 / 0.223 -> en:concentrated beet crystals
    n1=ipilimumab | n2=en:concentrated beet crystals | rel=r_associated | relid=0 | w=102
  2748. ipilimumab -- r_associated #0: 102 / 0.223 -> en:copp regimen
    n1=ipilimumab | n2=en:copp regimen | rel=r_associated | relid=0 | w=102
  2749. ipilimumab -- r_associated #0: 102 / 0.223 -> en:copper cu 62-ptsm
    n1=ipilimumab | n2=en:copper cu 62-ptsm | rel=r_associated | relid=0 | w=102
  2750. ipilimumab -- r_associated #0: 102 / 0.223 -> en:corticorelin acetate
    n1=ipilimumab | n2=en:corticorelin acetate | rel=r_associated | relid=0 | w=102
  2751. ipilimumab -- r_associated #0: 102 / 0.223 -> en:corticotropin releasing hormone
    n1=ipilimumab | n2=en:corticotropin releasing hormone | rel=r_associated | relid=0 | w=102
  2752. ipilimumab -- r_associated #0: 102 / 0.223 -> en:cridanimod sodium
    n1=ipilimumab | n2=en:cridanimod sodium | rel=r_associated | relid=0 | w=102
  2753. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ctp-37-dt vaccine
    n1=ipilimumab | n2=en:ctp-37-dt vaccine | rel=r_associated | relid=0 | w=102
  2754. ipilimumab -- r_associated #0: 102 / 0.223 -> en:curcumin
    n1=ipilimumab | n2=en:curcumin | rel=r_associated | relid=0 | w=102
  2755. ipilimumab -- r_associated #0: 102 / 0.223 -> en:cxc chemokine receptor 2 antagonist azd5069
    n1=ipilimumab | n2=en:cxc chemokine receptor 2 antagonist azd5069 | rel=r_associated | relid=0 | w=102
  2756. ipilimumab -- r_associated #0: 102 / 0.223 -> en:cyclobenzaprine hydrochloride
    n1=ipilimumab | n2=en:cyclobenzaprine hydrochloride | rel=r_associated | relid=0 | w=102
  2757. ipilimumab -- r_associated #0: 102 / 0.223 -> en:cyclophosphamide/dactinomycin/vincristine
    n1=ipilimumab | n2=en:cyclophosphamide/dactinomycin/vincristine | rel=r_associated | relid=0 | w=102
  2758. ipilimumab -- r_associated #0: 102 / 0.223 -> en:cyproterone
    n1=ipilimumab | n2=en:cyproterone | rel=r_associated | relid=0 | w=102
  2759. ipilimumab -- r_associated #0: 102 / 0.223 -> en:cytidine analog rx-3117
    n1=ipilimumab | n2=en:cytidine analog rx-3117 | rel=r_associated | relid=0 | w=102
  2760. ipilimumab -- r_associated #0: 102 / 0.223 -> en:d4064a
    n1=ipilimumab | n2=en:d4064a | rel=r_associated | relid=0 | w=102
  2761. ipilimumab -- r_associated #0: 102 / 0.223 -> en:dabigatran etexilate mesylate
    n1=ipilimumab | n2=en:dabigatran etexilate mesylate | rel=r_associated | relid=0 | w=102
  2762. ipilimumab -- r_associated #0: 102 / 0.223 -> en:daniquidone
    n1=ipilimumab | n2=en:daniquidone | rel=r_associated | relid=0 | w=102
  2763. ipilimumab -- r_associated #0: 102 / 0.223 -> en:deglycosylated ricin a chain-conjugated anti-cd19/anti-cd22 immunotoxins
    n1=ipilimumab | n2=en:deglycosylated ricin a chain-conjugated anti-cd19/anti-cd22 immunotoxins | rel=r_associated | relid=0 | w=102
  2764. ipilimumab -- r_associated #0: 102 / 0.223 -> en:delta-tocopherol
    n1=ipilimumab | n2=en:delta-tocopherol | rel=r_associated | relid=0 | w=102
  2765. ipilimumab -- r_associated #0: 102 / 0.223 -> en:dendritic cell-idiotype-keyhole limpet hemocyanin vaccine
    n1=ipilimumab | n2=en:dendritic cell-idiotype-keyhole limpet hemocyanin vaccine | rel=r_associated | relid=0 | w=102
  2766. ipilimumab -- r_associated #0: 102 / 0.223 -> en:dendritic cell-recombinant prostate-specific membrane antigen vaccine
    n1=ipilimumab | n2=en:dendritic cell-recombinant prostate-specific membrane antigen vaccine | rel=r_associated | relid=0 | w=102
  2767. ipilimumab -- r_associated #0: 102 / 0.223 -> en:denenicokin
    n1=ipilimumab | n2=en:denenicokin | rel=r_associated | relid=0 | w=102
  2768. ipilimumab -- r_associated #0: 102 / 0.223 -> en:denibulin hydrochloride
    n1=ipilimumab | n2=en:denibulin hydrochloride | rel=r_associated | relid=0 | w=102
  2769. ipilimumab -- r_associated #0: 102 / 0.223 -> en:deoxycytidine analogue tas-109
    n1=ipilimumab | n2=en:deoxycytidine analogue tas-109 | rel=r_associated | relid=0 | w=102
  2770. ipilimumab -- r_associated #0: 102 / 0.223 -> en:depatuxizumab
    n1=ipilimumab | n2=en:depatuxizumab | rel=r_associated | relid=0 | w=102
  2771. ipilimumab -- r_associated #0: 102 / 0.223 -> en:deslorelin
    n1=ipilimumab | n2=en:deslorelin | rel=r_associated | relid=0 | w=102
  2772. ipilimumab -- r_associated #0: 102 / 0.223 -> en:desogestrel
    n1=ipilimumab | n2=en:desogestrel | rel=r_associated | relid=0 | w=102
  2773. ipilimumab -- r_associated #0: 102 / 0.223 -> en:detorubicin
    n1=ipilimumab | n2=en:detorubicin | rel=r_associated | relid=0 | w=102
  2774. ipilimumab -- r_associated #0: 102 / 0.223 -> en:dexanabinol
    n1=ipilimumab | n2=en:dexanabinol | rel=r_associated | relid=0 | w=102
  2775. ipilimumab -- r_associated #0: 102 / 0.223 -> en:dexniguldipine
    n1=ipilimumab | n2=en:dexniguldipine | rel=r_associated | relid=0 | w=102
  2776. ipilimumab -- r_associated #0: 102 / 0.223 -> en:dexpanthenol mouthwash
    n1=ipilimumab | n2=en:dexpanthenol mouthwash | rel=r_associated | relid=0 | w=102
  2777. ipilimumab -- r_associated #0: 102 / 0.223 -> en:dexrazoxane hydrochloride
    n1=ipilimumab | n2=en:dexrazoxane hydrochloride | rel=r_associated | relid=0 | w=102
  2778. ipilimumab -- r_associated #0: 102 / 0.223 -> en:dichloromethotrexate
    n1=ipilimumab | n2=en:dichloromethotrexate | rel=r_associated | relid=0 | w=102
  2779. ipilimumab -- r_associated #0: 102 / 0.223 -> en:dicumarol
    n1=ipilimumab | n2=en:dicumarol | rel=r_associated | relid=0 | w=102
  2780. ipilimumab -- r_associated #0: 102 / 0.223 -> en:dietary product
    n1=ipilimumab | n2=en:dietary product | rel=r_associated | relid=0 | w=102
  2781. ipilimumab -- r_associated #0: 102 / 0.223 -> en:digitoxin
    n1=ipilimumab | n2=en:digitoxin | rel=r_associated | relid=0 | w=102
  2782. ipilimumab -- r_associated #0: 102 / 0.223 -> en:dihydrolenperone
    n1=ipilimumab | n2=en:dihydrolenperone | rel=r_associated | relid=0 | w=102
  2783. ipilimumab -- r_associated #0: 102 / 0.223 -> en:dinaciclib
    n1=ipilimumab | n2=en:dinaciclib | rel=r_associated | relid=0 | w=102
  2784. ipilimumab -- r_associated #0: 102 / 0.223 -> en:dinoprost tromethamine
    n1=ipilimumab | n2=en:dinoprost tromethamine | rel=r_associated | relid=0 | w=102
  2785. ipilimumab -- r_associated #0: 102 / 0.223 -> en:directly observed therapy
    n1=ipilimumab | n2=en:directly observed therapy | rel=r_associated | relid=0 | w=102
  2786. ipilimumab -- r_associated #0: 102 / 0.223 -> en:dl-selenomethionine
    n1=ipilimumab | n2=en:dl-selenomethionine | rel=r_associated | relid=0 | w=102
  2787. ipilimumab -- r_associated #0: 102 / 0.223 -> en:dna minor groove binding agent pm060184
    n1=ipilimumab | n2=en:dna minor groove binding agent pm060184 | rel=r_associated | relid=0 | w=102
  2788. ipilimumab -- r_associated #0: 102 / 0.223 -> en:donafenib
    n1=ipilimumab | n2=en:donafenib | rel=r_associated | relid=0 | w=102
  2789. ipilimumab -- r_associated #0: 102 / 0.223 -> en:donepezil + memantine
    n1=ipilimumab | n2=en:donepezil + memantine | rel=r_associated | relid=0 | w=102
  2790. ipilimumab -- r_associated #0: 102 / 0.223 -> en:donepezil hydrochloride
    n1=ipilimumab | n2=en:donepezil hydrochloride | rel=r_associated | relid=0 | w=102
  2791. ipilimumab -- r_associated #0: 102 / 0.223 -> en:dot1l inhibitor epz-5676
    n1=ipilimumab | n2=en:dot1l inhibitor epz-5676 | rel=r_associated | relid=0 | w=102
  2792. ipilimumab -- r_associated #0: 102 / 0.223 -> en:dotap:cholesterol-fus1 liposome complex
    n1=ipilimumab | n2=en:dotap:cholesterol-fus1 liposome complex | rel=r_associated | relid=0 | w=102
  2793. ipilimumab -- r_associated #0: 102 / 0.223 -> en:doxepin hydrochloride
    n1=ipilimumab | n2=en:doxepin hydrochloride | rel=r_associated | relid=0 | w=102
  2794. ipilimumab -- r_associated #0: 102 / 0.223 -> en:doxorubicin-dna complex
    n1=ipilimumab | n2=en:doxorubicin-dna complex | rel=r_associated | relid=0 | w=102
  2795. ipilimumab -- r_associated #0: 102 / 0.223 -> en:doxycycline
    n1=ipilimumab | n2=en:doxycycline | rel=r_associated | relid=0 | w=102
  2796. ipilimumab -- r_associated #0: 102 / 0.223 -> en:dpt/typhoid/staphylococcus aureus/paratyphoid a/paratyphoid b vaccine
    n1=ipilimumab | n2=en:dpt/typhoid/staphylococcus aureus/paratyphoid a/paratyphoid b vaccine | rel=r_associated | relid=0 | w=102
  2797. ipilimumab -- r_associated #0: 102 / 0.223 -> en:dromostanolone propionate
    n1=ipilimumab | n2=en:dromostanolone propionate | rel=r_associated | relid=0 | w=102
  2798. ipilimumab -- r_associated #0: 102 / 0.223 -> en:droperidol
    n1=ipilimumab | n2=en:droperidol | rel=r_associated | relid=0 | w=102
  2799. ipilimumab -- r_associated #0: 102 / 0.223 -> en:drugs, essential
    n1=ipilimumab | n2=en:drugs, essential | rel=r_associated | relid=0 | w=102
  2800. ipilimumab -- r_associated #0: 102 / 0.223 -> en:dual pi3 kinase/mtor inhibitor gdc-0980
    n1=ipilimumab | n2=en:dual pi3 kinase/mtor inhibitor gdc-0980 | rel=r_associated | relid=0 | w=102
  2801. ipilimumab -- r_associated #0: 102 / 0.223 -> en:duligotuzumab
    n1=ipilimumab | n2=en:duligotuzumab | rel=r_associated | relid=0 | w=102
  2802. ipilimumab -- r_associated #0: 102 / 0.223 -> en:dutpase/dpd inhibitor tas-114
    n1=ipilimumab | n2=en:dutpase/dpd inhibitor tas-114 | rel=r_associated | relid=0 | w=102
  2803. ipilimumab -- r_associated #0: 102 / 0.223 -> en:edetate calcium disodium
    n1=ipilimumab | n2=en:edetate calcium disodium | rel=r_associated | relid=0 | w=102
  2804. ipilimumab -- r_associated #0: 102 / 0.223 -> en:edoxaban tosylate
    n1=ipilimumab | n2=en:edoxaban tosylate | rel=r_associated | relid=0 | w=102
  2805. ipilimumab -- r_associated #0: 102 / 0.223 -> en:efalizumab
    n1=ipilimumab | n2=en:efalizumab | rel=r_associated | relid=0 | w=102
  2806. ipilimumab -- r_associated #0: 102 / 0.223 -> en:efaproxiral
    n1=ipilimumab | n2=en:efaproxiral | rel=r_associated | relid=0 | w=102
  2807. ipilimumab -- r_associated #0: 102 / 0.223 -> en:eflornithine
    n1=ipilimumab | n2=en:eflornithine | rel=r_associated | relid=0 | w=102
  2808. ipilimumab -- r_associated #0: 102 / 0.223 -> en:egfr car-cd3zeta-4-1bb-expressing autologous t-lymphocytes
    n1=ipilimumab | n2=en:egfr car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=102
  2809. ipilimumab -- r_associated #0: 102 / 0.223 -> en:egfr t790m inhibitor pf-06747775
    n1=ipilimumab | n2=en:egfr t790m inhibitor pf-06747775 | rel=r_associated | relid=0 | w=102
  2810. ipilimumab -- r_associated #0: 102 / 0.223 -> en:egfr/her2 inhibitor ap32788
    n1=ipilimumab | n2=en:egfr/her2 inhibitor ap32788 | rel=r_associated | relid=0 | w=102
  2811. ipilimumab -- r_associated #0: 102 / 0.223 -> en:egfr/her2 inhibitor av-412
    n1=ipilimumab | n2=en:egfr/her2 inhibitor av-412 | rel=r_associated | relid=0 | w=102
  2812. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ellagic acid/annona muricata supplement
    n1=ipilimumab | n2=en:ellagic acid/annona muricata supplement | rel=r_associated | relid=0 | w=102
  2813. ipilimumab -- r_associated #0: 102 / 0.223 -> en:emollients
    n1=ipilimumab | n2=en:emollients | rel=r_associated | relid=0 | w=102
  2814. ipilimumab -- r_associated #0: 102 / 0.223 -> en:eniluracil
    n1=ipilimumab | n2=en:eniluracil | rel=r_associated | relid=0 | w=102
  2815. ipilimumab -- r_associated #0: 102 / 0.223 -> en:entolimod
    n1=ipilimumab | n2=en:entolimod | rel=r_associated | relid=0 | w=102
  2816. ipilimumab -- r_associated #0: 102 / 0.223 -> en:epha2-targeting dopc-encapsulated sirna
    n1=ipilimumab | n2=en:epha2-targeting dopc-encapsulated sirna | rel=r_associated | relid=0 | w=102
  2817. ipilimumab -- r_associated #0: 102 / 0.223 -> en:epithelial cell adhesion molecule
    n1=ipilimumab | n2=en:epithelial cell adhesion molecule | rel=r_associated | relid=0 | w=102
  2818. ipilimumab -- r_associated #0: 102 / 0.223 -> en:eplerenone
    n1=ipilimumab | n2=en:eplerenone | rel=r_associated | relid=0 | w=102
  2819. ipilimumab -- r_associated #0: 102 / 0.223 -> en:epothilone kos-1584
    n1=ipilimumab | n2=en:epothilone kos-1584 | rel=r_associated | relid=0 | w=102
  2820. ipilimumab -- r_associated #0: 102 / 0.223 -> en:epratuzumab
    n1=ipilimumab | n2=en:epratuzumab | rel=r_associated | relid=0 | w=102
  2821. ipilimumab -- r_associated #0: 102 / 0.223 -> en:erb-38 immunotoxin
    n1=ipilimumab | n2=en:erb-38 immunotoxin | rel=r_associated | relid=0 | w=102
  2822. ipilimumab -- r_associated #0: 102 / 0.223 -> en:estradiol/norethindrone acetate tablet
    n1=ipilimumab | n2=en:estradiol/norethindrone acetate tablet | rel=r_associated | relid=0 | w=102
  2823. ipilimumab -- r_associated #0: 102 / 0.223 -> en:eszopiclone
    n1=ipilimumab | n2=en:eszopiclone | rel=r_associated | relid=0 | w=102
  2824. ipilimumab -- r_associated #0: 102 / 0.223 -> en:etanidazole
    n1=ipilimumab | n2=en:etanidazole | rel=r_associated | relid=0 | w=102
  2825. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ets-family transcription factor inhibitor tk216
    n1=ipilimumab | n2=en:ets-family transcription factor inhibitor tk216 | rel=r_associated | relid=0 | w=102
  2826. ipilimumab -- r_associated #0: 102 / 0.223 -> en:eucerin
    n1=ipilimumab | n2=en:eucerin | rel=r_associated | relid=0 | w=102
  2827. ipilimumab -- r_associated #0: 102 / 0.223 -> en:evaux spring water-based topical spray
    n1=ipilimumab | n2=en:evaux spring water-based topical spray | rel=r_associated | relid=0 | w=102
  2828. ipilimumab -- r_associated #0: 102 / 0.223 -> en:evolocumab
    n1=ipilimumab | n2=en:evolocumab | rel=r_associated | relid=0 | w=102
  2829. ipilimumab -- r_associated #0: 102 / 0.223 -> en:expanded umbilical cord blood product hsc835
    n1=ipilimumab | n2=en:expanded umbilical cord blood product hsc835 | rel=r_associated | relid=0 | w=102
  2830. ipilimumab -- r_associated #0: 102 / 0.223 -> en:eye agent
    n1=ipilimumab | n2=en:eye agent | rel=r_associated | relid=0 | w=102
  2831. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ezetimibe
    n1=ipilimumab | n2=en:ezetimibe | rel=r_associated | relid=0 | w=102
  2832. ipilimumab -- r_associated #0: 102 / 0.223 -> en:fact complex-targeting curaxin cbl0137
    n1=ipilimumab | n2=en:fact complex-targeting curaxin cbl0137 | rel=r_associated | relid=0 | w=102
  2833. ipilimumab -- r_associated #0: 102 / 0.223 -> en:fadrozole hydrochloride
    n1=ipilimumab | n2=en:fadrozole hydrochloride | rel=r_associated | relid=0 | w=102
  2834. ipilimumab -- r_associated #0: 102 / 0.223 -> en:famotidine
    n1=ipilimumab | n2=en:famotidine | rel=r_associated | relid=0 | w=102
  2835. ipilimumab -- r_associated #0: 102 / 0.223 -> en:fenretinide lipid matrix
    n1=ipilimumab | n2=en:fenretinide lipid matrix | rel=r_associated | relid=0 | w=102
  2836. ipilimumab -- r_associated #0: 102 / 0.223 -> en:fentanyl citrate
    n1=ipilimumab | n2=en:fentanyl citrate | rel=r_associated | relid=0 | w=102
  2837. ipilimumab -- r_associated #0: 102 / 0.223 -> en:fentanyl sublingual spray
    n1=ipilimumab | n2=en:fentanyl sublingual spray | rel=r_associated | relid=0 | w=102
  2838. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ferumoxsil oral suspension
    n1=ipilimumab | n2=en:ferumoxsil oral suspension | rel=r_associated | relid=0 | w=102
  2839. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ferumoxtran-10
    n1=ipilimumab | n2=en:ferumoxtran-10 | rel=r_associated | relid=0 | w=102
  2840. ipilimumab -- r_associated #0: 102 / 0.223 -> en:fgfr inhibitor asp5878
    n1=ipilimumab | n2=en:fgfr inhibitor asp5878 | rel=r_associated | relid=0 | w=102
  2841. ipilimumab -- r_associated #0: 102 / 0.223 -> en:fish oil/glycerol/egg lecithin-based emulsion
    n1=ipilimumab | n2=en:fish oil/glycerol/egg lecithin-based emulsion | rel=r_associated | relid=0 | w=102
  2842. ipilimumab -- r_associated #0: 102 / 0.223 -> en:flp injection
    n1=ipilimumab | n2=en:flp injection | rel=r_associated | relid=0 | w=102
  2843. ipilimumab -- r_associated #0: 102 / 0.223 -> en:flt3/abl/aurora kinase inhibitor kw-2449
    n1=ipilimumab | n2=en:flt3/abl/aurora kinase inhibitor kw-2449 | rel=r_associated | relid=0 | w=102
  2844. ipilimumab -- r_associated #0: 102 / 0.223 -> en:fluciclovine (18f)
    n1=ipilimumab | n2=en:fluciclovine (18f) | rel=r_associated | relid=0 | w=102
  2845. ipilimumab -- r_associated #0: 102 / 0.223 -> en:fluorine f 18 sodium fluoride
    n1=ipilimumab | n2=en:fluorine f 18 sodium fluoride | rel=r_associated | relid=0 | w=102
  2846. ipilimumab -- r_associated #0: 102 / 0.223 -> en:fluosol-da
    n1=ipilimumab | n2=en:fluosol-da | rel=r_associated | relid=0 | w=102
  2847. ipilimumab -- r_associated #0: 102 / 0.223 -> en:fluphenazine hydrochloride
    n1=ipilimumab | n2=en:fluphenazine hydrochloride | rel=r_associated | relid=0 | w=102
  2848. ipilimumab -- r_associated #0: 102 / 0.223 -> en:flutamide
    n1=ipilimumab | n2=en:flutamide | rel=r_associated | relid=0 | w=102
  2849. ipilimumab -- r_associated #0: 102 / 0.223 -> en:fluvoxamine maleate
    n1=ipilimumab | n2=en:fluvoxamine maleate | rel=r_associated | relid=0 | w=102
  2850. ipilimumab -- r_associated #0: 102 / 0.223 -> en:fondaparinux sodium
    n1=ipilimumab | n2=en:fondaparinux sodium | rel=r_associated | relid=0 | w=102
  2851. ipilimumab -- r_associated #0: 102 / 0.223 -> en:formoterol fumarate/roxithromycin
    n1=ipilimumab | n2=en:formoterol fumarate/roxithromycin | rel=r_associated | relid=0 | w=102
  2852. ipilimumab -- r_associated #0: 102 / 0.223 -> en:french maritime pine bark extract
    n1=ipilimumab | n2=en:french maritime pine bark extract | rel=r_associated | relid=0 | w=102
  2853. ipilimumab -- r_associated #0: 102 / 0.223 -> en:fresolimumab
    n1=ipilimumab | n2=en:fresolimumab | rel=r_associated | relid=0 | w=102
  2854. ipilimumab -- r_associated #0: 102 / 0.223 -> en:gadobutrol
    n1=ipilimumab | n2=en:gadobutrol | rel=r_associated | relid=0 | w=102
  2855. ipilimumab -- r_associated #0: 102 / 0.223 -> en:galactomannan derivative
    n1=ipilimumab | n2=en:galactomannan derivative | rel=r_associated | relid=0 | w=102
  2856. ipilimumab -- r_associated #0: 102 / 0.223 -> en:galunisertib
    n1=ipilimumab | n2=en:galunisertib | rel=r_associated | relid=0 | w=102
  2857. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ganglioside gm2
    n1=ipilimumab | n2=en:ganglioside gm2 | rel=r_associated | relid=0 | w=102
  2858. ipilimumab -- r_associated #0: 102 / 0.223 -> en:gastrin immunotoxin
    n1=ipilimumab | n2=en:gastrin immunotoxin | rel=r_associated | relid=0 | w=102
  2859. ipilimumab -- r_associated #0: 102 / 0.223 -> en:gd2 lactone/gd3 lactone-klh conjugate bivalent vaccine
    n1=ipilimumab | n2=en:gd2 lactone/gd3 lactone-klh conjugate bivalent vaccine | rel=r_associated | relid=0 | w=102
  2860. ipilimumab -- r_associated #0: 102 / 0.223 -> en:gemcitabine-oxaliplatin regimen
    n1=ipilimumab | n2=en:gemcitabine-oxaliplatin regimen | rel=r_associated | relid=0 | w=102
  2861. ipilimumab -- r_associated #0: 102 / 0.223 -> en:gitrl rna-transfected autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:gitrl rna-transfected autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=102
  2862. ipilimumab -- r_associated #0: 102 / 0.223 -> en:givinostat
    n1=ipilimumab | n2=en:givinostat | rel=r_associated | relid=0 | w=102
  2863. ipilimumab -- r_associated #0: 102 / 0.223 -> en:glipizide
    n1=ipilimumab | n2=en:glipizide | rel=r_associated | relid=0 | w=102
  2864. ipilimumab -- r_associated #0: 102 / 0.223 -> en:glutathione pegylated liposomal doxorubicin hydrochloride formulation 2b3-101
    n1=ipilimumab | n2=en:glutathione pegylated liposomal doxorubicin hydrochloride formulation 2b3-101 | rel=r_associated | relid=0 | w=102
  2865. ipilimumab -- r_associated #0: 102 / 0.223 -> en:glycopyrrolate
    n1=ipilimumab | n2=en:glycopyrrolate | rel=r_associated | relid=0 | w=102
  2866. ipilimumab -- r_associated #0: 102 / 0.223 -> en:glycyrrhiza glabra root
    n1=ipilimumab | n2=en:glycyrrhiza glabra root | rel=r_associated | relid=0 | w=102
  2867. ipilimumab -- r_associated #0: 102 / 0.223 -> en:glycyrrhizin
    n1=ipilimumab | n2=en:glycyrrhizin | rel=r_associated | relid=0 | w=102
  2868. ipilimumab -- r_associated #0: 102 / 0.223 -> en:gm2/gd2/gd3 lactone-klh conjugate trivalent vaccine
    n1=ipilimumab | n2=en:gm2/gd2/gd3 lactone-klh conjugate trivalent vaccine | rel=r_associated | relid=0 | w=102
  2869. ipilimumab -- r_associated #0: 102 / 0.223 -> en:golnerminogene pradenovec
    n1=ipilimumab | n2=en:golnerminogene pradenovec | rel=r_associated | relid=0 | w=102
  2870. ipilimumab -- r_associated #0: 102 / 0.223 -> en:goserelin acetate
    n1=ipilimumab | n2=en:goserelin acetate | rel=r_associated | relid=0 | w=102
  2871. ipilimumab -- r_associated #0: 102 / 0.223 -> en:gpi-0100
    n1=ipilimumab | n2=en:gpi-0100 | rel=r_associated | relid=0 | w=102
  2872. ipilimumab -- r_associated #0: 102 / 0.223 -> en:green tea
    n1=ipilimumab | n2=en:green tea | rel=r_associated | relid=0 | w=102
  2873. ipilimumab -- r_associated #0: 102 / 0.223 -> en:green tea extract-based antioxidant supplement
    n1=ipilimumab | n2=en:green tea extract-based antioxidant supplement | rel=r_associated | relid=0 | w=102
  2874. ipilimumab -- r_associated #0: 102 / 0.223 -> en:haemophilus influenzae b vaccine
    n1=ipilimumab | n2=en:haemophilus influenzae b vaccine | rel=r_associated | relid=0 | w=102
  2875. ipilimumab -- r_associated #0: 102 / 0.223 -> en:hdac inhibitor acy-241
    n1=ipilimumab | n2=en:hdac inhibitor acy-241 | rel=r_associated | relid=0 | w=102
  2876. ipilimumab -- r_associated #0: 102 / 0.223 -> en:hdac inhibitor shp-141
    n1=ipilimumab | n2=en:hdac inhibitor shp-141 | rel=r_associated | relid=0 | w=102
  2877. ipilimumab -- r_associated #0: 102 / 0.223 -> en:hdac/egfr/her2 inhibitor cudc-101
    n1=ipilimumab | n2=en:hdac/egfr/her2 inhibitor cudc-101 | rel=r_associated | relid=0 | w=102
  2878. ipilimumab -- r_associated #0: 102 / 0.223 -> en:heat shock protein inhibitor
    n1=ipilimumab | n2=en:heat shock protein inhibitor | rel=r_associated | relid=0 | w=102
  2879. ipilimumab -- r_associated #0: 102 / 0.223 -> en:heparan sulfate glycosaminoglycan mimetic m402
    n1=ipilimumab | n2=en:heparan sulfate glycosaminoglycan mimetic m402 | rel=r_associated | relid=0 | w=102
  2880. ipilimumab -- r_associated #0: 102 / 0.223 -> en:heparan sulfate glycosaminoglycan mimetic nanopolymer mouthwash
    n1=ipilimumab | n2=en:heparan sulfate glycosaminoglycan mimetic nanopolymer mouthwash | rel=r_associated | relid=0 | w=102
  2881. ipilimumab -- r_associated #0: 102 / 0.223 -> en:hepatitis b vaccine
    n1=ipilimumab | n2=en:hepatitis b vaccine | rel=r_associated | relid=0 | w=102
  2882. ipilimumab -- r_associated #0: 102 / 0.223 -> en:her2 ecd+tm virus-like replicon particles vaccine avx901
    n1=ipilimumab | n2=en:her2 ecd+tm virus-like replicon particles vaccine avx901 | rel=r_associated | relid=0 | w=102
  2883. ipilimumab -- r_associated #0: 102 / 0.223 -> en:herbal medicine agent
    n1=ipilimumab | n2=en:herbal medicine agent | rel=r_associated | relid=0 | w=102
  2884. ipilimumab -- r_associated #0: 102 / 0.223 -> en:hla-a*2402-restricted urlc10-ttk-vegfr1-vegfr2 multipeptide vaccine
    n1=ipilimumab | n2=en:hla-a*2402-restricted urlc10-ttk-vegfr1-vegfr2 multipeptide vaccine | rel=r_associated | relid=0 | w=102
  2885. ipilimumab -- r_associated #0: 102 / 0.223 -> en:hla-a*2402-restricted vegfr1/2 multipeptide vaccine
    n1=ipilimumab | n2=en:hla-a*2402-restricted vegfr1/2 multipeptide vaccine | rel=r_associated | relid=0 | w=102
  2886. ipilimumab -- r_associated #0: 102 / 0.223 -> en:hla-a2-binding tyr/mart-1/gp100 multipeptide-pulsed autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:hla-a2-binding tyr/mart-1/gp100 multipeptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=102
  2887. ipilimumab -- r_associated #0: 102 / 0.223 -> en:hla-a2, a3-restricted fgf-5 peptides/montanide isa-51 vaccine
    n1=ipilimumab | n2=en:hla-a2, a3-restricted fgf-5 peptides/montanide isa-51 vaccine | rel=r_associated | relid=0 | w=102
  2888. ipilimumab -- r_associated #0: 102 / 0.223 -> en:hodgkin's antigens-gm-csf-expressing cell vaccine
    n1=ipilimumab | n2=en:hodgkin's antigens-gm-csf-expressing cell vaccine | rel=r_associated | relid=0 | w=102
  2889. ipilimumab -- r_associated #0: 102 / 0.223 -> en:hpv 16 e7:12-20 peptide vaccine
    n1=ipilimumab | n2=en:hpv 16 e7:12-20 peptide vaccine | rel=r_associated | relid=0 | w=102
  2890. ipilimumab -- r_associated #0: 102 / 0.223 -> en:hsp90 inhibitor ds-2248
    n1=ipilimumab | n2=en:hsp90 inhibitor ds-2248 | rel=r_associated | relid=0 | w=102
  2891. ipilimumab -- r_associated #0: 102 / 0.223 -> en:htert-encoding dna vaccine invac-1
    n1=ipilimumab | n2=en:htert-encoding dna vaccine invac-1 | rel=r_associated | relid=0 | w=102
  2892. ipilimumab -- r_associated #0: 102 / 0.223 -> en:human gp100 plasmid dna vaccine
    n1=ipilimumab | n2=en:human gp100 plasmid dna vaccine | rel=r_associated | relid=0 | w=102
  2893. ipilimumab -- r_associated #0: 102 / 0.223 -> en:hydralazine hydrochloride
    n1=ipilimumab | n2=en:hydralazine hydrochloride | rel=r_associated | relid=0 | w=102
  2894. ipilimumab -- r_associated #0: 102 / 0.223 -> en:hydroxyprogesterone caproate
    n1=ipilimumab | n2=en:hydroxyprogesterone caproate | rel=r_associated | relid=0 | w=102
  2895. ipilimumab -- r_associated #0: 102 / 0.223 -> en:hyperpolarized carbon c 13 pyruvate
    n1=ipilimumab | n2=en:hyperpolarized carbon c 13 pyruvate | rel=r_associated | relid=0 | w=102
  2896. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ice mint
    n1=ipilimumab | n2=en:ice mint | rel=r_associated | relid=0 | w=102
  2897. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ice regimen
    n1=ipilimumab | n2=en:ice regimen | rel=r_associated | relid=0 | w=102
  2898. ipilimumab -- r_associated #0: 102 / 0.223 -> en:icodextrin
    n1=ipilimumab | n2=en:icodextrin | rel=r_associated | relid=0 | w=102
  2899. ipilimumab -- r_associated #0: 102 / 0.223 -> en:il-12-expressing mesenchymal stem cell vaccine gx-051
    n1=ipilimumab | n2=en:il-12-expressing mesenchymal stem cell vaccine gx-051 | rel=r_associated | relid=0 | w=102
  2900. ipilimumab -- r_associated #0: 102 / 0.223 -> en:il13ralpha2-specific hinge-optimized 41bb-co-stimulatory car truncated cd19-expressing autologous t-lymphocytes
    n1=ipilimumab | n2=en:il13ralpha2-specific hinge-optimized 41bb-co-stimulatory car truncated cd19-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=102
  2901. ipilimumab -- r_associated #0: 102 / 0.223 -> en:imisopasem manganese
    n1=ipilimumab | n2=en:imisopasem manganese | rel=r_associated | relid=0 | w=102
  2902. ipilimumab -- r_associated #0: 102 / 0.223 -> en:immunotherapy regimen mkc-1106-mt
    n1=ipilimumab | n2=en:immunotherapy regimen mkc-1106-mt | rel=r_associated | relid=0 | w=102
  2903. ipilimumab -- r_associated #0: 102 / 0.223 -> en:imreg-1
    n1=ipilimumab | n2=en:imreg-1 | rel=r_associated | relid=0 | w=102
  2904. ipilimumab -- r_associated #0: 102 / 0.223 -> en:in 111 monoclonal antibody hu3s193
    n1=ipilimumab | n2=en:in 111 monoclonal antibody hu3s193 | rel=r_associated | relid=0 | w=102
  2905. ipilimumab -- r_associated #0: 102 / 0.223 -> en:indicine-n-oxide
    n1=ipilimumab | n2=en:indicine-n-oxide | rel=r_associated | relid=0 | w=102
  2906. ipilimumab -- r_associated #0: 102 / 0.223 -> en:indium in 111/yttrium y90-dota-biotin
    n1=ipilimumab | n2=en:indium in 111/yttrium y90-dota-biotin | rel=r_associated | relid=0 | w=102
  2907. ipilimumab -- r_associated #0: 102 / 0.223 -> en:indole-3-carbinol
    n1=ipilimumab | n2=en:indole-3-carbinol | rel=r_associated | relid=0 | w=102
  2908. ipilimumab -- r_associated #0: 102 / 0.223 -> en:inducible cd4+cd25+ regulatory t cells
    n1=ipilimumab | n2=en:inducible cd4+cd25+ regulatory t cells | rel=r_associated | relid=0 | w=102
  2909. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ingenol mebutate
    n1=ipilimumab | n2=en:ingenol mebutate | rel=r_associated | relid=0 | w=102
  2910. ipilimumab -- r_associated #0: 102 / 0.223 -> en:insulin, regular
    n1=ipilimumab | n2=en:insulin, regular | rel=r_associated | relid=0 | w=102
  2911. ipilimumab -- r_associated #0: 102 / 0.223 -> en:integrin receptor antagonist glpg0187
    n1=ipilimumab | n2=en:integrin receptor antagonist glpg0187 | rel=r_associated | relid=0 | w=102
  2912. ipilimumab -- r_associated #0: 102 / 0.223 -> en:interleukin-2 gene
    n1=ipilimumab | n2=en:interleukin-2 gene | rel=r_associated | relid=0 | w=102
  2913. ipilimumab -- r_associated #0: 102 / 0.223 -> en:intermediate-affinity interleukin-2 receptor agonist alks 4230
    n1=ipilimumab | n2=en:intermediate-affinity interleukin-2 receptor agonist alks 4230 | rel=r_associated | relid=0 | w=102
  2914. ipilimumab -- r_associated #0: 102 / 0.223 -> en:intiquinatine
    n1=ipilimumab | n2=en:intiquinatine | rel=r_associated | relid=0 | w=102
  2915. ipilimumab -- r_associated #0: 102 / 0.223 -> en:intravesical bcg
    n1=ipilimumab | n2=en:intravesical bcg | rel=r_associated | relid=0 | w=102
  2916. ipilimumab -- r_associated #0: 102 / 0.223 -> en:investigational new drug
    n1=ipilimumab | n2=en:investigational new drug | rel=r_associated | relid=0 | w=102
  2917. ipilimumab -- r_associated #0: 102 / 0.223 -> en:iodine / sodium iodide
    n1=ipilimumab | n2=en:iodine / sodium iodide | rel=r_associated | relid=0 | w=102
  2918. ipilimumab -- r_associated #0: 102 / 0.223 -> en:iodine i 124 phospholipid ether analogue clr1404
    n1=ipilimumab | n2=en:iodine i 124 phospholipid ether analogue clr1404 | rel=r_associated | relid=0 | w=102
  2919. ipilimumab -- r_associated #0: 102 / 0.223 -> en:iodine i 124 pu-ad
    n1=ipilimumab | n2=en:iodine i 124 pu-ad | rel=r_associated | relid=0 | w=102
  2920. ipilimumab -- r_associated #0: 102 / 0.223 -> en:iodine i 125-anti-egfr-425 monoclonal antibody
    n1=ipilimumab | n2=en:iodine i 125-anti-egfr-425 monoclonal antibody | rel=r_associated | relid=0 | w=102
  2921. ipilimumab -- r_associated #0: 102 / 0.223 -> en:iodine i 131 monoclonal antibody 8h9
    n1=ipilimumab | n2=en:iodine i 131 monoclonal antibody 8h9 | rel=r_associated | relid=0 | w=102
  2922. ipilimumab -- r_associated #0: 102 / 0.223 -> en:iodine norcholestenol
    n1=ipilimumab | n2=en:iodine norcholestenol | rel=r_associated | relid=0 | w=102
  2923. ipilimumab -- r_associated #0: 102 / 0.223 -> en:iohexol
    n1=ipilimumab | n2=en:iohexol | rel=r_associated | relid=0 | w=102
  2924. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ioversol
    n1=ipilimumab | n2=en:ioversol | rel=r_associated | relid=0 | w=102
  2925. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ioxaglate
    n1=ipilimumab | n2=en:ioxaglate | rel=r_associated | relid=0 | w=102
  2926. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ipecac/phenylephrine/potassium guaiacolsulfonate/promethazine
    n1=ipilimumab | n2=en:ipecac/phenylephrine/potassium guaiacolsulfonate/promethazine | rel=r_associated | relid=0 | w=102
  2927. ipilimumab -- r_associated #0: 102 / 0.223 -> en:iron sucrose injection
    n1=ipilimumab | n2=en:iron sucrose injection | rel=r_associated | relid=0 | w=102
  2928. ipilimumab -- r_associated #0: 102 / 0.223 -> en:iron/multivitamins
    n1=ipilimumab | n2=en:iron/multivitamins | rel=r_associated | relid=0 | w=102
  2929. ipilimumab -- r_associated #0: 102 / 0.223 -> en:irx-2
    n1=ipilimumab | n2=en:irx-2 | rel=r_associated | relid=0 | w=102
  2930. ipilimumab -- r_associated #0: 102 / 0.223 -> en:isavuconazonium sulfate
    n1=ipilimumab | n2=en:isavuconazonium sulfate | rel=r_associated | relid=0 | w=102
  2931. ipilimumab -- r_associated #0: 102 / 0.223 -> en:iseganan hydrochloride
    n1=ipilimumab | n2=en:iseganan hydrochloride | rel=r_associated | relid=0 | w=102
  2932. ipilimumab -- r_associated #0: 102 / 0.223 -> en:isoniazid/pyridoxine
    n1=ipilimumab | n2=en:isoniazid/pyridoxine | rel=r_associated | relid=0 | w=102
  2933. ipilimumab -- r_associated #0: 102 / 0.223 -> en:isopropyl alcohol / salicylic acid / sodium thiosulfate
    n1=ipilimumab | n2=en:isopropyl alcohol / salicylic acid / sodium thiosulfate | rel=r_associated | relid=0 | w=102
  2934. ipilimumab -- r_associated #0: 102 / 0.223 -> en:isoquercetin
    n1=ipilimumab | n2=en:isoquercetin | rel=r_associated | relid=0 | w=102
  2935. ipilimumab -- r_associated #0: 102 / 0.223 -> en:itraconazole dispersion in polymer matrix
    n1=ipilimumab | n2=en:itraconazole dispersion in polymer matrix | rel=r_associated | relid=0 | w=102
  2936. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ixazomib
    n1=ipilimumab | n2=en:ixazomib | rel=r_associated | relid=0 | w=102
  2937. ipilimumab -- r_associated #0: 102 / 0.223 -> en:jak1 inhibitor incb039110
    n1=ipilimumab | n2=en:jak1 inhibitor incb039110 | rel=r_associated | relid=0 | w=102
  2938. ipilimumab -- r_associated #0: 102 / 0.223 -> en:l-lysine
    n1=ipilimumab | n2=en:l-lysine | rel=r_associated | relid=0 | w=102
  2939. ipilimumab -- r_associated #0: 102 / 0.223 -> en:lactated ringer solution
    n1=ipilimumab | n2=en:lactated ringer solution | rel=r_associated | relid=0 | w=102
  2940. ipilimumab -- r_associated #0: 102 / 0.223 -> en:lactobacillus acidophilus/estriol vaginal tablet
    n1=ipilimumab | n2=en:lactobacillus acidophilus/estriol vaginal tablet | rel=r_associated | relid=0 | w=102
  2941. ipilimumab -- r_associated #0: 102 / 0.223 -> en:lactobacillus plantarum strain 299
    n1=ipilimumab | n2=en:lactobacillus plantarum strain 299 | rel=r_associated | relid=0 | w=102
  2942. ipilimumab -- r_associated #0: 102 / 0.223 -> en:lactobacillus rhamnosus gg
    n1=ipilimumab | n2=en:lactobacillus rhamnosus gg | rel=r_associated | relid=0 | w=102
  2943. ipilimumab -- r_associated #0: 102 / 0.223 -> en:lactobacillus-based probiotic capsule
    n1=ipilimumab | n2=en:lactobacillus-based probiotic capsule | rel=r_associated | relid=0 | w=102
  2944. ipilimumab -- r_associated #0: 102 / 0.223 -> en:lenalidomide
    n1=ipilimumab | n2=en:lenalidomide | rel=r_associated | relid=0 | w=102
  2945. ipilimumab -- r_associated #0: 102 / 0.223 -> en:lenti-d/abcd1-transduced autologous hematopoietic stem cells
    n1=ipilimumab | n2=en:lenti-d/abcd1-transduced autologous hematopoietic stem cells | rel=r_associated | relid=0 | w=102
  2946. ipilimumab -- r_associated #0: 102 / 0.223 -> en:levocarnitine
    n1=ipilimumab | n2=en:levocarnitine | rel=r_associated | relid=0 | w=102
  2947. ipilimumab -- r_associated #0: 102 / 0.223 -> en:levofloxacin
    n1=ipilimumab | n2=en:levofloxacin | rel=r_associated | relid=0 | w=102
  2948. ipilimumab -- r_associated #0: 102 / 0.223 -> en:levonorgestrel
    n1=ipilimumab | n2=en:levonorgestrel | rel=r_associated | relid=0 | w=102
  2949. ipilimumab -- r_associated #0: 102 / 0.223 -> en:lexatumumab
    n1=ipilimumab | n2=en:lexatumumab | rel=r_associated | relid=0 | w=102
  2950. ipilimumab -- r_associated #0: 102 / 0.223 -> en:liposomal eribulin mesylate
    n1=ipilimumab | n2=en:liposomal eribulin mesylate | rel=r_associated | relid=0 | w=102
  2951. ipilimumab -- r_associated #0: 102 / 0.223 -> en:liposomal irinotecan
    n1=ipilimumab | n2=en:liposomal irinotecan | rel=r_associated | relid=0 | w=102
  2952. ipilimumab -- r_associated #0: 102 / 0.223 -> en:liposome-encapsulated mir-34 mimic mrx34
    n1=ipilimumab | n2=en:liposome-encapsulated mir-34 mimic mrx34 | rel=r_associated | relid=0 | w=102
  2953. ipilimumab -- r_associated #0: 102 / 0.223 -> en:live-attenuated listeria monocytogenes-encoding egfrviii-ny-eso-1 vaccine adu-623
    n1=ipilimumab | n2=en:live-attenuated listeria monocytogenes-encoding egfrviii-ny-eso-1 vaccine adu-623 | rel=r_associated | relid=0 | w=102
  2954. ipilimumab -- r_associated #0: 102 / 0.223 -> en:lmb-1 immunotoxin
    n1=ipilimumab | n2=en:lmb-1 immunotoxin | rel=r_associated | relid=0 | w=102
  2955. ipilimumab -- r_associated #0: 102 / 0.223 -> en:lmb-9 immunotoxin
    n1=ipilimumab | n2=en:lmb-9 immunotoxin | rel=r_associated | relid=0 | w=102
  2956. ipilimumab -- r_associated #0: 102 / 0.223 -> en:lmp2a-specific cytotoxic t-lymphocytes
    n1=ipilimumab | n2=en:lmp2a-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=102
  2957. ipilimumab -- r_associated #0: 102 / 0.223 -> en:lopinavir
    n1=ipilimumab | n2=en:lopinavir | rel=r_associated | relid=0 | w=102
  2958. ipilimumab -- r_associated #0: 102 / 0.223 -> en:lucitanib
    n1=ipilimumab | n2=en:lucitanib | rel=r_associated | relid=0 | w=102
  2959. ipilimumab -- r_associated #0: 102 / 0.223 -> en:lung tumor associated antigen
    n1=ipilimumab | n2=en:lung tumor associated antigen | rel=r_associated | relid=0 | w=102
  2960. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ly2624587
    n1=ipilimumab | n2=en:ly2624587 | rel=r_associated | relid=0 | w=102
  2961. ipilimumab -- r_associated #0: 102 / 0.223 -> en:lyophilized black raspberry lozenge
    n1=ipilimumab | n2=en:lyophilized black raspberry lozenge | rel=r_associated | relid=0 | w=102
  2962. ipilimumab -- r_associated #0: 102 / 0.223 -> en:mage-3.a1 peptide vaccine
    n1=ipilimumab | n2=en:mage-3.a1 peptide vaccine | rel=r_associated | relid=0 | w=102
  2963. ipilimumab -- r_associated #0: 102 / 0.223 -> en:magnesium sulfate
    n1=ipilimumab | n2=en:magnesium sulfate | rel=r_associated | relid=0 | w=102
  2964. ipilimumab -- r_associated #0: 102 / 0.223 -> en:magnesium valproate
    n1=ipilimumab | n2=en:magnesium valproate | rel=r_associated | relid=0 | w=102
  2965. ipilimumab -- r_associated #0: 102 / 0.223 -> en:maltose
    n1=ipilimumab | n2=en:maltose | rel=r_associated | relid=0 | w=102
  2966. ipilimumab -- r_associated #0: 102 / 0.223 -> en:mannitol
    n1=ipilimumab | n2=en:mannitol | rel=r_associated | relid=0 | w=102
  2967. ipilimumab -- r_associated #0: 102 / 0.223 -> en:mcs-5
    n1=ipilimumab | n2=en:mcs-5 | rel=r_associated | relid=0 | w=102
  2968. ipilimumab -- r_associated #0: 102 / 0.223 -> en:medical marijuana
    n1=ipilimumab | n2=en:medical marijuana | rel=r_associated | relid=0 | w=102
  2969. ipilimumab -- r_associated #0: 102 / 0.223 -> en:medication
    n1=ipilimumab | n2=en:medication | rel=r_associated | relid=0 | w=102
  2970. ipilimumab -- r_associated #0: 102 / 0.223 -> en:melanoma trp2 ctl epitope vaccine scib1
    n1=ipilimumab | n2=en:melanoma trp2 ctl epitope vaccine scib1 | rel=r_associated | relid=0 | w=102
  2971. ipilimumab -- r_associated #0: 102 / 0.223 -> en:mellaril
    n1=ipilimumab | n2=en:mellaril | rel=r_associated | relid=0 | w=102
  2972. ipilimumab -- r_associated #0: 102 / 0.223 -> en:menadione topical lotion
    n1=ipilimumab | n2=en:menadione topical lotion | rel=r_associated | relid=0 | w=102
  2973. ipilimumab -- r_associated #0: 102 / 0.223 -> en:merbarone
    n1=ipilimumab | n2=en:merbarone | rel=r_associated | relid=0 | w=102
  2974. ipilimumab -- r_associated #0: 102 / 0.223 -> en:metaiodobenzylguanidine[131i]
    n1=ipilimumab | n2=en:metaiodobenzylguanidine[131i] | rel=r_associated | relid=0 | w=102
  2975. ipilimumab -- r_associated #0: 102 / 0.223 -> en:methoxy polyethylene glycol-epoetin beta
    n1=ipilimumab | n2=en:methoxy polyethylene glycol-epoetin beta | rel=r_associated | relid=0 | w=102
  2976. ipilimumab -- r_associated #0: 102 / 0.223 -> en:methylcellulose
    n1=ipilimumab | n2=en:methylcellulose | rel=r_associated | relid=0 | w=102
  2977. ipilimumab -- r_associated #0: 102 / 0.223 -> en:methylmercaptopurine riboside
    n1=ipilimumab | n2=en:methylmercaptopurine riboside | rel=r_associated | relid=0 | w=102
  2978. ipilimumab -- r_associated #0: 102 / 0.223 -> en:methylphenidate hydrochloride
    n1=ipilimumab | n2=en:methylphenidate hydrochloride | rel=r_associated | relid=0 | w=102
  2979. ipilimumab -- r_associated #0: 102 / 0.223 -> en:methyltestosterone
    n1=ipilimumab | n2=en:methyltestosterone | rel=r_associated | relid=0 | w=102
  2980. ipilimumab -- r_associated #0: 102 / 0.223 -> en:metoprine
    n1=ipilimumab | n2=en:metoprine | rel=r_associated | relid=0 | w=102
  2981. ipilimumab -- r_associated #0: 102 / 0.223 -> en:metreleptin
    n1=ipilimumab | n2=en:metreleptin | rel=r_associated | relid=0 | w=102
  2982. ipilimumab -- r_associated #0: 102 / 0.223 -> en:mfe23 scfv-expressing autologous anti-cea mfez t lymphocytes
    n1=ipilimumab | n2=en:mfe23 scfv-expressing autologous anti-cea mfez t lymphocytes | rel=r_associated | relid=0 | w=102
  2983. ipilimumab -- r_associated #0: 102 / 0.223 -> en:micafungin sodium
    n1=ipilimumab | n2=en:micafungin sodium | rel=r_associated | relid=0 | w=102
  2984. ipilimumab -- r_associated #0: 102 / 0.223 -> en:microtubule-targeted agent bal101553
    n1=ipilimumab | n2=en:microtubule-targeted agent bal101553 | rel=r_associated | relid=0 | w=102
  2985. ipilimumab -- r_associated #0: 102 / 0.223 -> en:mimotope-p10s-padre peptide vaccine
    n1=ipilimumab | n2=en:mimotope-p10s-padre peptide vaccine | rel=r_associated | relid=0 | w=102
  2986. ipilimumab -- r_associated #0: 102 / 0.223 -> en:miotics
    n1=ipilimumab | n2=en:miotics | rel=r_associated | relid=0 | w=102
  2987. ipilimumab -- r_associated #0: 102 / 0.223 -> en:mipsagargin
    n1=ipilimumab | n2=en:mipsagargin | rel=r_associated | relid=0 | w=102
  2988. ipilimumab -- r_associated #0: 102 / 0.223 -> en:modified citrus pectin supplement
    n1=ipilimumab | n2=en:modified citrus pectin supplement | rel=r_associated | relid=0 | w=102
  2989. ipilimumab -- r_associated #0: 102 / 0.223 -> en:momelotinib
    n1=ipilimumab | n2=en:momelotinib | rel=r_associated | relid=0 | w=102
  2990. ipilimumab -- r_associated #0: 102 / 0.223 -> en:monocarboxylate transporter 1 inhibitor azd3965
    n1=ipilimumab | n2=en:monocarboxylate transporter 1 inhibitor azd3965 | rel=r_associated | relid=0 | w=102
  2991. ipilimumab -- r_associated #0: 102 / 0.223 -> en:monoclonal antibody 3622w94
    n1=ipilimumab | n2=en:monoclonal antibody 3622w94 | rel=r_associated | relid=0 | w=102
  2992. ipilimumab -- r_associated #0: 102 / 0.223 -> en:monoclonal antibody 3f8
    n1=ipilimumab | n2=en:monoclonal antibody 3f8 | rel=r_associated | relid=0 | w=102
  2993. ipilimumab -- r_associated #0: 102 / 0.223 -> en:monoclonal antibody c-58
    n1=ipilimumab | n2=en:monoclonal antibody c-58 | rel=r_associated | relid=0 | w=102
  2994. ipilimumab -- r_associated #0: 102 / 0.223 -> en:monoclonal antibody hefi-1
    n1=ipilimumab | n2=en:monoclonal antibody hefi-1 | rel=r_associated | relid=0 | w=102
  2995. ipilimumab -- r_associated #0: 102 / 0.223 -> en:monoclonal antibody huj591
    n1=ipilimumab | n2=en:monoclonal antibody huj591 | rel=r_associated | relid=0 | w=102
  2996. ipilimumab -- r_associated #0: 102 / 0.223 -> en:monoclonal antibody hupam4
    n1=ipilimumab | n2=en:monoclonal antibody hupam4 | rel=r_associated | relid=0 | w=102
  2997. ipilimumab -- r_associated #0: 102 / 0.223 -> en:monoclonal antibody mono-dga-rfb4
    n1=ipilimumab | n2=en:monoclonal antibody mono-dga-rfb4 | rel=r_associated | relid=0 | w=102
  2998. ipilimumab -- r_associated #0: 102 / 0.223 -> en:monoclonal antibody sgn-30
    n1=ipilimumab | n2=en:monoclonal antibody sgn-30 | rel=r_associated | relid=0 | w=102
  2999. ipilimumab -- r_associated #0: 102 / 0.223 -> en:montelukast sodium
    n1=ipilimumab | n2=en:montelukast sodium | rel=r_associated | relid=0 | w=102
  3000. ipilimumab -- r_associated #0: 102 / 0.223 -> en:mouse renal adenocarcinoma cell-encapsulated agarose-agarose macrobeads
    n1=ipilimumab | n2=en:mouse renal adenocarcinoma cell-encapsulated agarose-agarose macrobeads | rel=r_associated | relid=0 | w=102
  3001. ipilimumab -- r_associated #0: 102 / 0.223 -> en:mov-gamma chimeric receptor gene
    n1=ipilimumab | n2=en:mov-gamma chimeric receptor gene | rel=r_associated | relid=0 | w=102
  3002. ipilimumab -- r_associated #0: 102 / 0.223 -> en:mtor1/2 kinase inhibitor me-344
    n1=ipilimumab | n2=en:mtor1/2 kinase inhibitor me-344 | rel=r_associated | relid=0 | w=102
  3003. ipilimumab -- r_associated #0: 102 / 0.223 -> en:muc-1 peptide vaccine
    n1=ipilimumab | n2=en:muc-1 peptide vaccine | rel=r_associated | relid=0 | w=102
  3004. ipilimumab -- r_associated #0: 102 / 0.223 -> en:multi-targeted cyclin-dependent protein kinase inhibitor rgb-286638
    n1=ipilimumab | n2=en:multi-targeted cyclin-dependent protein kinase inhibitor rgb-286638 | rel=r_associated | relid=0 | w=102
  3005. ipilimumab -- r_associated #0: 102 / 0.223 -> en:multikinase inhibitor sar103168
    n1=ipilimumab | n2=en:multikinase inhibitor sar103168 | rel=r_associated | relid=0 | w=102
  3006. ipilimumab -- r_associated #0: 102 / 0.223 -> en:multivitamin
    n1=ipilimumab | n2=en:multivitamin | rel=r_associated | relid=0 | w=102
  3007. ipilimumab -- r_associated #0: 102 / 0.223 -> en:murine-human monoclonal igg antibody
    n1=ipilimumab | n2=en:murine-human monoclonal igg antibody | rel=r_associated | relid=0 | w=102
  3008. ipilimumab -- r_associated #0: 102 / 0.223 -> en:mva-psa/pap prostate cancer vaccine
    n1=ipilimumab | n2=en:mva-psa/pap prostate cancer vaccine | rel=r_associated | relid=0 | w=102
  3009. ipilimumab -- r_associated #0: 102 / 0.223 -> en:mvx-1-loaded macrocapsule/autologous tumor cell vaccine mvx-onco-1
    n1=ipilimumab | n2=en:mvx-1-loaded macrocapsule/autologous tumor cell vaccine mvx-onco-1 | rel=r_associated | relid=0 | w=102
  3010. ipilimumab -- r_associated #0: 102 / 0.223 -> en:mycophenolate mofetil
    n1=ipilimumab | n2=en:mycophenolate mofetil | rel=r_associated | relid=0 | w=102
  3011. ipilimumab -- r_associated #0: 102 / 0.223 -> en:myeloablative agonist
    n1=ipilimumab | n2=en:myeloablative agonist | rel=r_associated | relid=0 | w=102
  3012. ipilimumab -- r_associated #0: 102 / 0.223 -> en:nadolol
    n1=ipilimumab | n2=en:nadolol | rel=r_associated | relid=0 | w=102
  3013. ipilimumab -- r_associated #0: 102 / 0.223 -> en:nateglinide
    n1=ipilimumab | n2=en:nateglinide | rel=r_associated | relid=0 | w=102
  3014. ipilimumab -- r_associated #0: 102 / 0.223 -> en:navitoclax
    n1=ipilimumab | n2=en:navitoclax | rel=r_associated | relid=0 | w=102
  3015. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ncit antineoplastic agent terminology
    n1=ipilimumab | n2=en:ncit antineoplastic agent terminology | rel=r_associated | relid=0 | w=102
  3016. ipilimumab -- r_associated #0: 102 / 0.223 -> en:neihulizumab
    n1=ipilimumab | n2=en:neihulizumab | rel=r_associated | relid=0 | w=102
  3017. ipilimumab -- r_associated #0: 102 / 0.223 -> en:nilutamide
    n1=ipilimumab | n2=en:nilutamide | rel=r_associated | relid=0 | w=102
  3018. ipilimumab -- r_associated #0: 102 / 0.223 -> en:nintedanib
    n1=ipilimumab | n2=en:nintedanib | rel=r_associated | relid=0 | w=102
  3019. ipilimumab -- r_associated #0: 102 / 0.223 -> en:nitazoxanide
    n1=ipilimumab | n2=en:nitazoxanide | rel=r_associated | relid=0 | w=102
  3020. ipilimumab -- r_associated #0: 102 / 0.223 -> en:notch signaling inhibitor pf-06650808
    n1=ipilimumab | n2=en:notch signaling inhibitor pf-06650808 | rel=r_associated | relid=0 | w=102
  3021. ipilimumab -- r_associated #0: 102 / 0.223 -> en:nutrient-rich whole wheat flour supplement
    n1=ipilimumab | n2=en:nutrient-rich whole wheat flour supplement | rel=r_associated | relid=0 | w=102
  3022. ipilimumab -- r_associated #0: 102 / 0.223 -> en:oat biscuit
    n1=ipilimumab | n2=en:oat biscuit | rel=r_associated | relid=0 | w=102
  3023. ipilimumab -- r_associated #0: 102 / 0.223 -> en:obatoclax mesylate
    n1=ipilimumab | n2=en:obatoclax mesylate | rel=r_associated | relid=0 | w=102
  3024. ipilimumab -- r_associated #0: 102 / 0.223 -> en:off regimen
    n1=ipilimumab | n2=en:off regimen | rel=r_associated | relid=0 | w=102
  3025. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ombitasvir/paritaprevir/ritonavir
    n1=ipilimumab | n2=en:ombitasvir/paritaprevir/ritonavir | rel=r_associated | relid=0 | w=102
  3026. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ombrabulin
    n1=ipilimumab | n2=en:ombrabulin | rel=r_associated | relid=0 | w=102
  3027. ipilimumab -- r_associated #0: 102 / 0.223 -> en:onalespib
    n1=ipilimumab | n2=en:onalespib | rel=r_associated | relid=0 | w=102
  3028. ipilimumab -- r_associated #0: 102 / 0.223 -> en:oncolytic adenovirus encoding gm-csf
    n1=ipilimumab | n2=en:oncolytic adenovirus encoding gm-csf | rel=r_associated | relid=0 | w=102
  3029. ipilimumab -- r_associated #0: 102 / 0.223 -> en:oncolytic hsv1716
    n1=ipilimumab | n2=en:oncolytic hsv1716 | rel=r_associated | relid=0 | w=102
  3030. ipilimumab -- r_associated #0: 102 / 0.223 -> en:oncolytic measles virus encoding thyroidal sodium iodide symporter
    n1=ipilimumab | n2=en:oncolytic measles virus encoding thyroidal sodium iodide symporter | rel=r_associated | relid=0 | w=102
  3031. ipilimumab -- r_associated #0: 102 / 0.223 -> en:oncolytic newcastle disease virus
    n1=ipilimumab | n2=en:oncolytic newcastle disease virus | rel=r_associated | relid=0 | w=102
  3032. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ondansetron hydrochloride
    n1=ipilimumab | n2=en:ondansetron hydrochloride | rel=r_associated | relid=0 | w=102
  3033. ipilimumab -- r_associated #0: 102 / 0.223 -> en:onyx-015
    n1=ipilimumab | n2=en:onyx-015 | rel=r_associated | relid=0 | w=102
  3034. ipilimumab -- r_associated #0: 102 / 0.223 -> en:oppa regimen
    n1=ipilimumab | n2=en:oppa regimen | rel=r_associated | relid=0 | w=102
  3035. ipilimumab -- r_associated #0: 102 / 0.223 -> en:oral microencapsulated diindolylmethane
    n1=ipilimumab | n2=en:oral microencapsulated diindolylmethane | rel=r_associated | relid=0 | w=102
  3036. ipilimumab -- r_associated #0: 102 / 0.223 -> en:oropharyngeal dosage form product
    n1=ipilimumab | n2=en:oropharyngeal dosage form product | rel=r_associated | relid=0 | w=102
  3037. ipilimumab -- r_associated #0: 102 / 0.223 -> en:oshadi d
    n1=ipilimumab | n2=en:oshadi d | rel=r_associated | relid=0 | w=102
  3038. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ova bip peptide
    n1=ipilimumab | n2=en:ova bip peptide | rel=r_associated | relid=0 | w=102
  3039. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ovarian cancer peptide vaccine
    n1=ipilimumab | n2=en:ovarian cancer peptide vaccine | rel=r_associated | relid=0 | w=102
  3040. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ovarian cancer stem cell/htert/survivin mrnas-loaded autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:ovarian cancer stem cell/htert/survivin mrnas-loaded autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=102
  3041. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ovarian tumor antigen-activated autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:ovarian tumor antigen-activated autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=102
  3042. ipilimumab -- r_associated #0: 102 / 0.223 -> en:oxidized avidin
    n1=ipilimumab | n2=en:oxidized avidin | rel=r_associated | relid=0 | w=102
  3043. ipilimumab -- r_associated #0: 102 / 0.223 -> en:oxitriptan
    n1=ipilimumab | n2=en:oxitriptan | rel=r_associated | relid=0 | w=102
  3044. ipilimumab -- r_associated #0: 102 / 0.223 -> en:oxycodone hydrochloride
    n1=ipilimumab | n2=en:oxycodone hydrochloride | rel=r_associated | relid=0 | w=102
  3045. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ozarelix
    n1=ipilimumab | n2=en:ozarelix | rel=r_associated | relid=0 | w=102
  3046. ipilimumab -- r_associated #0: 102 / 0.223 -> en:p70s6k inhibitor ly2584702
    n1=ipilimumab | n2=en:p70s6k inhibitor ly2584702 | rel=r_associated | relid=0 | w=102
  3047. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pak4/nampt inhibitor kpt-9274
    n1=ipilimumab | n2=en:pak4/nampt inhibitor kpt-9274 | rel=r_associated | relid=0 | w=102
  3048. ipilimumab -- r_associated #0: 102 / 0.223 -> en:palifosfamide
    n1=ipilimumab | n2=en:palifosfamide | rel=r_associated | relid=0 | w=102
  3049. ipilimumab -- r_associated #0: 102 / 0.223 -> en:palifosfamide tromethamine
    n1=ipilimumab | n2=en:palifosfamide tromethamine | rel=r_associated | relid=0 | w=102
  3050. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pan fgfr inhibitor prn1371
    n1=ipilimumab | n2=en:pan fgfr inhibitor prn1371 | rel=r_associated | relid=0 | w=102
  3051. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pan-akt kinase inhibitor gsk690693
    n1=ipilimumab | n2=en:pan-akt kinase inhibitor gsk690693 | rel=r_associated | relid=0 | w=102
  3052. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pan-fgfr tyrosine kinase inhibitor bay1163877
    n1=ipilimumab | n2=en:pan-fgfr tyrosine kinase inhibitor bay1163877 | rel=r_associated | relid=0 | w=102
  3053. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pan-idh mutant inhibitor ag-881
    n1=ipilimumab | n2=en:pan-idh mutant inhibitor ag-881 | rel=r_associated | relid=0 | w=102
  3054. ipilimumab -- r_associated #0: 102 / 0.223 -> en:paromomycin sulfate
    n1=ipilimumab | n2=en:paromomycin sulfate | rel=r_associated | relid=0 | w=102
  3055. ipilimumab -- r_associated #0: 102 / 0.223 -> en:parp-1/2 inhibitor abt-767
    n1=ipilimumab | n2=en:parp-1/2 inhibitor abt-767 | rel=r_associated | relid=0 | w=102
  3056. ipilimumab -- r_associated #0: 102 / 0.223 -> en:parvovirus h-1
    n1=ipilimumab | n2=en:parvovirus h-1 | rel=r_associated | relid=0 | w=102
  3057. ipilimumab -- r_associated #0: 102 / 0.223 -> en:patupilone
    n1=ipilimumab | n2=en:patupilone | rel=r_associated | relid=0 | w=102
  3058. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pazopanib hydrochloride
    n1=ipilimumab | n2=en:pazopanib hydrochloride | rel=r_associated | relid=0 | w=102
  3059. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pbi-shrna stmn1 lipoplex
    n1=ipilimumab | n2=en:pbi-shrna stmn1 lipoplex | rel=r_associated | relid=0 | w=102
  3060. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pdgfr alpha/kit mutant-specific inhibitor blu-285
    n1=ipilimumab | n2=en:pdgfr alpha/kit mutant-specific inhibitor blu-285 | rel=r_associated | relid=0 | w=102
  3061. ipilimumab -- r_associated #0: 102 / 0.223 -> en:peg recombinant human megakaryocyte growth and development factor
    n1=ipilimumab | n2=en:peg recombinant human megakaryocyte growth and development factor | rel=r_associated | relid=0 | w=102
  3062. ipilimumab -- r_associated #0: 102 / 0.223 -> en:peg-proline-interferon alfa-2b
    n1=ipilimumab | n2=en:peg-proline-interferon alfa-2b | rel=r_associated | relid=0 | w=102
  3063. ipilimumab -- r_associated #0: 102 / 0.223 -> en:peginterferon alfa-2b
    n1=ipilimumab | n2=en:peginterferon alfa-2b | rel=r_associated | relid=0 | w=102
  3064. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pegylated irinotecan
    n1=ipilimumab | n2=en:pegylated irinotecan | rel=r_associated | relid=0 | w=102
  3065. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pegylated liposomal irinotecan
    n1=ipilimumab | n2=en:pegylated liposomal irinotecan | rel=r_associated | relid=0 | w=102
  3066. ipilimumab -- r_associated #0: 102 / 0.223 -> en:penicillamine
    n1=ipilimumab | n2=en:penicillamine | rel=r_associated | relid=0 | w=102
  3067. ipilimumab -- r_associated #0: 102 / 0.223 -> en:peptichemio
    n1=ipilimumab | n2=en:peptichemio | rel=r_associated | relid=0 | w=102
  3068. ipilimumab -- r_associated #0: 102 / 0.223 -> en:peretinoin
    n1=ipilimumab | n2=en:peretinoin | rel=r_associated | relid=0 | w=102
  3069. ipilimumab -- r_associated #0: 102 / 0.223 -> en:perindopril erbumine
    n1=ipilimumab | n2=en:perindopril erbumine | rel=r_associated | relid=0 | w=102
  3070. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pertuzumab
    n1=ipilimumab | n2=en:pertuzumab | rel=r_associated | relid=0 | w=102
  3071. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pesticide
    n1=ipilimumab | n2=en:pesticide | rel=r_associated | relid=0 | w=102
  3072. ipilimumab -- r_associated #0: 102 / 0.223 -> en:petrolatum-mineral oil-lanolin-ceresin ointment
    n1=ipilimumab | n2=en:petrolatum-mineral oil-lanolin-ceresin ointment | rel=r_associated | relid=0 | w=102
  3073. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pexastimogene-devacirepvec
    n1=ipilimumab | n2=en:pexastimogene-devacirepvec | rel=r_associated | relid=0 | w=102
  3074. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pgla/peg copolymer-based paclitaxel
    n1=ipilimumab | n2=en:pgla/peg copolymer-based paclitaxel | rel=r_associated | relid=0 | w=102
  3075. ipilimumab -- r_associated #0: 102 / 0.223 -> en:phaleria macrocarpa extract dlbs-1425
    n1=ipilimumab | n2=en:phaleria macrocarpa extract dlbs-1425 | rel=r_associated | relid=0 | w=102
  3076. ipilimumab -- r_associated #0: 102 / 0.223 -> en:phosphatidylcholine-bound silybin
    n1=ipilimumab | n2=en:phosphatidylcholine-bound silybin | rel=r_associated | relid=0 | w=102
  3077. ipilimumab -- r_associated #0: 102 / 0.223 -> en:phytonadione
    n1=ipilimumab | n2=en:phytonadione | rel=r_associated | relid=0 | w=102
  3078. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pi3k delta/gamma inhibitor rp6530
    n1=ipilimumab | n2=en:pi3k delta/gamma inhibitor rp6530 | rel=r_associated | relid=0 | w=102
  3079. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pi3k/hdac inhibitor cudc-907
    n1=ipilimumab | n2=en:pi3k/hdac inhibitor cudc-907 | rel=r_associated | relid=0 | w=102
  3080. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pi3k/mtor kinase inhibitor vs-5584
    n1=ipilimumab | n2=en:pi3k/mtor kinase inhibitor vs-5584 | rel=r_associated | relid=0 | w=102
  3081. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pi3kbeta inhibitor azd8186
    n1=ipilimumab | n2=en:pi3kbeta inhibitor azd8186 | rel=r_associated | relid=0 | w=102
  3082. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pigmenting agent
    n1=ipilimumab | n2=en:pigmenting agent | rel=r_associated | relid=0 | w=102
  3083. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pinaverium bromide
    n1=ipilimumab | n2=en:pinaverium bromide | rel=r_associated | relid=0 | w=102
  3084. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pipendoxifene
    n1=ipilimumab | n2=en:pipendoxifene | rel=r_associated | relid=0 | w=102
  3085. ipilimumab -- r_associated #0: 102 / 0.223 -> en:polatuzumab vedotin
    n1=ipilimumab | n2=en:polatuzumab vedotin | rel=r_associated | relid=0 | w=102
  3086. ipilimumab -- r_associated #0: 102 / 0.223 -> en:polo-like kinase 1 inhibitor mk1496
    n1=ipilimumab | n2=en:polo-like kinase 1 inhibitor mk1496 | rel=r_associated | relid=0 | w=102
  3087. ipilimumab -- r_associated #0: 102 / 0.223 -> en:polydextrose
    n1=ipilimumab | n2=en:polydextrose | rel=r_associated | relid=0 | w=102
  3088. ipilimumab -- r_associated #0: 102 / 0.223 -> en:polyethylene glycol 3350-containing enema ner1008
    n1=ipilimumab | n2=en:polyethylene glycol 3350-containing enema ner1008 | rel=r_associated | relid=0 | w=102
  3089. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pomegranate-extract pill
    n1=ipilimumab | n2=en:pomegranate-extract pill | rel=r_associated | relid=0 | w=102
  3090. ipilimumab -- r_associated #0: 102 / 0.223 -> en:porcupine inhibitor wnt974
    n1=ipilimumab | n2=en:porcupine inhibitor wnt974 | rel=r_associated | relid=0 | w=102
  3091. ipilimumab -- r_associated #0: 102 / 0.223 -> en:porfiromycin
    n1=ipilimumab | n2=en:porfiromycin | rel=r_associated | relid=0 | w=102
  3092. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pravastatin sodium
    n1=ipilimumab | n2=en:pravastatin sodium | rel=r_associated | relid=0 | w=102
  3093. ipilimumab -- r_associated #0: 102 / 0.223 -> en:prednimustine
    n1=ipilimumab | n2=en:prednimustine | rel=r_associated | relid=0 | w=102
  3094. ipilimumab -- r_associated #0: 102 / 0.223 -> en:procaspase activating compound-1 vo-100
    n1=ipilimumab | n2=en:procaspase activating compound-1 vo-100 | rel=r_associated | relid=0 | w=102
  3095. ipilimumab -- r_associated #0: 102 / 0.223 -> en:progenipoietin
    n1=ipilimumab | n2=en:progenipoietin | rel=r_associated | relid=0 | w=102
  3096. ipilimumab -- r_associated #0: 102 / 0.223 -> en:prohibitin-targeting peptide 1
    n1=ipilimumab | n2=en:prohibitin-targeting peptide 1 | rel=r_associated | relid=0 | w=102
  3097. ipilimumab -- r_associated #0: 102 / 0.223 -> en:prostate health cocktail dietary supplement
    n1=ipilimumab | n2=en:prostate health cocktail dietary supplement | rel=r_associated | relid=0 | w=102
  3098. ipilimumab -- r_associated #0: 102 / 0.223 -> en:prostatic acid phosphatase-sargramostim fusion protein
    n1=ipilimumab | n2=en:prostatic acid phosphatase-sargramostim fusion protein | rel=r_associated | relid=0 | w=102
  3099. ipilimumab -- r_associated #0: 102 / 0.223 -> en:protective agent
    n1=ipilimumab | n2=en:protective agent | rel=r_associated | relid=0 | w=102
  3100. ipilimumab -- r_associated #0: 102 / 0.223 -> en:psa-pap/klh-pulsed autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:psa-pap/klh-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=102
  3101. ipilimumab -- r_associated #0: 102 / 0.223 -> en:purple grape juice
    n1=ipilimumab | n2=en:purple grape juice | rel=r_associated | relid=0 | w=102
  3102. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pvaxrcpsav53l dna vaccine
    n1=ipilimumab | n2=en:pvaxrcpsav53l dna vaccine | rel=r_associated | relid=0 | w=102
  3103. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pyrimethamine
    n1=ipilimumab | n2=en:pyrimethamine | rel=r_associated | relid=0 | w=102
  3104. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pyroxamide
    n1=ipilimumab | n2=en:pyroxamide | rel=r_associated | relid=0 | w=102
  3105. ipilimumab -- r_associated #0: 102 / 0.223 -> en:pyruvate kinase inhibitor tln-232
    n1=ipilimumab | n2=en:pyruvate kinase inhibitor tln-232 | rel=r_associated | relid=0 | w=102
  3106. ipilimumab -- r_associated #0: 102 / 0.223 -> en:quaternary ammonium polyethylenimine nanoparticles
    n1=ipilimumab | n2=en:quaternary ammonium polyethylenimine nanoparticles | rel=r_associated | relid=0 | w=102
  3107. ipilimumab -- r_associated #0: 102 / 0.223 -> en:quercetin
    n1=ipilimumab | n2=en:quercetin | rel=r_associated | relid=0 | w=102
  3108. ipilimumab -- r_associated #0: 102 / 0.223 -> en:r(+)xk469
    n1=ipilimumab | n2=en:r(+)xk469 | rel=r_associated | relid=0 | w=102
  3109. ipilimumab -- r_associated #0: 102 / 0.223 -> en:raf kinase inhibitor hm95573
    n1=ipilimumab | n2=en:raf kinase inhibitor hm95573 | rel=r_associated | relid=0 | w=102
  3110. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ravuconazole
    n1=ipilimumab | n2=en:ravuconazole | rel=r_associated | relid=0 | w=102
  3111. ipilimumab -- r_associated #0: 102 / 0.223 -> en:rebastinib tosylate
    n1=ipilimumab | n2=en:rebastinib tosylate | rel=r_associated | relid=0 | w=102
  3112. ipilimumab -- r_associated #0: 102 / 0.223 -> en:recombinant adenovirus-p53 sch-58500
    n1=ipilimumab | n2=en:recombinant adenovirus-p53 sch-58500 | rel=r_associated | relid=0 | w=102
  3113. ipilimumab -- r_associated #0: 102 / 0.223 -> en:recombinant attenuated salmonella typhimurium expressing il-2
    n1=ipilimumab | n2=en:recombinant attenuated salmonella typhimurium expressing il-2 | rel=r_associated | relid=0 | w=102
  3114. ipilimumab -- r_associated #0: 102 / 0.223 -> en:recombinant interleukin-18
    n1=ipilimumab | n2=en:recombinant interleukin-18 | rel=r_associated | relid=0 | w=102
  3115. ipilimumab -- r_associated #0: 102 / 0.223 -> en:recombinant interleukin-3
    n1=ipilimumab | n2=en:recombinant interleukin-3 | rel=r_associated | relid=0 | w=102
  3116. ipilimumab -- r_associated #0: 102 / 0.223 -> en:recombinant oncolytic poliovirus pvs-ripo
    n1=ipilimumab | n2=en:recombinant oncolytic poliovirus pvs-ripo | rel=r_associated | relid=0 | w=102
  3117. ipilimumab -- r_associated #0: 102 / 0.223 -> en:recombinant oxytocin
    n1=ipilimumab | n2=en:recombinant oxytocin | rel=r_associated | relid=0 | w=102
  3118. ipilimumab -- r_associated #0: 102 / 0.223 -> en:recombinant thyroid-stimulating hormone
    n1=ipilimumab | n2=en:recombinant thyroid-stimulating hormone | rel=r_associated | relid=0 | w=102
  3119. ipilimumab -- r_associated #0: 102 / 0.223 -> en:relcovaptan
    n1=ipilimumab | n2=en:relcovaptan | rel=r_associated | relid=0 | w=102
  3120. ipilimumab -- r_associated #0: 102 / 0.223 -> en:reparixin
    n1=ipilimumab | n2=en:reparixin | rel=r_associated | relid=0 | w=102
  3121. ipilimumab -- r_associated #0: 102 / 0.223 -> en:resistant starch
    n1=ipilimumab | n2=en:resistant starch | rel=r_associated | relid=0 | w=102
  3122. ipilimumab -- r_associated #0: 102 / 0.223 -> en:resveratrol
    n1=ipilimumab | n2=en:resveratrol | rel=r_associated | relid=0 | w=102
  3123. ipilimumab -- r_associated #0: 102 / 0.223 -> en:resveratrol formulation srt501
    n1=ipilimumab | n2=en:resveratrol formulation srt501 | rel=r_associated | relid=0 | w=102
  3124. ipilimumab -- r_associated #0: 102 / 0.223 -> en:ricolinostat
    n1=ipilimumab | n2=en:ricolinostat | rel=r_associated | relid=0 | w=102
  3125. ipilimumab -- r_associated #0: 102 / 0.223 -> en:rifabutin
    n1=ipilimumab | n2=en:rifabutin | rel=r_associated | relid=0 | w=102
  3126. ipilimumab -- r_associated #0: 102 / 0.223 -> en:s-adenosyl-l-methionine disulfate p-toluene-sulfonate
    n1=ipilimumab | n2=en:s-adenosyl-l-methionine disulfate p-toluene-sulfonate | rel=r_associated | relid=0 | w=102
  3127. ipilimumab -- r_associated #0: 102 / 0.223 -> en:saob-0401
    n1=ipilimumab | n2=en:saob-0401 | rel=r_associated | relid=0 | w=102
  3128. ipilimumab -- r_associated #0: 102 / 0.223 -> en:saponin-cholesterol-phospholipid adjuvant
    n1=ipilimumab | n2=en:saponin-cholesterol-phospholipid adjuvant | rel=r_associated | relid=0 | w=102
  3129. ipilimumab -- r_associated #0: 102 / 0.223 -> en:saracatinib
    n1=ipilimumab | n2=en:saracatinib | rel=r_associated | relid=0 | w=102
  3130. ipilimumab -- r_associated #0: 102 / 0.223 -> en:sargramostim plasmid dna melanoma vaccine adjuvant
    n1=ipilimumab | n2=en:sargramostim plasmid dna melanoma vaccine adjuvant | rel=r_associated | relid=0 | w=102
  3131. ipilimumab -- r_associated #0: 102 / 0.223 -> en:sargramostim plasmid dna pancreatic tumor cell vaccine
    n1=ipilimumab | n2=en:sargramostim plasmid dna pancreatic tumor cell vaccine | rel=r_associated | relid=0 | w=102
  3132. ipilimumab -- r_associated #0: 102 / 0.223 -> en:sb as-2
    n1=ipilimumab | n2=en:sb as-2 | rel=r_associated | relid=0 | w=102
  3133. ipilimumab -- r_associated #0: 102 / 0.223 -> en:selective androgen receptor modulator ly2452473
    n1=ipilimumab | n2=en:selective androgen receptor modulator ly2452473 | rel=r_associated | relid=0 | w=102
  3134. ipilimumab -- r_associated #0: 102 / 0.223 -> en:selective estrogen receptor degrader lsz102
    n1=ipilimumab | n2=en:selective estrogen receptor degrader lsz102 | rel=r_associated | relid=0 | w=102
  3135. ipilimumab -- r_associated #0: 102 / 0.223 -> en:selective estrogen receptor degrader srn-927
    n1=ipilimumab | n2=en:selective estrogen receptor degrader srn-927 | rel=r_associated | relid=0 | w=102
  3136. ipilimumab -- r_associated #0: 102 / 0.223 -> en:selinexor
    n1=ipilimumab | n2=en:selinexor | rel=r_associated | relid=0 | w=102
  3137. ipilimumab -- r_associated #0: 102 / 0.223 -> en:serotonin 5-ht1 receptor agonists
    n1=ipilimumab | n2=en:serotonin 5-ht1 receptor agonists | rel=r_associated | relid=0 | w=102
  3138. ipilimumab -- r_associated #0: 102 / 0.223 -> en:sho-saiko-to
    n1=ipilimumab | n2=en:sho-saiko-to | rel=r_associated | relid=0 | w=102
  3139. ipilimumab -- r_associated #0: 102 / 0.223 -> en:simmitecan hydrochloride
    n1=ipilimumab | n2=en:simmitecan hydrochloride | rel=r_associated | relid=0 | w=102
  3140. ipilimumab -- r_associated #0: 102 / 0.223 -> en:simvastatin
    n1=ipilimumab | n2=en:simvastatin | rel=r_associated | relid=0 | w=102
  3141. ipilimumab -- r_associated #0: 102 / 0.223 -> en:smooth muscle relaxant
    n1=ipilimumab | n2=en:smooth muscle relaxant | rel=r_associated | relid=0 | w=102
  3142. ipilimumab -- r_associated #0: 102 / 0.223 -> en:sorghum bicolor supplement
    n1=ipilimumab | n2=en:sorghum bicolor supplement | rel=r_associated | relid=0 | w=102
  3143. ipilimumab -- r_associated #0: 102 / 0.223 -> en:sotrastaurin acetate
    n1=ipilimumab | n2=en:sotrastaurin acetate | rel=r_associated | relid=0 | w=102
  3144. ipilimumab -- r_associated #0: 102 / 0.223 -> en:sphingosine kinase-2 inhibitor abc294640
    n1=ipilimumab | n2=en:sphingosine kinase-2 inhibitor abc294640 | rel=r_associated | relid=0 | w=102
  3145. ipilimumab -- r_associated #0: 102 / 0.223 -> en:spiramycin
    n1=ipilimumab | n2=en:spiramycin | rel=r_associated | relid=0 | w=102
  3146. ipilimumab -- r_associated #0: 102 / 0.223 -> en:stabilized sulphur hexafluoride microbubble-based contrast agent
    n1=ipilimumab | n2=en:stabilized sulphur hexafluoride microbubble-based contrast agent | rel=r_associated | relid=0 | w=102
  3147. ipilimumab -- r_associated #0: 102 / 0.223 -> en:stat inhibitor opb-111077
    n1=ipilimumab | n2=en:stat inhibitor opb-111077 | rel=r_associated | relid=0 | w=102
  3148. ipilimumab -- r_associated #0: 102 / 0.223 -> en:sufentanil citrate
    n1=ipilimumab | n2=en:sufentanil citrate | rel=r_associated | relid=0 | w=102
  3149. ipilimumab -- r_associated #0: 102 / 0.223 -> en:sulfur hexafluoride
    n1=ipilimumab | n2=en:sulfur hexafluoride | rel=r_associated | relid=0 | w=102
  3150. ipilimumab -- r_associated #0: 102 / 0.223 -> en:syk inhibitor hmpl-523
    n1=ipilimumab | n2=en:syk inhibitor hmpl-523 | rel=r_associated | relid=0 | w=102
  3151. ipilimumab -- r_associated #0: 102 / 0.223 -> en:talampanel
    n1=ipilimumab | n2=en:talampanel | rel=r_associated | relid=0 | w=102
  3152. ipilimumab -- r_associated #0: 102 / 0.223 -> en:tamsulosin hydrochloride
    n1=ipilimumab | n2=en:tamsulosin hydrochloride | rel=r_associated | relid=0 | w=102
  3153. ipilimumab -- r_associated #0: 102 / 0.223 -> en:tandutinib
    n1=ipilimumab | n2=en:tandutinib | rel=r_associated | relid=0 | w=102
  3154. ipilimumab -- r_associated #0: 102 / 0.223 -> en:tanezumab
    n1=ipilimumab | n2=en:tanezumab | rel=r_associated | relid=0 | w=102
  3155. ipilimumab -- r_associated #0: 102 / 0.223 -> en:technetium tc 99m mip 1405
    n1=ipilimumab | n2=en:technetium tc 99m mip 1405 | rel=r_associated | relid=0 | w=102
  3156. ipilimumab -- r_associated #0: 102 / 0.223 -> en:technetium tc 99m-labeled rhenium sulfide nanocolloid
    n1=ipilimumab | n2=en:technetium tc 99m-labeled rhenium sulfide nanocolloid | rel=r_associated | relid=0 | w=102
  3157. ipilimumab -- r_associated #0: 102 / 0.223 -> en:telbivudine
    n1=ipilimumab | n2=en:telbivudine | rel=r_associated | relid=0 | w=102
  3158. ipilimumab -- r_associated #0: 102 / 0.223 -> en:temoporfin
    n1=ipilimumab | n2=en:temoporfin | rel=r_associated | relid=0 | w=102
  3159. ipilimumab -- r_associated #0: 102 / 0.223 -> en:tenofovir disoproxil fumarate
    n1=ipilimumab | n2=en:tenofovir disoproxil fumarate | rel=r_associated | relid=0 | w=102
  3160. ipilimumab -- r_associated #0: 102 / 0.223 -> en:terfluranol
    n1=ipilimumab | n2=en:terfluranol | rel=r_associated | relid=0 | w=102
  3161. ipilimumab -- r_associated #0: 102 / 0.223 -> en:tezacitabine
    n1=ipilimumab | n2=en:tezacitabine | rel=r_associated | relid=0 | w=102
  3162. ipilimumab -- r_associated #0: 102 / 0.223 -> en:tgfa-pe38 immunotoxin
    n1=ipilimumab | n2=en:tgfa-pe38 immunotoxin | rel=r_associated | relid=0 | w=102
  3163. ipilimumab -- r_associated #0: 102 / 0.223 -> en:tgfbdnrii-transduced autologous tumor infiltrating lymphocytes
    n1=ipilimumab | n2=en:tgfbdnrii-transduced autologous tumor infiltrating lymphocytes | rel=r_associated | relid=0 | w=102
  3164. ipilimumab -- r_associated #0: 102 / 0.223 -> en:therapeutic autologous lymphocytes
    n1=ipilimumab | n2=en:therapeutic autologous lymphocytes | rel=r_associated | relid=0 | w=102
  3165. ipilimumab -- r_associated #0: 102 / 0.223 -> en:therapeutic breast/ovarian/prostate peptide cancer vaccine dpx-0907
    n1=ipilimumab | n2=en:therapeutic breast/ovarian/prostate peptide cancer vaccine dpx-0907 | rel=r_associated | relid=0 | w=102
  3166. ipilimumab -- r_associated #0: 102 / 0.223 -> en:therapeutic hemin
    n1=ipilimumab | n2=en:therapeutic hemin | rel=r_associated | relid=0 | w=102
  3167. ipilimumab -- r_associated #0: 102 / 0.223 -> en:thyrotropin alfa
    n1=ipilimumab | n2=en:thyrotropin alfa | rel=r_associated | relid=0 | w=102
  3168. ipilimumab -- r_associated #0: 102 / 0.223 -> en:tiazofurin
    n1=ipilimumab | n2=en:tiazofurin | rel=r_associated | relid=0 | w=102
  3169. ipilimumab -- r_associated #0: 102 / 0.223 -> en:tocopherol
    n1=ipilimumab | n2=en:tocopherol | rel=r_associated | relid=0 | w=102
  3170. ipilimumab -- r_associated #0: 102 / 0.223 -> en:topical pvdf/sirolimus
    n1=ipilimumab | n2=en:topical pvdf/sirolimus | rel=r_associated | relid=0 | w=102
  3171. ipilimumab -- r_associated #0: 102 / 0.223 -> en:topoisomerase i inhibitor lmp400
    n1=ipilimumab | n2=en:topoisomerase i inhibitor lmp400 | rel=r_associated | relid=0 | w=102
  3172. ipilimumab -- r_associated #0: 102 / 0.223 -> en:topoisomerase i/ii inhibitor nev-801
    n1=ipilimumab | n2=en:topoisomerase i/ii inhibitor nev-801 | rel=r_associated | relid=0 | w=102
  3173. ipilimumab -- r_associated #0: 102 / 0.223 -> en:topotecan hydrochloride liposomes
    n1=ipilimumab | n2=en:topotecan hydrochloride liposomes | rel=r_associated | relid=0 | w=102
  3174. ipilimumab -- r_associated #0: 102 / 0.223 -> en:transdermal 4-hydroxytestosterone
    n1=ipilimumab | n2=en:transdermal 4-hydroxytestosterone | rel=r_associated | relid=0 | w=102
  3175. ipilimumab -- r_associated #0: 102 / 0.223 -> en:transferrin receptor-targeted anti-rrm2 sirna calaa-01
    n1=ipilimumab | n2=en:transferrin receptor-targeted anti-rrm2 sirna calaa-01 | rel=r_associated | relid=0 | w=102
  3176. ipilimumab -- r_associated #0: 102 / 0.223 -> en:transferrin-crm107
    n1=ipilimumab | n2=en:transferrin-crm107 | rel=r_associated | relid=0 | w=102
  3177. ipilimumab -- r_associated #0: 102 / 0.223 -> en:tremelimumab
    n1=ipilimumab | n2=en:tremelimumab | rel=r_associated | relid=0 | w=102
  3178. ipilimumab -- r_associated #0: 102 / 0.223 -> en:treosulfan
    n1=ipilimumab | n2=en:treosulfan | rel=r_associated | relid=0 | w=102
  3179. ipilimumab -- r_associated #0: 102 / 0.223 -> en:tretazicar
    n1=ipilimumab | n2=en:tretazicar | rel=r_associated | relid=0 | w=102
  3180. ipilimumab -- r_associated #0: 102 / 0.223 -> en:tretinoin liposome
    n1=ipilimumab | n2=en:tretinoin liposome | rel=r_associated | relid=0 | w=102
  3181. ipilimumab -- r_associated #0: 102 / 0.223 -> en:tributyrin
    n1=ipilimumab | n2=en:tributyrin | rel=r_associated | relid=0 | w=102
  3182. ipilimumab -- r_associated #0: 102 / 0.223 -> en:trimethoprim
    n1=ipilimumab | n2=en:trimethoprim | rel=r_associated | relid=0 | w=102
  3183. ipilimumab -- r_associated #0: 102 / 0.223 -> en:trioxifene mesylate
    n1=ipilimumab | n2=en:trioxifene mesylate | rel=r_associated | relid=0 | w=102
  3184. ipilimumab -- r_associated #0: 102 / 0.223 -> en:trp2 mrna-electroporated autologous langerhans-type dendritic cell vaccine
    n1=ipilimumab | n2=en:trp2 mrna-electroporated autologous langerhans-type dendritic cell vaccine | rel=r_associated | relid=0 | w=102
  3185. ipilimumab -- r_associated #0: 102 / 0.223 -> en:tubulin inhibitor alb 109564(a)
    n1=ipilimumab | n2=en:tubulin inhibitor alb 109564(a) | rel=r_associated | relid=0 | w=102
  3186. ipilimumab -- r_associated #0: 102 / 0.223 -> en:typhoid vaccine
    n1=ipilimumab | n2=en:typhoid vaccine | rel=r_associated | relid=0 | w=102
  3187. ipilimumab -- r_associated #0: 102 / 0.223 -> en:tyrosinase peptide
    n1=ipilimumab | n2=en:tyrosinase peptide | rel=r_associated | relid=0 | w=102
  3188. ipilimumab -- r_associated #0: 102 / 0.223 -> en:uae inhibitor tak-243
    n1=ipilimumab | n2=en:uae inhibitor tak-243 | rel=r_associated | relid=0 | w=102
  3189. ipilimumab -- r_associated #0: 102 / 0.223 -> en:urea/lactic acid-based topical cream
    n1=ipilimumab | n2=en:urea/lactic acid-based topical cream | rel=r_associated | relid=0 | w=102
  3190. ipilimumab -- r_associated #0: 102 / 0.223 -> en:urlc10-ttk-koc1-vegfr1-vegfr2 multipeptide vaccine
    n1=ipilimumab | n2=en:urlc10-ttk-koc1-vegfr1-vegfr2 multipeptide vaccine | rel=r_associated | relid=0 | w=102
  3191. ipilimumab -- r_associated #0: 102 / 0.223 -> en:uv1 telomerase peptide vaccine
    n1=ipilimumab | n2=en:uv1 telomerase peptide vaccine | rel=r_associated | relid=0 | w=102
  3192. ipilimumab -- r_associated #0: 102 / 0.223 -> en:v930 vaccine
    n1=ipilimumab | n2=en:v930 vaccine | rel=r_associated | relid=0 | w=102
  3193. ipilimumab -- r_associated #0: 102 / 0.223 -> en:vaccinia cea vaccine
    n1=ipilimumab | n2=en:vaccinia cea vaccine | rel=r_associated | relid=0 | w=102
  3194. ipilimumab -- r_associated #0: 102 / 0.223 -> en:vadimezan
    n1=ipilimumab | n2=en:vadimezan | rel=r_associated | relid=0 | w=102
  3195. ipilimumab -- r_associated #0: 102 / 0.223 -> en:valacyclovir
    n1=ipilimumab | n2=en:valacyclovir | rel=r_associated | relid=0 | w=102
  3196. ipilimumab -- r_associated #0: 102 / 0.223 -> en:valerian
    n1=ipilimumab | n2=en:valerian | rel=r_associated | relid=0 | w=102
  3197. ipilimumab -- r_associated #0: 102 / 0.223 -> en:valrubicin
    n1=ipilimumab | n2=en:valrubicin | rel=r_associated | relid=0 | w=102
  3198. ipilimumab -- r_associated #0: 102 / 0.223 -> en:valspodar
    n1=ipilimumab | n2=en:valspodar | rel=r_associated | relid=0 | w=102
  3199. ipilimumab -- r_associated #0: 102 / 0.223 -> en:vapreotide
    n1=ipilimumab | n2=en:vapreotide | rel=r_associated | relid=0 | w=102
  3200. ipilimumab -- r_associated #0: 102 / 0.223 -> en:varlitinib
    n1=ipilimumab | n2=en:varlitinib | rel=r_associated | relid=0 | w=102
  3201. ipilimumab -- r_associated #0: 102 / 0.223 -> en:vegfr2 tyrosine kinase inhibitor pf-00337210
    n1=ipilimumab | n2=en:vegfr2 tyrosine kinase inhibitor pf-00337210 | rel=r_associated | relid=0 | w=102
  3202. ipilimumab -- r_associated #0: 102 / 0.223 -> en:venlafaxine
    n1=ipilimumab | n2=en:venlafaxine | rel=r_associated | relid=0 | w=102
  3203. ipilimumab -- r_associated #0: 102 / 0.223 -> en:vepoloxamer
    n1=ipilimumab | n2=en:vepoloxamer | rel=r_associated | relid=0 | w=102
  3204. ipilimumab -- r_associated #0: 102 / 0.223 -> en:verpasep caltespen
    n1=ipilimumab | n2=en:verpasep caltespen | rel=r_associated | relid=0 | w=102
  3205. ipilimumab -- r_associated #0: 102 / 0.223 -> en:vincristine
    n1=ipilimumab | n2=en:vincristine | rel=r_associated | relid=0 | w=102
  3206. ipilimumab -- r_associated #0: 102 / 0.223 -> en:vincristine sulfate liposome
    n1=ipilimumab | n2=en:vincristine sulfate liposome | rel=r_associated | relid=0 | w=102
  3207. ipilimumab -- r_associated #0: 102 / 0.223 -> en:vinflunine
    n1=ipilimumab | n2=en:vinflunine | rel=r_associated | relid=0 | w=102
  3208. ipilimumab -- r_associated #0: 102 / 0.223 -> en:vitamin / trace element
    n1=ipilimumab | n2=en:vitamin / trace element | rel=r_associated | relid=0 | w=102
  3209. ipilimumab -- r_associated #0: 102 / 0.223 -> en:vitamin e compound
    n1=ipilimumab | n2=en:vitamin e compound | rel=r_associated | relid=0 | w=102
  3210. ipilimumab -- r_associated #0: 102 / 0.223 -> en:vitespen
    n1=ipilimumab | n2=en:vitespen | rel=r_associated | relid=0 | w=102
  3211. ipilimumab -- r_associated #0: 102 / 0.223 -> en:vlp-encapsulated tlr9 agonist cmp-001
    n1=ipilimumab | n2=en:vlp-encapsulated tlr9 agonist cmp-001 | rel=r_associated | relid=0 | w=102
  3212. ipilimumab -- r_associated #0: 102 / 0.223 -> en:volitinib
    n1=ipilimumab | n2=en:volitinib | rel=r_associated | relid=0 | w=102
  3213. ipilimumab -- r_associated #0: 102 / 0.223 -> en:vorozole
    n1=ipilimumab | n2=en:vorozole | rel=r_associated | relid=0 | w=102
  3214. ipilimumab -- r_associated #0: 102 / 0.223 -> en:vorsetuzumab-mafodotin
    n1=ipilimumab | n2=en:vorsetuzumab-mafodotin | rel=r_associated | relid=0 | w=102
  3215. ipilimumab -- r_associated #0: 102 / 0.223 -> en:white button mushroom extract
    n1=ipilimumab | n2=en:white button mushroom extract | rel=r_associated | relid=0 | w=102
  3216. ipilimumab -- r_associated #0: 102 / 0.223 -> en:white wine
    n1=ipilimumab | n2=en:white wine | rel=r_associated | relid=0 | w=102
  3217. ipilimumab -- r_associated #0: 102 / 0.223 -> en:wild-type reovirus
    n1=ipilimumab | n2=en:wild-type reovirus | rel=r_associated | relid=0 | w=102
  3218. ipilimumab -- r_associated #0: 102 / 0.223 -> en:wt1 analog peptide vaccine
    n1=ipilimumab | n2=en:wt1 analog peptide vaccine | rel=r_associated | relid=0 | w=102
  3219. ipilimumab -- r_associated #0: 102 / 0.223 -> en:wt1 peptide vaccine wt2725
    n1=ipilimumab | n2=en:wt1 peptide vaccine wt2725 | rel=r_associated | relid=0 | w=102
  3220. ipilimumab -- r_associated #0: 102 / 0.223 -> en:xaliproden hydrochloride
    n1=ipilimumab | n2=en:xaliproden hydrochloride | rel=r_associated | relid=0 | w=102
  3221. ipilimumab -- r_associated #0: 102 / 0.223 -> en:xl820
    n1=ipilimumab | n2=en:xl820 | rel=r_associated | relid=0 | w=102
  3222. ipilimumab -- r_associated #0: 102 / 0.223 -> en:y 90 monoclonal antibody lym-1
    n1=ipilimumab | n2=en:y 90 monoclonal antibody lym-1 | rel=r_associated | relid=0 | w=102
  3223. ipilimumab -- r_associated #0: 102 / 0.223 -> en:y 90 monoclonal antibody m170
    n1=ipilimumab | n2=en:y 90 monoclonal antibody m170 | rel=r_associated | relid=0 | w=102
  3224. ipilimumab -- r_associated #0: 102 / 0.223 -> en:yttrium y 90 anti-cd19 monoclonal antibody bu12
    n1=ipilimumab | n2=en:yttrium y 90 anti-cd19 monoclonal antibody bu12 | rel=r_associated | relid=0 | w=102
  3225. ipilimumab -- r_associated #0: 102 / 0.223 -> en:yttrium y 90 anti-cdh3 monoclonal antibody ff-21101
    n1=ipilimumab | n2=en:yttrium y 90 anti-cdh3 monoclonal antibody ff-21101 | rel=r_associated | relid=0 | w=102
  3226. ipilimumab -- r_associated #0: 102 / 0.223 -> en:yttrium y 90 colloid
    n1=ipilimumab | n2=en:yttrium y 90 colloid | rel=r_associated | relid=0 | w=102
  3227. ipilimumab -- r_associated #0: 102 / 0.223 -> en:yttrium y-90 tacatuzumab tetraxetan
    n1=ipilimumab | n2=en:yttrium y-90 tacatuzumab tetraxetan | rel=r_associated | relid=0 | w=102
  3228. ipilimumab -- r_associated #0: 102 / 0.223 -> en:yttrium y-90-dota-girentuximab
    n1=ipilimumab | n2=en:yttrium y-90-dota-girentuximab | rel=r_associated | relid=0 | w=102
  3229. ipilimumab -- r_associated #0: 102 / 0.223 -> en:zidovudine
    n1=ipilimumab | n2=en:zidovudine | rel=r_associated | relid=0 | w=102
  3230. ipilimumab -- r_associated #0: 102 / 0.223 -> en:zinc sulfate
    n1=ipilimumab | n2=en:zinc sulfate | rel=r_associated | relid=0 | w=102
  3231. ipilimumab -- r_associated #0: 102 / 0.223 -> en:zirconium zr 89 desferrioxamine b monoclonal antibody huj591
    n1=ipilimumab | n2=en:zirconium zr 89 desferrioxamine b monoclonal antibody huj591 | rel=r_associated | relid=0 | w=102
  3232. ipilimumab -- r_associated #0: 102 / 0.223 -> en:zosuquidar trihydrochloride
    n1=ipilimumab | n2=en:zosuquidar trihydrochloride | rel=r_associated | relid=0 | w=102
  3233. ipilimumab -- r_associated #0: 102 / 0.223 -> en:zyc300
    n1=ipilimumab | n2=en:zyc300 | rel=r_associated | relid=0 | w=102
  3234. ipilimumab -- r_associated #0: 102 / 0.223 -> pharmacie
    n1=ipilimumab | n2=pharmacie | rel=r_associated | relid=0 | w=102
  3235. ipilimumab -- r_associated #0: 101 / 0.221 -> biochimie
    n1=ipilimumab | n2=biochimie | rel=r_associated | relid=0 | w=101
  3236. ipilimumab -- r_associated #0: 101 / 0.221 -> en:2-fluoropropionyl-labeled pegylated dimeric rgd peptide
    n1=ipilimumab | n2=en:2-fluoropropionyl-labeled pegylated dimeric rgd peptide | rel=r_associated | relid=0 | w=101
  3237. ipilimumab -- r_associated #0: 101 / 0.221 -> en:2-hydroxyoleic acid
    n1=ipilimumab | n2=en:2-hydroxyoleic acid | rel=r_associated | relid=0 | w=101
  3238. ipilimumab -- r_associated #0: 101 / 0.221 -> en:2-methoxyestradiol nanocrystal colloidal dispersion
    n1=ipilimumab | n2=en:2-methoxyestradiol nanocrystal colloidal dispersion | rel=r_associated | relid=0 | w=101
  3239. ipilimumab -- r_associated #0: 101 / 0.221 -> en:3'-aminomethyl nicotine-p. aeruginosa r-exoprotein a conjugate vaccine
    n1=ipilimumab | n2=en:3'-aminomethyl nicotine-p. aeruginosa r-exoprotein a conjugate vaccine | rel=r_associated | relid=0 | w=101
  3240. ipilimumab -- r_associated #0: 101 / 0.221 -> en:5-[18f]fluorouracil
    n1=ipilimumab | n2=en:5-[18f]fluorouracil | rel=r_associated | relid=0 | w=101
  3241. ipilimumab -- r_associated #0: 101 / 0.221 -> en:5-fluorouracil/salicylic acid topical solution
    n1=ipilimumab | n2=en:5-fluorouracil/salicylic acid topical solution | rel=r_associated | relid=0 | w=101
  3242. ipilimumab -- r_associated #0: 101 / 0.221 -> en:abarelix
    n1=ipilimumab | n2=en:abarelix | rel=r_associated | relid=0 | w=101
  3243. ipilimumab -- r_associated #0: 101 / 0.221 -> en:abr-217620
    n1=ipilimumab | n2=en:abr-217620 | rel=r_associated | relid=0 | w=101
  3244. ipilimumab -- r_associated #0: 101 / 0.221 -> en:acenocoumarol
    n1=ipilimumab | n2=en:acenocoumarol | rel=r_associated | relid=0 | w=101
  3245. ipilimumab -- r_associated #0: 101 / 0.221 -> en:acetylcysteine
    n1=ipilimumab | n2=en:acetylcysteine | rel=r_associated | relid=0 | w=101
  3246. ipilimumab -- r_associated #0: 101 / 0.221 -> en:aclarubicin
    n1=ipilimumab | n2=en:aclarubicin | rel=r_associated | relid=0 | w=101
  3247. ipilimumab -- r_associated #0: 101 / 0.221 -> en:acodazole
    n1=ipilimumab | n2=en:acodazole | rel=r_associated | relid=0 | w=101
  3248. ipilimumab -- r_associated #0: 101 / 0.221 -> en:acolbifene hydrochloride
    n1=ipilimumab | n2=en:acolbifene hydrochloride | rel=r_associated | relid=0 | w=101
  3249. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ad5-ycd/muttk(sr39)rep-adp
    n1=ipilimumab | n2=en:ad5-ycd/muttk(sr39)rep-adp | rel=r_associated | relid=0 | w=101
  3250. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ad5-ycd/muttksr39rep-hil12
    n1=ipilimumab | n2=en:ad5-ycd/muttksr39rep-hil12 | rel=r_associated | relid=0 | w=101
  3251. ipilimumab -- r_associated #0: 101 / 0.221 -> en:adalimumab
    n1=ipilimumab | n2=en:adalimumab | rel=r_associated | relid=0 | w=101
  3252. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ade regimen
    n1=ipilimumab | n2=en:ade regimen | rel=r_associated | relid=0 | w=101
  3253. ipilimumab -- r_associated #0: 101 / 0.221 -> en:adenovirus encoding recombinant human endostatin
    n1=ipilimumab | n2=en:adenovirus encoding recombinant human endostatin | rel=r_associated | relid=0 | w=101
  3254. ipilimumab -- r_associated #0: 101 / 0.221 -> en:adenovirus-encoding e.coli pnp
    n1=ipilimumab | n2=en:adenovirus-encoding e.coli pnp | rel=r_associated | relid=0 | w=101
  3255. ipilimumab -- r_associated #0: 101 / 0.221 -> en:adipose-derived stromal vascular fraction cells
    n1=ipilimumab | n2=en:adipose-derived stromal vascular fraction cells | rel=r_associated | relid=0 | w=101
  3256. ipilimumab -- r_associated #0: 101 / 0.221 -> en:aerosolized liposomal rubitecan
    n1=ipilimumab | n2=en:aerosolized liposomal rubitecan | rel=r_associated | relid=0 | w=101
  3257. ipilimumab -- r_associated #0: 101 / 0.221 -> en:afp gene hepatocellular carcinoma vaccine
    n1=ipilimumab | n2=en:afp gene hepatocellular carcinoma vaccine | rel=r_associated | relid=0 | w=101
  3258. ipilimumab -- r_associated #0: 101 / 0.221 -> en:agent affecting cardiovascular system
    n1=ipilimumab | n2=en:agent affecting cardiovascular system | rel=r_associated | relid=0 | w=101
  3259. ipilimumab -- r_associated #0: 101 / 0.221 -> en:agonistic anti-cd40 monoclonal antibody adc-1013
    n1=ipilimumab | n2=en:agonistic anti-cd40 monoclonal antibody adc-1013 | rel=r_associated | relid=0 | w=101
  3260. ipilimumab -- r_associated #0: 101 / 0.221 -> en:agonistic anti-ox40 monoclonal antibody medi6469
    n1=ipilimumab | n2=en:agonistic anti-ox40 monoclonal antibody medi6469 | rel=r_associated | relid=0 | w=101
  3261. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ak 3012
    n1=ipilimumab | n2=en:ak 3012 | rel=r_associated | relid=0 | w=101
  3262. ipilimumab -- r_associated #0: 101 / 0.221 -> en:akt inhibitor ly2780301
    n1=ipilimumab | n2=en:akt inhibitor ly2780301 | rel=r_associated | relid=0 | w=101
  3263. ipilimumab -- r_associated #0: 101 / 0.221 -> en:al721
    n1=ipilimumab | n2=en:al721 | rel=r_associated | relid=0 | w=101
  3264. ipilimumab -- r_associated #0: 101 / 0.221 -> en:alemtuzumab
    n1=ipilimumab | n2=en:alemtuzumab | rel=r_associated | relid=0 | w=101
  3265. ipilimumab -- r_associated #0: 101 / 0.221 -> en:alitretinoin
    n1=ipilimumab | n2=en:alitretinoin | rel=r_associated | relid=0 | w=101
  3266. ipilimumab -- r_associated #0: 101 / 0.221 -> en:alk inhibitor ro5424802
    n1=ipilimumab | n2=en:alk inhibitor ro5424802 | rel=r_associated | relid=0 | w=101
  3267. ipilimumab -- r_associated #0: 101 / 0.221 -> en:alk/ros1 inhibitor pf-06463922
    n1=ipilimumab | n2=en:alk/ros1 inhibitor pf-06463922 | rel=r_associated | relid=0 | w=101
  3268. ipilimumab -- r_associated #0: 101 / 0.221 -> en:allogeneic gm-csf-based myeloma cell vaccine
    n1=ipilimumab | n2=en:allogeneic gm-csf-based myeloma cell vaccine | rel=r_associated | relid=0 | w=101
  3269. ipilimumab -- r_associated #0: 101 / 0.221 -> en:allogeneic irradiated melanoma cell vaccine csf470
    n1=ipilimumab | n2=en:allogeneic irradiated melanoma cell vaccine csf470 | rel=r_associated | relid=0 | w=101
  3270. ipilimumab -- r_associated #0: 101 / 0.221 -> en:allogeneic large multivalent immunogen melanoma vaccine lp2307
    n1=ipilimumab | n2=en:allogeneic large multivalent immunogen melanoma vaccine lp2307 | rel=r_associated | relid=0 | w=101
  3271. ipilimumab -- r_associated #0: 101 / 0.221 -> en:allogeneic lmp1/lmp2-specific cytotoxic t-lymphocytes
    n1=ipilimumab | n2=en:allogeneic lmp1/lmp2-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=101
  3272. ipilimumab -- r_associated #0: 101 / 0.221 -> en:allogeneic multivirus-specific cytotoxic t lymphocytes
    n1=ipilimumab | n2=en:allogeneic multivirus-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=101
  3273. ipilimumab -- r_associated #0: 101 / 0.221 -> en:alopecia preparation
    n1=ipilimumab | n2=en:alopecia preparation | rel=r_associated | relid=0 | w=101
  3274. ipilimumab -- r_associated #0: 101 / 0.221 -> en:alpha galactosylceramide
    n1=ipilimumab | n2=en:alpha galactosylceramide | rel=r_associated | relid=0 | w=101
  3275. ipilimumab -- r_associated #0: 101 / 0.221 -> en:alpha-type-1 polarized dendritic cells
    n1=ipilimumab | n2=en:alpha-type-1 polarized dendritic cells | rel=r_associated | relid=0 | w=101
  3276. ipilimumab -- r_associated #0: 101 / 0.221 -> en:alprazolam
    n1=ipilimumab | n2=en:alprazolam | rel=r_associated | relid=0 | w=101
  3277. ipilimumab -- r_associated #0: 101 / 0.221 -> en:alvac(2) melanoma multi-antigen therapeutic vaccine
    n1=ipilimumab | n2=en:alvac(2) melanoma multi-antigen therapeutic vaccine | rel=r_associated | relid=0 | w=101
  3278. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ametantrone
    n1=ipilimumab | n2=en:ametantrone | rel=r_associated | relid=0 | w=101
  3279. ipilimumab -- r_associated #0: 101 / 0.221 -> en:amiodarone hydrochloride
    n1=ipilimumab | n2=en:amiodarone hydrochloride | rel=r_associated | relid=0 | w=101
  3280. ipilimumab -- r_associated #0: 101 / 0.221 -> en:amnion-derived cellular cytokine solution
    n1=ipilimumab | n2=en:amnion-derived cellular cytokine solution | rel=r_associated | relid=0 | w=101
  3281. ipilimumab -- r_associated #0: 101 / 0.221 -> en:amoxicillin-clavulanate potassium
    n1=ipilimumab | n2=en:amoxicillin-clavulanate potassium | rel=r_associated | relid=0 | w=101
  3282. ipilimumab -- r_associated #0: 101 / 0.221 -> en:amsacrine
    n1=ipilimumab | n2=en:amsacrine | rel=r_associated | relid=0 | w=101
  3283. ipilimumab -- r_associated #0: 101 / 0.221 -> en:androgen receptor antisense oligonucleotide ezn-4176
    n1=ipilimumab | n2=en:androgen receptor antisense oligonucleotide ezn-4176 | rel=r_associated | relid=0 | w=101
  3284. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anetumab ravtansine
    n1=ipilimumab | n2=en:anetumab ravtansine | rel=r_associated | relid=0 | w=101
  3285. ipilimumab -- r_associated #0: 101 / 0.221 -> en:angiopoietin-2-specific fusion protein pf-04856884
    n1=ipilimumab | n2=en:angiopoietin-2-specific fusion protein pf-04856884 | rel=r_associated | relid=0 | w=101
  3286. ipilimumab -- r_associated #0: 101 / 0.221 -> en:aniline mustard
    n1=ipilimumab | n2=en:aniline mustard | rel=r_associated | relid=0 | w=101
  3287. ipilimumab -- r_associated #0: 101 / 0.221 -> en:annamycin liposomal
    n1=ipilimumab | n2=en:annamycin liposomal | rel=r_associated | relid=0 | w=101
  3288. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-ags-8 monoclonal antibody ags-8m4
    n1=ipilimumab | n2=en:anti-ags-8 monoclonal antibody ags-8m4 | rel=r_associated | relid=0 | w=101
  3289. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-cd157 monoclonal antibody men1112
    n1=ipilimumab | n2=en:anti-cd157 monoclonal antibody men1112 | rel=r_associated | relid=0 | w=101
  3290. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-cd19 monoclonal antibody di-b4
    n1=ipilimumab | n2=en:anti-cd19 monoclonal antibody di-b4 | rel=r_associated | relid=0 | w=101
  3291. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-cd19/cd28/cd3zeta car gammaretroviral vector-transduced autologous t lymphocytes kte-c19
    n1=ipilimumab | n2=en:anti-cd19/cd28/cd3zeta car gammaretroviral vector-transduced autologous t lymphocytes kte-c19 | rel=r_associated | relid=0 | w=101
  3292. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-cd19/cd3 tetravalent antibody afm11
    n1=ipilimumab | n2=en:anti-cd19/cd3 tetravalent antibody afm11 | rel=r_associated | relid=0 | w=101
  3293. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-cd20 b9e9 scfv-streptavidin fusion protein
    n1=ipilimumab | n2=en:anti-cd20 b9e9 scfv-streptavidin fusion protein | rel=r_associated | relid=0 | w=101
  3294. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-cd20 monoclonal antibody-interferon-alpha fusion protein ign002
    n1=ipilimumab | n2=en:anti-cd20 monoclonal antibody-interferon-alpha fusion protein ign002 | rel=r_associated | relid=0 | w=101
  3295. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-cd33/cd3 bite antibody amg 330
    n1=ipilimumab | n2=en:anti-cd33/cd3 bite antibody amg 330 | rel=r_associated | relid=0 | w=101
  3296. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-cd37 monoclonal antibody bi 836826
    n1=ipilimumab | n2=en:anti-cd37 monoclonal antibody bi 836826 | rel=r_associated | relid=0 | w=101
  3297. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-cd47 monoclonal antibody hu5f9-g4
    n1=ipilimumab | n2=en:anti-cd47 monoclonal antibody hu5f9-g4 | rel=r_associated | relid=0 | w=101
  3298. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-cd70 monoclonal antibody argx-110
    n1=ipilimumab | n2=en:anti-cd70 monoclonal antibody argx-110 | rel=r_associated | relid=0 | w=101
  3299. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-cd70 monoclonal antibody mdx-1411
    n1=ipilimumab | n2=en:anti-cd70 monoclonal antibody mdx-1411 | rel=r_associated | relid=0 | w=101
  3300. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/gp100 antigen/mart-1 antigen/montanide isa-51/tyrosinase peptide
    n1=ipilimumab | n2=en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/gp100 antigen/mart-1 antigen/montanide isa-51/tyrosinase peptide | rel=r_associated | relid=0 | w=101
  3301. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/interleukin-2
    n1=ipilimumab | n2=en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/interleukin-2 | rel=r_associated | relid=0 | w=101
  3302. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-denatured collagen monoclonal antibody trc093
    n1=ipilimumab | n2=en:anti-denatured collagen monoclonal antibody trc093 | rel=r_associated | relid=0 | w=101
  3303. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-dr5 agonist monoclonal antibody tra-8
    n1=ipilimumab | n2=en:anti-dr5 agonist monoclonal antibody tra-8 | rel=r_associated | relid=0 | w=101
  3304. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-dr5 agonistic antibody ds-8273a
    n1=ipilimumab | n2=en:anti-dr5 agonistic antibody ds-8273a | rel=r_associated | relid=0 | w=101
  3305. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-egfr monoclonal antibody sct200
    n1=ipilimumab | n2=en:anti-egfr monoclonal antibody sct200 | rel=r_associated | relid=0 | w=101
  3306. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-egfr/c-met bispecific antibody jnj-61186372
    n1=ipilimumab | n2=en:anti-egfr/c-met bispecific antibody jnj-61186372 | rel=r_associated | relid=0 | w=101
  3307. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-egfrviii car-transduced allogeneic t-lymphocytes
    n1=ipilimumab | n2=en:anti-egfrviii car-transduced allogeneic t-lymphocytes | rel=r_associated | relid=0 | w=101
  3308. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer t-lymphocytes
    n1=ipilimumab | n2=en:anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer t-lymphocytes | rel=r_associated | relid=0 | w=101
  3309. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-etbr/mmae antibody-drug conjugate dedn6526a
    n1=ipilimumab | n2=en:anti-etbr/mmae antibody-drug conjugate dedn6526a | rel=r_associated | relid=0 | w=101
  3310. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-fgfr2 monoclonal antibody fpa144
    n1=ipilimumab | n2=en:anti-fgfr2 monoclonal antibody fpa144 | rel=r_associated | relid=0 | w=101
  3311. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-her3 monoclonal antibody gsk2849330
    n1=ipilimumab | n2=en:anti-her3 monoclonal antibody gsk2849330 | rel=r_associated | relid=0 | w=101
  3312. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-hla-a2/ny-eso-1 tcr-transduced autologous t lymphocytes
    n1=ipilimumab | n2=en:anti-hla-a2/ny-eso-1 tcr-transduced autologous t lymphocytes | rel=r_associated | relid=0 | w=101
  3313. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-igf-1r recombinant monoclonal antibody biib022
    n1=ipilimumab | n2=en:anti-igf-1r recombinant monoclonal antibody biib022 | rel=r_associated | relid=0 | w=101
  3314. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-inflammatory antibody alxn1007
    n1=ipilimumab | n2=en:anti-inflammatory antibody alxn1007 | rel=r_associated | relid=0 | w=101
  3315. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-mesothelin-pseudomonas exotoxin 24 cytolytic fusion protein lmb-100
    n1=ipilimumab | n2=en:anti-mesothelin-pseudomonas exotoxin 24 cytolytic fusion protein lmb-100 | rel=r_associated | relid=0 | w=101
  3316. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-mmp-9 monoclonal antibody gs-5745
    n1=ipilimumab | n2=en:anti-mmp-9 monoclonal antibody gs-5745 | rel=r_associated | relid=0 | w=101
  3317. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-nectin-4 monoclonal antibody-drug conjugate ags-22m6e
    n1=ipilimumab | n2=en:anti-nectin-4 monoclonal antibody-drug conjugate ags-22m6e | rel=r_associated | relid=0 | w=101
  3318. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-ny-eso-1 immunotherapeutic gsk-2241658a
    n1=ipilimumab | n2=en:anti-ny-eso-1 immunotherapeutic gsk-2241658a | rel=r_associated | relid=0 | w=101
  3319. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-ox40 monoclonal antibody gsk3174998
    n1=ipilimumab | n2=en:anti-ox40 monoclonal antibody gsk3174998 | rel=r_associated | relid=0 | w=101
  3320. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-pd-1 checkpoint inhibitor pf-06801591
    n1=ipilimumab | n2=en:anti-pd-1 checkpoint inhibitor pf-06801591 | rel=r_associated | relid=0 | w=101
  3321. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-pd-1 monoclonal antibody shr-1210
    n1=ipilimumab | n2=en:anti-pd-1 monoclonal antibody shr-1210 | rel=r_associated | relid=0 | w=101
  3322. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-pkn3 sirna atu027
    n1=ipilimumab | n2=en:anti-pkn3 sirna atu027 | rel=r_associated | relid=0 | w=101
  3323. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-prolactin receptor antibody lfa102
    n1=ipilimumab | n2=en:anti-prolactin receptor antibody lfa102 | rel=r_associated | relid=0 | w=101
  3324. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-psma/cd3 bite monoclonal antibody mt112
    n1=ipilimumab | n2=en:anti-psma/cd3 bite monoclonal antibody mt112 | rel=r_associated | relid=0 | w=101
  3325. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-transthyretin sirna aln-ttr02
    n1=ipilimumab | n2=en:anti-transthyretin sirna aln-ttr02 | rel=r_associated | relid=0 | w=101
  3326. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-vegf anticalin prs-050-peg40
    n1=ipilimumab | n2=en:anti-vegf anticalin prs-050-peg40 | rel=r_associated | relid=0 | w=101
  3327. ipilimumab -- r_associated #0: 101 / 0.221 -> en:anti-von willebrand factor nanobody
    n1=ipilimumab | n2=en:anti-von willebrand factor nanobody | rel=r_associated | relid=0 | w=101
  3328. ipilimumab -- r_associated #0: 101 / 0.221 -> en:antiarrhythmic agent
    n1=ipilimumab | n2=en:antiarrhythmic agent | rel=r_associated | relid=0 | w=101
  3329. ipilimumab -- r_associated #0: 101 / 0.221 -> en:antibiotic
    n1=ipilimumab | n2=en:antibiotic | rel=r_associated | relid=0 | w=101
  3330. ipilimumab -- r_associated #0: 101 / 0.221 -> en:antibody-drug conjugate sc-002
    n1=ipilimumab | n2=en:antibody-drug conjugate sc-002 | rel=r_associated | relid=0 | w=101
  3331. ipilimumab -- r_associated #0: 101 / 0.221 -> en:antigen binding
    n1=ipilimumab | n2=en:antigen binding | rel=r_associated | relid=0 | w=101
  3332. ipilimumab -- r_associated #0: 101 / 0.221 -> en:antihypertensive agent
    n1=ipilimumab | n2=en:antihypertensive agent | rel=r_associated | relid=0 | w=101
  3333. ipilimumab -- r_associated #0: 101 / 0.221 -> en:antimetastatic agent
    n1=ipilimumab | n2=en:antimetastatic agent | rel=r_associated | relid=0 | w=101
  3334. ipilimumab -- r_associated #0: 101 / 0.221 -> en:antineoplastic agents, phytogenic
    n1=ipilimumab | n2=en:antineoplastic agents, phytogenic | rel=r_associated | relid=0 | w=101
  3335. ipilimumab -- r_associated #0: 101 / 0.221 -> en:antineoplastic radiopharmaceuticals
    n1=ipilimumab | n2=en:antineoplastic radiopharmaceuticals | rel=r_associated | relid=0 | w=101
  3336. ipilimumab -- r_associated #0: 101 / 0.221 -> en:apomine
    n1=ipilimumab | n2=en:apomine | rel=r_associated | relid=0 | w=101
  3337. ipilimumab -- r_associated #0: 101 / 0.221 -> en:apricoxib
    n1=ipilimumab | n2=en:apricoxib | rel=r_associated | relid=0 | w=101
  3338. ipilimumab -- r_associated #0: 101 / 0.221 -> en:aromatase inhibitors, 3rd generation
    n1=ipilimumab | n2=en:aromatase inhibitors, 3rd generation | rel=r_associated | relid=0 | w=101
  3339. ipilimumab -- r_associated #0: 101 / 0.221 -> en:asfotase alfa
    n1=ipilimumab | n2=en:asfotase alfa | rel=r_associated | relid=0 | w=101
  3340. ipilimumab -- r_associated #0: 101 / 0.221 -> en:astringent
    n1=ipilimumab | n2=en:astringent | rel=r_associated | relid=0 | w=101
  3341. ipilimumab -- r_associated #0: 101 / 0.221 -> en:at 211 monoclonal antibody 81c6
    n1=ipilimumab | n2=en:at 211 monoclonal antibody 81c6 | rel=r_associated | relid=0 | w=101
  3342. ipilimumab -- r_associated #0: 101 / 0.221 -> en:atomoxetine hydrochloride
    n1=ipilimumab | n2=en:atomoxetine hydrochloride | rel=r_associated | relid=0 | w=101
  3343. ipilimumab -- r_associated #0: 101 / 0.221 -> en:atr kinase inhibitor vx-970
    n1=ipilimumab | n2=en:atr kinase inhibitor vx-970 | rel=r_associated | relid=0 | w=101
  3344. ipilimumab -- r_associated #0: 101 / 0.221 -> en:aurora kinase inhibitor amg 900
    n1=ipilimumab | n2=en:aurora kinase inhibitor amg 900 | rel=r_associated | relid=0 | w=101
  3345. ipilimumab -- r_associated #0: 101 / 0.221 -> en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing t lymphocytes
    n1=ipilimumab | n2=en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing t lymphocytes | rel=r_associated | relid=0 | w=101
  3346. ipilimumab -- r_associated #0: 101 / 0.221 -> en:autologous cd171-specific car-cd28 zeta-4-1-bb-egfrt-expressing t lymphocytes
    n1=ipilimumab | n2=en:autologous cd171-specific car-cd28 zeta-4-1-bb-egfrt-expressing t lymphocytes | rel=r_associated | relid=0 | w=101
  3347. ipilimumab -- r_associated #0: 101 / 0.221 -> en:autologous cea-specific cytotoxic t-lymphocytes
    n1=ipilimumab | n2=en:autologous cea-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=101
  3348. ipilimumab -- r_associated #0: 101 / 0.221 -> en:autologous cytotoxic t-lymphocytes induced with muc1 gene-transfected dendritic cells
    n1=ipilimumab | n2=en:autologous cytotoxic t-lymphocytes induced with muc1 gene-transfected dendritic cells | rel=r_associated | relid=0 | w=101
  3349. ipilimumab -- r_associated #0: 101 / 0.221 -> en:autologous dendritic cell-autologous tumor mrna-human cd40l vaccine
    n1=ipilimumab | n2=en:autologous dendritic cell-autologous tumor mrna-human cd40l vaccine | rel=r_associated | relid=0 | w=101
  3350. ipilimumab -- r_associated #0: 101 / 0.221 -> en:autologous dendritic cell-tumor fusion vaccine
    n1=ipilimumab | n2=en:autologous dendritic cell-tumor fusion vaccine | rel=r_associated | relid=0 | w=101
  3351. ipilimumab -- r_associated #0: 101 / 0.221 -> en:autologous gm-csf-secreting lethally irradiated leukemia cell vaccine
    n1=ipilimumab | n2=en:autologous gm-csf-secreting lethally irradiated leukemia cell vaccine | rel=r_associated | relid=0 | w=101
  3352. ipilimumab -- r_associated #0: 101 / 0.221 -> en:autologous lymphoid effector cells specific against tumor cells
    n1=ipilimumab | n2=en:autologous lymphoid effector cells specific against tumor cells | rel=r_associated | relid=0 | w=101
  3353. ipilimumab -- r_associated #0: 101 / 0.221 -> en:banoxantrone
    n1=ipilimumab | n2=en:banoxantrone | rel=r_associated | relid=0 | w=101
  3354. ipilimumab -- r_associated #0: 101 / 0.221 -> en:batabulin sodium
    n1=ipilimumab | n2=en:batabulin sodium | rel=r_associated | relid=0 | w=101
  3355. ipilimumab -- r_associated #0: 101 / 0.221 -> en:bcr-abl peptide vaccine
    n1=ipilimumab | n2=en:bcr-abl peptide vaccine | rel=r_associated | relid=0 | w=101
  3356. ipilimumab -- r_associated #0: 101 / 0.221 -> en:begelomab
    n1=ipilimumab | n2=en:begelomab | rel=r_associated | relid=0 | w=101
  3357. ipilimumab -- r_associated #0: 101 / 0.221 -> en:benzaldehyde dimethane sulfonate
    n1=ipilimumab | n2=en:benzaldehyde dimethane sulfonate | rel=r_associated | relid=0 | w=101
  3358. ipilimumab -- r_associated #0: 101 / 0.221 -> en:bet inhibitor gs-5829
    n1=ipilimumab | n2=en:bet inhibitor gs-5829 | rel=r_associated | relid=0 | w=101
  3359. ipilimumab -- r_associated #0: 101 / 0.221 -> en:beta-glucan
    n1=ipilimumab | n2=en:beta-glucan | rel=r_associated | relid=0 | w=101
  3360. ipilimumab -- r_associated #0: 101 / 0.221 -> en:beta-glucan/alginate/hyaluronic acid/squalene/avocado oil-containing emulsion
    n1=ipilimumab | n2=en:beta-glucan/alginate/hyaluronic acid/squalene/avocado oil-containing emulsion | rel=r_associated | relid=0 | w=101
  3361. ipilimumab -- r_associated #0: 101 / 0.221 -> en:beta-thioguanine deoxyriboside
    n1=ipilimumab | n2=en:beta-thioguanine deoxyriboside | rel=r_associated | relid=0 | w=101
  3362. ipilimumab -- r_associated #0: 101 / 0.221 -> en:bimagrumab
    n1=ipilimumab | n2=en:bimagrumab | rel=r_associated | relid=0 | w=101
  3363. ipilimumab -- r_associated #0: 101 / 0.221 -> en:binimetinib
    n1=ipilimumab | n2=en:binimetinib | rel=r_associated | relid=0 | w=101
  3364. ipilimumab -- r_associated #0: 101 / 0.221 -> en:bispecific antibody 4g7xh22
    n1=ipilimumab | n2=en:bispecific antibody 4g7xh22 | rel=r_associated | relid=0 | w=101
  3365. ipilimumab -- r_associated #0: 101 / 0.221 -> en:bms-986205
    n1=ipilimumab | n2=en:bms-986205 | rel=r_associated | relid=0 | w=101
  3366. ipilimumab -- r_associated #0: 101 / 0.221 -> en:bone graft - material
    n1=ipilimumab | n2=en:bone graft - material | rel=r_associated | relid=0 | w=101
  3367. ipilimumab -- r_associated #0: 101 / 0.221 -> en:bp-cx1-platinum complex bp-c1
    n1=ipilimumab | n2=en:bp-cx1-platinum complex bp-c1 | rel=r_associated | relid=0 | w=101
  3368. ipilimumab -- r_associated #0: 101 / 0.221 -> en:brain tumor initiating cell vaccine
    n1=ipilimumab | n2=en:brain tumor initiating cell vaccine | rel=r_associated | relid=0 | w=101
  3369. ipilimumab -- r_associated #0: 101 / 0.221 -> en:brentuximab vedotin
    n1=ipilimumab | n2=en:brentuximab vedotin | rel=r_associated | relid=0 | w=101
  3370. ipilimumab -- r_associated #0: 101 / 0.221 -> en:brequinar
    n1=ipilimumab | n2=en:brequinar | rel=r_associated | relid=0 | w=101
  3371. ipilimumab -- r_associated #0: 101 / 0.221 -> en:brivudine
    n1=ipilimumab | n2=en:brivudine | rel=r_associated | relid=0 | w=101
  3372. ipilimumab -- r_associated #0: 101 / 0.221 -> en:bromine compound agent
    n1=ipilimumab | n2=en:bromine compound agent | rel=r_associated | relid=0 | w=101
  3373. ipilimumab -- r_associated #0: 101 / 0.221 -> en:btk inhibitor ono-4059
    n1=ipilimumab | n2=en:btk inhibitor ono-4059 | rel=r_associated | relid=0 | w=101
  3374. ipilimumab -- r_associated #0: 101 / 0.221 -> en:buserelin
    n1=ipilimumab | n2=en:buserelin | rel=r_associated | relid=0 | w=101
  3375. ipilimumab -- r_associated #0: 101 / 0.221 -> en:c-met inhibitor amg 337
    n1=ipilimumab | n2=en:c-met inhibitor amg 337 | rel=r_associated | relid=0 | w=101
  3376. ipilimumab -- r_associated #0: 101 / 0.221 -> en:c-met inhibitor jnj-38877605
    n1=ipilimumab | n2=en:c-met inhibitor jnj-38877605 | rel=r_associated | relid=0 | w=101
  3377. ipilimumab -- r_associated #0: 101 / 0.221 -> en:c-myb antisense oligonucleotide g4460
    n1=ipilimumab | n2=en:c-myb antisense oligonucleotide g4460 | rel=r_associated | relid=0 | w=101
  3378. ipilimumab -- r_associated #0: 101 / 0.221 -> en:caix inhibitor slc-0111
    n1=ipilimumab | n2=en:caix inhibitor slc-0111 | rel=r_associated | relid=0 | w=101
  3379. ipilimumab -- r_associated #0: 101 / 0.221 -> en:calcium carbonate
    n1=ipilimumab | n2=en:calcium carbonate | rel=r_associated | relid=0 | w=101
  3380. ipilimumab -- r_associated #0: 101 / 0.221 -> en:calcium citrate
    n1=ipilimumab | n2=en:calcium citrate | rel=r_associated | relid=0 | w=101
  3381. ipilimumab -- r_associated #0: 101 / 0.221 -> en:calcium-41 chloride aqueous solution
    n1=ipilimumab | n2=en:calcium-41 chloride aqueous solution | rel=r_associated | relid=0 | w=101
  3382. ipilimumab -- r_associated #0: 101 / 0.221 -> en:calendula ointment
    n1=ipilimumab | n2=en:calendula ointment | rel=r_associated | relid=0 | w=101
  3383. ipilimumab -- r_associated #0: 101 / 0.221 -> en:capecitabine rapidly disintegrating tablet
    n1=ipilimumab | n2=en:capecitabine rapidly disintegrating tablet | rel=r_associated | relid=0 | w=101
  3384. ipilimumab -- r_associated #0: 101 / 0.221 -> en:carbon c 11 sepantronium bromide
    n1=ipilimumab | n2=en:carbon c 11 sepantronium bromide | rel=r_associated | relid=0 | w=101
  3385. ipilimumab -- r_associated #0: 101 / 0.221 -> en:carbon c 13 phytoene
    n1=ipilimumab | n2=en:carbon c 13 phytoene | rel=r_associated | relid=0 | w=101
  3386. ipilimumab -- r_associated #0: 101 / 0.221 -> en:carbon c-14 dacomitinib
    n1=ipilimumab | n2=en:carbon c-14 dacomitinib | rel=r_associated | relid=0 | w=101
  3387. ipilimumab -- r_associated #0: 101 / 0.221 -> en:carcinoembryonic antigen peptide 1-6d
    n1=ipilimumab | n2=en:carcinoembryonic antigen peptide 1-6d | rel=r_associated | relid=0 | w=101
  3388. ipilimumab -- r_associated #0: 101 / 0.221 -> en:carrageenan-containing gel
    n1=ipilimumab | n2=en:carrageenan-containing gel | rel=r_associated | relid=0 | w=101
  3389. ipilimumab -- r_associated #0: 101 / 0.221 -> en:cathepsin-activatable cy5 fluorescent imaging probe lum015
    n1=ipilimumab | n2=en:cathepsin-activatable cy5 fluorescent imaging probe lum015 | rel=r_associated | relid=0 | w=101
  3390. ipilimumab -- r_associated #0: 101 / 0.221 -> en:cd19/cd3 dual-affinity retargeting protein jnj-64052781
    n1=ipilimumab | n2=en:cd19/cd3 dual-affinity retargeting protein jnj-64052781 | rel=r_associated | relid=0 | w=101
  3391. ipilimumab -- r_associated #0: 101 / 0.221 -> en:cd24 extracellular domain-igg1 fc domain recombinant fusion protein cd24fc
    n1=ipilimumab | n2=en:cd24 extracellular domain-igg1 fc domain recombinant fusion protein cd24fc | rel=r_associated | relid=0 | w=101
  3392. ipilimumab -- r_associated #0: 101 / 0.221 -> en:cda inhibitor e7727/decitabine combination agent astx727
    n1=ipilimumab | n2=en:cda inhibitor e7727/decitabine combination agent astx727 | rel=r_associated | relid=0 | w=101
  3393. ipilimumab -- r_associated #0: 101 / 0.221 -> en:cdk inhibitor p276-00
    n1=ipilimumab | n2=en:cdk inhibitor p276-00 | rel=r_associated | relid=0 | w=101
  3394. ipilimumab -- r_associated #0: 101 / 0.221 -> en:cediranib maleate
    n1=ipilimumab | n2=en:cediranib maleate | rel=r_associated | relid=0 | w=101
  3395. ipilimumab -- r_associated #0: 101 / 0.221 -> en:cefamandole
    n1=ipilimumab | n2=en:cefamandole | rel=r_associated | relid=0 | w=101
  3396. ipilimumab -- r_associated #0: 101 / 0.221 -> en:cefmetazole sodium
    n1=ipilimumab | n2=en:cefmetazole sodium | rel=r_associated | relid=0 | w=101
  3397. ipilimumab -- r_associated #0: 101 / 0.221 -> en:central nervous system agents
    n1=ipilimumab | n2=en:central nervous system agents | rel=r_associated | relid=0 | w=101
  3398. ipilimumab -- r_associated #0: 101 / 0.221 -> en:cesium cs 137
    n1=ipilimumab | n2=en:cesium cs 137 | rel=r_associated | relid=0 | w=101
  3399. ipilimumab -- r_associated #0: 101 / 0.221 -> en:cg7870
    n1=ipilimumab | n2=en:cg7870 | rel=r_associated | relid=0 | w=101
  3400. ipilimumab -- r_associated #0: 101 / 0.221 -> en:chelating agent
    n1=ipilimumab | n2=en:chelating agent | rel=r_associated | relid=0 | w=101
  3401. ipilimumab -- r_associated #0: 101 / 0.221 -> en:chiauranib
    n1=ipilimumab | n2=en:chiauranib | rel=r_associated | relid=0 | w=101
  3402. ipilimumab -- r_associated #0: 101 / 0.221 -> en:chidamide
    n1=ipilimumab | n2=en:chidamide | rel=r_associated | relid=0 | w=101
  3403. ipilimumab -- r_associated #0: 101 / 0.221 -> en:chimeric fibril-reactive monoclonal antibody 111f4
    n1=ipilimumab | n2=en:chimeric fibril-reactive monoclonal antibody 111f4 | rel=r_associated | relid=0 | w=101
  3404. ipilimumab -- r_associated #0: 101 / 0.221 -> en:chimeric humanized anti-cd47 antibody
    n1=ipilimumab | n2=en:chimeric humanized anti-cd47 antibody | rel=r_associated | relid=0 | w=101
  3405. ipilimumab -- r_associated #0: 101 / 0.221 -> en:chinese herbal formulation phy906
    n1=ipilimumab | n2=en:chinese herbal formulation phy906 | rel=r_associated | relid=0 | w=101
  3406. ipilimumab -- r_associated #0: 101 / 0.221 -> en:chlorzoxazone
    n1=ipilimumab | n2=en:chlorzoxazone | rel=r_associated | relid=0 | w=101
  3407. ipilimumab -- r_associated #0: 101 / 0.221 -> en:cholecalciferol/whey protein isolate/epa/dha-based nutritional supplement
    n1=ipilimumab | n2=en:cholecalciferol/whey protein isolate/epa/dha-based nutritional supplement | rel=r_associated | relid=0 | w=101
  3408. ipilimumab -- r_associated #0: 101 / 0.221 -> en:choline kinase alpha inhibitor tcd-717
    n1=ipilimumab | n2=en:choline kinase alpha inhibitor tcd-717 | rel=r_associated | relid=0 | w=101
  3409. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ciclopirox olamine lotion
    n1=ipilimumab | n2=en:ciclopirox olamine lotion | rel=r_associated | relid=0 | w=101
  3410. ipilimumab -- r_associated #0: 101 / 0.221 -> en:citatuzumab bogatox
    n1=ipilimumab | n2=en:citatuzumab bogatox | rel=r_associated | relid=0 | w=101
  3411. ipilimumab -- r_associated #0: 101 / 0.221 -> en:citrulline
    n1=ipilimumab | n2=en:citrulline | rel=r_associated | relid=0 | w=101
  3412. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ck2-targeting synthetic peptide cigb-300
    n1=ipilimumab | n2=en:ck2-targeting synthetic peptide cigb-300 | rel=r_associated | relid=0 | w=101
  3413. ipilimumab -- r_associated #0: 101 / 0.221 -> en:cladribine
    n1=ipilimumab | n2=en:cladribine | rel=r_associated | relid=0 | w=101
  3414. ipilimumab -- r_associated #0: 101 / 0.221 -> en:clino-san vaginal lubricant
    n1=ipilimumab | n2=en:clino-san vaginal lubricant | rel=r_associated | relid=0 | w=101
  3415. ipilimumab -- r_associated #0: 101 / 0.221 -> en:clobetasol propionate
    n1=ipilimumab | n2=en:clobetasol propionate | rel=r_associated | relid=0 | w=101
  3416. ipilimumab -- r_associated #0: 101 / 0.221 -> en:clomiphene citrate
    n1=ipilimumab | n2=en:clomiphene citrate | rel=r_associated | relid=0 | w=101
  3417. ipilimumab -- r_associated #0: 101 / 0.221 -> en:cmet car-mrna electroporated autologous t lymphocytes
    n1=ipilimumab | n2=en:cmet car-mrna electroporated autologous t lymphocytes | rel=r_associated | relid=0 | w=101
  3418. ipilimumab -- r_associated #0: 101 / 0.221 -> en:coenzyme q10
    n1=ipilimumab | n2=en:coenzyme q10 | rel=r_associated | relid=0 | w=101
  3419. ipilimumab -- r_associated #0: 101 / 0.221 -> en:combretastatin a1 diphosphate
    n1=ipilimumab | n2=en:combretastatin a1 diphosphate | rel=r_associated | relid=0 | w=101
  3420. ipilimumab -- r_associated #0: 101 / 0.221 -> en:concentrated fortified collagen protein hydrolysate liquid supplement
    n1=ipilimumab | n2=en:concentrated fortified collagen protein hydrolysate liquid supplement | rel=r_associated | relid=0 | w=101
  3421. ipilimumab -- r_associated #0: 101 / 0.221 -> en:conjugated estrogens/bazedoxifene
    n1=ipilimumab | n2=en:conjugated estrogens/bazedoxifene | rel=r_associated | relid=0 | w=101
  3422. ipilimumab -- r_associated #0: 101 / 0.221 -> en:copper cu 62 ethylglyoxal bis(thiosemicarbazone)
    n1=ipilimumab | n2=en:copper cu 62 ethylglyoxal bis(thiosemicarbazone) | rel=r_associated | relid=0 | w=101
  3423. ipilimumab -- r_associated #0: 101 / 0.221 -> en:copper cu 62-atsm
    n1=ipilimumab | n2=en:copper cu 62-atsm | rel=r_associated | relid=0 | w=101
  3424. ipilimumab -- r_associated #0: 101 / 0.221 -> en:copper cu 64 plerixafor
    n1=ipilimumab | n2=en:copper cu 64 plerixafor | rel=r_associated | relid=0 | w=101
  3425. ipilimumab -- r_associated #0: 101 / 0.221 -> en:copper cu 64 trastuzumab
    n1=ipilimumab | n2=en:copper cu 64 trastuzumab | rel=r_associated | relid=0 | w=101
  3426. ipilimumab -- r_associated #0: 101 / 0.221 -> en:copper cu 64-dota-trastuzumab
    n1=ipilimumab | n2=en:copper cu 64-dota-trastuzumab | rel=r_associated | relid=0 | w=101
  3427. ipilimumab -- r_associated #0: 101 / 0.221 -> en:coriolus versicolor extract
    n1=ipilimumab | n2=en:coriolus versicolor extract | rel=r_associated | relid=0 | w=101
  3428. ipilimumab -- r_associated #0: 101 / 0.221 -> en:coumarin
    n1=ipilimumab | n2=en:coumarin | rel=r_associated | relid=0 | w=101
  3429. ipilimumab -- r_associated #0: 101 / 0.221 -> en:cpg oligodeoxynucleotide gnkg168
    n1=ipilimumab | n2=en:cpg oligodeoxynucleotide gnkg168 | rel=r_associated | relid=0 | w=101
  3430. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ctrp agent terminology
    n1=ipilimumab | n2=en:ctrp agent terminology | rel=r_associated | relid=0 | w=101
  3431. ipilimumab -- r_associated #0: 101 / 0.221 -> en:cxcr4 inhibitor pol6326
    n1=ipilimumab | n2=en:cxcr4 inhibitor pol6326 | rel=r_associated | relid=0 | w=101
  3432. ipilimumab -- r_associated #0: 101 / 0.221 -> en:cyanocobalamin
    n1=ipilimumab | n2=en:cyanocobalamin | rel=r_associated | relid=0 | w=101
  3433. ipilimumab -- r_associated #0: 101 / 0.221 -> en:cyproheptadine hydrochloride
    n1=ipilimumab | n2=en:cyproheptadine hydrochloride | rel=r_associated | relid=0 | w=101
  3434. ipilimumab -- r_associated #0: 101 / 0.221 -> en:cyproterone acetate
    n1=ipilimumab | n2=en:cyproterone acetate | rel=r_associated | relid=0 | w=101
  3435. ipilimumab -- r_associated #0: 101 / 0.221 -> en:cysteine-rich non-denatured whey protein isolate imn1207
    n1=ipilimumab | n2=en:cysteine-rich non-denatured whey protein isolate imn1207 | rel=r_associated | relid=0 | w=101
  3436. ipilimumab -- r_associated #0: 101 / 0.221 -> en:cytarabine
    n1=ipilimumab | n2=en:cytarabine | rel=r_associated | relid=0 | w=101
  3437. ipilimumab -- r_associated #0: 101 / 0.221 -> en:cytomegalovirus pp65-specific cytotoxic t lymphocytes
    n1=ipilimumab | n2=en:cytomegalovirus pp65-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=101
  3438. ipilimumab -- r_associated #0: 101 / 0.221 -> en:cytotoxic t-lymphocyte protein 4
    n1=ipilimumab | n2=en:cytotoxic t-lymphocyte protein 4 | rel=r_associated | relid=0 | w=101
  3439. ipilimumab -- r_associated #0: 101 / 0.221 -> en:dacarbazine
    n1=ipilimumab | n2=en:dacarbazine | rel=r_associated | relid=0 | w=101
  3440. ipilimumab -- r_associated #0: 101 / 0.221 -> en:daclizumab
    n1=ipilimumab | n2=en:daclizumab | rel=r_associated | relid=0 | w=101
  3441. ipilimumab -- r_associated #0: 101 / 0.221 -> en:daratumumab
    n1=ipilimumab | n2=en:daratumumab | rel=r_associated | relid=0 | w=101
  3442. ipilimumab -- r_associated #0: 101 / 0.221 -> en:dcb-bo1202
    n1=ipilimumab | n2=en:dcb-bo1202 | rel=r_associated | relid=0 | w=101
  3443. ipilimumab -- r_associated #0: 101 / 0.221 -> en:deferasirox
    n1=ipilimumab | n2=en:deferasirox | rel=r_associated | relid=0 | w=101
  3444. ipilimumab -- r_associated #0: 101 / 0.221 -> en:delta-8-tetrahydrocannabinol
    n1=ipilimumab | n2=en:delta-8-tetrahydrocannabinol | rel=r_associated | relid=0 | w=101
  3445. ipilimumab -- r_associated #0: 101 / 0.221 -> en:delta-tocotrienol
    n1=ipilimumab | n2=en:delta-tocotrienol | rel=r_associated | relid=0 | w=101
  3446. ipilimumab -- r_associated #0: 101 / 0.221 -> en:derma-membrane-structure topical cream
    n1=ipilimumab | n2=en:derma-membrane-structure topical cream | rel=r_associated | relid=0 | w=101
  3447. ipilimumab -- r_associated #0: 101 / 0.221 -> en:desmopressin acetate
    n1=ipilimumab | n2=en:desmopressin acetate | rel=r_associated | relid=0 | w=101
  3448. ipilimumab -- r_associated #0: 101 / 0.221 -> en:dexverapamil
    n1=ipilimumab | n2=en:dexverapamil | rel=r_associated | relid=0 | w=101
  3449. ipilimumab -- r_associated #0: 101 / 0.221 -> en:di-leu16-il2 immunocytokine
    n1=ipilimumab | n2=en:di-leu16-il2 immunocytokine | rel=r_associated | relid=0 | w=101
  3450. ipilimumab -- r_associated #0: 101 / 0.221 -> en:diagnostic agents
    n1=ipilimumab | n2=en:diagnostic agents | rel=r_associated | relid=0 | w=101
  3451. ipilimumab -- r_associated #0: 101 / 0.221 -> en:didanosine
    n1=ipilimumab | n2=en:didanosine | rel=r_associated | relid=0 | w=101
  3452. ipilimumab -- r_associated #0: 101 / 0.221 -> en:diindolylmethane
    n1=ipilimumab | n2=en:diindolylmethane | rel=r_associated | relid=0 | w=101
  3453. ipilimumab -- r_associated #0: 101 / 0.221 -> en:dimesna
    n1=ipilimumab | n2=en:dimesna | rel=r_associated | relid=0 | w=101
  3454. ipilimumab -- r_associated #0: 101 / 0.221 -> en:dinitrophenyl
    n1=ipilimumab | n2=en:dinitrophenyl | rel=r_associated | relid=0 | w=101
  3455. ipilimumab -- r_associated #0: 101 / 0.221 -> en:dm-choc-pen
    n1=ipilimumab | n2=en:dm-choc-pen | rel=r_associated | relid=0 | w=101
  3456. ipilimumab -- r_associated #0: 101 / 0.221 -> en:dn-101
    n1=ipilimumab | n2=en:dn-101 | rel=r_associated | relid=0 | w=101
  3457. ipilimumab -- r_associated #0: 101 / 0.221 -> en:dobutamine
    n1=ipilimumab | n2=en:dobutamine | rel=r_associated | relid=0 | w=101
  3458. ipilimumab -- r_associated #0: 101 / 0.221 -> en:dolastatin 10
    n1=ipilimumab | n2=en:dolastatin 10 | rel=r_associated | relid=0 | w=101
  3459. ipilimumab -- r_associated #0: 101 / 0.221 -> en:domperidone
    n1=ipilimumab | n2=en:domperidone | rel=r_associated | relid=0 | w=101
  3460. ipilimumab -- r_associated #0: 101 / 0.221 -> en:donor lymphocytes
    n1=ipilimumab | n2=en:donor lymphocytes | rel=r_associated | relid=0 | w=101
  3461. ipilimumab -- r_associated #0: 101 / 0.221 -> en:dornase alfa
    n1=ipilimumab | n2=en:dornase alfa | rel=r_associated | relid=0 | w=101
  3462. ipilimumab -- r_associated #0: 101 / 0.221 -> en:doxazosin mesylate
    n1=ipilimumab | n2=en:doxazosin mesylate | rel=r_associated | relid=0 | w=101
  3463. ipilimumab -- r_associated #0: 101 / 0.221 -> en:drug products by fda established pharmacologic class
    n1=ipilimumab | n2=en:drug products by fda established pharmacologic class | rel=r_associated | relid=0 | w=101
  3464. ipilimumab -- r_associated #0: 101 / 0.221 -> en:e-selectin antagonist gmi-1271
    n1=ipilimumab | n2=en:e-selectin antagonist gmi-1271 | rel=r_associated | relid=0 | w=101
  3465. ipilimumab -- r_associated #0: 101 / 0.221 -> en:edotecarin
    n1=ipilimumab | n2=en:edotecarin | rel=r_associated | relid=0 | w=101
  3466. ipilimumab -- r_associated #0: 101 / 0.221 -> en:efatutazone dihydrochloride
    n1=ipilimumab | n2=en:efatutazone dihydrochloride | rel=r_associated | relid=0 | w=101
  3467. ipilimumab -- r_associated #0: 101 / 0.221 -> en:egfr antagonist hemay022
    n1=ipilimumab | n2=en:egfr antagonist hemay022 | rel=r_associated | relid=0 | w=101
  3468. ipilimumab -- r_associated #0: 101 / 0.221 -> en:egfr inhibitor abt-414
    n1=ipilimumab | n2=en:egfr inhibitor abt-414 | rel=r_associated | relid=0 | w=101
  3469. ipilimumab -- r_associated #0: 101 / 0.221 -> en:egfr inhibitor egf816
    n1=ipilimumab | n2=en:egfr inhibitor egf816 | rel=r_associated | relid=0 | w=101
  3470. ipilimumab -- r_associated #0: 101 / 0.221 -> en:egfr mutation-selective inhibitor ac0010ma
    n1=ipilimumab | n2=en:egfr mutation-selective inhibitor ac0010ma | rel=r_associated | relid=0 | w=101
  3471. ipilimumab -- r_associated #0: 101 / 0.221 -> en:elinafide
    n1=ipilimumab | n2=en:elinafide | rel=r_associated | relid=0 | w=101
  3472. ipilimumab -- r_associated #0: 101 / 0.221 -> en:elosulfase alfa
    n1=ipilimumab | n2=en:elosulfase alfa | rel=r_associated | relid=0 | w=101
  3473. ipilimumab -- r_associated #0: 101 / 0.221 -> en:elsamitrucin
    n1=ipilimumab | n2=en:elsamitrucin | rel=r_associated | relid=0 | w=101
  3474. ipilimumab -- r_associated #0: 101 / 0.221 -> en:emepepimut-s
    n1=ipilimumab | n2=en:emepepimut-s | rel=r_associated | relid=0 | w=101
  3475. ipilimumab -- r_associated #0: 101 / 0.221 -> en:emitefur
    n1=ipilimumab | n2=en:emitefur | rel=r_associated | relid=0 | w=101
  3476. ipilimumab -- r_associated #0: 101 / 0.221 -> en:enoxaparin
    n1=ipilimumab | n2=en:enoxaparin | rel=r_associated | relid=0 | w=101
  3477. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ensituximab
    n1=ipilimumab | n2=en:ensituximab | rel=r_associated | relid=0 | w=101
  3478. ipilimumab -- r_associated #0: 101 / 0.221 -> en:enteric transport medium
    n1=ipilimumab | n2=en:enteric transport medium | rel=r_associated | relid=0 | w=101
  3479. ipilimumab -- r_associated #0: 101 / 0.221 -> en:enteric-coated zoledronic acid tablet mer-101
    n1=ipilimumab | n2=en:enteric-coated zoledronic acid tablet mer-101 | rel=r_associated | relid=0 | w=101
  3480. ipilimumab -- r_associated #0: 101 / 0.221 -> en:entrectinib
    n1=ipilimumab | n2=en:entrectinib | rel=r_associated | relid=0 | w=101
  3481. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ep4 receptor antagonist aat-007
    n1=ipilimumab | n2=en:ep4 receptor antagonist aat-007 | rel=r_associated | relid=0 | w=101
  3482. ipilimumab -- r_associated #0: 101 / 0.221 -> en:epidermal growth factor receptor tyrosine kinase inhibitor
    n1=ipilimumab | n2=en:epidermal growth factor receptor tyrosine kinase inhibitor | rel=r_associated | relid=0 | w=101
  3483. ipilimumab -- r_associated #0: 101 / 0.221 -> en:era36 modulator icaritin
    n1=ipilimumab | n2=en:era36 modulator icaritin | rel=r_associated | relid=0 | w=101
  3484. ipilimumab -- r_associated #0: 101 / 0.221 -> en:estramustine phosphate sodium
    n1=ipilimumab | n2=en:estramustine phosphate sodium | rel=r_associated | relid=0 | w=101
  3485. ipilimumab -- r_associated #0: 101 / 0.221 -> en:estriol vaginal gel
    n1=ipilimumab | n2=en:estriol vaginal gel | rel=r_associated | relid=0 | w=101
  3486. ipilimumab -- r_associated #0: 101 / 0.221 -> en:estrogen receptor agonist gtx-758
    n1=ipilimumab | n2=en:estrogen receptor agonist gtx-758 | rel=r_associated | relid=0 | w=101
  3487. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ethaselen
    n1=ipilimumab | n2=en:ethaselen | rel=r_associated | relid=0 | w=101
  3488. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ethinyl estradiol
    n1=ipilimumab | n2=en:ethinyl estradiol | rel=r_associated | relid=0 | w=101
  3489. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ethosuximide
    n1=ipilimumab | n2=en:ethosuximide | rel=r_associated | relid=0 | w=101
  3490. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ethyl alcohol mouthwash
    n1=ipilimumab | n2=en:ethyl alcohol mouthwash | rel=r_associated | relid=0 | w=101
  3491. ipilimumab -- r_associated #0: 101 / 0.221 -> en:evaux thermal spring water-based solution
    n1=ipilimumab | n2=en:evaux thermal spring water-based solution | rel=r_associated | relid=0 | w=101
  3492. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ezetimibe/simvastatin
    n1=ipilimumab | n2=en:ezetimibe/simvastatin | rel=r_associated | relid=0 | w=101
  3493. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ezh2 inhibitor cpi-1205
    n1=ipilimumab | n2=en:ezh2 inhibitor cpi-1205 | rel=r_associated | relid=0 | w=101
  3494. ipilimumab -- r_associated #0: 101 / 0.221 -> en:fentanyl citrate buccal tablet
    n1=ipilimumab | n2=en:fentanyl citrate buccal tablet | rel=r_associated | relid=0 | w=101
  3495. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ferrous fumarate
    n1=ipilimumab | n2=en:ferrous fumarate | rel=r_associated | relid=0 | w=101
  3496. ipilimumab -- r_associated #0: 101 / 0.221 -> en:fgf receptor antagonist hgs1036
    n1=ipilimumab | n2=en:fgf receptor antagonist hgs1036 | rel=r_associated | relid=0 | w=101
  3497. ipilimumab -- r_associated #0: 101 / 0.221 -> en:fgfr inhibitor incb054828
    n1=ipilimumab | n2=en:fgfr inhibitor incb054828 | rel=r_associated | relid=0 | w=101
  3498. ipilimumab -- r_associated #0: 101 / 0.221 -> en:fgfr inhibitor tas-120
    n1=ipilimumab | n2=en:fgfr inhibitor tas-120 | rel=r_associated | relid=0 | w=101
  3499. ipilimumab -- r_associated #0: 101 / 0.221 -> en:filgrastim-primed peripheral blood progenitor cells
    n1=ipilimumab | n2=en:filgrastim-primed peripheral blood progenitor cells | rel=r_associated | relid=0 | w=101
  3500. ipilimumab -- r_associated #0: 101 / 0.221 -> en:flecainide acetate
    n1=ipilimumab | n2=en:flecainide acetate | rel=r_associated | relid=0 | w=101
  3501. ipilimumab -- r_associated #0: 101 / 0.221 -> en:fluconazole
    n1=ipilimumab | n2=en:fluconazole | rel=r_associated | relid=0 | w=101
  3502. ipilimumab -- r_associated #0: 101 / 0.221 -> en:fludarabine
    n1=ipilimumab | n2=en:fludarabine | rel=r_associated | relid=0 | w=101
  3503. ipilimumab -- r_associated #0: 101 / 0.221 -> en:fludrocortisone acetate
    n1=ipilimumab | n2=en:fludrocortisone acetate | rel=r_associated | relid=0 | w=101
  3504. ipilimumab -- r_associated #0: 101 / 0.221 -> en:fluorescein sodium injection
    n1=ipilimumab | n2=en:fluorescein sodium injection | rel=r_associated | relid=0 | w=101
  3505. ipilimumab -- r_associated #0: 101 / 0.221 -> en:fluorescent crgdy peg-cy5.5 c dots
    n1=ipilimumab | n2=en:fluorescent crgdy peg-cy5.5 c dots | rel=r_associated | relid=0 | w=101
  3506. ipilimumab -- r_associated #0: 101 / 0.221 -> en:fluorine f 18 5-fluoro-2-deoxycytidine
    n1=ipilimumab | n2=en:fluorine f 18 5-fluoro-2-deoxycytidine | rel=r_associated | relid=0 | w=101
  3507. ipilimumab -- r_associated #0: 101 / 0.221 -> en:fluorine f 18 fluoro furanyl norprogesterone
    n1=ipilimumab | n2=en:fluorine f 18 fluoro furanyl norprogesterone | rel=r_associated | relid=0 | w=101
  3508. ipilimumab -- r_associated #0: 101 / 0.221 -> en:fluorine f 18 l-glutamate derivative bay94-9392
    n1=ipilimumab | n2=en:fluorine f 18 l-glutamate derivative bay94-9392 | rel=r_associated | relid=0 | w=101
  3509. ipilimumab -- r_associated #0: 101 / 0.221 -> en:fluorine f 18 ski-249380
    n1=ipilimumab | n2=en:fluorine f 18 ski-249380 | rel=r_associated | relid=0 | w=101
  3510. ipilimumab -- r_associated #0: 101 / 0.221 -> en:fluorine f-18 6-fluorodopamine
    n1=ipilimumab | n2=en:fluorine f-18 6-fluorodopamine | rel=r_associated | relid=0 | w=101
  3511. ipilimumab -- r_associated #0: 101 / 0.221 -> en:fluorine f-18 hx4
    n1=ipilimumab | n2=en:fluorine f-18 hx4 | rel=r_associated | relid=0 | w=101
  3512. ipilimumab -- r_associated #0: 101 / 0.221 -> en:flutemetamol f 18
    n1=ipilimumab | n2=en:flutemetamol f 18 | rel=r_associated | relid=0 | w=101
  3513. ipilimumab -- r_associated #0: 101 / 0.221 -> en:fluticasone propionate
    n1=ipilimumab | n2=en:fluticasone propionate | rel=r_associated | relid=0 | w=101
  3514. ipilimumab -- r_associated #0: 101 / 0.221 -> en:folate receptor targeted epothilone bms753493
    n1=ipilimumab | n2=en:folate receptor targeted epothilone bms753493 | rel=r_associated | relid=0 | w=101
  3515. ipilimumab -- r_associated #0: 101 / 0.221 -> en:formestane
    n1=ipilimumab | n2=en:formestane | rel=r_associated | relid=0 | w=101
  3516. ipilimumab -- r_associated #0: 101 / 0.221 -> en:fusidic acid/betamethasone valerate topical cream
    n1=ipilimumab | n2=en:fusidic acid/betamethasone valerate topical cream | rel=r_associated | relid=0 | w=101
  3517. ipilimumab -- r_associated #0: 101 / 0.221 -> en:gabapentin
    n1=ipilimumab | n2=en:gabapentin | rel=r_associated | relid=0 | w=101
  3518. ipilimumab -- r_associated #0: 101 / 0.221 -> en:gabapentin enacarbil
    n1=ipilimumab | n2=en:gabapentin enacarbil | rel=r_associated | relid=0 | w=101
  3519. ipilimumab -- r_associated #0: 101 / 0.221 -> en:gallium ga 68 citrate
    n1=ipilimumab | n2=en:gallium ga 68 citrate | rel=r_associated | relid=0 | w=101
  3520. ipilimumab -- r_associated #0: 101 / 0.221 -> en:gallium ga 68-dotanoc
    n1=ipilimumab | n2=en:gallium ga 68-dotanoc | rel=r_associated | relid=0 | w=101
  3521. ipilimumab -- r_associated #0: 101 / 0.221 -> en:gallium ga 68-dotatate
    n1=ipilimumab | n2=en:gallium ga 68-dotatate | rel=r_associated | relid=0 | w=101
  3522. ipilimumab -- r_associated #0: 101 / 0.221 -> en:gallium ga 68-labeled psma ligand glu-urea-lys(ahx)-hbed-cc
    n1=ipilimumab | n2=en:gallium ga 68-labeled psma ligand glu-urea-lys(ahx)-hbed-cc | rel=r_associated | relid=0 | w=101
  3523. ipilimumab -- r_associated #0: 101 / 0.221 -> en:gallium ga 68-nota-ae105
    n1=ipilimumab | n2=en:gallium ga 68-nota-ae105 | rel=r_associated | relid=0 | w=101
  3524. ipilimumab -- r_associated #0: 101 / 0.221 -> en:gallium nitrate
    n1=ipilimumab | n2=en:gallium nitrate | rel=r_associated | relid=0 | w=101
  3525. ipilimumab -- r_associated #0: 101 / 0.221 -> en:gandotinib
    n1=ipilimumab | n2=en:gandotinib | rel=r_associated | relid=0 | w=101
  3526. ipilimumab -- r_associated #0: 101 / 0.221 -> en:gdc-0349
    n1=ipilimumab | n2=en:gdc-0349 | rel=r_associated | relid=0 | w=101
  3527. ipilimumab -- r_associated #0: 101 / 0.221 -> en:gemfibrozil
    n1=ipilimumab | n2=en:gemfibrozil | rel=r_associated | relid=0 | w=101
  3528. ipilimumab -- r_associated #0: 101 / 0.221 -> en:genistein
    n1=ipilimumab | n2=en:genistein | rel=r_associated | relid=0 | w=101
  3529. ipilimumab -- r_associated #0: 101 / 0.221 -> en:gi-4000 vaccine
    n1=ipilimumab | n2=en:gi-4000 vaccine | rel=r_associated | relid=0 | w=101
  3530. ipilimumab -- r_associated #0: 101 / 0.221 -> en:girentuximab
    n1=ipilimumab | n2=en:girentuximab | rel=r_associated | relid=0 | w=101
  3531. ipilimumab -- r_associated #0: 101 / 0.221 -> en:glioma-associated peptide-loaded dendritic cell vaccine sl-701
    n1=ipilimumab | n2=en:glioma-associated peptide-loaded dendritic cell vaccine sl-701 | rel=r_associated | relid=0 | w=101
  3532. ipilimumab -- r_associated #0: 101 / 0.221 -> en:glisoxepide
    n1=ipilimumab | n2=en:glisoxepide | rel=r_associated | relid=0 | w=101
  3533. ipilimumab -- r_associated #0: 101 / 0.221 -> en:globo h-gm2-lewis-y-muc1-32-mer-tf(c)-tn(c)-klh conjugate vaccine
    n1=ipilimumab | n2=en:globo h-gm2-lewis-y-muc1-32-mer-tf(c)-tn(c)-klh conjugate vaccine | rel=r_associated | relid=0 | w=101
  3534. ipilimumab -- r_associated #0: 101 / 0.221 -> en:glse compound
    n1=ipilimumab | n2=en:glse compound | rel=r_associated | relid=0 | w=101
  3535. ipilimumab -- r_associated #0: 101 / 0.221 -> en:glucagon
    n1=ipilimumab | n2=en:glucagon | rel=r_associated | relid=0 | w=101
  3536. ipilimumab -- r_associated #0: 101 / 0.221 -> en:glutamic acid
    n1=ipilimumab | n2=en:glutamic acid | rel=r_associated | relid=0 | w=101
  3537. ipilimumab -- r_associated #0: 101 / 0.221 -> en:golvatinib
    n1=ipilimumab | n2=en:golvatinib | rel=r_associated | relid=0 | w=101
  3538. ipilimumab -- r_associated #0: 101 / 0.221 -> en:gp100 antigen
    n1=ipilimumab | n2=en:gp100 antigen | rel=r_associated | relid=0 | w=101
  3539. ipilimumab -- r_associated #0: 101 / 0.221 -> en:granisetron transdermal patch
    n1=ipilimumab | n2=en:granisetron transdermal patch | rel=r_associated | relid=0 | w=101
  3540. ipilimumab -- r_associated #0: 101 / 0.221 -> en:gs/pan-notch inhibitor bms-986115
    n1=ipilimumab | n2=en:gs/pan-notch inhibitor bms-986115 | rel=r_associated | relid=0 | w=101
  3541. ipilimumab -- r_associated #0: 101 / 0.221 -> en:gti-2040
    n1=ipilimumab | n2=en:gti-2040 | rel=r_associated | relid=0 | w=101
  3542. ipilimumab -- r_associated #0: 101 / 0.221 -> en:guadecitabine
    n1=ipilimumab | n2=en:guadecitabine | rel=r_associated | relid=0 | w=101
  3543. ipilimumab -- r_associated #0: 101 / 0.221 -> en:guarana supplement
    n1=ipilimumab | n2=en:guarana supplement | rel=r_associated | relid=0 | w=101
  3544. ipilimumab -- r_associated #0: 101 / 0.221 -> en:halofuginone hydrobromide
    n1=ipilimumab | n2=en:halofuginone hydrobromide | rel=r_associated | relid=0 | w=101
  3545. ipilimumab -- r_associated #0: 101 / 0.221 -> en:hcv antigen therapeutic bivalent vaccine v5
    n1=ipilimumab | n2=en:hcv antigen therapeutic bivalent vaccine v5 | rel=r_associated | relid=0 | w=101
  3546. ipilimumab -- r_associated #0: 101 / 0.221 -> en:hematologic agents
    n1=ipilimumab | n2=en:hematologic agents | rel=r_associated | relid=0 | w=101
  3547. ipilimumab -- r_associated #0: 101 / 0.221 -> en:hepsulfam
    n1=ipilimumab | n2=en:hepsulfam | rel=r_associated | relid=0 | w=101
  3548. ipilimumab -- r_associated #0: 101 / 0.221 -> en:her-2-neu, cea peptides, gm-csf, montanide isa-51 vaccine
    n1=ipilimumab | n2=en:her-2-neu, cea peptides, gm-csf, montanide isa-51 vaccine | rel=r_associated | relid=0 | w=101
  3549. ipilimumab -- r_associated #0: 101 / 0.221 -> en:herbal medicine (product)
    n1=ipilimumab | n2=en:herbal medicine (product) | rel=r_associated | relid=0 | w=101
  3550. ipilimumab -- r_associated #0: 101 / 0.221 -> en:herbal polysaccharide saliva substitute
    n1=ipilimumab | n2=en:herbal polysaccharide saliva substitute | rel=r_associated | relid=0 | w=101
  3551. ipilimumab -- r_associated #0: 101 / 0.221 -> en:hif-2alpha inhibitor pt2385
    n1=ipilimumab | n2=en:hif-2alpha inhibitor pt2385 | rel=r_associated | relid=0 | w=101
  3552. ipilimumab -- r_associated #0: 101 / 0.221 -> en:high-titer rsv immune globulin ri-001
    n1=ipilimumab | n2=en:high-titer rsv immune globulin ri-001 | rel=r_associated | relid=0 | w=101
  3553. ipilimumab -- r_associated #0: 101 / 0.221 -> en:histrelin acetate
    n1=ipilimumab | n2=en:histrelin acetate | rel=r_associated | relid=0 | w=101
  3554. ipilimumab -- r_associated #0: 101 / 0.221 -> en:hla-a*2402-restricted multipeptide vaccine s-488410
    n1=ipilimumab | n2=en:hla-a*2402-restricted multipeptide vaccine s-488410 | rel=r_associated | relid=0 | w=101
  3555. ipilimumab -- r_associated #0: 101 / 0.221 -> en:hla-a*2402-restricted urlc10-cdca1-kif20a multipeptide vaccine
    n1=ipilimumab | n2=en:hla-a*2402-restricted urlc10-cdca1-kif20a multipeptide vaccine | rel=r_associated | relid=0 | w=101
  3556. ipilimumab -- r_associated #0: 101 / 0.221 -> en:hla-a*2402-restricted urlc10-cdca1-vegfr1-vegfr2 multipeptide vaccine
    n1=ipilimumab | n2=en:hla-a*2402-restricted urlc10-cdca1-vegfr1-vegfr2 multipeptide vaccine | rel=r_associated | relid=0 | w=101
  3557. ipilimumab -- r_associated #0: 101 / 0.221 -> en:honey-containing mouthwash
    n1=ipilimumab | n2=en:honey-containing mouthwash | rel=r_associated | relid=0 | w=101
  3558. ipilimumab -- r_associated #0: 101 / 0.221 -> en:hpv16 l2/e6/e7 fusion protein vaccine ta-cin
    n1=ipilimumab | n2=en:hpv16 l2/e6/e7 fusion protein vaccine ta-cin | rel=r_associated | relid=0 | w=101
  3559. ipilimumab -- r_associated #0: 101 / 0.221 -> en:hsp90 inhibitor hsp990
    n1=ipilimumab | n2=en:hsp90 inhibitor hsp990 | rel=r_associated | relid=0 | w=101
  3560. ipilimumab -- r_associated #0: 101 / 0.221 -> en:hsp90 inhibitor mpc-3100
    n1=ipilimumab | n2=en:hsp90 inhibitor mpc-3100 | rel=r_associated | relid=0 | w=101
  3561. ipilimumab -- r_associated #0: 101 / 0.221 -> en:hsp90 inhibitor snx-5542 mesylate
    n1=ipilimumab | n2=en:hsp90 inhibitor snx-5542 mesylate | rel=r_associated | relid=0 | w=101
  3562. ipilimumab -- r_associated #0: 101 / 0.221 -> en:hsv-1 hf10
    n1=ipilimumab | n2=en:hsv-1 hf10 | rel=r_associated | relid=0 | w=101
  3563. ipilimumab -- r_associated #0: 101 / 0.221 -> en:human papillomavirus tumor antigen vaccine
    n1=ipilimumab | n2=en:human papillomavirus tumor antigen vaccine | rel=r_associated | relid=0 | w=101
  3564. ipilimumab -- r_associated #0: 101 / 0.221 -> en:human papillomavirus vaccine v503
    n1=ipilimumab | n2=en:human papillomavirus vaccine v503 | rel=r_associated | relid=0 | w=101
  3565. ipilimumab -- r_associated #0: 101 / 0.221 -> en:hyperpolarized helium 3
    n1=ipilimumab | n2=en:hyperpolarized helium 3 | rel=r_associated | relid=0 | w=101
  3566. ipilimumab -- r_associated #0: 101 / 0.221 -> en:hyperpolarized xenon 129
    n1=ipilimumab | n2=en:hyperpolarized xenon 129 | rel=r_associated | relid=0 | w=101
  3567. ipilimumab -- r_associated #0: 101 / 0.221 -> en:hypoxia-activated prodrug th-4000
    n1=ipilimumab | n2=en:hypoxia-activated prodrug th-4000 | rel=r_associated | relid=0 | w=101
  3568. ipilimumab -- r_associated #0: 101 / 0.221 -> en:i [preparations]
    n1=ipilimumab | n2=en:i [preparations] | rel=r_associated | relid=0 | w=101
  3569. ipilimumab -- r_associated #0: 101 / 0.221 -> en:i 131 monoclonal antibody f19
    n1=ipilimumab | n2=en:i 131 monoclonal antibody f19 | rel=r_associated | relid=0 | w=101
  3570. ipilimumab -- r_associated #0: 101 / 0.221 -> en:iap inhibitor hgs1029
    n1=ipilimumab | n2=en:iap inhibitor hgs1029 | rel=r_associated | relid=0 | w=101
  3571. ipilimumab -- r_associated #0: 101 / 0.221 -> en:iapa-based dendritic cells/cytotoxic t lymphocytes
    n1=ipilimumab | n2=en:iapa-based dendritic cells/cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=101
  3572. ipilimumab -- r_associated #0: 101 / 0.221 -> en:idarubicin hydrochloride
    n1=ipilimumab | n2=en:idarubicin hydrochloride | rel=r_associated | relid=0 | w=101
  3573. ipilimumab -- r_associated #0: 101 / 0.221 -> en:idh1(r132) inhibitor idh305
    n1=ipilimumab | n2=en:idh1(r132) inhibitor idh305 | rel=r_associated | relid=0 | w=101
  3574. ipilimumab -- r_associated #0: 101 / 0.221 -> en:idiotype-pulsed autologous dendritic cell vaccine apc8020
    n1=ipilimumab | n2=en:idiotype-pulsed autologous dendritic cell vaccine apc8020 | rel=r_associated | relid=0 | w=101
  3575. ipilimumab -- r_associated #0: 101 / 0.221 -> en:idoxifene
    n1=ipilimumab | n2=en:idoxifene | rel=r_associated | relid=0 | w=101
  3576. ipilimumab -- r_associated #0: 101 / 0.221 -> en:idursulfase
    n1=ipilimumab | n2=en:idursulfase | rel=r_associated | relid=0 | w=101
  3577. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ifosfamide
    n1=ipilimumab | n2=en:ifosfamide | rel=r_associated | relid=0 | w=101
  3578. ipilimumab -- r_associated #0: 101 / 0.221 -> en:igf-1r antisense oligodeoxynucleotide-treated autologous glioma cells
    n1=ipilimumab | n2=en:igf-1r antisense oligodeoxynucleotide-treated autologous glioma cells | rel=r_associated | relid=0 | w=101
  3579. ipilimumab -- r_associated #0: 101 / 0.221 -> en:il-2 plasmid dna/lipid complex
    n1=ipilimumab | n2=en:il-2 plasmid dna/lipid complex | rel=r_associated | relid=0 | w=101
  3580. ipilimumab -- r_associated #0: 101 / 0.221 -> en:il-2/lptn gene-modified allogeneic neuroblastoma tumor cell vaccine
    n1=ipilimumab | n2=en:il-2/lptn gene-modified allogeneic neuroblastoma tumor cell vaccine | rel=r_associated | relid=0 | w=101
  3581. ipilimumab -- r_associated #0: 101 / 0.221 -> en:iloperidone
    n1=ipilimumab | n2=en:iloperidone | rel=r_associated | relid=0 | w=101
  3582. ipilimumab -- r_associated #0: 101 / 0.221 -> en:imexon
    n1=ipilimumab | n2=en:imexon | rel=r_associated | relid=0 | w=101
  3583. ipilimumab -- r_associated #0: 101 / 0.221 -> en:imidazolyl ethanamide pentandioic acid
    n1=ipilimumab | n2=en:imidazolyl ethanamide pentandioic acid | rel=r_associated | relid=0 | w=101
  3584. ipilimumab -- r_associated #0: 101 / 0.221 -> en:imipenem-cilastatin sodium
    n1=ipilimumab | n2=en:imipenem-cilastatin sodium | rel=r_associated | relid=0 | w=101
  3585. ipilimumab -- r_associated #0: 101 / 0.221 -> en:immediate-release tablet afuresertib
    n1=ipilimumab | n2=en:immediate-release tablet afuresertib | rel=r_associated | relid=0 | w=101
  3586. ipilimumab -- r_associated #0: 101 / 0.221 -> en:immunomodulator ohr/avr118
    n1=ipilimumab | n2=en:immunomodulator ohr/avr118 | rel=r_associated | relid=0 | w=101
  3587. ipilimumab -- r_associated #0: 101 / 0.221 -> en:in 111 monoclonal antibody lym-1
    n1=ipilimumab | n2=en:in 111 monoclonal antibody lym-1 | rel=r_associated | relid=0 | w=101
  3588. ipilimumab -- r_associated #0: 101 / 0.221 -> en:inalimarev
    n1=ipilimumab | n2=en:inalimarev | rel=r_associated | relid=0 | w=101
  3589. ipilimumab -- r_associated #0: 101 / 0.221 -> en:indium in 111 capromab pendetide
    n1=ipilimumab | n2=en:indium in 111 capromab pendetide | rel=r_associated | relid=0 | w=101
  3590. ipilimumab -- r_associated #0: 101 / 0.221 -> en:indium in 111-dota-di-hsg peptide imp-288
    n1=ipilimumab | n2=en:indium in 111-dota-di-hsg peptide imp-288 | rel=r_associated | relid=0 | w=101
  3591. ipilimumab -- r_associated #0: 101 / 0.221 -> en:indium in-111
    n1=ipilimumab | n2=en:indium in-111 | rel=r_associated | relid=0 | w=101
  3592. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ingenol derivative leo 43204 gel
    n1=ipilimumab | n2=en:ingenol derivative leo 43204 gel | rel=r_associated | relid=0 | w=101
  3593. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ino-1001
    n1=ipilimumab | n2=en:ino-1001 | rel=r_associated | relid=0 | w=101
  3594. ipilimumab -- r_associated #0: 101 / 0.221 -> en:inotropic agent
    n1=ipilimumab | n2=en:inotropic agent | rel=r_associated | relid=0 | w=101
  3595. ipilimumab -- r_associated #0: 101 / 0.221 -> en:interferon beta-secreting mesenchymal stem cells
    n1=ipilimumab | n2=en:interferon beta-secreting mesenchymal stem cells | rel=r_associated | relid=0 | w=101
  3596. ipilimumab -- r_associated #0: 101 / 0.221 -> en:intrinsic factor/iron/multivitamins
    n1=ipilimumab | n2=en:intrinsic factor/iron/multivitamins | rel=r_associated | relid=0 | w=101
  3597. ipilimumab -- r_associated #0: 101 / 0.221 -> en:iobenguane
    n1=ipilimumab | n2=en:iobenguane | rel=r_associated | relid=0 | w=101
  3598. ipilimumab -- r_associated #0: 101 / 0.221 -> en:iobitridol
    n1=ipilimumab | n2=en:iobitridol | rel=r_associated | relid=0 | w=101
  3599. ipilimumab -- r_associated #0: 101 / 0.221 -> en:iocetamic acid
    n1=ipilimumab | n2=en:iocetamic acid | rel=r_associated | relid=0 | w=101
  3600. ipilimumab -- r_associated #0: 101 / 0.221 -> en:iodamide meglumine
    n1=ipilimumab | n2=en:iodamide meglumine | rel=r_associated | relid=0 | w=101
  3601. ipilimumab -- r_associated #0: 101 / 0.221 -> en:iodine i 124 cpd-1028
    n1=ipilimumab | n2=en:iodine i 124 cpd-1028 | rel=r_associated | relid=0 | w=101
  3602. ipilimumab -- r_associated #0: 101 / 0.221 -> en:iodine i 131 ethiodized oil
    n1=ipilimumab | n2=en:iodine i 131 ethiodized oil | rel=r_associated | relid=0 | w=101
  3603. ipilimumab -- r_associated #0: 101 / 0.221 -> en:iodine i 131 monoclonal antibody bc8
    n1=ipilimumab | n2=en:iodine i 131 monoclonal antibody bc8 | rel=r_associated | relid=0 | w=101
  3604. ipilimumab -- r_associated #0: 101 / 0.221 -> en:iodine i 131 monoclonal antibody muj591
    n1=ipilimumab | n2=en:iodine i 131 monoclonal antibody muj591 | rel=r_associated | relid=0 | w=101
  3605. ipilimumab -- r_associated #0: 101 / 0.221 -> en:iodine i 131 tm-601
    n1=ipilimumab | n2=en:iodine i 131 tm-601 | rel=r_associated | relid=0 | w=101
  3606. ipilimumab -- r_associated #0: 101 / 0.221 -> en:iodine i-123
    n1=ipilimumab | n2=en:iodine i-123 | rel=r_associated | relid=0 | w=101
  3607. ipilimumab -- r_associated #0: 101 / 0.221 -> en:iodine i-123 iodometomidate
    n1=ipilimumab | n2=en:iodine i-123 iodometomidate | rel=r_associated | relid=0 | w=101
  3608. ipilimumab -- r_associated #0: 101 / 0.221 -> en:iodine i-124 girentuximab
    n1=ipilimumab | n2=en:iodine i-124 girentuximab | rel=r_associated | relid=0 | w=101
  3609. ipilimumab -- r_associated #0: 101 / 0.221 -> en:iodine i-125
    n1=ipilimumab | n2=en:iodine i-125 | rel=r_associated | relid=0 | w=101
  3610. ipilimumab -- r_associated #0: 101 / 0.221 -> en:iodophore product
    n1=ipilimumab | n2=en:iodophore product | rel=r_associated | relid=0 | w=101
  3611. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ionomycin
    n1=ipilimumab | n2=en:ionomycin | rel=r_associated | relid=0 | w=101
  3612. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ipamorelin
    n1=ipilimumab | n2=en:ipamorelin | rel=r_associated | relid=0 | w=101
  3613. ipilimumab -- r_associated #0: 101 / 0.221 -> en:iproplatin
    n1=ipilimumab | n2=en:iproplatin | rel=r_associated | relid=0 | w=101
  3614. ipilimumab -- r_associated #0: 101 / 0.221 -> en:iron dextran complex
    n1=ipilimumab | n2=en:iron dextran complex | rel=r_associated | relid=0 | w=101
  3615. ipilimumab -- r_associated #0: 101 / 0.221 -> en:iron isomaltoside 1000
    n1=ipilimumab | n2=en:iron isomaltoside 1000 | rel=r_associated | relid=0 | w=101
  3616. ipilimumab -- r_associated #0: 101 / 0.221 -> en:isis 5132
    n1=ipilimumab | n2=en:isis 5132 | rel=r_associated | relid=0 | w=101
  3617. ipilimumab -- r_associated #0: 101 / 0.221 -> en:isoleucine
    n1=ipilimumab | n2=en:isoleucine | rel=r_associated | relid=0 | w=101
  3618. ipilimumab -- r_associated #0: 101 / 0.221 -> en:isopropyl palmitate
    n1=ipilimumab | n2=en:isopropyl palmitate | rel=r_associated | relid=0 | w=101
  3619. ipilimumab -- r_associated #0: 101 / 0.221 -> en:isoproterenol/sodium chloride
    n1=ipilimumab | n2=en:isoproterenol/sodium chloride | rel=r_associated | relid=0 | w=101
  3620. ipilimumab -- r_associated #0: 101 / 0.221 -> en:isotretinoin
    n1=ipilimumab | n2=en:isotretinoin | rel=r_associated | relid=0 | w=101
  3621. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ispinesib
    n1=ipilimumab | n2=en:ispinesib | rel=r_associated | relid=0 | w=101
  3622. ipilimumab -- r_associated #0: 101 / 0.221 -> en:iss 1018 cpg oligodeoxynucleotide
    n1=ipilimumab | n2=en:iss 1018 cpg oligodeoxynucleotide | rel=r_associated | relid=0 | w=101
  3623. ipilimumab -- r_associated #0: 101 / 0.221 -> en:jeb regimen
    n1=ipilimumab | n2=en:jeb regimen | rel=r_associated | relid=0 | w=101
  3624. ipilimumab -- r_associated #0: 101 / 0.221 -> en:kanamycin sulfate
    n1=ipilimumab | n2=en:kanamycin sulfate | rel=r_associated | relid=0 | w=101
  3625. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ketorolac
    n1=ipilimumab | n2=en:ketorolac | rel=r_associated | relid=0 | w=101
  3626. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ketorolac + phenylephrine
    n1=ipilimumab | n2=en:ketorolac + phenylephrine | rel=r_associated | relid=0 | w=101
  3627. ipilimumab -- r_associated #0: 101 / 0.221 -> en:klh-fitc
    n1=ipilimumab | n2=en:klh-fitc | rel=r_associated | relid=0 | w=101
  3628. ipilimumab -- r_associated #0: 101 / 0.221 -> en:kunecatechins ointment
    n1=ipilimumab | n2=en:kunecatechins ointment | rel=r_associated | relid=0 | w=101
  3629. ipilimumab -- r_associated #0: 101 / 0.221 -> en:l-carnitine l-tartrate
    n1=ipilimumab | n2=en:l-carnitine l-tartrate | rel=r_associated | relid=0 | w=101
  3630. ipilimumab -- r_associated #0: 101 / 0.221 -> en:l-methylfolate
    n1=ipilimumab | n2=en:l-methylfolate | rel=r_associated | relid=0 | w=101
  3631. ipilimumab -- r_associated #0: 101 / 0.221 -> en:lactobacillus acidophilus
    n1=ipilimumab | n2=en:lactobacillus acidophilus | rel=r_associated | relid=0 | w=101
  3632. ipilimumab -- r_associated #0: 101 / 0.221 -> en:lactobacillus plantarum strain 299v
    n1=ipilimumab | n2=en:lactobacillus plantarum strain 299v | rel=r_associated | relid=0 | w=101
  3633. ipilimumab -- r_associated #0: 101 / 0.221 -> en:lanreotide acetate
    n1=ipilimumab | n2=en:lanreotide acetate | rel=r_associated | relid=0 | w=101
  3634. ipilimumab -- r_associated #0: 101 / 0.221 -> en:lanreotide long-acting aqueous gel
    n1=ipilimumab | n2=en:lanreotide long-acting aqueous gel | rel=r_associated | relid=0 | w=101
  3635. ipilimumab -- r_associated #0: 101 / 0.221 -> en:largetrifoliolious bugbane rhizome supplement
    n1=ipilimumab | n2=en:largetrifoliolious bugbane rhizome supplement | rel=r_associated | relid=0 | w=101
  3636. ipilimumab -- r_associated #0: 101 / 0.221 -> en:laromustine
    n1=ipilimumab | n2=en:laromustine | rel=r_associated | relid=0 | w=101
  3637. ipilimumab -- r_associated #0: 101 / 0.221 -> en:larotaxel
    n1=ipilimumab | n2=en:larotaxel | rel=r_associated | relid=0 | w=101
  3638. ipilimumab -- r_associated #0: 101 / 0.221 -> en:lawsone
    n1=ipilimumab | n2=en:lawsone | rel=r_associated | relid=0 | w=101
  3639. ipilimumab -- r_associated #0: 101 / 0.221 -> en:lead pb 212 tcmc-trastuzumab
    n1=ipilimumab | n2=en:lead pb 212 tcmc-trastuzumab | rel=r_associated | relid=0 | w=101
  3640. ipilimumab -- r_associated #0: 101 / 0.221 -> en:leridistim
    n1=ipilimumab | n2=en:leridistim | rel=r_associated | relid=0 | w=101
  3641. ipilimumab -- r_associated #0: 101 / 0.221 -> en:leucovorin calcium
    n1=ipilimumab | n2=en:leucovorin calcium | rel=r_associated | relid=0 | w=101
  3642. ipilimumab -- r_associated #0: 101 / 0.221 -> en:levamisole hydrochloride
    n1=ipilimumab | n2=en:levamisole hydrochloride | rel=r_associated | relid=0 | w=101
  3643. ipilimumab -- r_associated #0: 101 / 0.221 -> en:levobupivacaine hydrochloride
    n1=ipilimumab | n2=en:levobupivacaine hydrochloride | rel=r_associated | relid=0 | w=101
  3644. ipilimumab -- r_associated #0: 101 / 0.221 -> en:levocetirizine dihydrochloride
    n1=ipilimumab | n2=en:levocetirizine dihydrochloride | rel=r_associated | relid=0 | w=101
  3645. ipilimumab -- r_associated #0: 101 / 0.221 -> en:liothyronine
    n1=ipilimumab | n2=en:liothyronine | rel=r_associated | relid=0 | w=101
  3646. ipilimumab -- r_associated #0: 101 / 0.221 -> en:lipegfilgrastim
    n1=ipilimumab | n2=en:lipegfilgrastim | rel=r_associated | relid=0 | w=101
  3647. ipilimumab -- r_associated #0: 101 / 0.221 -> en:liposomal c-raf antisense oligonucleotide
    n1=ipilimumab | n2=en:liposomal c-raf antisense oligonucleotide | rel=r_associated | relid=0 | w=101
  3648. ipilimumab -- r_associated #0: 101 / 0.221 -> en:liposomal daunorubicin citrate
    n1=ipilimumab | n2=en:liposomal daunorubicin citrate | rel=r_associated | relid=0 | w=101
  3649. ipilimumab -- r_associated #0: 101 / 0.221 -> en:liposomal mnsod plasmid
    n1=ipilimumab | n2=en:liposomal mnsod plasmid | rel=r_associated | relid=0 | w=101
  3650. ipilimumab -- r_associated #0: 101 / 0.221 -> en:liposomal sn-38
    n1=ipilimumab | n2=en:liposomal sn-38 | rel=r_associated | relid=0 | w=101
  3651. ipilimumab -- r_associated #0: 101 / 0.221 -> en:lmp1/barf1/ebna1-specific cytotoxic t-lymphocytes
    n1=ipilimumab | n2=en:lmp1/barf1/ebna1-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=101
  3652. ipilimumab -- r_associated #0: 101 / 0.221 -> en:lobaplatin
    n1=ipilimumab | n2=en:lobaplatin | rel=r_associated | relid=0 | w=101
  3653. ipilimumab -- r_associated #0: 101 / 0.221 -> en:lometrexol
    n1=ipilimumab | n2=en:lometrexol | rel=r_associated | relid=0 | w=101
  3654. ipilimumab -- r_associated #0: 101 / 0.221 -> en:losoxantrone
    n1=ipilimumab | n2=en:losoxantrone | rel=r_associated | relid=0 | w=101
  3655. ipilimumab -- r_associated #0: 101 / 0.221 -> en:lutetium lu 177 dota-biotin
    n1=ipilimumab | n2=en:lutetium lu 177 dota-biotin | rel=r_associated | relid=0 | w=101
  3656. ipilimumab -- r_associated #0: 101 / 0.221 -> en:lutetium lu 177 dota-jr11
    n1=ipilimumab | n2=en:lutetium lu 177 dota-jr11 | rel=r_associated | relid=0 | w=101
  3657. ipilimumab -- r_associated #0: 101 / 0.221 -> en:lutetium lu 177 monoclonal antibody j591
    n1=ipilimumab | n2=en:lutetium lu 177 monoclonal antibody j591 | rel=r_associated | relid=0 | w=101
  3658. ipilimumab -- r_associated #0: 101 / 0.221 -> en:lutetium lu 177-dota-di-hsg peptide imp-288
    n1=ipilimumab | n2=en:lutetium lu 177-dota-di-hsg peptide imp-288 | rel=r_associated | relid=0 | w=101
  3659. ipilimumab -- r_associated #0: 101 / 0.221 -> en:lysine-specific demethylase 1 inhibitor incb059872
    n1=ipilimumab | n2=en:lysine-specific demethylase 1 inhibitor incb059872 | rel=r_associated | relid=0 | w=101
  3660. ipilimumab -- r_associated #0: 101 / 0.221 -> en:m87o-transduced cd34+ peripheral blood stem cells
    n1=ipilimumab | n2=en:m87o-transduced cd34+ peripheral blood stem cells | rel=r_associated | relid=0 | w=101
  3661. ipilimumab -- r_associated #0: 101 / 0.221 -> en:mage-a3/hpv 16 peptide vaccine
    n1=ipilimumab | n2=en:mage-a3/hpv 16 peptide vaccine | rel=r_associated | relid=0 | w=101
  3662. ipilimumab -- r_associated #0: 101 / 0.221 -> en:maltose tetrapalmitate
    n1=ipilimumab | n2=en:maltose tetrapalmitate | rel=r_associated | relid=0 | w=101
  3663. ipilimumab -- r_associated #0: 101 / 0.221 -> en:marcellomycin
    n1=ipilimumab | n2=en:marcellomycin | rel=r_associated | relid=0 | w=101
  3664. ipilimumab -- r_associated #0: 101 / 0.221 -> en:marijuana
    n1=ipilimumab | n2=en:marijuana | rel=r_associated | relid=0 | w=101
  3665. ipilimumab -- r_associated #0: 101 / 0.221 -> en:matricaria recutita topical infusion
    n1=ipilimumab | n2=en:matricaria recutita topical infusion | rel=r_associated | relid=0 | w=101
  3666. ipilimumab -- r_associated #0: 101 / 0.221 -> en:mdx-1379 melanoma vaccine
    n1=ipilimumab | n2=en:mdx-1379 melanoma vaccine | rel=r_associated | relid=0 | w=101
  3667. ipilimumab -- r_associated #0: 101 / 0.221 -> en:me-143
    n1=ipilimumab | n2=en:me-143 | rel=r_associated | relid=0 | w=101
  3668. ipilimumab -- r_associated #0: 101 / 0.221 -> en:meclofenamate sodium
    n1=ipilimumab | n2=en:meclofenamate sodium | rel=r_associated | relid=0 | w=101
  3669. ipilimumab -- r_associated #0: 101 / 0.221 -> en:mek inhibitor gdc-0623
    n1=ipilimumab | n2=en:mek inhibitor gdc-0623 | rel=r_associated | relid=0 | w=101
  3670. ipilimumab -- r_associated #0: 101 / 0.221 -> en:melphalan
    n1=ipilimumab | n2=en:melphalan | rel=r_associated | relid=0 | w=101
  3671. ipilimumab -- r_associated #0: 101 / 0.221 -> en:memantine hydrochloride
    n1=ipilimumab | n2=en:memantine hydrochloride | rel=r_associated | relid=0 | w=101
  3672. ipilimumab -- r_associated #0: 101 / 0.221 -> en:menogaril
    n1=ipilimumab | n2=en:menogaril | rel=r_associated | relid=0 | w=101
  3673. ipilimumab -- r_associated #0: 101 / 0.221 -> en:menthol
    n1=ipilimumab | n2=en:menthol | rel=r_associated | relid=0 | w=101
  3674. ipilimumab -- r_associated #0: 101 / 0.221 -> en:meropenem
    n1=ipilimumab | n2=en:meropenem | rel=r_associated | relid=0 | w=101
  3675. ipilimumab -- r_associated #0: 101 / 0.221 -> en:methylselenocysteine
    n1=ipilimumab | n2=en:methylselenocysteine | rel=r_associated | relid=0 | w=101
  3676. ipilimumab -- r_associated #0: 101 / 0.221 -> en:mg 98
    n1=ipilimumab | n2=en:mg 98 | rel=r_associated | relid=0 | w=101
  3677. ipilimumab -- r_associated #0: 101 / 0.221 -> en:micafungin
    n1=ipilimumab | n2=en:micafungin | rel=r_associated | relid=0 | w=101
  3678. ipilimumab -- r_associated #0: 101 / 0.221 -> en:midazolam-containing buccal liquid
    n1=ipilimumab | n2=en:midazolam-containing buccal liquid | rel=r_associated | relid=0 | w=101
  3679. ipilimumab -- r_associated #0: 101 / 0.221 -> en:mifepristone
    n1=ipilimumab | n2=en:mifepristone | rel=r_associated | relid=0 | w=101
  3680. ipilimumab -- r_associated #0: 101 / 0.221 -> en:miglitol
    n1=ipilimumab | n2=en:miglitol | rel=r_associated | relid=0 | w=101
  3681. ipilimumab -- r_associated #0: 101 / 0.221 -> en:miha-loaded pd-l1/l2-silenced dendritic cell vaccine
    n1=ipilimumab | n2=en:miha-loaded pd-l1/l2-silenced dendritic cell vaccine | rel=r_associated | relid=0 | w=101
  3682. ipilimumab -- r_associated #0: 101 / 0.221 -> en:milatuzumab-doxorubicin antibody-drug conjugate
    n1=ipilimumab | n2=en:milatuzumab-doxorubicin antibody-drug conjugate | rel=r_associated | relid=0 | w=101
  3683. ipilimumab -- r_associated #0: 101 / 0.221 -> en:minocycline hydrochloride
    n1=ipilimumab | n2=en:minocycline hydrochloride | rel=r_associated | relid=0 | w=101
  3684. ipilimumab -- r_associated #0: 101 / 0.221 -> en:mirtazapine
    n1=ipilimumab | n2=en:mirtazapine | rel=r_associated | relid=0 | w=101
  3685. ipilimumab -- r_associated #0: 101 / 0.221 -> en:mixed bacteria vaccine
    n1=ipilimumab | n2=en:mixed bacteria vaccine | rel=r_associated | relid=0 | w=101
  3686. ipilimumab -- r_associated #0: 101 / 0.221 -> en:mk0731
    n1=ipilimumab | n2=en:mk0731 | rel=r_associated | relid=0 | w=101
  3687. ipilimumab -- r_associated #0: 101 / 0.221 -> en:mkc-1
    n1=ipilimumab | n2=en:mkc-1 | rel=r_associated | relid=0 | w=101
  3688. ipilimumab -- r_associated #0: 101 / 0.221 -> en:modified vaccinia virus ankara vaccine expressing p53
    n1=ipilimumab | n2=en:modified vaccinia virus ankara vaccine expressing p53 | rel=r_associated | relid=0 | w=101
  3689. ipilimumab -- r_associated #0: 101 / 0.221 -> en:monobenzone
    n1=ipilimumab | n2=en:monobenzone | rel=r_associated | relid=0 | w=101
  3690. ipilimumab -- r_associated #0: 101 / 0.221 -> en:monoclonal antibody 11d10
    n1=ipilimumab | n2=en:monoclonal antibody 11d10 | rel=r_associated | relid=0 | w=101
  3691. ipilimumab -- r_associated #0: 101 / 0.221 -> en:monoclonal antibody d6.12
    n1=ipilimumab | n2=en:monoclonal antibody d6.12 | rel=r_associated | relid=0 | w=101
  3692. ipilimumab -- r_associated #0: 101 / 0.221 -> en:monoclonal t-cell receptor anti-cd3 scfv fusion protein imcgp100
    n1=ipilimumab | n2=en:monoclonal t-cell receptor anti-cd3 scfv fusion protein imcgp100 | rel=r_associated | relid=0 | w=101
  3693. ipilimumab -- r_associated #0: 101 / 0.221 -> en:montanide isa 720
    n1=ipilimumab | n2=en:montanide isa 720 | rel=r_associated | relid=0 | w=101
  3694. ipilimumab -- r_associated #0: 101 / 0.221 -> en:mosapride
    n1=ipilimumab | n2=en:mosapride | rel=r_associated | relid=0 | w=101
  3695. ipilimumab -- r_associated #0: 101 / 0.221 -> en:motesanib diphosphate
    n1=ipilimumab | n2=en:motesanib diphosphate | rel=r_associated | relid=0 | w=101
  3696. ipilimumab -- r_associated #0: 101 / 0.221 -> en:motexafin gadolinium
    n1=ipilimumab | n2=en:motexafin gadolinium | rel=r_associated | relid=0 | w=101
  3697. ipilimumab -- r_associated #0: 101 / 0.221 -> en:mrna-derived prostate cancer vaccine cv9104
    n1=ipilimumab | n2=en:mrna-derived prostate cancer vaccine cv9104 | rel=r_associated | relid=0 | w=101
  3698. ipilimumab -- r_associated #0: 101 / 0.221 -> en:muc-1 antigen
    n1=ipilimumab | n2=en:muc-1 antigen | rel=r_associated | relid=0 | w=101
  3699. ipilimumab -- r_associated #0: 101 / 0.221 -> en:multi-agc kinase inhibitor at13148
    n1=ipilimumab | n2=en:multi-agc kinase inhibitor at13148 | rel=r_associated | relid=0 | w=101
  3700. ipilimumab -- r_associated #0: 101 / 0.221 -> en:muscadine grape skin extract
    n1=ipilimumab | n2=en:muscadine grape skin extract | rel=r_associated | relid=0 | w=101
  3701. ipilimumab -- r_associated #0: 101 / 0.221 -> en:mutant p53 peptide pulsed dendritic cell vaccine
    n1=ipilimumab | n2=en:mutant p53 peptide pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=101
  3702. ipilimumab -- r_associated #0: 101 / 0.221 -> en:mva-muc1-il2 vaccine
    n1=ipilimumab | n2=en:mva-muc1-il2 vaccine | rel=r_associated | relid=0 | w=101
  3703. ipilimumab -- r_associated #0: 101 / 0.221 -> en:nanocell-encapsulated mir-16-based microrna mimic
    n1=ipilimumab | n2=en:nanocell-encapsulated mir-16-based microrna mimic | rel=r_associated | relid=0 | w=101
  3704. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ncmtrna oligonucleotide andes-1537
    n1=ipilimumab | n2=en:ncmtrna oligonucleotide andes-1537 | rel=r_associated | relid=0 | w=101
  3705. ipilimumab -- r_associated #0: 101 / 0.221 -> en:necitumumab
    n1=ipilimumab | n2=en:necitumumab | rel=r_associated | relid=0 | w=101
  3706. ipilimumab -- r_associated #0: 101 / 0.221 -> en:nepidermin
    n1=ipilimumab | n2=en:nepidermin | rel=r_associated | relid=0 | w=101
  3707. ipilimumab -- r_associated #0: 101 / 0.221 -> en:nesvacumab
    n1=ipilimumab | n2=en:nesvacumab | rel=r_associated | relid=0 | w=101
  3708. ipilimumab -- r_associated #0: 101 / 0.221 -> en:netupitant/palonosetron hydrochloride
    n1=ipilimumab | n2=en:netupitant/palonosetron hydrochloride | rel=r_associated | relid=0 | w=101
  3709. ipilimumab -- r_associated #0: 101 / 0.221 -> en:neutrophil activation probe imaging agent
    n1=ipilimumab | n2=en:neutrophil activation probe imaging agent | rel=r_associated | relid=0 | w=101
  3710. ipilimumab -- r_associated #0: 101 / 0.221 -> en:nicotine
    n1=ipilimumab | n2=en:nicotine | rel=r_associated | relid=0 | w=101
  3711. ipilimumab -- r_associated #0: 101 / 0.221 -> en:nicotine lozenge
    n1=ipilimumab | n2=en:nicotine lozenge | rel=r_associated | relid=0 | w=101
  3712. ipilimumab -- r_associated #0: 101 / 0.221 -> en:nicotine nasal spray
    n1=ipilimumab | n2=en:nicotine nasal spray | rel=r_associated | relid=0 | w=101
  3713. ipilimumab -- r_associated #0: 101 / 0.221 -> en:nimodipine
    n1=ipilimumab | n2=en:nimodipine | rel=r_associated | relid=0 | w=101
  3714. ipilimumab -- r_associated #0: 101 / 0.221 -> en:nimorazole
    n1=ipilimumab | n2=en:nimorazole | rel=r_associated | relid=0 | w=101
  3715. ipilimumab -- r_associated #0: 101 / 0.221 -> en:niraparib
    n1=ipilimumab | n2=en:niraparib | rel=r_associated | relid=0 | w=101
  3716. ipilimumab -- r_associated #0: 101 / 0.221 -> en:nitroglycerin
    n1=ipilimumab | n2=en:nitroglycerin | rel=r_associated | relid=0 | w=101
  3717. ipilimumab -- r_associated #0: 101 / 0.221 -> en:nitroglycerin/sodium citrate/ethanol solution
    n1=ipilimumab | n2=en:nitroglycerin/sodium citrate/ethanol solution | rel=r_associated | relid=0 | w=101
  3718. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ntrk/ros1 inhibitor ds-6051b
    n1=ipilimumab | n2=en:ntrk/ros1 inhibitor ds-6051b | rel=r_associated | relid=0 | w=101
  3719. ipilimumab -- r_associated #0: 101 / 0.221 -> en:oblimersen sodium
    n1=ipilimumab | n2=en:oblimersen sodium | rel=r_associated | relid=0 | w=101
  3720. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ocular dosage form product
    n1=ipilimumab | n2=en:ocular dosage form product | rel=r_associated | relid=0 | w=101
  3721. ipilimumab -- r_associated #0: 101 / 0.221 -> en:oligofructose-enriched inulin
    n1=ipilimumab | n2=en:oligofructose-enriched inulin | rel=r_associated | relid=0 | w=101
  3722. ipilimumab -- r_associated #0: 101 / 0.221 -> en:olive oil/soya oil/egg lecithin-based emulsion
    n1=ipilimumab | n2=en:olive oil/soya oil/egg lecithin-based emulsion | rel=r_associated | relid=0 | w=101
  3723. ipilimumab -- r_associated #0: 101 / 0.221 -> en:omalizumab
    n1=ipilimumab | n2=en:omalizumab | rel=r_associated | relid=0 | w=101
  3724. ipilimumab -- r_associated #0: 101 / 0.221 -> en:omiganan pentahydrochloride
    n1=ipilimumab | n2=en:omiganan pentahydrochloride | rel=r_associated | relid=0 | w=101
  3725. ipilimumab -- r_associated #0: 101 / 0.221 -> en:oncolytic herpes simplex virus-1-encoding gm-csf
    n1=ipilimumab | n2=en:oncolytic herpes simplex virus-1-encoding gm-csf | rel=r_associated | relid=0 | w=101
  3726. ipilimumab -- r_associated #0: 101 / 0.221 -> en:opb-111001
    n1=ipilimumab | n2=en:opb-111001 | rel=r_associated | relid=0 | w=101
  3727. ipilimumab -- r_associated #0: 101 / 0.221 -> en:opebacan
    n1=ipilimumab | n2=en:opebacan | rel=r_associated | relid=0 | w=101
  3728. ipilimumab -- r_associated #0: 101 / 0.221 -> en:oral aminolevulinic acid hydrochloride
    n1=ipilimumab | n2=en:oral aminolevulinic acid hydrochloride | rel=r_associated | relid=0 | w=101
  3729. ipilimumab -- r_associated #0: 101 / 0.221 -> en:oral dosage form product
    n1=ipilimumab | n2=en:oral dosage form product | rel=r_associated | relid=0 | w=101
  3730. ipilimumab -- r_associated #0: 101 / 0.221 -> en:oraxol
    n1=ipilimumab | n2=en:oraxol | rel=r_associated | relid=0 | w=101
  3731. ipilimumab -- r_associated #0: 101 / 0.221 -> en:osi-7904l
    n1=ipilimumab | n2=en:osi-7904l | rel=r_associated | relid=0 | w=101
  3732. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ovapuldencel-t
    n1=ipilimumab | n2=en:ovapuldencel-t | rel=r_associated | relid=0 | w=101
  3733. ipilimumab -- r_associated #0: 101 / 0.221 -> en:oxacillin sodium
    n1=ipilimumab | n2=en:oxacillin sodium | rel=r_associated | relid=0 | w=101
  3734. ipilimumab -- r_associated #0: 101 / 0.221 -> en:p110beta/delta pi3k inhibitor gs-9820
    n1=ipilimumab | n2=en:p110beta/delta pi3k inhibitor gs-9820 | rel=r_associated | relid=0 | w=101
  3735. ipilimumab -- r_associated #0: 101 / 0.221 -> en:p53-synthetic long peptides vaccine
    n1=ipilimumab | n2=en:p53-synthetic long peptides vaccine | rel=r_associated | relid=0 | w=101
  3736. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pacritinib
    n1=ipilimumab | n2=en:pacritinib | rel=r_associated | relid=0 | w=101
  3737. ipilimumab -- r_associated #0: 101 / 0.221 -> en:palivizumab
    n1=ipilimumab | n2=en:palivizumab | rel=r_associated | relid=0 | w=101
  3738. ipilimumab -- r_associated #0: 101 / 0.221 -> en:palladium pd-103
    n1=ipilimumab | n2=en:palladium pd-103 | rel=r_associated | relid=0 | w=101
  3739. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pan fgfr kinase inhibitor bgj398
    n1=ipilimumab | n2=en:pan fgfr kinase inhibitor bgj398 | rel=r_associated | relid=0 | w=101
  3740. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pan her/vegfr2 receptor tyrosine kinase inhibitor bms-690514
    n1=ipilimumab | n2=en:pan her/vegfr2 receptor tyrosine kinase inhibitor bms-690514 | rel=r_associated | relid=0 | w=101
  3741. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pan-her kinase inhibitor ac480
    n1=ipilimumab | n2=en:pan-her kinase inhibitor ac480 | rel=r_associated | relid=0 | w=101
  3742. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pan-pi3k inhibitor clr457
    n1=ipilimumab | n2=en:pan-pi3k inhibitor clr457 | rel=r_associated | relid=0 | w=101
  3743. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pan-raf inhibitor lxh254
    n1=ipilimumab | n2=en:pan-raf inhibitor lxh254 | rel=r_associated | relid=0 | w=101
  3744. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pancrelipase
    n1=ipilimumab | n2=en:pancrelipase | rel=r_associated | relid=0 | w=101
  3745. ipilimumab -- r_associated #0: 101 / 0.221 -> en:parp 1/2 inhibitor e7449
    n1=ipilimumab | n2=en:parp 1/2 inhibitor e7449 | rel=r_associated | relid=0 | w=101
  3746. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pcnu
    n1=ipilimumab | n2=en:pcnu | rel=r_associated | relid=0 | w=101
  3747. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pdk1 inhibitor ar-12
    n1=ipilimumab | n2=en:pdk1 inhibitor ar-12 | rel=r_associated | relid=0 | w=101
  3748. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pegaspargase
    n1=ipilimumab | n2=en:pegaspargase | rel=r_associated | relid=0 | w=101
  3749. ipilimumab -- r_associated #0: 101 / 0.221 -> en:peginesatide
    n1=ipilimumab | n2=en:peginesatide | rel=r_associated | relid=0 | w=101
  3750. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pegylated arginine deiminase
    n1=ipilimumab | n2=en:pegylated arginine deiminase | rel=r_associated | relid=0 | w=101
  3751. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pegylated liposomal nanoparticle-based docetaxel prodrug mnk-010
    n1=ipilimumab | n2=en:pegylated liposomal nanoparticle-based docetaxel prodrug mnk-010 | rel=r_associated | relid=0 | w=101
  3752. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pegylated recombinant human arginase i bct-100
    n1=ipilimumab | n2=en:pegylated recombinant human arginase i bct-100 | rel=r_associated | relid=0 | w=101
  3753. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pelitrexol
    n1=ipilimumab | n2=en:pelitrexol | rel=r_associated | relid=0 | w=101
  3754. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pentosan polysulfate sodium
    n1=ipilimumab | n2=en:pentosan polysulfate sodium | rel=r_associated | relid=0 | w=101
  3755. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pep-3-klh conjugate vaccine
    n1=ipilimumab | n2=en:pep-3-klh conjugate vaccine | rel=r_associated | relid=0 | w=101
  3756. ipilimumab -- r_associated #0: 101 / 0.221 -> en:peplomycin
    n1=ipilimumab | n2=en:peplomycin | rel=r_associated | relid=0 | w=101
  3757. ipilimumab -- r_associated #0: 101 / 0.221 -> en:perflenapent emulsion
    n1=ipilimumab | n2=en:perflenapent emulsion | rel=r_associated | relid=0 | w=101
  3758. ipilimumab -- r_associated #0: 101 / 0.221 -> en:perflutren protein-type a microspheres
    n1=ipilimumab | n2=en:perflutren protein-type a microspheres | rel=r_associated | relid=0 | w=101
  3759. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pharmaceutical fluid or solution agent
    n1=ipilimumab | n2=en:pharmaceutical fluid or solution agent | rel=r_associated | relid=0 | w=101
  3760. ipilimumab -- r_associated #0: 101 / 0.221 -> en:phenethyl isothiocyanate-containing watercress juice
    n1=ipilimumab | n2=en:phenethyl isothiocyanate-containing watercress juice | rel=r_associated | relid=0 | w=101
  3761. ipilimumab -- r_associated #0: 101 / 0.221 -> en:phenformin hydrochloride
    n1=ipilimumab | n2=en:phenformin hydrochloride | rel=r_associated | relid=0 | w=101
  3762. ipilimumab -- r_associated #0: 101 / 0.221 -> en:phosphorus p-32
    n1=ipilimumab | n2=en:phosphorus p-32 | rel=r_associated | relid=0 | w=101
  3763. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pi3k delta/gamma inhibitor ipi-145
    n1=ipilimumab | n2=en:pi3k delta/gamma inhibitor ipi-145 | rel=r_associated | relid=0 | w=101
  3764. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pi3k inhibitor acp-319
    n1=ipilimumab | n2=en:pi3k inhibitor acp-319 | rel=r_associated | relid=0 | w=101
  3765. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pi3k inhibitor zstk474
    n1=ipilimumab | n2=en:pi3k inhibitor zstk474 | rel=r_associated | relid=0 | w=101
  3766. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pi3k/mtor inhibitor bez235
    n1=ipilimumab | n2=en:pi3k/mtor inhibitor bez235 | rel=r_associated | relid=0 | w=101
  3767. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pi3k/mtor/alk-1/dna-pk inhibitor p7170
    n1=ipilimumab | n2=en:pi3k/mtor/alk-1/dna-pk inhibitor p7170 | rel=r_associated | relid=0 | w=101
  3768. ipilimumab -- r_associated #0: 101 / 0.221 -> en:picoplatin
    n1=ipilimumab | n2=en:picoplatin | rel=r_associated | relid=0 | w=101
  3769. ipilimumab -- r_associated #0: 101 / 0.221 -> en:piroxantrone
    n1=ipilimumab | n2=en:piroxantrone | rel=r_associated | relid=0 | w=101
  3770. ipilimumab -- r_associated #0: 101 / 0.221 -> en:plasmid encoding antiangiogenic metargidin peptide
    n1=ipilimumab | n2=en:plasmid encoding antiangiogenic metargidin peptide | rel=r_associated | relid=0 | w=101
  3771. ipilimumab -- r_associated #0: 101 / 0.221 -> en:plinabulin
    n1=ipilimumab | n2=en:plinabulin | rel=r_associated | relid=0 | w=101
  3772. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pm00104
    n1=ipilimumab | n2=en:pm00104 | rel=r_associated | relid=0 | w=101
  3773. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pneumococcal 13-valent conjugate vaccine
    n1=ipilimumab | n2=en:pneumococcal 13-valent conjugate vaccine | rel=r_associated | relid=0 | w=101
  3774. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pneumococcal 7-valent conjugate vaccine
    n1=ipilimumab | n2=en:pneumococcal 7-valent conjugate vaccine | rel=r_associated | relid=0 | w=101
  3775. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pnp-expressing ovine atadenovirus fp253
    n1=ipilimumab | n2=en:pnp-expressing ovine atadenovirus fp253 | rel=r_associated | relid=0 | w=101
  3776. ipilimumab -- r_associated #0: 101 / 0.221 -> en:poly au
    n1=ipilimumab | n2=en:poly au | rel=r_associated | relid=0 | w=101
  3777. ipilimumab -- r_associated #0: 101 / 0.221 -> en:polyamine synthesis inhibitor
    n1=ipilimumab | n2=en:polyamine synthesis inhibitor | rel=r_associated | relid=0 | w=101
  3778. ipilimumab -- r_associated #0: 101 / 0.221 -> en:polyunsaturated fatty acid
    n1=ipilimumab | n2=en:polyunsaturated fatty acid | rel=r_associated | relid=0 | w=101
  3779. ipilimumab -- r_associated #0: 101 / 0.221 -> en:prima-1 analog apr-246
    n1=ipilimumab | n2=en:prima-1 analog apr-246 | rel=r_associated | relid=0 | w=101
  3780. ipilimumab -- r_associated #0: 101 / 0.221 -> en:prinomastat
    n1=ipilimumab | n2=en:prinomastat | rel=r_associated | relid=0 | w=101
  3781. ipilimumab -- r_associated #0: 101 / 0.221 -> en:promethazine hydrochloride
    n1=ipilimumab | n2=en:promethazine hydrochloride | rel=r_associated | relid=0 | w=101
  3782. ipilimumab -- r_associated #0: 101 / 0.221 -> en:prostate cancer vaccine pf-06755990
    n1=ipilimumab | n2=en:prostate cancer vaccine pf-06755990 | rel=r_associated | relid=0 | w=101
  3783. ipilimumab -- r_associated #0: 101 / 0.221 -> en:protein stabilized liposomal docetaxel nanoparticles
    n1=ipilimumab | n2=en:protein stabilized liposomal docetaxel nanoparticles | rel=r_associated | relid=0 | w=101
  3784. ipilimumab -- r_associated #0: 101 / 0.221 -> en:protein tyrosine kinase 2 inhibitor bi 853520
    n1=ipilimumab | n2=en:protein tyrosine kinase 2 inhibitor bi 853520 | rel=r_associated | relid=0 | w=101
  3785. ipilimumab -- r_associated #0: 101 / 0.221 -> en:psma-targeted tubulysin b-containing conjugate ec1169
    n1=ipilimumab | n2=en:psma-targeted tubulysin b-containing conjugate ec1169 | rel=r_associated | relid=0 | w=101
  3786. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ptef-b/cdk9 inhibitor bay1251152
    n1=ipilimumab | n2=en:ptef-b/cdk9 inhibitor bay1251152 | rel=r_associated | relid=0 | w=101
  3787. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pyrazinamide
    n1=ipilimumab | n2=en:pyrazinamide | rel=r_associated | relid=0 | w=101
  3788. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pyrazoloacridine
    n1=ipilimumab | n2=en:pyrazoloacridine | rel=r_associated | relid=0 | w=101
  3789. ipilimumab -- r_associated #0: 101 / 0.221 -> en:pyridyl cyanoguanidine chs 828
    n1=ipilimumab | n2=en:pyridyl cyanoguanidine chs 828 | rel=r_associated | relid=0 | w=101
  3790. ipilimumab -- r_associated #0: 101 / 0.221 -> en:quinidine
    n1=ipilimumab | n2=en:quinidine | rel=r_associated | relid=0 | w=101
  3791. ipilimumab -- r_associated #0: 101 / 0.221 -> en:r-ice regimen
    n1=ipilimumab | n2=en:r-ice regimen | rel=r_associated | relid=0 | w=101
  3792. ipilimumab -- r_associated #0: 101 / 0.221 -> en:radiopharmaceutical agent
    n1=ipilimumab | n2=en:radiopharmaceutical agent | rel=r_associated | relid=0 | w=101
  3793. ipilimumab -- r_associated #0: 101 / 0.221 -> en:radiosensitizer rrx-001
    n1=ipilimumab | n2=en:radiosensitizer rrx-001 | rel=r_associated | relid=0 | w=101
  3794. ipilimumab -- r_associated #0: 101 / 0.221 -> en:radium ra 223 dichloride
    n1=ipilimumab | n2=en:radium ra 223 dichloride | rel=r_associated | relid=0 | w=101
  3795. ipilimumab -- r_associated #0: 101 / 0.221 -> en:radix angelicae sinensis/radix astragali herbal supplement
    n1=ipilimumab | n2=en:radix angelicae sinensis/radix astragali herbal supplement | rel=r_associated | relid=0 | w=101
  3796. ipilimumab -- r_associated #0: 101 / 0.221 -> en:raltitrexed
    n1=ipilimumab | n2=en:raltitrexed | rel=r_associated | relid=0 | w=101
  3797. ipilimumab -- r_associated #0: 101 / 0.221 -> en:rapamycin-polarized th1/tc1 autologous t lymphocytes
    n1=ipilimumab | n2=en:rapamycin-polarized th1/tc1 autologous t lymphocytes | rel=r_associated | relid=0 | w=101
  3798. ipilimumab -- r_associated #0: 101 / 0.221 -> en:realgar-indigo naturalis formulation
    n1=ipilimumab | n2=en:realgar-indigo naturalis formulation | rel=r_associated | relid=0 | w=101
  3799. ipilimumab -- r_associated #0: 101 / 0.221 -> en:recombinant dher2 vaccine
    n1=ipilimumab | n2=en:recombinant dher2 vaccine | rel=r_associated | relid=0 | w=101
  3800. ipilimumab -- r_associated #0: 101 / 0.221 -> en:recombinant fowlpox-b7.1 vaccine
    n1=ipilimumab | n2=en:recombinant fowlpox-b7.1 vaccine | rel=r_associated | relid=0 | w=101
  3801. ipilimumab -- r_associated #0: 101 / 0.221 -> en:recombinant fowlpox-tricom vaccine
    n1=ipilimumab | n2=en:recombinant fowlpox-tricom vaccine | rel=r_associated | relid=0 | w=101
  3802. ipilimumab -- r_associated #0: 101 / 0.221 -> en:recombinant fowlpox-tyrosinase vaccine
    n1=ipilimumab | n2=en:recombinant fowlpox-tyrosinase vaccine | rel=r_associated | relid=0 | w=101
  3803. ipilimumab -- r_associated #0: 101 / 0.221 -> en:recombinant interferon alfa-1b
    n1=ipilimumab | n2=en:recombinant interferon alfa-1b | rel=r_associated | relid=0 | w=101
  3804. ipilimumab -- r_associated #0: 101 / 0.221 -> en:recombinant interleukin-12
    n1=ipilimumab | n2=en:recombinant interleukin-12 | rel=r_associated | relid=0 | w=101
  3805. ipilimumab -- r_associated #0: 101 / 0.221 -> en:recombinant interleukin-7
    n1=ipilimumab | n2=en:recombinant interleukin-7 | rel=r_associated | relid=0 | w=101
  3806. ipilimumab -- r_associated #0: 101 / 0.221 -> en:recombinant soluble t4
    n1=ipilimumab | n2=en:recombinant soluble t4 | rel=r_associated | relid=0 | w=101
  3807. ipilimumab -- r_associated #0: 101 / 0.221 -> en:recombinant vaccinia df3/muc1 vaccine
    n1=ipilimumab | n2=en:recombinant vaccinia df3/muc1 vaccine | rel=r_associated | relid=0 | w=101
  3808. ipilimumab -- r_associated #0: 101 / 0.221 -> en:recombinant vaccinia-multiepitope melanoma peptides-b7.1-b7.2 vaccine
    n1=ipilimumab | n2=en:recombinant vaccinia-multiepitope melanoma peptides-b7.1-b7.2 vaccine | rel=r_associated | relid=0 | w=101
  3809. ipilimumab -- r_associated #0: 101 / 0.221 -> en:red tomato juice
    n1=ipilimumab | n2=en:red tomato juice | rel=r_associated | relid=0 | w=101
  3810. ipilimumab -- r_associated #0: 101 / 0.221 -> en:replacement agent
    n1=ipilimumab | n2=en:replacement agent | rel=r_associated | relid=0 | w=101
  3811. ipilimumab -- r_associated #0: 101 / 0.221 -> en:respiratory system agents
    n1=ipilimumab | n2=en:respiratory system agents | rel=r_associated | relid=0 | w=101
  3812. ipilimumab -- r_associated #0: 101 / 0.221 -> en:rexinoid nrx 194204
    n1=ipilimumab | n2=en:rexinoid nrx 194204 | rel=r_associated | relid=0 | w=101
  3813. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ribozyme rpi.4610
    n1=ipilimumab | n2=en:ribozyme rpi.4610 | rel=r_associated | relid=0 | w=101
  3814. ipilimumab -- r_associated #0: 101 / 0.221 -> en:rifaximin
    n1=ipilimumab | n2=en:rifaximin | rel=r_associated | relid=0 | w=101
  3815. ipilimumab -- r_associated #0: 101 / 0.221 -> en:rilimogene galvacirepvec
    n1=ipilimumab | n2=en:rilimogene galvacirepvec | rel=r_associated | relid=0 | w=101
  3816. ipilimumab -- r_associated #0: 101 / 0.221 -> en:romiplostim
    n1=ipilimumab | n2=en:romiplostim | rel=r_associated | relid=0 | w=101
  3817. ipilimumab -- r_associated #0: 101 / 0.221 -> en:ropivacaine hydrochloride
    n1=ipilimumab | n2=en:ropivacaine hydrochloride | rel=r_associated | relid=0 | w=101
  3818. ipilimumab -- r_associated #0: 101 / 0.221 -> en:rosiglitazone maleate
    n1=ipilimumab | n2=en:rosiglitazone maleate | rel=r_associated | relid=0 | w=101
  3819. ipilimumab -- r_associated #0: 101 / 0.221 -> en:salirasib
    n1=ipilimumab | n2=en:salirasib | rel=r_associated | relid=0 | w=101
  3820. ipilimumab -- r_associated #0: 101 / 0.221 -> en:salvia hispanica seed
    n1=ipilimumab | n2=en:salvia hispanica seed | rel=r_associated | relid=0 | w=101
  3821. ipilimumab -- r_associated #0: 101 / 0.221 -> en:sapitinib
    n1=ipilimumab | n2=en:sapitinib | rel=r_associated | relid=0 | w=101
  3822. ipilimumab -- r_associated #0: 101 / 0.221 -> en:saquinavir mesylate
    n1=ipilimumab | n2=en:saquinavir mesylate | rel=r_associated | relid=0 | w=101
  3823. ipilimumab -- r_associated #0: 101 / 0.221 -> en:sargramostim plasmid dna sarcoma vaccine
    n1=ipilimumab | n2=en:sargramostim plasmid dna sarcoma vaccine | rel=r_associated | relid=0 | w=101
  3824. ipilimumab -- r_associated #0: 101 / 0.221 -> en:saridegib
    n1=ipilimumab | n2=en:saridegib | rel=r_associated | relid=0 | w=101
  3825. ipilimumab -- r_associated #0: 101 / 0.221 -> en:selective estrogen receptor degrader azd9496
    n1=ipilimumab | n2=en:selective estrogen receptor degrader azd9496 | rel=r_associated | relid=0 | w=101
  3826. ipilimumab -- r_associated #0: 101 / 0.221 -> en:seneca valley virus-001
    n1=ipilimumab | n2=en:seneca valley virus-001 | rel=r_associated | relid=0 | w=101
  3827. ipilimumab -- r_associated #0: 101 / 0.221 -> en:shark cartilage extract ae-941
    n1=ipilimumab | n2=en:shark cartilage extract ae-941 | rel=r_associated | relid=0 | w=101
  3828. ipilimumab -- r_associated #0: 101 / 0.221 -> en:sivifene
    n1=ipilimumab | n2=en:sivifene | rel=r_associated | relid=0 | w=101
  3829. ipilimumab -- r_associated #0: 101 / 0.221 -> en:skeletal muscle relaxants
    n1=ipilimumab | n2=en:skeletal muscle relaxants | rel=r_associated | relid=0 | w=101
  3830. ipilimumab -- r_associated #0: 101 / 0.221 -> en:sodium phenylbutyrate
    n1=ipilimumab | n2=en:sodium phenylbutyrate | rel=r_associated | relid=0 | w=101
  3831. ipilimumab -- r_associated #0: 101 / 0.221 -> en:spiroplatin
    n1=ipilimumab | n2=en:spiroplatin | rel=r_associated | relid=0 | w=101
  3832. ipilimumab -- r_associated #0: 101 / 0.221 -> en:st. john's wort
    n1=ipilimumab | n2=en:st. john's wort | rel=r_associated | relid=0 | w=101
  3833. ipilimumab -- r_associated #0: 101 / 0.221 -> en:standardized freeze-dried table grape powder
    n1=ipilimumab | n2=en:standardized freeze-dried table grape powder | rel=r_associated | relid=0 | w=101
  3834. ipilimumab -- r_associated #0: 101 / 0.221 -> en:stanozolol
    n1=ipilimumab | n2=en:stanozolol | rel=r_associated | relid=0 | w=101
  3835. ipilimumab -- r_associated #0: 101 / 0.221 -> en:sufentanil transdermal system
    n1=ipilimumab | n2=en:sufentanil transdermal system | rel=r_associated | relid=0 | w=101
  3836. ipilimumab -- r_associated #0: 101 / 0.221 -> en:suramin
    n1=ipilimumab | n2=en:suramin | rel=r_associated | relid=0 | w=101
  3837. ipilimumab -- r_associated #0: 101 / 0.221 -> en:suvorexant
    n1=ipilimumab | n2=en:suvorexant | rel=r_associated | relid=0 | w=101
  3838. ipilimumab -- r_associated #0: 101 / 0.221 -> en:synthetic antiandrogen
    n1=ipilimumab | n2=en:synthetic antiandrogen | rel=r_associated | relid=0 | w=101
  3839. ipilimumab -- r_associated #0: 101 / 0.221 -> en:synthetic breast cancer peptides-tetanus toxoid-poly iclc vaccine
    n1=ipilimumab | n2=en:synthetic breast cancer peptides-tetanus toxoid-poly iclc vaccine | rel=r_associated | relid=0 | w=101
  3840. ipilimumab -- r_associated #0: 101 / 0.221 -> en:synthetic long e6/e7 peptides vaccine hpv-01
    n1=ipilimumab | n2=en:synthetic long e6/e7 peptides vaccine hpv-01 | rel=r_associated | relid=0 | w=101
  3841. ipilimumab -- r_associated #0: 101 / 0.221 -> en:tamibarotene
    n1=ipilimumab | n2=en:tamibarotene | rel=r_associated | relid=0 | w=101
  3842. ipilimumab -- r_associated #0: 101 / 0.221 -> en:tazemetostat
    n1=ipilimumab | n2=en:tazemetostat | rel=r_associated | relid=0 | w=101
  3843. ipilimumab -- r_associated #0: 101 / 0.221 -> en:technetium tc 99m-labeled tilmanocept
    n1=ipilimumab | n2=en:technetium tc 99m-labeled tilmanocept | rel=r_associated | relid=0 | w=101
  3844. ipilimumab -- r_associated #0: 101 / 0.221 -> en:technetium tc-99m albumin aggregated
    n1=ipilimumab | n2=en:technetium tc-99m albumin aggregated | rel=r_associated | relid=0 | w=101
  3845. ipilimumab -- r_associated #0: 101 / 0.221 -> en:technetium tc-99m glycopeptide
    n1=ipilimumab | n2=en:technetium tc-99m glycopeptide | rel=r_associated | relid=0 | w=101
  3846. ipilimumab -- r_associated #0: 101 / 0.221 -> en:technetium tc-99m human serum albumin colloid
    n1=ipilimumab | n2=en:technetium tc-99m human serum albumin colloid | rel=r_associated | relid=0 | w=101
  3847. ipilimumab -- r_associated #0: 101 / 0.221 -> en:technetium tc-99m sodium pertechnetate
    n1=ipilimumab | n2=en:technetium tc-99m sodium pertechnetate | rel=r_associated | relid=0 | w=101
  3848. ipilimumab -- r_associated #0: 101 / 0.221 -> en:telapristone acetate
    n1=ipilimumab | n2=en:telapristone acetate | rel=r_associated | relid=0 | w=101
  3849. ipilimumab -- r_associated #0: 101 / 0.221 -> en:telatinib mesylate
    n1=ipilimumab | n2=en:telatinib mesylate | rel=r_associated | relid=0 | w=101
  3850. ipilimumab -- r_associated #0: 101 / 0.221 -> en:temozolomide
    n1=ipilimumab | n2=en:temozolomide | rel=r_associated | relid=0 | w=101
  3851. ipilimumab -- r_associated #0: 101 / 0.221 -> en:teprotumumab
    n1=ipilimumab | n2=en:teprotumumab | rel=r_associated | relid=0 | w=101
  3852. ipilimumab -- r_associated #0: 101 / 0.221 -> en:terephthalamidine
    n1=ipilimumab | n2=en:terephthalamidine | rel=r_associated | relid=0 | w=101
  3853. ipilimumab -- r_associated #0: 101 / 0.221 -> en:tergenpumatucel-l
    n1=ipilimumab | n2=en:tergenpumatucel-l | rel=r_associated | relid=0 | w=101
  3854. ipilimumab -- r_associated #0: 101 / 0.221 -> en:teroxirone
    n1=ipilimumab | n2=en:teroxirone | rel=r_associated | relid=0 | w=101
  3855. ipilimumab -- r_associated #0: 101 / 0.221 -> en:testosterone cypionate
    n1=ipilimumab | n2=en:testosterone cypionate | rel=r_associated | relid=0 | w=101
  3856. ipilimumab -- r_associated #0: 101 / 0.221 -> en:tetracycline antibiotic
    n1=ipilimumab | n2=en:tetracycline antibiotic | rel=r_associated | relid=0 | w=101
  3857. ipilimumab -- r_associated #0: 101 / 0.221 -> en:tetracycline hydrochloride
    n1=ipilimumab | n2=en:tetracycline hydrochloride | rel=r_associated | relid=0 | w=101
  3858. ipilimumab -- r_associated #0: 101 / 0.221 -> en:tetradecanoylphorbol acetate
    n1=ipilimumab | n2=en:tetradecanoylphorbol acetate | rel=r_associated | relid=0 | w=101
  3859. ipilimumab -- r_associated #0: 101 / 0.221 -> en:tetrahydrouridine
    n1=ipilimumab | n2=en:tetrahydrouridine | rel=r_associated | relid=0 | w=101
  3860. ipilimumab -- r_associated #0: 101 / 0.221 -> en:tgf-beta-resistant lmp-specific cytotoxic t-lymphocytes
    n1=ipilimumab | n2=en:tgf-beta-resistant lmp-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=101
  3861. ipilimumab -- r_associated #0: 101 / 0.221 -> en:thalidomide
    n1=ipilimumab | n2=en:thalidomide | rel=r_associated | relid=0 | w=101
  3862. ipilimumab -- r_associated #0: 101 / 0.221 -> en:therapeutic tumor infiltrating lymphocytes
    n1=ipilimumab | n2=en:therapeutic tumor infiltrating lymphocytes | rel=r_associated | relid=0 | w=101
  3863. ipilimumab -- r_associated #0: 101 / 0.221 -> en:thomsen-friedenreich antigen
    n1=ipilimumab | n2=en:thomsen-friedenreich antigen | rel=r_associated | relid=0 | w=101
  3864. ipilimumab -- r_associated #0: 101 / 0.221 -> en:thyroid extract
    n1=ipilimumab | n2=en:thyroid extract | rel=r_associated | relid=0 | w=101
  3865. ipilimumab -- r_associated #0: 101 / 0.221 -> en:tigatuzumab
    n1=ipilimumab | n2=en:tigatuzumab | rel=r_associated | relid=0 | w=101
  3866. ipilimumab -- r_associated #0: 101 / 0.221 -> en:tin ethyl etiopurpurin
    n1=ipilimumab | n2=en:tin ethyl etiopurpurin | rel=r_associated | relid=0 | w=101
  3867. ipilimumab -- r_associated #0: 101 / 0.221 -> en:tirapazamine
    n1=ipilimumab | n2=en:tirapazamine | rel=r_associated | relid=0 | w=101
  3868. ipilimumab -- r_associated #0: 101 / 0.221 -> en:tolazamide
    n1=ipilimumab | n2=en:tolazamide | rel=r_associated | relid=0 | w=101
  3869. ipilimumab -- r_associated #0: 101 / 0.221 -> en:tolnidamine
    n1=ipilimumab | n2=en:tolnidamine | rel=r_associated | relid=0 | w=101
  3870. ipilimumab -- r_associated #0: 101 / 0.221 -> en:tolvaptan
    n1=ipilimumab | n2=en:tolvaptan | rel=r_associated | relid=0 | w=101
  3871. ipilimumab -- r_associated #0: 101 / 0.221 -> en:topical cocaine hydrochloride
    n1=ipilimumab | n2=en:topical cocaine hydrochloride | rel=r_associated | relid=0 | w=101
  3872. ipilimumab -- r_associated #0: 101 / 0.221 -> en:topical fluorouracil
    n1=ipilimumab | n2=en:topical fluorouracil | rel=r_associated | relid=0 | w=101
  3873. ipilimumab -- r_associated #0: 101 / 0.221 -> en:topical lfx453
    n1=ipilimumab | n2=en:topical lfx453 | rel=r_associated | relid=0 | w=101
  3874. ipilimumab -- r_associated #0: 101 / 0.221 -> en:topical phenylephrine solution
    n1=ipilimumab | n2=en:topical phenylephrine solution | rel=r_associated | relid=0 | w=101
  3875. ipilimumab -- r_associated #0: 101 / 0.221 -> en:topical wound spray hp802-247
    n1=ipilimumab | n2=en:topical wound spray hp802-247 | rel=r_associated | relid=0 | w=101
  3876. ipilimumab -- r_associated #0: 101 / 0.221 -> en:topoisomerase i inhibitor lmp776
    n1=ipilimumab | n2=en:topoisomerase i inhibitor lmp776 | rel=r_associated | relid=0 | w=101
  3877. ipilimumab -- r_associated #0: 101 / 0.221 -> en:topoisomerase inhibitor
    n1=ipilimumab | n2=en:topoisomerase inhibitor | rel=r_associated | relid=0 | w=101
  3878. ipilimumab -- r_associated #0: 101 / 0.221 -> en:tozasertib lactate
    n1=ipilimumab | n2=en:tozasertib lactate | rel=r_associated | relid=0 | w=101
  3879. ipilimumab -- r_associated #0: 101 / 0.221 -> en:trastuzumab
    n1=ipilimumab | n2=en:trastuzumab | rel=r_associated | relid=0 | w=101
  3880. ipilimumab -- r_associated #0: 101 / 0.221 -> en:tri-virus/gd2-specific allogeneic cytotoxic t-lymphocytes
    n1=ipilimumab | n2=en:tri-virus/gd2-specific allogeneic cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=101
  3881. ipilimumab -- r_associated #0: 101 / 0.221 -> en:triazinate
    n1=ipilimumab | n2=en:triazinate | rel=r_associated | relid=0 | w=101
  3882. ipilimumab -- r_associated #0: 101 / 0.221 -> en:trodusquemine
    n1=ipilimumab | n2=en:trodusquemine | rel=r_associated | relid=0 | w=101
  3883. ipilimumab -- r_associated #0: 101 / 0.221 -> en:trofosfamide
    n1=ipilimumab | n2=en:trofosfamide | rel=r_associated | relid=0 | w=101
  3884. ipilimumab -- r_associated #0: 101 / 0.221 -> en:udenafil
    n1=ipilimumab | n2=en:udenafil | rel=r_associated | relid=0 | w=101
  3885. ipilimumab -- r_associated #0: 101 / 0.221 -> en:uniformly-labeled [u-13c]glucose
    n1=ipilimumab | n2=en:uniformly-labeled [u-13c]glucose | rel=r_associated | relid=0 | w=101
  3886. ipilimumab -- r_associated #0: 101 / 0.221 -> en:urelumab
    n1=ipilimumab | n2=en:urelumab | rel=r_associated | relid=0 | w=101
  3887. ipilimumab -- r_associated #0: 101 / 0.221 -> en:uridine triacetate
    n1=ipilimumab | n2=en:uridine triacetate | rel=r_associated | relid=0 | w=101
  3888. ipilimumab -- r_associated #0: 101 / 0.221 -> en:vancomycin
    n1=ipilimumab | n2=en:vancomycin | rel=r_associated | relid=0 | w=101
  3889. ipilimumab -- r_associated #0: 101 / 0.221 -> en:vandortuzumab vedotin
    n1=ipilimumab | n2=en:vandortuzumab vedotin | rel=r_associated | relid=0 | w=101
  3890. ipilimumab -- r_associated #0: 101 / 0.221 -> en:vascular disrupting agent bnc105p
    n1=ipilimumab | n2=en:vascular disrupting agent bnc105p | rel=r_associated | relid=0 | w=101
  3891. ipilimumab -- r_associated #0: 101 / 0.221 -> en:vcl-cb01 vaccine
    n1=ipilimumab | n2=en:vcl-cb01 vaccine | rel=r_associated | relid=0 | w=101
  3892. ipilimumab -- r_associated #0: 101 / 0.221 -> en:velafermin
    n1=ipilimumab | n2=en:velafermin | rel=r_associated | relid=0 | w=101
  3893. ipilimumab -- r_associated #0: 101 / 0.221 -> en:veltuzumab
    n1=ipilimumab | n2=en:veltuzumab | rel=r_associated | relid=0 | w=101
  3894. ipilimumab -- r_associated #0: 101 / 0.221 -> en:venetoclax
    n1=ipilimumab | n2=en:venetoclax | rel=r_associated | relid=0 | w=101
  3895. ipilimumab -- r_associated #0: 101 / 0.221 -> en:vidarabine
    n1=ipilimumab | n2=en:vidarabine | rel=r_associated | relid=0 | w=101
  3896. ipilimumab -- r_associated #0: 101 / 0.221 -> en:vintafolide
    n1=ipilimumab | n2=en:vintafolide | rel=r_associated | relid=0 | w=101
  3897. ipilimumab -- r_associated #0: 101 / 0.221 -> en:virulizin
    n1=ipilimumab | n2=en:virulizin | rel=r_associated | relid=0 | w=101
  3898. ipilimumab -- r_associated #0: 101 / 0.221 -> en:water, mineral or uric acid metabolism drug
    n1=ipilimumab | n2=en:water, mineral or uric acid metabolism drug | rel=r_associated | relid=0 | w=101
  3899. ipilimumab -- r_associated #0: 101 / 0.221 -> en:wt1 protein-derived peptide vaccine dsp-7888
    n1=ipilimumab | n2=en:wt1 protein-derived peptide vaccine dsp-7888 | rel=r_associated | relid=0 | w=101
  3900. ipilimumab -- r_associated #0: 101 / 0.221 -> en:xbp1-us/xbp1-sp/cd138/cs1 multipeptide vaccine pvx-410
    n1=ipilimumab | n2=en:xbp1-us/xbp1-sp/cd138/cs1 multipeptide vaccine pvx-410 | rel=r_associated | relid=0 | w=101
  3901. ipilimumab -- r_associated #0: 101 / 0.221 -> en:xelox regimen
    n1=ipilimumab | n2=en:xelox regimen | rel=r_associated | relid=0 | w=101
  3902. ipilimumab -- r_associated #0: 101 / 0.221 -> en:xenogeneic tyrosinase dna vaccine
    n1=ipilimumab | n2=en:xenogeneic tyrosinase dna vaccine | rel=r_associated | relid=0 | w=101
  3903. ipilimumab -- r_associated #0: 101 / 0.221 -> en:yttrium y 90 anti-cd45 monoclonal antibody bc8
    n1=ipilimumab | n2=en:yttrium y 90 anti-cd45 monoclonal antibody bc8 | rel=r_associated | relid=0 | w=101
  3904. ipilimumab -- r_associated #0: 101 / 0.221 -> en:yttrium y-90 ibritumomab tiuxetan
    n1=ipilimumab | n2=en:yttrium y-90 ibritumomab tiuxetan | rel=r_associated | relid=0 | w=101
  3905. ipilimumab -- r_associated #0: 101 / 0.221 -> en:zanamivir
    n1=ipilimumab | n2=en:zanamivir | rel=r_associated | relid=0 | w=101
  3906. ipilimumab -- r_associated #0: 101 / 0.221 -> en:zirconium zr 89 df-iab2m
    n1=ipilimumab | n2=en:zirconium zr 89 df-iab2m | rel=r_associated | relid=0 | w=101
  3907. ipilimumab -- r_associated #0: 101 / 0.221 -> en:zirconium zr 89 trastuzumab
    n1=ipilimumab | n2=en:zirconium zr 89 trastuzumab | rel=r_associated | relid=0 | w=101
  3908. ipilimumab -- r_associated #0: 101 / 0.221 -> en:zirconium zr 89-labeled anti-pigf monoclonal antibody ro5323441
    n1=ipilimumab | n2=en:zirconium zr 89-labeled anti-pigf monoclonal antibody ro5323441 | rel=r_associated | relid=0 | w=101
  3909. ipilimumab -- r_associated #0: 101 / 0.221 -> en:zolpidem tartrate
    n1=ipilimumab | n2=en:zolpidem tartrate | rel=r_associated | relid=0 | w=101
  3910. ipilimumab -- r_associated #0: 101 / 0.221 -> spécialités médicales
    n1=ipilimumab | n2=spécialités médicales | rel=r_associated | relid=0 | w=101
  3911. ipilimumab -- r_associated #0: 100 / 0.218 -> en:40 ml ipilimumab 5 mg/ml injection
    n1=ipilimumab | n2=en:40 ml ipilimumab 5 mg/ml injection | rel=r_associated | relid=0 | w=100
  3912. ipilimumab -- r_associated #0: 100 / 0.218 -> en:adenovirus-mediated human interleukin-12
    n1=ipilimumab | n2=en:adenovirus-mediated human interleukin-12 | rel=r_associated | relid=0 | w=100
  3913. ipilimumab -- r_associated #0: 100 / 0.218 -> en:akt inhibitor arq 092
    n1=ipilimumab | n2=en:akt inhibitor arq 092 | rel=r_associated | relid=0 | w=100
  3914. ipilimumab -- r_associated #0: 100 / 0.218 -> en:akt inhibitor mk2206
    n1=ipilimumab | n2=en:akt inhibitor mk2206 | rel=r_associated | relid=0 | w=100
  3915. ipilimumab -- r_associated #0: 100 / 0.218 -> en:alisertib
    n1=ipilimumab | n2=en:alisertib | rel=r_associated | relid=0 | w=100
  3916. ipilimumab -- r_associated #0: 100 / 0.218 -> en:allergen product
    n1=ipilimumab | n2=en:allergen product | rel=r_associated | relid=0 | w=100
  3917. ipilimumab -- r_associated #0: 100 / 0.218 -> en:allogeneic adenovirus-specific cytotoxic t lymphocytes
    n1=ipilimumab | n2=en:allogeneic adenovirus-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=100
  3918. ipilimumab -- r_associated #0: 100 / 0.218 -> en:allogeneic gm-csf-secreting lethally irradiated whole melanoma cell vaccine
    n1=ipilimumab | n2=en:allogeneic gm-csf-secreting lethally irradiated whole melanoma cell vaccine | rel=r_associated | relid=0 | w=100
  3919. ipilimumab -- r_associated #0: 100 / 0.218 -> en:allogeneic il13-zetakine/hytk-expressing-glucocorticoid resistant cytotoxic t lymphocytes grm13z40-2
    n1=ipilimumab | n2=en:allogeneic il13-zetakine/hytk-expressing-glucocorticoid resistant cytotoxic t lymphocytes grm13z40-2 | rel=r_associated | relid=0 | w=100
  3920. ipilimumab -- r_associated #0: 100 / 0.218 -> en:alvac-hb7.1
    n1=ipilimumab | n2=en:alvac-hb7.1 | rel=r_associated | relid=0 | w=100
  3921. ipilimumab -- r_associated #0: 100 / 0.218 -> en:anetholtrithion
    n1=ipilimumab | n2=en:anetholtrithion | rel=r_associated | relid=0 | w=100
  3922. ipilimumab -- r_associated #0: 100 / 0.218 -> en:anti-cd123 monoclonal antibody csl360
    n1=ipilimumab | n2=en:anti-cd123 monoclonal antibody csl360 | rel=r_associated | relid=0 | w=100
  3923. ipilimumab -- r_associated #0: 100 / 0.218 -> en:anti-cd19-dm4 immunoconjugate sar3419
    n1=ipilimumab | n2=en:anti-cd19-dm4 immunoconjugate sar3419 | rel=r_associated | relid=0 | w=100
  3924. ipilimumab -- r_associated #0: 100 / 0.218 -> en:anti-cd45 monoclonal antibody ahn-12
    n1=ipilimumab | n2=en:anti-cd45 monoclonal antibody ahn-12 | rel=r_associated | relid=0 | w=100
  3925. ipilimumab -- r_associated #0: 100 / 0.218 -> en:anti-cea/cd3 bispecific antibody ro6958688
    n1=ipilimumab | n2=en:anti-cea/cd3 bispecific antibody ro6958688 | rel=r_associated | relid=0 | w=100
  3926. ipilimumab -- r_associated #0: 100 / 0.218 -> en:anti-epha2 monoclonal antibody-mmaf immunoconjugate medi-547
    n1=ipilimumab | n2=en:anti-epha2 monoclonal antibody-mmaf immunoconjugate medi-547 | rel=r_associated | relid=0 | w=100
  3927. ipilimumab -- r_associated #0: 100 / 0.218 -> en:anti-gnrh vaccine pep223
    n1=ipilimumab | n2=en:anti-gnrh vaccine pep223 | rel=r_associated | relid=0 | w=100
  3928. ipilimumab -- r_associated #0: 100 / 0.218 -> en:anti-il-1 alpha monoclonal antibody mabp1
    n1=ipilimumab | n2=en:anti-il-1 alpha monoclonal antibody mabp1 | rel=r_associated | relid=0 | w=100
  3929. ipilimumab -- r_associated #0: 100 / 0.218 -> en:anti-met monoclonal antibody mixture sym015
    n1=ipilimumab | n2=en:anti-met monoclonal antibody mixture sym015 | rel=r_associated | relid=0 | w=100
  3930. ipilimumab -- r_associated #0: 100 / 0.218 -> en:anti-pd-l1/tgfbetarii fusion protein msb0011359c
    n1=ipilimumab | n2=en:anti-pd-l1/tgfbetarii fusion protein msb0011359c | rel=r_associated | relid=0 | w=100
  3931. ipilimumab -- r_associated #0: 100 / 0.218 -> en:anti-psca fully human monoclonal antibody ags-1c4d4
    n1=ipilimumab | n2=en:anti-psca fully human monoclonal antibody ags-1c4d4 | rel=r_associated | relid=0 | w=100
  3932. ipilimumab -- r_associated #0: 100 / 0.218 -> en:anti-tim-3 monoclonal antibody mbg453
    n1=ipilimumab | n2=en:anti-tim-3 monoclonal antibody mbg453 | rel=r_associated | relid=0 | w=100
  3933. ipilimumab -- r_associated #0: 100 / 0.218 -> en:antibiotic sq109
    n1=ipilimumab | n2=en:antibiotic sq109 | rel=r_associated | relid=0 | w=100
  3934. ipilimumab -- r_associated #0: 100 / 0.218 -> en:antiestrogen
    n1=ipilimumab | n2=en:antiestrogen | rel=r_associated | relid=0 | w=100
  3935. ipilimumab -- r_associated #0: 100 / 0.218 -> en:antineoplastic agent combination sm-88
    n1=ipilimumab | n2=en:antineoplastic agent combination sm-88 | rel=r_associated | relid=0 | w=100
  3936. ipilimumab -- r_associated #0: 100 / 0.218 -> en:apomab
    n1=ipilimumab | n2=en:apomab | rel=r_associated | relid=0 | w=100
  3937. ipilimumab -- r_associated #0: 100 / 0.218 -> en:arginine/omega-3 fatty acids/nucleotides oral supplement
    n1=ipilimumab | n2=en:arginine/omega-3 fatty acids/nucleotides oral supplement | rel=r_associated | relid=0 | w=100
  3938. ipilimumab -- r_associated #0: 100 / 0.218 -> en:aspirin/simvastatin/atenolol/ramipril/thiazide capsule
    n1=ipilimumab | n2=en:aspirin/simvastatin/atenolol/ramipril/thiazide capsule | rel=r_associated | relid=0 | w=100
  3939. ipilimumab -- r_associated #0: 100 / 0.218 -> en:autologous ad-cd154-transduced cll b cells
    n1=ipilimumab | n2=en:autologous ad-cd154-transduced cll b cells | rel=r_associated | relid=0 | w=100
  3940. ipilimumab -- r_associated #0: 100 / 0.218 -> en:autologous cd8+ melanoma specific t cells
    n1=ipilimumab | n2=en:autologous cd8+ melanoma specific t cells | rel=r_associated | relid=0 | w=100
  3941. ipilimumab -- r_associated #0: 100 / 0.218 -> en:autologous mage-a3-specific hla-a*01-restricted t cell receptor gene engineered lymphocytes
    n1=ipilimumab | n2=en:autologous mage-a3-specific hla-a*01-restricted t cell receptor gene engineered lymphocytes | rel=r_associated | relid=0 | w=100
  3942. ipilimumab -- r_associated #0: 100 / 0.218 -> en:autologous tumor-associated peptide antigen-pulsed dendritic cell vaccine
    n1=ipilimumab | n2=en:autologous tumor-associated peptide antigen-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=100
  3943. ipilimumab -- r_associated #0: 100 / 0.218 -> en:avitinib maleate
    n1=ipilimumab | n2=en:avitinib maleate | rel=r_associated | relid=0 | w=100
  3944. ipilimumab -- r_associated #0: 100 / 0.218 -> en:b43-genistein immunoconjugate
    n1=ipilimumab | n2=en:b43-genistein immunoconjugate | rel=r_associated | relid=0 | w=100
  3945. ipilimumab -- r_associated #0: 100 / 0.218 -> en:bemiparin sodium
    n1=ipilimumab | n2=en:bemiparin sodium | rel=r_associated | relid=0 | w=100
  3946. ipilimumab -- r_associated #0: 100 / 0.218 -> en:bi 894999
    n1=ipilimumab | n2=en:bi 894999 | rel=r_associated | relid=0 | w=100
  3947. ipilimumab -- r_associated #0: 100 / 0.218 -> en:binetrakin
    n1=ipilimumab | n2=en:binetrakin | rel=r_associated | relid=0 | w=100
  3948. ipilimumab -- r_associated #0: 100 / 0.218 -> en:biological agent
    n1=ipilimumab | n2=en:biological agent | rel=r_associated | relid=0 | w=100
  3949. ipilimumab -- r_associated #0: 100 / 0.218 -> en:bismuth subsalicylate
    n1=ipilimumab | n2=en:bismuth subsalicylate | rel=r_associated | relid=0 | w=100
  3950. ipilimumab -- r_associated #0: 100 / 0.218 -> en:bispecific human anti-ang-2/anti-vegf-a antibody ro5520985
    n1=ipilimumab | n2=en:bispecific human anti-ang-2/anti-vegf-a antibody ro5520985 | rel=r_associated | relid=0 | w=100
  3951. ipilimumab -- r_associated #0: 100 / 0.218 -> en:boceprevir
    n1=ipilimumab | n2=en:boceprevir | rel=r_associated | relid=0 | w=100
  3952. ipilimumab -- r_associated #0: 100 / 0.218 -> en:bone resorption inhibitor
    n1=ipilimumab | n2=en:bone resorption inhibitor | rel=r_associated | relid=0 | w=100
  3953. ipilimumab -- r_associated #0: 100 / 0.218 -> en:buparlisib
    n1=ipilimumab | n2=en:buparlisib | rel=r_associated | relid=0 | w=100
  3954. ipilimumab -- r_associated #0: 100 / 0.218 -> en:c-met inhibitor amg 208
    n1=ipilimumab | n2=en:c-met inhibitor amg 208 | rel=r_associated | relid=0 | w=100
  3955. ipilimumab -- r_associated #0: 100 / 0.218 -> en:carbon c 11 sarcosine
    n1=ipilimumab | n2=en:carbon c 11 sarcosine | rel=r_associated | relid=0 | w=100
  3956. ipilimumab -- r_associated #0: 100 / 0.218 -> en:catumaxomab
    n1=ipilimumab | n2=en:catumaxomab | rel=r_associated | relid=0 | w=100
  3957. ipilimumab -- r_associated #0: 100 / 0.218 -> en:cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes
    n1=ipilimumab | n2=en:cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=100
  3958. ipilimumab -- r_associated #0: 100 / 0.218 -> en:cd30 car-expressing autologous t lymphocytes
    n1=ipilimumab | n2=en:cd30 car-expressing autologous t lymphocytes | rel=r_associated | relid=0 | w=100
  3959. ipilimumab -- r_associated #0: 100 / 0.218 -> en:cd5789 cream
    n1=ipilimumab | n2=en:cd5789 cream | rel=r_associated | relid=0 | w=100
  3960. ipilimumab -- r_associated #0: 100 / 0.218 -> en:ceteth-20
    n1=ipilimumab | n2=en:ceteth-20 | rel=r_associated | relid=0 | w=100
  3961. ipilimumab -- r_associated #0: 100 / 0.218 -> en:chinese herbal medicine compound tpe-1
    n1=ipilimumab | n2=en:chinese herbal medicine compound tpe-1 | rel=r_associated | relid=0 | w=100
  3962. ipilimumab -- r_associated #0: 100 / 0.218 -> en:cholelitholytic and/or choleretic agent
    n1=ipilimumab | n2=en:cholelitholytic and/or choleretic agent | rel=r_associated | relid=0 | w=100
  3963. ipilimumab -- r_associated #0: 100 / 0.218 -> en:cis-urocanic acid
    n1=ipilimumab | n2=en:cis-urocanic acid | rel=r_associated | relid=0 | w=100
  3964. ipilimumab -- r_associated #0: 100 / 0.218 -> en:corticotropin
    n1=ipilimumab | n2=en:corticotropin | rel=r_associated | relid=0 | w=100
  3965. ipilimumab -- r_associated #0: 100 / 0.218 -> en:cr2-fh fusion protein tt30
    n1=ipilimumab | n2=en:cr2-fh fusion protein tt30 | rel=r_associated | relid=0 | w=100
  3966. ipilimumab -- r_associated #0: 100 / 0.218 -> en:cxcr4 inhibitor x4p-001
    n1=ipilimumab | n2=en:cxcr4 inhibitor x4p-001 | rel=r_associated | relid=0 | w=100
  3967. ipilimumab -- r_associated #0: 100 / 0.218 -> en:cyclodextrin-based polymer-camptothecin crlx101
    n1=ipilimumab | n2=en:cyclodextrin-based polymer-camptothecin crlx101 | rel=r_associated | relid=0 | w=100
  3968. ipilimumab -- r_associated #0: 100 / 0.218 -> en:cyclophosphamide
    n1=ipilimumab | n2=en:cyclophosphamide | rel=r_associated | relid=0 | w=100
  3969. ipilimumab -- r_associated #0: 100 / 0.218 -> en:cyclosporine ophthalmic emulsion
    n1=ipilimumab | n2=en:cyclosporine ophthalmic emulsion | rel=r_associated | relid=0 | w=100
  3970. ipilimumab -- r_associated #0: 100 / 0.218 -> en:dasatinib
    n1=ipilimumab | n2=en:dasatinib | rel=r_associated | relid=0 | w=100
  3971. ipilimumab -- r_associated #0: 100 / 0.218 -> en:daunorubicin-dna complex
    n1=ipilimumab | n2=en:daunorubicin-dna complex | rel=r_associated | relid=0 | w=100
  3972. ipilimumab -- r_associated #0: 100 / 0.218 -> en:defined green tea catechin extract
    n1=ipilimumab | n2=en:defined green tea catechin extract | rel=r_associated | relid=0 | w=100
  3973. ipilimumab -- r_associated #0: 100 / 0.218 -> en:degarelix
    n1=ipilimumab | n2=en:degarelix | rel=r_associated | relid=0 | w=100
  3974. ipilimumab -- r_associated #0: 100 / 0.218 -> en:dendritic cell-precision multiple antigen t-lymphocytes
    n1=ipilimumab | n2=en:dendritic cell-precision multiple antigen t-lymphocytes | rel=r_associated | relid=0 | w=100
  3975. ipilimumab -- r_associated #0: 100 / 0.218 -> en:denileukin diftitox
    n1=ipilimumab | n2=en:denileukin diftitox | rel=r_associated | relid=0 | w=100
  3976. ipilimumab -- r_associated #0: 100 / 0.218 -> en:dextroamphetamine sulfate
    n1=ipilimumab | n2=en:dextroamphetamine sulfate | rel=r_associated | relid=0 | w=100
  3977. ipilimumab -- r_associated #0: 100 / 0.218 -> en:diacetylmorphine hydrochloride
    n1=ipilimumab | n2=en:diacetylmorphine hydrochloride | rel=r_associated | relid=0 | w=100
  3978. ipilimumab -- r_associated #0: 100 / 0.218 -> en:didox
    n1=ipilimumab | n2=en:didox | rel=r_associated | relid=0 | w=100
  3979. ipilimumab -- r_associated #0: 100 / 0.218 -> en:diethylnorspermine
    n1=ipilimumab | n2=en:diethylnorspermine | rel=r_associated | relid=0 | w=100
  3980. ipilimumab -- r_associated #0: 100 / 0.218 -> en:diflomotecan
    n1=ipilimumab | n2=en:diflomotecan | rel=r_associated | relid=0 | w=100
  3981. ipilimumab -- r_associated #0: 100 / 0.218 -> en:diphtheria toxin fragment-interleukin-2 fusion protein e7777
    n1=ipilimumab | n2=en:diphtheria toxin fragment-interleukin-2 fusion protein e7777 | rel=r_associated | relid=0 | w=100
  3982. ipilimumab -- r_associated #0: 100 / 0.218 -> en:docosahexaenoic acid
    n1=ipilimumab | n2=en:docosahexaenoic acid | rel=r_associated | relid=0 | w=100
  3983. ipilimumab -- r_associated #0: 100 / 0.218 -> en:dopamine-somatostatin chimeric molecule bim-23a760
    n1=ipilimumab | n2=en:dopamine-somatostatin chimeric molecule bim-23a760 | rel=r_associated | relid=0 | w=100
  3984. ipilimumab -- r_associated #0: 100 / 0.218 -> en:dr5-targeting tetrameric nanobody agonist tas266
    n1=ipilimumab | n2=en:dr5-targeting tetrameric nanobody agonist tas266 | rel=r_associated | relid=0 | w=100
  3985. ipilimumab -- r_associated #0: 100 / 0.218 -> en:e1m184v peptide vaccine
    n1=ipilimumab | n2=en:e1m184v peptide vaccine | rel=r_associated | relid=0 | w=100
  3986. ipilimumab -- r_associated #0: 100 / 0.218 -> en:efavirenz
    n1=ipilimumab | n2=en:efavirenz | rel=r_associated | relid=0 | w=100
  3987. ipilimumab -- r_associated #0: 100 / 0.218 -> en:egfr antisense dna
    n1=ipilimumab | n2=en:egfr antisense dna | rel=r_associated | relid=0 | w=100
  3988. ipilimumab -- r_associated #0: 100 / 0.218 -> en:electrolyte-free parenteral nutrition emulsion
    n1=ipilimumab | n2=en:electrolyte-free parenteral nutrition emulsion | rel=r_associated | relid=0 | w=100
  3989. ipilimumab -- r_associated #0: 100 / 0.218 -> en:emtricitabine
    n1=ipilimumab | n2=en:emtricitabine | rel=r_associated | relid=0 | w=100
  3990. ipilimumab -- r_associated #0: 100 / 0.218 -> en:enclomiphene citrate
    n1=ipilimumab | n2=en:enclomiphene citrate | rel=r_associated | relid=0 | w=100
  3991. ipilimumab -- r_associated #0: 100 / 0.218 -> en:ergoline derivative
    n1=ipilimumab | n2=en:ergoline derivative | rel=r_associated | relid=0 | w=100
  3992. ipilimumab -- r_associated #0: 100 / 0.218 -> en:estrogens, esterified (usp)
    n1=ipilimumab | n2=en:estrogens, esterified (usp) | rel=r_associated | relid=0 | w=100
  3993. ipilimumab -- r_associated #0: 100 / 0.218 -> en:etaracizumab
    n1=ipilimumab | n2=en:etaracizumab | rel=r_associated | relid=0 | w=100
  3994. ipilimumab -- r_associated #0: 100 / 0.218 -> en:everolimus tablets for oral suspension
    n1=ipilimumab | n2=en:everolimus tablets for oral suspension | rel=r_associated | relid=0 | w=100
  3995. ipilimumab -- r_associated #0: 100 / 0.218 -> en:exenatide
    n1=ipilimumab | n2=en:exenatide | rel=r_associated | relid=0 | w=100
  3996. ipilimumab -- r_associated #0: 100 / 0.218 -> en:ezh1/2 inhibitor ds-3201
    n1=ipilimumab | n2=en:ezh1/2 inhibitor ds-3201 | rel=r_associated | relid=0 | w=100
  3997. ipilimumab -- r_associated #0: 100 / 0.218 -> en:fak inhibitor vs-4718
    n1=ipilimumab | n2=en:fak inhibitor vs-4718 | rel=r_associated | relid=0 | w=100
  3998. ipilimumab -- r_associated #0: 100 / 0.218 -> en:fgf401 inhibitor fgf401
    n1=ipilimumab | n2=en:fgf401 inhibitor fgf401 | rel=r_associated | relid=0 | w=100
  3999. ipilimumab -- r_associated #0: 100 / 0.218 -> en:fluocinonide
    n1=ipilimumab | n2=en:fluocinonide | rel=r_associated | relid=0 | w=100
  4000. ipilimumab -- r_associated #0: 100 / 0.218 -> en:fowlpox-psa-tricom vaccine
    n1=ipilimumab | n2=en:fowlpox-psa-tricom vaccine | rel=r_associated | relid=0 | w=100
  4001. ipilimumab -- r_associated #0: 100 / 0.218 -> en:fruquintinib
    n1=ipilimumab | n2=en:fruquintinib | rel=r_associated | relid=0 | w=100
  4002. ipilimumab -- r_associated #0: 100 / 0.218 -> en:g-quadruplex stabilizer bmvc
    n1=ipilimumab | n2=en:g-quadruplex stabilizer bmvc | rel=r_associated | relid=0 | w=100
  4003. ipilimumab -- r_associated #0: 100 / 0.218 -> en:gadopentetate dimeglumine
    n1=ipilimumab | n2=en:gadopentetate dimeglumine | rel=r_associated | relid=0 | w=100
  4004. ipilimumab -- r_associated #0: 100 / 0.218 -> en:ganglioside gd2
    n1=ipilimumab | n2=en:ganglioside gd2 | rel=r_associated | relid=0 | w=100
  4005. ipilimumab -- r_associated #0: 100 / 0.218 -> en:gastrointestinal agents
    n1=ipilimumab | n2=en:gastrointestinal agents | rel=r_associated | relid=0 | w=100
  4006. ipilimumab -- r_associated #0: 100 / 0.218 -> en:gefitinib
    n1=ipilimumab | n2=en:gefitinib | rel=r_associated | relid=0 | w=100
  4007. ipilimumab -- r_associated #0: 100 / 0.218 -> en:gp100:280-288(288v) peptide vaccine
    n1=ipilimumab | n2=en:gp100:280-288(288v) peptide vaccine | rel=r_associated | relid=0 | w=100
  4008. ipilimumab -- r_associated #0: 100 / 0.218 -> en:gp2 peptide/gm-csf vaccine
    n1=ipilimumab | n2=en:gp2 peptide/gm-csf vaccine | rel=r_associated | relid=0 | w=100
  4009. ipilimumab -- r_associated #0: 100 / 0.218 -> en:gvax pancreatic cancer vaccine
    n1=ipilimumab | n2=en:gvax pancreatic cancer vaccine | rel=r_associated | relid=0 | w=100
  4010. ipilimumab -- r_associated #0: 100 / 0.218 -> en:gvax prostate cancer vaccine
    n1=ipilimumab | n2=en:gvax prostate cancer vaccine | rel=r_associated | relid=0 | w=100
  4011. ipilimumab -- r_associated #0: 100 / 0.218 -> en:hcv dna vaccine ino-8000
    n1=ipilimumab | n2=en:hcv dna vaccine ino-8000 | rel=r_associated | relid=0 | w=100
  4012. ipilimumab -- r_associated #0: 100 / 0.218 -> en:hematoporphyrin derivative
    n1=ipilimumab | n2=en:hematoporphyrin derivative | rel=r_associated | relid=0 | w=100
  4013. ipilimumab -- r_associated #0: 100 / 0.218 -> en:hepatitis b antigen vaccine
    n1=ipilimumab | n2=en:hepatitis b antigen vaccine | rel=r_associated | relid=0 | w=100
  4014. ipilimumab -- r_associated #0: 100 / 0.218 -> en:her2-targeting antibody fc fragment fs102
    n1=ipilimumab | n2=en:her2-targeting antibody fc fragment fs102 | rel=r_associated | relid=0 | w=100
  4015. ipilimumab -- r_associated #0: 100 / 0.218 -> en:htert/survivin/cmv multipeptide vaccine
    n1=ipilimumab | n2=en:htert/survivin/cmv multipeptide vaccine | rel=r_associated | relid=0 | w=100
  4016. ipilimumab -- r_associated #0: 100 / 0.218 -> en:hyaluronic acid
    n1=ipilimumab | n2=en:hyaluronic acid | rel=r_associated | relid=0 | w=100
  4017. ipilimumab -- r_associated #0: 100 / 0.218 -> en:hydroxychloroquine
    n1=ipilimumab | n2=en:hydroxychloroquine | rel=r_associated | relid=0 | w=100
  4018. ipilimumab -- r_associated #0: 100 / 0.218 -> en:hyperglycemic agent
    n1=ipilimumab | n2=en:hyperglycemic agent | rel=r_associated | relid=0 | w=100
  4019. ipilimumab -- r_associated #0: 100 / 0.218 -> en:idh1 inhibitor ag-120
    n1=ipilimumab | n2=en:idh1 inhibitor ag-120 | rel=r_associated | relid=0 | w=100
  4020. ipilimumab -- r_associated #0: 100 / 0.218 -> en:imalumab
    n1=ipilimumab | n2=en:imalumab | rel=r_associated | relid=0 | w=100
  4021. ipilimumab -- r_associated #0: 100 / 0.218 -> en:immunocytokine nhs-il12
    n1=ipilimumab | n2=en:immunocytokine nhs-il12 | rel=r_associated | relid=0 | w=100
  4022. ipilimumab -- r_associated #0: 100 / 0.218 -> en:indium in 111 chimeric monoclonal antibody 806
    n1=ipilimumab | n2=en:indium in 111 chimeric monoclonal antibody 806 | rel=r_associated | relid=0 | w=100
  4023. ipilimumab -- r_associated #0: 100 / 0.218 -> en:insulin degludec
    n1=ipilimumab | n2=en:insulin degludec | rel=r_associated | relid=0 | w=100
  4024. ipilimumab -- r_associated #0: 100 / 0.218 -> en:iodine i 124 iododeoxyuridine
    n1=ipilimumab | n2=en:iodine i 124 iododeoxyuridine | rel=r_associated | relid=0 | w=100
  4025. ipilimumab -- r_associated #0: 100 / 0.218 -> en:iodine potassium iodide
    n1=ipilimumab | n2=en:iodine potassium iodide | rel=r_associated | relid=0 | w=100
  4026. ipilimumab -- r_associated #0: 100 / 0.218 -> en:ioflupane
    n1=ipilimumab | n2=en:ioflupane | rel=r_associated | relid=0 | w=100
  4027. ipilimumab -- r_associated #0: 100 / 0.218 -> en:iotrolan
    n1=ipilimumab | n2=en:iotrolan | rel=r_associated | relid=0 | w=100
  4028. ipilimumab -- r_associated #0: 100 / 0.218 -> en:ipomeanol
    n1=ipilimumab | n2=en:ipomeanol | rel=r_associated | relid=0 | w=100
  4029. ipilimumab -- r_associated #0: 100 / 0.218 -> en:irritants
    n1=ipilimumab | n2=en:irritants | rel=r_associated | relid=0 | w=100
  4030. ipilimumab -- r_associated #0: 100 / 0.218 -> en:l-778,123
    n1=ipilimumab | n2=en:l-778,123 | rel=r_associated | relid=0 | w=100
  4031. ipilimumab -- r_associated #0: 100 / 0.218 -> en:liposome-encapsulated rb94 plasmid dna gene therapy agent sgt-94
    n1=ipilimumab | n2=en:liposome-encapsulated rb94 plasmid dna gene therapy agent sgt-94 | rel=r_associated | relid=0 | w=100
  4032. ipilimumab -- r_associated #0: 100 / 0.218 -> en:lmdda-llo-chher2 fusion protein-secreting live-attenuated listeria cancer vaccine adxs31-164
    n1=ipilimumab | n2=en:lmdda-llo-chher2 fusion protein-secreting live-attenuated listeria cancer vaccine adxs31-164 | rel=r_associated | relid=0 | w=100
  4033. ipilimumab -- r_associated #0: 100 / 0.218 -> en:long peptide vaccine 7
    n1=ipilimumab | n2=en:long peptide vaccine 7 | rel=r_associated | relid=0 | w=100
  4034. ipilimumab -- r_associated #0: 100 / 0.218 -> en:lurtotecan
    n1=ipilimumab | n2=en:lurtotecan | rel=r_associated | relid=0 | w=100
  4035. ipilimumab -- r_associated #0: 100 / 0.218 -> en:m-azidopyrimethamine
    n1=ipilimumab | n2=en:m-azidopyrimethamine | rel=r_associated | relid=0 | w=100
  4036. ipilimumab -- r_associated #0: 100 / 0.218 -> en:macrogol 3350-based iso-osmotic laxative
    n1=ipilimumab | n2=en:macrogol 3350-based iso-osmotic laxative | rel=r_associated | relid=0 | w=100
  4037. ipilimumab -- r_associated #0: 100 / 0.218 -> en:mafosfamide
    n1=ipilimumab | n2=en:mafosfamide | rel=r_associated | relid=0 | w=100
  4038. ipilimumab -- r_associated #0: 100 / 0.218 -> en:mage-12 peptide vaccine
    n1=ipilimumab | n2=en:mage-12 peptide vaccine | rel=r_associated | relid=0 | w=100
  4039. ipilimumab -- r_associated #0: 100 / 0.218 -> en:mage-a3 reactive t cell receptor-transduced autologous t cells
    n1=ipilimumab | n2=en:mage-a3 reactive t cell receptor-transduced autologous t cells | rel=r_associated | relid=0 | w=100
  4040. ipilimumab -- r_associated #0: 100 / 0.218 -> en:magnesium isoglycyrrhizinate
    n1=ipilimumab | n2=en:magnesium isoglycyrrhizinate | rel=r_associated | relid=0 | w=100
  4041. ipilimumab -- r_associated #0: 100 / 0.218 -> en:magnesium oxide
    n1=ipilimumab | n2=en:magnesium oxide | rel=r_associated | relid=0 | w=100
  4042. ipilimumab -- r_associated #0: 100 / 0.218 -> en:medical gases
    n1=ipilimumab | n2=en:medical gases | rel=r_associated | relid=0 | w=100
  4043. ipilimumab -- r_associated #0: 100 / 0.218 -> en:mek inhibitor wx-554
    n1=ipilimumab | n2=en:mek inhibitor wx-554 | rel=r_associated | relid=0 | w=100
  4044. ipilimumab -- r_associated #0: 100 / 0.218 -> en:melphalan hydrochloride/sulfobutyl ether beta-cyclodextrin complex
    n1=ipilimumab | n2=en:melphalan hydrochloride/sulfobutyl ether beta-cyclodextrin complex | rel=r_associated | relid=0 | w=100
  4045. ipilimumab -- r_associated #0: 100 / 0.218 -> en:mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=100
  4046. ipilimumab -- r_associated #0: 100 / 0.218 -> en:methotrexate-e therapeutic implant
    n1=ipilimumab | n2=en:methotrexate-e therapeutic implant | rel=r_associated | relid=0 | w=100
  4047. ipilimumab -- r_associated #0: 100 / 0.218 -> en:mnk1/2 inhibitor eft508
    n1=ipilimumab | n2=en:mnk1/2 inhibitor eft508 | rel=r_associated | relid=0 | w=100
  4048. ipilimumab -- r_associated #0: 100 / 0.218 -> en:modafinil
    n1=ipilimumab | n2=en:modafinil | rel=r_associated | relid=0 | w=100
  4049. ipilimumab -- r_associated #0: 100 / 0.218 -> en:molybdenum
    n1=ipilimumab | n2=en:molybdenum | rel=r_associated | relid=0 | w=100
  4050. ipilimumab -- r_associated #0: 100 / 0.218 -> en:monoclonal antibody agent
    n1=ipilimumab | n2=en:monoclonal antibody agent | rel=r_associated | relid=0 | w=100
  4051. ipilimumab -- r_associated #0: 100 / 0.218 -> en:monoclonal antibody gd2 anti-idiotype vaccine
    n1=ipilimumab | n2=en:monoclonal antibody gd2 anti-idiotype vaccine | rel=r_associated | relid=0 | w=100
  4052. ipilimumab -- r_associated #0: 100 / 0.218 -> en:monoclonal antibody mga271
    n1=ipilimumab | n2=en:monoclonal antibody mga271 | rel=r_associated | relid=0 | w=100
  4053. ipilimumab -- r_associated #0: 100 / 0.218 -> en:monoclonal antibody rav12
    n1=ipilimumab | n2=en:monoclonal antibody rav12 | rel=r_associated | relid=0 | w=100
  4054. ipilimumab -- r_associated #0: 100 / 0.218 -> en:multifunctional/multitargeted anticancer agent omn54
    n1=ipilimumab | n2=en:multifunctional/multitargeted anticancer agent omn54 | rel=r_associated | relid=0 | w=100
  4055. ipilimumab -- r_associated #0: 100 / 0.218 -> en:nadroparin calcium
    n1=ipilimumab | n2=en:nadroparin calcium | rel=r_associated | relid=0 | w=100
  4056. ipilimumab -- r_associated #0: 100 / 0.218 -> en:nasal dosage form product
    n1=ipilimumab | n2=en:nasal dosage form product | rel=r_associated | relid=0 | w=100
  4057. ipilimumab -- r_associated #0: 100 / 0.218 -> en:nimustine
    n1=ipilimumab | n2=en:nimustine | rel=r_associated | relid=0 | w=100
  4058. ipilimumab -- r_associated #0: 100 / 0.218 -> en:ny-eso-1 reactive tcr retroviral vector transduced autologous pbl
    n1=ipilimumab | n2=en:ny-eso-1 reactive tcr retroviral vector transduced autologous pbl | rel=r_associated | relid=0 | w=100
  4059. ipilimumab -- r_associated #0: 100 / 0.218 -> en:olaratumab
    n1=ipilimumab | n2=en:olaratumab | rel=r_associated | relid=0 | w=100
  4060. ipilimumab -- r_associated #0: 100 / 0.218 -> en:olive oil extract/curcumin-based capsule
    n1=ipilimumab | n2=en:olive oil extract/curcumin-based capsule | rel=r_associated | relid=0 | w=100
  4061. ipilimumab -- r_associated #0: 100 / 0.218 -> en:oltipraz
    n1=ipilimumab | n2=en:oltipraz | rel=r_associated | relid=0 | w=100
  4062. ipilimumab -- r_associated #0: 100 / 0.218 -> en:p97 inhibitor cb-5083
    n1=ipilimumab | n2=en:p97 inhibitor cb-5083 | rel=r_associated | relid=0 | w=100
  4063. ipilimumab -- r_associated #0: 100 / 0.218 -> en:palonosetron hydrochloride
    n1=ipilimumab | n2=en:palonosetron hydrochloride | rel=r_associated | relid=0 | w=100
  4064. ipilimumab -- r_associated #0: 100 / 0.218 -> en:panobinostat
    n1=ipilimumab | n2=en:panobinostat | rel=r_associated | relid=0 | w=100
  4065. ipilimumab -- r_associated #0: 100 / 0.218 -> en:peg-based laxative ner1006
    n1=ipilimumab | n2=en:peg-based laxative ner1006 | rel=r_associated | relid=0 | w=100
  4066. ipilimumab -- r_associated #0: 100 / 0.218 -> en:pegvisomant
    n1=ipilimumab | n2=en:pegvisomant | rel=r_associated | relid=0 | w=100
  4067. ipilimumab -- r_associated #0: 100 / 0.218 -> en:pexidartinib
    n1=ipilimumab | n2=en:pexidartinib | rel=r_associated | relid=0 | w=100
  4068. ipilimumab -- r_associated #0: 100 / 0.218 -> en:pi3k alpha inhibitor mln1117
    n1=ipilimumab | n2=en:pi3k alpha inhibitor mln1117 | rel=r_associated | relid=0 | w=100
  4069. ipilimumab -- r_associated #0: 100 / 0.218 -> en:pi3k inhibitor gsk1059615
    n1=ipilimumab | n2=en:pi3k inhibitor gsk1059615 | rel=r_associated | relid=0 | w=100
  4070. ipilimumab -- r_associated #0: 100 / 0.218 -> en:pi3k-delta inhibitor tgr-1202
    n1=ipilimumab | n2=en:pi3k-delta inhibitor tgr-1202 | rel=r_associated | relid=0 | w=100
  4071. ipilimumab -- r_associated #0: 100 / 0.218 -> en:pi3kdelta inhibitor incb040093
    n1=ipilimumab | n2=en:pi3kdelta inhibitor incb040093 | rel=r_associated | relid=0 | w=100
  4072. ipilimumab -- r_associated #0: 100 / 0.218 -> en:pimasertib
    n1=ipilimumab | n2=en:pimasertib | rel=r_associated | relid=0 | w=100
  4073. ipilimumab -- r_associated #0: 100 / 0.218 -> en:pled-based mnsod mimetic
    n1=ipilimumab | n2=en:pled-based mnsod mimetic | rel=r_associated | relid=0 | w=100
  4074. ipilimumab -- r_associated #0: 100 / 0.218 -> en:polo-like kinase 1 inhibitor gsk461364
    n1=ipilimumab | n2=en:polo-like kinase 1 inhibitor gsk461364 | rel=r_associated | relid=0 | w=100
  4075. ipilimumab -- r_associated #0: 100 / 0.218 -> en:polyethylene glycol recombinant endostatin
    n1=ipilimumab | n2=en:polyethylene glycol recombinant endostatin | rel=r_associated | relid=0 | w=100
  4076. ipilimumab -- r_associated #0: 100 / 0.218 -> en:povidone-iodine
    n1=ipilimumab | n2=en:povidone-iodine | rel=r_associated | relid=0 | w=100
  4077. ipilimumab -- r_associated #0: 100 / 0.218 -> en:prednisone
    n1=ipilimumab | n2=en:prednisone | rel=r_associated | relid=0 | w=100
  4078. ipilimumab -- r_associated #0: 100 / 0.218 -> en:preimplantation factor pif-1
    n1=ipilimumab | n2=en:preimplantation factor pif-1 | rel=r_associated | relid=0 | w=100
  4079. ipilimumab -- r_associated #0: 100 / 0.218 -> en:prostate cancer vaccine pf-06755992
    n1=ipilimumab | n2=en:prostate cancer vaccine pf-06755992 | rel=r_associated | relid=0 | w=100
  4080. ipilimumab -- r_associated #0: 100 / 0.218 -> en:psma-targeted docetaxel nanoparticles bind-014
    n1=ipilimumab | n2=en:psma-targeted docetaxel nanoparticles bind-014 | rel=r_associated | relid=0 | w=100
  4081. ipilimumab -- r_associated #0: 100 / 0.218 -> en:pva microporous hydrospheres/doxorubicin hydrochloride
    n1=ipilimumab | n2=en:pva microporous hydrospheres/doxorubicin hydrochloride | rel=r_associated | relid=0 | w=100
  4082. ipilimumab -- r_associated #0: 100 / 0.218 -> en:pyrazofurin
    n1=ipilimumab | n2=en:pyrazofurin | rel=r_associated | relid=0 | w=100
  4083. ipilimumab -- r_associated #0: 100 / 0.218 -> en:radiosensitizing agent
    n1=ipilimumab | n2=en:radiosensitizing agent | rel=r_associated | relid=0 | w=100
  4084. ipilimumab -- r_associated #0: 100 / 0.218 -> en:recombinant 70-kd heat-shock protein
    n1=ipilimumab | n2=en:recombinant 70-kd heat-shock protein | rel=r_associated | relid=0 | w=100
  4085. ipilimumab -- r_associated #0: 100 / 0.218 -> en:recombinant vesicular stomatitis virus-expressing interferon-beta
    n1=ipilimumab | n2=en:recombinant vesicular stomatitis virus-expressing interferon-beta | rel=r_associated | relid=0 | w=100
  4086. ipilimumab -- r_associated #0: 100 / 0.218 -> en:respiratory form lucinactant
    n1=ipilimumab | n2=en:respiratory form lucinactant | rel=r_associated | relid=0 | w=100
  4087. ipilimumab -- r_associated #0: 100 / 0.218 -> en:revm10 gene
    n1=ipilimumab | n2=en:revm10 gene | rel=r_associated | relid=0 | w=100
  4088. ipilimumab -- r_associated #0: 100 / 0.218 -> en:rhenium re 188 p2045
    n1=ipilimumab | n2=en:rhenium re 188 p2045 | rel=r_associated | relid=0 | w=100
  4089. ipilimumab -- r_associated #0: 100 / 0.218 -> en:rna electroporated cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes
    n1=ipilimumab | n2=en:rna electroporated cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=100
  4090. ipilimumab -- r_associated #0: 100 / 0.218 -> en:robatumumab
    n1=ipilimumab | n2=en:robatumumab | rel=r_associated | relid=0 | w=100
  4091. ipilimumab -- r_associated #0: 100 / 0.218 -> en:saperconazole
    n1=ipilimumab | n2=en:saperconazole | rel=r_associated | relid=0 | w=100
  4092. ipilimumab -- r_associated #0: 100 / 0.218 -> en:sargramostim plasmid dna hepatocellular carcinoma vaccine adjuvant
    n1=ipilimumab | n2=en:sargramostim plasmid dna hepatocellular carcinoma vaccine adjuvant | rel=r_associated | relid=0 | w=100
  4093. ipilimumab -- r_associated #0: 100 / 0.218 -> en:secretin human
    n1=ipilimumab | n2=en:secretin human | rel=r_associated | relid=0 | w=100
  4094. ipilimumab -- r_associated #0: 100 / 0.218 -> en:semustine
    n1=ipilimumab | n2=en:semustine | rel=r_associated | relid=0 | w=100
  4095. ipilimumab -- r_associated #0: 100 / 0.218 -> en:silodosin
    n1=ipilimumab | n2=en:silodosin | rel=r_associated | relid=0 | w=100
  4096. ipilimumab -- r_associated #0: 100 / 0.218 -> en:smoothened antagonist tak-441
    n1=ipilimumab | n2=en:smoothened antagonist tak-441 | rel=r_associated | relid=0 | w=100
  4097. ipilimumab -- r_associated #0: 100 / 0.218 -> en:soblidotin
    n1=ipilimumab | n2=en:soblidotin | rel=r_associated | relid=0 | w=100
  4098. ipilimumab -- r_associated #0: 100 / 0.218 -> en:sotagliflozin
    n1=ipilimumab | n2=en:sotagliflozin | rel=r_associated | relid=0 | w=100
  4099. ipilimumab -- r_associated #0: 100 / 0.218 -> en:soy protein isolate
    n1=ipilimumab | n2=en:soy protein isolate | rel=r_associated | relid=0 | w=100
  4100. ipilimumab -- r_associated #0: 100 / 0.218 -> en:strontium chloride sr-89
    n1=ipilimumab | n2=en:strontium chloride sr-89 | rel=r_associated | relid=0 | w=100
  4101. ipilimumab -- r_associated #0: 100 / 0.218 -> en:sulofenur
    n1=ipilimumab | n2=en:sulofenur | rel=r_associated | relid=0 | w=100
  4102. ipilimumab -- r_associated #0: 100 / 0.218 -> en:sun's soup
    n1=ipilimumab | n2=en:sun's soup | rel=r_associated | relid=0 | w=100
  4103. ipilimumab -- r_associated #0: 100 / 0.218 -> en:supersaturated calcium phosphate rinse
    n1=ipilimumab | n2=en:supersaturated calcium phosphate rinse | rel=r_associated | relid=0 | w=100
  4104. ipilimumab -- r_associated #0: 100 / 0.218 -> en:synchrotope ta2m plasmid dna vaccine
    n1=ipilimumab | n2=en:synchrotope ta2m plasmid dna vaccine | rel=r_associated | relid=0 | w=100
  4105. ipilimumab -- r_associated #0: 100 / 0.218 -> en:t-cell activation
    n1=ipilimumab | n2=en:t-cell activation | rel=r_associated | relid=0 | w=100
  4106. ipilimumab -- r_associated #0: 100 / 0.218 -> en:t900607
    n1=ipilimumab | n2=en:t900607 | rel=r_associated | relid=0 | w=100
  4107. ipilimumab -- r_associated #0: 100 / 0.218 -> en:talc
    n1=ipilimumab | n2=en:talc | rel=r_associated | relid=0 | w=100
  4108. ipilimumab -- r_associated #0: 100 / 0.218 -> en:theramide
    n1=ipilimumab | n2=en:theramide | rel=r_associated | relid=0 | w=100
  4109. ipilimumab -- r_associated #0: 100 / 0.218 -> en:ticarcillin
    n1=ipilimumab | n2=en:ticarcillin | rel=r_associated | relid=0 | w=100
  4110. ipilimumab -- r_associated #0: 100 / 0.218 -> en:tigecycline
    n1=ipilimumab | n2=en:tigecycline | rel=r_associated | relid=0 | w=100
  4111. ipilimumab -- r_associated #0: 100 / 0.218 -> en:tinzaparin sodium
    n1=ipilimumab | n2=en:tinzaparin sodium | rel=r_associated | relid=0 | w=100
  4112. ipilimumab -- r_associated #0: 100 / 0.218 -> en:tivozanib
    n1=ipilimumab | n2=en:tivozanib | rel=r_associated | relid=0 | w=100
  4113. ipilimumab -- r_associated #0: 100 / 0.218 -> en:tlr8 agonist vtx-2337
    n1=ipilimumab | n2=en:tlr8 agonist vtx-2337 | rel=r_associated | relid=0 | w=100
  4114. ipilimumab -- r_associated #0: 100 / 0.218 -> en:tocotrienol
    n1=ipilimumab | n2=en:tocotrienol | rel=r_associated | relid=0 | w=100
  4115. ipilimumab -- r_associated #0: 100 / 0.218 -> en:topical dosage form
    n1=ipilimumab | n2=en:topical dosage form | rel=r_associated | relid=0 | w=100
  4116. ipilimumab -- r_associated #0: 100 / 0.218 -> en:torc1/2 kinase inhibitor ds-3078a
    n1=ipilimumab | n2=en:torc1/2 kinase inhibitor ds-3078a | rel=r_associated | relid=0 | w=100
  4117. ipilimumab -- r_associated #0: 100 / 0.218 -> en:troxacitabine
    n1=ipilimumab | n2=en:troxacitabine | rel=r_associated | relid=0 | w=100
  4118. ipilimumab -- r_associated #0: 100 / 0.218 -> en:uridine
    n1=ipilimumab | n2=en:uridine | rel=r_associated | relid=0 | w=100
  4119. ipilimumab -- r_associated #0: 100 / 0.218 -> en:ursodiol
    n1=ipilimumab | n2=en:ursodiol | rel=r_associated | relid=0 | w=100
  4120. ipilimumab -- r_associated #0: 100 / 0.218 -> en:vegfr1-1084 peptide vaccine
    n1=ipilimumab | n2=en:vegfr1-1084 peptide vaccine | rel=r_associated | relid=0 | w=100
  4121. ipilimumab -- r_associated #0: 100 / 0.218 -> en:vinorelbine tartrate emulsion
    n1=ipilimumab | n2=en:vinorelbine tartrate emulsion | rel=r_associated | relid=0 | w=100
  4122. ipilimumab -- r_associated #0: 100 / 0.218 -> en:vip regimen
    n1=ipilimumab | n2=en:vip regimen | rel=r_associated | relid=0 | w=100
  4123. ipilimumab -- r_associated #0: 100 / 0.218 -> en:wt1-sensitized t cells
    n1=ipilimumab | n2=en:wt1-sensitized t cells | rel=r_associated | relid=0 | w=100
  4124. ipilimumab -- r_associated #0: 100 / 0.218 -> en:y 90 monoclonal antibody cc49
    n1=ipilimumab | n2=en:y 90 monoclonal antibody cc49 | rel=r_associated | relid=0 | w=100
  4125. ipilimumab -- r_associated #0: 100 / 0.218 -> en:yttrium y 90 anti-cea monoclonal antibody ct84.66
    n1=ipilimumab | n2=en:yttrium y 90 anti-cea monoclonal antibody ct84.66 | rel=r_associated | relid=0 | w=100
  4126. ipilimumab -- r_associated #0: 100 / 0.218 -> en:zirconium zr 89-labeled monoclonal antibody mmot0530a
    n1=ipilimumab | n2=en:zirconium zr 89-labeled monoclonal antibody mmot0530a | rel=r_associated | relid=0 | w=100
  4127. ipilimumab -- r_associated #0: 99 / 0.216 -> en:5-fluoro-2-deoxycytidine
    n1=ipilimumab | n2=en:5-fluoro-2-deoxycytidine | rel=r_associated | relid=0 | w=99
  4128. ipilimumab -- r_associated #0: 99 / 0.216 -> en:abt-751
    n1=ipilimumab | n2=en:abt-751 | rel=r_associated | relid=0 | w=99
  4129. ipilimumab -- r_associated #0: 99 / 0.216 -> en:afatinib dimaleate
    n1=ipilimumab | n2=en:afatinib dimaleate | rel=r_associated | relid=0 | w=99
  4130. ipilimumab -- r_associated #0: 99 / 0.216 -> en:akt-1/2 inhibitor-treated tumor infiltrating lymphocytes
    n1=ipilimumab | n2=en:akt-1/2 inhibitor-treated tumor infiltrating lymphocytes | rel=r_associated | relid=0 | w=99
  4131. ipilimumab -- r_associated #0: 99 / 0.216 -> en:albuterol sulfate
    n1=ipilimumab | n2=en:albuterol sulfate | rel=r_associated | relid=0 | w=99
  4132. ipilimumab -- r_associated #0: 99 / 0.216 -> en:alcohol products
    n1=ipilimumab | n2=en:alcohol products | rel=r_associated | relid=0 | w=99
  4133. ipilimumab -- r_associated #0: 99 / 0.216 -> en:alvac(2)-ny-eso-1 (m)/tricom vaccine
    n1=ipilimumab | n2=en:alvac(2)-ny-eso-1 (m)/tricom vaccine | rel=r_associated | relid=0 | w=99
  4134. ipilimumab -- r_associated #0: 99 / 0.216 -> en:alvespimycin hydrochloride
    n1=ipilimumab | n2=en:alvespimycin hydrochloride | rel=r_associated | relid=0 | w=99
  4135. ipilimumab -- r_associated #0: 99 / 0.216 -> en:ampicillin sodium/sulbactam sodium
    n1=ipilimumab | n2=en:ampicillin sodium/sulbactam sodium | rel=r_associated | relid=0 | w=99
  4136. ipilimumab -- r_associated #0: 99 / 0.216 -> en:anagrelide prolonged-release formulation
    n1=ipilimumab | n2=en:anagrelide prolonged-release formulation | rel=r_associated | relid=0 | w=99
  4137. ipilimumab -- r_associated #0: 99 / 0.216 -> en:anti-a33 monoclonal antibody krn330
    n1=ipilimumab | n2=en:anti-a33 monoclonal antibody krn330 | rel=r_associated | relid=0 | w=99
  4138. ipilimumab -- r_associated #0: 99 / 0.216 -> en:anti-ca19-9 monoclonal antibody 5b1
    n1=ipilimumab | n2=en:anti-ca19-9 monoclonal antibody 5b1 | rel=r_associated | relid=0 | w=99
  4139. ipilimumab -- r_associated #0: 99 / 0.216 -> en:anti-cd19 monoclonal antibody xmab5574
    n1=ipilimumab | n2=en:anti-cd19 monoclonal antibody xmab5574 | rel=r_associated | relid=0 | w=99
  4140. ipilimumab -- r_associated #0: 99 / 0.216 -> en:anti-cd98 monoclonal antibody ign523
    n1=ipilimumab | n2=en:anti-cd98 monoclonal antibody ign523 | rel=r_associated | relid=0 | w=99
  4141. ipilimumab -- r_associated #0: 99 / 0.216 -> en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/sargramostim
    n1=ipilimumab | n2=en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/sargramostim | rel=r_associated | relid=0 | w=99
  4142. ipilimumab -- r_associated #0: 99 / 0.216 -> en:anti-epcam antibody fragment-pseudomonas-exotoxin fusion protein
    n1=ipilimumab | n2=en:anti-epcam antibody fragment-pseudomonas-exotoxin fusion protein | rel=r_associated | relid=0 | w=99
  4143. ipilimumab -- r_associated #0: 99 / 0.216 -> en:anti-grp78 monoclonal antibody pat-sm6
    n1=ipilimumab | n2=en:anti-grp78 monoclonal antibody pat-sm6 | rel=r_associated | relid=0 | w=99
  4144. ipilimumab -- r_associated #0: 99 / 0.216 -> en:anti-inhibitor coagulant complex feiba nf
    n1=ipilimumab | n2=en:anti-inhibitor coagulant complex feiba nf | rel=r_associated | relid=0 | w=99
  4145. ipilimumab -- r_associated #0: 99 / 0.216 -> en:anti-ksp/anti-vegf sirnas aln-vsp02
    n1=ipilimumab | n2=en:anti-ksp/anti-vegf sirnas aln-vsp02 | rel=r_associated | relid=0 | w=99
  4146. ipilimumab -- r_associated #0: 99 / 0.216 -> en:antibody-drug conjugate sc16ld6.5
    n1=ipilimumab | n2=en:antibody-drug conjugate sc16ld6.5 | rel=r_associated | relid=0 | w=99
  4147. ipilimumab -- r_associated #0: 99 / 0.216 -> en:antiviral agent csj148
    n1=ipilimumab | n2=en:antiviral agent csj148 | rel=r_associated | relid=0 | w=99
  4148. ipilimumab -- r_associated #0: 99 / 0.216 -> en:apolizumab
    n1=ipilimumab | n2=en:apolizumab | rel=r_associated | relid=0 | w=99
  4149. ipilimumab -- r_associated #0: 99 / 0.216 -> en:aprotinin
    n1=ipilimumab | n2=en:aprotinin | rel=r_associated | relid=0 | w=99
  4150. ipilimumab -- r_associated #0: 99 / 0.216 -> en:arsenic
    n1=ipilimumab | n2=en:arsenic | rel=r_associated | relid=0 | w=99
  4151. ipilimumab -- r_associated #0: 99 / 0.216 -> en:aurora kinase inhibitor pf-03814735
    n1=ipilimumab | n2=en:aurora kinase inhibitor pf-03814735 | rel=r_associated | relid=0 | w=99
  4152. ipilimumab -- r_associated #0: 99 / 0.216 -> en:autologous cd8 positive pbl sensitized to drosophila cell-presented melanoma peptides
    n1=ipilimumab | n2=en:autologous cd8 positive pbl sensitized to drosophila cell-presented melanoma peptides | rel=r_associated | relid=0 | w=99
  4153. ipilimumab -- r_associated #0: 99 / 0.216 -> en:autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine
    n1=ipilimumab | n2=en:autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine | rel=r_associated | relid=0 | w=99
  4154. ipilimumab -- r_associated #0: 99 / 0.216 -> en:autologous glioma cell lysate
    n1=ipilimumab | n2=en:autologous glioma cell lysate | rel=r_associated | relid=0 | w=99
  4155. ipilimumab -- r_associated #0: 99 / 0.216 -> en:autologous oxidized ovarian tumor cell lysate vaccine
    n1=ipilimumab | n2=en:autologous oxidized ovarian tumor cell lysate vaccine | rel=r_associated | relid=0 | w=99
  4156. ipilimumab -- r_associated #0: 99 / 0.216 -> en:autologous tumor cell vaccine
    n1=ipilimumab | n2=en:autologous tumor cell vaccine | rel=r_associated | relid=0 | w=99
  4157. ipilimumab -- r_associated #0: 99 / 0.216 -> en:bacitracin
    n1=ipilimumab | n2=en:bacitracin | rel=r_associated | relid=0 | w=99
  4158. ipilimumab -- r_associated #0: 99 / 0.216 -> en:bcr-abl (b3a2)-derived peptide vaccine
    n1=ipilimumab | n2=en:bcr-abl (b3a2)-derived peptide vaccine | rel=r_associated | relid=0 | w=99
  4159. ipilimumab -- r_associated #0: 99 / 0.216 -> en:beta-glucan/lactobacillus casei/bifidobacterium lactis-based supplement
    n1=ipilimumab | n2=en:beta-glucan/lactobacillus casei/bifidobacterium lactis-based supplement | rel=r_associated | relid=0 | w=99
  4160. ipilimumab -- r_associated #0: 99 / 0.216 -> en:biafine cream
    n1=ipilimumab | n2=en:biafine cream | rel=r_associated | relid=0 | w=99
  4161. ipilimumab -- r_associated #0: 99 / 0.216 -> en:bispecific antibody 2b1
    n1=ipilimumab | n2=en:bispecific antibody 2b1 | rel=r_associated | relid=0 | w=99
  4162. ipilimumab -- r_associated #0: 99 / 0.216 -> en:bms-184476
    n1=ipilimumab | n2=en:bms-184476 | rel=r_associated | relid=0 | w=99
  4163. ipilimumab -- r_associated #0: 99 / 0.216 -> en:brivanib alaninate
    n1=ipilimumab | n2=en:brivanib alaninate | rel=r_associated | relid=0 | w=99
  4164. ipilimumab -- r_associated #0: 99 / 0.216 -> en:brivudine phosphoramidate
    n1=ipilimumab | n2=en:brivudine phosphoramidate | rel=r_associated | relid=0 | w=99
  4165. ipilimumab -- r_associated #0: 99 / 0.216 -> en:brontictuzumab
    n1=ipilimumab | n2=en:brontictuzumab | rel=r_associated | relid=0 | w=99
  4166. ipilimumab -- r_associated #0: 99 / 0.216 -> en:butylscopolamine bromide
    n1=ipilimumab | n2=en:butylscopolamine bromide | rel=r_associated | relid=0 | w=99
  4167. ipilimumab -- r_associated #0: 99 / 0.216 -> en:c-kit inhibitor plx9486
    n1=ipilimumab | n2=en:c-kit inhibitor plx9486 | rel=r_associated | relid=0 | w=99
  4168. ipilimumab -- r_associated #0: 99 / 0.216 -> en:calcium aluminosilicate anti-diarrheal
    n1=ipilimumab | n2=en:calcium aluminosilicate anti-diarrheal | rel=r_associated | relid=0 | w=99
  4169. ipilimumab -- r_associated #0: 99 / 0.216 -> en:carbon c 14 ombrabulin
    n1=ipilimumab | n2=en:carbon c 14 ombrabulin | rel=r_associated | relid=0 | w=99
  4170. ipilimumab -- r_associated #0: 99 / 0.216 -> en:carbon c 14 vemurafenib
    n1=ipilimumab | n2=en:carbon c 14 vemurafenib | rel=r_associated | relid=0 | w=99
  4171. ipilimumab -- r_associated #0: 99 / 0.216 -> en:carboxyphenyl retinamide
    n1=ipilimumab | n2=en:carboxyphenyl retinamide | rel=r_associated | relid=0 | w=99
  4172. ipilimumab -- r_associated #0: 99 / 0.216 -> en:carlumab
    n1=ipilimumab | n2=en:carlumab | rel=r_associated | relid=0 | w=99
  4173. ipilimumab -- r_associated #0: 99 / 0.216 -> en:cd3/cd28 costimulated autologous t-cells
    n1=ipilimumab | n2=en:cd3/cd28 costimulated autologous t-cells | rel=r_associated | relid=0 | w=99
  4174. ipilimumab -- r_associated #0: 99 / 0.216 -> en:cd34/tk75-transduced donor lymphocytes
    n1=ipilimumab | n2=en:cd34/tk75-transduced donor lymphocytes | rel=r_associated | relid=0 | w=99
  4175. ipilimumab -- r_associated #0: 99 / 0.216 -> en:cdki r547
    n1=ipilimumab | n2=en:cdki r547 | rel=r_associated | relid=0 | w=99
  4176. ipilimumab -- r_associated #0: 99 / 0.216 -> en:cep-2563 dihydrochloride
    n1=ipilimumab | n2=en:cep-2563 dihydrochloride | rel=r_associated | relid=0 | w=99
  4177. ipilimumab -- r_associated #0: 99 / 0.216 -> en:choline salicylate
    n1=ipilimumab | n2=en:choline salicylate | rel=r_associated | relid=0 | w=99
  4178. ipilimumab -- r_associated #0: 99 / 0.216 -> en:cl 246738
    n1=ipilimumab | n2=en:cl 246738 | rel=r_associated | relid=0 | w=99
  4179. ipilimumab -- r_associated #0: 99 / 0.216 -> en:clofarabine
    n1=ipilimumab | n2=en:clofarabine | rel=r_associated | relid=0 | w=99
  4180. ipilimumab -- r_associated #0: 99 / 0.216 -> en:cobiprostone
    n1=ipilimumab | n2=en:cobiprostone | rel=r_associated | relid=0 | w=99
  4181. ipilimumab -- r_associated #0: 99 / 0.216 -> en:copp-abv regimen
    n1=ipilimumab | n2=en:copp-abv regimen | rel=r_associated | relid=0 | w=99
  4182. ipilimumab -- r_associated #0: 99 / 0.216 -> en:cytomegalovirus ie-1-specific cytotoxic t lymphocytes
    n1=ipilimumab | n2=en:cytomegalovirus ie-1-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=99
  4183. ipilimumab -- r_associated #0: 99 / 0.216 -> en:cytoprotective agent
    n1=ipilimumab | n2=en:cytoprotective agent | rel=r_associated | relid=0 | w=99
  4184. ipilimumab -- r_associated #0: 99 / 0.216 -> en:dach polymer platinate ap5346
    n1=ipilimumab | n2=en:dach polymer platinate ap5346 | rel=r_associated | relid=0 | w=99
  4185. ipilimumab -- r_associated #0: 99 / 0.216 -> en:dach-platin micelle nc-4016
    n1=ipilimumab | n2=en:dach-platin micelle nc-4016 | rel=r_associated | relid=0 | w=99
  4186. ipilimumab -- r_associated #0: 99 / 0.216 -> en:daclatasvir
    n1=ipilimumab | n2=en:daclatasvir | rel=r_associated | relid=0 | w=99
  4187. ipilimumab -- r_associated #0: 99 / 0.216 -> en:dalotuzumab
    n1=ipilimumab | n2=en:dalotuzumab | rel=r_associated | relid=0 | w=99
  4188. ipilimumab -- r_associated #0: 99 / 0.216 -> en:dapsone gel
    n1=ipilimumab | n2=en:dapsone gel | rel=r_associated | relid=0 | w=99
  4189. ipilimumab -- r_associated #0: 99 / 0.216 -> en:dha-paclitaxel
    n1=ipilimumab | n2=en:dha-paclitaxel | rel=r_associated | relid=0 | w=99
  4190. ipilimumab -- r_associated #0: 99 / 0.216 -> en:di-dga-rfb4 immunotoxin
    n1=ipilimumab | n2=en:di-dga-rfb4 immunotoxin | rel=r_associated | relid=0 | w=99
  4191. ipilimumab -- r_associated #0: 99 / 0.216 -> en:diphencyprone
    n1=ipilimumab | n2=en:diphencyprone | rel=r_associated | relid=0 | w=99
  4192. ipilimumab -- r_associated #0: 99 / 0.216 -> en:doxercalciferol
    n1=ipilimumab | n2=en:doxercalciferol | rel=r_associated | relid=0 | w=99
  4193. ipilimumab -- r_associated #0: 99 / 0.216 -> en:drug combinations
    n1=ipilimumab | n2=en:drug combinations | rel=r_associated | relid=0 | w=99
  4194. ipilimumab -- r_associated #0: 99 / 0.216 -> en:e-101 solution
    n1=ipilimumab | n2=en:e-101 solution | rel=r_associated | relid=0 | w=99
  4195. ipilimumab -- r_associated #0: 99 / 0.216 -> en:emricasan
    n1=ipilimumab | n2=en:emricasan | rel=r_associated | relid=0 | w=99
  4196. ipilimumab -- r_associated #0: 99 / 0.216 -> en:erlotinib hydrochloride
    n1=ipilimumab | n2=en:erlotinib hydrochloride | rel=r_associated | relid=0 | w=99
  4197. ipilimumab -- r_associated #0: 99 / 0.216 -> en:escitalopram oxalate
    n1=ipilimumab | n2=en:escitalopram oxalate | rel=r_associated | relid=0 | w=99
  4198. ipilimumab -- r_associated #0: 99 / 0.216 -> en:ethacridine
    n1=ipilimumab | n2=en:ethacridine | rel=r_associated | relid=0 | w=99
  4199. ipilimumab -- r_associated #0: 99 / 0.216 -> en:fasn inhibitor tvb-2640
    n1=ipilimumab | n2=en:fasn inhibitor tvb-2640 | rel=r_associated | relid=0 | w=99
  4200. ipilimumab -- r_associated #0: 99 / 0.216 -> en:febuxostat
    n1=ipilimumab | n2=en:febuxostat | rel=r_associated | relid=0 | w=99
  4201. ipilimumab -- r_associated #0: 99 / 0.216 -> en:flaxseed
    n1=ipilimumab | n2=en:flaxseed | rel=r_associated | relid=0 | w=99
  4202. ipilimumab -- r_associated #0: 99 / 0.216 -> en:flt3/cdk4/6 inhibitor flx925
    n1=ipilimumab | n2=en:flt3/cdk4/6 inhibitor flx925 | rel=r_associated | relid=0 | w=99
  4203. ipilimumab -- r_associated #0: 99 / 0.216 -> en:flucytosine
    n1=ipilimumab | n2=en:flucytosine | rel=r_associated | relid=0 | w=99
  4204. ipilimumab -- r_associated #0: 99 / 0.216 -> en:fluorine f 18 fluoroethylcholine
    n1=ipilimumab | n2=en:fluorine f 18 fluoroethylcholine | rel=r_associated | relid=0 | w=99
  4205. ipilimumab -- r_associated #0: 99 / 0.216 -> en:fluorine f 18 galacto-rgd peptide
    n1=ipilimumab | n2=en:fluorine f 18 galacto-rgd peptide | rel=r_associated | relid=0 | w=99
  4206. ipilimumab -- r_associated #0: 99 / 0.216 -> en:folate binding protein j65 peptide vaccine
    n1=ipilimumab | n2=en:folate binding protein j65 peptide vaccine | rel=r_associated | relid=0 | w=99
  4207. ipilimumab -- r_associated #0: 99 / 0.216 -> en:folfiri regimen
    n1=ipilimumab | n2=en:folfiri regimen | rel=r_associated | relid=0 | w=99
  4208. ipilimumab -- r_associated #0: 99 / 0.216 -> en:folfiri-cetuximab regimen
    n1=ipilimumab | n2=en:folfiri-cetuximab regimen | rel=r_associated | relid=0 | w=99
  4209. ipilimumab -- r_associated #0: 99 / 0.216 -> en:fructooligosaccharide supplement
    n1=ipilimumab | n2=en:fructooligosaccharide supplement | rel=r_associated | relid=0 | w=99
  4210. ipilimumab -- r_associated #0: 99 / 0.216 -> en:gallium ga 68-dota-exendin-4
    n1=ipilimumab | n2=en:gallium ga 68-dota-exendin-4 | rel=r_associated | relid=0 | w=99
  4211. ipilimumab -- r_associated #0: 99 / 0.216 -> en:ginger extract
    n1=ipilimumab | n2=en:ginger extract | rel=r_associated | relid=0 | w=99
  4212. ipilimumab -- r_associated #0: 99 / 0.216 -> en:glutathione disulfide nov-002
    n1=ipilimumab | n2=en:glutathione disulfide nov-002 | rel=r_associated | relid=0 | w=99
  4213. ipilimumab -- r_associated #0: 99 / 0.216 -> en:guanazole
    n1=ipilimumab | n2=en:guanazole | rel=r_associated | relid=0 | w=99
  4214. ipilimumab -- r_associated #0: 99 / 0.216 -> en:her2bi-armed activated t cells
    n1=ipilimumab | n2=en:her2bi-armed activated t cells | rel=r_associated | relid=0 | w=99
  4215. ipilimumab -- r_associated #0: 99 / 0.216 -> en:hormones, synthetic substitutes and antagonists
    n1=ipilimumab | n2=en:hormones, synthetic substitutes and antagonists | rel=r_associated | relid=0 | w=99
  4216. ipilimumab -- r_associated #0: 99 / 0.216 -> en:hpv-6-targeting immunotherapeutic vaccine ino-3106
    n1=ipilimumab | n2=en:hpv-6-targeting immunotherapeutic vaccine ino-3106 | rel=r_associated | relid=0 | w=99
  4217. ipilimumab -- r_associated #0: 99 / 0.216 -> en:human myeloid progenitor cells clt-008
    n1=ipilimumab | n2=en:human myeloid progenitor cells clt-008 | rel=r_associated | relid=0 | w=99
  4218. ipilimumab -- r_associated #0: 99 / 0.216 -> en:idarubicin-eluting beads
    n1=ipilimumab | n2=en:idarubicin-eluting beads | rel=r_associated | relid=0 | w=99
  4219. ipilimumab -- r_associated #0: 99 / 0.216 -> en:idasanutlin
    n1=ipilimumab | n2=en:idasanutlin | rel=r_associated | relid=0 | w=99
  4220. ipilimumab -- r_associated #0: 99 / 0.216 -> en:ido inhibitor nlg919
    n1=ipilimumab | n2=en:ido inhibitor nlg919 | rel=r_associated | relid=0 | w=99
  4221. ipilimumab -- r_associated #0: 99 / 0.216 -> en:ih636 grape seed proanthocyanidin extract
    n1=ipilimumab | n2=en:ih636 grape seed proanthocyanidin extract | rel=r_associated | relid=0 | w=99
  4222. ipilimumab -- r_associated #0: 99 / 0.216 -> en:immunoconjugate ro5479599
    n1=ipilimumab | n2=en:immunoconjugate ro5479599 | rel=r_associated | relid=0 | w=99
  4223. ipilimumab -- r_associated #0: 99 / 0.216 -> en:imt-1012 immunotherapeutic vaccine
    n1=ipilimumab | n2=en:imt-1012 immunotherapeutic vaccine | rel=r_associated | relid=0 | w=99
  4224. ipilimumab -- r_associated #0: 99 / 0.216 -> en:incyclinide
    n1=ipilimumab | n2=en:incyclinide | rel=r_associated | relid=0 | w=99
  4225. ipilimumab -- r_associated #0: 99 / 0.216 -> en:indacaterol
    n1=ipilimumab | n2=en:indacaterol | rel=r_associated | relid=0 | w=99
  4226. ipilimumab -- r_associated #0: 99 / 0.216 -> en:indium in 111-labeled autologous polymorphonuclear leukocytes
    n1=ipilimumab | n2=en:indium in 111-labeled autologous polymorphonuclear leukocytes | rel=r_associated | relid=0 | w=99
  4227. ipilimumab -- r_associated #0: 99 / 0.216 -> en:innate defense regulator sgx942
    n1=ipilimumab | n2=en:innate defense regulator sgx942 | rel=r_associated | relid=0 | w=99
  4228. ipilimumab -- r_associated #0: 99 / 0.216 -> en:inotuzumab ozogamicin
    n1=ipilimumab | n2=en:inotuzumab ozogamicin | rel=r_associated | relid=0 | w=99
  4229. ipilimumab -- r_associated #0: 99 / 0.216 -> en:interleukin-2 fusion protein msb0010445
    n1=ipilimumab | n2=en:interleukin-2 fusion protein msb0010445 | rel=r_associated | relid=0 | w=99
  4230. ipilimumab -- r_associated #0: 99 / 0.216 -> en:iodine i 124 anti-phosphatidylserine monoclonal antibody pgn650
    n1=ipilimumab | n2=en:iodine i 124 anti-phosphatidylserine monoclonal antibody pgn650 | rel=r_associated | relid=0 | w=99
  4231. ipilimumab -- r_associated #0: 99 / 0.216 -> en:iron/vitamin c
    n1=ipilimumab | n2=en:iron/vitamin c | rel=r_associated | relid=0 | w=99
  4232. ipilimumab -- r_associated #0: 99 / 0.216 -> en:irrigation eye brand of benzalkonium chloride
    n1=ipilimumab | n2=en:irrigation eye brand of benzalkonium chloride | rel=r_associated | relid=0 | w=99
  4233. ipilimumab -- r_associated #0: 99 / 0.216 -> en:jak1 inhibitor incb052793
    n1=ipilimumab | n2=en:jak1 inhibitor incb052793 | rel=r_associated | relid=0 | w=99
  4234. ipilimumab -- r_associated #0: 99 / 0.216 -> en:jak2/src inhibitor ns-018
    n1=ipilimumab | n2=en:jak2/src inhibitor ns-018 | rel=r_associated | relid=0 | w=99
  4235. ipilimumab -- r_associated #0: 99 / 0.216 -> en:jin fu kang
    n1=ipilimumab | n2=en:jin fu kang | rel=r_associated | relid=0 | w=99
  4236. ipilimumab -- r_associated #0: 99 / 0.216 -> en:l-ornithine l-aspartate
    n1=ipilimumab | n2=en:l-ornithine l-aspartate | rel=r_associated | relid=0 | w=99
  4237. ipilimumab -- r_associated #0: 99 / 0.216 -> en:laniquidar
    n1=ipilimumab | n2=en:laniquidar | rel=r_associated | relid=0 | w=99
  4238. ipilimumab -- r_associated #0: 99 / 0.216 -> en:lerisetron
    n1=ipilimumab | n2=en:lerisetron | rel=r_associated | relid=0 | w=99
  4239. ipilimumab -- r_associated #0: 99 / 0.216 -> en:ly6k/vegfr1/vegfr2 multipeptide vaccine
    n1=ipilimumab | n2=en:ly6k/vegfr1/vegfr2 multipeptide vaccine | rel=r_associated | relid=0 | w=99
  4240. ipilimumab -- r_associated #0: 99 / 0.216 -> en:macitentan
    n1=ipilimumab | n2=en:macitentan | rel=r_associated | relid=0 | w=99
  4241. ipilimumab -- r_associated #0: 99 / 0.216 -> en:mdm2 antagonist ro6839921
    n1=ipilimumab | n2=en:mdm2 antagonist ro6839921 | rel=r_associated | relid=0 | w=99
  4242. ipilimumab -- r_associated #0: 99 / 0.216 -> en:mdm2/mdmx inhibitor alrn-6924
    n1=ipilimumab | n2=en:mdm2/mdmx inhibitor alrn-6924 | rel=r_associated | relid=0 | w=99
  4243. ipilimumab -- r_associated #0: 99 / 0.216 -> en:mercuric cyanide
    n1=ipilimumab | n2=en:mercuric cyanide | rel=r_associated | relid=0 | w=99
  4244. ipilimumab -- r_associated #0: 99 / 0.216 -> en:miltefosine
    n1=ipilimumab | n2=en:miltefosine | rel=r_associated | relid=0 | w=99
  4245. ipilimumab -- r_associated #0: 99 / 0.216 -> en:muc-2-globo h-klh conjugate vaccine
    n1=ipilimumab | n2=en:muc-2-globo h-klh conjugate vaccine | rel=r_associated | relid=0 | w=99
  4246. ipilimumab -- r_associated #0: 99 / 0.216 -> en:muc1-klh conjugate vaccine
    n1=ipilimumab | n2=en:muc1-klh conjugate vaccine | rel=r_associated | relid=0 | w=99
  4247. ipilimumab -- r_associated #0: 99 / 0.216 -> en:multi-epitope folate receptor alpha peptide vaccine
    n1=ipilimumab | n2=en:multi-epitope folate receptor alpha peptide vaccine | rel=r_associated | relid=0 | w=99
  4248. ipilimumab -- r_associated #0: 99 / 0.216 -> en:narnatumab
    n1=ipilimumab | n2=en:narnatumab | rel=r_associated | relid=0 | w=99
  4249. ipilimumab -- r_associated #0: 99 / 0.216 -> en:neratinib
    n1=ipilimumab | n2=en:neratinib | rel=r_associated | relid=0 | w=99
  4250. ipilimumab -- r_associated #0: 99 / 0.216 -> en:niacinamide
    n1=ipilimumab | n2=en:niacinamide | rel=r_associated | relid=0 | w=99
  4251. ipilimumab -- r_associated #0: 99 / 0.216 -> en:non-small cell lung cancer mrna-derived vaccine cv9201
    n1=ipilimumab | n2=en:non-small cell lung cancer mrna-derived vaccine cv9201 | rel=r_associated | relid=0 | w=99
  4252. ipilimumab -- r_associated #0: 99 / 0.216 -> en:ocaratuzumab
    n1=ipilimumab | n2=en:ocaratuzumab | rel=r_associated | relid=0 | w=99
  4253. ipilimumab -- r_associated #0: 99 / 0.216 -> en:ocrelizumab
    n1=ipilimumab | n2=en:ocrelizumab | rel=r_associated | relid=0 | w=99
  4254. ipilimumab -- r_associated #0: 99 / 0.216 -> en:ocv-103
    n1=ipilimumab | n2=en:ocv-103 | rel=r_associated | relid=0 | w=99
  4255. ipilimumab -- r_associated #0: 99 / 0.216 -> en:oxidopamine
    n1=ipilimumab | n2=en:oxidopamine | rel=r_associated | relid=0 | w=99
  4256. ipilimumab -- r_associated #0: 99 / 0.216 -> en:pad regimen
    n1=ipilimumab | n2=en:pad regimen | rel=r_associated | relid=0 | w=99
  4257. ipilimumab -- r_associated #0: 99 / 0.216 -> en:parenteral dosage form product
    n1=ipilimumab | n2=en:parenteral dosage form product | rel=r_associated | relid=0 | w=99
  4258. ipilimumab -- r_associated #0: 99 / 0.216 -> en:pdcd-1 knockout autologous t-lymphocytes
    n1=ipilimumab | n2=en:pdcd-1 knockout autologous t-lymphocytes | rel=r_associated | relid=0 | w=99
  4259. ipilimumab -- r_associated #0: 99 / 0.216 -> en:pegamotecan
    n1=ipilimumab | n2=en:pegamotecan | rel=r_associated | relid=0 | w=99
  4260. ipilimumab -- r_associated #0: 99 / 0.216 -> en:pegylated liposomal mitomycin c lipid-based prodrug
    n1=ipilimumab | n2=en:pegylated liposomal mitomycin c lipid-based prodrug | rel=r_associated | relid=0 | w=99
  4261. ipilimumab -- r_associated #0: 99 / 0.216 -> en:pembrolizumab
    n1=ipilimumab | n2=en:pembrolizumab | rel=r_associated | relid=0 | w=99
  4262. ipilimumab -- r_associated #0: 99 / 0.216 -> en:pentostatin
    n1=ipilimumab | n2=en:pentostatin | rel=r_associated | relid=0 | w=99
  4263. ipilimumab -- r_associated #0: 99 / 0.216 -> en:ph20 hyaluronidase-expressing adenovirus vcn-01
    n1=ipilimumab | n2=en:ph20 hyaluronidase-expressing adenovirus vcn-01 | rel=r_associated | relid=0 | w=99
  4264. ipilimumab -- r_associated #0: 99 / 0.216 -> en:pi3k-beta inhibitor gsk2636771
    n1=ipilimumab | n2=en:pi3k-beta inhibitor gsk2636771 | rel=r_associated | relid=0 | w=99
  4265. ipilimumab -- r_associated #0: 99 / 0.216 -> en:pi3k/mtor inhibitor ly3023414
    n1=ipilimumab | n2=en:pi3k/mtor inhibitor ly3023414 | rel=r_associated | relid=0 | w=99
  4266. ipilimumab -- r_associated #0: 99 / 0.216 -> en:pibenzimol
    n1=ipilimumab | n2=en:pibenzimol | rel=r_associated | relid=0 | w=99
  4267. ipilimumab -- r_associated #0: 99 / 0.216 -> en:picropodophyllin
    n1=ipilimumab | n2=en:picropodophyllin | rel=r_associated | relid=0 | w=99
  4268. ipilimumab -- r_associated #0: 99 / 0.216 -> en:pimecrolimus
    n1=ipilimumab | n2=en:pimecrolimus | rel=r_associated | relid=0 | w=99
  4269. ipilimumab -- r_associated #0: 99 / 0.216 -> en:pneumococcal polyvalent vaccine
    n1=ipilimumab | n2=en:pneumococcal polyvalent vaccine | rel=r_associated | relid=0 | w=99
  4270. ipilimumab -- r_associated #0: 99 / 0.216 -> en:polyamine analogue pg11047
    n1=ipilimumab | n2=en:polyamine analogue pg11047 | rel=r_associated | relid=0 | w=99
  4271. ipilimumab -- r_associated #0: 99 / 0.216 -> en:prame-targeting t-cell receptor/inducible caspase 9 bpx-701
    n1=ipilimumab | n2=en:prame-targeting t-cell receptor/inducible caspase 9 bpx-701 | rel=r_associated | relid=0 | w=99
  4272. ipilimumab -- r_associated #0: 99 / 0.216 -> en:prescription drugs
    n1=ipilimumab | n2=en:prescription drugs | rel=r_associated | relid=0 | w=99
  4273. ipilimumab -- r_associated #0: 99 / 0.216 -> en:quinoline
    n1=ipilimumab | n2=en:quinoline | rel=r_associated | relid=0 | w=99
  4274. ipilimumab -- r_associated #0: 99 / 0.216 -> en:ranolazine
    n1=ipilimumab | n2=en:ranolazine | rel=r_associated | relid=0 | w=99
  4275. ipilimumab -- r_associated #0: 99 / 0.216 -> en:rar-alpha agonist vtp195183
    n1=ipilimumab | n2=en:rar-alpha agonist vtp195183 | rel=r_associated | relid=0 | w=99
  4276. ipilimumab -- r_associated #0: 99 / 0.216 -> en:recombinant adenovirus-interferon sch 721015
    n1=ipilimumab | n2=en:recombinant adenovirus-interferon sch 721015 | rel=r_associated | relid=0 | w=99
  4277. ipilimumab -- r_associated #0: 99 / 0.216 -> en:recombinant super-compound interferon
    n1=ipilimumab | n2=en:recombinant super-compound interferon | rel=r_associated | relid=0 | w=99
  4278. ipilimumab -- r_associated #0: 99 / 0.216 -> en:ruthenium-based transferrin targeting agent nkp-1339
    n1=ipilimumab | n2=en:ruthenium-based transferrin targeting agent nkp-1339 | rel=r_associated | relid=0 | w=99
  4279. ipilimumab -- r_associated #0: 99 / 0.216 -> en:sagopilone
    n1=ipilimumab | n2=en:sagopilone | rel=r_associated | relid=0 | w=99
  4280. ipilimumab -- r_associated #0: 99 / 0.216 -> en:selective estrogen receptor degrader arn-810
    n1=ipilimumab | n2=en:selective estrogen receptor degrader arn-810 | rel=r_associated | relid=0 | w=99
  4281. ipilimumab -- r_associated #0: 99 / 0.216 -> en:sevacizumab
    n1=ipilimumab | n2=en:sevacizumab | rel=r_associated | relid=0 | w=99
  4282. ipilimumab -- r_associated #0: 99 / 0.216 -> en:sodium stibogluconate
    n1=ipilimumab | n2=en:sodium stibogluconate | rel=r_associated | relid=0 | w=99
  4283. ipilimumab -- r_associated #0: 99 / 0.216 -> en:sparfosic acid
    n1=ipilimumab | n2=en:sparfosic acid | rel=r_associated | relid=0 | w=99
  4284. ipilimumab -- r_associated #0: 99 / 0.216 -> en:splicing inhibitor h3b-8800
    n1=ipilimumab | n2=en:splicing inhibitor h3b-8800 | rel=r_associated | relid=0 | w=99
  4285. ipilimumab -- r_associated #0: 99 / 0.216 -> en:su014813
    n1=ipilimumab | n2=en:su014813 | rel=r_associated | relid=0 | w=99
  4286. ipilimumab -- r_associated #0: 99 / 0.216 -> en:tasisulam
    n1=ipilimumab | n2=en:tasisulam | rel=r_associated | relid=0 | w=99
  4287. ipilimumab -- r_associated #0: 99 / 0.216 -> en:technetium tc-99m dtpa
    n1=ipilimumab | n2=en:technetium tc-99m dtpa | rel=r_associated | relid=0 | w=99
  4288. ipilimumab -- r_associated #0: 99 / 0.216 -> en:technetium tc-99m medronate
    n1=ipilimumab | n2=en:technetium tc-99m medronate | rel=r_associated | relid=0 | w=99
  4289. ipilimumab -- r_associated #0: 99 / 0.216 -> en:tegafur
    n1=ipilimumab | n2=en:tegafur | rel=r_associated | relid=0 | w=99
  4290. ipilimumab -- r_associated #0: 99 / 0.216 -> en:tenifatecan
    n1=ipilimumab | n2=en:tenifatecan | rel=r_associated | relid=0 | w=99
  4291. ipilimumab -- r_associated #0: 99 / 0.216 -> en:tetravalent rna-lipoplex cancer vaccine
    n1=ipilimumab | n2=en:tetravalent rna-lipoplex cancer vaccine | rel=r_associated | relid=0 | w=99
  4292. ipilimumab -- r_associated #0: 99 / 0.216 -> en:therapeutic allogeneic lymphocytes
    n1=ipilimumab | n2=en:therapeutic allogeneic lymphocytes | rel=r_associated | relid=0 | w=99
  4293. ipilimumab -- r_associated #0: 99 / 0.216 -> en:therapeutic melatonin
    n1=ipilimumab | n2=en:therapeutic melatonin | rel=r_associated | relid=0 | w=99
  4294. ipilimumab -- r_associated #0: 99 / 0.216 -> en:thiabendazole
    n1=ipilimumab | n2=en:thiabendazole | rel=r_associated | relid=0 | w=99
  4295. ipilimumab -- r_associated #0: 99 / 0.216 -> en:toll-like receptor 9 agonist imo-2125
    n1=ipilimumab | n2=en:toll-like receptor 9 agonist imo-2125 | rel=r_associated | relid=0 | w=99
  4296. ipilimumab -- r_associated #0: 99 / 0.216 -> en:tpf regimen
    n1=ipilimumab | n2=en:tpf regimen | rel=r_associated | relid=0 | w=99
  4297. ipilimumab -- r_associated #0: 99 / 0.216 -> en:trebananib
    n1=ipilimumab | n2=en:trebananib | rel=r_associated | relid=0 | w=99
  4298. ipilimumab -- r_associated #0: 99 / 0.216 -> en:triazene derivative trin2755
    n1=ipilimumab | n2=en:triazene derivative trin2755 | rel=r_associated | relid=0 | w=99
  4299. ipilimumab -- r_associated #0: 99 / 0.216 -> en:tumor-homing peptide irgd
    n1=ipilimumab | n2=en:tumor-homing peptide irgd | rel=r_associated | relid=0 | w=99
  4300. ipilimumab -- r_associated #0: 99 / 0.216 -> en:tyrosinase related protein-1
    n1=ipilimumab | n2=en:tyrosinase related protein-1 | rel=r_associated | relid=0 | w=99
  4301. ipilimumab -- r_associated #0: 99 / 0.216 -> en:vaccine-sensitized draining lymph node cells
    n1=ipilimumab | n2=en:vaccine-sensitized draining lymph node cells | rel=r_associated | relid=0 | w=99
  4302. ipilimumab -- r_associated #0: 99 / 0.216 -> en:vandetanib
    n1=ipilimumab | n2=en:vandetanib | rel=r_associated | relid=0 | w=99
  4303. ipilimumab -- r_associated #0: 99 / 0.216 -> en:vascular disrupting agent zd6126
    n1=ipilimumab | n2=en:vascular disrupting agent zd6126 | rel=r_associated | relid=0 | w=99
  4304. ipilimumab -- r_associated #0: 99 / 0.216 -> en:vegfr/fgfr inhibitor odm-203
    n1=ipilimumab | n2=en:vegfr/fgfr inhibitor odm-203 | rel=r_associated | relid=0 | w=99
  4305. ipilimumab -- r_associated #0: 99 / 0.216 -> en:wee1 inhibitor azd1775
    n1=ipilimumab | n2=en:wee1 inhibitor azd1775 | rel=r_associated | relid=0 | w=99
  4306. ipilimumab -- r_associated #0: 99 / 0.216 -> en:wt1 mrna-electroporated autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:wt1 mrna-electroporated autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=99
  4307. ipilimumab -- r_associated #0: 99 / 0.216 -> en:yttrium y 90 resin microspheres
    n1=ipilimumab | n2=en:yttrium y 90 resin microspheres | rel=r_associated | relid=0 | w=99
  4308. ipilimumab -- r_associated #0: 99 / 0.216 -> lymphocyte
    n1=ipilimumab | n2=lymphocyte | rel=r_associated | relid=0 | w=99
  4309. ipilimumab -- r_associated #0: 99 / 0.216 -> lymphocyte T
    n1=ipilimumab | n2=lymphocyte T | rel=r_associated | relid=0 | w=99
  4310. ipilimumab -- r_associated #0: 98 / 0.214 -> en:10 ml ipilimumab 5 mg/ml injection [yervoy]
    n1=ipilimumab | n2=en:10 ml ipilimumab 5 mg/ml injection [yervoy] | rel=r_associated | relid=0 | w=98
  4311. ipilimumab -- r_associated #0: 98 / 0.214 -> en:adecatumumab
    n1=ipilimumab | n2=en:adecatumumab | rel=r_associated | relid=0 | w=98
  4312. ipilimumab -- r_associated #0: 98 / 0.214 -> en:allogeneic multipotent adult progenitor cells
    n1=ipilimumab | n2=en:allogeneic multipotent adult progenitor cells | rel=r_associated | relid=0 | w=98
  4313. ipilimumab -- r_associated #0: 98 / 0.214 -> en:aloe/anise/ascorbic acid/clove/peppermint/spearmint/thyme-based mouthwash
    n1=ipilimumab | n2=en:aloe/anise/ascorbic acid/clove/peppermint/spearmint/thyme-based mouthwash | rel=r_associated | relid=0 | w=98
  4314. ipilimumab -- r_associated #0: 98 / 0.214 -> en:aluminum sulfate
    n1=ipilimumab | n2=en:aluminum sulfate | rel=r_associated | relid=0 | w=98
  4315. ipilimumab -- r_associated #0: 98 / 0.214 -> en:ancitabine hydrochloride
    n1=ipilimumab | n2=en:ancitabine hydrochloride | rel=r_associated | relid=0 | w=98
  4316. ipilimumab -- r_associated #0: 98 / 0.214 -> en:anti-c-met monoclonal antibody ly2875358
    n1=ipilimumab | n2=en:anti-c-met monoclonal antibody ly2875358 | rel=r_associated | relid=0 | w=98
  4317. ipilimumab -- r_associated #0: 98 / 0.214 -> en:anti-fgfr4 monoclonal antibody u3-1784
    n1=ipilimumab | n2=en:anti-fgfr4 monoclonal antibody u3-1784 | rel=r_associated | relid=0 | w=98
  4318. ipilimumab -- r_associated #0: 98 / 0.214 -> en:anti-thyroglobulin mtcr-transduced autologous peripheral blood lymphocytes
    n1=ipilimumab | n2=en:anti-thyroglobulin mtcr-transduced autologous peripheral blood lymphocytes | rel=r_associated | relid=0 | w=98
  4319. ipilimumab -- r_associated #0: 98 / 0.214 -> en:antibody-drug conjugate abbv-399
    n1=ipilimumab | n2=en:antibody-drug conjugate abbv-399 | rel=r_associated | relid=0 | w=98
  4320. ipilimumab -- r_associated #0: 98 / 0.214 -> en:antibody-drug conjugate abbv-838
    n1=ipilimumab | n2=en:antibody-drug conjugate abbv-838 | rel=r_associated | relid=0 | w=98
  4321. ipilimumab -- r_associated #0: 98 / 0.214 -> en:arzoxifene hydrochloride
    n1=ipilimumab | n2=en:arzoxifene hydrochloride | rel=r_associated | relid=0 | w=98
  4322. ipilimumab -- r_associated #0: 98 / 0.214 -> en:autologous cd19-28z chimeric antigen receptor-expressing t-lymphocytes
    n1=ipilimumab | n2=en:autologous cd19-28z chimeric antigen receptor-expressing t-lymphocytes | rel=r_associated | relid=0 | w=98
  4323. ipilimumab -- r_associated #0: 98 / 0.214 -> en:autologous hbv-specific tcr-redirected t-lymphocytes
    n1=ipilimumab | n2=en:autologous hbv-specific tcr-redirected t-lymphocytes | rel=r_associated | relid=0 | w=98
  4324. ipilimumab -- r_associated #0: 98 / 0.214 -> en:barium sulfate
    n1=ipilimumab | n2=en:barium sulfate | rel=r_associated | relid=0 | w=98
  4325. ipilimumab -- r_associated #0: 98 / 0.214 -> en:broccoli sprout extract
    n1=ipilimumab | n2=en:broccoli sprout extract | rel=r_associated | relid=0 | w=98
  4326. ipilimumab -- r_associated #0: 98 / 0.214 -> en:budotitane
    n1=ipilimumab | n2=en:budotitane | rel=r_associated | relid=0 | w=98
  4327. ipilimumab -- r_associated #0: 98 / 0.214 -> en:caix inhibitor dtp348
    n1=ipilimumab | n2=en:caix inhibitor dtp348 | rel=r_associated | relid=0 | w=98
  4328. ipilimumab -- r_associated #0: 98 / 0.214 -> en:cd80 breast cancer vaccine
    n1=ipilimumab | n2=en:cd80 breast cancer vaccine | rel=r_associated | relid=0 | w=98
  4329. ipilimumab -- r_associated #0: 98 / 0.214 -> en:ciclopirox olamine oral
    n1=ipilimumab | n2=en:ciclopirox olamine oral | rel=r_associated | relid=0 | w=98
  4330. ipilimumab -- r_associated #0: 98 / 0.214 -> en:copper cu 64-dota-ae105
    n1=ipilimumab | n2=en:copper cu 64-dota-ae105 | rel=r_associated | relid=0 | w=98
  4331. ipilimumab -- r_associated #0: 98 / 0.214 -> en:crisnatol mesylate
    n1=ipilimumab | n2=en:crisnatol mesylate | rel=r_associated | relid=0 | w=98
  4332. ipilimumab -- r_associated #0: 98 / 0.214 -> en:cycloleucine
    n1=ipilimumab | n2=en:cycloleucine | rel=r_associated | relid=0 | w=98
  4333. ipilimumab -- r_associated #0: 98 / 0.214 -> en:dioscorea nipponica makino extract dne3
    n1=ipilimumab | n2=en:dioscorea nipponica makino extract dne3 | rel=r_associated | relid=0 | w=98
  4334. ipilimumab -- r_associated #0: 98 / 0.214 -> en:doxorubicin-magnetic targeted carrier complex
    n1=ipilimumab | n2=en:doxorubicin-magnetic targeted carrier complex | rel=r_associated | relid=0 | w=98
  4335. ipilimumab -- r_associated #0: 98 / 0.214 -> en:dual igf-1r/insr inhibitor bms-754807
    n1=ipilimumab | n2=en:dual igf-1r/insr inhibitor bms-754807 | rel=r_associated | relid=0 | w=98
  4336. ipilimumab -- r_associated #0: 98 / 0.214 -> en:epoetin beta
    n1=ipilimumab | n2=en:epoetin beta | rel=r_associated | relid=0 | w=98
  4337. ipilimumab -- r_associated #0: 98 / 0.214 -> en:epothilone d
    n1=ipilimumab | n2=en:epothilone d | rel=r_associated | relid=0 | w=98
  4338. ipilimumab -- r_associated #0: 98 / 0.214 -> en:eribulin mesylate
    n1=ipilimumab | n2=en:eribulin mesylate | rel=r_associated | relid=0 | w=98
  4339. ipilimumab -- r_associated #0: 98 / 0.214 -> en:everolimus
    n1=ipilimumab | n2=en:everolimus | rel=r_associated | relid=0 | w=98
  4340. ipilimumab -- r_associated #0: 98 / 0.214 -> en:famitinib
    n1=ipilimumab | n2=en:famitinib | rel=r_associated | relid=0 | w=98
  4341. ipilimumab -- r_associated #0: 98 / 0.214 -> en:fidaxomicin
    n1=ipilimumab | n2=en:fidaxomicin | rel=r_associated | relid=0 | w=98
  4342. ipilimumab -- r_associated #0: 98 / 0.214 -> en:fluorine f 18 bay 86-9596
    n1=ipilimumab | n2=en:fluorine f 18 bay 86-9596 | rel=r_associated | relid=0 | w=98
  4343. ipilimumab -- r_associated #0: 98 / 0.214 -> en:fluorine f 18 dcfpyl
    n1=ipilimumab | n2=en:fluorine f 18 dcfpyl | rel=r_associated | relid=0 | w=98
  4344. ipilimumab -- r_associated #0: 98 / 0.214 -> en:fluorine f 18 fluorobenzyl triphenyl phosphonium
    n1=ipilimumab | n2=en:fluorine f 18 fluorobenzyl triphenyl phosphonium | rel=r_associated | relid=0 | w=98
  4345. ipilimumab -- r_associated #0: 98 / 0.214 -> en:gallium ga 68 ops202
    n1=ipilimumab | n2=en:gallium ga 68 ops202 | rel=r_associated | relid=0 | w=98
  4346. ipilimumab -- r_associated #0: 98 / 0.214 -> en:ganoderma lucidum spores powder capsule
    n1=ipilimumab | n2=en:ganoderma lucidum spores powder capsule | rel=r_associated | relid=0 | w=98
  4347. ipilimumab -- r_associated #0: 98 / 0.214 -> en:ginsenoside rg3 capsule
    n1=ipilimumab | n2=en:ginsenoside rg3 capsule | rel=r_associated | relid=0 | w=98
  4348. ipilimumab -- r_associated #0: 98 / 0.214 -> en:glyt2/5ht2a antagonist vvz-149
    n1=ipilimumab | n2=en:glyt2/5ht2a antagonist vvz-149 | rel=r_associated | relid=0 | w=98
  4349. ipilimumab -- r_associated #0: 98 / 0.214 -> en:gout suppressants
    n1=ipilimumab | n2=en:gout suppressants | rel=r_associated | relid=0 | w=98
  4350. ipilimumab -- r_associated #0: 98 / 0.214 -> en:hla-a1-binding mage-1/mage-3 multipeptide-pulsed autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:hla-a1-binding mage-1/mage-3 multipeptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=98
  4351. ipilimumab -- r_associated #0: 98 / 0.214 -> en:human menopausal gonadotropin
    n1=ipilimumab | n2=en:human menopausal gonadotropin | rel=r_associated | relid=0 | w=98
  4352. ipilimumab -- r_associated #0: 98 / 0.214 -> en:ibuprofen / phenylephrine
    n1=ipilimumab | n2=en:ibuprofen / phenylephrine | rel=r_associated | relid=0 | w=98
  4353. ipilimumab -- r_associated #0: 98 / 0.214 -> en:in 111 monoclonal antibody ll2
    n1=ipilimumab | n2=en:in 111 monoclonal antibody ll2 | rel=r_associated | relid=0 | w=98
  4354. ipilimumab -- r_associated #0: 98 / 0.214 -> en:inactivated poliovirus vaccine
    n1=ipilimumab | n2=en:inactivated poliovirus vaccine | rel=r_associated | relid=0 | w=98
  4355. ipilimumab -- r_associated #0: 98 / 0.214 -> en:inamrinone
    n1=ipilimumab | n2=en:inamrinone | rel=r_associated | relid=0 | w=98
  4356. ipilimumab -- r_associated #0: 98 / 0.214 -> en:insulin sensitizer s-707106
    n1=ipilimumab | n2=en:insulin sensitizer s-707106 | rel=r_associated | relid=0 | w=98
  4357. ipilimumab -- r_associated #0: 98 / 0.214 -> en:interferon beta-1b
    n1=ipilimumab | n2=en:interferon beta-1b | rel=r_associated | relid=0 | w=98
  4358. ipilimumab -- r_associated #0: 98 / 0.214 -> en:iodine i 124-crgdy-peg-c dots
    n1=ipilimumab | n2=en:iodine i 124-crgdy-peg-c dots | rel=r_associated | relid=0 | w=98
  4359. ipilimumab -- r_associated #0: 98 / 0.214 -> en:iodine i-123 adam
    n1=ipilimumab | n2=en:iodine i-123 adam | rel=r_associated | relid=0 | w=98
  4360. ipilimumab -- r_associated #0: 98 / 0.214 -> en:ipp-204106n
    n1=ipilimumab | n2=en:ipp-204106n | rel=r_associated | relid=0 | w=98
  4361. ipilimumab -- r_associated #0: 98 / 0.214 -> en:irinotecan-eluting beads
    n1=ipilimumab | n2=en:irinotecan-eluting beads | rel=r_associated | relid=0 | w=98
  4362. ipilimumab -- r_associated #0: 98 / 0.214 -> en:isopropyl myristate
    n1=ipilimumab | n2=en:isopropyl myristate | rel=r_associated | relid=0 | w=98
  4363. ipilimumab -- r_associated #0: 98 / 0.214 -> en:jak2 inhibitor wp1066
    n1=ipilimumab | n2=en:jak2 inhibitor wp1066 | rel=r_associated | relid=0 | w=98
  4364. ipilimumab -- r_associated #0: 98 / 0.214 -> en:lesinurad
    n1=ipilimumab | n2=en:lesinurad | rel=r_associated | relid=0 | w=98
  4365. ipilimumab -- r_associated #0: 98 / 0.214 -> en:lithium carbonate
    n1=ipilimumab | n2=en:lithium carbonate | rel=r_associated | relid=0 | w=98
  4366. ipilimumab -- r_associated #0: 98 / 0.214 -> en:live freeze-dried lactic acid bacteria probiotic
    n1=ipilimumab | n2=en:live freeze-dried lactic acid bacteria probiotic | rel=r_associated | relid=0 | w=98
  4367. ipilimumab -- r_associated #0: 98 / 0.214 -> en:mcl-1 inhibitor amg 176
    n1=ipilimumab | n2=en:mcl-1 inhibitor amg 176 | rel=r_associated | relid=0 | w=98
  4368. ipilimumab -- r_associated #0: 98 / 0.214 -> en:methoxyamine
    n1=ipilimumab | n2=en:methoxyamine | rel=r_associated | relid=0 | w=98
  4369. ipilimumab -- r_associated #0: 98 / 0.214 -> en:misonidazole
    n1=ipilimumab | n2=en:misonidazole | rel=r_associated | relid=0 | w=98
  4370. ipilimumab -- r_associated #0: 98 / 0.214 -> en:mtor kinase inhibitor cc-223
    n1=ipilimumab | n2=en:mtor kinase inhibitor cc-223 | rel=r_associated | relid=0 | w=98
  4371. ipilimumab -- r_associated #0: 98 / 0.214 -> en:na17-a antigen
    n1=ipilimumab | n2=en:na17-a antigen | rel=r_associated | relid=0 | w=98
  4372. ipilimumab -- r_associated #0: 98 / 0.214 -> en:nanoparticle-encapsulated doxorubicin hydrochloride
    n1=ipilimumab | n2=en:nanoparticle-encapsulated doxorubicin hydrochloride | rel=r_associated | relid=0 | w=98
  4373. ipilimumab -- r_associated #0: 98 / 0.214 -> en:naptumomab
    n1=ipilimumab | n2=en:naptumomab | rel=r_associated | relid=0 | w=98
  4374. ipilimumab -- r_associated #0: 98 / 0.214 -> en:nedaplatin
    n1=ipilimumab | n2=en:nedaplatin | rel=r_associated | relid=0 | w=98
  4375. ipilimumab -- r_associated #0: 98 / 0.214 -> en:oxcarbazepine
    n1=ipilimumab | n2=en:oxcarbazepine | rel=r_associated | relid=0 | w=98
  4376. ipilimumab -- r_associated #0: 98 / 0.214 -> en:pbcar3/pirs2-phosphopeptide-tetanus peptide vaccine
    n1=ipilimumab | n2=en:pbcar3/pirs2-phosphopeptide-tetanus peptide vaccine | rel=r_associated | relid=0 | w=98
  4377. ipilimumab -- r_associated #0: 98 / 0.214 -> en:pegfilgrastim biosimilar la-ep2006
    n1=ipilimumab | n2=en:pegfilgrastim biosimilar la-ep2006 | rel=r_associated | relid=0 | w=98
  4378. ipilimumab -- r_associated #0: 98 / 0.214 -> en:pegylated recombinant l-asparaginase erwinia chrysanthemi
    n1=ipilimumab | n2=en:pegylated recombinant l-asparaginase erwinia chrysanthemi | rel=r_associated | relid=0 | w=98
  4379. ipilimumab -- r_associated #0: 98 / 0.214 -> en:penclomedine
    n1=ipilimumab | n2=en:penclomedine | rel=r_associated | relid=0 | w=98
  4380. ipilimumab -- r_associated #0: 98 / 0.214 -> en:pi3k/mtor kinase inhibitor ds-7423
    n1=ipilimumab | n2=en:pi3k/mtor kinase inhibitor ds-7423 | rel=r_associated | relid=0 | w=98
  4381. ipilimumab -- r_associated #0: 98 / 0.214 -> en:piritrexim
    n1=ipilimumab | n2=en:piritrexim | rel=r_associated | relid=0 | w=98
  4382. ipilimumab -- r_associated #0: 98 / 0.214 -> en:procarbazine
    n1=ipilimumab | n2=en:procarbazine | rel=r_associated | relid=0 | w=98
  4383. ipilimumab -- r_associated #0: 98 / 0.214 -> en:psilocybine
    n1=ipilimumab | n2=en:psilocybine | rel=r_associated | relid=0 | w=98
  4384. ipilimumab -- r_associated #0: 98 / 0.214 -> en:razoxane
    n1=ipilimumab | n2=en:razoxane | rel=r_associated | relid=0 | w=98
  4385. ipilimumab -- r_associated #0: 98 / 0.214 -> en:recombinant adenovirus-l523s vaccine
    n1=ipilimumab | n2=en:recombinant adenovirus-l523s vaccine | rel=r_associated | relid=0 | w=98
  4386. ipilimumab -- r_associated #0: 98 / 0.214 -> en:recombinant modified vaccinia ankara-5t4 vaccine
    n1=ipilimumab | n2=en:recombinant modified vaccinia ankara-5t4 vaccine | rel=r_associated | relid=0 | w=98
  4387. ipilimumab -- r_associated #0: 98 / 0.214 -> en:recombinant parathyroid hormone
    n1=ipilimumab | n2=en:recombinant parathyroid hormone | rel=r_associated | relid=0 | w=98
  4388. ipilimumab -- r_associated #0: 98 / 0.214 -> en:recombinant tumor necrosis factor family protein
    n1=ipilimumab | n2=en:recombinant tumor necrosis factor family protein | rel=r_associated | relid=0 | w=98
  4389. ipilimumab -- r_associated #0: 98 / 0.214 -> en:recombinant tyrosinase-related protein-2
    n1=ipilimumab | n2=en:recombinant tyrosinase-related protein-2 | rel=r_associated | relid=0 | w=98
  4390. ipilimumab -- r_associated #0: 98 / 0.214 -> en:ribonuclease qbi-139
    n1=ipilimumab | n2=en:ribonuclease qbi-139 | rel=r_associated | relid=0 | w=98
  4391. ipilimumab -- r_associated #0: 98 / 0.214 -> en:ro6895882
    n1=ipilimumab | n2=en:ro6895882 | rel=r_associated | relid=0 | w=98
  4392. ipilimumab -- r_associated #0: 98 / 0.214 -> en:rolapitant hydrochloride
    n1=ipilimumab | n2=en:rolapitant hydrochloride | rel=r_associated | relid=0 | w=98
  4393. ipilimumab -- r_associated #0: 98 / 0.214 -> en:rsv fusion inhibitor gs-5806
    n1=ipilimumab | n2=en:rsv fusion inhibitor gs-5806 | rel=r_associated | relid=0 | w=98
  4394. ipilimumab -- r_associated #0: 98 / 0.214 -> en:ruxolitinib
    n1=ipilimumab | n2=en:ruxolitinib | rel=r_associated | relid=0 | w=98
  4395. ipilimumab -- r_associated #0: 98 / 0.214 -> en:saxagliptin hydrochloride
    n1=ipilimumab | n2=en:saxagliptin hydrochloride | rel=r_associated | relid=0 | w=98
  4396. ipilimumab -- r_associated #0: 98 / 0.214 -> en:src/tubulin inhibitor kx02
    n1=ipilimumab | n2=en:src/tubulin inhibitor kx02 | rel=r_associated | relid=0 | w=98
  4397. ipilimumab -- r_associated #0: 98 / 0.214 -> en:staphage lysate
    n1=ipilimumab | n2=en:staphage lysate | rel=r_associated | relid=0 | w=98
  4398. ipilimumab -- r_associated #0: 98 / 0.214 -> en:talabostat mesylate
    n1=ipilimumab | n2=en:talabostat mesylate | rel=r_associated | relid=0 | w=98
  4399. ipilimumab -- r_associated #0: 98 / 0.214 -> en:telotristat etiprate
    n1=ipilimumab | n2=en:telotristat etiprate | rel=r_associated | relid=0 | w=98
  4400. ipilimumab -- r_associated #0: 98 / 0.214 -> en:temsirolimus
    n1=ipilimumab | n2=en:temsirolimus | rel=r_associated | relid=0 | w=98
  4401. ipilimumab -- r_associated #0: 98 / 0.214 -> en:tranylcypromine sulfate
    n1=ipilimumab | n2=en:tranylcypromine sulfate | rel=r_associated | relid=0 | w=98
  4402. ipilimumab -- r_associated #0: 98 / 0.214 -> en:trastuzumab emtansine
    n1=ipilimumab | n2=en:trastuzumab emtansine | rel=r_associated | relid=0 | w=98
  4403. ipilimumab -- r_associated #0: 98 / 0.214 -> en:vegf inhibitor ptc299
    n1=ipilimumab | n2=en:vegf inhibitor ptc299 | rel=r_associated | relid=0 | w=98
  4404. ipilimumab -- r_associated #0: 98 / 0.214 -> en:vinca alkaloid compound
    n1=ipilimumab | n2=en:vinca alkaloid compound | rel=r_associated | relid=0 | w=98
  4405. ipilimumab -- r_associated #0: 98 / 0.214 -> en:vismodegib
    n1=ipilimumab | n2=en:vismodegib | rel=r_associated | relid=0 | w=98
  4406. ipilimumab -- r_associated #0: 98 / 0.214 -> en:z-endoxifen hydrochloride
    n1=ipilimumab | n2=en:z-endoxifen hydrochloride | rel=r_associated | relid=0 | w=98
  4407. ipilimumab -- r_associated #0: 98 / 0.214 -> en:zirconium zr 89-labeled anti-ca19-9 monoclonal antibody 5b1
    n1=ipilimumab | n2=en:zirconium zr 89-labeled anti-ca19-9 monoclonal antibody 5b1 | rel=r_associated | relid=0 | w=98
  4408. ipilimumab -- r_associated #0: 98 / 0.214 -> en:zoledronic acid
    n1=ipilimumab | n2=en:zoledronic acid | rel=r_associated | relid=0 | w=98
  4409. ipilimumab -- r_associated #0: 97 / 0.212 -> en:activated marrow infiltrating lymphocytes
    n1=ipilimumab | n2=en:activated marrow infiltrating lymphocytes | rel=r_associated | relid=0 | w=97
  4410. ipilimumab -- r_associated #0: 97 / 0.212 -> en:allogeneic b7.1/hla-a1 transfected tumor cell vaccine
    n1=ipilimumab | n2=en:allogeneic b7.1/hla-a1 transfected tumor cell vaccine | rel=r_associated | relid=0 | w=97
  4411. ipilimumab -- r_associated #0: 97 / 0.212 -> en:allogeneic cytomegalovirus-specific cytotoxic t lymphocytes
    n1=ipilimumab | n2=en:allogeneic cytomegalovirus-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=97
  4412. ipilimumab -- r_associated #0: 97 / 0.212 -> en:anti-gd2 monoclonal antibody hu14.18k322a
    n1=ipilimumab | n2=en:anti-gd2 monoclonal antibody hu14.18k322a | rel=r_associated | relid=0 | w=97
  4413. ipilimumab -- r_associated #0: 97 / 0.212 -> en:anti-her2 antibody-drug conjugate arx788
    n1=ipilimumab | n2=en:anti-her2 antibody-drug conjugate arx788 | rel=r_associated | relid=0 | w=97
  4414. ipilimumab -- r_associated #0: 97 / 0.212 -> en:anti-pr1/hla-a2 monoclonal antibody hu8f4
    n1=ipilimumab | n2=en:anti-pr1/hla-a2 monoclonal antibody hu8f4 | rel=r_associated | relid=0 | w=97
  4415. ipilimumab -- r_associated #0: 97 / 0.212 -> en:antiangiogenic drug combination tl-118
    n1=ipilimumab | n2=en:antiangiogenic drug combination tl-118 | rel=r_associated | relid=0 | w=97
  4416. ipilimumab -- r_associated #0: 97 / 0.212 -> en:antrodia cinnamomea supplement
    n1=ipilimumab | n2=en:antrodia cinnamomea supplement | rel=r_associated | relid=0 | w=97
  4417. ipilimumab -- r_associated #0: 97 / 0.212 -> en:autologous hpv-16/18 e6/e7-specific tgf-beta-resistant t lymphocytes
    n1=ipilimumab | n2=en:autologous hpv-16/18 e6/e7-specific tgf-beta-resistant t lymphocytes | rel=r_associated | relid=0 | w=97
  4418. ipilimumab -- r_associated #0: 97 / 0.212 -> en:calculus bovis/moschus/olibanum/myrrha capsule
    n1=ipilimumab | n2=en:calculus bovis/moschus/olibanum/myrrha capsule | rel=r_associated | relid=0 | w=97
  4419. ipilimumab -- r_associated #0: 97 / 0.212 -> en:carbon c 14 anlotinib hydrochloride
    n1=ipilimumab | n2=en:carbon c 14 anlotinib hydrochloride | rel=r_associated | relid=0 | w=97
  4420. ipilimumab -- r_associated #0: 97 / 0.212 -> en:carcinogen
    n1=ipilimumab | n2=en:carcinogen | rel=r_associated | relid=0 | w=97
  4421. ipilimumab -- r_associated #0: 97 / 0.212 -> en:clonidine hydrochloride
    n1=ipilimumab | n2=en:clonidine hydrochloride | rel=r_associated | relid=0 | w=97
  4422. ipilimumab -- r_associated #0: 97 / 0.212 -> en:erythrocyte-encapsulated l-asparaginase suspension
    n1=ipilimumab | n2=en:erythrocyte-encapsulated l-asparaginase suspension | rel=r_associated | relid=0 | w=97
  4423. ipilimumab -- r_associated #0: 97 / 0.212 -> en:glucosamine sulfate/chondroitin sulfate tablet
    n1=ipilimumab | n2=en:glucosamine sulfate/chondroitin sulfate tablet | rel=r_associated | relid=0 | w=97
  4424. ipilimumab -- r_associated #0: 97 / 0.212 -> en:goldenrod
    n1=ipilimumab | n2=en:goldenrod | rel=r_associated | relid=0 | w=97
  4425. ipilimumab -- r_associated #0: 97 / 0.212 -> en:ibritumomab tiuxetan
    n1=ipilimumab | n2=en:ibritumomab tiuxetan | rel=r_associated | relid=0 | w=97
  4426. ipilimumab -- r_associated #0: 97 / 0.212 -> en:inositol
    n1=ipilimumab | n2=en:inositol | rel=r_associated | relid=0 | w=97
  4427. ipilimumab -- r_associated #0: 97 / 0.212 -> en:iodine i 131 monoclonal antibody cc49-deltach2
    n1=ipilimumab | n2=en:iodine i 131 monoclonal antibody cc49-deltach2 | rel=r_associated | relid=0 | w=97
  4428. ipilimumab -- r_associated #0: 97 / 0.212 -> en:isis 2503
    n1=ipilimumab | n2=en:isis 2503 | rel=r_associated | relid=0 | w=97
  4429. ipilimumab -- r_associated #0: 97 / 0.212 -> en:isobutane
    n1=ipilimumab | n2=en:isobutane | rel=r_associated | relid=0 | w=97
  4430. ipilimumab -- r_associated #0: 97 / 0.212 -> en:lmb-7 immunotoxin
    n1=ipilimumab | n2=en:lmb-7 immunotoxin | rel=r_associated | relid=0 | w=97
  4431. ipilimumab -- r_associated #0: 97 / 0.212 -> en:masoprocol
    n1=ipilimumab | n2=en:masoprocol | rel=r_associated | relid=0 | w=97
  4432. ipilimumab -- r_associated #0: 97 / 0.212 -> en:milatuzumab
    n1=ipilimumab | n2=en:milatuzumab | rel=r_associated | relid=0 | w=97
  4433. ipilimumab -- r_associated #0: 97 / 0.212 -> en:mirvetuximab soravtansine
    n1=ipilimumab | n2=en:mirvetuximab soravtansine | rel=r_associated | relid=0 | w=97
  4434. ipilimumab -- r_associated #0: 97 / 0.212 -> en:misoprostol
    n1=ipilimumab | n2=en:misoprostol | rel=r_associated | relid=0 | w=97
  4435. ipilimumab -- r_associated #0: 97 / 0.212 -> en:monophosphoryl lipid a
    n1=ipilimumab | n2=en:monophosphoryl lipid a | rel=r_associated | relid=0 | w=97
  4436. ipilimumab -- r_associated #0: 97 / 0.212 -> en:mrna-derived lung cancer vaccine cv9202
    n1=ipilimumab | n2=en:mrna-derived lung cancer vaccine cv9202 | rel=r_associated | relid=0 | w=97
  4437. ipilimumab -- r_associated #0: 97 / 0.212 -> en:muromonab-cd3
    n1=ipilimumab | n2=en:muromonab-cd3 | rel=r_associated | relid=0 | w=97
  4438. ipilimumab -- r_associated #0: 97 / 0.212 -> en:nicotine patch
    n1=ipilimumab | n2=en:nicotine patch | rel=r_associated | relid=0 | w=97
  4439. ipilimumab -- r_associated #0: 97 / 0.212 -> en:nostrums
    n1=ipilimumab | n2=en:nostrums | rel=r_associated | relid=0 | w=97
  4440. ipilimumab -- r_associated #0: 97 / 0.212 -> en:onartuzumab
    n1=ipilimumab | n2=en:onartuzumab | rel=r_associated | relid=0 | w=97
  4441. ipilimumab -- r_associated #0: 97 / 0.212 -> en:pegylated granulocyte colony stimulating factor maxy-g34
    n1=ipilimumab | n2=en:pegylated granulocyte colony stimulating factor maxy-g34 | rel=r_associated | relid=0 | w=97
  4442. ipilimumab -- r_associated #0: 97 / 0.212 -> en:pegylated human recombinant arginase 1 aeb1102
    n1=ipilimumab | n2=en:pegylated human recombinant arginase 1 aeb1102 | rel=r_associated | relid=0 | w=97
  4443. ipilimumab -- r_associated #0: 97 / 0.212 -> en:plectin-1 targeting agent ptp-01
    n1=ipilimumab | n2=en:plectin-1 targeting agent ptp-01 | rel=r_associated | relid=0 | w=97
  4444. ipilimumab -- r_associated #0: 97 / 0.212 -> en:plevitrexed
    n1=ipilimumab | n2=en:plevitrexed | rel=r_associated | relid=0 | w=97
  4445. ipilimumab -- r_associated #0: 97 / 0.212 -> en:polycarbophil/carbomer/glycerin/palm oil glyceride/mineral oil-containing vaginal moisturizer
    n1=ipilimumab | n2=en:polycarbophil/carbomer/glycerin/palm oil glyceride/mineral oil-containing vaginal moisturizer | rel=r_associated | relid=0 | w=97
  4446. ipilimumab -- r_associated #0: 97 / 0.212 -> en:prostate tumor antigen-activated autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:prostate tumor antigen-activated autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=97
  4447. ipilimumab -- r_associated #0: 97 / 0.212 -> en:psychopharmacologic agent
    n1=ipilimumab | n2=en:psychopharmacologic agent | rel=r_associated | relid=0 | w=97
  4448. ipilimumab -- r_associated #0: 97 / 0.212 -> en:pyrimethamine-sulfadoxine
    n1=ipilimumab | n2=en:pyrimethamine-sulfadoxine | rel=r_associated | relid=0 | w=97
  4449. ipilimumab -- r_associated #0: 97 / 0.212 -> en:recombinant adenovirus 5 encoding tumor necrosis factor-related apoptosis-inducing ligand
    n1=ipilimumab | n2=en:recombinant adenovirus 5 encoding tumor necrosis factor-related apoptosis-inducing ligand | rel=r_associated | relid=0 | w=97
  4450. ipilimumab -- r_associated #0: 97 / 0.212 -> en:sapanisertib
    n1=ipilimumab | n2=en:sapanisertib | rel=r_associated | relid=0 | w=97
  4451. ipilimumab -- r_associated #0: 97 / 0.212 -> en:sipuleucel-t
    n1=ipilimumab | n2=en:sipuleucel-t | rel=r_associated | relid=0 | w=97
  4452. ipilimumab -- r_associated #0: 97 / 0.212 -> en:sodium borocaptate
    n1=ipilimumab | n2=en:sodium borocaptate | rel=r_associated | relid=0 | w=97
  4453. ipilimumab -- r_associated #0: 97 / 0.212 -> en:sodium metaarsenite
    n1=ipilimumab | n2=en:sodium metaarsenite | rel=r_associated | relid=0 | w=97
  4454. ipilimumab -- r_associated #0: 97 / 0.212 -> en:surface-active agent
    n1=ipilimumab | n2=en:surface-active agent | rel=r_associated | relid=0 | w=97
  4455. ipilimumab -- r_associated #0: 97 / 0.212 -> en:synthesis inhibitors, dna
    n1=ipilimumab | n2=en:synthesis inhibitors, dna | rel=r_associated | relid=0 | w=97
  4456. ipilimumab -- r_associated #0: 97 / 0.212 -> en:tiomolibdate diammonium
    n1=ipilimumab | n2=en:tiomolibdate diammonium | rel=r_associated | relid=0 | w=97
  4457. ipilimumab -- r_associated #0: 97 / 0.212 -> en:tubulin polymerization inhibitor ckd-516
    n1=ipilimumab | n2=en:tubulin polymerization inhibitor ckd-516 | rel=r_associated | relid=0 | w=97
  4458. ipilimumab -- r_associated #0: 97 / 0.212 -> en:tyrosine kinase inhibitor xl228
    n1=ipilimumab | n2=en:tyrosine kinase inhibitor xl228 | rel=r_associated | relid=0 | w=97
  4459. ipilimumab -- r_associated #0: 97 / 0.212 -> en:vatalanib
    n1=ipilimumab | n2=en:vatalanib | rel=r_associated | relid=0 | w=97
  4460. ipilimumab -- r_associated #0: 97 / 0.212 -> en:veliparib
    n1=ipilimumab | n2=en:veliparib | rel=r_associated | relid=0 | w=97
  4461. ipilimumab -- r_associated #0: 97 / 0.212 -> en:vilazodone
    n1=ipilimumab | n2=en:vilazodone | rel=r_associated | relid=0 | w=97
  4462. ipilimumab -- r_associated #0: 97 / 0.212 -> traitement
    n1=ipilimumab | n2=traitement | rel=r_associated | relid=0 | w=97
  4463. ipilimumab -- r_associated #0: 76 / 0.166 -> anticorps
    n1=ipilimumab | n2=anticorps | rel=r_associated | relid=0 | w=76
  4464. ipilimumab -- r_associated #0: 58 / 0.127 -> en:cefazolin sodium
    n1=ipilimumab | n2=en:cefazolin sodium | rel=r_associated | relid=0 | w=58
  4465. ipilimumab -- r_associated #0: 58 / 0.127 -> en:ipafricept
    n1=ipilimumab | n2=en:ipafricept | rel=r_associated | relid=0 | w=58
  4466. ipilimumab -- r_associated #0: 58 / 0.127 -> en:lirilumab
    n1=ipilimumab | n2=en:lirilumab | rel=r_associated | relid=0 | w=58
  4467. ipilimumab -- r_associated #0: 58 / 0.127 -> en:methyl-5-aminolevulinate hydrochloride cream
    n1=ipilimumab | n2=en:methyl-5-aminolevulinate hydrochloride cream | rel=r_associated | relid=0 | w=58
  4468. ipilimumab -- r_associated #0: 58 / 0.127 -> en:protein e7, human papillomavirus type 16
    n1=ipilimumab | n2=en:protein e7, human papillomavirus type 16 | rel=r_associated | relid=0 | w=58
  4469. ipilimumab -- r_associated #0: 57 / 0.124 -> en:allogeneic t-lymphocytes bpx-501
    n1=ipilimumab | n2=en:allogeneic t-lymphocytes bpx-501 | rel=r_associated | relid=0 | w=57
  4470. ipilimumab -- r_associated #0: 57 / 0.124 -> en:cd138car-cd137/tcrzeta-expressing t lymphocytes
    n1=ipilimumab | n2=en:cd138car-cd137/tcrzeta-expressing t lymphocytes | rel=r_associated | relid=0 | w=57
  4471. ipilimumab -- r_associated #0: 57 / 0.124 -> en:elsiglutide
    n1=ipilimumab | n2=en:elsiglutide | rel=r_associated | relid=0 | w=57
  4472. ipilimumab -- r_associated #0: 57 / 0.124 -> en:falimarev
    n1=ipilimumab | n2=en:falimarev | rel=r_associated | relid=0 | w=57
  4473. ipilimumab -- r_associated #0: 57 / 0.124 -> en:indoximod
    n1=ipilimumab | n2=en:indoximod | rel=r_associated | relid=0 | w=57
  4474. ipilimumab -- r_associated #0: 57 / 0.124 -> en:methanol extraction residue of bcg
    n1=ipilimumab | n2=en:methanol extraction residue of bcg | rel=r_associated | relid=0 | w=57
  4475. ipilimumab -- r_associated #0: 57 / 0.124 -> en:parp inhibitor e7016
    n1=ipilimumab | n2=en:parp inhibitor e7016 | rel=r_associated | relid=0 | w=57
  4476. ipilimumab -- r_associated #0: 57 / 0.124 -> en:phenelzine sulfate
    n1=ipilimumab | n2=en:phenelzine sulfate | rel=r_associated | relid=0 | w=57
  4477. ipilimumab -- r_associated #0: 57 / 0.124 -> en:recombinant human apolipoprotein(a) kringle v mg1102
    n1=ipilimumab | n2=en:recombinant human apolipoprotein(a) kringle v mg1102 | rel=r_associated | relid=0 | w=57
  4478. ipilimumab -- r_associated #0: 57 / 0.124 -> en:warfarin
    n1=ipilimumab | n2=en:warfarin | rel=r_associated | relid=0 | w=57
  4479. ipilimumab -- r_associated #0: 56 / 0.122 -> en:anti-cd30 monoclonal antibody xmab2513
    n1=ipilimumab | n2=en:anti-cd30 monoclonal antibody xmab2513 | rel=r_associated | relid=0 | w=56
  4480. ipilimumab -- r_associated #0: 56 / 0.122 -> en:broccoli sprout/broccoli seed extract supplement
    n1=ipilimumab | n2=en:broccoli sprout/broccoli seed extract supplement | rel=r_associated | relid=0 | w=56
  4481. ipilimumab -- r_associated #0: 56 / 0.122 -> en:cc-8490
    n1=ipilimumab | n2=en:cc-8490 | rel=r_associated | relid=0 | w=56
  4482. ipilimumab -- r_associated #0: 56 / 0.122 -> en:cisplatin
    n1=ipilimumab | n2=en:cisplatin | rel=r_associated | relid=0 | w=56
  4483. ipilimumab -- r_associated #0: 56 / 0.122 -> en:cyclophosphamide/epirubicin/vincristine/prednisone
    n1=ipilimumab | n2=en:cyclophosphamide/epirubicin/vincristine/prednisone | rel=r_associated | relid=0 | w=56
  4484. ipilimumab -- r_associated #0: 56 / 0.122 -> en:gadobenate dimeglumine
    n1=ipilimumab | n2=en:gadobenate dimeglumine | rel=r_associated | relid=0 | w=56
  4485. ipilimumab -- r_associated #0: 56 / 0.122 -> en:gamma-delta tocotrienol
    n1=ipilimumab | n2=en:gamma-delta tocotrienol | rel=r_associated | relid=0 | w=56
  4486. ipilimumab -- r_associated #0: 56 / 0.122 -> en:mepivacaine hydrochloride
    n1=ipilimumab | n2=en:mepivacaine hydrochloride | rel=r_associated | relid=0 | w=56
  4487. ipilimumab -- r_associated #0: 56 / 0.122 -> en:multi-subtype natural human leukocyte interferon alpha
    n1=ipilimumab | n2=en:multi-subtype natural human leukocyte interferon alpha | rel=r_associated | relid=0 | w=56
  4488. ipilimumab -- r_associated #0: 56 / 0.122 -> en:oral hsp90 inhibitor ipi-493
    n1=ipilimumab | n2=en:oral hsp90 inhibitor ipi-493 | rel=r_associated | relid=0 | w=56
  4489. ipilimumab -- r_associated #0: 56 / 0.122 -> en:src kinase inhibitor kx2-391 ointment
    n1=ipilimumab | n2=en:src kinase inhibitor kx2-391 ointment | rel=r_associated | relid=0 | w=56
  4490. ipilimumab -- r_associated #0: 56 / 0.122 -> en:stat3 antisense oligonucleotide isis 481464
    n1=ipilimumab | n2=en:stat3 antisense oligonucleotide isis 481464 | rel=r_associated | relid=0 | w=56
  4491. ipilimumab -- r_associated #0: 56 / 0.122 -> en:traumeel s
    n1=ipilimumab | n2=en:traumeel s | rel=r_associated | relid=0 | w=56
  4492. ipilimumab -- r_associated #0: 55 / 0.12 -> en:anti-cd37 mmae antibody-drug conjugate ags67e
    n1=ipilimumab | n2=en:anti-cd37 mmae antibody-drug conjugate ags67e | rel=r_associated | relid=0 | w=55
  4493. ipilimumab -- r_associated #0: 55 / 0.12 -> en:autologous nsclc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine
    n1=ipilimumab | n2=en:autologous nsclc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine | rel=r_associated | relid=0 | w=55
  4494. ipilimumab -- r_associated #0: 55 / 0.12 -> en:cephalostatin
    n1=ipilimumab | n2=en:cephalostatin | rel=r_associated | relid=0 | w=55
  4495. ipilimumab -- r_associated #0: 55 / 0.12 -> en:endothelin b receptor agonist spi-1620
    n1=ipilimumab | n2=en:endothelin b receptor agonist spi-1620 | rel=r_associated | relid=0 | w=55
  4496. ipilimumab -- r_associated #0: 55 / 0.12 -> en:g207
    n1=ipilimumab | n2=en:g207 | rel=r_associated | relid=0 | w=55
  4497. ipilimumab -- r_associated #0: 55 / 0.12 -> en:generic drug
    n1=ipilimumab | n2=en:generic drug | rel=r_associated | relid=0 | w=55
  4498. ipilimumab -- r_associated #0: 55 / 0.12 -> en:lapatinib ditosylate
    n1=ipilimumab | n2=en:lapatinib ditosylate | rel=r_associated | relid=0 | w=55
  4499. ipilimumab -- r_associated #0: 55 / 0.12 -> en:netupitant
    n1=ipilimumab | n2=en:netupitant | rel=r_associated | relid=0 | w=55
  4500. ipilimumab -- r_associated #0: 55 / 0.12 -> en:oblimersen
    n1=ipilimumab | n2=en:oblimersen | rel=r_associated | relid=0 | w=55
  4501. ipilimumab -- r_associated #0: 55 / 0.12 -> en:sb-as15 adjuvant
    n1=ipilimumab | n2=en:sb-as15 adjuvant | rel=r_associated | relid=0 | w=55
  4502. ipilimumab -- r_associated #0: 55 / 0.12 -> en:siltuximab
    n1=ipilimumab | n2=en:siltuximab | rel=r_associated | relid=0 | w=55
  4503. ipilimumab -- r_associated #0: 55 / 0.12 -> en:stanford v regimen
    n1=ipilimumab | n2=en:stanford v regimen | rel=r_associated | relid=0 | w=55
  4504. ipilimumab -- r_associated #0: 54 / 0.118 -> en:acyclovir
    n1=ipilimumab | n2=en:acyclovir | rel=r_associated | relid=0 | w=54
  4505. ipilimumab -- r_associated #0: 54 / 0.118 -> en:anti-pd-l1 monoclonal antibody ly3300054
    n1=ipilimumab | n2=en:anti-pd-l1 monoclonal antibody ly3300054 | rel=r_associated | relid=0 | w=54
  4506. ipilimumab -- r_associated #0: 54 / 0.118 -> en:calcitonin salmon
    n1=ipilimumab | n2=en:calcitonin salmon | rel=r_associated | relid=0 | w=54
  4507. ipilimumab -- r_associated #0: 54 / 0.118 -> en:carbon c 11 choline
    n1=ipilimumab | n2=en:carbon c 11 choline | rel=r_associated | relid=0 | w=54
  4508. ipilimumab -- r_associated #0: 54 / 0.118 -> en:chp-her-2 peptide vaccine
    n1=ipilimumab | n2=en:chp-her-2 peptide vaccine | rel=r_associated | relid=0 | w=54
  4509. ipilimumab -- r_associated #0: 54 / 0.118 -> en:cyclin b1 peptide-pulsed autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:cyclin b1 peptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=54
  4510. ipilimumab -- r_associated #0: 54 / 0.118 -> en:depdc1/mphosh1 peptide vaccine
    n1=ipilimumab | n2=en:depdc1/mphosh1 peptide vaccine | rel=r_associated | relid=0 | w=54
  4511. ipilimumab -- r_associated #0: 54 / 0.118 -> en:dexmethylphenidate
    n1=ipilimumab | n2=en:dexmethylphenidate | rel=r_associated | relid=0 | w=54
  4512. ipilimumab -- r_associated #0: 54 / 0.118 -> en:folate binding protein e39 peptide vaccine
    n1=ipilimumab | n2=en:folate binding protein e39 peptide vaccine | rel=r_associated | relid=0 | w=54
  4513. ipilimumab -- r_associated #0: 54 / 0.118 -> en:fotemustine
    n1=ipilimumab | n2=en:fotemustine | rel=r_associated | relid=0 | w=54
  4514. ipilimumab -- r_associated #0: 54 / 0.118 -> en:human combinatorial antibody library-based monoclonal antibody vay736
    n1=ipilimumab | n2=en:human combinatorial antibody library-based monoclonal antibody vay736 | rel=r_associated | relid=0 | w=54
  4515. ipilimumab -- r_associated #0: 54 / 0.118 -> en:human trefoil factor 1-secreting lactococcus lactis ag013
    n1=ipilimumab | n2=en:human trefoil factor 1-secreting lactococcus lactis ag013 | rel=r_associated | relid=0 | w=54
  4516. ipilimumab -- r_associated #0: 54 / 0.118 -> en:influenza virus vaccine
    n1=ipilimumab | n2=en:influenza virus vaccine | rel=r_associated | relid=0 | w=54
  4517. ipilimumab -- r_associated #0: 54 / 0.118 -> en:lutetium lu 177 pp-f11n
    n1=ipilimumab | n2=en:lutetium lu 177 pp-f11n | rel=r_associated | relid=0 | w=54
  4518. ipilimumab -- r_associated #0: 54 / 0.118 -> en:monoclonal antibody 3h1 anti-idiotype vaccine
    n1=ipilimumab | n2=en:monoclonal antibody 3h1 anti-idiotype vaccine | rel=r_associated | relid=0 | w=54
  4519. ipilimumab -- r_associated #0: 54 / 0.118 -> en:ose 2101
    n1=ipilimumab | n2=en:ose 2101 | rel=r_associated | relid=0 | w=54
  4520. ipilimumab -- r_associated #0: 54 / 0.118 -> en:recombinant adenovirus-interferon/syn3
    n1=ipilimumab | n2=en:recombinant adenovirus-interferon/syn3 | rel=r_associated | relid=0 | w=54
  4521. ipilimumab -- r_associated #0: 54 / 0.118 -> en:rimiducid
    n1=ipilimumab | n2=en:rimiducid | rel=r_associated | relid=0 | w=54
  4522. ipilimumab -- r_associated #0: 54 / 0.118 -> en:s-3304
    n1=ipilimumab | n2=en:s-3304 | rel=r_associated | relid=0 | w=54
  4523. ipilimumab -- r_associated #0: 54 / 0.118 -> en:sn-38-loaded polymeric micelles nk012
    n1=ipilimumab | n2=en:sn-38-loaded polymeric micelles nk012 | rel=r_associated | relid=0 | w=54
  4524. ipilimumab -- r_associated #0: 54 / 0.118 -> en:vinfosiltine
    n1=ipilimumab | n2=en:vinfosiltine | rel=r_associated | relid=0 | w=54
  4525. ipilimumab -- r_associated #0: 53 / 0.116 -> en:acai berry juice
    n1=ipilimumab | n2=en:acai berry juice | rel=r_associated | relid=0 | w=53
  4526. ipilimumab -- r_associated #0: 53 / 0.116 -> en:allodepleted haploidentical t cells-expressing inducible caspase 9
    n1=ipilimumab | n2=en:allodepleted haploidentical t cells-expressing inducible caspase 9 | rel=r_associated | relid=0 | w=53
  4527. ipilimumab -- r_associated #0: 53 / 0.116 -> en:alpha-gal glycosphingolipids
    n1=ipilimumab | n2=en:alpha-gal glycosphingolipids | rel=r_associated | relid=0 | w=53
  4528. ipilimumab -- r_associated #0: 53 / 0.116 -> en:anti-cd20-engineered toxin body mt-3724
    n1=ipilimumab | n2=en:anti-cd20-engineered toxin body mt-3724 | rel=r_associated | relid=0 | w=53
  4529. ipilimumab -- r_associated #0: 53 / 0.116 -> en:autologous prostate cancer antigen-expressing dendritic cell vaccine bpx-101
    n1=ipilimumab | n2=en:autologous prostate cancer antigen-expressing dendritic cell vaccine bpx-101 | rel=r_associated | relid=0 | w=53
  4530. ipilimumab -- r_associated #0: 53 / 0.116 -> en:bms-188797
    n1=ipilimumab | n2=en:bms-188797 | rel=r_associated | relid=0 | w=53
  4531. ipilimumab -- r_associated #0: 53 / 0.116 -> en:braf inhibitor arq 736
    n1=ipilimumab | n2=en:braf inhibitor arq 736 | rel=r_associated | relid=0 | w=53
  4532. ipilimumab -- r_associated #0: 53 / 0.116 -> en:bupropion hydrochloride
    n1=ipilimumab | n2=en:bupropion hydrochloride | rel=r_associated | relid=0 | w=53
  4533. ipilimumab -- r_associated #0: 53 / 0.116 -> en:curcumin-based gel
    n1=ipilimumab | n2=en:curcumin-based gel | rel=r_associated | relid=0 | w=53
  4534. ipilimumab -- r_associated #0: 53 / 0.116 -> en:dendritic cell-targeting lentiviral vector id-lv305
    n1=ipilimumab | n2=en:dendritic cell-targeting lentiviral vector id-lv305 | rel=r_associated | relid=0 | w=53
  4535. ipilimumab -- r_associated #0: 53 / 0.116 -> en:folfiri-bevacizumab regimen
    n1=ipilimumab | n2=en:folfiri-bevacizumab regimen | rel=r_associated | relid=0 | w=53
  4536. ipilimumab -- r_associated #0: 53 / 0.116 -> en:fostamatinib disodium
    n1=ipilimumab | n2=en:fostamatinib disodium | rel=r_associated | relid=0 | w=53
  4537. ipilimumab -- r_associated #0: 53 / 0.116 -> en:l19-il2 monoclonal antibody-cytokine fusion protein
    n1=ipilimumab | n2=en:l19-il2 monoclonal antibody-cytokine fusion protein | rel=r_associated | relid=0 | w=53
  4538. ipilimumab -- r_associated #0: 53 / 0.116 -> en:lyso-thermosensitive liposome doxorubicin
    n1=ipilimumab | n2=en:lyso-thermosensitive liposome doxorubicin | rel=r_associated | relid=0 | w=53
  4539. ipilimumab -- r_associated #0: 53 / 0.116 -> en:shark cartilage
    n1=ipilimumab | n2=en:shark cartilage | rel=r_associated | relid=0 | w=53
  4540. ipilimumab -- r_associated #0: 52 / 0.114 -> en:anti-hla-dr monoclonal antibody immu-114
    n1=ipilimumab | n2=en:anti-hla-dr monoclonal antibody immu-114 | rel=r_associated | relid=0 | w=52
  4541. ipilimumab -- r_associated #0: 52 / 0.114 -> en:antirheumatic agents
    n1=ipilimumab | n2=en:antirheumatic agents | rel=r_associated | relid=0 | w=52
  4542. ipilimumab -- r_associated #0: 52 / 0.114 -> en:braf(v600e) kinase inhibitor ro5212054
    n1=ipilimumab | n2=en:braf(v600e) kinase inhibitor ro5212054 | rel=r_associated | relid=0 | w=52
  4543. ipilimumab -- r_associated #0: 52 / 0.114 -> en:dideoxyadenosine
    n1=ipilimumab | n2=en:dideoxyadenosine | rel=r_associated | relid=0 | w=52
  4544. ipilimumab -- r_associated #0: 52 / 0.114 -> en:gadoxetate disodium
    n1=ipilimumab | n2=en:gadoxetate disodium | rel=r_associated | relid=0 | w=52
  4545. ipilimumab -- r_associated #0: 52 / 0.114 -> en:i 131 monoclonal antibody cc49
    n1=ipilimumab | n2=en:i 131 monoclonal antibody cc49 | rel=r_associated | relid=0 | w=52
  4546. ipilimumab -- r_associated #0: 52 / 0.114 -> en:icodextrin solution
    n1=ipilimumab | n2=en:icodextrin solution | rel=r_associated | relid=0 | w=52
  4547. ipilimumab -- r_associated #0: 52 / 0.114 -> en:phellodendron amurense bark extract
    n1=ipilimumab | n2=en:phellodendron amurense bark extract | rel=r_associated | relid=0 | w=52
  4548. ipilimumab -- r_associated #0: 52 / 0.114 -> en:pi3k inhibitor bgt226
    n1=ipilimumab | n2=en:pi3k inhibitor bgt226 | rel=r_associated | relid=0 | w=52
  4549. ipilimumab -- r_associated #0: 52 / 0.114 -> en:taladegib
    n1=ipilimumab | n2=en:taladegib | rel=r_associated | relid=0 | w=52
  4550. ipilimumab -- r_associated #0: 52 / 0.114 -> en:tanomastat
    n1=ipilimumab | n2=en:tanomastat | rel=r_associated | relid=0 | w=52
  4551. ipilimumab -- r_associated #0: 52 / 0.114 -> en:yttrium y 90 anti-cd66 monoclonal antibody bw 250/183
    n1=ipilimumab | n2=en:yttrium y 90 anti-cd66 monoclonal antibody bw 250/183 | rel=r_associated | relid=0 | w=52
  4552. ipilimumab -- r_associated #0: 52 / 0.114 -> en:ziconotide
    n1=ipilimumab | n2=en:ziconotide | rel=r_associated | relid=0 | w=52
  4553. ipilimumab -- r_associated #0: 51 / 0.111 -> en:5-fitc-labeled gi-heptapeptide
    n1=ipilimumab | n2=en:5-fitc-labeled gi-heptapeptide | rel=r_associated | relid=0 | w=51
  4554. ipilimumab -- r_associated #0: 51 / 0.111 -> en:ac-t regimen
    n1=ipilimumab | n2=en:ac-t regimen | rel=r_associated | relid=0 | w=51
  4555. ipilimumab -- r_associated #0: 51 / 0.111 -> en:amitriptyline hydrochloride
    n1=ipilimumab | n2=en:amitriptyline hydrochloride | rel=r_associated | relid=0 | w=51
  4556. ipilimumab -- r_associated #0: 51 / 0.111 -> en:anti-csf1r monoclonal antibody imc-cs4
    n1=ipilimumab | n2=en:anti-csf1r monoclonal antibody imc-cs4 | rel=r_associated | relid=0 | w=51
  4557. ipilimumab -- r_associated #0: 51 / 0.111 -> en:antihistamines
    n1=ipilimumab | n2=en:antihistamines | rel=r_associated | relid=0 | w=51
  4558. ipilimumab -- r_associated #0: 51 / 0.111 -> en:intrinsic factor
    n1=ipilimumab | n2=en:intrinsic factor | rel=r_associated | relid=0 | w=51
  4559. ipilimumab -- r_associated #0: 51 / 0.111 -> en:kw-2149
    n1=ipilimumab | n2=en:kw-2149 | rel=r_associated | relid=0 | w=51
  4560. ipilimumab -- r_associated #0: 50 / 0.109 -> cancérologie
    n1=ipilimumab | n2=cancérologie | rel=r_associated | relid=0 | w=50
  4561. ipilimumab -- r_associated #0: 50 / 0.109 -> en:aminothiadiazole
    n1=ipilimumab | n2=en:aminothiadiazole | rel=r_associated | relid=0 | w=50
  4562. ipilimumab -- r_associated #0: 50 / 0.109 -> en:anti-erbb3 monoclonal antibody av-203
    n1=ipilimumab | n2=en:anti-erbb3 monoclonal antibody av-203 | rel=r_associated | relid=0 | w=50
  4563. ipilimumab -- r_associated #0: 50 / 0.109 -> en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ central memory t-lymphocytes jcar014
    n1=ipilimumab | n2=en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ central memory t-lymphocytes jcar014 | rel=r_associated | relid=0 | w=50
  4564. ipilimumab -- r_associated #0: 50 / 0.109 -> en:gd2-car-expressing autologous t-lymphocytes
    n1=ipilimumab | n2=en:gd2-car-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=50
  4565. ipilimumab -- r_associated #0: 50 / 0.109 -> en:olsalazine
    n1=ipilimumab | n2=en:olsalazine | rel=r_associated | relid=0 | w=50
  4566. ipilimumab -- r_associated #0: 49 / 0.107 -> en:alectinib
    n1=ipilimumab | n2=en:alectinib | rel=r_associated | relid=0 | w=49
  4567. ipilimumab -- r_associated #0: 49 / 0.107 -> en:anti-bcma antibody-drug conjugate gsk2857916
    n1=ipilimumab | n2=en:anti-bcma antibody-drug conjugate gsk2857916 | rel=r_associated | relid=0 | w=49
  4568. ipilimumab -- r_associated #0: 49 / 0.107 -> en:bizelesin
    n1=ipilimumab | n2=en:bizelesin | rel=r_associated | relid=0 | w=49
  4569. ipilimumab -- r_associated #0: 49 / 0.107 -> en:dextropropoxyphene hydrochloride
    n1=ipilimumab | n2=en:dextropropoxyphene hydrochloride | rel=r_associated | relid=0 | w=49
  4570. ipilimumab -- r_associated #0: 49 / 0.107 -> en:ethyl icosapentate
    n1=ipilimumab | n2=en:ethyl icosapentate | rel=r_associated | relid=0 | w=49
  4571. ipilimumab -- r_associated #0: 49 / 0.107 -> en:i 131 antiferritin immunoglobulin
    n1=ipilimumab | n2=en:i 131 antiferritin immunoglobulin | rel=r_associated | relid=0 | w=49
  4572. ipilimumab -- r_associated #0: 49 / 0.107 -> en:psa/il-2/gm-csf vaccine
    n1=ipilimumab | n2=en:psa/il-2/gm-csf vaccine | rel=r_associated | relid=0 | w=49
  4573. ipilimumab -- r_associated #0: 49 / 0.107 -> en:recombinant thyrotropin alfa
    n1=ipilimumab | n2=en:recombinant thyrotropin alfa | rel=r_associated | relid=0 | w=49
  4574. ipilimumab -- r_associated #0: 49 / 0.107 -> en:therapeutic androstanolone
    n1=ipilimumab | n2=en:therapeutic androstanolone | rel=r_associated | relid=0 | w=49
  4575. ipilimumab -- r_associated #0: 45 / 0.098 -> mélanome
    n1=ipilimumab | n2=mélanome | rel=r_associated | relid=0 | w=45
  4576. ipilimumab -- r_associated #0: 43 / 0.094 -> en:zorubicin hydrochloride
    n1=ipilimumab | n2=en:zorubicin hydrochloride | rel=r_associated | relid=0 | w=43
  4577. ipilimumab -- r_associated #0: 42 / 0.092 -> en:mk-8808
    n1=ipilimumab | n2=en:mk-8808 | rel=r_associated | relid=0 | w=42
  4578. ipilimumab -- r_associated #0: 41 / 0.09 -> en:phenesterin
    n1=ipilimumab | n2=en:phenesterin | rel=r_associated | relid=0 | w=41
  4579. ipilimumab -- r_associated #0: 41 / 0.09 -> système immunitaire
    n1=ipilimumab | n2=système immunitaire | rel=r_associated | relid=0 | w=41
  4580. ipilimumab -- r_associated #0: 40 / 0.087 -> en:carbon c 14 ibrutinib
    n1=ipilimumab | n2=en:carbon c 14 ibrutinib | rel=r_associated | relid=0 | w=40
  4581. ipilimumab -- r_associated #0: 40 / 0.087 -> en:fas-chimera transgene-expressing endothelial tumor cell-targeting adenovector vb-111
    n1=ipilimumab | n2=en:fas-chimera transgene-expressing endothelial tumor cell-targeting adenovector vb-111 | rel=r_associated | relid=0 | w=40
  4582. ipilimumab -- r_associated #0: 39 / 0.085 -> en:ace inhibitor
    n1=ipilimumab | n2=en:ace inhibitor | rel=r_associated | relid=0 | w=39
  4583. ipilimumab -- r_associated #0: 37 / 0.081 -> en:beta-lapachone prodrug arq 761
    n1=ipilimumab | n2=en:beta-lapachone prodrug arq 761 | rel=r_associated | relid=0 | w=37
  4584. ipilimumab -- r_associated #0: 37 / 0.081 -> en:counterfeit drugs
    n1=ipilimumab | n2=en:counterfeit drugs | rel=r_associated | relid=0 | w=37
  4585. ipilimumab -- r_associated #0: 37 / 0.081 -> en:parp inhibitor cep-9722
    n1=ipilimumab | n2=en:parp inhibitor cep-9722 | rel=r_associated | relid=0 | w=37
  4586. ipilimumab -- r_associated #0: 36 / 0.079 -> en:carboxyamidotriazole
    n1=ipilimumab | n2=en:carboxyamidotriazole | rel=r_associated | relid=0 | w=36
  4587. ipilimumab -- r_associated #0: 35 / 0.076 -> en:allogeneic gm-csf-secreting tumor vaccine panc 6.03 pcdna-1/gm-neo
    n1=ipilimumab | n2=en:allogeneic gm-csf-secreting tumor vaccine panc 6.03 pcdna-1/gm-neo | rel=r_associated | relid=0 | w=35
  4588. ipilimumab -- r_associated #0: 35 / 0.076 -> en:anakinra
    n1=ipilimumab | n2=en:anakinra | rel=r_associated | relid=0 | w=35
  4589. ipilimumab -- r_associated #0: 35 / 0.076 -> en:anidulafungin
    n1=ipilimumab | n2=en:anidulafungin | rel=r_associated | relid=0 | w=35
  4590. ipilimumab -- r_associated #0: 35 / 0.076 -> en:anti-fucosyl-gm1 monoclonal antibody bms-986012
    n1=ipilimumab | n2=en:anti-fucosyl-gm1 monoclonal antibody bms-986012 | rel=r_associated | relid=0 | w=35
  4591. ipilimumab -- r_associated #0: 35 / 0.076 -> en:anti-ganglioside gm2 monoclonal antibody biw-8962
    n1=ipilimumab | n2=en:anti-ganglioside gm2 monoclonal antibody biw-8962 | rel=r_associated | relid=0 | w=35
  4592. ipilimumab -- r_associated #0: 35 / 0.076 -> en:anti-her3 monoclonal antibody ljm716
    n1=ipilimumab | n2=en:anti-her3 monoclonal antibody ljm716 | rel=r_associated | relid=0 | w=35
  4593. ipilimumab -- r_associated #0: 35 / 0.076 -> en:anti-pgf monoclonal antibody ro5323441
    n1=ipilimumab | n2=en:anti-pgf monoclonal antibody ro5323441 | rel=r_associated | relid=0 | w=35
  4594. ipilimumab -- r_associated #0: 35 / 0.076 -> en:antihemophilic factor, human recombinant
    n1=ipilimumab | n2=en:antihemophilic factor, human recombinant | rel=r_associated | relid=0 | w=35
  4595. ipilimumab -- r_associated #0: 35 / 0.076 -> en:antineoplaston a10
    n1=ipilimumab | n2=en:antineoplaston a10 | rel=r_associated | relid=0 | w=35
  4596. ipilimumab -- r_associated #0: 35 / 0.076 -> en:attenuated listeria monocytogenes crs-100
    n1=ipilimumab | n2=en:attenuated listeria monocytogenes crs-100 | rel=r_associated | relid=0 | w=35
  4597. ipilimumab -- r_associated #0: 35 / 0.076 -> en:aurora kinase/vegfr2 inhibitor cyc116
    n1=ipilimumab | n2=en:aurora kinase/vegfr2 inhibitor cyc116 | rel=r_associated | relid=0 | w=35
  4598. ipilimumab -- r_associated #0: 35 / 0.076 -> en:autologous tumor cell proteoliposome chronic lymphocytic leukemia vaccine
    n1=ipilimumab | n2=en:autologous tumor cell proteoliposome chronic lymphocytic leukemia vaccine | rel=r_associated | relid=0 | w=35
  4599. ipilimumab -- r_associated #0: 35 / 0.076 -> en:barasertib
    n1=ipilimumab | n2=en:barasertib | rel=r_associated | relid=0 | w=35
  4600. ipilimumab -- r_associated #0: 35 / 0.076 -> en:bay 87-2243
    n1=ipilimumab | n2=en:bay 87-2243 | rel=r_associated | relid=0 | w=35
  4601. ipilimumab -- r_associated #0: 35 / 0.076 -> en:blackberry allergenic extract
    n1=ipilimumab | n2=en:blackberry allergenic extract | rel=r_associated | relid=0 | w=35
  4602. ipilimumab -- r_associated #0: 35 / 0.076 -> en:busulfan
    n1=ipilimumab | n2=en:busulfan | rel=r_associated | relid=0 | w=35
  4603. ipilimumab -- r_associated #0: 35 / 0.076 -> en:carbon c 14-labeled ixazomib
    n1=ipilimumab | n2=en:carbon c 14-labeled ixazomib | rel=r_associated | relid=0 | w=35
  4604. ipilimumab -- r_associated #0: 35 / 0.076 -> en:carzelesin
    n1=ipilimumab | n2=en:carzelesin | rel=r_associated | relid=0 | w=35
  4605. ipilimumab -- r_associated #0: 35 / 0.076 -> en:cd19car-cd3zeta-4-1bb-cd28-expressing autologous t-lymphocytes
    n1=ipilimumab | n2=en:cd19car-cd3zeta-4-1bb-cd28-expressing autologous t-lymphocytes | rel=r_associated | relid=0 | w=35
  4606. ipilimumab -- r_associated #0: 35 / 0.076 -> en:chamomile
    n1=ipilimumab | n2=en:chamomile | rel=r_associated | relid=0 | w=35
  4607. ipilimumab -- r_associated #0: 35 / 0.076 -> en:chlorogenic acid
    n1=ipilimumab | n2=en:chlorogenic acid | rel=r_associated | relid=0 | w=35
  4608. ipilimumab -- r_associated #0: 35 / 0.076 -> en:cidan herbal capsule
    n1=ipilimumab | n2=en:cidan herbal capsule | rel=r_associated | relid=0 | w=35
  4609. ipilimumab -- r_associated #0: 35 / 0.076 -> en:clindamycin phosphate
    n1=ipilimumab | n2=en:clindamycin phosphate | rel=r_associated | relid=0 | w=35
  4610. ipilimumab -- r_associated #0: 35 / 0.076 -> en:conjugated linoleic acid
    n1=ipilimumab | n2=en:conjugated linoleic acid | rel=r_associated | relid=0 | w=35
  4611. ipilimumab -- r_associated #0: 35 / 0.076 -> en:corynebacterium granulosum p40
    n1=ipilimumab | n2=en:corynebacterium granulosum p40 | rel=r_associated | relid=0 | w=35
  4612. ipilimumab -- r_associated #0: 35 / 0.076 -> en:cositecan
    n1=ipilimumab | n2=en:cositecan | rel=r_associated | relid=0 | w=35
  4613. ipilimumab -- r_associated #0: 35 / 0.076 -> en:custirsen sodium
    n1=ipilimumab | n2=en:custirsen sodium | rel=r_associated | relid=0 | w=35
  4614. ipilimumab -- r_associated #0: 35 / 0.076 -> en:cytokine-induced killer cells
    n1=ipilimumab | n2=en:cytokine-induced killer cells | rel=r_associated | relid=0 | w=35
  4615. ipilimumab -- r_associated #0: 35 / 0.076 -> en:danusertib
    n1=ipilimumab | n2=en:danusertib | rel=r_associated | relid=0 | w=35
  4616. ipilimumab -- r_associated #0: 35 / 0.076 -> en:defactinib
    n1=ipilimumab | n2=en:defactinib | rel=r_associated | relid=0 | w=35
  4617. ipilimumab -- r_associated #0: 35 / 0.076 -> en:dimethicone-containing botanicals-based lotion
    n1=ipilimumab | n2=en:dimethicone-containing botanicals-based lotion | rel=r_associated | relid=0 | w=35
  4618. ipilimumab -- r_associated #0: 35 / 0.076 -> en:dlk1/epha2/hbb/nrp1/rgs5/tem1 peptide-pulsed alpha-type-1 polarized dendritic cell vaccine
    n1=ipilimumab | n2=en:dlk1/epha2/hbb/nrp1/rgs5/tem1 peptide-pulsed alpha-type-1 polarized dendritic cell vaccine | rel=r_associated | relid=0 | w=35
  4619. ipilimumab -- r_associated #0: 35 / 0.076 -> en:doxycycline hyclate
    n1=ipilimumab | n2=en:doxycycline hyclate | rel=r_associated | relid=0 | w=35
  4620. ipilimumab -- r_associated #0: 35 / 0.076 -> en:drugs treating radiation contamination
    n1=ipilimumab | n2=en:drugs treating radiation contamination | rel=r_associated | relid=0 | w=35
  4621. ipilimumab -- r_associated #0: 35 / 0.076 -> en:epacadostat
    n1=ipilimumab | n2=en:epacadostat | rel=r_associated | relid=0 | w=35
  4622. ipilimumab -- r_associated #0: 35 / 0.076 -> en:ex vivo-expanded her2-specific t cells
    n1=ipilimumab | n2=en:ex vivo-expanded her2-specific t cells | rel=r_associated | relid=0 | w=35
  4623. ipilimumab -- r_associated #0: 35 / 0.076 -> en:fap-specific cd8-positive t cells
    n1=ipilimumab | n2=en:fap-specific cd8-positive t cells | rel=r_associated | relid=0 | w=35
  4624. ipilimumab -- r_associated #0: 35 / 0.076 -> en:ferrosoferric oxide
    n1=ipilimumab | n2=en:ferrosoferric oxide | rel=r_associated | relid=0 | w=35
  4625. ipilimumab -- r_associated #0: 35 / 0.076 -> en:folitixorin
    n1=ipilimumab | n2=en:folitixorin | rel=r_associated | relid=0 | w=35
  4626. ipilimumab -- r_associated #0: 35 / 0.076 -> en:fostriecin
    n1=ipilimumab | n2=en:fostriecin | rel=r_associated | relid=0 | w=35
  4627. ipilimumab -- r_associated #0: 35 / 0.076 -> en:gem 231
    n1=ipilimumab | n2=en:gem 231 | rel=r_associated | relid=0 | w=35
  4628. ipilimumab -- r_associated #0: 35 / 0.076 -> en:her-2/neu intracellular domain protein
    n1=ipilimumab | n2=en:her-2/neu intracellular domain protein | rel=r_associated | relid=0 | w=35
  4629. ipilimumab -- r_associated #0: 35 / 0.076 -> en:human monoclonal antibody b11-hcg beta fusion protein cdx-1307
    n1=ipilimumab | n2=en:human monoclonal antibody b11-hcg beta fusion protein cdx-1307 | rel=r_associated | relid=0 | w=35
  4630. ipilimumab -- r_associated #0: 35 / 0.076 -> en:human papillomavirus 16/18 l1 virus-like particle/as04 vaccine
    n1=ipilimumab | n2=en:human papillomavirus 16/18 l1 virus-like particle/as04 vaccine | rel=r_associated | relid=0 | w=35
  4631. ipilimumab -- r_associated #0: 35 / 0.076 -> en:imiglucerase
    n1=ipilimumab | n2=en:imiglucerase | rel=r_associated | relid=0 | w=35
  4632. ipilimumab -- r_associated #0: 35 / 0.076 -> en:imipenem
    n1=ipilimumab | n2=en:imipenem | rel=r_associated | relid=0 | w=35
  4633. ipilimumab -- r_associated #0: 35 / 0.076 -> en:immunotoxin cmd-193
    n1=ipilimumab | n2=en:immunotoxin cmd-193 | rel=r_associated | relid=0 | w=35
  4634. ipilimumab -- r_associated #0: 35 / 0.076 -> en:indium in 111 chx-a dtpa trastuzumab
    n1=ipilimumab | n2=en:indium in 111 chx-a dtpa trastuzumab | rel=r_associated | relid=0 | w=35
  4635. ipilimumab -- r_associated #0: 35 / 0.076 -> en:iopanoic acid
    n1=ipilimumab | n2=en:iopanoic acid | rel=r_associated | relid=0 | w=35
  4636. ipilimumab -- r_associated #0: 35 / 0.076 -> en:iratumumab
    n1=ipilimumab | n2=en:iratumumab | rel=r_associated | relid=0 | w=35
  4637. ipilimumab -- r_associated #0: 35 / 0.076 -> en:isometheptene mucate
    n1=ipilimumab | n2=en:isometheptene mucate | rel=r_associated | relid=0 | w=35
  4638. ipilimumab -- r_associated #0: 35 / 0.076 -> en:isoniazid
    n1=ipilimumab | n2=en:isoniazid | rel=r_associated | relid=0 | w=35
  4639. ipilimumab -- r_associated #0: 35 / 0.076 -> en:lactoferrin-derived lytic peptide ltx-315
    n1=ipilimumab | n2=en:lactoferrin-derived lytic peptide ltx-315 | rel=r_associated | relid=0 | w=35
  4640. ipilimumab -- r_associated #0: 35 / 0.076 -> en:levoleucovorin calcium
    n1=ipilimumab | n2=en:levoleucovorin calcium | rel=r_associated | relid=0 | w=35
  4641. ipilimumab -- r_associated #0: 35 / 0.076 -> en:midostaurin
    n1=ipilimumab | n2=en:midostaurin | rel=r_associated | relid=0 | w=35
  4642. ipilimumab -- r_associated #0: 35 / 0.076 -> en:mitoquidone
    n1=ipilimumab | n2=en:mitoquidone | rel=r_associated | relid=0 | w=35
  4643. ipilimumab -- r_associated #0: 35 / 0.076 -> en:monoclonal antibody m170
    n1=ipilimumab | n2=en:monoclonal antibody m170 | rel=r_associated | relid=0 | w=35
  4644. ipilimumab -- r_associated #0: 35 / 0.076 -> en:monoclonal antibody r24
    n1=ipilimumab | n2=en:monoclonal antibody r24 | rel=r_associated | relid=0 | w=35
  4645. ipilimumab -- r_associated #0: 35 / 0.076 -> en:montanide isa 51 vg
    n1=ipilimumab | n2=en:montanide isa 51 vg | rel=r_associated | relid=0 | w=35
  4646. ipilimumab -- r_associated #0: 35 / 0.076 -> en:morphine sulfate
    n1=ipilimumab | n2=en:morphine sulfate | rel=r_associated | relid=0 | w=35
  4647. ipilimumab -- r_associated #0: 35 / 0.076 -> en:ny-eso-1 plasmid dna cancer vaccine
    n1=ipilimumab | n2=en:ny-eso-1 plasmid dna cancer vaccine | rel=r_associated | relid=0 | w=35
  4648. ipilimumab -- r_associated #0: 35 / 0.076 -> en:ny-eso-1(157-165) peptide-pulsed autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:ny-eso-1(157-165) peptide-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=35
  4649. ipilimumab -- r_associated #0: 35 / 0.076 -> en:ocriplasmin
    n1=ipilimumab | n2=en:ocriplasmin | rel=r_associated | relid=0 | w=35
  4650. ipilimumab -- r_associated #0: 35 / 0.076 -> en:oleandrin
    n1=ipilimumab | n2=en:oleandrin | rel=r_associated | relid=0 | w=35
  4651. ipilimumab -- r_associated #0: 35 / 0.076 -> en:omega 3-marine triglycerides
    n1=ipilimumab | n2=en:omega 3-marine triglycerides | rel=r_associated | relid=0 | w=35
  4652. ipilimumab -- r_associated #0: 35 / 0.076 -> en:p-glycoprotein inhibitor hm30181ak
    n1=ipilimumab | n2=en:p-glycoprotein inhibitor hm30181ak | rel=r_associated | relid=0 | w=35
  4653. ipilimumab -- r_associated #0: 35 / 0.076 -> en:pa-1-stk ovarian carcinoma vaccine
    n1=ipilimumab | n2=en:pa-1-stk ovarian carcinoma vaccine | rel=r_associated | relid=0 | w=35
  4654. ipilimumab -- r_associated #0: 35 / 0.076 -> en:pemetrexed disodium
    n1=ipilimumab | n2=en:pemetrexed disodium | rel=r_associated | relid=0 | w=35
  4655. ipilimumab -- r_associated #0: 35 / 0.076 -> en:phenobarbital
    n1=ipilimumab | n2=en:phenobarbital | rel=r_associated | relid=0 | w=35
  4656. ipilimumab -- r_associated #0: 35 / 0.076 -> en:porfimer sodium
    n1=ipilimumab | n2=en:porfimer sodium | rel=r_associated | relid=0 | w=35
  4657. ipilimumab -- r_associated #0: 35 / 0.076 -> en:progestin
    n1=ipilimumab | n2=en:progestin | rel=r_associated | relid=0 | w=35
  4658. ipilimumab -- r_associated #0: 35 / 0.076 -> en:r-epoch regimen
    n1=ipilimumab | n2=en:r-epoch regimen | rel=r_associated | relid=0 | w=35
  4659. ipilimumab -- r_associated #0: 35 / 0.076 -> en:ramelteon
    n1=ipilimumab | n2=en:ramelteon | rel=r_associated | relid=0 | w=35
  4660. ipilimumab -- r_associated #0: 35 / 0.076 -> en:recombinant macrophage colony-stimulating factor
    n1=ipilimumab | n2=en:recombinant macrophage colony-stimulating factor | rel=r_associated | relid=0 | w=35
  4661. ipilimumab -- r_associated #0: 35 / 0.076 -> en:recombinant nematode anticoagulant protein c2
    n1=ipilimumab | n2=en:recombinant nematode anticoagulant protein c2 | rel=r_associated | relid=0 | w=35
  4662. ipilimumab -- r_associated #0: 35 / 0.076 -> en:recombinant vaccinia viral vector ro5217790
    n1=ipilimumab | n2=en:recombinant vaccinia viral vector ro5217790 | rel=r_associated | relid=0 | w=35
  4663. ipilimumab -- r_associated #0: 35 / 0.076 -> en:renal cell carcinoma/cd40l rna-transfected autologous dendritic cell vaccine ags-003
    n1=ipilimumab | n2=en:renal cell carcinoma/cd40l rna-transfected autologous dendritic cell vaccine ags-003 | rel=r_associated | relid=0 | w=35
  4664. ipilimumab -- r_associated #0: 35 / 0.076 -> en:rocuronium bromide
    n1=ipilimumab | n2=en:rocuronium bromide | rel=r_associated | relid=0 | w=35
  4665. ipilimumab -- r_associated #0: 35 / 0.076 -> en:roflumilast
    n1=ipilimumab | n2=en:roflumilast | rel=r_associated | relid=0 | w=35
  4666. ipilimumab -- r_associated #0: 35 / 0.076 -> en:salmonella vnp20009
    n1=ipilimumab | n2=en:salmonella vnp20009 | rel=r_associated | relid=0 | w=35
  4667. ipilimumab -- r_associated #0: 35 / 0.076 -> en:tasisulam sodium
    n1=ipilimumab | n2=en:tasisulam sodium | rel=r_associated | relid=0 | w=35
  4668. ipilimumab -- r_associated #0: 35 / 0.076 -> en:testolactone
    n1=ipilimumab | n2=en:testolactone | rel=r_associated | relid=0 | w=35
  4669. ipilimumab -- r_associated #0: 35 / 0.076 -> en:testosterone gel
    n1=ipilimumab | n2=en:testosterone gel | rel=r_associated | relid=0 | w=35
  4670. ipilimumab -- r_associated #0: 35 / 0.076 -> en:therapeutic hydrocortisone
    n1=ipilimumab | n2=en:therapeutic hydrocortisone | rel=r_associated | relid=0 | w=35
  4671. ipilimumab -- r_associated #0: 35 / 0.076 -> en:tilarginine
    n1=ipilimumab | n2=en:tilarginine | rel=r_associated | relid=0 | w=35
  4672. ipilimumab -- r_associated #0: 35 / 0.076 -> en:tivantinib
    n1=ipilimumab | n2=en:tivantinib | rel=r_associated | relid=0 | w=35
  4673. ipilimumab -- r_associated #0: 35 / 0.076 -> en:tlr-directed cationic lipid-dna complex jvrs-100
    n1=ipilimumab | n2=en:tlr-directed cationic lipid-dna complex jvrs-100 | rel=r_associated | relid=0 | w=35
  4674. ipilimumab -- r_associated #0: 35 / 0.076 -> en:topsalysin
    n1=ipilimumab | n2=en:topsalysin | rel=r_associated | relid=0 | w=35
  4675. ipilimumab -- r_associated #0: 35 / 0.076 -> en:transthyretin antisense oligonucleotide isis-ttr rx
    n1=ipilimumab | n2=en:transthyretin antisense oligonucleotide isis-ttr rx | rel=r_associated | relid=0 | w=35
  4676. ipilimumab -- r_associated #0: 35 / 0.076 -> en:triapine
    n1=ipilimumab | n2=en:triapine | rel=r_associated | relid=0 | w=35
  4677. ipilimumab -- r_associated #0: 35 / 0.076 -> en:urlc10 peptide vaccine
    n1=ipilimumab | n2=en:urlc10 peptide vaccine | rel=r_associated | relid=0 | w=35
  4678. ipilimumab -- r_associated #0: 35 / 0.076 -> en:vaccinia-gm-csf vaccine
    n1=ipilimumab | n2=en:vaccinia-gm-csf vaccine | rel=r_associated | relid=0 | w=35
  4679. ipilimumab -- r_associated #0: 35 / 0.076 -> en:vegfr/pdgfr dual kinase inhibitor x-82
    n1=ipilimumab | n2=en:vegfr/pdgfr dual kinase inhibitor x-82 | rel=r_associated | relid=0 | w=35
  4680. ipilimumab -- r_associated #0: 35 / 0.076 -> en:verapamil
    n1=ipilimumab | n2=en:verapamil | rel=r_associated | relid=0 | w=35
  4681. ipilimumab -- r_associated #0: 35 / 0.076 -> en:vistusertib
    n1=ipilimumab | n2=en:vistusertib | rel=r_associated | relid=0 | w=35
  4682. ipilimumab -- r_associated #0: 35 / 0.076 -> en:voxtalisib
    n1=ipilimumab | n2=en:voxtalisib | rel=r_associated | relid=0 | w=35
  4683. ipilimumab -- r_associated #0: 35 / 0.076 -> en:zibotentan
    n1=ipilimumab | n2=en:zibotentan | rel=r_associated | relid=0 | w=35
  4684. ipilimumab -- r_associated #0: 34 / 0.074 -> en:4-nitroestrone 3-methyl ether
    n1=ipilimumab | n2=en:4-nitroestrone 3-methyl ether | rel=r_associated | relid=0 | w=34
  4685. ipilimumab -- r_associated #0: 34 / 0.074 -> en:abve regimen
    n1=ipilimumab | n2=en:abve regimen | rel=r_associated | relid=0 | w=34
  4686. ipilimumab -- r_associated #0: 34 / 0.074 -> en:acetyl-l-carnitine hydrochloride
    n1=ipilimumab | n2=en:acetyl-l-carnitine hydrochloride | rel=r_associated | relid=0 | w=34
  4687. ipilimumab -- r_associated #0: 34 / 0.074 -> en:ad-reic/dkk3 vaccine
    n1=ipilimumab | n2=en:ad-reic/dkk3 vaccine | rel=r_associated | relid=0 | w=34
  4688. ipilimumab -- r_associated #0: 34 / 0.074 -> en:adefovir dipivoxil
    n1=ipilimumab | n2=en:adefovir dipivoxil | rel=r_associated | relid=0 | w=34
  4689. ipilimumab -- r_associated #0: 34 / 0.074 -> en:alizapride
    n1=ipilimumab | n2=en:alizapride | rel=r_associated | relid=0 | w=34
  4690. ipilimumab -- r_associated #0: 34 / 0.074 -> en:allogeneic dendritic cell-myeloma idiotype vaccine
    n1=ipilimumab | n2=en:allogeneic dendritic cell-myeloma idiotype vaccine | rel=r_associated | relid=0 | w=34
  4691. ipilimumab -- r_associated #0: 34 / 0.074 -> en:amg 224
    n1=ipilimumab | n2=en:amg 224 | rel=r_associated | relid=0 | w=34
  4692. ipilimumab -- r_associated #0: 34 / 0.074 -> en:aminocaproic acid
    n1=ipilimumab | n2=en:aminocaproic acid | rel=r_associated | relid=0 | w=34
  4693. ipilimumab -- r_associated #0: 34 / 0.074 -> en:anti-cd22 car-expressing t lymphocytes
    n1=ipilimumab | n2=en:anti-cd22 car-expressing t lymphocytes | rel=r_associated | relid=0 | w=34
  4694. ipilimumab -- r_associated #0: 34 / 0.074 -> en:anti-hbegf monoclonal antibody u3-1565
    n1=ipilimumab | n2=en:anti-hbegf monoclonal antibody u3-1565 | rel=r_associated | relid=0 | w=34
  4695. ipilimumab -- r_associated #0: 34 / 0.074 -> en:antibody-drug conjugate sc-003
    n1=ipilimumab | n2=en:antibody-drug conjugate sc-003 | rel=r_associated | relid=0 | w=34
  4696. ipilimumab -- r_associated #0: 34 / 0.074 -> en:antivaricose agent
    n1=ipilimumab | n2=en:antivaricose agent | rel=r_associated | relid=0 | w=34
  4697. ipilimumab -- r_associated #0: 34 / 0.074 -> en:aurora kinase inhibitor ttp607
    n1=ipilimumab | n2=en:aurora kinase inhibitor ttp607 | rel=r_associated | relid=0 | w=34
  4698. ipilimumab -- r_associated #0: 34 / 0.074 -> en:autologous cytomegalovirus-specific cytotoxic t-lymphocytes
    n1=ipilimumab | n2=en:autologous cytomegalovirus-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=34
  4699. ipilimumab -- r_associated #0: 34 / 0.074 -> en:autologous lmp1-/lmp2- specific cytotoxic t-lymphocytes
    n1=ipilimumab | n2=en:autologous lmp1-/lmp2- specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=34
  4700. ipilimumab -- r_associated #0: 34 / 0.074 -> en:azp
    n1=ipilimumab | n2=en:azp | rel=r_associated | relid=0 | w=34
  4701. ipilimumab -- r_associated #0: 34 / 0.074 -> en:bavituximab
    n1=ipilimumab | n2=en:bavituximab | rel=r_associated | relid=0 | w=34
  4702. ipilimumab -- r_associated #0: 34 / 0.074 -> en:bendamustine hydrochloride
    n1=ipilimumab | n2=en:bendamustine hydrochloride | rel=r_associated | relid=0 | w=34
  4703. ipilimumab -- r_associated #0: 34 / 0.074 -> en:bi 2536
    n1=ipilimumab | n2=en:bi 2536 | rel=r_associated | relid=0 | w=34
  4704. ipilimumab -- r_associated #0: 34 / 0.074 -> en:bibx 1382
    n1=ipilimumab | n2=en:bibx 1382 | rel=r_associated | relid=0 | w=34
  4705. ipilimumab -- r_associated #0: 34 / 0.074 -> en:carbendazim
    n1=ipilimumab | n2=en:carbendazim | rel=r_associated | relid=0 | w=34
  4706. ipilimumab -- r_associated #0: 34 / 0.074 -> en:carbenicillin
    n1=ipilimumab | n2=en:carbenicillin | rel=r_associated | relid=0 | w=34
  4707. ipilimumab -- r_associated #0: 34 / 0.074 -> en:carbon c 11 n-desmethyl-loperamide
    n1=ipilimumab | n2=en:carbon c 11 n-desmethyl-loperamide | rel=r_associated | relid=0 | w=34
  4708. ipilimumab -- r_associated #0: 34 / 0.074 -> en:carbon c 14 gilteritinib
    n1=ipilimumab | n2=en:carbon c 14 gilteritinib | rel=r_associated | relid=0 | w=34
  4709. ipilimumab -- r_associated #0: 34 / 0.074 -> en:carboxyamidotriazole orotate
    n1=ipilimumab | n2=en:carboxyamidotriazole orotate | rel=r_associated | relid=0 | w=34
  4710. ipilimumab -- r_associated #0: 34 / 0.074 -> en:carcinoembryonic antigen-expressing measles virus
    n1=ipilimumab | n2=en:carcinoembryonic antigen-expressing measles virus | rel=r_associated | relid=0 | w=34
  4711. ipilimumab -- r_associated #0: 34 / 0.074 -> en:cdc7 kinase inhibitor bms-863233
    n1=ipilimumab | n2=en:cdc7 kinase inhibitor bms-863233 | rel=r_associated | relid=0 | w=34
  4712. ipilimumab -- r_associated #0: 34 / 0.074 -> en:ceftazidime/avibactam sodium
    n1=ipilimumab | n2=en:ceftazidime/avibactam sodium | rel=r_associated | relid=0 | w=34
  4713. ipilimumab -- r_associated #0: 34 / 0.074 -> en:cell differentiating agent
    n1=ipilimumab | n2=en:cell differentiating agent | rel=r_associated | relid=0 | w=34
  4714. ipilimumab -- r_associated #0: 34 / 0.074 -> en:cilengitide
    n1=ipilimumab | n2=en:cilengitide | rel=r_associated | relid=0 | w=34
  4715. ipilimumab -- r_associated #0: 34 / 0.074 -> en:cintredekin besudotox
    n1=ipilimumab | n2=en:cintredekin besudotox | rel=r_associated | relid=0 | w=34
  4716. ipilimumab -- r_associated #0: 34 / 0.074 -> en:contrast agent cs-1000
    n1=ipilimumab | n2=en:contrast agent cs-1000 | rel=r_associated | relid=0 | w=34
  4717. ipilimumab -- r_associated #0: 34 / 0.074 -> en:cryoprotective agent
    n1=ipilimumab | n2=en:cryoprotective agent | rel=r_associated | relid=0 | w=34
  4718. ipilimumab -- r_associated #0: 34 / 0.074 -> en:ctrp terminology
    n1=ipilimumab | n2=en:ctrp terminology | rel=r_associated | relid=0 | w=34
  4719. ipilimumab -- r_associated #0: 34 / 0.074 -> en:declopramide
    n1=ipilimumab | n2=en:declopramide | rel=r_associated | relid=0 | w=34
  4720. ipilimumab -- r_associated #0: 34 / 0.074 -> en:dhap regimen
    n1=ipilimumab | n2=en:dhap regimen | rel=r_associated | relid=0 | w=34
  4721. ipilimumab -- r_associated #0: 34 / 0.074 -> en:diflunisal
    n1=ipilimumab | n2=en:diflunisal | rel=r_associated | relid=0 | w=34
  4722. ipilimumab -- r_associated #0: 34 / 0.074 -> en:dkk1-neutralizing monoclonal antibody dkn-01
    n1=ipilimumab | n2=en:dkk1-neutralizing monoclonal antibody dkn-01 | rel=r_associated | relid=0 | w=34
  4723. ipilimumab -- r_associated #0: 34 / 0.074 -> en:dnr-expressing nasopharyngeal carcinoma-specific cytotoxic t-lymphocytes
    n1=ipilimumab | n2=en:dnr-expressing nasopharyngeal carcinoma-specific cytotoxic t-lymphocytes | rel=r_associated | relid=0 | w=34
  4724. ipilimumab -- r_associated #0: 34 / 0.074 -> en:doconexent
    n1=ipilimumab | n2=en:doconexent | rel=r_associated | relid=0 | w=34
  4725. ipilimumab -- r_associated #0: 34 / 0.074 -> en:edrecolomab
    n1=ipilimumab | n2=en:edrecolomab | rel=r_associated | relid=0 | w=34
  4726. ipilimumab -- r_associated #0: 34 / 0.074 -> en:efungumab
    n1=ipilimumab | n2=en:efungumab | rel=r_associated | relid=0 | w=34
  4727. ipilimumab -- r_associated #0: 34 / 0.074 -> en:elotuzumab
    n1=ipilimumab | n2=en:elotuzumab | rel=r_associated | relid=0 | w=34
  4728. ipilimumab -- r_associated #0: 34 / 0.074 -> en:estradiol valerate
    n1=ipilimumab | n2=en:estradiol valerate | rel=r_associated | relid=0 | w=34
  4729. ipilimumab -- r_associated #0: 34 / 0.074 -> en:expectorant/mucolytic
    n1=ipilimumab | n2=en:expectorant/mucolytic | rel=r_associated | relid=0 | w=34
  4730. ipilimumab -- r_associated #0: 34 / 0.074 -> en:fertility agents
    n1=ipilimumab | n2=en:fertility agents | rel=r_associated | relid=0 | w=34
  4731. ipilimumab -- r_associated #0: 34 / 0.074 -> en:fesoterodine fumarate
    n1=ipilimumab | n2=en:fesoterodine fumarate | rel=r_associated | relid=0 | w=34
  4732. ipilimumab -- r_associated #0: 34 / 0.074 -> en:fluorine f 18 bay1075553
    n1=ipilimumab | n2=en:fluorine f 18 bay1075553 | rel=r_associated | relid=0 | w=34
  4733. ipilimumab -- r_associated #0: 34 / 0.074 -> en:fluorine f 18-vm4-037
    n1=ipilimumab | n2=en:fluorine f 18-vm4-037 | rel=r_associated | relid=0 | w=34
  4734. ipilimumab -- r_associated #0: 34 / 0.074 -> en:gd2-klh vaccine
    n1=ipilimumab | n2=en:gd2-klh vaccine | rel=r_associated | relid=0 | w=34
  4735. ipilimumab -- r_associated #0: 34 / 0.074 -> en:gimatecan
    n1=ipilimumab | n2=en:gimatecan | rel=r_associated | relid=0 | w=34
  4736. ipilimumab -- r_associated #0: 34 / 0.074 -> en:globo-h-gm2-lewis-y-muc1-32(aa)-stn(c)-tf(c)-tn(c)-klh conjugate vaccine
    n1=ipilimumab | n2=en:globo-h-gm2-lewis-y-muc1-32(aa)-stn(c)-tf(c)-tn(c)-klh conjugate vaccine | rel=r_associated | relid=0 | w=34
  4737. ipilimumab -- r_associated #0: 34 / 0.074 -> en:gp100:154-162 peptide vaccine
    n1=ipilimumab | n2=en:gp100:154-162 peptide vaccine | rel=r_associated | relid=0 | w=34
  4738. ipilimumab -- r_associated #0: 34 / 0.074 -> en:hla-dp0401/0402-restricted mage-a3-reactive t cell receptor-transduced autologous t cells
    n1=ipilimumab | n2=en:hla-dp0401/0402-restricted mage-a3-reactive t cell receptor-transduced autologous t cells | rel=r_associated | relid=0 | w=34
  4739. ipilimumab -- r_associated #0: 34 / 0.074 -> en:hpv 16 e7 antigen-expressing lactobacillis casei vaccine bls-ilb-e710c
    n1=ipilimumab | n2=en:hpv 16 e7 antigen-expressing lactobacillis casei vaccine bls-ilb-e710c | rel=r_associated | relid=0 | w=34
  4740. ipilimumab -- r_associated #0: 34 / 0.074 -> en:hu14.18-il2 fusion protein
    n1=ipilimumab | n2=en:hu14.18-il2 fusion protein | rel=r_associated | relid=0 | w=34
  4741. ipilimumab -- r_associated #0: 34 / 0.074 -> en:hyperbaric oxygen
    n1=ipilimumab | n2=en:hyperbaric oxygen | rel=r_associated | relid=0 | w=34
  4742. ipilimumab -- r_associated #0: 34 / 0.074 -> en:igf-methotrexate conjugate
    n1=ipilimumab | n2=en:igf-methotrexate conjugate | rel=r_associated | relid=0 | w=34
  4743. ipilimumab -- r_associated #0: 34 / 0.074 -> en:imidazole mustard
    n1=ipilimumab | n2=en:imidazole mustard | rel=r_associated | relid=0 | w=34
  4744. ipilimumab -- r_associated #0: 34 / 0.074 -> en:indium in 111-labeled autologous peripheral blood mononuclear cells
    n1=ipilimumab | n2=en:indium in 111-labeled autologous peripheral blood mononuclear cells | rel=r_associated | relid=0 | w=34
  4745. ipilimumab -- r_associated #0: 34 / 0.074 -> en:injectable liposomal vinorelbine
    n1=ipilimumab | n2=en:injectable liposomal vinorelbine | rel=r_associated | relid=0 | w=34
  4746. ipilimumab -- r_associated #0: 34 / 0.074 -> en:insulin, nph
    n1=ipilimumab | n2=en:insulin, nph | rel=r_associated | relid=0 | w=34
  4747. ipilimumab -- r_associated #0: 34 / 0.074 -> en:iodipamide meglumine
    n1=ipilimumab | n2=en:iodipamide meglumine | rel=r_associated | relid=0 | w=34
  4748. ipilimumab -- r_associated #0: 34 / 0.074 -> en:ionic silver-impregnated sodium carboxymethylcellulose antimicrobial dressing
    n1=ipilimumab | n2=en:ionic silver-impregnated sodium carboxymethylcellulose antimicrobial dressing | rel=r_associated | relid=0 | w=34
  4749. ipilimumab -- r_associated #0: 34 / 0.074 -> en:lactobacillus brevis cd2 lozenge
    n1=ipilimumab | n2=en:lactobacillus brevis cd2 lozenge | rel=r_associated | relid=0 | w=34
  4750. ipilimumab -- r_associated #0: 34 / 0.074 -> en:lactobacillus plantarum 299v/lactobacillus acidophilus/bifidobacterium lactis probiotic supplement
    n1=ipilimumab | n2=en:lactobacillus plantarum 299v/lactobacillus acidophilus/bifidobacterium lactis probiotic supplement | rel=r_associated | relid=0 | w=34
  4751. ipilimumab -- r_associated #0: 34 / 0.074 -> en:lexibulin
    n1=ipilimumab | n2=en:lexibulin | rel=r_associated | relid=0 | w=34
  4752. ipilimumab -- r_associated #0: 34 / 0.074 -> en:linoleyl carbonate-paclitaxel
    n1=ipilimumab | n2=en:linoleyl carbonate-paclitaxel | rel=r_associated | relid=0 | w=34
  4753. ipilimumab -- r_associated #0: 34 / 0.074 -> en:liposome-encapsulated doxorubicin citrate
    n1=ipilimumab | n2=en:liposome-encapsulated doxorubicin citrate | rel=r_associated | relid=0 | w=34
  4754. ipilimumab -- r_associated #0: 34 / 0.074 -> en:lonafarnib
    n1=ipilimumab | n2=en:lonafarnib | rel=r_associated | relid=0 | w=34
  4755. ipilimumab -- r_associated #0: 34 / 0.074 -> en:lucanthone
    n1=ipilimumab | n2=en:lucanthone | rel=r_associated | relid=0 | w=34
  4756. ipilimumab -- r_associated #0: 34 / 0.074 -> en:lycopene
    n1=ipilimumab | n2=en:lycopene | rel=r_associated | relid=0 | w=34
  4757. ipilimumab -- r_associated #0: 34 / 0.074 -> en:monoclonal antibody a1g4 anti-idiotype vaccine
    n1=ipilimumab | n2=en:monoclonal antibody a1g4 anti-idiotype vaccine | rel=r_associated | relid=0 | w=34
  4758. ipilimumab -- r_associated #0: 34 / 0.074 -> en:mopidamol
    n1=ipilimumab | n2=en:mopidamol | rel=r_associated | relid=0 | w=34
  4759. ipilimumab -- r_associated #0: 34 / 0.074 -> en:naproxen
    n1=ipilimumab | n2=en:naproxen | rel=r_associated | relid=0 | w=34
  4760. ipilimumab -- r_associated #0: 34 / 0.074 -> en:nicardipine
    n1=ipilimumab | n2=en:nicardipine | rel=r_associated | relid=0 | w=34
  4761. ipilimumab -- r_associated #0: 34 / 0.074 -> en:ny-eso-1-specific cd4-positive t lymphocytes
    n1=ipilimumab | n2=en:ny-eso-1-specific cd4-positive t lymphocytes | rel=r_associated | relid=0 | w=34
  4762. ipilimumab -- r_associated #0: 34 / 0.074 -> en:nystatin
    n1=ipilimumab | n2=en:nystatin | rel=r_associated | relid=0 | w=34
  4763. ipilimumab -- r_associated #0: 34 / 0.074 -> en:olive oil/soybean oil/multi-amino acid/glucose parenteral nutrition emulsion
    n1=ipilimumab | n2=en:olive oil/soybean oil/multi-amino acid/glucose parenteral nutrition emulsion | rel=r_associated | relid=0 | w=34
  4764. ipilimumab -- r_associated #0: 34 / 0.074 -> en:omega-3 fatty acid
    n1=ipilimumab | n2=en:omega-3 fatty acid | rel=r_associated | relid=0 | w=34
  4765. ipilimumab -- r_associated #0: 34 / 0.074 -> en:p38 mapk inhibitor ly2228820 dimesylate
    n1=ipilimumab | n2=en:p38 mapk inhibitor ly2228820 dimesylate | rel=r_associated | relid=0 | w=34
  4766. ipilimumab -- r_associated #0: 34 / 0.074 -> en:palladium-bacteriopheophorbide
    n1=ipilimumab | n2=en:palladium-bacteriopheophorbide | rel=r_associated | relid=0 | w=34
  4767. ipilimumab -- r_associated #0: 34 / 0.074 -> en:pamidronate disodium
    n1=ipilimumab | n2=en:pamidronate disodium | rel=r_associated | relid=0 | w=34
  4768. ipilimumab -- r_associated #0: 34 / 0.074 -> en:peptide 946-tetanus peptide conjugate melanoma vaccine
    n1=ipilimumab | n2=en:peptide 946-tetanus peptide conjugate melanoma vaccine | rel=r_associated | relid=0 | w=34
  4769. ipilimumab -- r_associated #0: 34 / 0.074 -> en:photocyanine
    n1=ipilimumab | n2=en:photocyanine | rel=r_associated | relid=0 | w=34
  4770. ipilimumab -- r_associated #0: 34 / 0.074 -> en:pi3k inhibitor ch5132799
    n1=ipilimumab | n2=en:pi3k inhibitor ch5132799 | rel=r_associated | relid=0 | w=34
  4771. ipilimumab -- r_associated #0: 34 / 0.074 -> en:pi3kdelta inhibitor gs-9901
    n1=ipilimumab | n2=en:pi3kdelta inhibitor gs-9901 | rel=r_associated | relid=0 | w=34
  4772. ipilimumab -- r_associated #0: 34 / 0.074 -> en:pim kinase inhibitor lgh447
    n1=ipilimumab | n2=en:pim kinase inhibitor lgh447 | rel=r_associated | relid=0 | w=34
  4773. ipilimumab -- r_associated #0: 34 / 0.074 -> en:pomegranate juice
    n1=ipilimumab | n2=en:pomegranate juice | rel=r_associated | relid=0 | w=34
  4774. ipilimumab -- r_associated #0: 34 / 0.074 -> en:probenecid
    n1=ipilimumab | n2=en:probenecid | rel=r_associated | relid=0 | w=34
  4775. ipilimumab -- r_associated #0: 34 / 0.074 -> en:pumvc3-higfbp-2 multi-epitope plasmid dna vaccine
    n1=ipilimumab | n2=en:pumvc3-higfbp-2 multi-epitope plasmid dna vaccine | rel=r_associated | relid=0 | w=34
  4776. ipilimumab -- r_associated #0: 34 / 0.074 -> en:pv701
    n1=ipilimumab | n2=en:pv701 | rel=r_associated | relid=0 | w=34
  4777. ipilimumab -- r_associated #0: 34 / 0.074 -> en:recombinant adenovirus-hifn-beta
    n1=ipilimumab | n2=en:recombinant adenovirus-hifn-beta | rel=r_associated | relid=0 | w=34
  4778. ipilimumab -- r_associated #0: 34 / 0.074 -> en:recombinant cd40-ligand
    n1=ipilimumab | n2=en:recombinant cd40-ligand | rel=r_associated | relid=0 | w=34
  4779. ipilimumab -- r_associated #0: 34 / 0.074 -> en:recombinant dna-l523s vaccine
    n1=ipilimumab | n2=en:recombinant dna-l523s vaccine | rel=r_associated | relid=0 | w=34
  4780. ipilimumab -- r_associated #0: 34 / 0.074 -> en:recombinant mip1-alpha variant eci301
    n1=ipilimumab | n2=en:recombinant mip1-alpha variant eci301 | rel=r_associated | relid=0 | w=34
  4781. ipilimumab -- r_associated #0: 34 / 0.074 -> en:resminostat
    n1=ipilimumab | n2=en:resminostat | rel=r_associated | relid=0 | w=34
  4782. ipilimumab -- r_associated #0: 34 / 0.074 -> en:rivastigmine tartrate
    n1=ipilimumab | n2=en:rivastigmine tartrate | rel=r_associated | relid=0 | w=34
  4783. ipilimumab -- r_associated #0: 34 / 0.074 -> en:ropidoxuridine
    n1=ipilimumab | n2=en:ropidoxuridine | rel=r_associated | relid=0 | w=34
  4784. ipilimumab -- r_associated #0: 34 / 0.074 -> en:rotigotine
    n1=ipilimumab | n2=en:rotigotine | rel=r_associated | relid=0 | w=34
  4785. ipilimumab -- r_associated #0: 34 / 0.074 -> en:sam68 modulator cwp232291
    n1=ipilimumab | n2=en:sam68 modulator cwp232291 | rel=r_associated | relid=0 | w=34
  4786. ipilimumab -- r_associated #0: 34 / 0.074 -> en:satraplatin
    n1=ipilimumab | n2=en:satraplatin | rel=r_associated | relid=0 | w=34
  4787. ipilimumab -- r_associated #0: 34 / 0.074 -> en:sertraline hydrochloride
    n1=ipilimumab | n2=en:sertraline hydrochloride | rel=r_associated | relid=0 | w=34
  4788. ipilimumab -- r_associated #0: 34 / 0.074 -> en:silatecan ar-67
    n1=ipilimumab | n2=en:silatecan ar-67 | rel=r_associated | relid=0 | w=34
  4789. ipilimumab -- r_associated #0: 34 / 0.074 -> en:silver sulfadiazine
    n1=ipilimumab | n2=en:silver sulfadiazine | rel=r_associated | relid=0 | w=34
  4790. ipilimumab -- r_associated #0: 34 / 0.074 -> en:sodium phosphate/sodium biphosphate laxative
    n1=ipilimumab | n2=en:sodium phosphate/sodium biphosphate laxative | rel=r_associated | relid=0 | w=34
  4791. ipilimumab -- r_associated #0: 34 / 0.074 -> en:solifenacin succinate
    n1=ipilimumab | n2=en:solifenacin succinate | rel=r_associated | relid=0 | w=34
  4792. ipilimumab -- r_associated #0: 34 / 0.074 -> en:solution
    n1=ipilimumab | n2=en:solution | rel=r_associated | relid=0 | w=34
  4793. ipilimumab -- r_associated #0: 34 / 0.074 -> en:t4n5 liposomal lotion
    n1=ipilimumab | n2=en:t4n5 liposomal lotion | rel=r_associated | relid=0 | w=34
  4794. ipilimumab -- r_associated #0: 34 / 0.074 -> en:talactoferrin alfa
    n1=ipilimumab | n2=en:talactoferrin alfa | rel=r_associated | relid=0 | w=34
  4795. ipilimumab -- r_associated #0: 34 / 0.074 -> en:tanespimycin
    n1=ipilimumab | n2=en:tanespimycin | rel=r_associated | relid=0 | w=34
  4796. ipilimumab -- r_associated #0: 34 / 0.074 -> en:teniposide
    n1=ipilimumab | n2=en:teniposide | rel=r_associated | relid=0 | w=34
  4797. ipilimumab -- r_associated #0: 34 / 0.074 -> en:tenofovir
    n1=ipilimumab | n2=en:tenofovir | rel=r_associated | relid=0 | w=34
  4798. ipilimumab -- r_associated #0: 34 / 0.074 -> en:tepotinib
    n1=ipilimumab | n2=en:tepotinib | rel=r_associated | relid=0 | w=34
  4799. ipilimumab -- r_associated #0: 34 / 0.074 -> en:tipifarnib
    n1=ipilimumab | n2=en:tipifarnib | rel=r_associated | relid=0 | w=34
  4800. ipilimumab -- r_associated #0: 34 / 0.074 -> en:tocophersolan
    n1=ipilimumab | n2=en:tocophersolan | rel=r_associated | relid=0 | w=34
  4801. ipilimumab -- r_associated #0: 34 / 0.074 -> en:topical vitamin e
    n1=ipilimumab | n2=en:topical vitamin e | rel=r_associated | relid=0 | w=34
  4802. ipilimumab -- r_associated #0: 34 / 0.074 -> en:toremifene
    n1=ipilimumab | n2=en:toremifene | rel=r_associated | relid=0 | w=34
  4803. ipilimumab -- r_associated #0: 34 / 0.074 -> en:wt1-a10/as01b immunotherapeutic gsk2130579a
    n1=ipilimumab | n2=en:wt1-a10/as01b immunotherapeutic gsk2130579a | rel=r_associated | relid=0 | w=34
  4804. ipilimumab -- r_associated #0: 34 / 0.074 -> en:zirconium zr 89-labeled ro5479599
    n1=ipilimumab | n2=en:zirconium zr 89-labeled ro5479599 | rel=r_associated | relid=0 | w=34
  4805. ipilimumab -- r_associated #0: 32 / 0.07 -> en:abexinostat
    n1=ipilimumab | n2=en:abexinostat | rel=r_associated | relid=0 | w=32
  4806. ipilimumab -- r_associated #0: 32 / 0.07 -> en:adenovirus 5-human guanylyl cyclase c-padre vaccine
    n1=ipilimumab | n2=en:adenovirus 5-human guanylyl cyclase c-padre vaccine | rel=r_associated | relid=0 | w=32
  4807. ipilimumab -- r_associated #0: 32 / 0.07 -> en:adenovirus-p53 transduced dendritic cell vaccine
    n1=ipilimumab | n2=en:adenovirus-p53 transduced dendritic cell vaccine | rel=r_associated | relid=0 | w=32
  4808. ipilimumab -- r_associated #0: 32 / 0.07 -> en:allogeneic aml antigen-expressing dendritic cell vaccine
    n1=ipilimumab | n2=en:allogeneic aml antigen-expressing dendritic cell vaccine | rel=r_associated | relid=0 | w=32
  4809. ipilimumab -- r_associated #0: 32 / 0.07 -> en:allogeneic dendritic cell vaccine combig-dc
    n1=ipilimumab | n2=en:allogeneic dendritic cell vaccine combig-dc | rel=r_associated | relid=0 | w=32
  4810. ipilimumab -- r_associated #0: 32 / 0.07 -> en:allogeneic gm-csf-secreting tumor vaccine panc 10.05 pcdna-1/gm-neo
    n1=ipilimumab | n2=en:allogeneic gm-csf-secreting tumor vaccine panc 10.05 pcdna-1/gm-neo | rel=r_associated | relid=0 | w=32
  4811. ipilimumab -- r_associated #0: 32 / 0.07 -> en:anti-cd19 antibody-drug conjugate sgn-cd19b
    n1=ipilimumab | n2=en:anti-cd19 antibody-drug conjugate sgn-cd19b | rel=r_associated | relid=0 | w=32
  4812. ipilimumab -- r_associated #0: 32 / 0.07 -> en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/gp100 antigen/montanide isa-51
    n1=ipilimumab | n2=en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/gp100 antigen/montanide isa-51 | rel=r_associated | relid=0 | w=32
  4813. ipilimumab -- r_associated #0: 32 / 0.07 -> en:anti-fgfr3 antibody-drug conjugate ly3076226
    n1=ipilimumab | n2=en:anti-fgfr3 antibody-drug conjugate ly3076226 | rel=r_associated | relid=0 | w=32
  4814. ipilimumab -- r_associated #0: 32 / 0.07 -> en:anti-gcc antibody-drug conjugate mln0264
    n1=ipilimumab | n2=en:anti-gcc antibody-drug conjugate mln0264 | rel=r_associated | relid=0 | w=32
  4815. ipilimumab -- r_associated #0: 32 / 0.07 -> en:anti-pd-1 monoclonal antibody tsr-042
    n1=ipilimumab | n2=en:anti-pd-1 monoclonal antibody tsr-042 | rel=r_associated | relid=0 | w=32
  4816. ipilimumab -- r_associated #0: 32 / 0.07 -> en:apatorsen
    n1=ipilimumab | n2=en:apatorsen | rel=r_associated | relid=0 | w=32
  4817. ipilimumab -- r_associated #0: 32 / 0.07 -> en:auranofin
    n1=ipilimumab | n2=en:auranofin | rel=r_associated | relid=0 | w=32
  4818. ipilimumab -- r_associated #0: 32 / 0.07 -> en:autologous prostate stem cell antigen-specific car t cells bpx-601
    n1=ipilimumab | n2=en:autologous prostate stem cell antigen-specific car t cells bpx-601 | rel=r_associated | relid=0 | w=32
  4819. ipilimumab -- r_associated #0: 32 / 0.07 -> en:cantuzumab ravtansine
    n1=ipilimumab | n2=en:cantuzumab ravtansine | rel=r_associated | relid=0 | w=32
  4820. ipilimumab -- r_associated #0: 32 / 0.07 -> en:carboxymethylcellulose sodium
    n1=ipilimumab | n2=en:carboxymethylcellulose sodium | rel=r_associated | relid=0 | w=32
  4821. ipilimumab -- r_associated #0: 32 / 0.07 -> en:cb10-277
    n1=ipilimumab | n2=en:cb10-277 | rel=r_associated | relid=0 | w=32
  4822. ipilimumab -- r_associated #0: 32 / 0.07 -> en:cbp/beta-catenin antagonist pri-724
    n1=ipilimumab | n2=en:cbp/beta-catenin antagonist pri-724 | rel=r_associated | relid=0 | w=32
  4823. ipilimumab -- r_associated #0: 32 / 0.07 -> en:cd19car-cd3zeta-expressing autologous t lymphocytes
    n1=ipilimumab | n2=en:cd19car-cd3zeta-expressing autologous t lymphocytes | rel=r_associated | relid=0 | w=32
  4824. ipilimumab -- r_associated #0: 32 / 0.07 -> en:cellulose, oxidized
    n1=ipilimumab | n2=en:cellulose, oxidized | rel=r_associated | relid=0 | w=32
  4825. ipilimumab -- r_associated #0: 32 / 0.07 -> en:cordycepin
    n1=ipilimumab | n2=en:cordycepin | rel=r_associated | relid=0 | w=32
  4826. ipilimumab -- r_associated #0: 32 / 0.07 -> en:cvp regimen
    n1=ipilimumab | n2=en:cvp regimen | rel=r_associated | relid=0 | w=32
  4827. ipilimumab -- r_associated #0: 32 / 0.07 -> en:diazooxonorleucine
    n1=ipilimumab | n2=en:diazooxonorleucine | rel=r_associated | relid=0 | w=32
  4828. ipilimumab -- r_associated #0: 32 / 0.07 -> en:dna-pk inhibitor msc2490484a
    n1=ipilimumab | n2=en:dna-pk inhibitor msc2490484a | rel=r_associated | relid=0 | w=32
  4829. ipilimumab -- r_associated #0: 32 / 0.07 -> en:ecromeximab
    n1=ipilimumab | n2=en:ecromeximab | rel=r_associated | relid=0 | w=32
  4830. ipilimumab -- r_associated #0: 32 / 0.07 -> en:ertapenem sodium
    n1=ipilimumab | n2=en:ertapenem sodium | rel=r_associated | relid=0 | w=32
  4831. ipilimumab -- r_associated #0: 32 / 0.07 -> en:ertumaxomab
    n1=ipilimumab | n2=en:ertumaxomab | rel=r_associated | relid=0 | w=32
  4832. ipilimumab -- r_associated #0: 32 / 0.07 -> en:evaux spring water-based cream
    n1=ipilimumab | n2=en:evaux spring water-based cream | rel=r_associated | relid=0 | w=32
  4833. ipilimumab -- r_associated #0: 32 / 0.07 -> en:exatecan mesylate
    n1=ipilimumab | n2=en:exatecan mesylate | rel=r_associated | relid=0 | w=32
  4834. ipilimumab -- r_associated #0: 32 / 0.07 -> en:farletuzumab
    n1=ipilimumab | n2=en:farletuzumab | rel=r_associated | relid=0 | w=32
  4835. ipilimumab -- r_associated #0: 32 / 0.07 -> en:fazarabine
    n1=ipilimumab | n2=en:fazarabine | rel=r_associated | relid=0 | w=32
  4836. ipilimumab -- r_associated #0: 32 / 0.07 -> en:fluorine f 18 dcfbc
    n1=ipilimumab | n2=en:fluorine f 18 dcfbc | rel=r_associated | relid=0 | w=32
  4837. ipilimumab -- r_associated #0: 32 / 0.07 -> en:fluorine f 18-labeled s-(3-fluoropropyl)homocysteine hydrochloride
    n1=ipilimumab | n2=en:fluorine f 18-labeled s-(3-fluoropropyl)homocysteine hydrochloride | rel=r_associated | relid=0 | w=32
  4838. ipilimumab -- r_associated #0: 32 / 0.07 -> en:fluorometholone acetate ophthalmic suspension
    n1=ipilimumab | n2=en:fluorometholone acetate ophthalmic suspension | rel=r_associated | relid=0 | w=32
  4839. ipilimumab -- r_associated #0: 32 / 0.07 -> en:gemigliptin
    n1=ipilimumab | n2=en:gemigliptin | rel=r_associated | relid=0 | w=32
  4840. ipilimumab -- r_associated #0: 32 / 0.07 -> en:gene-modified hiv-protected hematopoietic stem cells
    n1=ipilimumab | n2=en:gene-modified hiv-protected hematopoietic stem cells | rel=r_associated | relid=0 | w=32
  4841. ipilimumab -- r_associated #0: 32 / 0.07 -> en:genital system agent
    n1=ipilimumab | n2=en:genital system agent | rel=r_associated | relid=0 | w=32
  4842. ipilimumab -- r_associated #0: 32 / 0.07 -> en:gp100-fowlpox vaccine
    n1=ipilimumab | n2=en:gp100-fowlpox vaccine | rel=r_associated | relid=0 | w=32
  4843. ipilimumab -- r_associated #0: 32 / 0.07 -> en:halometasone
    n1=ipilimumab | n2=en:halometasone | rel=r_associated | relid=0 | w=32
  4844. ipilimumab -- r_associated #0: 32 / 0.07 -> en:henatinib maleate
    n1=ipilimumab | n2=en:henatinib maleate | rel=r_associated | relid=0 | w=32
  4845. ipilimumab -- r_associated #0: 32 / 0.07 -> en:hepatitis a vaccine
    n1=ipilimumab | n2=en:hepatitis a vaccine | rel=r_associated | relid=0 | w=32
  4846. ipilimumab -- r_associated #0: 32 / 0.07 -> en:hpv dna plasmids therapeutic vaccine vgx-3100
    n1=ipilimumab | n2=en:hpv dna plasmids therapeutic vaccine vgx-3100 | rel=r_associated | relid=0 | w=32
  4847. ipilimumab -- r_associated #0: 32 / 0.07 -> en:htert i540/r572y/d988y multipeptide vaccine
    n1=ipilimumab | n2=en:htert i540/r572y/d988y multipeptide vaccine | rel=r_associated | relid=0 | w=32
  4848. ipilimumab -- r_associated #0: 32 / 0.07 -> en:hydrocortisone sodium succinate
    n1=ipilimumab | n2=en:hydrocortisone sodium succinate | rel=r_associated | relid=0 | w=32
  4849. ipilimumab -- r_associated #0: 32 / 0.07 -> en:ibandronate sodium
    n1=ipilimumab | n2=en:ibandronate sodium | rel=r_associated | relid=0 | w=32
  4850. ipilimumab -- r_associated #0: 32 / 0.07 -> en:iodine i 124
    n1=ipilimumab | n2=en:iodine i 124 | rel=r_associated | relid=0 | w=32
  4851. ipilimumab -- r_associated #0: 32 / 0.07 -> en:iodine i 131 nm404
    n1=ipilimumab | n2=en:iodine i 131 nm404 | rel=r_associated | relid=0 | w=32
  4852. ipilimumab -- r_associated #0: 32 / 0.07 -> en:isradipine
    n1=ipilimumab | n2=en:isradipine | rel=r_associated | relid=0 | w=32
  4853. ipilimumab -- r_associated #0: 32 / 0.07 -> en:lenvatinib mesylate
    n1=ipilimumab | n2=en:lenvatinib mesylate | rel=r_associated | relid=0 | w=32
  4854. ipilimumab -- r_associated #0: 32 / 0.07 -> en:linaclotide acetate
    n1=ipilimumab | n2=en:linaclotide acetate | rel=r_associated | relid=0 | w=32
  4855. ipilimumab -- r_associated #0: 32 / 0.07 -> en:liposomal hpv-16 e6/e7 multipeptide vaccine pds0101
    n1=ipilimumab | n2=en:liposomal hpv-16 e6/e7 multipeptide vaccine pds0101 | rel=r_associated | relid=0 | w=32
  4856. ipilimumab -- r_associated #0: 32 / 0.07 -> en:lsd1 inhibitor gsk2879552
    n1=ipilimumab | n2=en:lsd1 inhibitor gsk2879552 | rel=r_associated | relid=0 | w=32
  4857. ipilimumab -- r_associated #0: 32 / 0.07 -> en:lutetium lu-177 girentuximab
    n1=ipilimumab | n2=en:lutetium lu-177 girentuximab | rel=r_associated | relid=0 | w=32
  4858. ipilimumab -- r_associated #0: 32 / 0.07 -> en:mag-tn3/as15 vaccine
    n1=ipilimumab | n2=en:mag-tn3/as15 vaccine | rel=r_associated | relid=0 | w=32
  4859. ipilimumab -- r_associated #0: 32 / 0.07 -> en:mangafodipir trisodium
    n1=ipilimumab | n2=en:mangafodipir trisodium | rel=r_associated | relid=0 | w=32
  4860. ipilimumab -- r_associated #0: 32 / 0.07 -> en:maraviroc
    n1=ipilimumab | n2=en:maraviroc | rel=r_associated | relid=0 | w=32
  4861. ipilimumab -- r_associated #0: 32 / 0.07 -> en:marimastat
    n1=ipilimumab | n2=en:marimastat | rel=r_associated | relid=0 | w=32
  4862. ipilimumab -- r_associated #0: 32 / 0.07 -> en:materia medica
    n1=ipilimumab | n2=en:materia medica | rel=r_associated | relid=0 | w=32
  4863. ipilimumab -- r_associated #0: 32 / 0.07 -> en:metoclopramide hydrochloride
    n1=ipilimumab | n2=en:metoclopramide hydrochloride | rel=r_associated | relid=0 | w=32
  4864. ipilimumab -- r_associated #0: 32 / 0.07 -> en:monoclonal antibody muj591
    n1=ipilimumab | n2=en:monoclonal antibody muj591 | rel=r_associated | relid=0 | w=32
  4865. ipilimumab -- r_associated #0: 32 / 0.07 -> en:morinda citrifolia fruit extract
    n1=ipilimumab | n2=en:morinda citrifolia fruit extract | rel=r_associated | relid=0 | w=32
  4866. ipilimumab -- r_associated #0: 32 / 0.07 -> en:mtor kinase inhibitor azd8055
    n1=ipilimumab | n2=en:mtor kinase inhibitor azd8055 | rel=r_associated | relid=0 | w=32
  4867. ipilimumab -- r_associated #0: 32 / 0.07 -> en:mucoadhesive hydrogel gargle
    n1=ipilimumab | n2=en:mucoadhesive hydrogel gargle | rel=r_associated | relid=0 | w=32
  4868. ipilimumab -- r_associated #0: 32 / 0.07 -> en:mycobacterium w
    n1=ipilimumab | n2=en:mycobacterium w | rel=r_associated | relid=0 | w=32
  4869. ipilimumab -- r_associated #0: 32 / 0.07 -> en:oncolytic adenovirus ad5-dnx-2401
    n1=ipilimumab | n2=en:oncolytic adenovirus ad5-dnx-2401 | rel=r_associated | relid=0 | w=32
  4870. ipilimumab -- r_associated #0: 32 / 0.07 -> en:padre-cmv fusion peptide vaccine
    n1=ipilimumab | n2=en:padre-cmv fusion peptide vaccine | rel=r_associated | relid=0 | w=32
  4871. ipilimumab -- r_associated #0: 32 / 0.07 -> en:pan fgfr inhibitor arq 087
    n1=ipilimumab | n2=en:pan fgfr inhibitor arq 087 | rel=r_associated | relid=0 | w=32
  4872. ipilimumab -- r_associated #0: 32 / 0.07 -> en:pan-raf kinase inhibitor tak-580
    n1=ipilimumab | n2=en:pan-raf kinase inhibitor tak-580 | rel=r_associated | relid=0 | w=32
  4873. ipilimumab -- r_associated #0: 32 / 0.07 -> en:pdm08
    n1=ipilimumab | n2=en:pdm08 | rel=r_associated | relid=0 | w=32
  4874. ipilimumab -- r_associated #0: 32 / 0.07 -> en:pegdinetanib
    n1=ipilimumab | n2=en:pegdinetanib | rel=r_associated | relid=0 | w=32
  4875. ipilimumab -- r_associated #0: 32 / 0.07 -> en:phentolamine mesylate
    n1=ipilimumab | n2=en:phentolamine mesylate | rel=r_associated | relid=0 | w=32
  4876. ipilimumab -- r_associated #0: 32 / 0.07 -> en:pibrozelesin
    n1=ipilimumab | n2=en:pibrozelesin | rel=r_associated | relid=0 | w=32
  4877. ipilimumab -- r_associated #0: 32 / 0.07 -> en:pleiotropic pathway modifier cc-122 hydrochloride
    n1=ipilimumab | n2=en:pleiotropic pathway modifier cc-122 hydrochloride | rel=r_associated | relid=0 | w=32
  4878. ipilimumab -- r_associated #0: 32 / 0.07 -> en:pol i inhibitor cx5461
    n1=ipilimumab | n2=en:pol i inhibitor cx5461 | rel=r_associated | relid=0 | w=32
  4879. ipilimumab -- r_associated #0: 32 / 0.07 -> en:polo-like kinase 4 inhibitor cfi-400945 fumarate
    n1=ipilimumab | n2=en:polo-like kinase 4 inhibitor cfi-400945 fumarate | rel=r_associated | relid=0 | w=32
  4880. ipilimumab -- r_associated #0: 32 / 0.07 -> en:poly (adp-ribose) polymerase inhibitor
    n1=ipilimumab | n2=en:poly (adp-ribose) polymerase inhibitor | rel=r_associated | relid=0 | w=32
  4881. ipilimumab -- r_associated #0: 32 / 0.07 -> en:ramosetron hydrochloride
    n1=ipilimumab | n2=en:ramosetron hydrochloride | rel=r_associated | relid=0 | w=32
  4882. ipilimumab -- r_associated #0: 32 / 0.07 -> en:recombinant human chorionic gonadotropin
    n1=ipilimumab | n2=en:recombinant human chorionic gonadotropin | rel=r_associated | relid=0 | w=32
  4883. ipilimumab -- r_associated #0: 32 / 0.07 -> en:rhubarb/licorice herbal supplement
    n1=ipilimumab | n2=en:rhubarb/licorice herbal supplement | rel=r_associated | relid=0 | w=32
  4884. ipilimumab -- r_associated #0: 32 / 0.07 -> en:sabarubicin
    n1=ipilimumab | n2=en:sabarubicin | rel=r_associated | relid=0 | w=32
  4885. ipilimumab -- r_associated #0: 32 / 0.07 -> en:semaxanib
    n1=ipilimumab | n2=en:semaxanib | rel=r_associated | relid=0 | w=32
  4886. ipilimumab -- r_associated #0: 32 / 0.07 -> en:smoothened antagonist leq506
    n1=ipilimumab | n2=en:smoothened antagonist leq506 | rel=r_associated | relid=0 | w=32
  4887. ipilimumab -- r_associated #0: 32 / 0.07 -> en:sodium selenite
    n1=ipilimumab | n2=en:sodium selenite | rel=r_associated | relid=0 | w=32
  4888. ipilimumab -- r_associated #0: 32 / 0.07 -> en:somatropin
    n1=ipilimumab | n2=en:somatropin | rel=r_associated | relid=0 | w=32
  4889. ipilimumab -- r_associated #0: 32 / 0.07 -> en:sonidegib
    n1=ipilimumab | n2=en:sonidegib | rel=r_associated | relid=0 | w=32
  4890. ipilimumab -- r_associated #0: 32 / 0.07 -> en:survivin sur1m2 peptide vaccine
    n1=ipilimumab | n2=en:survivin sur1m2 peptide vaccine | rel=r_associated | relid=0 | w=32
  4891. ipilimumab -- r_associated #0: 32 / 0.07 -> en:synthetic human papillomavirus 16 e6 peptide
    n1=ipilimumab | n2=en:synthetic human papillomavirus 16 e6 peptide | rel=r_associated | relid=0 | w=32
  4892. ipilimumab -- r_associated #0: 32 / 0.07 -> en:tangerine tomato juice
    n1=ipilimumab | n2=en:tangerine tomato juice | rel=r_associated | relid=0 | w=32
  4893. ipilimumab -- r_associated #0: 32 / 0.07 -> en:technetium tc-99m demobesin-4
    n1=ipilimumab | n2=en:technetium tc-99m demobesin-4 | rel=r_associated | relid=0 | w=32
  4894. ipilimumab -- r_associated #0: 32 / 0.07 -> en:topotecan hydrochloride
    n1=ipilimumab | n2=en:topotecan hydrochloride | rel=r_associated | relid=0 | w=32
  4895. ipilimumab -- r_associated #0: 32 / 0.07 -> en:trabectedin
    n1=ipilimumab | n2=en:trabectedin | rel=r_associated | relid=0 | w=32
  4896. ipilimumab -- r_associated #0: 32 / 0.07 -> en:uracil ointment
    n1=ipilimumab | n2=en:uracil ointment | rel=r_associated | relid=0 | w=32
  4897. ipilimumab -- r_associated #0: 32 / 0.07 -> en:xonrid cream
    n1=ipilimumab | n2=en:xonrid cream | rel=r_associated | relid=0 | w=32
  4898. ipilimumab -- r_associated #0: 31 / 0.068 -> en:[18f]l-fac
    n1=ipilimumab | n2=en:[18f]l-fac | rel=r_associated | relid=0 | w=31
  4899. ipilimumab -- r_associated #0: 31 / 0.068 -> en:ad-isf35
    n1=ipilimumab | n2=en:ad-isf35 | rel=r_associated | relid=0 | w=31
  4900. ipilimumab -- r_associated #0: 31 / 0.068 -> en:agonistic anti-ox40 monoclonal antibody medi6383
    n1=ipilimumab | n2=en:agonistic anti-ox40 monoclonal antibody medi6383 | rel=r_associated | relid=0 | w=31
  4901. ipilimumab -- r_associated #0: 31 / 0.068 -> en:alkaline water
    n1=ipilimumab | n2=en:alkaline water | rel=r_associated | relid=0 | w=31
  4902. ipilimumab -- r_associated #0: 31 / 0.068 -> en:allogeneic cd56-positive cd3-negative natural killer cells
    n1=ipilimumab | n2=en:allogeneic cd56-positive cd3-negative natural killer cells | rel=r_associated | relid=0 | w=31
  4903. ipilimumab -- r_associated #0: 31 / 0.068 -> en:ammonia n-13
    n1=ipilimumab | n2=en:ammonia n-13 | rel=r_associated | relid=0 | w=31
  4904. ipilimumab -- r_associated #0: 31 / 0.068 -> en:anti glaucoma preparation
    n1=ipilimumab | n2=en:anti glaucoma preparation | rel=r_associated | relid=0 | w=31
  4905. ipilimumab -- r_associated #0: 31 / 0.068 -> en:anti-cd19-car fmc63-28z retroviral vector-transduced allogeneic t-lymphocytes
    n1=ipilimumab | n2=en:anti-cd19-car fmc63-28z retroviral vector-transduced allogeneic t-lymphocytes | rel=r_associated | relid=0 | w=31
  4906. ipilimumab -- r_associated #0: 31 / 0.068 -> en:anti-cd33 antibody-drug conjugate imgn779
    n1=ipilimumab | n2=en:anti-cd33 antibody-drug conjugate imgn779 | rel=r_associated | relid=0 | w=31
  4907. ipilimumab -- r_associated #0: 31 / 0.068 -> en:anti-ceacam6 afaikl2 antibody fragment/jack bean urease immunoconjugate l-dos47
    n1=ipilimumab | n2=en:anti-ceacam6 afaikl2 antibody fragment/jack bean urease immunoconjugate l-dos47 | rel=r_associated | relid=0 | w=31
  4908. ipilimumab -- r_associated #0: 31 / 0.068 -> en:anti-diabetic agent
    n1=ipilimumab | n2=en:anti-diabetic agent | rel=r_associated | relid=0 | w=31
  4909. ipilimumab -- r_associated #0: 31 / 0.068 -> en:anti-gitr monoclonal antibody gwn 323
    n1=ipilimumab | n2=en:anti-gitr monoclonal antibody gwn 323 | rel=r_associated | relid=0 | w=31
  4910. ipilimumab -- r_associated #0: 31 / 0.068 -> en:anti-nf-p2x7 antibody ointment bil-010t
    n1=ipilimumab | n2=en:anti-nf-p2x7 antibody ointment bil-010t | rel=r_associated | relid=0 | w=31
  4911. ipilimumab -- r_associated #0: 31 / 0.068 -> en:antimetabolite chemotherapy
    n1=ipilimumab | n2=en:antimetabolite chemotherapy | rel=r_associated | relid=0 | w=31
  4912. ipilimumab -- r_associated #0: 31 / 0.068 -> en:antineoplastic metal complex agent
    n1=ipilimumab | n2=en:antineoplastic metal complex agent | rel=r_associated | relid=0 | w=31
  4913. ipilimumab -- r_associated #0: 31 / 0.068 -> en:attenuated live listeria encoding hpv 16 e7 vaccine adxs11-001
    n1=ipilimumab | n2=en:attenuated live listeria encoding hpv 16 e7 vaccine adxs11-001 | rel=r_associated | relid=0 | w=31
  4914. ipilimumab -- r_associated #0: 31 / 0.068 -> en:autologous colorectal tumor antigen-pulsed dendritic cell vaccine
    n1=ipilimumab | n2=en:autologous colorectal tumor antigen-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=31
  4915. ipilimumab -- r_associated #0: 31 / 0.068 -> en:autologous ic9-gd2-car-expressing vzv-specific t lymphocytes
    n1=ipilimumab | n2=en:autologous ic9-gd2-car-expressing vzv-specific t lymphocytes | rel=r_associated | relid=0 | w=31
  4916. ipilimumab -- r_associated #0: 31 / 0.068 -> en:bardoxolone
    n1=ipilimumab | n2=en:bardoxolone | rel=r_associated | relid=0 | w=31
  4917. ipilimumab -- r_associated #0: 31 / 0.068 -> en:bevacizumab-irdye 800cw
    n1=ipilimumab | n2=en:bevacizumab-irdye 800cw | rel=r_associated | relid=0 | w=31
  4918. ipilimumab -- r_associated #0: 31 / 0.068 -> en:btct4465a
    n1=ipilimumab | n2=en:btct4465a | rel=r_associated | relid=0 | w=31
  4919. ipilimumab -- r_associated #0: 31 / 0.068 -> en:cabergoline
    n1=ipilimumab | n2=en:cabergoline | rel=r_associated | relid=0 | w=31
  4920. ipilimumab -- r_associated #0: 31 / 0.068 -> en:camptothecin analogue tlc388
    n1=ipilimumab | n2=en:camptothecin analogue tlc388 | rel=r_associated | relid=0 | w=31
  4921. ipilimumab -- r_associated #0: 31 / 0.068 -> en:carbohydrate processing inhibitor
    n1=ipilimumab | n2=en:carbohydrate processing inhibitor | rel=r_associated | relid=0 | w=31
  4922. ipilimumab -- r_associated #0: 31 / 0.068 -> en:carboplatin
    n1=ipilimumab | n2=en:carboplatin | rel=r_associated | relid=0 | w=31
  4923. ipilimumab -- r_associated #0: 31 / 0.068 -> en:cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine
    n1=ipilimumab | n2=en:cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine | rel=r_associated | relid=0 | w=31
  4924. ipilimumab -- r_associated #0: 31 / 0.068 -> en:cesium cs-131
    n1=ipilimumab | n2=en:cesium cs-131 | rel=r_associated | relid=0 | w=31
  4925. ipilimumab -- r_associated #0: 31 / 0.068 -> en:cgp-6809
    n1=ipilimumab | n2=en:cgp-6809 | rel=r_associated | relid=0 | w=31
  4926. ipilimumab -- r_associated #0: 31 / 0.068 -> en:chk1 inhibitor gdc-0575
    n1=ipilimumab | n2=en:chk1 inhibitor gdc-0575 | rel=r_associated | relid=0 | w=31
  4927. ipilimumab -- r_associated #0: 31 / 0.068 -> en:cisapride
    n1=ipilimumab | n2=en:cisapride | rel=r_associated | relid=0 | w=31
  4928. ipilimumab -- r_associated #0: 31 / 0.068 -> en:cisplatin liposomal
    n1=ipilimumab | n2=en:cisplatin liposomal | rel=r_associated | relid=0 | w=31
  4929. ipilimumab -- r_associated #0: 31 / 0.068 -> en:controlled substance
    n1=ipilimumab | n2=en:controlled substance | rel=r_associated | relid=0 | w=31
  4930. ipilimumab -- r_associated #0: 31 / 0.068 -> en:copper cu 64 tp3805
    n1=ipilimumab | n2=en:copper cu 64 tp3805 | rel=r_associated | relid=0 | w=31
  4931. ipilimumab -- r_associated #0: 31 / 0.068 -> en:crotoxin
    n1=ipilimumab | n2=en:crotoxin | rel=r_associated | relid=0 | w=31
  4932. ipilimumab -- r_associated #0: 31 / 0.068 -> en:daunorubicin hydrochloride
    n1=ipilimumab | n2=en:daunorubicin hydrochloride | rel=r_associated | relid=0 | w=31
  4933. ipilimumab -- r_associated #0: 31 / 0.068 -> en:dc-ova vaccine
    n1=ipilimumab | n2=en:dc-ova vaccine | rel=r_associated | relid=0 | w=31
  4934. ipilimumab -- r_associated #0: 31 / 0.068 -> en:dermatologic agents
    n1=ipilimumab | n2=en:dermatologic agents | rel=r_associated | relid=0 | w=31
  4935. ipilimumab -- r_associated #0: 31 / 0.068 -> en:dexamethasone intravitreal implant
    n1=ipilimumab | n2=en:dexamethasone intravitreal implant | rel=r_associated | relid=0 | w=31
  4936. ipilimumab -- r_associated #0: 31 / 0.068 -> en:digoxin
    n1=ipilimumab | n2=en:digoxin | rel=r_associated | relid=0 | w=31
  4937. ipilimumab -- r_associated #0: 31 / 0.068 -> en:dimethyl sulfone
    n1=ipilimumab | n2=en:dimethyl sulfone | rel=r_associated | relid=0 | w=31
  4938. ipilimumab -- r_associated #0: 31 / 0.068 -> en:dmuc4064a
    n1=ipilimumab | n2=en:dmuc4064a | rel=r_associated | relid=0 | w=31
  4939. ipilimumab -- r_associated #0: 31 / 0.068 -> en:docetaxel-loaded nanopharmaceutical crlx301
    n1=ipilimumab | n2=en:docetaxel-loaded nanopharmaceutical crlx301 | rel=r_associated | relid=0 | w=31
  4940. ipilimumab -- r_associated #0: 31 / 0.068 -> en:donor regulatory t-lymphocytes
    n1=ipilimumab | n2=en:donor regulatory t-lymphocytes | rel=r_associated | relid=0 | w=31
  4941. ipilimumab -- r_associated #0: 31 / 0.068 -> en:doxycycline hyclate foam
    n1=ipilimumab | n2=en:doxycycline hyclate foam | rel=r_associated | relid=0 | w=31
  4942. ipilimumab -- r_associated #0: 31 / 0.068 -> en:entecavir
    n1=ipilimumab | n2=en:entecavir | rel=r_associated | relid=0 | w=31
  4943. ipilimumab -- r_associated #0: 31 / 0.068 -> en:entinostat
    n1=ipilimumab | n2=en:entinostat | rel=r_associated | relid=0 | w=31
  4944. ipilimumab -- r_associated #0: 31 / 0.068 -> en:eutectic mixture of local anesthetics
    n1=ipilimumab | n2=en:eutectic mixture of local anesthetics | rel=r_associated | relid=0 | w=31
  4945. ipilimumab -- r_associated #0: 31 / 0.068 -> en:fgfr4 inhibitor blu-554
    n1=ipilimumab | n2=en:fgfr4 inhibitor blu-554 | rel=r_associated | relid=0 | w=31
  4946. ipilimumab -- r_associated #0: 31 / 0.068 -> en:ficlatuzumab
    n1=ipilimumab | n2=en:ficlatuzumab | rel=r_associated | relid=0 | w=31
  4947. ipilimumab -- r_associated #0: 31 / 0.068 -> en:gadofosveset trisodium
    n1=ipilimumab | n2=en:gadofosveset trisodium | rel=r_associated | relid=0 | w=31
  4948. ipilimumab -- r_associated #0: 31 / 0.068 -> en:gel protein, gelonium multiflorum
    n1=ipilimumab | n2=en:gel protein, gelonium multiflorum | rel=r_associated | relid=0 | w=31
  4949. ipilimumab -- r_associated #0: 31 / 0.068 -> en:glycerin cream (10%)
    n1=ipilimumab | n2=en:glycerin cream (10%) | rel=r_associated | relid=0 | w=31
  4950. ipilimumab -- r_associated #0: 31 / 0.068 -> en:hdac inhibitor chr-2845
    n1=ipilimumab | n2=en:hdac inhibitor chr-2845 | rel=r_associated | relid=0 | w=31
  4951. ipilimumab -- r_associated #0: 31 / 0.068 -> en:hdac inhibitor obp-801
    n1=ipilimumab | n2=en:hdac inhibitor obp-801 | rel=r_associated | relid=0 | w=31
  4952. ipilimumab -- r_associated #0: 31 / 0.068 -> en:heparin
    n1=ipilimumab | n2=en:heparin | rel=r_associated | relid=0 | w=31
  4953. ipilimumab -- r_associated #0: 31 / 0.068 -> en:heparin derivative sst0001
    n1=ipilimumab | n2=en:heparin derivative sst0001 | rel=r_associated | relid=0 | w=31
  4954. ipilimumab -- r_associated #0: 31 / 0.068 -> en:hla-a*0201-restricted vegfr1-vegfr2 multipeptide vaccine
    n1=ipilimumab | n2=en:hla-a*0201-restricted vegfr1-vegfr2 multipeptide vaccine | rel=r_associated | relid=0 | w=31
  4955. ipilimumab -- r_associated #0: 31 / 0.068 -> en:hla-a*2402-restricted cdca1-kif20a multipeptide vaccine
    n1=ipilimumab | n2=en:hla-a*2402-restricted cdca1-kif20a multipeptide vaccine | rel=r_associated | relid=0 | w=31
  4956. ipilimumab -- r_associated #0: 31 / 0.068 -> en:host dendritic cell vaccine-001 mssm/biir
    n1=ipilimumab | n2=en:host dendritic cell vaccine-001 mssm/biir | rel=r_associated | relid=0 | w=31
  4957. ipilimumab -- r_associated #0: 31 / 0.068 -> en:hsp90 inhibitor auy922
    n1=ipilimumab | n2=en:hsp90 inhibitor auy922 | rel=r_associated | relid=0 | w=31
  4958. ipilimumab -- r_associated #0: 31 / 0.068 -> en:hsp90 inhibitor biib021
    n1=ipilimumab | n2=en:hsp90 inhibitor biib021 | rel=r_associated | relid=0 | w=31
  4959. ipilimumab -- r_associated #0: 31 / 0.068 -> en:hsp90 inhibitor pu-h71
    n1=ipilimumab | n2=en:hsp90 inhibitor pu-h71 | rel=r_associated | relid=0 | w=31
  4960. ipilimumab -- r_associated #0: 31 / 0.068 -> en:human papilloma virus l1 virus-like particle v504 vaccine
    n1=ipilimumab | n2=en:human papilloma virus l1 virus-like particle v504 vaccine | rel=r_associated | relid=0 | w=31
  4961. ipilimumab -- r_associated #0: 31 / 0.068 -> en:hydrazine sulfate
    n1=ipilimumab | n2=en:hydrazine sulfate | rel=r_associated | relid=0 | w=31
  4962. ipilimumab -- r_associated #0: 31 / 0.068 -> en:i 131 monoclonal antibody lym-1
    n1=ipilimumab | n2=en:i 131 monoclonal antibody lym-1 | rel=r_associated | relid=0 | w=31
  4963. ipilimumab -- r_associated #0: 31 / 0.068 -> en:immunoadjuvant qs-dg
    n1=ipilimumab | n2=en:immunoadjuvant qs-dg | rel=r_associated | relid=0 | w=31
  4964. ipilimumab -- r_associated #0: 31 / 0.068 -> en:indisulam
    n1=ipilimumab | n2=en:indisulam | rel=r_associated | relid=0 | w=31
  4965. ipilimumab -- r_associated #0: 31 / 0.068 -> en:intrinsic factor/minerals/multivitamins
    n1=ipilimumab | n2=en:intrinsic factor/minerals/multivitamins | rel=r_associated | relid=0 | w=31
  4966. ipilimumab -- r_associated #0: 31 / 0.068 -> en:introlite
    n1=ipilimumab | n2=en:introlite | rel=r_associated | relid=0 | w=31
  4967. ipilimumab -- r_associated #0: 31 / 0.068 -> en:iodine 131-6-beta-iodomethyl-19-norcholesterol
    n1=ipilimumab | n2=en:iodine 131-6-beta-iodomethyl-19-norcholesterol | rel=r_associated | relid=0 | w=31
  4968. ipilimumab -- r_associated #0: 31 / 0.068 -> en:ioflubenzamide i-131
    n1=ipilimumab | n2=en:ioflubenzamide i-131 | rel=r_associated | relid=0 | w=31
  4969. ipilimumab -- r_associated #0: 31 / 0.068 -> en:iothalamate
    n1=ipilimumab | n2=en:iothalamate | rel=r_associated | relid=0 | w=31
  4970. ipilimumab -- r_associated #0: 31 / 0.068 -> en:isoniazid, pyrazinamide, rifampin drug combination
    n1=ipilimumab | n2=en:isoniazid, pyrazinamide, rifampin drug combination | rel=r_associated | relid=0 | w=31
  4971. ipilimumab -- r_associated #0: 31 / 0.068 -> en:jak2 inhibitor xl019
    n1=ipilimumab | n2=en:jak2 inhibitor xl019 | rel=r_associated | relid=0 | w=31
  4972. ipilimumab -- r_associated #0: 31 / 0.068 -> en:keyhole limpet hemocyanin
    n1=ipilimumab | n2=en:keyhole limpet hemocyanin | rel=r_associated | relid=0 | w=31
  4973. ipilimumab -- r_associated #0: 31 / 0.068 -> en:labetuzumab-sn-38 immunoconjugate immu-130
    n1=ipilimumab | n2=en:labetuzumab-sn-38 immunoconjugate immu-130 | rel=r_associated | relid=0 | w=31
  4974. ipilimumab -- r_associated #0: 31 / 0.068 -> en:levoleucovorin
    n1=ipilimumab | n2=en:levoleucovorin | rel=r_associated | relid=0 | w=31
  4975. ipilimumab -- r_associated #0: 31 / 0.068 -> en:liposomal docetaxel
    n1=ipilimumab | n2=en:liposomal docetaxel | rel=r_associated | relid=0 | w=31
  4976. ipilimumab -- r_associated #0: 31 / 0.068 -> en:lv.il-2/b7.1-transduced aml blast vaccine
    n1=ipilimumab | n2=en:lv.il-2/b7.1-transduced aml blast vaccine | rel=r_associated | relid=0 | w=31
  4977. ipilimumab -- r_associated #0: 31 / 0.068 -> en:lymphokine-activated killer cells
    n1=ipilimumab | n2=en:lymphokine-activated killer cells | rel=r_associated | relid=0 | w=31
  4978. ipilimumab -- r_associated #0: 31 / 0.068 -> en:magnesium l-threonate
    n1=ipilimumab | n2=en:magnesium l-threonate | rel=r_associated | relid=0 | w=31
  4979. ipilimumab -- r_associated #0: 31 / 0.068 -> en:margetuximab
    n1=ipilimumab | n2=en:margetuximab | rel=r_associated | relid=0 | w=31
  4980. ipilimumab -- r_associated #0: 31 / 0.068 -> en:maxzide
    n1=ipilimumab | n2=en:maxzide | rel=r_associated | relid=0 | w=31
  4981. ipilimumab -- r_associated #0: 31 / 0.068 -> en:melphalan hydrochloride
    n1=ipilimumab | n2=en:melphalan hydrochloride | rel=r_associated | relid=0 | w=31
  4982. ipilimumab -- r_associated #0: 31 / 0.068 -> en:mibefradil dihydrochloride
    n1=ipilimumab | n2=en:mibefradil dihydrochloride | rel=r_associated | relid=0 | w=31
  4983. ipilimumab -- r_associated #0: 31 / 0.068 -> en:mitoguazone
    n1=ipilimumab | n2=en:mitoguazone | rel=r_associated | relid=0 | w=31
  4984. ipilimumab -- r_associated #0: 31 / 0.068 -> en:monoclonal antibody cc49-delta ch2
    n1=ipilimumab | n2=en:monoclonal antibody cc49-delta ch2 | rel=r_associated | relid=0 | w=31
  4985. ipilimumab -- r_associated #0: 31 / 0.068 -> en:monoclonal antibody f19
    n1=ipilimumab | n2=en:monoclonal antibody f19 | rel=r_associated | relid=0 | w=31
  4986. ipilimumab -- r_associated #0: 31 / 0.068 -> en:mouse gp100 plasmid dna vaccine
    n1=ipilimumab | n2=en:mouse gp100 plasmid dna vaccine | rel=r_associated | relid=0 | w=31
  4987. ipilimumab -- r_associated #0: 31 / 0.068 -> en:naloxone + oxycodone
    n1=ipilimumab | n2=en:naloxone + oxycodone | rel=r_associated | relid=0 | w=31
  4988. ipilimumab -- r_associated #0: 31 / 0.068 -> en:nefopam hydrochloride
    n1=ipilimumab | n2=en:nefopam hydrochloride | rel=r_associated | relid=0 | w=31
  4989. ipilimumab -- r_associated #0: 31 / 0.068 -> en:nevirapine
    n1=ipilimumab | n2=en:nevirapine | rel=r_associated | relid=0 | w=31
  4990. ipilimumab -- r_associated #0: 31 / 0.068 -> en:ns-9
    n1=ipilimumab | n2=en:ns-9 | rel=r_associated | relid=0 | w=31
  4991. ipilimumab -- r_associated #0: 31 / 0.068 -> en:opioid growth factor
    n1=ipilimumab | n2=en:opioid growth factor | rel=r_associated | relid=0 | w=31
  4992. ipilimumab -- r_associated #0: 31 / 0.068 -> en:oral topotecan hydrochloride
    n1=ipilimumab | n2=en:oral topotecan hydrochloride | rel=r_associated | relid=0 | w=31
  4993. ipilimumab -- r_associated #0: 31 / 0.068 -> en:oregovomab
    n1=ipilimumab | n2=en:oregovomab | rel=r_associated | relid=0 | w=31
  4994. ipilimumab -- r_associated #0: 31 / 0.068 -> en:otd70derm
    n1=ipilimumab | n2=en:otd70derm | rel=r_associated | relid=0 | w=31
  4995. ipilimumab -- r_associated #0: 31 / 0.068 -> en:paclitaxel liposome
    n1=ipilimumab | n2=en:paclitaxel liposome | rel=r_associated | relid=0 | w=31
  4996. ipilimumab -- r_associated #0: 31 / 0.068 -> en:pegol sihematide
    n1=ipilimumab | n2=en:pegol sihematide | rel=r_associated | relid=0 | w=31
  4997. ipilimumab -- r_associated #0: 31 / 0.068 -> en:penberol
    n1=ipilimumab | n2=en:penberol | rel=r_associated | relid=0 | w=31
  4998. ipilimumab -- r_associated #0: 31 / 0.068 -> en:pi3k p110beta/delta inhibitor ka2237
    n1=ipilimumab | n2=en:pi3k p110beta/delta inhibitor ka2237 | rel=r_associated | relid=0 | w=31
  4999. ipilimumab -- r_associated #0: 31 / 0.068 -> en:pi3k-beta inhibitor sar260301
    n1=ipilimumab | n2=en:pi3k-beta inhibitor sar260301 | rel=r_associated | relid=0 | w=31
  5000. ipilimumab -- r_associated #0: 31 / 0.068 -> en:piperacillin sodium
    n1=ipilimumab | n2=en:piperacillin sodium | rel=r_associated | relid=0 | w=31
  5001. ipilimumab -- r_associated #0: 31 / 0.068 -> en:policosanol
    n1=ipilimumab | n2=en:policosanol | rel=r_associated | relid=0 | w=31
  5002. ipilimumab -- r_associated #0: 31 / 0.068 -> en:prilocaine hydrochloride
    n1=ipilimumab | n2=en:prilocaine hydrochloride | rel=r_associated | relid=0 | w=31
  5003. ipilimumab -- r_associated #0: 31 / 0.068 -> en:pumvc3-igfbp2-her2-igf1r plasmid dna vaccine
    n1=ipilimumab | n2=en:pumvc3-igfbp2-her2-igf1r plasmid dna vaccine | rel=r_associated | relid=0 | w=31
  5004. ipilimumab -- r_associated #0: 31 / 0.068 -> en:raloxifene
    n1=ipilimumab | n2=en:raloxifene | rel=r_associated | relid=0 | w=31
  5005. ipilimumab -- r_associated #0: 31 / 0.068 -> en:recombinant flt3 ligand
    n1=ipilimumab | n2=en:recombinant flt3 ligand | rel=r_associated | relid=0 | w=31
  5006. ipilimumab -- r_associated #0: 31 / 0.068 -> en:ribavirin
    n1=ipilimumab | n2=en:ribavirin | rel=r_associated | relid=0 | w=31
  5007. ipilimumab -- r_associated #0: 31 / 0.068 -> en:sarcnu
    n1=ipilimumab | n2=en:sarcnu | rel=r_associated | relid=0 | w=31
  5008. ipilimumab -- r_associated #0: 31 / 0.068 -> en:smoked plum
    n1=ipilimumab | n2=en:smoked plum | rel=r_associated | relid=0 | w=31
  5009. ipilimumab -- r_associated #0: 31 / 0.068 -> en:sodium bicarbonate
    n1=ipilimumab | n2=en:sodium bicarbonate | rel=r_associated | relid=0 | w=31
  5010. ipilimumab -- r_associated #0: 31 / 0.068 -> en:sofosbuvir
    n1=ipilimumab | n2=en:sofosbuvir | rel=r_associated | relid=0 | w=31
  5011. ipilimumab -- r_associated #0: 31 / 0.068 -> en:synthetic breast cancer peptides-tetanus toxoid-montanide isa-51 vaccine
    n1=ipilimumab | n2=en:synthetic breast cancer peptides-tetanus toxoid-montanide isa-51 vaccine | rel=r_associated | relid=0 | w=31
  5012. ipilimumab -- r_associated #0: 31 / 0.068 -> en:synthetic glioblastoma tumor-associated peptides vaccine therapy apvac1
    n1=ipilimumab | n2=en:synthetic glioblastoma tumor-associated peptides vaccine therapy apvac1 | rel=r_associated | relid=0 | w=31
  5013. ipilimumab -- r_associated #0: 31 / 0.068 -> en:tarextumab
    n1=ipilimumab | n2=en:tarextumab | rel=r_associated | relid=0 | w=31
  5014. ipilimumab -- r_associated #0: 31 / 0.068 -> en:taurultam
    n1=ipilimumab | n2=en:taurultam | rel=r_associated | relid=0 | w=31
  5015. ipilimumab -- r_associated #0: 31 / 0.068 -> en:therapeutic autologous dendritic cells
    n1=ipilimumab | n2=en:therapeutic autologous dendritic cells | rel=r_associated | relid=0 | w=31
  5016. ipilimumab -- r_associated #0: 31 / 0.068 -> en:tin sn 117m dtpa
    n1=ipilimumab | n2=en:tin sn 117m dtpa | rel=r_associated | relid=0 | w=31
  5017. ipilimumab -- r_associated #0: 31 / 0.068 -> en:trans sodium crocetinate
    n1=ipilimumab | n2=en:trans sodium crocetinate | rel=r_associated | relid=0 | w=31
  5018. ipilimumab -- r_associated #0: 31 / 0.068 -> en:tyrosine kinase inhibitor osi-930
    n1=ipilimumab | n2=en:tyrosine kinase inhibitor osi-930 | rel=r_associated | relid=0 | w=31
  5019. ipilimumab -- r_associated #0: 31 / 0.068 -> en:vindesine
    n1=ipilimumab | n2=en:vindesine | rel=r_associated | relid=0 | w=31
  5020. ipilimumab -- r_associated #0: 31 / 0.068 -> en:vocimagene amiretrorepvec
    n1=ipilimumab | n2=en:vocimagene amiretrorepvec | rel=r_associated | relid=0 | w=31
  5021. ipilimumab -- r_associated #0: 31 / 0.068 -> en:wobe-mugos e
    n1=ipilimumab | n2=en:wobe-mugos e | rel=r_associated | relid=0 | w=31
  5022. ipilimumab -- r_associated #0: 31 / 0.068 -> en:wt1 247-261 peptide vaccine
    n1=ipilimumab | n2=en:wt1 247-261 peptide vaccine | rel=r_associated | relid=0 | w=31
  5023. ipilimumab -- r_associated #0: 31 / 0.068 -> en:xiap/ciap1 antagonist astx660
    n1=ipilimumab | n2=en:xiap/ciap1 antagonist astx660 | rel=r_associated | relid=0 | w=31
  5024. ipilimumab -- r_associated #0: 31 / 0.068 -> en:z-360
    n1=ipilimumab | n2=en:z-360 | rel=r_associated | relid=0 | w=31
  5025. ipilimumab -- r_associated #0: 31 / 0.068 -> en:zirconium zr 89 dfo-mstp2109a
    n1=ipilimumab | n2=en:zirconium zr 89 dfo-mstp2109a | rel=r_associated | relid=0 | w=31
  5026. ipilimumab -- r_associated #0: 30 / 0.066 -> en:(61)cu-atsm
    n1=ipilimumab | n2=en:(61)cu-atsm | rel=r_associated | relid=0 | w=30
  5027. ipilimumab -- r_associated #0: 30 / 0.066 -> en:5-fluoropyrimidinone
    n1=ipilimumab | n2=en:5-fluoropyrimidinone | rel=r_associated | relid=0 | w=30
  5028. ipilimumab -- r_associated #0: 30 / 0.066 -> en:abp 215
    n1=ipilimumab | n2=en:abp 215 | rel=r_associated | relid=0 | w=30
  5029. ipilimumab -- r_associated #0: 30 / 0.066 -> en:adipose-derived regenerative cells
    n1=ipilimumab | n2=en:adipose-derived regenerative cells | rel=r_associated | relid=0 | w=30
  5030. ipilimumab -- r_associated #0: 30 / 0.066 -> en:aee788
    n1=ipilimumab | n2=en:aee788 | rel=r_associated | relid=0 | w=30
  5031. ipilimumab -- r_associated #0: 30 / 0.066 -> en:alk/fak/pyk2 inhibitor ct-707
    n1=ipilimumab | n2=en:alk/fak/pyk2 inhibitor ct-707 | rel=r_associated | relid=0 | w=30
  5032. ipilimumab -- r_associated #0: 30 / 0.066 -> en:alk5 inhibitor tew-7197
    n1=ipilimumab | n2=en:alk5 inhibitor tew-7197 | rel=r_associated | relid=0 | w=30
  5033. ipilimumab -- r_associated #0: 30 / 0.066 -> en:allosteric bcr-abl tyrosine kinase inhibitor abl001
    n1=ipilimumab | n2=en:allosteric bcr-abl tyrosine kinase inhibitor abl001 | rel=r_associated | relid=0 | w=30
  5034. ipilimumab -- r_associated #0: 30 / 0.066 -> en:alvelestat
    n1=ipilimumab | n2=en:alvelestat | rel=r_associated | relid=0 | w=30
  5035. ipilimumab -- r_associated #0: 30 / 0.066 -> en:ambazone
    n1=ipilimumab | n2=en:ambazone | rel=r_associated | relid=0 | w=30
  5036. ipilimumab -- r_associated #0: 30 / 0.066 -> en:aminophylline
    n1=ipilimumab | n2=en:aminophylline | rel=r_associated | relid=0 | w=30
  5037. ipilimumab -- r_associated #0: 30 / 0.066 -> en:aml mrna positive lysate loaded autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:aml mrna positive lysate loaded autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=30
  5038. ipilimumab -- r_associated #0: 30 / 0.066 -> en:angiogenesis inhibitor ji-101
    n1=ipilimumab | n2=en:angiogenesis inhibitor ji-101 | rel=r_associated | relid=0 | w=30
  5039. ipilimumab -- r_associated #0: 30 / 0.066 -> en:anti-cd20 monoclonal antibody sct400
    n1=ipilimumab | n2=en:anti-cd20 monoclonal antibody sct400 | rel=r_associated | relid=0 | w=30
  5040. ipilimumab -- r_associated #0: 30 / 0.066 -> en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/autologous dendritic cells/mart-1 antigen
    n1=ipilimumab | n2=en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/autologous dendritic cells/mart-1 antigen | rel=r_associated | relid=0 | w=30
  5041. ipilimumab -- r_associated #0: 30 / 0.066 -> en:anti-erbb3 monoclonal antibody regn1400
    n1=ipilimumab | n2=en:anti-erbb3 monoclonal antibody regn1400 | rel=r_associated | relid=0 | w=30
  5042. ipilimumab -- r_associated #0: 30 / 0.066 -> en:anti-ly6e antibody-drug conjugate dlye5953a
    n1=ipilimumab | n2=en:anti-ly6e antibody-drug conjugate dlye5953a | rel=r_associated | relid=0 | w=30
  5043. ipilimumab -- r_associated #0: 30 / 0.066 -> en:antigen-targeted personalized breast cancer vaccine
    n1=ipilimumab | n2=en:antigen-targeted personalized breast cancer vaccine | rel=r_associated | relid=0 | w=30
  5044. ipilimumab -- r_associated #0: 30 / 0.066 -> en:apoptotic autologous tumor cells-pulsed alpha-type-1 polarized dendritic cells
    n1=ipilimumab | n2=en:apoptotic autologous tumor cells-pulsed alpha-type-1 polarized dendritic cells | rel=r_associated | relid=0 | w=30
  5045. ipilimumab -- r_associated #0: 30 / 0.066 -> en:ar ligand binding domain-targeting agent azd3514
    n1=ipilimumab | n2=en:ar ligand binding domain-targeting agent azd3514 | rel=r_associated | relid=0 | w=30
  5046. ipilimumab -- r_associated #0: 30 / 0.066 -> en:autologous cytotoxic t-lymphocytes induced with muc1 peptide-pulsed dendritic cells
    n1=ipilimumab | n2=en:autologous cytotoxic t-lymphocytes induced with muc1 peptide-pulsed dendritic cells | rel=r_associated | relid=0 | w=30
  5047. ipilimumab -- r_associated #0: 30 / 0.066 -> en:autologous ofa-ilrp rna-transfected dendritic cell vaccine
    n1=ipilimumab | n2=en:autologous ofa-ilrp rna-transfected dendritic cell vaccine | rel=r_associated | relid=0 | w=30
  5048. ipilimumab -- r_associated #0: 30 / 0.066 -> en:autologous tarp peptide-pulsed dendritic cell vaccine
    n1=ipilimumab | n2=en:autologous tarp peptide-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=30
  5049. ipilimumab -- r_associated #0: 30 / 0.066 -> en:axl inhibitor tp-0903
    n1=ipilimumab | n2=en:axl inhibitor tp-0903 | rel=r_associated | relid=0 | w=30
  5050. ipilimumab -- r_associated #0: 30 / 0.066 -> en:bet inhibitor incb057643
    n1=ipilimumab | n2=en:bet inhibitor incb057643 | rel=r_associated | relid=0 | w=30
  5051. ipilimumab -- r_associated #0: 30 / 0.066 -> en:bms-275183
    n1=ipilimumab | n2=en:bms-275183 | rel=r_associated | relid=0 | w=30
  5052. ipilimumab -- r_associated #0: 30 / 0.066 -> en:buthionine sulfoximine
    n1=ipilimumab | n2=en:buthionine sulfoximine | rel=r_associated | relid=0 | w=30
  5053. ipilimumab -- r_associated #0: 30 / 0.066 -> en:cabazitaxel
    n1=ipilimumab | n2=en:cabazitaxel | rel=r_associated | relid=0 | w=30
  5054. ipilimumab -- r_associated #0: 30 / 0.066 -> en:camptothecin-20(s)-o-propionate hydrate
    n1=ipilimumab | n2=en:camptothecin-20(s)-o-propionate hydrate | rel=r_associated | relid=0 | w=30
  5055. ipilimumab -- r_associated #0: 30 / 0.066 -> en:cancer stemness kinase inhibitor bbi503
    n1=ipilimumab | n2=en:cancer stemness kinase inhibitor bbi503 | rel=r_associated | relid=0 | w=30
  5056. ipilimumab -- r_associated #0: 30 / 0.066 -> en:cd4+ cd25+ regulatory t cells
    n1=ipilimumab | n2=en:cd4+ cd25+ regulatory t cells | rel=r_associated | relid=0 | w=30
  5057. ipilimumab -- r_associated #0: 30 / 0.066 -> en:cdk2/5/9 inhibitor cyc065
    n1=ipilimumab | n2=en:cdk2/5/9 inhibitor cyc065 | rel=r_associated | relid=0 | w=30
  5058. ipilimumab -- r_associated #0: 30 / 0.066 -> en:cefpodoxime proxetil
    n1=ipilimumab | n2=en:cefpodoxime proxetil | rel=r_associated | relid=0 | w=30
  5059. ipilimumab -- r_associated #0: 30 / 0.066 -> en:ceritinib
    n1=ipilimumab | n2=en:ceritinib | rel=r_associated | relid=0 | w=30
  5060. ipilimumab -- r_associated #0: 30 / 0.066 -> en:chloroquinoxaline sulfonamide
    n1=ipilimumab | n2=en:chloroquinoxaline sulfonamide | rel=r_associated | relid=0 | w=30
  5061. ipilimumab -- r_associated #0: 30 / 0.066 -> en:cmvpp65/gb plasmid vaccine asp0113
    n1=ipilimumab | n2=en:cmvpp65/gb plasmid vaccine asp0113 | rel=r_associated | relid=0 | w=30
  5062. ipilimumab -- r_associated #0: 30 / 0.066 -> en:cngrc peptide-tnf alpha conjugate
    n1=ipilimumab | n2=en:cngrc peptide-tnf alpha conjugate | rel=r_associated | relid=0 | w=30
  5063. ipilimumab -- r_associated #0: 30 / 0.066 -> en:copper cu 64 anti-cea monoclonal antibody m5a
    n1=ipilimumab | n2=en:copper cu 64 anti-cea monoclonal antibody m5a | rel=r_associated | relid=0 | w=30
  5064. ipilimumab -- r_associated #0: 30 / 0.066 -> en:crl 1005
    n1=ipilimumab | n2=en:crl 1005 | rel=r_associated | relid=0 | w=30
  5065. ipilimumab -- r_associated #0: 30 / 0.066 -> en:cycle-phase nonspecific agent
    n1=ipilimumab | n2=en:cycle-phase nonspecific agent | rel=r_associated | relid=0 | w=30
  5066. ipilimumab -- r_associated #0: 30 / 0.066 -> en:cycle-phase specific agent
    n1=ipilimumab | n2=en:cycle-phase specific agent | rel=r_associated | relid=0 | w=30
  5067. ipilimumab -- r_associated #0: 30 / 0.066 -> en:cytembena
    n1=ipilimumab | n2=en:cytembena | rel=r_associated | relid=0 | w=30
  5068. ipilimumab -- r_associated #0: 30 / 0.066 -> en:detox-b adjuvant
    n1=ipilimumab | n2=en:detox-b adjuvant | rel=r_associated | relid=0 | w=30
  5069. ipilimumab -- r_associated #0: 30 / 0.066 -> en:docetaxel lipid microspheres
    n1=ipilimumab | n2=en:docetaxel lipid microspheres | rel=r_associated | relid=0 | w=30
  5070. ipilimumab -- r_associated #0: 30 / 0.066 -> en:doxifluridine
    n1=ipilimumab | n2=en:doxifluridine | rel=r_associated | relid=0 | w=30
  5071. ipilimumab -- r_associated #0: 30 / 0.066 -> en:dpt/bcg/measles/serratia/pneumococcus vaccine
    n1=ipilimumab | n2=en:dpt/bcg/measles/serratia/pneumococcus vaccine | rel=r_associated | relid=0 | w=30
  5072. ipilimumab -- r_associated #0: 30 / 0.066 -> en:dronabinol
    n1=ipilimumab | n2=en:dronabinol | rel=r_associated | relid=0 | w=30
  5073. ipilimumab -- r_associated #0: 30 / 0.066 -> en:durvalumab
    n1=ipilimumab | n2=en:durvalumab | rel=r_associated | relid=0 | w=30
  5074. ipilimumab -- r_associated #0: 30 / 0.066 -> en:eg5 kinesin-related motor protein inhibitor 4sc-205
    n1=ipilimumab | n2=en:eg5 kinesin-related motor protein inhibitor 4sc-205 | rel=r_associated | relid=0 | w=30
  5075. ipilimumab -- r_associated #0: 30 / 0.066 -> en:elesclomol sodium
    n1=ipilimumab | n2=en:elesclomol sodium | rel=r_associated | relid=0 | w=30
  5076. ipilimumab -- r_associated #0: 30 / 0.066 -> en:ergocalciferol
    n1=ipilimumab | n2=en:ergocalciferol | rel=r_associated | relid=0 | w=30
  5077. ipilimumab -- r_associated #0: 30 / 0.066 -> en:etalocib
    n1=ipilimumab | n2=en:etalocib | rel=r_associated | relid=0 | w=30
  5078. ipilimumab -- r_associated #0: 30 / 0.066 -> en:etoposide phosphate
    n1=ipilimumab | n2=en:etoposide phosphate | rel=r_associated | relid=0 | w=30
  5079. ipilimumab -- r_associated #0: 30 / 0.066 -> en:fentanyl buccal soluble film
    n1=ipilimumab | n2=en:fentanyl buccal soluble film | rel=r_associated | relid=0 | w=30
  5080. ipilimumab -- r_associated #0: 30 / 0.066 -> en:flavonoid tablet
    n1=ipilimumab | n2=en:flavonoid tablet | rel=r_associated | relid=0 | w=30
  5081. ipilimumab -- r_associated #0: 30 / 0.066 -> en:fluticasone + vilanterol
    n1=ipilimumab | n2=en:fluticasone + vilanterol | rel=r_associated | relid=0 | w=30
  5082. ipilimumab -- r_associated #0: 30 / 0.066 -> en:glutamine
    n1=ipilimumab | n2=en:glutamine | rel=r_associated | relid=0 | w=30
  5083. ipilimumab -- r_associated #0: 30 / 0.066 -> en:glyburide
    n1=ipilimumab | n2=en:glyburide | rel=r_associated | relid=0 | w=30
  5084. ipilimumab -- r_associated #0: 30 / 0.066 -> en:guar gum
    n1=ipilimumab | n2=en:guar gum | rel=r_associated | relid=0 | w=30
  5085. ipilimumab -- r_associated #0: 30 / 0.066 -> en:hdac inhibitor chr-3996
    n1=ipilimumab | n2=en:hdac inhibitor chr-3996 | rel=r_associated | relid=0 | w=30
  5086. ipilimumab -- r_associated #0: 30 / 0.066 -> en:hyaluronic acid-containing topical cream
    n1=ipilimumab | n2=en:hyaluronic acid-containing topical cream | rel=r_associated | relid=0 | w=30
  5087. ipilimumab -- r_associated #0: 30 / 0.066 -> en:hydromorphone hydrochloride
    n1=ipilimumab | n2=en:hydromorphone hydrochloride | rel=r_associated | relid=0 | w=30
  5088. ipilimumab -- r_associated #0: 30 / 0.066 -> en:iap inhibitor at-406
    n1=ipilimumab | n2=en:iap inhibitor at-406 | rel=r_associated | relid=0 | w=30
  5089. ipilimumab -- r_associated #0: 30 / 0.066 -> en:idelalisib
    n1=ipilimumab | n2=en:idelalisib | rel=r_associated | relid=0 | w=30
  5090. ipilimumab -- r_associated #0: 30 / 0.066 -> en:interleukin-4 pe38kdel immunotoxin
    n1=ipilimumab | n2=en:interleukin-4 pe38kdel immunotoxin | rel=r_associated | relid=0 | w=30
  5091. ipilimumab -- r_associated #0: 30 / 0.066 -> en:iodine compounds
    n1=ipilimumab | n2=en:iodine compounds | rel=r_associated | relid=0 | w=30
  5092. ipilimumab -- r_associated #0: 30 / 0.066 -> en:iodine i 124-labeled hsp90 inhibitor puh71
    n1=ipilimumab | n2=en:iodine i 124-labeled hsp90 inhibitor puh71 | rel=r_associated | relid=0 | w=30
  5093. ipilimumab -- r_associated #0: 30 / 0.066 -> en:iodine i 131 sgmib-anti-her2 vhh1
    n1=ipilimumab | n2=en:iodine i 131 sgmib-anti-her2 vhh1 | rel=r_associated | relid=0 | w=30
  5094. ipilimumab -- r_associated #0: 30 / 0.066 -> en:isosource 1.5
    n1=ipilimumab | n2=en:isosource 1.5 | rel=r_associated | relid=0 | w=30
  5095. ipilimumab -- r_associated #0: 30 / 0.066 -> en:isoton
    n1=ipilimumab | n2=en:isoton | rel=r_associated | relid=0 | w=30
  5096. ipilimumab -- r_associated #0: 30 / 0.066 -> en:lactobacillus acidophilus/streptococcus thermophilus/bifidobacterium lactis/l. rhamnosus/b. longum/b. bifidum-based probiotic supplement
    n1=ipilimumab | n2=en:lactobacillus acidophilus/streptococcus thermophilus/bifidobacterium lactis/l. rhamnosus/b. longum/b. bifidum-based probiotic supplement | rel=r_associated | relid=0 | w=30
  5097. ipilimumab -- r_associated #0: 30 / 0.066 -> en:liarozole fumarate
    n1=ipilimumab | n2=en:liarozole fumarate | rel=r_associated | relid=0 | w=30
  5098. ipilimumab -- r_associated #0: 30 / 0.066 -> en:lipopolysaccharide
    n1=ipilimumab | n2=en:lipopolysaccharide | rel=r_associated | relid=0 | w=30
  5099. ipilimumab -- r_associated #0: 30 / 0.066 -> en:lovastatin
    n1=ipilimumab | n2=en:lovastatin | rel=r_associated | relid=0 | w=30
  5100. ipilimumab -- r_associated #0: 30 / 0.066 -> en:manuka honey
    n1=ipilimumab | n2=en:manuka honey | rel=r_associated | relid=0 | w=30
  5101. ipilimumab -- r_associated #0: 30 / 0.066 -> en:mek inhibitor ro4987655
    n1=ipilimumab | n2=en:mek inhibitor ro4987655 | rel=r_associated | relid=0 | w=30
  5102. ipilimumab -- r_associated #0: 30 / 0.066 -> en:melan-a vlp vaccine
    n1=ipilimumab | n2=en:melan-a vlp vaccine | rel=r_associated | relid=0 | w=30
  5103. ipilimumab -- r_associated #0: 30 / 0.066 -> en:meloxicam
    n1=ipilimumab | n2=en:meloxicam | rel=r_associated | relid=0 | w=30
  5104. ipilimumab -- r_associated #0: 30 / 0.066 -> en:miracle mouthwash plus hydrocortisone
    n1=ipilimumab | n2=en:miracle mouthwash plus hydrocortisone | rel=r_associated | relid=0 | w=30
  5105. ipilimumab -- r_associated #0: 30 / 0.066 -> en:mk0429
    n1=ipilimumab | n2=en:mk0429 | rel=r_associated | relid=0 | w=30
  5106. ipilimumab -- r_associated #0: 30 / 0.066 -> en:monoclonal antibody huhmfg1
    n1=ipilimumab | n2=en:monoclonal antibody huhmfg1 | rel=r_associated | relid=0 | w=30
  5107. ipilimumab -- r_associated #0: 30 / 0.066 -> en:monoclonal antibody ing-1
    n1=ipilimumab | n2=en:monoclonal antibody ing-1 | rel=r_associated | relid=0 | w=30
  5108. ipilimumab -- r_associated #0: 30 / 0.066 -> en:nm-3
    n1=ipilimumab | n2=en:nm-3 | rel=r_associated | relid=0 | w=30
  5109. ipilimumab -- r_associated #0: 30 / 0.066 -> en:norepinephrine, dl-
    n1=ipilimumab | n2=en:norepinephrine, dl- | rel=r_associated | relid=0 | w=30
  5110. ipilimumab -- r_associated #0: 30 / 0.066 -> en:obatoclax
    n1=ipilimumab | n2=en:obatoclax | rel=r_associated | relid=0 | w=30
  5111. ipilimumab -- r_associated #0: 30 / 0.066 -> en:ocv-104
    n1=ipilimumab | n2=en:ocv-104 | rel=r_associated | relid=0 | w=30
  5112. ipilimumab -- r_associated #0: 30 / 0.066 -> en:oligonucleotide spc2996
    n1=ipilimumab | n2=en:oligonucleotide spc2996 | rel=r_associated | relid=0 | w=30
  5113. ipilimumab -- r_associated #0: 30 / 0.066 -> en:organic sulfone compound
    n1=ipilimumab | n2=en:organic sulfone compound | rel=r_associated | relid=0 | w=30
  5114. ipilimumab -- r_associated #0: 30 / 0.066 -> en:panitumumab
    n1=ipilimumab | n2=en:panitumumab | rel=r_associated | relid=0 | w=30
  5115. ipilimumab -- r_associated #0: 30 / 0.066 -> en:piritramide
    n1=ipilimumab | n2=en:piritramide | rel=r_associated | relid=0 | w=30
  5116. ipilimumab -- r_associated #0: 30 / 0.066 -> en:propylthiouracil
    n1=ipilimumab | n2=en:propylthiouracil | rel=r_associated | relid=0 | w=30
  5117. ipilimumab -- r_associated #0: 30 / 0.066 -> en:prostate cancer vaccine ony-p1
    n1=ipilimumab | n2=en:prostate cancer vaccine ony-p1 | rel=r_associated | relid=0 | w=30
  5118. ipilimumab -- r_associated #0: 30 / 0.066 -> en:psa/psma dna plasmid ino-5150
    n1=ipilimumab | n2=en:psa/psma dna plasmid ino-5150 | rel=r_associated | relid=0 | w=30
  5119. ipilimumab -- r_associated #0: 30 / 0.066 -> en:pyrotinib
    n1=ipilimumab | n2=en:pyrotinib | rel=r_associated | relid=0 | w=30
  5120. ipilimumab -- r_associated #0: 30 / 0.066 -> en:recombinant human angiotensin converting enzyme 2 apn01
    n1=ipilimumab | n2=en:recombinant human angiotensin converting enzyme 2 apn01 | rel=r_associated | relid=0 | w=30
  5121. ipilimumab -- r_associated #0: 30 / 0.066 -> en:recombinant thyroglobulin
    n1=ipilimumab | n2=en:recombinant thyroglobulin | rel=r_associated | relid=0 | w=30
  5122. ipilimumab -- r_associated #0: 30 / 0.066 -> en:seribantumab
    n1=ipilimumab | n2=en:seribantumab | rel=r_associated | relid=0 | w=30
  5123. ipilimumab -- r_associated #0: 30 / 0.066 -> en:silver nitrate
    n1=ipilimumab | n2=en:silver nitrate | rel=r_associated | relid=0 | w=30
  5124. ipilimumab -- r_associated #0: 30 / 0.066 -> en:sitagliptin phosphate
    n1=ipilimumab | n2=en:sitagliptin phosphate | rel=r_associated | relid=0 | w=30
  5125. ipilimumab -- r_associated #0: 30 / 0.066 -> en:sodium bicarbonate/potassium bicarbonate/anhydrous citric acid
    n1=ipilimumab | n2=en:sodium bicarbonate/potassium bicarbonate/anhydrous citric acid | rel=r_associated | relid=0 | w=30
  5126. ipilimumab -- r_associated #0: 30 / 0.066 -> en:sorafenib tosylate
    n1=ipilimumab | n2=en:sorafenib tosylate | rel=r_associated | relid=0 | w=30
  5127. ipilimumab -- r_associated #0: 30 / 0.066 -> en:soy isoflavones
    n1=ipilimumab | n2=en:soy isoflavones | rel=r_associated | relid=0 | w=30
  5128. ipilimumab -- r_associated #0: 30 / 0.066 -> en:src/abl kinase inhibitor azd0424
    n1=ipilimumab | n2=en:src/abl kinase inhibitor azd0424 | rel=r_associated | relid=0 | w=30
  5129. ipilimumab -- r_associated #0: 30 / 0.066 -> en:tazobactam sodium
    n1=ipilimumab | n2=en:tazobactam sodium | rel=r_associated | relid=0 | w=30
  5130. ipilimumab -- r_associated #0: 30 / 0.066 -> en:tetanus peptide melanoma vaccine
    n1=ipilimumab | n2=en:tetanus peptide melanoma vaccine | rel=r_associated | relid=0 | w=30
  5131. ipilimumab -- r_associated #0: 30 / 0.066 -> en:thymidine
    n1=ipilimumab | n2=en:thymidine | rel=r_associated | relid=0 | w=30
  5132. ipilimumab -- r_associated #0: 30 / 0.066 -> en:topical agent ad17137
    n1=ipilimumab | n2=en:topical agent ad17137 | rel=r_associated | relid=0 | w=30
  5133. ipilimumab -- r_associated #0: 30 / 0.066 -> en:trpv6 calcium channel inhibitor sor-c13
    n1=ipilimumab | n2=en:trpv6 calcium channel inhibitor sor-c13 | rel=r_associated | relid=0 | w=30
  5134. ipilimumab -- r_associated #0: 30 / 0.066 -> en:vantictumab
    n1=ipilimumab | n2=en:vantictumab | rel=r_associated | relid=0 | w=30
  5135. ipilimumab -- r_associated #0: 30 / 0.066 -> en:vegfr/pdgfr tyrosine kinase inhibitor tak-593
    n1=ipilimumab | n2=en:vegfr/pdgfr tyrosine kinase inhibitor tak-593 | rel=r_associated | relid=0 | w=30
  5136. ipilimumab -- r_associated #0: 30 / 0.066 -> en:vinblastine
    n1=ipilimumab | n2=en:vinblastine | rel=r_associated | relid=0 | w=30
  5137. ipilimumab -- r_associated #0: 30 / 0.066 -> en:xenobiotics
    n1=ipilimumab | n2=en:xenobiotics | rel=r_associated | relid=0 | w=30
  5138. ipilimumab -- r_associated #0: 30 / 0.066 -> en:yttrium y 90 monoclonal antibody b3
    n1=ipilimumab | n2=en:yttrium y 90 monoclonal antibody b3 | rel=r_associated | relid=0 | w=30
  5139. ipilimumab -- r_associated #0: 30 / 0.066 -> en:zirconium zr 89 cetuximab
    n1=ipilimumab | n2=en:zirconium zr 89 cetuximab | rel=r_associated | relid=0 | w=30
  5140. ipilimumab -- r_associated #0: 29 / 0.063 -> en:2-hydroxyflutamide depot
    n1=ipilimumab | n2=en:2-hydroxyflutamide depot | rel=r_associated | relid=0 | w=29
  5141. ipilimumab -- r_associated #0: 29 / 0.063 -> en:adenovirus 5-cd40 ligand
    n1=ipilimumab | n2=en:adenovirus 5-cd40 ligand | rel=r_associated | relid=0 | w=29
  5142. ipilimumab -- r_associated #0: 29 / 0.063 -> en:adozelesin
    n1=ipilimumab | n2=en:adozelesin | rel=r_associated | relid=0 | w=29
  5143. ipilimumab -- r_associated #0: 29 / 0.063 -> en:akt 1/2 inhibitor bay1125976
    n1=ipilimumab | n2=en:akt 1/2 inhibitor bay1125976 | rel=r_associated | relid=0 | w=29
  5144. ipilimumab -- r_associated #0: 29 / 0.063 -> en:aldoxorubicin
    n1=ipilimumab | n2=en:aldoxorubicin | rel=r_associated | relid=0 | w=29
  5145. ipilimumab -- r_associated #0: 29 / 0.063 -> en:alefacept
    n1=ipilimumab | n2=en:alefacept | rel=r_associated | relid=0 | w=29
  5146. ipilimumab -- r_associated #0: 29 / 0.063 -> en:amonafide l-malate
    n1=ipilimumab | n2=en:amonafide l-malate | rel=r_associated | relid=0 | w=29
  5147. ipilimumab -- r_associated #0: 29 / 0.063 -> en:anti-alphavbeta3 monoclonal antibody emd 525797
    n1=ipilimumab | n2=en:anti-alphavbeta3 monoclonal antibody emd 525797 | rel=r_associated | relid=0 | w=29
  5148. ipilimumab -- r_associated #0: 29 / 0.063 -> en:anti-cd19-car retroviral vector-transduced autologous t cells
    n1=ipilimumab | n2=en:anti-cd19-car retroviral vector-transduced autologous t cells | rel=r_associated | relid=0 | w=29
  5149. ipilimumab -- r_associated #0: 29 / 0.063 -> en:anti-cd19-car-cd3zeta-4-1bb-expressing allogenic natural killer cells
    n1=ipilimumab | n2=en:anti-cd19-car-cd3zeta-4-1bb-expressing allogenic natural killer cells | rel=r_associated | relid=0 | w=29
  5150. ipilimumab -- r_associated #0: 29 / 0.063 -> en:anti-gpc3-car autologous t lymphocytes
    n1=ipilimumab | n2=en:anti-gpc3-car autologous t lymphocytes | rel=r_associated | relid=0 | w=29
  5151. ipilimumab -- r_associated #0: 29 / 0.063 -> en:anti-vegf/ang2 nanobody bi 836880
    n1=ipilimumab | n2=en:anti-vegf/ang2 nanobody bi 836880 | rel=r_associated | relid=0 | w=29
  5152. ipilimumab -- r_associated #0: 29 / 0.063 -> en:antineoplastic alkaloid
    n1=ipilimumab | n2=en:antineoplastic alkaloid | rel=r_associated | relid=0 | w=29
  5153. ipilimumab -- r_associated #0: 29 / 0.063 -> en:arcitumomab
    n1=ipilimumab | n2=en:arcitumomab | rel=r_associated | relid=0 | w=29
  5154. ipilimumab -- r_associated #0: 29 / 0.063 -> en:ascorbic acid
    n1=ipilimumab | n2=en:ascorbic acid | rel=r_associated | relid=0 | w=29
  5155. ipilimumab -- r_associated #0: 29 / 0.063 -> en:atrasentan hydrochloride
    n1=ipilimumab | n2=en:atrasentan hydrochloride | rel=r_associated | relid=0 | w=29
  5156. ipilimumab -- r_associated #0: 29 / 0.063 -> en:attenuated chimpanzee adenovirus 5t4 vaccine
    n1=ipilimumab | n2=en:attenuated chimpanzee adenovirus 5t4 vaccine | rel=r_associated | relid=0 | w=29
  5157. ipilimumab -- r_associated #0: 29 / 0.063 -> en:aurora b/c kinase inhibitor gsk1070916a
    n1=ipilimumab | n2=en:aurora b/c kinase inhibitor gsk1070916a | rel=r_associated | relid=0 | w=29
  5158. ipilimumab -- r_associated #0: 29 / 0.063 -> en:aurora kinase inhibitor sns-314
    n1=ipilimumab | n2=en:aurora kinase inhibitor sns-314 | rel=r_associated | relid=0 | w=29
  5159. ipilimumab -- r_associated #0: 29 / 0.063 -> en:autologous anti-cd123 car tcr/4-1bb-expressing t-lymphocytes
    n1=ipilimumab | n2=en:autologous anti-cd123 car tcr/4-1bb-expressing t-lymphocytes | rel=r_associated | relid=0 | w=29
  5160. ipilimumab -- r_associated #0: 29 / 0.063 -> en:autologous ebv-transformed b lymphoblastoid-tumor fusion cell vaccine
    n1=ipilimumab | n2=en:autologous ebv-transformed b lymphoblastoid-tumor fusion cell vaccine | rel=r_associated | relid=0 | w=29
  5161. ipilimumab -- r_associated #0: 29 / 0.063 -> en:autologous her2 chimeric receptor/tgfbeta dominant negative receptor-expressing ebv-specific cytotoxic t lymphocytes
    n1=ipilimumab | n2=en:autologous her2 chimeric receptor/tgfbeta dominant negative receptor-expressing ebv-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=29
  5162. ipilimumab -- r_associated #0: 29 / 0.063 -> en:azadirachta indica
    n1=ipilimumab | n2=en:azadirachta indica | rel=r_associated | relid=0 | w=29
  5163. ipilimumab -- r_associated #0: 29 / 0.063 -> en:benznidazole
    n1=ipilimumab | n2=en:benznidazole | rel=r_associated | relid=0 | w=29
  5164. ipilimumab -- r_associated #0: 29 / 0.063 -> en:carbon c 14 eribulin acetate
    n1=ipilimumab | n2=en:carbon c 14 eribulin acetate | rel=r_associated | relid=0 | w=29
  5165. ipilimumab -- r_associated #0: 29 / 0.063 -> en:cbp-501
    n1=ipilimumab | n2=en:cbp-501 | rel=r_associated | relid=0 | w=29
  5166. ipilimumab -- r_associated #0: 29 / 0.063 -> en:cc-401
    n1=ipilimumab | n2=en:cc-401 | rel=r_associated | relid=0 | w=29
  5167. ipilimumab -- r_associated #0: 29 / 0.063 -> en:chloroquine
    n1=ipilimumab | n2=en:chloroquine | rel=r_associated | relid=0 | w=29
  5168. ipilimumab -- r_associated #0: 29 / 0.063 -> en:clopidogrel bisulfate
    n1=ipilimumab | n2=en:clopidogrel bisulfate | rel=r_associated | relid=0 | w=29
  5169. ipilimumab -- r_associated #0: 29 / 0.063 -> en:cobimetinib
    n1=ipilimumab | n2=en:cobimetinib | rel=r_associated | relid=0 | w=29
  5170. ipilimumab -- r_associated #0: 29 / 0.063 -> en:copdac regimen
    n1=ipilimumab | n2=en:copdac regimen | rel=r_associated | relid=0 | w=29
  5171. ipilimumab -- r_associated #0: 29 / 0.063 -> en:copper cu 64-atsm
    n1=ipilimumab | n2=en:copper cu 64-atsm | rel=r_associated | relid=0 | w=29
  5172. ipilimumab -- r_associated #0: 29 / 0.063 -> en:demeclocycline hydrochloride
    n1=ipilimumab | n2=en:demeclocycline hydrochloride | rel=r_associated | relid=0 | w=29
  5173. ipilimumab -- r_associated #0: 29 / 0.063 -> en:desflurane
    n1=ipilimumab | n2=en:desflurane | rel=r_associated | relid=0 | w=29
  5174. ipilimumab -- r_associated #0: 29 / 0.063 -> en:diazoxide
    n1=ipilimumab | n2=en:diazoxide | rel=r_associated | relid=0 | w=29
  5175. ipilimumab -- r_associated #0: 29 / 0.063 -> en:diethylstilbestrol
    n1=ipilimumab | n2=en:diethylstilbestrol | rel=r_associated | relid=0 | w=29
  5176. ipilimumab -- r_associated #0: 29 / 0.063 -> en:docetaxel-pnp
    n1=ipilimumab | n2=en:docetaxel-pnp | rel=r_associated | relid=0 | w=29
  5177. ipilimumab -- r_associated #0: 29 / 0.063 -> en:edatrexate
    n1=ipilimumab | n2=en:edatrexate | rel=r_associated | relid=0 | w=29
  5178. ipilimumab -- r_associated #0: 29 / 0.063 -> en:egfr inhibitor asp8273
    n1=ipilimumab | n2=en:egfr inhibitor asp8273 | rel=r_associated | relid=0 | w=29
  5179. ipilimumab -- r_associated #0: 29 / 0.063 -> en:egfr inhibitor co-1686
    n1=ipilimumab | n2=en:egfr inhibitor co-1686 | rel=r_associated | relid=0 | w=29
  5180. ipilimumab -- r_associated #0: 29 / 0.063 -> en:egfrviii-specific car-transduced autologous t lymphocytes
    n1=ipilimumab | n2=en:egfrviii-specific car-transduced autologous t lymphocytes | rel=r_associated | relid=0 | w=29
  5181. ipilimumab -- r_associated #0: 29 / 0.063 -> en:extended-release onapristone
    n1=ipilimumab | n2=en:extended-release onapristone | rel=r_associated | relid=0 | w=29
  5182. ipilimumab -- r_associated #0: 29 / 0.063 -> en:f-18 16 alpha-fluoroestradiol
    n1=ipilimumab | n2=en:f-18 16 alpha-fluoroestradiol | rel=r_associated | relid=0 | w=29
  5183. ipilimumab -- r_associated #0: 29 / 0.063 -> en:fludeoxyglucose f-18
    n1=ipilimumab | n2=en:fludeoxyglucose f-18 | rel=r_associated | relid=0 | w=29
  5184. ipilimumab -- r_associated #0: 29 / 0.063 -> en:fluorine f 18 ara-g
    n1=ipilimumab | n2=en:fluorine f 18 ara-g | rel=r_associated | relid=0 | w=29
  5185. ipilimumab -- r_associated #0: 29 / 0.063 -> en:fluorine f 18 d-fmau
    n1=ipilimumab | n2=en:fluorine f 18 d-fmau | rel=r_associated | relid=0 | w=29
  5186. ipilimumab -- r_associated #0: 29 / 0.063 -> en:fluorouracil implant
    n1=ipilimumab | n2=en:fluorouracil implant | rel=r_associated | relid=0 | w=29
  5187. ipilimumab -- r_associated #0: 29 / 0.063 -> en:gadoteridol
    n1=ipilimumab | n2=en:gadoteridol | rel=r_associated | relid=0 | w=29
  5188. ipilimumab -- r_associated #0: 29 / 0.063 -> en:ganetespib
    n1=ipilimumab | n2=en:ganetespib | rel=r_associated | relid=0 | w=29
  5189. ipilimumab -- r_associated #0: 29 / 0.063 -> en:garlic extract
    n1=ipilimumab | n2=en:garlic extract | rel=r_associated | relid=0 | w=29
  5190. ipilimumab -- r_associated #0: 29 / 0.063 -> en:gemcitabine prodrug ly2334737
    n1=ipilimumab | n2=en:gemcitabine prodrug ly2334737 | rel=r_associated | relid=0 | w=29
  5191. ipilimumab -- r_associated #0: 29 / 0.063 -> en:gluten-free compact nutritional supplement drink
    n1=ipilimumab | n2=en:gluten-free compact nutritional supplement drink | rel=r_associated | relid=0 | w=29
  5192. ipilimumab -- r_associated #0: 29 / 0.063 -> en:golotimod
    n1=ipilimumab | n2=en:golotimod | rel=r_associated | relid=0 | w=29
  5193. ipilimumab -- r_associated #0: 29 / 0.063 -> en:gomiliximab
    n1=ipilimumab | n2=en:gomiliximab | rel=r_associated | relid=0 | w=29
  5194. ipilimumab -- r_associated #0: 29 / 0.063 -> en:her2-targeted liposomal doxorubicin hydrochloride mm-302
    n1=ipilimumab | n2=en:her2-targeted liposomal doxorubicin hydrochloride mm-302 | rel=r_associated | relid=0 | w=29
  5195. ipilimumab -- r_associated #0: 29 / 0.063 -> en:htert vaccine v934/v935
    n1=ipilimumab | n2=en:htert vaccine v934/v935 | rel=r_associated | relid=0 | w=29
  5196. ipilimumab -- r_associated #0: 29 / 0.063 -> en:idh1r132h-specific peptide vaccine pepidh1m
    n1=ipilimumab | n2=en:idh1r132h-specific peptide vaccine pepidh1m | rel=r_associated | relid=0 | w=29
  5197. ipilimumab -- r_associated #0: 29 / 0.063 -> en:idh2 inhibitor ag-221
    n1=ipilimumab | n2=en:idh2 inhibitor ag-221 | rel=r_associated | relid=0 | w=29
  5198. ipilimumab -- r_associated #0: 29 / 0.063 -> en:imidazolidinyl urea/paraben/mineral oil/petrolatum
    n1=ipilimumab | n2=en:imidazolidinyl urea/paraben/mineral oil/petrolatum | rel=r_associated | relid=0 | w=29
  5199. ipilimumab -- r_associated #0: 29 / 0.063 -> en:immunotherapeutic gsk1572932a
    n1=ipilimumab | n2=en:immunotherapeutic gsk1572932a | rel=r_associated | relid=0 | w=29
  5200. ipilimumab -- r_associated #0: 29 / 0.063 -> en:indium in 111 pentetate
    n1=ipilimumab | n2=en:indium in 111 pentetate | rel=r_associated | relid=0 | w=29
  5201. ipilimumab -- r_associated #0: 29 / 0.063 -> en:jak2 inhibitor azd1480
    n1=ipilimumab | n2=en:jak2 inhibitor azd1480 | rel=r_associated | relid=0 | w=29
  5202. ipilimumab -- r_associated #0: 29 / 0.063 -> en:lamivudine
    n1=ipilimumab | n2=en:lamivudine | rel=r_associated | relid=0 | w=29
  5203. ipilimumab -- r_associated #0: 29 / 0.063 -> en:lepirudin
    n1=ipilimumab | n2=en:lepirudin | rel=r_associated | relid=0 | w=29
  5204. ipilimumab -- r_associated #0: 29 / 0.063 -> en:lps/cd40l-activated klh- and melanoma/hiv peptides-loaded autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:lps/cd40l-activated klh- and melanoma/hiv peptides-loaded autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=29
  5205. ipilimumab -- r_associated #0: 29 / 0.063 -> en:luspatercept
    n1=ipilimumab | n2=en:luspatercept | rel=r_associated | relid=0 | w=29
  5206. ipilimumab -- r_associated #0: 29 / 0.063 -> en:lutetium lu 177 peptide receptor radionuclide
    n1=ipilimumab | n2=en:lutetium lu 177 peptide receptor radionuclide | rel=r_associated | relid=0 | w=29
  5207. ipilimumab -- r_associated #0: 29 / 0.063 -> en:lutetium lu-177 capromab
    n1=ipilimumab | n2=en:lutetium lu-177 capromab | rel=r_associated | relid=0 | w=29
  5208. ipilimumab -- r_associated #0: 29 / 0.063 -> en:maltodextrin
    n1=ipilimumab | n2=en:maltodextrin | rel=r_associated | relid=0 | w=29
  5209. ipilimumab -- r_associated #0: 29 / 0.063 -> en:mast cell stabilizer
    n1=ipilimumab | n2=en:mast cell stabilizer | rel=r_associated | relid=0 | w=29
  5210. ipilimumab -- r_associated #0: 29 / 0.063 -> en:mercaptopurine
    n1=ipilimumab | n2=en:mercaptopurine | rel=r_associated | relid=0 | w=29
  5211. ipilimumab -- r_associated #0: 29 / 0.063 -> en:metap2 inhibitor sdx-7320
    n1=ipilimumab | n2=en:metap2 inhibitor sdx-7320 | rel=r_associated | relid=0 | w=29
  5212. ipilimumab -- r_associated #0: 29 / 0.063 -> en:mk-1248
    n1=ipilimumab | n2=en:mk-1248 | rel=r_associated | relid=0 | w=29
  5213. ipilimumab -- r_associated #0: 29 / 0.063 -> en:monoclonal antibody abgn-7
    n1=ipilimumab | n2=en:monoclonal antibody abgn-7 | rel=r_associated | relid=0 | w=29
  5214. ipilimumab -- r_associated #0: 29 / 0.063 -> en:monoclonal antibody mik-beta-1
    n1=ipilimumab | n2=en:monoclonal antibody mik-beta-1 | rel=r_associated | relid=0 | w=29
  5215. ipilimumab -- r_associated #0: 29 / 0.063 -> en:mycobacterial cell wall-dna complex
    n1=ipilimumab | n2=en:mycobacterial cell wall-dna complex | rel=r_associated | relid=0 | w=29
  5216. ipilimumab -- r_associated #0: 29 / 0.063 -> en:nx-1207
    n1=ipilimumab | n2=en:nx-1207 | rel=r_associated | relid=0 | w=29
  5217. ipilimumab -- r_associated #0: 29 / 0.063 -> en:oglufanide disodium
    n1=ipilimumab | n2=en:oglufanide disodium | rel=r_associated | relid=0 | w=29
  5218. ipilimumab -- r_associated #0: 29 / 0.063 -> en:oral ixabepilone
    n1=ipilimumab | n2=en:oral ixabepilone | rel=r_associated | relid=0 | w=29
  5219. ipilimumab -- r_associated #0: 29 / 0.063 -> en:p.dom-wt1-126 dna vaccine
    n1=ipilimumab | n2=en:p.dom-wt1-126 dna vaccine | rel=r_associated | relid=0 | w=29
  5220. ipilimumab -- r_associated #0: 29 / 0.063 -> en:pan-akt inhibitor arq751
    n1=ipilimumab | n2=en:pan-akt inhibitor arq751 | rel=r_associated | relid=0 | w=29
  5221. ipilimumab -- r_associated #0: 29 / 0.063 -> en:pan-raf inhibitor ly3009120
    n1=ipilimumab | n2=en:pan-raf inhibitor ly3009120 | rel=r_associated | relid=0 | w=29
  5222. ipilimumab -- r_associated #0: 29 / 0.063 -> en:paroxetine hydrochloride
    n1=ipilimumab | n2=en:paroxetine hydrochloride | rel=r_associated | relid=0 | w=29
  5223. ipilimumab -- r_associated #0: 29 / 0.063 -> en:patritumab
    n1=ipilimumab | n2=en:patritumab | rel=r_associated | relid=0 | w=29
  5224. ipilimumab -- r_associated #0: 29 / 0.063 -> en:pefloxacin
    n1=ipilimumab | n2=en:pefloxacin | rel=r_associated | relid=0 | w=29
  5225. ipilimumab -- r_associated #0: 29 / 0.063 -> en:pegylated interferon alfa
    n1=ipilimumab | n2=en:pegylated interferon alfa | rel=r_associated | relid=0 | w=29
  5226. ipilimumab -- r_associated #0: 29 / 0.063 -> en:pi3k alpha/beta inhibitor bay1082439
    n1=ipilimumab | n2=en:pi3k alpha/beta inhibitor bay1082439 | rel=r_associated | relid=0 | w=29
  5227. ipilimumab -- r_associated #0: 29 / 0.063 -> en:pngvl3-hicd vaccine
    n1=ipilimumab | n2=en:pngvl3-hicd vaccine | rel=r_associated | relid=0 | w=29
  5228. ipilimumab -- r_associated #0: 29 / 0.063 -> en:polyethylene glycol polymer surgical sealant
    n1=ipilimumab | n2=en:polyethylene glycol polymer surgical sealant | rel=r_associated | relid=0 | w=29
  5229. ipilimumab -- r_associated #0: 29 / 0.063 -> en:ponesimod
    n1=ipilimumab | n2=en:ponesimod | rel=r_associated | relid=0 | w=29
  5230. ipilimumab -- r_associated #0: 29 / 0.063 -> en:racotumomab
    n1=ipilimumab | n2=en:racotumomab | rel=r_associated | relid=0 | w=29
  5231. ipilimumab -- r_associated #0: 29 / 0.063 -> en:recombinant anti-wt1 immunotherapeutic gsk2302024a
    n1=ipilimumab | n2=en:recombinant anti-wt1 immunotherapeutic gsk2302024a | rel=r_associated | relid=0 | w=29
  5232. ipilimumab -- r_associated #0: 29 / 0.063 -> en:recombinant fowlpox-cea(6d)/tricom vaccine
    n1=ipilimumab | n2=en:recombinant fowlpox-cea(6d)/tricom vaccine | rel=r_associated | relid=0 | w=29
  5233. ipilimumab -- r_associated #0: 29 / 0.063 -> en:recombinant human granulocyte colony stimulating factor
    n1=ipilimumab | n2=en:recombinant human granulocyte colony stimulating factor | rel=r_associated | relid=0 | w=29
  5234. ipilimumab -- r_associated #0: 29 / 0.063 -> en:recombinant vaccinia-cea(6d)-tricom vaccine
    n1=ipilimumab | n2=en:recombinant vaccinia-cea(6d)-tricom vaccine | rel=r_associated | relid=0 | w=29
  5235. ipilimumab -- r_associated #0: 29 / 0.063 -> en:roniciclib
    n1=ipilimumab | n2=en:roniciclib | rel=r_associated | relid=0 | w=29
  5236. ipilimumab -- r_associated #0: 29 / 0.063 -> en:saccharomyces boulardii probiotic supplement
    n1=ipilimumab | n2=en:saccharomyces boulardii probiotic supplement | rel=r_associated | relid=0 | w=29
  5237. ipilimumab -- r_associated #0: 29 / 0.063 -> en:sirpa-fc fusion protein tti-621
    n1=ipilimumab | n2=en:sirpa-fc fusion protein tti-621 | rel=r_associated | relid=0 | w=29
  5238. ipilimumab -- r_associated #0: 29 / 0.063 -> en:sodium thiosulfate
    n1=ipilimumab | n2=en:sodium thiosulfate | rel=r_associated | relid=0 | w=29
  5239. ipilimumab -- r_associated #0: 29 / 0.063 -> en:squalamine lactate
    n1=ipilimumab | n2=en:squalamine lactate | rel=r_associated | relid=0 | w=29
  5240. ipilimumab -- r_associated #0: 29 / 0.063 -> en:substance p-saporin
    n1=ipilimumab | n2=en:substance p-saporin | rel=r_associated | relid=0 | w=29
  5241. ipilimumab -- r_associated #0: 29 / 0.063 -> en:taxol analogue sid 530
    n1=ipilimumab | n2=en:taxol analogue sid 530 | rel=r_associated | relid=0 | w=29
  5242. ipilimumab -- r_associated #0: 29 / 0.063 -> en:technetium tc 99m trofolastat
    n1=ipilimumab | n2=en:technetium tc 99m trofolastat | rel=r_associated | relid=0 | w=29
  5243. ipilimumab -- r_associated #0: 29 / 0.063 -> en:tlr9 agonist emd 1201081
    n1=ipilimumab | n2=en:tlr9 agonist emd 1201081 | rel=r_associated | relid=0 | w=29
  5244. ipilimumab -- r_associated #0: 29 / 0.063 -> en:tofacitinib
    n1=ipilimumab | n2=en:tofacitinib | rel=r_associated | relid=0 | w=29
  5245. ipilimumab -- r_associated #0: 29 / 0.063 -> en:tositumomab and iodine i 131 tositumomab
    n1=ipilimumab | n2=en:tositumomab and iodine i 131 tositumomab | rel=r_associated | relid=0 | w=29
  5246. ipilimumab -- r_associated #0: 29 / 0.063 -> en:valdecoxib
    n1=ipilimumab | n2=en:valdecoxib | rel=r_associated | relid=0 | w=29
  5247. ipilimumab -- r_associated #0: 29 / 0.063 -> en:vecuronium bromide
    n1=ipilimumab | n2=en:vecuronium bromide | rel=r_associated | relid=0 | w=29
  5248. ipilimumab -- r_associated #0: 29 / 0.063 -> en:vedolizumab
    n1=ipilimumab | n2=en:vedolizumab | rel=r_associated | relid=0 | w=29
  5249. ipilimumab -- r_associated #0: 29 / 0.063 -> en:vegfr2-targeted contrast agent br55
    n1=ipilimumab | n2=en:vegfr2-targeted contrast agent br55 | rel=r_associated | relid=0 | w=29
  5250. ipilimumab -- r_associated #0: 29 / 0.063 -> en:voriconazole
    n1=ipilimumab | n2=en:voriconazole | rel=r_associated | relid=0 | w=29
  5251. ipilimumab -- r_associated #0: 29 / 0.063 -> en:yttrium y 90 basiliximab
    n1=ipilimumab | n2=en:yttrium y 90 basiliximab | rel=r_associated | relid=0 | w=29
  5252. ipilimumab -- r_associated #0: 28 / 0.061 -> Bristol Myers Squibb
    n1=ipilimumab | n2=Bristol Myers Squibb | rel=r_associated | relid=0 | w=28
  5253. ipilimumab -- r_associated #0: 28 / 0.061 -> en:adenosine triphosphate
    n1=ipilimumab | n2=en:adenosine triphosphate | rel=r_associated | relid=0 | w=28
  5254. ipilimumab -- r_associated #0: 28 / 0.061 -> en:aerosolized aldesleukin
    n1=ipilimumab | n2=en:aerosolized aldesleukin | rel=r_associated | relid=0 | w=28
  5255. ipilimumab -- r_associated #0: 28 / 0.061 -> en:albumin
    n1=ipilimumab | n2=en:albumin | rel=r_associated | relid=0 | w=28
  5256. ipilimumab -- r_associated #0: 28 / 0.061 -> en:alendronate sodium
    n1=ipilimumab | n2=en:alendronate sodium | rel=r_associated | relid=0 | w=28
  5257. ipilimumab -- r_associated #0: 28 / 0.061 -> en:alpha-galactosylceramide-pulsed autologous dendritic cells
    n1=ipilimumab | n2=en:alpha-galactosylceramide-pulsed autologous dendritic cells | rel=r_associated | relid=0 | w=28
  5258. ipilimumab -- r_associated #0: 28 / 0.061 -> en:amifostine
    n1=ipilimumab | n2=en:amifostine | rel=r_associated | relid=0 | w=28
  5259. ipilimumab -- r_associated #0: 28 / 0.061 -> en:aminocamptothecin
    n1=ipilimumab | n2=en:aminocamptothecin | rel=r_associated | relid=0 | w=28
  5260. ipilimumab -- r_associated #0: 28 / 0.061 -> en:anagrelide hydrochloride
    n1=ipilimumab | n2=en:anagrelide hydrochloride | rel=r_associated | relid=0 | w=28
  5261. ipilimumab -- r_associated #0: 28 / 0.061 -> en:angelica sinensis root extract
    n1=ipilimumab | n2=en:angelica sinensis root extract | rel=r_associated | relid=0 | w=28
  5262. ipilimumab -- r_associated #0: 28 / 0.061 -> en:anthracycline analogue gpx-150
    n1=ipilimumab | n2=en:anthracycline analogue gpx-150 | rel=r_associated | relid=0 | w=28
  5263. ipilimumab -- r_associated #0: 28 / 0.061 -> en:anti-c-kit monoclonal antibody ktn0158
    n1=ipilimumab | n2=en:anti-c-kit monoclonal antibody ktn0158 | rel=r_associated | relid=0 | w=28
  5264. ipilimumab -- r_associated #0: 28 / 0.061 -> en:anti-cldn6 monoclonal antibody imab027
    n1=ipilimumab | n2=en:anti-cldn6 monoclonal antibody imab027 | rel=r_associated | relid=0 | w=28
  5265. ipilimumab -- r_associated #0: 28 / 0.061 -> en:anti-hb-egf monoclonal antibody khk2866
    n1=ipilimumab | n2=en:anti-hb-egf monoclonal antibody khk2866 | rel=r_associated | relid=0 | w=28
  5266. ipilimumab -- r_associated #0: 28 / 0.061 -> en:anti-programmed cell death protein 1 antibody expressing pluripotent killer t-lymphocytes
    n1=ipilimumab | n2=en:anti-programmed cell death protein 1 antibody expressing pluripotent killer t-lymphocytes | rel=r_associated | relid=0 | w=28
  5267. ipilimumab -- r_associated #0: 28 / 0.061 -> en:anti-rspo3 monoclonal antibody omp-131r10
    n1=ipilimumab | n2=en:anti-rspo3 monoclonal antibody omp-131r10 | rel=r_associated | relid=0 | w=28
  5268. ipilimumab -- r_associated #0: 28 / 0.061 -> en:anti-vista monoclonal antibody jnj 61610588
    n1=ipilimumab | n2=en:anti-vista monoclonal antibody jnj 61610588 | rel=r_associated | relid=0 | w=28
  5269. ipilimumab -- r_associated #0: 28 / 0.061 -> en:antibody-drug conjugate pf-06647263
    n1=ipilimumab | n2=en:antibody-drug conjugate pf-06647263 | rel=r_associated | relid=0 | w=28
  5270. ipilimumab -- r_associated #0: 28 / 0.061 -> en:ar antagonist bms-641988
    n1=ipilimumab | n2=en:ar antagonist bms-641988 | rel=r_associated | relid=0 | w=28
  5271. ipilimumab -- r_associated #0: 28 / 0.061 -> en:as03-adjuvanted h1n1 pandemic influenza vaccine
    n1=ipilimumab | n2=en:as03-adjuvanted h1n1 pandemic influenza vaccine | rel=r_associated | relid=0 | w=28
  5272. ipilimumab -- r_associated #0: 28 / 0.061 -> en:autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytes
    n1=ipilimumab | n2=en:autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytes | rel=r_associated | relid=0 | w=28
  5273. ipilimumab -- r_associated #0: 28 / 0.061 -> en:bet bromodomains 2/3/4 inhibitor mk-8628
    n1=ipilimumab | n2=en:bet bromodomains 2/3/4 inhibitor mk-8628 | rel=r_associated | relid=0 | w=28
  5274. ipilimumab -- r_associated #0: 28 / 0.061 -> en:bet inhibitor
    n1=ipilimumab | n2=en:bet inhibitor | rel=r_associated | relid=0 | w=28
  5275. ipilimumab -- r_associated #0: 28 / 0.061 -> en:bh3 mimetic abt-737
    n1=ipilimumab | n2=en:bh3 mimetic abt-737 | rel=r_associated | relid=0 | w=28
  5276. ipilimumab -- r_associated #0: 28 / 0.061 -> en:broxuridine
    n1=ipilimumab | n2=en:broxuridine | rel=r_associated | relid=0 | w=28
  5277. ipilimumab -- r_associated #0: 28 / 0.061 -> en:cephalexin
    n1=ipilimumab | n2=en:cephalexin | rel=r_associated | relid=0 | w=28
  5278. ipilimumab -- r_associated #0: 28 / 0.061 -> en:cetuximab-irdye 800cw
    n1=ipilimumab | n2=en:cetuximab-irdye 800cw | rel=r_associated | relid=0 | w=28
  5279. ipilimumab -- r_associated #0: 28 / 0.061 -> en:chinese herbal formulation changtai keli
    n1=ipilimumab | n2=en:chinese herbal formulation changtai keli | rel=r_associated | relid=0 | w=28
  5280. ipilimumab -- r_associated #0: 28 / 0.061 -> en:citalopram hydrobromide
    n1=ipilimumab | n2=en:citalopram hydrobromide | rel=r_associated | relid=0 | w=28
  5281. ipilimumab -- r_associated #0: 28 / 0.061 -> en:curcumin/green tea extract/polygonum cuspidatum extract/soybean extract capsule
    n1=ipilimumab | n2=en:curcumin/green tea extract/polygonum cuspidatum extract/soybean extract capsule | rel=r_associated | relid=0 | w=28
  5282. ipilimumab -- r_associated #0: 28 / 0.061 -> en:darinaparsin
    n1=ipilimumab | n2=en:darinaparsin | rel=r_associated | relid=0 | w=28
  5283. ipilimumab -- r_associated #0: 28 / 0.061 -> en:dec-205/ny-eso-1 fusion protein cdx-1401
    n1=ipilimumab | n2=en:dec-205/ny-eso-1 fusion protein cdx-1401 | rel=r_associated | relid=0 | w=28
  5284. ipilimumab -- r_associated #0: 28 / 0.061 -> en:dextromethorphan hydrobromide
    n1=ipilimumab | n2=en:dextromethorphan hydrobromide | rel=r_associated | relid=0 | w=28
  5285. ipilimumab -- r_associated #0: 28 / 0.061 -> en:dolutegravir
    n1=ipilimumab | n2=en:dolutegravir | rel=r_associated | relid=0 | w=28
  5286. ipilimumab -- r_associated #0: 28 / 0.061 -> en:egb761
    n1=ipilimumab | n2=en:egb761 | rel=r_associated | relid=0 | w=28
  5287. ipilimumab -- r_associated #0: 28 / 0.061 -> en:elacytarabine
    n1=ipilimumab | n2=en:elacytarabine | rel=r_associated | relid=0 | w=28
  5288. ipilimumab -- r_associated #0: 28 / 0.061 -> en:ex vivo-activated autologous lymph node lymphocytes
    n1=ipilimumab | n2=en:ex vivo-activated autologous lymph node lymphocytes | rel=r_associated | relid=0 | w=28
  5289. ipilimumab -- r_associated #0: 28 / 0.061 -> en:fexofenadine hydrochloride
    n1=ipilimumab | n2=en:fexofenadine hydrochloride | rel=r_associated | relid=0 | w=28
  5290. ipilimumab -- r_associated #0: 28 / 0.061 -> en:fluorothymidine f-18
    n1=ipilimumab | n2=en:fluorothymidine f-18 | rel=r_associated | relid=0 | w=28
  5291. ipilimumab -- r_associated #0: 28 / 0.061 -> en:fowlpox-ny-eso-1 vaccine
    n1=ipilimumab | n2=en:fowlpox-ny-eso-1 vaccine | rel=r_associated | relid=0 | w=28
  5292. ipilimumab -- r_associated #0: 28 / 0.061 -> en:fumagillin-derived polymer conjugate xmt-1107
    n1=ipilimumab | n2=en:fumagillin-derived polymer conjugate xmt-1107 | rel=r_associated | relid=0 | w=28
  5293. ipilimumab -- r_associated #0: 28 / 0.061 -> en:gallium ga 68-labeled grpr antagonist bay86-7548
    n1=ipilimumab | n2=en:gallium ga 68-labeled grpr antagonist bay86-7548 | rel=r_associated | relid=0 | w=28
  5294. ipilimumab -- r_associated #0: 28 / 0.061 -> en:gm.cd40l cell vaccine
    n1=ipilimumab | n2=en:gm.cd40l cell vaccine | rel=r_associated | relid=0 | w=28
  5295. ipilimumab -- r_associated #0: 28 / 0.061 -> en:hdac inhibitor mpt0e028
    n1=ipilimumab | n2=en:hdac inhibitor mpt0e028 | rel=r_associated | relid=0 | w=28
  5296. ipilimumab -- r_associated #0: 28 / 0.061 -> en:hdm2 antagonist jnj-26854165
    n1=ipilimumab | n2=en:hdm2 antagonist jnj-26854165 | rel=r_associated | relid=0 | w=28
  5297. ipilimumab -- r_associated #0: 28 / 0.061 -> en:her2-pulsed autologous type-1 polarized dendritic cell vaccine
    n1=ipilimumab | n2=en:her2-pulsed autologous type-1 polarized dendritic cell vaccine | rel=r_associated | relid=0 | w=28
  5298. ipilimumab -- r_associated #0: 28 / 0.061 -> en:high-selenium brassica juncea
    n1=ipilimumab | n2=en:high-selenium brassica juncea | rel=r_associated | relid=0 | w=28
  5299. ipilimumab -- r_associated #0: 28 / 0.061 -> en:ho/02/02
    n1=ipilimumab | n2=en:ho/02/02 | rel=r_associated | relid=0 | w=28
  5300. ipilimumab -- r_associated #0: 28 / 0.061 -> en:human mhc non-restricted cytotoxic t-cell line tall-104
    n1=ipilimumab | n2=en:human mhc non-restricted cytotoxic t-cell line tall-104 | rel=r_associated | relid=0 | w=28
  5301. ipilimumab -- r_associated #0: 28 / 0.061 -> en:immunotherapeutic combination product cmb305
    n1=ipilimumab | n2=en:immunotherapeutic combination product cmb305 | rel=r_associated | relid=0 | w=28
  5302. ipilimumab -- r_associated #0: 28 / 0.061 -> en:indomethacin
    n1=ipilimumab | n2=en:indomethacin | rel=r_associated | relid=0 | w=28
  5303. ipilimumab -- r_associated #0: 28 / 0.061 -> en:infliximab
    n1=ipilimumab | n2=en:infliximab | rel=r_associated | relid=0 | w=28
  5304. ipilimumab -- r_associated #0: 28 / 0.061 -> en:isoflurophate
    n1=ipilimumab | n2=en:isoflurophate | rel=r_associated | relid=0 | w=28
  5305. ipilimumab -- r_associated #0: 28 / 0.061 -> en:isoxsuprine
    n1=ipilimumab | n2=en:isoxsuprine | rel=r_associated | relid=0 | w=28
  5306. ipilimumab -- r_associated #0: 28 / 0.061 -> en:klebsiella pneumoniae glycoprotein
    n1=ipilimumab | n2=en:klebsiella pneumoniae glycoprotein | rel=r_associated | relid=0 | w=28
  5307. ipilimumab -- r_associated #0: 28 / 0.061 -> en:lacosamide
    n1=ipilimumab | n2=en:lacosamide | rel=r_associated | relid=0 | w=28
  5308. ipilimumab -- r_associated #0: 28 / 0.061 -> en:leucine-enhanced essential amino acid dietary supplement
    n1=ipilimumab | n2=en:leucine-enhanced essential amino acid dietary supplement | rel=r_associated | relid=0 | w=28
  5309. ipilimumab -- r_associated #0: 28 / 0.061 -> en:linagliptin + metformin
    n1=ipilimumab | n2=en:linagliptin + metformin | rel=r_associated | relid=0 | w=28
  5310. ipilimumab -- r_associated #0: 28 / 0.061 -> en:litronesib
    n1=ipilimumab | n2=en:litronesib | rel=r_associated | relid=0 | w=28
  5311. ipilimumab -- r_associated #0: 28 / 0.061 -> en:marizomib
    n1=ipilimumab | n2=en:marizomib | rel=r_associated | relid=0 | w=28
  5312. ipilimumab -- r_associated #0: 28 / 0.061 -> en:meperidine hydrochloride
    n1=ipilimumab | n2=en:meperidine hydrochloride | rel=r_associated | relid=0 | w=28
  5313. ipilimumab -- r_associated #0: 28 / 0.061 -> en:milodistim
    n1=ipilimumab | n2=en:milodistim | rel=r_associated | relid=0 | w=28
  5314. ipilimumab -- r_associated #0: 28 / 0.061 -> en:mk-6592
    n1=ipilimumab | n2=en:mk-6592 | rel=r_associated | relid=0 | w=28
  5315. ipilimumab -- r_associated #0: 28 / 0.061 -> en:mnsod mimetic bmx-001
    n1=ipilimumab | n2=en:mnsod mimetic bmx-001 | rel=r_associated | relid=0 | w=28
  5316. ipilimumab -- r_associated #0: 28 / 0.061 -> en:modified vaccinia ankara (bavarian nordic)-her2 vaccine
    n1=ipilimumab | n2=en:modified vaccinia ankara (bavarian nordic)-her2 vaccine | rel=r_associated | relid=0 | w=28
  5317. ipilimumab -- r_associated #0: 28 / 0.061 -> en:monoclonal antibody cc49-streptavidin conjugate
    n1=ipilimumab | n2=en:monoclonal antibody cc49-streptavidin conjugate | rel=r_associated | relid=0 | w=28
  5318. ipilimumab -- r_associated #0: 28 / 0.061 -> en:monoclonal antibody idec-159
    n1=ipilimumab | n2=en:monoclonal antibody idec-159 | rel=r_associated | relid=0 | w=28
  5319. ipilimumab -- r_associated #0: 28 / 0.061 -> en:motexafin lutetium
    n1=ipilimumab | n2=en:motexafin lutetium | rel=r_associated | relid=0 | w=28
  5320. ipilimumab -- r_associated #0: 28 / 0.061 -> en:muc16-targeted antibody-drug conjugate dmuc5754a
    n1=ipilimumab | n2=en:muc16-targeted antibody-drug conjugate dmuc5754a | rel=r_associated | relid=0 | w=28
  5321. ipilimumab -- r_associated #0: 28 / 0.061 -> en:multicarotenoid supplement mcs-8
    n1=ipilimumab | n2=en:multicarotenoid supplement mcs-8 | rel=r_associated | relid=0 | w=28
  5322. ipilimumab -- r_associated #0: 28 / 0.061 -> en:na17.a2 peptide vaccine
    n1=ipilimumab | n2=en:na17.a2 peptide vaccine | rel=r_associated | relid=0 | w=28
  5323. ipilimumab -- r_associated #0: 28 / 0.061 -> en:nitric oxide-releasing acetylsalicylic acid derivative
    n1=ipilimumab | n2=en:nitric oxide-releasing acetylsalicylic acid derivative | rel=r_associated | relid=0 | w=28
  5324. ipilimumab -- r_associated #0: 28 / 0.061 -> en:nolatrexed dihydrochloride
    n1=ipilimumab | n2=en:nolatrexed dihydrochloride | rel=r_associated | relid=0 | w=28
  5325. ipilimumab -- r_associated #0: 28 / 0.061 -> en:norgestrel
    n1=ipilimumab | n2=en:norgestrel | rel=r_associated | relid=0 | w=28
  5326. ipilimumab -- r_associated #0: 28 / 0.061 -> en:oepa regimen
    n1=ipilimumab | n2=en:oepa regimen | rel=r_associated | relid=0 | w=28
  5327. ipilimumab -- r_associated #0: 28 / 0.061 -> en:olanzapine
    n1=ipilimumab | n2=en:olanzapine | rel=r_associated | relid=0 | w=28
  5328. ipilimumab -- r_associated #0: 28 / 0.061 -> en:opium tincture
    n1=ipilimumab | n2=en:opium tincture | rel=r_associated | relid=0 | w=28
  5329. ipilimumab -- r_associated #0: 28 / 0.061 -> en:oshadi r
    n1=ipilimumab | n2=en:oshadi r | rel=r_associated | relid=0 | w=28
  5330. ipilimumab -- r_associated #0: 28 / 0.061 -> en:oteracil potassium
    n1=ipilimumab | n2=en:oteracil potassium | rel=r_associated | relid=0 | w=28
  5331. ipilimumab -- r_associated #0: 28 / 0.061 -> en:p53 peptide vaccine
    n1=ipilimumab | n2=en:p53 peptide vaccine | rel=r_associated | relid=0 | w=28
  5332. ipilimumab -- r_associated #0: 28 / 0.061 -> en:paclitaxel poliglumex
    n1=ipilimumab | n2=en:paclitaxel poliglumex | rel=r_associated | relid=0 | w=28
  5333. ipilimumab -- r_associated #0: 28 / 0.061 -> en:ppi-2458
    n1=ipilimumab | n2=en:ppi-2458 | rel=r_associated | relid=0 | w=28
  5334. ipilimumab -- r_associated #0: 28 / 0.061 -> en:ramucirumab
    n1=ipilimumab | n2=en:ramucirumab | rel=r_associated | relid=0 | w=28
  5335. ipilimumab -- r_associated #0: 28 / 0.061 -> en:ranimustine
    n1=ipilimumab | n2=en:ranimustine | rel=r_associated | relid=0 | w=28
  5336. ipilimumab -- r_associated #0: 28 / 0.061 -> en:rebamipide
    n1=ipilimumab | n2=en:rebamipide | rel=r_associated | relid=0 | w=28
  5337. ipilimumab -- r_associated #0: 28 / 0.061 -> en:selatinib ditosilate
    n1=ipilimumab | n2=en:selatinib ditosilate | rel=r_associated | relid=0 | w=28
  5338. ipilimumab -- r_associated #0: 28 / 0.061 -> en:sevoflurane
    n1=ipilimumab | n2=en:sevoflurane | rel=r_associated | relid=0 | w=28
  5339. ipilimumab -- r_associated #0: 28 / 0.061 -> en:sns01-t nanoparticles
    n1=ipilimumab | n2=en:sns01-t nanoparticles | rel=r_associated | relid=0 | w=28
  5340. ipilimumab -- r_associated #0: 28 / 0.061 -> en:sodium iodide i-131
    n1=ipilimumab | n2=en:sodium iodide i-131 | rel=r_associated | relid=0 | w=28
  5341. ipilimumab -- r_associated #0: 28 / 0.061 -> en:spiromustine
    n1=ipilimumab | n2=en:spiromustine | rel=r_associated | relid=0 | w=28
  5342. ipilimumab -- r_associated #0: 28 / 0.061 -> en:tc 99m monoclonal antibody 170
    n1=ipilimumab | n2=en:tc 99m monoclonal antibody 170 | rel=r_associated | relid=0 | w=28
  5343. ipilimumab -- r_associated #0: 28 / 0.061 -> en:tetanus toxoid helper peptide
    n1=ipilimumab | n2=en:tetanus toxoid helper peptide | rel=r_associated | relid=0 | w=28
  5344. ipilimumab -- r_associated #0: 28 / 0.061 -> en:tf(c)-klh conjugate vaccine
    n1=ipilimumab | n2=en:tf(c)-klh conjugate vaccine | rel=r_associated | relid=0 | w=28
  5345. ipilimumab -- r_associated #0: 28 / 0.061 -> en:transdermal 17beta-estradiol gel bhr-200
    n1=ipilimumab | n2=en:transdermal 17beta-estradiol gel bhr-200 | rel=r_associated | relid=0 | w=28
  5346. ipilimumab -- r_associated #0: 28 / 0.061 -> en:tyloxapol
    n1=ipilimumab | n2=en:tyloxapol | rel=r_associated | relid=0 | w=28
  5347. ipilimumab -- r_associated #0: 27 / 0.059 -> en:18f-labeled mini-peg spacered rgd dimer
    n1=ipilimumab | n2=en:18f-labeled mini-peg spacered rgd dimer | rel=r_associated | relid=0 | w=27
  5348. ipilimumab -- r_associated #0: 27 / 0.059 -> en:2-deoxy-d-glucose
    n1=ipilimumab | n2=en:2-deoxy-d-glucose | rel=r_associated | relid=0 | w=27
  5349. ipilimumab -- r_associated #0: 27 / 0.059 -> en:adenosine a2 receptor agonists
    n1=ipilimumab | n2=en:adenosine a2 receptor agonists | rel=r_associated | relid=0 | w=27
  5350. ipilimumab -- r_associated #0: 27 / 0.059 -> en:adenovirus encoding tyrosinase/mart-1/magea6-transduced autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:adenovirus encoding tyrosinase/mart-1/magea6-transduced autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=27
  5351. ipilimumab -- r_associated #0: 27 / 0.059 -> en:alk inhibitor asp3026
    n1=ipilimumab | n2=en:alk inhibitor asp3026 | rel=r_associated | relid=0 | w=27
  5352. ipilimumab -- r_associated #0: 27 / 0.059 -> en:allogeneic cd4+ memory th1-like t cells/microparticle-bound anti-cd3/anti-cd28
    n1=ipilimumab | n2=en:allogeneic cd4+ memory th1-like t cells/microparticle-bound anti-cd3/anti-cd28 | rel=r_associated | relid=0 | w=27
  5353. ipilimumab -- r_associated #0: 27 / 0.059 -> en:amifampridine
    n1=ipilimumab | n2=en:amifampridine | rel=r_associated | relid=0 | w=27
  5354. ipilimumab -- r_associated #0: 27 / 0.059 -> en:annonaceous acetogenins
    n1=ipilimumab | n2=en:annonaceous acetogenins | rel=r_associated | relid=0 | w=27
  5355. ipilimumab -- r_associated #0: 27 / 0.059 -> en:anti-cd20-car-cd3zeta-4-1bb-expressing autologous t-lymphocyte cells
    n1=ipilimumab | n2=en:anti-cd20-car-cd3zeta-4-1bb-expressing autologous t-lymphocyte cells | rel=r_associated | relid=0 | w=27
  5356. ipilimumab -- r_associated #0: 27 / 0.059 -> en:anti-cd27l antibody-drug conjugate amg 172
    n1=ipilimumab | n2=en:anti-cd27l antibody-drug conjugate amg 172 | rel=r_associated | relid=0 | w=27
  5357. ipilimumab -- r_associated #0: 27 / 0.059 -> en:anti-cd33 monoclonal antibody bi 836858
    n1=ipilimumab | n2=en:anti-cd33 monoclonal antibody bi 836858 | rel=r_associated | relid=0 | w=27
  5358. ipilimumab -- r_associated #0: 27 / 0.059 -> en:anti-neuropilin-1 monoclonal antibody mnrp1685a
    n1=ipilimumab | n2=en:anti-neuropilin-1 monoclonal antibody mnrp1685a | rel=r_associated | relid=0 | w=27
  5359. ipilimumab -- r_associated #0: 27 / 0.059 -> en:antibody-drug conjugate abbv-085
    n1=ipilimumab | n2=en:antibody-drug conjugate abbv-085 | rel=r_associated | relid=0 | w=27
  5360. ipilimumab -- r_associated #0: 27 / 0.059 -> en:apixaban
    n1=ipilimumab | n2=en:apixaban | rel=r_associated | relid=0 | w=27
  5361. ipilimumab -- r_associated #0: 27 / 0.059 -> en:argipressin
    n1=ipilimumab | n2=en:argipressin | rel=r_associated | relid=0 | w=27
  5362. ipilimumab -- r_associated #0: 27 / 0.059 -> en:armodafinil
    n1=ipilimumab | n2=en:armodafinil | rel=r_associated | relid=0 | w=27
  5363. ipilimumab -- r_associated #0: 27 / 0.059 -> en:aurora a kinase inhibitor mk5108
    n1=ipilimumab | n2=en:aurora a kinase inhibitor mk5108 | rel=r_associated | relid=0 | w=27
  5364. ipilimumab -- r_associated #0: 27 / 0.059 -> en:autologous cd34-positive hematopoietic progenitor cells
    n1=ipilimumab | n2=en:autologous cd34-positive hematopoietic progenitor cells | rel=r_associated | relid=0 | w=27
  5365. ipilimumab -- r_associated #0: 27 / 0.059 -> en:autologous interferon-producing killer dendritic cells
    n1=ipilimumab | n2=en:autologous interferon-producing killer dendritic cells | rel=r_associated | relid=0 | w=27
  5366. ipilimumab -- r_associated #0: 27 / 0.059 -> en:autologous neuroblastoma lysate/klh-pulsed dendritic cell vaccine
    n1=ipilimumab | n2=en:autologous neuroblastoma lysate/klh-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=27
  5367. ipilimumab -- r_associated #0: 27 / 0.059 -> en:autologous ovarian tumor cell lysate-pulsed dendritic cell vaccine
    n1=ipilimumab | n2=en:autologous ovarian tumor cell lysate-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=27
  5368. ipilimumab -- r_associated #0: 27 / 0.059 -> en:autologous renal cell carcinoma tumor lysate-pulsed dendritic cell vaccine
    n1=ipilimumab | n2=en:autologous renal cell carcinoma tumor lysate-pulsed dendritic cell vaccine | rel=r_associated | relid=0 | w=27
  5369. ipilimumab -- r_associated #0: 27 / 0.059 -> en:bispecific antibody mdx-h210
    n1=ipilimumab | n2=en:bispecific antibody mdx-h210 | rel=r_associated | relid=0 | w=27
  5370. ipilimumab -- r_associated #0: 27 / 0.059 -> en:blinatumomab
    n1=ipilimumab | n2=en:blinatumomab | rel=r_associated | relid=0 | w=27
  5371. ipilimumab -- r_associated #0: 27 / 0.059 -> en:blueberry powder supplement
    n1=ipilimumab | n2=en:blueberry powder supplement | rel=r_associated | relid=0 | w=27
  5372. ipilimumab -- r_associated #0: 27 / 0.059 -> en:boanmycin hydrochloride
    n1=ipilimumab | n2=en:boanmycin hydrochloride | rel=r_associated | relid=0 | w=27
  5373. ipilimumab -- r_associated #0: 27 / 0.059 -> en:brachyury-expressing modified vaccinia ankara-tricom vaccine
    n1=ipilimumab | n2=en:brachyury-expressing modified vaccinia ankara-tricom vaccine | rel=r_associated | relid=0 | w=27
  5374. ipilimumab -- r_associated #0: 27 / 0.059 -> en:cannabis extract oil sr capsule
    n1=ipilimumab | n2=en:cannabis extract oil sr capsule | rel=r_associated | relid=0 | w=27
  5375. ipilimumab -- r_associated #0: 27 / 0.059 -> en:capecitabine
    n1=ipilimumab | n2=en:capecitabine | rel=r_associated | relid=0 | w=27
  5376. ipilimumab -- r_associated #0: 27 / 0.059 -> en:carbon c 13 lycopene
    n1=ipilimumab | n2=en:carbon c 13 lycopene | rel=r_associated | relid=0 | w=27
  5377. ipilimumab -- r_associated #0: 27 / 0.059 -> en:carbon c 13 octanoate
    n1=ipilimumab | n2=en:carbon c 13 octanoate | rel=r_associated | relid=0 | w=27
  5378. ipilimumab -- r_associated #0: 27 / 0.059 -> en:certolizumab pegol
    n1=ipilimumab | n2=en:certolizumab pegol | rel=r_associated | relid=0 | w=27
  5379. ipilimumab -- r_associated #0: 27 / 0.059 -> en:cp 461
    n1=ipilimumab | n2=en:cp 461 | rel=r_associated | relid=0 | w=27
  5380. ipilimumab -- r_associated #0: 27 / 0.059 -> en:cytostatic agents
    n1=ipilimumab | n2=en:cytostatic agents | rel=r_associated | relid=0 | w=27
  5381. ipilimumab -- r_associated #0: 27 / 0.059 -> en:defibrotide sodium
    n1=ipilimumab | n2=en:defibrotide sodium | rel=r_associated | relid=0 | w=27
  5382. ipilimumab -- r_associated #0: 27 / 0.059 -> en:dinitrophenyl-modified autologous renal cell carcinoma tumor cell vaccine
    n1=ipilimumab | n2=en:dinitrophenyl-modified autologous renal cell carcinoma tumor cell vaccine | rel=r_associated | relid=0 | w=27
  5383. ipilimumab -- r_associated #0: 27 / 0.059 -> en:diphenhydramine/lidocaine/antacid mouthwash
    n1=ipilimumab | n2=en:diphenhydramine/lidocaine/antacid mouthwash | rel=r_associated | relid=0 | w=27
  5384. ipilimumab -- r_associated #0: 27 / 0.059 -> en:diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis-haemophilus influenzae type b vaccine
    n1=ipilimumab | n2=en:diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis-haemophilus influenzae type b vaccine | rel=r_associated | relid=0 | w=27
  5385. ipilimumab -- r_associated #0: 27 / 0.059 -> en:dna plasmid encoding interleukin-12 ino-9012
    n1=ipilimumab | n2=en:dna plasmid encoding interleukin-12 ino-9012 | rel=r_associated | relid=0 | w=27
  5386. ipilimumab -- r_associated #0: 27 / 0.059 -> en:dna plasmid-encoding interleukin-12/hpv dna plasmids therapeutic vaccine ino-3112
    n1=ipilimumab | n2=en:dna plasmid-encoding interleukin-12/hpv dna plasmids therapeutic vaccine ino-3112 | rel=r_associated | relid=0 | w=27
  5387. ipilimumab -- r_associated #0: 27 / 0.059 -> en:dna-dependent protein kinase-targeting sidna dt01
    n1=ipilimumab | n2=en:dna-dependent protein kinase-targeting sidna dt01 | rel=r_associated | relid=0 | w=27
  5388. ipilimumab -- r_associated #0: 27 / 0.059 -> en:doxycycline hyclate injection
    n1=ipilimumab | n2=en:doxycycline hyclate injection | rel=r_associated | relid=0 | w=27
  5389. ipilimumab -- r_associated #0: 27 / 0.059 -> en:epidermal growth factor ointment
    n1=ipilimumab | n2=en:epidermal growth factor ointment | rel=r_associated | relid=0 | w=27
  5390. ipilimumab -- r_associated #0: 27 / 0.059 -> en:eprodisate disodium
    n1=ipilimumab | n2=en:eprodisate disodium | rel=r_associated | relid=0 | w=27
  5391. ipilimumab -- r_associated #0: 27 / 0.059 -> en:ergoline
    n1=ipilimumab | n2=en:ergoline | rel=r_associated | relid=0 | w=27
  5392. ipilimumab -- r_associated #0: 27 / 0.059 -> en:finasteride
    n1=ipilimumab | n2=en:finasteride | rel=r_associated | relid=0 | w=27
  5393. ipilimumab -- r_associated #0: 27 / 0.059 -> en:fluorine f 18 cp18 peptide
    n1=ipilimumab | n2=en:fluorine f 18 cp18 peptide | rel=r_associated | relid=0 | w=27
  5394. ipilimumab -- r_associated #0: 27 / 0.059 -> en:fluvastatin sodium
    n1=ipilimumab | n2=en:fluvastatin sodium | rel=r_associated | relid=0 | w=27
  5395. ipilimumab -- r_associated #0: 27 / 0.059 -> en:fursultiamine
    n1=ipilimumab | n2=en:fursultiamine | rel=r_associated | relid=0 | w=27
  5396. ipilimumab -- r_associated #0: 27 / 0.059 -> en:gallium ga 68-labeled affibody aby-025
    n1=ipilimumab | n2=en:gallium ga 68-labeled affibody aby-025 | rel=r_associated | relid=0 | w=27
  5397. ipilimumab -- r_associated #0: 27 / 0.059 -> en:gemcitabine-erlotinib regimen
    n1=ipilimumab | n2=en:gemcitabine-erlotinib regimen | rel=r_associated | relid=0 | w=27
  5398. ipilimumab -- r_associated #0: 27 / 0.059 -> en:gsk-3 inhibitor ly2090314
    n1=ipilimumab | n2=en:gsk-3 inhibitor ly2090314 | rel=r_associated | relid=0 | w=27
  5399. ipilimumab -- r_associated #0: 27 / 0.059 -> en:herpes zoster vaccine gsk1437173a
    n1=ipilimumab | n2=en:herpes zoster vaccine gsk1437173a | rel=r_associated | relid=0 | w=27
  5400. ipilimumab -- r_associated #0: 27 / 0.059 -> en:hsp90 inhibitor xl888
    n1=ipilimumab | n2=en:hsp90 inhibitor xl888 | rel=r_associated | relid=0 | w=27
  5401. ipilimumab -- r_associated #0: 27 / 0.059 -> en:huaier extract granule
    n1=ipilimumab | n2=en:huaier extract granule | rel=r_associated | relid=0 | w=27
  5402. ipilimumab -- r_associated #0: 27 / 0.059 -> en:hvegf26-104/rfase peptide vaccine
    n1=ipilimumab | n2=en:hvegf26-104/rfase peptide vaccine | rel=r_associated | relid=0 | w=27
  5403. ipilimumab -- r_associated #0: 27 / 0.059 -> en:ibuprofen + pseudoephedrine
    n1=ipilimumab | n2=en:ibuprofen + pseudoephedrine | rel=r_associated | relid=0 | w=27
  5404. ipilimumab -- r_associated #0: 27 / 0.059 -> en:igf ligand neutralizing antibody bi 836845
    n1=ipilimumab | n2=en:igf ligand neutralizing antibody bi 836845 | rel=r_associated | relid=0 | w=27
  5405. ipilimumab -- r_associated #0: 27 / 0.059 -> en:immediate-release oral liquid formulation oxymorphone hydrochloride
    n1=ipilimumab | n2=en:immediate-release oral liquid formulation oxymorphone hydrochloride | rel=r_associated | relid=0 | w=27
  5406. ipilimumab -- r_associated #0: 27 / 0.059 -> en:indium in 111 anti-cd45 monoclonal antibody bc8
    n1=ipilimumab | n2=en:indium in 111 anti-cd45 monoclonal antibody bc8 | rel=r_associated | relid=0 | w=27
  5407. ipilimumab -- r_associated #0: 27 / 0.059 -> en:indium in 111 pertuzumab
    n1=ipilimumab | n2=en:indium in 111 pertuzumab | rel=r_associated | relid=0 | w=27
  5408. ipilimumab -- r_associated #0: 27 / 0.059 -> en:indium in 111-dota-exendin-4
    n1=ipilimumab | n2=en:indium in 111-dota-exendin-4 | rel=r_associated | relid=0 | w=27
  5409. ipilimumab -- r_associated #0: 27 / 0.059 -> en:interferon alfa-n3
    n1=ipilimumab | n2=en:interferon alfa-n3 | rel=r_associated | relid=0 | w=27
  5410. ipilimumab -- r_associated #0: 27 / 0.059 -> en:interferon-gamma-expressing adenovirus vaccine asn-002
    n1=ipilimumab | n2=en:interferon-gamma-expressing adenovirus vaccine asn-002 | rel=r_associated | relid=0 | w=27
  5411. ipilimumab -- r_associated #0: 27 / 0.059 -> en:iobenguane sulfate i-123
    n1=ipilimumab | n2=en:iobenguane sulfate i-123 | rel=r_associated | relid=0 | w=27
  5412. ipilimumab -- r_associated #0: 27 / 0.059 -> en:iodine i 131 tositumomab
    n1=ipilimumab | n2=en:iodine i 131 tositumomab | rel=r_associated | relid=0 | w=27
  5413. ipilimumab -- r_associated #0: 27 / 0.059 -> en:iodocholesterol i^131^
    n1=ipilimumab | n2=en:iodocholesterol i^131^ | rel=r_associated | relid=0 | w=27
  5414. ipilimumab -- r_associated #0: 27 / 0.059 -> en:isocal
    n1=ipilimumab | n2=en:isocal | rel=r_associated | relid=0 | w=27
  5415. ipilimumab -- r_associated #0: 27 / 0.059 -> en:ivabradine
    n1=ipilimumab | n2=en:ivabradine | rel=r_associated | relid=0 | w=27
  5416. ipilimumab -- r_associated #0: 27 / 0.059 -> en:liposomal amphotericin b
    n1=ipilimumab | n2=en:liposomal amphotericin b | rel=r_associated | relid=0 | w=27
  5417. ipilimumab -- r_associated #0: 27 / 0.059 -> en:long-acting granulocyte colony-stimulating factor analog spi-2012
    n1=ipilimumab | n2=en:long-acting granulocyte colony-stimulating factor analog spi-2012 | rel=r_associated | relid=0 | w=27
  5418. ipilimumab -- r_associated #0: 27 / 0.059 -> en:megestrol acetate
    n1=ipilimumab | n2=en:megestrol acetate | rel=r_associated | relid=0 | w=27
  5419. ipilimumab -- r_associated #0: 27 / 0.059 -> en:mek inhibitor azd8330
    n1=ipilimumab | n2=en:mek inhibitor azd8330 | rel=r_associated | relid=0 | w=27
  5420. ipilimumab -- r_associated #0: 27 / 0.059 -> en:mek inhibitor tak-733
    n1=ipilimumab | n2=en:mek inhibitor tak-733 | rel=r_associated | relid=0 | w=27
  5421. ipilimumab -- r_associated #0: 27 / 0.059 -> en:mesothelin-specific chimeric antigen receptor-engineered peripheral blood lymphocytes
    n1=ipilimumab | n2=en:mesothelin-specific chimeric antigen receptor-engineered peripheral blood lymphocytes | rel=r_associated | relid=0 | w=27
  5422. ipilimumab -- r_associated #0: 27 / 0.059 -> en:met tyrosine kinase inhibitor emd 1204831
    n1=ipilimumab | n2=en:met tyrosine kinase inhibitor emd 1204831 | rel=r_associated | relid=0 | w=27
  5423. ipilimumab -- r_associated #0: 27 / 0.059 -> en:micronutrient-fortified probiotic yogurt
    n1=ipilimumab | n2=en:micronutrient-fortified probiotic yogurt | rel=r_associated | relid=0 | w=27
  5424. ipilimumab -- r_associated #0: 27 / 0.059 -> en:na-17/mage-3.a2/ny-eso-1 peptide vaccine
    n1=ipilimumab | n2=en:na-17/mage-3.a2/ny-eso-1 peptide vaccine | rel=r_associated | relid=0 | w=27
  5425. ipilimumab -- r_associated #0: 27 / 0.059 -> en:nucleolin antagonist ipp-204106n
    n1=ipilimumab | n2=en:nucleolin antagonist ipp-204106n | rel=r_associated | relid=0 | w=27
  5426. ipilimumab -- r_associated #0: 27 / 0.059 -> en:opioid agonist gic-1001
    n1=ipilimumab | n2=en:opioid agonist gic-1001 | rel=r_associated | relid=0 | w=27
  5427. ipilimumab -- r_associated #0: 27 / 0.059 -> en:oral medication
    n1=ipilimumab | n2=en:oral medication | rel=r_associated | relid=0 | w=27
  5428. ipilimumab -- r_associated #0: 27 / 0.059 -> en:oxphos inhibitor vlx600
    n1=ipilimumab | n2=en:oxphos inhibitor vlx600 | rel=r_associated | relid=0 | w=27
  5429. ipilimumab -- r_associated #0: 27 / 0.059 -> en:pan-pi3k/mtor inhibitor sf1126
    n1=ipilimumab | n2=en:pan-pi3k/mtor inhibitor sf1126 | rel=r_associated | relid=0 | w=27
  5430. ipilimumab -- r_associated #0: 27 / 0.059 -> en:pharmaceutic aids
    n1=ipilimumab | n2=en:pharmaceutic aids | rel=r_associated | relid=0 | w=27
  5431. ipilimumab -- r_associated #0: 27 / 0.059 -> en:photosensitizing agent
    n1=ipilimumab | n2=en:photosensitizing agent | rel=r_associated | relid=0 | w=27
  5432. ipilimumab -- r_associated #0: 27 / 0.059 -> en:phytochlorin sodium-polyvinylpyrrolidone complex
    n1=ipilimumab | n2=en:phytochlorin sodium-polyvinylpyrrolidone complex | rel=r_associated | relid=0 | w=27
  5433. ipilimumab -- r_associated #0: 27 / 0.059 -> en:pr-104
    n1=ipilimumab | n2=en:pr-104 | rel=r_associated | relid=0 | w=27
  5434. ipilimumab -- r_associated #0: 27 / 0.059 -> en:procarbazine hydrochloride
    n1=ipilimumab | n2=en:procarbazine hydrochloride | rel=r_associated | relid=0 | w=27
  5435. ipilimumab -- r_associated #0: 27 / 0.059 -> en:pyridoxine hydrochloride
    n1=ipilimumab | n2=en:pyridoxine hydrochloride | rel=r_associated | relid=0 | w=27
  5436. ipilimumab -- r_associated #0: 27 / 0.059 -> en:recombinant human hsp110-gp100 chaperone complex vaccine
    n1=ipilimumab | n2=en:recombinant human hsp110-gp100 chaperone complex vaccine | rel=r_associated | relid=0 | w=27
  5437. ipilimumab -- r_associated #0: 27 / 0.059 -> en:recombinant human serum amyloid p/pentraxin 2
    n1=ipilimumab | n2=en:recombinant human serum amyloid p/pentraxin 2 | rel=r_associated | relid=0 | w=27
  5438. ipilimumab -- r_associated #0: 27 / 0.059 -> en:remestemcel-l
    n1=ipilimumab | n2=en:remestemcel-l | rel=r_associated | relid=0 | w=27
  5439. ipilimumab -- r_associated #0: 27 / 0.059 -> en:retinoid 9cuab30
    n1=ipilimumab | n2=en:retinoid 9cuab30 | rel=r_associated | relid=0 | w=27
  5440. ipilimumab -- r_associated #0: 27 / 0.059 -> en:rintatolimod
    n1=ipilimumab | n2=en:rintatolimod | rel=r_associated | relid=0 | w=27
  5441. ipilimumab -- r_associated #0: 27 / 0.059 -> en:romidepsin
    n1=ipilimumab | n2=en:romidepsin | rel=r_associated | relid=0 | w=27
  5442. ipilimumab -- r_associated #0: 27 / 0.059 -> en:secukinumab
    n1=ipilimumab | n2=en:secukinumab | rel=r_associated | relid=0 | w=27
  5443. ipilimumab -- r_associated #0: 27 / 0.059 -> en:silymarin
    n1=ipilimumab | n2=en:silymarin | rel=r_associated | relid=0 | w=27
  5444. ipilimumab -- r_associated #0: 27 / 0.059 -> en:smac mimetic lcl161
    n1=ipilimumab | n2=en:smac mimetic lcl161 | rel=r_associated | relid=0 | w=27
  5445. ipilimumab -- r_associated #0: 27 / 0.059 -> en:sodium carboxymethylcellulose dressing
    n1=ipilimumab | n2=en:sodium carboxymethylcellulose dressing | rel=r_associated | relid=0 | w=27
  5446. ipilimumab -- r_associated #0: 27 / 0.059 -> en:sodium salicylate
    n1=ipilimumab | n2=en:sodium salicylate | rel=r_associated | relid=0 | w=27
  5447. ipilimumab -- r_associated #0: 27 / 0.059 -> en:sotatercept
    n1=ipilimumab | n2=en:sotatercept | rel=r_associated | relid=0 | w=27
  5448. ipilimumab -- r_associated #0: 27 / 0.059 -> en:staphylococcus aureus protein a
    n1=ipilimumab | n2=en:staphylococcus aureus protein a | rel=r_associated | relid=0 | w=27
  5449. ipilimumab -- r_associated #0: 27 / 0.059 -> en:svn53-67/m57-klh peptide vaccine
    n1=ipilimumab | n2=en:svn53-67/m57-klh peptide vaccine | rel=r_associated | relid=0 | w=27
  5450. ipilimumab -- r_associated #0: 27 / 0.059 -> en:syk-jak inhibitor prt062070
    n1=ipilimumab | n2=en:syk-jak inhibitor prt062070 | rel=r_associated | relid=0 | w=27
  5451. ipilimumab -- r_associated #0: 27 / 0.059 -> en:t1e28z car-expressing autologous cd4-positive t lymphocytes
    n1=ipilimumab | n2=en:t1e28z car-expressing autologous cd4-positive t lymphocytes | rel=r_associated | relid=0 | w=27
  5452. ipilimumab -- r_associated #0: 27 / 0.059 -> en:talotrexin ammonium
    n1=ipilimumab | n2=en:talotrexin ammonium | rel=r_associated | relid=0 | w=27
  5453. ipilimumab -- r_associated #0: 27 / 0.059 -> en:tariquidar
    n1=ipilimumab | n2=en:tariquidar | rel=r_associated | relid=0 | w=27
  5454. ipilimumab -- r_associated #0: 27 / 0.059 -> en:teglarinad
    n1=ipilimumab | n2=en:teglarinad | rel=r_associated | relid=0 | w=27
  5455. ipilimumab -- r_associated #0: 27 / 0.059 -> en:terameprocol
    n1=ipilimumab | n2=en:terameprocol | rel=r_associated | relid=0 | w=27
  5456. ipilimumab -- r_associated #0: 27 / 0.059 -> en:testosterone undecanoate
    n1=ipilimumab | n2=en:testosterone undecanoate | rel=r_associated | relid=0 | w=27
  5457. ipilimumab -- r_associated #0: 27 / 0.059 -> en:therapeutic estradiol
    n1=ipilimumab | n2=en:therapeutic estradiol | rel=r_associated | relid=0 | w=27
  5458. ipilimumab -- r_associated #0: 27 / 0.059 -> en:therapeutic estrone
    n1=ipilimumab | n2=en:therapeutic estrone | rel=r_associated | relid=0 | w=27
  5459. ipilimumab -- r_associated #0: 27 / 0.059 -> en:tp40 immunotoxin
    n1=ipilimumab | n2=en:tp40 immunotoxin | rel=r_associated | relid=0 | w=27
  5460. ipilimumab -- r_associated #0: 27 / 0.059 -> en:trastuzumab vc-seco-duba
    n1=ipilimumab | n2=en:trastuzumab vc-seco-duba | rel=r_associated | relid=0 | w=27
  5461. ipilimumab -- r_associated #0: 27 / 0.059 -> en:trimetrexate glucuronate
    n1=ipilimumab | n2=en:trimetrexate glucuronate | rel=r_associated | relid=0 | w=27
  5462. ipilimumab -- r_associated #0: 27 / 0.059 -> en:troglitazone
    n1=ipilimumab | n2=en:troglitazone | rel=r_associated | relid=0 | w=27
  5463. ipilimumab -- r_associated #0: 27 / 0.059 -> en:tyrosine kinase inhibitor
    n1=ipilimumab | n2=en:tyrosine kinase inhibitor | rel=r_associated | relid=0 | w=27
  5464. ipilimumab -- r_associated #0: 27 / 0.059 -> en:usp14/uchl5 inhibitor vlx1570
    n1=ipilimumab | n2=en:usp14/uchl5 inhibitor vlx1570 | rel=r_associated | relid=0 | w=27
  5465. ipilimumab -- r_associated #0: 27 / 0.059 -> en:ustekinumab
    n1=ipilimumab | n2=en:ustekinumab | rel=r_associated | relid=0 | w=27
  5466. ipilimumab -- r_associated #0: 27 / 0.059 -> en:valsartan
    n1=ipilimumab | n2=en:valsartan | rel=r_associated | relid=0 | w=27
  5467. ipilimumab -- r_associated #0: 27 / 0.059 -> en:vascular endothelial growth factor antisense oligonucleotide
    n1=ipilimumab | n2=en:vascular endothelial growth factor antisense oligonucleotide | rel=r_associated | relid=0 | w=27
  5468. ipilimumab -- r_associated #0: 27 / 0.059 -> en:xeliri regimen
    n1=ipilimumab | n2=en:xeliri regimen | rel=r_associated | relid=0 | w=27
  5469. ipilimumab -- r_associated #0: 27 / 0.059 -> en:yttrium y 90-labeled anti-fzd10 monoclonal antibody otsa101
    n1=ipilimumab | n2=en:yttrium y 90-labeled anti-fzd10 monoclonal antibody otsa101 | rel=r_associated | relid=0 | w=27
  5470. ipilimumab -- r_associated #0: 26 / 0.057 -> en:3,4-methylenedioxymethamphetamine
    n1=ipilimumab | n2=en:3,4-methylenedioxymethamphetamine | rel=r_associated | relid=0 | w=26
  5471. ipilimumab -- r_associated #0: 26 / 0.057 -> en:abacavir sulfate
    n1=ipilimumab | n2=en:abacavir sulfate | rel=r_associated | relid=0 | w=26
  5472. ipilimumab -- r_associated #0: 26 / 0.057 -> en:abortifacient agents
    n1=ipilimumab | n2=en:abortifacient agents | rel=r_associated | relid=0 | w=26
  5473. ipilimumab -- r_associated #0: 26 / 0.057 -> en:adenoviral vector ad5-cea(6d) vaccine
    n1=ipilimumab | n2=en:adenoviral vector ad5-cea(6d) vaccine | rel=r_associated | relid=0 | w=26
  5474. ipilimumab -- r_associated #0: 26 / 0.057 -> en:adgmcaix-transduced autologous dendritic cells
    n1=ipilimumab | n2=en:adgmcaix-transduced autologous dendritic cells | rel=r_associated | relid=0 | w=26
  5475. ipilimumab -- r_associated #0: 26 / 0.057 -> en:alanosine
    n1=ipilimumab | n2=en:alanosine | rel=r_associated | relid=0 | w=26
  5476. ipilimumab -- r_associated #0: 26 / 0.057 -> en:alcohol deterrents
    n1=ipilimumab | n2=en:alcohol deterrents | rel=r_associated | relid=0 | w=26
  5477. ipilimumab -- r_associated #0: 26 / 0.057 -> en:alfentanil hydrochloride
    n1=ipilimumab | n2=en:alfentanil hydrochloride | rel=r_associated | relid=0 | w=26
  5478. ipilimumab -- r_associated #0: 26 / 0.057 -> en:alfuzosin hydrochloride
    n1=ipilimumab | n2=en:alfuzosin hydrochloride | rel=r_associated | relid=0 | w=26
  5479. ipilimumab -- r_associated #0: 26 / 0.057 -> en:anti-cd40 monoclonal antibody chi lob 7/4
    n1=ipilimumab | n2=en:anti-cd40 monoclonal antibody chi lob 7/4 | rel=r_associated | relid=0 | w=26
  5480. ipilimumab -- r_associated #0: 26 / 0.057 -> en:anti-nectin 4 antibody-drug conjugate asg-22ce
    n1=ipilimumab | n2=en:anti-nectin 4 antibody-drug conjugate asg-22ce | rel=r_associated | relid=0 | w=26
  5481. ipilimumab -- r_associated #0: 26 / 0.057 -> en:anti-ox40 antibody pf-04518600
    n1=ipilimumab | n2=en:anti-ox40 antibody pf-04518600 | rel=r_associated | relid=0 | w=26
  5482. ipilimumab -- r_associated #0: 26 / 0.057 -> en:antidote
    n1=ipilimumab | n2=en:antidote | rel=r_associated | relid=0 | w=26
  5483. ipilimumab -- r_associated #0: 26 / 0.057 -> en:ask1 inhibitor gs-4997
    n1=ipilimumab | n2=en:ask1 inhibitor gs-4997 | rel=r_associated | relid=0 | w=26
  5484. ipilimumab -- r_associated #0: 26 / 0.057 -> en:astuprotimut-r
    n1=ipilimumab | n2=en:astuprotimut-r | rel=r_associated | relid=0 | w=26
  5485. ipilimumab -- r_associated #0: 26 / 0.057 -> en:asunaprevir
    n1=ipilimumab | n2=en:asunaprevir | rel=r_associated | relid=0 | w=26
  5486. ipilimumab -- r_associated #0: 26 / 0.057 -> en:autologous melanoma lysate-pulsed autologous dendritic cell vaccine
    n1=ipilimumab | n2=en:autologous melanoma lysate-pulsed autologous dendritic cell vaccine | rel=r_associated | relid=0 | w=26
  5487. ipilimumab -- r_associated #0: 26 / 0.057 -> en:azd5438
    n1=ipilimumab | n2=en:azd5438 | rel=r_associated | relid=0 | w=26
  5488. ipilimumab -- r_associated #0: 26 / 0.057 -> en:benzydamine hydrochloride
    n1=ipilimumab | n2=en:benzydamine hydrochloride | rel=r_associated | relid=0 | w=26
  5489. ipilimumab -- r_associated #0: 26 / 0.057 -> en:brachyury-expressing yeast vaccine gi-6301
    n1=ipilimumab | n2=en:brachyury-expressing yeast vaccine gi-6301 | rel=r_associated | relid=0 | w=26
  5490. ipilimumab -- r_associated #0: 26 / 0.057 -> en:carbon c 11 alpha-methyltryptophan
    n1=ipilimumab | n2=en:carbon c 11 alpha-methyltryptophan | rel=r_associated | relid=0 | w=26
  5491. ipilimumab -- r_associated #0: 26 / 0.057 -> en:cetirizine
    n1=ipilimumab | n2=en:cetirizine | rel=r_associated | relid=0 | w=26
  5492. ipilimumab -- r_associated #0: 26 / 0.057 -> en:chemotherapeutic topical agent
    n1=ipilimumab | n2=en:chemotherapeutic topical agent | rel=r_associated | relid=0 | w=26
  5493. ipilimumab -- r_associated #0: 26 / 0.057 -> en:cimetidine
    n1=ipilimumab | n2=en:cimetidine | rel=r_associated | relid=0 | w=26
  5494. ipilimumab -- r_associated #0: 26 / 0.057 -> en:cmv n495 peptide
    n1=ipilimumab | n2=en:cmv n495 peptide | rel=r_associated | relid=0 | w=26
  5495. ipilimumab -- r_associated #0: 26 / 0.057 -> en:collagen
    n1=ipilimumab | n2=en:collagen | rel=r_associated | relid=0 | w=26
  5496. ipilimumab -- r_associated #0: 26 / 0.057 -> en:copper supplement
    n1=ipilimumab | n2=en:copper supplement | rel=r_associated | relid=0 | w=26
  5497. ipilimumab -- r_associated #0: 26 / 0.057 -> en:crenolanib
    n1=ipilimumab | n2=en:crenolanib | rel=r_associated | relid=0 | w=26
  5498. ipilimumab -- r_associated #0: 26 / 0.057 -> en:cyclopentenyl cytosine
    n1=ipilimumab | n2=en:cyclopentenyl cytosine | rel=r_associated | relid=0 | w=26
  5499. ipilimumab -- r_associated #0: 26 / 0.057 -> en:cyp17/androgen receptor inhibitor odm 204
    n1=ipilimumab | n2=en:cyp17/androgen receptor inhibitor odm 204 | rel=r_associated | relid=0 | w=26
  5500. ipilimumab -- r_associated #0: 26 / 0.057 -> en:cytotoxic t-lymphocyte
    n1=ipilimumab | n2=en:cytotoxic t-lymphocyte | rel=r_associated | relid=0 | w=26
  5501. ipilimumab -- r_associated #0: 26 / 0.057 -> en:dacetuzumab
    n1=ipilimumab | n2=en:dacetuzumab | rel=r_associated | relid=0 | w=26
  5502. ipilimumab -- r_associated #0: 26 / 0.057 -> en:desmethylmisonidazole
    n1=ipilimumab | n2=en:desmethylmisonidazole | rel=r_associated | relid=0 | w=26
  5503. ipilimumab -- r_associated #0: 26 / 0.057 -> en:diazepinomicin
    n1=ipilimumab | n2=en:diazepinomicin | rel=r_associated | relid=0 | w=26
  5504. ipilimumab -- r_associated #0: 26 / 0.057 -> en:dimethylmyleran
    n1=ipilimumab | n2=en:dimethylmyleran | rel=r_associated | relid=0 | w=26
  5505. ipilimumab -- r_associated #0: 26 / 0.057 -> en:diuretic
    n1=ipilimumab | n2=en:diuretic | rel=r_associated | relid=0 | w=26
  5506. ipilimumab -- r_associated #0: 26 / 0.057 -> en:ebselen-containing oral capsule spi-1005
    n1=ipilimumab | n2=en:ebselen-containing oral capsule spi-1005 | rel=r_associated | relid=0 | w=26
  5507. ipilimumab -- r_associated #0: 26 / 0.057 -> en:edelfosine
    n1=ipilimumab | n2=en:edelfosine | rel=r_associated | relid=0 | w=26
  5508. ipilimumab -- r_associated #0: 26 / 0.057 -> en:fenretinide
    n1=ipilimumab | n2=en:fenretinide | rel=r_associated | relid=0 | w=26
  5509. ipilimumab -- r_associated #0: 26 / 0.057 -> en:flumatinib mesylate
    n1=ipilimumab | n2=en:flumatinib mesylate | rel=r_associated | relid=0 | w=26
  5510. ipilimumab -- r_associated #0: 26 / 0.057 -> en:fluorine f-18 ml-10
    n1=ipilimumab | n2=en:fluorine f-18 ml-10 | rel=r_associated | relid=0 | w=26
  5511. ipilimumab -- r_associated #0: 26 / 0.057 -> en:fosfomycin tromethamine
    n1=ipilimumab | n2=en:fosfomycin tromethamine | rel=r_associated | relid=0 | w=26
  5512. ipilimumab -- r_associated #0: 26 / 0.057 -> en:gedatolisib
    n1=ipilimumab | n2=en:gedatolisib | rel=r_associated | relid=0 | w=26
  5513. ipilimumab -- r_associated #0: 26 / 0.057 -> en:gilteritinib
    n1=ipilimumab | n2=en:gilteritinib | rel=r_associated | relid=0 | w=26
  5514. ipilimumab -- r_associated #0: 26 / 0.057 -> en:glymidine
    n1=ipilimumab | n2=en:glymidine | rel=r_associated | relid=0 | w=26
  5515. ipilimumab -- r_associated #0: 26 / 0.057 -> en:gpi 1485
    n1=ipilimumab | n2=en:gpi 1485 | rel=r_associated | relid=0 | w=26
  5516. ipilimumab -- r_associated #0: 26 / 0.057 -> en:hdac inhibitor cg200745
    n1=ipilimumab | n2=en:hdac inhibitor cg200745 | rel=r_associated | relid=0 | w=26
  5517. ipilimumab -- r_associated #0: 26 / 0.057 -> en:hpv 16 e7:86-93 peptide vaccine
    n1=ipilimumab | n2=en:hpv 16 e7:86-93 peptide vaccine | rel=r_associated | relid=0 | w=26
  5518. ipilimumab -- r_associated #0: 26 / 0.057 -> en:hypercvad regimen
    n1=ipilimumab | n2=en:hypercvad regimen | rel=r_associated | relid=0 | w=26
  5519. ipilimumab -- r_associated #0: 26 / 0.057 -> en:ilorasertib
    n1=ipilimumab | n2=en:ilorasertib | rel=r_associated | relid=0 | w=26
  5520. ipilimumab -- r_associated #0: 26 / 0.057 -> en:imuvert
    n1=ipilimumab | n2=en:imuvert | rel=r_associated | relid=0 | w=26
  5521. ipilimumab -- r_associated #0: 26 / 0.057 -> en:interferon beta-1a
    n1=ipilimumab | n2=en:interferon beta-1a | rel=r_associated | relid=0 | w=26
  5522. ipilimumab -- r_associated #0: 26 / 0.057 -> en:inulin
    n1=ipilimumab | n2=en:inulin | rel=r_associated | relid=0 | w=26
  5523. ipilimumab -- r_associated #0: 26 / 0.057 -> en:iobenguane i-124
    n1=ipilimumab | n2=en:iobenguane i-124 | rel=r_associated | relid=0 | w=26
  5524. ipilimumab -- r_associated #0: 26 / 0.057 -> en:iodixanol
    n1=ipilimumab | n2=en:iodixanol | rel=r_associated | relid=0 | w=26
  5525. ipilimumab -- r_associated #0: 26 / 0.057 -> en:irinotecan
    n1=ipilimumab | n2=en:irinotecan | rel=r_associated | relid=0 | w=26
  5526. ipilimumab -- r_associated #0: 26 / 0.057 -> en:irosustat
    n1=ipilimumab | n2=en:irosustat | rel=r_associated | relid=0 | w=26
  5527. ipilimumab -- r_associated #0: 26 / 0.057 -> en:ketoconazole
    n1=ipilimumab | n2=en:ketoconazole | rel=r_associated | relid=0 | w=26
  5528. ipilimumab -- r_associated #0: 26 / 0.057 -> en:l-menthol preparation npo-11
    n1=ipilimumab | n2=en:l-menthol preparation npo-11 | rel=r_associated | relid=0 | w=26
  5529. ipilimumab -- r_associated #0: 26 / 0.057 -> en:l-tryptophan/thymine-based supplement
    n1=ipilimumab | n2=en:l-tryptophan/thymine-based supplement | rel=r_associated | relid=0 | w=26
  5530. ipilimumab -- r_associated #0: 26 / 0.057 -> en:licartin
    n1=ipilimumab | n2=en:licartin | rel=r_associated | relid=0 | w=26
  5531. ipilimumab -- r_associated #0: 26 / 0.057 -> en:lidocaine patch
    n1=ipilimumab | n2=en:lidocaine patch | rel=r_associated | relid=0 | w=26
  5532. ipilimumab -- r_associated #0: 26 / 0.057 -> en:lung-targeted immunomodulator qbkpn
    n1=ipilimumab | n2=en:lung-targeted immunomodulator qbkpn | rel=r_associated | relid=0 | w=26
  5533. ipilimumab -- r_associated #0: 26 / 0.057 -> en:lymphoma taa-specific cytotoxic t lymphocytes
    n1=ipilimumab | n2=en:lymphoma taa-specific cytotoxic t lymphocytes | rel=r_associated | relid=0 | w=26
  5534. ipilimumab -- r_associated #0: 26 / 0.057 -> en:mage-a1/mage-a3/ny-eso-1 peptides vaccine
    n1=ipilimumab | n2=en:mage-a1/mage-a3/ny-eso-1 peptides vaccine | rel=r_associated | relid=0 | w=26
  5535. ipilimumab -- r_associated #0: 26 / 0.057 -> en:mage-a4-specific tcr gene-transduced autologous t lymphocytes tbi-1201
    n1=ipilimumab | n2=en:mage-a4-specific tcr gene-transduced autologous t lymphocytes tbi-1201 | rel=r_associated | relid=0 | w=26
  5536. ipilimumab -- r_associated #0: 26 / 0.057 -> en:medroxyprogesterone
    n1=ipilimumab | n2=en:medroxyprogesterone | rel=r_associated | relid=0 | w=26
  5537. ipilimumab -- r_associated #0: 26 / 0.057 -> en:metronidazole hydrochloride
    n1=ipilimumab | n2=en:metronidazole hydrochloride | rel=r_associated | relid=0 | w=26
  5538. ipilimumab -- r_associated #0: 26 / 0.057 -> en:monoclonal antibody cbe-11
    n1=ipilimumab | n2=en:monoclonal antibody cbe-11 | rel=r_associated | relid=0 | w=26
  5539. ipilimumab -- r_associated #0: 26 / 0.057 -> en:multi-epitope melanoma peptide vaccine
    n1=ipilimumab | n2=en:multi-epitope melanoma peptide vaccine | rel=r_associated | relid=0 | w=26
  5540. ipilimumab -- r_associated #0: 26 / 0.057 -> en:mutagen
    n1=ipilimumab | n2=en:mutagen | rel=r_associated | relid=0 | w=26
  5541. ipilimumab -- r_associated #0: 26 / 0.057 -> en:naltrexone hydrochloride
    n1=ipilimumab | n2=en:naltrexone hydrochloride | rel=r_associated | relid=0 | w=26
  5542. ipilimumab -- r_associated #0: 26 / 0.057 -> en:niclosamide
    n1=ipilimumab | n2=en:niclosamide | rel=r_associated | relid=0 | w=26
  5543. ipilimumab -- r_associated #0: 26 / 0.057 -> en:north american ginseng extract afx-2
    n1=ipilimumab | n2=en:north american ginseng extract afx-2 | rel=r_associated | relid=0 | w=26
  5544. ipilimumab -- r_associated #0: 26 / 0.057 -> en:oxycodone/acetaminophen
    n1=ipilimumab | n2=en:oxycodone/acetaminophen | rel=r_associated | relid=0 | w=26
  5545. ipilimumab -- r_associated #0: 26 / 0.057 -> en:palifermin
    n1=ipilimumab | n2=en:palifermin | rel=r_associated | relid=0 | w=26
  5546. ipilimumab -- r_associated #0: 26 / 0.057 -> en:pentamidine
    n1=ipilimumab | n2=en:pentamidine | rel=r_associated | relid=0 | w=26
  5547. ipilimumab -- r_associated #0: 26 / 0.057 -> en:pevonedistat
    n1=ipilimumab | n2=en:pevonedistat | rel=r_associated | relid=0 | w=26
  5548. ipilimumab -- r_associated #0: 26 / 0.057 -> en:pharmaceutical dosage form
    n1=ipilimumab | n2=en:pharmaceutical dosage form | rel=r_associated | relid=0 | w=26
  5549. ipilimumab -- r_associated #0: 26 / 0.057 -> en:phenoxybenzamine hydrochloride
    n1=ipilimumab | n2=en:phenoxybenzamine hydrochloride | rel=r_associated | relid=0 | w=26
  5550. ipilimumab -- r_associated #0: 26 / 0.057 -> en:phenyl acetate
    n1=ipilimumab | n2=en:phenyl acetate | rel=r_associated | relid=0 | w=26
  5551. ipilimumab -- r_associated #0: 26 / 0.057 -> en:pi3ka/mtor inhibitor pki-179
    n1=ipilimumab | n2=en:pi3ka/mtor inhibitor pki-179 | rel=r_associated | relid=0 | w=26
  5552. ipilimumab -- r_associated #0: 26 / 0.057 -> en:piperacillin-tazobactam
    n1=ipilimumab | n2=en:piperacillin-tazobactam | rel=r_associated | relid=0 | w=26
  5553. ipilimumab -- r_associated #0: 26 / 0.057 -> en:pr1 leukemia peptide vaccine
    n1=ipilimumab | n2=en:pr1 leukemia peptide vaccine | rel=r_associated | relid=0 | w=26
  5554. ipilimumab -- r_associated #0: 26 / 0.057 -> en:raltegravir potassium
    n1=ipilimumab | n2=en:raltegravir potassium | rel=r_associated | relid=0 | w=26
  5555. ipilimumab -- r_associated #0: 26 / 0.057 -> en:sheng-yu-tang
    n1=ipilimumab | n2=en:sheng-yu-tang | rel=r_associated | relid=0 | w=26
  5556. ipilimumab -- r_associated #0: 26 / 0.057 -> en:simo decoction
    n1=ipilimumab | n2=en:simo decoction | rel=r_associated | relid=0 | w=26
  5557. ipilimumab -- r_associated #0: 26 / 0.057 -> en:simotinib hydrochloride
    n1=ipilimumab | n2=en:simotinib hydrochloride | rel=r_associated | relid=0 | w=26
  5558. ipilimumab -- r_associated #0: 26 / 0.057 -> en:sodium dichloroacetate
    n1=ipilimumab | n2=en:sodium dichloroacetate | rel=r_associated | relid=0 | w=26
  5559. ipilimumab -- r_associated #0: 26 / 0.057 -> en:soy lecithin/glycerol dioleate-based oral spray
    n1=ipilimumab | n2=en:soy lecithin/glycerol dioleate-based oral spray | rel=r_associated | relid=0 | w=26
  5560. ipilimumab -- r_associated #0: 26 / 0.057 -> en:spleen tyrosine kinase inhibitor tak-659
    n1=ipilimumab | n2=en:spleen tyrosine kinase inhibitor tak-659 | rel=r_associated | relid=0 | w=26
  5561. ipilimumab -- r_associated #0: 26 / 0.057 -> en:sr31747a
    n1=ipilimumab | n2=en:sr31747a | rel=r_associated | relid=0 | w=26
  5562. ipilimumab -- r_associated #0: 26 / 0.057 -> en:staphylococcal enterotoxin b
    n1=ipilimumab | n2=en:staphylococcal enterotoxin b | rel=r_associated | relid=0 | w=26
  5563. ipilimumab -- r_associated #0: 26 / 0.057 -> en:streptonigrin
    n1=ipilimumab | n2=en:streptonigrin | rel=r_associated | relid=0 | w=26
  5564. ipilimumab -- r_associated #0: 26 / 0.057 -> en:talimogene laherparepvec
    n1=ipilimumab | n2=en:talimogene laherparepvec | rel=r_associated | relid=0 | w=26
  5565. ipilimumab -- r_associated #0: 26 / 0.057 -> en:technetium tc-99m hydroxydiphosphonate
    n1=ipilimumab | n2=en:technetium tc-99m hydroxydiphosphonate | rel=r_associated | relid=0 | w=26
  5566. ipilimumab -- r_associated #0: 26 / 0.057 -> en:telaprevir
    n1=ipilimumab | n2=en:telaprevir | rel=r_associated | relid=0 | w=26
  5567. ipilimumab -- r_associated #0: 26 / 0.057 -> en:tinidazole
    n1=ipilimumab | n2=en:tinidazole | rel=r_associated | relid=0 | w=26
  5568. ipilimumab -- r_associated #0: 26 / 0.057 -> en:trk inhibitor azd6918
    n1=ipilimumab | n2=en:trk inhibitor azd6918 | rel=r_associated | relid=0 | w=26
  5569. ipilimumab -- r_associated #0: 26 / 0.057 -> en:veterinary drugs
    n1=ipilimumab | n2=en:veterinary drugs | rel=r_associated | relid=0 | w=26
  5570. ipilimumab -- r_associated #0: 26 / 0.057 -> en:water-based vaginal lubricant
    n1=ipilimumab | n2=en:water-based vaginal lubricant | rel=r_associated | relid=0 | w=26
  5571. ipilimumab -- r_associated #0: 26 / 0.057 -> en:xianling gubao
    n1=ipilimumab | n2=en:xianling gubao | rel=r_associated | relid=0 | w=26
  5572. ipilimumab -- r_associated #0: 26 / 0.057 -> en:yttrium y-90 epratuzumab tetraxetan
    n1=ipilimumab | n2=en:yttrium y-90 epratuzumab tetraxetan | rel=r_associated | relid=0 | w=26
  5573. ipilimumab -- r_associated #0: 26 / 0.057 -> en:zalcitabine
    n1=ipilimumab | n2=en:zalcitabine | rel=r_associated | relid=0 | w=26
  5574. ipilimumab -- r_associated #0: 26 / 0.057 -> en:zileuton
    n1=ipilimumab | n2=en:zileuton | rel=r_associated | relid=0 | w=26
  5575. ipilimumab -- r_associated #0: 26 / 0.057 -> médecine
    (science)
    n1=ipilimumab | n2=médecine
    (science)
    | rel=r_associated | relid=0 | w=26
  5576. ipilimumab -- r_associated #0: 21 / 0.046 -> en:ipilimumab
    n1=ipilimumab | n2=en:ipilimumab | rel=r_associated | relid=0 | w=21
  5577. ipilimumab -- r_associated #0: 20 / 0.044 -> en:melanoma
    n1=ipilimumab | n2=en:melanoma | rel=r_associated | relid=0 | w=20
  5578. ipilimumab -- r_associated #0: 20 / 0.044 -> melanoma
    n1=ipilimumab | n2=melanoma | rel=r_associated | relid=0 | w=20
  5579. ipilimumab -- r_associated #0: 15 / 0.033 -> agent antinéoplasique
    n1=ipilimumab | n2=agent antinéoplasique | rel=r_associated | relid=0 | w=15
  5580. ipilimumab -- r_associated #0: 15 / 0.033 -> carcinologie
    (oncologie)
    n1=ipilimumab | n2=carcinologie
    (oncologie)
    | rel=r_associated | relid=0 | w=15
  5581. ipilimumab -- r_associated #0: 15 / 0.033 -> en:amynology
    n1=ipilimumab | n2=en:amynology | rel=r_associated | relid=0 | w=15
  5582. ipilimumab -- r_associated #0: 15 / 0.033 -> en:biochemics
    n1=ipilimumab | n2=en:biochemics | rel=r_associated | relid=0 | w=15
  5583. ipilimumab -- r_associated #0: 15 / 0.033 -> en:biochemistry
    n1=ipilimumab | n2=en:biochemistry | rel=r_associated | relid=0 | w=15
  5584. ipilimumab -- r_associated #0: 15 / 0.033 -> en:immune system
    n1=ipilimumab | n2=en:immune system | rel=r_associated | relid=0 | w=15
  5585. ipilimumab -- r_associated #0: 15 / 0.033 -> en:immunization therapy
    n1=ipilimumab | n2=en:immunization therapy | rel=r_associated | relid=0 | w=15
  5586. ipilimumab -- r_associated #0: 15 / 0.033 -> en:immunology
    n1=ipilimumab | n2=en:immunology | rel=r_associated | relid=0 | w=15
  5587. ipilimumab -- r_associated #0: 15 / 0.033 -> en:oncology
    n1=ipilimumab | n2=en:oncology | rel=r_associated | relid=0 | w=15
  5588. ipilimumab -- r_associated #0: 15 / 0.033 -> en:specialized branches of medicine
    n1=ipilimumab | n2=en:specialized branches of medicine | rel=r_associated | relid=0 | w=15
  5589. ipilimumab -- r_associated #0: 15 / 0.033 -> immunologie
    n1=ipilimumab | n2=immunologie | rel=r_associated | relid=0 | w=15
  5590. ipilimumab -- r_associated #0: 15 / 0.033 -> Spécialités médicales
    n1=ipilimumab | n2=Spécialités médicales | rel=r_associated | relid=0 | w=15
  5591. ipilimumab -- r_associated #0: 15 / 0.033 -> Système immunitaire
    n1=ipilimumab | n2=Système immunitaire | rel=r_associated | relid=0 | w=15
  5592. ipilimumab -- r_associated #0: 10 / 0.022 -> 3TC
    n1=ipilimumab | n2=3TC | rel=r_associated | relid=0 | w=10
  5593. ipilimumab -- r_associated #0: 10 / 0.022 -> abatacept
    n1=ipilimumab | n2=abatacept | rel=r_associated | relid=0 | w=10
  5594. ipilimumab -- r_associated #0: 10 / 0.022 -> acarbose
    n1=ipilimumab | n2=acarbose | rel=r_associated | relid=0 | w=10
  5595. ipilimumab -- r_associated #0: 10 / 0.022 -> acénocoumarol
    n1=ipilimumab | n2=acénocoumarol | rel=r_associated | relid=0 | w=10
  5596. ipilimumab -- r_associated #0: 10 / 0.022 -> acétaminophène
    n1=ipilimumab | n2=acétaminophène | rel=r_associated | relid=0 | w=10
  5597. ipilimumab -- r_associated #0: 10 / 0.022 -> acétylcystéine
    n1=ipilimumab | n2=acétylcystéine | rel=r_associated | relid=0 | w=10
  5598. ipilimumab -- r_associated #0: 10 / 0.022 -> acide docosahexaènoïque
    n1=ipilimumab | n2=acide docosahexaènoïque | rel=r_associated | relid=0 | w=10
  5599. ipilimumab -- r_associated #0: 10 / 0.022 -> acide éicosapentaénoïque
    n1=ipilimumab | n2=acide éicosapentaénoïque | rel=r_associated | relid=0 | w=10
  5600. ipilimumab -- r_associated #0: 10 / 0.022 -> acide tranexamique
    n1=ipilimumab | n2=acide tranexamique | rel=r_associated | relid=0 | w=10
  5601. ipilimumab -- r_associated #0: 10 / 0.022 -> acide valproïque
    n1=ipilimumab | n2=acide valproïque | rel=r_associated | relid=0 | w=10
  5602. ipilimumab -- r_associated #0: 10 / 0.022 -> acitrétine
    n1=ipilimumab | n2=acitrétine | rel=r_associated | relid=0 | w=10
  5603. ipilimumab -- r_associated #0: 10 / 0.022 -> agent antibactérien
    n1=ipilimumab | n2=agent antibactérien | rel=r_associated | relid=0 | w=10
  5604. ipilimumab -- r_associated #0: 10 / 0.022 -> agent biologique
    n1=ipilimumab | n2=agent biologique | rel=r_associated | relid=0 | w=10
  5605. ipilimumab -- r_associated #0: 10 / 0.022 -> agent tensioactif
    n1=ipilimumab | n2=agent tensioactif | rel=r_associated | relid=0 | w=10
  5606. ipilimumab -- r_associated #0: 10 / 0.022 -> agoniste myelo ablatif
    n1=ipilimumab | n2=agoniste myelo ablatif | rel=r_associated | relid=0 | w=10
  5607. ipilimumab -- r_associated #0: 10 / 0.022 -> agonistes myelo ablatifs
    n1=ipilimumab | n2=agonistes myelo ablatifs | rel=r_associated | relid=0 | w=10
  5608. ipilimumab -- r_associated #0: 10 / 0.022 -> agonistes myelo-ablatifs
    n1=ipilimumab | n2=agonistes myelo-ablatifs | rel=r_associated | relid=0 | w=10
  5609. ipilimumab -- r_associated #0: 10 / 0.022 -> agonistes myélo-ablatifs
    n1=ipilimumab | n2=agonistes myélo-ablatifs | rel=r_associated | relid=0 | w=10
  5610. ipilimumab -- r_associated #0: 10 / 0.022 -> agonistes myéloablatifs
    n1=ipilimumab | n2=agonistes myéloablatifs | rel=r_associated | relid=0 | w=10
  5611. ipilimumab -- r_associated #0: 10 / 0.022 -> alcoylant
    n1=ipilimumab | n2=alcoylant | rel=r_associated | relid=0 | w=10
  5612. ipilimumab -- r_associated #0: 10 / 0.022 -> aller ensemble
    n1=ipilimumab | n2=aller ensemble | rel=r_associated | relid=0 | w=10
  5613. ipilimumab -- r_associated #0: 10 / 0.022 -> amifampridine
    n1=ipilimumab | n2=amifampridine | rel=r_associated | relid=0 | w=10
  5614. ipilimumab -- r_associated #0: 10 / 0.022 -> amifostine
    n1=ipilimumab | n2=amifostine | rel=r_associated | relid=0 | w=10
  5615. ipilimumab -- r_associated #0: 10 / 0.022 -> anæsthésique
    n1=ipilimumab | n2=anæsthésique | rel=r_associated | relid=0 | w=10
  5616. ipilimumab -- r_associated #0: 10 / 0.022 -> anesthésique
    n1=ipilimumab | n2=anesthésique | rel=r_associated | relid=0 | w=10
  5617. ipilimumab -- r_associated #0: 10 / 0.022 -> angiostatine
    n1=ipilimumab | n2=angiostatine | rel=r_associated | relid=0 | w=10
  5618. ipilimumab -- r_associated #0: 10 / 0.022 -> anhydride arsénieux
    n1=ipilimumab | n2=anhydride arsénieux | rel=r_associated | relid=0 | w=10
  5619. ipilimumab -- r_associated #0: 10 / 0.022 -> antibiotique
    n1=ipilimumab | n2=antibiotique | rel=r_associated | relid=0 | w=10
  5620. ipilimumab -- r_associated #0: 10 / 0.022 -> antibiotique antinéoplasique
    n1=ipilimumab | n2=antibiotique antinéoplasique | rel=r_associated | relid=0 | w=10
  5621. ipilimumab -- r_associated #0: 10 / 0.022 -> antibiotique antineoplasique
    n1=ipilimumab | n2=antibiotique antineoplasique | rel=r_associated | relid=0 | w=10
  5622. ipilimumab -- r_associated #0: 10 / 0.022 -> Anticorps monoclonal
    n1=ipilimumab | n2=Anticorps monoclonal | rel=r_associated | relid=0 | w=10
  5623. ipilimumab -- r_associated #0: 10 / 0.022 -> antienzyme
    n1=ipilimumab | n2=antienzyme | rel=r_associated | relid=0 | w=10
  5624. ipilimumab -- r_associated #0: 10 / 0.022 -> antimétabolite
    n1=ipilimumab | n2=antimétabolite | rel=r_associated | relid=0 | w=10
  5625. ipilimumab -- r_associated #0: 10 / 0.022 -> apixaban
    n1=ipilimumab | n2=apixaban | rel=r_associated | relid=0 | w=10
  5626. ipilimumab -- r_associated #0: 10 / 0.022 -> arsenic blanc
    n1=ipilimumab | n2=arsenic blanc | rel=r_associated | relid=0 | w=10
  5627. ipilimumab -- r_associated #0: 10 / 0.022 -> asparaginase
    n1=ipilimumab | n2=asparaginase | rel=r_associated | relid=0 | w=10
  5628. ipilimumab -- r_associated #0: 10 / 0.022 -> astringente
    n1=ipilimumab | n2=astringente | rel=r_associated | relid=0 | w=10
  5629. ipilimumab -- r_associated #0: 10 / 0.022 -> aténolol
    n1=ipilimumab | n2=aténolol | rel=r_associated | relid=0 | w=10
  5630. ipilimumab -- r_associated #0: 10 / 0.022 -> auranofine
    n1=ipilimumab | n2=auranofine | rel=r_associated | relid=0 | w=10
  5631. ipilimumab -- r_associated #0: 10 / 0.022 -> axitinib
    n1=ipilimumab | n2=axitinib | rel=r_associated | relid=0 | w=10
  5632. ipilimumab -- r_associated #0: 10 / 0.022 -> Azadirachta indica
    n1=ipilimumab | n2=Azadirachta indica | rel=r_associated | relid=0 | w=10
  5633. ipilimumab -- r_associated #0: 10 / 0.022 -> baclofen
    n1=ipilimumab | n2=baclofen | rel=r_associated | relid=0 | w=10
  5634. ipilimumab -- r_associated #0: 10 / 0.022 -> baclofène
    n1=ipilimumab | n2=baclofène | rel=r_associated | relid=0 | w=10
  5635. ipilimumab -- r_associated #0: 10 / 0.022 -> baricitinib
    n1=ipilimumab | n2=baricitinib | rel=r_associated | relid=0 | w=10
  5636. ipilimumab -- r_associated #0: 10 / 0.022 -> belimumab
    n1=ipilimumab | n2=belimumab | rel=r_associated | relid=0 | w=10
  5637. ipilimumab -- r_associated #0: 10 / 0.022 -> bevacizumab
    n1=ipilimumab | n2=bevacizumab | rel=r_associated | relid=0 | w=10
  5638. ipilimumab -- r_associated #0: 10 / 0.022 -> bléomycine sulfate
    n1=ipilimumab | n2=bléomycine sulfate | rel=r_associated | relid=0 | w=10
  5639. ipilimumab -- r_associated #0: 10 / 0.022 -> busulfan
    n1=ipilimumab | n2=busulfan | rel=r_associated | relid=0 | w=10
  5640. ipilimumab -- r_associated #0: 10 / 0.022 -> cabergoline
    n1=ipilimumab | n2=cabergoline | rel=r_associated | relid=0 | w=10
  5641. ipilimumab -- r_associated #0: 10 / 0.022 -> canakinumab
    n1=ipilimumab | n2=canakinumab | rel=r_associated | relid=0 | w=10
  5642. ipilimumab -- r_associated #0: 10 / 0.022 -> cannabidiol
    n1=ipilimumab | n2=cannabidiol | rel=r_associated | relid=0 | w=10
  5643. ipilimumab -- r_associated #0: 10 / 0.022 -> cannabinol
    n1=ipilimumab | n2=cannabinol | rel=r_associated | relid=0 | w=10
  5644. ipilimumab -- r_associated #0: 10 / 0.022 -> capécitabine
    n1=ipilimumab | n2=capécitabine | rel=r_associated | relid=0 | w=10
  5645. ipilimumab -- r_associated #0: 10 / 0.022 -> capsaïcine
    n1=ipilimumab | n2=capsaïcine | rel=r_associated | relid=0 | w=10
  5646. ipilimumab -- r_associated #0: 10 / 0.022 -> carbendazime
    n1=ipilimumab | n2=carbendazime | rel=r_associated | relid=0 | w=10
  5647. ipilimumab -- r_associated #0: 10 / 0.022 -> carbonate lithium
    n1=ipilimumab | n2=carbonate lithium | rel=r_associated | relid=0 | w=10
  5648. ipilimumab -- r_associated #0: 10 / 0.022 -> carcinogène
    n1=ipilimumab | n2=carcinogène | rel=r_associated | relid=0 | w=10
  5649. ipilimumab -- r_associated #0: 10 / 0.022 -> carmustine
    n1=ipilimumab | n2=carmustine | rel=r_associated | relid=0 | w=10
  5650. ipilimumab -- r_associated #0: 10 / 0.022 -> cefpodoxime proxétil
    n1=ipilimumab | n2=cefpodoxime proxétil | rel=r_associated | relid=0 | w=10
  5651. ipilimumab -- r_associated #0: 10 / 0.022 -> ceritinib
    n1=ipilimumab | n2=ceritinib | rel=r_associated | relid=0 | w=10
  5652. ipilimumab -- r_associated #0: 10 / 0.022 -> certolizumab
    n1=ipilimumab | n2=certolizumab | rel=r_associated | relid=0 | w=10
  5653. ipilimumab -- r_associated #0: 10 / 0.022 -> certolizumab pegol
    n1=ipilimumab | n2=certolizumab pegol | rel=r_associated | relid=0 | w=10
  5654. ipilimumab -- r_associated #0: 10 / 0.022 -> cétirizine
    n1=ipilimumab | n2=cétirizine | rel=r_associated | relid=0 | w=10
  5655. ipilimumab -- r_associated #0: 10 / 0.022 -> cetuximab
    n1=ipilimumab | n2=cetuximab | rel=r_associated | relid=0 | w=10
  5656. ipilimumab -- r_associated #0: 10 / 0.022 -> chélateur
    n1=ipilimumab | n2=chélateur | rel=r_associated | relid=0 | w=10
  5657. ipilimumab -- r_associated #0: 10 / 0.022 -> chlorhydrate de doxorubicine
    n1=ipilimumab | n2=chlorhydrate de doxorubicine | rel=r_associated | relid=0 | w=10
  5658. ipilimumab -- r_associated #0: 10 / 0.022 -> chlorhydrate de métronidazole
    n1=ipilimumab | n2=chlorhydrate de métronidazole | rel=r_associated | relid=0 | w=10
  5659. ipilimumab -- r_associated #0: 10 / 0.022 -> cimétidine
    n1=ipilimumab | n2=cimétidine | rel=r_associated | relid=0 | w=10
  5660. ipilimumab -- r_associated #0: 10 / 0.022 -> cis-diaminedichloroplatine
    n1=ipilimumab | n2=cis-diaminedichloroplatine | rel=r_associated | relid=0 | w=10
  5661. ipilimumab -- r_associated #0: 10 / 0.022 -> cisplatine
    n1=ipilimumab | n2=cisplatine | rel=r_associated | relid=0 | w=10
  5662. ipilimumab -- r_associated #0: 10 / 0.022 -> citrate de clomifène
    n1=ipilimumab | n2=citrate de clomifène | rel=r_associated | relid=0 | w=10
  5663. ipilimumab -- r_associated #0: 10 / 0.022 -> citrate de clomiphène
    n1=ipilimumab | n2=citrate de clomiphène | rel=r_associated | relid=0 | w=10
  5664. ipilimumab -- r_associated #0: 10 / 0.022 -> citrate de magnésium
    n1=ipilimumab | n2=citrate de magnésium | rel=r_associated | relid=0 | w=10
  5665. ipilimumab -- r_associated #0: 10 / 0.022 -> citrulline
    n1=ipilimumab | n2=citrulline | rel=r_associated | relid=0 | w=10
  5666. ipilimumab -- r_associated #0: 10 / 0.022 -> clarithromycine
    n1=ipilimumab | n2=clarithromycine | rel=r_associated | relid=0 | w=10
  5667. ipilimumab -- r_associated #0: 10 / 0.022 -> clé à fourche
    n1=ipilimumab | n2=clé à fourche | rel=r_associated | relid=0 | w=10
  5668. ipilimumab -- r_associated #0: 10 / 0.022 -> clé à fourches
    n1=ipilimumab | n2=clé à fourches | rel=r_associated | relid=0 | w=10
  5669. ipilimumab -- r_associated #0: 10 / 0.022 -> clé ouverte
    n1=ipilimumab | n2=clé ouverte | rel=r_associated | relid=0 | w=10
  5670. ipilimumab -- r_associated #0: 10 / 0.022 -> clef
    n1=ipilimumab | n2=clef | rel=r_associated | relid=0 | w=10
  5671. ipilimumab -- r_associated #0: 10 / 0.022 -> clef à fourche
    n1=ipilimumab | n2=clef à fourche | rel=r_associated | relid=0 | w=10
  5672. ipilimumab -- r_associated #0: 10 / 0.022 -> clef à fourches
    n1=ipilimumab | n2=clef à fourches | rel=r_associated | relid=0 | w=10
  5673. ipilimumab -- r_associated #0: 10 / 0.022 -> clef ouverte
    n1=ipilimumab | n2=clef ouverte | rel=r_associated | relid=0 | w=10
  5674. ipilimumab -- r_associated #0: 10 / 0.022 -> cobalamine
    n1=ipilimumab | n2=cobalamine | rel=r_associated | relid=0 | w=10
  5675. ipilimumab -- r_associated #0: 10 / 0.022 -> cortisol
    n1=ipilimumab | n2=cortisol | rel=r_associated | relid=0 | w=10
  5676. ipilimumab -- r_associated #0: 10 / 0.022 -> coumaphène
    n1=ipilimumab | n2=coumaphène | rel=r_associated | relid=0 | w=10
  5677. ipilimumab -- r_associated #0: 10 / 0.022 -> créatine phosphate
    n1=ipilimumab | n2=créatine phosphate | rel=r_associated | relid=0 | w=10
  5678. ipilimumab -- r_associated #0: 10 / 0.022 -> curcumine
    n1=ipilimumab | n2=curcumine | rel=r_associated | relid=0 | w=10
  5679. ipilimumab -- r_associated #0: 10 / 0.022 -> cycloleucine
    n1=ipilimumab | n2=cycloleucine | rel=r_associated | relid=0 | w=10
  5680. ipilimumab -- r_associated #0: 10 / 0.022 -> cyclophosphamide
    n1=ipilimumab | n2=cyclophosphamide | rel=r_associated | relid=0 | w=10
  5681. ipilimumab -- r_associated #0: 10 / 0.022 -> cyprotérone
    n1=ipilimumab | n2=cyprotérone | rel=r_associated | relid=0 | w=10
  5682. ipilimumab -- r_associated #0: 10 / 0.022 -> dabrafenib
    n1=ipilimumab | n2=dabrafenib | rel=r_associated | relid=0 | w=10
  5683. ipilimumab -- r_associated #0: 10 / 0.022 -> daclatasvir
    n1=ipilimumab | n2=daclatasvir | rel=r_associated | relid=0 | w=10
  5684. ipilimumab -- r_associated #0: 10 / 0.022 -> dactinomycine
    n1=ipilimumab | n2=dactinomycine | rel=r_associated | relid=0 | w=10
  5685. ipilimumab -- r_associated #0: 10 / 0.022 -> dapsone
    n1=ipilimumab | n2=dapsone | rel=r_associated | relid=0 | w=10
  5686. ipilimumab -- r_associated #0: 10 / 0.022 -> dasatinib
    n1=ipilimumab | n2=dasatinib | rel=r_associated | relid=0 | w=10
  5687. ipilimumab -- r_associated #0: 10 / 0.022 -> dextran
    n1=ipilimumab | n2=dextran | rel=r_associated | relid=0 | w=10
  5688. ipilimumab -- r_associated #0: 10 / 0.022 -> dextrane
    n1=ipilimumab | n2=dextrane | rel=r_associated | relid=0 | w=10
  5689. ipilimumab -- r_associated #0: 10 / 0.022 -> dichlorhydrate d'histamine
    n1=ipilimumab | n2=dichlorhydrate d'histamine | rel=r_associated | relid=0 | w=10
  5690. ipilimumab -- r_associated #0: 10 / 0.022 -> dicumarol
    n1=ipilimumab | n2=dicumarol | rel=r_associated | relid=0 | w=10
  5691. ipilimumab -- r_associated #0: 10 / 0.022 -> diéthylstilbestrol
    n1=ipilimumab | n2=diéthylstilbestrol | rel=r_associated | relid=0 | w=10
  5692. ipilimumab -- r_associated #0: 10 / 0.022 -> diéthylstilboestrol
    n1=ipilimumab | n2=diéthylstilboestrol | rel=r_associated | relid=0 | w=10
  5693. ipilimumab -- r_associated #0: 10 / 0.022 -> digitoxine
    n1=ipilimumab | n2=digitoxine | rel=r_associated | relid=0 | w=10
  5694. ipilimumab -- r_associated #0: 10 / 0.022 -> dobutamine
    n1=ipilimumab | n2=dobutamine | rel=r_associated | relid=0 | w=10
  5695. ipilimumab -- r_associated #0: 10 / 0.022 -> docusate
    n1=ipilimumab | n2=docusate | rel=r_associated | relid=0 | w=10
  5696. ipilimumab -- r_associated #0: 10 / 0.022 -> E100
    n1=ipilimumab | n2=E100 | rel=r_associated | relid=0 | w=10
  5697. ipilimumab -- r_associated #0: 10 / 0.022 -> E100(i)
    n1=ipilimumab | n2=E100(i) | rel=r_associated | relid=0 | w=10
  5698. ipilimumab -- r_associated #0: 10 / 0.022 -> E1200
    n1=ipilimumab | n2=E1200 | rel=r_associated | relid=0 | w=10
  5699. ipilimumab -- r_associated #0: 10 / 0.022 -> E1521
    n1=ipilimumab | n2=E1521 | rel=r_associated | relid=0 | w=10
  5700. ipilimumab -- r_associated #0: 10 / 0.022 -> E553(iii)
    n1=ipilimumab | n2=E553(iii) | rel=r_associated | relid=0 | w=10
  5701. ipilimumab -- r_associated #0: 10 / 0.022 -> eau distillée
    n1=ipilimumab | n2=eau distillée | rel=r_associated | relid=0 | w=10
  5702. ipilimumab -- r_associated #0: 10 / 0.022 -> échinomycine
    n1=ipilimumab | n2=échinomycine | rel=r_associated | relid=0 | w=10
  5703. ipilimumab -- r_associated #0: 10 / 0.022 -> emtricitabine
    n1=ipilimumab | n2=emtricitabine | rel=r_associated | relid=0 | w=10
  5704. ipilimumab -- r_associated #0: 10 / 0.022 -> en:11 epicortisol
    n1=ipilimumab | n2=en:11 epicortisol | rel=r_associated | relid=0 | w=10
  5705. ipilimumab -- r_associated #0: 10 / 0.022 -> en:17-hydroxycorticosterone
    n1=ipilimumab | n2=en:17-hydroxycorticosterone | rel=r_associated | relid=0 | w=10
  5706. ipilimumab -- r_associated #0: 10 / 0.022 -> en:2-fluorofucose-containing sgn-2ff
    n1=ipilimumab | n2=en:2-fluorofucose-containing sgn-2ff | rel=r_associated | relid=0 | w=10
  5707. ipilimumab -- r_associated #0: 10 / 0.022 -> en:agerafenib
    n1=ipilimumab | n2=en:agerafenib | rel=r_associated | relid=0 | w=10
  5708. ipilimumab -- r_associated #0: 10 / 0.022 -> en:al-721
    n1=ipilimumab | n2=en:al-721 | rel=r_associated | relid=0 | w=10
  5709. ipilimumab -- r_associated #0: 10 / 0.022 -> en:American ginseng
    n1=ipilimumab | n2=en:American ginseng | rel=r_associated | relid=0 | w=10
  5710. ipilimumab -- r_associated #0: 10 / 0.022 -> en:answer
    n1=ipilimumab | n2=en:answer | rel=r_associated | relid=0 | w=10
  5711. ipilimumab -- r_associated #0: 10 / 0.022 -> en:answer [sb] back
    n1=ipilimumab | n2=en:answer [sb] back | rel=r_associated | relid=0 | w=10
  5712. ipilimumab -- r_associated #0: 10 / 0.022 -> en:answer sb back
    n1=ipilimumab | n2=en:answer sb back | rel=r_associated | relid=0 | w=10
  5713. ipilimumab -- r_associated #0: 10 / 0.022 -> en:answer somebody back
    n1=ipilimumab | n2=en:answer somebody back | rel=r_associated | relid=0 | w=10
  5714. ipilimumab -- r_associated #0: 10 / 0.022 -> en:anti-cd123/cd3 bispecific antibody apvo436
    n1=ipilimumab | n2=en:anti-cd123/cd3 bispecific antibody apvo436 | rel=r_associated | relid=0 | w=10
  5715. ipilimumab -- r_associated #0: 10 / 0.022 -> en:anti-cd19/cd3 bite antibody amg 562
    n1=ipilimumab | n2=en:anti-cd19/cd3 bite antibody amg 562 | rel=r_associated | relid=0 | w=10
  5716. ipilimumab -- r_associated #0: 10 / 0.022 -> en:anti-cd20 monoclonal antibody
    n1=ipilimumab | n2=en:anti-cd20 monoclonal antibody | rel=r_associated | relid=0 | w=10
  5717. ipilimumab -- r_associated #0: 10 / 0.022 -> en:anti-cd20 monoclonal antibody b001
    n1=ipilimumab | n2=en:anti-cd20 monoclonal antibody b001 | rel=r_associated | relid=0 | w=10
  5718. ipilimumab -- r_associated #0: 10 / 0.022 -> en:anti-cd26 monoclonal antibody ys110
    n1=ipilimumab | n2=en:anti-cd26 monoclonal antibody ys110 | rel=r_associated | relid=0 | w=10
  5719. ipilimumab -- r_associated #0: 10 / 0.022 -> en:anti-ctla-4 monoclonal antibody agen1181
    n1=ipilimumab | n2=en:anti-ctla-4 monoclonal antibody agen1181 | rel=r_associated | relid=0 | w=10
  5720. ipilimumab -- r_associated #0: 10 / 0.022 -> en:anti-ctla4 monoclonal antibody bms-986218
    n1=ipilimumab | n2=en:anti-ctla4 monoclonal antibody bms-986218 | rel=r_associated | relid=0 | w=10
  5721. ipilimumab -- r_associated #0: 10 / 0.022 -> en:anti-ha epitope monoclonal antibody medi8852
    n1=ipilimumab | n2=en:anti-ha epitope monoclonal antibody medi8852 | rel=r_associated | relid=0 | w=10
  5722. ipilimumab -- r_associated #0: 10 / 0.022 -> en:anti-human gitr monoclonal antibody amg 228
    n1=ipilimumab | n2=en:anti-human gitr monoclonal antibody amg 228 | rel=r_associated | relid=0 | w=10
  5723. ipilimumab -- r_associated #0: 10 / 0.022 -> en:anti-icos agonist monoclonal antibody jtx-2011
    n1=ipilimumab | n2=en:anti-icos agonist monoclonal antibody jtx-2011 | rel=r_associated | relid=0 | w=10
  5724. ipilimumab -- r_associated #0: 10 / 0.022 -> en:anti-lag-3 monoclonal antibody
    n1=ipilimumab | n2=en:anti-lag-3 monoclonal antibody | rel=r_associated | relid=0 | w=10
  5725. ipilimumab -- r_associated #0: 10 / 0.022 -> en:anti-pd-l1 monoclonal antibody faz053
    n1=ipilimumab | n2=en:anti-pd-l1 monoclonal antibody faz053 | rel=r_associated | relid=0 | w=10
  5726. ipilimumab -- r_associated #0: 10 / 0.022 -> en:antibacterial agent
    n1=ipilimumab | n2=en:antibacterial agent | rel=r_associated | relid=0 | w=10
  5727. ipilimumab -- r_associated #0: 10 / 0.022 -> en:antienzyme
    n1=ipilimumab | n2=en:antienzyme | rel=r_associated | relid=0 | w=10
  5728. ipilimumab -- r_associated #0: 10 / 0.022 -> en:antineoplastic protein inhibitor
    n1=ipilimumab | n2=en:antineoplastic protein inhibitor | rel=r_associated | relid=0 | w=10
  5729. ipilimumab -- r_associated #0: 10 / 0.022 -> en:antineoplastic radiopharmaceutical agent
    n1=ipilimumab | n2=en:antineoplastic radiopharmaceutical agent | rel=r_associated | relid=0 | w=10
  5730. ipilimumab -- r_associated #0: 10 / 0.022 -> en:Azadirachta indica
    n1=ipilimumab | n2=en:Azadirachta indica | rel=r_associated | relid=0 | w=10
  5731. ipilimumab -- r_associated #0: 10 / 0.022 -> en:be a counterpart to something
    n1=ipilimumab | n2=en:be a counterpart to something | rel=r_associated | relid=0 | w=10
  5732. ipilimumab -- r_associated #0: 10 / 0.022 -> en:be the counterpart of
    n1=ipilimumab | n2=en:be the counterpart of | rel=r_associated | relid=0 | w=10
  5733. ipilimumab -- r_associated #0: 10 / 0.022 -> en:bexmarilimab
    n1=ipilimumab | n2=en:bexmarilimab | rel=r_associated | relid=0 | w=10
  5734. ipilimumab -- r_associated #0: 10 / 0.022 -> en:bi-layered skin substitute from keratinocytes and fibroblasts
    n1=ipilimumab | n2=en:bi-layered skin substitute from keratinocytes and fibroblasts | rel=r_associated | relid=0 | w=10
  5735. ipilimumab -- r_associated #0: 10 / 0.022 -> en:binimetinib-containing product
    n1=ipilimumab | n2=en:binimetinib-containing product | rel=r_associated | relid=0 | w=10
  5736. ipilimumab -- r_associated #0: 10 / 0.022 -> en:busulphan
    n1=ipilimumab | n2=en:busulphan | rel=r_associated | relid=0 | w=10
  5737. ipilimumab -- r_associated #0: 10 / 0.022 -> en:calcium channel inhibitor
    n1=ipilimumab | n2=en:calcium channel inhibitor | rel=r_associated | relid=0 | w=10
  5738. ipilimumab -- r_associated #0: 10 / 0.022 -> en:cd47 antagonist alx148
    n1=ipilimumab | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=10
  5739. ipilimumab -- r_associated #0: 10 / 0.022 -> en:cefpodoxim
    n1=ipilimumab | n2=en:cefpodoxim | rel=r_associated | relid=0 | w=10
  5740. ipilimumab -- r_associated #0: 10 / 0.022 -> en:cisplatinum
    n1=ipilimumab | n2=en:cisplatinum | rel=r_associated | relid=0 | w=10
  5741. ipilimumab -- r_associated #0: 10 / 0.022 -> en:clomiphen citrate
    n1=ipilimumab | n2=en:clomiphen citrate | rel=r_associated | relid=0 | w=10
  5742. ipilimumab -- r_associated #0: 10 / 0.022 -> en:code
    n1=ipilimumab | n2=en:code | rel=r_associated | relid=0 | w=10
  5743. ipilimumab -- r_associated #0: 10 / 0.022 -> en:computer language
    n1=ipilimumab | n2=en:computer language | rel=r_associated | relid=0 | w=10
  5744. ipilimumab -- r_associated #0: 10 / 0.022 -> en:correspond to
    n1=ipilimumab | n2=en:correspond to | rel=r_associated | relid=0 | w=10
  5745. ipilimumab -- r_associated #0: 10 / 0.022 -> en:cortifair
    n1=ipilimumab | n2=en:cortifair | rel=r_associated | relid=0 | w=10
  5746. ipilimumab -- r_associated #0: 10 / 0.022 -> en:cortisol
    n1=ipilimumab | n2=en:cortisol | rel=r_associated | relid=0 | w=10
  5747. ipilimumab -- r_associated #0: 10 / 0.022 -> en:e-z scrub
    n1=ipilimumab | n2=en:e-z scrub | rel=r_associated | relid=0 | w=10
  5748. ipilimumab -- r_associated #0: 10 / 0.022 -> en:epsom salt
    n1=ipilimumab | n2=en:epsom salt | rel=r_associated | relid=0 | w=10
  5749. ipilimumab -- r_associated #0: 10 / 0.022 -> en:Epsom salt
    n1=ipilimumab | n2=en:Epsom salt | rel=r_associated | relid=0 | w=10
  5750. ipilimumab -- r_associated #0: 10 / 0.022 -> en:erfonrilimab
    n1=ipilimumab | n2=en:erfonrilimab | rel=r_associated | relid=0 | w=10
  5751. ipilimumab -- r_associated #0: 10 / 0.022 -> en:fluoro-uracile
    n1=ipilimumab | n2=en:fluoro-uracile | rel=r_associated | relid=0 | w=10
  5752. ipilimumab -- r_associated #0: 10 / 0.022 -> en:fork wrench
    n1=ipilimumab | n2=en:fork wrench | rel=r_associated | relid=0 | w=10
  5753. ipilimumab -- r_associated #0: 10 / 0.022 -> en:form a pair with something
    n1=ipilimumab | n2=en:form a pair with something | rel=r_associated | relid=0 | w=10
  5754. ipilimumab -- r_associated #0: 10 / 0.022 -> en:gallium ga 68-labeled psma-11
    n1=ipilimumab | n2=en:gallium ga 68-labeled psma-11 | rel=r_associated | relid=0 | w=10
  5755. ipilimumab -- r_associated #0: 10 / 0.022 -> en:gelatin sponge, absorbable
    n1=ipilimumab | n2=en:gelatin sponge, absorbable | rel=r_associated | relid=0 | w=10
  5756. ipilimumab -- r_associated #0: 10 / 0.022 -> en:get acquainted with somebody
    n1=ipilimumab | n2=en:get acquainted with somebody | rel=r_associated | relid=0 | w=10
  5757. ipilimumab -- r_associated #0: 10 / 0.022 -> en:get to know somebody
    n1=ipilimumab | n2=en:get to know somebody | rel=r_associated | relid=0 | w=10
  5758. ipilimumab -- r_associated #0: 10 / 0.022 -> en:go well together
    n1=ipilimumab | n2=en:go well together | rel=r_associated | relid=0 | w=10
  5759. ipilimumab -- r_associated #0: 10 / 0.022 -> en:go with something
    n1=ipilimumab | n2=en:go with something | rel=r_associated | relid=0 | w=10
  5760. ipilimumab -- r_associated #0: 10 / 0.022 -> en:haemato fu
    n1=ipilimumab | n2=en:haemato fu | rel=r_associated | relid=0 | w=10
  5761. ipilimumab -- r_associated #0: 10 / 0.022 -> en:hepatitis A vaccine
    n1=ipilimumab | n2=en:hepatitis A vaccine | rel=r_associated | relid=0 | w=10
  5762. ipilimumab -- r_associated #0: 10 / 0.022 -> en:hepatitis B vaccine
    n1=ipilimumab | n2=en:hepatitis B vaccine | rel=r_associated | relid=0 | w=10
  5763. ipilimumab -- r_associated #0: 10 / 0.022 -> en:hif-2alpha inhibitor pt2977
    n1=ipilimumab | n2=en:hif-2alpha inhibitor pt2977 | rel=r_associated | relid=0 | w=10
  5764. ipilimumab -- r_associated #0: 10 / 0.022 -> en:human menopausal gonadotrophin
    n1=ipilimumab | n2=en:human menopausal gonadotrophin | rel=r_associated | relid=0 | w=10
  5765. ipilimumab -- r_associated #0: 10 / 0.022 -> en:hydrocortisone
    n1=ipilimumab | n2=en:hydrocortisone | rel=r_associated | relid=0 | w=10
  5766. ipilimumab -- r_associated #0: 10 / 0.022 -> en:increased immunologic activity [pe]
    n1=ipilimumab | n2=en:increased immunologic activity [pe] | rel=r_associated | relid=0 | w=10
  5767. ipilimumab -- r_associated #0: 10 / 0.022 -> en:increased t lymphocyte activation
    n1=ipilimumab | n2=en:increased t lymphocyte activation | rel=r_associated | relid=0 | w=10
  5768. ipilimumab -- r_associated #0: 10 / 0.022 -> en:indanazolin hydrochloride
    n1=ipilimumab | n2=en:indanazolin hydrochloride | rel=r_associated | relid=0 | w=10
  5769. ipilimumab -- r_associated #0: 10 / 0.022 -> en:interleukin-12, human recombinant
    n1=ipilimumab | n2=en:interleukin-12, human recombinant | rel=r_associated | relid=0 | w=10
  5770. ipilimumab -- r_associated #0: 10 / 0.022 -> en:iodine i 123 monoclonal antibody 81c6
    n1=ipilimumab | n2=en:iodine i 123 monoclonal antibody 81c6 | rel=r_associated | relid=0 | w=10
  5771. ipilimumab -- r_associated #0: 10 / 0.022 -> en:iron bile salts
    n1=ipilimumab | n2=en:iron bile salts | rel=r_associated | relid=0 | w=10
  5772. ipilimumab -- r_associated #0: 10 / 0.022 -> en:iron succinyl milk protein complex
    n1=ipilimumab | n2=en:iron succinyl milk protein complex | rel=r_associated | relid=0 | w=10
  5773. ipilimumab -- r_associated #0: 10 / 0.022 -> en:iso-sulfan blue
    n1=ipilimumab | n2=en:iso-sulfan blue | rel=r_associated | relid=0 | w=10
  5774. ipilimumab -- r_associated #0: 10 / 0.022 -> en:isopréniques
    n1=ipilimumab | n2=en:isopréniques | rel=r_associated | relid=0 | w=10
  5775. ipilimumab -- r_associated #0: 10 / 0.022 -> en:key moment
    n1=ipilimumab | n2=en:key moment | rel=r_associated | relid=0 | w=10
  5776. ipilimumab -- r_associated #0: 10 / 0.022 -> en:lorlatinib
    n1=ipilimumab | n2=en:lorlatinib | rel=r_associated | relid=0 | w=10
  5777. ipilimumab -- r_associated #0: 10 / 0.022 -> en:magnesium sulphate
    n1=ipilimumab | n2=en:magnesium sulphate | rel=r_associated | relid=0 | w=10
  5778. ipilimumab -- r_associated #0: 10 / 0.022 -> en:make a counterpart to something
    n1=ipilimumab | n2=en:make a counterpart to something | rel=r_associated | relid=0 | w=10
  5779. ipilimumab -- r_associated #0: 10 / 0.022 -> en:make a pair with something
    n1=ipilimumab | n2=en:make a pair with something | rel=r_associated | relid=0 | w=10
  5780. ipilimumab -- r_associated #0: 10 / 0.022 -> en:make somebody 's acquaintance
    n1=ipilimumab | n2=en:make somebody 's acquaintance | rel=r_associated | relid=0 | w=10
  5781. ipilimumab -- r_associated #0: 10 / 0.022 -> en:make somebody's acquaintance
    n1=ipilimumab | n2=en:make somebody's acquaintance | rel=r_associated | relid=0 | w=10
  5782. ipilimumab -- r_associated #0: 10 / 0.022 -> en:match
    n1=ipilimumab | n2=en:match | rel=r_associated | relid=0 | w=10
  5783. ipilimumab -- r_associated #0: 10 / 0.022 -> en:meet
    n1=ipilimumab | n2=en:meet | rel=r_associated | relid=0 | w=10
  5784. ipilimumab -- r_associated #0: 10 / 0.022 -> en:melanoma antigen recognized by t-cells 1, human
    n1=ipilimumab | n2=en:melanoma antigen recognized by t-cells 1, human | rel=r_associated | relid=0 | w=10
  5785. ipilimumab -- r_associated #0: 10 / 0.022 -> en:methyl-gag
    n1=ipilimumab | n2=en:methyl-gag | rel=r_associated | relid=0 | w=10
  5786. ipilimumab -- r_associated #0: 10 / 0.022 -> en:monoclonal ab
    n1=ipilimumab | n2=en:monoclonal ab | rel=r_associated | relid=0 | w=10
  5787. ipilimumab -- r_associated #0: 10 / 0.022 -> en:mouth off to [sb]
    n1=ipilimumab | n2=en:mouth off to [sb] | rel=r_associated | relid=0 | w=10
  5788. ipilimumab -- r_associated #0: 10 / 0.022 -> en:nab-paclitaxel
    n1=ipilimumab | n2=en:nab-paclitaxel | rel=r_associated | relid=0 | w=10
  5789. ipilimumab -- r_associated #0: 10 / 0.022 -> en:nilandron
    n1=ipilimumab | n2=en:nilandron | rel=r_associated | relid=0 | w=10
  5790. ipilimumab -- r_associated #0: 10 / 0.022 -> en:nivatrotamab
    n1=ipilimumab | n2=en:nivatrotamab | rel=r_associated | relid=0 | w=10
  5791. ipilimumab -- r_associated #0: 10 / 0.022 -> en:open end wrench
    n1=ipilimumab | n2=en:open end wrench | rel=r_associated | relid=0 | w=10
  5792. ipilimumab -- r_associated #0: 10 / 0.022 -> en:open-end wrench
    n1=ipilimumab | n2=en:open-end wrench | rel=r_associated | relid=0 | w=10
  5793. ipilimumab -- r_associated #0: 10 / 0.022 -> en:open-ended spanner
    n1=ipilimumab | n2=en:open-ended spanner | rel=r_associated | relid=0 | w=10
  5794. ipilimumab -- r_associated #0: 10 / 0.022 -> en:orilanolimab
    n1=ipilimumab | n2=en:orilanolimab | rel=r_associated | relid=0 | w=10
  5795. ipilimumab -- r_associated #0: 10 / 0.022 -> en:paracetamol
    n1=ipilimumab | n2=en:paracetamol | rel=r_associated | relid=0 | w=10
  5796. ipilimumab -- r_associated #0: 10 / 0.022 -> en:parenteral form ipilimumab
    n1=ipilimumab | n2=en:parenteral form ipilimumab | rel=r_associated | relid=0 | w=10
  5797. ipilimumab -- r_associated #0: 10 / 0.022 -> en:peptide hydrolases
    n1=ipilimumab | n2=en:peptide hydrolases | rel=r_associated | relid=0 | w=10
  5798. ipilimumab -- r_associated #0: 10 / 0.022 -> en:perflutren protein-a microsphere
    n1=ipilimumab | n2=en:perflutren protein-a microsphere | rel=r_associated | relid=0 | w=10
  5799. ipilimumab -- r_associated #0: 10 / 0.022 -> en:phytomenadione
    n1=ipilimumab | n2=en:phytomenadione | rel=r_associated | relid=0 | w=10
  5800. ipilimumab -- r_associated #0: 10 / 0.022 -> en:pivotal moment
    n1=ipilimumab | n2=en:pivotal moment | rel=r_associated | relid=0 | w=10
  5801. ipilimumab -- r_associated #0: 10 / 0.022 -> en:polyéthylène glycol
    n1=ipilimumab | n2=en:polyéthylène glycol | rel=r_associated | relid=0 | w=10
  5802. ipilimumab -- r_associated #0: 10 / 0.022 -> en:powder [sth]
    n1=ipilimumab | n2=en:powder [sth] | rel=r_associated | relid=0 | w=10
  5803. ipilimumab -- r_associated #0: 10 / 0.022 -> en:put powder on something
    n1=ipilimumab | n2=en:put powder on something | rel=r_associated | relid=0 | w=10
  5804. ipilimumab -- r_associated #0: 10 / 0.022 -> en:put talc on something
    n1=ipilimumab | n2=en:put talc on something | rel=r_associated | relid=0 | w=10
  5805. ipilimumab -- r_associated #0: 10 / 0.022 -> en:raralpha agonist irx5183
    n1=ipilimumab | n2=en:raralpha agonist irx5183 | rel=r_associated | relid=0 | w=10
  5806. ipilimumab -- r_associated #0: 10 / 0.022 -> en:recombinant interferon beta-1b
    n1=ipilimumab | n2=en:recombinant interferon beta-1b | rel=r_associated | relid=0 | w=10
  5807. ipilimumab -- r_associated #0: 10 / 0.022 -> en:recombinant interleukin-6
    n1=ipilimumab | n2=en:recombinant interleukin-6 | rel=r_associated | relid=0 | w=10
  5808. ipilimumab -- r_associated #0: 10 / 0.022 -> en:recombinant transforming growth factor-beta 2
    n1=ipilimumab | n2=en:recombinant transforming growth factor-beta 2 | rel=r_associated | relid=0 | w=10
  5809. ipilimumab -- r_associated #0: 10 / 0.022 -> en:refills prescribed:num:pt:medication:qn
    n1=ipilimumab | n2=en:refills prescribed:num:pt:medication:qn | rel=r_associated | relid=0 | w=10
  5810. ipilimumab -- r_associated #0: 10 / 0.022 -> en:regular insulin
    n1=ipilimumab | n2=en:regular insulin | rel=r_associated | relid=0 | w=10
  5811. ipilimumab -- r_associated #0: 10 / 0.022 -> en:reply to
    n1=ipilimumab | n2=en:reply to | rel=r_associated | relid=0 | w=10
  5812. ipilimumab -- r_associated #0: 10 / 0.022 -> en:reply to somebody
    n1=ipilimumab | n2=en:reply to somebody | rel=r_associated | relid=0 | w=10
  5813. ipilimumab -- r_associated #0: 10 / 0.022 -> en:respond
    n1=ipilimumab | n2=en:respond | rel=r_associated | relid=0 | w=10
  5814. ipilimumab -- r_associated #0: 10 / 0.022 -> en:respond to somebody
    n1=ipilimumab | n2=en:respond to somebody | rel=r_associated | relid=0 | w=10
  5815. ipilimumab -- r_associated #0: 10 / 0.022 -> en:rotavirus vaccine, live, oral
    n1=ipilimumab | n2=en:rotavirus vaccine, live, oral | rel=r_associated | relid=0 | w=10
  5816. ipilimumab -- r_associated #0: 10 / 0.022 -> en:rucaparib
    n1=ipilimumab | n2=en:rucaparib | rel=r_associated | relid=0 | w=10
  5817. ipilimumab -- r_associated #0: 10 / 0.022 -> en:slamf7-directed immunostimulatory antibody
    n1=ipilimumab | n2=en:slamf7-directed immunostimulatory antibody | rel=r_associated | relid=0 | w=10
  5818. ipilimumab -- r_associated #0: 10 / 0.022 -> en:soapstone
    n1=ipilimumab | n2=en:soapstone | rel=r_associated | relid=0 | w=10
  5819. ipilimumab -- r_associated #0: 10 / 0.022 -> en:source code
    n1=ipilimumab | n2=en:source code | rel=r_associated | relid=0 | w=10
  5820. ipilimumab -- r_associated #0: 10 / 0.022 -> en:source text
    n1=ipilimumab | n2=en:source text | rel=r_associated | relid=0 | w=10
  5821. ipilimumab -- r_associated #0: 10 / 0.022 -> en:spanner
    n1=ipilimumab | n2=en:spanner | rel=r_associated | relid=0 | w=10
  5822. ipilimumab -- r_associated #0: 10 / 0.022 -> en:steatite
    n1=ipilimumab | n2=en:steatite | rel=r_associated | relid=0 | w=10
  5823. ipilimumab -- r_associated #0: 10 / 0.022 -> en:surfactant agent
    n1=ipilimumab | n2=en:surfactant agent | rel=r_associated | relid=0 | w=10
  5824. ipilimumab -- r_associated #0: 10 / 0.022 -> en:talcum
    n1=ipilimumab | n2=en:talcum | rel=r_associated | relid=0 | w=10
  5825. ipilimumab -- r_associated #0: 10 / 0.022 -> en:talcum powder
    n1=ipilimumab | n2=en:talcum powder | rel=r_associated | relid=0 | w=10
  5826. ipilimumab -- r_associated #0: 10 / 0.022 -> en:talquetamab
    n1=ipilimumab | n2=en:talquetamab | rel=r_associated | relid=0 | w=10
  5827. ipilimumab -- r_associated #0: 10 / 0.022 -> en:to answer
    n1=ipilimumab | n2=en:to answer | rel=r_associated | relid=0 | w=10
  5828. ipilimumab -- r_associated #0: 10 / 0.022 -> en:to answer sb back
    n1=ipilimumab | n2=en:to answer sb back | rel=r_associated | relid=0 | w=10
  5829. ipilimumab -- r_associated #0: 10 / 0.022 -> en:to be the counterpart of
    n1=ipilimumab | n2=en:to be the counterpart of | rel=r_associated | relid=0 | w=10
  5830. ipilimumab -- r_associated #0: 10 / 0.022 -> en:to correspond to
    n1=ipilimumab | n2=en:to correspond to | rel=r_associated | relid=0 | w=10
  5831. ipilimumab -- r_associated #0: 10 / 0.022 -> en:to match
    n1=ipilimumab | n2=en:to match | rel=r_associated | relid=0 | w=10
  5832. ipilimumab -- r_associated #0: 10 / 0.022 -> en:to meet
    n1=ipilimumab | n2=en:to meet | rel=r_associated | relid=0 | w=10
  5833. ipilimumab -- r_associated #0: 10 / 0.022 -> en:to reply to
    n1=ipilimumab | n2=en:to reply to | rel=r_associated | relid=0 | w=10
  5834. ipilimumab -- r_associated #0: 10 / 0.022 -> en:to respond to
    n1=ipilimumab | n2=en:to respond to | rel=r_associated | relid=0 | w=10
  5835. ipilimumab -- r_associated #0: 10 / 0.022 -> en:to return
    n1=ipilimumab | n2=en:to return | rel=r_associated | relid=0 | w=10
  5836. ipilimumab -- r_associated #0: 10 / 0.022 -> en:urethan
    n1=ipilimumab | n2=en:urethan | rel=r_associated | relid=0 | w=10
  5837. ipilimumab -- r_associated #0: 10 / 0.022 -> en:vudalimab
    n1=ipilimumab | n2=en:vudalimab | rel=r_associated | relid=0 | w=10
  5838. ipilimumab -- r_associated #0: 10 / 0.022 -> en:wrench
    n1=ipilimumab | n2=en:wrench | rel=r_associated | relid=0 | w=10
  5839. ipilimumab -- r_associated #0: 10 / 0.022 -> en:zimberelimab
    n1=ipilimumab | n2=en:zimberelimab | rel=r_associated | relid=0 | w=10
  5840. ipilimumab -- r_associated #0: 10 / 0.022 -> en:zinc sulphate
    n1=ipilimumab | n2=en:zinc sulphate | rel=r_associated | relid=0 | w=10
  5841. ipilimumab -- r_associated #0: 10 / 0.022 -> enzalutamide
    n1=ipilimumab | n2=enzalutamide | rel=r_associated | relid=0 | w=10
  5842. ipilimumab -- r_associated #0: 10 / 0.022 -> eplérénone
    n1=ipilimumab | n2=eplérénone | rel=r_associated | relid=0 | w=10
  5843. ipilimumab -- r_associated #0: 10 / 0.022 -> éponge de gélatine résorbable
    n1=ipilimumab | n2=éponge de gélatine résorbable | rel=r_associated | relid=0 | w=10
  5844. ipilimumab -- r_associated #0: 10 / 0.022 -> érythropoïétine
    n1=ipilimumab | n2=érythropoïétine | rel=r_associated | relid=0 | w=10
  5845. ipilimumab -- r_associated #0: 10 / 0.022 -> éthosuximide
    n1=ipilimumab | n2=éthosuximide | rel=r_associated | relid=0 | w=10
  5846. ipilimumab -- r_associated #0: 10 / 0.022 -> ézétimibe
    n1=ipilimumab | n2=ézétimibe | rel=r_associated | relid=0 | w=10
  5847. ipilimumab -- r_associated #0: 10 / 0.022 -> facteurs biologiques
    n1=ipilimumab | n2=facteurs biologiques | rel=r_associated | relid=0 | w=10
  5848. ipilimumab -- r_associated #0: 10 / 0.022 -> faire connaissance
    n1=ipilimumab | n2=faire connaissance | rel=r_associated | relid=0 | w=10
  5849. ipilimumab -- r_associated #0: 10 / 0.022 -> faire connaissance avec
    n1=ipilimumab | n2=faire connaissance avec | rel=r_associated | relid=0 | w=10
  5850. ipilimumab -- r_associated #0: 10 / 0.022 -> faire connaissance avec [qqn]
    n1=ipilimumab | n2=faire connaissance avec [qqn] | rel=r_associated | relid=0 | w=10
  5851. ipilimumab -- r_associated #0: 10 / 0.022 -> faire connaissance avec quelqu'un
    n1=ipilimumab | n2=faire connaissance avec quelqu'un | rel=r_associated | relid=0 | w=10
  5852. ipilimumab -- r_associated #0: 10 / 0.022 -> faire connaissance de
    n1=ipilimumab | n2=faire connaissance de | rel=r_associated | relid=0 | w=10
  5853. ipilimumab -- r_associated #0: 10 / 0.022 -> faire connaissance de [qqn]
    n1=ipilimumab | n2=faire connaissance de [qqn] | rel=r_associated | relid=0 | w=10
  5854. ipilimumab -- r_associated #0: 10 / 0.022 -> faire connaissance de quelqu'un
    n1=ipilimumab | n2=faire connaissance de quelqu'un | rel=r_associated | relid=0 | w=10
  5855. ipilimumab -- r_associated #0: 10 / 0.022 -> faire pendant
    n1=ipilimumab | n2=faire pendant | rel=r_associated | relid=0 | w=10
  5856. ipilimumab -- r_associated #0: 10 / 0.022 -> faire pendant à
    n1=ipilimumab | n2=faire pendant à | rel=r_associated | relid=0 | w=10
  5857. ipilimumab -- r_associated #0: 10 / 0.022 -> famitinib
    n1=ipilimumab | n2=famitinib | rel=r_associated | relid=0 | w=10
  5858. ipilimumab -- r_associated #0: 10 / 0.022 -> filgrastim
    n1=ipilimumab | n2=filgrastim | rel=r_associated | relid=0 | w=10
  5859. ipilimumab -- r_associated #0: 10 / 0.022 -> finastéride
    n1=ipilimumab | n2=finastéride | rel=r_associated | relid=0 | w=10
  5860. ipilimumab -- r_associated #0: 10 / 0.022 -> flucytosine
    n1=ipilimumab | n2=flucytosine | rel=r_associated | relid=0 | w=10
  5861. ipilimumab -- r_associated #0: 10 / 0.022 -> fludarabine
    n1=ipilimumab | n2=fludarabine | rel=r_associated | relid=0 | w=10
  5862. ipilimumab -- r_associated #0: 10 / 0.022 -> fluoro-uracile
    n1=ipilimumab | n2=fluoro-uracile | rel=r_associated | relid=0 | w=10
  5863. ipilimumab -- r_associated #0: 10 / 0.022 -> fluorouracile
    n1=ipilimumab | n2=fluorouracile | rel=r_associated | relid=0 | w=10
  5864. ipilimumab -- r_associated #0: 10 / 0.022 -> gemcitabine
    n1=ipilimumab | n2=gemcitabine | rel=r_associated | relid=0 | w=10
  5865. ipilimumab -- r_associated #0: 10 / 0.022 -> génistéine
    n1=ipilimumab | n2=génistéine | rel=r_associated | relid=0 | w=10
  5866. ipilimumab -- r_associated #0: 10 / 0.022 -> girentuximab
    n1=ipilimumab | n2=girentuximab | rel=r_associated | relid=0 | w=10
  5867. ipilimumab -- r_associated #0: 10 / 0.022 -> gluconate de cuivre
    n1=ipilimumab | n2=gluconate de cuivre | rel=r_associated | relid=0 | w=10
  5868. ipilimumab -- r_associated #0: 10 / 0.022 -> glutathion
    n1=ipilimumab | n2=glutathion | rel=r_associated | relid=0 | w=10
  5869. ipilimumab -- r_associated #0: 10 / 0.022 -> glycol polyéthylénique
    n1=ipilimumab | n2=glycol polyéthylénique | rel=r_associated | relid=0 | w=10
  5870. ipilimumab -- r_associated #0: 10 / 0.022 -> golimumab
    n1=ipilimumab | n2=golimumab | rel=r_associated | relid=0 | w=10
  5871. ipilimumab -- r_associated #0: 10 / 0.022 -> gonadotrophine de femmes ménopausées
    n1=ipilimumab | n2=gonadotrophine de femmes ménopausées | rel=r_associated | relid=0 | w=10
  5872. ipilimumab -- r_associated #0: 10 / 0.022 -> gonadotrophine ménopausique humaine
    n1=ipilimumab | n2=gonadotrophine ménopausique humaine | rel=r_associated | relid=0 | w=10
  5873. ipilimumab -- r_associated #0: 10 / 0.022 -> hormone gonadotrope ménopausique humaine
    n1=ipilimumab | n2=hormone gonadotrope ménopausique humaine | rel=r_associated | relid=0 | w=10
  5874. ipilimumab -- r_associated #0: 10 / 0.022 -> hydrocortisone
    n1=ipilimumab | n2=hydrocortisone | rel=r_associated | relid=0 | w=10
  5875. ipilimumab -- r_associated #0: 10 / 0.022 -> hydrocortisones
    n1=ipilimumab | n2=hydrocortisones | rel=r_associated | relid=0 | w=10
  5876. ipilimumab -- r_associated #0: 10 / 0.022 -> hydroxytyrosol
    n1=ipilimumab | n2=hydroxytyrosol | rel=r_associated | relid=0 | w=10
  5877. ipilimumab -- r_associated #0: 10 / 0.022 -> ibrutinib
    n1=ipilimumab | n2=ibrutinib | rel=r_associated | relid=0 | w=10
  5878. ipilimumab -- r_associated #0: 10 / 0.022 -> imatinib
    n1=ipilimumab | n2=imatinib | rel=r_associated | relid=0 | w=10
  5879. ipilimumab -- r_associated #0: 10 / 0.022 -> immuno-modulateurs
    n1=ipilimumab | n2=immuno-modulateurs | rel=r_associated | relid=0 | w=10
  5880. ipilimumab -- r_associated #0: 10 / 0.022 -> immunomodulateurs
    n1=ipilimumab | n2=immunomodulateurs | rel=r_associated | relid=0 | w=10
  5881. ipilimumab -- r_associated #0: 10 / 0.022 -> indométacine
    n1=ipilimumab | n2=indométacine | rel=r_associated | relid=0 | w=10
  5882. ipilimumab -- r_associated #0: 10 / 0.022 -> indométhacine
    n1=ipilimumab | n2=indométhacine | rel=r_associated | relid=0 | w=10
  5883. ipilimumab -- r_associated #0: 10 / 0.022 -> inhibiteur d'enzymes
    n1=ipilimumab | n2=inhibiteur d'enzymes | rel=r_associated | relid=0 | w=10
  5884. ipilimumab -- r_associated #0: 10 / 0.022 -> inhibiteur de l'aromatase
    n1=ipilimumab | n2=inhibiteur de l'aromatase | rel=r_associated | relid=0 | w=10
  5885. ipilimumab -- r_associated #0: 10 / 0.022 -> inhibiteur de transduction du signal
    n1=ipilimumab | n2=inhibiteur de transduction du signal | rel=r_associated | relid=0 | w=10
  5886. ipilimumab -- r_associated #0: 10 / 0.022 -> inhibiteur des canaux calciques
    n1=ipilimumab | n2=inhibiteur des canaux calciques | rel=r_associated | relid=0 | w=10
  5887. ipilimumab -- r_associated #0: 10 / 0.022 -> inhibiteur enzymatique
    n1=ipilimumab | n2=inhibiteur enzymatique | rel=r_associated | relid=0 | w=10
  5888. ipilimumab -- r_associated #0: 10 / 0.022 -> Inhibiteur enzymatique
    n1=ipilimumab | n2=Inhibiteur enzymatique | rel=r_associated | relid=0 | w=10
  5889. ipilimumab -- r_associated #0: 10 / 0.022 -> inhibiteurs de l'aromatase
    n1=ipilimumab | n2=inhibiteurs de l'aromatase | rel=r_associated | relid=0 | w=10
  5890. ipilimumab -- r_associated #0: 10 / 0.022 -> inositol
    n1=ipilimumab | n2=inositol | rel=r_associated | relid=0 | w=10
  5891. ipilimumab -- r_associated #0: 10 / 0.022 -> insuline glargine
    n1=ipilimumab | n2=insuline glargine | rel=r_associated | relid=0 | w=10
  5892. ipilimumab -- r_associated #0: 10 / 0.022 -> insuline normale
    n1=ipilimumab | n2=insuline normale | rel=r_associated | relid=0 | w=10
  5893. ipilimumab -- r_associated #0: 10 / 0.022 -> insuline ordinaire
    n1=ipilimumab | n2=insuline ordinaire | rel=r_associated | relid=0 | w=10
  5894. ipilimumab -- r_associated #0: 10 / 0.022 -> inuline
    n1=ipilimumab | n2=inuline | rel=r_associated | relid=0 | w=10
  5895. ipilimumab -- r_associated #0: 10 / 0.022 -> iodine
    n1=ipilimumab | n2=iodine | rel=r_associated | relid=0 | w=10
  5896. ipilimumab -- r_associated #0: 10 / 0.022 -> iodoquinol
    n1=ipilimumab | n2=iodoquinol | rel=r_associated | relid=0 | w=10
  5897. ipilimumab -- r_associated #0: 10 / 0.022 -> ionomycine
    n1=ipilimumab | n2=ionomycine | rel=r_associated | relid=0 | w=10
  5898. ipilimumab -- r_associated #0: 10 / 0.022 -> irinotecan
    n1=ipilimumab | n2=irinotecan | rel=r_associated | relid=0 | w=10
  5899. ipilimumab -- r_associated #0: 10 / 0.022 -> isavuconazole
    n1=ipilimumab | n2=isavuconazole | rel=r_associated | relid=0 | w=10
  5900. ipilimumab -- r_associated #0: 10 / 0.022 -> isoflurane
    n1=ipilimumab | n2=isoflurane | rel=r_associated | relid=0 | w=10
  5901. ipilimumab -- r_associated #0: 10 / 0.022 -> isoniazide
    n1=ipilimumab | n2=isoniazide | rel=r_associated | relid=0 | w=10
  5902. ipilimumab -- r_associated #0: 10 / 0.022 -> isotrétinoïne
    n1=ipilimumab | n2=isotrétinoïne | rel=r_associated | relid=0 | w=10
  5903. ipilimumab -- r_associated #0: 10 / 0.022 -> lamivudine
    n1=ipilimumab | n2=lamivudine | rel=r_associated | relid=0 | w=10
  5904. ipilimumab -- r_associated #0: 10 / 0.022 -> langage de programmation
    n1=ipilimumab | n2=langage de programmation | rel=r_associated | relid=0 | w=10
  5905. ipilimumab -- r_associated #0: 10 / 0.022 -> Langage informatique
    n1=ipilimumab | n2=Langage informatique | rel=r_associated | relid=0 | w=10
  5906. ipilimumab -- r_associated #0: 10 / 0.022 -> langage informatique
    n1=ipilimumab | n2=langage informatique | rel=r_associated | relid=0 | w=10
  5907. ipilimumab -- r_associated #0: 10 / 0.022 -> lévofloxacine
    n1=ipilimumab | n2=lévofloxacine | rel=r_associated | relid=0 | w=10
  5908. ipilimumab -- r_associated #0: 10 / 0.022 -> lier connaissance avec
    n1=ipilimumab | n2=lier connaissance avec | rel=r_associated | relid=0 | w=10
  5909. ipilimumab -- r_associated #0: 10 / 0.022 -> lier connaissance avec [qqn]
    n1=ipilimumab | n2=lier connaissance avec [qqn] | rel=r_associated | relid=0 | w=10
  5910. ipilimumab -- r_associated #0: 10 / 0.022 -> lier connaissance avec quelqu'un
    n1=ipilimumab | n2=lier connaissance avec quelqu'un | rel=r_associated | relid=0 | w=10
  5911. ipilimumab -- r_associated #0: 10 / 0.022 -> lilas d'Espagne
    n1=ipilimumab | n2=lilas d'Espagne | rel=r_associated | relid=0 | w=10
  5912. ipilimumab -- r_associated #0: 10 / 0.022 -> liraglutide
    n1=ipilimumab | n2=liraglutide | rel=r_associated | relid=0 | w=10
  5913. ipilimumab -- r_associated #0: 10 / 0.022 -> lisinopril
    n1=ipilimumab | n2=lisinopril | rel=r_associated | relid=0 | w=10
  5914. ipilimumab -- r_associated #0: 10 / 0.022 -> lovastatine
    n1=ipilimumab | n2=lovastatine | rel=r_associated | relid=0 | w=10
  5915. ipilimumab -- r_associated #0: 10 / 0.022 -> macitentan
    n1=ipilimumab | n2=macitentan | rel=r_associated | relid=0 | w=10
  5916. ipilimumab -- r_associated #0: 10 / 0.022 -> médicaments animaux
    n1=ipilimumab | n2=médicaments animaux | rel=r_associated | relid=0 | w=10
  5917. ipilimumab -- r_associated #0: 10 / 0.022 -> médicaments vétérinaires
    n1=ipilimumab | n2=médicaments vétérinaires | rel=r_associated | relid=0 | w=10
  5918. ipilimumab -- r_associated #0: 10 / 0.022 -> mesna
    n1=ipilimumab | n2=mesna | rel=r_associated | relid=0 | w=10
  5919. ipilimumab -- r_associated #0: 10 / 0.022 -> méthoxsalène
    n1=ipilimumab | n2=méthoxsalène | rel=r_associated | relid=0 | w=10
  5920. ipilimumab -- r_associated #0: 10 / 0.022 -> mitogène
    n1=ipilimumab | n2=mitogène | rel=r_associated | relid=0 | w=10
  5921. ipilimumab -- r_associated #0: 10 / 0.022 -> mitoguazone
    n1=ipilimumab | n2=mitoguazone | rel=r_associated | relid=0 | w=10
  5922. ipilimumab -- r_associated #0: 10 / 0.022 -> mitoguazones
    n1=ipilimumab | n2=mitoguazones | rel=r_associated | relid=0 | w=10
  5923. ipilimumab -- r_associated #0: 10 / 0.022 -> modafinil
    n1=ipilimumab | n2=modafinil | rel=r_associated | relid=0 | w=10
  5924. ipilimumab -- r_associated #0: 10 / 0.022 -> modulateur sélectif des récepteurs ?strogéniques
    n1=ipilimumab | n2=modulateur sélectif des récepteurs ?strogéniques | rel=r_associated | relid=0 | w=10
  5925. ipilimumab -- r_associated #0: 10 / 0.022 -> mutagène
    n1=ipilimumab | n2=mutagène | rel=r_associated | relid=0 | w=10
  5926. ipilimumab -- r_associated #0: 10 / 0.022 -> myorelaxante
    n1=ipilimumab | n2=myorelaxante | rel=r_associated | relid=0 | w=10
  5927. ipilimumab -- r_associated #0: 10 / 0.022 -> nadolol
    n1=ipilimumab | n2=nadolol | rel=r_associated | relid=0 | w=10
  5928. ipilimumab -- r_associated #0: 10 / 0.022 -> nadroparine calcique
    n1=ipilimumab | n2=nadroparine calcique | rel=r_associated | relid=0 | w=10
  5929. ipilimumab -- r_associated #0: 10 / 0.022 -> naproxène
    n1=ipilimumab | n2=naproxène | rel=r_associated | relid=0 | w=10
  5930. ipilimumab -- r_associated #0: 10 / 0.022 -> natalizumab
    n1=ipilimumab | n2=natalizumab | rel=r_associated | relid=0 | w=10
  5931. ipilimumab -- r_associated #0: 10 / 0.022 -> niacinamide
    n1=ipilimumab | n2=niacinamide | rel=r_associated | relid=0 | w=10
  5932. ipilimumab -- r_associated #0: 10 / 0.022 -> nicotinamide
    n1=ipilimumab | n2=nicotinamide | rel=r_associated | relid=0 | w=10
  5933. ipilimumab -- r_associated #0: 10 / 0.022 -> nicotine
    n1=ipilimumab | n2=nicotine | rel=r_associated | relid=0 | w=10
  5934. ipilimumab -- r_associated #0: 10 / 0.022 -> novobiocine
    n1=ipilimumab | n2=novobiocine | rel=r_associated | relid=0 | w=10
  5935. ipilimumab -- r_associated #0: 10 / 0.022 -> ocrelizumab
    n1=ipilimumab | n2=ocrelizumab | rel=r_associated | relid=0 | w=10
  5936. ipilimumab -- r_associated #0: 10 / 0.022 -> olanzapine
    n1=ipilimumab | n2=olanzapine | rel=r_associated | relid=0 | w=10
  5937. ipilimumab -- r_associated #0: 10 / 0.022 -> olaparib
    n1=ipilimumab | n2=olaparib | rel=r_associated | relid=0 | w=10
  5938. ipilimumab -- r_associated #0: 10 / 0.022 -> omalizumab
    n1=ipilimumab | n2=omalizumab | rel=r_associated | relid=0 | w=10
  5939. ipilimumab -- r_associated #0: 10 / 0.022 -> oméprazole
    n1=ipilimumab | n2=oméprazole | rel=r_associated | relid=0 | w=10
  5940. ipilimumab -- r_associated #0: 10 / 0.022 -> omeprazole
    n1=ipilimumab | n2=omeprazole | rel=r_associated | relid=0 | w=10
  5941. ipilimumab -- r_associated #0: 10 / 0.022 -> oxitriptan
    n1=ipilimumab | n2=oxitriptan | rel=r_associated | relid=0 | w=10
  5942. ipilimumab -- r_associated #0: 10 / 0.022 -> oxyde de magnésium
    n1=ipilimumab | n2=oxyde de magnésium | rel=r_associated | relid=0 | w=10
  5943. ipilimumab -- r_associated #0: 10 / 0.022 -> oxymétholone
    n1=ipilimumab | n2=oxymétholone | rel=r_associated | relid=0 | w=10
  5944. ipilimumab -- r_associated #0: 10 / 0.022 -> palbociclib
    n1=ipilimumab | n2=palbociclib | rel=r_associated | relid=0 | w=10
  5945. ipilimumab -- r_associated #0: 10 / 0.022 -> pénicillamine
    n1=ipilimumab | n2=pénicillamine | rel=r_associated | relid=0 | w=10
  5946. ipilimumab -- r_associated #0: 10 / 0.022 -> pentamidine
    n1=ipilimumab | n2=pentamidine | rel=r_associated | relid=0 | w=10
  5947. ipilimumab -- r_associated #0: 10 / 0.022 -> pentoxifylline
    n1=ipilimumab | n2=pentoxifylline | rel=r_associated | relid=0 | w=10
  5948. ipilimumab -- r_associated #0: 10 / 0.022 -> peptides hydrolases
    n1=ipilimumab | n2=peptides hydrolases | rel=r_associated | relid=0 | w=10
  5949. ipilimumab -- r_associated #0: 10 / 0.022 -> pesticide
    n1=ipilimumab | n2=pesticide | rel=r_associated | relid=0 | w=10
  5950. ipilimumab -- r_associated #0: 10 / 0.022 -> phénobarbital
    n1=ipilimumab | n2=phénobarbital | rel=r_associated | relid=0 | w=10
  5951. ipilimumab -- r_associated #0: 10 / 0.022 -> phylloquinone
    n1=ipilimumab | n2=phylloquinone | rel=r_associated | relid=0 | w=10
  5952. ipilimumab -- r_associated #0: 10 / 0.022 -> phytoménadione
    n1=ipilimumab | n2=phytoménadione | rel=r_associated | relid=0 | w=10
  5953. ipilimumab -- r_associated #0: 10 / 0.022 -> phytonadione
    n1=ipilimumab | n2=phytonadione | rel=r_associated | relid=0 | w=10
  5954. ipilimumab -- r_associated #0: 10 / 0.022 -> Pierre à savon
    n1=ipilimumab | n2=Pierre à savon | rel=r_associated | relid=0 | w=10
  5955. ipilimumab -- r_associated #0: 10 / 0.022 -> pierre à savon
    n1=ipilimumab | n2=pierre à savon | rel=r_associated | relid=0 | w=10
  5956. ipilimumab -- r_associated #0: 10 / 0.022 -> pimecrolimus
    n1=ipilimumab | n2=pimecrolimus | rel=r_associated | relid=0 | w=10
  5957. ipilimumab -- r_associated #0: 10 / 0.022 -> piroxicam
    n1=ipilimumab | n2=piroxicam | rel=r_associated | relid=0 | w=10
  5958. ipilimumab -- r_associated #0: 10 / 0.022 -> polydextrose
    n1=ipilimumab | n2=polydextrose | rel=r_associated | relid=0 | w=10
  5959. ipilimumab -- r_associated #0: 10 / 0.022 -> polyéthylène glycol
    n1=ipilimumab | n2=polyéthylène glycol | rel=r_associated | relid=0 | w=10
  5960. ipilimumab -- r_associated #0: 10 / 0.022 -> ponesimod
    n1=ipilimumab | n2=ponesimod | rel=r_associated | relid=0 | w=10
  5961. ipilimumab -- r_associated #0: 10 / 0.022 -> posaconazole
    n1=ipilimumab | n2=posaconazole | rel=r_associated | relid=0 | w=10
  5962. ipilimumab -- r_associated #0: 10 / 0.022 -> poudrer
    n1=ipilimumab | n2=poudrer | rel=r_associated | relid=0 | w=10
  5963. ipilimumab -- r_associated #0: 10 / 0.022 -> prastérone
    n1=ipilimumab | n2=prastérone | rel=r_associated | relid=0 | w=10
  5964. ipilimumab -- r_associated #0: 10 / 0.022 -> préparation d'hydrocortisone
    n1=ipilimumab | n2=préparation d'hydrocortisone | rel=r_associated | relid=0 | w=10
  5965. ipilimumab -- r_associated #0: 10 / 0.022 -> préparation de cortisol
    n1=ipilimumab | n2=préparation de cortisol | rel=r_associated | relid=0 | w=10
  5966. ipilimumab -- r_associated #0: 10 / 0.022 -> préparation du composé f
    n1=ipilimumab | n2=préparation du composé f | rel=r_associated | relid=0 | w=10
  5967. ipilimumab -- r_associated #0: 10 / 0.022 -> préparation du composé F
    n1=ipilimumab | n2=préparation du composé F | rel=r_associated | relid=0 | w=10
  5968. ipilimumab -- r_associated #0: 10 / 0.022 -> préparation pharmaceutique
    n1=ipilimumab | n2=préparation pharmaceutique | rel=r_associated | relid=0 | w=10
  5969. ipilimumab -- r_associated #0: 10 / 0.022 -> procarbazine
    n1=ipilimumab | n2=procarbazine | rel=r_associated | relid=0 | w=10
  5970. ipilimumab -- r_associated #0: 10 / 0.022 -> prochlorpérazine
    n1=ipilimumab | n2=prochlorpérazine | rel=r_associated | relid=0 | w=10
  5971. ipilimumab -- r_associated #0: 10 / 0.022 -> produit anesthésiant
    n1=ipilimumab | n2=produit anesthésiant | rel=r_associated | relid=0 | w=10
  5972. ipilimumab -- r_associated #0: 10 / 0.022 -> proflavine
    n1=ipilimumab | n2=proflavine | rel=r_associated | relid=0 | w=10
  5973. ipilimumab -- r_associated #0: 10 / 0.022 -> progestine
    n1=ipilimumab | n2=progestine | rel=r_associated | relid=0 | w=10
  5974. ipilimumab -- r_associated #0: 10 / 0.022 -> ramipril
    n1=ipilimumab | n2=ramipril | rel=r_associated | relid=0 | w=10
  5975. ipilimumab -- r_associated #0: 10 / 0.022 -> ramucirumab
    n1=ipilimumab | n2=ramucirumab | rel=r_associated | relid=0 | w=10
  5976. ipilimumab -- r_associated #0: 10 / 0.022 -> relaxant musculaire
    n1=ipilimumab | n2=relaxant musculaire | rel=r_associated | relid=0 | w=10
  5977. ipilimumab -- r_associated #0: 10 / 0.022 -> répondre à
    n1=ipilimumab | n2=répondre à | rel=r_associated | relid=0 | w=10
  5978. ipilimumab -- r_associated #0: 10 / 0.022 -> répondre à [qqn]
    n1=ipilimumab | n2=répondre à [qqn] | rel=r_associated | relid=0 | w=10
  5979. ipilimumab -- r_associated #0: 10 / 0.022 -> répondre à qn
    n1=ipilimumab | n2=répondre à qn | rel=r_associated | relid=0 | w=10
  5980. ipilimumab -- r_associated #0: 10 / 0.022 -> répondre à quelqu'un
    n1=ipilimumab | n2=répondre à quelqu'un | rel=r_associated | relid=0 | w=10
  5981. ipilimumab -- r_associated #0: 10 / 0.022 -> rituximab
    n1=ipilimumab | n2=rituximab | rel=r_associated | relid=0 | w=10
  5982. ipilimumab -- r_associated #0: 10 / 0.022 -> rivaroxaban
    n1=ipilimumab | n2=rivaroxaban | rel=r_associated | relid=0 | w=10
  5983. ipilimumab -- r_associated #0: 10 / 0.022 -> se joindre
    n1=ipilimumab | n2=se joindre | rel=r_associated | relid=0 | w=10
  5984. ipilimumab -- r_associated #0: 10 / 0.022 -> sel d'Epsom
    n1=ipilimumab | n2=sel d'Epsom | rel=r_associated | relid=0 | w=10
  5985. ipilimumab -- r_associated #0: 10 / 0.022 -> sel d'epsom
    n1=ipilimumab | n2=sel d'epsom | rel=r_associated | relid=0 | w=10
  5986. ipilimumab -- r_associated #0: 10 / 0.022 -> spanner
    n1=ipilimumab | n2=spanner | rel=r_associated | relid=0 | w=10
  5987. ipilimumab -- r_associated #0: 10 / 0.022 -> stéatite
    n1=ipilimumab | n2=stéatite | rel=r_associated | relid=0 | w=10
  5988. ipilimumab -- r_associated #0: 10 / 0.022 -> sulfate de magnésium
    n1=ipilimumab | n2=sulfate de magnésium | rel=r_associated | relid=0 | w=10
  5989. ipilimumab -- r_associated #0: 10 / 0.022 -> sulfate de zinc
    n1=ipilimumab | n2=sulfate de zinc | rel=r_associated | relid=0 | w=10
  5990. ipilimumab -- r_associated #0: 10 / 0.022 -> talc
    n1=ipilimumab | n2=talc | rel=r_associated | relid=0 | w=10
  5991. ipilimumab -- r_associated #0: 10 / 0.022 -> talquer quelque chose
    n1=ipilimumab | n2=talquer quelque chose | rel=r_associated | relid=0 | w=10
  5992. ipilimumab -- r_associated #0: 10 / 0.022 -> temsirolimus
    n1=ipilimumab | n2=temsirolimus | rel=r_associated | relid=0 | w=10
  5993. ipilimumab -- r_associated #0: 10 / 0.022 -> téniposide
    n1=ipilimumab | n2=téniposide | rel=r_associated | relid=0 | w=10
  5994. ipilimumab -- r_associated #0: 10 / 0.022 -> tératogène
    n1=ipilimumab | n2=tératogène | rel=r_associated | relid=0 | w=10
  5995. ipilimumab -- r_associated #0: 10 / 0.022 -> texte source
    n1=ipilimumab | n2=texte source | rel=r_associated | relid=0 | w=10
  5996. ipilimumab -- r_associated #0: 10 / 0.022 -> Thé noir
    n1=ipilimumab | n2=Thé noir | rel=r_associated | relid=0 | w=10
  5997. ipilimumab -- r_associated #0: 10 / 0.022 -> thé noir
    n1=ipilimumab | n2=thé noir | rel=r_associated | relid=0 | w=10
  5998. ipilimumab -- r_associated #0: 10 / 0.022 -> thiamine
    n1=ipilimumab | n2=thiamine | rel=r_associated | relid=0 | w=10
  5999. ipilimumab -- r_associated #0: 10 / 0.022 -> thyrotropine alfa
    n1=ipilimumab | n2=thyrotropine alfa | rel=r_associated | relid=0 | w=10
  6000. ipilimumab -- r_associated #0: 10 / 0.022 -> timbre anti-tabac
    n1=ipilimumab | n2=timbre anti-tabac | rel=r_associated | relid=0 | w=10
  6001. ipilimumab -- r_associated #0: 10 / 0.022 -> tocilizumab
    n1=ipilimumab | n2=tocilizumab | rel=r_associated | relid=0 | w=10
  6002. ipilimumab -- r_associated #0: 10 / 0.022 -> trastuzumab
    n1=ipilimumab | n2=trastuzumab | rel=r_associated | relid=0 | w=10
  6003. ipilimumab -- r_associated #0: 10 / 0.022 -> trétinoïne
    n1=ipilimumab | n2=trétinoïne | rel=r_associated | relid=0 | w=10
  6004. ipilimumab -- r_associated #0: 10 / 0.022 -> trioxyde d'arsenic
    n1=ipilimumab | n2=trioxyde d'arsenic | rel=r_associated | relid=0 | w=10
  6005. ipilimumab -- r_associated #0: 10 / 0.022 -> uréthane
    n1=ipilimumab | n2=uréthane | rel=r_associated | relid=0 | w=10
  6006. ipilimumab -- r_associated #0: 10 / 0.022 -> ustekinumab
    n1=ipilimumab | n2=ustekinumab | rel=r_associated | relid=0 | w=10
  6007. ipilimumab -- r_associated #0: 10 / 0.022 -> vaccin anti-hépatite A
    n1=ipilimumab | n2=vaccin anti-hépatite A | rel=r_associated | relid=0 | w=10
  6008. ipilimumab -- r_associated #0: 10 / 0.022 -> vaccin anti-hépatite B
    n1=ipilimumab | n2=vaccin anti-hépatite B | rel=r_associated | relid=0 | w=10
  6009. ipilimumab -- r_associated #0: 10 / 0.022 -> vaccin anti-hépatite b
    n1=ipilimumab | n2=vaccin anti-hépatite b | rel=r_associated | relid=0 | w=10
  6010. ipilimumab -- r_associated #0: 10 / 0.022 -> vaccin antigrippal
    n1=ipilimumab | n2=vaccin antigrippal | rel=r_associated | relid=0 | w=10
  6011. ipilimumab -- r_associated #0: 10 / 0.022 -> vaccin contre l'hépatite a
    n1=ipilimumab | n2=vaccin contre l'hépatite a | rel=r_associated | relid=0 | w=10
  6012. ipilimumab -- r_associated #0: 10 / 0.022 -> vaccin contre l'hépatite A
    n1=ipilimumab | n2=vaccin contre l'hépatite A | rel=r_associated | relid=0 | w=10
  6013. ipilimumab -- r_associated #0: 10 / 0.022 -> vaccin contre l'hépatite B
    n1=ipilimumab | n2=vaccin contre l'hépatite B | rel=r_associated | relid=0 | w=10
  6014. ipilimumab -- r_associated #0: 10 / 0.022 -> vaccin contre l'hépatite b
    n1=ipilimumab | n2=vaccin contre l'hépatite b | rel=r_associated | relid=0 | w=10
  6015. ipilimumab -- r_associated #0: 10 / 0.022 -> Valeriana
    n1=ipilimumab | n2=Valeriana | rel=r_associated | relid=0 | w=10
  6016. ipilimumab -- r_associated #0: 10 / 0.022 -> valériane
    n1=ipilimumab | n2=valériane | rel=r_associated | relid=0 | w=10
  6017. ipilimumab -- r_associated #0: 10 / 0.022 -> vancomycine
    n1=ipilimumab | n2=vancomycine | rel=r_associated | relid=0 | w=10
  6018. ipilimumab -- r_associated #0: 10 / 0.022 -> vedolizumab
    n1=ipilimumab | n2=vedolizumab | rel=r_associated | relid=0 | w=10
  6019. ipilimumab -- r_associated #0: 10 / 0.022 -> vinblastine
    n1=ipilimumab | n2=vinblastine | rel=r_associated | relid=0 | w=10
  6020. ipilimumab -- r_associated #0: 10 / 0.022 -> vitamine B1
    n1=ipilimumab | n2=vitamine B1 | rel=r_associated | relid=0 | w=10
  6021. ipilimumab -- r_associated #0: 10 / 0.022 -> Vitamine K1
    n1=ipilimumab | n2=Vitamine K1 | rel=r_associated | relid=0 | w=10
  6022. ipilimumab -- r_associated #0: 10 / 0.022 -> vitamine K1
    n1=ipilimumab | n2=vitamine K1 | rel=r_associated | relid=0 | w=10
  6023. ipilimumab -- r_associated #0: 10 / 0.022 -> vitamine k1
    n1=ipilimumab | n2=vitamine k1 | rel=r_associated | relid=0 | w=10
  6024. ipilimumab -- r_associated #0: 10 / 0.022 -> warfarine
    n1=ipilimumab | n2=warfarine | rel=r_associated | relid=0 | w=10
  6025. ipilimumab -- r_associated #0: 10 / 0.022 -> zidovudine
    n1=ipilimumab | n2=zidovudine | rel=r_associated | relid=0 | w=10
  6026. ipilimumab -- r_associated #0: 10 / 0.022 -> zolmitriptan
    n1=ipilimumab | n2=zolmitriptan | rel=r_associated | relid=0 | w=10
  6027. ipilimumab -- r_associated #0: 9 / 0.02 -> anticorps monoclonal
    n1=ipilimumab | n2=anticorps monoclonal | rel=r_associated | relid=0 | w=9
  6028. ipilimumab -- r_associated #0: 6 / 0.013 -> en:immunoglobulin
    n1=ipilimumab | n2=en:immunoglobulin | rel=r_associated | relid=0 | w=6
  6029. ipilimumab -- r_associated #0: 5 / 0.011 -> en:cancer research
    n1=ipilimumab | n2=en:cancer research | rel=r_associated | relid=0 | w=5
  6030. ipilimumab -- r_associated #0: 5 / 0.011 -> en:cancrology
    n1=ipilimumab | n2=en:cancrology | rel=r_associated | relid=0 | w=5
  6031. ipilimumab -- r_associated #0: 5 / 0.011 -> en:carcinology
    n1=ipilimumab | n2=en:carcinology | rel=r_associated | relid=0 | w=5
  6032. ipilimumab -- r_associated #0: 5 / 0.011 -> Médecine
    n1=ipilimumab | n2=Médecine | rel=r_associated | relid=0 | w=5
  6033. ipilimumab -- r_associated #0: 2 / 0.004 -> monoclonal antibody
    n1=ipilimumab | n2=monoclonal antibody | rel=r_associated | relid=0 | w=2
≈ 6263 relations entrantes

  1. médecine --- r_associated #0: 383 --> ipilimumab
    n1=médecine | n2=ipilimumab | rel=r_associated | relid=0 | w=383
  2. Spécialités médicales --- r_associated #0: 165 --> ipilimumab
    n1=Spécialités médicales | n2=ipilimumab | rel=r_associated | relid=0 | w=165
  3. spécialités médicales --- r_associated #0: 164 --> ipilimumab
    n1=spécialités médicales | n2=ipilimumab | rel=r_associated | relid=0 | w=164
  4. oncologie --- r_associated #0: 64 --> ipilimumab
    n1=oncologie | n2=ipilimumab | rel=r_associated | relid=0 | w=64
  5. carcinologie
    (oncologie)
     --- r_associated #0: 62 --> ipilimumab
    n1=carcinologie
    (oncologie)
    | n2=ipilimumab | rel=r_associated | relid=0 | w=62
  6. cancérologie --- r_associated #0: 59 --> ipilimumab
    n1=cancérologie | n2=ipilimumab | rel=r_associated | relid=0 | w=59
  7. en:oncology --- r_associated #0: 57 --> ipilimumab
    n1=en:oncology | n2=ipilimumab | rel=r_associated | relid=0 | w=57
  8. en:melanoma --- r_associated #0: 45 --> ipilimumab
    n1=en:melanoma | n2=ipilimumab | rel=r_associated | relid=0 | w=45
  9. mélanome --- r_associated #0: 45 --> ipilimumab
    n1=mélanome | n2=ipilimumab | rel=r_associated | relid=0 | w=45
  10. immunothérapie --- r_associated #0: 43 --> ipilimumab
    n1=immunothérapie | n2=ipilimumab | rel=r_associated | relid=0 | w=43
  11. en:immunization therapy --- r_associated #0: 42 --> ipilimumab
    n1=en:immunization therapy | n2=ipilimumab | rel=r_associated | relid=0 | w=42
  12. biochimie --- r_associated #0: 41 --> ipilimumab
    n1=biochimie | n2=ipilimumab | rel=r_associated | relid=0 | w=41
  13. melanoma --- r_associated #0: 41 --> ipilimumab
    n1=melanoma | n2=ipilimumab | rel=r_associated | relid=0 | w=41
  14. en:biochemics --- r_associated #0: 40 --> ipilimumab
    n1=en:biochemics | n2=ipilimumab | rel=r_associated | relid=0 | w=40
  15. Yervoy --- r_associated #0: 30 --> ipilimumab
    n1=Yervoy | n2=ipilimumab | rel=r_associated | relid=0 | w=30
  16. en:biochemistry --- r_associated #0: 30 --> ipilimumab
    n1=en:biochemistry | n2=ipilimumab | rel=r_associated | relid=0 | w=30
  17. en:cancer research --- r_associated #0: 30 --> ipilimumab
    n1=en:cancer research | n2=ipilimumab | rel=r_associated | relid=0 | w=30
  18. en:cancrology --- r_associated #0: 30 --> ipilimumab
    n1=en:cancrology | n2=ipilimumab | rel=r_associated | relid=0 | w=30
  19. en:carcinology --- r_associated #0: 30 --> ipilimumab
    n1=en:carcinology | n2=ipilimumab | rel=r_associated | relid=0 | w=30
  20. CTLA-4 --- r_associated #0: 29 --> ipilimumab
    n1=CTLA-4 | n2=ipilimumab | rel=r_associated | relid=0 | w=29
  21. IgG --- r_associated #0: 29 --> ipilimumab
    n1=IgG | n2=ipilimumab | rel=r_associated | relid=0 | w=29
  22. cancer --- r_associated #0: 29 --> ipilimumab
    n1=cancer | n2=ipilimumab | rel=r_associated | relid=0 | w=29
  23. en:specialized branches of medicine --- r_associated #0: 29 --> ipilimumab
    n1=en:specialized branches of medicine | n2=ipilimumab | rel=r_associated | relid=0 | w=29
  24. maladies --- r_associated #0: 29 --> ipilimumab
    n1=maladies | n2=ipilimumab | rel=r_associated | relid=0 | w=29
  25. médecine spécialisée --- r_associated #0: 29 --> ipilimumab
    n1=médecine spécialisée | n2=ipilimumab | rel=r_associated | relid=0 | w=29
  26. IgG1 --- r_associated #0: 28 --> ipilimumab
    n1=IgG1 | n2=ipilimumab | rel=r_associated | relid=0 | w=28
  27. lymphocyte --- r_associated #0: 27 --> ipilimumab
    n1=lymphocyte | n2=ipilimumab | rel=r_associated | relid=0 | w=27
  28. pharmacie
    (médicaments)
     --- r_associated #0: 27 --> ipilimumab
    n1=pharmacie
    (médicaments)
    | n2=ipilimumab | rel=r_associated | relid=0 | w=27
  29. Bristol Myers Squibb --- r_associated #0: 26 --> ipilimumab
    n1=Bristol Myers Squibb | n2=ipilimumab | rel=r_associated | relid=0 | w=26
  30. pharmacie --- r_associated #0: 24 --> ipilimumab
    n1=pharmacie | n2=ipilimumab | rel=r_associated | relid=0 | w=24
  31. traitement --- r_associated #0: 24 --> ipilimumab
    n1=traitement | n2=ipilimumab | rel=r_associated | relid=0 | w=24
  32. Maladies --- r_associated #0: 22 --> ipilimumab
    n1=Maladies | n2=ipilimumab | rel=r_associated | relid=0 | w=22
  33. carcinologie --- r_associated #0: 22 --> ipilimumab
    n1=carcinologie | n2=ipilimumab | rel=r_associated | relid=0 | w=22
  34. en:cancerology --- r_associated #0: 22 --> ipilimumab
    n1=en:cancerology | n2=ipilimumab | rel=r_associated | relid=0 | w=22
  35. en:immunotherapy --- r_associated #0: 22 --> ipilimumab
    n1=en:immunotherapy | n2=ipilimumab | rel=r_associated | relid=0 | w=22
  36. en:ipilimumab --- r_associated #0: 22 --> ipilimumab
    n1=en:ipilimumab | n2=ipilimumab | rel=r_associated | relid=0 | w=22
  37. lymphocyte T --- r_associated #0: 22 --> ipilimumab
    n1=lymphocyte T | n2=ipilimumab | rel=r_associated | relid=0 | w=22
  38. traitement
    (médecine)
     --- r_associated #0: 22 --> ipilimumab
    n1=traitement
    (médecine)
    | n2=ipilimumab | rel=r_associated | relid=0 | w=22
  39. albumine --- r_associated #0: 20 --> ipilimumab
    n1=albumine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  40. anticorps --- r_associated #0: 20 --> ipilimumab
    n1=anticorps | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  41. dianhydro-galactitol --- r_associated #0: 20 --> ipilimumab
    n1=dianhydro-galactitol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  42. en:(61)cu-atsm --- r_associated #0: 20 --> ipilimumab
    n1=en:(61)cu-atsm | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  43. en:1,2-carbon c 13-labeled glucose --- r_associated #0: 20 --> ipilimumab
    n1=en:1,2-carbon c 13-labeled glucose | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  44. en:10 ml ipilimumab 5 mg/ml injection --- r_associated #0: 20 --> ipilimumab
    n1=en:10 ml ipilimumab 5 mg/ml injection | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  45. en:10 ml ipilimumab 5 mg/ml injection [yervoy] --- r_associated #0: 20 --> ipilimumab
    n1=en:10 ml ipilimumab 5 mg/ml injection [yervoy] | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  46. en:11c topotecan --- r_associated #0: 20 --> ipilimumab
    n1=en:11c topotecan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  47. en:13-deoxydoxorubicin --- r_associated #0: 20 --> ipilimumab
    n1=en:13-deoxydoxorubicin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  48. en:14c bms-275183 --- r_associated #0: 20 --> ipilimumab
    n1=en:14c bms-275183 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  49. en:16,16-dimethyl prostaglandin e2 --- r_associated #0: 20 --> ipilimumab
    n1=en:16,16-dimethyl prostaglandin e2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  50. en:18-f-fluoroacetate --- r_associated #0: 20 --> ipilimumab
    n1=en:18-f-fluoroacetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  51. en:18f-fhbg --- r_associated #0: 20 --> ipilimumab
    n1=en:18f-fhbg | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  52. en:18f-fluoroazomycin arabinoside --- r_associated #0: 20 --> ipilimumab
    n1=en:18f-fluoroazomycin arabinoside | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  53. en:18f-fluoromisonidazole --- r_associated #0: 20 --> ipilimumab
    n1=en:18f-fluoromisonidazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  54. en:18f-labeled mini-peg spacered rgd dimer --- r_associated #0: 20 --> ipilimumab
    n1=en:18f-labeled mini-peg spacered rgd dimer | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  55. en:2'-f-ara-deoxyuridine --- r_associated #0: 20 --> ipilimumab
    n1=en:2'-f-ara-deoxyuridine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  56. en:2-0, 3-0 desulfated heparin --- r_associated #0: 20 --> ipilimumab
    n1=en:2-0, 3-0 desulfated heparin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  57. en:2-deoxy-d-glucose --- r_associated #0: 20 --> ipilimumab
    n1=en:2-deoxy-d-glucose | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  58. en:2-fluoropropionyl-labeled pegylated dimeric rgd peptide --- r_associated #0: 20 --> ipilimumab
    n1=en:2-fluoropropionyl-labeled pegylated dimeric rgd peptide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  59. en:2-hydroxyflutamide depot --- r_associated #0: 20 --> ipilimumab
    n1=en:2-hydroxyflutamide depot | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  60. en:2-hydroxyoleic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:2-hydroxyoleic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  61. en:2-methoxyestradiol --- r_associated #0: 20 --> ipilimumab
    n1=en:2-methoxyestradiol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  62. en:2-methoxyestradiol nanocrystal colloidal dispersion --- r_associated #0: 20 --> ipilimumab
    n1=en:2-methoxyestradiol nanocrystal colloidal dispersion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  63. en:2g-1 tcr retroviral vector-transduced lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:2g-1 tcr retroviral vector-transduced lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  64. en:3'-aminomethyl nicotine-p. aeruginosa r-exoprotein a conjugate vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:3'-aminomethyl nicotine-p. aeruginosa r-exoprotein a conjugate vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  65. en:3'-c-ethynylcytidine --- r_associated #0: 20 --> ipilimumab
    n1=en:3'-c-ethynylcytidine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  66. en:3,4-methylenedioxymethamphetamine --- r_associated #0: 20 --> ipilimumab
    n1=en:3,4-methylenedioxymethamphetamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  67. en:3-deazauridine --- r_associated #0: 20 --> ipilimumab
    n1=en:3-deazauridine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  68. en:3-iodo-2-propynylbutylcarbamate --- r_associated #0: 20 --> ipilimumab
    n1=en:3-iodo-2-propynylbutylcarbamate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  69. en:4'-iodo-4'-deoxydoxorubicin --- r_associated #0: 20 --> ipilimumab
    n1=en:4'-iodo-4'-deoxydoxorubicin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  70. en:4-(n-(s-glutathionylacetyl)amino)phenylarsenoxide --- r_associated #0: 20 --> ipilimumab
    n1=en:4-(n-(s-glutathionylacetyl)amino)phenylarsenoxide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  71. en:4-1bb agonist monoclonal antibody pf-05082566 --- r_associated #0: 20 --> ipilimumab
    n1=en:4-1bb agonist monoclonal antibody pf-05082566 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  72. en:4-nitroestrone 3-methyl ether --- r_associated #0: 20 --> ipilimumab
    n1=en:4-nitroestrone 3-methyl ether | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  73. en:4-peptide melanoma vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:4-peptide melanoma vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  74. en:4-thio-2-deoxycytidine --- r_associated #0: 20 --> ipilimumab
    n1=en:4-thio-2-deoxycytidine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  75. en:40 ml ipilimumab 5 mg/ml injection --- r_associated #0: 20 --> ipilimumab
    n1=en:40 ml ipilimumab 5 mg/ml injection | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  76. en:40 ml ipilimumab 5 mg/ml injection [yervoy] --- r_associated #0: 20 --> ipilimumab
    n1=en:40 ml ipilimumab 5 mg/ml injection [yervoy] | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  77. en:5-[18f]fluorouracil --- r_associated #0: 20 --> ipilimumab
    n1=en:5-[18f]fluorouracil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  78. en:5-fitc-labeled colon-heptapeptide --- r_associated #0: 20 --> ipilimumab
    n1=en:5-fitc-labeled colon-heptapeptide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  79. en:5-fitc-labeled gi-heptapeptide --- r_associated #0: 20 --> ipilimumab
    n1=en:5-fitc-labeled gi-heptapeptide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  80. en:5-fluoro-2-deoxycytidine --- r_associated #0: 20 --> ipilimumab
    n1=en:5-fluoro-2-deoxycytidine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  81. en:5-fluoropyrimidinone --- r_associated #0: 20 --> ipilimumab
    n1=en:5-fluoropyrimidinone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  82. en:5-fluorouracil/salicylic acid topical solution --- r_associated #0: 20 --> ipilimumab
    n1=en:5-fluorouracil/salicylic acid topical solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  83. en:5-ht3 receptor antagonist --- r_associated #0: 20 --> ipilimumab
    n1=en:5-ht3 receptor antagonist | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  84. en:50% oxygen/50% nitrous oxide premix --- r_associated #0: 20 --> ipilimumab
    n1=en:50% oxygen/50% nitrous oxide premix | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  85. en:6,8-bis(benzylthio)octanoic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:6,8-bis(benzylthio)octanoic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  86. en:6-azauridine --- r_associated #0: 20 --> ipilimumab
    n1=en:6-azauridine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  87. en:6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases isoform 3 inhibitor act-pfk-158 --- r_associated #0: 20 --> ipilimumab
    n1=en:6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases isoform 3 inhibitor act-pfk-158 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  88. en:7-cyanoquinocarcinol --- r_associated #0: 20 --> ipilimumab
    n1=en:7-cyanoquinocarcinol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  89. en:7-hydroxystaurosporine --- r_associated #0: 20 --> ipilimumab
    n1=en:7-hydroxystaurosporine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  90. en:714-x --- r_associated #0: 20 --> ipilimumab
    n1=en:714-x | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  91. en:8-hydroxyquinoline sulfate ointment --- r_associated #0: 20 --> ipilimumab
    n1=en:8-hydroxyquinoline sulfate ointment | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  92. en:851b gel --- r_associated #0: 20 --> ipilimumab
    n1=en:851b gel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  93. en:[18f]-labeled substance p antagonist receptor quantifier --- r_associated #0: 20 --> ipilimumab
    n1=en:[18f]-labeled substance p antagonist receptor quantifier | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  94. en:[18f]l-fac --- r_associated #0: 20 --> ipilimumab
    n1=en:[18f]l-fac | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  95. en:[18f]l-fmac --- r_associated #0: 20 --> ipilimumab
    n1=en:[18f]l-fmac | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  96. en:abacavir sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:abacavir sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  97. en:abagovomab --- r_associated #0: 20 --> ipilimumab
    n1=en:abagovomab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  98. en:abarelix --- r_associated #0: 20 --> ipilimumab
    n1=en:abarelix | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  99. en:abatacept --- r_associated #0: 20 --> ipilimumab
    n1=en:abatacept | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  100. en:abbv-221 --- r_associated #0: 20 --> ipilimumab
    n1=en:abbv-221 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  101. en:abciximab --- r_associated #0: 20 --> ipilimumab
    n1=en:abciximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  102. en:abemaciclib --- r_associated #0: 20 --> ipilimumab
    n1=en:abemaciclib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  103. en:abexinostat --- r_associated #0: 20 --> ipilimumab
    n1=en:abexinostat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  104. en:abiraterone acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:abiraterone acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  105. en:abortifacient agents --- r_associated #0: 20 --> ipilimumab
    n1=en:abortifacient agents | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  106. en:abp 215 --- r_associated #0: 20 --> ipilimumab
    n1=en:abp 215 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  107. en:abr-217620 --- r_associated #0: 20 --> ipilimumab
    n1=en:abr-217620 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  108. en:absorbable adhesion barrier gel --- r_associated #0: 20 --> ipilimumab
    n1=en:absorbable adhesion barrier gel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  109. en:absorbable fibrin sealant patch --- r_associated #0: 20 --> ipilimumab
    n1=en:absorbable fibrin sealant patch | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  110. en:absorbable gelatin sponge --- r_associated #0: 20 --> ipilimumab
    n1=en:absorbable gelatin sponge | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  111. en:absorbable modified polymer hemostatic powder --- r_associated #0: 20 --> ipilimumab
    n1=en:absorbable modified polymer hemostatic powder | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  112. en:abt-510 --- r_associated #0: 20 --> ipilimumab
    n1=en:abt-510 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  113. en:abt-751 --- r_associated #0: 20 --> ipilimumab
    n1=en:abt-751 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  114. en:abvd regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:abvd regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  115. en:abve regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:abve regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  116. en:ac regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:ac regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  117. en:ac-t regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:ac-t regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  118. en:acadesine --- r_associated #0: 20 --> ipilimumab
    n1=en:acadesine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  119. en:acai berry juice --- r_associated #0: 20 --> ipilimumab
    n1=en:acai berry juice | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  120. en:acalabrutinib --- r_associated #0: 20 --> ipilimumab
    n1=en:acalabrutinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  121. en:acarbose --- r_associated #0: 20 --> ipilimumab
    n1=en:acarbose | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  122. en:acaricides --- r_associated #0: 20 --> ipilimumab
    n1=en:acaricides | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  123. en:ace inhibitor --- r_associated #0: 20 --> ipilimumab
    n1=en:ace inhibitor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  124. en:acellular cadaveric dermal matrix --- r_associated #0: 20 --> ipilimumab
    n1=en:acellular cadaveric dermal matrix | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  125. en:acenocoumarol --- r_associated #0: 20 --> ipilimumab
    n1=en:acenocoumarol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  126. en:acetaminophen --- r_associated #0: 20 --> ipilimumab
    n1=en:acetaminophen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  127. en:acetazolamide sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:acetazolamide sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  128. en:acetic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:acetic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  129. en:acetohexamide --- r_associated #0: 20 --> ipilimumab
    n1=en:acetohexamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  130. en:acetyl-l-carnitine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:acetyl-l-carnitine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  131. en:acetylcysteine --- r_associated #0: 20 --> ipilimumab
    n1=en:acetylcysteine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  132. en:acitretin --- r_associated #0: 20 --> ipilimumab
    n1=en:acitretin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  133. en:acivicin --- r_associated #0: 20 --> ipilimumab
    n1=en:acivicin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  134. en:aclarubicin --- r_associated #0: 20 --> ipilimumab
    n1=en:aclarubicin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  135. en:acodazole --- r_associated #0: 20 --> ipilimumab
    n1=en:acodazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  136. en:acolbifene hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:acolbifene hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  137. en:acoustic coupling fluid --- r_associated #0: 20 --> ipilimumab
    n1=en:acoustic coupling fluid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  138. en:acridine carboxamide --- r_associated #0: 20 --> ipilimumab
    n1=en:acridine carboxamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  139. en:actinium ac 225 lintuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:actinium ac 225 lintuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  140. en:activated marrow infiltrating lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:activated marrow infiltrating lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  141. en:activin type 2b receptor fc fusion protein stm 434 --- r_associated #0: 20 --> ipilimumab
    n1=en:activin type 2b receptor fc fusion protein stm 434 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  142. en:acyclovir --- r_associated #0: 20 --> ipilimumab
    n1=en:acyclovir | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  143. en:acyclovir sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:acyclovir sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  144. en:ad-hcmv-flt3l --- r_associated #0: 20 --> ipilimumab
    n1=en:ad-hcmv-flt3l | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  145. en:ad-hcmv-tk --- r_associated #0: 20 --> ipilimumab
    n1=en:ad-hcmv-tk | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  146. en:ad-isf35 --- r_associated #0: 20 --> ipilimumab
    n1=en:ad-isf35 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  147. en:ad-reic/dkk3 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:ad-reic/dkk3 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  148. en:ad-sig-hmuc-1/ecdcd40l vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:ad-sig-hmuc-1/ecdcd40l vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  149. en:ad5-cmv-nis --- r_associated #0: 20 --> ipilimumab
    n1=en:ad5-cmv-nis | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  150. en:ad5-ycd/muttk(sr39)rep-adp --- r_associated #0: 20 --> ipilimumab
    n1=en:ad5-ycd/muttk(sr39)rep-adp | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  151. en:ad5-ycd/muttksr39rep-hil12 --- r_associated #0: 20 --> ipilimumab
    n1=en:ad5-ycd/muttksr39rep-hil12 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  152. en:ad5.sstr/tk.rgd --- r_associated #0: 20 --> ipilimumab
    n1=en:ad5.sstr/tk.rgd | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  153. en:ad5cmv-p53 gene --- r_associated #0: 20 --> ipilimumab
    n1=en:ad5cmv-p53 gene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  154. en:ad5f35-lmp1/lmp2-transduced autologous dendritic cells --- r_associated #0: 20 --> ipilimumab
    n1=en:ad5f35-lmp1/lmp2-transduced autologous dendritic cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  155. en:adalimumab --- r_associated #0: 20 --> ipilimumab
    n1=en:adalimumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  156. en:ade regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:ade regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  157. en:adecatumumab --- r_associated #0: 20 --> ipilimumab
    n1=en:adecatumumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  158. en:adefovir dipivoxil --- r_associated #0: 20 --> ipilimumab
    n1=en:adefovir dipivoxil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  159. en:adenosine a2 receptor agonists --- r_associated #0: 20 --> ipilimumab
    n1=en:adenosine a2 receptor agonists | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  160. en:adenosine a2a receptor antagonist pbf-509 --- r_associated #0: 20 --> ipilimumab
    n1=en:adenosine a2a receptor antagonist pbf-509 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  161. en:adenosine a3 receptor agonist cf102 --- r_associated #0: 20 --> ipilimumab
    n1=en:adenosine a3 receptor agonist cf102 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  162. en:adenosine triphosphate --- r_associated #0: 20 --> ipilimumab
    n1=en:adenosine triphosphate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  163. en:adenosine-a2a receptor antagonist cpi-444 --- r_associated #0: 20 --> ipilimumab
    n1=en:adenosine-a2a receptor antagonist cpi-444 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  164. en:adenovector encoding mda7 --- r_associated #0: 20 --> ipilimumab
    n1=en:adenovector encoding mda7 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  165. en:adenovector-transduced ap1903-inducible myd88/cd40-expressing autologous psma-specific prostate cancer vaccine bpx-201 --- r_associated #0: 20 --> ipilimumab
    n1=en:adenovector-transduced ap1903-inducible myd88/cd40-expressing autologous psma-specific prostate cancer vaccine bpx-201 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  166. en:adenoviral transduced hil-12-expressing autologous dendritic cells inxn-3001 plus activator ligand inxn-1001 --- r_associated #0: 20 --> ipilimumab
    n1=en:adenoviral transduced hil-12-expressing autologous dendritic cells inxn-3001 plus activator ligand inxn-1001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  167. en:adenoviral vector ad5-cea(6d) vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:adenoviral vector ad5-cea(6d) vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  168. en:adenovirus 5-cd40 ligand --- r_associated #0: 20 --> ipilimumab
    n1=en:adenovirus 5-cd40 ligand | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  169. en:adenovirus 5-human guanylyl cyclase c-padre vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:adenovirus 5-human guanylyl cyclase c-padre vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  170. en:adenovirus b7-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:adenovirus b7-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  171. en:adenovirus encoding human aquaporin-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:adenovirus encoding human aquaporin-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  172. en:adenovirus encoding rat her-2/neu --- r_associated #0: 20 --> ipilimumab
    n1=en:adenovirus encoding rat her-2/neu | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  173. en:adenovirus encoding recombinant human endostatin --- r_associated #0: 20 --> ipilimumab
    n1=en:adenovirus encoding recombinant human endostatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  174. en:adenovirus encoding tyrosinase/mart-1/magea6-transduced autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:adenovirus encoding tyrosinase/mart-1/magea6-transduced autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  175. en:adenovirus her2-transduced autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:adenovirus her2-transduced autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  176. en:adenovirus rsv-tk --- r_associated #0: 20 --> ipilimumab
    n1=en:adenovirus rsv-tk | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  177. en:adenovirus vector --- r_associated #0: 20 --> ipilimumab
    n1=en:adenovirus vector | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  178. en:adenovirus-encoding e.coli pnp --- r_associated #0: 20 --> ipilimumab
    n1=en:adenovirus-encoding e.coli pnp | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  179. en:adenovirus-mediated human interleukin-12 --- r_associated #0: 20 --> ipilimumab
    n1=en:adenovirus-mediated human interleukin-12 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  180. en:adenovirus-mediated human interleukin-12 inxn-2001 plus activator ligand inxn-1001 --- r_associated #0: 20 --> ipilimumab
    n1=en:adenovirus-mediated human interleukin-12 inxn-2001 plus activator ligand inxn-1001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  181. en:adenovirus-p53 transduced dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:adenovirus-p53 transduced dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  182. en:adenovirus-psa prostate cancer vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:adenovirus-psa prostate cancer vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  183. en:adenovirus/cytomegalovirus/epstein-barr virus-specific allogeneic cytotoxic t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:adenovirus/cytomegalovirus/epstein-barr virus-specific allogeneic cytotoxic t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  184. en:adgmcaix-transduced autologous dendritic cells --- r_associated #0: 20 --> ipilimumab
    n1=en:adgmcaix-transduced autologous dendritic cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  185. en:adh-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:adh-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  186. en:adipose-derived regenerative cells --- r_associated #0: 20 --> ipilimumab
    n1=en:adipose-derived regenerative cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  187. en:adipose-derived stromal vascular fraction cells --- r_associated #0: 20 --> ipilimumab
    n1=en:adipose-derived stromal vascular fraction cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  188. en:adozelesin --- r_associated #0: 20 --> ipilimumab
    n1=en:adozelesin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  189. en:adrtvp-1-transduced prostate cancer cell-based vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:adrtvp-1-transduced prostate cancer cell-based vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  190. en:ae37 peptide/gm-csf vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:ae37 peptide/gm-csf vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  191. en:aee788 --- r_associated #0: 20 --> ipilimumab
    n1=en:aee788 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  192. en:aeg35156 --- r_associated #0: 20 --> ipilimumab
    n1=en:aeg35156 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  193. en:aerosol sargramostim --- r_associated #0: 20 --> ipilimumab
    n1=en:aerosol sargramostim | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  194. en:aerosolized aldesleukin --- r_associated #0: 20 --> ipilimumab
    n1=en:aerosolized aldesleukin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  195. en:aerosolized liposomal rubitecan --- r_associated #0: 20 --> ipilimumab
    n1=en:aerosolized liposomal rubitecan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  196. en:afamelanotide --- r_associated #0: 20 --> ipilimumab
    n1=en:afamelanotide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  197. en:afatinib dimaleate --- r_associated #0: 20 --> ipilimumab
    n1=en:afatinib dimaleate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  198. en:afimoxifene --- r_associated #0: 20 --> ipilimumab
    n1=en:afimoxifene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  199. en:afp gene hepatocellular carcinoma vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:afp gene hepatocellular carcinoma vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  200. en:afp464 --- r_associated #0: 20 --> ipilimumab
    n1=en:afp464 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  201. en:afuresertib --- r_associated #0: 20 --> ipilimumab
    n1=en:afuresertib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  202. en:ag-024322 --- r_associated #0: 20 --> ipilimumab
    n1=en:ag-024322 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  203. en:agaricus blazei murill extract --- r_associated #0: 20 --> ipilimumab
    n1=en:agaricus blazei murill extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  204. en:agatolimod sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:agatolimod sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  205. en:agent affecting cardiovascular system --- r_associated #0: 20 --> ipilimumab
    n1=en:agent affecting cardiovascular system | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  206. en:aglatimagene besadenovec --- r_associated #0: 20 --> ipilimumab
    n1=en:aglatimagene besadenovec | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  207. en:agonistic anti-cd40 monoclonal antibody adc-1013 --- r_associated #0: 20 --> ipilimumab
    n1=en:agonistic anti-cd40 monoclonal antibody adc-1013 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  208. en:agonistic anti-ox40 monoclonal antibody medi6383 --- r_associated #0: 20 --> ipilimumab
    n1=en:agonistic anti-ox40 monoclonal antibody medi6383 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  209. en:agonistic anti-ox40 monoclonal antibody medi6469 --- r_associated #0: 20 --> ipilimumab
    n1=en:agonistic anti-ox40 monoclonal antibody medi6469 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  210. en:aim2(-1)/ht001(-1)/taf1b(-1) frameshift peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:aim2(-1)/ht001(-1)/taf1b(-1) frameshift peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  211. en:ak 3012 --- r_associated #0: 20 --> ipilimumab
    n1=en:ak 3012 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  212. en:akt 1/2 inhibitor bay1125976 --- r_associated #0: 20 --> ipilimumab
    n1=en:akt 1/2 inhibitor bay1125976 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  213. en:akt inhibitor arq 092 --- r_associated #0: 20 --> ipilimumab
    n1=en:akt inhibitor arq 092 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  214. en:akt inhibitor azd5363 --- r_associated #0: 20 --> ipilimumab
    n1=en:akt inhibitor azd5363 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  215. en:akt inhibitor gsk2141795 --- r_associated #0: 20 --> ipilimumab
    n1=en:akt inhibitor gsk2141795 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  216. en:akt inhibitor ly2780301 --- r_associated #0: 20 --> ipilimumab
    n1=en:akt inhibitor ly2780301 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  217. en:akt inhibitor mk2206 --- r_associated #0: 20 --> ipilimumab
    n1=en:akt inhibitor mk2206 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  218. en:akt inhibitor sr13668 --- r_associated #0: 20 --> ipilimumab
    n1=en:akt inhibitor sr13668 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  219. en:akt-1/2 inhibitor-treated tumor infiltrating lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:akt-1/2 inhibitor-treated tumor infiltrating lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  220. en:akt/erk inhibitor onc201 --- r_associated #0: 20 --> ipilimumab
    n1=en:akt/erk inhibitor onc201 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  221. en:al-721 --- r_associated #0: 20 --> ipilimumab
    n1=en:al-721 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  222. en:al721 --- r_associated #0: 20 --> ipilimumab
    n1=en:al721 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  223. en:alanosine --- r_associated #0: 20 --> ipilimumab
    n1=en:alanosine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  224. en:albumin --- r_associated #0: 20 --> ipilimumab
    n1=en:albumin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  225. en:albuterol sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:albuterol sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  226. en:alcohol --- r_associated #0: 20 --> ipilimumab
    n1=en:alcohol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  227. en:alcohol deterrents --- r_associated #0: 20 --> ipilimumab
    n1=en:alcohol deterrents | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  228. en:alcohol products --- r_associated #0: 20 --> ipilimumab
    n1=en:alcohol products | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  229. en:aldesleukin --- r_associated #0: 20 --> ipilimumab
    n1=en:aldesleukin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  230. en:aldoxorubicin --- r_associated #0: 20 --> ipilimumab
    n1=en:aldoxorubicin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  231. en:alectinib --- r_associated #0: 20 --> ipilimumab
    n1=en:alectinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  232. en:alefacept --- r_associated #0: 20 --> ipilimumab
    n1=en:alefacept | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  233. en:alemtuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:alemtuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  234. en:alendronate sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:alendronate sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  235. en:alfentanil hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:alfentanil hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  236. en:alfuzosin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:alfuzosin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  237. en:algenpantucel-l --- r_associated #0: 20 --> ipilimumab
    n1=en:algenpantucel-l | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  238. en:alisertib --- r_associated #0: 20 --> ipilimumab
    n1=en:alisertib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  239. en:alitretinoin --- r_associated #0: 20 --> ipilimumab
    n1=en:alitretinoin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  240. en:alizapride --- r_associated #0: 20 --> ipilimumab
    n1=en:alizapride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  241. en:alk inhibitor asp3026 --- r_associated #0: 20 --> ipilimumab
    n1=en:alk inhibitor asp3026 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  242. en:alk inhibitor ro5424802 --- r_associated #0: 20 --> ipilimumab
    n1=en:alk inhibitor ro5424802 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  243. en:alk inhibitor x-396 --- r_associated #0: 20 --> ipilimumab
    n1=en:alk inhibitor x-396 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  244. en:alk-fak inhibitor cep-37440 --- r_associated #0: 20 --> ipilimumab
    n1=en:alk-fak inhibitor cep-37440 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  245. en:alk/fak/pyk2 inhibitor ct-707 --- r_associated #0: 20 --> ipilimumab
    n1=en:alk/fak/pyk2 inhibitor ct-707 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  246. en:alk/ros1 inhibitor pf-06463922 --- r_associated #0: 20 --> ipilimumab
    n1=en:alk/ros1 inhibitor pf-06463922 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  247. en:alk/trk inhibitor tsr-011 --- r_associated #0: 20 --> ipilimumab
    n1=en:alk/trk inhibitor tsr-011 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  248. en:alk5 inhibitor tew-7197 --- r_associated #0: 20 --> ipilimumab
    n1=en:alk5 inhibitor tew-7197 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  249. en:alkaline water --- r_associated #0: 20 --> ipilimumab
    n1=en:alkaline water | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  250. en:alkalinizing agent (substance) --- r_associated #0: 20 --> ipilimumab
    n1=en:alkalinizing agent (substance) | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  251. en:alkylating agent --- r_associated #0: 20 --> ipilimumab
    n1=en:alkylating agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  252. en:allergen product --- r_associated #0: 20 --> ipilimumab
    n1=en:allergen product | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  253. en:allergenic extract --- r_associated #0: 20 --> ipilimumab
    n1=en:allergenic extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  254. en:allodepleted haploidentical t cells-expressing inducible caspase 9 --- r_associated #0: 20 --> ipilimumab
    n1=en:allodepleted haploidentical t cells-expressing inducible caspase 9 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  255. en:allodepleted t cell immunotherapeutic atir101 --- r_associated #0: 20 --> ipilimumab
    n1=en:allodepleted t cell immunotherapeutic atir101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  256. en:allogeneic adenovirus-specific cytotoxic t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic adenovirus-specific cytotoxic t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  257. en:allogeneic aml antigen-expressing dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic aml antigen-expressing dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  258. en:allogeneic b7.1/hla-a1 transfected tumor cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic b7.1/hla-a1 transfected tumor cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  259. en:allogeneic cd19-specific car-modified cd8 plus central memory-derived virus-specific t cells --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic cd19-specific car-modified cd8 plus central memory-derived virus-specific t cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  260. en:allogeneic cd4+ memory th1-like t cells/microparticle-bound anti-cd3/anti-cd28 --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic cd4+ memory th1-like t cells/microparticle-bound anti-cd3/anti-cd28 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  261. en:allogeneic cd56-positive cd3-negative natural killer cells --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic cd56-positive cd3-negative natural killer cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  262. en:allogeneic cmv/adv-specific cytotoxic t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic cmv/adv-specific cytotoxic t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  263. en:allogeneic cytomegalovirus-specific cytotoxic t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic cytomegalovirus-specific cytotoxic t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  264. en:allogeneic dendritic cell vaccine combig-dc --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic dendritic cell vaccine combig-dc | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  265. en:allogeneic dendritic cell-myeloma idiotype vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic dendritic cell-myeloma idiotype vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  266. en:allogeneic epstein-barr virus-specific cytotoxic t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic epstein-barr virus-specific cytotoxic t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  267. en:allogeneic glioblastoma stem-like cell line lysate-pulsed autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic glioblastoma stem-like cell line lysate-pulsed autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  268. en:allogeneic gm-csf-based myeloma cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic gm-csf-based myeloma cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  269. en:allogeneic gm-csf-secreting breast cancer vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic gm-csf-secreting breast cancer vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  270. en:allogeneic gm-csf-secreting lethally irradiated whole melanoma cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic gm-csf-secreting lethally irradiated whole melanoma cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  271. en:allogeneic gm-csf-secreting tumor vaccine panc 10.05 pcdna-1/gm-neo --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic gm-csf-secreting tumor vaccine panc 10.05 pcdna-1/gm-neo | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  272. en:allogeneic gm-csf-secreting tumor vaccine panc 6.03 pcdna-1/gm-neo --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic gm-csf-secreting tumor vaccine panc 6.03 pcdna-1/gm-neo | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  273. en:allogeneic hla-a2/4-1bb ligand-expressing melanoma vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic hla-a2/4-1bb ligand-expressing melanoma vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  274. en:allogeneic il13-zetakine/hytk-expressing-glucocorticoid resistant cytotoxic t lymphocytes grm13z40-2 --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic il13-zetakine/hytk-expressing-glucocorticoid resistant cytotoxic t lymphocytes grm13z40-2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  275. en:allogeneic irradiated melanoma cell vaccine csf470 --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic irradiated melanoma cell vaccine csf470 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  276. en:allogeneic large multivalent immunogen breast cancer vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic large multivalent immunogen breast cancer vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  277. en:allogeneic large multivalent immunogen melanoma vaccine lp2307 --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic large multivalent immunogen melanoma vaccine lp2307 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  278. en:allogeneic lmp1/lmp2-specific cytotoxic t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic lmp1/lmp2-specific cytotoxic t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  279. en:allogeneic melanoma vaccine agi-101h --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic melanoma vaccine agi-101h | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  280. en:allogeneic mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  281. en:allogeneic multipotent adult progenitor cells --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic multipotent adult progenitor cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  282. en:allogeneic multivirus-specific cytotoxic t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic multivirus-specific cytotoxic t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  283. en:allogeneic natural killer cell line mg4101 --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic natural killer cell line mg4101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  284. en:allogeneic natural killer cell line nk-92 --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic natural killer cell line nk-92 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  285. en:allogeneic renal cell carcinoma vaccine mgn1601 --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic renal cell carcinoma vaccine mgn1601 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  286. en:allogeneic t-lymphocytes bpx-501 --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic t-lymphocytes bpx-501 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  287. en:allogeneic tumor cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:allogeneic tumor cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  288. en:allopurinol --- r_associated #0: 20 --> ipilimumab
    n1=en:allopurinol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  289. en:allosteric bcr-abl tyrosine kinase inhibitor abl001 --- r_associated #0: 20 --> ipilimumab
    n1=en:allosteric bcr-abl tyrosine kinase inhibitor abl001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  290. en:allovectin-7 --- r_associated #0: 20 --> ipilimumab
    n1=en:allovectin-7 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  291. en:alloxan --- r_associated #0: 20 --> ipilimumab
    n1=en:alloxan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  292. en:almurtide --- r_associated #0: 20 --> ipilimumab
    n1=en:almurtide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  293. en:aloe vera gel --- r_associated #0: 20 --> ipilimumab
    n1=en:aloe vera gel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  294. en:aloe/anise/ascorbic acid/clove/peppermint/spearmint/thyme-based mouthwash --- r_associated #0: 20 --> ipilimumab
    n1=en:aloe/anise/ascorbic acid/clove/peppermint/spearmint/thyme-based mouthwash | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  295. en:alogliptin --- r_associated #0: 20 --> ipilimumab
    n1=en:alogliptin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  296. en:alopecia preparation --- r_associated #0: 20 --> ipilimumab
    n1=en:alopecia preparation | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  297. en:alpelisib --- r_associated #0: 20 --> ipilimumab
    n1=en:alpelisib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  298. en:alpha fetoprotein adenoviral vector vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:alpha fetoprotein adenoviral vector vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  299. en:alpha fetoprotein plasmid dna vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:alpha fetoprotein plasmid dna vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  300. en:alpha galactosylceramide --- r_associated #0: 20 --> ipilimumab
    n1=en:alpha galactosylceramide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  301. en:alpha-1,3-galactosyltransferase-expressing allogeneic renal cell carcinoma vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:alpha-1,3-galactosyltransferase-expressing allogeneic renal cell carcinoma vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  302. en:alpha-1-proteinase inhibitor human --- r_associated #0: 20 --> ipilimumab
    n1=en:alpha-1-proteinase inhibitor human | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  303. en:alpha-fetoprotein peptide-pulsed autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:alpha-fetoprotein peptide-pulsed autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  304. en:alpha-folate receptor-targeting thymidylate synthase inhibitor onx-0801 --- r_associated #0: 20 --> ipilimumab
    n1=en:alpha-folate receptor-targeting thymidylate synthase inhibitor onx-0801 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  305. en:alpha-gal glycosphingolipids --- r_associated #0: 20 --> ipilimumab
    n1=en:alpha-gal glycosphingolipids | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  306. en:alpha-galactosylceramide-pulsed autologous dendritic cells --- r_associated #0: 20 --> ipilimumab
    n1=en:alpha-galactosylceramide-pulsed autologous dendritic cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  307. en:alpha-lipoic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:alpha-lipoic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  308. en:alpha-lipoic acid-palladium/vitamin/mineral supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:alpha-lipoic acid-palladium/vitamin/mineral supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  309. en:alpha-tocopheryloxyacetic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:alpha-tocopheryloxyacetic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  310. en:alpha-type-1 polarized dendritic cells --- r_associated #0: 20 --> ipilimumab
    n1=en:alpha-type-1 polarized dendritic cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  311. en:alprazolam --- r_associated #0: 20 --> ipilimumab
    n1=en:alprazolam | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  312. en:alprostadil --- r_associated #0: 20 --> ipilimumab
    n1=en:alprostadil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  313. en:alteplase --- r_associated #0: 20 --> ipilimumab
    n1=en:alteplase | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  314. en:altiratinib --- r_associated #0: 20 --> ipilimumab
    n1=en:altiratinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  315. en:altretamine --- r_associated #0: 20 --> ipilimumab
    n1=en:altretamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  316. en:aluminum hydroxide/magnesium hydroxide --- r_associated #0: 20 --> ipilimumab
    n1=en:aluminum hydroxide/magnesium hydroxide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  317. en:aluminum sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:aluminum sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  318. en:alvac(2) melanoma multi-antigen therapeutic vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:alvac(2) melanoma multi-antigen therapeutic vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  319. en:alvac(2)-ny-eso-1 (m)/tricom vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:alvac(2)-ny-eso-1 (m)/tricom vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  320. en:alvac-cea b7.1 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:alvac-cea b7.1 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  321. en:alvac-cea vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:alvac-cea vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  322. en:alvac-eso-1 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:alvac-eso-1 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  323. en:alvac-hb7.1 --- r_associated #0: 20 --> ipilimumab
    n1=en:alvac-hb7.1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  324. en:alvac-mart-1 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:alvac-mart-1 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  325. en:alvelestat --- r_associated #0: 20 --> ipilimumab
    n1=en:alvelestat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  326. en:alvespimycin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:alvespimycin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  327. en:alvimopan --- r_associated #0: 20 --> ipilimumab
    n1=en:alvimopan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  328. en:alvocidib hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:alvocidib hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  329. en:amantadine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:amantadine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  330. en:amatuximab --- r_associated #0: 20 --> ipilimumab
    n1=en:amatuximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  331. en:ambazone --- r_associated #0: 20 --> ipilimumab
    n1=en:ambazone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  332. en:american ginseng --- r_associated #0: 20 --> ipilimumab
    n1=en:american ginseng | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  333. en:ametantrone --- r_associated #0: 20 --> ipilimumab
    n1=en:ametantrone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  334. en:amg 224 --- r_associated #0: 20 --> ipilimumab
    n1=en:amg 224 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  335. en:amidino tic --- r_associated #0: 20 --> ipilimumab
    n1=en:amidino tic | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  336. en:amifampridine --- r_associated #0: 20 --> ipilimumab
    n1=en:amifampridine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  337. en:amifostine --- r_associated #0: 20 --> ipilimumab
    n1=en:amifostine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  338. en:amikacin sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:amikacin sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  339. en:amilomer --- r_associated #0: 20 --> ipilimumab
    n1=en:amilomer | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  340. en:amino acid injection --- r_associated #0: 20 --> ipilimumab
    n1=en:amino acid injection | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  341. en:aminobenzoate potassium --- r_associated #0: 20 --> ipilimumab
    n1=en:aminobenzoate potassium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  342. en:aminocamptothecin --- r_associated #0: 20 --> ipilimumab
    n1=en:aminocamptothecin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  343. en:aminocamptothecin colloidal dispersion --- r_associated #0: 20 --> ipilimumab
    n1=en:aminocamptothecin colloidal dispersion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  344. en:aminocaproic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:aminocaproic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  345. en:aminoglutethimide --- r_associated #0: 20 --> ipilimumab
    n1=en:aminoglutethimide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  346. en:aminolevulinic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:aminolevulinic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  347. en:aminolevulinic acid hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:aminolevulinic acid hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  348. en:aminophylline --- r_associated #0: 20 --> ipilimumab
    n1=en:aminophylline | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  349. en:aminopterin --- r_associated #0: 20 --> ipilimumab
    n1=en:aminopterin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  350. en:aminosyn --- r_associated #0: 20 --> ipilimumab
    n1=en:aminosyn | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  351. en:aminothiadiazole --- r_associated #0: 20 --> ipilimumab
    n1=en:aminothiadiazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  352. en:amiodarone hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:amiodarone hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  353. en:amitriptyline hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:amitriptyline hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  354. en:aml mrna positive lysate loaded autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:aml mrna positive lysate loaded autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  355. en:ammonia n-13 --- r_associated #0: 20 --> ipilimumab
    n1=en:ammonia n-13 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  356. en:ammonium glycyrrhizate --- r_associated #0: 20 --> ipilimumab
    n1=en:ammonium glycyrrhizate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  357. en:amnion-derived cellular cytokine solution --- r_associated #0: 20 --> ipilimumab
    n1=en:amnion-derived cellular cytokine solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  358. en:amolimogene bepiplasmid --- r_associated #0: 20 --> ipilimumab
    n1=en:amolimogene bepiplasmid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  359. en:amonafide dihydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:amonafide dihydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  360. en:amonafide l-malate --- r_associated #0: 20 --> ipilimumab
    n1=en:amonafide l-malate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  361. en:amoxicillin --- r_associated #0: 20 --> ipilimumab
    n1=en:amoxicillin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  362. en:amoxicillin-clavulanate potassium --- r_associated #0: 20 --> ipilimumab
    n1=en:amoxicillin-clavulanate potassium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  363. en:amphotericin b deoxycholate --- r_associated #0: 20 --> ipilimumab
    n1=en:amphotericin b deoxycholate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  364. en:ampicillin sodium/sulbactam sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:ampicillin sodium/sulbactam sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  365. en:amrubicin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:amrubicin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  366. en:amsacrine --- r_associated #0: 20 --> ipilimumab
    n1=en:amsacrine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  367. en:amsilarotene --- r_associated #0: 20 --> ipilimumab
    n1=en:amsilarotene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  368. en:amt2003 --- r_associated #0: 20 --> ipilimumab
    n1=en:amt2003 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  369. en:amuvatinib --- r_associated #0: 20 --> ipilimumab
    n1=en:amuvatinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  370. en:amylin analog --- r_associated #0: 20 --> ipilimumab
    n1=en:amylin analog | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  371. en:anagrelide hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:anagrelide hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  372. en:anagrelide prolonged-release formulation --- r_associated #0: 20 --> ipilimumab
    n1=en:anagrelide prolonged-release formulation | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  373. en:anakinra --- r_associated #0: 20 --> ipilimumab
    n1=en:anakinra | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  374. en:analgesic agent --- r_associated #0: 20 --> ipilimumab
    n1=en:analgesic agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  375. en:anamorelin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:anamorelin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  376. en:anastrozole --- r_associated #0: 20 --> ipilimumab
    n1=en:anastrozole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  377. en:anaxirone --- r_associated #0: 20 --> ipilimumab
    n1=en:anaxirone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  378. en:ancestim --- r_associated #0: 20 --> ipilimumab
    n1=en:ancestim | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  379. en:ancitabine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:ancitabine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  380. en:androgen antagonist apc-100 --- r_associated #0: 20 --> ipilimumab
    n1=en:androgen antagonist apc-100 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  381. en:androgen receptor antagonist arn-509 --- r_associated #0: 20 --> ipilimumab
    n1=en:androgen receptor antagonist arn-509 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  382. en:androgen receptor antagonist shr3680 --- r_associated #0: 20 --> ipilimumab
    n1=en:androgen receptor antagonist shr3680 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  383. en:androgen receptor antisense oligonucleotide azd5312 --- r_associated #0: 20 --> ipilimumab
    n1=en:androgen receptor antisense oligonucleotide azd5312 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  384. en:androgen receptor antisense oligonucleotide ezn-4176 --- r_associated #0: 20 --> ipilimumab
    n1=en:androgen receptor antisense oligonucleotide ezn-4176 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  385. en:androgen receptor inhibitor epi-506 --- r_associated #0: 20 --> ipilimumab
    n1=en:androgen receptor inhibitor epi-506 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  386. en:androgen receptor ligand-binding domain-encoding plasmid dna vaccine mvi-118 --- r_associated #0: 20 --> ipilimumab
    n1=en:androgen receptor ligand-binding domain-encoding plasmid dna vaccine mvi-118 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  387. en:andrographolide --- r_associated #0: 20 --> ipilimumab
    n1=en:andrographolide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  388. en:androstane steroid he3235 --- r_associated #0: 20 --> ipilimumab
    n1=en:androstane steroid he3235 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  389. en:anesthetic agent --- r_associated #0: 20 --> ipilimumab
    n1=en:anesthetic agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  390. en:anetholtrithion --- r_associated #0: 20 --> ipilimumab
    n1=en:anetholtrithion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  391. en:anetumab ravtansine --- r_associated #0: 20 --> ipilimumab
    n1=en:anetumab ravtansine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  392. en:ang2/vegf-binding peptides-antibody fusion protein cvx-241 --- r_associated #0: 20 --> ipilimumab
    n1=en:ang2/vegf-binding peptides-antibody fusion protein cvx-241 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  393. en:angelica sinensis root extract --- r_associated #0: 20 --> ipilimumab
    n1=en:angelica sinensis root extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  394. en:angiogenesis inhibitor --- r_associated #0: 20 --> ipilimumab
    n1=en:angiogenesis inhibitor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  395. en:angiogenesis inhibitor gt-111 --- r_associated #0: 20 --> ipilimumab
    n1=en:angiogenesis inhibitor gt-111 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  396. en:angiogenesis inhibitor ji-101 --- r_associated #0: 20 --> ipilimumab
    n1=en:angiogenesis inhibitor ji-101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  397. en:angiogenesis/heparanase inhibitor pg545 --- r_associated #0: 20 --> ipilimumab
    n1=en:angiogenesis/heparanase inhibitor pg545 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  398. en:angiopoietin-2-specific fusion protein pf-04856884 --- r_associated #0: 20 --> ipilimumab
    n1=en:angiopoietin-2-specific fusion protein pf-04856884 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  399. en:angiostatin --- r_associated #0: 20 --> ipilimumab
    n1=en:angiostatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  400. en:anguidine --- r_associated #0: 20 --> ipilimumab
    n1=en:anguidine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  401. en:anhydrovinblastine --- r_associated #0: 20 --> ipilimumab
    n1=en:anhydrovinblastine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  402. en:anidulafungin --- r_associated #0: 20 --> ipilimumab
    n1=en:anidulafungin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  403. en:aniline mustard --- r_associated #0: 20 --> ipilimumab
    n1=en:aniline mustard | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  404. en:anlotinib hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:anlotinib hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  405. en:annamycin liposomal --- r_associated #0: 20 --> ipilimumab
    n1=en:annamycin liposomal | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  406. en:annonaceous acetogenins --- r_associated #0: 20 --> ipilimumab
    n1=en:annonaceous acetogenins | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  407. en:anthocyanin-rich corn extract --- r_associated #0: 20 --> ipilimumab
    n1=en:anthocyanin-rich corn extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  408. en:anthracycline analogue gpx-150 --- r_associated #0: 20 --> ipilimumab
    n1=en:anthracycline analogue gpx-150 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  409. en:anti c-kit antibody-drug conjugate lop628 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti c-kit antibody-drug conjugate lop628 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  410. en:anti glaucoma preparation --- r_associated #0: 20 --> ipilimumab
    n1=en:anti glaucoma preparation | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  411. en:anti-5t4 antibody-drug conjugate pf-06263507 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-5t4 antibody-drug conjugate pf-06263507 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  412. en:anti-a33 monoclonal antibody krn330 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-a33 monoclonal antibody krn330 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  413. en:anti-a5b1 integrin monoclonal antibody pf-04605412 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-a5b1 integrin monoclonal antibody pf-04605412 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  414. en:anti-ags-16 monoclonal antibody ags-16m18 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ags-16 monoclonal antibody ags-16m18 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  415. en:anti-ags-5 antibody-drug conjugate asg-5me --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ags-5 antibody-drug conjugate asg-5me | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  416. en:anti-ags-8 monoclonal antibody ags-8m4 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ags-8 monoclonal antibody ags-8m4 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  417. en:anti-alk-1 monoclonal antibody pf-03446962 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-alk-1 monoclonal antibody pf-03446962 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  418. en:anti-allergic agents --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-allergic agents | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  419. en:anti-alpha5beta1 integrin antibody mint1526a --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-alpha5beta1 integrin antibody mint1526a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  420. en:anti-alphavbeta3 monoclonal antibody emd 525797 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-alphavbeta3 monoclonal antibody emd 525797 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  421. en:anti-amyloid monoclonal antibody neod001 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-amyloid monoclonal antibody neod001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  422. en:anti-androgen --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-androgen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  423. en:anti-ang2 monoclonal antibody medi-3617 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ang2 monoclonal antibody medi-3617 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  424. en:anti-angiopoietin monoclonal antibody amg 780 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-angiopoietin monoclonal antibody amg 780 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  425. en:anti-b4 blocked ricin immunotoxin --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-b4 blocked ricin immunotoxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  426. en:anti-b7-h3 antibody ds-5573a --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-b7-h3 antibody ds-5573a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  427. en:anti-bcma antibody-drug conjugate gsk2857916 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-bcma antibody-drug conjugate gsk2857916 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  428. en:anti-c-fms monoclonal antibody amg 820 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-c-fms monoclonal antibody amg 820 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  429. en:anti-c-kit monoclonal antibody ktn0158 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-c-kit monoclonal antibody ktn0158 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  430. en:anti-c-met monoclonal antibody abt-700 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-c-met monoclonal antibody abt-700 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  431. en:anti-c-met monoclonal antibody argx-111 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-c-met monoclonal antibody argx-111 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  432. en:anti-c-met monoclonal antibody ly2875358 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-c-met monoclonal antibody ly2875358 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  433. en:anti-c-met monoclonal antibody sait301 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-c-met monoclonal antibody sait301 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  434. en:anti-c4.4a antibody-drug conjugate bay1129980 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-c4.4a antibody-drug conjugate bay1129980 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  435. en:anti-ca19-9 monoclonal antibody 5b1 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ca19-9 monoclonal antibody 5b1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  436. en:anti-ca6-dm4 immunoconjugate sar566658 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ca6-dm4 immunoconjugate sar566658 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  437. en:anti-cd123 monoclonal antibody csl360 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd123 monoclonal antibody csl360 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  438. en:anti-cd123 monoclonal antibody csl362 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd123 monoclonal antibody csl362 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  439. en:anti-cd123 monoclonal antibody khk2823 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd123 monoclonal antibody khk2823 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  440. en:anti-cd123 x anti-cd3 bispecific antibody xmab1404 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd123 x anti-cd3 bispecific antibody xmab1404 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  441. en:anti-cd123/cd3 bispecific antibody jnj-63709178 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd123/cd3 bispecific antibody jnj-63709178 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  442. en:anti-cd123/cd3 monoclonal antibody mgd006 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd123/cd3 monoclonal antibody mgd006 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  443. en:anti-cd133-car vector-transduced allogeneic t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd133-car vector-transduced allogeneic t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  444. en:anti-cd157 monoclonal antibody men1112 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd157 monoclonal antibody men1112 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  445. en:anti-cd19 antibody-drug conjugate sgn-cd19b --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd19 antibody-drug conjugate sgn-cd19b | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  446. en:anti-cd19 monoclonal antibody di-b4 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd19 monoclonal antibody di-b4 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  447. en:anti-cd19 monoclonal antibody mdx-1342 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd19 monoclonal antibody mdx-1342 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  448. en:anti-cd19 monoclonal antibody medi-551 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd19 monoclonal antibody medi-551 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  449. en:anti-cd19 monoclonal antibody xmab5574 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd19 monoclonal antibody xmab5574 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  450. en:anti-cd19-car fmc63-28z retroviral vector-transduced allogeneic t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd19-car fmc63-28z retroviral vector-transduced allogeneic t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  451. en:anti-cd19-car retroviral vector-transduced autologous t cells --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd19-car retroviral vector-transduced autologous t cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  452. en:anti-cd19-car-cd3zeta-4-1bb-expressing allogenic natural killer cells --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd19-car-cd3zeta-4-1bb-expressing allogenic natural killer cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  453. en:anti-cd19-dm4 immunoconjugate sar3419 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd19-dm4 immunoconjugate sar3419 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  454. en:anti-cd19/anti-cd22 bispecific immunotoxin dt2219arl --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd19/anti-cd22 bispecific immunotoxin dt2219arl | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  455. en:anti-cd19/cd28/cd3zeta car gammaretroviral vector-transduced autologous t lymphocytes kte-c19 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd19/cd28/cd3zeta car gammaretroviral vector-transduced autologous t lymphocytes kte-c19 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  456. en:anti-cd19/cd3 tetravalent antibody afm11 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd19/cd3 tetravalent antibody afm11 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  457. en:anti-cd20 b9e9 scfv-streptavidin fusion protein --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd20 b9e9 scfv-streptavidin fusion protein | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  458. en:anti-cd20 monoclonal antibody pro131921 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd20 monoclonal antibody pro131921 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  459. en:anti-cd20 monoclonal antibody sct400 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd20 monoclonal antibody sct400 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  460. en:anti-cd20 monoclonal antibody tl011 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd20 monoclonal antibody tl011 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  461. en:anti-cd20 monoclonal antibody-interferon-alpha fusion protein ign002 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd20 monoclonal antibody-interferon-alpha fusion protein ign002 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  462. en:anti-cd20-car-cd3zeta-4-1bb-expressing autologous t-lymphocyte cells --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd20-car-cd3zeta-4-1bb-expressing autologous t-lymphocyte cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  463. en:anti-cd20-engineered toxin body mt-3724 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd20-engineered toxin body mt-3724 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  464. en:anti-cd20/cd3 monoclonal antibody regn1979 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd20/cd3 monoclonal antibody regn1979 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  465. en:anti-cd200 monoclonal antibody alxn6000 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd200 monoclonal antibody alxn6000 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  466. en:anti-cd22 car-expressing t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd22 car-expressing t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  467. en:anti-cd22 monoclonal antibody-mmae conjugate dcdt2980s --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd22 monoclonal antibody-mmae conjugate dcdt2980s | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  468. en:anti-cd22 scfv tcrz:41bb-car lentiviral vector-transduced autologous t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd22 scfv tcrz:41bb-car lentiviral vector-transduced autologous t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  469. en:anti-cd22-car m971-bbz lentiviral vector-transduced autologous t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd22-car m971-bbz lentiviral vector-transduced autologous t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  470. en:anti-cd25-pbd antibody-drug conjugate adct-301 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd25-pbd antibody-drug conjugate adct-301 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  471. en:anti-cd27l antibody-drug conjugate amg 172 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd27l antibody-drug conjugate amg 172 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  472. en:anti-cd3 immunotoxin a-dmdt390-bisfv(ucht1) --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd3 immunotoxin a-dmdt390-bisfv(ucht1) | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  473. en:anti-cd3 okt3/humanized anti-gd2 3f8 bispecific antibody-activated t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd3 okt3/humanized anti-gd2 3f8 bispecific antibody-activated t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  474. en:anti-cd3 x anti-cd20 bispecific antibody-armed activated t cells --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd3 x anti-cd20 bispecific antibody-armed activated t cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  475. en:anti-cd3/anti-cd20 trifunctional bispecific monoclonal antibody fbta05 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd3/anti-cd20 trifunctional bispecific monoclonal antibody fbta05 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  476. en:anti-cd3/anti-egfr-bispecific monoclonal antibody-armed activated autologous t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd3/anti-egfr-bispecific monoclonal antibody-armed activated autologous t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  477. en:anti-cd30 monoclonal antibody mdx-1401 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd30 monoclonal antibody mdx-1401 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  478. en:anti-cd30 monoclonal antibody xmab2513 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd30 monoclonal antibody xmab2513 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  479. en:anti-cd30/cd16a monoclonal antibody afm13 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd30/cd16a monoclonal antibody afm13 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  480. en:anti-cd33 antibody-drug conjugate imgn779 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd33 antibody-drug conjugate imgn779 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  481. en:anti-cd33 monoclonal antibody bi 836858 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd33 monoclonal antibody bi 836858 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  482. en:anti-cd33 monoclonal antibody-dm4 conjugate ave9633 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd33 monoclonal antibody-dm4 conjugate ave9633 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  483. en:anti-cd33/cd3 bite antibody amg 330 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd33/cd3 bite antibody amg 330 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  484. en:anti-cd37 antibody-drug conjugate imgn529 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd37 antibody-drug conjugate imgn529 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  485. en:anti-cd37 mmae antibody-drug conjugate ags67e --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd37 mmae antibody-drug conjugate ags67e | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  486. en:anti-cd37 monoclonal antibody bi 836826 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd37 monoclonal antibody bi 836826 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  487. en:anti-cd38 monoclonal antibody mor03087 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd38 monoclonal antibody mor03087 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  488. en:anti-cd38 monoclonal antibody sar650984 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd38 monoclonal antibody sar650984 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  489. en:anti-cd40 monoclonal antibody chi lob 7/4 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd40 monoclonal antibody chi lob 7/4 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  490. en:anti-cd40 monoclonal antibody sea-cd40 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd40 monoclonal antibody sea-cd40 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  491. en:anti-cd40l fc-fusion protein bms-986004 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd40l fc-fusion protein bms-986004 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  492. en:anti-cd44 monoclonal antibody ro5429083 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd44 monoclonal antibody ro5429083 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  493. en:anti-cd45 bc8 monoclonal antibody-streptavidin conjugate --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd45 bc8 monoclonal antibody-streptavidin conjugate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  494. en:anti-cd45 monoclonal antibody --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd45 monoclonal antibody | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  495. en:anti-cd45 monoclonal antibody ahn-12 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd45 monoclonal antibody ahn-12 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  496. en:anti-cd45 monoclonal antibody bc8 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd45 monoclonal antibody bc8 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  497. en:anti-cd47 monoclonal antibody cc-90002 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd47 monoclonal antibody cc-90002 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  498. en:anti-cd47 monoclonal antibody hu5f9-g4 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd47 monoclonal antibody hu5f9-g4 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  499. en:anti-cd7 immunotoxin --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd7 immunotoxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  500. en:anti-cd70 antibody-drug conjugate mdx-1203 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd70 antibody-drug conjugate mdx-1203 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  501. en:anti-cd70 antibody-drug conjugate sgn-cd70a --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd70 antibody-drug conjugate sgn-cd70a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  502. en:anti-cd70 monoclonal antibody argx-110 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd70 monoclonal antibody argx-110 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  503. en:anti-cd70 monoclonal antibody mdx-1411 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd70 monoclonal antibody mdx-1411 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  504. en:anti-cd73 monoclonal antibody medi9447 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd73 monoclonal antibody medi9447 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  505. en:anti-cd98 monoclonal antibody ign523 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd98 monoclonal antibody ign523 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  506. en:anti-cd98 monoclonal antibody khk2898 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cd98 monoclonal antibody khk2898 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  507. en:anti-cea bite monoclonal antibody amg211 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cea bite monoclonal antibody amg211 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  508. en:anti-cea igcd28tcr-transduced autologous t cells --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cea igcd28tcr-transduced autologous t cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  509. en:anti-cea tcr retroviral vector-transduced autologous peripheral blood lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cea tcr retroviral vector-transduced autologous peripheral blood lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  510. en:anti-cea-car autologous t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cea-car autologous t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  511. en:anti-cea/anti-dtpa-in (f6-734) bispecific antibody --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cea/anti-dtpa-in (f6-734) bispecific antibody | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  512. en:anti-cea/anti-hsg bispecific monoclonal antibody tf2 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cea/anti-hsg bispecific monoclonal antibody tf2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  513. en:anti-cea/cd3 bispecific antibody ro6958688 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cea/cd3 bispecific antibody ro6958688 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  514. en:anti-ceacam1 monoclonal antibody cm-24 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ceacam1 monoclonal antibody cm-24 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  515. en:anti-ceacam5 antibody-drug conjugate sar408701 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ceacam5 antibody-drug conjugate sar408701 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  516. en:anti-ceacam6 afaikl2 antibody fragment/jack bean urease immunoconjugate l-dos47 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ceacam6 afaikl2 antibody fragment/jack bean urease immunoconjugate l-dos47 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  517. en:anti-cldn6 monoclonal antibody imab027 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cldn6 monoclonal antibody imab027 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  518. en:anti-csf1r monoclonal antibody fpa008 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-csf1r monoclonal antibody fpa008 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  519. en:anti-csf1r monoclonal antibody imc-cs4 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-csf1r monoclonal antibody imc-cs4 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  520. en:anti-ctgf monoclonal antibody fg-3019 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ctgf monoclonal antibody fg-3019 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  521. en:anti-ctla-4 mab rna-transfected autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ctla-4 mab rna-transfected autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  522. en:anti-ctla-4 monoclonal antibody agen1884 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ctla-4 monoclonal antibody agen1884 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  523. en:anti-ctla4 moab rna/gitrl rna-transfected autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ctla4 moab rna/gitrl rna-transfected autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  524. en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/autologous dendritic cells/mart-1 antigen --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/autologous dendritic cells/mart-1 antigen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  525. en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/docetaxel --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/docetaxel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  526. en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/fowlpox-psa-tricom vaccine/sargramostim/vaccinia-psa-tricom vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/fowlpox-psa-tricom vaccine/sargramostim/vaccinia-psa-tricom vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  527. en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/gp100 antigen/mart-1 antigen/montanide isa-51/tyrosinase peptide --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/gp100 antigen/mart-1 antigen/montanide isa-51/tyrosinase peptide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  528. en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/gp100 antigen/montanide isa-51 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/gp100 antigen/montanide isa-51 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  529. en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/interleukin-2 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/interleukin-2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  530. en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/mdx-1379 melanoma vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/mdx-1379 melanoma vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  531. en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/sargramostim --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-cytotoxic t-lymphocyte-associated antigen-4 monoclonal antibody/sargramostim | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  532. en:anti-denatured collagen monoclonal antibody trc093 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-denatured collagen monoclonal antibody trc093 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  533. en:anti-diabetic agent --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-diabetic agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  534. en:anti-dkk-1 monoclonal antibody ly2812176 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-dkk-1 monoclonal antibody ly2812176 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  535. en:anti-dkk1 monoclonal antibody bhq880 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-dkk1 monoclonal antibody bhq880 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  536. en:anti-dll4 monoclonal antibody medi0639 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-dll4 monoclonal antibody medi0639 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  537. en:anti-dll4 monoclonal antibody regn421 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-dll4 monoclonal antibody regn421 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  538. en:anti-dll4/vegf bispecific monoclonal antibody omp-305b83 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-dll4/vegf bispecific monoclonal antibody omp-305b83 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  539. en:anti-dr5 agonist monoclonal antibody tra-8 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-dr5 agonist monoclonal antibody tra-8 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  540. en:anti-dr5 agonistic antibody ds-8273a --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-dr5 agonistic antibody ds-8273a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  541. en:anti-egfr monoclonal antibody gc1118 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-egfr monoclonal antibody gc1118 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  542. en:anti-egfr monoclonal antibody gt-mab 5.2-gex --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-egfr monoclonal antibody gt-mab 5.2-gex | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  543. en:anti-egfr monoclonal antibody mixture mm-151 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-egfr monoclonal antibody mixture mm-151 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  544. en:anti-egfr monoclonal antibody mixture sym004 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-egfr monoclonal antibody mixture sym004 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  545. en:anti-egfr monoclonal antibody ro5083945 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-egfr monoclonal antibody ro5083945 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  546. en:anti-egfr monoclonal antibody sct200 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-egfr monoclonal antibody sct200 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  547. en:anti-egfr monoclonal antibody syn004 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-egfr monoclonal antibody syn004 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  548. en:anti-egfr tap antibody-drug conjugate imgn289 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-egfr tap antibody-drug conjugate imgn289 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  549. en:anti-egfr/c-met bispecific antibody jnj-61186372 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-egfr/c-met bispecific antibody jnj-61186372 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  550. en:anti-egfrviii antibody drug conjugate amg 595 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-egfrviii antibody drug conjugate amg 595 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  551. en:anti-egfrviii car-transduced allogeneic t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-egfrviii car-transduced allogeneic t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  552. en:anti-egfrviii immunotoxin mr1-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-egfrviii immunotoxin mr1-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  553. en:anti-egp-2 immunotoxin moc31-pe --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-egp-2 immunotoxin moc31-pe | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  554. en:anti-endoglin chimeric monoclonal antibody trc105 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-endoglin chimeric monoclonal antibody trc105 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  555. en:anti-endosialin monoclonal antibody morab-004 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-endosialin monoclonal antibody morab-004 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  556. en:anti-enpp3 antibody-drug conjugate ags-16c3f --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-enpp3 antibody-drug conjugate ags-16c3f | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  557. en:anti-enpp3/mmaf antibody-drug conjugate ags-16m8f --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-enpp3/mmaf antibody-drug conjugate ags-16m8f | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  558. en:anti-epcam antibody fragment-pseudomonas-exotoxin fusion protein --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-epcam antibody fragment-pseudomonas-exotoxin fusion protein | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  559. en:anti-epha2 monoclonal antibody ds-8895a --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-epha2 monoclonal antibody ds-8895a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  560. en:anti-epha2 monoclonal antibody-mmaf immunoconjugate medi-547 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-epha2 monoclonal antibody-mmaf immunoconjugate medi-547 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  561. en:anti-epha3 monoclonal antibody kb004 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-epha3 monoclonal antibody kb004 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  562. en:anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-epidermal growth factor receptor 2 antibody expressing pluripotent killer t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  563. en:anti-erbb2/anti-erbb3 bispecific monoclonal antibody mm-111 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-erbb2/anti-erbb3 bispecific monoclonal antibody mm-111 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  564. en:anti-erbb3 monoclonal antibody av-203 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-erbb3 monoclonal antibody av-203 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  565. en:anti-erbb3 monoclonal antibody ktn3379 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-erbb3 monoclonal antibody ktn3379 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  566. en:anti-erbb3 monoclonal antibody regn1400 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-erbb3 monoclonal antibody regn1400 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  567. en:anti-erbb3/anti-igf-1r bispecific monoclonal antibody mm-141 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-erbb3/anti-igf-1r bispecific monoclonal antibody mm-141 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  568. en:anti-etbr/mmae antibody-drug conjugate dedn6526a --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-etbr/mmae antibody-drug conjugate dedn6526a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  569. en:anti-fgf23 igg1 monoclonal antibody krn23 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-fgf23 igg1 monoclonal antibody krn23 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  570. en:anti-fgfr2 antibody bay1179470 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-fgfr2 antibody bay1179470 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  571. en:anti-fgfr2 antibody-drug conjugate bay1187982 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-fgfr2 antibody-drug conjugate bay1187982 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  572. en:anti-fgfr2 monoclonal antibody fpa144 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-fgfr2 monoclonal antibody fpa144 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  573. en:anti-fgfr3 antibody-drug conjugate ly3076226 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-fgfr3 antibody-drug conjugate ly3076226 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  574. en:anti-fgfr3 monoclonal antibody b-701 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-fgfr3 monoclonal antibody b-701 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  575. en:anti-fgfr3 monoclonal antibody mfgr1877s --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-fgfr3 monoclonal antibody mfgr1877s | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  576. en:anti-fgfr4 monoclonal antibody u3-1784 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-fgfr4 monoclonal antibody u3-1784 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  577. en:anti-flt3 monoclonal antibody imc-eb10 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-flt3 monoclonal antibody imc-eb10 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  578. en:anti-fucosyl-gm1 monoclonal antibody bms-986012 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-fucosyl-gm1 monoclonal antibody bms-986012 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  579. en:anti-ganglioside gm2 monoclonal antibody biw-8962 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ganglioside gm2 monoclonal antibody biw-8962 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  580. en:anti-gcc antibody-drug conjugate mln0264 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-gcc antibody-drug conjugate mln0264 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  581. en:anti-gd2 monoclonal antibody hu14.18k322a --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-gd2 monoclonal antibody hu14.18k322a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  582. en:anti-gd2 monoclonal antibody morab-028 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-gd2 monoclonal antibody morab-028 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  583. en:anti-gitr agonistic monoclonal antibody incagn01876 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-gitr agonistic monoclonal antibody incagn01876 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  584. en:anti-gitr monoclonal antibody gwn 323 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-gitr monoclonal antibody gwn 323 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  585. en:anti-gitr monoclonal antibody mk-4166 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-gitr monoclonal antibody mk-4166 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  586. en:anti-gnrh vaccine pep223 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-gnrh vaccine pep223 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  587. en:anti-gpa33/cd3 monoclonal antibody mgd007 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-gpa33/cd3 monoclonal antibody mgd007 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  588. en:anti-gpc3 monoclonal antibody gc33 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-gpc3 monoclonal antibody gc33 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  589. en:anti-gpc3-car autologous t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-gpc3-car autologous t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  590. en:anti-grp78 monoclonal antibody pat-sm6 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-grp78 monoclonal antibody pat-sm6 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  591. en:anti-hb-egf monoclonal antibody khk2866 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-hb-egf monoclonal antibody khk2866 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  592. en:anti-hbegf monoclonal antibody u3-1565 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-hbegf monoclonal antibody u3-1565 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  593. en:anti-hcv e2 monoclonal antibody mbl-hcv1 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-hcv e2 monoclonal antibody mbl-hcv1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  594. en:anti-hepcidin monoclonal antibody ly2787106 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-hepcidin monoclonal antibody ly2787106 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  595. en:anti-her-2-car retroviral vector-transduced autologous peripheral blood lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-her-2-car retroviral vector-transduced autologous peripheral blood lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  596. en:anti-her2 antibody-drug conjugate arx788 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-her2 antibody-drug conjugate arx788 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  597. en:anti-her2 antibody-drug conjugate medi4276 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-her2 antibody-drug conjugate medi4276 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  598. en:anti-her2 monoclonal antibody ct-p6 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-her2 monoclonal antibody ct-p6 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  599. en:anti-her2-car autologous cmv-specific cytotoxic t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-her2-car autologous cmv-specific cytotoxic t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  600. en:anti-her3 monoclonal antibody gsk2849330 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-her3 monoclonal antibody gsk2849330 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  601. en:anti-her3 monoclonal antibody ljm716 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-her3 monoclonal antibody ljm716 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  602. en:anti-hgf monoclonal antibody tak-701 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-hgf monoclonal antibody tak-701 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  603. en:anti-hif-1alpha lna antisense oligonucleotide ezn-2968 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-hif-1alpha lna antisense oligonucleotide ezn-2968 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  604. en:anti-hla-a2/ny-eso-1 tcr-transduced autologous t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-hla-a2/ny-eso-1 tcr-transduced autologous t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  605. en:anti-hla-dr monoclonal antibody immu-114 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-hla-dr monoclonal antibody immu-114 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  606. en:anti-human chorionic gonadotropin vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-human chorionic gonadotropin vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  607. en:anti-human gitr monoclonal antibody trx518 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-human gitr monoclonal antibody trx518 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  608. en:anti-icam-1 monoclonal antibody bi-505 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-icam-1 monoclonal antibody bi-505 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  609. en:anti-icos agonist antibody gsk3359609 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-icos agonist antibody gsk3359609 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  610. en:anti-icos monoclonal antibody medi-570 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-icos monoclonal antibody medi-570 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  611. en:anti-idiotypic monoclonal antibody bec2 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-idiotypic monoclonal antibody bec2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  612. en:anti-igf-1r monoclonal antibody ave1642 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-igf-1r monoclonal antibody ave1642 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  613. en:anti-igf-1r recombinant monoclonal antibody biib022 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-igf-1r recombinant monoclonal antibody biib022 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  614. en:anti-igf1/2 monoclonal antibody medi-573 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-igf1/2 monoclonal antibody medi-573 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  615. en:anti-il-1 alpha monoclonal antibody ca-18c3 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-il-1 alpha monoclonal antibody ca-18c3 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  616. en:anti-il-1 alpha monoclonal antibody mabp1 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-il-1 alpha monoclonal antibody mabp1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  617. en:anti-il-13 humanized monoclonal antibody tnx-650 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-il-13 humanized monoclonal antibody tnx-650 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  618. en:anti-il-15 monoclonal antibody amg 714 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-il-15 monoclonal antibody amg 714 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  619. en:anti-il-4/il-13 combination agent qbx258 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-il-4/il-13 combination agent qbx258 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  620. en:anti-il-8 monoclonal antibody humax-il8 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-il-8 monoclonal antibody humax-il8 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  621. en:anti-infective agent --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-infective agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  622. en:anti-inflammatory agents --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-inflammatory agents | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  623. en:anti-inflammatory antibody alxn1007 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-inflammatory antibody alxn1007 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  624. en:anti-inhibitor coagulant complex feiba nf --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-inhibitor coagulant complex feiba nf | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  625. en:anti-integrin monoclonal antibody-dm4 immunoconjugate imgn388 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-integrin monoclonal antibody-dm4 immunoconjugate imgn388 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  626. en:anti-interferon gamma monoclonal antibody ni-0501 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-interferon gamma monoclonal antibody ni-0501 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  627. en:anti-interleukin 6 monoclonal antibody ald518 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-interleukin 6 monoclonal antibody ald518 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  628. en:anti-kir monoclonal antibody iph 2101 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-kir monoclonal antibody iph 2101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  629. en:anti-kir3dl2 monoclonal antibody iph4102 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-kir3dl2 monoclonal antibody iph4102 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  630. en:anti-ksp/anti-vegf sirnas aln-vsp02 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ksp/anti-vegf sirnas aln-vsp02 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  631. en:anti-lag-3 monoclonal antibody bms-986016 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-lag-3 monoclonal antibody bms-986016 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  632. en:anti-lag-3 monoclonal antibody lag525 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-lag-3 monoclonal antibody lag525 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  633. en:anti-lamp1 antibody-drug conjugate sar428926 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-lamp1 antibody-drug conjugate sar428926 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  634. en:anti-lgr5 monoclonal antibody bnc101 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-lgr5 monoclonal antibody bnc101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  635. en:anti-liv-1 monoclonal antibody-mmae conjugate sgn-liv1a --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-liv-1 monoclonal antibody-mmae conjugate sgn-liv1a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  636. en:anti-ly6e antibody-drug conjugate dlye5953a --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ly6e antibody-drug conjugate dlye5953a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  637. en:anti-m-csf monoclonal antibody mcs110 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-m-csf monoclonal antibody mcs110 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  638. en:anti-masp-2 monoclonal antibody oms721 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-masp-2 monoclonal antibody oms721 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  639. en:anti-melanin monoclonal antibody pti-6d2 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-melanin monoclonal antibody pti-6d2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  640. en:anti-mesothelin antibody-drug conjugate bms-986148 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-mesothelin antibody-drug conjugate bms-986148 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  641. en:anti-mesothelin car vector-transduced autologous t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-mesothelin car vector-transduced autologous t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  642. en:anti-mesothelin cir mrna-electroporated autologous t cells --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-mesothelin cir mrna-electroporated autologous t cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  643. en:anti-mesothelin icasp9m28z car-transduced autologous t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-mesothelin icasp9m28z car-transduced autologous t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  644. en:anti-mesothelin-pseudomonas exotoxin 24 cytolytic fusion protein lmb-100 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-mesothelin-pseudomonas exotoxin 24 cytolytic fusion protein lmb-100 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  645. en:anti-mesothelin/mmae antibody-drug conjugate dmot4039a --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-mesothelin/mmae antibody-drug conjugate dmot4039a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  646. en:anti-met monoclonal antibody mixture sym015 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-met monoclonal antibody mixture sym015 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  647. en:anti-met/egfr monoclonal antibody ly3164530 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-met/egfr monoclonal antibody ly3164530 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  648. en:anti-mmp-9 monoclonal antibody gs-5745 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-mmp-9 monoclonal antibody gs-5745 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  649. en:anti-muc1 car-transduced autologous t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-muc1 car-transduced autologous t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  650. en:anti-muc1 monoclonal antibody bth1704 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-muc1 monoclonal antibody bth1704 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  651. en:anti-myeloma monoclonal antibody-dm4 immunoconjugate bt-062 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-myeloma monoclonal antibody-dm4 immunoconjugate bt-062 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  652. en:anti-myostatin monoclonal antibody ly2495655 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-myostatin monoclonal antibody ly2495655 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  653. en:anti-napi2b/mmae antibody-drug conjugate dnib0600a --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-napi2b/mmae antibody-drug conjugate dnib0600a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  654. en:anti-nectin 4 antibody-drug conjugate asg-22ce --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-nectin 4 antibody-drug conjugate asg-22ce | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  655. en:anti-nectin-4 monoclonal antibody-drug conjugate ags-22m6e --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-nectin-4 monoclonal antibody-drug conjugate ags-22m6e | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  656. en:anti-neuropilin-1 monoclonal antibody mnrp1685a --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-neuropilin-1 monoclonal antibody mnrp1685a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  657. en:anti-nf-p2x7 antibody ointment bil-010t --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-nf-p2x7 antibody ointment bil-010t | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  658. en:anti-nucleolin aptamer as1411 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-nucleolin aptamer as1411 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  659. en:anti-ny-eso-1 immunotherapeutic gsk-2241658a --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ny-eso-1 immunotherapeutic gsk-2241658a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  660. en:anti-ny-eso1 tcr-transduced autologous cd62l+-derived t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ny-eso1 tcr-transduced autologous cd62l+-derived t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  661. en:anti-ofa immunotherapeutic bb-mpi-03 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ofa immunotherapeutic bb-mpi-03 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  662. en:anti-ox40 antibody bms 986178 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ox40 antibody bms 986178 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  663. en:anti-ox40 antibody pf-04518600 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ox40 antibody pf-04518600 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  664. en:anti-ox40 monoclonal antibody --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ox40 monoclonal antibody | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  665. en:anti-ox40 monoclonal antibody gsk3174998 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ox40 monoclonal antibody gsk3174998 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  666. en:anti-ox40 monoclonal antibody medi0562 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ox40 monoclonal antibody medi0562 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  667. en:anti-ox40 monoclonal antibody moxr0916 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ox40 monoclonal antibody moxr0916 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  668. en:anti-p53 t-cell receptor-transduced peripheral blood lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-p53 t-cell receptor-transduced peripheral blood lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  669. en:anti-pd-1 checkpoint inhibitor pf-06801591 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-pd-1 checkpoint inhibitor pf-06801591 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  670. en:anti-pd-1 fusion protein amp-224 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-pd-1 fusion protein amp-224 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  671. en:anti-pd-1 monoclonal antibody bgb-a317 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-pd-1 monoclonal antibody bgb-a317 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  672. en:anti-pd-1 monoclonal antibody medi0680 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-pd-1 monoclonal antibody medi0680 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  673. en:anti-pd-1 monoclonal antibody pdr001 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-pd-1 monoclonal antibody pdr001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  674. en:anti-pd-1 monoclonal antibody regn2810 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-pd-1 monoclonal antibody regn2810 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  675. en:anti-pd-1 monoclonal antibody shr-1210 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-pd-1 monoclonal antibody shr-1210 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  676. en:anti-pd-1 monoclonal antibody tsr-042 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-pd-1 monoclonal antibody tsr-042 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  677. en:anti-pd-l1 monoclonal antibody ly3300054 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-pd-l1 monoclonal antibody ly3300054 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  678. en:anti-pd-l1 monoclonal antibody mdx-1105 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-pd-l1 monoclonal antibody mdx-1105 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  679. en:anti-pd-l1/tgfbetarii fusion protein msb0011359c --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-pd-l1/tgfbetarii fusion protein msb0011359c | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  680. en:anti-pdgfr alpha monoclonal antibody medi-575 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-pdgfr alpha monoclonal antibody medi-575 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  681. en:anti-pgf monoclonal antibody ro5323441 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-pgf monoclonal antibody ro5323441 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  682. en:anti-pkn3 sirna atu027 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-pkn3 sirna atu027 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  683. en:anti-plgf monoclonal antibody tb-403 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-plgf monoclonal antibody tb-403 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  684. en:anti-pr1/hla-a2 monoclonal antibody hu8f4 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-pr1/hla-a2 monoclonal antibody hu8f4 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  685. en:anti-prame immunotherapeutic gsk2302032a --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-prame immunotherapeutic gsk2302032a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  686. en:anti-programmed cell death protein 1 antibody expressing pluripotent killer t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-programmed cell death protein 1 antibody expressing pluripotent killer t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  687. en:anti-prolactin receptor antibody lfa102 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-prolactin receptor antibody lfa102 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  688. en:anti-psca fully human monoclonal antibody ags-1c4d4 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-psca fully human monoclonal antibody ags-1c4d4 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  689. en:anti-psma monoclonal antibody mdx1201-a488 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-psma monoclonal antibody mdx1201-a488 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  690. en:anti-psma monoclonal antibody-mmae conjugate --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-psma monoclonal antibody-mmae conjugate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  691. en:anti-psma/cd3 bite monoclonal antibody mt112 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-psma/cd3 bite monoclonal antibody mt112 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  692. en:anti-psma/cd3 monoclonal antibody mor209/es414 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-psma/cd3 monoclonal antibody mor209/es414 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  693. en:anti-rspo3 monoclonal antibody omp-131r10 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-rspo3 monoclonal antibody omp-131r10 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  694. en:anti-sclu monoclonal antibody ab-16b5 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-sclu monoclonal antibody ab-16b5 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  695. en:anti-sema4d monoclonal antibody vx15/2503 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-sema4d monoclonal antibody vx15/2503 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  696. en:anti-slitrk6 monoclonal antibody-mmae conjugate ags15e --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-slitrk6 monoclonal antibody-mmae conjugate ags15e | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  697. en:anti-ta-muc1 monoclonal antibody pankomab --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-ta-muc1 monoclonal antibody pankomab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  698. en:anti-tf monoclonal antibody alt-836 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-tf monoclonal antibody alt-836 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  699. en:anti-tf monoclonal antibody-mmae conjugate --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-tf monoclonal antibody-mmae conjugate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  700. en:anti-tgf-beta rii monoclonal antibody imc-tr1 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-tgf-beta rii monoclonal antibody imc-tr1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  701. en:anti-thymocyte globulin --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-thymocyte globulin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  702. en:anti-thyroglobulin mtcr-transduced autologous peripheral blood lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-thyroglobulin mtcr-transduced autologous peripheral blood lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  703. en:anti-tim-3 monoclonal antibody mbg453 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-tim-3 monoclonal antibody mbg453 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  704. en:anti-tissue factor monoclonal antibody morab-066 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-tissue factor monoclonal antibody morab-066 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  705. en:anti-tlr2 monoclonal antibody opn-305 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-tlr2 monoclonal antibody opn-305 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  706. en:anti-transthyretin sirna aln-ttr02 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-transthyretin sirna aln-ttr02 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  707. en:anti-tumor necrosis factor alpha drug --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-tumor necrosis factor alpha drug | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  708. en:anti-tweak monoclonal antibody ro5458640 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-tweak monoclonal antibody ro5458640 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  709. en:anti-vegf anticalin prs-050-peg40 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-vegf anticalin prs-050-peg40 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  710. en:anti-vegf/ang2 nanobody bi 836880 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-vegf/ang2 nanobody bi 836880 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  711. en:anti-vegfc monoclonal antibody vgx-100 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-vegfc monoclonal antibody vgx-100 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  712. en:anti-vegfr2-car retroviral vector-transduced autologous t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-vegfr2-car retroviral vector-transduced autologous t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  713. en:anti-vegfr3 monoclonal antibody imc-3c5 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-vegfr3 monoclonal antibody imc-3c5 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  714. en:anti-vista monoclonal antibody jnj 61610588 --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-vista monoclonal antibody jnj 61610588 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  715. en:anti-von willebrand factor nanobody --- r_associated #0: 20 --> ipilimumab
    n1=en:anti-von willebrand factor nanobody | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  716. en:antiangiogenic drug combination tl-118 --- r_associated #0: 20 --> ipilimumab
    n1=en:antiangiogenic drug combination tl-118 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  717. en:antiarrhythmic agent --- r_associated #0: 20 --> ipilimumab
    n1=en:antiarrhythmic agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  718. en:antiarthritic agent --- r_associated #0: 20 --> ipilimumab
    n1=en:antiarthritic agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  719. en:antibiotic --- r_associated #0: 20 --> ipilimumab
    n1=en:antibiotic | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  720. en:antibiotic sq109 --- r_associated #0: 20 --> ipilimumab
    n1=en:antibiotic sq109 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  721. en:antibody-drug conjugate abbv-085 --- r_associated #0: 20 --> ipilimumab
    n1=en:antibody-drug conjugate abbv-085 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  722. en:antibody-drug conjugate abbv-399 --- r_associated #0: 20 --> ipilimumab
    n1=en:antibody-drug conjugate abbv-399 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  723. en:antibody-drug conjugate abbv-838 --- r_associated #0: 20 --> ipilimumab
    n1=en:antibody-drug conjugate abbv-838 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  724. en:antibody-drug conjugate adct-402 --- r_associated #0: 20 --> ipilimumab
    n1=en:antibody-drug conjugate adct-402 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  725. en:antibody-drug conjugate bay79-4620 --- r_associated #0: 20 --> ipilimumab
    n1=en:antibody-drug conjugate bay79-4620 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  726. en:antibody-drug conjugate dfrf4539a --- r_associated #0: 20 --> ipilimumab
    n1=en:antibody-drug conjugate dfrf4539a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  727. en:antibody-drug conjugate pf-06647020 --- r_associated #0: 20 --> ipilimumab
    n1=en:antibody-drug conjugate pf-06647020 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  728. en:antibody-drug conjugate pf-06647263 --- r_associated #0: 20 --> ipilimumab
    n1=en:antibody-drug conjugate pf-06647263 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  729. en:antibody-drug conjugate pf-06664178 --- r_associated #0: 20 --> ipilimumab
    n1=en:antibody-drug conjugate pf-06664178 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  730. en:antibody-drug conjugate sc-002 --- r_associated #0: 20 --> ipilimumab
    n1=en:antibody-drug conjugate sc-002 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  731. en:antibody-drug conjugate sc-003 --- r_associated #0: 20 --> ipilimumab
    n1=en:antibody-drug conjugate sc-003 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  732. en:antibody-drug conjugate sc16ld6.5 --- r_associated #0: 20 --> ipilimumab
    n1=en:antibody-drug conjugate sc16ld6.5 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  733. en:anticachexia agent mt-102 --- r_associated #0: 20 --> ipilimumab
    n1=en:anticachexia agent mt-102 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  734. en:anticarcinogenic agents --- r_associated #0: 20 --> ipilimumab
    n1=en:anticarcinogenic agents | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  735. en:antidiuretic --- r_associated #0: 20 --> ipilimumab
    n1=en:antidiuretic | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  736. en:antidote --- r_associated #0: 20 --> ipilimumab
    n1=en:antidote | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  737. en:antiestrogen --- r_associated #0: 20 --> ipilimumab
    n1=en:antiestrogen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  738. en:antifungal agent f901318 --- r_associated #0: 20 --> ipilimumab
    n1=en:antifungal agent f901318 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  739. en:antigen binding --- r_associated #0: 20 --> ipilimumab
    n1=en:antigen binding | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  740. en:antigen-targeted personalized breast cancer vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:antigen-targeted personalized breast cancer vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  741. en:antihemophilic factor, human recombinant --- r_associated #0: 20 --> ipilimumab
    n1=en:antihemophilic factor, human recombinant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  742. en:antihistamines --- r_associated #0: 20 --> ipilimumab
    n1=en:antihistamines | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  743. en:antihypertensive agent --- r_associated #0: 20 --> ipilimumab
    n1=en:antihypertensive agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  744. en:antileukemic agent --- r_associated #0: 20 --> ipilimumab
    n1=en:antileukemic agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  745. en:antilipemic agent --- r_associated #0: 20 --> ipilimumab
    n1=en:antilipemic agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  746. en:antimetabolite --- r_associated #0: 20 --> ipilimumab
    n1=en:antimetabolite | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  747. en:antimetabolite chemotherapy --- r_associated #0: 20 --> ipilimumab
    n1=en:antimetabolite chemotherapy | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  748. en:antimetabolite ff-10502 --- r_associated #0: 20 --> ipilimumab
    n1=en:antimetabolite ff-10502 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  749. en:antimetastatic agent --- r_associated #0: 20 --> ipilimumab
    n1=en:antimetastatic agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  750. en:antimitotic agent --- r_associated #0: 20 --> ipilimumab
    n1=en:antimitotic agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  751. en:antimoniotungstate --- r_associated #0: 20 --> ipilimumab
    n1=en:antimoniotungstate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  752. en:antimony --- r_associated #0: 20 --> ipilimumab
    n1=en:antimony | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  753. en:antineoplastic adjuvants --- r_associated #0: 20 --> ipilimumab
    n1=en:antineoplastic adjuvants | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  754. en:antineoplastic agent --- r_associated #0: 20 --> ipilimumab
    n1=en:antineoplastic agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  755. en:antineoplastic agent combination sm-88 --- r_associated #0: 20 --> ipilimumab
    n1=en:antineoplastic agent combination sm-88 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  756. en:antineoplastic agent trx-818 --- r_associated #0: 20 --> ipilimumab
    n1=en:antineoplastic agent trx-818 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  757. en:antineoplastic agents, hormonal --- r_associated #0: 20 --> ipilimumab
    n1=en:antineoplastic agents, hormonal | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  758. en:antineoplastic agents, phytogenic --- r_associated #0: 20 --> ipilimumab
    n1=en:antineoplastic agents, phytogenic | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  759. en:antineoplastic alkaloid --- r_associated #0: 20 --> ipilimumab
    n1=en:antineoplastic alkaloid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  760. en:antineoplastic alkylating agent --- r_associated #0: 20 --> ipilimumab
    n1=en:antineoplastic alkylating agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  761. en:antineoplastic anthraquinone --- r_associated #0: 20 --> ipilimumab
    n1=en:antineoplastic anthraquinone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  762. en:antineoplastic antibiotic --- r_associated #0: 20 --> ipilimumab
    n1=en:antineoplastic antibiotic | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  763. en:antineoplastic hormones --- r_associated #0: 20 --> ipilimumab
    n1=en:antineoplastic hormones | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  764. en:antineoplastic metal complex agent --- r_associated #0: 20 --> ipilimumab
    n1=en:antineoplastic metal complex agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  765. en:antineoplastic metal complex preparation --- r_associated #0: 20 --> ipilimumab
    n1=en:antineoplastic metal complex preparation | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  766. en:antineoplastic radiopharmaceuticals --- r_associated #0: 20 --> ipilimumab
    n1=en:antineoplastic radiopharmaceuticals | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  767. en:antineoplastic vinca alkaloid --- r_associated #0: 20 --> ipilimumab
    n1=en:antineoplastic vinca alkaloid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  768. en:antineoplastics, other --- r_associated #0: 20 --> ipilimumab
    n1=en:antineoplastics, other | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  769. en:antineoplaston a10 --- r_associated #0: 20 --> ipilimumab
    n1=en:antineoplaston a10 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  770. en:antineoplaston as2-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:antineoplaston as2-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  771. en:antiperspirant cream f511 --- r_associated #0: 20 --> ipilimumab
    n1=en:antiperspirant cream f511 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  772. en:antiplatelet agent --- r_associated #0: 20 --> ipilimumab
    n1=en:antiplatelet agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  773. en:antirheumatic agents --- r_associated #0: 20 --> ipilimumab
    n1=en:antirheumatic agents | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  774. en:antispasmodic agent --- r_associated #0: 20 --> ipilimumab
    n1=en:antispasmodic agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  775. en:antitumor b --- r_associated #0: 20 --> ipilimumab
    n1=en:antitumor b | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  776. en:antivaricose agent --- r_associated #0: 20 --> ipilimumab
    n1=en:antivaricose agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  777. en:antiviral agent csj148 --- r_associated #0: 20 --> ipilimumab
    n1=en:antiviral agent csj148 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  778. en:antrodia cinnamomea supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:antrodia cinnamomea supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  779. en:antroquinonol capsule --- r_associated #0: 20 --> ipilimumab
    n1=en:antroquinonol capsule | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  780. en:apatinib --- r_associated #0: 20 --> ipilimumab
    n1=en:apatinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  781. en:apatorsen --- r_associated #0: 20 --> ipilimumab
    n1=en:apatorsen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  782. en:apaziquone --- r_associated #0: 20 --> ipilimumab
    n1=en:apaziquone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  783. en:apc8015f --- r_associated #0: 20 --> ipilimumab
    n1=en:apc8015f | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  784. en:apf530 --- r_associated #0: 20 --> ipilimumab
    n1=en:apf530 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  785. en:api 31510 topical cream --- r_associated #0: 20 --> ipilimumab
    n1=en:api 31510 topical cream | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  786. en:apilimod dimesylate capsule --- r_associated #0: 20 --> ipilimumab
    n1=en:apilimod dimesylate capsule | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  787. en:apixaban --- r_associated #0: 20 --> ipilimumab
    n1=en:apixaban | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  788. en:apolizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:apolizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  789. en:apomab --- r_associated #0: 20 --> ipilimumab
    n1=en:apomab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  790. en:apomine --- r_associated #0: 20 --> ipilimumab
    n1=en:apomine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  791. en:apoptosis inducer bzl101 --- r_associated #0: 20 --> ipilimumab
    n1=en:apoptosis inducer bzl101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  792. en:apoptosis inducer gcs-100 --- r_associated #0: 20 --> ipilimumab
    n1=en:apoptosis inducer gcs-100 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  793. en:apoptosis inducer mpc-2130 --- r_associated #0: 20 --> ipilimumab
    n1=en:apoptosis inducer mpc-2130 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  794. en:apoptotic autologous tumor cells-pulsed alpha-type-1 polarized dendritic cells --- r_associated #0: 20 --> ipilimumab
    n1=en:apoptotic autologous tumor cells-pulsed alpha-type-1 polarized dendritic cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  795. en:aprepitant --- r_associated #0: 20 --> ipilimumab
    n1=en:aprepitant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  796. en:apricoxib --- r_associated #0: 20 --> ipilimumab
    n1=en:apricoxib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  797. en:aprotinin --- r_associated #0: 20 --> ipilimumab
    n1=en:aprotinin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  798. en:ar antagonist bms-641988 --- r_associated #0: 20 --> ipilimumab
    n1=en:ar antagonist bms-641988 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  799. en:ar antagonist odm-201 --- r_associated #0: 20 --> ipilimumab
    n1=en:ar antagonist odm-201 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  800. en:ar ligand binding domain-targeting agent azd3514 --- r_associated #0: 20 --> ipilimumab
    n1=en:ar ligand binding domain-targeting agent azd3514 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  801. en:archexin --- r_associated #0: 20 --> ipilimumab
    n1=en:archexin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  802. en:arcitumomab --- r_associated #0: 20 --> ipilimumab
    n1=en:arcitumomab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  803. en:arginine butyrate --- r_associated #0: 20 --> ipilimumab
    n1=en:arginine butyrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  804. en:arginine/omega-3 fatty acids/nucleotides oral supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:arginine/omega-3 fatty acids/nucleotides oral supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  805. en:argipressin --- r_associated #0: 20 --> ipilimumab
    n1=en:argipressin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  806. en:armodafinil --- r_associated #0: 20 --> ipilimumab
    n1=en:armodafinil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  807. en:arnebia indigo jade pearl topical cream --- r_associated #0: 20 --> ipilimumab
    n1=en:arnebia indigo jade pearl topical cream | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  808. en:aromatase inhibitor --- r_associated #0: 20 --> ipilimumab
    n1=en:aromatase inhibitor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  809. en:aromatase inhibitors, 3rd generation --- r_associated #0: 20 --> ipilimumab
    n1=en:aromatase inhibitors, 3rd generation | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  810. en:arsanilic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:arsanilic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  811. en:arsenic --- r_associated #0: 20 --> ipilimumab
    n1=en:arsenic | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  812. en:arsenic trioxide --- r_associated #0: 20 --> ipilimumab
    n1=en:arsenic trioxide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  813. en:artemether sublingual spray --- r_associated #0: 20 --> ipilimumab
    n1=en:artemether sublingual spray | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  814. en:artemisia vulgaris --- r_associated #0: 20 --> ipilimumab
    n1=en:artemisia vulgaris | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  815. en:artesunate --- r_associated #0: 20 --> ipilimumab
    n1=en:artesunate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  816. en:artichoke whole phytocomplex concentrate --- r_associated #0: 20 --> ipilimumab
    n1=en:artichoke whole phytocomplex concentrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  817. en:arzoxifene hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:arzoxifene hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  818. en:as03-adjuvanted h1n1 pandemic influenza vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:as03-adjuvanted h1n1 pandemic influenza vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  819. en:asaley --- r_associated #0: 20 --> ipilimumab
    n1=en:asaley | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  820. en:ascorbic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:ascorbic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  821. en:asfotase alfa --- r_associated #0: 20 --> ipilimumab
    n1=en:asfotase alfa | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  822. en:ashwagandha root powder extract --- r_associated #0: 20 --> ipilimumab
    n1=en:ashwagandha root powder extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  823. en:asian ginseng --- r_associated #0: 20 --> ipilimumab
    n1=en:asian ginseng | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  824. en:ask1 inhibitor gs-4997 --- r_associated #0: 20 --> ipilimumab
    n1=en:ask1 inhibitor gs-4997 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  825. en:asp4132 --- r_associated #0: 20 --> ipilimumab
    n1=en:asp4132 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  826. en:asp9521 --- r_associated #0: 20 --> ipilimumab
    n1=en:asp9521 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  827. en:asp9853 --- r_associated #0: 20 --> ipilimumab
    n1=en:asp9853 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  828. en:asparaginase --- r_associated #0: 20 --> ipilimumab
    n1=en:asparaginase | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  829. en:asparaginase erwinia chrysanthemi --- r_associated #0: 20 --> ipilimumab
    n1=en:asparaginase erwinia chrysanthemi | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  830. en:aspirin --- r_associated #0: 20 --> ipilimumab
    n1=en:aspirin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  831. en:aspirin/simvastatin/atenolol/ramipril/thiazide capsule --- r_associated #0: 20 --> ipilimumab
    n1=en:aspirin/simvastatin/atenolol/ramipril/thiazide capsule | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  832. en:astragalus-based formulation qing shu yi qi tang --- r_associated #0: 20 --> ipilimumab
    n1=en:astragalus-based formulation qing shu yi qi tang | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  833. en:astringent --- r_associated #0: 20 --> ipilimumab
    n1=en:astringent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  834. en:astuprotimut-r --- r_associated #0: 20 --> ipilimumab
    n1=en:astuprotimut-r | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  835. en:asulacrine isethionate --- r_associated #0: 20 --> ipilimumab
    n1=en:asulacrine isethionate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  836. en:asunaprevir --- r_associated #0: 20 --> ipilimumab
    n1=en:asunaprevir | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  837. en:at 211 monoclonal antibody 81c6 --- r_associated #0: 20 --> ipilimumab
    n1=en:at 211 monoclonal antibody 81c6 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  838. en:atamestane --- r_associated #0: 20 --> ipilimumab
    n1=en:atamestane | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  839. en:atenolol --- r_associated #0: 20 --> ipilimumab
    n1=en:atenolol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  840. en:atezolizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:atezolizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  841. en:atiprimod --- r_associated #0: 20 --> ipilimumab
    n1=en:atiprimod | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  842. en:atm kinase inhibitor azd0156 --- r_associated #0: 20 --> ipilimumab
    n1=en:atm kinase inhibitor azd0156 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  843. en:atn-161 --- r_associated #0: 20 --> ipilimumab
    n1=en:atn-161 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  844. en:atomoxetine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:atomoxetine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  845. en:atorvastatin calcium --- r_associated #0: 20 --> ipilimumab
    n1=en:atorvastatin calcium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  846. en:atr kinase inhibitor azd6738 --- r_associated #0: 20 --> ipilimumab
    n1=en:atr kinase inhibitor azd6738 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  847. en:atr kinase inhibitor vx-970 --- r_associated #0: 20 --> ipilimumab
    n1=en:atr kinase inhibitor vx-970 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  848. en:atr-101 --- r_associated #0: 20 --> ipilimumab
    n1=en:atr-101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  849. en:atrasentan hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:atrasentan hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  850. en:atropine sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:atropine sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  851. en:attenuated chimpanzee adenovirus 5t4 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:attenuated chimpanzee adenovirus 5t4 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  852. en:attenuated corynebacterium parvum --- r_associated #0: 20 --> ipilimumab
    n1=en:attenuated corynebacterium parvum | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  853. en:attenuated listeria monocytogenes crs-100 --- r_associated #0: 20 --> ipilimumab
    n1=en:attenuated listeria monocytogenes crs-100 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  854. en:attenuated live listeria encoding hpv 16 e7 vaccine adxs11-001 --- r_associated #0: 20 --> ipilimumab
    n1=en:attenuated live listeria encoding hpv 16 e7 vaccine adxs11-001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  855. en:auranofin --- r_associated #0: 20 --> ipilimumab
    n1=en:auranofin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  856. en:aurora a kinase inhibitor mk5108 --- r_associated #0: 20 --> ipilimumab
    n1=en:aurora a kinase inhibitor mk5108 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  857. en:aurora a kinase inhibitor tas-119 --- r_associated #0: 20 --> ipilimumab
    n1=en:aurora a kinase inhibitor tas-119 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  858. en:aurora a kinase/tyrosine kinase inhibitor enmd-2076 --- r_associated #0: 20 --> ipilimumab
    n1=en:aurora a kinase/tyrosine kinase inhibitor enmd-2076 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  859. en:aurora b serine/threonine kinase inhibitor tak-901 --- r_associated #0: 20 --> ipilimumab
    n1=en:aurora b serine/threonine kinase inhibitor tak-901 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  860. en:aurora b/c kinase inhibitor gsk1070916a --- r_associated #0: 20 --> ipilimumab
    n1=en:aurora b/c kinase inhibitor gsk1070916a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  861. en:aurora kinase inhibitor amg 900 --- r_associated #0: 20 --> ipilimumab
    n1=en:aurora kinase inhibitor amg 900 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  862. en:aurora kinase inhibitor bi 811283 --- r_associated #0: 20 --> ipilimumab
    n1=en:aurora kinase inhibitor bi 811283 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  863. en:aurora kinase inhibitor mln8054 --- r_associated #0: 20 --> ipilimumab
    n1=en:aurora kinase inhibitor mln8054 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  864. en:aurora kinase inhibitor pf-03814735 --- r_associated #0: 20 --> ipilimumab
    n1=en:aurora kinase inhibitor pf-03814735 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  865. en:aurora kinase inhibitor sns-314 --- r_associated #0: 20 --> ipilimumab
    n1=en:aurora kinase inhibitor sns-314 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  866. en:aurora kinase inhibitor ttp607 --- r_associated #0: 20 --> ipilimumab
    n1=en:aurora kinase inhibitor ttp607 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  867. en:aurora kinase/vegfr2 inhibitor cyc116 --- r_associated #0: 20 --> ipilimumab
    n1=en:aurora kinase/vegfr2 inhibitor cyc116 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  868. en:autologous ad-cd154-transduced cll b cells --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous ad-cd154-transduced cll b cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  869. en:autologous anti-cd123 car tcr/4-1bb-expressing t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous anti-cd123 car tcr/4-1bb-expressing t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  870. en:autologous anti-cd19 car-expressing t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous anti-cd19 car-expressing t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  871. en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ central memory t-lymphocytes jcar014 --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ central memory t-lymphocytes jcar014 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  872. en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ t-lymphocytes jcar017 --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing cd4+/cd8+ t-lymphocytes jcar017 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  873. en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  874. en:autologous anti-gp100:154-162 t-cell receptor gene-engineered peripheral blood lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous anti-gp100:154-162 t-cell receptor gene-engineered peripheral blood lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  875. en:autologous anti-mart-1 f5 t-cell receptor gene-engineered peripheral blood lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous anti-mart-1 f5 t-cell receptor gene-engineered peripheral blood lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  876. en:autologous anti-psma gene-modified t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous anti-psma gene-modified t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  877. en:autologous beta-a(t87q)-globin gene-transduced cd34-positive cells --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous beta-a(t87q)-globin gene-transduced cd34-positive cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  878. en:autologous bone marrow-derived cd34/cxcr4-positive stem cells amr-001 --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous bone marrow-derived cd34/cxcr4-positive stem cells amr-001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  879. en:autologous cd123car-cd28-cd3zeta-egfrt-expressing t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous cd123car-cd28-cd3zeta-egfrt-expressing t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  880. en:autologous cd133-positive btsc mrna-pulsed autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous cd133-positive btsc mrna-pulsed autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  881. en:autologous cd171-specific car-cd28 zeta-4-1-bb-egfrt-expressing t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous cd171-specific car-cd28 zeta-4-1-bb-egfrt-expressing t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  882. en:autologous cd19-28z chimeric antigen receptor-expressing t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous cd19-28z chimeric antigen receptor-expressing t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  883. en:autologous cd19car-cd28-cd3zeta-egfrt-expressing tcm-enriched t cells --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous cd19car-cd28-cd3zeta-egfrt-expressing tcm-enriched t cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  884. en:autologous cd34-positive hematopoietic progenitor cells --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous cd34-positive hematopoietic progenitor cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  885. en:autologous cd8 positive pbl sensitized to drosophila cell-presented melanoma peptides --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous cd8 positive pbl sensitized to drosophila cell-presented melanoma peptides | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  886. en:autologous cd8+ melanoma specific t cells --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous cd8+ melanoma specific t cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  887. en:autologous cea-specific cytotoxic t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous cea-specific cytotoxic t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  888. en:autologous colon cancer cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous colon cancer cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  889. en:autologous colorectal tumor antigen-pulsed dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous colorectal tumor antigen-pulsed dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  890. en:autologous ct7/mage-a3/wt1 mrna-electroporated langerhans-type dendritic cells --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous ct7/mage-a3/wt1 mrna-electroporated langerhans-type dendritic cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  891. en:autologous cultured acute myeloid leukemia-specific cytotoxic t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous cultured acute myeloid leukemia-specific cytotoxic t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  892. en:autologous cytomegalovirus-specific cytotoxic t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous cytomegalovirus-specific cytotoxic t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  893. en:autologous cytotoxic t-lymphocytes induced with muc1 gene-transfected dendritic cells --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous cytotoxic t-lymphocytes induced with muc1 gene-transfected dendritic cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  894. en:autologous cytotoxic t-lymphocytes induced with muc1 peptide-pulsed dendritic cells --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous cytotoxic t-lymphocytes induced with muc1 peptide-pulsed dendritic cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  895. en:autologous dendritic cell vaccine act2001 --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous dendritic cell vaccine act2001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  896. en:autologous dendritic cell-adenovirus ccl21 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous dendritic cell-adenovirus ccl21 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  897. en:autologous dendritic cell-adenovirus p53 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous dendritic cell-adenovirus p53 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  898. en:autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  899. en:autologous dendritic cell-autologous tumor mrna-human cd40l vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous dendritic cell-autologous tumor mrna-human cd40l vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  900. en:autologous dendritic cell-based immunotherapeutic av0113 --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous dendritic cell-based immunotherapeutic av0113 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  901. en:autologous dendritic cell-tumor fusion vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous dendritic cell-tumor fusion vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  902. en:autologous dendritic cells/cmv pp65 peptide --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous dendritic cells/cmv pp65 peptide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  903. en:autologous dinitrophenyl-modified ovarian cancer vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous dinitrophenyl-modified ovarian cancer vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  904. en:autologous ebv-ctl cd19car zeta --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous ebv-ctl cd19car zeta | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  905. en:autologous ebv-transformed b lymphoblastoid-tumor fusion cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous ebv-transformed b lymphoblastoid-tumor fusion cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  906. en:autologous epstein-barr virus-transformed b-lymphoblastoid cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous epstein-barr virus-transformed b-lymphoblastoid cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  907. en:autologous expanded mesenchymal stem cells oti-010 --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous expanded mesenchymal stem cells oti-010 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  908. en:autologous glioma cell lysate --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous glioma cell lysate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  909. en:autologous gm-csf-secreting breast cancer vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous gm-csf-secreting breast cancer vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  910. en:autologous gm-csf-secreting lethally irradiated colorectal cancer cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous gm-csf-secreting lethally irradiated colorectal cancer cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  911. en:autologous gm-csf-secreting lethally irradiated leukemia cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous gm-csf-secreting lethally irradiated leukemia cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  912. en:autologous gm-csf-secreting melanoma vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous gm-csf-secreting melanoma vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  913. en:autologous hbv-specific tcr-redirected t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous hbv-specific tcr-redirected t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  914. en:autologous heat-shock protein 70 peptide vaccine ag-858 --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous heat-shock protein 70 peptide vaccine ag-858 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  915. en:autologous her2 chimeric receptor/tgfbeta dominant negative receptor-expressing ebv-specific cytotoxic t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous her2 chimeric receptor/tgfbeta dominant negative receptor-expressing ebv-specific cytotoxic t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  916. en:autologous hnscc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous hnscc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  917. en:autologous hpv-16/18 e6/e7-specific tgf-beta-resistant t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous hpv-16/18 e6/e7-specific tgf-beta-resistant t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  918. en:autologous ic9-gd2-car-expressing vzv-specific t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous ic9-gd2-car-expressing vzv-specific t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  919. en:autologous il-21-modulated cd8+ mart1-specific t cells --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous il-21-modulated cd8+ mart1-specific t cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  920. en:autologous immunoglobulin idiotype-klh conjugate vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous immunoglobulin idiotype-klh conjugate vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  921. en:autologous interferon-producing killer dendritic cells --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous interferon-producing killer dendritic cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  922. en:autologous lmp1-/lmp2- specific cytotoxic t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous lmp1-/lmp2- specific cytotoxic t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  923. en:autologous lymphoid effector cells specific against tumor cells --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous lymphoid effector cells specific against tumor cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  924. en:autologous lymphoma cell lysate-pulsed autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous lymphoma cell lysate-pulsed autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  925. en:autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous lymphoma cell/allogeneic dendritic cell electrofusion hybrid vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  926. en:autologous lymphoma cell/autologous dendritic cell electrofusion hybrid vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous lymphoma cell/autologous dendritic cell electrofusion hybrid vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  927. en:autologous lymphoma immunoglobulin-derived scfv-chemokine dna vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous lymphoma immunoglobulin-derived scfv-chemokine dna vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  928. en:autologous mage-a3-specific hla-a*01-restricted t cell receptor gene engineered lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous mage-a3-specific hla-a*01-restricted t cell receptor gene engineered lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  929. en:autologous melanoma lysate-pulsed autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous melanoma lysate-pulsed autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  930. en:autologous melanoma lysate/klh-pulsed autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous melanoma lysate/klh-pulsed autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  931. en:autologous melanoma lysate/ny-eso-1-pulsed autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous melanoma lysate/ny-eso-1-pulsed autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  932. en:autologous mesenchymal stem cells apceth_101 --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous mesenchymal stem cells apceth_101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  933. en:autologous muc1-mannan fusion protein pulsed dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous muc1-mannan fusion protein pulsed dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  934. en:autologous neuroblastoma lysate/klh-pulsed dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous neuroblastoma lysate/klh-pulsed dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  935. en:autologous nsclc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous nsclc dna-transfected semi-allogeneic fibroblasts mrc-5 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  936. en:autologous nsclc peptide-specific dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous nsclc peptide-specific dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  937. en:autologous ny-eso-1-melanoma-specific cd8+ t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous ny-eso-1-melanoma-specific cd8+ t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  938. en:autologous ofa-ilrp rna-transfected dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous ofa-ilrp rna-transfected dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  939. en:autologous ovarian tumor cell lysate-pulsed dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous ovarian tumor cell lysate-pulsed dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  940. en:autologous oxidized ovarian tumor cell lysate vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous oxidized ovarian tumor cell lysate vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  941. en:autologous peripheral blood lymphocytes cotransduced with retroviral vectors encoding inducible il-12 and anti-ny-eso-1 tcr --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous peripheral blood lymphocytes cotransduced with retroviral vectors encoding inducible il-12 and anti-ny-eso-1 tcr | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  942. en:autologous pluripotent aldhbr stem cells ald-451 --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous pluripotent aldhbr stem cells ald-451 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  943. en:autologous prostate cancer antigen-expressing dendritic cell vaccine bpx-101 --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous prostate cancer antigen-expressing dendritic cell vaccine bpx-101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  944. en:autologous prostate stem cell antigen-specific car t cells bpx-601 --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous prostate stem cell antigen-specific car t cells bpx-601 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  945. en:autologous renal cell carcinoma tumor lysate-pulsed dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous renal cell carcinoma tumor lysate-pulsed dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  946. en:autologous sarcoma cell lysate --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous sarcoma cell lysate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  947. en:autologous sarcoma lysate-pulsed dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous sarcoma lysate-pulsed dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  948. en:autologous t-lymphocytes-expressing ny-eso-1-c259-specific enhanced t-cell receptors --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous t-lymphocytes-expressing ny-eso-1-c259-specific enhanced t-cell receptors | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  949. en:autologous tarp peptide-pulsed dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous tarp peptide-pulsed dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  950. en:autologous tns9.3.55-transduced cd34-positive cells --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous tns9.3.55-transduced cd34-positive cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  951. en:autologous trimix-dc melanoma vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous trimix-dc melanoma vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  952. en:autologous tumor cell proteoliposome chronic lymphocytic leukemia vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous tumor cell proteoliposome chronic lymphocytic leukemia vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  953. en:autologous tumor cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous tumor cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  954. en:autologous tumor infiltrating lymphocytes ln-144 --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous tumor infiltrating lymphocytes ln-144 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  955. en:autologous tumor-associated peptide antigen-pulsed dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous tumor-associated peptide antigen-pulsed dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  956. en:autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:autologous wt1-tcrc4 gene-transduced cd8-positive tcm/tn lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  957. en:autonomic agents --- r_associated #0: 20 --> ipilimumab
    n1=en:autonomic agents | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  958. en:av2-dm antiviral spray --- r_associated #0: 20 --> ipilimumab
    n1=en:av2-dm antiviral spray | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  959. en:avanafil --- r_associated #0: 20 --> ipilimumab
    n1=en:avanafil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  960. en:avelumab --- r_associated #0: 20 --> ipilimumab
    n1=en:avelumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  961. en:avitinib maleate --- r_associated #0: 20 --> ipilimumab
    n1=en:avitinib maleate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  962. en:avn944 --- r_associated #0: 20 --> ipilimumab
    n1=en:avn944 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  963. en:axitinib --- r_associated #0: 20 --> ipilimumab
    n1=en:axitinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  964. en:axl inhibitor bgb324 --- r_associated #0: 20 --> ipilimumab
    n1=en:axl inhibitor bgb324 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  965. en:axl inhibitor tp-0903 --- r_associated #0: 20 --> ipilimumab
    n1=en:axl inhibitor tp-0903 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  966. en:azacitidine --- r_associated #0: 20 --> ipilimumab
    n1=en:azacitidine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  967. en:azadirachta indica --- r_associated #0: 20 --> ipilimumab
    n1=en:azadirachta indica | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  968. en:azapicyl --- r_associated #0: 20 --> ipilimumab
    n1=en:azapicyl | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  969. en:azaribine --- r_associated #0: 20 --> ipilimumab
    n1=en:azaribine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  970. en:azaserine --- r_associated #0: 20 --> ipilimumab
    n1=en:azaserine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  971. en:azathioprine sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:azathioprine sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  972. en:azd5438 --- r_associated #0: 20 --> ipilimumab
    n1=en:azd5438 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  973. en:azimexon --- r_associated #0: 20 --> ipilimumab
    n1=en:azimexon | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  974. en:aziridinylbenzoquinone rh1 --- r_associated #0: 20 --> ipilimumab
    n1=en:aziridinylbenzoquinone rh1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  975. en:azithromycin --- r_associated #0: 20 --> ipilimumab
    n1=en:azithromycin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  976. en:azlocillin --- r_associated #0: 20 --> ipilimumab
    n1=en:azlocillin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  977. en:azp --- r_associated #0: 20 --> ipilimumab
    n1=en:azp | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  978. en:azurin:50-77 cell penetrating peptide p28 --- r_associated #0: 20 --> ipilimumab
    n1=en:azurin:50-77 cell penetrating peptide p28 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  979. en:b-raf/vegfr-2 inhibitor raf265 --- r_associated #0: 20 --> ipilimumab
    n1=en:b-raf/vegfr-2 inhibitor raf265 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  980. en:b16alphagal melanoma vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:b16alphagal melanoma vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  981. en:b43-genistein immunoconjugate --- r_associated #0: 20 --> ipilimumab
    n1=en:b43-genistein immunoconjugate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  982. en:b43-pap immunotoxin --- r_associated #0: 20 --> ipilimumab
    n1=en:b43-pap immunotoxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  983. en:b7-dc crosslinking antibody rhigm12b7 --- r_associated #0: 20 --> ipilimumab
    n1=en:b7-dc crosslinking antibody rhigm12b7 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  984. en:bacitracin --- r_associated #0: 20 --> ipilimumab
    n1=en:bacitracin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  985. en:baclofen --- r_associated #0: 20 --> ipilimumab
    n1=en:baclofen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  986. en:baclofen/amitriptyline/ketamine gel --- r_associated #0: 20 --> ipilimumab
    n1=en:baclofen/amitriptyline/ketamine gel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  987. en:bacteriophage phi x 174 --- r_associated #0: 20 --> ipilimumab
    n1=en:bacteriophage phi x 174 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  988. en:bafetinib --- r_associated #0: 20 --> ipilimumab
    n1=en:bafetinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  989. en:balanced crystalloid solution --- r_associated #0: 20 --> ipilimumab
    n1=en:balanced crystalloid solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  990. en:banoxantrone --- r_associated #0: 20 --> ipilimumab
    n1=en:banoxantrone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  991. en:barasertib --- r_associated #0: 20 --> ipilimumab
    n1=en:barasertib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  992. en:bardoxolone --- r_associated #0: 20 --> ipilimumab
    n1=en:bardoxolone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  993. en:bardoxolone methyl --- r_associated #0: 20 --> ipilimumab
    n1=en:bardoxolone methyl | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  994. en:baricitinib --- r_associated #0: 20 --> ipilimumab
    n1=en:baricitinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  995. en:barium sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:barium sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  996. en:basiliximab --- r_associated #0: 20 --> ipilimumab
    n1=en:basiliximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  997. en:batabulin sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:batabulin sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  998. en:batanopride --- r_associated #0: 20 --> ipilimumab
    n1=en:batanopride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  999. en:bavituximab --- r_associated #0: 20 --> ipilimumab
    n1=en:bavituximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1000. en:bay 56-3722 --- r_associated #0: 20 --> ipilimumab
    n1=en:bay 56-3722 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1001. en:bay 86-4367 --- r_associated #0: 20 --> ipilimumab
    n1=en:bay 86-4367 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1002. en:bay 87-2243 --- r_associated #0: 20 --> ipilimumab
    n1=en:bay 87-2243 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1003. en:bazedoxifene --- r_associated #0: 20 --> ipilimumab
    n1=en:bazedoxifene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1004. en:bbr 3464 --- r_associated #0: 20 --> ipilimumab
    n1=en:bbr 3464 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1005. en:bc-819 plasmid/polyethylenimine complex --- r_associated #0: 20 --> ipilimumab
    n1=en:bc-819 plasmid/polyethylenimine complex | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1006. en:bcg solution --- r_associated #0: 20 --> ipilimumab
    n1=en:bcg solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1007. en:bcg vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:bcg vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1008. en:bcl-2 inhibitor bcl201 --- r_associated #0: 20 --> ipilimumab
    n1=en:bcl-2 inhibitor bcl201 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1009. en:bcma-specific car-expressing t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:bcma-specific car-expressing t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1010. en:bcr-abl (b2a2)-derived peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:bcr-abl (b2a2)-derived peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1011. en:bcr-abl (b3a2)-derived peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:bcr-abl (b3a2)-derived peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1012. en:bcr-abl p210-b3a2 breakpoint-derived pentapeptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:bcr-abl p210-b3a2 breakpoint-derived pentapeptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1013. en:bcr-abl peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:bcr-abl peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1014. en:beacopp regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:beacopp regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1015. en:becatecarin --- r_associated #0: 20 --> ipilimumab
    n1=en:becatecarin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1016. en:beclomethasone dipropionate --- r_associated #0: 20 --> ipilimumab
    n1=en:beclomethasone dipropionate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1017. en:beetroot juice --- r_associated #0: 20 --> ipilimumab
    n1=en:beetroot juice | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1018. en:begelomab --- r_associated #0: 20 --> ipilimumab
    n1=en:begelomab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1019. en:belagenpumatucel-l --- r_associated #0: 20 --> ipilimumab
    n1=en:belagenpumatucel-l | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1020. en:belimumab --- r_associated #0: 20 --> ipilimumab
    n1=en:belimumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1021. en:belinostat --- r_associated #0: 20 --> ipilimumab
    n1=en:belinostat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1022. en:beloranib --- r_associated #0: 20 --> ipilimumab
    n1=en:beloranib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1023. en:belotecan hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:belotecan hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1024. en:bemiparin sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:bemiparin sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1025. en:benaxibine --- r_associated #0: 20 --> ipilimumab
    n1=en:benaxibine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1026. en:benazepril hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:benazepril hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1027. en:bendamustine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:bendamustine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1028. en:bendamustine-containing nanoparticle-based formulation rxdx-107 --- r_associated #0: 20 --> ipilimumab
    n1=en:bendamustine-containing nanoparticle-based formulation rxdx-107 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1029. en:bendamustine-vorinostat fusion molecule edo-s101 --- r_associated #0: 20 --> ipilimumab
    n1=en:bendamustine-vorinostat fusion molecule edo-s101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1030. en:benegrastim --- r_associated #0: 20 --> ipilimumab
    n1=en:benegrastim | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1031. en:benzaldehyde dimethane sulfonate --- r_associated #0: 20 --> ipilimumab
    n1=en:benzaldehyde dimethane sulfonate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1032. en:benznidazole --- r_associated #0: 20 --> ipilimumab
    n1=en:benznidazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1033. en:benzoylphenylurea --- r_associated #0: 20 --> ipilimumab
    n1=en:benzoylphenylurea | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1034. en:benzydamine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:benzydamine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1035. en:bep regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:bep regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1036. en:berberine chloride --- r_associated #0: 20 --> ipilimumab
    n1=en:berberine chloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1037. en:berubicin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:berubicin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1038. en:bet bromodomain inhibitor zen-3694 --- r_associated #0: 20 --> ipilimumab
    n1=en:bet bromodomain inhibitor zen-3694 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1039. en:bet bromodomains 2/3/4 inhibitor mk-8628 --- r_associated #0: 20 --> ipilimumab
    n1=en:bet bromodomains 2/3/4 inhibitor mk-8628 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1040. en:bet inhibitor --- r_associated #0: 20 --> ipilimumab
    n1=en:bet inhibitor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1041. en:bet inhibitor bay1238097 --- r_associated #0: 20 --> ipilimumab
    n1=en:bet inhibitor bay1238097 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1042. en:bet inhibitor bms-986158 --- r_associated #0: 20 --> ipilimumab
    n1=en:bet inhibitor bms-986158 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1043. en:bet inhibitor cpi-0610 --- r_associated #0: 20 --> ipilimumab
    n1=en:bet inhibitor cpi-0610 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1044. en:bet inhibitor ft-1101 --- r_associated #0: 20 --> ipilimumab
    n1=en:bet inhibitor ft-1101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1045. en:bet inhibitor gs-5829 --- r_associated #0: 20 --> ipilimumab
    n1=en:bet inhibitor gs-5829 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1046. en:bet inhibitor gsk2820151 --- r_associated #0: 20 --> ipilimumab
    n1=en:bet inhibitor gsk2820151 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1047. en:bet inhibitor gsk525762 --- r_associated #0: 20 --> ipilimumab
    n1=en:bet inhibitor gsk525762 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1048. en:bet inhibitor incb054329 --- r_associated #0: 20 --> ipilimumab
    n1=en:bet inhibitor incb054329 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1049. en:bet inhibitor incb057643 --- r_associated #0: 20 --> ipilimumab
    n1=en:bet inhibitor incb057643 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1050. en:bet inhibitor ten-010 --- r_associated #0: 20 --> ipilimumab
    n1=en:bet inhibitor ten-010 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1051. en:beta alethine --- r_associated #0: 20 --> ipilimumab
    n1=en:beta alethine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1052. en:beta endophorin --- r_associated #0: 20 --> ipilimumab
    n1=en:beta endophorin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1053. en:beta-carotene --- r_associated #0: 20 --> ipilimumab
    n1=en:beta-carotene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1054. en:beta-elemene --- r_associated #0: 20 --> ipilimumab
    n1=en:beta-elemene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1055. en:beta-glucan --- r_associated #0: 20 --> ipilimumab
    n1=en:beta-glucan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1056. en:beta-glucan mm-10-001 --- r_associated #0: 20 --> ipilimumab
    n1=en:beta-glucan mm-10-001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1057. en:beta-glucan/alginate/hyaluronic acid/squalene/avocado oil-containing emulsion --- r_associated #0: 20 --> ipilimumab
    n1=en:beta-glucan/alginate/hyaluronic acid/squalene/avocado oil-containing emulsion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1058. en:beta-glucan/lactobacillus casei/bifidobacterium lactis-based supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:beta-glucan/lactobacillus casei/bifidobacterium lactis-based supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1059. en:beta-hydroxy-beta-methylbutyrate supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:beta-hydroxy-beta-methylbutyrate supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1060. en:beta-lapachone prodrug arq 761 --- r_associated #0: 20 --> ipilimumab
    n1=en:beta-lapachone prodrug arq 761 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1061. en:beta-thioguanine deoxyriboside --- r_associated #0: 20 --> ipilimumab
    n1=en:beta-thioguanine deoxyriboside | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1062. en:betamethasone --- r_associated #0: 20 --> ipilimumab
    n1=en:betamethasone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1063. en:betulinic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:betulinic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1064. en:bevacizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:bevacizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1065. en:bevacizumab-irdye 800cw --- r_associated #0: 20 --> ipilimumab
    n1=en:bevacizumab-irdye 800cw | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1066. en:bexarotene --- r_associated #0: 20 --> ipilimumab
    n1=en:bexarotene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1067. en:bh3 mimetic abt-737 --- r_associated #0: 20 --> ipilimumab
    n1=en:bh3 mimetic abt-737 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1068. en:bi 2536 --- r_associated #0: 20 --> ipilimumab
    n1=en:bi 2536 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1069. en:bi 831266 --- r_associated #0: 20 --> ipilimumab
    n1=en:bi 831266 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1070. en:bi 894999 --- r_associated #0: 20 --> ipilimumab
    n1=en:bi 894999 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1071. en:bi-functional alkylating agent val-083 --- r_associated #0: 20 --> ipilimumab
    n1=en:bi-functional alkylating agent val-083 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1072. en:bi-shrna-furin/gm-csf-expressing autologous tumor cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:bi-shrna-furin/gm-csf-expressing autologous tumor cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1073. en:biafine cream --- r_associated #0: 20 --> ipilimumab
    n1=en:biafine cream | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1074. en:bibx 1382 --- r_associated #0: 20 --> ipilimumab
    n1=en:bibx 1382 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1075. en:bicalutamide --- r_associated #0: 20 --> ipilimumab
    n1=en:bicalutamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1076. en:bifidobacterium lactis/lactobacillus acidophilus/l. plantarum/l. salivarius probiotic supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:bifidobacterium lactis/lactobacillus acidophilus/l. plantarum/l. salivarius probiotic supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1077. en:bifunctional expression vector plasmid dna-bi-shrna ews/fli1 type 1 lipoplex --- r_associated #0: 20 --> ipilimumab
    n1=en:bifunctional expression vector plasmid dna-bi-shrna ews/fli1 type 1 lipoplex | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1078. en:bimagrumab --- r_associated #0: 20 --> ipilimumab
    n1=en:bimagrumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1079. en:bimatoprost --- r_associated #0: 20 --> ipilimumab
    n1=en:bimatoprost | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1080. en:binetrakin --- r_associated #0: 20 --> ipilimumab
    n1=en:binetrakin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1081. en:binimetinib --- r_associated #0: 20 --> ipilimumab
    n1=en:binimetinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1082. en:biological agent --- r_associated #0: 20 --> ipilimumab
    n1=en:biological agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1083. en:biological factors --- r_associated #0: 20 --> ipilimumab
    n1=en:biological factors | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1084. en:biomed 101 --- r_associated #0: 20 --> ipilimumab
    n1=en:biomed 101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1085. en:biricodar dicitrate --- r_associated #0: 20 --> ipilimumab
    n1=en:biricodar dicitrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1086. en:birinapant --- r_associated #0: 20 --> ipilimumab
    n1=en:birinapant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1087. en:bis(choline)tetrathiomolybdate --- r_associated #0: 20 --> ipilimumab
    n1=en:bis(choline)tetrathiomolybdate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1088. en:bisacodyl --- r_associated #0: 20 --> ipilimumab
    n1=en:bisacodyl | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1089. en:bisantrene hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:bisantrene hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1090. en:bismuth bi213 monoclonal antibody m195 --- r_associated #0: 20 --> ipilimumab
    n1=en:bismuth bi213 monoclonal antibody m195 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1091. en:bismuth compound --- r_associated #0: 20 --> ipilimumab
    n1=en:bismuth compound | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1092. en:bismuth subcitrate --- r_associated #0: 20 --> ipilimumab
    n1=en:bismuth subcitrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1093. en:bismuth subsalicylate --- r_associated #0: 20 --> ipilimumab
    n1=en:bismuth subsalicylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1094. en:bisoprolol fumarate --- r_associated #0: 20 --> ipilimumab
    n1=en:bisoprolol fumarate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1095. en:bispecific antibody 2b1 --- r_associated #0: 20 --> ipilimumab
    n1=en:bispecific antibody 2b1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1096. en:bispecific antibody 4g7xh22 --- r_associated #0: 20 --> ipilimumab
    n1=en:bispecific antibody 4g7xh22 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1097. en:bispecific antibody mdx-h210 --- r_associated #0: 20 --> ipilimumab
    n1=en:bispecific antibody mdx-h210 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1098. en:bispecific antibody mdx447 --- r_associated #0: 20 --> ipilimumab
    n1=en:bispecific antibody mdx447 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1099. en:bispecific human anti-ang-2/anti-vegf-a antibody ro5520985 --- r_associated #0: 20 --> ipilimumab
    n1=en:bispecific human anti-ang-2/anti-vegf-a antibody ro5520985 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1100. en:bivalent hpv16/18 therapeutic cervical cancer vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:bivalent hpv16/18 therapeutic cervical cancer vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1101. en:bizelesin --- r_associated #0: 20 --> ipilimumab
    n1=en:bizelesin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1102. en:bl22 immunotoxin --- r_associated #0: 20 --> ipilimumab
    n1=en:bl22 immunotoxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1103. en:black cohosh --- r_associated #0: 20 --> ipilimumab
    n1=en:black cohosh | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1104. en:black raspberry nectar --- r_associated #0: 20 --> ipilimumab
    n1=en:black raspberry nectar | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1105. en:black seed oil --- r_associated #0: 20 --> ipilimumab
    n1=en:black seed oil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1106. en:black tea --- r_associated #0: 20 --> ipilimumab
    n1=en:black tea | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1107. en:blackberry allergenic extract --- r_associated #0: 20 --> ipilimumab
    n1=en:blackberry allergenic extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1108. en:bleomycin sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:bleomycin sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1109. en:blex 404 --- r_associated #0: 20 --> ipilimumab
    n1=en:blex 404 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1110. en:blinatumomab --- r_associated #0: 20 --> ipilimumab
    n1=en:blinatumomab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1111. en:blue citrus-based herbal capsule --- r_associated #0: 20 --> ipilimumab
    n1=en:blue citrus-based herbal capsule | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1112. en:blueberry powder supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:blueberry powder supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1113. en:bmi1 inhibitor ptc596 --- r_associated #0: 20 --> ipilimumab
    n1=en:bmi1 inhibitor ptc596 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1114. en:bms-184476 --- r_associated #0: 20 --> ipilimumab
    n1=en:bms-184476 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1115. en:bms-188797 --- r_associated #0: 20 --> ipilimumab
    n1=en:bms-188797 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1116. en:bms-214662 --- r_associated #0: 20 --> ipilimumab
    n1=en:bms-214662 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1117. en:bms-275183 --- r_associated #0: 20 --> ipilimumab
    n1=en:bms-275183 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1118. en:bms-817378 --- r_associated #0: 20 --> ipilimumab
    n1=en:bms-817378 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1119. en:bms-986156 --- r_associated #0: 20 --> ipilimumab
    n1=en:bms-986156 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1120. en:bms-986205 --- r_associated #0: 20 --> ipilimumab
    n1=en:bms-986205 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1121. en:boanmycin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:boanmycin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1122. en:boceprevir --- r_associated #0: 20 --> ipilimumab
    n1=en:boceprevir | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1123. en:bone cements --- r_associated #0: 20 --> ipilimumab
    n1=en:bone cements | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1124. en:bone graft - material --- r_associated #0: 20 --> ipilimumab
    n1=en:bone graft - material | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1125. en:bone metastasis targeting peptide-11 --- r_associated #0: 20 --> ipilimumab
    n1=en:bone metastasis targeting peptide-11 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1126. en:bone resorption inhibitor --- r_associated #0: 20 --> ipilimumab
    n1=en:bone resorption inhibitor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1127. en:boron phenylalanine --- r_associated #0: 20 --> ipilimumab
    n1=en:boron phenylalanine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1128. en:boronophenylalanine-fructose complex --- r_associated #0: 20 --> ipilimumab
    n1=en:boronophenylalanine-fructose complex | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1129. en:bortezomib --- r_associated #0: 20 --> ipilimumab
    n1=en:bortezomib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1130. en:bosutinib --- r_associated #0: 20 --> ipilimumab
    n1=en:bosutinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1131. en:boswellia serrata extract --- r_associated #0: 20 --> ipilimumab
    n1=en:boswellia serrata extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1132. en:botanical extracts rinse izn-6n4 --- r_associated #0: 20 --> ipilimumab
    n1=en:botanical extracts rinse izn-6n4 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1133. en:botanical lotion cg428 --- r_associated #0: 20 --> ipilimumab
    n1=en:botanical lotion cg428 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1134. en:botulinum toxin type a --- r_associated #0: 20 --> ipilimumab
    n1=en:botulinum toxin type a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1135. en:bovine cartilage --- r_associated #0: 20 --> ipilimumab
    n1=en:bovine cartilage | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1136. en:bovine lactoferrin supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:bovine lactoferrin supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1137. en:bowman-birk inhibitor concentrate --- r_associated #0: 20 --> ipilimumab
    n1=en:bowman-birk inhibitor concentrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1138. en:bp-cx1-platinum complex bp-c1 --- r_associated #0: 20 --> ipilimumab
    n1=en:bp-cx1-platinum complex bp-c1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1139. en:br96-doxorubicin immunoconjugate --- r_associated #0: 20 --> ipilimumab
    n1=en:br96-doxorubicin immunoconjugate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1140. en:brachyury-expressing modified vaccinia ankara-tricom vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:brachyury-expressing modified vaccinia ankara-tricom vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1141. en:brachyury-expressing yeast vaccine gi-6301 --- r_associated #0: 20 --> ipilimumab
    n1=en:brachyury-expressing yeast vaccine gi-6301 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1142. en:braf inhibitor --- r_associated #0: 20 --> ipilimumab
    n1=en:braf inhibitor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1143. en:braf inhibitor arq 736 --- r_associated #0: 20 --> ipilimumab
    n1=en:braf inhibitor arq 736 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1144. en:braf inhibitor plx8394 --- r_associated #0: 20 --> ipilimumab
    n1=en:braf inhibitor plx8394 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1145. en:braf(v600e) inhibitor cep-32496 --- r_associated #0: 20 --> ipilimumab
    n1=en:braf(v600e) inhibitor cep-32496 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1146. en:braf(v600e) kinase inhibitor ro5212054 --- r_associated #0: 20 --> ipilimumab
    n1=en:braf(v600e) kinase inhibitor ro5212054 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1147. en:braf/egfr inhibitor bgb-283 --- r_associated #0: 20 --> ipilimumab
    n1=en:braf/egfr inhibitor bgb-283 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1148. en:brain tumor initiating cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:brain tumor initiating cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1149. en:branched-chain amino acid supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:branched-chain amino acid supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1150. en:brassica vegetable --- r_associated #0: 20 --> ipilimumab
    n1=en:brassica vegetable | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1151. en:brd4 inhibitor plx51107 --- r_associated #0: 20 --> ipilimumab
    n1=en:brd4 inhibitor plx51107 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1152. en:breflate --- r_associated #0: 20 --> ipilimumab
    n1=en:breflate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1153. en:brentuximab vedotin --- r_associated #0: 20 --> ipilimumab
    n1=en:brentuximab vedotin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1154. en:brequinar --- r_associated #0: 20 --> ipilimumab
    n1=en:brequinar | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1155. en:briciclib sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:briciclib sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1156. en:brigatinib --- r_associated #0: 20 --> ipilimumab
    n1=en:brigatinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1157. en:brilacidin oral rinse --- r_associated #0: 20 --> ipilimumab
    n1=en:brilacidin oral rinse | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1158. en:brincidofovir --- r_associated #0: 20 --> ipilimumab
    n1=en:brincidofovir | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1159. en:brivanib --- r_associated #0: 20 --> ipilimumab
    n1=en:brivanib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1160. en:brivanib alaninate --- r_associated #0: 20 --> ipilimumab
    n1=en:brivanib alaninate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1161. en:brivudine --- r_associated #0: 20 --> ipilimumab
    n1=en:brivudine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1162. en:brivudine phosphoramidate --- r_associated #0: 20 --> ipilimumab
    n1=en:brivudine phosphoramidate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1163. en:brn01 --- r_associated #0: 20 --> ipilimumab
    n1=en:brn01 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1164. en:broad-spectrum human papillomavirus vaccine v505 --- r_associated #0: 20 --> ipilimumab
    n1=en:broad-spectrum human papillomavirus vaccine v505 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1165. en:broccoli sprout extract --- r_associated #0: 20 --> ipilimumab
    n1=en:broccoli sprout extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1166. en:broccoli sprout/broccoli seed extract supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:broccoli sprout/broccoli seed extract supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1167. en:bromacrylide --- r_associated #0: 20 --> ipilimumab
    n1=en:bromacrylide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1168. en:bromelains --- r_associated #0: 20 --> ipilimumab
    n1=en:bromelains | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1169. en:bromine compound agent --- r_associated #0: 20 --> ipilimumab
    n1=en:bromine compound agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1170. en:bromocriptine mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:bromocriptine mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1171. en:bromodomain inhibitor abbv-075 --- r_associated #0: 20 --> ipilimumab
    n1=en:bromodomain inhibitor abbv-075 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1172. en:brontictuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:brontictuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1173. en:bropirimine --- r_associated #0: 20 --> ipilimumab
    n1=en:bropirimine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1174. en:brostallicin --- r_associated #0: 20 --> ipilimumab
    n1=en:brostallicin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1175. en:broxuridine --- r_associated #0: 20 --> ipilimumab
    n1=en:broxuridine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1176. en:bruceantin --- r_associated #0: 20 --> ipilimumab
    n1=en:bruceantin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1177. en:bryostatin 1 --- r_associated #0: 20 --> ipilimumab
    n1=en:bryostatin 1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1178. en:btct4465a --- r_associated #0: 20 --> ipilimumab
    n1=en:btct4465a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1179. en:btk inhibitor bgb-3111 --- r_associated #0: 20 --> ipilimumab
    n1=en:btk inhibitor bgb-3111 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1180. en:btk inhibitor gdc-0853 --- r_associated #0: 20 --> ipilimumab
    n1=en:btk inhibitor gdc-0853 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1181. en:btk inhibitor ono-4059 --- r_associated #0: 20 --> ipilimumab
    n1=en:btk inhibitor ono-4059 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1182. en:budesonide --- r_associated #0: 20 --> ipilimumab
    n1=en:budesonide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1183. en:budesonide/formoterol fumarate dihydrate inhalation aerosol --- r_associated #0: 20 --> ipilimumab
    n1=en:budesonide/formoterol fumarate dihydrate inhalation aerosol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1184. en:budotitane --- r_associated #0: 20 --> ipilimumab
    n1=en:budotitane | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1185. en:buformin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:buformin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1186. en:buparlisib --- r_associated #0: 20 --> ipilimumab
    n1=en:buparlisib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1187. en:bupivacaine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:bupivacaine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1188. en:buprenorphine transdermal matrix patch --- r_associated #0: 20 --> ipilimumab
    n1=en:buprenorphine transdermal matrix patch | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1189. en:bupropion + naltrexone --- r_associated #0: 20 --> ipilimumab
    n1=en:bupropion + naltrexone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1190. en:bupropion hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:bupropion hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1191. en:burixafor --- r_associated #0: 20 --> ipilimumab
    n1=en:burixafor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1192. en:buserelin --- r_associated #0: 20 --> ipilimumab
    n1=en:buserelin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1193. en:buspirone hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:buspirone hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1194. en:busulfan --- r_associated #0: 20 --> ipilimumab
    n1=en:busulfan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1195. en:busulfan/melphalan regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:busulfan/melphalan regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1196. en:buthionine sulfoximine --- r_associated #0: 20 --> ipilimumab
    n1=en:buthionine sulfoximine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1197. en:butocin --- r_associated #0: 20 --> ipilimumab
    n1=en:butocin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1198. en:butylscopolamine bromide --- r_associated #0: 20 --> ipilimumab
    n1=en:butylscopolamine bromide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1199. en:bw a773u --- r_associated #0: 20 --> ipilimumab
    n1=en:bw a773u | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1200. en:c-kit inhibitor plx9486 --- r_associated #0: 20 --> ipilimumab
    n1=en:c-kit inhibitor plx9486 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1201. en:c-met inhibitor amg 208 --- r_associated #0: 20 --> ipilimumab
    n1=en:c-met inhibitor amg 208 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1202. en:c-met inhibitor amg 337 --- r_associated #0: 20 --> ipilimumab
    n1=en:c-met inhibitor amg 337 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1203. en:c-met inhibitor jnj-38877605 --- r_associated #0: 20 --> ipilimumab
    n1=en:c-met inhibitor jnj-38877605 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1204. en:c-met inhibitor mk2461 --- r_associated #0: 20 --> ipilimumab
    n1=en:c-met inhibitor mk2461 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1205. en:c-met inhibitor mk8033 --- r_associated #0: 20 --> ipilimumab
    n1=en:c-met inhibitor mk8033 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1206. en:c-met inhibitor msc2156119j --- r_associated #0: 20 --> ipilimumab
    n1=en:c-met inhibitor msc2156119j | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1207. en:c-myb antisense oligonucleotide g4460 --- r_associated #0: 20 --> ipilimumab
    n1=en:c-myb antisense oligonucleotide g4460 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1208. en:c-visa bikdd:liposome --- r_associated #0: 20 --> ipilimumab
    n1=en:c-visa bikdd:liposome | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1209. en:c3-targeted complement inhibitor apl-2 --- r_associated #0: 20 --> ipilimumab
    n1=en:c3-targeted complement inhibitor apl-2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1210. en:cabazitaxel --- r_associated #0: 20 --> ipilimumab
    n1=en:cabazitaxel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1211. en:cabergoline --- r_associated #0: 20 --> ipilimumab
    n1=en:cabergoline | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1212. en:cabozantinib s-malate --- r_associated #0: 20 --> ipilimumab
    n1=en:cabozantinib s-malate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1213. en:cadazolid --- r_associated #0: 20 --> ipilimumab
    n1=en:cadazolid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1214. en:caf regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:caf regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1215. en:caffeine --- r_associated #0: 20 --> ipilimumab
    n1=en:caffeine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1216. en:cafusertib hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:cafusertib hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1217. en:caix inhibitor dtp348 --- r_associated #0: 20 --> ipilimumab
    n1=en:caix inhibitor dtp348 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1218. en:caix inhibitor slc-0111 --- r_associated #0: 20 --> ipilimumab
    n1=en:caix inhibitor slc-0111 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1219. en:calamine --- r_associated #0: 20 --> ipilimumab
    n1=en:calamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1220. en:calaspargase pegol --- r_associated #0: 20 --> ipilimumab
    n1=en:calaspargase pegol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1221. en:calcipotriene --- r_associated #0: 20 --> ipilimumab
    n1=en:calcipotriene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1222. en:calcitonin salmon --- r_associated #0: 20 --> ipilimumab
    n1=en:calcitonin salmon | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1223. en:calcitriol --- r_associated #0: 20 --> ipilimumab
    n1=en:calcitriol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1224. en:calcium aluminosilicate anti-diarrheal --- r_associated #0: 20 --> ipilimumab
    n1=en:calcium aluminosilicate anti-diarrheal | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1225. en:calcium carbonate --- r_associated #0: 20 --> ipilimumab
    n1=en:calcium carbonate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1226. en:calcium channel blocker --- r_associated #0: 20 --> ipilimumab
    n1=en:calcium channel blocker | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1227. en:calcium chloride --- r_associated #0: 20 --> ipilimumab
    n1=en:calcium chloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1228. en:calcium citrate --- r_associated #0: 20 --> ipilimumab
    n1=en:calcium citrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1229. en:calcium gluconate --- r_associated #0: 20 --> ipilimumab
    n1=en:calcium gluconate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1230. en:calcium regulating agent --- r_associated #0: 20 --> ipilimumab
    n1=en:calcium regulating agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1231. en:calcium saccharate --- r_associated #0: 20 --> ipilimumab
    n1=en:calcium saccharate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1232. en:calcium-41 chloride aqueous solution --- r_associated #0: 20 --> ipilimumab
    n1=en:calcium-41 chloride aqueous solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1233. en:calcium-46 chloride aqueous solution --- r_associated #0: 20 --> ipilimumab
    n1=en:calcium-46 chloride aqueous solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1234. en:calculus bovis/moschus/olibanum/myrrha capsule --- r_associated #0: 20 --> ipilimumab
    n1=en:calculus bovis/moschus/olibanum/myrrha capsule | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1235. en:calendula officinalis/plantago major/cochlearia armoracia/hamamelis virginiana herbal toothpaste --- r_associated #0: 20 --> ipilimumab
    n1=en:calendula officinalis/plantago major/cochlearia armoracia/hamamelis virginiana herbal toothpaste | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1236. en:calendula ointment --- r_associated #0: 20 --> ipilimumab
    n1=en:calendula ointment | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1237. en:calfactant --- r_associated #0: 20 --> ipilimumab
    n1=en:calfactant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1238. en:calusterone --- r_associated #0: 20 --> ipilimumab
    n1=en:calusterone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1239. en:camptothecin --- r_associated #0: 20 --> ipilimumab
    n1=en:camptothecin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1240. en:camptothecin analogue tlc388 --- r_associated #0: 20 --> ipilimumab
    n1=en:camptothecin analogue tlc388 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1241. en:camptothecin-20(s)-o-propionate hydrate --- r_associated #0: 20 --> ipilimumab
    n1=en:camptothecin-20(s)-o-propionate hydrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1242. en:campy cva agar --- r_associated #0: 20 --> ipilimumab
    n1=en:campy cva agar | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1243. en:canakinumab --- r_associated #0: 20 --> ipilimumab
    n1=en:canakinumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1244. en:canarypox-hil-12 melanoma vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:canarypox-hil-12 melanoma vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1245. en:cancell --- r_associated #0: 20 --> ipilimumab
    n1=en:cancell | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1246. en:cancer peptide vaccine s-588410 --- r_associated #0: 20 --> ipilimumab
    n1=en:cancer peptide vaccine s-588410 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1247. en:cancer stemness kinase inhibitor bbi503 --- r_associated #0: 20 --> ipilimumab
    n1=en:cancer stemness kinase inhibitor bbi503 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1248. en:candesartan cilexetil --- r_associated #0: 20 --> ipilimumab
    n1=en:candesartan cilexetil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1249. en:candida albicans skin test reagent --- r_associated #0: 20 --> ipilimumab
    n1=en:candida albicans skin test reagent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1250. en:canertinib dihydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:canertinib dihydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1251. en:canfosfamide hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:canfosfamide hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1252. en:cannabidiol --- r_associated #0: 20 --> ipilimumab
    n1=en:cannabidiol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1253. en:cannabinol --- r_associated #0: 20 --> ipilimumab
    n1=en:cannabinol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1254. en:cannabis extract oil sr capsule --- r_associated #0: 20 --> ipilimumab
    n1=en:cannabis extract oil sr capsule | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1255. en:cantuzumab ravtansine --- r_associated #0: 20 --> ipilimumab
    n1=en:cantuzumab ravtansine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1256. en:capecitabine --- r_associated #0: 20 --> ipilimumab
    n1=en:capecitabine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1257. en:capecitabine rapidly disintegrating tablet --- r_associated #0: 20 --> ipilimumab
    n1=en:capecitabine rapidly disintegrating tablet | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1258. en:capmatinib --- r_associated #0: 20 --> ipilimumab
    n1=en:capmatinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1259. en:capox regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:capox regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1260. en:capsaicin --- r_associated #0: 20 --> ipilimumab
    n1=en:capsaicin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1261. en:captopril --- r_associated #0: 20 --> ipilimumab
    n1=en:captopril | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1262. en:car.cd30-expressing autologous epstein-barr virus-specific cytotoxic t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:car.cd30-expressing autologous epstein-barr virus-specific cytotoxic t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1263. en:caracemide --- r_associated #0: 20 --> ipilimumab
    n1=en:caracemide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1264. en:carbamazepine --- r_associated #0: 20 --> ipilimumab
    n1=en:carbamazepine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1265. en:carbamide peroxide --- r_associated #0: 20 --> ipilimumab
    n1=en:carbamide peroxide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1266. en:carbendazim --- r_associated #0: 20 --> ipilimumab
    n1=en:carbendazim | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1267. en:carbenicillin --- r_associated #0: 20 --> ipilimumab
    n1=en:carbenicillin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1268. en:carbetimer --- r_associated #0: 20 --> ipilimumab
    n1=en:carbetimer | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1269. en:carbidopa --- r_associated #0: 20 --> ipilimumab
    n1=en:carbidopa | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1270. en:carbogen --- r_associated #0: 20 --> ipilimumab
    n1=en:carbogen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1271. en:carbohydrate processing inhibitor --- r_associated #0: 20 --> ipilimumab
    n1=en:carbohydrate processing inhibitor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1272. en:carbohydrate supplement drink --- r_associated #0: 20 --> ipilimumab
    n1=en:carbohydrate supplement drink | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1273. en:carbon c 11 alpha-methyltryptophan --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 11 alpha-methyltryptophan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1274. en:carbon c 11 choline --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 11 choline | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1275. en:carbon c 11 erlotinib hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 11 erlotinib hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1276. en:carbon c 11 methylaminoisobutyrate --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 11 methylaminoisobutyrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1277. en:carbon c 11 n-desmethyl-loperamide --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 11 n-desmethyl-loperamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1278. en:carbon c 11 pbr-28 --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 11 pbr-28 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1279. en:carbon c 11 sarcosine --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 11 sarcosine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1280. en:carbon c 11 sepantronium bromide --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 11 sepantronium bromide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1281. en:carbon c 13 acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 13 acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1282. en:carbon c 13 lycopene --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 13 lycopene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1283. en:carbon c 13 octanoate --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 13 octanoate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1284. en:carbon c 13 phytoene --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 13 phytoene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1285. en:carbon c 13 phytofluene --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 13 phytofluene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1286. en:carbon c 13/nitrogen n 15-labeled valine --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 13/nitrogen n 15-labeled valine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1287. en:carbon c 14 anlotinib hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 14 anlotinib hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1288. en:carbon c 14 eribulin acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 14 eribulin acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1289. en:carbon c 14 gilteritinib --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 14 gilteritinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1290. en:carbon c 14 ibrutinib --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 14 ibrutinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1291. en:carbon c 14 lenvatinib mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 14 lenvatinib mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1292. en:carbon c 14 ombrabulin --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 14 ombrabulin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1293. en:carbon c 14 oxaliplatin --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 14 oxaliplatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1294. en:carbon c 14 roniciclib --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 14 roniciclib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1295. en:carbon c 14 selumetinib --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 14 selumetinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1296. en:carbon c 14 telotristat etiprate --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 14 telotristat etiprate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1297. en:carbon c 14 vemurafenib --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 14 vemurafenib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1298. en:carbon c 14-labeled ixazomib --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c 14-labeled ixazomib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1299. en:carbon c-13 dextromethorphan --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c-13 dextromethorphan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1300. en:carbon c-14 dacomitinib --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c-14 dacomitinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1301. en:carbon c11 temozolomide --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon c11 temozolomide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1302. en:carbon nanoparticle-based formulation --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon nanoparticle-based formulation | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1303. en:carbon-11 acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:carbon-11 acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1304. en:carboplatin --- r_associated #0: 20 --> ipilimumab
    n1=en:carboplatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1305. en:carboplatin-taxol regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:carboplatin-taxol regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1306. en:carboplatin-taxol-bevacizumab regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:carboplatin-taxol-bevacizumab regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1307. en:carboplatin/etoposide/melphalan regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:carboplatin/etoposide/melphalan regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1308. en:carboxyamidotriazole --- r_associated #0: 20 --> ipilimumab
    n1=en:carboxyamidotriazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1309. en:carboxyamidotriazole orotate --- r_associated #0: 20 --> ipilimumab
    n1=en:carboxyamidotriazole orotate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1310. en:carboxylesterase-expressing allogeneic neural stem cells --- r_associated #0: 20 --> ipilimumab
    n1=en:carboxylesterase-expressing allogeneic neural stem cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1311. en:carboxymethylcellulose sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:carboxymethylcellulose sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1312. en:carboxyphenyl retinamide --- r_associated #0: 20 --> ipilimumab
    n1=en:carboxyphenyl retinamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1313. en:carbutamide --- r_associated #0: 20 --> ipilimumab
    n1=en:carbutamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1314. en:carcinoembryonic antigen peptide 1 --- r_associated #0: 20 --> ipilimumab
    n1=en:carcinoembryonic antigen peptide 1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1315. en:carcinoembryonic antigen peptide 1-6d --- r_associated #0: 20 --> ipilimumab
    n1=en:carcinoembryonic antigen peptide 1-6d | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1316. en:carcinoembryonic antigen peptide 1-6d virus-like replicon particles vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:carcinoembryonic antigen peptide 1-6d virus-like replicon particles vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1317. en:carcinoembryonic antigen peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:carcinoembryonic antigen peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1318. en:carcinoembryonic antigen rna-pulsed dc cancer vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:carcinoembryonic antigen rna-pulsed dc cancer vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1319. en:carcinoembryonic antigen-expressing measles virus --- r_associated #0: 20 --> ipilimumab
    n1=en:carcinoembryonic antigen-expressing measles virus | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1320. en:carcinogen --- r_associated #0: 20 --> ipilimumab
    n1=en:carcinogen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1321. en:carfilzomib --- r_associated #0: 20 --> ipilimumab
    n1=en:carfilzomib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1322. en:caricotamide/tretazicar --- r_associated #0: 20 --> ipilimumab
    n1=en:caricotamide/tretazicar | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1323. en:carlumab --- r_associated #0: 20 --> ipilimumab
    n1=en:carlumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1324. en:carmustine --- r_associated #0: 20 --> ipilimumab
    n1=en:carmustine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1325. en:carmustine in ethanol --- r_associated #0: 20 --> ipilimumab
    n1=en:carmustine in ethanol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1326. en:carmustine sustained-release implant wafer --- r_associated #0: 20 --> ipilimumab
    n1=en:carmustine sustained-release implant wafer | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1327. en:carrageenan-containing gel --- r_associated #0: 20 --> ipilimumab
    n1=en:carrageenan-containing gel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1328. en:carrot juice --- r_associated #0: 20 --> ipilimumab
    n1=en:carrot juice | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1329. en:carrot/jilin ginseng/licorice root/tangerine peel/soy beverage --- r_associated #0: 20 --> ipilimumab
    n1=en:carrot/jilin ginseng/licorice root/tangerine peel/soy beverage | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1330. en:carubicin --- r_associated #0: 20 --> ipilimumab
    n1=en:carubicin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1331. en:carvedilol --- r_associated #0: 20 --> ipilimumab
    n1=en:carvedilol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1332. en:carvedilol phosphate extended-release capsule --- r_associated #0: 20 --> ipilimumab
    n1=en:carvedilol phosphate extended-release capsule | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1333. en:carzelesin --- r_associated #0: 20 --> ipilimumab
    n1=en:carzelesin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1334. en:casein/whey protein/soy protein/pea protein/fat mix/epa/dha-based nutritional supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:casein/whey protein/soy protein/pea protein/fat mix/epa/dha-based nutritional supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1335. en:caseinate protein isolate --- r_associated #0: 20 --> ipilimumab
    n1=en:caseinate protein isolate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1336. en:casopitant mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:casopitant mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1337. en:caspofungin acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:caspofungin acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1338. en:cathelicidin ll-37 --- r_associated #0: 20 --> ipilimumab
    n1=en:cathelicidin ll-37 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1339. en:cathepsin-activatable cy5 fluorescent imaging probe lum015 --- r_associated #0: 20 --> ipilimumab
    n1=en:cathepsin-activatable cy5 fluorescent imaging probe lum015 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1340. en:cationic liposome-encapsulated paclitaxel --- r_associated #0: 20 --> ipilimumab
    n1=en:cationic liposome-encapsulated paclitaxel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1341. en:catumaxomab --- r_associated #0: 20 --> ipilimumab
    n1=en:catumaxomab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1342. en:cb10-277 --- r_associated #0: 20 --> ipilimumab
    n1=en:cb10-277 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1343. en:cbp-501 --- r_associated #0: 20 --> ipilimumab
    n1=en:cbp-501 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1344. en:cbp/beta-catenin antagonist pri-724 --- r_associated #0: 20 --> ipilimumab
    n1=en:cbp/beta-catenin antagonist pri-724 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1345. en:cc-1088 --- r_associated #0: 20 --> ipilimumab
    n1=en:cc-1088 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1346. en:cc-401 --- r_associated #0: 20 --> ipilimumab
    n1=en:cc-401 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1347. en:cc-8490 --- r_associated #0: 20 --> ipilimumab
    n1=en:cc-8490 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1348. en:ccl21-expressing h1944 cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:ccl21-expressing h1944 cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1349. en:ccr2 antagonist ccx872-b --- r_associated #0: 20 --> ipilimumab
    n1=en:ccr2 antagonist ccx872-b | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1350. en:ccr2 antagonist pf-04136309 --- r_associated #0: 20 --> ipilimumab
    n1=en:ccr2 antagonist pf-04136309 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1351. en:cd-expressing bifidobacterium aps001f --- r_associated #0: 20 --> ipilimumab
    n1=en:cd-expressing bifidobacterium aps001f | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1352. en:cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1353. en:cd133 antigen peptide-pulsed autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:cd133 antigen peptide-pulsed autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1354. en:cd138car-cd137/tcrzeta-expressing t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:cd138car-cd137/tcrzeta-expressing t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1355. en:cd19/cd3 dual-affinity retargeting protein jnj-64052781 --- r_associated #0: 20 --> ipilimumab
    n1=en:cd19/cd3 dual-affinity retargeting protein jnj-64052781 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1356. en:cd19car-cd28zeta-4-1bb-expressing allogeneic t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:cd19car-cd28zeta-4-1bb-expressing allogeneic t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1357. en:cd19car-cd3zeta-4-1bb-cd28-expressing autologous t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:cd19car-cd3zeta-4-1bb-cd28-expressing autologous t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1358. en:cd19car-cd3zeta-4-1bb-expressing allogeneic t-lymphocyte cells --- r_associated #0: 20 --> ipilimumab
    n1=en:cd19car-cd3zeta-4-1bb-expressing allogeneic t-lymphocyte cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1359. en:cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1360. en:cd19car-cd3zeta-expressing autologous t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:cd19car-cd3zeta-expressing autologous t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1361. en:cd20-targeted polypeptide tru-015 --- r_associated #0: 20 --> ipilimumab
    n1=en:cd20-targeted polypeptide tru-015 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1362. en:cd24 extracellular domain-igg1 fc domain recombinant fusion protein cd24fc --- r_associated #0: 20 --> ipilimumab
    n1=en:cd24 extracellular domain-igg1 fc domain recombinant fusion protein cd24fc | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1363. en:cd28car/cd137car-expressing t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:cd28car/cd137car-expressing t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1364. en:cd3/cd28 costimulated autologous t-cells --- r_associated #0: 20 --> ipilimumab
    n1=en:cd3/cd28 costimulated autologous t-cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1365. en:cd30 car-expressing autologous t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:cd30 car-expressing autologous t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1366. en:cd33car-cd3zeta-4-1bb-expressing autologous t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:cd33car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1367. en:cd34/tk75-transduced donor lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:cd34/tk75-transduced donor lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1368. en:cd4+ cd25+ regulatory t cells --- r_associated #0: 20 --> ipilimumab
    n1=en:cd4+ cd25+ regulatory t cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1369. en:cd40 agonist monoclonal antibody cp-870,893 --- r_associated #0: 20 --> ipilimumab
    n1=en:cd40 agonist monoclonal antibody cp-870,893 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1370. en:cd40 agonist monoclonal antibody ro7009789 --- r_associated #0: 20 --> ipilimumab
    n1=en:cd40 agonist monoclonal antibody ro7009789 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1371. en:cd40 agonistic monoclonal antibody apx005m --- r_associated #0: 20 --> ipilimumab
    n1=en:cd40 agonistic monoclonal antibody apx005m | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1372. en:cd5789 cream --- r_associated #0: 20 --> ipilimumab
    n1=en:cd5789 cream | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1373. en:cd80 breast cancer vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:cd80 breast cancer vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1374. en:cd95 ecd/igg-fc fusion protein apg101 --- r_associated #0: 20 --> ipilimumab
    n1=en:cd95 ecd/igg-fc fusion protein apg101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1375. en:cda inhibitor e7727/decitabine combination agent astx727 --- r_associated #0: 20 --> ipilimumab
    n1=en:cda inhibitor e7727/decitabine combination agent astx727 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1376. en:cdc7 inhibitor tak-931 --- r_associated #0: 20 --> ipilimumab
    n1=en:cdc7 inhibitor tak-931 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1377. en:cdc7 kinase inhibitor bms-863233 --- r_associated #0: 20 --> ipilimumab
    n1=en:cdc7 kinase inhibitor bms-863233 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1378. en:cdc7 kinase inhibitor nms-1116354 --- r_associated #0: 20 --> ipilimumab
    n1=en:cdc7 kinase inhibitor nms-1116354 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1379. en:cdk inhibitor p276-00 --- r_associated #0: 20 --> ipilimumab
    n1=en:cdk inhibitor p276-00 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1380. en:cdk inhibitor sns-032 --- r_associated #0: 20 --> ipilimumab
    n1=en:cdk inhibitor sns-032 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1381. en:cdk/jak2/flt3 inhibitor tg02 citrate --- r_associated #0: 20 --> ipilimumab
    n1=en:cdk/jak2/flt3 inhibitor tg02 citrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1382. en:cdk2/5/9 inhibitor cyc065 --- r_associated #0: 20 --> ipilimumab
    n1=en:cdk2/5/9 inhibitor cyc065 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1383. en:cdk2/trka inhibitor pha-848125 ac --- r_associated #0: 20 --> ipilimumab
    n1=en:cdk2/trka inhibitor pha-848125 ac | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1384. en:cdk4 inhibitor p1446a-05 --- r_associated #0: 20 --> ipilimumab
    n1=en:cdk4 inhibitor p1446a-05 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1385. en:cdk4/6 inhibitor g1t28 --- r_associated #0: 20 --> ipilimumab
    n1=en:cdk4/6 inhibitor g1t28 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1386. en:cdk4/6 inhibitor shr6390 --- r_associated #0: 20 --> ipilimumab
    n1=en:cdk4/6 inhibitor shr6390 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1387. en:cdki at7519 --- r_associated #0: 20 --> ipilimumab
    n1=en:cdki at7519 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1388. en:cdki r547 --- r_associated #0: 20 --> ipilimumab
    n1=en:cdki r547 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1389. en:cea/tetanus toxoid t helper epitope fusion protein-expressing dna plasmid vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:cea/tetanus toxoid t helper epitope fusion protein-expressing dna plasmid vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1390. en:cebpa-targeting sarna mtl-cebpa liposome --- r_associated #0: 20 --> ipilimumab
    n1=en:cebpa-targeting sarna mtl-cebpa liposome | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1391. en:cebranopadol --- r_associated #0: 20 --> ipilimumab
    n1=en:cebranopadol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1392. en:cedefingol --- r_associated #0: 20 --> ipilimumab
    n1=en:cedefingol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1393. en:cediranib maleate --- r_associated #0: 20 --> ipilimumab
    n1=en:cediranib maleate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1394. en:cef regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:cef regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1395. en:cefamandole --- r_associated #0: 20 --> ipilimumab
    n1=en:cefamandole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1396. en:cefazolin sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:cefazolin sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1397. en:cefepime hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:cefepime hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1398. en:cefixime --- r_associated #0: 20 --> ipilimumab
    n1=en:cefixime | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1399. en:cefmetazole sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:cefmetazole sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1400. en:cefotaxime --- r_associated #0: 20 --> ipilimumab
    n1=en:cefotaxime | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1401. en:cefpodoxime proxetil --- r_associated #0: 20 --> ipilimumab
    n1=en:cefpodoxime proxetil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1402. en:ceftazidime sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:ceftazidime sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1403. en:ceftazidime/avibactam sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:ceftazidime/avibactam sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1404. en:ceftobiprole medocaril --- r_associated #0: 20 --> ipilimumab
    n1=en:ceftobiprole medocaril | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1405. en:ceftriaxone sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:ceftriaxone sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1406. en:celecoxib --- r_associated #0: 20 --> ipilimumab
    n1=en:celecoxib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1407. en:cell cycle checkpoint/dna repair antagonist ic83 --- r_associated #0: 20 --> ipilimumab
    n1=en:cell cycle checkpoint/dna repair antagonist ic83 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1408. en:cell differentiating agent --- r_associated #0: 20 --> ipilimumab
    n1=en:cell differentiating agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1409. en:cellulose, oxidized --- r_associated #0: 20 --> ipilimumab
    n1=en:cellulose, oxidized | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1410. en:cemadotin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:cemadotin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1411. en:cenersen --- r_associated #0: 20 --> ipilimumab
    n1=en:cenersen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1412. en:cenisertib --- r_associated #0: 20 --> ipilimumab
    n1=en:cenisertib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1413. en:cenp-e inhibitor gsk-923295 --- r_associated #0: 20 --> ipilimumab
    n1=en:cenp-e inhibitor gsk-923295 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1414. en:central nervous system agents --- r_associated #0: 20 --> ipilimumab
    n1=en:central nervous system agents | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1415. en:cep-2563 dihydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:cep-2563 dihydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1416. en:cephalexin --- r_associated #0: 20 --> ipilimumab
    n1=en:cephalexin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1417. en:cephalostatin --- r_associated #0: 20 --> ipilimumab
    n1=en:cephalostatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1418. en:cephalothin sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:cephalothin sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1419. en:ceramide --- r_associated #0: 20 --> ipilimumab
    n1=en:ceramide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1420. en:ceritinib --- r_associated #0: 20 --> ipilimumab
    n1=en:ceritinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1421. en:certolizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:certolizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1422. en:certolizumab pegol --- r_associated #0: 20 --> ipilimumab
    n1=en:certolizumab pegol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1423. en:ceruminolytic agent --- r_associated #0: 20 --> ipilimumab
    n1=en:ceruminolytic agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1424. en:cesium cs 137 --- r_associated #0: 20 --> ipilimumab
    n1=en:cesium cs 137 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1425. en:cesium cs-131 --- r_associated #0: 20 --> ipilimumab
    n1=en:cesium cs-131 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1426. en:ceteth-20 --- r_associated #0: 20 --> ipilimumab
    n1=en:ceteth-20 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1427. en:cetirizine --- r_associated #0: 20 --> ipilimumab
    n1=en:cetirizine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1428. en:cetrorelix --- r_associated #0: 20 --> ipilimumab
    n1=en:cetrorelix | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1429. en:cetuximab --- r_associated #0: 20 --> ipilimumab
    n1=en:cetuximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1430. en:cetuximab-ir700 conjugate rm-1929 --- r_associated #0: 20 --> ipilimumab
    n1=en:cetuximab-ir700 conjugate rm-1929 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1431. en:cetuximab-irdye 800cw --- r_associated #0: 20 --> ipilimumab
    n1=en:cetuximab-irdye 800cw | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1432. en:cevimeline hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:cevimeline hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1433. en:cfms tyrosine kinase inhibitor arry-382 --- r_associated #0: 20 --> ipilimumab
    n1=en:cfms tyrosine kinase inhibitor arry-382 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1434. en:cg7870 --- r_associated #0: 20 --> ipilimumab
    n1=en:cg7870 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1435. en:cgp-6809 --- r_associated #0: 20 --> ipilimumab
    n1=en:cgp-6809 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1436. en:chamomile --- r_associated #0: 20 --> ipilimumab
    n1=en:chamomile | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1437. en:changchun marina --- r_associated #0: 20 --> ipilimumab
    n1=en:changchun marina | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1438. en:checkpoint kinase inhibitor azd7762 --- r_associated #0: 20 --> ipilimumab
    n1=en:checkpoint kinase inhibitor azd7762 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1439. en:checkpoint kinase inhibitor xl844 --- r_associated #0: 20 --> ipilimumab
    n1=en:checkpoint kinase inhibitor xl844 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1440. en:chelating agent --- r_associated #0: 20 --> ipilimumab
    n1=en:chelating agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1441. en:chelating agents and antidotes --- r_associated #0: 20 --> ipilimumab
    n1=en:chelating agents and antidotes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1442. en:chemotherapeutic topical agent --- r_associated #0: 20 --> ipilimumab
    n1=en:chemotherapeutic topical agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1443. en:chewing gum dosage form --- r_associated #0: 20 --> ipilimumab
    n1=en:chewing gum dosage form | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1444. en:chiauranib --- r_associated #0: 20 --> ipilimumab
    n1=en:chiauranib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1445. en:chidamide --- r_associated #0: 20 --> ipilimumab
    n1=en:chidamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1446. en:chimeric fibril-reactive monoclonal antibody 111f4 --- r_associated #0: 20 --> ipilimumab
    n1=en:chimeric fibril-reactive monoclonal antibody 111f4 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1447. en:chimeric humanized anti-cd47 antibody --- r_associated #0: 20 --> ipilimumab
    n1=en:chimeric humanized anti-cd47 antibody | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1448. en:chinese herbal formulation changtai keli --- r_associated #0: 20 --> ipilimumab
    n1=en:chinese herbal formulation changtai keli | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1449. en:chinese herbal formulation phy906 --- r_associated #0: 20 --> ipilimumab
    n1=en:chinese herbal formulation phy906 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1450. en:chinese herbal medicine compound tpe-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:chinese herbal medicine compound tpe-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1451. en:chinese herbs --- r_associated #0: 20 --> ipilimumab
    n1=en:chinese herbs | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1452. en:chining decoction --- r_associated #0: 20 --> ipilimumab
    n1=en:chining decoction | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1453. en:chk1 inhibitor gdc-0425 --- r_associated #0: 20 --> ipilimumab
    n1=en:chk1 inhibitor gdc-0425 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1454. en:chk1 inhibitor gdc-0575 --- r_associated #0: 20 --> ipilimumab
    n1=en:chk1 inhibitor gdc-0575 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1455. en:chk1 inhibitor mk-8776 --- r_associated #0: 20 --> ipilimumab
    n1=en:chk1 inhibitor mk-8776 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1456. en:chk1 inhibitor pf-477736 --- r_associated #0: 20 --> ipilimumab
    n1=en:chk1 inhibitor pf-477736 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1457. en:chlorambucil --- r_associated #0: 20 --> ipilimumab
    n1=en:chlorambucil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1458. en:chlorambucil-prednisone regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:chlorambucil-prednisone regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1459. en:chlorhexidine --- r_associated #0: 20 --> ipilimumab
    n1=en:chlorhexidine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1460. en:chlorhexidine gluconate --- r_associated #0: 20 --> ipilimumab
    n1=en:chlorhexidine gluconate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1461. en:chlorhexidine/ethyl alcohol mouthwash --- r_associated #0: 20 --> ipilimumab
    n1=en:chlorhexidine/ethyl alcohol mouthwash | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1462. en:chlorogenic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:chlorogenic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1463. en:chloroquine --- r_associated #0: 20 --> ipilimumab
    n1=en:chloroquine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1464. en:chloroquinoxaline sulfonamide --- r_associated #0: 20 --> ipilimumab
    n1=en:chloroquinoxaline sulfonamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1465. en:chlorotoxin [131i] --- r_associated #0: 20 --> ipilimumab
    n1=en:chlorotoxin [131i] | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1466. en:chlorotoxin-indocyanine green imaging agent blz-100 --- r_associated #0: 20 --> ipilimumab
    n1=en:chlorotoxin-indocyanine green imaging agent blz-100 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1467. en:chlorozotocin --- r_associated #0: 20 --> ipilimumab
    n1=en:chlorozotocin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1468. en:chlorpromazine --- r_associated #0: 20 --> ipilimumab
    n1=en:chlorpromazine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1469. en:chlorpropamide --- r_associated #0: 20 --> ipilimumab
    n1=en:chlorpropamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1470. en:chlorzoxazone --- r_associated #0: 20 --> ipilimumab
    n1=en:chlorzoxazone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1471. en:cholecalciferol --- r_associated #0: 20 --> ipilimumab
    n1=en:cholecalciferol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1472. en:cholecalciferol/whey protein isolate/epa/dha-based nutritional supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:cholecalciferol/whey protein isolate/epa/dha-based nutritional supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1473. en:cholelitholytic and/or choleretic agent --- r_associated #0: 20 --> ipilimumab
    n1=en:cholelitholytic and/or choleretic agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1474. en:choleretic agent --- r_associated #0: 20 --> ipilimumab
    n1=en:choleretic agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1475. en:choline kinase alpha inhibitor tcd-717 --- r_associated #0: 20 --> ipilimumab
    n1=en:choline kinase alpha inhibitor tcd-717 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1476. en:choline magnesium trisalicylate --- r_associated #0: 20 --> ipilimumab
    n1=en:choline magnesium trisalicylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1477. en:choline salicylate --- r_associated #0: 20 --> ipilimumab
    n1=en:choline salicylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1478. en:chop regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:chop regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1479. en:chp-her-2 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:chp-her-2 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1480. en:chp-ny-eso-1 peptide vaccine imf-001 --- r_associated #0: 20 --> ipilimumab
    n1=en:chp-ny-eso-1 peptide vaccine imf-001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1481. en:chromomycin a3 --- r_associated #0: 20 --> ipilimumab
    n1=en:chromomycin a3 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1482. en:ciclopirox olamine lotion --- r_associated #0: 20 --> ipilimumab
    n1=en:ciclopirox olamine lotion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1483. en:ciclopirox olamine oral --- r_associated #0: 20 --> ipilimumab
    n1=en:ciclopirox olamine oral | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1484. en:cidan herbal capsule --- r_associated #0: 20 --> ipilimumab
    n1=en:cidan herbal capsule | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1485. en:cidofovir --- r_associated #0: 20 --> ipilimumab
    n1=en:cidofovir | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1486. en:cilengitide --- r_associated #0: 20 --> ipilimumab
    n1=en:cilengitide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1487. en:cimetidine --- r_associated #0: 20 --> ipilimumab
    n1=en:cimetidine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1488. en:cinacalcet hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:cinacalcet hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1489. en:cinobufagin --- r_associated #0: 20 --> ipilimumab
    n1=en:cinobufagin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1490. en:cintredekin besudotox --- r_associated #0: 20 --> ipilimumab
    n1=en:cintredekin besudotox | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1491. en:cipatinib --- r_associated #0: 20 --> ipilimumab
    n1=en:cipatinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1492. en:ciprofloxacin --- r_associated #0: 20 --> ipilimumab
    n1=en:ciprofloxacin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1493. en:cirmtuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:cirmtuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1494. en:cis-urocanic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:cis-urocanic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1495. en:cisapride --- r_associated #0: 20 --> ipilimumab
    n1=en:cisapride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1496. en:cisatracurium besylate --- r_associated #0: 20 --> ipilimumab
    n1=en:cisatracurium besylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1497. en:cisplatin --- r_associated #0: 20 --> ipilimumab
    n1=en:cisplatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1498. en:cisplatin liposomal --- r_associated #0: 20 --> ipilimumab
    n1=en:cisplatin liposomal | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1499. en:cisplatin-e therapeutic implant --- r_associated #0: 20 --> ipilimumab
    n1=en:cisplatin-e therapeutic implant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1500. en:citalopram hydrobromide --- r_associated #0: 20 --> ipilimumab
    n1=en:citalopram hydrobromide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1501. en:citatuzumab bogatox --- r_associated #0: 20 --> ipilimumab
    n1=en:citatuzumab bogatox | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1502. en:citicoline --- r_associated #0: 20 --> ipilimumab
    n1=en:citicoline | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1503. en:citric acid + magnesium oxide + sodium picosulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:citric acid + magnesium oxide + sodium picosulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1504. en:citrulline --- r_associated #0: 20 --> ipilimumab
    n1=en:citrulline | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1505. en:cixutumumab --- r_associated #0: 20 --> ipilimumab
    n1=en:cixutumumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1506. en:ck2-targeting synthetic peptide cigb-300 --- r_associated #0: 20 --> ipilimumab
    n1=en:ck2-targeting synthetic peptide cigb-300 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1507. en:cl 246738 --- r_associated #0: 20 --> ipilimumab
    n1=en:cl 246738 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1508. en:cladribine --- r_associated #0: 20 --> ipilimumab
    n1=en:cladribine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1509. en:clanfenur --- r_associated #0: 20 --> ipilimumab
    n1=en:clanfenur | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1510. en:clarithromycin --- r_associated #0: 20 --> ipilimumab
    n1=en:clarithromycin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1511. en:claudiximab --- r_associated #0: 20 --> ipilimumab
    n1=en:claudiximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1512. en:clevidipine --- r_associated #0: 20 --> ipilimumab
    n1=en:clevidipine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1513. en:clevudine --- r_associated #0: 20 --> ipilimumab
    n1=en:clevudine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1514. en:clindamycin --- r_associated #0: 20 --> ipilimumab
    n1=en:clindamycin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1515. en:clindamycin phosphate --- r_associated #0: 20 --> ipilimumab
    n1=en:clindamycin phosphate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1516. en:clindamycin/hydrocortisone lotion --- r_associated #0: 20 --> ipilimumab
    n1=en:clindamycin/hydrocortisone lotion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1517. en:clino-san vaginal lubricant --- r_associated #0: 20 --> ipilimumab
    n1=en:clino-san vaginal lubricant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1518. en:clioquinol --- r_associated #0: 20 --> ipilimumab
    n1=en:clioquinol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1519. en:clobetasol propionate --- r_associated #0: 20 --> ipilimumab
    n1=en:clobetasol propionate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1520. en:clodronate disodium --- r_associated #0: 20 --> ipilimumab
    n1=en:clodronate disodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1521. en:clofarabine --- r_associated #0: 20 --> ipilimumab
    n1=en:clofarabine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1522. en:clofibrate --- r_associated #0: 20 --> ipilimumab
    n1=en:clofibrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1523. en:clomiphene citrate --- r_associated #0: 20 --> ipilimumab
    n1=en:clomiphene citrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1524. en:clonidine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:clonidine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1525. en:clonidine-containing mucoadhesive buccal tablet --- r_associated #0: 20 --> ipilimumab
    n1=en:clonidine-containing mucoadhesive buccal tablet | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1526. en:clopidogrel bisulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:clopidogrel bisulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1527. en:clostridium butyricum-containing probiotic --- r_associated #0: 20 --> ipilimumab
    n1=en:clostridium butyricum-containing probiotic | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1528. en:clostridium novyi-nt spores --- r_associated #0: 20 --> ipilimumab
    n1=en:clostridium novyi-nt spores | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1529. en:clotrimazole --- r_associated #0: 20 --> ipilimumab
    n1=en:clotrimazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1530. en:cmet car-mrna electroporated autologous t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:cmet car-mrna electroporated autologous t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1531. en:cmf regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:cmf regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1532. en:cmv n495 peptide --- r_associated #0: 20 --> ipilimumab
    n1=en:cmv n495 peptide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1533. en:cmv pp65 peptide-pulsed autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:cmv pp65 peptide-pulsed autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1534. en:cmvpp65-a*0201 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:cmvpp65-a*0201 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1535. en:cmvpp65/gb plasmid vaccine asp0113 --- r_associated #0: 20 --> ipilimumab
    n1=en:cmvpp65/gb plasmid vaccine asp0113 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1536. en:cndo-109-activated allogeneic natural killer cells --- r_associated #0: 20 --> ipilimumab
    n1=en:cndo-109-activated allogeneic natural killer cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1537. en:cngrc peptide-tnf alpha conjugate --- r_associated #0: 20 --> ipilimumab
    n1=en:cngrc peptide-tnf alpha conjugate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1538. en:cobalamin --- r_associated #0: 20 --> ipilimumab
    n1=en:cobalamin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1539. en:cobimetinib --- r_associated #0: 20 --> ipilimumab
    n1=en:cobimetinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1540. en:cobiprostone --- r_associated #0: 20 --> ipilimumab
    n1=en:cobiprostone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1541. en:cocculus/nux vomica/tabacum/petroleum extract --- r_associated #0: 20 --> ipilimumab
    n1=en:cocculus/nux vomica/tabacum/petroleum extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1542. en:cocoa extract --- r_associated #0: 20 --> ipilimumab
    n1=en:cocoa extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1543. en:codeine phosphate --- r_associated #0: 20 --> ipilimumab
    n1=en:codeine phosphate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1544. en:coenzyme q10 --- r_associated #0: 20 --> ipilimumab
    n1=en:coenzyme q10 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1545. en:coffee dietary supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:coffee dietary supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1546. en:colchicine --- r_associated #0: 20 --> ipilimumab
    n1=en:colchicine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1547. en:cold contaminant-free iobenguane i-131 --- r_associated #0: 20 --> ipilimumab
    n1=en:cold contaminant-free iobenguane i-131 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1548. en:colesevelam hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:colesevelam hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1549. en:colistin sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:colistin sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1550. en:collagen --- r_associated #0: 20 --> ipilimumab
    n1=en:collagen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1551. en:collagen/aloe vera/vitamin e/lidocaine topical hydrogel --- r_associated #0: 20 --> ipilimumab
    n1=en:collagen/aloe vera/vitamin e/lidocaine topical hydrogel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1552. en:colloidal gold-bound tumor necrosis factor --- r_associated #0: 20 --> ipilimumab
    n1=en:colloidal gold-bound tumor necrosis factor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1553. en:colloidal oatmeal cream --- r_associated #0: 20 --> ipilimumab
    n1=en:colloidal oatmeal cream | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1554. en:colorectal tumor-associated peptides vaccine ima910 --- r_associated #0: 20 --> ipilimumab
    n1=en:colorectal tumor-associated peptides vaccine ima910 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1555. en:combretastatin a1 diphosphate --- r_associated #0: 20 --> ipilimumab
    n1=en:combretastatin a1 diphosphate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1556. en:complement c5 inhibitor alxn1210 --- r_associated #0: 20 --> ipilimumab
    n1=en:complement c5 inhibitor alxn1210 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1557. en:compound kushen injection --- r_associated #0: 20 --> ipilimumab
    n1=en:compound kushen injection | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1558. en:compound sodium lactate solution --- r_associated #0: 20 --> ipilimumab
    n1=en:compound sodium lactate solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1559. en:conatumumab --- r_associated #0: 20 --> ipilimumab
    n1=en:conatumumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1560. en:concentrated beet crystals --- r_associated #0: 20 --> ipilimumab
    n1=en:concentrated beet crystals | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1561. en:concentrated fortified collagen protein hydrolysate liquid supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:concentrated fortified collagen protein hydrolysate liquid supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1562. en:conditionally replicative adenovirus 5/3-delta24 --- r_associated #0: 20 --> ipilimumab
    n1=en:conditionally replicative adenovirus 5/3-delta24 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1563. en:conjugated estrogens/bazedoxifene --- r_associated #0: 20 --> ipilimumab
    n1=en:conjugated estrogens/bazedoxifene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1564. en:conjugated linoleic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:conjugated linoleic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1565. en:contrast agent cs-1000 --- r_associated #0: 20 --> ipilimumab
    n1=en:contrast agent cs-1000 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1566. en:controlled substance --- r_associated #0: 20 --> ipilimumab
    n1=en:controlled substance | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1567. en:copanlisib --- r_associated #0: 20 --> ipilimumab
    n1=en:copanlisib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1568. en:copdac regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:copdac regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1569. en:copovithane --- r_associated #0: 20 --> ipilimumab
    n1=en:copovithane | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1570. en:copp regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:copp regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1571. en:copp-abv regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:copp-abv regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1572. en:copper cu 62 ethylglyoxal bis(thiosemicarbazone) --- r_associated #0: 20 --> ipilimumab
    n1=en:copper cu 62 ethylglyoxal bis(thiosemicarbazone) | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1573. en:copper cu 62-atsm --- r_associated #0: 20 --> ipilimumab
    n1=en:copper cu 62-atsm | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1574. en:copper cu 62-ptsm --- r_associated #0: 20 --> ipilimumab
    n1=en:copper cu 62-ptsm | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1575. en:copper cu 64 anti-cea monoclonal antibody m5a --- r_associated #0: 20 --> ipilimumab
    n1=en:copper cu 64 anti-cea monoclonal antibody m5a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1576. en:copper cu 64 plerixafor --- r_associated #0: 20 --> ipilimumab
    n1=en:copper cu 64 plerixafor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1577. en:copper cu 64 tp3805 --- r_associated #0: 20 --> ipilimumab
    n1=en:copper cu 64 tp3805 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1578. en:copper cu 64 trastuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:copper cu 64 trastuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1579. en:copper cu 64-atsm --- r_associated #0: 20 --> ipilimumab
    n1=en:copper cu 64-atsm | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1580. en:copper cu 64-dota b-fab --- r_associated #0: 20 --> ipilimumab
    n1=en:copper cu 64-dota b-fab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1581. en:copper cu 64-dota-ae105 --- r_associated #0: 20 --> ipilimumab
    n1=en:copper cu 64-dota-ae105 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1582. en:copper cu 64-dota-anti-her3 monoclonal antibody u3-1287 --- r_associated #0: 20 --> ipilimumab
    n1=en:copper cu 64-dota-anti-her3 monoclonal antibody u3-1287 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1583. en:copper cu 64-dota-rituximab --- r_associated #0: 20 --> ipilimumab
    n1=en:copper cu 64-dota-rituximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1584. en:copper cu 64-dota-trastuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:copper cu 64-dota-trastuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1585. en:copper gluconate --- r_associated #0: 20 --> ipilimumab
    n1=en:copper gluconate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1586. en:copper supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:copper supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1587. en:cord blood-derived expanded natural killer cell infusion pnk-007 --- r_associated #0: 20 --> ipilimumab
    n1=en:cord blood-derived expanded natural killer cell infusion pnk-007 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1588. en:cordycepin --- r_associated #0: 20 --> ipilimumab
    n1=en:cordycepin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1589. en:corifollitropin alfa --- r_associated #0: 20 --> ipilimumab
    n1=en:corifollitropin alfa | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1590. en:coriolus versicolor extract --- r_associated #0: 20 --> ipilimumab
    n1=en:coriolus versicolor extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1591. en:corticorelin acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:corticorelin acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1592. en:corticotropin --- r_associated #0: 20 --> ipilimumab
    n1=en:corticotropin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1593. en:corticotropin releasing hormone --- r_associated #0: 20 --> ipilimumab
    n1=en:corticotropin releasing hormone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1594. en:corynebacterium granulosum p40 --- r_associated #0: 20 --> ipilimumab
    n1=en:corynebacterium granulosum p40 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1595. en:cositecan --- r_associated #0: 20 --> ipilimumab
    n1=en:cositecan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1596. en:cosmeceuticals --- r_associated #0: 20 --> ipilimumab
    n1=en:cosmeceuticals | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1597. en:coumarin --- r_associated #0: 20 --> ipilimumab
    n1=en:coumarin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1598. en:counterfeit drugs --- r_associated #0: 20 --> ipilimumab
    n1=en:counterfeit drugs | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1599. en:coxsackievirus a21 --- r_associated #0: 20 --> ipilimumab
    n1=en:coxsackievirus a21 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1600. en:cp 461 --- r_associated #0: 20 --> ipilimumab
    n1=en:cp 461 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1601. en:cp-547632 --- r_associated #0: 20 --> ipilimumab
    n1=en:cp-547632 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1602. en:cp-609,754 --- r_associated #0: 20 --> ipilimumab
    n1=en:cp-609,754 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1603. en:cp-724,714 --- r_associated #0: 20 --> ipilimumab
    n1=en:cp-724,714 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1604. en:cpg oligodeoxynucleotide gnkg168 --- r_associated #0: 20 --> ipilimumab
    n1=en:cpg oligodeoxynucleotide gnkg168 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1605. en:cpg-28 oligodeoxynucleotide --- r_associated #0: 20 --> ipilimumab
    n1=en:cpg-28 oligodeoxynucleotide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1606. en:cr2-fh fusion protein tt30 --- r_associated #0: 20 --> ipilimumab
    n1=en:cr2-fh fusion protein tt30 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1607. en:creatine monohydrate --- r_associated #0: 20 --> ipilimumab
    n1=en:creatine monohydrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1608. en:crenolanib --- r_associated #0: 20 --> ipilimumab
    n1=en:crenolanib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1609. en:crenolanib besylate --- r_associated #0: 20 --> ipilimumab
    n1=en:crenolanib besylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1610. en:cridanimod sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:cridanimod sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1611. en:crisnatol mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:crisnatol mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1612. en:crizotinib --- r_associated #0: 20 --> ipilimumab
    n1=en:crizotinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1613. en:crl 1005 --- r_associated #0: 20 --> ipilimumab
    n1=en:crl 1005 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1614. en:crolibulin --- r_associated #0: 20 --> ipilimumab
    n1=en:crolibulin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1615. en:cromolyn sodium inhalant pa101 --- r_associated #0: 20 --> ipilimumab
    n1=en:cromolyn sodium inhalant pa101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1616. en:crotoxin --- r_associated #0: 20 --> ipilimumab
    n1=en:crotoxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1617. en:cryoprotective agent --- r_associated #0: 20 --> ipilimumab
    n1=en:cryoprotective agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1618. en:crystalline genistein formulation axp107-11 --- r_associated #0: 20 --> ipilimumab
    n1=en:crystalline genistein formulation axp107-11 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1619. en:ct2584 hms --- r_associated #0: 20 --> ipilimumab
    n1=en:ct2584 hms | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1620. en:ctla 4-directed antibody interactions --- r_associated #0: 20 --> ipilimumab
    n1=en:ctla 4-directed antibody interactions | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1621. en:ctp-37-dt vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:ctp-37-dt vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1622. en:ctrp agent terminology --- r_associated #0: 20 --> ipilimumab
    n1=en:ctrp agent terminology | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1623. en:ctrp terminology --- r_associated #0: 20 --> ipilimumab
    n1=en:ctrp terminology | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1624. en:curcumin --- r_associated #0: 20 --> ipilimumab
    n1=en:curcumin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1625. en:curcumin-based gel --- r_associated #0: 20 --> ipilimumab
    n1=en:curcumin-based gel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1626. en:curcumin/green tea extract/polygonum cuspidatum extract/soybean extract capsule --- r_associated #0: 20 --> ipilimumab
    n1=en:curcumin/green tea extract/polygonum cuspidatum extract/soybean extract capsule | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1627. en:custirsen sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:custirsen sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1628. en:cvp regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:cvp regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1629. en:cxc chemokine receptor 2 antagonist azd5069 --- r_associated #0: 20 --> ipilimumab
    n1=en:cxc chemokine receptor 2 antagonist azd5069 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1630. en:cxcr4 antagonist bl-8040 --- r_associated #0: 20 --> ipilimumab
    n1=en:cxcr4 antagonist bl-8040 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1631. en:cxcr4 inhibitor msx-122 --- r_associated #0: 20 --> ipilimumab
    n1=en:cxcr4 inhibitor msx-122 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1632. en:cxcr4 inhibitor pol6326 --- r_associated #0: 20 --> ipilimumab
    n1=en:cxcr4 inhibitor pol6326 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1633. en:cxcr4 inhibitor x4p-001 --- r_associated #0: 20 --> ipilimumab
    n1=en:cxcr4 inhibitor x4p-001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1634. en:cxcr4 peptide antagonist ly2510924 --- r_associated #0: 20 --> ipilimumab
    n1=en:cxcr4 peptide antagonist ly2510924 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1635. en:cyanocobalamin --- r_associated #0: 20 --> ipilimumab
    n1=en:cyanocobalamin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1636. en:cyanocobalamin/dexamethasone/gentamicin/procaine formulation --- r_associated #0: 20 --> ipilimumab
    n1=en:cyanocobalamin/dexamethasone/gentamicin/procaine formulation | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1637. en:cycle-phase nonspecific agent --- r_associated #0: 20 --> ipilimumab
    n1=en:cycle-phase nonspecific agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1638. en:cycle-phase specific agent --- r_associated #0: 20 --> ipilimumab
    n1=en:cycle-phase specific agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1639. en:cyclin b1 peptide-pulsed autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:cyclin b1 peptide-pulsed autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1640. en:cyclobenzaprine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:cyclobenzaprine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1641. en:cyclodextrin-based polymer-camptothecin crlx101 --- r_associated #0: 20 --> ipilimumab
    n1=en:cyclodextrin-based polymer-camptothecin crlx101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1642. en:cycloleucine --- r_associated #0: 20 --> ipilimumab
    n1=en:cycloleucine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1643. en:cyclopentenyl cytosine --- r_associated #0: 20 --> ipilimumab
    n1=en:cyclopentenyl cytosine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1644. en:cyclophosphamide --- r_associated #0: 20 --> ipilimumab
    n1=en:cyclophosphamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1645. en:cyclophosphamide/dactinomycin/vincristine --- r_associated #0: 20 --> ipilimumab
    n1=en:cyclophosphamide/dactinomycin/vincristine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1646. en:cyclophosphamide/epirubicin/vincristine/prednisone --- r_associated #0: 20 --> ipilimumab
    n1=en:cyclophosphamide/epirubicin/vincristine/prednisone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1647. en:cycloserine --- r_associated #0: 20 --> ipilimumab
    n1=en:cycloserine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1648. en:cyclosporine --- r_associated #0: 20 --> ipilimumab
    n1=en:cyclosporine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1649. en:cyclosporine ophthalmic emulsion --- r_associated #0: 20 --> ipilimumab
    n1=en:cyclosporine ophthalmic emulsion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1650. en:cyl-02 plasmid dna --- r_associated #0: 20 --> ipilimumab
    n1=en:cyl-02 plasmid dna | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1651. en:cyp17 inhibitor cfg920 --- r_associated #0: 20 --> ipilimumab
    n1=en:cyp17 inhibitor cfg920 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1652. en:cyp17 inhibitor vt-464 --- r_associated #0: 20 --> ipilimumab
    n1=en:cyp17 inhibitor vt-464 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1653. en:cyp17 lyase inhibitor asn001 --- r_associated #0: 20 --> ipilimumab
    n1=en:cyp17 lyase inhibitor asn001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1654. en:cyp17/androgen receptor inhibitor odm 204 --- r_associated #0: 20 --> ipilimumab
    n1=en:cyp17/androgen receptor inhibitor odm 204 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1655. en:cyproheptadine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:cyproheptadine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1656. en:cyproterone --- r_associated #0: 20 --> ipilimumab
    n1=en:cyproterone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1657. en:cyproterone acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:cyproterone acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1658. en:cysteine-rich non-denatured whey protein isolate imn1207 --- r_associated #0: 20 --> ipilimumab
    n1=en:cysteine-rich non-denatured whey protein isolate imn1207 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1659. en:cystemustine --- r_associated #0: 20 --> ipilimumab
    n1=en:cystemustine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1660. en:cytarabine --- r_associated #0: 20 --> ipilimumab
    n1=en:cytarabine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1661. en:cytarabine monophosphate prodrug mb07133 --- r_associated #0: 20 --> ipilimumab
    n1=en:cytarabine monophosphate prodrug mb07133 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1662. en:cytembena --- r_associated #0: 20 --> ipilimumab
    n1=en:cytembena | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1663. en:cytidine analog rx-3117 --- r_associated #0: 20 --> ipilimumab
    n1=en:cytidine analog rx-3117 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1664. en:cytochlor --- r_associated #0: 20 --> ipilimumab
    n1=en:cytochlor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1665. en:cytokine agent --- r_associated #0: 20 --> ipilimumab
    n1=en:cytokine agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1666. en:cytokine-induced killer cells --- r_associated #0: 20 --> ipilimumab
    n1=en:cytokine-induced killer cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1667. en:cytomegalovirus ie-1-specific cytotoxic t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:cytomegalovirus ie-1-specific cytotoxic t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1668. en:cytomegalovirus pp65-specific cytotoxic t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:cytomegalovirus pp65-specific cytotoxic t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1669. en:cytoprotective agent --- r_associated #0: 20 --> ipilimumab
    n1=en:cytoprotective agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1670. en:cytostatic agents --- r_associated #0: 20 --> ipilimumab
    n1=en:cytostatic agents | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1671. en:cytotoxic agent --- r_associated #0: 20 --> ipilimumab
    n1=en:cytotoxic agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1672. en:cytotoxic t-lymphocyte --- r_associated #0: 20 --> ipilimumab
    n1=en:cytotoxic t-lymphocyte | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1673. en:cytotoxic t-lymphocyte protein 4 --- r_associated #0: 20 --> ipilimumab
    n1=en:cytotoxic t-lymphocyte protein 4 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1674. en:d vitamin --- r_associated #0: 20 --> ipilimumab
    n1=en:d vitamin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1675. en:d-methionine formulation mrx-1024 --- r_associated #0: 20 --> ipilimumab
    n1=en:d-methionine formulation mrx-1024 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1676. en:d1/3-mage-3-his fusion protein --- r_associated #0: 20 --> ipilimumab
    n1=en:d1/3-mage-3-his fusion protein | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1677. en:d4064a --- r_associated #0: 20 --> ipilimumab
    n1=en:d4064a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1678. en:dab389 epidermal growth factor --- r_associated #0: 20 --> ipilimumab
    n1=en:dab389 epidermal growth factor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1679. en:dabigatran etexilate mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:dabigatran etexilate mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1680. en:dabrafenib --- r_associated #0: 20 --> ipilimumab
    n1=en:dabrafenib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1681. en:dacarbazine --- r_associated #0: 20 --> ipilimumab
    n1=en:dacarbazine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1682. en:dacetuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:dacetuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1683. en:dach polymer platinate ap5346 --- r_associated #0: 20 --> ipilimumab
    n1=en:dach polymer platinate ap5346 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1684. en:dach-platin micelle nc-4016 --- r_associated #0: 20 --> ipilimumab
    n1=en:dach-platin micelle nc-4016 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1685. en:daclatasvir --- r_associated #0: 20 --> ipilimumab
    n1=en:daclatasvir | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1686. en:daclizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:daclizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1687. en:dacomitinib --- r_associated #0: 20 --> ipilimumab
    n1=en:dacomitinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1688. en:dactinomycin --- r_associated #0: 20 --> ipilimumab
    n1=en:dactinomycin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1689. en:daflon 500 --- r_associated #0: 20 --> ipilimumab
    n1=en:daflon 500 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1690. en:dakins solution --- r_associated #0: 20 --> ipilimumab
    n1=en:dakins solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1691. en:dalantercept --- r_associated #0: 20 --> ipilimumab
    n1=en:dalantercept | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1692. en:dalbavancin --- r_associated #0: 20 --> ipilimumab
    n1=en:dalbavancin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1693. en:dalotuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:dalotuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1694. en:dalteparin --- r_associated #0: 20 --> ipilimumab
    n1=en:dalteparin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1695. en:danazol --- r_associated #0: 20 --> ipilimumab
    n1=en:danazol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1696. en:daniquidone --- r_associated #0: 20 --> ipilimumab
    n1=en:daniquidone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1697. en:danusertib --- r_associated #0: 20 --> ipilimumab
    n1=en:danusertib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1698. en:daporinad --- r_associated #0: 20 --> ipilimumab
    n1=en:daporinad | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1699. en:dapsone --- r_associated #0: 20 --> ipilimumab
    n1=en:dapsone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1700. en:dapsone gel --- r_associated #0: 20 --> ipilimumab
    n1=en:dapsone gel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1701. en:daptomycin --- r_associated #0: 20 --> ipilimumab
    n1=en:daptomycin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1702. en:daratumumab --- r_associated #0: 20 --> ipilimumab
    n1=en:daratumumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1703. en:darbepoetin alfa --- r_associated #0: 20 --> ipilimumab
    n1=en:darbepoetin alfa | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1704. en:darinaparsin --- r_associated #0: 20 --> ipilimumab
    n1=en:darinaparsin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1705. en:dasabuvir --- r_associated #0: 20 --> ipilimumab
    n1=en:dasabuvir | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1706. en:dasatinib --- r_associated #0: 20 --> ipilimumab
    n1=en:dasatinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1707. en:daunorubicin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:daunorubicin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1708. en:daunorubicin-dna complex --- r_associated #0: 20 --> ipilimumab
    n1=en:daunorubicin-dna complex | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1709. en:dbve-pc regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:dbve-pc regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1710. en:dc-cholesterol liposome --- r_associated #0: 20 --> ipilimumab
    n1=en:dc-cholesterol liposome | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1711. en:dc-ova vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:dc-ova vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1712. en:dcb-bo1202 --- r_associated #0: 20 --> ipilimumab
    n1=en:dcb-bo1202 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1713. en:dcds0780a --- r_associated #0: 20 --> ipilimumab
    n1=en:dcds0780a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1714. en:dcr ligand-bearing liposome-encapsulated melanoma antigens vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:dcr ligand-bearing liposome-encapsulated melanoma antigens vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1715. en:dec-205/ny-eso-1 fusion protein cdx-1401 --- r_associated #0: 20 --> ipilimumab
    n1=en:dec-205/ny-eso-1 fusion protein cdx-1401 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1716. en:decitabine --- r_associated #0: 20 --> ipilimumab
    n1=en:decitabine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1717. en:declopramide --- r_associated #0: 20 --> ipilimumab
    n1=en:declopramide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1718. en:defactinib --- r_associated #0: 20 --> ipilimumab
    n1=en:defactinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1719. en:deferasirox --- r_associated #0: 20 --> ipilimumab
    n1=en:deferasirox | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1720. en:deferiprone --- r_associated #0: 20 --> ipilimumab
    n1=en:deferiprone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1721. en:deferoxamine mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:deferoxamine mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1722. en:defibrotide sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:defibrotide sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1723. en:defined green tea catechin extract --- r_associated #0: 20 --> ipilimumab
    n1=en:defined green tea catechin extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1724. en:degarelix --- r_associated #0: 20 --> ipilimumab
    n1=en:degarelix | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1725. en:deglycosylated ricin a chain-conjugated anti-cd19/anti-cd22 immunotoxins --- r_associated #0: 20 --> ipilimumab
    n1=en:deglycosylated ricin a chain-conjugated anti-cd19/anti-cd22 immunotoxins | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1726. en:dehydrated human amnion/chorion membrane --- r_associated #0: 20 --> ipilimumab
    n1=en:dehydrated human amnion/chorion membrane | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1727. en:dehydroemetine --- r_associated #0: 20 --> ipilimumab
    n1=en:dehydroemetine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1728. en:delanzomib --- r_associated #0: 20 --> ipilimumab
    n1=en:delanzomib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1729. en:delta-8-tetrahydrocannabinol --- r_associated #0: 20 --> ipilimumab
    n1=en:delta-8-tetrahydrocannabinol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1730. en:delta-tocopherol --- r_associated #0: 20 --> ipilimumab
    n1=en:delta-tocopherol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1731. en:delta-tocotrienol --- r_associated #0: 20 --> ipilimumab
    n1=en:delta-tocotrienol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1732. en:demcizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:demcizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1733. en:demeclocycline hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:demeclocycline hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1734. en:demineralized bone matrix --- r_associated #0: 20 --> ipilimumab
    n1=en:demineralized bone matrix | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1735. en:dendritic cell-autologous lung tumor vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:dendritic cell-autologous lung tumor vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1736. en:dendritic cell-cea peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:dendritic cell-cea peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1737. en:dendritic cell-gp100-mart-1 antigen vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:dendritic cell-gp100-mart-1 antigen vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1738. en:dendritic cell-idiotype-keyhole limpet hemocyanin vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:dendritic cell-idiotype-keyhole limpet hemocyanin vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1739. en:dendritic cell-mart-1 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:dendritic cell-mart-1 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1740. en:dendritic cell-precision multiple antigen t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:dendritic cell-precision multiple antigen t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1741. en:dendritic cell-recombinant prostate-specific membrane antigen vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:dendritic cell-recombinant prostate-specific membrane antigen vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1742. en:dendritic cell-targeting lentiviral vector id-lv305 --- r_associated #0: 20 --> ipilimumab
    n1=en:dendritic cell-targeting lentiviral vector id-lv305 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1743. en:denenicokin --- r_associated #0: 20 --> ipilimumab
    n1=en:denenicokin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1744. en:denibulin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:denibulin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1745. en:denileukin diftitox --- r_associated #0: 20 --> ipilimumab
    n1=en:denileukin diftitox | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1746. en:denintuzumab mafodotin --- r_associated #0: 20 --> ipilimumab
    n1=en:denintuzumab mafodotin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1747. en:denosumab --- r_associated #0: 20 --> ipilimumab
    n1=en:denosumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1748. en:dental agent --- r_associated #0: 20 --> ipilimumab
    n1=en:dental agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1749. en:dental disclosing preparation --- r_associated #0: 20 --> ipilimumab
    n1=en:dental disclosing preparation | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1750. en:deoxycytidine --- r_associated #0: 20 --> ipilimumab
    n1=en:deoxycytidine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1751. en:deoxycytidine analogue tas-109 --- r_associated #0: 20 --> ipilimumab
    n1=en:deoxycytidine analogue tas-109 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1752. en:depatuxizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:depatuxizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1753. en:depdc1/mphosh1 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:depdc1/mphosh1 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1754. en:derma-membrane-structure topical cream --- r_associated #0: 20 --> ipilimumab
    n1=en:derma-membrane-structure topical cream | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1755. en:dermatologic agents --- r_associated #0: 20 --> ipilimumab
    n1=en:dermatologic agents | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1756. en:desflurane --- r_associated #0: 20 --> ipilimumab
    n1=en:desflurane | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1757. en:designer drugs --- r_associated #0: 20 --> ipilimumab
    n1=en:designer drugs | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1758. en:desipramine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:desipramine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1759. en:deslorelin --- r_associated #0: 20 --> ipilimumab
    n1=en:deslorelin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1760. en:desmethylmisonidazole --- r_associated #0: 20 --> ipilimumab
    n1=en:desmethylmisonidazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1761. en:desmopressin acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:desmopressin acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1762. en:desogestrel --- r_associated #0: 20 --> ipilimumab
    n1=en:desogestrel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1763. en:desvenlafaxine succinate --- r_associated #0: 20 --> ipilimumab
    n1=en:desvenlafaxine succinate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1764. en:detorubicin --- r_associated #0: 20 --> ipilimumab
    n1=en:detorubicin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1765. en:detox-b adjuvant --- r_associated #0: 20 --> ipilimumab
    n1=en:detox-b adjuvant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1766. en:detoxpc --- r_associated #0: 20 --> ipilimumab
    n1=en:detoxpc | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1767. en:deuterated 3-methylhistidine --- r_associated #0: 20 --> ipilimumab
    n1=en:deuterated 3-methylhistidine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1768. en:deuterated phenanthrene --- r_associated #0: 20 --> ipilimumab
    n1=en:deuterated phenanthrene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1769. en:deuterium oxide --- r_associated #0: 20 --> ipilimumab
    n1=en:deuterium oxide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1770. en:dexamethasone --- r_associated #0: 20 --> ipilimumab
    n1=en:dexamethasone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1771. en:dexamethasone intravitreal implant --- r_associated #0: 20 --> ipilimumab
    n1=en:dexamethasone intravitreal implant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1772. en:dexanabinol --- r_associated #0: 20 --> ipilimumab
    n1=en:dexanabinol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1773. en:dexmedetomidine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:dexmedetomidine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1774. en:dexmethylphenidate --- r_associated #0: 20 --> ipilimumab
    n1=en:dexmethylphenidate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1775. en:dexniguldipine --- r_associated #0: 20 --> ipilimumab
    n1=en:dexniguldipine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1776. en:dexpanthenol --- r_associated #0: 20 --> ipilimumab
    n1=en:dexpanthenol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1777. en:dexpanthenol mouthwash --- r_associated #0: 20 --> ipilimumab
    n1=en:dexpanthenol mouthwash | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1778. en:dexrazoxane hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:dexrazoxane hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1779. en:dextran --- r_associated #0: 20 --> ipilimumab
    n1=en:dextran | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1780. en:dextran sulfate sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:dextran sulfate sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1781. en:dextroamphetamine sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:dextroamphetamine sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1782. en:dextroamphetamine-amphetamine --- r_associated #0: 20 --> ipilimumab
    n1=en:dextroamphetamine-amphetamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1783. en:dextromethorphan hydrobromide --- r_associated #0: 20 --> ipilimumab
    n1=en:dextromethorphan hydrobromide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1784. en:dextropropoxyphene hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:dextropropoxyphene hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1785. en:dexverapamil --- r_associated #0: 20 --> ipilimumab
    n1=en:dexverapamil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1786. en:dezaguanine --- r_associated #0: 20 --> ipilimumab
    n1=en:dezaguanine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1787. en:dha-paclitaxel --- r_associated #0: 20 --> ipilimumab
    n1=en:dha-paclitaxel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1788. en:dhap regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:dhap regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1789. en:dhea mustard --- r_associated #0: 20 --> ipilimumab
    n1=en:dhea mustard | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1790. en:dher2 vaccine+as15 adjuvant --- r_associated #0: 20 --> ipilimumab
    n1=en:dher2 vaccine+as15 adjuvant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1791. en:di-dga-rfb4 immunotoxin --- r_associated #0: 20 --> ipilimumab
    n1=en:di-dga-rfb4 immunotoxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1792. en:di-leu16-il2 immunocytokine --- r_associated #0: 20 --> ipilimumab
    n1=en:di-leu16-il2 immunocytokine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1793. en:diacetylmorphine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:diacetylmorphine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1794. en:diagnostic agents --- r_associated #0: 20 --> ipilimumab
    n1=en:diagnostic agents | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1795. en:diammonium glycyrrhizinate --- r_associated #0: 20 --> ipilimumab
    n1=en:diammonium glycyrrhizinate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1796. en:dianhydrogalactitol --- r_associated #0: 20 --> ipilimumab
    n1=en:dianhydrogalactitol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1797. en:dianicline --- r_associated #0: 20 --> ipilimumab
    n1=en:dianicline | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1798. en:diarylsulfonylurea compound --- r_associated #0: 20 --> ipilimumab
    n1=en:diarylsulfonylurea compound | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1799. en:diazepinomicin --- r_associated #0: 20 --> ipilimumab
    n1=en:diazepinomicin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1800. en:diaziquone --- r_associated #0: 20 --> ipilimumab
    n1=en:diaziquone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1801. en:diazooxonorleucine --- r_associated #0: 20 --> ipilimumab
    n1=en:diazooxonorleucine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1802. en:diazoxide --- r_associated #0: 20 --> ipilimumab
    n1=en:diazoxide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1803. en:dichloromethotrexate --- r_associated #0: 20 --> ipilimumab
    n1=en:dichloromethotrexate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1804. en:diclofenac epolamine patch --- r_associated #0: 20 --> ipilimumab
    n1=en:diclofenac epolamine patch | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1805. en:diclofenac sodium gel --- r_associated #0: 20 --> ipilimumab
    n1=en:diclofenac sodium gel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1806. en:dicumarol --- r_associated #0: 20 --> ipilimumab
    n1=en:dicumarol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1807. en:didanosine --- r_associated #0: 20 --> ipilimumab
    n1=en:didanosine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1808. en:didemnin b --- r_associated #0: 20 --> ipilimumab
    n1=en:didemnin b | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1809. en:dideoxyadenosine --- r_associated #0: 20 --> ipilimumab
    n1=en:dideoxyadenosine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1810. en:didox --- r_associated #0: 20 --> ipilimumab
    n1=en:didox | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1811. en:dienogest --- r_associated #0: 20 --> ipilimumab
    n1=en:dienogest | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1812. en:dietary product --- r_associated #0: 20 --> ipilimumab
    n1=en:dietary product | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1813. en:diethylhomospermine --- r_associated #0: 20 --> ipilimumab
    n1=en:diethylhomospermine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1814. en:diethylnorspermine --- r_associated #0: 20 --> ipilimumab
    n1=en:diethylnorspermine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1815. en:diethylstilbestrol --- r_associated #0: 20 --> ipilimumab
    n1=en:diethylstilbestrol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1816. en:diflomotecan --- r_associated #0: 20 --> ipilimumab
    n1=en:diflomotecan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1817. en:diflunisal --- r_associated #0: 20 --> ipilimumab
    n1=en:diflunisal | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1818. en:digitoxin --- r_associated #0: 20 --> ipilimumab
    n1=en:digitoxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1819. en:digoxin --- r_associated #0: 20 --> ipilimumab
    n1=en:digoxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1820. en:dihydro-5-azacytidine --- r_associated #0: 20 --> ipilimumab
    n1=en:dihydro-5-azacytidine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1821. en:dihydrolenperone --- r_associated #0: 20 --> ipilimumab
    n1=en:dihydrolenperone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1822. en:diindolylmethane --- r_associated #0: 20 --> ipilimumab
    n1=en:diindolylmethane | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1823. en:diltiazem hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:diltiazem hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1824. en:dimesna --- r_associated #0: 20 --> ipilimumab
    n1=en:dimesna | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1825. en:dimethicone-containing botanicals-based lotion --- r_associated #0: 20 --> ipilimumab
    n1=en:dimethicone-containing botanicals-based lotion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1826. en:dimethicone/polymer barrier cream --- r_associated #0: 20 --> ipilimumab
    n1=en:dimethicone/polymer barrier cream | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1827. en:dimethyl fumarate --- r_associated #0: 20 --> ipilimumab
    n1=en:dimethyl fumarate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1828. en:dimethyl sulfone --- r_associated #0: 20 --> ipilimumab
    n1=en:dimethyl sulfone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1829. en:dimethyl sulfoxide --- r_associated #0: 20 --> ipilimumab
    n1=en:dimethyl sulfoxide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1830. en:dimethylmyleran --- r_associated #0: 20 --> ipilimumab
    n1=en:dimethylmyleran | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1831. en:dinaciclib --- r_associated #0: 20 --> ipilimumab
    n1=en:dinaciclib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1832. en:dinitrochlorobenzene --- r_associated #0: 20 --> ipilimumab
    n1=en:dinitrochlorobenzene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1833. en:dinitrofluorobenzene --- r_associated #0: 20 --> ipilimumab
    n1=en:dinitrofluorobenzene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1834. en:dinitrophenyl --- r_associated #0: 20 --> ipilimumab
    n1=en:dinitrophenyl | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1835. en:dinitrophenyl-modified autologous renal cell carcinoma tumor cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:dinitrophenyl-modified autologous renal cell carcinoma tumor cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1836. en:dinoprost tromethamine --- r_associated #0: 20 --> ipilimumab
    n1=en:dinoprost tromethamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1837. en:dinutuximab --- r_associated #0: 20 --> ipilimumab
    n1=en:dinutuximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1838. en:dioscorea nipponica makino extract dne3 --- r_associated #0: 20 --> ipilimumab
    n1=en:dioscorea nipponica makino extract dne3 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1839. en:diphencyprone --- r_associated #0: 20 --> ipilimumab
    n1=en:diphencyprone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1840. en:diphenhydramine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:diphenhydramine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1841. en:diphenhydramine hydrochloride/dexamethasone/nystatin magic mouthwash --- r_associated #0: 20 --> ipilimumab
    n1=en:diphenhydramine hydrochloride/dexamethasone/nystatin magic mouthwash | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1842. en:diphenhydramine/lidocaine/antacid mouthwash --- r_associated #0: 20 --> ipilimumab
    n1=en:diphenhydramine/lidocaine/antacid mouthwash | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1843. en:diphtheria toxin fragment-interleukin-2 fusion protein e7777 --- r_associated #0: 20 --> ipilimumab
    n1=en:diphtheria toxin fragment-interleukin-2 fusion protein e7777 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1844. en:diphtheria toxoid/tetanus toxoid vaccine adsorbed --- r_associated #0: 20 --> ipilimumab
    n1=en:diphtheria toxoid/tetanus toxoid vaccine adsorbed | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1845. en:diphtheria toxoid/tetanus toxoid/acellular pertussis adsorbed, recombinant hepatitis b/inactivated poliovirus vaccine combined --- r_associated #0: 20 --> ipilimumab
    n1=en:diphtheria toxoid/tetanus toxoid/acellular pertussis adsorbed, recombinant hepatitis b/inactivated poliovirus vaccine combined | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1846. en:diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine adsorbed --- r_associated #0: 20 --> ipilimumab
    n1=en:diphtheria toxoid/tetanus toxoid/acellular pertussis vaccine adsorbed | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1847. en:diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis-haemophilus influenzae type b vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis-haemophilus influenzae type b vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1848. en:dipyridamole --- r_associated #0: 20 --> ipilimumab
    n1=en:dipyridamole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1849. en:directly observed therapy --- r_associated #0: 20 --> ipilimumab
    n1=en:directly observed therapy | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1850. en:disaccharide tripeptide glycerol dipalmitoyl --- r_associated #0: 20 --> ipilimumab
    n1=en:disaccharide tripeptide glycerol dipalmitoyl | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1851. en:distilled water --- r_associated #0: 20 --> ipilimumab
    n1=en:distilled water | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1852. en:disulfiram --- r_associated #0: 20 --> ipilimumab
    n1=en:disulfiram | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1853. en:ditiocarb --- r_associated #0: 20 --> ipilimumab
    n1=en:ditiocarb | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1854. en:diuretic --- r_associated #0: 20 --> ipilimumab
    n1=en:diuretic | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1855. en:divalproex sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:divalproex sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1856. en:dkk1-neutralizing monoclonal antibody dkn-01 --- r_associated #0: 20 --> ipilimumab
    n1=en:dkk1-neutralizing monoclonal antibody dkn-01 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1857. en:dl-selenomethionine --- r_associated #0: 20 --> ipilimumab
    n1=en:dl-selenomethionine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1858. en:dlk1/epha2/hbb/nrp1/rgs5/tem1 peptide-pulsed alpha-type-1 polarized dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:dlk1/epha2/hbb/nrp1/rgs5/tem1 peptide-pulsed alpha-type-1 polarized dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1859. en:dm-choc-pen --- r_associated #0: 20 --> ipilimumab
    n1=en:dm-choc-pen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1860. en:dm4-conjugated anti-cripto monoclonal antibody biib015 --- r_associated #0: 20 --> ipilimumab
    n1=en:dm4-conjugated anti-cripto monoclonal antibody biib015 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1861. en:dmuc4064a --- r_associated #0: 20 --> ipilimumab
    n1=en:dmuc4064a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1862. en:dn-101 --- r_associated #0: 20 --> ipilimumab
    n1=en:dn-101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1863. en:dna binding agent --- r_associated #0: 20 --> ipilimumab
    n1=en:dna binding agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1864. en:dna interference oligonucleotide pnt2258 --- r_associated #0: 20 --> ipilimumab
    n1=en:dna interference oligonucleotide pnt2258 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1865. en:dna minor groove binding agent pm060184 --- r_associated #0: 20 --> ipilimumab
    n1=en:dna minor groove binding agent pm060184 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1866. en:dna minor groove binding agent sg2000 --- r_associated #0: 20 --> ipilimumab
    n1=en:dna minor groove binding agent sg2000 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1867. en:dna plasmid encoding interleukin-12 ino-9012 --- r_associated #0: 20 --> ipilimumab
    n1=en:dna plasmid encoding interleukin-12 ino-9012 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1868. en:dna plasmid-encoding interleukin-12/hpv dna plasmids therapeutic vaccine ino-3112 --- r_associated #0: 20 --> ipilimumab
    n1=en:dna plasmid-encoding interleukin-12/hpv dna plasmids therapeutic vaccine ino-3112 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1869. en:dna vaccine vb10.16 --- r_associated #0: 20 --> ipilimumab
    n1=en:dna vaccine vb10.16 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1870. en:dna vector ppra-psm vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:dna vector ppra-psm vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1871. en:dna-dependent protein kinase-targeting sidna dt01 --- r_associated #0: 20 --> ipilimumab
    n1=en:dna-dependent protein kinase-targeting sidna dt01 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1872. en:dna-pk inhibitor msc2490484a --- r_associated #0: 20 --> ipilimumab
    n1=en:dna-pk inhibitor msc2490484a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1873. en:dna-pk/tor kinase inhibitor cc-115 --- r_associated #0: 20 --> ipilimumab
    n1=en:dna-pk/tor kinase inhibitor cc-115 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1874. en:dna-rna transcription regulator --- r_associated #0: 20 --> ipilimumab
    n1=en:dna-rna transcription regulator | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1875. en:dnr-expressing nasopharyngeal carcinoma-specific cytotoxic t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:dnr-expressing nasopharyngeal carcinoma-specific cytotoxic t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1876. en:dobutamine --- r_associated #0: 20 --> ipilimumab
    n1=en:dobutamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1877. en:docetaxel --- r_associated #0: 20 --> ipilimumab
    n1=en:docetaxel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1878. en:docetaxel emulsion anx-514 --- r_associated #0: 20 --> ipilimumab
    n1=en:docetaxel emulsion anx-514 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1879. en:docetaxel formulation ckd-810 --- r_associated #0: 20 --> ipilimumab
    n1=en:docetaxel formulation ckd-810 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1880. en:docetaxel lipid microspheres --- r_associated #0: 20 --> ipilimumab
    n1=en:docetaxel lipid microspheres | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1881. en:docetaxel-loaded nanopharmaceutical crlx301 --- r_associated #0: 20 --> ipilimumab
    n1=en:docetaxel-loaded nanopharmaceutical crlx301 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1882. en:docetaxel-pnp --- r_associated #0: 20 --> ipilimumab
    n1=en:docetaxel-pnp | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1883. en:doconexent --- r_associated #0: 20 --> ipilimumab
    n1=en:doconexent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1884. en:docosahexaenoic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:docosahexaenoic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1885. en:docusate --- r_associated #0: 20 --> ipilimumab
    n1=en:docusate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1886. en:dofequidar fumarate --- r_associated #0: 20 --> ipilimumab
    n1=en:dofequidar fumarate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1887. en:dolasetron mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:dolasetron mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1888. en:dolastatin 10 --- r_associated #0: 20 --> ipilimumab
    n1=en:dolastatin 10 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1889. en:dolutegravir --- r_associated #0: 20 --> ipilimumab
    n1=en:dolutegravir | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1890. en:domperidone --- r_associated #0: 20 --> ipilimumab
    n1=en:domperidone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1891. en:donafenib --- r_associated #0: 20 --> ipilimumab
    n1=en:donafenib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1892. en:donepezil + memantine --- r_associated #0: 20 --> ipilimumab
    n1=en:donepezil + memantine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1893. en:donepezil hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:donepezil hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1894. en:donor lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:donor lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1895. en:donor regulatory t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:donor regulatory t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1896. en:donor-derived wt1/prame/ny-eso-1/survivin-specific t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:donor-derived wt1/prame/ny-eso-1/survivin-specific t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1897. en:dopamine-somatostatin chimeric molecule bim-23a760 --- r_associated #0: 20 --> ipilimumab
    n1=en:dopamine-somatostatin chimeric molecule bim-23a760 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1898. en:dornase alfa --- r_associated #0: 20 --> ipilimumab
    n1=en:dornase alfa | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1899. en:dornase alfa inhalation solution --- r_associated #0: 20 --> ipilimumab
    n1=en:dornase alfa inhalation solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1900. en:dot1l inhibitor epz-5676 --- r_associated #0: 20 --> ipilimumab
    n1=en:dot1l inhibitor epz-5676 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1901. en:dotap:cholesterol-fus1 liposome complex --- r_associated #0: 20 --> ipilimumab
    n1=en:dotap:cholesterol-fus1 liposome complex | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1902. en:dovitinib lactate --- r_associated #0: 20 --> ipilimumab
    n1=en:dovitinib lactate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1903. en:doxazosin mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:doxazosin mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1904. en:doxepin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:doxepin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1905. en:doxercalciferol --- r_associated #0: 20 --> ipilimumab
    n1=en:doxercalciferol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1906. en:doxifluridine --- r_associated #0: 20 --> ipilimumab
    n1=en:doxifluridine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1907. en:doxorubicin hcl inhalation solution --- r_associated #0: 20 --> ipilimumab
    n1=en:doxorubicin hcl inhalation solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1908. en:doxorubicin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:doxorubicin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1909. en:doxorubicin-dna complex --- r_associated #0: 20 --> ipilimumab
    n1=en:doxorubicin-dna complex | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1910. en:doxorubicin-eluting beads --- r_associated #0: 20 --> ipilimumab
    n1=en:doxorubicin-eluting beads | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1911. en:doxorubicin-hpma conjugate --- r_associated #0: 20 --> ipilimumab
    n1=en:doxorubicin-hpma conjugate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1912. en:doxorubicin-magnetic targeted carrier complex --- r_associated #0: 20 --> ipilimumab
    n1=en:doxorubicin-magnetic targeted carrier complex | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1913. en:doxycycline --- r_associated #0: 20 --> ipilimumab
    n1=en:doxycycline | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1914. en:doxycycline hyclate --- r_associated #0: 20 --> ipilimumab
    n1=en:doxycycline hyclate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1915. en:doxycycline hyclate foam --- r_associated #0: 20 --> ipilimumab
    n1=en:doxycycline hyclate foam | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1916. en:doxycycline hyclate injection --- r_associated #0: 20 --> ipilimumab
    n1=en:doxycycline hyclate injection | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1917. en:dpt/bcg/measles/serratia/pneumococcus vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:dpt/bcg/measles/serratia/pneumococcus vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1918. en:dpt/typhoid/staphylococcus aureus/paratyphoid a/paratyphoid b vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:dpt/typhoid/staphylococcus aureus/paratyphoid a/paratyphoid b vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1919. en:dr5-targeting tetrameric nanobody agonist tas266 --- r_associated #0: 20 --> ipilimumab
    n1=en:dr5-targeting tetrameric nanobody agonist tas266 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1920. en:dromostanolone propionate --- r_associated #0: 20 --> ipilimumab
    n1=en:dromostanolone propionate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1921. en:dronabinol --- r_associated #0: 20 --> ipilimumab
    n1=en:dronabinol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1922. en:droperidol --- r_associated #0: 20 --> ipilimumab
    n1=en:droperidol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1923. en:drotrecogin alfa (activated) --- r_associated #0: 20 --> ipilimumab
    n1=en:drotrecogin alfa (activated) | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1924. en:drug combinations --- r_associated #0: 20 --> ipilimumab
    n1=en:drug combinations | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1925. en:drug groups primarily affecting the musculoskeletal system --- r_associated #0: 20 --> ipilimumab
    n1=en:drug groups primarily affecting the musculoskeletal system | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1926. en:drug products by fda established pharmacologic class --- r_associated #0: 20 --> ipilimumab
    n1=en:drug products by fda established pharmacologic class | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1927. en:drug products by generic ingredient combinations --- r_associated #0: 20 --> ipilimumab
    n1=en:drug products by generic ingredient combinations | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1928. en:drug products by va class --- r_associated #0: 20 --> ipilimumab
    n1=en:drug products by va class | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1929. en:drug values --- r_associated #0: 20 --> ipilimumab
    n1=en:drug values | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1930. en:drug-device combination product --- r_associated #0: 20 --> ipilimumab
    n1=en:drug-device combination product | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1931. en:drugs treating radiation contamination --- r_associated #0: 20 --> ipilimumab
    n1=en:drugs treating radiation contamination | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1932. en:drugs used in metabolic disorders --- r_associated #0: 20 --> ipilimumab
    n1=en:drugs used in metabolic disorders | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1933. en:drugs used to treat addiction --- r_associated #0: 20 --> ipilimumab
    n1=en:drugs used to treat addiction | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1934. en:drugs, chinese herbal --- r_associated #0: 20 --> ipilimumab
    n1=en:drugs, chinese herbal | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1935. en:drugs, essential --- r_associated #0: 20 --> ipilimumab
    n1=en:drugs, essential | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1936. en:dt(388)il3 fusion protein sl-401 --- r_associated #0: 20 --> ipilimumab
    n1=en:dt(388)il3 fusion protein sl-401 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1937. en:dta-h19 plasmid --- r_associated #0: 20 --> ipilimumab
    n1=en:dta-h19 plasmid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1938. en:dtgm fusion protein --- r_associated #0: 20 --> ipilimumab
    n1=en:dtgm fusion protein | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1939. en:dual igf-1r/insr inhibitor bms-754807 --- r_associated #0: 20 --> ipilimumab
    n1=en:dual igf-1r/insr inhibitor bms-754807 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1940. en:dual pi3 kinase/mtor inhibitor gdc-0980 --- r_associated #0: 20 --> ipilimumab
    n1=en:dual pi3 kinase/mtor inhibitor gdc-0980 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1941. en:dual variable domain immunoglobulin abt-165 --- r_associated #0: 20 --> ipilimumab
    n1=en:dual variable domain immunoglobulin abt-165 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1942. en:duborimycin --- r_associated #0: 20 --> ipilimumab
    n1=en:duborimycin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1943. en:dulanermin --- r_associated #0: 20 --> ipilimumab
    n1=en:dulanermin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1944. en:duligotuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:duligotuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1945. en:duloxetine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:duloxetine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1946. en:durvalumab --- r_associated #0: 20 --> ipilimumab
    n1=en:durvalumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1947. en:dutasteride --- r_associated #0: 20 --> ipilimumab
    n1=en:dutasteride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1948. en:dutpase/dpd inhibitor tas-114 --- r_associated #0: 20 --> ipilimumab
    n1=en:dutpase/dpd inhibitor tas-114 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1949. en:dwj1319 --- r_associated #0: 20 --> ipilimumab
    n1=en:dwj1319 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1950. en:e-101 solution --- r_associated #0: 20 --> ipilimumab
    n1=en:e-101 solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1951. en:e-selectin antagonist gmi-1271 --- r_associated #0: 20 --> ipilimumab
    n1=en:e-selectin antagonist gmi-1271 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1952. en:e. coli cd-expressing genetically modified neural stem cells --- r_associated #0: 20 --> ipilimumab
    n1=en:e. coli cd-expressing genetically modified neural stem cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1953. en:e1a lipid complex --- r_associated #0: 20 --> ipilimumab
    n1=en:e1a lipid complex | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1954. en:e1m184v peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:e1m184v peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1955. en:e2f1 pathway activator arq 171 --- r_associated #0: 20 --> ipilimumab
    n1=en:e2f1 pathway activator arq 171 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1956. en:e7046 --- r_associated #0: 20 --> ipilimumab
    n1=en:e7046 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1957. en:e7820 --- r_associated #0: 20 --> ipilimumab
    n1=en:e7820 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1958. en:east indian sandalwood oil mouth rinse --- r_associated #0: 20 --> ipilimumab
    n1=en:east indian sandalwood oil mouth rinse | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1959. en:ebselen-containing oral capsule spi-1005 --- r_associated #0: 20 --> ipilimumab
    n1=en:ebselen-containing oral capsule spi-1005 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1960. en:ebv-specific cytotoxic t-lymphocyte --- r_associated #0: 20 --> ipilimumab
    n1=en:ebv-specific cytotoxic t-lymphocyte | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1961. en:echinomycin --- r_associated #0: 20 --> ipilimumab
    n1=en:echinomycin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1962. en:ecromeximab --- r_associated #0: 20 --> ipilimumab
    n1=en:ecromeximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1963. en:eculizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:eculizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1964. en:edatrexate --- r_associated #0: 20 --> ipilimumab
    n1=en:edatrexate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1965. en:edelfosine --- r_associated #0: 20 --> ipilimumab
    n1=en:edelfosine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1966. en:edetate calcium disodium --- r_associated #0: 20 --> ipilimumab
    n1=en:edetate calcium disodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1967. en:edotecarin --- r_associated #0: 20 --> ipilimumab
    n1=en:edotecarin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1968. en:edoxaban tosylate --- r_associated #0: 20 --> ipilimumab
    n1=en:edoxaban tosylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1969. en:edrecolomab --- r_associated #0: 20 --> ipilimumab
    n1=en:edrecolomab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1970. en:ef5 --- r_associated #0: 20 --> ipilimumab
    n1=en:ef5 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1971. en:efalizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:efalizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1972. en:efaproxiral --- r_associated #0: 20 --> ipilimumab
    n1=en:efaproxiral | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1973. en:efatutazone dihydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:efatutazone dihydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1974. en:efavirenz --- r_associated #0: 20 --> ipilimumab
    n1=en:efavirenz | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1975. en:eflornithine --- r_associated #0: 20 --> ipilimumab
    n1=en:eflornithine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1976. en:eflornithine hydrochloride ointment --- r_associated #0: 20 --> ipilimumab
    n1=en:eflornithine hydrochloride ointment | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1977. en:efs-ada lentiviral vector-transduced cd34-positive autologous lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:efs-ada lentiviral vector-transduced cd34-positive autologous lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1978. en:efungumab --- r_associated #0: 20 --> ipilimumab
    n1=en:efungumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1979. en:eg5 kinesin-related motor protein inhibitor 4sc-205 --- r_associated #0: 20 --> ipilimumab
    n1=en:eg5 kinesin-related motor protein inhibitor 4sc-205 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1980. en:eg5 kinesin-related motor protein inhibitor arq 621 --- r_associated #0: 20 --> ipilimumab
    n1=en:eg5 kinesin-related motor protein inhibitor arq 621 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1981. en:egb761 --- r_associated #0: 20 --> ipilimumab
    n1=en:egb761 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1982. en:egfr antagonist hemay022 --- r_associated #0: 20 --> ipilimumab
    n1=en:egfr antagonist hemay022 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1983. en:egfr antisense dna --- r_associated #0: 20 --> ipilimumab
    n1=en:egfr antisense dna | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1984. en:egfr car-cd3zeta-4-1bb-expressing autologous t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:egfr car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1985. en:egfr inhibitor abt-414 --- r_associated #0: 20 --> ipilimumab
    n1=en:egfr inhibitor abt-414 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1986. en:egfr inhibitor asp8273 --- r_associated #0: 20 --> ipilimumab
    n1=en:egfr inhibitor asp8273 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1987. en:egfr inhibitor azd3759 --- r_associated #0: 20 --> ipilimumab
    n1=en:egfr inhibitor azd3759 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1988. en:egfr inhibitor co-1686 --- r_associated #0: 20 --> ipilimumab
    n1=en:egfr inhibitor co-1686 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1989. en:egfr inhibitor egf816 --- r_associated #0: 20 --> ipilimumab
    n1=en:egfr inhibitor egf816 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1990. en:egfr inhibitor hm61713 --- r_associated #0: 20 --> ipilimumab
    n1=en:egfr inhibitor hm61713 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1991. en:egfr mutation-selective inhibitor ac0010ma --- r_associated #0: 20 --> ipilimumab
    n1=en:egfr mutation-selective inhibitor ac0010ma | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1992. en:egfr t790m inhibitor pf-06747775 --- r_associated #0: 20 --> ipilimumab
    n1=en:egfr t790m inhibitor pf-06747775 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1993. en:egfr/her2 inhibitor ap32788 --- r_associated #0: 20 --> ipilimumab
    n1=en:egfr/her2 inhibitor ap32788 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1994. en:egfr/her2 inhibitor av-412 --- r_associated #0: 20 --> ipilimumab
    n1=en:egfr/her2 inhibitor av-412 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1995. en:egfr/her2 kinase inhibitor tak-285 --- r_associated #0: 20 --> ipilimumab
    n1=en:egfr/her2 kinase inhibitor tak-285 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1996. en:egfrbi-armed autologous t cells --- r_associated #0: 20 --> ipilimumab
    n1=en:egfrbi-armed autologous t cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1997. en:egfrviii-specific car-transduced autologous t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:egfrviii-specific car-transduced autologous t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1998. en:eicosapentaenoic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:eicosapentaenoic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  1999. en:eicosapentaenoic acid-enriched nutritional supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:eicosapentaenoic acid-enriched nutritional supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2000. en:eif4e antisense oligonucleotide isis 183750 --- r_associated #0: 20 --> ipilimumab
    n1=en:eif4e antisense oligonucleotide isis 183750 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2001. en:elacytarabine --- r_associated #0: 20 --> ipilimumab
    n1=en:elacytarabine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2002. en:electrokinetically modified water --- r_associated #0: 20 --> ipilimumab
    n1=en:electrokinetically modified water | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2003. en:electrolyte-free parenteral nutrition emulsion --- r_associated #0: 20 --> ipilimumab
    n1=en:electrolyte-free parenteral nutrition emulsion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2004. en:elesclomol --- r_associated #0: 20 --> ipilimumab
    n1=en:elesclomol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2005. en:elesclomol sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:elesclomol sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2006. en:elinafide --- r_associated #0: 20 --> ipilimumab
    n1=en:elinafide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2007. en:elisidepsin --- r_associated #0: 20 --> ipilimumab
    n1=en:elisidepsin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2008. en:ellagic acid/annona muricata supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:ellagic acid/annona muricata supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2009. en:elliptinium acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:elliptinium acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2010. en:elosulfase alfa --- r_associated #0: 20 --> ipilimumab
    n1=en:elosulfase alfa | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2011. en:elotuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:elotuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2012. en:elsamitrucin --- r_associated #0: 20 --> ipilimumab
    n1=en:elsamitrucin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2013. en:elsiglutide --- r_associated #0: 20 --> ipilimumab
    n1=en:elsiglutide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2014. en:eltrombopag olamine --- r_associated #0: 20 --> ipilimumab
    n1=en:eltrombopag olamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2015. en:emactuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:emactuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2016. en:embolic agent --- r_associated #0: 20 --> ipilimumab
    n1=en:embolic agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2017. en:emepepimut-s --- r_associated #0: 20 --> ipilimumab
    n1=en:emepepimut-s | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2018. en:emitefur --- r_associated #0: 20 --> ipilimumab
    n1=en:emitefur | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2019. en:emollients --- r_associated #0: 20 --> ipilimumab
    n1=en:emollients | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2020. en:emricasan --- r_associated #0: 20 --> ipilimumab
    n1=en:emricasan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2021. en:emtricitabine --- r_associated #0: 20 --> ipilimumab
    n1=en:emtricitabine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2022. en:enadenotucirev --- r_associated #0: 20 --> ipilimumab
    n1=en:enadenotucirev | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2023. en:enalapril maleate --- r_associated #0: 20 --> ipilimumab
    n1=en:enalapril maleate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2024. en:enavatuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:enavatuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2025. en:enclomiphene citrate --- r_associated #0: 20 --> ipilimumab
    n1=en:enclomiphene citrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2026. en:endothelin b receptor agonist spi-1620 --- r_associated #0: 20 --> ipilimumab
    n1=en:endothelin b receptor agonist spi-1620 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2027. en:eniluracil --- r_associated #0: 20 --> ipilimumab
    n1=en:eniluracil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2028. en:enobosarm --- r_associated #0: 20 --> ipilimumab
    n1=en:enobosarm | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2029. en:enoxaparin --- r_associated #0: 20 --> ipilimumab
    n1=en:enoxaparin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2030. en:ensituximab --- r_associated #0: 20 --> ipilimumab
    n1=en:ensituximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2031. en:entecavir --- r_associated #0: 20 --> ipilimumab
    n1=en:entecavir | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2032. en:enteric transport medium --- r_associated #0: 20 --> ipilimumab
    n1=en:enteric transport medium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2033. en:enteric-coated trpm8 agonist d-3263 hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:enteric-coated trpm8 agonist d-3263 hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2034. en:enteric-coated zoledronic acid tablet mer-101 --- r_associated #0: 20 --> ipilimumab
    n1=en:enteric-coated zoledronic acid tablet mer-101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2035. en:entinostat --- r_associated #0: 20 --> ipilimumab
    n1=en:entinostat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2036. en:entolimod --- r_associated #0: 20 --> ipilimumab
    n1=en:entolimod | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2037. en:entospletinib --- r_associated #0: 20 --> ipilimumab
    n1=en:entospletinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2038. en:entrectinib --- r_associated #0: 20 --> ipilimumab
    n1=en:entrectinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2039. en:enzalutamide --- r_associated #0: 20 --> ipilimumab
    n1=en:enzalutamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2040. en:enzastaurin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:enzastaurin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2041. en:enzymatically-hydrolyzed whey protein-based nutritional supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:enzymatically-hydrolyzed whey protein-based nutritional supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2042. en:enzyme agent --- r_associated #0: 20 --> ipilimumab
    n1=en:enzyme agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2043. en:enzyme inhibitor --- r_associated #0: 20 --> ipilimumab
    n1=en:enzyme inhibitor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2044. en:ep4 receptor antagonist aat-007 --- r_associated #0: 20 --> ipilimumab
    n1=en:ep4 receptor antagonist aat-007 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2045. en:epacadostat --- r_associated #0: 20 --> ipilimumab
    n1=en:epacadostat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2046. en:epcam-specific car-expressing autologous t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:epcam-specific car-expressing autologous t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2047. en:epha2-targeting dopc-encapsulated sirna --- r_associated #0: 20 --> ipilimumab
    n1=en:epha2-targeting dopc-encapsulated sirna | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2048. en:epidermal growth factor ointment --- r_associated #0: 20 --> ipilimumab
    n1=en:epidermal growth factor ointment | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2049. en:epidermal growth factor receptor tyrosine kinase inhibitor --- r_associated #0: 20 --> ipilimumab
    n1=en:epidermal growth factor receptor tyrosine kinase inhibitor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2050. en:epigallocatechin gallate --- r_associated #0: 20 --> ipilimumab
    n1=en:epigallocatechin gallate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2051. en:epipropidine --- r_associated #0: 20 --> ipilimumab
    n1=en:epipropidine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2052. en:epirubicin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:epirubicin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2053. en:epithelial cell adhesion molecule --- r_associated #0: 20 --> ipilimumab
    n1=en:epithelial cell adhesion molecule | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2054. en:eplerenone --- r_associated #0: 20 --> ipilimumab
    n1=en:eplerenone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2055. en:epoch regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:epoch regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2056. en:epoetin alfa --- r_associated #0: 20 --> ipilimumab
    n1=en:epoetin alfa | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2057. en:epoetin beta --- r_associated #0: 20 --> ipilimumab
    n1=en:epoetin beta | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2058. en:epoetin zeta --- r_associated #0: 20 --> ipilimumab
    n1=en:epoetin zeta | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2059. en:epothilone analog utd1 --- r_associated #0: 20 --> ipilimumab
    n1=en:epothilone analog utd1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2060. en:epothilone compound --- r_associated #0: 20 --> ipilimumab
    n1=en:epothilone compound | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2061. en:epothilone d --- r_associated #0: 20 --> ipilimumab
    n1=en:epothilone d | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2062. en:epothilone kos-1584 --- r_associated #0: 20 --> ipilimumab
    n1=en:epothilone kos-1584 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2063. en:epratuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:epratuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2064. en:eprodisate disodium --- r_associated #0: 20 --> ipilimumab
    n1=en:eprodisate disodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2065. en:era36 modulator icaritin --- r_associated #0: 20 --> ipilimumab
    n1=en:era36 modulator icaritin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2066. en:erastin analogue prlx 93936 --- r_associated #0: 20 --> ipilimumab
    n1=en:erastin analogue prlx 93936 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2067. en:erb-38 immunotoxin --- r_associated #0: 20 --> ipilimumab
    n1=en:erb-38 immunotoxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2068. en:erbb-2 inhibitor arry-380 --- r_associated #0: 20 --> ipilimumab
    n1=en:erbb-2 inhibitor arry-380 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2069. en:ergocalciferol --- r_associated #0: 20 --> ipilimumab
    n1=en:ergocalciferol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2070. en:ergoline --- r_associated #0: 20 --> ipilimumab
    n1=en:ergoline | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2071. en:ergoline derivative --- r_associated #0: 20 --> ipilimumab
    n1=en:ergoline derivative | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2072. en:eribulin mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:eribulin mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2073. en:eritoran tetrasodium --- r_associated #0: 20 --> ipilimumab
    n1=en:eritoran tetrasodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2074. en:erk inhibitor cc-90003 --- r_associated #0: 20 --> ipilimumab
    n1=en:erk inhibitor cc-90003 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2075. en:erk inhibitor gdc-0994 --- r_associated #0: 20 --> ipilimumab
    n1=en:erk inhibitor gdc-0994 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2076. en:erk inhibitor ltt462 --- r_associated #0: 20 --> ipilimumab
    n1=en:erk inhibitor ltt462 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2077. en:erk inhibitor mk-8353 --- r_associated #0: 20 --> ipilimumab
    n1=en:erk inhibitor mk-8353 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2078. en:erlotinib hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:erlotinib hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2079. en:ertapenem sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:ertapenem sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2080. en:ertumaxomab --- r_associated #0: 20 --> ipilimumab
    n1=en:ertumaxomab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2081. en:erythrocyte-encapsulated l-asparaginase suspension --- r_associated #0: 20 --> ipilimumab
    n1=en:erythrocyte-encapsulated l-asparaginase suspension | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2082. en:erythromycin --- r_associated #0: 20 --> ipilimumab
    n1=en:erythromycin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2083. en:erythromycin topical cream --- r_associated #0: 20 --> ipilimumab
    n1=en:erythromycin topical cream | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2084. en:escherichia coli monoclonal antibody --- r_associated #0: 20 --> ipilimumab
    n1=en:escherichia coli monoclonal antibody | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2085. en:escitalopram oxalate --- r_associated #0: 20 --> ipilimumab
    n1=en:escitalopram oxalate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2086. en:eslicarbazepine --- r_associated #0: 20 --> ipilimumab
    n1=en:eslicarbazepine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2087. en:esmolol --- r_associated #0: 20 --> ipilimumab
    n1=en:esmolol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2088. en:esomeprazole magnesium --- r_associated #0: 20 --> ipilimumab
    n1=en:esomeprazole magnesium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2089. en:esorubicin --- r_associated #0: 20 --> ipilimumab
    n1=en:esorubicin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2090. en:essiac --- r_associated #0: 20 --> ipilimumab
    n1=en:essiac | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2091. en:estradiol vaginal ring --- r_associated #0: 20 --> ipilimumab
    n1=en:estradiol vaginal ring | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2092. en:estradiol valerate --- r_associated #0: 20 --> ipilimumab
    n1=en:estradiol valerate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2093. en:estradiol/norethindrone acetate tablet --- r_associated #0: 20 --> ipilimumab
    n1=en:estradiol/norethindrone acetate tablet | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2094. en:estramustine phosphate sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:estramustine phosphate sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2095. en:estriol vaginal gel --- r_associated #0: 20 --> ipilimumab
    n1=en:estriol vaginal gel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2096. en:estrogen receptor agonist gtx-758 --- r_associated #0: 20 --> ipilimumab
    n1=en:estrogen receptor agonist gtx-758 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2097. en:estrogens, conjugated --- r_associated #0: 20 --> ipilimumab
    n1=en:estrogens, conjugated | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2098. en:estrogens, esterified (usp) --- r_associated #0: 20 --> ipilimumab
    n1=en:estrogens, esterified (usp) | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2099. en:eszopiclone --- r_associated #0: 20 --> ipilimumab
    n1=en:eszopiclone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2100. en:etalocib --- r_associated #0: 20 --> ipilimumab
    n1=en:etalocib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2101. en:etanercept --- r_associated #0: 20 --> ipilimumab
    n1=en:etanercept | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2102. en:etanidazole --- r_associated #0: 20 --> ipilimumab
    n1=en:etanidazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2103. en:etaracizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:etaracizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2104. en:ethacridine --- r_associated #0: 20 --> ipilimumab
    n1=en:ethacridine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2105. en:ethacrynic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:ethacrynic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2106. en:ethambutol --- r_associated #0: 20 --> ipilimumab
    n1=en:ethambutol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2107. en:ethaselen --- r_associated #0: 20 --> ipilimumab
    n1=en:ethaselen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2108. en:ethinyl estradiol --- r_associated #0: 20 --> ipilimumab
    n1=en:ethinyl estradiol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2109. en:ethinyl estradiol/levonorgestrel --- r_associated #0: 20 --> ipilimumab
    n1=en:ethinyl estradiol/levonorgestrel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2110. en:ethinyl estradiol/norethindrone --- r_associated #0: 20 --> ipilimumab
    n1=en:ethinyl estradiol/norethindrone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2111. en:ethiodized oil --- r_associated #0: 20 --> ipilimumab
    n1=en:ethiodized oil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2112. en:ethosuximide --- r_associated #0: 20 --> ipilimumab
    n1=en:ethosuximide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2113. en:ethyl alcohol mouthwash --- r_associated #0: 20 --> ipilimumab
    n1=en:ethyl alcohol mouthwash | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2114. en:ethyl icosapentate --- r_associated #0: 20 --> ipilimumab
    n1=en:ethyl icosapentate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2115. en:ethylchlorformate --- r_associated #0: 20 --> ipilimumab
    n1=en:ethylchlorformate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2116. en:ethylchlorformate vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:ethylchlorformate vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2117. en:etidronate-cytarabine conjugate mbc-11 --- r_associated #0: 20 --> ipilimumab
    n1=en:etidronate-cytarabine conjugate mbc-11 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2118. en:etidronic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:etidronic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2119. en:etodolac --- r_associated #0: 20 --> ipilimumab
    n1=en:etodolac | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2120. en:etoglucid --- r_associated #0: 20 --> ipilimumab
    n1=en:etoglucid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2121. en:etoposide --- r_associated #0: 20 --> ipilimumab
    n1=en:etoposide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2122. en:etoposide phosphate --- r_associated #0: 20 --> ipilimumab
    n1=en:etoposide phosphate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2123. en:etoposide prodrug cap7.1 --- r_associated #0: 20 --> ipilimumab
    n1=en:etoposide prodrug cap7.1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2124. en:etoricoxib --- r_associated #0: 20 --> ipilimumab
    n1=en:etoricoxib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2125. en:ets-family transcription factor inhibitor tk216 --- r_associated #0: 20 --> ipilimumab
    n1=en:ets-family transcription factor inhibitor tk216 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2126. en:eucerin --- r_associated #0: 20 --> ipilimumab
    n1=en:eucerin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2127. en:eutectic mixture of local anesthetics --- r_associated #0: 20 --> ipilimumab
    n1=en:eutectic mixture of local anesthetics | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2128. en:evaux spring water-based cream --- r_associated #0: 20 --> ipilimumab
    n1=en:evaux spring water-based cream | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2129. en:evaux spring water-based topical spray --- r_associated #0: 20 --> ipilimumab
    n1=en:evaux spring water-based topical spray | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2130. en:evaux thermal spring water-based solution --- r_associated #0: 20 --> ipilimumab
    n1=en:evaux thermal spring water-based solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2131. en:everolimus --- r_associated #0: 20 --> ipilimumab
    n1=en:everolimus | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2132. en:everolimus tablets for oral suspension --- r_associated #0: 20 --> ipilimumab
    n1=en:everolimus tablets for oral suspension | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2133. en:evolocumab --- r_associated #0: 20 --> ipilimumab
    n1=en:evolocumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2134. en:ex vivo-activated autologous lymph node lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:ex vivo-activated autologous lymph node lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2135. en:ex vivo-expanded her2-specific t cells --- r_associated #0: 20 --> ipilimumab
    n1=en:ex vivo-expanded her2-specific t cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2136. en:exatecan mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:exatecan mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2137. en:exemestane --- r_associated #0: 20 --> ipilimumab
    n1=en:exemestane | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2138. en:exenatide --- r_associated #0: 20 --> ipilimumab
    n1=en:exenatide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2139. en:exisulind --- r_associated #0: 20 --> ipilimumab
    n1=en:exisulind | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2140. en:expanded umbilical cord blood product hsc835 --- r_associated #0: 20 --> ipilimumab
    n1=en:expanded umbilical cord blood product hsc835 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2141. en:expectorant/mucolytic --- r_associated #0: 20 --> ipilimumab
    n1=en:expectorant/mucolytic | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2142. en:extended release bupivacaine hydrochloride resorbable matrix formulation --- r_associated #0: 20 --> ipilimumab
    n1=en:extended release bupivacaine hydrochloride resorbable matrix formulation | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2143. en:extended release flucytosine --- r_associated #0: 20 --> ipilimumab
    n1=en:extended release flucytosine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2144. en:extended-release onapristone --- r_associated #0: 20 --> ipilimumab
    n1=en:extended-release onapristone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2145. en:eye agent --- r_associated #0: 20 --> ipilimumab
    n1=en:eye agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2146. en:ezatiostat hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:ezatiostat hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2147. en:ezetimibe --- r_associated #0: 20 --> ipilimumab
    n1=en:ezetimibe | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2148. en:ezetimibe/simvastatin --- r_associated #0: 20 --> ipilimumab
    n1=en:ezetimibe/simvastatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2149. en:ezh1/2 inhibitor ds-3201 --- r_associated #0: 20 --> ipilimumab
    n1=en:ezh1/2 inhibitor ds-3201 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2150. en:ezh2 inhibitor cpi-1205 --- r_associated #0: 20 --> ipilimumab
    n1=en:ezh2 inhibitor cpi-1205 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2151. en:f-18 16 alpha-fluoroestradiol --- r_associated #0: 20 --> ipilimumab
    n1=en:f-18 16 alpha-fluoroestradiol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2152. en:f-18 fluoroethyltyrosine --- r_associated #0: 20 --> ipilimumab
    n1=en:f-18 fluoroethyltyrosine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2153. en:f16-il2 fusion protein --- r_associated #0: 20 --> ipilimumab
    n1=en:f16-il2 fusion protein | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2154. en:fact complex-targeting curaxin cbl0137 --- r_associated #0: 20 --> ipilimumab
    n1=en:fact complex-targeting curaxin cbl0137 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2155. en:factor viia inhibitor pci-27483 --- r_associated #0: 20 --> ipilimumab
    n1=en:factor viia inhibitor pci-27483 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2156. en:fadrozole hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:fadrozole hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2157. en:fak inhibitor gsk2256098 --- r_associated #0: 20 --> ipilimumab
    n1=en:fak inhibitor gsk2256098 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2158. en:fak inhibitor pf-00562271 --- r_associated #0: 20 --> ipilimumab
    n1=en:fak inhibitor pf-00562271 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2159. en:fak inhibitor vs-4718 --- r_associated #0: 20 --> ipilimumab
    n1=en:fak inhibitor vs-4718 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2160. en:falimarev --- r_associated #0: 20 --> ipilimumab
    n1=en:falimarev | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2161. en:famitinib --- r_associated #0: 20 --> ipilimumab
    n1=en:famitinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2162. en:famotidine --- r_associated #0: 20 --> ipilimumab
    n1=en:famotidine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2163. en:fap-specific cd8-positive t cells --- r_associated #0: 20 --> ipilimumab
    n1=en:fap-specific cd8-positive t cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2164. en:farletuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:farletuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2165. en:fas receptor agonist apo010 --- r_associated #0: 20 --> ipilimumab
    n1=en:fas receptor agonist apo010 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2166. en:fas-chimera transgene-expressing endothelial tumor cell-targeting adenovector vb-111 --- r_associated #0: 20 --> ipilimumab
    n1=en:fas-chimera transgene-expressing endothelial tumor cell-targeting adenovector vb-111 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2167. en:fasn inhibitor tvb-2640 --- r_associated #0: 20 --> ipilimumab
    n1=en:fasn inhibitor tvb-2640 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2168. en:fat emulsion --- r_associated #0: 20 --> ipilimumab
    n1=en:fat emulsion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2169. en:fazarabine --- r_associated #0: 20 --> ipilimumab
    n1=en:fazarabine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2170. en:fda established names and unique ingredient identifier codes terminology --- r_associated #0: 20 --> ipilimumab
    n1=en:fda established names and unique ingredient identifier codes terminology | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2171. en:febuxostat --- r_associated #0: 20 --> ipilimumab
    n1=en:febuxostat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2172. en:fenofibrate --- r_associated #0: 20 --> ipilimumab
    n1=en:fenofibrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2173. en:fenretinide --- r_associated #0: 20 --> ipilimumab
    n1=en:fenretinide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2174. en:fenretinide lipid matrix --- r_associated #0: 20 --> ipilimumab
    n1=en:fenretinide lipid matrix | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2175. en:fentanyl buccal soluble film --- r_associated #0: 20 --> ipilimumab
    n1=en:fentanyl buccal soluble film | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2176. en:fentanyl citrate --- r_associated #0: 20 --> ipilimumab
    n1=en:fentanyl citrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2177. en:fentanyl citrate buccal tablet --- r_associated #0: 20 --> ipilimumab
    n1=en:fentanyl citrate buccal tablet | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2178. en:fentanyl citrate pectin-based nasal spray --- r_associated #0: 20 --> ipilimumab
    n1=en:fentanyl citrate pectin-based nasal spray | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2179. en:fentanyl citrate-containing nasal spray --- r_associated #0: 20 --> ipilimumab
    n1=en:fentanyl citrate-containing nasal spray | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2180. en:fentanyl matrix transdermal patch --- r_associated #0: 20 --> ipilimumab
    n1=en:fentanyl matrix transdermal patch | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2181. en:fentanyl sublingual spray --- r_associated #0: 20 --> ipilimumab
    n1=en:fentanyl sublingual spray | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2182. en:fermented soybean protein beverage --- r_associated #0: 20 --> ipilimumab
    n1=en:fermented soybean protein beverage | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2183. en:fermented wheat germ extract --- r_associated #0: 20 --> ipilimumab
    n1=en:fermented wheat germ extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2184. en:ferric carboxymaltose solution --- r_associated #0: 20 --> ipilimumab
    n1=en:ferric carboxymaltose solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2185. en:ferrosoferric oxide --- r_associated #0: 20 --> ipilimumab
    n1=en:ferrosoferric oxide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2186. en:ferrous fumarate --- r_associated #0: 20 --> ipilimumab
    n1=en:ferrous fumarate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2187. en:ferrous sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:ferrous sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2188. en:fertility agents --- r_associated #0: 20 --> ipilimumab
    n1=en:fertility agents | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2189. en:ferumoxides injectable solution --- r_associated #0: 20 --> ipilimumab
    n1=en:ferumoxides injectable solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2190. en:ferumoxsil oral suspension --- r_associated #0: 20 --> ipilimumab
    n1=en:ferumoxsil oral suspension | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2191. en:ferumoxtran-10 --- r_associated #0: 20 --> ipilimumab
    n1=en:ferumoxtran-10 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2192. en:fesoterodine fumarate --- r_associated #0: 20 --> ipilimumab
    n1=en:fesoterodine fumarate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2193. en:fexofenadine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:fexofenadine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2194. en:fgf receptor antagonist hgs1036 --- r_associated #0: 20 --> ipilimumab
    n1=en:fgf receptor antagonist hgs1036 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2195. en:fgf/fgfr pathway inhibitor e7090 --- r_associated #0: 20 --> ipilimumab
    n1=en:fgf/fgfr pathway inhibitor e7090 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2196. en:fgf401 inhibitor fgf401 --- r_associated #0: 20 --> ipilimumab
    n1=en:fgf401 inhibitor fgf401 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2197. en:fgfr inhibitor asp5878 --- r_associated #0: 20 --> ipilimumab
    n1=en:fgfr inhibitor asp5878 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2198. en:fgfr inhibitor azd4547 --- r_associated #0: 20 --> ipilimumab
    n1=en:fgfr inhibitor azd4547 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2199. en:fgfr inhibitor debio 1347 --- r_associated #0: 20 --> ipilimumab
    n1=en:fgfr inhibitor debio 1347 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2200. en:fgfr inhibitor incb054828 --- r_associated #0: 20 --> ipilimumab
    n1=en:fgfr inhibitor incb054828 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2201. en:fgfr inhibitor ly2874455 --- r_associated #0: 20 --> ipilimumab
    n1=en:fgfr inhibitor ly2874455 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2202. en:fgfr inhibitor tas-120 --- r_associated #0: 20 --> ipilimumab
    n1=en:fgfr inhibitor tas-120 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2203. en:fgfr/vegfr/pdgfr/flt3/src inhibitor xl999 --- r_associated #0: 20 --> ipilimumab
    n1=en:fgfr/vegfr/pdgfr/flt3/src inhibitor xl999 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2204. en:fgfr4 inhibitor blu-554 --- r_associated #0: 20 --> ipilimumab
    n1=en:fgfr4 inhibitor blu-554 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2205. en:fibrin sealant --- r_associated #0: 20 --> ipilimumab
    n1=en:fibrin sealant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2206. en:ficlatuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:ficlatuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2207. en:fidaxomicin --- r_associated #0: 20 --> ipilimumab
    n1=en:fidaxomicin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2208. en:figitumumab --- r_associated #0: 20 --> ipilimumab
    n1=en:figitumumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2209. en:filgrastim --- r_associated #0: 20 --> ipilimumab
    n1=en:filgrastim | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2210. en:filgrastim-primed peripheral blood progenitor cells --- r_associated #0: 20 --> ipilimumab
    n1=en:filgrastim-primed peripheral blood progenitor cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2211. en:finasteride --- r_associated #0: 20 --> ipilimumab
    n1=en:finasteride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2212. en:fingolimod --- r_associated #0: 20 --> ipilimumab
    n1=en:fingolimod | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2213. en:fingolimod hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:fingolimod hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2214. en:firtecan pegol --- r_associated #0: 20 --> ipilimumab
    n1=en:firtecan pegol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2215. en:fish oil/glycerol/egg lecithin-based emulsion --- r_associated #0: 20 --> ipilimumab
    n1=en:fish oil/glycerol/egg lecithin-based emulsion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2216. en:flanvotumab --- r_associated #0: 20 --> ipilimumab
    n1=en:flanvotumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2217. en:flavonoid tablet --- r_associated #0: 20 --> ipilimumab
    n1=en:flavonoid tablet | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2218. en:flaxseed --- r_associated #0: 20 --> ipilimumab
    n1=en:flaxseed | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2219. en:flecainide acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:flecainide acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2220. en:floxuridine --- r_associated #0: 20 --> ipilimumab
    n1=en:floxuridine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2221. en:flp injection --- r_associated #0: 20 --> ipilimumab
    n1=en:flp injection | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2222. en:flt3/abl/aurora kinase inhibitor kw-2449 --- r_associated #0: 20 --> ipilimumab
    n1=en:flt3/abl/aurora kinase inhibitor kw-2449 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2223. en:flt3/cdk4/6 inhibitor flx925 --- r_associated #0: 20 --> ipilimumab
    n1=en:flt3/cdk4/6 inhibitor flx925 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2224. en:flt3/kit kinase inhibitor akn-028 --- r_associated #0: 20 --> ipilimumab
    n1=en:flt3/kit kinase inhibitor akn-028 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2225. en:flu matrix peptide p58-66 --- r_associated #0: 20 --> ipilimumab
    n1=en:flu matrix peptide p58-66 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2226. en:fluciclatide f-18 --- r_associated #0: 20 --> ipilimumab
    n1=en:fluciclatide f-18 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2227. en:fluciclovine (18f) --- r_associated #0: 20 --> ipilimumab
    n1=en:fluciclovine (18f) | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2228. en:fluconazole --- r_associated #0: 20 --> ipilimumab
    n1=en:fluconazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2229. en:flucytosine --- r_associated #0: 20 --> ipilimumab
    n1=en:flucytosine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2230. en:fludarabine --- r_associated #0: 20 --> ipilimumab
    n1=en:fludarabine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2231. en:fludarabine phosphate --- r_associated #0: 20 --> ipilimumab
    n1=en:fludarabine phosphate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2232. en:fludeoxyglucose f-18 --- r_associated #0: 20 --> ipilimumab
    n1=en:fludeoxyglucose f-18 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2233. en:fludrocortisone acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:fludrocortisone acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2234. en:flumatinib mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:flumatinib mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2235. en:fluocinonide --- r_associated #0: 20 --> ipilimumab
    n1=en:fluocinonide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2236. en:fluorescein sodium injection --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorescein sodium injection | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2237. en:fluorescence imaging agent emi-137 --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorescence imaging agent emi-137 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2238. en:fluorescent antibody sgm-101 --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorescent antibody sgm-101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2239. en:fluorescent crgdy peg-cy5.5 c dots --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorescent crgdy peg-cy5.5 c dots | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2240. en:fluorescent imaging ligand otl38 --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorescent imaging ligand otl38 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2241. en:fluorescent protease-activated peptide avb-620 --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorescent protease-activated peptide avb-620 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2242. en:fluorides --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorides | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2243. en:fluorine 18 f fludarabine --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine 18 f fludarabine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2244. en:fluorine f 18 4-l-fluoroglutamine (2s,4r) --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 4-l-fluoroglutamine (2s,4r) | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2245. en:fluorine f 18 5-fluoro-2-deoxycytidine --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 5-fluoro-2-deoxycytidine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2246. en:fluorine f 18 alfatide ii --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 alfatide ii | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2247. en:fluorine f 18 ara-g --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 ara-g | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2248. en:fluorine f 18 bay 85-8050 --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 bay 85-8050 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2249. en:fluorine f 18 bay 86-9596 --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 bay 86-9596 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2250. en:fluorine f 18 bay1075553 --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 bay1075553 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2251. en:fluorine f 18 choline --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 choline | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2252. en:fluorine f 18 cp18 peptide --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 cp18 peptide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2253. en:fluorine f 18 d-fmau --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 d-fmau | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2254. en:fluorine f 18 dabrafenib --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 dabrafenib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2255. en:fluorine f 18 dcfbc --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 dcfbc | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2256. en:fluorine f 18 dcfpyl --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 dcfpyl | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2257. en:fluorine f 18 ef5 --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 ef5 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2258. en:fluorine f 18 fdht --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 fdht | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2259. en:fluorine f 18 feqa --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 feqa | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2260. en:fluorine f 18 fluoro furanyl norprogesterone --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 fluoro furanyl norprogesterone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2261. en:fluorine f 18 fluoro-peg6-ipqa --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 fluoro-peg6-ipqa | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2262. en:fluorine f 18 fluorobenzyl triphenyl phosphonium --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 fluorobenzyl triphenyl phosphonium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2263. en:fluorine f 18 fluorodopa --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 fluorodopa | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2264. en:fluorine f 18 fluoroethylcholine --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 fluoroethylcholine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2265. en:fluorine f 18 fluoromethylcholine --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 fluoromethylcholine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2266. en:fluorine f 18 fluorthanatrace --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 fluorthanatrace | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2267. en:fluorine f 18 fmdht --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 fmdht | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2268. en:fluorine f 18 fp-r01-mg-f2 --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 fp-r01-mg-f2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2269. en:fluorine f 18 galacto-rgd peptide --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 galacto-rgd peptide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2270. en:fluorine f 18 iso-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 iso-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2271. en:fluorine f 18 l-glutamate derivative bay94-9392 --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 l-glutamate derivative bay94-9392 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2272. en:fluorine f 18 rgd-k5 --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 rgd-k5 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2273. en:fluorine f 18 ski-249380 --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 ski-249380 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2274. en:fluorine f 18 sodium fluoride --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18 sodium fluoride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2275. en:fluorine f 18-av-133 --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18-av-133 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2276. en:fluorine f 18-labeled s-(3-fluoropropyl)homocysteine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18-labeled s-(3-fluoropropyl)homocysteine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2277. en:fluorine f 18-vm4-037 --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f 18-vm4-037 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2278. en:fluorine f-18 6-fluorodopamine --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f-18 6-fluorodopamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2279. en:fluorine f-18 fluoropaclitaxel --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f-18 fluoropaclitaxel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2280. en:fluorine f-18 hx4 --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f-18 hx4 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2281. en:fluorine f-18 ml-10 --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorine f-18 ml-10 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2282. en:fluorodeoxygalactose f-18 --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorodeoxygalactose f-18 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2283. en:fluorometholone acetate ophthalmic suspension --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorometholone acetate ophthalmic suspension | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2284. en:fluorothymidine f-18 --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorothymidine f-18 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2285. en:fluorouracil --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorouracil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2286. en:fluorouracil implant --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorouracil implant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2287. en:fluorouracil-e therapeutic implant --- r_associated #0: 20 --> ipilimumab
    n1=en:fluorouracil-e therapeutic implant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2288. en:fluosol-da --- r_associated #0: 20 --> ipilimumab
    n1=en:fluosol-da | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2289. en:fluoxetine --- r_associated #0: 20 --> ipilimumab
    n1=en:fluoxetine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2290. en:fluoxymesterone --- r_associated #0: 20 --> ipilimumab
    n1=en:fluoxymesterone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2291. en:fluphenazine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:fluphenazine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2292. en:flurbiprofen --- r_associated #0: 20 --> ipilimumab
    n1=en:flurbiprofen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2293. en:flurocitabine --- r_associated #0: 20 --> ipilimumab
    n1=en:flurocitabine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2294. en:flutamide --- r_associated #0: 20 --> ipilimumab
    n1=en:flutamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2295. en:flutemetamol f 18 --- r_associated #0: 20 --> ipilimumab
    n1=en:flutemetamol f 18 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2296. en:fluticasone + vilanterol --- r_associated #0: 20 --> ipilimumab
    n1=en:fluticasone + vilanterol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2297. en:fluticasone propionate --- r_associated #0: 20 --> ipilimumab
    n1=en:fluticasone propionate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2298. en:fluvastatin sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:fluvastatin sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2299. en:fluvoxamine maleate --- r_associated #0: 20 --> ipilimumab
    n1=en:fluvoxamine maleate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2300. en:fluzoparib --- r_associated #0: 20 --> ipilimumab
    n1=en:fluzoparib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2301. en:fms inhibitor jnj-40346527 --- r_associated #0: 20 --> ipilimumab
    n1=en:fms inhibitor jnj-40346527 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2302. en:fms/trk tyrosine kinase inhibitor plx7486 --- r_associated #0: 20 --> ipilimumab
    n1=en:fms/trk tyrosine kinase inhibitor plx7486 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2303. en:folate binding protein e39 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:folate binding protein e39 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2304. en:folate binding protein j65 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:folate binding protein j65 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2305. en:folate receptor alpha-loaded dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:folate receptor alpha-loaded dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2306. en:folate receptor targeted epothilone bms753493 --- r_associated #0: 20 --> ipilimumab
    n1=en:folate receptor targeted epothilone bms753493 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2307. en:folate receptor-targeted technetium tc-99m ec20 --- r_associated #0: 20 --> ipilimumab
    n1=en:folate receptor-targeted technetium tc-99m ec20 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2308. en:folate receptor-targeted tubulysin conjugate ec1456 --- r_associated #0: 20 --> ipilimumab
    n1=en:folate receptor-targeted tubulysin conjugate ec1456 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2309. en:folate receptor-targeted vinca alkaloid ec0489 --- r_associated #0: 20 --> ipilimumab
    n1=en:folate receptor-targeted vinca alkaloid ec0489 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2310. en:folate receptor-targeted vinca alkaloid/mitomycin c ec0225 --- r_associated #0: 20 --> ipilimumab
    n1=en:folate receptor-targeted vinca alkaloid/mitomycin c ec0225 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2311. en:folate-fitc --- r_associated #0: 20 --> ipilimumab
    n1=en:folate-fitc | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2312. en:folfiri regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:folfiri regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2313. en:folfiri-bevacizumab regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:folfiri-bevacizumab regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2314. en:folfiri-cetuximab regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:folfiri-cetuximab regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2315. en:folfirinox regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:folfirinox regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2316. en:folfox regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:folfox regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2317. en:folic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:folic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2318. en:folitixorin --- r_associated #0: 20 --> ipilimumab
    n1=en:folitixorin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2319. en:fondaparinux sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:fondaparinux sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2320. en:foretinib --- r_associated #0: 20 --> ipilimumab
    n1=en:foretinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2321. en:formestane --- r_associated #0: 20 --> ipilimumab
    n1=en:formestane | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2322. en:formoterol fumarate oral --- r_associated #0: 20 --> ipilimumab
    n1=en:formoterol fumarate oral | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2323. en:formoterol fumarate/roxithromycin --- r_associated #0: 20 --> ipilimumab
    n1=en:formoterol fumarate/roxithromycin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2324. en:forodesine --- r_associated #0: 20 --> ipilimumab
    n1=en:forodesine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2325. en:forodesine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:forodesine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2326. en:fosaprepitant dimeglumine --- r_associated #0: 20 --> ipilimumab
    n1=en:fosaprepitant dimeglumine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2327. en:fosbretabulin disodium --- r_associated #0: 20 --> ipilimumab
    n1=en:fosbretabulin disodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2328. en:fosbretabulin tromethamine --- r_associated #0: 20 --> ipilimumab
    n1=en:fosbretabulin tromethamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2329. en:foscarnet sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:foscarnet sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2330. en:fosfestrol --- r_associated #0: 20 --> ipilimumab
    n1=en:fosfestrol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2331. en:fosfomycin tromethamine --- r_associated #0: 20 --> ipilimumab
    n1=en:fosfomycin tromethamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2332. en:fosquidone --- r_associated #0: 20 --> ipilimumab
    n1=en:fosquidone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2333. en:fostamatinib disodium --- r_associated #0: 20 --> ipilimumab
    n1=en:fostamatinib disodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2334. en:fostriecin --- r_associated #0: 20 --> ipilimumab
    n1=en:fostriecin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2335. en:fotemustine --- r_associated #0: 20 --> ipilimumab
    n1=en:fotemustine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2336. en:fowlpox virus vaccine vector --- r_associated #0: 20 --> ipilimumab
    n1=en:fowlpox virus vaccine vector | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2337. en:fowlpox-ny-eso-1 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:fowlpox-ny-eso-1 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2338. en:fowlpox-psa-tricom vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:fowlpox-psa-tricom vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2339. en:freeze-dried black raspberry bioadhesive gel --- r_associated #0: 20 --> ipilimumab
    n1=en:freeze-dried black raspberry bioadhesive gel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2340. en:french maritime pine bark extract --- r_associated #0: 20 --> ipilimumab
    n1=en:french maritime pine bark extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2341. en:fresolimumab --- r_associated #0: 20 --> ipilimumab
    n1=en:fresolimumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2342. en:freund's adjuvant --- r_associated #0: 20 --> ipilimumab
    n1=en:freund's adjuvant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2343. en:fructooligosaccharide supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:fructooligosaccharide supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2344. en:fructooligosaccharide/lactobacillus paracasei/lactobacillus rhamnosus/lactobacillus acidophilus/bifidobacterium lactis probiotic supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:fructooligosaccharide/lactobacillus paracasei/lactobacillus rhamnosus/lactobacillus acidophilus/bifidobacterium lactis probiotic supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2345. en:fruit and vegetable extract --- r_associated #0: 20 --> ipilimumab
    n1=en:fruit and vegetable extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2346. en:fruquintinib --- r_associated #0: 20 --> ipilimumab
    n1=en:fruquintinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2347. en:ft-2102 --- r_associated #0: 20 --> ipilimumab
    n1=en:ft-2102 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2348. en:fu-lv regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:fu-lv regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2349. en:fulranumab --- r_associated #0: 20 --> ipilimumab
    n1=en:fulranumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2350. en:fulvestrant --- r_associated #0: 20 --> ipilimumab
    n1=en:fulvestrant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2351. en:fumagillin-derived polymer conjugate xmt-1107 --- r_associated #0: 20 --> ipilimumab
    n1=en:fumagillin-derived polymer conjugate xmt-1107 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2352. en:furosemide --- r_associated #0: 20 --> ipilimumab
    n1=en:furosemide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2353. en:fursultiamine --- r_associated #0: 20 --> ipilimumab
    n1=en:fursultiamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2354. en:fusidic acid/betamethasone valerate topical cream --- r_associated #0: 20 --> ipilimumab
    n1=en:fusidic acid/betamethasone valerate topical cream | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2355. en:g-quadruplex stabilizer bmvc --- r_associated #0: 20 --> ipilimumab
    n1=en:g-quadruplex stabilizer bmvc | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2356. en:g207 --- r_associated #0: 20 --> ipilimumab
    n1=en:g207 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2357. en:g250 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:g250 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2358. en:ga-68-labeled f(ab') 2- trastuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:ga-68-labeled f(ab') 2- trastuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2359. en:gabapentin --- r_associated #0: 20 --> ipilimumab
    n1=en:gabapentin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2360. en:gabapentin enacarbil --- r_associated #0: 20 --> ipilimumab
    n1=en:gabapentin enacarbil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2361. en:gadobenate dimeglumine --- r_associated #0: 20 --> ipilimumab
    n1=en:gadobenate dimeglumine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2362. en:gadobutrol --- r_associated #0: 20 --> ipilimumab
    n1=en:gadobutrol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2363. en:gadodiamide --- r_associated #0: 20 --> ipilimumab
    n1=en:gadodiamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2364. en:gadofosveset trisodium --- r_associated #0: 20 --> ipilimumab
    n1=en:gadofosveset trisodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2365. en:gadolinium-chelate --- r_associated #0: 20 --> ipilimumab
    n1=en:gadolinium-chelate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2366. en:gadopentetate dimeglumine --- r_associated #0: 20 --> ipilimumab
    n1=en:gadopentetate dimeglumine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2367. en:gadoterate meglumine --- r_associated #0: 20 --> ipilimumab
    n1=en:gadoterate meglumine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2368. en:gadoteridol --- r_associated #0: 20 --> ipilimumab
    n1=en:gadoteridol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2369. en:gadoxetate disodium --- r_associated #0: 20 --> ipilimumab
    n1=en:gadoxetate disodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2370. en:gag:267-274 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:gag:267-274 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2371. en:galactomannan derivative --- r_associated #0: 20 --> ipilimumab
    n1=en:galactomannan derivative | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2372. en:galactose --- r_associated #0: 20 --> ipilimumab
    n1=en:galactose | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2373. en:galantamine hydrobromide --- r_associated #0: 20 --> ipilimumab
    n1=en:galantamine hydrobromide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2374. en:galectin inhibitor gr-md-02 --- r_associated #0: 20 --> ipilimumab
    n1=en:galectin inhibitor gr-md-02 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2375. en:galectin-1 inhibitor otx008 --- r_associated #0: 20 --> ipilimumab
    n1=en:galectin-1 inhibitor otx008 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2376. en:galeterone --- r_associated #0: 20 --> ipilimumab
    n1=en:galeterone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2377. en:galiximab --- r_associated #0: 20 --> ipilimumab
    n1=en:galiximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2378. en:gallium citrate ga-67 --- r_associated #0: 20 --> ipilimumab
    n1=en:gallium citrate ga-67 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2379. en:gallium ga 68 citrate --- r_associated #0: 20 --> ipilimumab
    n1=en:gallium ga 68 citrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2380. en:gallium ga 68 dota-jr11 --- r_associated #0: 20 --> ipilimumab
    n1=en:gallium ga 68 dota-jr11 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2381. en:gallium ga 68 ops202 --- r_associated #0: 20 --> ipilimumab
    n1=en:gallium ga 68 ops202 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2382. en:gallium ga 68-dota-exendin-4 --- r_associated #0: 20 --> ipilimumab
    n1=en:gallium ga 68-dota-exendin-4 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2383. en:gallium ga 68-dotanoc --- r_associated #0: 20 --> ipilimumab
    n1=en:gallium ga 68-dotanoc | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2384. en:gallium ga 68-dotatate --- r_associated #0: 20 --> ipilimumab
    n1=en:gallium ga 68-dotatate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2385. en:gallium ga 68-edotreotide --- r_associated #0: 20 --> ipilimumab
    n1=en:gallium ga 68-edotreotide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2386. en:gallium ga 68-labeled affibody aby-025 --- r_associated #0: 20 --> ipilimumab
    n1=en:gallium ga 68-labeled affibody aby-025 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2387. en:gallium ga 68-labeled bnota-prgd2 --- r_associated #0: 20 --> ipilimumab
    n1=en:gallium ga 68-labeled bnota-prgd2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2388. en:gallium ga 68-labeled dota di-hsg peptide imp-288 --- r_associated #0: 20 --> ipilimumab
    n1=en:gallium ga 68-labeled dota di-hsg peptide imp-288 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2389. en:gallium ga 68-labeled grpr antagonist bay86-7548 --- r_associated #0: 20 --> ipilimumab
    n1=en:gallium ga 68-labeled grpr antagonist bay86-7548 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2390. en:gallium ga 68-labeled mln6907 --- r_associated #0: 20 --> ipilimumab
    n1=en:gallium ga 68-labeled mln6907 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2391. en:gallium ga 68-labeled psma ligand glu-urea-lys(ahx)-hbed-cc --- r_associated #0: 20 --> ipilimumab
    n1=en:gallium ga 68-labeled psma ligand glu-urea-lys(ahx)-hbed-cc | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2392. en:gallium ga 68-labeled-nodaga-mj9 --- r_associated #0: 20 --> ipilimumab
    n1=en:gallium ga 68-labeled-nodaga-mj9 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2393. en:gallium ga 68-neb --- r_associated #0: 20 --> ipilimumab
    n1=en:gallium ga 68-neb | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2394. en:gallium ga 68-nota-aca-bbn(7-14) --- r_associated #0: 20 --> ipilimumab
    n1=en:gallium ga 68-nota-aca-bbn(7-14) | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2395. en:gallium ga 68-nota-ae105 --- r_associated #0: 20 --> ipilimumab
    n1=en:gallium ga 68-nota-ae105 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2396. en:gallium ga 68-nota-bbn(7-14)-rgd --- r_associated #0: 20 --> ipilimumab
    n1=en:gallium ga 68-nota-bbn(7-14)-rgd | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2397. en:gallium ga 68-nota-nfb --- r_associated #0: 20 --> ipilimumab
    n1=en:gallium ga 68-nota-nfb | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2398. en:gallium ga 68-rgd --- r_associated #0: 20 --> ipilimumab
    n1=en:gallium ga 68-rgd | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2399. en:gallium maltolate --- r_associated #0: 20 --> ipilimumab
    n1=en:gallium maltolate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2400. en:gallium nitrate --- r_associated #0: 20 --> ipilimumab
    n1=en:gallium nitrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2401. en:galnac-anti-c5 sirna aln-cc5 --- r_associated #0: 20 --> ipilimumab
    n1=en:galnac-anti-c5 sirna aln-cc5 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2402. en:galunisertib --- r_associated #0: 20 --> ipilimumab
    n1=en:galunisertib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2403. en:gamboge resin extract tsb-9-w1 --- r_associated #0: 20 --> ipilimumab
    n1=en:gamboge resin extract tsb-9-w1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2404. en:gamma secretase inhibitor pf-03084014 --- r_associated #0: 20 --> ipilimumab
    n1=en:gamma secretase inhibitor pf-03084014 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2405. en:gamma-delta tocotrienol --- r_associated #0: 20 --> ipilimumab
    n1=en:gamma-delta tocotrienol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2406. en:gamma-secretase inhibitor ly3039478 --- r_associated #0: 20 --> ipilimumab
    n1=en:gamma-secretase inhibitor ly3039478 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2407. en:gamma-secretase inhibitor ro4929097 --- r_associated #0: 20 --> ipilimumab
    n1=en:gamma-secretase inhibitor ro4929097 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2408. en:ganciclovir --- r_associated #0: 20 --> ipilimumab
    n1=en:ganciclovir | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2409. en:gandotinib --- r_associated #0: 20 --> ipilimumab
    n1=en:gandotinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2410. en:ganetespib --- r_associated #0: 20 --> ipilimumab
    n1=en:ganetespib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2411. en:ganglioside gd2 --- r_associated #0: 20 --> ipilimumab
    n1=en:ganglioside gd2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2412. en:ganglioside gm2 --- r_associated #0: 20 --> ipilimumab
    n1=en:ganglioside gm2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2413. en:ganitumab --- r_associated #0: 20 --> ipilimumab
    n1=en:ganitumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2414. en:ganoderma lucidum spores powder capsule --- r_associated #0: 20 --> ipilimumab
    n1=en:ganoderma lucidum spores powder capsule | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2415. en:garlic extract --- r_associated #0: 20 --> ipilimumab
    n1=en:garlic extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2416. en:gastrin immunotoxin --- r_associated #0: 20 --> ipilimumab
    n1=en:gastrin immunotoxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2417. en:gastroenteral dosage form product --- r_associated #0: 20 --> ipilimumab
    n1=en:gastroenteral dosage form product | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2418. en:gastrointestinal agents --- r_associated #0: 20 --> ipilimumab
    n1=en:gastrointestinal agents | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2419. en:gataparsen sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:gataparsen sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2420. en:gavilimomab --- r_associated #0: 20 --> ipilimumab
    n1=en:gavilimomab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2421. en:gd2 lactone/gd3 lactone-klh conjugate bivalent vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:gd2 lactone/gd3 lactone-klh conjugate bivalent vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2422. en:gd2-car-expressing autologous t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:gd2-car-expressing autologous t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2423. en:gd2-klh vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:gd2-klh vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2424. en:gdc-0349 --- r_associated #0: 20 --> ipilimumab
    n1=en:gdc-0349 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2425. en:gedatolisib --- r_associated #0: 20 --> ipilimumab
    n1=en:gedatolisib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2426. en:gefitinib --- r_associated #0: 20 --> ipilimumab
    n1=en:gefitinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2427. en:gel protein, gelonium multiflorum --- r_associated #0: 20 --> ipilimumab
    n1=en:gel protein, gelonium multiflorum | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2428. en:gelatin --- r_associated #0: 20 --> ipilimumab
    n1=en:gelatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2429. en:gem 231 --- r_associated #0: 20 --> ipilimumab
    n1=en:gem 231 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2430. en:gemcitabine --- r_associated #0: 20 --> ipilimumab
    n1=en:gemcitabine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2431. en:gemcitabine elaidate --- r_associated #0: 20 --> ipilimumab
    n1=en:gemcitabine elaidate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2432. en:gemcitabine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:gemcitabine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2433. en:gemcitabine hydrochloride emulsion --- r_associated #0: 20 --> ipilimumab
    n1=en:gemcitabine hydrochloride emulsion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2434. en:gemcitabine prodrug ly2334737 --- r_associated #0: 20 --> ipilimumab
    n1=en:gemcitabine prodrug ly2334737 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2435. en:gemcitabine-cisplatin regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:gemcitabine-cisplatin regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2436. en:gemcitabine-erlotinib regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:gemcitabine-erlotinib regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2437. en:gemcitabine-oxaliplatin regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:gemcitabine-oxaliplatin regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2438. en:gemcitabine-phosphoramidate hydrochloride nuc-1031 --- r_associated #0: 20 --> ipilimumab
    n1=en:gemcitabine-phosphoramidate hydrochloride nuc-1031 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2439. en:gemfibrozil --- r_associated #0: 20 --> ipilimumab
    n1=en:gemfibrozil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2440. en:gemigliptin --- r_associated #0: 20 --> ipilimumab
    n1=en:gemigliptin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2441. en:gemtuzumab ozogamicin --- r_associated #0: 20 --> ipilimumab
    n1=en:gemtuzumab ozogamicin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2442. en:gene-modified hiv-protected hematopoietic stem cells --- r_associated #0: 20 --> ipilimumab
    n1=en:gene-modified hiv-protected hematopoietic stem cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2443. en:generic drug --- r_associated #0: 20 --> ipilimumab
    n1=en:generic drug | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2444. en:genetically engineered ny-eso-1-specific t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:genetically engineered ny-eso-1-specific t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2445. en:genetically-modified mage-a3-expressing mg1 maraba virus vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:genetically-modified mage-a3-expressing mg1 maraba virus vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2446. en:genistein --- r_associated #0: 20 --> ipilimumab
    n1=en:genistein | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2447. en:genital system agent --- r_associated #0: 20 --> ipilimumab
    n1=en:genital system agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2448. en:gentamicin --- r_associated #0: 20 --> ipilimumab
    n1=en:gentamicin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2449. en:geranylgeranyltransferase i inhibitor --- r_associated #0: 20 --> ipilimumab
    n1=en:geranylgeranyltransferase i inhibitor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2450. en:ghrelin peptide analogue --- r_associated #0: 20 --> ipilimumab
    n1=en:ghrelin peptide analogue | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2451. en:gi-4000 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:gi-4000 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2452. en:gilteritinib --- r_associated #0: 20 --> ipilimumab
    n1=en:gilteritinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2453. en:gimatecan --- r_associated #0: 20 --> ipilimumab
    n1=en:gimatecan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2454. en:gimeracil --- r_associated #0: 20 --> ipilimumab
    n1=en:gimeracil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2455. en:ginger extract --- r_associated #0: 20 --> ipilimumab
    n1=en:ginger extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2456. en:ginseng compound --- r_associated #0: 20 --> ipilimumab
    n1=en:ginseng compound | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2457. en:ginsenoside rg3 capsule --- r_associated #0: 20 --> ipilimumab
    n1=en:ginsenoside rg3 capsule | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2458. en:giracodazole --- r_associated #0: 20 --> ipilimumab
    n1=en:giracodazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2459. en:girentuximab --- r_associated #0: 20 --> ipilimumab
    n1=en:girentuximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2460. en:gitr agonist medi1873 --- r_associated #0: 20 --> ipilimumab
    n1=en:gitr agonist medi1873 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2461. en:gitrl rna-transfected autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:gitrl rna-transfected autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2462. en:givinostat --- r_associated #0: 20 --> ipilimumab
    n1=en:givinostat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2463. en:gk567 --- r_associated #0: 20 --> ipilimumab
    n1=en:gk567 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2464. en:glembatumumab vedotin --- r_associated #0: 20 --> ipilimumab
    n1=en:glembatumumab vedotin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2465. en:glibornuride --- r_associated #0: 20 --> ipilimumab
    n1=en:glibornuride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2466. en:gliclazide --- r_associated #0: 20 --> ipilimumab
    n1=en:gliclazide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2467. en:glimepiride --- r_associated #0: 20 --> ipilimumab
    n1=en:glimepiride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2468. en:glioblastoma cancer vaccine erc1671 --- r_associated #0: 20 --> ipilimumab
    n1=en:glioblastoma cancer vaccine erc1671 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2469. en:glioblastoma multiforme multipeptide vaccine ima950 --- r_associated #0: 20 --> ipilimumab
    n1=en:glioblastoma multiforme multipeptide vaccine ima950 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2470. en:glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:glioma-associated antigen peptide-pulsed autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2471. en:glioma-associated peptide-loaded dendritic cell vaccine sl-701 --- r_associated #0: 20 --> ipilimumab
    n1=en:glioma-associated peptide-loaded dendritic cell vaccine sl-701 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2472. en:glipizide --- r_associated #0: 20 --> ipilimumab
    n1=en:glipizide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2473. en:gliquidone --- r_associated #0: 20 --> ipilimumab
    n1=en:gliquidone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2474. en:glisoxepide --- r_associated #0: 20 --> ipilimumab
    n1=en:glisoxepide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2475. en:globo h-dt vaccine obi-833 --- r_associated #0: 20 --> ipilimumab
    n1=en:globo h-dt vaccine obi-833 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2476. en:globo h-gm2-lewis-y-muc1-32-mer-tf(c)-tn(c)-klh conjugate vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:globo h-gm2-lewis-y-muc1-32-mer-tf(c)-tn(c)-klh conjugate vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2477. en:globo h-klh immunostimulant opt-822 --- r_associated #0: 20 --> ipilimumab
    n1=en:globo h-klh immunostimulant opt-822 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2478. en:globo-h-gm2-lewis-y-muc1-32(aa)-stn(c)-tf(c)-tn(c)-klh conjugate vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:globo-h-gm2-lewis-y-muc1-32(aa)-stn(c)-tf(c)-tn(c)-klh conjugate vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2479. en:globulin component macrophage-activating factor --- r_associated #0: 20 --> ipilimumab
    n1=en:globulin component macrophage-activating factor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2480. en:glse compound --- r_associated #0: 20 --> ipilimumab
    n1=en:glse compound | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2481. en:glucagon --- r_associated #0: 20 --> ipilimumab
    n1=en:glucagon | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2482. en:glucarpidase --- r_associated #0: 20 --> ipilimumab
    n1=en:glucarpidase | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2483. en:glucocorticoid receptor antagonist cort125134 --- r_associated #0: 20 --> ipilimumab
    n1=en:glucocorticoid receptor antagonist cort125134 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2484. en:glucosamine sulfate/chondroitin sulfate tablet --- r_associated #0: 20 --> ipilimumab
    n1=en:glucosamine sulfate/chondroitin sulfate tablet | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2485. en:glucuronic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:glucuronic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2486. en:glufosfamide --- r_associated #0: 20 --> ipilimumab
    n1=en:glufosfamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2487. en:glutamic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:glutamic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2488. en:glutaminase inhibitor cb-839 --- r_associated #0: 20 --> ipilimumab
    n1=en:glutaminase inhibitor cb-839 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2489. en:glutaminase-asparaginase --- r_associated #0: 20 --> ipilimumab
    n1=en:glutaminase-asparaginase | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2490. en:glutamine --- r_associated #0: 20 --> ipilimumab
    n1=en:glutamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2491. en:glutathione --- r_associated #0: 20 --> ipilimumab
    n1=en:glutathione | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2492. en:glutathione disulfide nov-002 --- r_associated #0: 20 --> ipilimumab
    n1=en:glutathione disulfide nov-002 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2493. en:glutathione pegylated liposomal doxorubicin hydrochloride formulation 2b3-101 --- r_associated #0: 20 --> ipilimumab
    n1=en:glutathione pegylated liposomal doxorubicin hydrochloride formulation 2b3-101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2494. en:gluten-free compact nutritional supplement drink --- r_associated #0: 20 --> ipilimumab
    n1=en:gluten-free compact nutritional supplement drink | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2495. en:gluten-free dha/epa/gla/antioxidant-rich nutritional liquid --- r_associated #0: 20 --> ipilimumab
    n1=en:gluten-free dha/epa/gla/antioxidant-rich nutritional liquid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2496. en:gluten-free/fiber-enriched compact nutritional supplement drink --- r_associated #0: 20 --> ipilimumab
    n1=en:gluten-free/fiber-enriched compact nutritional supplement drink | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2497. en:glyburide --- r_associated #0: 20 --> ipilimumab
    n1=en:glyburide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2498. en:glycerin cream (10%) --- r_associated #0: 20 --> ipilimumab
    n1=en:glycerin cream (10%) | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2499. en:glycerin enema --- r_associated #0: 20 --> ipilimumab
    n1=en:glycerin enema | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2500. en:glycine --- r_associated #0: 20 --> ipilimumab
    n1=en:glycine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2501. en:glycooptimized trastuzumab-gex --- r_associated #0: 20 --> ipilimumab
    n1=en:glycooptimized trastuzumab-gex | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2502. en:glycopeptide antibiotic --- r_associated #0: 20 --> ipilimumab
    n1=en:glycopeptide antibiotic | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2503. en:glycopyrrolate --- r_associated #0: 20 --> ipilimumab
    n1=en:glycopyrrolate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2504. en:glycosylated recombinant human g-csf avi-014 --- r_associated #0: 20 --> ipilimumab
    n1=en:glycosylated recombinant human g-csf avi-014 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2505. en:glycosylated recombinant human interleukin-7 --- r_associated #0: 20 --> ipilimumab
    n1=en:glycosylated recombinant human interleukin-7 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2506. en:glycyrrhiza glabra root --- r_associated #0: 20 --> ipilimumab
    n1=en:glycyrrhiza glabra root | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2507. en:glycyrrhizin --- r_associated #0: 20 --> ipilimumab
    n1=en:glycyrrhizin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2508. en:glymidine --- r_associated #0: 20 --> ipilimumab
    n1=en:glymidine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2509. en:glyt2/5ht2a antagonist vvz-149 --- r_associated #0: 20 --> ipilimumab
    n1=en:glyt2/5ht2a antagonist vvz-149 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2510. en:gm-csf-encoding oncolytic adenovirus cgtg-102 --- r_associated #0: 20 --> ipilimumab
    n1=en:gm-csf-encoding oncolytic adenovirus cgtg-102 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2511. en:gm-k562 cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:gm-k562 cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2512. en:gm.cd40l cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:gm.cd40l cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2513. en:gm2-klh vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:gm2-klh vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2514. en:gm2/gd2/gd3 lactone-klh conjugate trivalent vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:gm2/gd2/gd3 lactone-klh conjugate trivalent vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2515. en:gnrh antagonist tak-385 --- r_associated #0: 20 --> ipilimumab
    n1=en:gnrh antagonist tak-385 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2516. en:gold sodium thiomalate --- r_associated #0: 20 --> ipilimumab
    n1=en:gold sodium thiomalate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2517. en:goldenrod --- r_associated #0: 20 --> ipilimumab
    n1=en:goldenrod | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2518. en:golimumab --- r_associated #0: 20 --> ipilimumab
    n1=en:golimumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2519. en:golnerminogene pradenovec --- r_associated #0: 20 --> ipilimumab
    n1=en:golnerminogene pradenovec | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2520. en:golotimod --- r_associated #0: 20 --> ipilimumab
    n1=en:golotimod | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2521. en:golvatinib --- r_associated #0: 20 --> ipilimumab
    n1=en:golvatinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2522. en:gomiliximab --- r_associated #0: 20 --> ipilimumab
    n1=en:gomiliximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2523. en:gonadotropin-releasing hormone analog --- r_associated #0: 20 --> ipilimumab
    n1=en:gonadotropin-releasing hormone analog | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2524. en:goserelin acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:goserelin acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2525. en:gossypol --- r_associated #0: 20 --> ipilimumab
    n1=en:gossypol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2526. en:gout suppressants --- r_associated #0: 20 --> ipilimumab
    n1=en:gout suppressants | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2527. en:gp100 antigen --- r_associated #0: 20 --> ipilimumab
    n1=en:gp100 antigen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2528. en:gp100-fowlpox vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:gp100-fowlpox vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2529. en:gp100:154-162 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:gp100:154-162 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2530. en:gp100:209-217(210m) peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:gp100:209-217(210m) peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2531. en:gp100:280-288(288v) peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:gp100:280-288(288v) peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2532. en:gp2 peptide/gm-csf vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:gp2 peptide/gm-csf vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2533. en:gp2013 --- r_associated #0: 20 --> ipilimumab
    n1=en:gp2013 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2534. en:gp209-2m antigen --- r_associated #0: 20 --> ipilimumab
    n1=en:gp209-2m antigen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2535. en:gp96-secreting allogeneic bladder cancer cell vaccine hs-410 --- r_associated #0: 20 --> ipilimumab
    n1=en:gp96-secreting allogeneic bladder cancer cell vaccine hs-410 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2536. en:gpi 1485 --- r_associated #0: 20 --> ipilimumab
    n1=en:gpi 1485 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2537. en:gpi-0100 --- r_associated #0: 20 --> ipilimumab
    n1=en:gpi-0100 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2538. en:granisetron hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:granisetron hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2539. en:granisetron hydrochloride nasal spray --- r_associated #0: 20 --> ipilimumab
    n1=en:granisetron hydrochloride nasal spray | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2540. en:granisetron transdermal patch --- r_associated #0: 20 --> ipilimumab
    n1=en:granisetron transdermal patch | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2541. en:green tea --- r_associated #0: 20 --> ipilimumab
    n1=en:green tea | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2542. en:green tea extract --- r_associated #0: 20 --> ipilimumab
    n1=en:green tea extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2543. en:green tea extract-based antioxidant supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:green tea extract-based antioxidant supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2544. en:green tea lozenge --- r_associated #0: 20 --> ipilimumab
    n1=en:green tea lozenge | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2545. en:gs/pan-notch inhibitor bms-906024 --- r_associated #0: 20 --> ipilimumab
    n1=en:gs/pan-notch inhibitor bms-906024 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2546. en:gs/pan-notch inhibitor bms-986115 --- r_associated #0: 20 --> ipilimumab
    n1=en:gs/pan-notch inhibitor bms-986115 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2547. en:gsk-3 inhibitor ly2090314 --- r_associated #0: 20 --> ipilimumab
    n1=en:gsk-3 inhibitor ly2090314 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2548. en:gti-2040 --- r_associated #0: 20 --> ipilimumab
    n1=en:gti-2040 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2549. en:guadecitabine --- r_associated #0: 20 --> ipilimumab
    n1=en:guadecitabine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2550. en:guanabenz acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:guanabenz acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2551. en:guanazole --- r_associated #0: 20 --> ipilimumab
    n1=en:guanazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2552. en:guar gum --- r_associated #0: 20 --> ipilimumab
    n1=en:guar gum | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2553. en:guarana supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:guarana supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2554. en:gusperimus trihydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:gusperimus trihydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2555. en:gvax lung cancer vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:gvax lung cancer vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2556. en:gvax pancreatic cancer vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:gvax pancreatic cancer vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2557. en:gvax prostate cancer vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:gvax prostate cancer vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2558. en:h1299 tumor cell lysate vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:h1299 tumor cell lysate vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2559. en:haemophilus influenzae b vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:haemophilus influenzae b vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2560. en:hafnium oxide-containing nanoparticles nbtxr3 --- r_associated #0: 20 --> ipilimumab
    n1=en:hafnium oxide-containing nanoparticles nbtxr3 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2561. en:halofuginone hydrobromide --- r_associated #0: 20 --> ipilimumab
    n1=en:halofuginone hydrobromide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2562. en:halometasone --- r_associated #0: 20 --> ipilimumab
    n1=en:halometasone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2563. en:haloperidol --- r_associated #0: 20 --> ipilimumab
    n1=en:haloperidol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2564. en:harringtonines --- r_associated #0: 20 --> ipilimumab
    n1=en:harringtonines | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2565. en:hcv antigen therapeutic bivalent vaccine v5 --- r_associated #0: 20 --> ipilimumab
    n1=en:hcv antigen therapeutic bivalent vaccine v5 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2566. en:hcv dna vaccine ino-8000 --- r_associated #0: 20 --> ipilimumab
    n1=en:hcv dna vaccine ino-8000 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2567. en:hdac inhibitor 4sc-202 --- r_associated #0: 20 --> ipilimumab
    n1=en:hdac inhibitor 4sc-202 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2568. en:hdac inhibitor acy-241 --- r_associated #0: 20 --> ipilimumab
    n1=en:hdac inhibitor acy-241 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2569. en:hdac inhibitor ar-42 --- r_associated #0: 20 --> ipilimumab
    n1=en:hdac inhibitor ar-42 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2570. en:hdac inhibitor cg200745 --- r_associated #0: 20 --> ipilimumab
    n1=en:hdac inhibitor cg200745 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2571. en:hdac inhibitor chr-2845 --- r_associated #0: 20 --> ipilimumab
    n1=en:hdac inhibitor chr-2845 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2572. en:hdac inhibitor chr-3996 --- r_associated #0: 20 --> ipilimumab
    n1=en:hdac inhibitor chr-3996 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2573. en:hdac inhibitor cxd101 --- r_associated #0: 20 --> ipilimumab
    n1=en:hdac inhibitor cxd101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2574. en:hdac inhibitor mpt0e028 --- r_associated #0: 20 --> ipilimumab
    n1=en:hdac inhibitor mpt0e028 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2575. en:hdac inhibitor obp-801 --- r_associated #0: 20 --> ipilimumab
    n1=en:hdac inhibitor obp-801 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2576. en:hdac inhibitor shp-141 --- r_associated #0: 20 --> ipilimumab
    n1=en:hdac inhibitor shp-141 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2577. en:hdac/egfr/her2 inhibitor cudc-101 --- r_associated #0: 20 --> ipilimumab
    n1=en:hdac/egfr/her2 inhibitor cudc-101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2578. en:hdm2 antagonist jnj-26854165 --- r_associated #0: 20 --> ipilimumab
    n1=en:hdm2 antagonist jnj-26854165 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2579. en:hdm2 inhibitor hdm201 --- r_associated #0: 20 --> ipilimumab
    n1=en:hdm2 inhibitor hdm201 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2580. en:hdm2 inhibitor mk-8242 --- r_associated #0: 20 --> ipilimumab
    n1=en:hdm2 inhibitor mk-8242 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2581. en:heat shock protein inhibitor --- r_associated #0: 20 --> ipilimumab
    n1=en:heat shock protein inhibitor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2582. en:heat-killed mycobacterial product imm-101 --- r_associated #0: 20 --> ipilimumab
    n1=en:heat-killed mycobacterial product imm-101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2583. en:heat-treated varicella-zoster virus vaccine v212 --- r_associated #0: 20 --> ipilimumab
    n1=en:heat-treated varicella-zoster virus vaccine v212 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2584. en:hedgehog inhibitor pf-04449913 --- r_associated #0: 20 --> ipilimumab
    n1=en:hedgehog inhibitor pf-04449913 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2585. en:hematologic agents --- r_associated #0: 20 --> ipilimumab
    n1=en:hematologic agents | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2586. en:hematoporphyrin derivative --- r_associated #0: 20 --> ipilimumab
    n1=en:hematoporphyrin derivative | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2587. en:heme iron polypeptide --- r_associated #0: 20 --> ipilimumab
    n1=en:heme iron polypeptide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2588. en:hemiasterlin analog e7974 --- r_associated #0: 20 --> ipilimumab
    n1=en:hemiasterlin analog e7974 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2589. en:hemorrhoid preparation --- r_associated #0: 20 --> ipilimumab
    n1=en:hemorrhoid preparation | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2590. en:henatinib maleate --- r_associated #0: 20 --> ipilimumab
    n1=en:henatinib maleate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2591. en:heparan sulfate glycosaminoglycan mimetic m402 --- r_associated #0: 20 --> ipilimumab
    n1=en:heparan sulfate glycosaminoglycan mimetic m402 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2592. en:heparan sulfate glycosaminoglycan mimetic nanopolymer mouthwash --- r_associated #0: 20 --> ipilimumab
    n1=en:heparan sulfate glycosaminoglycan mimetic nanopolymer mouthwash | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2593. en:heparin --- r_associated #0: 20 --> ipilimumab
    n1=en:heparin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2594. en:heparin derivative sst0001 --- r_associated #0: 20 --> ipilimumab
    n1=en:heparin derivative sst0001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2595. en:hepatitis a vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hepatitis a vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2596. en:hepatitis b antigen vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hepatitis b antigen vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2597. en:hepatitis b vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hepatitis b vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2598. en:hepsulfam --- r_associated #0: 20 --> ipilimumab
    n1=en:hepsulfam | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2599. en:her-2-neu, cea peptides, gm-csf, montanide isa-51 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:her-2-neu, cea peptides, gm-csf, montanide isa-51 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2600. en:her-2-positive b-cell peptide antigen p467-dt-crm197/montanide vaccine imu-131 --- r_associated #0: 20 --> ipilimumab
    n1=en:her-2-positive b-cell peptide antigen p467-dt-crm197/montanide vaccine imu-131 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2601. en:her-2/neu intracellular domain protein --- r_associated #0: 20 --> ipilimumab
    n1=en:her-2/neu intracellular domain protein | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2602. en:her-2/neu peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:her-2/neu peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2603. en:her2 ecd+tm virus-like replicon particles vaccine avx901 --- r_associated #0: 20 --> ipilimumab
    n1=en:her2 ecd+tm virus-like replicon particles vaccine avx901 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2604. en:her2-pulsed autologous type-1 polarized dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:her2-pulsed autologous type-1 polarized dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2605. en:her2-targeted liposomal doxorubicin hydrochloride mm-302 --- r_associated #0: 20 --> ipilimumab
    n1=en:her2-targeted liposomal doxorubicin hydrochloride mm-302 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2606. en:her2-targeting antibody fc fragment fs102 --- r_associated #0: 20 --> ipilimumab
    n1=en:her2-targeting antibody fc fragment fs102 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2607. en:her2bi-armed activated t cells --- r_associated #0: 20 --> ipilimumab
    n1=en:her2bi-armed activated t cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2608. en:herba scutellaria barbata --- r_associated #0: 20 --> ipilimumab
    n1=en:herba scutellaria barbata | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2609. en:herbal medicine (product) --- r_associated #0: 20 --> ipilimumab
    n1=en:herbal medicine (product) | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2610. en:herbal medicine agent --- r_associated #0: 20 --> ipilimumab
    n1=en:herbal medicine agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2611. en:herbal polysaccharide saliva substitute --- r_associated #0: 20 --> ipilimumab
    n1=en:herbal polysaccharide saliva substitute | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2612. en:herpes zoster vaccine gsk1437173a --- r_associated #0: 20 --> ipilimumab
    n1=en:herpes zoster vaccine gsk1437173a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2613. en:hetastarch --- r_associated #0: 20 --> ipilimumab
    n1=en:hetastarch | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2614. en:heterodimeric interleukin-15 --- r_associated #0: 20 --> ipilimumab
    n1=en:heterodimeric interleukin-15 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2615. en:hexamethylene bisacetamide --- r_associated #0: 20 --> ipilimumab
    n1=en:hexamethylene bisacetamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2616. en:hexaminolevulinate --- r_associated #0: 20 --> ipilimumab
    n1=en:hexaminolevulinate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2617. en:hexaminolevulinate hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:hexaminolevulinate hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2618. en:hif-1alpha inhibitor px-478 --- r_associated #0: 20 --> ipilimumab
    n1=en:hif-1alpha inhibitor px-478 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2619. en:hif-2alpha inhibitor pt2385 --- r_associated #0: 20 --> ipilimumab
    n1=en:hif-2alpha inhibitor pt2385 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2620. en:high-selenium baker's yeast --- r_associated #0: 20 --> ipilimumab
    n1=en:high-selenium baker's yeast | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2621. en:high-selenium brassica juncea --- r_associated #0: 20 --> ipilimumab
    n1=en:high-selenium brassica juncea | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2622. en:high-titer rsv immune globulin ri-001 --- r_associated #0: 20 --> ipilimumab
    n1=en:high-titer rsv immune globulin ri-001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2623. en:highly purified staphylococcal protein a prtx-100 --- r_associated #0: 20 --> ipilimumab
    n1=en:highly purified staphylococcal protein a prtx-100 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2624. en:histamine dihydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:histamine dihydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2625. en:histone-lysine n-methyltransferase ezh2 inhibitor gsk2816126 --- r_associated #0: 20 --> ipilimumab
    n1=en:histone-lysine n-methyltransferase ezh2 inhibitor gsk2816126 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2626. en:histrelin acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:histrelin acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2627. en:hla-a*0201 restricted tert(572y)/tert(572) peptides vaccine vx-001 --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-a*0201 restricted tert(572y)/tert(572) peptides vaccine vx-001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2628. en:hla-a*0201-restricted trp2-gp100-epha2-her2 multipeptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-a*0201-restricted trp2-gp100-epha2-her2 multipeptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2629. en:hla-a*0201-restricted urlc10-vegfr1-vegfr2 multipeptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-a*0201-restricted urlc10-vegfr1-vegfr2 multipeptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2630. en:hla-a*0201-restricted vegfr1 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-a*0201-restricted vegfr1 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2631. en:hla-a*0201-restricted vegfr1-vegfr2 multipeptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-a*0201-restricted vegfr1-vegfr2 multipeptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2632. en:hla-a*2402-restricted cdca1-a24-56 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-a*2402-restricted cdca1-a24-56 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2633. en:hla-a*2402-restricted cdca1-kif20a multipeptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-a*2402-restricted cdca1-kif20a multipeptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2634. en:hla-a*2402-restricted koc1-ttk-co16-depdc1-mphosph1 multipeptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-a*2402-restricted koc1-ttk-co16-depdc1-mphosph1 multipeptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2635. en:hla-a*2402-restricted multipeptide vaccine s-488410 --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-a*2402-restricted multipeptide vaccine s-488410 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2636. en:hla-a*2402-restricted urlc10 peptides vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-a*2402-restricted urlc10 peptides vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2637. en:hla-a*2402-restricted urlc10-cdca1-kif20a multipeptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-a*2402-restricted urlc10-cdca1-kif20a multipeptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2638. en:hla-a*2402-restricted urlc10-cdca1-vegfr1-vegfr2 multipeptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-a*2402-restricted urlc10-cdca1-vegfr1-vegfr2 multipeptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2639. en:hla-a*2402-restricted urlc10-koc1-vegfr1-vegfr2 multipeptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-a*2402-restricted urlc10-koc1-vegfr1-vegfr2 multipeptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2640. en:hla-a*2402-restricted urlc10-ttk-koc1 multipeptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-a*2402-restricted urlc10-ttk-koc1 multipeptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2641. en:hla-a*2402-restricted urlc10-ttk-vegfr1-vegfr2 multipeptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-a*2402-restricted urlc10-ttk-vegfr1-vegfr2 multipeptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2642. en:hla-a*2402-restricted vegfr1 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-a*2402-restricted vegfr1 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2643. en:hla-a*2402-restricted vegfr1/2 multipeptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-a*2402-restricted vegfr1/2 multipeptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2644. en:hla-a*2404-restricted rnf43-tomm34-vegfr1-vegfr2 multipeptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-a*2404-restricted rnf43-tomm34-vegfr1-vegfr2 multipeptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2645. en:hla-a1, a2, b35-restricted survivin peptides/montanide isa-51 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-a1, a2, b35-restricted survivin peptides/montanide isa-51 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2646. en:hla-a1-binding mage-1/mage-3 multipeptide-pulsed autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-a1-binding mage-1/mage-3 multipeptide-pulsed autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2647. en:hla-a2, a3-restricted fgf-5 peptides/montanide isa-51 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-a2, a3-restricted fgf-5 peptides/montanide isa-51 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2648. en:hla-a2-binding tyr/mart-1/gp100 multipeptide-pulsed autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-a2-binding tyr/mart-1/gp100 multipeptide-pulsed autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2649. en:hla-a2-restricted synthetic glioma antigen peptides vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-a2-restricted synthetic glioma antigen peptides vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2650. en:hla-dp0401/0402-restricted mage-a3-reactive t cell receptor-transduced autologous t cells --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-dp0401/0402-restricted mage-a3-reactive t cell receptor-transduced autologous t cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2651. en:hla-matched donor mononuclear cell-enriched leukocytes apocell --- r_associated #0: 20 --> ipilimumab
    n1=en:hla-matched donor mononuclear cell-enriched leukocytes apocell | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2652. en:ho 166 dotmp --- r_associated #0: 20 --> ipilimumab
    n1=en:ho 166 dotmp | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2653. en:ho/02/02 --- r_associated #0: 20 --> ipilimumab
    n1=en:ho/02/02 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2654. en:hodgkin's antigens-gm-csf-expressing cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hodgkin's antigens-gm-csf-expressing cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2655. en:holmium ho 166 poly(l-lactic acid) microspheres --- r_associated #0: 20 --> ipilimumab
    n1=en:holmium ho 166 poly(l-lactic acid) microspheres | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2656. en:homeopathic remedies --- r_associated #0: 20 --> ipilimumab
    n1=en:homeopathic remedies | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2657. en:honey --- r_associated #0: 20 --> ipilimumab
    n1=en:honey | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2658. en:honey-containing mouthwash --- r_associated #0: 20 --> ipilimumab
    n1=en:honey-containing mouthwash | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2659. en:hormone, hormone metabolite, hormone precursor, synthetic hormone substitute, and/or hormone antagonist --- r_associated #0: 20 --> ipilimumab
    n1=en:hormone, hormone metabolite, hormone precursor, synthetic hormone substitute, and/or hormone antagonist | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2660. en:hormones, synthetic substitutes and antagonists --- r_associated #0: 20 --> ipilimumab
    n1=en:hormones, synthetic substitutes and antagonists | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2661. en:host dendritic cell vaccine-001 mssm/biir --- r_associated #0: 20 --> ipilimumab
    n1=en:host dendritic cell vaccine-001 mssm/biir | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2662. en:hpph --- r_associated #0: 20 --> ipilimumab
    n1=en:hpph | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2663. en:hpv 16 e7 antigen-expressing lactobacillis casei vaccine bls-ilb-e710c --- r_associated #0: 20 --> ipilimumab
    n1=en:hpv 16 e7 antigen-expressing lactobacillis casei vaccine bls-ilb-e710c | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2664. en:hpv 16 e7:12-20 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hpv 16 e7:12-20 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2665. en:hpv 16 e7:86-93 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hpv 16 e7:86-93 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2666. en:hpv dna plasmids therapeutic vaccine vgx-3100 --- r_associated #0: 20 --> ipilimumab
    n1=en:hpv dna plasmids therapeutic vaccine vgx-3100 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2667. en:hpv e1/e2 interaction inhibitor gel ap611074 --- r_associated #0: 20 --> ipilimumab
    n1=en:hpv e1/e2 interaction inhibitor gel ap611074 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2668. en:hpv e6/e7 dna vaccine gx-188e --- r_associated #0: 20 --> ipilimumab
    n1=en:hpv e6/e7 dna vaccine gx-188e | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2669. en:hpv-16 e6 peptides vaccine/candida albicans extract --- r_associated #0: 20 --> ipilimumab
    n1=en:hpv-16 e6 peptides vaccine/candida albicans extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2670. en:hpv-6-targeting immunotherapeutic vaccine ino-3106 --- r_associated #0: 20 --> ipilimumab
    n1=en:hpv-6-targeting immunotherapeutic vaccine ino-3106 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2671. en:hpv16 l2/e6/e7 fusion protein vaccine ta-cin --- r_associated #0: 20 --> ipilimumab
    n1=en:hpv16 l2/e6/e7 fusion protein vaccine ta-cin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2672. en:hsp70-peptide tkd/il-2-activated autologous natural killer cells --- r_associated #0: 20 --> ipilimumab
    n1=en:hsp70-peptide tkd/il-2-activated autologous natural killer cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2673. en:hsp90 antagonist kw-2478 --- r_associated #0: 20 --> ipilimumab
    n1=en:hsp90 antagonist kw-2478 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2674. en:hsp90 inhibitor ab-010 --- r_associated #0: 20 --> ipilimumab
    n1=en:hsp90 inhibitor ab-010 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2675. en:hsp90 inhibitor auy922 --- r_associated #0: 20 --> ipilimumab
    n1=en:hsp90 inhibitor auy922 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2676. en:hsp90 inhibitor biib021 --- r_associated #0: 20 --> ipilimumab
    n1=en:hsp90 inhibitor biib021 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2677. en:hsp90 inhibitor biib028 --- r_associated #0: 20 --> ipilimumab
    n1=en:hsp90 inhibitor biib028 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2678. en:hsp90 inhibitor debio 0932 --- r_associated #0: 20 --> ipilimumab
    n1=en:hsp90 inhibitor debio 0932 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2679. en:hsp90 inhibitor ds-2248 --- r_associated #0: 20 --> ipilimumab
    n1=en:hsp90 inhibitor ds-2248 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2680. en:hsp90 inhibitor hsp990 --- r_associated #0: 20 --> ipilimumab
    n1=en:hsp90 inhibitor hsp990 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2681. en:hsp90 inhibitor mpc-3100 --- r_associated #0: 20 --> ipilimumab
    n1=en:hsp90 inhibitor mpc-3100 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2682. en:hsp90 inhibitor pu-h71 --- r_associated #0: 20 --> ipilimumab
    n1=en:hsp90 inhibitor pu-h71 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2683. en:hsp90 inhibitor snx-5542 mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:hsp90 inhibitor snx-5542 mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2684. en:hsp90 inhibitor xl888 --- r_associated #0: 20 --> ipilimumab
    n1=en:hsp90 inhibitor xl888 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2685. en:hsv-1 hf10 --- r_associated #0: 20 --> ipilimumab
    n1=en:hsv-1 hf10 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2686. en:hsv-tk-transduced donor lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:hsv-tk-transduced donor lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2687. en:htert i540/r572y/d988y multipeptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:htert i540/r572y/d988y multipeptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2688. en:htert mrna/survivin peptide-double-loaded autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:htert mrna/survivin peptide-double-loaded autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2689. en:htert multipeptide/montanide isa-51 vg/imiquimod gx 301 --- r_associated #0: 20 --> ipilimumab
    n1=en:htert multipeptide/montanide isa-51 vg/imiquimod gx 301 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2690. en:htert vaccine v934/v935 --- r_associated #0: 20 --> ipilimumab
    n1=en:htert vaccine v934/v935 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2691. en:htert-encoding dna vaccine invac-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:htert-encoding dna vaccine invac-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2692. en:htert-lamp mrna-loaded autologous dendritic cell vaccine grnvac1 --- r_associated #0: 20 --> ipilimumab
    n1=en:htert-lamp mrna-loaded autologous dendritic cell vaccine grnvac1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2693. en:htert/survivin/cmv multipeptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:htert/survivin/cmv multipeptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2694. en:htert/survivin/melanoma tumor cell-derived mrna-transfected dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:htert/survivin/melanoma tumor cell-derived mrna-transfected dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2695. en:hu14.18-il2 fusion protein --- r_associated #0: 20 --> ipilimumab
    n1=en:hu14.18-il2 fusion protein | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2696. en:huachansu --- r_associated #0: 20 --> ipilimumab
    n1=en:huachansu | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2697. en:huaier extract granule --- r_associated #0: 20 --> ipilimumab
    n1=en:huaier extract granule | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2698. en:huang lian --- r_associated #0: 20 --> ipilimumab
    n1=en:huang lian | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2699. en:hubc1-huil12 fusion protein as1409 --- r_associated #0: 20 --> ipilimumab
    n1=en:hubc1-huil12 fusion protein as1409 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2700. en:human combinatorial antibody library-based monoclonal antibody vay736 --- r_associated #0: 20 --> ipilimumab
    n1=en:human combinatorial antibody library-based monoclonal antibody vay736 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2701. en:human gp100 plasmid dna vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:human gp100 plasmid dna vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2702. en:human lactoferrin peptide hlf1-11 --- r_associated #0: 20 --> ipilimumab
    n1=en:human lactoferrin peptide hlf1-11 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2703. en:human menopausal gonadotropin --- r_associated #0: 20 --> ipilimumab
    n1=en:human menopausal gonadotropin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2704. en:human mhc non-restricted cytotoxic t-cell line tall-104 --- r_associated #0: 20 --> ipilimumab
    n1=en:human mhc non-restricted cytotoxic t-cell line tall-104 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2705. en:human monoclonal antibody 216 --- r_associated #0: 20 --> ipilimumab
    n1=en:human monoclonal antibody 216 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2706. en:human monoclonal antibody b11-hcg beta fusion protein cdx-1307 --- r_associated #0: 20 --> ipilimumab
    n1=en:human monoclonal antibody b11-hcg beta fusion protein cdx-1307 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2707. en:human myeloid progenitor cells clt-008 --- r_associated #0: 20 --> ipilimumab
    n1=en:human myeloid progenitor cells clt-008 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2708. en:human papilloma virus l1 virus-like particle v504 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:human papilloma virus l1 virus-like particle v504 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2709. en:human papillomavirus 16/18 l1 virus-like particle/as04 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:human papillomavirus 16/18 l1 virus-like particle/as04 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2710. en:human papillomavirus tumor antigen vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:human papillomavirus tumor antigen vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2711. en:human papillomavirus vaccine v503 --- r_associated #0: 20 --> ipilimumab
    n1=en:human papillomavirus vaccine v503 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2712. en:human prostate-specific membrane antigen plasmid dna vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:human prostate-specific membrane antigen plasmid dna vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2713. en:human trefoil factor 1-secreting lactococcus lactis ag013 --- r_associated #0: 20 --> ipilimumab
    n1=en:human trefoil factor 1-secreting lactococcus lactis ag013 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2714. en:human varicella zoster immune globulin --- r_associated #0: 20 --> ipilimumab
    n1=en:human varicella zoster immune globulin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2715. en:humanized monoclonal antibody 3f8 --- r_associated #0: 20 --> ipilimumab
    n1=en:humanized monoclonal antibody 3f8 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2716. en:hvegf26-104/rfase peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:hvegf26-104/rfase peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2717. en:hyaluronic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:hyaluronic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2718. en:hyaluronic acid-based hydrating vaginal gel --- r_associated #0: 20 --> ipilimumab
    n1=en:hyaluronic acid-based hydrating vaginal gel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2719. en:hyaluronic acid-containing topical cream --- r_associated #0: 20 --> ipilimumab
    n1=en:hyaluronic acid-containing topical cream | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2720. en:hyb2055 --- r_associated #0: 20 --> ipilimumab
    n1=en:hyb2055 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2721. en:hycanthone --- r_associated #0: 20 --> ipilimumab
    n1=en:hycanthone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2722. en:hydralazine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:hydralazine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2723. en:hydrated sodium calcium aluminosilicate --- r_associated #0: 20 --> ipilimumab
    n1=en:hydrated sodium calcium aluminosilicate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2724. en:hydrazine sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:hydrazine sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2725. en:hydrocodone/acetaminophen --- r_associated #0: 20 --> ipilimumab
    n1=en:hydrocodone/acetaminophen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2726. en:hydrocortisone sodium succinate --- r_associated #0: 20 --> ipilimumab
    n1=en:hydrocortisone sodium succinate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2727. en:hydromorphone hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:hydromorphone hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2728. en:hydroxychloroquine --- r_associated #0: 20 --> ipilimumab
    n1=en:hydroxychloroquine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2729. en:hydroxyprogesterone caproate --- r_associated #0: 20 --> ipilimumab
    n1=en:hydroxyprogesterone caproate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2730. en:hydroxytyrosol --- r_associated #0: 20 --> ipilimumab
    n1=en:hydroxytyrosol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2731. en:hydroxyurea --- r_associated #0: 20 --> ipilimumab
    n1=en:hydroxyurea | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2732. en:hyperbaric oxygen --- r_associated #0: 20 --> ipilimumab
    n1=en:hyperbaric oxygen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2733. en:hypercvad regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:hypercvad regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2734. en:hyperglycemic agent --- r_associated #0: 20 --> ipilimumab
    n1=en:hyperglycemic agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2735. en:hyperimmune bovine colostrum --- r_associated #0: 20 --> ipilimumab
    n1=en:hyperimmune bovine colostrum | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2736. en:hyperpolarized carbon c 13 pyruvate --- r_associated #0: 20 --> ipilimumab
    n1=en:hyperpolarized carbon c 13 pyruvate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2737. en:hyperpolarized helium 3 --- r_associated #0: 20 --> ipilimumab
    n1=en:hyperpolarized helium 3 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2738. en:hyperpolarized xenon 129 --- r_associated #0: 20 --> ipilimumab
    n1=en:hyperpolarized xenon 129 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2739. en:hypertonic saline --- r_associated #0: 20 --> ipilimumab
    n1=en:hypertonic saline | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2740. en:hypoglycemic agents --- r_associated #0: 20 --> ipilimumab
    n1=en:hypoglycemic agents | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2741. en:hypoxia-activated prodrug th-302 --- r_associated #0: 20 --> ipilimumab
    n1=en:hypoxia-activated prodrug th-302 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2742. en:hypoxia-activated prodrug th-4000 --- r_associated #0: 20 --> ipilimumab
    n1=en:hypoxia-activated prodrug th-4000 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2743. en:i 123 monoclonal antibody 81c6 --- r_associated #0: 20 --> ipilimumab
    n1=en:i 123 monoclonal antibody 81c6 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2744. en:i 131 antiferritin immunoglobulin --- r_associated #0: 20 --> ipilimumab
    n1=en:i 131 antiferritin immunoglobulin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2745. en:i 131 monoclonal antibody a33 --- r_associated #0: 20 --> ipilimumab
    n1=en:i 131 monoclonal antibody a33 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2746. en:i 131 monoclonal antibody cc49 --- r_associated #0: 20 --> ipilimumab
    n1=en:i 131 monoclonal antibody cc49 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2747. en:i 131 monoclonal antibody f19 --- r_associated #0: 20 --> ipilimumab
    n1=en:i 131 monoclonal antibody f19 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2748. en:i 131 monoclonal antibody lym-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:i 131 monoclonal antibody lym-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2749. en:i [preparations] --- r_associated #0: 20 --> ipilimumab
    n1=en:i [preparations] | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2750. en:i.s.p. lotion --- r_associated #0: 20 --> ipilimumab
    n1=en:i.s.p. lotion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2751. en:iap inhibitor at-406 --- r_associated #0: 20 --> ipilimumab
    n1=en:iap inhibitor at-406 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2752. en:iap inhibitor hgs1029 --- r_associated #0: 20 --> ipilimumab
    n1=en:iap inhibitor hgs1029 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2753. en:iapa-based dendritic cells/cytotoxic t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:iapa-based dendritic cells/cytotoxic t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2754. en:ibandronate --- r_associated #0: 20 --> ipilimumab
    n1=en:ibandronate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2755. en:ibandronate sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:ibandronate sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2756. en:ibogaine --- r_associated #0: 20 --> ipilimumab
    n1=en:ibogaine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2757. en:ibritumomab --- r_associated #0: 20 --> ipilimumab
    n1=en:ibritumomab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2758. en:ibritumomab tiuxetan --- r_associated #0: 20 --> ipilimumab
    n1=en:ibritumomab tiuxetan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2759. en:ibrutinib --- r_associated #0: 20 --> ipilimumab
    n1=en:ibrutinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2760. en:ibuprofen --- r_associated #0: 20 --> ipilimumab
    n1=en:ibuprofen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2761. en:ibuprofen + pseudoephedrine --- r_associated #0: 20 --> ipilimumab
    n1=en:ibuprofen + pseudoephedrine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2762. en:ibuprofen / phenylephrine --- r_associated #0: 20 --> ipilimumab
    n1=en:ibuprofen / phenylephrine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2763. en:ibuprofen injection --- r_associated #0: 20 --> ipilimumab
    n1=en:ibuprofen injection | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2764. en:ibutilide --- r_associated #0: 20 --> ipilimumab
    n1=en:ibutilide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2765. en:ic9-gd2-cd28-ox40-expressing t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:ic9-gd2-cd28-ox40-expressing t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2766. en:icatibant --- r_associated #0: 20 --> ipilimumab
    n1=en:icatibant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2767. en:ice mint --- r_associated #0: 20 --> ipilimumab
    n1=en:ice mint | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2768. en:ice regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:ice regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2769. en:ichthammol --- r_associated #0: 20 --> ipilimumab
    n1=en:ichthammol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2770. en:ichthammol/lanolin/petrolatum --- r_associated #0: 20 --> ipilimumab
    n1=en:ichthammol/lanolin/petrolatum | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2771. en:icodextrin --- r_associated #0: 20 --> ipilimumab
    n1=en:icodextrin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2772. en:icodextrin solution --- r_associated #0: 20 --> ipilimumab
    n1=en:icodextrin solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2773. en:icotinib hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:icotinib hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2774. en:icrucumab --- r_associated #0: 20 --> ipilimumab
    n1=en:icrucumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2775. en:idarubicin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:idarubicin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2776. en:idarubicin-eluting beads --- r_associated #0: 20 --> ipilimumab
    n1=en:idarubicin-eluting beads | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2777. en:idarucizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:idarucizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2778. en:idasanutlin --- r_associated #0: 20 --> ipilimumab
    n1=en:idasanutlin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2779. en:idelalisib --- r_associated #0: 20 --> ipilimumab
    n1=en:idelalisib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2780. en:idh1 inhibitor ag-120 --- r_associated #0: 20 --> ipilimumab
    n1=en:idh1 inhibitor ag-120 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2781. en:idh1(r132) inhibitor idh305 --- r_associated #0: 20 --> ipilimumab
    n1=en:idh1(r132) inhibitor idh305 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2782. en:idh1r132h mutation-targeting idh1 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:idh1r132h mutation-targeting idh1 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2783. en:idh1r132h-specific peptide vaccine pepidh1m --- r_associated #0: 20 --> ipilimumab
    n1=en:idh1r132h-specific peptide vaccine pepidh1m | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2784. en:idh2 inhibitor ag-221 --- r_associated #0: 20 --> ipilimumab
    n1=en:idh2 inhibitor ag-221 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2785. en:idiotype-pulsed autologous dendritic cell vaccine apc8020 --- r_associated #0: 20 --> ipilimumab
    n1=en:idiotype-pulsed autologous dendritic cell vaccine apc8020 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2786. en:ido inhibitor nlg919 --- r_associated #0: 20 --> ipilimumab
    n1=en:ido inhibitor nlg919 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2787. en:idoxifene --- r_associated #0: 20 --> ipilimumab
    n1=en:idoxifene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2788. en:idoxuridine --- r_associated #0: 20 --> ipilimumab
    n1=en:idoxuridine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2789. en:idronoxil --- r_associated #0: 20 --> ipilimumab
    n1=en:idronoxil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2790. en:idursulfase --- r_associated #0: 20 --> ipilimumab
    n1=en:idursulfase | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2791. en:ifosfamide --- r_associated #0: 20 --> ipilimumab
    n1=en:ifosfamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2792. en:ifosfamide / mesna --- r_associated #0: 20 --> ipilimumab
    n1=en:ifosfamide / mesna | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2793. en:igf ligand neutralizing antibody bi 836845 --- r_associated #0: 20 --> ipilimumab
    n1=en:igf ligand neutralizing antibody bi 836845 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2794. en:igf-1r antisense oligodeoxynucleotide-treated autologous glioma cells --- r_associated #0: 20 --> ipilimumab
    n1=en:igf-1r antisense oligodeoxynucleotide-treated autologous glioma cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2795. en:igf-1r inhibitor pl225b --- r_associated #0: 20 --> ipilimumab
    n1=en:igf-1r inhibitor pl225b | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2796. en:igf-1r/ir inhibitor kw-2450 --- r_associated #0: 20 --> ipilimumab
    n1=en:igf-1r/ir inhibitor kw-2450 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2797. en:igf-methotrexate conjugate --- r_associated #0: 20 --> ipilimumab
    n1=en:igf-methotrexate conjugate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2798. en:ih636 grape seed proanthocyanidin extract --- r_associated #0: 20 --> ipilimumab
    n1=en:ih636 grape seed proanthocyanidin extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2799. en:il-10 immunomodulator mk-1966 --- r_associated #0: 20 --> ipilimumab
    n1=en:il-10 immunomodulator mk-1966 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2800. en:il-12-expressing hsv-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:il-12-expressing hsv-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2801. en:il-12-expressing mesenchymal stem cell vaccine gx-051 --- r_associated #0: 20 --> ipilimumab
    n1=en:il-12-expressing mesenchymal stem cell vaccine gx-051 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2802. en:il-2 plasmid dna/lipid complex --- r_associated #0: 20 --> ipilimumab
    n1=en:il-2 plasmid dna/lipid complex | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2803. en:il-2 recombinant fusion protein alt-801 --- r_associated #0: 20 --> ipilimumab
    n1=en:il-2 recombinant fusion protein alt-801 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2804. en:il-2/lptn gene-modified allogeneic neuroblastoma tumor cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:il-2/lptn gene-modified allogeneic neuroblastoma tumor cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2805. en:il13ralpha2-specific hinge-optimized 41bb-co-stimulatory car truncated cd19-expressing autologous t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:il13ralpha2-specific hinge-optimized 41bb-co-stimulatory car truncated cd19-expressing autologous t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2806. en:il4-pseudomonas exotoxin fusion protein prx321 --- r_associated #0: 20 --> ipilimumab
    n1=en:il4-pseudomonas exotoxin fusion protein prx321 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2807. en:ilaprazole --- r_associated #0: 20 --> ipilimumab
    n1=en:ilaprazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2808. en:iloperidone --- r_associated #0: 20 --> ipilimumab
    n1=en:iloperidone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2809. en:iloprost --- r_associated #0: 20 --> ipilimumab
    n1=en:iloprost | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2810. en:ilorasertib --- r_associated #0: 20 --> ipilimumab
    n1=en:ilorasertib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2811. en:ilx-295501 --- r_associated #0: 20 --> ipilimumab
    n1=en:ilx-295501 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2812. en:ilx23-7553 --- r_associated #0: 20 --> ipilimumab
    n1=en:ilx23-7553 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2813. en:imalumab --- r_associated #0: 20 --> ipilimumab
    n1=en:imalumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2814. en:imatinib --- r_associated #0: 20 --> ipilimumab
    n1=en:imatinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2815. en:imatinib mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:imatinib mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2816. en:imetelstat sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:imetelstat sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2817. en:imexon --- r_associated #0: 20 --> ipilimumab
    n1=en:imexon | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2818. en:imidazole mustard --- r_associated #0: 20 --> ipilimumab
    n1=en:imidazole mustard | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2819. en:imidazolidinyl urea/paraben/mineral oil/petrolatum --- r_associated #0: 20 --> ipilimumab
    n1=en:imidazolidinyl urea/paraben/mineral oil/petrolatum | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2820. en:imidazolyl ethanamide pentandioic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:imidazolyl ethanamide pentandioic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2821. en:imiglucerase --- r_associated #0: 20 --> ipilimumab
    n1=en:imiglucerase | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2822. en:imipenem --- r_associated #0: 20 --> ipilimumab
    n1=en:imipenem | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2823. en:imipenem-cilastatin sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:imipenem-cilastatin sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2824. en:imipramine --- r_associated #0: 20 --> ipilimumab
    n1=en:imipramine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2825. en:imiquimod --- r_associated #0: 20 --> ipilimumab
    n1=en:imiquimod | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2826. en:imisopasem manganese --- r_associated #0: 20 --> ipilimumab
    n1=en:imisopasem manganese | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2827. en:immediate-release onapristone --- r_associated #0: 20 --> ipilimumab
    n1=en:immediate-release onapristone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2828. en:immediate-release oral liquid formulation oxymorphone hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:immediate-release oral liquid formulation oxymorphone hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2829. en:immediate-release tablet afuresertib --- r_associated #0: 20 --> ipilimumab
    n1=en:immediate-release tablet afuresertib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2830. en:immunoadjuvant qs-dg --- r_associated #0: 20 --> ipilimumab
    n1=en:immunoadjuvant qs-dg | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2831. en:immunoconjugate ro5479599 --- r_associated #0: 20 --> ipilimumab
    n1=en:immunoconjugate ro5479599 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2832. en:immunocytokine nhs-il12 --- r_associated #0: 20 --> ipilimumab
    n1=en:immunocytokine nhs-il12 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2833. en:immunocytokine nhs-il2-lt --- r_associated #0: 20 --> ipilimumab
    n1=en:immunocytokine nhs-il2-lt | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2834. en:immunomodulating agent --- r_associated #0: 20 --> ipilimumab
    n1=en:immunomodulating agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2835. en:immunomodulator ohr/avr118 --- r_associated #0: 20 --> ipilimumab
    n1=en:immunomodulator ohr/avr118 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2836. en:immunomodulators --- r_associated #0: 20 --> ipilimumab
    n1=en:immunomodulators | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2837. en:immunomodulatory agent cc-11006 --- r_associated #0: 20 --> ipilimumab
    n1=en:immunomodulatory agent cc-11006 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2838. en:immunopotentiation --- r_associated #0: 20 --> ipilimumab
    n1=en:immunopotentiation | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2839. en:immunotherapeutic agent --- r_associated #0: 20 --> ipilimumab
    n1=en:immunotherapeutic agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2840. en:immunotherapeutic combination product cmb305 --- r_associated #0: 20 --> ipilimumab
    n1=en:immunotherapeutic combination product cmb305 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2841. en:immunotherapeutic gsk1572932a --- r_associated #0: 20 --> ipilimumab
    n1=en:immunotherapeutic gsk1572932a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2842. en:immunotherapy regimen mkc-1106-mt --- r_associated #0: 20 --> ipilimumab
    n1=en:immunotherapy regimen mkc-1106-mt | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2843. en:immunotoxin cmd-193 --- r_associated #0: 20 --> ipilimumab
    n1=en:immunotoxin cmd-193 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2844. en:immunotoxin d2c7-(scdsfv)-pe38kdel --- r_associated #0: 20 --> ipilimumab
    n1=en:immunotoxin d2c7-(scdsfv)-pe38kdel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2845. en:imp321 --- r_associated #0: 20 --> ipilimumab
    n1=en:imp321 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2846. en:imreg-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:imreg-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2847. en:imt-1012 immunotherapeutic vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:imt-1012 immunotherapeutic vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2848. en:imuvert --- r_associated #0: 20 --> ipilimumab
    n1=en:imuvert | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2849. en:in 111 folic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:in 111 folic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2850. en:in 111 monoclonal antibody b3 --- r_associated #0: 20 --> ipilimumab
    n1=en:in 111 monoclonal antibody b3 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2851. en:in 111 monoclonal antibody hu3s193 --- r_associated #0: 20 --> ipilimumab
    n1=en:in 111 monoclonal antibody hu3s193 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2852. en:in 111 monoclonal antibody ll2 --- r_associated #0: 20 --> ipilimumab
    n1=en:in 111 monoclonal antibody ll2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2853. en:in 111 monoclonal antibody lym-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:in 111 monoclonal antibody lym-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2854. en:in 111 monoclonal antibody m170 --- r_associated #0: 20 --> ipilimumab
    n1=en:in 111 monoclonal antibody m170 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2855. en:in 111 monoclonal antibody mn-14 --- r_associated #0: 20 --> ipilimumab
    n1=en:in 111 monoclonal antibody mn-14 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2856. en:in 111 satumomab pendetide --- r_associated #0: 20 --> ipilimumab
    n1=en:in 111 satumomab pendetide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2857. en:inactivated poliovirus vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:inactivated poliovirus vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2858. en:inalimarev --- r_associated #0: 20 --> ipilimumab
    n1=en:inalimarev | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2859. en:inamrinone --- r_associated #0: 20 --> ipilimumab
    n1=en:inamrinone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2860. en:incomplete freund's adjuvant --- r_associated #0: 20 --> ipilimumab
    n1=en:incomplete freund's adjuvant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2861. en:incyclinide --- r_associated #0: 20 --> ipilimumab
    n1=en:incyclinide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2862. en:indacaterol --- r_associated #0: 20 --> ipilimumab
    n1=en:indacaterol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2863. en:indibulin --- r_associated #0: 20 --> ipilimumab
    n1=en:indibulin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2864. en:indicine-n-oxide --- r_associated #0: 20 --> ipilimumab
    n1=en:indicine-n-oxide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2865. en:indinavir --- r_associated #0: 20 --> ipilimumab
    n1=en:indinavir | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2866. en:indinavir sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:indinavir sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2867. en:indisulam --- r_associated #0: 20 --> ipilimumab
    n1=en:indisulam | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2868. en:indium in 111 anti-cd45 monoclonal antibody bc8 --- r_associated #0: 20 --> ipilimumab
    n1=en:indium in 111 anti-cd45 monoclonal antibody bc8 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2869. en:indium in 111 anti-egfr monoclonal antibody abt-806 --- r_associated #0: 20 --> ipilimumab
    n1=en:indium in 111 anti-egfr monoclonal antibody abt-806 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2870. en:indium in 111 bevacizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:indium in 111 bevacizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2871. en:indium in 111 capromab pendetide --- r_associated #0: 20 --> ipilimumab
    n1=en:indium in 111 capromab pendetide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2872. en:indium in 111 chimeric monoclonal antibody 806 --- r_associated #0: 20 --> ipilimumab
    n1=en:indium in 111 chimeric monoclonal antibody 806 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2873. en:indium in 111 chx-a dtpa trastuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:indium in 111 chx-a dtpa trastuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2874. en:indium in 111 girentuximab --- r_associated #0: 20 --> ipilimumab
    n1=en:indium in 111 girentuximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2875. en:indium in 111 her2-specific high-affinity protein aby-025 --- r_associated #0: 20 --> ipilimumab
    n1=en:indium in 111 her2-specific high-affinity protein aby-025 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2876. en:indium in 111 monoclonal antibody bre-3 --- r_associated #0: 20 --> ipilimumab
    n1=en:indium in 111 monoclonal antibody bre-3 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2877. en:indium in 111 monoclonal antibody hupam4 --- r_associated #0: 20 --> ipilimumab
    n1=en:indium in 111 monoclonal antibody hupam4 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2878. en:indium in 111 pentetate --- r_associated #0: 20 --> ipilimumab
    n1=en:indium in 111 pentetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2879. en:indium in 111 pertuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:indium in 111 pertuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2880. en:indium in 111-cmd-193 --- r_associated #0: 20 --> ipilimumab
    n1=en:indium in 111-cmd-193 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2881. en:indium in 111-dota-biotin --- r_associated #0: 20 --> ipilimumab
    n1=en:indium in 111-dota-biotin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2882. en:indium in 111-dota-di-hsg peptide imp-288 --- r_associated #0: 20 --> ipilimumab
    n1=en:indium in 111-dota-di-hsg peptide imp-288 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2883. en:indium in 111-dota-exendin-4 --- r_associated #0: 20 --> ipilimumab
    n1=en:indium in 111-dota-exendin-4 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2884. en:indium in 111-labeled autologous peripheral blood mononuclear cells --- r_associated #0: 20 --> ipilimumab
    n1=en:indium in 111-labeled autologous peripheral blood mononuclear cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2885. en:indium in 111-labeled autologous polymorphonuclear leukocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:indium in 111-labeled autologous polymorphonuclear leukocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2886. en:indium in 111-labeled macroaggregated albumin --- r_associated #0: 20 --> ipilimumab
    n1=en:indium in 111-labeled macroaggregated albumin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2887. en:indium in 111/yttrium y90-dota-biotin --- r_associated #0: 20 --> ipilimumab
    n1=en:indium in 111/yttrium y90-dota-biotin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2888. en:indium in-111 --- r_associated #0: 20 --> ipilimumab
    n1=en:indium in-111 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2889. en:indium in-111 ibritumomab tiuxetan --- r_associated #0: 20 --> ipilimumab
    n1=en:indium in-111 ibritumomab tiuxetan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2890. en:indium in-111 pentetreotide --- r_associated #0: 20 --> ipilimumab
    n1=en:indium in-111 pentetreotide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2891. en:indocyanine green solution --- r_associated #0: 20 --> ipilimumab
    n1=en:indocyanine green solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2892. en:indocyanine green/albumin solution --- r_associated #0: 20 --> ipilimumab
    n1=en:indocyanine green/albumin solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2893. en:indole-3-carbinol --- r_associated #0: 20 --> ipilimumab
    n1=en:indole-3-carbinol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2894. en:indole-3-carbinol/calcium/schizandra/vitamin d3/milk thistle/stinging nettle/lignan-based nutritional capsule --- r_associated #0: 20 --> ipilimumab
    n1=en:indole-3-carbinol/calcium/schizandra/vitamin d3/milk thistle/stinging nettle/lignan-based nutritional capsule | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2895. en:indoleamine 2,3-dioxygenase peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:indoleamine 2,3-dioxygenase peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2896. en:indomethacin --- r_associated #0: 20 --> ipilimumab
    n1=en:indomethacin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2897. en:indoximod --- r_associated #0: 20 --> ipilimumab
    n1=en:indoximod | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2898. en:inducible cd4+cd25+ regulatory t cells --- r_associated #0: 20 --> ipilimumab
    n1=en:inducible cd4+cd25+ regulatory t cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2899. en:inecalcitol --- r_associated #0: 20 --> ipilimumab
    n1=en:inecalcitol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2900. en:infliximab --- r_associated #0: 20 --> ipilimumab
    n1=en:infliximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2901. en:influenza virus vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:influenza virus vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2902. en:information --- r_associated #0: 20 --> ipilimumab
    n1=en:information | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2903. en:ingenol --- r_associated #0: 20 --> ipilimumab
    n1=en:ingenol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2904. en:ingenol derivative leo 43204 gel --- r_associated #0: 20 --> ipilimumab
    n1=en:ingenol derivative leo 43204 gel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2905. en:ingenol mebutate --- r_associated #0: 20 --> ipilimumab
    n1=en:ingenol mebutate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2906. en:ingenol mebutate gel --- r_associated #0: 20 --> ipilimumab
    n1=en:ingenol mebutate gel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2907. en:iniparib --- r_associated #0: 20 --> ipilimumab
    n1=en:iniparib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2908. en:injectable astragalus membranaceus polysaccharide --- r_associated #0: 20 --> ipilimumab
    n1=en:injectable astragalus membranaceus polysaccharide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2909. en:injectable liposomal vinorelbine --- r_associated #0: 20 --> ipilimumab
    n1=en:injectable liposomal vinorelbine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2910. en:innate defense regulator sgx942 --- r_associated #0: 20 --> ipilimumab
    n1=en:innate defense regulator sgx942 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2911. en:innate immunostimulator rbbx-01 --- r_associated #0: 20 --> ipilimumab
    n1=en:innate immunostimulator rbbx-01 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2912. en:ino-1001 --- r_associated #0: 20 --> ipilimumab
    n1=en:ino-1001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2913. en:inosine 5'-monophosphate dehydrogenase inhibitor ff-10501-01 --- r_associated #0: 20 --> ipilimumab
    n1=en:inosine 5'-monophosphate dehydrogenase inhibitor ff-10501-01 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2914. en:inosine dialdehyde --- r_associated #0: 20 --> ipilimumab
    n1=en:inosine dialdehyde | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2915. en:inosine pranobex --- r_associated #0: 20 --> ipilimumab
    n1=en:inosine pranobex | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2916. en:inositol --- r_associated #0: 20 --> ipilimumab
    n1=en:inositol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2917. en:inotropic agent --- r_associated #0: 20 --> ipilimumab
    n1=en:inotropic agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2918. en:inotuzumab ozogamicin --- r_associated #0: 20 --> ipilimumab
    n1=en:inotuzumab ozogamicin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2919. en:inpact --- r_associated #0: 20 --> ipilimumab
    n1=en:inpact | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2920. en:inproquone --- r_associated #0: 20 --> ipilimumab
    n1=en:inproquone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2921. en:ins316 --- r_associated #0: 20 --> ipilimumab
    n1=en:ins316 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2922. en:insect extract --- r_associated #0: 20 --> ipilimumab
    n1=en:insect extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2923. en:insulin aspart --- r_associated #0: 20 --> ipilimumab
    n1=en:insulin aspart | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2924. en:insulin degludec --- r_associated #0: 20 --> ipilimumab
    n1=en:insulin degludec | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2925. en:insulin glargine --- r_associated #0: 20 --> ipilimumab
    n1=en:insulin glargine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2926. en:insulin lispro --- r_associated #0: 20 --> ipilimumab
    n1=en:insulin lispro | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2927. en:insulin sensitizer s-707106 --- r_associated #0: 20 --> ipilimumab
    n1=en:insulin sensitizer s-707106 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2928. en:insulin, nph --- r_associated #0: 20 --> ipilimumab
    n1=en:insulin, nph | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2929. en:insulin, regular --- r_associated #0: 20 --> ipilimumab
    n1=en:insulin, regular | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2930. en:integrin receptor antagonist glpg0187 --- r_associated #0: 20 --> ipilimumab
    n1=en:integrin receptor antagonist glpg0187 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2931. en:interferon alfa-n3 --- r_associated #0: 20 --> ipilimumab
    n1=en:interferon alfa-n3 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2932. en:interferon alfacon-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:interferon alfacon-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2933. en:interferon beta-1a --- r_associated #0: 20 --> ipilimumab
    n1=en:interferon beta-1a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2934. en:interferon beta-1b --- r_associated #0: 20 --> ipilimumab
    n1=en:interferon beta-1b | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2935. en:interferon beta-secreting mesenchymal stem cells --- r_associated #0: 20 --> ipilimumab
    n1=en:interferon beta-secreting mesenchymal stem cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2936. en:interferon-gamma-expressing adenovirus vaccine asn-002 --- r_associated #0: 20 --> ipilimumab
    n1=en:interferon-gamma-expressing adenovirus vaccine asn-002 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2937. en:interleukin-10 --- r_associated #0: 20 --> ipilimumab
    n1=en:interleukin-10 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2938. en:interleukin-12 gene --- r_associated #0: 20 --> ipilimumab
    n1=en:interleukin-12 gene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2939. en:interleukin-2 fusion protein msb0010445 --- r_associated #0: 20 --> ipilimumab
    n1=en:interleukin-2 fusion protein msb0010445 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2940. en:interleukin-2 gene --- r_associated #0: 20 --> ipilimumab
    n1=en:interleukin-2 gene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2941. en:interleukin-2 liposome --- r_associated #0: 20 --> ipilimumab
    n1=en:interleukin-2 liposome | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2942. en:interleukin-4 pe38kdel immunotoxin --- r_associated #0: 20 --> ipilimumab
    n1=en:interleukin-4 pe38kdel immunotoxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2943. en:interleukin-6 --- r_associated #0: 20 --> ipilimumab
    n1=en:interleukin-6 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2944. en:intermediate-affinity interleukin-2 receptor agonist alks 4230 --- r_associated #0: 20 --> ipilimumab
    n1=en:intermediate-affinity interleukin-2 receptor agonist alks 4230 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2945. en:intetumumab --- r_associated #0: 20 --> ipilimumab
    n1=en:intetumumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2946. en:intiquinatine --- r_associated #0: 20 --> ipilimumab
    n1=en:intiquinatine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2947. en:intoplicine --- r_associated #0: 20 --> ipilimumab
    n1=en:intoplicine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2948. en:intranasal ketamine --- r_associated #0: 20 --> ipilimumab
    n1=en:intranasal ketamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2949. en:intravesical bcg --- r_associated #0: 20 --> ipilimumab
    n1=en:intravesical bcg | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2950. en:intrinsic factor --- r_associated #0: 20 --> ipilimumab
    n1=en:intrinsic factor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2951. en:intrinsic factor/iron/liver/multivitamins --- r_associated #0: 20 --> ipilimumab
    n1=en:intrinsic factor/iron/liver/multivitamins | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2952. en:intrinsic factor/iron/multivitamins --- r_associated #0: 20 --> ipilimumab
    n1=en:intrinsic factor/iron/multivitamins | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2953. en:intrinsic factor/minerals/multivitamins --- r_associated #0: 20 --> ipilimumab
    n1=en:intrinsic factor/minerals/multivitamins | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2954. en:introlite --- r_associated #0: 20 --> ipilimumab
    n1=en:introlite | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2955. en:inulin --- r_associated #0: 20 --> ipilimumab
    n1=en:inulin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2956. en:invert sugar --- r_associated #0: 20 --> ipilimumab
    n1=en:invert sugar | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2957. en:invert sugar/potassium chloride/sodium chloride --- r_associated #0: 20 --> ipilimumab
    n1=en:invert sugar/potassium chloride/sodium chloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2958. en:investigational new drug --- r_associated #0: 20 --> ipilimumab
    n1=en:investigational new drug | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2959. en:iobenguane --- r_associated #0: 20 --> ipilimumab
    n1=en:iobenguane | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2960. en:iobenguane i-124 --- r_associated #0: 20 --> ipilimumab
    n1=en:iobenguane i-124 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2961. en:iobenguane i-131 --- r_associated #0: 20 --> ipilimumab
    n1=en:iobenguane i-131 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2962. en:iobenguane sulfate i-123 --- r_associated #0: 20 --> ipilimumab
    n1=en:iobenguane sulfate i-123 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2963. en:iobitridol --- r_associated #0: 20 --> ipilimumab
    n1=en:iobitridol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2964. en:iocetamic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:iocetamic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2965. en:iodamide meglumine --- r_associated #0: 20 --> ipilimumab
    n1=en:iodamide meglumine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2966. en:iodinated contrast agent --- r_associated #0: 20 --> ipilimumab
    n1=en:iodinated contrast agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2967. en:iodine --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2968. en:iodine / potassium iodide / zinc phenolsulfonate --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine / potassium iodide / zinc phenolsulfonate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2969. en:iodine / sodium iodide --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine / sodium iodide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2970. en:iodine 131-6-beta-iodomethyl-19-norcholesterol --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine 131-6-beta-iodomethyl-19-norcholesterol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2971. en:iodine compounds --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine compounds | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2972. en:iodine i 123 anti-cea recombinant diabody t84.66 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 123 anti-cea recombinant diabody t84.66 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2973. en:iodine i 123 iodobenzamide --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 123 iodobenzamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2974. en:iodine i 124 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 124 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2975. en:iodine i 124 anti-phosphatidylserine monoclonal antibody pgn650 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 124 anti-phosphatidylserine monoclonal antibody pgn650 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2976. en:iodine i 124 cpd-1028 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 124 cpd-1028 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2977. en:iodine i 124 iododeoxyuridine --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 124 iododeoxyuridine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2978. en:iodine i 124 monoclonal antibody 3f8 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 124 monoclonal antibody 3f8 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2979. en:iodine i 124 monoclonal antibody 8h9 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 124 monoclonal antibody 8h9 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2980. en:iodine i 124 monoclonal antibody a33 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 124 monoclonal antibody a33 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2981. en:iodine i 124 nm404 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 124 nm404 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2982. en:iodine i 124 phospholipid ether analogue clr1404 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 124 phospholipid ether analogue clr1404 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2983. en:iodine i 124 pu-ad --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 124 pu-ad | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2984. en:iodine i 124-crgdy-peg-c dots --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 124-crgdy-peg-c dots | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2985. en:iodine i 124-iodo-azomycin galactopyranoside --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 124-iodo-azomycin galactopyranoside | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2986. en:iodine i 124-labeled anti-psca a11 minibody --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 124-labeled anti-psca a11 minibody | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2987. en:iodine i 124-labeled hsp90 inhibitor puh71 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 124-labeled hsp90 inhibitor puh71 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2988. en:iodine i 125-anti-egfr-425 monoclonal antibody --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 125-anti-egfr-425 monoclonal antibody | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2989. en:iodine i 131 anti-fibronectin antibody fragment l19-sip --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 131 anti-fibronectin antibody fragment l19-sip | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2990. en:iodine i 131 ethiodized oil --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 131 ethiodized oil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2991. en:iodine i 131 monoclonal antibody 3f8 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 131 monoclonal antibody 3f8 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2992. en:iodine i 131 monoclonal antibody 81c6 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 131 monoclonal antibody 81c6 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2993. en:iodine i 131 monoclonal antibody 8h9 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 131 monoclonal antibody 8h9 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2994. en:iodine i 131 monoclonal antibody bc8 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 131 monoclonal antibody bc8 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2995. en:iodine i 131 monoclonal antibody cc49-deltach2 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 131 monoclonal antibody cc49-deltach2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2996. en:iodine i 131 monoclonal antibody f16sip --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 131 monoclonal antibody f16sip | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2997. en:iodine i 131 monoclonal antibody g-250 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 131 monoclonal antibody g-250 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2998. en:iodine i 131 monoclonal antibody muj591 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 131 monoclonal antibody muj591 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  2999. en:iodine i 131 monoclonal antibody tnt-1/b --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 131 monoclonal antibody tnt-1/b | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3000. en:iodine i 131 nm404 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 131 nm404 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3001. en:iodine i 131 phospholipid ether analogue clr1404 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 131 phospholipid ether analogue clr1404 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3002. en:iodine i 131 rituximab --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 131 rituximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3003. en:iodine i 131 sgmib-anti-her2 vhh1 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 131 sgmib-anti-her2 vhh1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3004. en:iodine i 131 tenatumomab --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 131 tenatumomab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3005. en:iodine i 131 tm-601 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 131 tm-601 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3006. en:iodine i 131 tositumomab --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 131 tositumomab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3007. en:iodine i 131-labeled anti-cea/anti-hsg bispecific monoclonal antibody tf2 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i 131-labeled anti-cea/anti-hsg bispecific monoclonal antibody tf2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3008. en:iodine i-123 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i-123 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3009. en:iodine i-123 adam --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i-123 adam | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3010. en:iodine i-123 iodometomidate --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i-123 iodometomidate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3011. en:iodine i-123 mip-1095 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i-123 mip-1095 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3012. en:iodine i-124 fiau --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i-124 fiau | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3013. en:iodine i-124 girentuximab --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i-124 girentuximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3014. en:iodine i-125 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i-125 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3015. en:iodine i-131 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine i-131 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3016. en:iodine norcholestenol --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine norcholestenol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3017. en:iodine potassium iodide --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine potassium iodide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3018. en:iodine/phenol/potassium iodide/trichloroacetic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:iodine/phenol/potassium iodide/trichloroacetic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3019. en:iodipamide meglumine --- r_associated #0: 20 --> ipilimumab
    n1=en:iodipamide meglumine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3020. en:iodixanol --- r_associated #0: 20 --> ipilimumab
    n1=en:iodixanol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3021. en:iodocholesterol i^131^ --- r_associated #0: 20 --> ipilimumab
    n1=en:iodocholesterol i^131^ | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3022. en:iodohippurate --- r_associated #0: 20 --> ipilimumab
    n1=en:iodohippurate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3023. en:iodohippurate sodium i-131 --- r_associated #0: 20 --> ipilimumab
    n1=en:iodohippurate sodium i-131 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3024. en:iodophore product --- r_associated #0: 20 --> ipilimumab
    n1=en:iodophore product | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3025. en:iodoquinol --- r_associated #0: 20 --> ipilimumab
    n1=en:iodoquinol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3026. en:ioflubenzamide i-131 --- r_associated #0: 20 --> ipilimumab
    n1=en:ioflubenzamide i-131 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3027. en:ioflupane --- r_associated #0: 20 --> ipilimumab
    n1=en:ioflupane | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3028. en:iofolastat i123 --- r_associated #0: 20 --> ipilimumab
    n1=en:iofolastat i123 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3029. en:iohexol --- r_associated #0: 20 --> ipilimumab
    n1=en:iohexol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3030. en:ionic silver-impregnated sodium carboxymethylcellulose antimicrobial dressing --- r_associated #0: 20 --> ipilimumab
    n1=en:ionic silver-impregnated sodium carboxymethylcellulose antimicrobial dressing | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3031. en:ionomycin --- r_associated #0: 20 --> ipilimumab
    n1=en:ionomycin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3032. en:iopanoic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:iopanoic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3033. en:iophendylate --- r_associated #0: 20 --> ipilimumab
    n1=en:iophendylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3034. en:iopromide --- r_associated #0: 20 --> ipilimumab
    n1=en:iopromide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3035. en:iothalamate --- r_associated #0: 20 --> ipilimumab
    n1=en:iothalamate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3036. en:iotrolan --- r_associated #0: 20 --> ipilimumab
    n1=en:iotrolan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3037. en:ioversol --- r_associated #0: 20 --> ipilimumab
    n1=en:ioversol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3038. en:ioxaglate --- r_associated #0: 20 --> ipilimumab
    n1=en:ioxaglate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3039. en:ipafricept --- r_associated #0: 20 --> ipilimumab
    n1=en:ipafricept | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3040. en:ipamorelin --- r_associated #0: 20 --> ipilimumab
    n1=en:ipamorelin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3041. en:ipatasertib --- r_associated #0: 20 --> ipilimumab
    n1=en:ipatasertib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3042. en:ipecac --- r_associated #0: 20 --> ipilimumab
    n1=en:ipecac | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3043. en:ipecac/phenylephrine/potassium guaiacolsulfonate/promethazine --- r_associated #0: 20 --> ipilimumab
    n1=en:ipecac/phenylephrine/potassium guaiacolsulfonate/promethazine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3044. en:ipilimumab 5 mg/ml injection [yervoy] --- r_associated #0: 20 --> ipilimumab
    n1=en:ipilimumab 5 mg/ml injection [yervoy] | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3045. en:ipodic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:ipodic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3046. en:ipomeanol --- r_associated #0: 20 --> ipilimumab
    n1=en:ipomeanol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3047. en:ipp-204106n --- r_associated #0: 20 --> ipilimumab
    n1=en:ipp-204106n | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3048. en:ipratropium --- r_associated #0: 20 --> ipilimumab
    n1=en:ipratropium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3049. en:ipriflavone --- r_associated #0: 20 --> ipilimumab
    n1=en:ipriflavone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3050. en:iproplatin --- r_associated #0: 20 --> ipilimumab
    n1=en:iproplatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3051. en:iratumumab --- r_associated #0: 20 --> ipilimumab
    n1=en:iratumumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3052. en:iridium ir 192 --- r_associated #0: 20 --> ipilimumab
    n1=en:iridium ir 192 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3053. en:irinotecan --- r_associated #0: 20 --> ipilimumab
    n1=en:irinotecan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3054. en:irinotecan hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:irinotecan hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3055. en:irinotecan-eluting beads --- r_associated #0: 20 --> ipilimumab
    n1=en:irinotecan-eluting beads | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3056. en:irinotecan/p-glycoprotein inhibitor hm30181ak combination tablet --- r_associated #0: 20 --> ipilimumab
    n1=en:irinotecan/p-glycoprotein inhibitor hm30181ak combination tablet | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3057. en:irish moss/mineral oil --- r_associated #0: 20 --> ipilimumab
    n1=en:irish moss/mineral oil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3058. en:irofulven --- r_associated #0: 20 --> ipilimumab
    n1=en:irofulven | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3059. en:iron --- r_associated #0: 20 --> ipilimumab
    n1=en:iron | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3060. en:iron dextran complex --- r_associated #0: 20 --> ipilimumab
    n1=en:iron dextran complex | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3061. en:iron isomaltoside 1000 --- r_associated #0: 20 --> ipilimumab
    n1=en:iron isomaltoside 1000 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3062. en:iron sucrose injection --- r_associated #0: 20 --> ipilimumab
    n1=en:iron sucrose injection | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3063. en:iron/multivitamins --- r_associated #0: 20 --> ipilimumab
    n1=en:iron/multivitamins | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3064. en:iron/multivitamins/procaine --- r_associated #0: 20 --> ipilimumab
    n1=en:iron/multivitamins/procaine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3065. en:iron/multivitamins/sorbitol --- r_associated #0: 20 --> ipilimumab
    n1=en:iron/multivitamins/sorbitol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3066. en:iron/vitamin c --- r_associated #0: 20 --> ipilimumab
    n1=en:iron/vitamin c | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3067. en:irosustat --- r_associated #0: 20 --> ipilimumab
    n1=en:irosustat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3068. en:irrigation eye brand of benzalkonium chloride --- r_associated #0: 20 --> ipilimumab
    n1=en:irrigation eye brand of benzalkonium chloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3069. en:irritants --- r_associated #0: 20 --> ipilimumab
    n1=en:irritants | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3070. en:irx-2 --- r_associated #0: 20 --> ipilimumab
    n1=en:irx-2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3071. en:isavuconazole --- r_associated #0: 20 --> ipilimumab
    n1=en:isavuconazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3072. en:isavuconazonium sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:isavuconazonium sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3073. en:iseganan hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:iseganan hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3074. en:isis 2503 --- r_associated #0: 20 --> ipilimumab
    n1=en:isis 2503 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3075. en:isis 3521 --- r_associated #0: 20 --> ipilimumab
    n1=en:isis 3521 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3076. en:isis 5132 --- r_associated #0: 20 --> ipilimumab
    n1=en:isis 5132 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3077. en:iso-fludelone --- r_associated #0: 20 --> ipilimumab
    n1=en:iso-fludelone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3078. en:iso-sulfan blue --- r_associated #0: 20 --> ipilimumab
    n1=en:iso-sulfan blue | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3079. en:isobutane --- r_associated #0: 20 --> ipilimumab
    n1=en:isobutane | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3080. en:isocal --- r_associated #0: 20 --> ipilimumab
    n1=en:isocal | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3081. en:isocarboxazid --- r_associated #0: 20 --> ipilimumab
    n1=en:isocarboxazid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3082. en:isodecyl oleate --- r_associated #0: 20 --> ipilimumab
    n1=en:isodecyl oleate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3083. en:isoetharine --- r_associated #0: 20 --> ipilimumab
    n1=en:isoetharine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3084. en:isoflurane --- r_associated #0: 20 --> ipilimumab
    n1=en:isoflurane | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3085. en:isoflurophate --- r_associated #0: 20 --> ipilimumab
    n1=en:isoflurophate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3086. en:isolate compound --- r_associated #0: 20 --> ipilimumab
    n1=en:isolate compound | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3087. en:isoleucine --- r_associated #0: 20 --> ipilimumab
    n1=en:isoleucine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3088. en:isoleucine + leucine + valine --- r_associated #0: 20 --> ipilimumab
    n1=en:isoleucine + leucine + valine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3089. en:isometheptene mucate --- r_associated #0: 20 --> ipilimumab
    n1=en:isometheptene mucate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3090. en:isoniazid --- r_associated #0: 20 --> ipilimumab
    n1=en:isoniazid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3091. en:isoniazid, pyrazinamide, rifampin drug combination --- r_associated #0: 20 --> ipilimumab
    n1=en:isoniazid, pyrazinamide, rifampin drug combination | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3092. en:isoniazid/pyridoxine --- r_associated #0: 20 --> ipilimumab
    n1=en:isoniazid/pyridoxine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3093. en:isoparaffin --- r_associated #0: 20 --> ipilimumab
    n1=en:isoparaffin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3094. en:isopropamide --- r_associated #0: 20 --> ipilimumab
    n1=en:isopropamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3095. en:isopropamide / prochlorperazine --- r_associated #0: 20 --> ipilimumab
    n1=en:isopropamide / prochlorperazine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3096. en:isopropyl alcohol / salicylic acid / sodium thiosulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:isopropyl alcohol / salicylic acid / sodium thiosulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3097. en:isopropyl myristate --- r_associated #0: 20 --> ipilimumab
    n1=en:isopropyl myristate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3098. en:isopropyl palmitate --- r_associated #0: 20 --> ipilimumab
    n1=en:isopropyl palmitate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3099. en:isoproterenol / phenylephrine --- r_associated #0: 20 --> ipilimumab
    n1=en:isoproterenol / phenylephrine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3100. en:isoproterenol/sodium chloride --- r_associated #0: 20 --> ipilimumab
    n1=en:isoproterenol/sodium chloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3101. en:isoquercetin --- r_associated #0: 20 --> ipilimumab
    n1=en:isoquercetin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3102. en:isosorbide --- r_associated #0: 20 --> ipilimumab
    n1=en:isosorbide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3103. en:isosource --- r_associated #0: 20 --> ipilimumab
    n1=en:isosource | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3104. en:isosource 1.5 --- r_associated #0: 20 --> ipilimumab
    n1=en:isosource 1.5 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3105. en:isosource hn --- r_associated #0: 20 --> ipilimumab
    n1=en:isosource hn | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3106. en:isosource vhn --- r_associated #0: 20 --> ipilimumab
    n1=en:isosource vhn | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3107. en:isosulfan blue --- r_associated #0: 20 --> ipilimumab
    n1=en:isosulfan blue | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3108. en:isosulfan blue/potassium phosphate/sodium phosphate --- r_associated #0: 20 --> ipilimumab
    n1=en:isosulfan blue/potassium phosphate/sodium phosphate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3109. en:isotein hn --- r_associated #0: 20 --> ipilimumab
    n1=en:isotein hn | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3110. en:isoton --- r_associated #0: 20 --> ipilimumab
    n1=en:isoton | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3111. en:isotretinoin --- r_associated #0: 20 --> ipilimumab
    n1=en:isotretinoin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3112. en:isoxsuprine --- r_associated #0: 20 --> ipilimumab
    n1=en:isoxsuprine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3113. en:ispaghula extract --- r_associated #0: 20 --> ipilimumab
    n1=en:ispaghula extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3114. en:ispinesib --- r_associated #0: 20 --> ipilimumab
    n1=en:ispinesib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3115. en:isradipine --- r_associated #0: 20 --> ipilimumab
    n1=en:isradipine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3116. en:iss 1018 cpg oligodeoxynucleotide --- r_associated #0: 20 --> ipilimumab
    n1=en:iss 1018 cpg oligodeoxynucleotide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3117. en:itraconazole --- r_associated #0: 20 --> ipilimumab
    n1=en:itraconazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3118. en:itraconazole dispersion in polymer matrix --- r_associated #0: 20 --> ipilimumab
    n1=en:itraconazole dispersion in polymer matrix | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3119. en:ivabradine --- r_associated #0: 20 --> ipilimumab
    n1=en:ivabradine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3120. en:ivac mutanome vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:ivac mutanome vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3121. en:ivacaftor --- r_associated #0: 20 --> ipilimumab
    n1=en:ivacaftor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3122. en:ixabepilone --- r_associated #0: 20 --> ipilimumab
    n1=en:ixabepilone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3123. en:ixazomib --- r_associated #0: 20 --> ipilimumab
    n1=en:ixazomib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3124. en:ixazomib citrate --- r_associated #0: 20 --> ipilimumab
    n1=en:ixazomib citrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3125. en:j5 antiserum --- r_associated #0: 20 --> ipilimumab
    n1=en:j5 antiserum | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3126. en:jak inhibitor incb047986 --- r_associated #0: 20 --> ipilimumab
    n1=en:jak inhibitor incb047986 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3127. en:jak1 inhibitor incb039110 --- r_associated #0: 20 --> ipilimumab
    n1=en:jak1 inhibitor incb039110 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3128. en:jak1 inhibitor incb052793 --- r_associated #0: 20 --> ipilimumab
    n1=en:jak1 inhibitor incb052793 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3129. en:jak2 inhibitor azd1480 --- r_associated #0: 20 --> ipilimumab
    n1=en:jak2 inhibitor azd1480 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3130. en:jak2 inhibitor bms-911543 --- r_associated #0: 20 --> ipilimumab
    n1=en:jak2 inhibitor bms-911543 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3131. en:jak2 inhibitor tg101348 --- r_associated #0: 20 --> ipilimumab
    n1=en:jak2 inhibitor tg101348 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3132. en:jak2 inhibitor wp1066 --- r_associated #0: 20 --> ipilimumab
    n1=en:jak2 inhibitor wp1066 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3133. en:jak2 inhibitor xl019 --- r_associated #0: 20 --> ipilimumab
    n1=en:jak2 inhibitor xl019 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3134. en:jak2/src inhibitor ns-018 --- r_associated #0: 20 --> ipilimumab
    n1=en:jak2/src inhibitor ns-018 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3135. en:jeb regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:jeb regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3136. en:jin fu kang --- r_associated #0: 20 --> ipilimumab
    n1=en:jin fu kang | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3137. en:juven --- r_associated #0: 20 --> ipilimumab
    n1=en:juven | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3138. en:kanamycin sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:kanamycin sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3139. en:kanglaite --- r_associated #0: 20 --> ipilimumab
    n1=en:kanglaite | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3140. en:kava-based supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:kava-based supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3141. en:ketamine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:ketamine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3142. en:ketamine/amitriptyline np-h cream --- r_associated #0: 20 --> ipilimumab
    n1=en:ketamine/amitriptyline np-h cream | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3143. en:ketoconazole --- r_associated #0: 20 --> ipilimumab
    n1=en:ketoconazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3144. en:ketoprofen --- r_associated #0: 20 --> ipilimumab
    n1=en:ketoprofen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3145. en:ketorolac --- r_associated #0: 20 --> ipilimumab
    n1=en:ketorolac | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3146. en:ketorolac + phenylephrine --- r_associated #0: 20 --> ipilimumab
    n1=en:ketorolac + phenylephrine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3147. en:ketorolac tromethamine --- r_associated #0: 20 --> ipilimumab
    n1=en:ketorolac tromethamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3148. en:keyhole limpet hemocyanin --- r_associated #0: 20 --> ipilimumab
    n1=en:keyhole limpet hemocyanin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3149. en:kit/pdgfr inhibitor dcc-2618 --- r_associated #0: 20 --> ipilimumab
    n1=en:kit/pdgfr inhibitor dcc-2618 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3150. en:klebsiella pneumoniae glycoprotein --- r_associated #0: 20 --> ipilimumab
    n1=en:klebsiella pneumoniae glycoprotein | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3151. en:klh-fitc --- r_associated #0: 20 --> ipilimumab
    n1=en:klh-fitc | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3152. en:krn5500 --- r_associated #0: 20 --> ipilimumab
    n1=en:krn5500 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3153. en:ksa-klh conjugate vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:ksa-klh conjugate vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3154. en:ksp inhibitor arry-520 --- r_associated #0: 20 --> ipilimumab
    n1=en:ksp inhibitor arry-520 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3155. en:ksp inhibitor azd4877 --- r_associated #0: 20 --> ipilimumab
    n1=en:ksp inhibitor azd4877 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3156. en:kunecatechins ointment --- r_associated #0: 20 --> ipilimumab
    n1=en:kunecatechins ointment | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3157. en:kw-2149 --- r_associated #0: 20 --> ipilimumab
    n1=en:kw-2149 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3158. en:l-377,202 --- r_associated #0: 20 --> ipilimumab
    n1=en:l-377,202 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3159. en:l-4-chlorokynurenine --- r_associated #0: 20 --> ipilimumab
    n1=en:l-4-chlorokynurenine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3160. en:l-778,123 --- r_associated #0: 20 --> ipilimumab
    n1=en:l-778,123 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3161. en:l-arginine/korean ginseng/ginkgo biloba/damiana-based supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:l-arginine/korean ginseng/ginkgo biloba/damiana-based supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3162. en:l-carnitine l-tartrate --- r_associated #0: 20 --> ipilimumab
    n1=en:l-carnitine l-tartrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3163. en:l-gossypol --- r_associated #0: 20 --> ipilimumab
    n1=en:l-gossypol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3164. en:l-leucyl-l-leucine methyl ester --- r_associated #0: 20 --> ipilimumab
    n1=en:l-leucyl-l-leucine methyl ester | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3165. en:l-lysine --- r_associated #0: 20 --> ipilimumab
    n1=en:l-lysine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3166. en:l-menthol preparation npo-11 --- r_associated #0: 20 --> ipilimumab
    n1=en:l-menthol preparation npo-11 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3167. en:l-methylfolate --- r_associated #0: 20 --> ipilimumab
    n1=en:l-methylfolate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3168. en:l-ornithine l-aspartate --- r_associated #0: 20 --> ipilimumab
    n1=en:l-ornithine l-aspartate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3169. en:l-tryptophan/thymine-based supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:l-tryptophan/thymine-based supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3170. en:l19-il2 monoclonal antibody-cytokine fusion protein --- r_associated #0: 20 --> ipilimumab
    n1=en:l19-il2 monoclonal antibody-cytokine fusion protein | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3171. en:labetuzumab-sn-38 immunoconjugate immu-130 --- r_associated #0: 20 --> ipilimumab
    n1=en:labetuzumab-sn-38 immunoconjugate immu-130 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3172. en:labradimil --- r_associated #0: 20 --> ipilimumab
    n1=en:labradimil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3173. en:lacosamide --- r_associated #0: 20 --> ipilimumab
    n1=en:lacosamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3174. en:lactated ringer solution --- r_associated #0: 20 --> ipilimumab
    n1=en:lactated ringer solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3175. en:lactobacillus acidophilus --- r_associated #0: 20 --> ipilimumab
    n1=en:lactobacillus acidophilus | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3176. en:lactobacillus acidophilus/estriol vaginal tablet --- r_associated #0: 20 --> ipilimumab
    n1=en:lactobacillus acidophilus/estriol vaginal tablet | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3177. en:lactobacillus acidophilus/streptococcus thermophilus/bifidobacterium lactis/l. rhamnosus/b. longum/b. bifidum-based probiotic supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:lactobacillus acidophilus/streptococcus thermophilus/bifidobacterium lactis/l. rhamnosus/b. longum/b. bifidum-based probiotic supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3178. en:lactobacillus brevis cd2 lozenge --- r_associated #0: 20 --> ipilimumab
    n1=en:lactobacillus brevis cd2 lozenge | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3179. en:lactobacillus fermented extract --- r_associated #0: 20 --> ipilimumab
    n1=en:lactobacillus fermented extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3180. en:lactobacillus plantarum 299v/lactobacillus acidophilus/bifidobacterium lactis probiotic supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:lactobacillus plantarum 299v/lactobacillus acidophilus/bifidobacterium lactis probiotic supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3181. en:lactobacillus plantarum strain 299 --- r_associated #0: 20 --> ipilimumab
    n1=en:lactobacillus plantarum strain 299 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3182. en:lactobacillus plantarum strain 299v --- r_associated #0: 20 --> ipilimumab
    n1=en:lactobacillus plantarum strain 299v | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3183. en:lactobacillus rhamnosus gg --- r_associated #0: 20 --> ipilimumab
    n1=en:lactobacillus rhamnosus gg | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3184. en:lactobacillus rhamnosus/l. jensenii/l. crispatus/l. gasseri oral supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:lactobacillus rhamnosus/l. jensenii/l. crispatus/l. gasseri oral supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3185. en:lactobacillus-based probiotic capsule --- r_associated #0: 20 --> ipilimumab
    n1=en:lactobacillus-based probiotic capsule | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3186. en:lactoferrin-derived lytic peptide ltx-315 --- r_associated #0: 20 --> ipilimumab
    n1=en:lactoferrin-derived lytic peptide ltx-315 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3187. en:lactoperoxidase/lysozyme/lactoferrin-based prebiotic vaginal lubricant --- r_associated #0: 20 --> ipilimumab
    n1=en:lactoperoxidase/lysozyme/lactoferrin-based prebiotic vaginal lubricant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3188. en:laetrile --- r_associated #0: 20 --> ipilimumab
    n1=en:laetrile | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3189. en:lamellar body mimetic mouth spray lms-611 --- r_associated #0: 20 --> ipilimumab
    n1=en:lamellar body mimetic mouth spray lms-611 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3190. en:lamivudine --- r_associated #0: 20 --> ipilimumab
    n1=en:lamivudine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3191. en:lamotrigine --- r_associated #0: 20 --> ipilimumab
    n1=en:lamotrigine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3192. en:laniquidar --- r_associated #0: 20 --> ipilimumab
    n1=en:laniquidar | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3193. en:lanreotide acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:lanreotide acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3194. en:lanreotide acetate copolymer microparticles --- r_associated #0: 20 --> ipilimumab
    n1=en:lanreotide acetate copolymer microparticles | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3195. en:lanreotide long-acting aqueous gel --- r_associated #0: 20 --> ipilimumab
    n1=en:lanreotide long-acting aqueous gel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3196. en:lapachone --- r_associated #0: 20 --> ipilimumab
    n1=en:lapachone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3197. en:lapatinib ditosylate --- r_associated #0: 20 --> ipilimumab
    n1=en:lapatinib ditosylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3198. en:lapuleucel-t --- r_associated #0: 20 --> ipilimumab
    n1=en:lapuleucel-t | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3199. en:largetrifoliolious bugbane rhizome supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:largetrifoliolious bugbane rhizome supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3200. en:laromustine --- r_associated #0: 20 --> ipilimumab
    n1=en:laromustine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3201. en:laronidase --- r_associated #0: 20 --> ipilimumab
    n1=en:laronidase | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3202. en:larotaxel --- r_associated #0: 20 --> ipilimumab
    n1=en:larotaxel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3203. en:las41007 --- r_associated #0: 20 --> ipilimumab
    n1=en:las41007 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3204. en:lasw1510 --- r_associated #0: 20 --> ipilimumab
    n1=en:lasw1510 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3205. en:lawsone --- r_associated #0: 20 --> ipilimumab
    n1=en:lawsone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3206. en:lead pb 212 tcmc-trastuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:lead pb 212 tcmc-trastuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3207. en:leflunomide --- r_associated #0: 20 --> ipilimumab
    n1=en:leflunomide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3208. en:lenalidomide --- r_associated #0: 20 --> ipilimumab
    n1=en:lenalidomide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3209. en:lenapenem --- r_associated #0: 20 --> ipilimumab
    n1=en:lenapenem | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3210. en:lenograstim --- r_associated #0: 20 --> ipilimumab
    n1=en:lenograstim | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3211. en:lenti-d/abcd1-transduced autologous hematopoietic stem cells --- r_associated #0: 20 --> ipilimumab
    n1=en:lenti-d/abcd1-transduced autologous hematopoietic stem cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3212. en:lentivirus vector ccr5 shrna/trim5alpha/tar decoy-transduced autologous cd34-positive hematopoietic progenitor cells --- r_associated #0: 20 --> ipilimumab
    n1=en:lentivirus vector ccr5 shrna/trim5alpha/tar decoy-transduced autologous cd34-positive hematopoietic progenitor cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3213. en:lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells --- r_associated #0: 20 --> ipilimumab
    n1=en:lentivirus vector rhiv7-shi-tar-ccr5rz-transduced hematopoietic progenitor cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3214. en:lenvatinib mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:lenvatinib mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3215. en:lenzilumab --- r_associated #0: 20 --> ipilimumab
    n1=en:lenzilumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3216. en:lepirudin --- r_associated #0: 20 --> ipilimumab
    n1=en:lepirudin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3217. en:leridistim --- r_associated #0: 20 --> ipilimumab
    n1=en:leridistim | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3218. en:lerisetron --- r_associated #0: 20 --> ipilimumab
    n1=en:lerisetron | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3219. en:lesinurad --- r_associated #0: 20 --> ipilimumab
    n1=en:lesinurad | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3220. en:lestaurtinib --- r_associated #0: 20 --> ipilimumab
    n1=en:lestaurtinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3221. en:letermovir --- r_associated #0: 20 --> ipilimumab
    n1=en:letermovir | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3222. en:letrozole --- r_associated #0: 20 --> ipilimumab
    n1=en:letrozole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3223. en:leucine-enhanced essential amino acid dietary supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:leucine-enhanced essential amino acid dietary supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3224. en:leucovorin calcium --- r_associated #0: 20 --> ipilimumab
    n1=en:leucovorin calcium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3225. en:leukemic apoptotic corpse-pulsed autologous dendritic cells --- r_associated #0: 20 --> ipilimumab
    n1=en:leukemic apoptotic corpse-pulsed autologous dendritic cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3226. en:leuprolide --- r_associated #0: 20 --> ipilimumab
    n1=en:leuprolide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3227. en:leuprolide acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:leuprolide acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3228. en:leuprolide mesylate injectable suspension --- r_associated #0: 20 --> ipilimumab
    n1=en:leuprolide mesylate injectable suspension | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3229. en:levamisole hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:levamisole hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3230. en:levetiracetam --- r_associated #0: 20 --> ipilimumab
    n1=en:levetiracetam | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3231. en:levobupivacaine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:levobupivacaine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3232. en:levocarnitine --- r_associated #0: 20 --> ipilimumab
    n1=en:levocarnitine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3233. en:levocetirizine dihydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:levocetirizine dihydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3234. en:levodopa --- r_associated #0: 20 --> ipilimumab
    n1=en:levodopa | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3235. en:levofloxacin --- r_associated #0: 20 --> ipilimumab
    n1=en:levofloxacin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3236. en:levoleucovorin --- r_associated #0: 20 --> ipilimumab
    n1=en:levoleucovorin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3237. en:levoleucovorin calcium --- r_associated #0: 20 --> ipilimumab
    n1=en:levoleucovorin calcium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3238. en:levonantradol --- r_associated #0: 20 --> ipilimumab
    n1=en:levonantradol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3239. en:levonorgestrel --- r_associated #0: 20 --> ipilimumab
    n1=en:levonorgestrel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3240. en:levonorgestrel-releasing intrauterine system --- r_associated #0: 20 --> ipilimumab
    n1=en:levonorgestrel-releasing intrauterine system | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3241. en:levothyroxine sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:levothyroxine sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3242. en:lexatumumab --- r_associated #0: 20 --> ipilimumab
    n1=en:lexatumumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3243. en:lexibulin --- r_associated #0: 20 --> ipilimumab
    n1=en:lexibulin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3244. en:liarozole fumarate --- r_associated #0: 20 --> ipilimumab
    n1=en:liarozole fumarate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3245. en:licartin --- r_associated #0: 20 --> ipilimumab
    n1=en:licartin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3246. en:lidocaine --- r_associated #0: 20 --> ipilimumab
    n1=en:lidocaine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3247. en:lidocaine patch --- r_associated #0: 20 --> ipilimumab
    n1=en:lidocaine patch | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3248. en:light-emitting oncolytic vaccinia virus gl-onc1 --- r_associated #0: 20 --> ipilimumab
    n1=en:light-emitting oncolytic vaccinia virus gl-onc1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3249. en:limonene --- r_associated #0: 20 --> ipilimumab
    n1=en:limonene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3250. en:linaclotide acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:linaclotide acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3251. en:linagliptin + metformin --- r_associated #0: 20 --> ipilimumab
    n1=en:linagliptin + metformin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3252. en:linezolid --- r_associated #0: 20 --> ipilimumab
    n1=en:linezolid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3253. en:linifanib --- r_associated #0: 20 --> ipilimumab
    n1=en:linifanib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3254. en:linoleyl carbonate-paclitaxel --- r_associated #0: 20 --> ipilimumab
    n1=en:linoleyl carbonate-paclitaxel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3255. en:linsitinib --- r_associated #0: 20 --> ipilimumab
    n1=en:linsitinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3256. en:lintuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:lintuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3257. en:liothyronine --- r_associated #0: 20 --> ipilimumab
    n1=en:liothyronine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3258. en:liothyronine i-131 --- r_associated #0: 20 --> ipilimumab
    n1=en:liothyronine i-131 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3259. en:liothyronine sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:liothyronine sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3260. en:lipegfilgrastim --- r_associated #0: 20 --> ipilimumab
    n1=en:lipegfilgrastim | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3261. en:lipid --- r_associated #0: 20 --> ipilimumab
    n1=en:lipid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3262. en:lipid encapsulated anti-plk1 sirna tkm-plk1 --- r_associated #0: 20 --> ipilimumab
    n1=en:lipid encapsulated anti-plk1 sirna tkm-plk1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3263. en:lipopolysaccharide --- r_associated #0: 20 --> ipilimumab
    n1=en:lipopolysaccharide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3264. en:liposomal amphotericin b --- r_associated #0: 20 --> ipilimumab
    n1=en:liposomal amphotericin b | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3265. en:liposomal bupivacaine --- r_associated #0: 20 --> ipilimumab
    n1=en:liposomal bupivacaine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3266. en:liposomal c-raf antisense oligonucleotide --- r_associated #0: 20 --> ipilimumab
    n1=en:liposomal c-raf antisense oligonucleotide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3267. en:liposomal curcumin --- r_associated #0: 20 --> ipilimumab
    n1=en:liposomal curcumin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3268. en:liposomal cytarabine --- r_associated #0: 20 --> ipilimumab
    n1=en:liposomal cytarabine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3269. en:liposomal cytarabine-daunorubicin cpx-351 --- r_associated #0: 20 --> ipilimumab
    n1=en:liposomal cytarabine-daunorubicin cpx-351 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3270. en:liposomal daunorubicin citrate --- r_associated #0: 20 --> ipilimumab
    n1=en:liposomal daunorubicin citrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3271. en:liposomal docetaxel --- r_associated #0: 20 --> ipilimumab
    n1=en:liposomal docetaxel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3272. en:liposomal eribulin mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:liposomal eribulin mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3273. en:liposomal hpv-16 e6/e7 multipeptide vaccine pds0101 --- r_associated #0: 20 --> ipilimumab
    n1=en:liposomal hpv-16 e6/e7 multipeptide vaccine pds0101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3274. en:liposomal irinotecan --- r_associated #0: 20 --> ipilimumab
    n1=en:liposomal irinotecan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3275. en:liposomal mitoxantrone hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:liposomal mitoxantrone hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3276. en:liposomal mnsod plasmid --- r_associated #0: 20 --> ipilimumab
    n1=en:liposomal mnsod plasmid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3277. en:liposomal muc1/pet-lipid a vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:liposomal muc1/pet-lipid a vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3278. en:liposomal nddp --- r_associated #0: 20 --> ipilimumab
    n1=en:liposomal nddp | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3279. en:liposomal oxaliplatin --- r_associated #0: 20 --> ipilimumab
    n1=en:liposomal oxaliplatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3280. en:liposomal rhenium re 186 --- r_associated #0: 20 --> ipilimumab
    n1=en:liposomal rhenium re 186 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3281. en:liposomal sn-38 --- r_associated #0: 20 --> ipilimumab
    n1=en:liposomal sn-38 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3282. en:liposome-encapsulated doxorubicin citrate --- r_associated #0: 20 --> ipilimumab
    n1=en:liposome-encapsulated doxorubicin citrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3283. en:liposome-encapsulated mir-34 mimic mrx34 --- r_associated #0: 20 --> ipilimumab
    n1=en:liposome-encapsulated mir-34 mimic mrx34 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3284. en:liposome-encapsulated rb94 plasmid dna gene therapy agent sgt-94 --- r_associated #0: 20 --> ipilimumab
    n1=en:liposome-encapsulated rb94 plasmid dna gene therapy agent sgt-94 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3285. en:liposome-encapsulated recombinant human cu/zn superoxide-dismutase --- r_associated #0: 20 --> ipilimumab
    n1=en:liposome-encapsulated recombinant human cu/zn superoxide-dismutase | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3286. en:liposome-incorporated grb2 antisense oligodeoxynucleotide --- r_associated #0: 20 --> ipilimumab
    n1=en:liposome-incorporated grb2 antisense oligodeoxynucleotide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3287. en:liraglutide --- r_associated #0: 20 --> ipilimumab
    n1=en:liraglutide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3288. en:lirilumab --- r_associated #0: 20 --> ipilimumab
    n1=en:lirilumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3289. en:lisdexamfetamine dimesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:lisdexamfetamine dimesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3290. en:lisinopril --- r_associated #0: 20 --> ipilimumab
    n1=en:lisinopril | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3291. en:lisofylline --- r_associated #0: 20 --> ipilimumab
    n1=en:lisofylline | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3292. en:listeria monocytogenes-llo-psa vaccine adxs31-142 --- r_associated #0: 20 --> ipilimumab
    n1=en:listeria monocytogenes-llo-psa vaccine adxs31-142 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3293. en:lithium carbonate --- r_associated #0: 20 --> ipilimumab
    n1=en:lithium carbonate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3294. en:litronesib --- r_associated #0: 20 --> ipilimumab
    n1=en:litronesib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3295. en:live attenuated measles virus vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:live attenuated measles virus vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3296. en:live freeze-dried lactic acid bacteria probiotic --- r_associated #0: 20 --> ipilimumab
    n1=en:live freeze-dried lactic acid bacteria probiotic | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3297. en:live-attenuated double-deleted listeria monocytogenes bacteria jnj-64041809 --- r_associated #0: 20 --> ipilimumab
    n1=en:live-attenuated double-deleted listeria monocytogenes bacteria jnj-64041809 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3298. en:live-attenuated listeria encoding human mesothelin vaccine crs-207 --- r_associated #0: 20 --> ipilimumab
    n1=en:live-attenuated listeria encoding human mesothelin vaccine crs-207 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3299. en:live-attenuated listeria monocytogenes encoding egfrviii-mesothelin vaccine jnj-64041757 --- r_associated #0: 20 --> ipilimumab
    n1=en:live-attenuated listeria monocytogenes encoding egfrviii-mesothelin vaccine jnj-64041757 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3300. en:live-attenuated listeria monocytogenes-encoding egfrviii-ny-eso-1 vaccine adu-623 --- r_associated #0: 20 --> ipilimumab
    n1=en:live-attenuated listeria monocytogenes-encoding egfrviii-ny-eso-1 vaccine adu-623 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3301. en:liver extract --- r_associated #0: 20 --> ipilimumab
    n1=en:liver extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3302. en:lmb-1 immunotoxin --- r_associated #0: 20 --> ipilimumab
    n1=en:lmb-1 immunotoxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3303. en:lmb-2 immunotoxin --- r_associated #0: 20 --> ipilimumab
    n1=en:lmb-2 immunotoxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3304. en:lmb-7 immunotoxin --- r_associated #0: 20 --> ipilimumab
    n1=en:lmb-7 immunotoxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3305. en:lmb-9 immunotoxin --- r_associated #0: 20 --> ipilimumab
    n1=en:lmb-9 immunotoxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3306. en:lmdda-llo-chher2 fusion protein-secreting live-attenuated listeria cancer vaccine adxs31-164 --- r_associated #0: 20 --> ipilimumab
    n1=en:lmdda-llo-chher2 fusion protein-secreting live-attenuated listeria cancer vaccine adxs31-164 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3307. en:lmp-2:340-349 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:lmp-2:340-349 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3308. en:lmp-2:419-427 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:lmp-2:419-427 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3309. en:lmp1/barf1/ebna1-specific cytotoxic t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:lmp1/barf1/ebna1-specific cytotoxic t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3310. en:lmp2a-specific cytotoxic t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:lmp2a-specific cytotoxic t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3311. en:lna-based antimir-155 mrg-106 --- r_associated #0: 20 --> ipilimumab
    n1=en:lna-based antimir-155 mrg-106 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3312. en:lobaplatin --- r_associated #0: 20 --> ipilimumab
    n1=en:lobaplatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3313. en:lometrexol --- r_associated #0: 20 --> ipilimumab
    n1=en:lometrexol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3314. en:lomustine --- r_associated #0: 20 --> ipilimumab
    n1=en:lomustine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3315. en:lonafarnib --- r_associated #0: 20 --> ipilimumab
    n1=en:lonafarnib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3316. en:lonaprisan --- r_associated #0: 20 --> ipilimumab
    n1=en:lonaprisan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3317. en:long peptide vaccine 7 --- r_associated #0: 20 --> ipilimumab
    n1=en:long peptide vaccine 7 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3318. en:long-acting granulocyte colony-stimulating factor analog spi-2012 --- r_associated #0: 20 --> ipilimumab
    n1=en:long-acting granulocyte colony-stimulating factor analog spi-2012 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3319. en:long-acting release pasireotide --- r_associated #0: 20 --> ipilimumab
    n1=en:long-acting release pasireotide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3320. en:lonidamine --- r_associated #0: 20 --> ipilimumab
    n1=en:lonidamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3321. en:loperamide hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:loperamide hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3322. en:lopinavir --- r_associated #0: 20 --> ipilimumab
    n1=en:lopinavir | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3323. en:loratadine --- r_associated #0: 20 --> ipilimumab
    n1=en:loratadine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3324. en:lorazepam --- r_associated #0: 20 --> ipilimumab
    n1=en:lorazepam | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3325. en:lorvotuzumab mertansine --- r_associated #0: 20 --> ipilimumab
    n1=en:lorvotuzumab mertansine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3326. en:losartan potassium --- r_associated #0: 20 --> ipilimumab
    n1=en:losartan potassium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3327. en:losoxantrone --- r_associated #0: 20 --> ipilimumab
    n1=en:losoxantrone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3328. en:lovastatin --- r_associated #0: 20 --> ipilimumab
    n1=en:lovastatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3329. en:loxoribine --- r_associated #0: 20 --> ipilimumab
    n1=en:loxoribine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3330. en:lps/cd40l-activated klh- and melanoma/hiv peptides-loaded autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:lps/cd40l-activated klh- and melanoma/hiv peptides-loaded autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3331. en:lsd1 inhibitor gsk2879552 --- r_associated #0: 20 --> ipilimumab
    n1=en:lsd1 inhibitor gsk2879552 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3332. en:lubiprostone --- r_associated #0: 20 --> ipilimumab
    n1=en:lubiprostone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3333. en:lucanthone --- r_associated #0: 20 --> ipilimumab
    n1=en:lucanthone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3334. en:lucatumumab --- r_associated #0: 20 --> ipilimumab
    n1=en:lucatumumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3335. en:lucitanib --- r_associated #0: 20 --> ipilimumab
    n1=en:lucitanib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3336. en:lugol's solution --- r_associated #0: 20 --> ipilimumab
    n1=en:lugol's solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3337. en:lumacaftor, ivacaftor drug combination --- r_associated #0: 20 --> ipilimumab
    n1=en:lumacaftor, ivacaftor drug combination | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3338. en:lung tumor associated antigen --- r_associated #0: 20 --> ipilimumab
    n1=en:lung tumor associated antigen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3339. en:lung-targeted immunomodulator qbkpn --- r_associated #0: 20 --> ipilimumab
    n1=en:lung-targeted immunomodulator qbkpn | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3340. en:lurasidone --- r_associated #0: 20 --> ipilimumab
    n1=en:lurasidone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3341. en:lurbinectedin --- r_associated #0: 20 --> ipilimumab
    n1=en:lurbinectedin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3342. en:lurtotecan --- r_associated #0: 20 --> ipilimumab
    n1=en:lurtotecan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3343. en:lurtotecan liposome --- r_associated #0: 20 --> ipilimumab
    n1=en:lurtotecan liposome | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3344. en:luspatercept --- r_associated #0: 20 --> ipilimumab
    n1=en:luspatercept | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3345. en:lutetium lu 177 dota-biotin --- r_associated #0: 20 --> ipilimumab
    n1=en:lutetium lu 177 dota-biotin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3346. en:lutetium lu 177 dota-jr11 --- r_associated #0: 20 --> ipilimumab
    n1=en:lutetium lu 177 dota-jr11 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3347. en:lutetium lu 177 dota-tetulomab --- r_associated #0: 20 --> ipilimumab
    n1=en:lutetium lu 177 dota-tetulomab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3348. en:lutetium lu 177 monoclonal antibody cc49 --- r_associated #0: 20 --> ipilimumab
    n1=en:lutetium lu 177 monoclonal antibody cc49 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3349. en:lutetium lu 177 monoclonal antibody j591 --- r_associated #0: 20 --> ipilimumab
    n1=en:lutetium lu 177 monoclonal antibody j591 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3350. en:lutetium lu 177 peptide receptor radionuclide --- r_associated #0: 20 --> ipilimumab
    n1=en:lutetium lu 177 peptide receptor radionuclide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3351. en:lutetium lu 177 pp-f11n --- r_associated #0: 20 --> ipilimumab
    n1=en:lutetium lu 177 pp-f11n | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3352. en:lutetium lu 177-dota-di-hsg peptide imp-288 --- r_associated #0: 20 --> ipilimumab
    n1=en:lutetium lu 177-dota-di-hsg peptide imp-288 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3353. en:lutetium lu 177-dota-octreotate --- r_associated #0: 20 --> ipilimumab
    n1=en:lutetium lu 177-dota-octreotate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3354. en:lutetium lu 177-dota-tate --- r_associated #0: 20 --> ipilimumab
    n1=en:lutetium lu 177-dota-tate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3355. en:lutetium lu 177-edotreotide --- r_associated #0: 20 --> ipilimumab
    n1=en:lutetium lu 177-edotreotide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3356. en:lutetium lu-177 capromab --- r_associated #0: 20 --> ipilimumab
    n1=en:lutetium lu-177 capromab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3357. en:lutetium lu-177 girentuximab --- r_associated #0: 20 --> ipilimumab
    n1=en:lutetium lu-177 girentuximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3358. en:lv.il-2/b7.1-transduced aml blast vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:lv.il-2/b7.1-transduced aml blast vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3359. en:ly2624587 --- r_associated #0: 20 --> ipilimumab
    n1=en:ly2624587 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3360. en:ly2880070 --- r_associated #0: 20 --> ipilimumab
    n1=en:ly2880070 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3361. en:ly6k/vegfr1/vegfr2 multipeptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:ly6k/vegfr1/vegfr2 multipeptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3362. en:lycopene --- r_associated #0: 20 --> ipilimumab
    n1=en:lycopene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3363. en:lymphokine-activated killer cells --- r_associated #0: 20 --> ipilimumab
    n1=en:lymphokine-activated killer cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3364. en:lymphoma taa-specific cytotoxic t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:lymphoma taa-specific cytotoxic t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3365. en:lyophilized black raspberry lozenge --- r_associated #0: 20 --> ipilimumab
    n1=en:lyophilized black raspberry lozenge | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3366. en:lyophilized black raspberry saliva substitute --- r_associated #0: 20 --> ipilimumab
    n1=en:lyophilized black raspberry saliva substitute | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3367. en:lysine-specific demethylase 1 inhibitor incb059872 --- r_associated #0: 20 --> ipilimumab
    n1=en:lysine-specific demethylase 1 inhibitor incb059872 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3368. en:lyso-thermosensitive liposome doxorubicin --- r_associated #0: 20 --> ipilimumab
    n1=en:lyso-thermosensitive liposome doxorubicin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3369. en:m-azidopyrimethamine --- r_associated #0: 20 --> ipilimumab
    n1=en:m-azidopyrimethamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3370. en:m87o-transduced cd34+ peripheral blood stem cells --- r_associated #0: 20 --> ipilimumab
    n1=en:m87o-transduced cd34+ peripheral blood stem cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3371. en:mac321 --- r_associated #0: 20 --> ipilimumab
    n1=en:mac321 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3372. en:macimorelin --- r_associated #0: 20 --> ipilimumab
    n1=en:macimorelin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3373. en:macitentan --- r_associated #0: 20 --> ipilimumab
    n1=en:macitentan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3374. en:macrogol 3350-based iso-osmotic laxative --- r_associated #0: 20 --> ipilimumab
    n1=en:macrogol 3350-based iso-osmotic laxative | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3375. en:mafosfamide --- r_associated #0: 20 --> ipilimumab
    n1=en:mafosfamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3376. en:mag-tn3/as15 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:mag-tn3/as15 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3377. en:mage-10.a2 --- r_associated #0: 20 --> ipilimumab
    n1=en:mage-10.a2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3378. en:mage-12 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:mage-12 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3379. en:mage-3.a1 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:mage-3.a1 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3380. en:mage-a1, her-2/neu, fbp peptides cancer vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:mage-a1, her-2/neu, fbp peptides cancer vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3381. en:mage-a1/mage-a3/ny-eso-1 peptides vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:mage-a1/mage-a3/ny-eso-1 peptides vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3382. en:mage-a3 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:mage-a3 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3383. en:mage-a3 reactive t cell receptor-transduced autologous t cells --- r_associated #0: 20 --> ipilimumab
    n1=en:mage-a3 reactive t cell receptor-transduced autologous t cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3384. en:mage-a3-expressing adenovirus type 5 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:mage-a3-expressing adenovirus type 5 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3385. en:mage-a3/12-specific tcr gene-transduced autologous pbls --- r_associated #0: 20 --> ipilimumab
    n1=en:mage-a3/12-specific tcr gene-transduced autologous pbls | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3386. en:mage-a3/hpv 16 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:mage-a3/hpv 16 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3387. en:mage-a4-specific tcr gene-transduced autologous t lymphocytes tbi-1201 --- r_associated #0: 20 --> ipilimumab
    n1=en:mage-a4-specific tcr gene-transduced autologous t lymphocytes tbi-1201 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3388. en:magnesium citrate --- r_associated #0: 20 --> ipilimumab
    n1=en:magnesium citrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3389. en:magnesium hydroxide --- r_associated #0: 20 --> ipilimumab
    n1=en:magnesium hydroxide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3390. en:magnesium isoglycyrrhizinate --- r_associated #0: 20 --> ipilimumab
    n1=en:magnesium isoglycyrrhizinate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3391. en:magnesium l-threonate --- r_associated #0: 20 --> ipilimumab
    n1=en:magnesium l-threonate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3392. en:magnesium oxide --- r_associated #0: 20 --> ipilimumab
    n1=en:magnesium oxide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3393. en:magnesium sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:magnesium sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3394. en:magnesium valproate --- r_associated #0: 20 --> ipilimumab
    n1=en:magnesium valproate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3395. en:maitake mushroom extract --- r_associated #0: 20 --> ipilimumab
    n1=en:maitake mushroom extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3396. en:malignant glioma tumor lysate-pulsed autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:malignant glioma tumor lysate-pulsed autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3397. en:maltodextrin --- r_associated #0: 20 --> ipilimumab
    n1=en:maltodextrin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3398. en:maltose --- r_associated #0: 20 --> ipilimumab
    n1=en:maltose | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3399. en:maltose tetrapalmitate --- r_associated #0: 20 --> ipilimumab
    n1=en:maltose tetrapalmitate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3400. en:mammaglobin-a dna vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:mammaglobin-a dna vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3401. en:mangafodipir trisodium --- r_associated #0: 20 --> ipilimumab
    n1=en:mangafodipir trisodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3402. en:mannitol --- r_associated #0: 20 --> ipilimumab
    n1=en:mannitol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3403. en:mannose-binding lectin --- r_associated #0: 20 --> ipilimumab
    n1=en:mannose-binding lectin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3404. en:manuka honey --- r_associated #0: 20 --> ipilimumab
    n1=en:manuka honey | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3405. en:mapatumumab --- r_associated #0: 20 --> ipilimumab
    n1=en:mapatumumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3406. en:maraviroc --- r_associated #0: 20 --> ipilimumab
    n1=en:maraviroc | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3407. en:marcellomycin --- r_associated #0: 20 --> ipilimumab
    n1=en:marcellomycin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3408. en:margetuximab --- r_associated #0: 20 --> ipilimumab
    n1=en:margetuximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3409. en:maribavir --- r_associated #0: 20 --> ipilimumab
    n1=en:maribavir | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3410. en:marijuana --- r_associated #0: 20 --> ipilimumab
    n1=en:marijuana | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3411. en:marimastat --- r_associated #0: 20 --> ipilimumab
    n1=en:marimastat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3412. en:marizomib --- r_associated #0: 20 --> ipilimumab
    n1=en:marizomib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3413. en:mart-1 reactive cd8+ lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:mart-1 reactive cd8+ lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3414. en:mart-1/gp100/tyrosinase/mage-a3 peptides-loaded irradiated allogeneic plasmacytoid dendritic cells --- r_associated #0: 20 --> ipilimumab
    n1=en:mart-1/gp100/tyrosinase/mage-a3 peptides-loaded irradiated allogeneic plasmacytoid dendritic cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3415. en:mart-1:26-35(27l) peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:mart-1:26-35(27l) peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3416. en:mart-1:27-35 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:mart-1:27-35 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3417. en:masitinib mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:masitinib mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3418. en:masoprocol --- r_associated #0: 20 --> ipilimumab
    n1=en:masoprocol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3419. en:mast cell stabilizer --- r_associated #0: 20 --> ipilimumab
    n1=en:mast cell stabilizer | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3420. en:mast cell stabilizer tf002 --- r_associated #0: 20 --> ipilimumab
    n1=en:mast cell stabilizer tf002 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3421. en:materia medica --- r_associated #0: 20 --> ipilimumab
    n1=en:materia medica | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3422. en:matricaria recutita gel --- r_associated #0: 20 --> ipilimumab
    n1=en:matricaria recutita gel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3423. en:matricaria recutita topical infusion --- r_associated #0: 20 --> ipilimumab
    n1=en:matricaria recutita topical infusion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3424. en:matuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:matuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3425. en:maxzide --- r_associated #0: 20 --> ipilimumab
    n1=en:maxzide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3426. en:maytansine --- r_associated #0: 20 --> ipilimumab
    n1=en:maytansine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3427. en:mcl-1 inhibitor amg 176 --- r_associated #0: 20 --> ipilimumab
    n1=en:mcl-1 inhibitor amg 176 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3428. en:mcpyv tag-specific polyclonal autologous cd8-positive t cells --- r_associated #0: 20 --> ipilimumab
    n1=en:mcpyv tag-specific polyclonal autologous cd8-positive t cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3429. en:mcs-5 --- r_associated #0: 20 --> ipilimumab
    n1=en:mcs-5 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3430. en:mct/lct lipid emulsion --- r_associated #0: 20 --> ipilimumab
    n1=en:mct/lct lipid emulsion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3431. en:mct/lct/fish oil omega-3 fatty acid lipid emulsion --- r_associated #0: 20 --> ipilimumab
    n1=en:mct/lct/fish oil omega-3 fatty acid lipid emulsion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3432. en:mdm2 antagonist ro5045337 --- r_associated #0: 20 --> ipilimumab
    n1=en:mdm2 antagonist ro5045337 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3433. en:mdm2 antagonist ro6839921 --- r_associated #0: 20 --> ipilimumab
    n1=en:mdm2 antagonist ro6839921 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3434. en:mdm2 inhibitor amg-232 --- r_associated #0: 20 --> ipilimumab
    n1=en:mdm2 inhibitor amg-232 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3435. en:mdm2 inhibitor ds-3032b --- r_associated #0: 20 --> ipilimumab
    n1=en:mdm2 inhibitor ds-3032b | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3436. en:mdm2/mdmx inhibitor alrn-6924 --- r_associated #0: 20 --> ipilimumab
    n1=en:mdm2/mdmx inhibitor alrn-6924 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3437. en:mdr modulator cbt-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:mdr modulator cbt-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3438. en:mdx-1379 melanoma vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:mdx-1379 melanoma vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3439. en:me-143 --- r_associated #0: 20 --> ipilimumab
    n1=en:me-143 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3440. en:measles/mumps/rubella vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:measles/mumps/rubella vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3441. en:mebendazole --- r_associated #0: 20 --> ipilimumab
    n1=en:mebendazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3442. en:mechlorethamine --- r_associated #0: 20 --> ipilimumab
    n1=en:mechlorethamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3443. en:mechlorethamine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:mechlorethamine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3444. en:mechlorethamine hydrochloride gel --- r_associated #0: 20 --> ipilimumab
    n1=en:mechlorethamine hydrochloride gel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3445. en:meclocycline sulfosalicylate --- r_associated #0: 20 --> ipilimumab
    n1=en:meclocycline sulfosalicylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3446. en:meclofenamate sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:meclofenamate sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3447. en:medical gases --- r_associated #0: 20 --> ipilimumab
    n1=en:medical gases | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3448. en:medical marijuana --- r_associated #0: 20 --> ipilimumab
    n1=en:medical marijuana | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3449. en:medication --- r_associated #0: 20 --> ipilimumab
    n1=en:medication | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3450. en:medroxyprogesterone --- r_associated #0: 20 --> ipilimumab
    n1=en:medroxyprogesterone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3451. en:mefloquine --- r_associated #0: 20 --> ipilimumab
    n1=en:mefloquine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3452. en:megestrol --- r_associated #0: 20 --> ipilimumab
    n1=en:megestrol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3453. en:megestrol acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:megestrol acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3454. en:meglumine ioxithalamate --- r_associated #0: 20 --> ipilimumab
    n1=en:meglumine ioxithalamate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3455. en:mek 1/2 inhibitor as703988/msc2015103b --- r_associated #0: 20 --> ipilimumab
    n1=en:mek 1/2 inhibitor as703988/msc2015103b | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3456. en:mek inhibitor azd8330 --- r_associated #0: 20 --> ipilimumab
    n1=en:mek inhibitor azd8330 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3457. en:mek inhibitor ci-1040 --- r_associated #0: 20 --> ipilimumab
    n1=en:mek inhibitor ci-1040 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3458. en:mek inhibitor gdc-0623 --- r_associated #0: 20 --> ipilimumab
    n1=en:mek inhibitor gdc-0623 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3459. en:mek inhibitor ro4987655 --- r_associated #0: 20 --> ipilimumab
    n1=en:mek inhibitor ro4987655 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3460. en:mek inhibitor tak-733 --- r_associated #0: 20 --> ipilimumab
    n1=en:mek inhibitor tak-733 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3461. en:mek inhibitor wx-554 --- r_associated #0: 20 --> ipilimumab
    n1=en:mek inhibitor wx-554 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3462. en:mek-1/mekk-1 inhibitor e6201 --- r_associated #0: 20 --> ipilimumab
    n1=en:mek-1/mekk-1 inhibitor e6201 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3463. en:mek/aurora kinase inhibitor bi 847325 --- r_associated #0: 20 --> ipilimumab
    n1=en:mek/aurora kinase inhibitor bi 847325 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3464. en:melan-a vlp vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:melan-a vlp vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3465. en:melan-a/mage-3.dp4 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:melan-a/mage-3.dp4 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3466. en:melanoma antigen recognized by t-cells 1 --- r_associated #0: 20 --> ipilimumab
    n1=en:melanoma antigen recognized by t-cells 1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3467. en:melanoma helper peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:melanoma helper peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3468. en:melanoma trp2 ctl epitope vaccine scib1 --- r_associated #0: 20 --> ipilimumab
    n1=en:melanoma trp2 ctl epitope vaccine scib1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3469. en:melitac 12.1 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:melitac 12.1 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3470. en:melk inhibitor ots167 --- r_associated #0: 20 --> ipilimumab
    n1=en:melk inhibitor ots167 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3471. en:mellaril --- r_associated #0: 20 --> ipilimumab
    n1=en:mellaril | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3472. en:meloxicam --- r_associated #0: 20 --> ipilimumab
    n1=en:meloxicam | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3473. en:melphalan --- r_associated #0: 20 --> ipilimumab
    n1=en:melphalan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3474. en:melphalan hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:melphalan hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3475. en:melphalan hydrochloride/sulfobutyl ether beta-cyclodextrin complex --- r_associated #0: 20 --> ipilimumab
    n1=en:melphalan hydrochloride/sulfobutyl ether beta-cyclodextrin complex | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3476. en:melphalan-flufenamide prodrug --- r_associated #0: 20 --> ipilimumab
    n1=en:melphalan-flufenamide prodrug | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3477. en:memantine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:memantine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3478. en:membrane-disrupting peptide ep-100 --- r_associated #0: 20 --> ipilimumab
    n1=en:membrane-disrupting peptide ep-100 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3479. en:menadione topical lotion --- r_associated #0: 20 --> ipilimumab
    n1=en:menadione topical lotion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3480. en:menatetrenone --- r_associated #0: 20 --> ipilimumab
    n1=en:menatetrenone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3481. en:menogaril --- r_associated #0: 20 --> ipilimumab
    n1=en:menogaril | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3482. en:menthol --- r_associated #0: 20 --> ipilimumab
    n1=en:menthol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3483. en:meperidine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:meperidine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3484. en:mepivacaine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:mepivacaine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3485. en:merbarone --- r_associated #0: 20 --> ipilimumab
    n1=en:merbarone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3486. en:mercaptopurine --- r_associated #0: 20 --> ipilimumab
    n1=en:mercaptopurine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3487. en:mercaptopurine anhydrous --- r_associated #0: 20 --> ipilimumab
    n1=en:mercaptopurine anhydrous | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3488. en:mercaptopurine oral suspension --- r_associated #0: 20 --> ipilimumab
    n1=en:mercaptopurine oral suspension | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3489. en:mercuric cyanide --- r_associated #0: 20 --> ipilimumab
    n1=en:mercuric cyanide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3490. en:merestinib --- r_associated #0: 20 --> ipilimumab
    n1=en:merestinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3491. en:meropenem --- r_associated #0: 20 --> ipilimumab
    n1=en:meropenem | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3492. en:mesalamine --- r_associated #0: 20 --> ipilimumab
    n1=en:mesalamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3493. en:mesna --- r_associated #0: 20 --> ipilimumab
    n1=en:mesna | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3494. en:mesothelin-specific chimeric antigen receptor-engineered peripheral blood lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:mesothelin-specific chimeric antigen receptor-engineered peripheral blood lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3495. en:mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3496. en:met tyrosine kinase inhibitor bms-777607 --- r_associated #0: 20 --> ipilimumab
    n1=en:met tyrosine kinase inhibitor bms-777607 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3497. en:met tyrosine kinase inhibitor emd 1204831 --- r_associated #0: 20 --> ipilimumab
    n1=en:met tyrosine kinase inhibitor emd 1204831 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3498. en:met tyrosine kinase inhibitor pf-04217903 --- r_associated #0: 20 --> ipilimumab
    n1=en:met tyrosine kinase inhibitor pf-04217903 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3499. en:met tyrosine kinase inhibitor sar125844 --- r_associated #0: 20 --> ipilimumab
    n1=en:met tyrosine kinase inhibitor sar125844 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3500. en:met tyrosine kinase inhibitor sgx523 --- r_associated #0: 20 --> ipilimumab
    n1=en:met tyrosine kinase inhibitor sgx523 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3501. en:meta-fluorine f 18 fluorobenzylguanidine --- r_associated #0: 20 --> ipilimumab
    n1=en:meta-fluorine f 18 fluorobenzylguanidine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3502. en:metahexamide --- r_associated #0: 20 --> ipilimumab
    n1=en:metahexamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3503. en:metaiodobenzylguanidine[131i] --- r_associated #0: 20 --> ipilimumab
    n1=en:metaiodobenzylguanidine[131i] | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3504. en:metap2 inhibitor sdx-7320 --- r_associated #0: 20 --> ipilimumab
    n1=en:metap2 inhibitor sdx-7320 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3505. en:metatinib tromethamine --- r_associated #0: 20 --> ipilimumab
    n1=en:metatinib tromethamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3506. en:metformin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:metformin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3507. en:methadone hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:methadone hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3508. en:methanol extraction residue of bcg --- r_associated #0: 20 --> ipilimumab
    n1=en:methanol extraction residue of bcg | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3509. en:methazolamide --- r_associated #0: 20 --> ipilimumab
    n1=en:methazolamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3510. en:methimazole --- r_associated #0: 20 --> ipilimumab
    n1=en:methimazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3511. en:methionine c 11 --- r_associated #0: 20 --> ipilimumab
    n1=en:methionine c 11 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3512. en:methotrexate --- r_associated #0: 20 --> ipilimumab
    n1=en:methotrexate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3513. en:methotrexate-e therapeutic implant --- r_associated #0: 20 --> ipilimumab
    n1=en:methotrexate-e therapeutic implant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3514. en:methotrexate-encapsulating autologous tumor-derived microparticles --- r_associated #0: 20 --> ipilimumab
    n1=en:methotrexate-encapsulating autologous tumor-derived microparticles | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3515. en:methoxsalen --- r_associated #0: 20 --> ipilimumab
    n1=en:methoxsalen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3516. en:methoxy polyethylene glycol-epoetin beta --- r_associated #0: 20 --> ipilimumab
    n1=en:methoxy polyethylene glycol-epoetin beta | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3517. en:methoxyamine --- r_associated #0: 20 --> ipilimumab
    n1=en:methoxyamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3518. en:methoxyamine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:methoxyamine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3519. en:methoxyflurane --- r_associated #0: 20 --> ipilimumab
    n1=en:methoxyflurane | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3520. en:methyl-5-aminolevulinate hydrochloride cream --- r_associated #0: 20 --> ipilimumab
    n1=en:methyl-5-aminolevulinate hydrochloride cream | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3521. en:methylcellulose --- r_associated #0: 20 --> ipilimumab
    n1=en:methylcellulose | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3522. en:methylene blue --- r_associated #0: 20 --> ipilimumab
    n1=en:methylene blue | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3523. en:methylene dimethane sulfonate --- r_associated #0: 20 --> ipilimumab
    n1=en:methylene dimethane sulfonate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3524. en:methylmercaptopurine riboside --- r_associated #0: 20 --> ipilimumab
    n1=en:methylmercaptopurine riboside | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3525. en:methylnaltrexone --- r_associated #0: 20 --> ipilimumab
    n1=en:methylnaltrexone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3526. en:methylphenidate hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:methylphenidate hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3527. en:methylprednisolone --- r_associated #0: 20 --> ipilimumab
    n1=en:methylprednisolone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3528. en:methylselenocysteine --- r_associated #0: 20 --> ipilimumab
    n1=en:methylselenocysteine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3529. en:methyltestosterone --- r_associated #0: 20 --> ipilimumab
    n1=en:methyltestosterone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3530. en:metoclopramide hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:metoclopramide hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3531. en:metoprine --- r_associated #0: 20 --> ipilimumab
    n1=en:metoprine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3532. en:metoprolol --- r_associated #0: 20 --> ipilimumab
    n1=en:metoprolol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3533. en:metreleptin --- r_associated #0: 20 --> ipilimumab
    n1=en:metreleptin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3534. en:metronidazole hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:metronidazole hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3535. en:metyrosine --- r_associated #0: 20 --> ipilimumab
    n1=en:metyrosine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3536. en:mezlocillin --- r_associated #0: 20 --> ipilimumab
    n1=en:mezlocillin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3537. en:mfe23 scfv-expressing autologous anti-cea mfez t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:mfe23 scfv-expressing autologous anti-cea mfez t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3538. en:mg 98 --- r_associated #0: 20 --> ipilimumab
    n1=en:mg 98 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3539. en:mgmtp140k-encoding retroviral vector --- r_associated #0: 20 --> ipilimumab
    n1=en:mgmtp140k-encoding retroviral vector | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3540. en:mibefradil dihydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:mibefradil dihydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3541. en:micafungin --- r_associated #0: 20 --> ipilimumab
    n1=en:micafungin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3542. en:micafungin sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:micafungin sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3543. en:micellar nanoparticle-encapsulated cisplatin nc-6004 --- r_associated #0: 20 --> ipilimumab
    n1=en:micellar nanoparticle-encapsulated cisplatin nc-6004 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3544. en:micronutrient-fortified probiotic yogurt --- r_associated #0: 20 --> ipilimumab
    n1=en:micronutrient-fortified probiotic yogurt | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3545. en:microtubule-targeted agent bal101553 --- r_associated #0: 20 --> ipilimumab
    n1=en:microtubule-targeted agent bal101553 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3546. en:midazolam hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:midazolam hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3547. en:midazolam-containing buccal liquid --- r_associated #0: 20 --> ipilimumab
    n1=en:midazolam-containing buccal liquid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3548. en:midostaurin --- r_associated #0: 20 --> ipilimumab
    n1=en:midostaurin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3549. en:mifamurtide --- r_associated #0: 20 --> ipilimumab
    n1=en:mifamurtide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3550. en:mifepristone --- r_associated #0: 20 --> ipilimumab
    n1=en:mifepristone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3551. en:miglitol --- r_associated #0: 20 --> ipilimumab
    n1=en:miglitol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3552. en:miglustat --- r_associated #0: 20 --> ipilimumab
    n1=en:miglustat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3553. en:miha-loaded pd-l1/l2-silenced dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:miha-loaded pd-l1/l2-silenced dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3554. en:milatuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:milatuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3555. en:milatuzumab-doxorubicin antibody-drug conjugate --- r_associated #0: 20 --> ipilimumab
    n1=en:milatuzumab-doxorubicin antibody-drug conjugate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3556. en:milk protein-based energy drink --- r_associated #0: 20 --> ipilimumab
    n1=en:milk protein-based energy drink | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3557. en:milk thistle --- r_associated #0: 20 --> ipilimumab
    n1=en:milk thistle | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3558. en:milodistim --- r_associated #0: 20 --> ipilimumab
    n1=en:milodistim | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3559. en:miltefosine --- r_associated #0: 20 --> ipilimumab
    n1=en:miltefosine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3560. en:mimotope-p10s-padre peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:mimotope-p10s-padre peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3561. en:minocycline hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:minocycline hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3562. en:minocycline-edta --- r_associated #0: 20 --> ipilimumab
    n1=en:minocycline-edta | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3563. en:miotics --- r_associated #0: 20 --> ipilimumab
    n1=en:miotics | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3564. en:mipsagargin --- r_associated #0: 20 --> ipilimumab
    n1=en:mipsagargin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3565. en:mirabegron --- r_associated #0: 20 --> ipilimumab
    n1=en:mirabegron | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3566. en:miracle mouthwash plus hydrocortisone --- r_associated #0: 20 --> ipilimumab
    n1=en:miracle mouthwash plus hydrocortisone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3567. en:mirtazapine --- r_associated #0: 20 --> ipilimumab
    n1=en:mirtazapine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3568. en:mirvetuximab soravtansine --- r_associated #0: 20 --> ipilimumab
    n1=en:mirvetuximab soravtansine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3569. en:misonidazole --- r_associated #0: 20 --> ipilimumab
    n1=en:misonidazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3570. en:misoprostol --- r_associated #0: 20 --> ipilimumab
    n1=en:misoprostol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3571. en:mistletoe extract --- r_associated #0: 20 --> ipilimumab
    n1=en:mistletoe extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3572. en:mitoflaxone --- r_associated #0: 20 --> ipilimumab
    n1=en:mitoflaxone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3573. en:mitogen --- r_associated #0: 20 --> ipilimumab
    n1=en:mitogen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3574. en:mitoguazone --- r_associated #0: 20 --> ipilimumab
    n1=en:mitoguazone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3575. en:mitolactol --- r_associated #0: 20 --> ipilimumab
    n1=en:mitolactol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3576. en:mitomycin --- r_associated #0: 20 --> ipilimumab
    n1=en:mitomycin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3577. en:mitoquidone --- r_associated #0: 20 --> ipilimumab
    n1=en:mitoquidone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3578. en:mitotane --- r_associated #0: 20 --> ipilimumab
    n1=en:mitotane | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3579. en:mitoxantrone --- r_associated #0: 20 --> ipilimumab
    n1=en:mitoxantrone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3580. en:mitoxantrone hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:mitoxantrone hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3581. en:mitozolomide --- r_associated #0: 20 --> ipilimumab
    n1=en:mitozolomide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3582. en:mivobulin isethionate --- r_associated #0: 20 --> ipilimumab
    n1=en:mivobulin isethionate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3583. en:mixed bacteria vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:mixed bacteria vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3584. en:mk-1248 --- r_associated #0: 20 --> ipilimumab
    n1=en:mk-1248 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3585. en:mk-4280 --- r_associated #0: 20 --> ipilimumab
    n1=en:mk-4280 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3586. en:mk-6592 --- r_associated #0: 20 --> ipilimumab
    n1=en:mk-6592 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3587. en:mk-8808 --- r_associated #0: 20 --> ipilimumab
    n1=en:mk-8808 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3588. en:mk0429 --- r_associated #0: 20 --> ipilimumab
    n1=en:mk0429 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3589. en:mk0731 --- r_associated #0: 20 --> ipilimumab
    n1=en:mk0731 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3590. en:mkc-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:mkc-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3591. en:mknk1 inhibitor bay 1143269 --- r_associated #0: 20 --> ipilimumab
    n1=en:mknk1 inhibitor bay 1143269 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3592. en:mln2704 --- r_associated #0: 20 --> ipilimumab
    n1=en:mln2704 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3593. en:mnk1/2 inhibitor eft508 --- r_associated #0: 20 --> ipilimumab
    n1=en:mnk1/2 inhibitor eft508 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3594. en:mnsod mimetic bmx-001 --- r_associated #0: 20 --> ipilimumab
    n1=en:mnsod mimetic bmx-001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3595. en:mocetinostat --- r_associated #0: 20 --> ipilimumab
    n1=en:mocetinostat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3596. en:modafinil --- r_associated #0: 20 --> ipilimumab
    n1=en:modafinil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3597. en:modified citrus pectin supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:modified citrus pectin supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3598. en:modified vaccinia ankara (bavarian nordic)-her2 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:modified vaccinia ankara (bavarian nordic)-her2 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3599. en:modified vaccinia virus ankara vaccine expressing p53 --- r_associated #0: 20 --> ipilimumab
    n1=en:modified vaccinia virus ankara vaccine expressing p53 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3600. en:modified-release calcifediol capsule --- r_associated #0: 20 --> ipilimumab
    n1=en:modified-release calcifediol capsule | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3601. en:mogamulizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:mogamulizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3602. en:molecular target inhibitors --- r_associated #0: 20 --> ipilimumab
    n1=en:molecular target inhibitors | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3603. en:molybdenum --- r_associated #0: 20 --> ipilimumab
    n1=en:molybdenum | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3604. en:momelotinib --- r_associated #0: 20 --> ipilimumab
    n1=en:momelotinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3605. en:mometasone furoate --- r_associated #0: 20 --> ipilimumab
    n1=en:mometasone furoate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3606. en:monalizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:monalizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3607. en:monoacetyldiglyceride ec-18 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoacetyldiglyceride ec-18 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3608. en:monobenzone --- r_associated #0: 20 --> ipilimumab
    n1=en:monobenzone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3609. en:monocarboxylate transporter 1 inhibitor azd3965 --- r_associated #0: 20 --> ipilimumab
    n1=en:monocarboxylate transporter 1 inhibitor azd3965 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3610. en:monoclonal antibodies, antineoplastic --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibodies, antineoplastic | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3611. en:monoclonal antibody --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3612. en:monoclonal antibody 105ad7 anti-idiotype vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody 105ad7 anti-idiotype vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3613. en:monoclonal antibody 11d10 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody 11d10 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3614. en:monoclonal antibody 11d10 anti-idiotype vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody 11d10 anti-idiotype vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3615. en:monoclonal antibody 14g2a --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody 14g2a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3616. en:monoclonal antibody 3622w94 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody 3622w94 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3617. en:monoclonal antibody 3f8 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody 3f8 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3618. en:monoclonal antibody 3h1 anti-idiotype vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody 3h1 anti-idiotype vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3619. en:monoclonal antibody 4b5 anti-idiotype vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody 4b5 anti-idiotype vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3620. en:monoclonal antibody a1g4 anti-idiotype vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody a1g4 anti-idiotype vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3621. en:monoclonal antibody a27.15 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody a27.15 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3622. en:monoclonal antibody a33 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody a33 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3623. en:monoclonal antibody abgn-7 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody abgn-7 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3624. en:monoclonal antibody agent --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3625. en:monoclonal antibody amg 228 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody amg 228 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3626. en:monoclonal antibody c-58 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody c-58 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3627. en:monoclonal antibody cal --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody cal | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3628. en:monoclonal antibody cbe-11 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody cbe-11 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3629. en:monoclonal antibody cc49 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody cc49 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3630. en:monoclonal antibody cc49-delta ch2 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody cc49-delta ch2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3631. en:monoclonal antibody cc49-streptavidin conjugate --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody cc49-streptavidin conjugate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3632. en:monoclonal antibody cd19 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody cd19 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3633. en:monoclonal antibody cep-37250/khk2804 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody cep-37250/khk2804 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3634. en:monoclonal antibody d6.12 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody d6.12 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3635. en:monoclonal antibody e2.3 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody e2.3 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3636. en:monoclonal antibody f19 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody f19 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3637. en:monoclonal antibody gd2 anti-idiotype vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody gd2 anti-idiotype vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3638. en:monoclonal antibody hefi-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody hefi-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3639. en:monoclonal antibody hu3s193 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody hu3s193 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3640. en:monoclonal antibody huafp31 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody huafp31 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3641. en:monoclonal antibody huhmfg1 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody huhmfg1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3642. en:monoclonal antibody huj591 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody huj591 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3643. en:monoclonal antibody hupam4 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody hupam4 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3644. en:monoclonal antibody idec-159 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody idec-159 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3645. en:monoclonal antibody ing-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody ing-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3646. en:monoclonal antibody l6 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody l6 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3647. en:monoclonal antibody lym-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody lym-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3648. en:monoclonal antibody m170 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody m170 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3649. en:monoclonal antibody me1-14 f(ab')2 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody me1-14 f(ab')2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3650. en:monoclonal antibody mga271 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody mga271 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3651. en:monoclonal antibody mik-beta-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody mik-beta-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3652. en:monoclonal antibody mono-dga-rfb4 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody mono-dga-rfb4 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3653. en:monoclonal antibody muj591 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody muj591 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3654. en:monoclonal antibody mx35 f(ab')2 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody mx35 f(ab')2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3655. en:monoclonal antibody r24 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody r24 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3656. en:monoclonal antibody rav12 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody rav12 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3657. en:monoclonal antibody sgn-30 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody sgn-30 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3658. en:monoclonal antibody t101 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal antibody t101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3659. en:monoclonal t-cell receptor anti-cd3 scfv fusion protein imcgp100 --- r_associated #0: 20 --> ipilimumab
    n1=en:monoclonal t-cell receptor anti-cd3 scfv fusion protein imcgp100 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3660. en:monophosphoryl lipid a --- r_associated #0: 20 --> ipilimumab
    n1=en:monophosphoryl lipid a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3661. en:monosialotetrahexosylganglioside --- r_associated #0: 20 --> ipilimumab
    n1=en:monosialotetrahexosylganglioside | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3662. en:montanide isa 51 vg --- r_associated #0: 20 --> ipilimumab
    n1=en:montanide isa 51 vg | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3663. en:montanide isa 720 --- r_associated #0: 20 --> ipilimumab
    n1=en:montanide isa 720 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3664. en:montelukast sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:montelukast sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3665. en:mopidamol --- r_associated #0: 20 --> ipilimumab
    n1=en:mopidamol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3666. en:mopp regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:mopp regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3667. en:morinda citrifolia fruit extract --- r_associated #0: 20 --> ipilimumab
    n1=en:morinda citrifolia fruit extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3668. en:morphine --- r_associated #0: 20 --> ipilimumab
    n1=en:morphine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3669. en:morphine sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:morphine sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3670. en:morphine sulfate sustained-release tablet --- r_associated #0: 20 --> ipilimumab
    n1=en:morphine sulfate sustained-release tablet | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3671. en:mosapride --- r_associated #0: 20 --> ipilimumab
    n1=en:mosapride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3672. en:motesanib diphosphate --- r_associated #0: 20 --> ipilimumab
    n1=en:motesanib diphosphate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3673. en:motexafin gadolinium --- r_associated #0: 20 --> ipilimumab
    n1=en:motexafin gadolinium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3674. en:motexafin lutetium --- r_associated #0: 20 --> ipilimumab
    n1=en:motexafin lutetium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3675. en:mouse gp100 plasmid dna vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:mouse gp100 plasmid dna vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3676. en:mouse monoclonal antibody --- r_associated #0: 20 --> ipilimumab
    n1=en:mouse monoclonal antibody | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3677. en:mouse prostate-specific membrane antigen plasmid dna vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:mouse prostate-specific membrane antigen plasmid dna vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3678. en:mouse renal adenocarcinoma cell-encapsulated agarose-agarose macrobeads --- r_associated #0: 20 --> ipilimumab
    n1=en:mouse renal adenocarcinoma cell-encapsulated agarose-agarose macrobeads | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3679. en:mov-gamma chimeric receptor gene --- r_associated #0: 20 --> ipilimumab
    n1=en:mov-gamma chimeric receptor gene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3680. en:moxalactam --- r_associated #0: 20 --> ipilimumab
    n1=en:moxalactam | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3681. en:moxetumomab pasudotox --- r_associated #0: 20 --> ipilimumab
    n1=en:moxetumomab pasudotox | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3682. en:moxifloxacin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:moxifloxacin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3683. en:mps1 inhibitor bay 1217389 --- r_associated #0: 20 --> ipilimumab
    n1=en:mps1 inhibitor bay 1217389 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3684. en:mps1 kinase inhibitor bay1161909 --- r_associated #0: 20 --> ipilimumab
    n1=en:mps1 kinase inhibitor bay1161909 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3685. en:mrna-derived lung cancer vaccine cv9202 --- r_associated #0: 20 --> ipilimumab
    n1=en:mrna-derived lung cancer vaccine cv9202 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3686. en:mrna-derived prostate cancer vaccine cv9103 --- r_associated #0: 20 --> ipilimumab
    n1=en:mrna-derived prostate cancer vaccine cv9103 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3687. en:mrna-derived prostate cancer vaccine cv9104 --- r_associated #0: 20 --> ipilimumab
    n1=en:mrna-derived prostate cancer vaccine cv9104 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3688. en:mtf-1 inhibitor apto-253 hcl --- r_associated #0: 20 --> ipilimumab
    n1=en:mtf-1 inhibitor apto-253 hcl | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3689. en:mtig7192a --- r_associated #0: 20 --> ipilimumab
    n1=en:mtig7192a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3690. en:mtor kinase inhibitor azd8055 --- r_associated #0: 20 --> ipilimumab
    n1=en:mtor kinase inhibitor azd8055 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3691. en:mtor kinase inhibitor cc-223 --- r_associated #0: 20 --> ipilimumab
    n1=en:mtor kinase inhibitor cc-223 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3692. en:mtor kinase inhibitor osi-027 --- r_associated #0: 20 --> ipilimumab
    n1=en:mtor kinase inhibitor osi-027 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3693. en:mtor1/2 kinase inhibitor me-344 --- r_associated #0: 20 --> ipilimumab
    n1=en:mtor1/2 kinase inhibitor me-344 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3694. en:mtorc1/2 kinase inhibitor bi 860585 --- r_associated #0: 20 --> ipilimumab
    n1=en:mtorc1/2 kinase inhibitor bi 860585 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3695. en:mtorc1/mtorc2/dhfr inhibitor abtl0812 --- r_associated #0: 20 --> ipilimumab
    n1=en:mtorc1/mtorc2/dhfr inhibitor abtl0812 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3696. en:muc-1 antigen --- r_associated #0: 20 --> ipilimumab
    n1=en:muc-1 antigen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3697. en:muc-1 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:muc-1 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3698. en:muc-2-globo h-klh conjugate vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:muc-2-globo h-klh conjugate vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3699. en:muc-2-klh vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:muc-2-klh vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3700. en:muc1 antigen/sb as-2 --- r_associated #0: 20 --> ipilimumab
    n1=en:muc1 antigen/sb as-2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3701. en:muc1 peptide-poly-iclc adjuvant vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:muc1 peptide-poly-iclc adjuvant vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3702. en:muc1-klh conjugate vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:muc1-klh conjugate vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3703. en:muc1-klh vaccine/qs21 --- r_associated #0: 20 --> ipilimumab
    n1=en:muc1-klh vaccine/qs21 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3704. en:muc1-targeted peptide go-203-2c --- r_associated #0: 20 --> ipilimumab
    n1=en:muc1-targeted peptide go-203-2c | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3705. en:muc16-targeted antibody-drug conjugate dmuc5754a --- r_associated #0: 20 --> ipilimumab
    n1=en:muc16-targeted antibody-drug conjugate dmuc5754a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3706. en:mucoadhesive hydrogel gargle --- r_associated #0: 20 --> ipilimumab
    n1=en:mucoadhesive hydrogel gargle | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3707. en:mucoadhesive oral wound rinse --- r_associated #0: 20 --> ipilimumab
    n1=en:mucoadhesive oral wound rinse | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3708. en:mucoadhesive paclitaxel formulation --- r_associated #0: 20 --> ipilimumab
    n1=en:mucoadhesive paclitaxel formulation | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3709. en:mucoprotective agent xer2020 --- r_associated #0: 20 --> ipilimumab
    n1=en:mucoprotective agent xer2020 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3710. en:multi-agc kinase inhibitor at13148 --- r_associated #0: 20 --> ipilimumab
    n1=en:multi-agc kinase inhibitor at13148 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3711. en:multi-epitope folate receptor alpha peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:multi-epitope folate receptor alpha peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3712. en:multi-epitope melanoma peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:multi-epitope melanoma peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3713. en:multi-glioblastoma-peptide-targeting autologous dendritic cell vaccine ict-107 --- r_associated #0: 20 --> ipilimumab
    n1=en:multi-glioblastoma-peptide-targeting autologous dendritic cell vaccine ict-107 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3714. en:multi-peptide cmv-modified vaccinia ankara vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:multi-peptide cmv-modified vaccinia ankara vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3715. en:multi-subtype natural human leukocyte interferon alpha --- r_associated #0: 20 --> ipilimumab
    n1=en:multi-subtype natural human leukocyte interferon alpha | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3716. en:multi-targeted cyclin-dependent protein kinase inhibitor rgb-286638 --- r_associated #0: 20 --> ipilimumab
    n1=en:multi-targeted cyclin-dependent protein kinase inhibitor rgb-286638 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3717. en:multicarotenoid supplement mcs-8 --- r_associated #0: 20 --> ipilimumab
    n1=en:multicarotenoid supplement mcs-8 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3718. en:multidrug resistance modulator --- r_associated #0: 20 --> ipilimumab
    n1=en:multidrug resistance modulator | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3719. en:multifunctional/multitargeted anticancer agent omn54 --- r_associated #0: 20 --> ipilimumab
    n1=en:multifunctional/multitargeted anticancer agent omn54 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3720. en:multikinase inhibitor 4sc-203 --- r_associated #0: 20 --> ipilimumab
    n1=en:multikinase inhibitor 4sc-203 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3721. en:multikinase inhibitor arry614 --- r_associated #0: 20 --> ipilimumab
    n1=en:multikinase inhibitor arry614 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3722. en:multikinase inhibitor at9283 --- r_associated #0: 20 --> ipilimumab
    n1=en:multikinase inhibitor at9283 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3723. en:multikinase inhibitor sar103168 --- r_associated #0: 20 --> ipilimumab
    n1=en:multikinase inhibitor sar103168 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3724. en:multipeptide vaccine s-588210 --- r_associated #0: 20 --> ipilimumab
    n1=en:multipeptide vaccine s-588210 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3725. en:multitargeted kinase inhibitor mgcd516 --- r_associated #0: 20 --> ipilimumab
    n1=en:multitargeted kinase inhibitor mgcd516 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3726. en:multitargeted tyrosine kinase inhibitor jnj-26483327 --- r_associated #0: 20 --> ipilimumab
    n1=en:multitargeted tyrosine kinase inhibitor jnj-26483327 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3727. en:multitargeted tyrosine kinase inhibitor mgcd265 --- r_associated #0: 20 --> ipilimumab
    n1=en:multitargeted tyrosine kinase inhibitor mgcd265 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3728. en:multivitamin --- r_associated #0: 20 --> ipilimumab
    n1=en:multivitamin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3729. en:mureletecan --- r_associated #0: 20 --> ipilimumab
    n1=en:mureletecan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3730. en:murine tyrp2 plasmid dna vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:murine tyrp2 plasmid dna vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3731. en:murine-human monoclonal igg antibody --- r_associated #0: 20 --> ipilimumab
    n1=en:murine-human monoclonal igg antibody | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3732. en:muromonab-cd3 --- r_associated #0: 20 --> ipilimumab
    n1=en:muromonab-cd3 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3733. en:muscadine grape skin extract --- r_associated #0: 20 --> ipilimumab
    n1=en:muscadine grape skin extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3734. en:muscarinic agonist apd515 --- r_associated #0: 20 --> ipilimumab
    n1=en:muscarinic agonist apd515 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3735. en:muscle relaxant --- r_associated #0: 20 --> ipilimumab
    n1=en:muscle relaxant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3736. en:mutagen --- r_associated #0: 20 --> ipilimumab
    n1=en:mutagen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3737. en:mutant p53 activator coti-2 --- r_associated #0: 20 --> ipilimumab
    n1=en:mutant p53 activator coti-2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3738. en:mutant p53 peptide pulsed dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:mutant p53 peptide pulsed dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3739. en:mutant-selective egfr inhibitor pf-06459988 --- r_associated #0: 20 --> ipilimumab
    n1=en:mutant-selective egfr inhibitor pf-06459988 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3740. en:mva-ebna1/lmp2 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:mva-ebna1/lmp2 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3741. en:mva-fcu1 tg4023 --- r_associated #0: 20 --> ipilimumab
    n1=en:mva-fcu1 tg4023 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3742. en:mva-muc1-il2 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:mva-muc1-il2 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3743. en:mva-psa/pap prostate cancer vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:mva-psa/pap prostate cancer vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3744. en:mvf-her-2(597-626)/mvf-her-2 (266-296) peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:mvf-her-2(597-626)/mvf-her-2 (266-296) peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3745. en:mvf-her-2(628-647)-crl 1005 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:mvf-her-2(628-647)-crl 1005 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3746. en:mvx-1-loaded macrocapsule/autologous tumor cell vaccine mvx-onco-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:mvx-1-loaded macrocapsule/autologous tumor cell vaccine mvx-onco-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3747. en:myc-targeting sirna dcr-myc --- r_associated #0: 20 --> ipilimumab
    n1=en:myc-targeting sirna dcr-myc | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3748. en:mycobacterial cell wall-dna complex --- r_associated #0: 20 --> ipilimumab
    n1=en:mycobacterial cell wall-dna complex | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3749. en:mycobacterium tuberculosis arabinomannan z-100 --- r_associated #0: 20 --> ipilimumab
    n1=en:mycobacterium tuberculosis arabinomannan z-100 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3750. en:mycobacterium w --- r_associated #0: 20 --> ipilimumab
    n1=en:mycobacterium w | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3751. en:mycophenolate mofetil --- r_associated #0: 20 --> ipilimumab
    n1=en:mycophenolate mofetil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3752. en:mycophenolic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:mycophenolic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3753. en:myeloablative agonist --- r_associated #0: 20 --> ipilimumab
    n1=en:myeloablative agonist | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3754. en:n-methylformamide --- r_associated #0: 20 --> ipilimumab
    n1=en:n-methylformamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3755. en:na-17/mage-3.a2/ny-eso-1 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:na-17/mage-3.a2/ny-eso-1 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3756. en:na17-a antigen --- r_associated #0: 20 --> ipilimumab
    n1=en:na17-a antigen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3757. en:na17.a2 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:na17.a2 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3758. en:nabilone --- r_associated #0: 20 --> ipilimumab
    n1=en:nabilone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3759. en:nabiximols --- r_associated #0: 20 --> ipilimumab
    n1=en:nabiximols | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3760. en:nadolol --- r_associated #0: 20 --> ipilimumab
    n1=en:nadolol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3761. en:nadroparin calcium --- r_associated #0: 20 --> ipilimumab
    n1=en:nadroparin calcium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3762. en:nafarelin --- r_associated #0: 20 --> ipilimumab
    n1=en:nafarelin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3763. en:nafazatrom --- r_associated #0: 20 --> ipilimumab
    n1=en:nafazatrom | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3764. en:nafoxidine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:nafoxidine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3765. en:naloxegol --- r_associated #0: 20 --> ipilimumab
    n1=en:naloxegol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3766. en:naloxone + oxycodone --- r_associated #0: 20 --> ipilimumab
    n1=en:naloxone + oxycodone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3767. en:naloxone hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:naloxone hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3768. en:naltrexone hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:naltrexone hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3769. en:nandrolone decanoate --- r_associated #0: 20 --> ipilimumab
    n1=en:nandrolone decanoate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3770. en:nanocell-encapsulated mir-16-based microrna mimic --- r_associated #0: 20 --> ipilimumab
    n1=en:nanocell-encapsulated mir-16-based microrna mimic | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3771. en:nanoparticle albumin-bound docetaxel --- r_associated #0: 20 --> ipilimumab
    n1=en:nanoparticle albumin-bound docetaxel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3772. en:nanoparticle albumin-bound rapamycin --- r_associated #0: 20 --> ipilimumab
    n1=en:nanoparticle albumin-bound rapamycin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3773. en:nanoparticle albumin-bound thiocolchicine dimer nab-5404 --- r_associated #0: 20 --> ipilimumab
    n1=en:nanoparticle albumin-bound thiocolchicine dimer nab-5404 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3774. en:nanoparticle-encapsulated docetaxel --- r_associated #0: 20 --> ipilimumab
    n1=en:nanoparticle-encapsulated docetaxel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3775. en:nanoparticle-encapsulated doxorubicin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:nanoparticle-encapsulated doxorubicin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3776. en:nanosomal docetaxel lipid suspension --- r_associated #0: 20 --> ipilimumab
    n1=en:nanosomal docetaxel lipid suspension | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3777. en:napabucasin --- r_associated #0: 20 --> ipilimumab
    n1=en:napabucasin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3778. en:naphthalimide analogue unbs5162 --- r_associated #0: 20 --> ipilimumab
    n1=en:naphthalimide analogue unbs5162 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3779. en:naproxen --- r_associated #0: 20 --> ipilimumab
    n1=en:naproxen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3780. en:naptumomab --- r_associated #0: 20 --> ipilimumab
    n1=en:naptumomab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3781. en:narnatumab --- r_associated #0: 20 --> ipilimumab
    n1=en:narnatumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3782. en:nasal dosage form product --- r_associated #0: 20 --> ipilimumab
    n1=en:nasal dosage form product | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3783. en:nasal saline irrigation solution --- r_associated #0: 20 --> ipilimumab
    n1=en:nasal saline irrigation solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3784. en:natalizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:natalizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3785. en:nateglinide --- r_associated #0: 20 --> ipilimumab
    n1=en:nateglinide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3786. en:natural ifn-alpha opc-18 --- r_associated #0: 20 --> ipilimumab
    n1=en:natural ifn-alpha opc-18 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3787. en:natural killer cells zrx101 --- r_associated #0: 20 --> ipilimumab
    n1=en:natural killer cells zrx101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3788. en:navitoclax --- r_associated #0: 20 --> ipilimumab
    n1=en:navitoclax | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3789. en:navy bean powder --- r_associated #0: 20 --> ipilimumab
    n1=en:navy bean powder | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3790. en:ncit antineoplastic agent terminology --- r_associated #0: 20 --> ipilimumab
    n1=en:ncit antineoplastic agent terminology | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3791. en:ncmtrna oligonucleotide andes-1537 --- r_associated #0: 20 --> ipilimumab
    n1=en:ncmtrna oligonucleotide andes-1537 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3792. en:nd-420 --- r_associated #0: 20 --> ipilimumab
    n1=en:nd-420 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3793. en:necitumumab --- r_associated #0: 20 --> ipilimumab
    n1=en:necitumumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3794. en:nedaplatin --- r_associated #0: 20 --> ipilimumab
    n1=en:nedaplatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3795. en:nefopam hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:nefopam hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3796. en:neihulizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:neihulizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3797. en:nelarabine --- r_associated #0: 20 --> ipilimumab
    n1=en:nelarabine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3798. en:nelfinavir mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:nelfinavir mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3799. en:nelipepimut-s plus gm-csf vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:nelipepimut-s plus gm-csf vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3800. en:neoantigen-based glioblastoma vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:neoantigen-based glioblastoma vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3801. en:neoantigen-based melanoma-poly-iclc vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:neoantigen-based melanoma-poly-iclc vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3802. en:neomycin --- r_associated #0: 20 --> ipilimumab
    n1=en:neomycin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3803. en:nepidermin --- r_associated #0: 20 --> ipilimumab
    n1=en:nepidermin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3804. en:neratinib --- r_associated #0: 20 --> ipilimumab
    n1=en:neratinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3805. en:nesiritide --- r_associated #0: 20 --> ipilimumab
    n1=en:nesiritide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3806. en:nesvacumab --- r_associated #0: 20 --> ipilimumab
    n1=en:nesvacumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3807. en:netazepide --- r_associated #0: 20 --> ipilimumab
    n1=en:netazepide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3808. en:netupitant --- r_associated #0: 20 --> ipilimumab
    n1=en:netupitant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3809. en:netupitant/palonosetron hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:netupitant/palonosetron hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3810. en:neuromuscular blocking agents --- r_associated #0: 20 --> ipilimumab
    n1=en:neuromuscular blocking agents | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3811. en:neuropharmacologic agent --- r_associated #0: 20 --> ipilimumab
    n1=en:neuropharmacologic agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3812. en:neutrophil activation probe imaging agent --- r_associated #0: 20 --> ipilimumab
    n1=en:neutrophil activation probe imaging agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3813. en:nevirapine --- r_associated #0: 20 --> ipilimumab
    n1=en:nevirapine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3814. en:ng-nitro-l-arginine --- r_associated #0: 20 --> ipilimumab
    n1=en:ng-nitro-l-arginine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3815. en:ngfr-transduced autologous t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:ngfr-transduced autologous t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3816. en:niacin --- r_associated #0: 20 --> ipilimumab
    n1=en:niacin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3817. en:niacinamide --- r_associated #0: 20 --> ipilimumab
    n1=en:niacinamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3818. en:nicardipine --- r_associated #0: 20 --> ipilimumab
    n1=en:nicardipine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3819. en:niclosamide --- r_associated #0: 20 --> ipilimumab
    n1=en:niclosamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3820. en:nicotine --- r_associated #0: 20 --> ipilimumab
    n1=en:nicotine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3821. en:nicotine gum --- r_associated #0: 20 --> ipilimumab
    n1=en:nicotine gum | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3822. en:nicotine lozenge --- r_associated #0: 20 --> ipilimumab
    n1=en:nicotine lozenge | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3823. en:nicotine nasal spray --- r_associated #0: 20 --> ipilimumab
    n1=en:nicotine nasal spray | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3824. en:nicotine patch --- r_associated #0: 20 --> ipilimumab
    n1=en:nicotine patch | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3825. en:nifurtimox --- r_associated #0: 20 --> ipilimumab
    n1=en:nifurtimox | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3826. en:nilotinib --- r_associated #0: 20 --> ipilimumab
    n1=en:nilotinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3827. en:nilutamide --- r_associated #0: 20 --> ipilimumab
    n1=en:nilutamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3828. en:nimodipine --- r_associated #0: 20 --> ipilimumab
    n1=en:nimodipine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3829. en:nimorazole --- r_associated #0: 20 --> ipilimumab
    n1=en:nimorazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3830. en:nimotuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:nimotuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3831. en:nimustine --- r_associated #0: 20 --> ipilimumab
    n1=en:nimustine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3832. en:nintedanib --- r_associated #0: 20 --> ipilimumab
    n1=en:nintedanib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3833. en:niraparib --- r_associated #0: 20 --> ipilimumab
    n1=en:niraparib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3834. en:nitazoxanide --- r_associated #0: 20 --> ipilimumab
    n1=en:nitazoxanide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3835. en:nitric oxide-releasing acetylsalicylic acid derivative --- r_associated #0: 20 --> ipilimumab
    n1=en:nitric oxide-releasing acetylsalicylic acid derivative | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3836. en:nitroglycerin --- r_associated #0: 20 --> ipilimumab
    n1=en:nitroglycerin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3837. en:nitroglycerin transdermal patch --- r_associated #0: 20 --> ipilimumab
    n1=en:nitroglycerin transdermal patch | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3838. en:nitroglycerin/sodium citrate/ethanol solution --- r_associated #0: 20 --> ipilimumab
    n1=en:nitroglycerin/sodium citrate/ethanol solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3839. en:nivolumab --- r_associated #0: 20 --> ipilimumab
    n1=en:nivolumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3840. en:nm-3 --- r_associated #0: 20 --> ipilimumab
    n1=en:nm-3 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3841. en:nolatrexed dihydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:nolatrexed dihydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3842. en:non-adjuvanted a(h1n1) influenza vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:non-adjuvanted a(h1n1) influenza vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3843. en:non-small cell lung cancer mrna-derived vaccine cv9201 --- r_associated #0: 20 --> ipilimumab
    n1=en:non-small cell lung cancer mrna-derived vaccine cv9201 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3844. en:nonenzyme proteolytic agent --- r_associated #0: 20 --> ipilimumab
    n1=en:nonenzyme proteolytic agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3845. en:norepinephrine, dl- --- r_associated #0: 20 --> ipilimumab
    n1=en:norepinephrine, dl- | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3846. en:norethindrone acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:norethindrone acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3847. en:norgestrel --- r_associated #0: 20 --> ipilimumab
    n1=en:norgestrel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3848. en:north american ginseng extract afx-2 --- r_associated #0: 20 --> ipilimumab
    n1=en:north american ginseng extract afx-2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3849. en:nortriptyline hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:nortriptyline hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3850. en:noscapine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:noscapine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3851. en:nostrums --- r_associated #0: 20 --> ipilimumab
    n1=en:nostrums | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3852. en:notch signaling inhibitor pf-06650808 --- r_associated #0: 20 --> ipilimumab
    n1=en:notch signaling inhibitor pf-06650808 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3853. en:notch signaling pathway inhibitor mk0752 --- r_associated #0: 20 --> ipilimumab
    n1=en:notch signaling pathway inhibitor mk0752 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3854. en:novobiocin --- r_associated #0: 20 --> ipilimumab
    n1=en:novobiocin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3855. en:nrf2 activator rta 408 --- r_associated #0: 20 --> ipilimumab
    n1=en:nrf2 activator rta 408 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3856. en:ns-9 --- r_associated #0: 20 --> ipilimumab
    n1=en:ns-9 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3857. en:ns5b polymerase inhibitor bms-791325 --- r_associated #0: 20 --> ipilimumab
    n1=en:ns5b polymerase inhibitor bms-791325 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3858. en:nsclc antigen-loaded dendritic cell-derived exosomesnon-small cell lung cancer tumor antigen-loaded dendritic cell-derived exosomes --- r_associated #0: 20 --> ipilimumab
    n1=en:nsclc antigen-loaded dendritic cell-derived exosomesnon-small cell lung cancer tumor antigen-loaded dendritic cell-derived exosomes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3859. en:ntrk/ros1 inhibitor ds-6051b --- r_associated #0: 20 --> ipilimumab
    n1=en:ntrk/ros1 inhibitor ds-6051b | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3860. en:nucleolin antagonist ipp-204106n --- r_associated #0: 20 --> ipilimumab
    n1=en:nucleolin antagonist ipp-204106n | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3861. en:nucleoside analog dfp-10917 --- r_associated #0: 20 --> ipilimumab
    n1=en:nucleoside analog dfp-10917 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3862. en:nucleotide analogue gs 9219 --- r_associated #0: 20 --> ipilimumab
    n1=en:nucleotide analogue gs 9219 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3863. en:nutlin-3a --- r_associated #0: 20 --> ipilimumab
    n1=en:nutlin-3a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3864. en:nutraceutical tbl-12 --- r_associated #0: 20 --> ipilimumab
    n1=en:nutraceutical tbl-12 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3865. en:nutrient-rich whole wheat flour supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:nutrient-rich whole wheat flour supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3866. en:nutritional supplement drink --- r_associated #0: 20 --> ipilimumab
    n1=en:nutritional supplement drink | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3867. en:nv1020 --- r_associated #0: 20 --> ipilimumab
    n1=en:nv1020 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3868. en:nx-1207 --- r_associated #0: 20 --> ipilimumab
    n1=en:nx-1207 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3869. en:ny-eso-1 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:ny-eso-1 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3870. en:ny-eso-1 plasmid dna cancer vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:ny-eso-1 plasmid dna cancer vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3871. en:ny-eso-1 protein vaccine plus montanide isa-51 vg --- r_associated #0: 20 --> ipilimumab
    n1=en:ny-eso-1 protein vaccine plus montanide isa-51 vg | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3872. en:ny-eso-1 reactive tcr retroviral vector transduced autologous pbl --- r_associated #0: 20 --> ipilimumab
    n1=en:ny-eso-1 reactive tcr retroviral vector transduced autologous pbl | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3873. en:ny-eso-1(157-165) peptide-pulsed autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:ny-eso-1(157-165) peptide-pulsed autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3874. en:ny-eso-1-specific cd4-positive t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:ny-eso-1-specific cd4-positive t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3875. en:ny-eso-1-specific tcr gene-transduced t lymphocytes tbi-1301 --- r_associated #0: 20 --> ipilimumab
    n1=en:ny-eso-1-specific tcr gene-transduced t lymphocytes tbi-1301 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3876. en:ny-eso-1/gla-se vaccine id-g305 --- r_associated #0: 20 --> ipilimumab
    n1=en:ny-eso-1/gla-se vaccine id-g305 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3877. en:ny-eso-1/lage-1 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:ny-eso-1/lage-1 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3878. en:ny-eso-1/mage-a4/prame/survivin/ssx-specific autologous cytotoxic t lymphoyctes --- r_associated #0: 20 --> ipilimumab
    n1=en:ny-eso-1/mage-a4/prame/survivin/ssx-specific autologous cytotoxic t lymphoyctes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3879. en:ny-eso-1/mart-1 peptide-pulsed dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:ny-eso-1/mart-1 peptide-pulsed dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3880. en:ny-eso-1/prame/mage-a3/wt-1 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:ny-eso-1/prame/mage-a3/wt-1 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3881. en:ny-eso-1b peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:ny-eso-1b peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3882. en:ny-eso-b --- r_associated #0: 20 --> ipilimumab
    n1=en:ny-eso-b | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3883. en:nystatin --- r_associated #0: 20 --> ipilimumab
    n1=en:nystatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3884. en:o-chloroacetylcarbamoylfumagillol --- r_associated #0: 20 --> ipilimumab
    n1=en:o-chloroacetylcarbamoylfumagillol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3885. en:o6-benzylguanine --- r_associated #0: 20 --> ipilimumab
    n1=en:o6-benzylguanine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3886. en:oat biscuit --- r_associated #0: 20 --> ipilimumab
    n1=en:oat biscuit | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3887. en:obatoclax --- r_associated #0: 20 --> ipilimumab
    n1=en:obatoclax | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3888. en:obatoclax mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:obatoclax mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3889. en:obinutuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:obinutuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3890. en:oblimersen --- r_associated #0: 20 --> ipilimumab
    n1=en:oblimersen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3891. en:oblimersen sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:oblimersen sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3892. en:ocaratuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:ocaratuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3893. en:ocrelizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:ocrelizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3894. en:ocriplasmin --- r_associated #0: 20 --> ipilimumab
    n1=en:ocriplasmin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3895. en:octreotide acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:octreotide acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3896. en:octreotide pamoate --- r_associated #0: 20 --> ipilimumab
    n1=en:octreotide pamoate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3897. en:ocular dosage form product --- r_associated #0: 20 --> ipilimumab
    n1=en:ocular dosage form product | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3898. en:ocv-103 --- r_associated #0: 20 --> ipilimumab
    n1=en:ocv-103 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3899. en:ocv-104 --- r_associated #0: 20 --> ipilimumab
    n1=en:ocv-104 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3900. en:odanacatib --- r_associated #0: 20 --> ipilimumab
    n1=en:odanacatib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3901. en:oepa regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:oepa regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3902. en:ofatumumab --- r_associated #0: 20 --> ipilimumab
    n1=en:ofatumumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3903. en:off regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:off regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3904. en:ofloxacin --- r_associated #0: 20 --> ipilimumab
    n1=en:ofloxacin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3905. en:oglufanide disodium --- r_associated #0: 20 --> ipilimumab
    n1=en:oglufanide disodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3906. en:olanzapine --- r_associated #0: 20 --> ipilimumab
    n1=en:olanzapine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3907. en:olaparib --- r_associated #0: 20 --> ipilimumab
    n1=en:olaparib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3908. en:olaratumab --- r_associated #0: 20 --> ipilimumab
    n1=en:olaratumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3909. en:oleandrin --- r_associated #0: 20 --> ipilimumab
    n1=en:oleandrin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3910. en:oligofructose-enriched inulin --- r_associated #0: 20 --> ipilimumab
    n1=en:oligofructose-enriched inulin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3911. en:oligonucleotide spc2996 --- r_associated #0: 20 --> ipilimumab
    n1=en:oligonucleotide spc2996 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3912. en:olive oil extract/curcumin-based capsule --- r_associated #0: 20 --> ipilimumab
    n1=en:olive oil extract/curcumin-based capsule | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3913. en:olive oil/soya oil/egg lecithin-based emulsion --- r_associated #0: 20 --> ipilimumab
    n1=en:olive oil/soya oil/egg lecithin-based emulsion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3914. en:olive oil/soybean oil/multi-amino acid/glucose parenteral nutrition emulsion --- r_associated #0: 20 --> ipilimumab
    n1=en:olive oil/soybean oil/multi-amino acid/glucose parenteral nutrition emulsion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3915. en:olodaterol --- r_associated #0: 20 --> ipilimumab
    n1=en:olodaterol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3916. en:olsalazine --- r_associated #0: 20 --> ipilimumab
    n1=en:olsalazine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3917. en:oltipraz --- r_associated #0: 20 --> ipilimumab
    n1=en:oltipraz | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3918. en:omacetaxine mepesuccinate --- r_associated #0: 20 --> ipilimumab
    n1=en:omacetaxine mepesuccinate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3919. en:omalizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:omalizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3920. en:ombitasvir/paritaprevir/ritonavir --- r_associated #0: 20 --> ipilimumab
    n1=en:ombitasvir/paritaprevir/ritonavir | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3921. en:ombrabulin --- r_associated #0: 20 --> ipilimumab
    n1=en:ombrabulin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3922. en:omega 3-marine triglycerides --- r_associated #0: 20 --> ipilimumab
    n1=en:omega 3-marine triglycerides | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3923. en:omega-3 fatty acid --- r_associated #0: 20 --> ipilimumab
    n1=en:omega-3 fatty acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3924. en:omeprazole --- r_associated #0: 20 --> ipilimumab
    n1=en:omeprazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3925. en:omiganan pentahydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:omiganan pentahydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3926. en:onalespib --- r_associated #0: 20 --> ipilimumab
    n1=en:onalespib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3927. en:onartuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:onartuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3928. en:oncolytic adenovirus ad5-dnx-2401 --- r_associated #0: 20 --> ipilimumab
    n1=en:oncolytic adenovirus ad5-dnx-2401 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3929. en:oncolytic adenovirus encoding gm-csf --- r_associated #0: 20 --> ipilimumab
    n1=en:oncolytic adenovirus encoding gm-csf | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3930. en:oncolytic adenovirus icovir5-infected autologous mesenchymal stem cells --- r_associated #0: 20 --> ipilimumab
    n1=en:oncolytic adenovirus icovir5-infected autologous mesenchymal stem cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3931. en:oncolytic herpes simplex virus-1-encoding gm-csf --- r_associated #0: 20 --> ipilimumab
    n1=en:oncolytic herpes simplex virus-1-encoding gm-csf | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3932. en:oncolytic hsv-1 rrp450 --- r_associated #0: 20 --> ipilimumab
    n1=en:oncolytic hsv-1 rrp450 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3933. en:oncolytic hsv1716 --- r_associated #0: 20 --> ipilimumab
    n1=en:oncolytic hsv1716 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3934. en:oncolytic measles virus encoding thyroidal sodium iodide symporter --- r_associated #0: 20 --> ipilimumab
    n1=en:oncolytic measles virus encoding thyroidal sodium iodide symporter | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3935. en:oncolytic newcastle disease virus --- r_associated #0: 20 --> ipilimumab
    n1=en:oncolytic newcastle disease virus | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3936. en:ondansetron --- r_associated #0: 20 --> ipilimumab
    n1=en:ondansetron | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3937. en:ondansetron hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:ondansetron hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3938. en:onyx-015 --- r_associated #0: 20 --> ipilimumab
    n1=en:onyx-015 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3939. en:opb-111001 --- r_associated #0: 20 --> ipilimumab
    n1=en:opb-111001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3940. en:opcs/green tea/spirullina/curcumin/antrodia camphorate/fermented soymilk extract capsule --- r_associated #0: 20 --> ipilimumab
    n1=en:opcs/green tea/spirullina/curcumin/antrodia camphorate/fermented soymilk extract capsule | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3941. en:opebacan --- r_associated #0: 20 --> ipilimumab
    n1=en:opebacan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3942. en:opioid agonist gic-1001 --- r_associated #0: 20 --> ipilimumab
    n1=en:opioid agonist gic-1001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3943. en:opioid agonist gic-1002 --- r_associated #0: 20 --> ipilimumab
    n1=en:opioid agonist gic-1002 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3944. en:opioid growth factor --- r_associated #0: 20 --> ipilimumab
    n1=en:opioid growth factor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3945. en:opium tincture --- r_associated #0: 20 --> ipilimumab
    n1=en:opium tincture | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3946. en:oppa regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:oppa regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3947. en:oprelvekin --- r_associated #0: 20 --> ipilimumab
    n1=en:oprelvekin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3948. en:oprozomib --- r_associated #0: 20 --> ipilimumab
    n1=en:oprozomib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3949. en:oral aminolevulinic acid hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:oral aminolevulinic acid hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3950. en:oral azacitidine --- r_associated #0: 20 --> ipilimumab
    n1=en:oral azacitidine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3951. en:oral dosage form product --- r_associated #0: 20 --> ipilimumab
    n1=en:oral dosage form product | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3952. en:oral fludarabine phosphate --- r_associated #0: 20 --> ipilimumab
    n1=en:oral fludarabine phosphate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3953. en:oral hsp90 inhibitor ipi-493 --- r_associated #0: 20 --> ipilimumab
    n1=en:oral hsp90 inhibitor ipi-493 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3954. en:oral ixabepilone --- r_associated #0: 20 --> ipilimumab
    n1=en:oral ixabepilone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3955. en:oral medication --- r_associated #0: 20 --> ipilimumab
    n1=en:oral medication | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3956. en:oral microencapsulated diindolylmethane --- r_associated #0: 20 --> ipilimumab
    n1=en:oral microencapsulated diindolylmethane | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3957. en:oral milataxel --- r_associated #0: 20 --> ipilimumab
    n1=en:oral milataxel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3958. en:oral picoplatin --- r_associated #0: 20 --> ipilimumab
    n1=en:oral picoplatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3959. en:oral rehydration solution os-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:oral rehydration solution os-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3960. en:oral sodium phenylbutyrate --- r_associated #0: 20 --> ipilimumab
    n1=en:oral sodium phenylbutyrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3961. en:oral topotecan hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:oral topotecan hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3962. en:orantinib --- r_associated #0: 20 --> ipilimumab
    n1=en:orantinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3963. en:oraxol --- r_associated #0: 20 --> ipilimumab
    n1=en:oraxol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3964. en:oregovomab --- r_associated #0: 20 --> ipilimumab
    n1=en:oregovomab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3965. en:organic sulfone compound --- r_associated #0: 20 --> ipilimumab
    n1=en:organic sulfone compound | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3966. en:ormaplatin --- r_associated #0: 20 --> ipilimumab
    n1=en:ormaplatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3967. en:oropharyngeal dosage form product --- r_associated #0: 20 --> ipilimumab
    n1=en:oropharyngeal dosage form product | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3968. en:ortataxel --- r_associated #0: 20 --> ipilimumab
    n1=en:ortataxel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3969. en:orteronel --- r_associated #0: 20 --> ipilimumab
    n1=en:orteronel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3970. en:ose 2101 --- r_associated #0: 20 --> ipilimumab
    n1=en:ose 2101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3971. en:oseltamivir phosphate --- r_associated #0: 20 --> ipilimumab
    n1=en:oseltamivir phosphate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3972. en:oshadi d --- r_associated #0: 20 --> ipilimumab
    n1=en:oshadi d | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3973. en:oshadi r --- r_associated #0: 20 --> ipilimumab
    n1=en:oshadi r | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3974. en:osi-7904l --- r_associated #0: 20 --> ipilimumab
    n1=en:osi-7904l | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3975. en:osimertinib --- r_associated #0: 20 --> ipilimumab
    n1=en:osimertinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3976. en:otd70derm --- r_associated #0: 20 --> ipilimumab
    n1=en:otd70derm | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3977. en:oteracil potassium --- r_associated #0: 20 --> ipilimumab
    n1=en:oteracil potassium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3978. en:otic preparation --- r_associated #0: 20 --> ipilimumab
    n1=en:otic preparation | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3979. en:otlertuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:otlertuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3980. en:otsgc-a24 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:otsgc-a24 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3981. en:ova bip peptide --- r_associated #0: 20 --> ipilimumab
    n1=en:ova bip peptide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3982. en:ovapuldencel-t --- r_associated #0: 20 --> ipilimumab
    n1=en:ovapuldencel-t | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3983. en:ovarian cancer peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:ovarian cancer peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3984. en:ovarian cancer stem cell/htert/survivin mrnas-loaded autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:ovarian cancer stem cell/htert/survivin mrnas-loaded autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3985. en:ovarian tumor antigen-activated autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:ovarian tumor antigen-activated autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3986. en:over the counter product --- r_associated #0: 20 --> ipilimumab
    n1=en:over the counter product | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3987. en:ovine submaxillary mucin --- r_associated #0: 20 --> ipilimumab
    n1=en:ovine submaxillary mucin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3988. en:oxacillin sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:oxacillin sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3989. en:oxaliplatin --- r_associated #0: 20 --> ipilimumab
    n1=en:oxaliplatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3990. en:oxaliplatin-encapsulated transferrin-conjugated n-glutaryl phosphatidylethanolamine liposome --- r_associated #0: 20 --> ipilimumab
    n1=en:oxaliplatin-encapsulated transferrin-conjugated n-glutaryl phosphatidylethanolamine liposome | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3991. en:oxandrolone --- r_associated #0: 20 --> ipilimumab
    n1=en:oxandrolone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3992. en:oxcarbazepine --- r_associated #0: 20 --> ipilimumab
    n1=en:oxcarbazepine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3993. en:oxidized avidin --- r_associated #0: 20 --> ipilimumab
    n1=en:oxidized avidin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3994. en:oxidopamine --- r_associated #0: 20 --> ipilimumab
    n1=en:oxidopamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3995. en:oxitriptan --- r_associated #0: 20 --> ipilimumab
    n1=en:oxitriptan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3996. en:oxphos inhibitor vlx600 --- r_associated #0: 20 --> ipilimumab
    n1=en:oxphos inhibitor vlx600 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3997. en:oxycodone hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:oxycodone hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3998. en:oxycodone hydrochloride/naloxone hydrochloride prolonged-release tablet --- r_associated #0: 20 --> ipilimumab
    n1=en:oxycodone hydrochloride/naloxone hydrochloride prolonged-release tablet | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  3999. en:oxycodone/acetaminophen --- r_associated #0: 20 --> ipilimumab
    n1=en:oxycodone/acetaminophen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4000. en:oxymetholone --- r_associated #0: 20 --> ipilimumab
    n1=en:oxymetholone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4001. en:oxymorphone hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:oxymorphone hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4002. en:oxytocics --- r_associated #0: 20 --> ipilimumab
    n1=en:oxytocics | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4003. en:ozarelix --- r_associated #0: 20 --> ipilimumab
    n1=en:ozarelix | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4004. en:ozone-based agent --- r_associated #0: 20 --> ipilimumab
    n1=en:ozone-based agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4005. en:p-cadherin antagonist pf-03732010 --- r_associated #0: 20 --> ipilimumab
    n1=en:p-cadherin antagonist pf-03732010 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4006. en:p-cadherin inhibitor pca062 --- r_associated #0: 20 --> ipilimumab
    n1=en:p-cadherin inhibitor pca062 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4007. en:p-cadherin-targeting agent pf-06671008 --- r_associated #0: 20 --> ipilimumab
    n1=en:p-cadherin-targeting agent pf-06671008 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4008. en:p-glycoprotein inhibitor hm30181ak --- r_associated #0: 20 --> ipilimumab
    n1=en:p-glycoprotein inhibitor hm30181ak | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4009. en:p-p68 inhibitor rx-5902 --- r_associated #0: 20 --> ipilimumab
    n1=en:p-p68 inhibitor rx-5902 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4010. en:p-tefb inhibitor bay1143572 --- r_associated #0: 20 --> ipilimumab
    n1=en:p-tefb inhibitor bay1143572 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4011. en:p.dom-wt1-126 dna vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:p.dom-wt1-126 dna vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4012. en:p.dom-wt1-37 dna vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:p.dom-wt1-37 dna vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4013. en:p110beta/delta pi3k inhibitor gs-9820 --- r_associated #0: 20 --> ipilimumab
    n1=en:p110beta/delta pi3k inhibitor gs-9820 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4014. en:p16_37-63 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:p16_37-63 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4015. en:p38 mapk inhibitor ly2228820 dimesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:p38 mapk inhibitor ly2228820 dimesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4016. en:p38 mapk inhibitor ly3007113 --- r_associated #0: 20 --> ipilimumab
    n1=en:p38 mapk inhibitor ly3007113 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4017. en:p501-as15 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:p501-as15 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4018. en:p53 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:p53 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4019. en:p53-hdm2 interaction inhibitor mi-773 --- r_associated #0: 20 --> ipilimumab
    n1=en:p53-hdm2 interaction inhibitor mi-773 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4020. en:p53-synthetic long peptides vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:p53-synthetic long peptides vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4021. en:p53/hdm2 interaction inhibitor cgm097 --- r_associated #0: 20 --> ipilimumab
    n1=en:p53/hdm2 interaction inhibitor cgm097 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4022. en:p70s6k inhibitor ly2584702 --- r_associated #0: 20 --> ipilimumab
    n1=en:p70s6k inhibitor ly2584702 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4023. en:p70s6k/akt inhibitor msc2363318a --- r_associated #0: 20 --> ipilimumab
    n1=en:p70s6k/akt inhibitor msc2363318a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4024. en:p97 inhibitor cb-5083 --- r_associated #0: 20 --> ipilimumab
    n1=en:p97 inhibitor cb-5083 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4025. en:pa-1-stk ovarian carcinoma vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:pa-1-stk ovarian carcinoma vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4026. en:paclitaxel --- r_associated #0: 20 --> ipilimumab
    n1=en:paclitaxel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4027. en:paclitaxel albumin-stabilized nanoparticle formulation --- r_associated #0: 20 --> ipilimumab
    n1=en:paclitaxel albumin-stabilized nanoparticle formulation | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4028. en:paclitaxel injection concentrate for nanodispersion --- r_associated #0: 20 --> ipilimumab
    n1=en:paclitaxel injection concentrate for nanodispersion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4029. en:paclitaxel liposome --- r_associated #0: 20 --> ipilimumab
    n1=en:paclitaxel liposome | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4030. en:paclitaxel poliglumex --- r_associated #0: 20 --> ipilimumab
    n1=en:paclitaxel poliglumex | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4031. en:paclitaxel trevatide --- r_associated #0: 20 --> ipilimumab
    n1=en:paclitaxel trevatide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4032. en:paclitaxel vitamin e-based emulsion --- r_associated #0: 20 --> ipilimumab
    n1=en:paclitaxel vitamin e-based emulsion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4033. en:paclitaxel-loaded polymeric micelle --- r_associated #0: 20 --> ipilimumab
    n1=en:paclitaxel-loaded polymeric micelle | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4034. en:pacritinib --- r_associated #0: 20 --> ipilimumab
    n1=en:pacritinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4035. en:pad regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:pad regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4036. en:padeliporfin --- r_associated #0: 20 --> ipilimumab
    n1=en:padeliporfin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4037. en:padre 965.10 --- r_associated #0: 20 --> ipilimumab
    n1=en:padre 965.10 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4038. en:padre-cmv fusion peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:padre-cmv fusion peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4039. en:pak4 inhibitor pf-03758309 --- r_associated #0: 20 --> ipilimumab
    n1=en:pak4 inhibitor pf-03758309 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4040. en:pak4/nampt inhibitor kpt-9274 --- r_associated #0: 20 --> ipilimumab
    n1=en:pak4/nampt inhibitor kpt-9274 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4041. en:palbociclib --- r_associated #0: 20 --> ipilimumab
    n1=en:palbociclib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4042. en:palifermin --- r_associated #0: 20 --> ipilimumab
    n1=en:palifermin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4043. en:palifosfamide --- r_associated #0: 20 --> ipilimumab
    n1=en:palifosfamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4044. en:palifosfamide tromethamine --- r_associated #0: 20 --> ipilimumab
    n1=en:palifosfamide tromethamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4045. en:palivizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:palivizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4046. en:palladium pd-103 --- r_associated #0: 20 --> ipilimumab
    n1=en:palladium pd-103 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4047. en:palladium-bacteriopheophorbide --- r_associated #0: 20 --> ipilimumab
    n1=en:palladium-bacteriopheophorbide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4048. en:palm extract phytonutrient supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:palm extract phytonutrient supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4049. en:palonosetron hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:palonosetron hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4050. en:pamidronate disodium --- r_associated #0: 20 --> ipilimumab
    n1=en:pamidronate disodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4051. en:pan fgfr inhibitor arq 087 --- r_associated #0: 20 --> ipilimumab
    n1=en:pan fgfr inhibitor arq 087 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4052. en:pan fgfr inhibitor prn1371 --- r_associated #0: 20 --> ipilimumab
    n1=en:pan fgfr inhibitor prn1371 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4053. en:pan fgfr kinase inhibitor bgj398 --- r_associated #0: 20 --> ipilimumab
    n1=en:pan fgfr kinase inhibitor bgj398 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4054. en:pan her/vegfr2 receptor tyrosine kinase inhibitor bms-690514 --- r_associated #0: 20 --> ipilimumab
    n1=en:pan her/vegfr2 receptor tyrosine kinase inhibitor bms-690514 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4055. en:pan-akt inhibitor arq751 --- r_associated #0: 20 --> ipilimumab
    n1=en:pan-akt inhibitor arq751 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4056. en:pan-akt kinase inhibitor gsk690693 --- r_associated #0: 20 --> ipilimumab
    n1=en:pan-akt kinase inhibitor gsk690693 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4057. en:pan-fgfr tyrosine kinase inhibitor bay1163877 --- r_associated #0: 20 --> ipilimumab
    n1=en:pan-fgfr tyrosine kinase inhibitor bay1163877 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4058. en:pan-fgfr tyrosine kinase inhibitor jnj-42756493 --- r_associated #0: 20 --> ipilimumab
    n1=en:pan-fgfr tyrosine kinase inhibitor jnj-42756493 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4059. en:pan-her kinase inhibitor ac480 --- r_associated #0: 20 --> ipilimumab
    n1=en:pan-her kinase inhibitor ac480 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4060. en:pan-idh mutant inhibitor ag-881 --- r_associated #0: 20 --> ipilimumab
    n1=en:pan-idh mutant inhibitor ag-881 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4061. en:pan-pi3k inhibitor clr457 --- r_associated #0: 20 --> ipilimumab
    n1=en:pan-pi3k inhibitor clr457 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4062. en:pan-pi3k/mtor inhibitor pqr309 --- r_associated #0: 20 --> ipilimumab
    n1=en:pan-pi3k/mtor inhibitor pqr309 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4063. en:pan-pi3k/mtor inhibitor sf1126 --- r_associated #0: 20 --> ipilimumab
    n1=en:pan-pi3k/mtor inhibitor sf1126 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4064. en:pan-pim inhibitor incb053914 --- r_associated #0: 20 --> ipilimumab
    n1=en:pan-pim inhibitor incb053914 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4065. en:pan-pim kinase inhibitor azd1208 --- r_associated #0: 20 --> ipilimumab
    n1=en:pan-pim kinase inhibitor azd1208 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4066. en:pan-raf inhibitor lxh254 --- r_associated #0: 20 --> ipilimumab
    n1=en:pan-raf inhibitor lxh254 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4067. en:pan-raf inhibitor ly3009120 --- r_associated #0: 20 --> ipilimumab
    n1=en:pan-raf inhibitor ly3009120 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4068. en:pan-raf kinase inhibitor cct3833 --- r_associated #0: 20 --> ipilimumab
    n1=en:pan-raf kinase inhibitor cct3833 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4069. en:pan-raf kinase inhibitor tak-580 --- r_associated #0: 20 --> ipilimumab
    n1=en:pan-raf kinase inhibitor tak-580 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4070. en:pan-selectin antagonist gmi-1070 --- r_associated #0: 20 --> ipilimumab
    n1=en:pan-selectin antagonist gmi-1070 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4071. en:pan-vegfr/tie2 tyrosine kinase inhibitor cep-11981 --- r_associated #0: 20 --> ipilimumab
    n1=en:pan-vegfr/tie2 tyrosine kinase inhibitor cep-11981 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4072. en:pancrelipase --- r_associated #0: 20 --> ipilimumab
    n1=en:pancrelipase | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4073. en:panitumumab --- r_associated #0: 20 --> ipilimumab
    n1=en:panitumumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4074. en:panitumumab-irdye800 --- r_associated #0: 20 --> ipilimumab
    n1=en:panitumumab-irdye800 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4075. en:panobinostat --- r_associated #0: 20 --> ipilimumab
    n1=en:panobinostat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4076. en:pantoprazole sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:pantoprazole sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4077. en:papaverine --- r_associated #0: 20 --> ipilimumab
    n1=en:papaverine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4078. en:parathyroid hormone-related protein (1-36) --- r_associated #0: 20 --> ipilimumab
    n1=en:parathyroid hormone-related protein (1-36) | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4079. en:parecoxib sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:parecoxib sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4080. en:parenteral dosage form product --- r_associated #0: 20 --> ipilimumab
    n1=en:parenteral dosage form product | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4081. en:paricalcitol --- r_associated #0: 20 --> ipilimumab
    n1=en:paricalcitol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4082. en:paromomycin sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:paromomycin sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4083. en:paroxetine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:paroxetine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4084. en:parp 1/2 inhibitor e7449 --- r_associated #0: 20 --> ipilimumab
    n1=en:parp 1/2 inhibitor e7449 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4085. en:parp inhibitor azd2461 --- r_associated #0: 20 --> ipilimumab
    n1=en:parp inhibitor azd2461 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4086. en:parp inhibitor bgb-290 --- r_associated #0: 20 --> ipilimumab
    n1=en:parp inhibitor bgb-290 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4087. en:parp inhibitor cep-9722 --- r_associated #0: 20 --> ipilimumab
    n1=en:parp inhibitor cep-9722 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4088. en:parp inhibitor e7016 --- r_associated #0: 20 --> ipilimumab
    n1=en:parp inhibitor e7016 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4089. en:parp-1/2 inhibitor abt-767 --- r_associated #0: 20 --> ipilimumab
    n1=en:parp-1/2 inhibitor abt-767 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4090. en:parsatuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:parsatuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4091. en:parvovirus h-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:parvovirus h-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4092. en:pasireotide --- r_associated #0: 20 --> ipilimumab
    n1=en:pasireotide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4093. en:patent blue v dye --- r_associated #0: 20 --> ipilimumab
    n1=en:patent blue v dye | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4094. en:patient-specific follicular lymphoma-derived anti-idiotype vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:patient-specific follicular lymphoma-derived anti-idiotype vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4095. en:patritumab --- r_associated #0: 20 --> ipilimumab
    n1=en:patritumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4096. en:patupilone --- r_associated #0: 20 --> ipilimumab
    n1=en:patupilone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4097. en:pazopanib hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:pazopanib hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4098. en:pbcar3 phosphopeptide-tetanus peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:pbcar3 phosphopeptide-tetanus peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4099. en:pbcar3/pirs2-phosphopeptide-tetanus peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:pbcar3/pirs2-phosphopeptide-tetanus peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4100. en:pbi-shrna stmn1 lipoplex --- r_associated #0: 20 --> ipilimumab
    n1=en:pbi-shrna stmn1 lipoplex | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4101. en:pbn derivative okn-007 --- r_associated #0: 20 --> ipilimumab
    n1=en:pbn derivative okn-007 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4102. en:pbtl cd19car-28 zeta --- r_associated #0: 20 --> ipilimumab
    n1=en:pbtl cd19car-28 zeta | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4103. en:pc-spes --- r_associated #0: 20 --> ipilimumab
    n1=en:pc-spes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4104. en:pcnu --- r_associated #0: 20 --> ipilimumab
    n1=en:pcnu | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4105. en:pcv regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:pcv regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4106. en:pd l 506 --- r_associated #0: 20 --> ipilimumab
    n1=en:pd l 506 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4107. en:pd0325901 --- r_associated #0: 20 --> ipilimumab
    n1=en:pd0325901 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4108. en:pdcd-1 knockout autologous t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:pdcd-1 knockout autologous t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4109. en:pdgfr alpha/kit mutant-specific inhibitor blu-285 --- r_associated #0: 20 --> ipilimumab
    n1=en:pdgfr alpha/kit mutant-specific inhibitor blu-285 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4110. en:pdk1 inhibitor ar-12 --- r_associated #0: 20 --> ipilimumab
    n1=en:pdk1 inhibitor ar-12 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4111. en:pdm08 --- r_associated #0: 20 --> ipilimumab
    n1=en:pdm08 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4112. en:pe/hpv16 e7/kdel fusion protein tvgv-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:pe/hpv16 e7/kdel fusion protein tvgv-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4113. en:pediatric nutritional supplement drink --- r_associated #0: 20 --> ipilimumab
    n1=en:pediatric nutritional supplement drink | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4114. en:pefloxacin --- r_associated #0: 20 --> ipilimumab
    n1=en:pefloxacin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4115. en:peg recombinant human megakaryocyte growth and development factor --- r_associated #0: 20 --> ipilimumab
    n1=en:peg recombinant human megakaryocyte growth and development factor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4116. en:peg-3350/sodium sulfate/sodium chloride/potassium chloride/sodium ascorbate/ascorbic acid-based laxative --- r_associated #0: 20 --> ipilimumab
    n1=en:peg-3350/sodium sulfate/sodium chloride/potassium chloride/sodium ascorbate/ascorbic acid-based laxative | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4117. en:peg-based laxative ner1006 --- r_associated #0: 20 --> ipilimumab
    n1=en:peg-based laxative ner1006 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4118. en:peg-interleukin-2 --- r_associated #0: 20 --> ipilimumab
    n1=en:peg-interleukin-2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4119. en:peg-linked l-rna oligonucleotide hepcidin-targeting agent nox-h94 --- r_associated #0: 20 --> ipilimumab
    n1=en:peg-linked l-rna oligonucleotide hepcidin-targeting agent nox-h94 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4120. en:peg-pei-cholesterol lipopolymer-encased il-12 dna plasmid vector gen-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:peg-pei-cholesterol lipopolymer-encased il-12 dna plasmid vector gen-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4121. en:peg-proline-interferon alfa-2b --- r_associated #0: 20 --> ipilimumab
    n1=en:peg-proline-interferon alfa-2b | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4122. en:pegamotecan --- r_associated #0: 20 --> ipilimumab
    n1=en:pegamotecan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4123. en:pegaspargase --- r_associated #0: 20 --> ipilimumab
    n1=en:pegaspargase | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4124. en:pegdinetanib --- r_associated #0: 20 --> ipilimumab
    n1=en:pegdinetanib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4125. en:pegfilgrastim --- r_associated #0: 20 --> ipilimumab
    n1=en:pegfilgrastim | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4126. en:pegfilgrastim anti-neutropenic factor --- r_associated #0: 20 --> ipilimumab
    n1=en:pegfilgrastim anti-neutropenic factor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4127. en:pegfilgrastim biosimilar la-ep2006 --- r_associated #0: 20 --> ipilimumab
    n1=en:pegfilgrastim biosimilar la-ep2006 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4128. en:peginesatide --- r_associated #0: 20 --> ipilimumab
    n1=en:peginesatide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4129. en:peginterferon alfa-2a --- r_associated #0: 20 --> ipilimumab
    n1=en:peginterferon alfa-2a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4130. en:peginterferon alfa-2b --- r_associated #0: 20 --> ipilimumab
    n1=en:peginterferon alfa-2b | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4131. en:pegol sihematide --- r_associated #0: 20 --> ipilimumab
    n1=en:pegol sihematide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4132. en:pegvisomant --- r_associated #0: 20 --> ipilimumab
    n1=en:pegvisomant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4133. en:pegylated anti-gfr antibody fragment --- r_associated #0: 20 --> ipilimumab
    n1=en:pegylated anti-gfr antibody fragment | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4134. en:pegylated arginine deiminase --- r_associated #0: 20 --> ipilimumab
    n1=en:pegylated arginine deiminase | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4135. en:pegylated granulocyte colony stimulating factor maxy-g34 --- r_associated #0: 20 --> ipilimumab
    n1=en:pegylated granulocyte colony stimulating factor maxy-g34 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4136. en:pegylated human recombinant arginase 1 aeb1102 --- r_associated #0: 20 --> ipilimumab
    n1=en:pegylated human recombinant arginase 1 aeb1102 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4137. en:pegylated interferon alfa --- r_associated #0: 20 --> ipilimumab
    n1=en:pegylated interferon alfa | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4138. en:pegylated irinotecan --- r_associated #0: 20 --> ipilimumab
    n1=en:pegylated irinotecan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4139. en:pegylated liposomal belotecan --- r_associated #0: 20 --> ipilimumab
    n1=en:pegylated liposomal belotecan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4140. en:pegylated liposomal doxorubicin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:pegylated liposomal doxorubicin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4141. en:pegylated liposomal irinotecan --- r_associated #0: 20 --> ipilimumab
    n1=en:pegylated liposomal irinotecan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4142. en:pegylated liposomal mitomycin c lipid-based prodrug --- r_associated #0: 20 --> ipilimumab
    n1=en:pegylated liposomal mitomycin c lipid-based prodrug | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4143. en:pegylated liposomal nanoparticle-based docetaxel prodrug mnk-010 --- r_associated #0: 20 --> ipilimumab
    n1=en:pegylated liposomal nanoparticle-based docetaxel prodrug mnk-010 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4144. en:pegylated paclitaxel --- r_associated #0: 20 --> ipilimumab
    n1=en:pegylated paclitaxel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4145. en:pegylated recombinant human arginase i bct-100 --- r_associated #0: 20 --> ipilimumab
    n1=en:pegylated recombinant human arginase i bct-100 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4146. en:pegylated recombinant human hyaluronidase ph20 --- r_associated #0: 20 --> ipilimumab
    n1=en:pegylated recombinant human hyaluronidase ph20 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4147. en:pegylated recombinant human interleukin-10 am0010 --- r_associated #0: 20 --> ipilimumab
    n1=en:pegylated recombinant human interleukin-10 am0010 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4148. en:pegylated recombinant l-asparaginase erwinia chrysanthemi --- r_associated #0: 20 --> ipilimumab
    n1=en:pegylated recombinant l-asparaginase erwinia chrysanthemi | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4149. en:peldesine --- r_associated #0: 20 --> ipilimumab
    n1=en:peldesine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4150. en:pelitinib --- r_associated #0: 20 --> ipilimumab
    n1=en:pelitinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4151. en:pelitrexol --- r_associated #0: 20 --> ipilimumab
    n1=en:pelitrexol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4152. en:pembrolizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:pembrolizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4153. en:pemetrexed disodium --- r_associated #0: 20 --> ipilimumab
    n1=en:pemetrexed disodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4154. en:penberol --- r_associated #0: 20 --> ipilimumab
    n1=en:penberol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4155. en:penclomedine --- r_associated #0: 20 --> ipilimumab
    n1=en:penclomedine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4156. en:penicillamine --- r_associated #0: 20 --> ipilimumab
    n1=en:penicillamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4157. en:penicillin v potassium --- r_associated #0: 20 --> ipilimumab
    n1=en:penicillin v potassium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4158. en:pentamethylmelamine --- r_associated #0: 20 --> ipilimumab
    n1=en:pentamethylmelamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4159. en:pentamidine --- r_associated #0: 20 --> ipilimumab
    n1=en:pentamidine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4160. en:pentamidine isethionate --- r_associated #0: 20 --> ipilimumab
    n1=en:pentamidine isethionate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4161. en:pentavalent klh conjugate vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:pentavalent klh conjugate vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4162. en:pentetic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:pentetic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4163. en:pentetic acid calcium --- r_associated #0: 20 --> ipilimumab
    n1=en:pentetic acid calcium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4164. en:pentosan polysulfate sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:pentosan polysulfate sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4165. en:pentostatin --- r_associated #0: 20 --> ipilimumab
    n1=en:pentostatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4166. en:pentoxifylline --- r_associated #0: 20 --> ipilimumab
    n1=en:pentoxifylline | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4167. en:pep-3-klh conjugate vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:pep-3-klh conjugate vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4168. en:pep-cmv vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:pep-cmv vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4169. en:peplomycin --- r_associated #0: 20 --> ipilimumab
    n1=en:peplomycin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4170. en:peptichemio --- r_associated #0: 20 --> ipilimumab
    n1=en:peptichemio | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4171. en:peptide 946 melanoma vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:peptide 946 melanoma vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4172. en:peptide 946-tetanus peptide conjugate melanoma vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:peptide 946-tetanus peptide conjugate melanoma vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4173. en:peptides hydrolases --- r_associated #0: 20 --> ipilimumab
    n1=en:peptides hydrolases | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4174. en:perampanel --- r_associated #0: 20 --> ipilimumab
    n1=en:perampanel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4175. en:peretinoin --- r_associated #0: 20 --> ipilimumab
    n1=en:peretinoin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4176. en:perflenapent emulsion --- r_associated #0: 20 --> ipilimumab
    n1=en:perflenapent emulsion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4177. en:perflubron --- r_associated #0: 20 --> ipilimumab
    n1=en:perflubron | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4178. en:perflubutane --- r_associated #0: 20 --> ipilimumab
    n1=en:perflubutane | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4179. en:perflutren --- r_associated #0: 20 --> ipilimumab
    n1=en:perflutren | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4180. en:perflutren lipid microspheres --- r_associated #0: 20 --> ipilimumab
    n1=en:perflutren lipid microspheres | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4181. en:perflutren protein-type a microspheres --- r_associated #0: 20 --> ipilimumab
    n1=en:perflutren protein-type a microspheres | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4182. en:perfosfamide --- r_associated #0: 20 --> ipilimumab
    n1=en:perfosfamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4183. en:perifosine --- r_associated #0: 20 --> ipilimumab
    n1=en:perifosine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4184. en:perillyl alcohol --- r_associated #0: 20 --> ipilimumab
    n1=en:perillyl alcohol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4185. en:perindopril erbumine --- r_associated #0: 20 --> ipilimumab
    n1=en:perindopril erbumine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4186. en:personalized polyepitope plasmid dna breast cancer vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:personalized polyepitope plasmid dna breast cancer vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4187. en:personalized synthetic long peptide breast cancer vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:personalized synthetic long peptide breast cancer vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4188. en:pertuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:pertuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4189. en:pesticide --- r_associated #0: 20 --> ipilimumab
    n1=en:pesticide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4190. en:petrolatum-mineral oil-lanolin-ceresin ointment --- r_associated #0: 20 --> ipilimumab
    n1=en:petrolatum-mineral oil-lanolin-ceresin ointment | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4191. en:pevonedistat --- r_associated #0: 20 --> ipilimumab
    n1=en:pevonedistat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4192. en:pexastimogene-devacirepvec --- r_associated #0: 20 --> ipilimumab
    n1=en:pexastimogene-devacirepvec | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4193. en:pexidartinib --- r_associated #0: 20 --> ipilimumab
    n1=en:pexidartinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4194. en:pg13-cd19-h3 (anti-cd19 car) retroviral vector-transduced peripheral blood lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:pg13-cd19-h3 (anti-cd19 car) retroviral vector-transduced peripheral blood lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4195. en:pgg beta-glucan --- r_associated #0: 20 --> ipilimumab
    n1=en:pgg beta-glucan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4196. en:pgla/peg copolymer-based paclitaxel --- r_associated #0: 20 --> ipilimumab
    n1=en:pgla/peg copolymer-based paclitaxel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4197. en:ph20 hyaluronidase-expressing adenovirus vcn-01 --- r_associated #0: 20 --> ipilimumab
    n1=en:ph20 hyaluronidase-expressing adenovirus vcn-01 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4198. en:phaleria macrocarpa extract dlbs-1425 --- r_associated #0: 20 --> ipilimumab
    n1=en:phaleria macrocarpa extract dlbs-1425 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4199. en:pharmaceutic aids --- r_associated #0: 20 --> ipilimumab
    n1=en:pharmaceutic aids | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4200. en:pharmaceutical base or inactive agent --- r_associated #0: 20 --> ipilimumab
    n1=en:pharmaceutical base or inactive agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4201. en:pharmaceutical dosage form --- r_associated #0: 20 --> ipilimumab
    n1=en:pharmaceutical dosage form | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4202. en:pharmaceutical fluid or solution agent --- r_associated #0: 20 --> ipilimumab
    n1=en:pharmaceutical fluid or solution agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4203. en:pharmaceutical preparations, dental --- r_associated #0: 20 --> ipilimumab
    n1=en:pharmaceutical preparations, dental | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4204. en:phellodendron amurense bark extract --- r_associated #0: 20 --> ipilimumab
    n1=en:phellodendron amurense bark extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4205. en:phenelzine sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:phenelzine sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4206. en:phenesterin --- r_associated #0: 20 --> ipilimumab
    n1=en:phenesterin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4207. en:phenethyl isothiocyanate --- r_associated #0: 20 --> ipilimumab
    n1=en:phenethyl isothiocyanate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4208. en:phenethyl isothiocyanate-containing watercress juice --- r_associated #0: 20 --> ipilimumab
    n1=en:phenethyl isothiocyanate-containing watercress juice | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4209. en:phenformin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:phenformin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4210. en:phenobarbital --- r_associated #0: 20 --> ipilimumab
    n1=en:phenobarbital | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4211. en:phenoxybenzamine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:phenoxybenzamine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4212. en:phenprocoumon --- r_associated #0: 20 --> ipilimumab
    n1=en:phenprocoumon | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4213. en:phentolamine mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:phentolamine mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4214. en:phenyl acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:phenyl acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4215. en:phosphaplatin pt-112 --- r_associated #0: 20 --> ipilimumab
    n1=en:phosphaplatin pt-112 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4216. en:phosphatidylcholine-bound silybin --- r_associated #0: 20 --> ipilimumab
    n1=en:phosphatidylcholine-bound silybin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4217. en:phosphomannopentaose sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:phosphomannopentaose sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4218. en:phosphorodiamidate morpholino oligomer avi-4126 --- r_associated #0: 20 --> ipilimumab
    n1=en:phosphorodiamidate morpholino oligomer avi-4126 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4219. en:phosphorus p-32 --- r_associated #0: 20 --> ipilimumab
    n1=en:phosphorus p-32 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4220. en:photocyanine --- r_associated #0: 20 --> ipilimumab
    n1=en:photocyanine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4221. en:photosensitizer luz 11 --- r_associated #0: 20 --> ipilimumab
    n1=en:photosensitizer luz 11 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4222. en:photosensitizing agent --- r_associated #0: 20 --> ipilimumab
    n1=en:photosensitizing agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4223. en:phytochemical --- r_associated #0: 20 --> ipilimumab
    n1=en:phytochemical | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4224. en:phytochlorin sodium-polyvinylpyrrolidone complex --- r_associated #0: 20 --> ipilimumab
    n1=en:phytochlorin sodium-polyvinylpyrrolidone complex | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4225. en:phytonadione --- r_associated #0: 20 --> ipilimumab
    n1=en:phytonadione | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4226. en:pi3k alpha inhibitor mln1117 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k alpha inhibitor mln1117 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4227. en:pi3k alpha/beta inhibitor bay1082439 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k alpha/beta inhibitor bay1082439 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4228. en:pi3k alpha/mtor inhibitor pwt33597 mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k alpha/mtor inhibitor pwt33597 mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4229. en:pi3k delta/gamma inhibitor ipi-145 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k delta/gamma inhibitor ipi-145 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4230. en:pi3k delta/gamma inhibitor rp6530 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k delta/gamma inhibitor rp6530 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4231. en:pi3k family kinase inhibitor xl147 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k family kinase inhibitor xl147 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4232. en:pi3k inhibitor acp-319 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k inhibitor acp-319 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4233. en:pi3k inhibitor bgt226 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k inhibitor bgt226 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4234. en:pi3k inhibitor ch5132799 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k inhibitor ch5132799 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4235. en:pi3k inhibitor gdc-0084 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k inhibitor gdc-0084 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4236. en:pi3k inhibitor gdc-0941 bismesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k inhibitor gdc-0941 bismesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4237. en:pi3k inhibitor gsk1059615 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k inhibitor gsk1059615 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4238. en:pi3k inhibitor gsk2126458 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k inhibitor gsk2126458 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4239. en:pi3k inhibitor px-866 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k inhibitor px-866 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4240. en:pi3k inhibitor wx-037 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k inhibitor wx-037 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4241. en:pi3k inhibitor zstk474 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k inhibitor zstk474 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4242. en:pi3k p110beta/delta inhibitor ka2237 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k p110beta/delta inhibitor ka2237 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4243. en:pi3k-beta inhibitor gsk2636771 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k-beta inhibitor gsk2636771 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4244. en:pi3k-beta inhibitor sar260301 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k-beta inhibitor sar260301 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4245. en:pi3k-delta inhibitor amg 319 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k-delta inhibitor amg 319 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4246. en:pi3k-delta inhibitor incb050465 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k-delta inhibitor incb050465 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4247. en:pi3k-delta inhibitor pwt143 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k-delta inhibitor pwt143 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4248. en:pi3k-delta inhibitor tgr-1202 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k-delta inhibitor tgr-1202 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4249. en:pi3k-gamma inhibitor ipi-549 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k-gamma inhibitor ipi-549 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4250. en:pi3k/hdac inhibitor cudc-907 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k/hdac inhibitor cudc-907 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4251. en:pi3k/mtor inhibitor bez235 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k/mtor inhibitor bez235 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4252. en:pi3k/mtor inhibitor ly3023414 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k/mtor inhibitor ly3023414 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4253. en:pi3k/mtor kinase inhibitor ds-7423 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k/mtor kinase inhibitor ds-7423 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4254. en:pi3k/mtor kinase inhibitor pf-04691502 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k/mtor kinase inhibitor pf-04691502 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4255. en:pi3k/mtor kinase inhibitor vs-5584 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k/mtor kinase inhibitor vs-5584 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4256. en:pi3k/mtor/alk-1/dna-pk inhibitor p7170 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k/mtor/alk-1/dna-pk inhibitor p7170 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4257. en:pi3k/mtorc1/mtorc2 inhibitor dcbci0901 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3k/mtorc1/mtorc2 inhibitor dcbci0901 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4258. en:pi3ka/mtor inhibitor pki-179 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3ka/mtor inhibitor pki-179 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4259. en:pi3kalpha inhibitor azd8835 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3kalpha inhibitor azd8835 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4260. en:pi3kbeta inhibitor azd8186 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3kbeta inhibitor azd8186 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4261. en:pi3kdelta inhibitor gs-9901 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3kdelta inhibitor gs-9901 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4262. en:pi3kdelta inhibitor incb040093 --- r_associated #0: 20 --> ipilimumab
    n1=en:pi3kdelta inhibitor incb040093 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4263. en:pibenzimol --- r_associated #0: 20 --> ipilimumab
    n1=en:pibenzimol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4264. en:pibrozelesin --- r_associated #0: 20 --> ipilimumab
    n1=en:pibrozelesin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4265. en:picibanil --- r_associated #0: 20 --> ipilimumab
    n1=en:picibanil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4266. en:picoplatin --- r_associated #0: 20 --> ipilimumab
    n1=en:picoplatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4267. en:picropodophyllin --- r_associated #0: 20 --> ipilimumab
    n1=en:picropodophyllin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4268. en:pidilizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:pidilizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4269. en:pigmenting agent --- r_associated #0: 20 --> ipilimumab
    n1=en:pigmenting agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4270. en:pilocarpine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:pilocarpine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4271. en:pim kinase inhibitor lgh447 --- r_associated #0: 20 --> ipilimumab
    n1=en:pim kinase inhibitor lgh447 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4272. en:pim kinase inhibitor sgi-1776 --- r_associated #0: 20 --> ipilimumab
    n1=en:pim kinase inhibitor sgi-1776 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4273. en:pimasertib --- r_associated #0: 20 --> ipilimumab
    n1=en:pimasertib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4274. en:pimecrolimus --- r_associated #0: 20 --> ipilimumab
    n1=en:pimecrolimus | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4275. en:pimonidazole --- r_associated #0: 20 --> ipilimumab
    n1=en:pimonidazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4276. en:pimonidazole hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:pimonidazole hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4277. en:pinaverium bromide --- r_associated #0: 20 --> ipilimumab
    n1=en:pinaverium bromide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4278. en:pioglitazone hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:pioglitazone hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4279. en:pipendoxifene --- r_associated #0: 20 --> ipilimumab
    n1=en:pipendoxifene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4280. en:piperacillin sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:piperacillin sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4281. en:piperacillin-tazobactam --- r_associated #0: 20 --> ipilimumab
    n1=en:piperacillin-tazobactam | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4282. en:piperazinedione --- r_associated #0: 20 --> ipilimumab
    n1=en:piperazinedione | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4283. en:piperine extract (standardized) --- r_associated #0: 20 --> ipilimumab
    n1=en:piperine extract (standardized) | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4284. en:pirarubicin --- r_associated #0: 20 --> ipilimumab
    n1=en:pirarubicin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4285. en:pirfenidone --- r_associated #0: 20 --> ipilimumab
    n1=en:pirfenidone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4286. en:piritramide --- r_associated #0: 20 --> ipilimumab
    n1=en:piritramide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4287. en:piritrexim --- r_associated #0: 20 --> ipilimumab
    n1=en:piritrexim | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4288. en:pirotinib --- r_associated #0: 20 --> ipilimumab
    n1=en:pirotinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4289. en:piroxantrone --- r_associated #0: 20 --> ipilimumab
    n1=en:piroxantrone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4290. en:piroxicam --- r_associated #0: 20 --> ipilimumab
    n1=en:piroxicam | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4291. en:pirs2 phosphopeptide-tetanus peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:pirs2 phosphopeptide-tetanus peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4292. en:pivaloyloxymethylbutyrate --- r_associated #0: 20 --> ipilimumab
    n1=en:pivaloyloxymethylbutyrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4293. en:pixantrone dimaleate --- r_associated #0: 20 --> ipilimumab
    n1=en:pixantrone dimaleate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4294. en:placebo administration --- r_associated #0: 20 --> ipilimumab
    n1=en:placebo administration | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4295. en:pladienolide derivative e7107 --- r_associated #0: 20 --> ipilimumab
    n1=en:pladienolide derivative e7107 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4296. en:plant extracts --- r_associated #0: 20 --> ipilimumab
    n1=en:plant extracts | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4297. en:plant-derived hematopoiesis enhancer pg2 --- r_associated #0: 20 --> ipilimumab
    n1=en:plant-derived hematopoiesis enhancer pg2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4298. en:plasmacytoid dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:plasmacytoid dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4299. en:plasmid encoding antiangiogenic metargidin peptide --- r_associated #0: 20 --> ipilimumab
    n1=en:plasmid encoding antiangiogenic metargidin peptide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4300. en:plectin-1 targeting agent ptp-01 --- r_associated #0: 20 --> ipilimumab
    n1=en:plectin-1 targeting agent ptp-01 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4301. en:pled-based mnsod mimetic --- r_associated #0: 20 --> ipilimumab
    n1=en:pled-based mnsod mimetic | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4302. en:pleiotropic pathway modifier cc-122 hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:pleiotropic pathway modifier cc-122 hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4303. en:plerixafor --- r_associated #0: 20 --> ipilimumab
    n1=en:plerixafor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4304. en:plevitrexed --- r_associated #0: 20 --> ipilimumab
    n1=en:plevitrexed | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4305. en:plicamycin --- r_associated #0: 20 --> ipilimumab
    n1=en:plicamycin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4306. en:plinabulin --- r_associated #0: 20 --> ipilimumab
    n1=en:plinabulin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4307. en:plitidepsin --- r_associated #0: 20 --> ipilimumab
    n1=en:plitidepsin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4308. en:plk1 inhibitor tak-960 --- r_associated #0: 20 --> ipilimumab
    n1=en:plk1 inhibitor tak-960 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4309. en:plozalizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:plozalizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4310. en:plx73086 --- r_associated #0: 20 --> ipilimumab
    n1=en:plx73086 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4311. en:pm00104 --- r_associated #0: 20 --> ipilimumab
    n1=en:pm00104 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4312. en:pneumococcal 13-valent conjugate vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:pneumococcal 13-valent conjugate vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4313. en:pneumococcal 7-valent conjugate vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:pneumococcal 7-valent conjugate vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4314. en:pneumococcal polyvalent vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:pneumococcal polyvalent vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4315. en:pngvl3-hicd vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:pngvl3-hicd vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4316. en:pngvl4a-crt/e7(detox) dna vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:pngvl4a-crt/e7(detox) dna vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4317. en:pngvl4a-sig/e7(detox)/hsp70 dna vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:pngvl4a-sig/e7(detox)/hsp70 dna vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4318. en:pnp-expressing ovine atadenovirus fp253 --- r_associated #0: 20 --> ipilimumab
    n1=en:pnp-expressing ovine atadenovirus fp253 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4319. en:pol i inhibitor cx5461 --- r_associated #0: 20 --> ipilimumab
    n1=en:pol i inhibitor cx5461 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4320. en:polaprezinc --- r_associated #0: 20 --> ipilimumab
    n1=en:polaprezinc | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4321. en:polatuzumab vedotin --- r_associated #0: 20 --> ipilimumab
    n1=en:polatuzumab vedotin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4322. en:policosanol --- r_associated #0: 20 --> ipilimumab
    n1=en:policosanol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4323. en:polifeprosan 20 with carmustine implant --- r_associated #0: 20 --> ipilimumab
    n1=en:polifeprosan 20 with carmustine implant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4324. en:polihexanide solution --- r_associated #0: 20 --> ipilimumab
    n1=en:polihexanide solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4325. en:polo-like kinase 1 inhibitor gsk461364 --- r_associated #0: 20 --> ipilimumab
    n1=en:polo-like kinase 1 inhibitor gsk461364 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4326. en:polo-like kinase 1 inhibitor mk1496 --- r_associated #0: 20 --> ipilimumab
    n1=en:polo-like kinase 1 inhibitor mk1496 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4327. en:polo-like kinase 1 inhibitor nms-1286937 --- r_associated #0: 20 --> ipilimumab
    n1=en:polo-like kinase 1 inhibitor nms-1286937 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4328. en:polo-like kinase 4 inhibitor cfi-400945 fumarate --- r_associated #0: 20 --> ipilimumab
    n1=en:polo-like kinase 4 inhibitor cfi-400945 fumarate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4329. en:poly (adp-ribose) polymerase inhibitor --- r_associated #0: 20 --> ipilimumab
    n1=en:poly (adp-ribose) polymerase inhibitor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4330. en:poly au --- r_associated #0: 20 --> ipilimumab
    n1=en:poly au | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4331. en:poly ic --- r_associated #0: 20 --> ipilimumab
    n1=en:poly ic | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4332. en:poly iclc --- r_associated #0: 20 --> ipilimumab
    n1=en:poly iclc | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4333. en:poly-alendronate dextran-guanidine conjugate --- r_associated #0: 20 --> ipilimumab
    n1=en:poly-alendronate dextran-guanidine conjugate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4334. en:poly-gamma glutamic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:poly-gamma glutamic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4335. en:polyacrylamide hydrogel --- r_associated #0: 20 --> ipilimumab
    n1=en:polyacrylamide hydrogel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4336. en:polyamine analogue --- r_associated #0: 20 --> ipilimumab
    n1=en:polyamine analogue | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4337. en:polyamine analogue pg11047 --- r_associated #0: 20 --> ipilimumab
    n1=en:polyamine analogue pg11047 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4338. en:polyamine synthesis inhibitor --- r_associated #0: 20 --> ipilimumab
    n1=en:polyamine synthesis inhibitor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4339. en:polycarbophil/carbomer/glycerin/palm oil glyceride/mineral oil-containing vaginal moisturizer --- r_associated #0: 20 --> ipilimumab
    n1=en:polycarbophil/carbomer/glycerin/palm oil glyceride/mineral oil-containing vaginal moisturizer | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4340. en:polydextrose --- r_associated #0: 20 --> ipilimumab
    n1=en:polydextrose | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4341. en:polyethylene glycol --- r_associated #0: 20 --> ipilimumab
    n1=en:polyethylene glycol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4342. en:polyethylene glycol 3350-containing enema ner1008 --- r_associated #0: 20 --> ipilimumab
    n1=en:polyethylene glycol 3350-containing enema ner1008 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4343. en:polyethylene glycol polymer surgical sealant --- r_associated #0: 20 --> ipilimumab
    n1=en:polyethylene glycol polymer surgical sealant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4344. en:polyethylene glycol recombinant endostatin --- r_associated #0: 20 --> ipilimumab
    n1=en:polyethylene glycol recombinant endostatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4345. en:polyethyleneglycol-7-ethyl-10-hydroxycamptothecin dfp-13318 --- r_associated #0: 20 --> ipilimumab
    n1=en:polyethyleneglycol-7-ethyl-10-hydroxycamptothecin dfp-13318 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4346. en:polyglutamate camptothecin --- r_associated #0: 20 --> ipilimumab
    n1=en:polyglutamate camptothecin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4347. en:polymeric camptothecin prodrug xmt-1001 --- r_associated #0: 20 --> ipilimumab
    n1=en:polymeric camptothecin prodrug xmt-1001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4348. en:polymyxin b --- r_associated #0: 20 --> ipilimumab
    n1=en:polymyxin b | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4349. en:polysaccharide-k --- r_associated #0: 20 --> ipilimumab
    n1=en:polysaccharide-k | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4350. en:polyunsaturated fatty acid --- r_associated #0: 20 --> ipilimumab
    n1=en:polyunsaturated fatty acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4351. en:polyvalent antigen-klh conjugate vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:polyvalent antigen-klh conjugate vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4352. en:polyvalent melanoma vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:polyvalent melanoma vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4353. en:polyvinylpyrrolidone-sodium hyaluronate gel --- r_associated #0: 20 --> ipilimumab
    n1=en:polyvinylpyrrolidone-sodium hyaluronate gel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4354. en:pomalidomide --- r_associated #0: 20 --> ipilimumab
    n1=en:pomalidomide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4355. en:pomegranate juice --- r_associated #0: 20 --> ipilimumab
    n1=en:pomegranate juice | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4356. en:pomegranate liquid extract --- r_associated #0: 20 --> ipilimumab
    n1=en:pomegranate liquid extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4357. en:pomegranate-extract pill --- r_associated #0: 20 --> ipilimumab
    n1=en:pomegranate-extract pill | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4358. en:ponatinib hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:ponatinib hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4359. en:ponesimod --- r_associated #0: 20 --> ipilimumab
    n1=en:ponesimod | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4360. en:porcupine inhibitor etc-1922159 --- r_associated #0: 20 --> ipilimumab
    n1=en:porcupine inhibitor etc-1922159 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4361. en:porcupine inhibitor wnt974 --- r_associated #0: 20 --> ipilimumab
    n1=en:porcupine inhibitor wnt974 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4362. en:porfimer sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:porfimer sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4363. en:porfiromycin --- r_associated #0: 20 --> ipilimumab
    n1=en:porfiromycin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4364. en:posaconazole --- r_associated #0: 20 --> ipilimumab
    n1=en:posaconazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4365. en:povidone-iodine --- r_associated #0: 20 --> ipilimumab
    n1=en:povidone-iodine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4366. en:poziotinib --- r_associated #0: 20 --> ipilimumab
    n1=en:poziotinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4367. en:ppe-expressing replication-defective hsv-1 vector np2 --- r_associated #0: 20 --> ipilimumab
    n1=en:ppe-expressing replication-defective hsv-1 vector np2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4368. en:ppi-2458 --- r_associated #0: 20 --> ipilimumab
    n1=en:ppi-2458 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4369. en:pr-104 --- r_associated #0: 20 --> ipilimumab
    n1=en:pr-104 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4370. en:pr1 leukemia peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:pr1 leukemia peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4371. en:pracinostat --- r_associated #0: 20 --> ipilimumab
    n1=en:pracinostat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4372. en:pralatrexate --- r_associated #0: 20 --> ipilimumab
    n1=en:pralatrexate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4373. en:prame-targeting t-cell receptor/inducible caspase 9 bpx-701 --- r_associated #0: 20 --> ipilimumab
    n1=en:prame-targeting t-cell receptor/inducible caspase 9 bpx-701 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4374. en:pramipexole dihydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:pramipexole dihydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4375. en:prasterone --- r_associated #0: 20 --> ipilimumab
    n1=en:prasterone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4376. en:pravastatin sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:pravastatin sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4377. en:prednimustine --- r_associated #0: 20 --> ipilimumab
    n1=en:prednimustine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4378. en:prednisolone --- r_associated #0: 20 --> ipilimumab
    n1=en:prednisolone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4379. en:prednisone --- r_associated #0: 20 --> ipilimumab
    n1=en:prednisone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4380. en:pregabalin --- r_associated #0: 20 --> ipilimumab
    n1=en:pregabalin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4381. en:preimplantation factor pif-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:preimplantation factor pif-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4382. en:prescription drugs --- r_associated #0: 20 --> ipilimumab
    n1=en:prescription drugs | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4383. en:prexasertib --- r_associated #0: 20 --> ipilimumab
    n1=en:prexasertib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4384. en:prilocaine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:prilocaine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4385. en:prima-1 analog apr-246 --- r_associated #0: 20 --> ipilimumab
    n1=en:prima-1 analog apr-246 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4386. en:primary prostate cancer tissue/htert/survivin mrna-loaded autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:primary prostate cancer tissue/htert/survivin mrna-loaded autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4387. en:prinomastat --- r_associated #0: 20 --> ipilimumab
    n1=en:prinomastat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4388. en:probenecid --- r_associated #0: 20 --> ipilimumab
    n1=en:probenecid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4389. en:procarbazine --- r_associated #0: 20 --> ipilimumab
    n1=en:procarbazine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4390. en:procarbazine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:procarbazine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4391. en:procaspase activating compound-1 vo-100 --- r_associated #0: 20 --> ipilimumab
    n1=en:procaspase activating compound-1 vo-100 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4392. en:prochlorperazine --- r_associated #0: 20 --> ipilimumab
    n1=en:prochlorperazine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4393. en:prodrugs --- r_associated #0: 20 --> ipilimumab
    n1=en:prodrugs | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4394. en:product bases and inactive substances --- r_associated #0: 20 --> ipilimumab
    n1=en:product bases and inactive substances | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4395. en:proflavine --- r_associated #0: 20 --> ipilimumab
    n1=en:proflavine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4396. en:proflavine hemisulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:proflavine hemisulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4397. en:progenipoietin --- r_associated #0: 20 --> ipilimumab
    n1=en:progenipoietin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4398. en:progesterone vaginal insert --- r_associated #0: 20 --> ipilimumab
    n1=en:progesterone vaginal insert | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4399. en:progestin --- r_associated #0: 20 --> ipilimumab
    n1=en:progestin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4400. en:prohibitin-targeting peptide 1 --- r_associated #0: 20 --> ipilimumab
    n1=en:prohibitin-targeting peptide 1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4401. en:proliferant agent --- r_associated #0: 20 --> ipilimumab
    n1=en:proliferant agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4402. en:promegapoietin --- r_associated #0: 20 --> ipilimumab
    n1=en:promegapoietin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4403. en:promestriene --- r_associated #0: 20 --> ipilimumab
    n1=en:promestriene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4404. en:promethazine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:promethazine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4405. en:pronase oral solution --- r_associated #0: 20 --> ipilimumab
    n1=en:pronase oral solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4406. en:propacetamol --- r_associated #0: 20 --> ipilimumab
    n1=en:propacetamol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4407. en:propofol --- r_associated #0: 20 --> ipilimumab
    n1=en:propofol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4408. en:propranolol hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:propranolol hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4409. en:propylthiouracil --- r_associated #0: 20 --> ipilimumab
    n1=en:propylthiouracil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4410. en:prostate cancer vaccine ony-p1 --- r_associated #0: 20 --> ipilimumab
    n1=en:prostate cancer vaccine ony-p1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4411. en:prostate cancer vaccine pf-06755990 --- r_associated #0: 20 --> ipilimumab
    n1=en:prostate cancer vaccine pf-06755990 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4412. en:prostate cancer vaccine pf-06755992 --- r_associated #0: 20 --> ipilimumab
    n1=en:prostate cancer vaccine pf-06755992 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4413. en:prostate health cocktail dietary supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:prostate health cocktail dietary supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4414. en:prostate tumor antigen-activated autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:prostate tumor antigen-activated autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4415. en:prostatic acid phosphatase-sargramostim fusion protein --- r_associated #0: 20 --> ipilimumab
    n1=en:prostatic acid phosphatase-sargramostim fusion protein | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4416. en:proteasome inhibitor --- r_associated #0: 20 --> ipilimumab
    n1=en:proteasome inhibitor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4417. en:protective agent --- r_associated #0: 20 --> ipilimumab
    n1=en:protective agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4418. en:protein e7, human papillomavirus type 16 --- r_associated #0: 20 --> ipilimumab
    n1=en:protein e7, human papillomavirus type 16 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4419. en:protein kinase c inhibitor lxs196 --- r_associated #0: 20 --> ipilimumab
    n1=en:protein kinase c inhibitor lxs196 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4420. en:protein phosphatase 2a inhibitor lb-100 --- r_associated #0: 20 --> ipilimumab
    n1=en:protein phosphatase 2a inhibitor lb-100 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4421. en:protein stabilized liposomal docetaxel nanoparticles --- r_associated #0: 20 --> ipilimumab
    n1=en:protein stabilized liposomal docetaxel nanoparticles | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4422. en:protein tyrosine kinase 2 inhibitor bi 853520 --- r_associated #0: 20 --> ipilimumab
    n1=en:protein tyrosine kinase 2 inhibitor bi 853520 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4423. en:psa rna-pulsed dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:psa rna-pulsed dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4424. en:psa-pap/klh-pulsed autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:psa-pap/klh-pulsed autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4425. en:psa/il-2/gm-csf vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:psa/il-2/gm-csf vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4426. en:psa/psma dna plasmid ino-5150 --- r_associated #0: 20 --> ipilimumab
    n1=en:psa/psma dna plasmid ino-5150 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4427. en:psa:154-163(155l) peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:psa:154-163(155l) peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4428. en:pseudomonas aeruginosa preparation --- r_associated #0: 20 --> ipilimumab
    n1=en:pseudomonas aeruginosa preparation | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4429. en:psicrip-mfg-s-tk1-67 --- r_associated #0: 20 --> ipilimumab
    n1=en:psicrip-mfg-s-tk1-67 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4430. en:psilocybine --- r_associated #0: 20 --> ipilimumab
    n1=en:psilocybine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4431. en:psma-targeted docetaxel nanoparticles bind-014 --- r_associated #0: 20 --> ipilimumab
    n1=en:psma-targeted docetaxel nanoparticles bind-014 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4432. en:psma-targeted tubulysin b-containing conjugate ec1169 --- r_associated #0: 20 --> ipilimumab
    n1=en:psma-targeted tubulysin b-containing conjugate ec1169 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4433. en:psma/tarp peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:psma/tarp peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4434. en:psoralen --- r_associated #0: 20 --> ipilimumab
    n1=en:psoralen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4435. en:psychopharmacologic agent --- r_associated #0: 20 --> ipilimumab
    n1=en:psychopharmacologic agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4436. en:ptef-b/cdk9 inhibitor bay1251152 --- r_associated #0: 20 --> ipilimumab
    n1=en:ptef-b/cdk9 inhibitor bay1251152 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4437. en:ptvg-hp plasmid dna vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:ptvg-hp plasmid dna vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4438. en:pumvc3-higfbp-2 multi-epitope plasmid dna vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:pumvc3-higfbp-2 multi-epitope plasmid dna vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4439. en:pumvc3-igfbp2-her2-igf1r plasmid dna vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:pumvc3-igfbp2-her2-igf1r plasmid dna vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4440. en:purple grape juice --- r_associated #0: 20 --> ipilimumab
    n1=en:purple grape juice | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4441. en:pv-10 --- r_associated #0: 20 --> ipilimumab
    n1=en:pv-10 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4442. en:pv701 --- r_associated #0: 20 --> ipilimumab
    n1=en:pv701 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4443. en:pva microporous hydrospheres --- r_associated #0: 20 --> ipilimumab
    n1=en:pva microporous hydrospheres | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4444. en:pva microporous hydrospheres/doxorubicin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:pva microporous hydrospheres/doxorubicin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4445. en:pvaxrcpsav53l dna vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:pvaxrcpsav53l dna vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4446. en:pyrazinamide --- r_associated #0: 20 --> ipilimumab
    n1=en:pyrazinamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4447. en:pyrazine diazohydroxide --- r_associated #0: 20 --> ipilimumab
    n1=en:pyrazine diazohydroxide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4448. en:pyrazofurin --- r_associated #0: 20 --> ipilimumab
    n1=en:pyrazofurin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4449. en:pyrazole derivative --- r_associated #0: 20 --> ipilimumab
    n1=en:pyrazole derivative | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4450. en:pyrazoloacridine --- r_associated #0: 20 --> ipilimumab
    n1=en:pyrazoloacridine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4451. en:pyridoxine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:pyridoxine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4452. en:pyridyl cyanoguanidine chs 828 --- r_associated #0: 20 --> ipilimumab
    n1=en:pyridyl cyanoguanidine chs 828 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4453. en:pyrimethamine --- r_associated #0: 20 --> ipilimumab
    n1=en:pyrimethamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4454. en:pyrimethamine-sulfadoxine --- r_associated #0: 20 --> ipilimumab
    n1=en:pyrimethamine-sulfadoxine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4455. en:pyrogen --- r_associated #0: 20 --> ipilimumab
    n1=en:pyrogen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4456. en:pyrotinib --- r_associated #0: 20 --> ipilimumab
    n1=en:pyrotinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4457. en:pyroxamide --- r_associated #0: 20 --> ipilimumab
    n1=en:pyroxamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4458. en:pyruvate kinase inhibitor tln-232 --- r_associated #0: 20 --> ipilimumab
    n1=en:pyruvate kinase inhibitor tln-232 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4459. en:qs21 --- r_associated #0: 20 --> ipilimumab
    n1=en:qs21 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4460. en:quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4461. en:quarfloxin --- r_associated #0: 20 --> ipilimumab
    n1=en:quarfloxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4462. en:quaternary ammonium polyethylenimine nanoparticles --- r_associated #0: 20 --> ipilimumab
    n1=en:quaternary ammonium polyethylenimine nanoparticles | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4463. en:quercetin --- r_associated #0: 20 --> ipilimumab
    n1=en:quercetin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4464. en:quinacrine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:quinacrine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4465. en:quinidine --- r_associated #0: 20 --> ipilimumab
    n1=en:quinidine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4466. en:quinine --- r_associated #0: 20 --> ipilimumab
    n1=en:quinine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4467. en:quinoline --- r_associated #0: 20 --> ipilimumab
    n1=en:quinoline | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4468. en:quisinostat --- r_associated #0: 20 --> ipilimumab
    n1=en:quisinostat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4469. en:quizartinib --- r_associated #0: 20 --> ipilimumab
    n1=en:quizartinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4470. en:r 7160 --- r_associated #0: 20 --> ipilimumab
    n1=en:r 7160 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4471. en:r(+)xk469 --- r_associated #0: 20 --> ipilimumab
    n1=en:r(+)xk469 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4472. en:r-(-)-gossypol acetic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:r-(-)-gossypol acetic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4473. en:r-chop regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:r-chop regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4474. en:r-cvp regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:r-cvp regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4475. en:r-epoch regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:r-epoch regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4476. en:r-ice regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:r-ice regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4477. en:r1 cooling gel plus r2 moisturizing/sun protecting lotion --- r_associated #0: 20 --> ipilimumab
    n1=en:r1 cooling gel plus r2 moisturizing/sun protecting lotion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4478. en:rabeprazole sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:rabeprazole sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4479. en:rabusertib --- r_associated #0: 20 --> ipilimumab
    n1=en:rabusertib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4480. en:racotumomab --- r_associated #0: 20 --> ipilimumab
    n1=en:racotumomab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4481. en:radiopharmaceutical agent --- r_associated #0: 20 --> ipilimumab
    n1=en:radiopharmaceutical agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4482. en:radiopharmaceutical bay1862864 --- r_associated #0: 20 --> ipilimumab
    n1=en:radiopharmaceutical bay1862864 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4483. en:radiopharmaceutical compound --- r_associated #0: 20 --> ipilimumab
    n1=en:radiopharmaceutical compound | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4484. en:radioprotective agent --- r_associated #0: 20 --> ipilimumab
    n1=en:radioprotective agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4485. en:radiosensitizer rrx-001 --- r_associated #0: 20 --> ipilimumab
    n1=en:radiosensitizer rrx-001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4486. en:radiosensitizing agent --- r_associated #0: 20 --> ipilimumab
    n1=en:radiosensitizing agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4487. en:radium ra 223 dichloride --- r_associated #0: 20 --> ipilimumab
    n1=en:radium ra 223 dichloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4488. en:radix angelicae sinensis/radix astragali herbal supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:radix angelicae sinensis/radix astragali herbal supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4489. en:radotinib hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:radotinib hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4490. en:raf kinase inhibitor hm95573 --- r_associated #0: 20 --> ipilimumab
    n1=en:raf kinase inhibitor hm95573 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4491. en:raf kinase inhibitor lgx818 --- r_associated #0: 20 --> ipilimumab
    n1=en:raf kinase inhibitor lgx818 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4492. en:raf kinase inhibitor xl281 --- r_associated #0: 20 --> ipilimumab
    n1=en:raf kinase inhibitor xl281 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4493. en:raf/mek serine/threonine kinase inhibitor ro5126766 --- r_associated #0: 20 --> ipilimumab
    n1=en:raf/mek serine/threonine kinase inhibitor ro5126766 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4494. en:raloxifene --- r_associated #0: 20 --> ipilimumab
    n1=en:raloxifene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4495. en:raltegravir potassium --- r_associated #0: 20 --> ipilimumab
    n1=en:raltegravir potassium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4496. en:raltitrexed --- r_associated #0: 20 --> ipilimumab
    n1=en:raltitrexed | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4497. en:ramelteon --- r_associated #0: 20 --> ipilimumab
    n1=en:ramelteon | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4498. en:ramipril --- r_associated #0: 20 --> ipilimumab
    n1=en:ramipril | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4499. en:ramosetron hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:ramosetron hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4500. en:ramucirumab --- r_associated #0: 20 --> ipilimumab
    n1=en:ramucirumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4501. en:ranibizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:ranibizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4502. en:ranimustine --- r_associated #0: 20 --> ipilimumab
    n1=en:ranimustine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4503. en:ranitidine hydrochloride/bismuth potassium citrate/sucralfate hydrate formulation --- r_associated #0: 20 --> ipilimumab
    n1=en:ranitidine hydrochloride/bismuth potassium citrate/sucralfate hydrate formulation | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4504. en:ranolazine --- r_associated #0: 20 --> ipilimumab
    n1=en:ranolazine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4505. en:ranpirnase --- r_associated #0: 20 --> ipilimumab
    n1=en:ranpirnase | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4506. en:rapamycin-polarized th1/tc1 autologous t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:rapamycin-polarized th1/tc1 autologous t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4507. en:rar-alpha agonist vtp195183 --- r_associated #0: 20 --> ipilimumab
    n1=en:rar-alpha agonist vtp195183 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4508. en:ras peptide cancer vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:ras peptide cancer vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4509. en:rasburicase --- r_associated #0: 20 --> ipilimumab
    n1=en:rasburicase | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4510. en:ravuconazole --- r_associated #0: 20 --> ipilimumab
    n1=en:ravuconazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4511. en:razoxane --- r_associated #0: 20 --> ipilimumab
    n1=en:razoxane | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4512. en:rbl001/rbl002 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:rbl001/rbl002 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4513. en:realgar-indigo naturalis formulation --- r_associated #0: 20 --> ipilimumab
    n1=en:realgar-indigo naturalis formulation | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4514. en:rebamipide --- r_associated #0: 20 --> ipilimumab
    n1=en:rebamipide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4515. en:rebastinib tosylate --- r_associated #0: 20 --> ipilimumab
    n1=en:rebastinib tosylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4516. en:rebimastat --- r_associated #0: 20 --> ipilimumab
    n1=en:rebimastat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4517. en:receptor tyrosine kinase inhibitor r1530 --- r_associated #0: 20 --> ipilimumab
    n1=en:receptor tyrosine kinase inhibitor r1530 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4518. en:recombinant 70-kd heat-shock protein --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant 70-kd heat-shock protein | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4519. en:recombinant adenovirus 5 encoding tumor necrosis factor-related apoptosis-inducing ligand --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant adenovirus 5 encoding tumor necrosis factor-related apoptosis-inducing ligand | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4520. en:recombinant adenovirus encoding p53 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant adenovirus encoding p53 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4521. en:recombinant adenovirus-hifn-beta --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant adenovirus-hifn-beta | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4522. en:recombinant adenovirus-interferon sch 721015 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant adenovirus-interferon sch 721015 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4523. en:recombinant adenovirus-interferon/syn3 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant adenovirus-interferon/syn3 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4524. en:recombinant adenovirus-l523s vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant adenovirus-l523s vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4525. en:recombinant adenovirus-p53 sch-58500 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant adenovirus-p53 sch-58500 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4526. en:recombinant anti-wt1 immunotherapeutic gsk2302024a --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant anti-wt1 immunotherapeutic gsk2302024a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4527. en:recombinant attenuated salmonella typhimurium expressing il-2 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant attenuated salmonella typhimurium expressing il-2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4528. en:recombinant b. pertussis adenylate cyclase toxin-tyrosinase a2 epitope vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant b. pertussis adenylate cyclase toxin-tyrosinase a2 epitope vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4529. en:recombinant bispecific single-chain antibody rm28 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant bispecific single-chain antibody rm28 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4530. en:recombinant cd40-ligand --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant cd40-ligand | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4531. en:recombinant cell-surface anchored sialidase das181 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant cell-surface anchored sialidase das181 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4532. en:recombinant dher2 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant dher2 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4533. en:recombinant dna-l523s vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant dna-l523s vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4534. en:recombinant ephb4-hsa fusion protein --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant ephb4-hsa fusion protein | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4535. en:recombinant flt3 ligand --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant flt3 ligand | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4536. en:recombinant fowlpox gm-csf vaccine adjuvant --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant fowlpox gm-csf vaccine adjuvant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4537. en:recombinant fowlpox-b7.1 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant fowlpox-b7.1 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4538. en:recombinant fowlpox-cea(6d)/tricom vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant fowlpox-cea(6d)/tricom vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4539. en:recombinant fowlpox-prostate specific antigen vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant fowlpox-prostate specific antigen vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4540. en:recombinant fowlpox-tricom vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant fowlpox-tricom vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4541. en:recombinant fowlpox-tyrosinase vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant fowlpox-tyrosinase vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4542. en:recombinant gonadorelin --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant gonadorelin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4543. en:recombinant granulocyte-macrophage colony-stimulating factor --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant granulocyte-macrophage colony-stimulating factor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4544. en:recombinant human 6ckine --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant human 6ckine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4545. en:recombinant human adenovirus type 5 h101 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant human adenovirus type 5 h101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4546. en:recombinant human albumin-human granulocyte colony-stimulating factor --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant human albumin-human granulocyte colony-stimulating factor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4547. en:recombinant human angiotensin converting enzyme 2 apn01 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant human angiotensin converting enzyme 2 apn01 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4548. en:recombinant human apolipoprotein(a) kringle v mg1102 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant human apolipoprotein(a) kringle v mg1102 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4549. en:recombinant human chorionic gonadotropin --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant human chorionic gonadotropin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4550. en:recombinant human egf-rp64k/montanide isa 51 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant human egf-rp64k/montanide isa 51 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4551. en:recombinant human endostatin --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant human endostatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4552. en:recombinant human fusion protein l19tnfalpha --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant human fusion protein l19tnfalpha | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4553. en:recombinant human granulocyte colony stimulating factor --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant human granulocyte colony stimulating factor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4554. en:recombinant human hsp110-gp100 chaperone complex vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant human hsp110-gp100 chaperone complex vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4555. en:recombinant human hyaluronidase --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant human hyaluronidase | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4556. en:recombinant human interleukin-15 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant human interleukin-15 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4557. en:recombinant human papillomavirus nonavalent vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant human papillomavirus nonavalent vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4558. en:recombinant human serum amyloid p/pentraxin 2 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant human serum amyloid p/pentraxin 2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4559. en:recombinant interferon --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant interferon | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4560. en:recombinant interferon alfa --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant interferon alfa | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4561. en:recombinant interferon alfa-1b --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant interferon alfa-1b | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4562. en:recombinant interferon alfa-2a --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant interferon alfa-2a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4563. en:recombinant interferon alfa-2b --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant interferon alfa-2b | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4564. en:recombinant interferon alpha 2b-like protein --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant interferon alpha 2b-like protein | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4565. en:recombinant interferon beta --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant interferon beta | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4566. en:recombinant interferon gamma --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant interferon gamma | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4567. en:recombinant interleukin-1-alpha --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant interleukin-1-alpha | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4568. en:recombinant interleukin-1-beta --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant interleukin-1-beta | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4569. en:recombinant interleukin-12 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant interleukin-12 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4570. en:recombinant interleukin-18 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant interleukin-18 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4571. en:recombinant interleukin-3 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant interleukin-3 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4572. en:recombinant interleukin-7 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant interleukin-7 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4573. en:recombinant leukocyte interleukin --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant leukocyte interleukin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4574. en:recombinant macrophage colony-stimulating factor --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant macrophage colony-stimulating factor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4575. en:recombinant mage-3.1 antigen --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant mage-3.1 antigen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4576. en:recombinant mip1-alpha variant eci301 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant mip1-alpha variant eci301 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4577. en:recombinant modified vaccinia ankara-5t4 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant modified vaccinia ankara-5t4 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4578. en:recombinant nematode anticoagulant protein c2 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant nematode anticoagulant protein c2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4579. en:recombinant oncolytic poliovirus pvs-ripo --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant oncolytic poliovirus pvs-ripo | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4580. en:recombinant oxytocin --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant oxytocin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4581. en:recombinant parathyroid hormone --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant parathyroid hormone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4582. en:recombinant platelet factor 4 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant platelet factor 4 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4583. en:recombinant prame protein plus as15 adjuvant gsk2302025a --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant prame protein plus as15 adjuvant gsk2302025a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4584. en:recombinant saccharomyces cerevisia-cea(610d)-expressing vaccine gi-6207 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant saccharomyces cerevisia-cea(610d)-expressing vaccine gi-6207 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4585. en:recombinant soluble human cd4 protein --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant soluble human cd4 protein | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4586. en:recombinant soluble t4 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant soluble t4 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4587. en:recombinant super-compound interferon --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant super-compound interferon | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4588. en:recombinant thymosin --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant thymosin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4589. en:recombinant thyroglobulin --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant thyroglobulin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4590. en:recombinant thyroid-stimulating hormone --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant thyroid-stimulating hormone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4591. en:recombinant thyrotropin alfa --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant thyrotropin alfa | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4592. en:recombinant transforming growth factor-beta-2 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant transforming growth factor-beta-2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4593. en:recombinant tumor necrosis factor family protein --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant tumor necrosis factor family protein | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4594. en:recombinant tyrosinase-related protein-2 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant tyrosinase-related protein-2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4595. en:recombinant urokinase --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant urokinase | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4596. en:recombinant vaccinia df3/muc1 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant vaccinia df3/muc1 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4597. en:recombinant vaccinia psa vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant vaccinia psa vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4598. en:recombinant vaccinia viral vector ro5217790 --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant vaccinia viral vector ro5217790 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4599. en:recombinant vaccinia-b7.1 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant vaccinia-b7.1 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4600. en:recombinant vaccinia-cea(6d)-tricom vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant vaccinia-cea(6d)-tricom vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4601. en:recombinant vaccinia-muc-1 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant vaccinia-muc-1 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4602. en:recombinant vaccinia-multiepitope melanoma peptides-b7.1-b7.2 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant vaccinia-multiepitope melanoma peptides-b7.1-b7.2 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4603. en:recombinant vaccinia-ny-eso-1 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant vaccinia-ny-eso-1 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4604. en:recombinant vaccinia-tricom vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant vaccinia-tricom vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4605. en:recombinant vesicular stomatitis virus-expressing interferon-beta --- r_associated #0: 20 --> ipilimumab
    n1=en:recombinant vesicular stomatitis virus-expressing interferon-beta | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4606. en:rectal dosage form product --- r_associated #0: 20 --> ipilimumab
    n1=en:rectal dosage form product | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4607. en:red tomato juice --- r_associated #0: 20 --> ipilimumab
    n1=en:red tomato juice | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4608. en:reduced glutathione-l-cysteine-anthocyanins gel --- r_associated #0: 20 --> ipilimumab
    n1=en:reduced glutathione-l-cysteine-anthocyanins gel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4609. en:refametinib --- r_associated #0: 20 --> ipilimumab
    n1=en:refametinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4610. en:regadenoson --- r_associated #0: 20 --> ipilimumab
    n1=en:regadenoson | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4611. en:regorafenib --- r_associated #0: 20 --> ipilimumab
    n1=en:regorafenib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4612. en:relcovaptan --- r_associated #0: 20 --> ipilimumab
    n1=en:relcovaptan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4613. en:remestemcel-l --- r_associated #0: 20 --> ipilimumab
    n1=en:remestemcel-l | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4614. en:remifentanil hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:remifentanil hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4615. en:renal agents --- r_associated #0: 20 --> ipilimumab
    n1=en:renal agents | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4616. en:renal cell carcinoma peptides vaccine ima901 --- r_associated #0: 20 --> ipilimumab
    n1=en:renal cell carcinoma peptides vaccine ima901 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4617. en:renal cell carcinoma/cd40l rna-transfected autologous dendritic cell vaccine ags-003 --- r_associated #0: 20 --> ipilimumab
    n1=en:renal cell carcinoma/cd40l rna-transfected autologous dendritic cell vaccine ags-003 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4618. en:repaglinide --- r_associated #0: 20 --> ipilimumab
    n1=en:repaglinide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4619. en:reparixin --- r_associated #0: 20 --> ipilimumab
    n1=en:reparixin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4620. en:replacement agent --- r_associated #0: 20 --> ipilimumab
    n1=en:replacement agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4621. en:reproductive system drug --- r_associated #0: 20 --> ipilimumab
    n1=en:reproductive system drug | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4622. en:resiniferatoxin --- r_associated #0: 20 --> ipilimumab
    n1=en:resiniferatoxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4623. en:resiquimod --- r_associated #0: 20 --> ipilimumab
    n1=en:resiquimod | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4624. en:resiquimod topical gel --- r_associated #0: 20 --> ipilimumab
    n1=en:resiquimod topical gel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4625. en:resistant starch --- r_associated #0: 20 --> ipilimumab
    n1=en:resistant starch | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4626. en:reslizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:reslizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4627. en:resminostat --- r_associated #0: 20 --> ipilimumab
    n1=en:resminostat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4628. en:respiratory form lucinactant --- r_associated #0: 20 --> ipilimumab
    n1=en:respiratory form lucinactant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4629. en:respiratory form tiotropium --- r_associated #0: 20 --> ipilimumab
    n1=en:respiratory form tiotropium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4630. en:respiratory system agents --- r_associated #0: 20 --> ipilimumab
    n1=en:respiratory system agents | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4631. en:resveratrol --- r_associated #0: 20 --> ipilimumab
    n1=en:resveratrol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4632. en:resveratrol formulation srt501 --- r_associated #0: 20 --> ipilimumab
    n1=en:resveratrol formulation srt501 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4633. en:retaspimycin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:retaspimycin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4634. en:retinoic acid agent --- r_associated #0: 20 --> ipilimumab
    n1=en:retinoic acid agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4635. en:retinoid 9cuab30 --- r_associated #0: 20 --> ipilimumab
    n1=en:retinoid 9cuab30 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4636. en:retinoid analogue nrx 195183 --- r_associated #0: 20 --> ipilimumab
    n1=en:retinoid analogue nrx 195183 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4637. en:retinyl acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:retinyl acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4638. en:retrovector encoding mutant anti-cyclin g1 --- r_associated #0: 20 --> ipilimumab
    n1=en:retrovector encoding mutant anti-cyclin g1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4639. en:retrovirus vector ln --- r_associated #0: 20 --> ipilimumab
    n1=en:retrovirus vector ln | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4640. en:revm10 gene --- r_associated #0: 20 --> ipilimumab
    n1=en:revm10 gene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4641. en:revm10 gene/polas gene --- r_associated #0: 20 --> ipilimumab
    n1=en:revm10 gene/polas gene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4642. en:rexinoid nrx 194204 --- r_associated #0: 20 --> ipilimumab
    n1=en:rexinoid nrx 194204 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4643. en:rft5-dga immunotoxin --- r_associated #0: 20 --> ipilimumab
    n1=en:rft5-dga immunotoxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4644. en:rg 12915 --- r_associated #0: 20 --> ipilimumab
    n1=en:rg 12915 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4645. en:rhenium re 188 bmeda-labeled liposomes --- r_associated #0: 20 --> ipilimumab
    n1=en:rhenium re 188 bmeda-labeled liposomes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4646. en:rhenium re 188 p2045 --- r_associated #0: 20 --> ipilimumab
    n1=en:rhenium re 188 p2045 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4647. en:rhenium re-186 hydroxyethylidene diphosphonate --- r_associated #0: 20 --> ipilimumab
    n1=en:rhenium re-186 hydroxyethylidene diphosphonate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4648. en:rhenium re-188 ethiodized oil --- r_associated #0: 20 --> ipilimumab
    n1=en:rhenium re-188 ethiodized oil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4649. en:rhizoxin --- r_associated #0: 20 --> ipilimumab
    n1=en:rhizoxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4650. en:rhubarb/licorice herbal supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:rhubarb/licorice herbal supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4651. en:ribavirin --- r_associated #0: 20 --> ipilimumab
    n1=en:ribavirin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4652. en:ribavirin+interferon alpha-2b --- r_associated #0: 20 --> ipilimumab
    n1=en:ribavirin+interferon alpha-2b | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4653. en:ribociclib --- r_associated #0: 20 --> ipilimumab
    n1=en:ribociclib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4654. en:riboflavin --- r_associated #0: 20 --> ipilimumab
    n1=en:riboflavin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4655. en:ribonuclease qbi-139 --- r_associated #0: 20 --> ipilimumab
    n1=en:ribonuclease qbi-139 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4656. en:ribosome-inactivating protein cy503 --- r_associated #0: 20 --> ipilimumab
    n1=en:ribosome-inactivating protein cy503 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4657. en:ribozyme rpi.4610 --- r_associated #0: 20 --> ipilimumab
    n1=en:ribozyme rpi.4610 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4658. en:rice bran --- r_associated #0: 20 --> ipilimumab
    n1=en:rice bran | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4659. en:ricin immunoconjugate --- r_associated #0: 20 --> ipilimumab
    n1=en:ricin immunoconjugate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4660. en:ricolinostat --- r_associated #0: 20 --> ipilimumab
    n1=en:ricolinostat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4661. en:ridaforolimus --- r_associated #0: 20 --> ipilimumab
    n1=en:ridaforolimus | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4662. en:rifabutin --- r_associated #0: 20 --> ipilimumab
    n1=en:rifabutin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4663. en:rifampicin+isoniazid --- r_associated #0: 20 --> ipilimumab
    n1=en:rifampicin+isoniazid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4664. en:rifampin --- r_associated #0: 20 --> ipilimumab
    n1=en:rifampin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4665. en:rifaximin --- r_associated #0: 20 --> ipilimumab
    n1=en:rifaximin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4666. en:rigosertib sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:rigosertib sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4667. en:rilimogene galvacirepvec --- r_associated #0: 20 --> ipilimumab
    n1=en:rilimogene galvacirepvec | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4668. en:rilotumumab --- r_associated #0: 20 --> ipilimumab
    n1=en:rilotumumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4669. en:riluzole --- r_associated #0: 20 --> ipilimumab
    n1=en:riluzole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4670. en:rimiducid --- r_associated #0: 20 --> ipilimumab
    n1=en:rimiducid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4671. en:rindopepimut --- r_associated #0: 20 --> ipilimumab
    n1=en:rindopepimut | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4672. en:rintatolimod --- r_associated #0: 20 --> ipilimumab
    n1=en:rintatolimod | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4673. en:risedronate sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:risedronate sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4674. en:ritonavir --- r_associated #0: 20 --> ipilimumab
    n1=en:ritonavir | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4675. en:rituximab --- r_associated #0: 20 --> ipilimumab
    n1=en:rituximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4676. en:rivaroxaban --- r_associated #0: 20 --> ipilimumab
    n1=en:rivaroxaban | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4677. en:rivastigmine tartrate --- r_associated #0: 20 --> ipilimumab
    n1=en:rivastigmine tartrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4678. en:rizatriptan benzoate --- r_associated #0: 20 --> ipilimumab
    n1=en:rizatriptan benzoate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4679. en:rk-0202 --- r_associated #0: 20 --> ipilimumab
    n1=en:rk-0202 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4680. en:rna electroporated cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:rna electroporated cd19car-cd3zeta-4-1bb-expressing autologous t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4681. en:rnr inhibitor coh29 --- r_associated #0: 20 --> ipilimumab
    n1=en:rnr inhibitor coh29 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4682. en:ro6874813 --- r_associated #0: 20 --> ipilimumab
    n1=en:ro6874813 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4683. en:ro6895882 --- r_associated #0: 20 --> ipilimumab
    n1=en:ro6895882 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4684. en:robatumumab --- r_associated #0: 20 --> ipilimumab
    n1=en:robatumumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4685. en:rocuronium bromide --- r_associated #0: 20 --> ipilimumab
    n1=en:rocuronium bromide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4686. en:rofecoxib --- r_associated #0: 20 --> ipilimumab
    n1=en:rofecoxib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4687. en:roflumilast --- r_associated #0: 20 --> ipilimumab
    n1=en:roflumilast | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4688. en:rogletimide --- r_associated #0: 20 --> ipilimumab
    n1=en:rogletimide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4689. en:rolapitant hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:rolapitant hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4690. en:romidepsin --- r_associated #0: 20 --> ipilimumab
    n1=en:romidepsin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4691. en:romiplostim --- r_associated #0: 20 --> ipilimumab
    n1=en:romiplostim | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4692. en:roniciclib --- r_associated #0: 20 --> ipilimumab
    n1=en:roniciclib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4693. en:ropidoxuridine --- r_associated #0: 20 --> ipilimumab
    n1=en:ropidoxuridine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4694. en:ropinirole hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:ropinirole hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4695. en:ropivacaine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:ropivacaine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4696. en:roquinimex --- r_associated #0: 20 --> ipilimumab
    n1=en:roquinimex | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4697. en:ror1 car-specific autologous t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:ror1 car-specific autologous t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4698. en:rosabulin --- r_associated #0: 20 --> ipilimumab
    n1=en:rosabulin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4699. en:rosiglitazone maleate --- r_associated #0: 20 --> ipilimumab
    n1=en:rosiglitazone maleate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4700. en:rosuvastatin calcium --- r_associated #0: 20 --> ipilimumab
    n1=en:rosuvastatin calcium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4701. en:rotavirus vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:rotavirus vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4702. en:rotigotine --- r_associated #0: 20 --> ipilimumab
    n1=en:rotigotine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4703. en:roxithromycin --- r_associated #0: 20 --> ipilimumab
    n1=en:roxithromycin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4704. en:rsv fusion inhibitor gs-5806 --- r_associated #0: 20 --> ipilimumab
    n1=en:rsv fusion inhibitor gs-5806 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4705. en:rubidium rb-82 --- r_associated #0: 20 --> ipilimumab
    n1=en:rubidium rb-82 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4706. en:rubitecan --- r_associated #0: 20 --> ipilimumab
    n1=en:rubitecan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4707. en:rucaparib phosphate --- r_associated #0: 20 --> ipilimumab
    n1=en:rucaparib phosphate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4708. en:ruthenium ru-106 --- r_associated #0: 20 --> ipilimumab
    n1=en:ruthenium ru-106 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4709. en:ruthenium-based transferrin targeting agent nkp-1339 --- r_associated #0: 20 --> ipilimumab
    n1=en:ruthenium-based transferrin targeting agent nkp-1339 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4710. en:rutin --- r_associated #0: 20 --> ipilimumab
    n1=en:rutin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4711. en:ruxolitinib --- r_associated #0: 20 --> ipilimumab
    n1=en:ruxolitinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4712. en:ruxolitinib phosphate --- r_associated #0: 20 --> ipilimumab
    n1=en:ruxolitinib phosphate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4713. en:s-3304 --- r_associated #0: 20 --> ipilimumab
    n1=en:s-3304 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4714. en:s-adenosyl-l-methionine disulfate p-toluene-sulfonate --- r_associated #0: 20 --> ipilimumab
    n1=en:s-adenosyl-l-methionine disulfate p-toluene-sulfonate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4715. en:s-adenosylmethionine --- r_associated #0: 20 --> ipilimumab
    n1=en:s-adenosylmethionine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4716. en:s-equol --- r_associated #0: 20 --> ipilimumab
    n1=en:s-equol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4717. en:s1p receptor agonist krp203 --- r_associated #0: 20 --> ipilimumab
    n1=en:s1p receptor agonist krp203 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4718. en:sabarubicin --- r_associated #0: 20 --> ipilimumab
    n1=en:sabarubicin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4719. en:saccharomyces boulardii preparation --- r_associated #0: 20 --> ipilimumab
    n1=en:saccharomyces boulardii preparation | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4720. en:saccharomyces boulardii probiotic supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:saccharomyces boulardii probiotic supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4721. en:sacituzumab govitecan --- r_associated #0: 20 --> ipilimumab
    n1=en:sacituzumab govitecan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4722. en:safingol --- r_associated #0: 20 --> ipilimumab
    n1=en:safingol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4723. en:sagopilone --- r_associated #0: 20 --> ipilimumab
    n1=en:sagopilone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4724. en:salirasib --- r_associated #0: 20 --> ipilimumab
    n1=en:salirasib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4725. en:salmonella vnp20009 --- r_associated #0: 20 --> ipilimumab
    n1=en:salmonella vnp20009 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4726. en:salvia hispanica seed --- r_associated #0: 20 --> ipilimumab
    n1=en:salvia hispanica seed | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4727. en:salvia officinalis extract tablet --- r_associated #0: 20 --> ipilimumab
    n1=en:salvia officinalis extract tablet | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4728. en:sam68 modulator cwp232291 --- r_associated #0: 20 --> ipilimumab
    n1=en:sam68 modulator cwp232291 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4729. en:samarium sm-153 lexidronam pentasodium --- r_associated #0: 20 --> ipilimumab
    n1=en:samarium sm-153 lexidronam pentasodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4730. en:saob-0401 --- r_associated #0: 20 --> ipilimumab
    n1=en:saob-0401 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4731. en:sapacitabine --- r_associated #0: 20 --> ipilimumab
    n1=en:sapacitabine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4732. en:sapanisertib --- r_associated #0: 20 --> ipilimumab
    n1=en:sapanisertib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4733. en:saperconazole --- r_associated #0: 20 --> ipilimumab
    n1=en:saperconazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4734. en:sapitinib --- r_associated #0: 20 --> ipilimumab
    n1=en:sapitinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4735. en:saponin-based immunoadjuvant obi-821 --- r_associated #0: 20 --> ipilimumab
    n1=en:saponin-based immunoadjuvant obi-821 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4736. en:saponin-cholesterol-phospholipid adjuvant --- r_associated #0: 20 --> ipilimumab
    n1=en:saponin-cholesterol-phospholipid adjuvant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4737. en:saquinavir mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:saquinavir mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4738. en:saracatinib --- r_associated #0: 20 --> ipilimumab
    n1=en:saracatinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4739. en:sarcnu --- r_associated #0: 20 --> ipilimumab
    n1=en:sarcnu | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4740. en:sardomozide --- r_associated #0: 20 --> ipilimumab
    n1=en:sardomozide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4741. en:sargramostim plasmid dna hepatocellular carcinoma vaccine adjuvant --- r_associated #0: 20 --> ipilimumab
    n1=en:sargramostim plasmid dna hepatocellular carcinoma vaccine adjuvant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4742. en:sargramostim plasmid dna melanoma vaccine adjuvant --- r_associated #0: 20 --> ipilimumab
    n1=en:sargramostim plasmid dna melanoma vaccine adjuvant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4743. en:sargramostim plasmid dna pancreatic tumor cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:sargramostim plasmid dna pancreatic tumor cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4744. en:sargramostim plasmid dna sarcoma vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:sargramostim plasmid dna sarcoma vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4745. en:saridegib --- r_associated #0: 20 --> ipilimumab
    n1=en:saridegib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4746. en:satraplatin --- r_associated #0: 20 --> ipilimumab
    n1=en:satraplatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4747. en:saw palmetto berry extract --- r_associated #0: 20 --> ipilimumab
    n1=en:saw palmetto berry extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4748. en:saxagliptin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:saxagliptin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4749. en:sb as-2 --- r_associated #0: 20 --> ipilimumab
    n1=en:sb as-2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4750. en:sb injection --- r_associated #0: 20 --> ipilimumab
    n1=en:sb injection | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4751. en:sb-743921 --- r_associated #0: 20 --> ipilimumab
    n1=en:sb-743921 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4752. en:sb-as02b adjuvant --- r_associated #0: 20 --> ipilimumab
    n1=en:sb-as02b adjuvant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4753. en:sb-as15 adjuvant --- r_associated #0: 20 --> ipilimumab
    n1=en:sb-as15 adjuvant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4754. en:scb01a --- r_associated #0: 20 --> ipilimumab
    n1=en:scb01a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4755. en:sdf-1-targeted agent nox-a12 --- r_associated #0: 20 --> ipilimumab
    n1=en:sdf-1-targeted agent nox-a12 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4756. en:secretin human --- r_associated #0: 20 --> ipilimumab
    n1=en:secretin human | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4757. en:secukinumab --- r_associated #0: 20 --> ipilimumab
    n1=en:secukinumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4758. en:sedoxantrone trihydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:sedoxantrone trihydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4759. en:selatinib ditosilate --- r_associated #0: 20 --> ipilimumab
    n1=en:selatinib ditosilate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4760. en:selective androgen receptor modulator ly2452473 --- r_associated #0: 20 --> ipilimumab
    n1=en:selective androgen receptor modulator ly2452473 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4761. en:selective estrogen receptor degrader arn-810 --- r_associated #0: 20 --> ipilimumab
    n1=en:selective estrogen receptor degrader arn-810 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4762. en:selective estrogen receptor degrader azd9496 --- r_associated #0: 20 --> ipilimumab
    n1=en:selective estrogen receptor degrader azd9496 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4763. en:selective estrogen receptor degrader lsz102 --- r_associated #0: 20 --> ipilimumab
    n1=en:selective estrogen receptor degrader lsz102 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4764. en:selective estrogen receptor degrader srn-927 --- r_associated #0: 20 --> ipilimumab
    n1=en:selective estrogen receptor degrader srn-927 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4765. en:selective estrogen receptor degrader/modulator rad1901 --- r_associated #0: 20 --> ipilimumab
    n1=en:selective estrogen receptor degrader/modulator rad1901 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4766. en:selective estrogen receptor modulator --- r_associated #0: 20 --> ipilimumab
    n1=en:selective estrogen receptor modulator | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4767. en:selenium --- r_associated #0: 20 --> ipilimumab
    n1=en:selenium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4768. en:seliciclib --- r_associated #0: 20 --> ipilimumab
    n1=en:seliciclib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4769. en:selinexor --- r_associated #0: 20 --> ipilimumab
    n1=en:selinexor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4770. en:selumetinib --- r_associated #0: 20 --> ipilimumab
    n1=en:selumetinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4771. en:semaxanib --- r_associated #0: 20 --> ipilimumab
    n1=en:semaxanib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4772. en:semuloparin --- r_associated #0: 20 --> ipilimumab
    n1=en:semuloparin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4773. en:semustine --- r_associated #0: 20 --> ipilimumab
    n1=en:semustine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4774. en:seneca valley virus-001 --- r_associated #0: 20 --> ipilimumab
    n1=en:seneca valley virus-001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4775. en:senna extract --- r_associated #0: 20 --> ipilimumab
    n1=en:senna extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4776. en:senna fruit --- r_associated #0: 20 --> ipilimumab
    n1=en:senna fruit | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4777. en:seocalcitol --- r_associated #0: 20 --> ipilimumab
    n1=en:seocalcitol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4778. en:sepantronium bromide --- r_associated #0: 20 --> ipilimumab
    n1=en:sepantronium bromide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4779. en:seribantumab --- r_associated #0: 20 --> ipilimumab
    n1=en:seribantumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4780. en:serine protease inhibitor wx-671 --- r_associated #0: 20 --> ipilimumab
    n1=en:serine protease inhibitor wx-671 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4781. en:serine/threonine kinase inhibitor xl418 --- r_associated #0: 20 --> ipilimumab
    n1=en:serine/threonine kinase inhibitor xl418 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4782. en:serotonin 5-ht1 receptor agonists --- r_associated #0: 20 --> ipilimumab
    n1=en:serotonin 5-ht1 receptor agonists | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4783. en:sertraline hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:sertraline hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4784. en:serum-derived bovine immunoglobulin protein isolate --- r_associated #0: 20 --> ipilimumab
    n1=en:serum-derived bovine immunoglobulin protein isolate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4785. en:sevacizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:sevacizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4786. en:sevoflurane --- r_associated #0: 20 --> ipilimumab
    n1=en:sevoflurane | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4787. en:sh u04722 --- r_associated #0: 20 --> ipilimumab
    n1=en:sh u04722 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4788. en:shark cartilage --- r_associated #0: 20 --> ipilimumab
    n1=en:shark cartilage | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4789. en:shark cartilage extract ae-941 --- r_associated #0: 20 --> ipilimumab
    n1=en:shark cartilage extract ae-941 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4790. en:sheddase inhibitor incb007839 --- r_associated #0: 20 --> ipilimumab
    n1=en:sheddase inhibitor incb007839 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4791. en:sheng-mai san --- r_associated #0: 20 --> ipilimumab
    n1=en:sheng-mai san | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4792. en:sheng-yu-tang --- r_associated #0: 20 --> ipilimumab
    n1=en:sheng-yu-tang | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4793. en:shi pi yin herbal decoction --- r_associated #0: 20 --> ipilimumab
    n1=en:shi pi yin herbal decoction | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4794. en:sho-saiko-to --- r_associated #0: 20 --> ipilimumab
    n1=en:sho-saiko-to | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4795. en:short chain fatty acid hqk-1004 --- r_associated #0: 20 --> ipilimumab
    n1=en:short chain fatty acid hqk-1004 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4796. en:shu yu wan formula --- r_associated #0: 20 --> ipilimumab
    n1=en:shu yu wan formula | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4797. en:sialyl lewis-keyhole limpet hemocyanin conjugate vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:sialyl lewis-keyhole limpet hemocyanin conjugate vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4798. en:sialyl tn antigen --- r_associated #0: 20 --> ipilimumab
    n1=en:sialyl tn antigen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4799. en:sig12d loder --- r_associated #0: 20 --> ipilimumab
    n1=en:sig12d loder | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4800. en:signal transduction inhibitor --- r_associated #0: 20 --> ipilimumab
    n1=en:signal transduction inhibitor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4801. en:silatecan ar-67 --- r_associated #0: 20 --> ipilimumab
    n1=en:silatecan ar-67 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4802. en:sildenafil citrate --- r_associated #0: 20 --> ipilimumab
    n1=en:sildenafil citrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4803. en:silicon phthalocyanine 4 --- r_associated #0: 20 --> ipilimumab
    n1=en:silicon phthalocyanine 4 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4804. en:silmitasertib --- r_associated #0: 20 --> ipilimumab
    n1=en:silmitasertib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4805. en:silodosin --- r_associated #0: 20 --> ipilimumab
    n1=en:silodosin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4806. en:siltuximab --- r_associated #0: 20 --> ipilimumab
    n1=en:siltuximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4807. en:silver nitrate --- r_associated #0: 20 --> ipilimumab
    n1=en:silver nitrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4808. en:silver sulfadiazine --- r_associated #0: 20 --> ipilimumab
    n1=en:silver sulfadiazine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4809. en:silymarin --- r_associated #0: 20 --> ipilimumab
    n1=en:silymarin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4810. en:simethicone --- r_associated #0: 20 --> ipilimumab
    n1=en:simethicone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4811. en:simmitecan hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:simmitecan hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4812. en:simo decoction --- r_associated #0: 20 --> ipilimumab
    n1=en:simo decoction | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4813. en:simotinib hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:simotinib hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4814. en:simtrazene --- r_associated #0: 20 --> ipilimumab
    n1=en:simtrazene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4815. en:simtuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:simtuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4816. en:simvastatin --- r_associated #0: 20 --> ipilimumab
    n1=en:simvastatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4817. en:siplizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:siplizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4818. en:sipuleucel-t --- r_associated #0: 20 --> ipilimumab
    n1=en:sipuleucel-t | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4819. en:sirna-expressing sv40 vector --- r_associated #0: 20 --> ipilimumab
    n1=en:sirna-expressing sv40 vector | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4820. en:sirna-transfected peripheral blood mononuclear cells apn401 --- r_associated #0: 20 --> ipilimumab
    n1=en:sirna-transfected peripheral blood mononuclear cells apn401 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4821. en:sirolimus --- r_associated #0: 20 --> ipilimumab
    n1=en:sirolimus | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4822. en:sirpa-fc fusion protein tti-621 --- r_associated #0: 20 --> ipilimumab
    n1=en:sirpa-fc fusion protein tti-621 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4823. en:sitagliptin phosphate --- r_associated #0: 20 --> ipilimumab
    n1=en:sitagliptin phosphate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4824. en:sivifene --- r_associated #0: 20 --> ipilimumab
    n1=en:sivifene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4825. en:sizofiran --- r_associated #0: 20 --> ipilimumab
    n1=en:sizofiran | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4826. en:skeletal muscle relaxants --- r_associated #0: 20 --> ipilimumab
    n1=en:skeletal muscle relaxants | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4827. en:smac mimetic gdc-0152 --- r_associated #0: 20 --> ipilimumab
    n1=en:smac mimetic gdc-0152 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4828. en:smac mimetic gdc-0917 --- r_associated #0: 20 --> ipilimumab
    n1=en:smac mimetic gdc-0917 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4829. en:smac mimetic lcl161 --- r_associated #0: 20 --> ipilimumab
    n1=en:smac mimetic lcl161 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4830. en:smoked plum --- r_associated #0: 20 --> ipilimumab
    n1=en:smoked plum | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4831. en:smokeless tobacco --- r_associated #0: 20 --> ipilimumab
    n1=en:smokeless tobacco | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4832. en:smooth muscle relaxant --- r_associated #0: 20 --> ipilimumab
    n1=en:smooth muscle relaxant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4833. en:smoothened antagonist bms-833923 --- r_associated #0: 20 --> ipilimumab
    n1=en:smoothened antagonist bms-833923 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4834. en:smoothened antagonist lde225 topical --- r_associated #0: 20 --> ipilimumab
    n1=en:smoothened antagonist lde225 topical | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4835. en:smoothened antagonist leq506 --- r_associated #0: 20 --> ipilimumab
    n1=en:smoothened antagonist leq506 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4836. en:smoothened antagonist tak-441 --- r_associated #0: 20 --> ipilimumab
    n1=en:smoothened antagonist tak-441 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4837. en:sn-38-loaded polymeric micelles nk012 --- r_associated #0: 20 --> ipilimumab
    n1=en:sn-38-loaded polymeric micelles nk012 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4838. en:sns01-t nanoparticles --- r_associated #0: 20 --> ipilimumab
    n1=en:sns01-t nanoparticles | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4839. en:soblidotin --- r_associated #0: 20 --> ipilimumab
    n1=en:soblidotin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4840. en:sodium alginate microspheres --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium alginate microspheres | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4841. en:sodium bicarbonate --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium bicarbonate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4842. en:sodium bicarbonate solution --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium bicarbonate solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4843. en:sodium bicarbonate/potassium bicarbonate/anhydrous citric acid --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium bicarbonate/potassium bicarbonate/anhydrous citric acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4844. en:sodium borocaptate --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium borocaptate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4845. en:sodium butyrate --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium butyrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4846. en:sodium carboxymethylcellulose dressing --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium carboxymethylcellulose dressing | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4847. en:sodium citrate --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium citrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4848. en:sodium dibunate --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium dibunate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4849. en:sodium dichloroacetate --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium dichloroacetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4850. en:sodium ferric gluconate complex in sucrose --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium ferric gluconate complex in sucrose | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4851. en:sodium fluoride --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium fluoride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4852. en:sodium glycididazole --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium glycididazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4853. en:sodium hyaluronate topical hydrogel --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium hyaluronate topical hydrogel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4854. en:sodium iodide i-131 --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium iodide i-131 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4855. en:sodium metaarsenite --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium metaarsenite | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4856. en:sodium phenylbutyrate --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium phenylbutyrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4857. en:sodium phosphate --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium phosphate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4858. en:sodium phosphate/sodium biphosphate laxative --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium phosphate/sodium biphosphate laxative | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4859. en:sodium picosulfate/magnesium oxide/citric acid laxative --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium picosulfate/magnesium oxide/citric acid laxative | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4860. en:sodium salicylate --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium salicylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4861. en:sodium selenite --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium selenite | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4862. en:sodium stibogluconate --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium stibogluconate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4863. en:sodium sulfate/potassium sulfate/magnesium sulfate-based laxative --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium sulfate/potassium sulfate/magnesium sulfate-based laxative | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4864. en:sodium thiosulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:sodium thiosulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4865. en:sofosbuvir --- r_associated #0: 20 --> ipilimumab
    n1=en:sofosbuvir | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4866. en:solifenacin succinate --- r_associated #0: 20 --> ipilimumab
    n1=en:solifenacin succinate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4867. en:solitomab --- r_associated #0: 20 --> ipilimumab
    n1=en:solitomab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4868. en:solution --- r_associated #0: 20 --> ipilimumab
    n1=en:solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4869. en:somatropin --- r_associated #0: 20 --> ipilimumab
    n1=en:somatropin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4870. en:sonepcizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:sonepcizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4871. en:sonidegib --- r_associated #0: 20 --> ipilimumab
    n1=en:sonidegib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4872. en:sorafenib tosylate --- r_associated #0: 20 --> ipilimumab
    n1=en:sorafenib tosylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4873. en:sorghum bicolor supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:sorghum bicolor supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4874. en:sorivudine --- r_associated #0: 20 --> ipilimumab
    n1=en:sorivudine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4875. en:sotagliflozin --- r_associated #0: 20 --> ipilimumab
    n1=en:sotagliflozin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4876. en:sotatercept --- r_associated #0: 20 --> ipilimumab
    n1=en:sotatercept | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4877. en:sotrastaurin acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:sotrastaurin acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4878. en:soy isoflavones --- r_associated #0: 20 --> ipilimumab
    n1=en:soy isoflavones | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4879. en:soy lecithin/glycerol dioleate-based oral spray --- r_associated #0: 20 --> ipilimumab
    n1=en:soy lecithin/glycerol dioleate-based oral spray | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4880. en:soy protein isolate --- r_associated #0: 20 --> ipilimumab
    n1=en:soy protein isolate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4881. en:sparfosic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:sparfosic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4882. en:spebrutinib --- r_associated #0: 20 --> ipilimumab
    n1=en:spebrutinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4883. en:sphingosine kinase-2 inhibitor abc294640 --- r_associated #0: 20 --> ipilimumab
    n1=en:sphingosine kinase-2 inhibitor abc294640 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4884. en:spiramycin --- r_associated #0: 20 --> ipilimumab
    n1=en:spiramycin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4885. en:spirogermanium --- r_associated #0: 20 --> ipilimumab
    n1=en:spirogermanium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4886. en:spiromustine --- r_associated #0: 20 --> ipilimumab
    n1=en:spiromustine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4887. en:spironolactone --- r_associated #0: 20 --> ipilimumab
    n1=en:spironolactone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4888. en:spiroplatin --- r_associated #0: 20 --> ipilimumab
    n1=en:spiroplatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4889. en:spleen tyrosine kinase inhibitor tak-659 --- r_associated #0: 20 --> ipilimumab
    n1=en:spleen tyrosine kinase inhibitor tak-659 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4890. en:splicing inhibitor h3b-8800 --- r_associated #0: 20 --> ipilimumab
    n1=en:splicing inhibitor h3b-8800 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4891. en:squalamine lactate --- r_associated #0: 20 --> ipilimumab
    n1=en:squalamine lactate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4892. en:sr-t100 gel --- r_associated #0: 20 --> ipilimumab
    n1=en:sr-t100 gel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4893. en:sr31747a --- r_associated #0: 20 --> ipilimumab
    n1=en:sr31747a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4894. en:src kinase inhibitor kx2-391 --- r_associated #0: 20 --> ipilimumab
    n1=en:src kinase inhibitor kx2-391 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4895. en:src kinase inhibitor kx2-391 ointment --- r_associated #0: 20 --> ipilimumab
    n1=en:src kinase inhibitor kx2-391 ointment | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4896. en:src/abl kinase inhibitor azd0424 --- r_associated #0: 20 --> ipilimumab
    n1=en:src/abl kinase inhibitor azd0424 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4897. en:src/tubulin inhibitor kx02 --- r_associated #0: 20 --> ipilimumab
    n1=en:src/tubulin inhibitor kx02 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4898. en:ss1(dsfv)-pe38 immunotoxin --- r_associated #0: 20 --> ipilimumab
    n1=en:ss1(dsfv)-pe38 immunotoxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4899. en:ssr411298 --- r_associated #0: 20 --> ipilimumab
    n1=en:ssr411298 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4900. en:st. john's wort --- r_associated #0: 20 --> ipilimumab
    n1=en:st. john's wort | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4901. en:stabilized sulphur hexafluoride microbubble-based contrast agent --- r_associated #0: 20 --> ipilimumab
    n1=en:stabilized sulphur hexafluoride microbubble-based contrast agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4902. en:standardized freeze-dried table grape powder --- r_associated #0: 20 --> ipilimumab
    n1=en:standardized freeze-dried table grape powder | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4903. en:stanford v regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:stanford v regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4904. en:stanozolol --- r_associated #0: 20 --> ipilimumab
    n1=en:stanozolol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4905. en:staphage lysate --- r_associated #0: 20 --> ipilimumab
    n1=en:staphage lysate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4906. en:staphylococcal enterotoxin a --- r_associated #0: 20 --> ipilimumab
    n1=en:staphylococcal enterotoxin a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4907. en:staphylococcal enterotoxin b --- r_associated #0: 20 --> ipilimumab
    n1=en:staphylococcal enterotoxin b | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4908. en:staphylococcus aureus protein a --- r_associated #0: 20 --> ipilimumab
    n1=en:staphylococcus aureus protein a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4909. en:stat inhibitor opb-111077 --- r_associated #0: 20 --> ipilimumab
    n1=en:stat inhibitor opb-111077 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4910. en:stat3 antisense oligonucleotide isis 481464 --- r_associated #0: 20 --> ipilimumab
    n1=en:stat3 antisense oligonucleotide isis 481464 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4911. en:stat3 decoy oligonucleotide --- r_associated #0: 20 --> ipilimumab
    n1=en:stat3 decoy oligonucleotide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4912. en:stat3 inhibitor opb-31121 --- r_associated #0: 20 --> ipilimumab
    n1=en:stat3 inhibitor opb-31121 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4913. en:stat3 inhibitor opb-51602 --- r_associated #0: 20 --> ipilimumab
    n1=en:stat3 inhibitor opb-51602 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4914. en:stavudine --- r_associated #0: 20 --> ipilimumab
    n1=en:stavudine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4915. en:stimulant/agonist --- r_associated #0: 20 --> ipilimumab
    n1=en:stimulant/agonist | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4916. en:sting-activating cyclic dinucleotide agonist miw815 --- r_associated #0: 20 --> ipilimumab
    n1=en:sting-activating cyclic dinucleotide agonist miw815 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4917. en:strawberry-blackberry-black raspberry-blueberry mixture --- r_associated #0: 20 --> ipilimumab
    n1=en:strawberry-blackberry-black raspberry-blueberry mixture | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4918. en:street drugs --- r_associated #0: 20 --> ipilimumab
    n1=en:street drugs | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4919. en:streptavidin --- r_associated #0: 20 --> ipilimumab
    n1=en:streptavidin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4920. en:streptonigrin --- r_associated #0: 20 --> ipilimumab
    n1=en:streptonigrin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4921. en:streptozocin --- r_associated #0: 20 --> ipilimumab
    n1=en:streptozocin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4922. en:strontium chloride sr-89 --- r_associated #0: 20 --> ipilimumab
    n1=en:strontium chloride sr-89 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4923. en:su014813 --- r_associated #0: 20 --> ipilimumab
    n1=en:su014813 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4924. en:substance p-saporin --- r_associated #0: 20 --> ipilimumab
    n1=en:substance p-saporin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4925. en:substance p/neurokinin 1 receptor antagonist --- r_associated #0: 20 --> ipilimumab
    n1=en:substance p/neurokinin 1 receptor antagonist | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4926. en:sucralfate --- r_associated #0: 20 --> ipilimumab
    n1=en:sucralfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4927. en:sufentanil citrate --- r_associated #0: 20 --> ipilimumab
    n1=en:sufentanil citrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4928. en:sufentanil transdermal system --- r_associated #0: 20 --> ipilimumab
    n1=en:sufentanil transdermal system | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4929. en:sugammadex sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:sugammadex sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4930. en:sulfasalazine --- r_associated #0: 20 --> ipilimumab
    n1=en:sulfasalazine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4931. en:sulfate-based laxative bli850 --- r_associated #0: 20 --> ipilimumab
    n1=en:sulfate-based laxative bli850 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4932. en:sulfatinib --- r_associated #0: 20 --> ipilimumab
    n1=en:sulfatinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4933. en:sulforaphane --- r_associated #0: 20 --> ipilimumab
    n1=en:sulforaphane | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4934. en:sulforaphane-cyclodextrin complex --- r_associated #0: 20 --> ipilimumab
    n1=en:sulforaphane-cyclodextrin complex | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4935. en:sulfur hexafluoride --- r_associated #0: 20 --> ipilimumab
    n1=en:sulfur hexafluoride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4936. en:sulindac --- r_associated #0: 20 --> ipilimumab
    n1=en:sulindac | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4937. en:sulofenur --- r_associated #0: 20 --> ipilimumab
    n1=en:sulofenur | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4938. en:sumac/black cumin powder --- r_associated #0: 20 --> ipilimumab
    n1=en:sumac/black cumin powder | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4939. en:sumatriptan succinate --- r_associated #0: 20 --> ipilimumab
    n1=en:sumatriptan succinate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4940. en:sun protection agent md-3511356 --- r_associated #0: 20 --> ipilimumab
    n1=en:sun protection agent md-3511356 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4941. en:sun's soup --- r_associated #0: 20 --> ipilimumab
    n1=en:sun's soup | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4942. en:sunitinib malate --- r_associated #0: 20 --> ipilimumab
    n1=en:sunitinib malate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4943. en:sunless tanning lotion --- r_associated #0: 20 --> ipilimumab
    n1=en:sunless tanning lotion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4944. en:sunscreen --- r_associated #0: 20 --> ipilimumab
    n1=en:sunscreen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4945. en:superagonist interleukin-15:interleukin-15 receptor alphasu/fc fusion complex alt-803 --- r_associated #0: 20 --> ipilimumab
    n1=en:superagonist interleukin-15:interleukin-15 receptor alphasu/fc fusion complex alt-803 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4946. en:supersaturated calcium phosphate rinse --- r_associated #0: 20 --> ipilimumab
    n1=en:supersaturated calcium phosphate rinse | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4947. en:suramin --- r_associated #0: 20 --> ipilimumab
    n1=en:suramin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4948. en:surface-active agent --- r_associated #0: 20 --> ipilimumab
    n1=en:surface-active agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4949. en:survivin antigen --- r_associated #0: 20 --> ipilimumab
    n1=en:survivin antigen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4950. en:survivin antigen vaccine dpx-survivac --- r_associated #0: 20 --> ipilimumab
    n1=en:survivin antigen vaccine dpx-survivac | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4951. en:survivin mrna antagonist ezn-3042 --- r_associated #0: 20 --> ipilimumab
    n1=en:survivin mrna antagonist ezn-3042 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4952. en:survivin sur1m2 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:survivin sur1m2 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4953. en:survivin/p53/her2 antigen-loaded autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:survivin/p53/her2 antigen-loaded autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4954. en:sustained-release lipid inhaled cisplatin --- r_associated #0: 20 --> ipilimumab
    n1=en:sustained-release lipid inhaled cisplatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4955. en:sustained-release mitomycin c hydrogel formulation --- r_associated #0: 20 --> ipilimumab
    n1=en:sustained-release mitomycin c hydrogel formulation | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4956. en:suvorexant --- r_associated #0: 20 --> ipilimumab
    n1=en:suvorexant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4957. en:svn53-67/m57-klh peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:svn53-67/m57-klh peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4958. en:syk inhibitor hmpl-523 --- r_associated #0: 20 --> ipilimumab
    n1=en:syk inhibitor hmpl-523 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4959. en:syk-jak inhibitor prt062070 --- r_associated #0: 20 --> ipilimumab
    n1=en:syk-jak inhibitor prt062070 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4960. en:synbiotic supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:synbiotic supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4961. en:synchrotope ta2m plasmid dna vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:synchrotope ta2m plasmid dna vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4962. en:synchrovax sem plasmid dna vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:synchrovax sem plasmid dna vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4963. en:synthesis inhibitors, dna --- r_associated #0: 20 --> ipilimumab
    n1=en:synthesis inhibitors, dna | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4964. en:synthetic antiandrogen --- r_associated #0: 20 --> ipilimumab
    n1=en:synthetic antiandrogen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4965. en:synthetic antiestrogen --- r_associated #0: 20 --> ipilimumab
    n1=en:synthetic antiestrogen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4966. en:synthetic brain tumor peptides-pulsed autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:synthetic brain tumor peptides-pulsed autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4967. en:synthetic breast cancer peptides-tetanus toxoid-montanide isa-51 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:synthetic breast cancer peptides-tetanus toxoid-montanide isa-51 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4968. en:synthetic breast cancer peptides-tetanus toxoid-poly iclc vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:synthetic breast cancer peptides-tetanus toxoid-poly iclc vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4969. en:synthetic glioblastoma mutated tumor-specific peptides vaccine therapy apvac2 --- r_associated #0: 20 --> ipilimumab
    n1=en:synthetic glioblastoma mutated tumor-specific peptides vaccine therapy apvac2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4970. en:synthetic glioblastoma tumor-associated peptides vaccine therapy apvac1 --- r_associated #0: 20 --> ipilimumab
    n1=en:synthetic glioblastoma tumor-associated peptides vaccine therapy apvac1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4971. en:synthetic htert dna vaccine ino-1400 --- r_associated #0: 20 --> ipilimumab
    n1=en:synthetic htert dna vaccine ino-1400 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4972. en:synthetic human papillomavirus 16 e6 peptide --- r_associated #0: 20 --> ipilimumab
    n1=en:synthetic human papillomavirus 16 e6 peptide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4973. en:synthetic hypericin --- r_associated #0: 20 --> ipilimumab
    n1=en:synthetic hypericin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4974. en:synthetic long e6/e7 peptides vaccine hpv-01 --- r_associated #0: 20 --> ipilimumab
    n1=en:synthetic long e6/e7 peptides vaccine hpv-01 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4975. en:synthetic melanoma-associated antigens vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:synthetic melanoma-associated antigens vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4976. en:synthetic peptides e-pra and e-psm vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:synthetic peptides e-pra and e-psm vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4977. en:syp-0704a --- r_associated #0: 20 --> ipilimumab
    n1=en:syp-0704a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4978. en:t-cell activation --- r_associated #0: 20 --> ipilimumab
    n1=en:t-cell activation | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4979. en:t-type calcium channel blocker abt-639 --- r_associated #0: 20 --> ipilimumab
    n1=en:t-type calcium channel blocker abt-639 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4980. en:t1e28z car-expressing autologous cd4-positive t lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:t1e28z car-expressing autologous cd4-positive t lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4981. en:t4n5 liposomal lotion --- r_associated #0: 20 --> ipilimumab
    n1=en:t4n5 liposomal lotion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4982. en:t900607 --- r_associated #0: 20 --> ipilimumab
    n1=en:t900607 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4983. en:tabalumab --- r_associated #0: 20 --> ipilimumab
    n1=en:tabalumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4984. en:tac regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:tac regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4985. en:tacedinaline --- r_associated #0: 20 --> ipilimumab
    n1=en:tacedinaline | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4986. en:tacrolimus --- r_associated #0: 20 --> ipilimumab
    n1=en:tacrolimus | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4987. en:tadalafil --- r_associated #0: 20 --> ipilimumab
    n1=en:tadalafil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4988. en:tafamidis meglumine --- r_associated #0: 20 --> ipilimumab
    n1=en:tafamidis meglumine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4989. en:tak-448 --- r_associated #0: 20 --> ipilimumab
    n1=en:tak-448 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4990. en:talabostat mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:talabostat mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4991. en:talactoferrin alfa --- r_associated #0: 20 --> ipilimumab
    n1=en:talactoferrin alfa | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4992. en:taladegib --- r_associated #0: 20 --> ipilimumab
    n1=en:taladegib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4993. en:talampanel --- r_associated #0: 20 --> ipilimumab
    n1=en:talampanel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4994. en:talaporfin sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:talaporfin sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4995. en:talazoparib --- r_associated #0: 20 --> ipilimumab
    n1=en:talazoparib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4996. en:talc --- r_associated #0: 20 --> ipilimumab
    n1=en:talc | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4997. en:taliglucerase alfa --- r_associated #0: 20 --> ipilimumab
    n1=en:taliglucerase alfa | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4998. en:talimogene laherparepvec --- r_associated #0: 20 --> ipilimumab
    n1=en:talimogene laherparepvec | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  4999. en:tallimustine --- r_associated #0: 20 --> ipilimumab
    n1=en:tallimustine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5000. en:talmapimod --- r_associated #0: 20 --> ipilimumab
    n1=en:talmapimod | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5001. en:talotrexin ammonium --- r_associated #0: 20 --> ipilimumab
    n1=en:talotrexin ammonium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5002. en:taltirelin hydrate --- r_associated #0: 20 --> ipilimumab
    n1=en:taltirelin hydrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5003. en:tamibarotene --- r_associated #0: 20 --> ipilimumab
    n1=en:tamibarotene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5004. en:tamoxifen citrate --- r_associated #0: 20 --> ipilimumab
    n1=en:tamoxifen citrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5005. en:tamsulosin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:tamsulosin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5006. en:tandutinib --- r_associated #0: 20 --> ipilimumab
    n1=en:tandutinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5007. en:tanespimycin --- r_associated #0: 20 --> ipilimumab
    n1=en:tanespimycin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5008. en:tanezumab --- r_associated #0: 20 --> ipilimumab
    n1=en:tanezumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5009. en:tangerine tomato juice --- r_associated #0: 20 --> ipilimumab
    n1=en:tangerine tomato juice | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5010. en:tanibirumab --- r_associated #0: 20 --> ipilimumab
    n1=en:tanibirumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5011. en:tanomastat --- r_associated #0: 20 --> ipilimumab
    n1=en:tanomastat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5012. en:tapentadol hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:tapentadol hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5013. en:tarenflurbil --- r_associated #0: 20 --> ipilimumab
    n1=en:tarenflurbil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5014. en:tarextumab --- r_associated #0: 20 --> ipilimumab
    n1=en:tarextumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5015. en:tariquidar --- r_associated #0: 20 --> ipilimumab
    n1=en:tariquidar | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5016. en:tarp 27-35 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:tarp 27-35 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5017. en:tarp 29-37-9v peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:tarp 29-37-9v peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5018. en:tas-108 --- r_associated #0: 20 --> ipilimumab
    n1=en:tas-108 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5019. en:taselisib --- r_associated #0: 20 --> ipilimumab
    n1=en:taselisib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5020. en:tasidotin --- r_associated #0: 20 --> ipilimumab
    n1=en:tasidotin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5021. en:tasisulam --- r_associated #0: 20 --> ipilimumab
    n1=en:tasisulam | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5022. en:tasisulam sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:tasisulam sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5023. en:tasquinimod --- r_associated #0: 20 --> ipilimumab
    n1=en:tasquinimod | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5024. en:taurolidine --- r_associated #0: 20 --> ipilimumab
    n1=en:taurolidine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5025. en:tauromustine --- r_associated #0: 20 --> ipilimumab
    n1=en:tauromustine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5026. en:taurultam --- r_associated #0: 20 --> ipilimumab
    n1=en:taurultam | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5027. en:taxane analogue mst-997 --- r_associated #0: 20 --> ipilimumab
    n1=en:taxane analogue mst-997 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5028. en:taxane analogue tpi 287 --- r_associated #0: 20 --> ipilimumab
    n1=en:taxane analogue tpi 287 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5029. en:taxol analogue sid 530 --- r_associated #0: 20 --> ipilimumab
    n1=en:taxol analogue sid 530 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5030. en:tazarotene --- r_associated #0: 20 --> ipilimumab
    n1=en:tazarotene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5031. en:tazemetostat --- r_associated #0: 20 --> ipilimumab
    n1=en:tazemetostat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5032. en:tazobactam sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:tazobactam sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5033. en:tc 99m monoclonal antibody 170 --- r_associated #0: 20 --> ipilimumab
    n1=en:tc 99m monoclonal antibody 170 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5034. en:technetium tc 94m sestamibi --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc 94m sestamibi | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5035. en:technetium tc 99 hydrazinonicotinamide-tricine-linked interleukin-2 --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc 99 hydrazinonicotinamide-tricine-linked interleukin-2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5036. en:technetium tc 99m epratuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc 99m epratuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5037. en:technetium tc 99m galactosyl human serum albumin --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc 99m galactosyl human serum albumin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5038. en:technetium tc 99m mip 1405 --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc 99m mip 1405 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5039. en:technetium tc 99m trofolastat --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc 99m trofolastat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5040. en:technetium tc 99m-3prgd2 --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc 99m-3prgd2 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5041. en:technetium tc 99m-labeled albumin microspheres --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc 99m-labeled albumin microspheres | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5042. en:technetium tc 99m-labeled rhenium sulfide nanocolloid --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc 99m-labeled rhenium sulfide nanocolloid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5043. en:technetium tc 99m-labeled tilmanocept --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc 99m-labeled tilmanocept | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5044. en:technetium tc-99m --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc-99m | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5045. en:technetium tc-99m albumin aggregated --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc-99m albumin aggregated | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5046. en:technetium tc-99m demobesin-4 --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc-99m demobesin-4 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5047. en:technetium tc-99m dextran --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc-99m dextran | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5048. en:technetium tc-99m dtpa --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc-99m dtpa | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5049. en:technetium tc-99m ethylenedicysteine-deoxyglucose --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc-99m ethylenedicysteine-deoxyglucose | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5050. en:technetium tc-99m glycopeptide --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc-99m glycopeptide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5051. en:technetium tc-99m human serum albumin colloid --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc-99m human serum albumin colloid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5052. en:technetium tc-99m hydroxydiphosphonate --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc-99m hydroxydiphosphonate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5053. en:technetium tc-99m mebrofenin --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc-99m mebrofenin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5054. en:technetium tc-99m medronate --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc-99m medronate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5055. en:technetium tc-99m sestamibi --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc-99m sestamibi | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5056. en:technetium tc-99m sodium pertechnetate --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc-99m sodium pertechnetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5057. en:technetium tc-99m sulfur colloid --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc-99m sulfur colloid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5058. en:technetium tc-99m-nc100692 --- r_associated #0: 20 --> ipilimumab
    n1=en:technetium tc-99m-nc100692 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5059. en:tecogalan sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:tecogalan sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5060. en:teduglutide --- r_associated #0: 20 --> ipilimumab
    n1=en:teduglutide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5061. en:tegafur --- r_associated #0: 20 --> ipilimumab
    n1=en:tegafur | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5062. en:tegafur-gimeracil-oteracil potassium --- r_associated #0: 20 --> ipilimumab
    n1=en:tegafur-gimeracil-oteracil potassium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5063. en:tegafur-gimeracil-oteracil potassium-leucovorin calcium oral formulation --- r_associated #0: 20 --> ipilimumab
    n1=en:tegafur-gimeracil-oteracil potassium-leucovorin calcium oral formulation | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5064. en:tegafur-uracil --- r_associated #0: 20 --> ipilimumab
    n1=en:tegafur-uracil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5065. en:teglarinad --- r_associated #0: 20 --> ipilimumab
    n1=en:teglarinad | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5066. en:teglarinad chloride --- r_associated #0: 20 --> ipilimumab
    n1=en:teglarinad chloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5067. en:teicoplanin --- r_associated #0: 20 --> ipilimumab
    n1=en:teicoplanin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5068. en:telaprevir --- r_associated #0: 20 --> ipilimumab
    n1=en:telaprevir | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5069. en:telapristone acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:telapristone acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5070. en:telatinib mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:telatinib mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5071. en:telavancin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:telavancin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5072. en:telbivudine --- r_associated #0: 20 --> ipilimumab
    n1=en:telbivudine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5073. en:telomerase peptide vaccine gv1001 --- r_associated #0: 20 --> ipilimumab
    n1=en:telomerase peptide vaccine gv1001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5074. en:telomerase-specific type 5 adenovirus obp-301 --- r_associated #0: 20 --> ipilimumab
    n1=en:telomerase-specific type 5 adenovirus obp-301 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5075. en:telomerase: 540-548 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:telomerase: 540-548 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5076. en:telotristat etiprate --- r_associated #0: 20 --> ipilimumab
    n1=en:telotristat etiprate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5077. en:teloxantrone hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:teloxantrone hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5078. en:temoporfin --- r_associated #0: 20 --> ipilimumab
    n1=en:temoporfin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5079. en:temozolomide --- r_associated #0: 20 --> ipilimumab
    n1=en:temozolomide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5080. en:temsirolimus --- r_associated #0: 20 --> ipilimumab
    n1=en:temsirolimus | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5081. en:tenifatecan --- r_associated #0: 20 --> ipilimumab
    n1=en:tenifatecan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5082. en:teniposide --- r_associated #0: 20 --> ipilimumab
    n1=en:teniposide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5083. en:tenofovir --- r_associated #0: 20 --> ipilimumab
    n1=en:tenofovir | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5084. en:tenofovir disoproxil fumarate --- r_associated #0: 20 --> ipilimumab
    n1=en:tenofovir disoproxil fumarate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5085. en:tepotinib --- r_associated #0: 20 --> ipilimumab
    n1=en:tepotinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5086. en:teprotumumab --- r_associated #0: 20 --> ipilimumab
    n1=en:teprotumumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5087. en:terameprocol --- r_associated #0: 20 --> ipilimumab
    n1=en:terameprocol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5088. en:teratogen --- r_associated #0: 20 --> ipilimumab
    n1=en:teratogen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5089. en:terephthalamidine --- r_associated #0: 20 --> ipilimumab
    n1=en:terephthalamidine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5090. en:terfluranol --- r_associated #0: 20 --> ipilimumab
    n1=en:terfluranol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5091. en:tergenpumatucel-l --- r_associated #0: 20 --> ipilimumab
    n1=en:tergenpumatucel-l | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5092. en:teroxirone --- r_associated #0: 20 --> ipilimumab
    n1=en:teroxirone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5093. en:tesetaxel --- r_associated #0: 20 --> ipilimumab
    n1=en:tesetaxel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5094. en:tesevatinib --- r_associated #0: 20 --> ipilimumab
    n1=en:tesevatinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5095. en:tesmilifene --- r_associated #0: 20 --> ipilimumab
    n1=en:tesmilifene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5096. en:testolactone --- r_associated #0: 20 --> ipilimumab
    n1=en:testolactone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5097. en:testosterone cypionate --- r_associated #0: 20 --> ipilimumab
    n1=en:testosterone cypionate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5098. en:testosterone enanthate --- r_associated #0: 20 --> ipilimumab
    n1=en:testosterone enanthate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5099. en:testosterone gel --- r_associated #0: 20 --> ipilimumab
    n1=en:testosterone gel | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5100. en:testosterone undecanoate --- r_associated #0: 20 --> ipilimumab
    n1=en:testosterone undecanoate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5101. en:testosterone vaginal cream --- r_associated #0: 20 --> ipilimumab
    n1=en:testosterone vaginal cream | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5102. en:tetanus peptide melanoma vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:tetanus peptide melanoma vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5103. en:tetanus toxoid helper peptide --- r_associated #0: 20 --> ipilimumab
    n1=en:tetanus toxoid helper peptide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5104. en:tetanus toxoid vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:tetanus toxoid vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5105. en:tetanus-cmv fusion peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:tetanus-cmv fusion peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5106. en:tetracycline antibiotic --- r_associated #0: 20 --> ipilimumab
    n1=en:tetracycline antibiotic | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5107. en:tetracycline hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:tetracycline hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5108. en:tetradecanoylphorbol acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:tetradecanoylphorbol acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5109. en:tetrahydrouridine --- r_associated #0: 20 --> ipilimumab
    n1=en:tetrahydrouridine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5110. en:tetraphenyl chlorin disulfonate --- r_associated #0: 20 --> ipilimumab
    n1=en:tetraphenyl chlorin disulfonate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5111. en:tetravalent rna-lipoplex cancer vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:tetravalent rna-lipoplex cancer vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5112. en:tetrodotoxin --- r_associated #0: 20 --> ipilimumab
    n1=en:tetrodotoxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5113. en:tezacitabine --- r_associated #0: 20 --> ipilimumab
    n1=en:tezacitabine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5114. en:tf(c)-klh conjugate vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:tf(c)-klh conjugate vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5115. en:tgf-beta-resistant lmp-specific cytotoxic t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:tgf-beta-resistant lmp-specific cytotoxic t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5116. en:tgfa-pe38 immunotoxin --- r_associated #0: 20 --> ipilimumab
    n1=en:tgfa-pe38 immunotoxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5117. en:tgfbdnrii-transduced autologous tumor infiltrating lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:tgfbdnrii-transduced autologous tumor infiltrating lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5118. en:thalicarpine --- r_associated #0: 20 --> ipilimumab
    n1=en:thalicarpine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5119. en:thalidomide --- r_associated #0: 20 --> ipilimumab
    n1=en:thalidomide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5120. en:theophylline --- r_associated #0: 20 --> ipilimumab
    n1=en:theophylline | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5121. en:theramide --- r_associated #0: 20 --> ipilimumab
    n1=en:theramide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5122. en:therapeutic allogeneic cytotoxic t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:therapeutic allogeneic cytotoxic t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5123. en:therapeutic allogeneic lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:therapeutic allogeneic lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5124. en:therapeutic androstanolone --- r_associated #0: 20 --> ipilimumab
    n1=en:therapeutic androstanolone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5125. en:therapeutic angiotensin-(1-7) --- r_associated #0: 20 --> ipilimumab
    n1=en:therapeutic angiotensin-(1-7) | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5126. en:therapeutic autologous dendritic cells --- r_associated #0: 20 --> ipilimumab
    n1=en:therapeutic autologous dendritic cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5127. en:therapeutic autologous lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:therapeutic autologous lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5128. en:therapeutic breast/ovarian/prostate peptide cancer vaccine dpx-0907 --- r_associated #0: 20 --> ipilimumab
    n1=en:therapeutic breast/ovarian/prostate peptide cancer vaccine dpx-0907 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5129. en:therapeutic cortisone --- r_associated #0: 20 --> ipilimumab
    n1=en:therapeutic cortisone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5130. en:therapeutic dendritic cells/cytokine-induced killer cells --- r_associated #0: 20 --> ipilimumab
    n1=en:therapeutic dendritic cells/cytokine-induced killer cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5131. en:therapeutic epinephrine --- r_associated #0: 20 --> ipilimumab
    n1=en:therapeutic epinephrine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5132. en:therapeutic estetrol --- r_associated #0: 20 --> ipilimumab
    n1=en:therapeutic estetrol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5133. en:therapeutic estradiol --- r_associated #0: 20 --> ipilimumab
    n1=en:therapeutic estradiol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5134. en:therapeutic estrone --- r_associated #0: 20 --> ipilimumab
    n1=en:therapeutic estrone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5135. en:therapeutic gamma delta t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:therapeutic gamma delta t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5136. en:therapeutic hemin --- r_associated #0: 20 --> ipilimumab
    n1=en:therapeutic hemin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5137. en:therapeutic hepatitis c immune globulin --- r_associated #0: 20 --> ipilimumab
    n1=en:therapeutic hepatitis c immune globulin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5138. en:therapeutic hydrocortisone --- r_associated #0: 20 --> ipilimumab
    n1=en:therapeutic hydrocortisone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5139. en:therapeutic immune globulin --- r_associated #0: 20 --> ipilimumab
    n1=en:therapeutic immune globulin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5140. en:therapeutic insulin --- r_associated #0: 20 --> ipilimumab
    n1=en:therapeutic insulin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5141. en:therapeutic melatonin --- r_associated #0: 20 --> ipilimumab
    n1=en:therapeutic melatonin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5142. en:therapeutic progesterone --- r_associated #0: 20 --> ipilimumab
    n1=en:therapeutic progesterone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5143. en:therapeutic testosterone --- r_associated #0: 20 --> ipilimumab
    n1=en:therapeutic testosterone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5144. en:therapeutic tumor infiltrating lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:therapeutic tumor infiltrating lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5145. en:thiabendazole --- r_associated #0: 20 --> ipilimumab
    n1=en:thiabendazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5146. en:thiamine --- r_associated #0: 20 --> ipilimumab
    n1=en:thiamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5147. en:thiarabine --- r_associated #0: 20 --> ipilimumab
    n1=en:thiarabine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5148. en:thioguanine --- r_associated #0: 20 --> ipilimumab
    n1=en:thioguanine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5149. en:thioinosine --- r_associated #0: 20 --> ipilimumab
    n1=en:thioinosine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5150. en:thioredoxin-1 inhibitor px-12 --- r_associated #0: 20 --> ipilimumab
    n1=en:thioredoxin-1 inhibitor px-12 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5151. en:thiotepa --- r_associated #0: 20 --> ipilimumab
    n1=en:thiotepa | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5152. en:thioureidobutyronitrile --- r_associated #0: 20 --> ipilimumab
    n1=en:thioureidobutyronitrile | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5153. en:thl-p --- r_associated #0: 20 --> ipilimumab
    n1=en:thl-p | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5154. en:thomsen-friedenreich antigen --- r_associated #0: 20 --> ipilimumab
    n1=en:thomsen-friedenreich antigen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5155. en:threonine tyrosine kinase inhibitor cfi-402257 --- r_associated #0: 20 --> ipilimumab
    n1=en:threonine tyrosine kinase inhibitor cfi-402257 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5156. en:thrombopoietin receptor agonist lgd-4665 --- r_associated #0: 20 --> ipilimumab
    n1=en:thrombopoietin receptor agonist lgd-4665 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5157. en:thymidine --- r_associated #0: 20 --> ipilimumab
    n1=en:thymidine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5158. en:thymidylate synthase inhibitor dfp-11207 --- r_associated #0: 20 --> ipilimumab
    n1=en:thymidylate synthase inhibitor dfp-11207 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5159. en:thymopentin --- r_associated #0: 20 --> ipilimumab
    n1=en:thymopentin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5160. en:thyroid extract --- r_associated #0: 20 --> ipilimumab
    n1=en:thyroid extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5161. en:thyrotropin alfa --- r_associated #0: 20 --> ipilimumab
    n1=en:thyrotropin alfa | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5162. en:thyroxine --- r_associated #0: 20 --> ipilimumab
    n1=en:thyroxine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5163. en:tiazofurin --- r_associated #0: 20 --> ipilimumab
    n1=en:tiazofurin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5164. en:tibolone --- r_associated #0: 20 --> ipilimumab
    n1=en:tibolone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5165. en:ticarcillin --- r_associated #0: 20 --> ipilimumab
    n1=en:ticarcillin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5166. en:tigapotide --- r_associated #0: 20 --> ipilimumab
    n1=en:tigapotide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5167. en:tigatuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:tigatuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5168. en:tigecycline --- r_associated #0: 20 --> ipilimumab
    n1=en:tigecycline | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5169. en:til 1383i t cell receptor-transduced autologous t cells --- r_associated #0: 20 --> ipilimumab
    n1=en:til 1383i t cell receptor-transduced autologous t cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5170. en:tilarginine --- r_associated #0: 20 --> ipilimumab
    n1=en:tilarginine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5171. en:tilorone --- r_associated #0: 20 --> ipilimumab
    n1=en:tilorone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5172. en:timcodar dimesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:timcodar dimesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5173. en:timolol maleate gel forming solution --- r_associated #0: 20 --> ipilimumab
    n1=en:timolol maleate gel forming solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5174. en:timonacic --- r_associated #0: 20 --> ipilimumab
    n1=en:timonacic | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5175. en:tin ethyl etiopurpurin --- r_associated #0: 20 --> ipilimumab
    n1=en:tin ethyl etiopurpurin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5176. en:tin sn 117m dtpa --- r_associated #0: 20 --> ipilimumab
    n1=en:tin sn 117m dtpa | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5177. en:tinidazole --- r_associated #0: 20 --> ipilimumab
    n1=en:tinidazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5178. en:tinzaparin sodium --- r_associated #0: 20 --> ipilimumab
    n1=en:tinzaparin sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5179. en:tiomolibdate diammonium --- r_associated #0: 20 --> ipilimumab
    n1=en:tiomolibdate diammonium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5180. en:tiotropium bromide monohydrate --- r_associated #0: 20 --> ipilimumab
    n1=en:tiotropium bromide monohydrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5181. en:tipifarnib --- r_associated #0: 20 --> ipilimumab
    n1=en:tipifarnib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5182. en:tirapazamine --- r_associated #0: 20 --> ipilimumab
    n1=en:tirapazamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5183. en:titanium dioxide/zinc oxide sunscreen --- r_associated #0: 20 --> ipilimumab
    n1=en:titanium dioxide/zinc oxide sunscreen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5184. en:tivantinib --- r_associated #0: 20 --> ipilimumab
    n1=en:tivantinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5185. en:tivozanib --- r_associated #0: 20 --> ipilimumab
    n1=en:tivozanib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5186. en:tizanidine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:tizanidine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5187. en:tlr 7/8 agonist medi9197 --- r_associated #0: 20 --> ipilimumab
    n1=en:tlr 7/8 agonist medi9197 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5188. en:tlr agonist cadi-05 --- r_associated #0: 20 --> ipilimumab
    n1=en:tlr agonist cadi-05 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5189. en:tlr-directed cationic lipid-dna complex jvrs-100 --- r_associated #0: 20 --> ipilimumab
    n1=en:tlr-directed cationic lipid-dna complex jvrs-100 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5190. en:tlr4 agonist gla-se --- r_associated #0: 20 --> ipilimumab
    n1=en:tlr4 agonist gla-se | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5191. en:tlr4 agonist gsk1795091 --- r_associated #0: 20 --> ipilimumab
    n1=en:tlr4 agonist gsk1795091 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5192. en:tlr7 agonist 852a --- r_associated #0: 20 --> ipilimumab
    n1=en:tlr7 agonist 852a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5193. en:tlr7 agonist ana773 tosylate --- r_associated #0: 20 --> ipilimumab
    n1=en:tlr7 agonist ana773 tosylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5194. en:tlr7/8/9 antagonist imo-8400 --- r_associated #0: 20 --> ipilimumab
    n1=en:tlr7/8/9 antagonist imo-8400 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5195. en:tlr8 agonist vtx-2337 --- r_associated #0: 20 --> ipilimumab
    n1=en:tlr8 agonist vtx-2337 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5196. en:tlr9 agonist duk-cpg-001 --- r_associated #0: 20 --> ipilimumab
    n1=en:tlr9 agonist duk-cpg-001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5197. en:tlr9 agonist emd 1201081 --- r_associated #0: 20 --> ipilimumab
    n1=en:tlr9 agonist emd 1201081 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5198. en:tlr9 agonist mgn1703 --- r_associated #0: 20 --> ipilimumab
    n1=en:tlr9 agonist mgn1703 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5199. en:tlr9 agonist sd-101 --- r_associated #0: 20 --> ipilimumab
    n1=en:tlr9 agonist sd-101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5200. en:tn(c)-klh conjugate vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:tn(c)-klh conjugate vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5201. en:tobramycin sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:tobramycin sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5202. en:tocilizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:tocilizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5203. en:tocladesine --- r_associated #0: 20 --> ipilimumab
    n1=en:tocladesine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5204. en:tocolytic agents --- r_associated #0: 20 --> ipilimumab
    n1=en:tocolytic agents | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5205. en:tocopherol --- r_associated #0: 20 --> ipilimumab
    n1=en:tocopherol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5206. en:tocophersolan --- r_associated #0: 20 --> ipilimumab
    n1=en:tocophersolan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5207. en:tocotrienol --- r_associated #0: 20 --> ipilimumab
    n1=en:tocotrienol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5208. en:tocotrienol-rich fraction --- r_associated #0: 20 --> ipilimumab
    n1=en:tocotrienol-rich fraction | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5209. en:tofacitinib --- r_associated #0: 20 --> ipilimumab
    n1=en:tofacitinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5210. en:tolazamide --- r_associated #0: 20 --> ipilimumab
    n1=en:tolazamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5211. en:tolbutamide --- r_associated #0: 20 --> ipilimumab
    n1=en:tolbutamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5212. en:tolfenamic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:tolfenamic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5213. en:toll-like receptor 9 agonist imo-2125 --- r_associated #0: 20 --> ipilimumab
    n1=en:toll-like receptor 9 agonist imo-2125 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5214. en:tolnidamine --- r_associated #0: 20 --> ipilimumab
    n1=en:tolnidamine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5215. en:tolvaptan --- r_associated #0: 20 --> ipilimumab
    n1=en:tolvaptan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5216. en:tomato-soy juice --- r_associated #0: 20 --> ipilimumab
    n1=en:tomato-soy juice | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5217. en:topical agent ad17137 --- r_associated #0: 20 --> ipilimumab
    n1=en:topical agent ad17137 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5218. en:topical betulinic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:topical betulinic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5219. en:topical calcitriol --- r_associated #0: 20 --> ipilimumab
    n1=en:topical calcitriol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5220. en:topical cocaine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:topical cocaine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5221. en:topical dosage form --- r_associated #0: 20 --> ipilimumab
    n1=en:topical dosage form | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5222. en:topical fluorouracil --- r_associated #0: 20 --> ipilimumab
    n1=en:topical fluorouracil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5223. en:topical gemcitabine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:topical gemcitabine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5224. en:topical keratin --- r_associated #0: 20 --> ipilimumab
    n1=en:topical keratin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5225. en:topical lfx453 --- r_associated #0: 20 --> ipilimumab
    n1=en:topical lfx453 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5226. en:topical menthol cream --- r_associated #0: 20 --> ipilimumab
    n1=en:topical menthol cream | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5227. en:topical myristyl nicotinate cream --- r_associated #0: 20 --> ipilimumab
    n1=en:topical myristyl nicotinate cream | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5228. en:topical phenylephrine solution --- r_associated #0: 20 --> ipilimumab
    n1=en:topical phenylephrine solution | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5229. en:topical piperidine nitroxide mts-01 --- r_associated #0: 20 --> ipilimumab
    n1=en:topical piperidine nitroxide mts-01 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5230. en:topical pvdf/sirolimus --- r_associated #0: 20 --> ipilimumab
    n1=en:topical pvdf/sirolimus | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5231. en:topical sirolimus --- r_associated #0: 20 --> ipilimumab
    n1=en:topical sirolimus | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5232. en:topical trichloroacetic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:topical trichloroacetic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5233. en:topical vitamin e --- r_associated #0: 20 --> ipilimumab
    n1=en:topical vitamin e | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5234. en:topical wound spray hp802-247 --- r_associated #0: 20 --> ipilimumab
    n1=en:topical wound spray hp802-247 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5235. en:topiramate --- r_associated #0: 20 --> ipilimumab
    n1=en:topiramate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5236. en:topoisomerase i inhibitor genz-644282 --- r_associated #0: 20 --> ipilimumab
    n1=en:topoisomerase i inhibitor genz-644282 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5237. en:topoisomerase i inhibitor lmp400 --- r_associated #0: 20 --> ipilimumab
    n1=en:topoisomerase i inhibitor lmp400 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5238. en:topoisomerase i inhibitor lmp776 --- r_associated #0: 20 --> ipilimumab
    n1=en:topoisomerase i inhibitor lmp776 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5239. en:topoisomerase i/ii inhibitor nev-801 --- r_associated #0: 20 --> ipilimumab
    n1=en:topoisomerase i/ii inhibitor nev-801 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5240. en:topoisomerase inhibitor --- r_associated #0: 20 --> ipilimumab
    n1=en:topoisomerase inhibitor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5241. en:topoisomerase-ii inhibitor --- r_associated #0: 20 --> ipilimumab
    n1=en:topoisomerase-ii inhibitor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5242. en:topotecan hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:topotecan hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5243. en:topotecan hydrochloride liposomes --- r_associated #0: 20 --> ipilimumab
    n1=en:topotecan hydrochloride liposomes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5244. en:topsalysin --- r_associated #0: 20 --> ipilimumab
    n1=en:topsalysin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5245. en:torc1/2 kinase inhibitor ds-3078a --- r_associated #0: 20 --> ipilimumab
    n1=en:torc1/2 kinase inhibitor ds-3078a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5246. en:toremifene --- r_associated #0: 20 --> ipilimumab
    n1=en:toremifene | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5247. en:tosedostat --- r_associated #0: 20 --> ipilimumab
    n1=en:tosedostat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5248. en:tositumomab --- r_associated #0: 20 --> ipilimumab
    n1=en:tositumomab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5249. en:tositumomab and iodine i 131 tositumomab --- r_associated #0: 20 --> ipilimumab
    n1=en:tositumomab and iodine i 131 tositumomab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5250. en:total tumor rna-loaded dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:total tumor rna-loaded dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5251. en:tozasertib lactate --- r_associated #0: 20 --> ipilimumab
    n1=en:tozasertib lactate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5252. en:tp40 immunotoxin --- r_associated #0: 20 --> ipilimumab
    n1=en:tp40 immunotoxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5253. en:tpf regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:tpf regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5254. en:tpo receptor agonist ono-7746 --- r_associated #0: 20 --> ipilimumab
    n1=en:tpo receptor agonist ono-7746 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5255. en:trabectedin --- r_associated #0: 20 --> ipilimumab
    n1=en:trabectedin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5256. en:trabedersen --- r_associated #0: 20 --> ipilimumab
    n1=en:trabedersen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5257. en:trametinib --- r_associated #0: 20 --> ipilimumab
    n1=en:trametinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5258. en:tranexamic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:tranexamic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5259. en:trans sodium crocetinate --- r_associated #0: 20 --> ipilimumab
    n1=en:trans sodium crocetinate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5260. en:transdermal 17beta-estradiol gel bhr-200 --- r_associated #0: 20 --> ipilimumab
    n1=en:transdermal 17beta-estradiol gel bhr-200 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5261. en:transdermal 4-hydroxytestosterone --- r_associated #0: 20 --> ipilimumab
    n1=en:transdermal 4-hydroxytestosterone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5262. en:transdermal estrogen --- r_associated #0: 20 --> ipilimumab
    n1=en:transdermal estrogen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5263. en:transferrin receptor-targeted anti-rrm2 sirna calaa-01 --- r_associated #0: 20 --> ipilimumab
    n1=en:transferrin receptor-targeted anti-rrm2 sirna calaa-01 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5264. en:transferrin receptor-targeted liposomal p53 cdna --- r_associated #0: 20 --> ipilimumab
    n1=en:transferrin receptor-targeted liposomal p53 cdna | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5265. en:transferrin-crm107 --- r_associated #0: 20 --> ipilimumab
    n1=en:transferrin-crm107 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5266. en:transgenic lymphocyte immunization vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:transgenic lymphocyte immunization vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5267. en:transthyretin antisense oligonucleotide isis-ttr rx --- r_associated #0: 20 --> ipilimumab
    n1=en:transthyretin antisense oligonucleotide isis-ttr rx | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5268. en:tranylcypromine sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:tranylcypromine sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5269. en:trastuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:trastuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5270. en:trastuzumab emtansine --- r_associated #0: 20 --> ipilimumab
    n1=en:trastuzumab emtansine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5271. en:trastuzumab vc-seco-duba --- r_associated #0: 20 --> ipilimumab
    n1=en:trastuzumab vc-seco-duba | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5272. en:traumeel s --- r_associated #0: 20 --> ipilimumab
    n1=en:traumeel s | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5273. en:trebananib --- r_associated #0: 20 --> ipilimumab
    n1=en:trebananib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5274. en:tremelimumab --- r_associated #0: 20 --> ipilimumab
    n1=en:tremelimumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5275. en:treosulfan --- r_associated #0: 20 --> ipilimumab
    n1=en:treosulfan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5276. en:tretazicar --- r_associated #0: 20 --> ipilimumab
    n1=en:tretazicar | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5277. en:tretinoin --- r_associated #0: 20 --> ipilimumab
    n1=en:tretinoin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5278. en:tretinoin liposome --- r_associated #0: 20 --> ipilimumab
    n1=en:tretinoin liposome | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5279. en:tri-virus/gd2-specific allogeneic cytotoxic t-lymphocytes --- r_associated #0: 20 --> ipilimumab
    n1=en:tri-virus/gd2-specific allogeneic cytotoxic t-lymphocytes | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5280. en:triamcinolone --- r_associated #0: 20 --> ipilimumab
    n1=en:triamcinolone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5281. en:triamcinolone acetonide --- r_associated #0: 20 --> ipilimumab
    n1=en:triamcinolone acetonide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5282. en:triapine --- r_associated #0: 20 --> ipilimumab
    n1=en:triapine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5283. en:triazene derivative trin2755 --- r_associated #0: 20 --> ipilimumab
    n1=en:triazene derivative trin2755 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5284. en:triazinate --- r_associated #0: 20 --> ipilimumab
    n1=en:triazinate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5285. en:tributyrin --- r_associated #0: 20 --> ipilimumab
    n1=en:tributyrin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5286. en:triciribine phosphate --- r_associated #0: 20 --> ipilimumab
    n1=en:triciribine phosphate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5287. en:trientine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:trientine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5288. en:trifluoperazine hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:trifluoperazine hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5289. en:trifluridine --- r_associated #0: 20 --> ipilimumab
    n1=en:trifluridine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5290. en:trifluridine/tipiracil hydrochloride combination agent tas-102 --- r_associated #0: 20 --> ipilimumab
    n1=en:trifluridine/tipiracil hydrochloride combination agent tas-102 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5291. en:trilostane --- r_associated #0: 20 --> ipilimumab
    n1=en:trilostane | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5292. en:trimethoprim --- r_associated #0: 20 --> ipilimumab
    n1=en:trimethoprim | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5293. en:trimethoprim-sulfamethoxazole --- r_associated #0: 20 --> ipilimumab
    n1=en:trimethoprim-sulfamethoxazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5294. en:trimethylcolchicinic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:trimethylcolchicinic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5295. en:trimetrexate --- r_associated #0: 20 --> ipilimumab
    n1=en:trimetrexate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5296. en:trimetrexate glucuronate --- r_associated #0: 20 --> ipilimumab
    n1=en:trimetrexate glucuronate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5297. en:trioxifene mesylate --- r_associated #0: 20 --> ipilimumab
    n1=en:trioxifene mesylate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5298. en:triptolide analog --- r_associated #0: 20 --> ipilimumab
    n1=en:triptolide analog | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5299. en:triptorelin --- r_associated #0: 20 --> ipilimumab
    n1=en:triptorelin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5300. en:triptorelin pamoate --- r_associated #0: 20 --> ipilimumab
    n1=en:triptorelin pamoate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5301. en:tris-acryl gelatin microspheres --- r_associated #0: 20 --> ipilimumab
    n1=en:tris-acryl gelatin microspheres | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5302. en:trivalent influenza vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:trivalent influenza vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5303. en:trivalent live-attenuated influenza vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:trivalent live-attenuated influenza vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5304. en:trk inhibitor azd6918 --- r_associated #0: 20 --> ipilimumab
    n1=en:trk inhibitor azd6918 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5305. en:trk inhibitor loxo-101 --- r_associated #0: 20 --> ipilimumab
    n1=en:trk inhibitor loxo-101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5306. en:trodusquemine --- r_associated #0: 20 --> ipilimumab
    n1=en:trodusquemine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5307. en:trofosfamide --- r_associated #0: 20 --> ipilimumab
    n1=en:trofosfamide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5308. en:troglitazone --- r_associated #0: 20 --> ipilimumab
    n1=en:troglitazone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5309. en:tropisetron --- r_associated #0: 20 --> ipilimumab
    n1=en:tropisetron | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5310. en:tropisetron hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:tropisetron hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5311. en:tropomyosin receptor kinase inhibitor azd7451 --- r_associated #0: 20 --> ipilimumab
    n1=en:tropomyosin receptor kinase inhibitor azd7451 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5312. en:troxacitabine --- r_associated #0: 20 --> ipilimumab
    n1=en:troxacitabine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5313. en:trp2 mrna-electroporated autologous langerhans-type dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:trp2 mrna-electroporated autologous langerhans-type dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5314. en:trpv6 calcium channel inhibitor sor-c13 --- r_associated #0: 20 --> ipilimumab
    n1=en:trpv6 calcium channel inhibitor sor-c13 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5315. en:tsp-1 mimetic fusion protein cvx-045 --- r_associated #0: 20 --> ipilimumab
    n1=en:tsp-1 mimetic fusion protein cvx-045 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5316. en:tti-237 --- r_associated #0: 20 --> ipilimumab
    n1=en:tti-237 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5317. en:tubercidin --- r_associated #0: 20 --> ipilimumab
    n1=en:tubercidin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5318. en:tubulin inhibitor alb 109564(a) --- r_associated #0: 20 --> ipilimumab
    n1=en:tubulin inhibitor alb 109564(a) | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5319. en:tubulin polymerization inhibitor ckd-516 --- r_associated #0: 20 --> ipilimumab
    n1=en:tubulin polymerization inhibitor ckd-516 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5320. en:tubulin-binding agent ssr97225 --- r_associated #0: 20 --> ipilimumab
    n1=en:tubulin-binding agent ssr97225 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5321. en:tucotuzumab celmoleukin --- r_associated #0: 20 --> ipilimumab
    n1=en:tucotuzumab celmoleukin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5322. en:tumor cell-derived dribbles vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:tumor cell-derived dribbles vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5323. en:tumor peptide-loaded myeloid dendritic cells --- r_associated #0: 20 --> ipilimumab
    n1=en:tumor peptide-loaded myeloid dendritic cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5324. en:tumor-associated antigen peptide vaccine grn-1201 --- r_associated #0: 20 --> ipilimumab
    n1=en:tumor-associated antigen peptide vaccine grn-1201 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5325. en:tumor-cells apoptosis factor hormone-peptide --- r_associated #0: 20 --> ipilimumab
    n1=en:tumor-cells apoptosis factor hormone-peptide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5326. en:tumor-homing peptide irgd --- r_associated #0: 20 --> ipilimumab
    n1=en:tumor-homing peptide irgd | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5327. en:tw1025 supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:tw1025 supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5328. en:tyloxapol --- r_associated #0: 20 --> ipilimumab
    n1=en:tyloxapol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5329. en:typhoid vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:typhoid vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5330. en:tyroserleutide --- r_associated #0: 20 --> ipilimumab
    n1=en:tyroserleutide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5331. en:tyrosinase peptide --- r_associated #0: 20 --> ipilimumab
    n1=en:tyrosinase peptide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5332. en:tyrosinase related protein-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:tyrosinase related protein-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5333. en:tyrosinase-klh --- r_associated #0: 20 --> ipilimumab
    n1=en:tyrosinase-klh | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5334. en:tyrosine kinase inhibitor --- r_associated #0: 20 --> ipilimumab
    n1=en:tyrosine kinase inhibitor | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5335. en:tyrosine kinase inhibitor osi-930 --- r_associated #0: 20 --> ipilimumab
    n1=en:tyrosine kinase inhibitor osi-930 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5336. en:tyrosine kinase inhibitor xl228 --- r_associated #0: 20 --> ipilimumab
    n1=en:tyrosine kinase inhibitor xl228 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5337. en:uae inhibitor tak-243 --- r_associated #0: 20 --> ipilimumab
    n1=en:uae inhibitor tak-243 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5338. en:ubenimex --- r_associated #0: 20 --> ipilimumab
    n1=en:ubenimex | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5339. en:ubidecarenone injectable nanosuspension --- r_associated #0: 20 --> ipilimumab
    n1=en:ubidecarenone injectable nanosuspension | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5340. en:ublituximab --- r_associated #0: 20 --> ipilimumab
    n1=en:ublituximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5341. en:udenafil --- r_associated #0: 20 --> ipilimumab
    n1=en:udenafil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5342. en:ulimorelin hyrdrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:ulimorelin hyrdrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5343. en:ulinastatin --- r_associated #0: 20 --> ipilimumab
    n1=en:ulinastatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5344. en:ulipristal acetate --- r_associated #0: 20 --> ipilimumab
    n1=en:ulipristal acetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5345. en:ulixertinib --- r_associated #0: 20 --> ipilimumab
    n1=en:ulixertinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5346. en:ulocuplumab --- r_associated #0: 20 --> ipilimumab
    n1=en:ulocuplumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5347. en:ulvwf multimer-targeting agent arc1779 --- r_associated #0: 20 --> ipilimumab
    n1=en:ulvwf multimer-targeting agent arc1779 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5348. en:umbilical cord blood-derived hematopoietic cd34-positive progenitor cells --- r_associated #0: 20 --> ipilimumab
    n1=en:umbilical cord blood-derived hematopoietic cd34-positive progenitor cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5349. en:umbilical cord blood-derived mesenchymal stem cells --- r_associated #0: 20 --> ipilimumab
    n1=en:umbilical cord blood-derived mesenchymal stem cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5350. en:umbilical cord blood-derived natural killer cells --- r_associated #0: 20 --> ipilimumab
    n1=en:umbilical cord blood-derived natural killer cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5351. en:umeclidinium --- r_associated #0: 20 --> ipilimumab
    n1=en:umeclidinium | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5352. en:uncaria tomentosa extract --- r_associated #0: 20 --> ipilimumab
    n1=en:uncaria tomentosa extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5353. en:uniformly-labeled [u-13c]glucose --- r_associated #0: 20 --> ipilimumab
    n1=en:uniformly-labeled [u-13c]glucose | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5354. en:uracil --- r_associated #0: 20 --> ipilimumab
    n1=en:uracil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5355. en:uracil ointment --- r_associated #0: 20 --> ipilimumab
    n1=en:uracil ointment | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5356. en:urea --- r_associated #0: 20 --> ipilimumab
    n1=en:urea | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5357. en:urea/lactic acid-based topical cream --- r_associated #0: 20 --> ipilimumab
    n1=en:urea/lactic acid-based topical cream | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5358. en:urelumab --- r_associated #0: 20 --> ipilimumab
    n1=en:urelumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5359. en:urethane --- r_associated #0: 20 --> ipilimumab
    n1=en:urethane | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5360. en:uridine --- r_associated #0: 20 --> ipilimumab
    n1=en:uridine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5361. en:uridine triacetate --- r_associated #0: 20 --> ipilimumab
    n1=en:uridine triacetate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5362. en:urlc10 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:urlc10 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5363. en:urlc10-cdca1-koc1 multipeptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:urlc10-cdca1-koc1 multipeptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5364. en:urlc10-ttk-koc1-vegfr1-vegfr2 multipeptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:urlc10-ttk-koc1-vegfr1-vegfr2 multipeptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5365. en:urokinase-derived peptide a6 --- r_associated #0: 20 --> ipilimumab
    n1=en:urokinase-derived peptide a6 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5366. en:ursodiol --- r_associated #0: 20 --> ipilimumab
    n1=en:ursodiol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5367. en:usp14/uchl5 inhibitor vlx1570 --- r_associated #0: 20 --> ipilimumab
    n1=en:usp14/uchl5 inhibitor vlx1570 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5368. en:ustekinumab --- r_associated #0: 20 --> ipilimumab
    n1=en:ustekinumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5369. en:uv1 telomerase peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:uv1 telomerase peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5370. en:v930 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:v930 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5371. en:vaccine-sensitized draining lymph node cells --- r_associated #0: 20 --> ipilimumab
    n1=en:vaccine-sensitized draining lymph node cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5372. en:vaccinia cea vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:vaccinia cea vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5373. en:vaccinia virus dd-cdsr --- r_associated #0: 20 --> ipilimumab
    n1=en:vaccinia virus dd-cdsr | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5374. en:vaccinia-gm-csf vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:vaccinia-gm-csf vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5375. en:vaccinia-tyrosinase vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:vaccinia-tyrosinase vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5376. en:vaccinium myrtillus/macleaya cordata/echinacea angustifolia extract granules --- r_associated #0: 20 --> ipilimumab
    n1=en:vaccinium myrtillus/macleaya cordata/echinacea angustifolia extract granules | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5377. en:vadastuximab talirine --- r_associated #0: 20 --> ipilimumab
    n1=en:vadastuximab talirine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5378. en:vadimezan --- r_associated #0: 20 --> ipilimumab
    n1=en:vadimezan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5379. en:vaginal dosage form product --- r_associated #0: 20 --> ipilimumab
    n1=en:vaginal dosage form product | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5380. en:valacyclovir --- r_associated #0: 20 --> ipilimumab
    n1=en:valacyclovir | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5381. en:valdecoxib --- r_associated #0: 20 --> ipilimumab
    n1=en:valdecoxib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5382. en:valerian --- r_associated #0: 20 --> ipilimumab
    n1=en:valerian | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5383. en:valganciclovir --- r_associated #0: 20 --> ipilimumab
    n1=en:valganciclovir | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5384. en:valproic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:valproic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5385. en:valrubicin --- r_associated #0: 20 --> ipilimumab
    n1=en:valrubicin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5386. en:valsartan --- r_associated #0: 20 --> ipilimumab
    n1=en:valsartan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5387. en:valspodar --- r_associated #0: 20 --> ipilimumab
    n1=en:valspodar | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5388. en:vamp regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:vamp regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5389. en:vancomycin --- r_associated #0: 20 --> ipilimumab
    n1=en:vancomycin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5390. en:vandetanib --- r_associated #0: 20 --> ipilimumab
    n1=en:vandetanib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5391. en:vandortuzumab vedotin --- r_associated #0: 20 --> ipilimumab
    n1=en:vandortuzumab vedotin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5392. en:vantictumab --- r_associated #0: 20 --> ipilimumab
    n1=en:vantictumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5393. en:vapreotide --- r_associated #0: 20 --> ipilimumab
    n1=en:vapreotide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5394. en:vardenafil hydrochloride trihydrate --- r_associated #0: 20 --> ipilimumab
    n1=en:vardenafil hydrochloride trihydrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5395. en:varenicline --- r_associated #0: 20 --> ipilimumab
    n1=en:varenicline | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5396. en:varicella-zoster virus strain oka/merck live antigen --- r_associated #0: 20 --> ipilimumab
    n1=en:varicella-zoster virus strain oka/merck live antigen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5397. en:varlilumab --- r_associated #0: 20 --> ipilimumab
    n1=en:varlilumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5398. en:varlitinib --- r_associated #0: 20 --> ipilimumab
    n1=en:varlitinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5399. en:vascular disrupting agent bnc105p --- r_associated #0: 20 --> ipilimumab
    n1=en:vascular disrupting agent bnc105p | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5400. en:vascular disrupting agent zd6126 --- r_associated #0: 20 --> ipilimumab
    n1=en:vascular disrupting agent zd6126 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5401. en:vascular endothelial growth factor antisense oligonucleotide --- r_associated #0: 20 --> ipilimumab
    n1=en:vascular endothelial growth factor antisense oligonucleotide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5402. en:vatalanib --- r_associated #0: 20 --> ipilimumab
    n1=en:vatalanib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5403. en:vcl-cb01 vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:vcl-cb01 vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5404. en:vecuronium bromide --- r_associated #0: 20 --> ipilimumab
    n1=en:vecuronium bromide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5405. en:vedolizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:vedolizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5406. en:vegf inhibitor ptc299 --- r_associated #0: 20 --> ipilimumab
    n1=en:vegf inhibitor ptc299 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5407. en:vegf/hgf-targeting darpin mp0250 --- r_associated #0: 20 --> ipilimumab
    n1=en:vegf/hgf-targeting darpin mp0250 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5408. en:vegfr inhibitor krn951 --- r_associated #0: 20 --> ipilimumab
    n1=en:vegfr inhibitor krn951 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5409. en:vegfr-2 dna vaccine vxm01 --- r_associated #0: 20 --> ipilimumab
    n1=en:vegfr-2 dna vaccine vxm01 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5410. en:vegfr/fgfr inhibitor odm-203 --- r_associated #0: 20 --> ipilimumab
    n1=en:vegfr/fgfr inhibitor odm-203 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5411. en:vegfr/pdgfr dual kinase inhibitor x-82 --- r_associated #0: 20 --> ipilimumab
    n1=en:vegfr/pdgfr dual kinase inhibitor x-82 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5412. en:vegfr/pdgfr tyrosine kinase inhibitor tak-593 --- r_associated #0: 20 --> ipilimumab
    n1=en:vegfr/pdgfr tyrosine kinase inhibitor tak-593 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5413. en:vegfr1-1084 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:vegfr1-1084 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5414. en:vegfr2 tyrosine kinase inhibitor pf-00337210 --- r_associated #0: 20 --> ipilimumab
    n1=en:vegfr2 tyrosine kinase inhibitor pf-00337210 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5415. en:vegfr2-169 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:vegfr2-169 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5416. en:vegfr2-targeted contrast agent br55 --- r_associated #0: 20 --> ipilimumab
    n1=en:vegfr2-targeted contrast agent br55 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5417. en:veip regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:veip regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5418. en:velafermin --- r_associated #0: 20 --> ipilimumab
    n1=en:velafermin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5419. en:veliparib --- r_associated #0: 20 --> ipilimumab
    n1=en:veliparib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5420. en:veltuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:veltuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5421. en:vemurafenib --- r_associated #0: 20 --> ipilimumab
    n1=en:vemurafenib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5422. en:venetoclax --- r_associated #0: 20 --> ipilimumab
    n1=en:venetoclax | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5423. en:venlafaxine --- r_associated #0: 20 --> ipilimumab
    n1=en:venlafaxine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5424. en:vepoloxamer --- r_associated #0: 20 --> ipilimumab
    n1=en:vepoloxamer | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5425. en:verapamil --- r_associated #0: 20 --> ipilimumab
    n1=en:verapamil | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5426. en:verpasep caltespen --- r_associated #0: 20 --> ipilimumab
    n1=en:verpasep caltespen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5427. en:verteporfin --- r_associated #0: 20 --> ipilimumab
    n1=en:verteporfin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5428. en:verubulin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:verubulin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5429. en:veterinary drugs --- r_associated #0: 20 --> ipilimumab
    n1=en:veterinary drugs | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5430. en:viagenpumatucel-l --- r_associated #0: 20 --> ipilimumab
    n1=en:viagenpumatucel-l | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5431. en:vidarabine --- r_associated #0: 20 --> ipilimumab
    n1=en:vidarabine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5432. en:vigabatrin --- r_associated #0: 20 --> ipilimumab
    n1=en:vigabatrin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5433. en:vilazodone --- r_associated #0: 20 --> ipilimumab
    n1=en:vilazodone | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5434. en:vildagliptin --- r_associated #0: 20 --> ipilimumab
    n1=en:vildagliptin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5435. en:vinblastine --- r_associated #0: 20 --> ipilimumab
    n1=en:vinblastine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5436. en:vinblastine sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:vinblastine sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5437. en:vinca alkaloid compound --- r_associated #0: 20 --> ipilimumab
    n1=en:vinca alkaloid compound | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5438. en:vincristine --- r_associated #0: 20 --> ipilimumab
    n1=en:vincristine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5439. en:vincristine sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:vincristine sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5440. en:vincristine sulfate liposome --- r_associated #0: 20 --> ipilimumab
    n1=en:vincristine sulfate liposome | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5441. en:vindesine --- r_associated #0: 20 --> ipilimumab
    n1=en:vindesine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5442. en:vinflunine --- r_associated #0: 20 --> ipilimumab
    n1=en:vinflunine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5443. en:vinfosiltine --- r_associated #0: 20 --> ipilimumab
    n1=en:vinfosiltine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5444. en:vinorelbine tartrate --- r_associated #0: 20 --> ipilimumab
    n1=en:vinorelbine tartrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5445. en:vinorelbine tartrate emulsion --- r_associated #0: 20 --> ipilimumab
    n1=en:vinorelbine tartrate emulsion | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5446. en:vinorelbine tartrate oral --- r_associated #0: 20 --> ipilimumab
    n1=en:vinorelbine tartrate oral | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5447. en:vintafolide --- r_associated #0: 20 --> ipilimumab
    n1=en:vintafolide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5448. en:vinzolidine --- r_associated #0: 20 --> ipilimumab
    n1=en:vinzolidine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5449. en:vip regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:vip regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5450. en:virulizin --- r_associated #0: 20 --> ipilimumab
    n1=en:virulizin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5451. en:visilizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:visilizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5452. en:vismodegib --- r_associated #0: 20 --> ipilimumab
    n1=en:vismodegib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5453. en:vistusertib --- r_associated #0: 20 --> ipilimumab
    n1=en:vistusertib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5454. en:vitamin --- r_associated #0: 20 --> ipilimumab
    n1=en:vitamin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5455. en:vitamin / trace element --- r_associated #0: 20 --> ipilimumab
    n1=en:vitamin / trace element | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5456. en:vitamin a compound --- r_associated #0: 20 --> ipilimumab
    n1=en:vitamin a compound | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5457. en:vitamin e compound --- r_associated #0: 20 --> ipilimumab
    n1=en:vitamin e compound | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5458. en:vitamin k1-containing urea skin cream --- r_associated #0: 20 --> ipilimumab
    n1=en:vitamin k1-containing urea skin cream | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5459. en:vitespen --- r_associated #0: 20 --> ipilimumab
    n1=en:vitespen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5460. en:vlp-encapsulated tlr9 agonist cmp-001 --- r_associated #0: 20 --> ipilimumab
    n1=en:vlp-encapsulated tlr9 agonist cmp-001 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5461. en:vocimagene amiretrorepvec --- r_associated #0: 20 --> ipilimumab
    n1=en:vocimagene amiretrorepvec | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5462. en:voglibose --- r_associated #0: 20 --> ipilimumab
    n1=en:voglibose | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5463. en:volasertib --- r_associated #0: 20 --> ipilimumab
    n1=en:volasertib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5464. en:volitinib --- r_associated #0: 20 --> ipilimumab
    n1=en:volitinib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5465. en:volociximab --- r_associated #0: 20 --> ipilimumab
    n1=en:volociximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5466. en:von hippel-lindau peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:von hippel-lindau peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5467. en:voriconazole --- r_associated #0: 20 --> ipilimumab
    n1=en:voriconazole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5468. en:vorinostat --- r_associated #0: 20 --> ipilimumab
    n1=en:vorinostat | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5469. en:vorozole --- r_associated #0: 20 --> ipilimumab
    n1=en:vorozole | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5470. en:vorsetuzumab-mafodotin --- r_associated #0: 20 --> ipilimumab
    n1=en:vorsetuzumab-mafodotin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5471. en:vortioxetine hydrobromide --- r_associated #0: 20 --> ipilimumab
    n1=en:vortioxetine hydrobromide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5472. en:vosaroxin --- r_associated #0: 20 --> ipilimumab
    n1=en:vosaroxin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5473. en:voxtalisib --- r_associated #0: 20 --> ipilimumab
    n1=en:voxtalisib | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5474. en:vx-803 --- r_associated #0: 20 --> ipilimumab
    n1=en:vx-803 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5475. en:warfarin --- r_associated #0: 20 --> ipilimumab
    n1=en:warfarin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5476. en:water o-15 --- r_associated #0: 20 --> ipilimumab
    n1=en:water o-15 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5477. en:water, mineral or uric acid metabolism drug --- r_associated #0: 20 --> ipilimumab
    n1=en:water, mineral or uric acid metabolism drug | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5478. en:water-based vaginal lubricant --- r_associated #0: 20 --> ipilimumab
    n1=en:water-based vaginal lubricant | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5479. en:wee1 inhibitor azd1775 --- r_associated #0: 20 --> ipilimumab
    n1=en:wee1 inhibitor azd1775 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5480. en:weight control agent --- r_associated #0: 20 --> ipilimumab
    n1=en:weight control agent | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5481. en:wheatgrass juice --- r_associated #0: 20 --> ipilimumab
    n1=en:wheatgrass juice | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5482. en:whey protein isolate --- r_associated #0: 20 --> ipilimumab
    n1=en:whey protein isolate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5483. en:white button mushroom extract --- r_associated #0: 20 --> ipilimumab
    n1=en:white button mushroom extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5484. en:white carrot --- r_associated #0: 20 --> ipilimumab
    n1=en:white carrot | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5485. en:white wine --- r_associated #0: 20 --> ipilimumab
    n1=en:white wine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5486. en:wild-type reovirus --- r_associated #0: 20 --> ipilimumab
    n1=en:wild-type reovirus | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5487. en:wnt signaling inhibitor sm04755 --- r_associated #0: 20 --> ipilimumab
    n1=en:wnt signaling inhibitor sm04755 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5488. en:wnt-5a mimic hexapeptide foxy-5 --- r_associated #0: 20 --> ipilimumab
    n1=en:wnt-5a mimic hexapeptide foxy-5 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5489. en:wobe-mugos e --- r_associated #0: 20 --> ipilimumab
    n1=en:wobe-mugos e | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5490. en:wt1 124-138 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:wt1 124-138 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5491. en:wt1 126-134 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:wt1 126-134 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5492. en:wt1 235-243 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:wt1 235-243 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5493. en:wt1 247-261 peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:wt1 247-261 peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5494. en:wt1 analog peptide vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:wt1 analog peptide vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5495. en:wt1 mrna-electroporated autologous dendritic cell vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:wt1 mrna-electroporated autologous dendritic cell vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5496. en:wt1 peptide vaccine ocv-501 --- r_associated #0: 20 --> ipilimumab
    n1=en:wt1 peptide vaccine ocv-501 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5497. en:wt1 peptide vaccine wt2725 --- r_associated #0: 20 --> ipilimumab
    n1=en:wt1 peptide vaccine wt2725 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5498. en:wt1 protein-derived peptide vaccine dsp-7888 --- r_associated #0: 20 --> ipilimumab
    n1=en:wt1 protein-derived peptide vaccine dsp-7888 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5499. en:wt1-a10/as01b immunotherapeutic gsk2130579a --- r_associated #0: 20 --> ipilimumab
    n1=en:wt1-a10/as01b immunotherapeutic gsk2130579a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5500. en:wt1-sensitized t cells --- r_associated #0: 20 --> ipilimumab
    n1=en:wt1-sensitized t cells | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5501. en:wu-ling-san --- r_associated #0: 20 --> ipilimumab
    n1=en:wu-ling-san | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5502. en:wx-uk1 --- r_associated #0: 20 --> ipilimumab
    n1=en:wx-uk1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5503. en:xaliproden hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:xaliproden hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5504. en:xanthohumol --- r_associated #0: 20 --> ipilimumab
    n1=en:xanthohumol | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5505. en:xbp1-us/xbp1-sp/cd138/cs1 multipeptide vaccine pvx-410 --- r_associated #0: 20 --> ipilimumab
    n1=en:xbp1-us/xbp1-sp/cd138/cs1 multipeptide vaccine pvx-410 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5506. en:xeliri regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:xeliri regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5507. en:xelox regimen --- r_associated #0: 20 --> ipilimumab
    n1=en:xelox regimen | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5508. en:xenobiotics --- r_associated #0: 20 --> ipilimumab
    n1=en:xenobiotics | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5509. en:xenogeneic tyrosinase dna vaccine --- r_associated #0: 20 --> ipilimumab
    n1=en:xenogeneic tyrosinase dna vaccine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5510. en:xenon --- r_associated #0: 20 --> ipilimumab
    n1=en:xenon | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5511. en:xianling gubao --- r_associated #0: 20 --> ipilimumab
    n1=en:xianling gubao | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5512. en:xiap/ciap1 antagonist astx660 --- r_associated #0: 20 --> ipilimumab
    n1=en:xiap/ciap1 antagonist astx660 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5513. en:xl820 --- r_associated #0: 20 --> ipilimumab
    n1=en:xl820 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5514. en:xonrid cream --- r_associated #0: 20 --> ipilimumab
    n1=en:xonrid cream | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5515. en:xpo1 inhibitor kpt-8602 --- r_associated #0: 20 --> ipilimumab
    n1=en:xpo1 inhibitor kpt-8602 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5516. en:xpo1 inhibitor sl-801 --- r_associated #0: 20 --> ipilimumab
    n1=en:xpo1 inhibitor sl-801 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5517. en:y 90 monoclonal antibody cc49 --- r_associated #0: 20 --> ipilimumab
    n1=en:y 90 monoclonal antibody cc49 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5518. en:y 90 monoclonal antibody hmfg1 --- r_associated #0: 20 --> ipilimumab
    n1=en:y 90 monoclonal antibody hmfg1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5519. en:y 90 monoclonal antibody lym-1 --- r_associated #0: 20 --> ipilimumab
    n1=en:y 90 monoclonal antibody lym-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5520. en:y 90 monoclonal antibody m170 --- r_associated #0: 20 --> ipilimumab
    n1=en:y 90 monoclonal antibody m170 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5521. en:y 90 monoclonal antibody m195 --- r_associated #0: 20 --> ipilimumab
    n1=en:y 90 monoclonal antibody m195 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5522. en:y-shape branched pegylated filgrastim --- r_associated #0: 20 --> ipilimumab
    n1=en:y-shape branched pegylated filgrastim | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5523. en:yangzheng xiaoji extract --- r_associated #0: 20 --> ipilimumab
    n1=en:yangzheng xiaoji extract | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5524. en:yangzheng xiaoji supplement --- r_associated #0: 20 --> ipilimumab
    n1=en:yangzheng xiaoji supplement | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5525. en:ym598 --- r_associated #0: 20 --> ipilimumab
    n1=en:ym598 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5526. en:yoshi-864 --- r_associated #0: 20 --> ipilimumab
    n1=en:yoshi-864 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5527. en:yttrium y 90 anti-cd19 monoclonal antibody bu12 --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y 90 anti-cd19 monoclonal antibody bu12 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5528. en:yttrium y 90 anti-cd45 monoclonal antibody ahn-12 --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y 90 anti-cd45 monoclonal antibody ahn-12 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5529. en:yttrium y 90 anti-cd45 monoclonal antibody bc8 --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y 90 anti-cd45 monoclonal antibody bc8 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5530. en:yttrium y 90 anti-cd66 monoclonal antibody bw 250/183 --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y 90 anti-cd66 monoclonal antibody bw 250/183 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5531. en:yttrium y 90 anti-cdh3 monoclonal antibody ff-21101 --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y 90 anti-cdh3 monoclonal antibody ff-21101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5532. en:yttrium y 90 anti-cea monoclonal antibody ct84.66 --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y 90 anti-cea monoclonal antibody ct84.66 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5533. en:yttrium y 90 basiliximab --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y 90 basiliximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5534. en:yttrium y 90 colloid --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y 90 colloid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5535. en:yttrium y 90 daclizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y 90 daclizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5536. en:yttrium y 90 dota anti-cea monoclonal antibody m5a --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y 90 dota anti-cea monoclonal antibody m5a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5537. en:yttrium y 90 glass microspheres --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y 90 glass microspheres | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5538. en:yttrium y 90 monoclonal antibody b3 --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y 90 monoclonal antibody b3 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5539. en:yttrium y 90 monoclonal antibody bre-3 --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y 90 monoclonal antibody bre-3 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5540. en:yttrium y 90 monoclonal antibody hu3s193 --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y 90 monoclonal antibody hu3s193 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5541. en:yttrium y 90 monoclonal antibody idec-159 --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y 90 monoclonal antibody idec-159 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5542. en:yttrium y 90 monoclonal antibody mn-14 --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y 90 monoclonal antibody mn-14 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5543. en:yttrium y 90 resin microspheres --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y 90 resin microspheres | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5544. en:yttrium y 90-dota-biotin --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y 90-dota-biotin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5545. en:yttrium y 90-dota-di-hsg peptide imp-288 --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y 90-dota-di-hsg peptide imp-288 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5546. en:yttrium y 90-edotreotide --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y 90-edotreotide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5547. en:yttrium y 90-labeled anti-fzd10 monoclonal antibody otsa101 --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y 90-labeled anti-fzd10 monoclonal antibody otsa101 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5548. en:yttrium y-90 clivatuzumab tetraxetan --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y-90 clivatuzumab tetraxetan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5549. en:yttrium y-90 epratuzumab tetraxetan --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y-90 epratuzumab tetraxetan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5550. en:yttrium y-90 ibritumomab tiuxetan --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y-90 ibritumomab tiuxetan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5551. en:yttrium y-90 tacatuzumab tetraxetan --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y-90 tacatuzumab tetraxetan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5552. en:yttrium y-90-dota-girentuximab --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium y-90-dota-girentuximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5553. en:yttrium-90 polycarbonate brachytherapy plaque --- r_associated #0: 20 --> ipilimumab
    n1=en:yttrium-90 polycarbonate brachytherapy plaque | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5554. en:z-360 --- r_associated #0: 20 --> ipilimumab
    n1=en:z-360 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5555. en:z-endoxifen hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:z-endoxifen hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5556. en:zalcitabine --- r_associated #0: 20 --> ipilimumab
    n1=en:zalcitabine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5557. en:zalutumumab --- r_associated #0: 20 --> ipilimumab
    n1=en:zalutumumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5558. en:zanamivir --- r_associated #0: 20 --> ipilimumab
    n1=en:zanamivir | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5559. en:zanolimumab --- r_associated #0: 20 --> ipilimumab
    n1=en:zanolimumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5560. en:zen003365 --- r_associated #0: 20 --> ipilimumab
    n1=en:zen003365 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5561. en:zeniplatin --- r_associated #0: 20 --> ipilimumab
    n1=en:zeniplatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5562. en:zhongyao fufang --- r_associated #0: 20 --> ipilimumab
    n1=en:zhongyao fufang | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5563. en:zibotentan --- r_associated #0: 20 --> ipilimumab
    n1=en:zibotentan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5564. en:ziconotide --- r_associated #0: 20 --> ipilimumab
    n1=en:ziconotide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5565. en:zidovudine --- r_associated #0: 20 --> ipilimumab
    n1=en:zidovudine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5566. en:zileuton --- r_associated #0: 20 --> ipilimumab
    n1=en:zileuton | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5567. en:zinc finger nuclease zfn-603 --- r_associated #0: 20 --> ipilimumab
    n1=en:zinc finger nuclease zfn-603 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5568. en:zinc finger nuclease zfn-758 --- r_associated #0: 20 --> ipilimumab
    n1=en:zinc finger nuclease zfn-758 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5569. en:zinc gluconate --- r_associated #0: 20 --> ipilimumab
    n1=en:zinc gluconate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5570. en:zinc oxide --- r_associated #0: 20 --> ipilimumab
    n1=en:zinc oxide | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5571. en:zinc oxide/aluminum starch octenylsuccinate/glycyrrhetinic phytosome/vitamin e/botanical extracts-based skin protectant paste --- r_associated #0: 20 --> ipilimumab
    n1=en:zinc oxide/aluminum starch octenylsuccinate/glycyrrhetinic phytosome/vitamin e/botanical extracts-based skin protectant paste | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5572. en:zinc sulfate --- r_associated #0: 20 --> ipilimumab
    n1=en:zinc sulfate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5573. en:zinostatin --- r_associated #0: 20 --> ipilimumab
    n1=en:zinostatin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5574. en:zirconium zr 89 bevacizumab --- r_associated #0: 20 --> ipilimumab
    n1=en:zirconium zr 89 bevacizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5575. en:zirconium zr 89 cetuximab --- r_associated #0: 20 --> ipilimumab
    n1=en:zirconium zr 89 cetuximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5576. en:zirconium zr 89 desferrioxamine b monoclonal antibody huj591 --- r_associated #0: 20 --> ipilimumab
    n1=en:zirconium zr 89 desferrioxamine b monoclonal antibody huj591 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5577. en:zirconium zr 89 df-iab2m --- r_associated #0: 20 --> ipilimumab
    n1=en:zirconium zr 89 df-iab2m | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5578. en:zirconium zr 89 dfo-mstp2109a --- r_associated #0: 20 --> ipilimumab
    n1=en:zirconium zr 89 dfo-mstp2109a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5579. en:zirconium zr 89 girentuximab --- r_associated #0: 20 --> ipilimumab
    n1=en:zirconium zr 89 girentuximab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5580. en:zirconium zr 89 trastuzumab --- r_associated #0: 20 --> ipilimumab
    n1=en:zirconium zr 89 trastuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5581. en:zirconium zr 89-labeled anti-ca19-9 monoclonal antibody 5b1 --- r_associated #0: 20 --> ipilimumab
    n1=en:zirconium zr 89-labeled anti-ca19-9 monoclonal antibody 5b1 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5582. en:zirconium zr 89-labeled anti-pd-l1 monoclonal antibody mpdl3280a --- r_associated #0: 20 --> ipilimumab
    n1=en:zirconium zr 89-labeled anti-pd-l1 monoclonal antibody mpdl3280a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5583. en:zirconium zr 89-labeled anti-pigf monoclonal antibody ro5323441 --- r_associated #0: 20 --> ipilimumab
    n1=en:zirconium zr 89-labeled anti-pigf monoclonal antibody ro5323441 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5584. en:zirconium zr 89-labeled monoclonal antibody mmot0530a --- r_associated #0: 20 --> ipilimumab
    n1=en:zirconium zr 89-labeled monoclonal antibody mmot0530a | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5585. en:zirconium zr 89-labeled ro5479599 --- r_associated #0: 20 --> ipilimumab
    n1=en:zirconium zr 89-labeled ro5479599 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5586. en:ziv-aflibercept --- r_associated #0: 20 --> ipilimumab
    n1=en:ziv-aflibercept | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5587. en:zoledronic acid --- r_associated #0: 20 --> ipilimumab
    n1=en:zoledronic acid | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5588. en:zolmitriptan --- r_associated #0: 20 --> ipilimumab
    n1=en:zolmitriptan | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5589. en:zolpidem tartrate --- r_associated #0: 20 --> ipilimumab
    n1=en:zolpidem tartrate | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5590. en:zoptarelin doxorubicin --- r_associated #0: 20 --> ipilimumab
    n1=en:zoptarelin doxorubicin | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5591. en:zorubicin hydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:zorubicin hydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5592. en:zosuquidar trihydrochloride --- r_associated #0: 20 --> ipilimumab
    n1=en:zosuquidar trihydrochloride | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5593. en:zyc300 --- r_associated #0: 20 --> ipilimumab
    n1=en:zyc300 | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5594. isoleucine --- r_associated #0: 20 --> ipilimumab
    n1=isoleucine | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5595. système immunitaire --- r_associated #0: 20 --> ipilimumab
    n1=système immunitaire | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5596. tartrate de zolpidem --- r_associated #0: 20 --> ipilimumab
    n1=tartrate de zolpidem | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5597. uréthane --- r_associated #0: 20 --> ipilimumab
    n1=uréthane | n2=ipilimumab | rel=r_associated | relid=0 | w=20
  5598. Binswanger (maladie de) --- r_associated #0: 15 --> ipilimumab
    n1=Binswanger (maladie de) | n2=ipilimumab | rel=r_associated | relid=0 | w=15
  5599. anticorps monoclonal agoniste anti-cd40 adc-1013 --- r_associated #0: 15 --> ipilimumab
    n1=anticorps monoclonal agoniste anti-cd40 adc-1013 | n2=ipilimumab | rel=r_associated | relid=0 | w=15
  5600. anticorps monoclonal agoniste anti-ox40 medi6383 --- r_associated #0: 15 --> ipilimumab
    n1=anticorps monoclonal agoniste anti-ox40 medi6383 | n2=ipilimumab | rel=r_associated | relid=0 | w=15
  5601. anticorps monoclonal agoniste anti-ox40 medi6469 --- r_associated #0: 15 --> ipilimumab
    n1=anticorps monoclonal agoniste anti-ox40 medi6469 | n2=ipilimumab | rel=r_associated | relid=0 | w=15
  5602. cellules dendritiques autologues pulsées avec de l'alpha-galactosylcéramide --- r_associated #0: 15 --> ipilimumab
    n1=cellules dendritiques autologues pulsées avec de l'alpha-galactosylcéramide | n2=ipilimumab | rel=r_associated | relid=0 | w=15
  5603. chlorpromazine --- r_associated #0: 15 --> ipilimumab
    n1=chlorpromazine | n2=ipilimumab | rel=r_associated | relid=0 | w=15
  5604. conjugué anticorps-médicament anti-c-kit lop628 --- r_associated #0: 15 --> ipilimumab
    n1=conjugué anticorps-médicament anti-c-kit lop628 | n2=ipilimumab | rel=r_associated | relid=0 | w=15
  5605. dapsone --- r_associated #0: 15 --> ipilimumab
    n1=dapsone | n2=ipilimumab | rel=r_associated | relid=0 | w=15
  5606. dianhydrogalactitol --- r_associated #0: 15 --> ipilimumab
    n1=dianhydrogalactitol | n2=ipilimumab | rel=r_associated | relid=0 | w=15
  5607. en:marihuana --- r_associated #0: 15 --> ipilimumab
    n1=en:marihuana | n2=ipilimumab | rel=r_associated | relid=0 | w=15
  5608. lamivudine --- r_associated #0: 15 --> ipilimumab
    n1=lamivudine | n2=ipilimumab | rel=r_associated | relid=0 | w=15
  5609. marihuana --- r_associated #0: 15 --> ipilimumab
    n1=marihuana | n2=ipilimumab | rel=r_associated | relid=0 | w=15
  5610. marijuana --- r_associated #0: 15 --> ipilimumab
    n1=marijuana | n2=ipilimumab | rel=r_associated | relid=0 | w=15
  5611. mutagène --- r_associated #0: 15 --> ipilimumab
    n1=mutagène | n2=ipilimumab | rel=r_associated | relid=0 | w=15
  5612. rifampicines --- r_associated #0: 15 --> ipilimumab
    n1=rifampicines | n2=ipilimumab | rel=r_associated | relid=0 | w=15
  5613. 3TC --- r_associated #0: 10 --> ipilimumab
    n1=3TC | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5614. Ac --- r_associated #0: 10 --> ipilimumab
    n1=Ac | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5615. Anticorps --- r_associated #0: 10 --> ipilimumab
    n1=Anticorps | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5616. Artemisia vulgaris --- r_associated #0: 10 --> ipilimumab
    n1=Artemisia vulgaris | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5617. Azadirachta indica --- r_associated #0: 10 --> ipilimumab
    n1=Azadirachta indica | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5618. Biochimie --- r_associated #0: 10 --> ipilimumab
    n1=Biochimie | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5619. Cancérologie --- r_associated #0: 10 --> ipilimumab
    n1=Cancérologie | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5620. Immunothérapie --- r_associated #0: 10 --> ipilimumab
    n1=Immunothérapie | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5621. Lactobacillus acidophilus --- r_associated #0: 10 --> ipilimumab
    n1=Lactobacillus acidophilus | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5622. Melanoma --- r_associated #0: 10 --> ipilimumab
    n1=Melanoma | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5623. Mélanome --- r_associated #0: 10 --> ipilimumab
    n1=Mélanome | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5624. Oncologie --- r_associated #0: 10 --> ipilimumab
    n1=Oncologie | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5625. S-adénosylméthionine --- r_associated #0: 10 --> ipilimumab
    n1=S-adénosylméthionine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5626. Valeriana --- r_associated #0: 10 --> ipilimumab
    n1=Valeriana | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5627. abatacept --- r_associated #0: 10 --> ipilimumab
    n1=abatacept | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5628. abciximab --- r_associated #0: 10 --> ipilimumab
    n1=abciximab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5629. acarbose --- r_associated #0: 10 --> ipilimumab
    n1=acarbose | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5630. acide acétylsalicylique --- r_associated #0: 10 --> ipilimumab
    n1=acide acétylsalicylique | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5631. acitrétine --- r_associated #0: 10 --> ipilimumab
    n1=acitrétine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5632. acyclovir --- r_associated #0: 10 --> ipilimumab
    n1=acyclovir | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5633. acénocoumarol --- r_associated #0: 10 --> ipilimumab
    n1=acénocoumarol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5634. acétaminophène --- r_associated #0: 10 --> ipilimumab
    n1=acétaminophène | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5635. acétylcystéine --- r_associated #0: 10 --> ipilimumab
    n1=acétylcystéine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5636. adalimumab --- r_associated #0: 10 --> ipilimumab
    n1=adalimumab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5637. adénosine triphosphate --- r_associated #0: 10 --> ipilimumab
    n1=adénosine triphosphate | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5638. agent alcalinisant --- r_associated #0: 10 --> ipilimumab
    n1=agent alcalinisant | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5639. agent anti-infectueux --- r_associated #0: 10 --> ipilimumab
    n1=agent anti-infectueux | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5640. agent antibactérien --- r_associated #0: 10 --> ipilimumab
    n1=agent antibactérien | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5641. agent antinéoplasique --- r_associated #0: 10 --> ipilimumab
    n1=agent antinéoplasique | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5642. agoniste du récepteur A3 de l'adénosine CF102 --- r_associated #0: 10 --> ipilimumab
    n1=agoniste du récepteur A3 de l'adénosine CF102 | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5643. agonistes du récepteur A2 de l'adénosine --- r_associated #0: 10 --> ipilimumab
    n1=agonistes du récepteur A2 de l'adénosine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5644. albumin --- r_associated #0: 10 --> ipilimumab
    n1=albumin | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5645. alemtuzumab --- r_associated #0: 10 --> ipilimumab
    n1=alemtuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5646. alprostadil --- r_associated #0: 10 --> ipilimumab
    n1=alprostadil | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5647. amifampridine --- r_associated #0: 10 --> ipilimumab
    n1=amifampridine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5648. amifostine --- r_associated #0: 10 --> ipilimumab
    n1=amifostine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5649. aminophylline --- r_associated #0: 10 --> ipilimumab
    n1=aminophylline | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5650. aminophyllines --- r_associated #0: 10 --> ipilimumab
    n1=aminophyllines | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5651. amoxicilline --- r_associated #0: 10 --> ipilimumab
    n1=amoxicilline | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5652. anakinra --- r_associated #0: 10 --> ipilimumab
    n1=anakinra | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5653. analogue de l'hormone de libération des gonadotrophines --- r_associated #0: 10 --> ipilimumab
    n1=analogue de l'hormone de libération des gonadotrophines | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5654. anastrozole --- r_associated #0: 10 --> ipilimumab
    n1=anastrozole | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5655. angiostatine --- r_associated #0: 10 --> ipilimumab
    n1=angiostatine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5656. antagoniste du récepteur A2A de l'adénosine CPI-444 --- r_associated #0: 10 --> ipilimumab
    n1=antagoniste du récepteur A2A de l'adénosine CPI-444 | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5657. antagoniste du récepteur A2A de l'adénosine PBF-509 --- r_associated #0: 10 --> ipilimumab
    n1=antagoniste du récepteur A2A de l'adénosine PBF-509 | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5658. antagoniste du récepteur des androgènes ARN-509 --- r_associated #0: 10 --> ipilimumab
    n1=antagoniste du récepteur des androgènes ARN-509 | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5659. antagoniste du récepteur des androgènes SHR3680 --- r_associated #0: 10 --> ipilimumab
    n1=antagoniste du récepteur des androgènes SHR3680 | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5660. anti-androgène --- r_associated #0: 10 --> ipilimumab
    n1=anti-androgène | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5661. anticorps monoclonal --- r_associated #0: 10 --> ipilimumab
    n1=anticorps monoclonal | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5662. antimétabolite --- r_associated #0: 10 --> ipilimumab
    n1=antimétabolite | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5663. apixaban --- r_associated #0: 10 --> ipilimumab
    n1=apixaban | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5664. aprotinine --- r_associated #0: 10 --> ipilimumab
    n1=aprotinine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5665. asparaginase --- r_associated #0: 10 --> ipilimumab
    n1=asparaginase | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5666. astringente --- r_associated #0: 10 --> ipilimumab
    n1=astringente | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5667. aténolol --- r_associated #0: 10 --> ipilimumab
    n1=aténolol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5668. auranofine --- r_associated #0: 10 --> ipilimumab
    n1=auranofine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5669. avanafil --- r_associated #0: 10 --> ipilimumab
    n1=avanafil | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5670. axitinib --- r_associated #0: 10 --> ipilimumab
    n1=axitinib | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5671. azithromycine --- r_associated #0: 10 --> ipilimumab
    n1=azithromycine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5672. bacitracine --- r_associated #0: 10 --> ipilimumab
    n1=bacitracine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5673. baclofen --- r_associated #0: 10 --> ipilimumab
    n1=baclofen | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5674. baclofène --- r_associated #0: 10 --> ipilimumab
    n1=baclofène | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5675. baricitinib --- r_associated #0: 10 --> ipilimumab
    n1=baricitinib | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5676. basiliximab --- r_associated #0: 10 --> ipilimumab
    n1=basiliximab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5677. belimumab --- r_associated #0: 10 --> ipilimumab
    n1=belimumab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5678. bevacizumab --- r_associated #0: 10 --> ipilimumab
    n1=bevacizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5679. bisacodyl --- r_associated #0: 10 --> ipilimumab
    n1=bisacodyl | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5680. bisoprolol --- r_associated #0: 10 --> ipilimumab
    n1=bisoprolol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5681. bisoprolol fumarate --- r_associated #0: 10 --> ipilimumab
    n1=bisoprolol fumarate | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5682. blinatumomab --- r_associated #0: 10 --> ipilimumab
    n1=blinatumomab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5683. brincidofovir --- r_associated #0: 10 --> ipilimumab
    n1=brincidofovir | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5684. budésonide --- r_associated #0: 10 --> ipilimumab
    n1=budésonide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5685. busulfan --- r_associated #0: 10 --> ipilimumab
    n1=busulfan | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5686. béta-carotène --- r_associated #0: 10 --> ipilimumab
    n1=béta-carotène | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5687. bétaméthasone --- r_associated #0: 10 --> ipilimumab
    n1=bétaméthasone | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5688. bêta-carotène --- r_associated #0: 10 --> ipilimumab
    n1=bêta-carotène | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5689. bêta-glucane --- r_associated #0: 10 --> ipilimumab
    n1=bêta-glucane | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5690. bêtacarotène --- r_associated #0: 10 --> ipilimumab
    n1=bêtacarotène | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5691. bêtaméthasone --- r_associated #0: 10 --> ipilimumab
    n1=bêtaméthasone | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5692. cabergoline --- r_associated #0: 10 --> ipilimumab
    n1=cabergoline | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5693. caféine --- r_associated #0: 10 --> ipilimumab
    n1=caféine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5694. calcitriol --- r_associated #0: 10 --> ipilimumab
    n1=calcitriol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5695. camptothécine --- r_associated #0: 10 --> ipilimumab
    n1=camptothécine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5696. canakinumab --- r_associated #0: 10 --> ipilimumab
    n1=canakinumab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5697. cannabidiol --- r_associated #0: 10 --> ipilimumab
    n1=cannabidiol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5698. cannabinol --- r_associated #0: 10 --> ipilimumab
    n1=cannabinol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5699. capsaïcine --- r_associated #0: 10 --> ipilimumab
    n1=capsaïcine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5700. captopril --- r_associated #0: 10 --> ipilimumab
    n1=captopril | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5701. carbamazépine --- r_associated #0: 10 --> ipilimumab
    n1=carbamazépine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5702. carbendazime --- r_associated #0: 10 --> ipilimumab
    n1=carbendazime | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5703. carbidopa --- r_associated #0: 10 --> ipilimumab
    n1=carbidopa | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5704. carboplatine --- r_associated #0: 10 --> ipilimumab
    n1=carboplatine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5705. carbutamide --- r_associated #0: 10 --> ipilimumab
    n1=carbutamide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5706. carbénicilline --- r_associated #0: 10 --> ipilimumab
    n1=carbénicilline | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5707. carine --- r_associated #0: 10 --> ipilimumab
    n1=carine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5708. carmustine --- r_associated #0: 10 --> ipilimumab
    n1=carmustine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5709. cefpodoxime proxétil --- r_associated #0: 10 --> ipilimumab
    n1=cefpodoxime proxétil | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5710. ceritinib --- r_associated #0: 10 --> ipilimumab
    n1=ceritinib | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5711. certolizumab --- r_associated #0: 10 --> ipilimumab
    n1=certolizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5712. certolizumab pegol --- r_associated #0: 10 --> ipilimumab
    n1=certolizumab pegol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5713. cetuximab --- r_associated #0: 10 --> ipilimumab
    n1=cetuximab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5714. chlorambucil --- r_associated #0: 10 --> ipilimumab
    n1=chlorambucil | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5715. chlorhexidine --- r_associated #0: 10 --> ipilimumab
    n1=chlorhexidine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5716. chlorhydrate d'oxymorphone --- r_associated #0: 10 --> ipilimumab
    n1=chlorhydrate d'oxymorphone | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5717. chloroquine --- r_associated #0: 10 --> ipilimumab
    n1=chloroquine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5718. chlorpropamide --- r_associated #0: 10 --> ipilimumab
    n1=chlorpropamide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5719. chlorzoxazone --- r_associated #0: 10 --> ipilimumab
    n1=chlorzoxazone | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5720. cholécalciférol --- r_associated #0: 10 --> ipilimumab
    n1=cholécalciférol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5721. cidofovir --- r_associated #0: 10 --> ipilimumab
    n1=cidofovir | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5722. cimétidine --- r_associated #0: 10 --> ipilimumab
    n1=cimétidine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5723. ciprofloxacine --- r_associated #0: 10 --> ipilimumab
    n1=ciprofloxacine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5724. cis-diaminedichloroplatine --- r_associated #0: 10 --> ipilimumab
    n1=cis-diaminedichloroplatine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5725. cisapride --- r_associated #0: 10 --> ipilimumab
    n1=cisapride | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5726. cisplatine --- r_associated #0: 10 --> ipilimumab
    n1=cisplatine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5727. citicoline --- r_associated #0: 10 --> ipilimumab
    n1=citicoline | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5728. citrate de sodium --- r_associated #0: 10 --> ipilimumab
    n1=citrate de sodium | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5729. clarithromycine --- r_associated #0: 10 --> ipilimumab
    n1=clarithromycine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5730. clindamycine --- r_associated #0: 10 --> ipilimumab
    n1=clindamycine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5731. clioquinol --- r_associated #0: 10 --> ipilimumab
    n1=clioquinol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5732. clofibrate --- r_associated #0: 10 --> ipilimumab
    n1=clofibrate | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5733. clotrimazole --- r_associated #0: 10 --> ipilimumab
    n1=clotrimazole | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5734. cobalamine --- r_associated #0: 10 --> ipilimumab
    n1=cobalamine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5735. composé organique de sulfone --- r_associated #0: 10 --> ipilimumab
    n1=composé organique de sulfone | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5736. comprimé d'aspirine --- r_associated #0: 10 --> ipilimumab
    n1=comprimé d'aspirine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5737. comprimé multivitaminé --- r_associated #0: 10 --> ipilimumab
    n1=comprimé multivitaminé | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5738. corticotropine --- r_associated #0: 10 --> ipilimumab
    n1=corticotropine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5739. coumarine --- r_associated #0: 10 --> ipilimumab
    n1=coumarine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5740. curcumine --- r_associated #0: 10 --> ipilimumab
    n1=curcumine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5741. cycloleucine --- r_associated #0: 10 --> ipilimumab
    n1=cycloleucine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5742. cyclopentylpropionate de testostérone --- r_associated #0: 10 --> ipilimumab
    n1=cyclopentylpropionate de testostérone | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5743. cyclophosphamide --- r_associated #0: 10 --> ipilimumab
    n1=cyclophosphamide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5744. cyclosporine --- r_associated #0: 10 --> ipilimumab
    n1=cyclosporine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5745. cyclosérine --- r_associated #0: 10 --> ipilimumab
    n1=cyclosérine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5746. cyprotérone --- r_associated #0: 10 --> ipilimumab
    n1=cyprotérone | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5747. cytarabine --- r_associated #0: 10 --> ipilimumab
    n1=cytarabine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5748. céfamandole --- r_associated #0: 10 --> ipilimumab
    n1=céfamandole | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5749. céfixime --- r_associated #0: 10 --> ipilimumab
    n1=céfixime | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5750. céfotaxime --- r_associated #0: 10 --> ipilimumab
    n1=céfotaxime | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5751. céphalexine --- r_associated #0: 10 --> ipilimumab
    n1=céphalexine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5752. céramide --- r_associated #0: 10 --> ipilimumab
    n1=céramide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5753. cétirizine --- r_associated #0: 10 --> ipilimumab
    n1=cétirizine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5754. dabrafenib --- r_associated #0: 10 --> ipilimumab
    n1=dabrafenib | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5755. dacarbazine --- r_associated #0: 10 --> ipilimumab
    n1=dacarbazine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5756. daclatasvir --- r_associated #0: 10 --> ipilimumab
    n1=daclatasvir | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5757. daclizumab --- r_associated #0: 10 --> ipilimumab
    n1=daclizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5758. danazol --- r_associated #0: 10 --> ipilimumab
    n1=danazol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5759. daptomycine --- r_associated #0: 10 --> ipilimumab
    n1=daptomycine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5760. daratumumab --- r_associated #0: 10 --> ipilimumab
    n1=daratumumab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5761. dasabuvir --- r_associated #0: 10 --> ipilimumab
    n1=dasabuvir | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5762. dasatinib --- r_associated #0: 10 --> ipilimumab
    n1=dasatinib | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5763. dexaméthasone --- r_associated #0: 10 --> ipilimumab
    n1=dexaméthasone | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5764. dextran --- r_associated #0: 10 --> ipilimumab
    n1=dextran | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5765. dextrane --- r_associated #0: 10 --> ipilimumab
    n1=dextrane | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5766. diazoxide --- r_associated #0: 10 --> ipilimumab
    n1=diazoxide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5767. dicumarol --- r_associated #0: 10 --> ipilimumab
    n1=dicumarol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5768. didanosine --- r_associated #0: 10 --> ipilimumab
    n1=didanosine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5769. diflunisal --- r_associated #0: 10 --> ipilimumab
    n1=diflunisal | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5770. digitoxine --- r_associated #0: 10 --> ipilimumab
    n1=digitoxine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5771. digoxine --- r_associated #0: 10 --> ipilimumab
    n1=digoxine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5772. dinitrochlorobenzène --- r_associated #0: 10 --> ipilimumab
    n1=dinitrochlorobenzène | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5773. dinitrofluorobenzène --- r_associated #0: 10 --> ipilimumab
    n1=dinitrofluorobenzène | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5774. disulfirame --- r_associated #0: 10 --> ipilimumab
    n1=disulfirame | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5775. dobutamine --- r_associated #0: 10 --> ipilimumab
    n1=dobutamine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5776. docusate --- r_associated #0: 10 --> ipilimumab
    n1=docusate | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5777. dompéridone --- r_associated #0: 10 --> ipilimumab
    n1=dompéridone | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5778. doxycycline --- r_associated #0: 10 --> ipilimumab
    n1=doxycycline | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5779. dronabinol --- r_associated #0: 10 --> ipilimumab
    n1=dronabinol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5780. droperidol --- r_associated #0: 10 --> ipilimumab
    n1=droperidol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5781. dropéridol --- r_associated #0: 10 --> ipilimumab
    n1=dropéridol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5782. eau distillée --- r_associated #0: 10 --> ipilimumab
    n1=eau distillée | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5783. emtricitabine --- r_associated #0: 10 --> ipilimumab
    n1=emtricitabine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5784. en:aminodur --- r_associated #0: 10 --> ipilimumab
    n1=en:aminodur | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5785. en:aminophyllin --- r_associated #0: 10 --> ipilimumab
    n1=en:aminophyllin | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5786. en:cardophyllin --- r_associated #0: 10 --> ipilimumab
    n1=en:cardophyllin | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5787. en:carine --- r_associated #0: 10 --> ipilimumab
    n1=en:carine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5788. en:clonofilin --- r_associated #0: 10 --> ipilimumab
    n1=en:clonofilin | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5789. en:corophyllin --- r_associated #0: 10 --> ipilimumab
    n1=en:corophyllin | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5790. en:diaphyllin --- r_associated #0: 10 --> ipilimumab
    n1=en:diaphyllin | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5791. en:drafilyn --- r_associated #0: 10 --> ipilimumab
    n1=en:drafilyn | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5792. en:duraphyllin --- r_associated #0: 10 --> ipilimumab
    n1=en:duraphyllin | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5793. en:euphyllin --- r_associated #0: 10 --> ipilimumab
    n1=en:euphyllin | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5794. en:euphylline --- r_associated #0: 10 --> ipilimumab
    n1=en:euphylline | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5795. en:godafilin --- r_associated #0: 10 --> ipilimumab
    n1=en:godafilin | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5796. en:immune system --- r_associated #0: 10 --> ipilimumab
    n1=en:immune system | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5797. en:mundiphyllin --- r_associated #0: 10 --> ipilimumab
    n1=en:mundiphyllin | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5798. en:novophyllin --- r_associated #0: 10 --> ipilimumab
    n1=en:novophyllin | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5799. en:somophyllin --- r_associated #0: 10 --> ipilimumab
    n1=en:somophyllin | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5800. enoxaparine --- r_associated #0: 10 --> ipilimumab
    n1=enoxaparine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5801. enzalutamide --- r_associated #0: 10 --> ipilimumab
    n1=enzalutamide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5802. ergocalciférol --- r_associated #0: 10 --> ipilimumab
    n1=ergocalciférol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5803. facteurs biologiques --- r_associated #0: 10 --> ipilimumab
    n1=facteurs biologiques | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5804. faux médicaments --- r_associated #0: 10 --> ipilimumab
    n1=faux médicaments | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5805. febuxostat --- r_associated #0: 10 --> ipilimumab
    n1=febuxostat | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5806. filgrastim --- r_associated #0: 10 --> ipilimumab
    n1=filgrastim | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5807. floxuridine --- r_associated #0: 10 --> ipilimumab
    n1=floxuridine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5808. fluconazole --- r_associated #0: 10 --> ipilimumab
    n1=fluconazole | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5809. flucytosine --- r_associated #0: 10 --> ipilimumab
    n1=flucytosine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5810. fludarabine --- r_associated #0: 10 --> ipilimumab
    n1=fludarabine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5811. fluocinonide --- r_associated #0: 10 --> ipilimumab
    n1=fluocinonide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5812. fluorouracile --- r_associated #0: 10 --> ipilimumab
    n1=fluorouracile | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5813. fluoxétine --- r_associated #0: 10 --> ipilimumab
    n1=fluoxétine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5814. flutamide --- r_associated #0: 10 --> ipilimumab
    n1=flutamide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5815. formestane --- r_associated #0: 10 --> ipilimumab
    n1=formestane | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5816. fosfestrol --- r_associated #0: 10 --> ipilimumab
    n1=fosfestrol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5817. fumarate de bisoprolol --- r_associated #0: 10 --> ipilimumab
    n1=fumarate de bisoprolol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5818. furosémide --- r_associated #0: 10 --> ipilimumab
    n1=furosémide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5819. fénofibrate --- r_associated #0: 10 --> ipilimumab
    n1=fénofibrate | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5820. galactose --- r_associated #0: 10 --> ipilimumab
    n1=galactose | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5821. ganciclovir --- r_associated #0: 10 --> ipilimumab
    n1=ganciclovir | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5822. gemcitabine --- r_associated #0: 10 --> ipilimumab
    n1=gemcitabine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5823. gentamicine --- r_associated #0: 10 --> ipilimumab
    n1=gentamicine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5824. gerbe d'or --- r_associated #0: 10 --> ipilimumab
    n1=gerbe d'or | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5825. girentuximab --- r_associated #0: 10 --> ipilimumab
    n1=girentuximab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5826. glibenclamide --- r_associated #0: 10 --> ipilimumab
    n1=glibenclamide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5827. gliclazide --- r_associated #0: 10 --> ipilimumab
    n1=gliclazide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5828. glipizide --- r_associated #0: 10 --> ipilimumab
    n1=glipizide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5829. glucagon --- r_associated #0: 10 --> ipilimumab
    n1=glucagon | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5830. glutamine --- r_associated #0: 10 --> ipilimumab
    n1=glutamine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5831. glutathion --- r_associated #0: 10 --> ipilimumab
    n1=glutathion | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5832. glyburide --- r_associated #0: 10 --> ipilimumab
    n1=glyburide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5833. glycopyrrolate --- r_associated #0: 10 --> ipilimumab
    n1=glycopyrrolate | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5834. glycyrrhizine --- r_associated #0: 10 --> ipilimumab
    n1=glycyrrhizine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5835. golimumab --- r_associated #0: 10 --> ipilimumab
    n1=golimumab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5836. gonadotrophine ménopausique humaine --- r_associated #0: 10 --> ipilimumab
    n1=gonadotrophine ménopausique humaine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5837. halopéridol --- r_associated #0: 10 --> ipilimumab
    n1=halopéridol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5838. hydroxychloroquine --- r_associated #0: 10 --> ipilimumab
    n1=hydroxychloroquine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5839. hydroxytyrosol --- r_associated #0: 10 --> ipilimumab
    n1=hydroxytyrosol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5840. héparine --- r_associated #0: 10 --> ipilimumab
    n1=héparine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5841. ibandronate --- r_associated #0: 10 --> ipilimumab
    n1=ibandronate | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5842. ibogaïne --- r_associated #0: 10 --> ipilimumab
    n1=ibogaïne | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5843. ibrutinib --- r_associated #0: 10 --> ipilimumab
    n1=ibrutinib | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5844. icatibant --- r_associated #0: 10 --> ipilimumab
    n1=icatibant | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5845. idarucizumab --- r_associated #0: 10 --> ipilimumab
    n1=idarucizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5846. idoxuridine --- r_associated #0: 10 --> ipilimumab
    n1=idoxuridine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5847. ifosfamide --- r_associated #0: 10 --> ipilimumab
    n1=ifosfamide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5848. iloprost --- r_associated #0: 10 --> ipilimumab
    n1=iloprost | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5849. imatinib --- r_associated #0: 10 --> ipilimumab
    n1=imatinib | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5850. imipenem --- r_associated #0: 10 --> ipilimumab
    n1=imipenem | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5851. imipramine --- r_associated #0: 10 --> ipilimumab
    n1=imipramine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5852. imipénème --- r_associated #0: 10 --> ipilimumab
    n1=imipénème | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5853. imiquimod --- r_associated #0: 10 --> ipilimumab
    n1=imiquimod | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5854. immuno-modulateurs --- r_associated #0: 10 --> ipilimumab
    n1=immuno-modulateurs | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5855. immunomodulateurs --- r_associated #0: 10 --> ipilimumab
    n1=immunomodulateurs | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5856. immunoperoxydases en dermatologie (technique des) --- r_associated #0: 10 --> ipilimumab
    n1=immunoperoxydases en dermatologie (technique des) | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5857. indinavir --- r_associated #0: 10 --> ipilimumab
    n1=indinavir | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5858. indométhacine --- r_associated #0: 10 --> ipilimumab
    n1=indométhacine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5859. infliximab --- r_associated #0: 10 --> ipilimumab
    n1=infliximab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5860. inhibiteur de la thymidylate synthase ciblant le récepteur alpha-folate ONX-0801 --- r_associated #0: 10 --> ipilimumab
    n1=inhibiteur de la thymidylate synthase ciblant le récepteur alpha-folate ONX-0801 | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5861. inhibiteur du récepteur des androgènes EPI-506 --- r_associated #0: 10 --> ipilimumab
    n1=inhibiteur du récepteur des androgènes EPI-506 | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5862. inosine pranobex --- r_associated #0: 10 --> ipilimumab
    n1=inosine pranobex | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5863. inositol --- r_associated #0: 10 --> ipilimumab
    n1=inositol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5864. inuline --- r_associated #0: 10 --> ipilimumab
    n1=inuline | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5865. iobenguane --- r_associated #0: 10 --> ipilimumab
    n1=iobenguane | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5866. iodixanol --- r_associated #0: 10 --> ipilimumab
    n1=iodixanol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5867. iodoquinol --- r_associated #0: 10 --> ipilimumab
    n1=iodoquinol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5868. iohexol --- r_associated #0: 10 --> ipilimumab
    n1=iohexol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5869. ionomycine --- r_associated #0: 10 --> ipilimumab
    n1=ionomycine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5870. iophendylate --- r_associated #0: 10 --> ipilimumab
    n1=iophendylate | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5871. iopromide --- r_associated #0: 10 --> ipilimumab
    n1=iopromide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5872. ioversol --- r_associated #0: 10 --> ipilimumab
    n1=ioversol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5873. ioxaglate --- r_associated #0: 10 --> ipilimumab
    n1=ioxaglate | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5874. ipratropium --- r_associated #0: 10 --> ipilimumab
    n1=ipratropium | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5875. irinotecan --- r_associated #0: 10 --> ipilimumab
    n1=irinotecan | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5876. irritants --- r_associated #0: 10 --> ipilimumab
    n1=irritants | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5877. isavuconazole --- r_associated #0: 10 --> ipilimumab
    n1=isavuconazole | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5878. isobutane --- r_associated #0: 10 --> ipilimumab
    n1=isobutane | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5879. isocarboxazide --- r_associated #0: 10 --> ipilimumab
    n1=isocarboxazide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5880. isoflurane --- r_associated #0: 10 --> ipilimumab
    n1=isoflurane | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5881. isoflurophate --- r_associated #0: 10 --> ipilimumab
    n1=isoflurophate | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5882. isoniazide --- r_associated #0: 10 --> ipilimumab
    n1=isoniazide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5883. isopropamide --- r_associated #0: 10 --> ipilimumab
    n1=isopropamide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5884. isosorbide --- r_associated #0: 10 --> ipilimumab
    n1=isosorbide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5885. isotrétinoïne --- r_associated #0: 10 --> ipilimumab
    n1=isotrétinoïne | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5886. isoxsuprine --- r_associated #0: 10 --> ipilimumab
    n1=isoxsuprine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5887. isradipine --- r_associated #0: 10 --> ipilimumab
    n1=isradipine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5888. itraconazole --- r_associated #0: 10 --> ipilimumab
    n1=itraconazole | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5889. ivabradine --- r_associated #0: 10 --> ipilimumab
    n1=ivabradine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5890. ivacaftor --- r_associated #0: 10 --> ipilimumab
    n1=ivacaftor | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5891. ixazomib --- r_associated #0: 10 --> ipilimumab
    n1=ixazomib | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5892. kétoconazole --- r_associated #0: 10 --> ipilimumab
    n1=kétoconazole | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5893. kétoprofène --- r_associated #0: 10 --> ipilimumab
    n1=kétoprofène | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5894. kétorolac --- r_associated #0: 10 --> ipilimumab
    n1=kétorolac | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5895. la recherche contre le cancer --- r_associated #0: 10 --> ipilimumab
    n1=la recherche contre le cancer | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5896. la recherche sur le cancer --- r_associated #0: 10 --> ipilimumab
    n1=la recherche sur le cancer | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5897. lacosamide --- r_associated #0: 10 --> ipilimumab
    n1=lacosamide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5898. lamotrigine --- r_associated #0: 10 --> ipilimumab
    n1=lamotrigine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5899. letermovir --- r_associated #0: 10 --> ipilimumab
    n1=letermovir | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5900. lidocaïne --- r_associated #0: 10 --> ipilimumab
    n1=lidocaïne | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5901. limonène --- r_associated #0: 10 --> ipilimumab
    n1=limonène | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5902. liothyronine --- r_associated #0: 10 --> ipilimumab
    n1=liothyronine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5903. lipide --- r_associated #0: 10 --> ipilimumab
    n1=lipide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5904. lipopolysaccharide --- r_associated #0: 10 --> ipilimumab
    n1=lipopolysaccharide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5905. lisinopril --- r_associated #0: 10 --> ipilimumab
    n1=lisinopril | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5906. lomustine --- r_associated #0: 10 --> ipilimumab
    n1=lomustine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5907. lonafarnib --- r_associated #0: 10 --> ipilimumab
    n1=lonafarnib | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5908. lopinavir --- r_associated #0: 10 --> ipilimumab
    n1=lopinavir | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5909. loratadine --- r_associated #0: 10 --> ipilimumab
    n1=loratadine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5910. lorazépam --- r_associated #0: 10 --> ipilimumab
    n1=lorazépam | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5911. lovastatine --- r_associated #0: 10 --> ipilimumab
    n1=lovastatine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5912. lubiprostone --- r_associated #0: 10 --> ipilimumab
    n1=lubiprostone | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5913. lucanthone --- r_associated #0: 10 --> ipilimumab
    n1=lucanthone | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5914. lurasidone --- r_associated #0: 10 --> ipilimumab
    n1=lurasidone | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5915. lymphocyte thymo-dépendant --- r_associated #0: 10 --> ipilimumab
    n1=lymphocyte thymo-dépendant | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5916. lépirudine --- r_associated #0: 10 --> ipilimumab
    n1=lépirudine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5917. lévodopa --- r_associated #0: 10 --> ipilimumab
    n1=lévodopa | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5918. lévofloxacine --- r_associated #0: 10 --> ipilimumab
    n1=lévofloxacine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5919. lévonorgestrel --- r_associated #0: 10 --> ipilimumab
    n1=lévonorgestrel | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5920. macitentan --- r_associated #0: 10 --> ipilimumab
    n1=macitentan | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5921. maltose --- r_associated #0: 10 --> ipilimumab
    n1=maltose | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5922. mannitol --- r_associated #0: 10 --> ipilimumab
    n1=mannitol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5923. maraviroc --- r_associated #0: 10 --> ipilimumab
    n1=maraviroc | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5924. marie-jeanne --- r_associated #0: 10 --> ipilimumab
    n1=marie-jeanne | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5925. medroxyprogesterone --- r_associated #0: 10 --> ipilimumab
    n1=medroxyprogesterone | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5926. melphalan --- r_associated #0: 10 --> ipilimumab
    n1=melphalan | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5927. mercaptopurine --- r_associated #0: 10 --> ipilimumab
    n1=mercaptopurine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5928. mesna --- r_associated #0: 10 --> ipilimumab
    n1=mesna | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5929. mezlocilline --- r_associated #0: 10 --> ipilimumab
    n1=mezlocilline | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5930. mifépristone --- r_associated #0: 10 --> ipilimumab
    n1=mifépristone | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5931. miglitol --- r_associated #0: 10 --> ipilimumab
    n1=miglitol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5932. mirtazapine --- r_associated #0: 10 --> ipilimumab
    n1=mirtazapine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5933. misoprostol --- r_associated #0: 10 --> ipilimumab
    n1=misoprostol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5934. mitoguazone --- r_associated #0: 10 --> ipilimumab
    n1=mitoguazone | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5935. mitoguazones --- r_associated #0: 10 --> ipilimumab
    n1=mitoguazones | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5936. mitotane --- r_associated #0: 10 --> ipilimumab
    n1=mitotane | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5937. mitoxantrone --- r_associated #0: 10 --> ipilimumab
    n1=mitoxantrone | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5938. mébendazole --- r_associated #0: 10 --> ipilimumab
    n1=mébendazole | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5939. médicaments de contrefaçon --- r_associated #0: 10 --> ipilimumab
    n1=médicaments de contrefaçon | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5940. médicaments vétérinaires --- r_associated #0: 10 --> ipilimumab
    n1=médicaments vétérinaires | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5941. méfloquine --- r_associated #0: 10 --> ipilimumab
    n1=méfloquine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5942. mélanisation (unité épidermique de) --- r_associated #0: 10 --> ipilimumab
    n1=mélanisation (unité épidermique de) | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5943. méropénem --- r_associated #0: 10 --> ipilimumab
    n1=méropénem | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5944. mésalamine --- r_associated #0: 10 --> ipilimumab
    n1=mésalamine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5945. méthotrexate --- r_associated #0: 10 --> ipilimumab
    n1=méthotrexate | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5946. méthoxsalène --- r_associated #0: 10 --> ipilimumab
    n1=méthoxsalène | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5947. méthoxyflurane --- r_associated #0: 10 --> ipilimumab
    n1=méthoxyflurane | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5948. méthylcellulose --- r_associated #0: 10 --> ipilimumab
    n1=méthylcellulose | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5949. métoprolol --- r_associated #0: 10 --> ipilimumab
    n1=métoprolol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5950. nabilone --- r_associated #0: 10 --> ipilimumab
    n1=nabilone | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5951. nabiximols --- r_associated #0: 10 --> ipilimumab
    n1=nabiximols | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5952. nadolol --- r_associated #0: 10 --> ipilimumab
    n1=nadolol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5953. naproxène --- r_associated #0: 10 --> ipilimumab
    n1=naproxène | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5954. natalizumab --- r_associated #0: 10 --> ipilimumab
    n1=natalizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5955. niacinamide --- r_associated #0: 10 --> ipilimumab
    n1=niacinamide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5956. nicardipine --- r_associated #0: 10 --> ipilimumab
    n1=nicardipine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5957. niclosamide --- r_associated #0: 10 --> ipilimumab
    n1=niclosamide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5958. nifurtimox --- r_associated #0: 10 --> ipilimumab
    n1=nifurtimox | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5959. nimodipine --- r_associated #0: 10 --> ipilimumab
    n1=nimodipine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5960. nitroglycérine --- r_associated #0: 10 --> ipilimumab
    n1=nitroglycérine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5961. nivolumab --- r_associated #0: 10 --> ipilimumab
    n1=nivolumab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5962. novobiocine --- r_associated #0: 10 --> ipilimumab
    n1=novobiocine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5963. nystatine --- r_associated #0: 10 --> ipilimumab
    n1=nystatine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5964. néomycine --- r_associated #0: 10 --> ipilimumab
    n1=néomycine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5965. névirapine --- r_associated #0: 10 --> ipilimumab
    n1=névirapine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5966. ocrelizumab --- r_associated #0: 10 --> ipilimumab
    n1=ocrelizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5967. ofatumumab --- r_associated #0: 10 --> ipilimumab
    n1=ofatumumab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5968. ofloxacine --- r_associated #0: 10 --> ipilimumab
    n1=ofloxacine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5969. olaparib --- r_associated #0: 10 --> ipilimumab
    n1=olaparib | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5970. olaratumab --- r_associated #0: 10 --> ipilimumab
    n1=olaratumab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5971. oligonucléotide antisens du récepteur des androgènes AZD5312 --- r_associated #0: 10 --> ipilimumab
    n1=oligonucléotide antisens du récepteur des androgènes AZD5312 | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5972. oligonucléotide antisens du récepteur des androgènes EZN-4176 --- r_associated #0: 10 --> ipilimumab
    n1=oligonucléotide antisens du récepteur des androgènes EZN-4176 | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5973. oléandrine --- r_associated #0: 10 --> ipilimumab
    n1=oléandrine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5974. omalizumab --- r_associated #0: 10 --> ipilimumab
    n1=omalizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5975. oméprazole --- r_associated #0: 10 --> ipilimumab
    n1=oméprazole | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5976. ondansétron --- r_associated #0: 10 --> ipilimumab
    n1=ondansétron | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5977. oxacilline sodique --- r_associated #0: 10 --> ipilimumab
    n1=oxacilline sodique | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5978. oxitriptan --- r_associated #0: 10 --> ipilimumab
    n1=oxitriptan | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5979. oxymétholone --- r_associated #0: 10 --> ipilimumab
    n1=oxymétholone | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5980. palbociclib --- r_associated #0: 10 --> ipilimumab
    n1=palbociclib | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5981. papavérine --- r_associated #0: 10 --> ipilimumab
    n1=papavérine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5982. pegvisomant --- r_associated #0: 10 --> ipilimumab
    n1=pegvisomant | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5983. pembrolizumab --- r_associated #0: 10 --> ipilimumab
    n1=pembrolizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5984. pentamidine --- r_associated #0: 10 --> ipilimumab
    n1=pentamidine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5985. pentoxifylline --- r_associated #0: 10 --> ipilimumab
    n1=pentoxifylline | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5986. peptides hydrolases --- r_associated #0: 10 --> ipilimumab
    n1=peptides hydrolases | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5987. pertuzumab --- r_associated #0: 10 --> ipilimumab
    n1=pertuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5988. phytonadione --- r_associated #0: 10 --> ipilimumab
    n1=phytonadione | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5989. phénobarbital --- r_associated #0: 10 --> ipilimumab
    n1=phénobarbital | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5990. phénprocoumone --- r_associated #0: 10 --> ipilimumab
    n1=phénprocoumone | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5991. pimecrolimus --- r_associated #0: 10 --> ipilimumab
    n1=pimecrolimus | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5992. piroxicam --- r_associated #0: 10 --> ipilimumab
    n1=piroxicam | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5993. plicamycine --- r_associated #0: 10 --> ipilimumab
    n1=plicamycine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5994. polydextrose --- r_associated #0: 10 --> ipilimumab
    n1=polydextrose | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5995. polyéthylène glycol --- r_associated #0: 10 --> ipilimumab
    n1=polyéthylène glycol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5996. posaconazole --- r_associated #0: 10 --> ipilimumab
    n1=posaconazole | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5997. prednisolone --- r_associated #0: 10 --> ipilimumab
    n1=prednisolone | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5998. prednisone --- r_associated #0: 10 --> ipilimumab
    n1=prednisone | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  5999. probénécide --- r_associated #0: 10 --> ipilimumab
    n1=probénécide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6000. procarbazine --- r_associated #0: 10 --> ipilimumab
    n1=procarbazine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6001. prochlorpérazine --- r_associated #0: 10 --> ipilimumab
    n1=prochlorpérazine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6002. proflavine --- r_associated #0: 10 --> ipilimumab
    n1=proflavine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6003. progestine --- r_associated #0: 10 --> ipilimumab
    n1=progestine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6004. protéine de fusion Fc du récepteur de type 2B de l'activine STM 434 --- r_associated #0: 10 --> ipilimumab
    n1=protéine de fusion Fc du récepteur de type 2B de l'activine STM 434 | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6005. préparation à usage auriculaire --- r_associated #0: 10 --> ipilimumab
    n1=préparation à usage auriculaire | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6006. psilocybine --- r_associated #0: 10 --> ipilimumab
    n1=psilocybine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6007. psoralène --- r_associated #0: 10 --> ipilimumab
    n1=psoralène | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6008. pyrazinamide --- r_associated #0: 10 --> ipilimumab
    n1=pyrazinamide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6009. péfloxacine --- r_associated #0: 10 --> ipilimumab
    n1=péfloxacine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6010. pénicillamine --- r_associated #0: 10 --> ipilimumab
    n1=pénicillamine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6011. péthidine --- r_associated #0: 10 --> ipilimumab
    n1=péthidine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6012. péthidines --- r_associated #0: 10 --> ipilimumab
    n1=péthidines | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6013. quinidine --- r_associated #0: 10 --> ipilimumab
    n1=quinidine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6014. quinine --- r_associated #0: 10 --> ipilimumab
    n1=quinine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6015. ramipril --- r_associated #0: 10 --> ipilimumab
    n1=ramipril | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6016. ramucirumab --- r_associated #0: 10 --> ipilimumab
    n1=ramucirumab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6017. ranibizumab --- r_associated #0: 10 --> ipilimumab
    n1=ranibizumab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6018. ranolazine --- r_associated #0: 10 --> ipilimumab
    n1=ranolazine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6019. ranpirnase --- r_associated #0: 10 --> ipilimumab
    n1=ranpirnase | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6020. rasburicase --- r_associated #0: 10 --> ipilimumab
    n1=rasburicase | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6021. recherche contre le cancer --- r_associated #0: 10 --> ipilimumab
    n1=recherche contre le cancer | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6022. recherche sur le cancer --- r_associated #0: 10 --> ipilimumab
    n1=recherche sur le cancer | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6023. resvératrol --- r_associated #0: 10 --> ipilimumab
    n1=resvératrol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6024. riboflavin --- r_associated #0: 10 --> ipilimumab
    n1=riboflavin | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6025. rifabutine --- r_associated #0: 10 --> ipilimumab
    n1=rifabutine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6026. riluzole --- r_associated #0: 10 --> ipilimumab
    n1=riluzole | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6027. ritonavir --- r_associated #0: 10 --> ipilimumab
    n1=ritonavir | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6028. rivaroxaban --- r_associated #0: 10 --> ipilimumab
    n1=rivaroxaban | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6029. roflumilast --- r_associated #0: 10 --> ipilimumab
    n1=roflumilast | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6030. romiplostim --- r_associated #0: 10 --> ipilimumab
    n1=romiplostim | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6031. rotigotine --- r_associated #0: 10 --> ipilimumab
    n1=rotigotine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6032. rutine --- r_associated #0: 10 --> ipilimumab
    n1=rutine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6033. ruxolitinib --- r_associated #0: 10 --> ipilimumab
    n1=ruxolitinib | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6034. secukinumab --- r_associated #0: 10 --> ipilimumab
    n1=secukinumab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6035. sel d'Epsom --- r_associated #0: 10 --> ipilimumab
    n1=sel d'Epsom | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6036. selumetinib --- r_associated #0: 10 --> ipilimumab
    n1=selumetinib | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6037. service des renseignements --- r_associated #0: 10 --> ipilimumab
    n1=service des renseignements | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6038. siltuximab --- r_associated #0: 10 --> ipilimumab
    n1=siltuximab | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6039. simvastatine --- r_associated #0: 10 --> ipilimumab
    n1=simvastatine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6040. sirolimus --- r_associated #0: 10 --> ipilimumab
    n1=sirolimus | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6041. sofosbuvir --- r_associated #0: 10 --> ipilimumab
    n1=sofosbuvir | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6042. solidage --- r_associated #0: 10 --> ipilimumab
    n1=solidage | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6043. somatotrophine --- r_associated #0: 10 --> ipilimumab
    n1=somatotrophine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6044. somatropine --- r_associated #0: 10 --> ipilimumab
    n1=somatropine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6045. spironolactone --- r_associated #0: 10 --> ipilimumab
    n1=spironolactone | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6046. stavudine --- r_associated #0: 10 --> ipilimumab
    n1=stavudine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6047. sucralfate --- r_associated #0: 10 --> ipilimumab
    n1=sucralfate | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6048. sulfasalazine --- r_associated #0: 10 --> ipilimumab
    n1=sulfasalazine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6049. sulindac --- r_associated #0: 10 --> ipilimumab
    n1=sulindac | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6050. suramine --- r_associated #0: 10 --> ipilimumab
    n1=suramine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6051. sémustine --- r_associated #0: 10 --> ipilimumab
    n1=sémustine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6052. tacrolimus --- r_associated #0: 10 --> ipilimumab
    n1=tacrolimus | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6053. tadalafil --- r_associated #0: 10 --> ipilimumab
    n1=tadalafil | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6054. teicoplanine --- r_associated #0: 10 --> ipilimumab
    n1=teicoplanine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6055. thiabendazole --- r_associated #0: 10 --> ipilimumab
    n1=thiabendazole | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6056. thioguanine --- r_associated #0: 10 --> ipilimumab
    n1=thioguanine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6057. thymidine --- r_associated #0: 10 --> ipilimumab
    n1=thymidine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6058. thyroxine --- r_associated #0: 10 --> ipilimumab
    n1=thyroxine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6059. thé noir --- r_associated #0: 10 --> ipilimumab
    n1=thé noir | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6060. théophylline --- r_associated #0: 10 --> ipilimumab
    n1=théophylline | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6061. ticarcilline --- r_associated #0: 10 --> ipilimumab
    n1=ticarcilline | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6062. tinidazole --- r_associated #0: 10 --> ipilimumab
    n1=tinidazole | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6063. tocotriénol --- r_associated #0: 10 --> ipilimumab
    n1=tocotriénol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6064. triamcinolone --- r_associated #0: 10 --> ipilimumab
    n1=triamcinolone | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6065. triméthoprime --- r_associated #0: 10 --> ipilimumab
    n1=triméthoprime | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6066. trinitrate de glycérol --- r_associated #0: 10 --> ipilimumab
    n1=trinitrate de glycérol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6067. trinitrine --- r_associated #0: 10 --> ipilimumab
    n1=trinitrine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6068. trétinoïne --- r_associated #0: 10 --> ipilimumab
    n1=trétinoïne | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6069. tégafur --- r_associated #0: 10 --> ipilimumab
    n1=tégafur | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6070. téniposide --- r_associated #0: 10 --> ipilimumab
    n1=téniposide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6071. tératogène --- r_associated #0: 10 --> ipilimumab
    n1=tératogène | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6072. tétrahydro-uridine --- r_associated #0: 10 --> ipilimumab
    n1=tétrahydro-uridine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6073. tétrahydrouridine --- r_associated #0: 10 --> ipilimumab
    n1=tétrahydrouridine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6074. tétrodotoxine --- r_associated #0: 10 --> ipilimumab
    n1=tétrodotoxine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6075. valériane --- r_associated #0: 10 --> ipilimumab
    n1=valériane | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6076. vancomycine --- r_associated #0: 10 --> ipilimumab
    n1=vancomycine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6077. verge d'or --- r_associated #0: 10 --> ipilimumab
    n1=verge d'or | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6078. vidarabine --- r_associated #0: 10 --> ipilimumab
    n1=vidarabine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6079. vigabatrin --- r_associated #0: 10 --> ipilimumab
    n1=vigabatrin | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6080. vigabatrine --- r_associated #0: 10 --> ipilimumab
    n1=vigabatrine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6081. vin blanc --- r_associated #0: 10 --> ipilimumab
    n1=vin blanc | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6082. vinblastine --- r_associated #0: 10 --> ipilimumab
    n1=vinblastine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6083. vincristine --- r_associated #0: 10 --> ipilimumab
    n1=vincristine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6084. vindésine --- r_associated #0: 10 --> ipilimumab
    n1=vindésine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6085. vitamine D3 --- r_associated #0: 10 --> ipilimumab
    n1=vitamine D3 | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6086. vitamine K1 --- r_associated #0: 10 --> ipilimumab
    n1=vitamine K1 | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6087. voriconazole --- r_associated #0: 10 --> ipilimumab
    n1=voriconazole | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6088. vérapamil --- r_associated #0: 10 --> ipilimumab
    n1=vérapamil | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6089. warfarine --- r_associated #0: 10 --> ipilimumab
    n1=warfarine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6090. zalcitabine --- r_associated #0: 10 --> ipilimumab
    n1=zalcitabine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6091. zanamivir --- r_associated #0: 10 --> ipilimumab
    n1=zanamivir | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6092. zolmitriptan --- r_associated #0: 10 --> ipilimumab
    n1=zolmitriptan | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6093. échinomycine --- r_associated #0: 10 --> ipilimumab
    n1=échinomycine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6094. éflornithine --- r_associated #0: 10 --> ipilimumab
    n1=éflornithine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6095. éponge de gélatine résorbable --- r_associated #0: 10 --> ipilimumab
    n1=éponge de gélatine résorbable | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6096. érythromycine --- r_associated #0: 10 --> ipilimumab
    n1=érythromycine | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6097. éthambutol --- r_associated #0: 10 --> ipilimumab
    n1=éthambutol | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6098. étoposide --- r_associated #0: 10 --> ipilimumab
    n1=étoposide | n2=ipilimumab | rel=r_associated | relid=0 | w=10
  6099. Albumine --- r_associated #0: 5 --> ipilimumab
    n1=Albumine | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6100. Céphalexine --- r_associated #0: 5 --> ipilimumab
    n1=Céphalexine | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6101. L-dopa --- r_associated #0: 5 --> ipilimumab
    n1=L-dopa | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6102. Marihuana --- r_associated #0: 5 --> ipilimumab
    n1=Marihuana | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6103. Mary Jane --- r_associated #0: 5 --> ipilimumab
    n1=Mary Jane | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6104. acide hyaluronique --- r_associated #0: 5 --> ipilimumab
    n1=acide hyaluronique | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6105. adjuvant de Freund --- r_associated #0: 5 --> ipilimumab
    n1=adjuvant de Freund | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6106. agent biologique --- r_associated #0: 5 --> ipilimumab
    n1=agent biologique | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6107. allopurinol --- r_associated #0: 5 --> ipilimumab
    n1=allopurinol | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6108. alloxane --- r_associated #0: 5 --> ipilimumab
    n1=alloxane | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6109. alprazolam --- r_associated #0: 5 --> ipilimumab
    n1=alprazolam | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6110. anti-corps --- r_associated #0: 5 --> ipilimumab
    n1=anti-corps | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6111. antihistamines --- r_associated #0: 5 --> ipilimumab
    n1=antihistamines | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6112. benznidazole --- r_associated #0: 5 --> ipilimumab
    n1=benznidazole | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6113. bio-adhésivité --- r_associated #0: 5 --> ipilimumab
    n1=bio-adhésivité | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6114. bioaccumulation --- r_associated #0: 5 --> ipilimumab
    n1=bioaccumulation | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6115. bioamplification --- r_associated #0: 5 --> ipilimumab
    n1=bioamplification | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6116. biocatalyseur --- r_associated #0: 5 --> ipilimumab
    n1=biocatalyseur | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6117. biocénose --- r_associated #0: 5 --> ipilimumab
    n1=biocénose | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6118. cellule T --- r_associated #0: 5 --> ipilimumab
    n1=cellule T | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6119. cellules dendritiques myéloïdes chargées de peptides tumoraux --- r_associated #0: 5 --> ipilimumab
    n1=cellules dendritiques myéloïdes chargées de peptides tumoraux | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6120. cellules lymphocytaires T allogéniques exprimant CD19CAR-CD3zeta-4-1BB --- r_associated #0: 5 --> ipilimumab
    n1=cellules lymphocytaires T allogéniques exprimant CD19CAR-CD3zeta-4-1BB | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6121. cellules lymphocytaires T autologues exprimant CAR-CD3zeta-4-1BB anti-CD20 --- r_associated #0: 5 --> ipilimumab
    n1=cellules lymphocytaires T autologues exprimant CAR-CD3zeta-4-1BB anti-CD20 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6122. chlorhydrate de clonidine --- r_associated #0: 5 --> ipilimumab
    n1=chlorhydrate de clonidine | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6123. chlorhydrate de lopéramide --- r_associated #0: 5 --> ipilimumab
    n1=chlorhydrate de lopéramide | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6124. chlorhydrate de midazolam --- r_associated #0: 5 --> ipilimumab
    n1=chlorhydrate de midazolam | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6125. chlorhydrate de métronidazole --- r_associated #0: 5 --> ipilimumab
    n1=chlorhydrate de métronidazole | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6126. chlorhydrate de péthidine --- r_associated #0: 5 --> ipilimumab
    n1=chlorhydrate de péthidine | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6127. citrate de clomifène --- r_associated #0: 5 --> ipilimumab
    n1=citrate de clomifène | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6128. citrate de clomiphène --- r_associated #0: 5 --> ipilimumab
    n1=citrate de clomiphène | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6129. citrulline --- r_associated #0: 5 --> ipilimumab
    n1=citrulline | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6130. cladribine --- r_associated #0: 5 --> ipilimumab
    n1=cladribine | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6131. colchicine --- r_associated #0: 5 --> ipilimumab
    n1=colchicine | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6132. corticostimuline --- r_associated #0: 5 --> ipilimumab
    n1=corticostimuline | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6133. crizotinib --- r_associated #0: 5 --> ipilimumab
    n1=crizotinib | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6134. cyanure de mercure --- r_associated #0: 5 --> ipilimumab
    n1=cyanure de mercure | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6135. dimethyl fumarate --- r_associated #0: 5 --> ipilimumab
    n1=dimethyl fumarate | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6136. dipyridamole --- r_associated #0: 5 --> ipilimumab
    n1=dipyridamole | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6137. diéthylstilbestrol --- r_associated #0: 5 --> ipilimumab
    n1=diéthylstilbestrol | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6138. docetaxel --- r_associated #0: 5 --> ipilimumab
    n1=docetaxel | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6139. efavirenz --- r_associated #0: 5 --> ipilimumab
    n1=efavirenz | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6140. en:Artemisia vulgaris --- r_associated #0: 5 --> ipilimumab
    n1=en:Artemisia vulgaris | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6141. en:antibacterial agent --- r_associated #0: 5 --> ipilimumab
    n1=en:antibacterial agent | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6142. en:antibody --- r_associated #0: 5 --> ipilimumab
    n1=en:antibody | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6143. en:sarcolysin --- r_associated #0: 5 --> ipilimumab
    n1=en:sarcolysin | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6144. en:t-lymphocyte --- r_associated #0: 5 --> ipilimumab
    n1=en:t-lymphocyte | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6145. ergoline --- r_associated #0: 5 --> ipilimumab
    n1=ergoline | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6146. facteur d'apoptose des cellules tumorales hormone-peptide --- r_associated #0: 5 --> ipilimumab
    n1=facteur d'apoptose des cellules tumorales hormone-peptide | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6147. famitinib --- r_associated #0: 5 --> ipilimumab
    n1=famitinib | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6148. ficlatuzumab --- r_associated #0: 5 --> ipilimumab
    n1=ficlatuzumab | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6149. finastéride --- r_associated #0: 5 --> ipilimumab
    n1=finastéride | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6150. globuline antithymocyte --- r_associated #0: 5 --> ipilimumab
    n1=globuline antithymocyte | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6151. génistéine --- r_associated #0: 5 --> ipilimumab
    n1=génistéine | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6152. hormones antinéoplasiques --- r_associated #0: 5 --> ipilimumab
    n1=hormones antinéoplasiques | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6153. ibuprofène --- r_associated #0: 5 --> ipilimumab
    n1=ibuprofène | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6154. inhibiteur de l'aromatase --- r_associated #0: 5 --> ipilimumab
    n1=inhibiteur de l'aromatase | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6155. inhibiteur de transduction du signal --- r_associated #0: 5 --> ipilimumab
    n1=inhibiteur de transduction du signal | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6156. insuline ordinaire --- r_associated #0: 5 --> ipilimumab
    n1=insuline ordinaire | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6157. liraglutide --- r_associated #0: 5 --> ipilimumab
    n1=liraglutide | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6158. losartan de potassium --- r_associated #0: 5 --> ipilimumab
    n1=losartan de potassium | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6159. losartan potassique --- r_associated #0: 5 --> ipilimumab
    n1=losartan potassique | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6160. lymphocyte T cytotoxique spécifique de l'EBV --- r_associated #0: 5 --> ipilimumab
    n1=lymphocyte T cytotoxique spécifique de l'EBV | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6161. lymphocytes CD8+ réactifs au MART-1 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes CD8+ réactifs au MART-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6162. lymphocytes T CD4-positifs autologues exprimant le CAR T1E28Z --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T CD4-positifs autologues exprimant le CAR T1E28Z | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6163. lymphocytes T CD4-positifs spécifiques de NY-ESO-1 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T CD4-positifs spécifiques de NY-ESO-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6164. lymphocytes T CD8+ autologues spécifiques du mélanome NY-ESO-1 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T CD8+ autologues spécifiques du mélanome NY-ESO-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6165. lymphocytes T TBI-1301 transduits avec le gène TCR spécifique de NY-ESO-1 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T TBI-1301 transduits avec le gène TCR spécifique de NY-ESO-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6166. lymphocytes T allogéniques BPX-501 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T allogéniques BPX-501 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6167. lymphocytes T allogéniques exprimant CD19CAR-CD28zeta-4-1BB --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T allogéniques exprimant CD19CAR-CD28zeta-4-1BB | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6168. lymphocytes T allogéniques transduits par CAR anti-EGFRvIII --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T allogéniques transduits par CAR anti-EGFRvIII | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6169. lymphocytes T allogéniques transduits par un vecteur CAR anti-CD133 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T allogéniques transduits par un vecteur CAR anti-CD133 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6170. lymphocytes T allogéniques transduits par un vecteur rétroviral CAR anti-CD19 FMC63-28z --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T allogéniques transduits par un vecteur rétroviral CAR anti-CD19 FMC63-28z | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6171. lymphocytes T autologues CAR anti-CEA --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues CAR anti-CEA | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6172. lymphocytes T autologues CAR anti-GPC3 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues CAR anti-GPC3 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6173. lymphocytes T autologues anti-CEA MFE23 exprimant le scFv MFE23 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues anti-CEA MFE23 exprimant le scFv MFE23 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6174. lymphocytes T autologues avec knockout de PDCD-1 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues avec knockout de PDCD-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6175. lymphocytes T autologues dérivés de CD62L+ transduits par TCR anti-NY-ESO1 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues dérivés de CD62L+ transduits par TCR anti-NY-ESO1 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6176. lymphocytes T autologues exprimant CAR anti-CD19 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues exprimant CAR anti-CD19 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6177. lymphocytes T autologues exprimant CAR spécifique de CD171-CD28 zeta-4-1-BB-EGFRt --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues exprimant CAR spécifique de CD171-CD28 zeta-4-1-BB-EGFRt | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6178. lymphocytes T autologues exprimant CAR-CD3zeta-4-1BB ciblant l'EGFR --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues exprimant CAR-CD3zeta-4-1BB ciblant l'EGFR | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6179. lymphocytes T autologues exprimant CD123CAR-CD28-CD3zeta-EGFRt --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues exprimant CD123CAR-CD28-CD3zeta-EGFRt | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6180. lymphocytes T autologues exprimant CD19CAR-CD3zeta --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues exprimant CD19CAR-CD3zeta | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6181. lymphocytes T autologues exprimant CD19CAR-CD3zeta-4-1BB --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues exprimant CD19CAR-CD3zeta-4-1BB | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6182. lymphocytes T autologues exprimant CD19CAR-CD3zeta-4-1BB électroporés avec de l'ARN --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues exprimant CD19CAR-CD3zeta-4-1BB électroporés avec de l'ARN | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6183. lymphocytes T autologues exprimant CD19CAR-CD3zeta-4-1BB-CD28 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues exprimant CD19CAR-CD3zeta-4-1BB-CD28 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6184. lymphocytes T autologues exprimant CD33CAR-CD3zeta-4-1BB --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues exprimant CD33CAR-CD3zeta-4-1BB | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6185. lymphocytes T autologues exprimant anti-CD19CAR-4-1BB-CD3zeta-EGFRt --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues exprimant anti-CD19CAR-4-1BB-CD3zeta-EGFRt | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6186. lymphocytes T autologues exprimant des récepteurs de cellules T améliorés spécifiques à NY-ESO-1-C259 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues exprimant des récepteurs de cellules T améliorés spécifiques à NY-ESO-1-C259 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6187. lymphocytes T autologues exprimant le récepteur d'antigène chimérique CD19-28z --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues exprimant le récepteur d'antigène chimérique CD19-28z | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6188. lymphocytes T autologues exprimant un CAR CD30 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues exprimant un CAR CD30 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6189. lymphocytes T autologues exprimant un CAR ciblant GD2 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues exprimant un CAR ciblant GD2 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6190. lymphocytes T autologues exprimant un CAR optimisé pour la charnière, co-stimulateur 41BB, spécifique de l'IL13Ralpha2 et un CD19 tronqué --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues exprimant un CAR optimisé pour la charnière, co-stimulateur 41BB, spécifique de l'IL13Ralpha2 et un CD19 tronqué | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6191. lymphocytes T autologues exprimant un CAR spécifique de l'EpCAM --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues exprimant un CAR spécifique de l'EpCAM | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6192. lymphocytes T autologues génétiquement modifiés anti-PSMA --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues génétiquement modifiés anti-PSMA | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6193. lymphocytes T autologues redirigés par TCR spécifique du VHB --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues redirigés par TCR spécifique du VHB | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6194. lymphocytes T autologues spécifiques du CAR ROR1 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues spécifiques du CAR ROR1 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6195. lymphocytes T autologues spécifiques du VZV exprimant iC9-GD2-CAR --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues spécifiques du VZV exprimant iC9-GD2-CAR | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6196. lymphocytes T autologues transduits avec CAR spécifique de l'EGFRvIII --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues transduits avec CAR spécifique de l'EGFRvIII | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6197. lymphocytes T autologues transduits avec NGFR --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues transduits avec NGFR | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6198. lymphocytes T autologues transduits par CAR anti-MUC1 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues transduits par CAR anti-MUC1 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6199. lymphocytes T autologues transduits par CAR iCasp9M28z anti-mésothéline --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues transduits par CAR iCasp9M28z anti-mésothéline | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6200. lymphocytes T autologues transduits par un vecteur CAR anti-mésothéline --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues transduits par un vecteur CAR anti-mésothéline | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6201. lymphocytes T autologues transduits par un vecteur lentiviral CAR anti-CD22 M971-BBZ --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues transduits par un vecteur lentiviral CAR anti-CD22 M971-BBZ | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6202. lymphocytes T autologues transduits par vecteur rétroviral CAR anti-VEGFR2 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues transduits par vecteur rétroviral CAR anti-VEGFR2 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6203. lymphocytes T autologues électroporés avec ARNm CAR-cMET --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T autologues électroporés avec ARNm CAR-cMET | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6204. lymphocytes T cytotoxiques allogéniques thérapeutiques --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T cytotoxiques allogéniques thérapeutiques | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6205. lymphocytes T cytotoxiques autologues cultivés spécifiques de la leucémie myéloïde aiguë --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T cytotoxiques autologues cultivés spécifiques de la leucémie myéloïde aiguë | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6206. lymphocytes T cytotoxiques autologues induits par des cellules dendritiques pulsées avec le peptide MUC1 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T cytotoxiques autologues induits par des cellules dendritiques pulsées avec le peptide MUC1 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6207. lymphocytes T cytotoxiques autologues induits par des cellules dendritiques transfectées avec le gène MUC1 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T cytotoxiques autologues induits par des cellules dendritiques transfectées avec le gène MUC1 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6208. lymphocytes T cytotoxiques autologues spécifiques de CEA --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T cytotoxiques autologues spécifiques de CEA | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6209. lymphocytes T cytotoxiques autologues spécifiques du CMV CAR anti-HER2 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T cytotoxiques autologues spécifiques du CMV CAR anti-HER2 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6210. lymphocytes T cytotoxiques spécifiques de LMP résistants au TGF-beta --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T cytotoxiques spécifiques de LMP résistants au TGF-beta | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6211. lymphocytes T cytotoxiques spécifiques de LMP2A --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T cytotoxiques spécifiques de LMP2A | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6212. lymphocytes T cytotoxiques spécifiques de l'IE-1 du cytomégalovirus --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T cytotoxiques spécifiques de l'IE-1 du cytomégalovirus | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6213. lymphocytes T cytotoxiques spécifiques de la pp65 du cytomégalovirus --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T cytotoxiques spécifiques de la pp65 du cytomégalovirus | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6214. lymphocytes T cytotoxiques spécifiques du carcinome nasopharyngé exprimant DNR --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T cytotoxiques spécifiques du carcinome nasopharyngé exprimant DNR | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6215. lymphocytes T exprimant IC9-GD2-CD28-OX40 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T exprimant IC9-GD2-CD28-OX40 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6216. lymphocytes T exprimant le CAR anti-CD22 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T exprimant le CAR anti-CD22 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6217. lymphocytes T exprimant un CAR spécifique au BCMA --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T exprimant un CAR spécifique au BCMA | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6218. lymphocytes T gamma delta thérapeutiques --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T gamma delta thérapeutiques | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6219. lymphocytes T génétiquement modifiés spécifiques de NY-ESO-1 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T génétiquement modifiés spécifiques de NY-ESO-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6220. lymphocytes T régulateurs du donneur --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T régulateurs du donneur | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6221. lymphocytes T tueurs pluripotents exprimant l'anticorps anti-protéine 1 de mort cellulaire programmée --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T tueurs pluripotents exprimant l'anticorps anti-protéine 1 de mort cellulaire programmée | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6222. lymphocytes T tueurs pluripotents exprimant l'anticorps anti-récepteur 2 du facteur de croissance épidermique --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T tueurs pluripotents exprimant l'anticorps anti-récepteur 2 du facteur de croissance épidermique | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6223. lymphocytes T à antigènes multiples de précision des cellules dendritiques --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes T à antigènes multiples de précision des cellules dendritiques | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6224. lymphocytes allogéniques thérapeutiques --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes allogéniques thérapeutiques | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6225. lymphocytes autologues CD34-positifs transduits par vecteur lentiviral EFS-ADA --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes autologues CD34-positifs transduits par vecteur lentiviral EFS-ADA | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6226. lymphocytes autologues des ganglions lymphatiques activés ex vivo --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes autologues des ganglions lymphatiques activés ex vivo | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6227. lymphocytes autologues du sang périphérique transduits par MTCR anti-thyroglobuline --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes autologues du sang périphérique transduits par MTCR anti-thyroglobuline | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6228. lymphocytes autologues thérapeutiques --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes autologues thérapeutiques | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6229. lymphocytes du donneur --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes du donneur | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6230. lymphocytes du donneur transduits avec HSV-TK --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes du donneur transduits avec HSV-TK | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6231. lymphocytes du sang périphérique autologues co-transduits avec des vecteurs rétroviraux codant pour l'IL-12 inductible et le TCR anti-NY-ESO-1 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes du sang périphérique autologues co-transduits avec des vecteurs rétroviraux codant pour l'IL-12 inductible et le TCR anti-NY-ESO-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6232. lymphocytes du sang périphérique autologues génétiquement modifiés avec le récepteur des cellules T F5 anti-MART-1 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes du sang périphérique autologues génétiquement modifiés avec le récepteur des cellules T F5 anti-MART-1 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6233. lymphocytes du sang périphérique autologues transduits par un vecteur rétroviral CAR anti-HER-2 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes du sang périphérique autologues transduits par un vecteur rétroviral CAR anti-HER-2 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6234. lymphocytes du sang périphérique autologues transduits par un vecteur rétroviral TCR anti-CEA --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes du sang périphérique autologues transduits par un vecteur rétroviral TCR anti-CEA | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6235. lymphocytes du sang périphérique modifiés avec un récepteur d'antigène chimérique spécifique à la mésothéline --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes du sang périphérique modifiés avec un récepteur d'antigène chimérique spécifique à la mésothéline | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6236. lymphocytes du sang périphérique transduits par récepteur des cellules T anti-p53 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes du sang périphérique transduits par récepteur des cellules T anti-p53 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6237. lymphocytes infiltrant la moelle activés --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes infiltrant la moelle activés | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6238. lymphocytes t autologues tbi-1201 transduits avec le gène tcr spécifique de mage-a4 --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes t autologues tbi-1201 transduits avec le gène tcr spécifique de mage-a4 | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6239. lymphocytes t cytotoxiques spécifiques des taa du lymphome --- r_associated #0: 5 --> ipilimumab
    n1=lymphocytes t cytotoxiques spécifiques des taa du lymphome | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6240. maladie de Binswanger --- r_associated #0: 5 --> ipilimumab
    n1=maladie de Binswanger | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6241. mitomycine --- r_associated #0: 5 --> ipilimumab
    n1=mitomycine | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6242. modafinil --- r_associated #0: 5 --> ipilimumab
    n1=modafinil | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6243. médicaments animaux --- r_associated #0: 5 --> ipilimumab
    n1=médicaments animaux | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6244. médicaments contrefaits --- r_associated #0: 5 --> ipilimumab
    n1=médicaments contrefaits | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6245. oltipraz --- r_associated #0: 5 --> ipilimumab
    n1=oltipraz | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6246. peptide irgd ciblant la tumeur --- r_associated #0: 5 --> ipilimumab
    n1=peptide irgd ciblant la tumeur | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6247. phytoménadione --- r_associated #0: 5 --> ipilimumab
    n1=phytoménadione | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6248. ponesimod --- r_associated #0: 5 --> ipilimumab
    n1=ponesimod | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6249. prastérone --- r_associated #0: 5 --> ipilimumab
    n1=prastérone | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6250. produit anesthésiant --- r_associated #0: 5 --> ipilimumab
    n1=produit anesthésiant | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6251. protéine 4 des lymphocytes T cytotoxiques --- r_associated #0: 5 --> ipilimumab
    n1=protéine 4 des lymphocytes T cytotoxiques | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6252. rifampicine --- r_associated #0: 5 --> ipilimumab
    n1=rifampicine | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6253. rituximab --- r_associated #0: 5 --> ipilimumab
    n1=rituximab | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6254. rutoside --- r_associated #0: 5 --> ipilimumab
    n1=rutoside | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6255. stabilisant mastocytaire --- r_associated #0: 5 --> ipilimumab
    n1=stabilisant mastocytaire | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6256. sulfate de morphine --- r_associated #0: 5 --> ipilimumab
    n1=sulfate de morphine | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6257. thyrotropine alfa --- r_associated #0: 5 --> ipilimumab
    n1=thyrotropine alfa | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6258. théophylline éthylènediamine --- r_associated #0: 5 --> ipilimumab
    n1=théophylline éthylènediamine | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6259. tolvaptan --- r_associated #0: 5 --> ipilimumab
    n1=tolvaptan | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6260. trinitroglycérine --- r_associated #0: 5 --> ipilimumab
    n1=trinitroglycérine | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6261. ziconotide --- r_associated #0: 5 --> ipilimumab
    n1=ziconotide | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6262. éthosuximide --- r_associated #0: 5 --> ipilimumab
    n1=éthosuximide | n2=ipilimumab | rel=r_associated | relid=0 | w=5
  6263. médecine
    (science)
     --- r_associated #0: 1 --> ipilimumab
    n1=médecine
    (science)
    | n2=ipilimumab | rel=r_associated | relid=0 | w=1
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr